PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dayel, MJ; King, N				Dayel, Mark J.; King, Nicole			Prey Capture and Phagocytosis in the Choanoflagellate Salpingoeca rosetta	PLOS ONE			English	Article							CALCAREOUS SPONGE; ULTRASTRUCTURE; ANCESTRY; METAZOA; COLLAR	Choanoflagellates are unicellular and colonial aquatic microeukaryotes that capture bacteria using an apical flagellum surrounded by a feeding collar composed of actin-filled microvilli. Flow produced by the apical flagellum drives prey bacteria to the feeding collar for phagocytosis. We report here on the cell biology of prey capture in rosette-shaped colonies and unicellular "thecate'' or substrate attached cells from the choanoflagellate S. rosetta. In thecate cells and rosette colonies, phagocytosis initially involves fusion of multiple microvilli, followed by remodeling of the collar membrane to engulf the prey, and transport of engulfed bacteria into the cell. Although both thecate cells and rosette colony cells produce,70 nm "collar links'' that connect and potentially stabilize adjacent microvilli, only thecate cells were observed to produce a lamellipod-like "collar skirt'' that encircles the base of the collar. This study offers insight into the process of prey ingestion by S. rosetta, and provides a context within which to consider potential ecological differences between solitary cells and colonies in choanoflagellates.	[Dayel, Mark J.; King, Nicole] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [King, Nicole] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	King, N (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	nking@berkeley.edu			NSF [IOS-1147215]; Miller Institute for Basic Research in Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099533] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1147215, 1146634] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF award IOS-1147215 and a post-doctoral fellowship to M.J.D. from the Miller Institute for Basic Research in Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2008, SCIENCE, V319, P946, DOI 10.1126/science.1151084; Calkins G, 1901, PROTOZOA; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; Dayel MJ, 2011, DEV BIOL, V357, P73, DOI 10.1016/j.ydbio.2011.06.003; De SAEDELEER HENRI, 1929, RECUEIL INST ZOOL TORLEY ROUS SEAU [BRUXELLES], V2, P241; De Vos L, 1991, ATLAS SPONGE MORPHOL; DOFLEIN F, 1916, LEHRBUCH PROTOZOENKU; Eerkes-Medrano DI, 2006, INVERTEBR BIOL, V125, P177, DOI 10.1111/j.1744-7410.2006.00051.x; FJERDINGSTAD EJ, 1961, Z ZELLFORSCH MIK ANA, V54, P499, DOI 10.1007/BF00340451; HIBBERD DJ, 1975, J CELL SCI, V17, P191; James-Clark H., 1868, BOWERBANK ANN MAG NA, V1, P133; Karpov SA, 1998, J EUKARYOT MICROBIOL, V45, P361, DOI 10.1111/j.1550-7408.1998.tb04550.x; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2009, COLD SPRING HARB PRO, V2009, DOI [10.1101/pdb.prot5148, DOI 10.1101/PDB.PR0T5148]; Lapage G, 1925, Q J MICROSCOPICAL SC; Leadbeater B, 1977, J MAR BIOL ASS UK; Leadbeater B, 2008, PROTISTOLOGY; LEADBEATER BSC, 1974, BIOL J LINN SOC, V6, P337, DOI 10.1111/j.1095-8312.1974.tb00728.x; LEADBEATER BSC, 1983, J MAR BIOL ASSOC UK, V63, P135, DOI 10.1017/S0025315400049857; LEADBEATER BSC, 1983, PROTISTOLOGICA, V19, P157; Leys SP, 2006, BIOL BULL-US, V211, P157, DOI 10.2307/4134590; Pettitt ME, 2002, EUR J PROTISTOL, V38, P313, DOI 10.1078/0932-4739-00854; Roper M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228104; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Saville Kent W., 1880, MANUAL INFUSORIA; Shimeta J, 1997, J EXP MAR BIOL ECOL, V209, P47, DOI 10.1016/S0022-0981(96)02684-6; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011	28	49	50	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95577	10.1371/journal.pone.0095577	http://dx.doi.org/10.1371/journal.pone.0095577			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806026	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900021
J	Kroghsbo, S; Rigby, NM; Johnson, PE; Adel-Patient, K; Bogh, KL; Salt, LJ; Mills, ENC; Madsen, CB				Kroghsbo, Stine; Rigby, Neil M.; Johnson, Philip E.; Adel-Patient, Karine; Bogh, Katrine L.; Salt, Louise J.; Mills, E. N. Clare; Madsen, Charlotte B.			Assessment of the Sensitizing Potential of Processed Peanut Proteins in Brown Norway Rats: Roasting Does Not Enhance Allergenicity	PLOS ONE			English	Article							ARA H 1; MAILLARD REACTION; MAJOR ALLERGEN; FOOD MATRIX; IGE; DEGRANULATION; RESPONSES; IMPACT	Background: IgE-binding of process-modified foods or proteins is the most common method for examination of how food processing affects allergenicity of food allergens. How processing affects sensitization capacity is generally studied by administration of purified food proteins or food extracts and not allergens present in their natural food matrix. Objectives: The aim was to investigate if thermal processing increases sensitization potential of whole peanuts via the oral route. In parallel, the effect of heating on sensitization potential of the major peanut allergen Ara h 1 was assessed via the intraperitoneal route. Methods: Sensitization potential of processed peanut products and Ara h 1 was examined in Brown Norway (BN) rats by oral administration of blanched or oil-roasted peanuts or peanut butter or by intraperitoneal immunization of purified native (N-), heated (H-) or heat glycated (G-) Ara h 1. Levels of specific IgG and IgE were determined by ELISA and IgE functionality was examined by rat basophilic leukemia (RBL) cell assay. Results: In rats dosed orally, roasted peanuts induced significant higher levels of specific IgE to NAra h 1 and 2 than blanched peanuts or peanut butter but with the lowest level of RBL degranulation. However, extract from roasted peanuts was found to be a superior elicitor of RBL degranulation. Process-modified Ara h 1 had similar sensitizing capacity as NAra h 1 but specific IgE reacted more readily with process-modified Ara h 1 than with native. Conclusions: Peanut products induce functional specific IgE when dosed orally to BN rats. Roasted peanuts do not have a higher sensitizing capacity than blanched peanuts. In spite of this, extract from roasted peanuts is a superior elicitor of RBL cell degranulation irrespectively of the peanut product used for sensitization. The results also suggest that new epitopes are formed or disclosed by heating Ara h 1 without glucose.	[Kroghsbo, Stine; Bogh, Katrine L.; Madsen, Charlotte B.] Tech Univ Denmark, Natl Food Inst, Soborg, Denmark; [Rigby, Neil M.; Johnson, Philip E.; Salt, Louise J.; Mills, E. N. Clare] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Adel-Patient, Karine] INRA, UR496, Unite Immunoallergie Alimentaire, Jouy En Josas, France	Technical University of Denmark; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Madsen, CB (corresponding author), Tech Univ Denmark, Natl Food Inst, Soborg, Denmark.	charm@food.dtu.dk	Mills, Clare/P-4261-2015	Mills, Clare/0000-0001-7433-1740; Madsen, Charlotte Bernhard/0000-0002-9086-7120; Bogh, Katrine Lindholm/0000-0002-5266-0372	EU [FP6-FOOD-CT-2005-514000]	EU(European Commission)	This work was funded by the EU through the project EuroPrevall (FP6-FOOD-CT-2005-514000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKHOLT V, 1989, ANAL BIOCHEM, V177, P318, DOI 10.1016/0003-2697(89)90059-6; Beyer KB, 2001, J ALLERGY CLIN IMMUN, V107, P1077, DOI 10.1067/mai.2001.115480; Blanc F, 2009, CLIN EXP ALLERGY, V39, P1277, DOI 10.1111/j.1365-2222.2009.03294.x; Blanc F, 2011, MOL NUTR FOOD RES, V55, P1887, DOI 10.1002/mnfr.201100251; Bogh KL, 2009, CLIN EXP ALLERGY, V39, P1611, DOI 10.1111/j.1365-2222.2009.03333.x; Boulay A, 2008, ALLERGY, V63, P797, DOI 10.1111/j.1398-9995.2008.01776.x; Breiteneder H, 2005, J ALLERGY CLIN IMMUN, V115, P14, DOI 10.1016/j.jaci.2004.10.022; Chung SY, 2003, J AGR FOOD CHEM, V51, P4273, DOI 10.1021/jf021212d; Chung SY, 2001, J AGR FOOD CHEM, V49, P3911, DOI 10.1021/jf001186o; Davis PJ, 1998, ALLERGY, V53, P102, DOI 10.1111/j.1398-9995.1998.tb04975.x; Dyer S, 2008, J ALLERGY CLIN IMMUN, V121, pS183, DOI 10.1016/j.jaci.2007.12.678; Grimshaw KEC, 2003, CLIN EXP ALLERGY, V33, P1581, DOI 10.1046/j.1365-2222.2003.01795.x; Gruber P, 2004, J AGR FOOD CHEM, V52, P4002, DOI 10.1021/jf035458+; Gruber P, 2005, J AGR FOOD CHEM, V53, P2289, DOI 10.1021/jf048398w; Iwan M, 2011, J AGR FOOD CHEM, V59, P7163, DOI 10.1021/jf2007375; Johnson PE, 2010, MOL NUTR FOOD RES, V54, P1701, DOI 10.1002/mnfr.201000006; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Kroghsbo S, 2008, TOXICOLOGY, V245, P24, DOI 10.1016/j.tox.2007.12.005; Kroghsbo S, 2011, INT ARCH ALLERGY IMM, V155, P212, DOI 10.1159/000321200; Ladics GS, 2009, MOL NUTR FOOD RES, V53, P945, DOI 10.1002/mnfr.200990025; Lehmann K, 2006, BIOCHEM J, V395, P463, DOI 10.1042/BJ20051728; Li XM, 2000, J ALLERGY CLIN IMMUN, V106, P150, DOI 10.1067/mai.2000.107395; Maleki SJ, 2000, J ALLERGY CLIN IMMUN, V106, P763, DOI 10.1067/mai.2000.109620; Maleki SJ, 2004, J AOAC INT, V87, P1475; Maleki SJ, 2003, J ALLERGY CLIN IMMUN, V112, P190, DOI 10.1067/mai.2003.1551; Marsh J, 2008, MOL NUTR FOOD RES, V52, pS272, DOI 10.1002/mnfr.200700524; Mills ENC, 2008, CURR OPIN ALLERGY CL, V8, P249, DOI 10.1097/ACI.0b013e3282ffb123; Mills ENC, 2009, MOL NUTR FOOD RES, V53, P963, DOI 10.1002/mnfr.200800236; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Nakamura A, 2005, J AGR FOOD CHEM, V53, P7559, DOI 10.1021/jf0502045; Nakamura A, 2006, J AGR FOOD CHEM, V54, P9529, DOI 10.1021/jf061070d; Nakamura S, 2008, FOOD CHEM, V109, P538, DOI 10.1016/j.foodchem.2007.12.075; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P234, DOI 10.1097/ACI.0b013e32832b88e7; Paschke A, 2009, MOL NUTR FOOD RES, V53, P959, DOI 10.1002/mnfr.200800187; Poms RE, 2004, MOL NUTR FOOD RES, V48, P459, DOI 10.1002/mnfr.200400052; Sancho AI, 2005, ALLERGY, V60, P1262, DOI 10.1111/j.1398-9995.2005.00876.x; Sathe SK, 2009, MOL NUTR FOOD RES, V53, P970, DOI 10.1002/mnfr.200800194; Schmitt DA, 2010, J AGR FOOD CHEM, V58, P1138, DOI 10.1021/jf902694j; Taheri-Kafrani A, 2009, J AGR FOOD CHEM, V57, P4974, DOI 10.1021/jf804038t; van Wijk F, 2005, TOXICOL SCI, V86, P333, DOI 10.1093/toxsci/kfi187; Vissers YM, 2011, CLIN EXP ALLERGY, V41, P1631, DOI 10.1111/j.1365-2222.2011.03830.x; Vissers YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023998; Westphal CD, 2004, J AOAC INT, V87, P1458	43	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96475	10.1371/journal.pone.0096475	http://dx.doi.org/10.1371/journal.pone.0096475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805813	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900061
J	Pant, C; Deshpande, A; Olyaee, M; Anderson, MP; Bitar, A; Steele, MI; Bass, PF; Sferra, TJ				Pant, Chaitanya; Deshpande, Abhishek; Olyaee, Mojtaba; Anderson, Michael P.; Bitar, Anas; Steele, Marilyn I.; Bass, Pat F., III; Sferra, Thomas J.			Epidemiology of Acute Pancreatitis in Hospitalized Children in the United States from 2000-2009	PLOS ONE			English	Article							CHANGING INCIDENCE; DISEASE	Background: Single-center studies suggest an increasing incidence of acute pancreatitis (AP) in children. Our specific aims were to (i) estimate the recent secular trends, (ii) assess the disease burden, and (iii) define the demographics and comorbid conditions of AP in hospitalized children within the United States. Methods: We used the Healthcare Cost and Utilization Project Kids' Inpatient Database, Agency for Healthcare Research and Quality for the years 2000 to 2009. Extracted data were weighted to generate national-level estimates. We used the Cochrane-Armitage test to analyze trends; cohort-matching to evaluate the association of AP and in-hospital mortality, length of stay, and charges; and multivariable logistic regression to test the association of AP and demographics and comorbid conditions. Results: We identified 55,012 cases of AP in hospitalized children (1-20 years of age). The incidence of AP increased from 23.1 to 34.9 (cases per 10,000 hospitalizations per year; P<0.001) and for all-diagnoses 38.7 to 61.1 (P, <0.001). There was an increasing trend in the incidence of both primary and all-diagnoses of AP (P<0.001). In- hospital mortality decreased (13.1 to 7.6 per 1,000 cases, P<0.001), median length of stay decreased (5 to 4 days, P, <0.001), and median charges increased ($ 14,956 to $ 22,663, P<0.001). Children with AP compared to those without the disease had lower in-hospital mortality (adjusted odds ratio, aOR 0.86, 95% CI, 0.78-0.95), longer lengths of stay (aOR 2.42, 95% CI, 2.40-2.46), and higher charges (aOR 1.62, 95% CI, 1.59-1.65). AP was more likely to occur in children older than 5 years of age (aORs 2.81 to 5.25 for each 5year age interval). Hepatobiliary disease was the comorbid condition with the greatest association with AP. Conclusions: These results demonstrate a rising incidence of AP in hospitalized children. Despite improvements in mortality and length of stay, hospitalized children with AP have significant morbidity.	[Pant, Chaitanya; Olyaee, Mojtaba] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Deshpande, Abhishek] Cleveland Clin, Inst Med, Ctr Value Based Care, Cleveland, OH 44106 USA; [Anderson, Michael P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biostat & Epidemiol, Oklahoma City, OK USA; [Bitar, Anas; Steele, Marilyn I.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73190 USA; [Bass, Pat F., III] Louisiana Hlth Sci Ctr Shreveport, Dept Med, Shreveport, LA USA; [Bass, Pat F., III] Louisiana Hlth Sci Ctr Shreveport, Dept Pediat, Shreveport, LA USA; [Sferra, Thomas J.] Case Western Reserve Univ, Sch Med, Dept Pediat, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA	University of Kansas; University of Kansas Medical Center; Cleveland Clinic Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Sferra, TJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, UH Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA.	thomas.sferra@uhhospitals.org		Anderson, Michael/0000-0002-2319-2282; BITAR, ANAS/0000-0003-2618-2474				Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Benchimol EI, 2011, INFLAMM BOWEL DIS, V17, P423, DOI 10.1002/ibd.21349; BRADLEY EL, 1993, ARCH SURG-CHICAGO, V128, P586; Choi BH, 2003, J GASTROEN HEPATOL, V18, P915, DOI 10.1046/j.1440-1746.2003.03080.x; Cucchiara S, 2011, INFLAMM BOWEL DIS, V17, P1048, DOI 10.1002/ibd.21497; DeBanto JR, 2002, AM J GASTROENTEROL, V97, P1726; Henderson P, 2012, INFLAMM BOWEL DIS, V18, P999, DOI 10.1002/ibd.21797; Kandula L, 2008, J PEDIATR, V152, P106, DOI 10.1016/j.jpeds.2007.05.050; Lautz TB, 2011, J PEDIATR SURG, V46, P1144, DOI 10.1016/j.jpedsurg.2011.03.044; Lopez MJ, 2002, J PEDIATR-US, V140, P622, DOI 10.1067/mpd.2002.123880; Ma MH, 2012, J PEDIATR GASTR NUTR, V54, P651, DOI 10.1097/MPG.0b013e31823a897d; Morinville VD, 2012, J PEDIATR GASTR NUTR, V55, P261, DOI 10.1097/MPG.0b013e31824f1516; Morinville VD, 2010, PANCREAS, V39, P5, DOI 10.1097/MPA.0b013e3181baac47; Nydegger A, 2007, J GASTROEN HEPATOL, V22, P1313, DOI 10.1111/j.1440-1746.2007.04936.x; Nylund CM, 2011, ARCH PEDIAT ADOL MED, V165, P451, DOI 10.1001/archpediatrics.2010.282; Park A, 2009, J PEDIATR GASTR NUTR, V49, P316, DOI 10.1097/MPG.0b013e31818d7db3; Parsons LS., 2004, SAS SUGI, V29, P165; Rassekh SR, 2010, J CANCER EPIDEMIOL, V2010, DOI 10.1155/2010/569517; Sanchez-Ramirez CA, 2007, ACTA PAEDIATR, V96, P534, DOI 10.1111/j.1651-2227.2007.00225.x; WEIZMAN Z, 1988, J PEDIATR-US, V113, P24, DOI 10.1016/S0022-3476(88)80523-7; Werlin SL, 2003, J PEDIATR GASTR NUTR, V37, P591, DOI 10.1097/00005176-200311000-00017	21	64	67	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95552	10.1371/journal.pone.0095552	http://dx.doi.org/10.1371/journal.pone.0095552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805879	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900020
J	Caldarelli, G; Chessa, A; Pammolli, F; Pompa, G; Puliga, M; Riccaboni, M; Riotta, G				Caldarelli, Guido; Chessa, Alessandro; Pammolli, Fabio; Pompa, Gabriele; Puliga, Michelangelo; Riccaboni, Massimo; Riotta, Gianni			A Multi-Level Geographical Study of Italian Political Elections from Twitter Data	PLOS ONE			English	Article								In this paper we present an analysis of the behavior of Italian Twitter users during national political elections. We monitor the volumes of the tweets related to the leaders of the various political parties and we compare them to the elections results. Furthermore, we study the topics that are associated with the co-occurrence of two politicians in the same tweet. We cannot conclude, from a simple statistical analysis of tweet volume and their time evolution, that it is possible to precisely predict the election outcome (or at least not in our case of study that was characterized by a "too-close-to-call'' scenario). On the other hand, we found that the volume of tweets and their change in time provide a very good proxy of the final results. We present this analysis both at a national level and at smaller levels, ranging from the regions composing the country to macro-areas (North, Center, South).	[Caldarelli, Guido; Chessa, Alessandro; Pammolli, Fabio; Pompa, Gabriele; Puliga, Michelangelo; Riccaboni, Massimo; Riotta, Gianni] IMT Inst Adv Studies, Lucca, Italy; [Caldarelli, Guido] Univ Roma La Sapienza, Dept Phys, Ist Sistemi Complessi, Rome, Italy; [Caldarelli, Guido] London Inst Math Sci, London, England; [Caldarelli, Guido; Chessa, Alessandro; Puliga, Michelangelo] Linkalab, Complex Syst Computat Lab, Cagliari, Italy; [Pammolli, Fabio] Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; [Pammolli, Fabio] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Riccaboni, Massimo] Katholieke Univ Leuven, Dept Managerial Econ Strategy & Innovat, Louvain, Belgium; [Riotta, Gianni] Princeton Univ, Dept French & Italian, Princeton, NJ 08544 USA	IMT School for Advanced Studies Lucca; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; Boston University; Boston University; KU Leuven; Princeton University	Puliga, M (corresponding author), IMT Inst Adv Studies, Lucca, Italy.	michelangelo.puliga@imtlucca.it	Caldarelli, Guido/AAB-8206-2022; puliga, michelangelo/AAS-9954-2020; Caldarelli, Guido/A-5274-2010	Pammolli, Fabio/0000-0001-7056-1303; Caldarelli, Guido/0000-0001-9377-3616; RICCABONI, Massimo/0000-0003-4979-8933	FET Open Project FOC "Forecasting Financial Crises'' [255987]; IP Project MULTIPLEX [317532]; Progetto di Interesse CNR "CrisisLab'', FET project SIMPOL [610704]; U.S. Department of the Defense; Defense Threat Reduction Agency [HDTRA1-11-1-0048]; LINKALAB	FET Open Project FOC "Forecasting Financial Crises''; IP Project MULTIPLEX; Progetto di Interesse CNR "CrisisLab'', FET project SIMPOL; U.S. Department of the Defense(United States Department of Defense); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); LINKALAB	The authors acknowledge support from FET Open Project FOC "Forecasting Financial Crises'' nr. 255987, IP Project MULTIPLEX nr 317532 and Progetto di Interesse CNR "CrisisLab'', FET project SIMPOL 610704. GC also acknowledges partial support from the U.S. Department of the Defense, Defense Threat Reduction Agency, grant HDTRA1-11-1-0048. All authors acknowledge enlightening discussions and support from people in LINKALAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A ZCulotta, 2010, ACM P 1 WORKSH SOC M; Agarwal A., 2011, P WORKSHOP LANGUAGES, P30; [Anonymous], 2008, NATURE, V453, P698, DOI 10.1038/453698a; [Anonymous], 2012, ARXIV12046441; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; Bordino I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040014; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Borondo J, 2012, CHAOS, V22, DOI 10.1063/1.4729139; Butler D, 2008, NATURE, V456, P287, DOI 10.1038/456287a; Capocci A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036116; Ciulla F, 2012, BEATING NEWS USING S, P6; Di Grazia J, 2013, SSRN ELECT J; Garcia C, 2013, WHAT CAN SOCIAL MEDI; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Graham-Rowe D, 2008, NATURE, V455, P8, DOI 10.1038/455008a; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Livne A, 2011, P 5 INT C WEBL SOC M; Metaxas P, 2011, PRIV SEC RISK TRUST, P165; Mislove A, P 5 INT AAAI C WEBLO; Nguyen VD, 2013, ANAL VISUALISING PUB, V9; OConnor B., 2010, ICWSM, P122; Papacharissi Z, 2009, NEW MEDIA SOC, V11, P199, DOI 10.1177/1461444808099577; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Ratkiewicz J, 2011, 20 INT WORLD WID WEB, P249; Ratkiewicz J, 2011, 5 INT AAAI C WEBL SO, V297; Sang E, 2012, EACL, V53; Skoric M, 2012, IEEE 2012 45 HAW INT; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Williams CB, 2007, SOCIAL NETWORKS POLI; Zlatic V, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016115	32	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95809	10.1371/journal.pone.0095809	http://dx.doi.org/10.1371/journal.pone.0095809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802857	Green Accepted, Green Published, gold			2022-12-27	WOS:000338029800035
J	Chen, M; Huang, YL; Huang, YC; Shui, IM; Giovannucci, E; Chen, YC; Chen, YMA				Chen, Marcelo; Huang, Yi-Ling; Huang, Yu-Chuen; Shui, Irene M.; Giovannucci, Edward; Chen, Yen-Ching; Chen, Yi-Ming Arthur			Genetic Polymorphisms of the Glycine N-Methyltransferase and Prostate Cancer Risk in the Health Professionals Follow-Up Study	PLOS ONE			English	Article							TUMOR SUSCEPTIBILITY GENE; RECTAL EXAMINATION FAILS; EXPRESSION; SARCOSINE; PROTEIN; MARKER; IDENTIFICATION; DEFICIENCY; PROFILES; URINE	Purpose: Glycine N-methyltransferase (GNMT) affects genetic stability by regulating the ratio of S-adenosylmethionine to S-adenosylhomocysteine, by binding to folate, and by interacting with environmental carcinogens. In Taiwanese men, GNMT was found to be a tumor susceptibility gene for prostate cancer. However, the association of GNMT with prostate cancer risk in other ethnicities has not been studied. It was recently reported that sarcosine, which is regulated by GNMT, increased markedly in metastatic prostate cancer. We hereby explored the association of GNMT polymorphisms with prostate cancer risk in individuals of European descent from the Health Professionals Follow-up Study (HPFS). Methods: A total of 661 incident prostate cancer cases and 656 controls were identified from HPFS. The GNMT short tandem repeat polymorphism 1 (STRP1), 4-bp insertion/deletion polymorphisms (INS/DEL) and the single nucleotide polymorphism rs10948059 were genotyped to test for their association with prostate cancer risk. Results: The rs10948059 T/T genotype was associated with a 1.62-fold increase in prostate cancer risk (95% confidence interval (CI): 1.18, 2.22) when compared with the C/C genotype. The STRP1 >= 16GAs/>= 16GAs genotype was associated with decreased risk of prostate cancer when compared with the,<16GAs/<16GAs genotype (odds ratio (OR) = 0.68; 95% CI: 0.46, 1.01). INS/DEL was not associated with prostate cancer risk. Haplotypes containing the rs10948059 T allele were significantly associated with increased prostate cancer risk. Conclusion: In men of European descent, the GNMT rs10948059 and STRP1 were associated with prostate cancer risk. Compared to the study conducted in Taiwanese men, the susceptibility GNMT alleles for prostate cancer had a reverse relationship. This study highlights the differences in allelic frequencies and prostate cancer susceptibility in different ethnicities.	[Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Chen, Marcelo] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Marcelo] Mackay Med Coll, Sch Med, New Taipei City, Taiwan; [Huang, Yi-Ling; Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Huang, Yu-Chuen] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung, Taiwan; [Huang, Yu-Chuen] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Shui, Irene M.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chen, Yen-Ching] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Sch Med, Dept Microbiol, Kaohsiung, Taiwan; [Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan	Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Mackay Medical College; National Taiwan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; National Taiwan University; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University	Chen, YC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan.	karenchen@ntu.edu.tw; arthur@kmu.edu.tw	Huang, YiLing/ABH-8788-2020; Chen, Yen-Ching/D-1098-2010	Chen, Yen-Ching/0000-0002-8159-7202	National Science Council of the Republic of China (National Research Program for Biopharmaceuticals [NRPB]) [NSC102-2325-B-037-009]; Ministry of Education of the Republic of China; Mackay Memorial Hospital [MMH-10185]; National Institutes of Health [P01CA055075]; NCI NRSA [T32 CA09001]; US Army Prostate Cancer Post-doctoral fellowship; NATIONAL CANCER INSTITUTE [T32CA009001, P01CA055075, U19CA055075] Funding Source: NIH RePORTER	National Science Council of the Republic of China (National Research Program for Biopharmaceuticals [NRPB]); Ministry of Education of the Republic of China(Ministry of Education, Taiwan); Mackay Memorial Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Army Prostate Cancer Post-doctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Science Council of the Republic of China (National Research Program for Biopharmaceuticals [NRPB], grant NSC102-2325-B-037-009), Ministry of Education of the Republic of China (Aim for the Top University Plan), Mackay Memorial Hospital (grant MMH-10185), and National Institutes of Health (P01CA055075). Irene Shui is supported by the NCI NRSA T32 CA09001 (PI: Stampfer) and a US Army Prostate Cancer Post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beagle B, 2005, J NUTR, V135, P2780, DOI 10.1093/jn/135.12.2780; Chen SY, 2004, CANCER RES, V64, P3617, DOI 10.1158/0008-5472.CAN-03-3726; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Chen YMA, 2000, GENOMICS, V66, P43, DOI 10.1006/geno.2000.6188; Colleselli D, 2010, EUR UROL, V58, pE51, DOI 10.1016/j.eururo.2010.08.017; Huang YC, 2005, HORMONAL CARCINOGENESIS IV, P293, DOI 10.1007/0-387-23761-5_25; Huang YC, 2007, CLIN CANCER RES, V13, P1412, DOI 10.1158/1078-0432.CCR-06-1551; Ianni M, 2013, PROSTATE CANCER P D, V16, P56, DOI 10.1038/pcan.2012.30; Jentzmik F, 2011, J UROLOGY, V185, P706, DOI 10.1016/j.juro.2010.09.077; Jentzmik F, 2010, EUR UROL, V58, P12, DOI 10.1016/j.eururo.2010.01.035; KATO S, 1992, CANCER RES, V52, P6712; KERR SJ, 1972, J BIOL CHEM, V247, P4248; Koutros S, 2013, CARCINOGENESIS; Lee CM, 2006, TOXICOL APPL PHARM, V214, P126, DOI 10.1016/j.taap.2005.12.020; Liao YJ, 2012, MOL MED, V18, P412, DOI 10.2119/molmed.2011.00258; Liao YJ, 2010, PROTEOM CLIN APPL, V4, P394, DOI 10.1002/prca.200900074; Liao YJ, 2009, INT J CANCER, V124, P816, DOI 10.1002/ijc.23979; Liu HH, 2003, J BIOMED SCI, V10, P87, DOI 10.1159/000068083; Liu SP, 2007, HEPATOLOGY, V46, P1413, DOI 10.1002/hep.21863; Song YH, 2011, MODERN PATHOL, V24, P1272, DOI 10.1038/modpathol.2011.76; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Struys EA, 2010, ANN CLIN BIOCHEM, V47, P282, DOI 10.1258/acb.2010.009270; Tseng TL, 2003, CANCER RES, V63, P647; Yen CH, 2012, MOL MED, V18, P286, DOI 10.2119/molmed.2011.00331; Yen CH, 2009, TOXICOL APPL PHARM, V235, P296, DOI 10.1016/j.taap.2008.12.013; YEO EJ, 1994, P NATL ACAD SCI USA, V91, P210, DOI 10.1073/pnas.91.1.210; Zahm SH, 1995, ENVIRON HEALTH PERSP, V103, P283, DOI 10.2307/3432326; Zhao JH, 2004, BIOINFORMATICS, V20, P1325, DOI 10.1093/bioinformatics/bth071; Zhao JH, 2002, BIOINFORMATICS, V18, P1694, DOI 10.1093/bioinformatics/18.12.1694	30	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94683	10.1371/journal.pone.0094683	http://dx.doi.org/10.1371/journal.pone.0094683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800880	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800020
J	Kanungo, S; Lopez, AL; Ali, M; Manna, B; Kim, DR; Mahapatra, T; Holmgren, J; Dhingra, MS; Weirzba, TF; Nair, GB; Bhattacharya, SK; Clemens, JD; Sur, D				Kanungo, Suman; Lopez, Anna Lena; Ali, Mohammad; Manna, Byomkesh; Kim, Deok Ryon; Mahapatra, Tanmay; Holmgren, Jan; Dhingra, Mandeep S.; Weirzba, Thomas F.; Nair, G. Balakrish; Bhattacharya, Sujit K.; Clemens, John D.; Sur, Dipika			Vibriocidal Antibody Responses to a Bivalent Killed Whole-Cell Oral Cholera Vaccine in a Phase III Trial in Kolkata, India	PLOS ONE			English	Article							IMMUNOLOGICAL MEMORY; SWEDISH VOLUNTEERS; FIELD TRIAL; B-SUBUNIT; IMMUNOGENICITY; ADULTS; O139; IMMUNIZATION; PROTECTION; BANGLADESH	Background: During the development of a vaccine, identification of the correlates of protection is of paramount importance for establishing an objective criterion for the protective performance of the vaccine. However, the ascertainment of correlates of immunity conferred by any vaccine is a difficult task. Methods: While conducting a phase three double-blind, cluster-randomized, placebo-controlled trial of a bivalent killed whole-cell oral cholera vaccine in Kolkata, we evaluated the immunogenicity of the vaccine in a subset of participants. Randomly chosen participants (recipients of vaccine or placebo) were invited to provide blood samples at baseline, 14 days after the second dose and one year after the first dose. At these time points, serum geometric mean titers (GMT) of vibriocidal antibodies and seroconversion rates for vaccine and placebo arms were calculated and compared across the age strata (1 to 5 years, 5 to 15 years and more than 15 years) as well as for all age groups. Results: Out of 137 subjects included in analysis, 69 were vaccinees and 68 received placebo. There were 5.7 and 5.8 geometric mean fold (GMF) rises in titers to Vibrio cholerae Inaba and Ogawa, respectively at 14 days after the second dose, with 57% and 61% of vaccinees showing a four-fold or greater titer rise, respectively. After one year, the titers to Inaba and Ogawa remained 1.7 and 2.8 fold higher, respectively, compared to baseline. Serum vibriocidal antibody response to V. cholerae O139 was much lower than that to Inaba or Ogawa. No significant differences in the GMF-rises were observed among the age groups. Conclusions: The reformulated oral cholera vaccine induced a statistically significant anti-O1 Inaba and O1 Ogawa vibriocidal antibody response 14 days after vaccination, which although declined after one year remained significantly higher than baseline. Despite this decline, the vaccine remained protective five years after vaccination.	[Kanungo, Suman; Manna, Byomkesh; Mahapatra, Tanmay; Sur, Dipika] Natl Inst Cholera & Enter Dis, Dept Epidemiol, Kolkata, W Bengal, India; [Lopez, Anna Lena] Univ Philippines, Natl Inst Hlth, Manila, Philippines; [Ali, Mohammad; Kim, Deok Ryon; Weirzba, Thomas F.] Int Vaccine Inst, Seoul, South Korea; [Holmgren, Jan] Univ Gothenburg, Gothenburg, Sweden; [Dhingra, Mandeep S.] Shantha Biotech Ltd, Hyderabad, Andhra Pradesh, India; [Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India; [Bhattacharya, Sujit K.] Natl Acad Sci, Allahabad, Uttar Pradesh, India; [Clemens, John D.] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of the Philippines System; University of the Philippines Manila; International Vaccine Institute; University of Gothenburg; Sanofi-Aventis; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Department of Science & Technology (India); National Academy of Sciences, India (NASI); International Centre for Diarrhoeal Disease Research (ICDDR)	Kanungo, S (corresponding author), Natl Inst Cholera & Enter Dis, Dept Epidemiol, Kolkata, W Bengal, India.	sumankanungo@gmail.com	Kanungo, Sloka/HHM-7508-2022; Lopez, Anna Lena/AAF-6481-2019; Ali, Mohammad/E-2365-2017	Lopez, Anna Lena/0000-0003-0013-620X; Ali, Mohammad/0000-0003-1410-388X; Holmgren, Jan/0000-0003-1784-5918; Kanungo, Suman/0000-0003-4441-4443; Dhingra, Mandeep Singh/0000-0002-2507-7165	International Vaccine Institute, Seoul, Korea; "Cholera Vaccine Initiative" of Bill & Melinda Gates Foundation; Swedish International Development Cooperation Agency; Government of South Korea; Government of Sweden; Government of Kuwait	International Vaccine Institute, Seoul, Korea; "Cholera Vaccine Initiative" of Bill & Melinda Gates Foundation; Swedish International Development Cooperation Agency; Government of South Korea(Korean Government); Government of Sweden; Government of Kuwait	This study was supported by the International Vaccine Institute, Seoul, Korea through the "Diseases of the Most Impoverished" Program and the "Cholera Vaccine Initiative" of Bill & Melinda Gates Foundation. Additional funding was provided by the Swedish International Development Cooperation Agency and the Governments of South Korea, Sweden, and Kuwait. Shantha Biotechnics Limited donated the vaccine and placebo for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2007, VACCINE, V25, P1149, DOI 10.1016/j.vaccine.2006.09.049; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; [Anonymous], 2004, TECHNICAL REPORT SER, P924; Attridge SR, 2002, CLIN DIAGN LAB IMMUN, V9, P383, DOI 10.1128/CDLI.9.2.383-387.2002; BEGUE RE, 1995, INFECT IMMUN, V63, P3726, DOI 10.1128/IAI.63.9.3726-3728.1995; Bhattacharya S, N ENGL J MED UNPUB; JERTBORN M, 1988, J INFECT DIS, V157, P374, DOI 10.1093/infdis/157.2.374; JERTBORN M, 1994, VACCINE, V12, P1078, DOI 10.1016/0264-410X(94)90176-7; Losonsky GA, 1997, CLIN DIAGN LAB IMMUN, V4, P264, DOI 10.1128/CDLI.4.3.264-269.1997; LYCKE N, 1987, SCAND J IMMUNOL, V26, P207, DOI 10.1111/j.1365-3083.1987.tb02253.x; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; SACK DA, 1991, J INFECT DIS, V164, P407, DOI 10.1093/infdis/164.2.407; Saha A, 2011, VACCINE, V29, P8285, DOI 10.1016/j.vaccine.2011.08.108; Saha D, 2004, J INFECT DIS, V189, P2318, DOI 10.1086/421275; Sur D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001289; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; Trach DD, 1997, LANCET, V349, P231, DOI 10.1016/S0140-6736(96)06107-7; WASSERMAN SS, 1994, VACCINE, V12, P1000, DOI 10.1016/0264-410X(94)90335-2	20	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96499	10.1371/journal.pone.0096499	http://dx.doi.org/10.1371/journal.pone.0096499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800828	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800078
J	Lind, J; Backert, S; Pfleiderer, K; Berg, DE; Yamaoka, Y; Sticht, H; Tegtmeyer, N				Lind, Judith; Backert, Steffen; Pfleiderer, Klaus; Berg, Douglas E.; Yamaoka, Yoshio; Sticht, Heinrich; Tegtmeyer, Nicole			Systematic Analysis of Phosphotyrosine Antibodies Recognizing Single Phosphorylated EPIYA-Motifs in CagA of Western-Type Helicobacter pylori Strains	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; ANAPLASMA-PHAGOCYTOPHILUM ANKA; IV SECRETION; HOST-CELL; TYROSINE PHOSPHORYLATION; EFFECTOR PROTEIN; E-CADHERIN; KINASE; SCATTERING; ADHESION	The clinical outcome of Helicobacter pylori infections is determined by multiple host-pathogen interactions that may develop to chronic gastritis, and sometimes peptic ulcers or gastric cancer. Highly virulent strains encode a type IV secretion system (T4SS) that delivers the effector protein CagA into gastric epithelial cells. Translocated CagA undergoes tyrosine phosphorylation at EPIYA-sequence motifs, called A, B and C in Western-type strains, by members of the oncogenic Src and Abl host kinases. Phosphorylated EPIYA-motifs mediate interactions of CagA with host signaling factors - in particular various SH2-domain containing human proteins - thereby hijacking multiple downstream signaling cascades. Observations of tyrosine-phosphorylated CagA are mainly based on the use of commercial phosphotyrosine antibodies, which originally were selected to detect phosphotyrosines in mammalian proteins. Systematic studies of phosphorylated EPIYA-motif detection by the different antibodies would be very useful, but are not yet available. To address this issue, we synthesized phospho-and non-phosphopeptides representing each predominant Western CagA EPIYA-motif, and determined the recognition patterns of seven different phosphotyrosine antibodies in Western blots, and also performed infection studies with diverse representative Western H. pylori strains. Our results show that a total of 9-11 amino acids containing the phosphorylated EPIYA-motifs are necessary and sufficient for specific detection by these antibodies, but revealed great variability in sequence recognition. Three of the antibodies recognized phosphorylated EPIYA-motifs A, B and C similarly well; whereas preferential binding to phosphorylated motif A and motifs A and C was found with two and one antibodies, respectively, and the seventh anti-phosphotyrosine antibody did not recognize any phosphorylated EPIYA-motif. Controls showed that none of the antibodies recognized the corresponding non-phospho CagA peptides, and that all of them recognized phosphotyrosines in mammalian proteins. These data are valuable in judicious application of commercial antiphosphotyrosine antibodies and in characterization of CagA phosphorylation during infection and disease development.	[Lind, Judith; Backert, Steffen; Pfleiderer, Klaus; Tegtmeyer, Nicole] Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany; [Berg, Douglas E.] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of California System; University of California San Diego; Oita University; University of Erlangen Nuremberg	Tegtmeyer, N (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Div Microbiol, D-91054 Erlangen, Germany.	Nicole.Tegtmeyer@fau.de		Yamaoka, Yoshio/0000-0002-1222-5819; Sticht, Heinrich/0000-0001-5644-045X	DFG [B10, A2 of CRC-796]; US National Institutes of Health [R21 AI078237, R21 AI088337, R01DK62813]; Grants-in-Aid for Scientific Research [24659200] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813, P30DK056338] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work of SB and HS is supported through DFG grants (projects B10 and A2 of CRC-796). The research in DB's group has been supported by US National Institutes of Health Grants (R21 AI078237 and R21 AI088337). YY is supported by US National Institutes of Health Grant R01DK62813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras RA, 2003, J INFECT DIS, V188, P486, DOI 10.1086/377098; Argent RH, 2005, J CLIN MICROBIOL, V43, P791, DOI 10.1128/JCM.43.2.791-795.2005; Asahi M, 2003, HELICOBACTER, V8, P1, DOI 10.1046/j.1523-5378.2003.00118.x; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Backert S, 2004, INFECT IMMUN, V72, P1043, DOI 10.1128/IAI.72.2.1043-1056.2004; Backert S, 2001, PROTEOMICS, V1, P608, DOI 10.1002/1615-9861(200104)1:4<608::AID-PROT608>3.3.CO;2-7; Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Blaydes JP, 2000, METH MOL B, V99, P177; Boehm M, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00017; Boehm M, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-3; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Brandt S, 2009, CELL MOTIL CYTOSKEL, V66, P874, DOI 10.1002/cm.20373; Bui XT, 2009, J CLIN MICROBIOL, V47, P4021, DOI 10.1128/JCM.00504-09; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Conradi J, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00070; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Covacci A, 2000, J EXP MED, V191, P587, DOI 10.1084/jem.191.4.587; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; Furuta Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023499; Hayashi T, 2013, CELL MICROBIOL, V15, P377, DOI 10.1111/cmi.12040; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirsch C, 2012, J GASTROENTEROL, V47, P936, DOI 10.1007/s00535-012-0618-8; Houseman BT, 2002, NAT BIOTECHNOL, V20, P270, DOI 10.1038/nbt0302-270; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ijdo JW, 2007, CELL MICROBIOL, V9, P1284, DOI 10.1111/j.1462-5822.2006.00871.x; Jones KR, 2009, J CLIN MICROBIOL, V47, P959, DOI 10.1128/JCM.02330-08; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kim M, 2010, BIOPOLYMERS, V94, P753, DOI 10.1002/bip.21506; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Moese S, 2004, INFECT IMMUN, V72, P3646, DOI 10.1128/IAI.72.6.3646-3649.2004; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mueller D, 2012, J CLIN INVEST, V122, P1553, DOI 10.1172/JCI61143; Naito M, 2006, GASTROENTEROLOGY, V130, P1181, DOI 10.1053/j.gastro.2005.12.038; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Pachathundikandi SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019614; Panayotopoulou EG, 2007, J CLIN MICROBIOL, V45, P488, DOI 10.1128/JCM.01616-06; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Posselt G, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-77; Puels M, 2002, MOL MICROBIOL, V43, P962; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikihisa Y, 2010, CURR OPIN MICROBIOL, V13, P59, DOI 10.1016/j.mib.2009.12.008; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Schmidt HMA, 2009, HELICOBACTER, V14, P256, DOI 10.1111/j.1523-5378.2009.00684.x; Schneider Sabine, 2008, Cell Commun Signal, V6, P2, DOI 10.1186/1478-811X-6-2; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Smolka AJ, 2012, J GASTROENTEROL, V47, P609, DOI 10.1007/s00535-012-0592-1; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tanaka J, 2003, CELL MICROBIOL, V5, P395, DOI 10.1046/j.1462-5822.2003.00286.x; Tegtmeyer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071220; Tegtmeyer N, 2011, EUR J CELL BIOL, V90, P880, DOI 10.1016/j.ejcb.2010.11.006; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Tinti M, 2012, NEW BIOTECHNOL, V29, P571, DOI 10.1016/j.nbt.2011.12.001; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Traverso FR, 2010, HELICOBACTER, V15, P403, DOI 10.1111/j.1523-5378.2010.00770.x; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 1998, J CLIN MICROBIOL, V36, P2258, DOI 10.1128/JCM.36.8.2258-2263.1998; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	82	27	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96488	10.1371/journal.pone.0096488	http://dx.doi.org/10.1371/journal.pone.0096488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800748	gold, Green Published			2022-12-27	WOS:000338029800076
J	Wieland, LS; Rutkow, L; Vedula, SS; Kaufmann, CN; Rosman, LM; Twose, C; Mahendraratnam, N; Dickersin, K				Wieland, L. Susan; Rutkow, Lainie; Vedula, S. Swaroop; Kaufmann, Christopher N.; Rosman, Lori M.; Twose, Claire; Mahendraratnam, Nirosha; Dickersin, Kay			Who Has Used Internal Company Documents for Biomedical and Public Health Research and Where Did They Find Them?	PLOS ONE			English	Article							INDUSTRY DOCUMENTS; ROFECOXIB LITIGATION; RANDOMIZED-TRIALS; CLINICAL-TRIALS; REPORTING BIAS; PROMOTION; GABAPENTIN; OLANZAPINE; PROTOCOLS; LEGACY	Objective: To describe the sources of internal company documents used in public health and healthcare research. Methods: We searched PubMed and Embase for articles using internal company documents to address a research question about a health-related topic. Our primary interest was where authors obtained internal company documents for their research. We also extracted information on type of company, type of research question, type of internal documents, and funding source. Results: Our searches identified 9,305 citations of which 357 were eligible. Scanning of reference lists and consultation with colleagues identified 4 additional articles, resulting in 361 included articles. Most articles examined internal tobacco company documents (325/361; 90%). Articles using documents from pharmaceutical companies (20/361; 6%) were the next most common. Tobacco articles used documents from repositories; pharmaceutical documents were from a range of sources. Most included articles relied upon internal company documents obtained through litigation (350/361; 97%). The research questions posed were primarily about company strategies to promote or position the company and its products (326/361; 90%). Most articles (346/361; 96%) used information from miscellaneous documents such as memos or letters, or from unspecified types of documents. When explicit information about study funding was provided (290/361 articles), the most common source was the US-based National Cancer Institute. We developed an alternative and more sensitive search targeted at identifying additional research articles using internal pharmaceutical company documents, but the search retrieved an impractical number of citations for review. Conclusions: Internal company documents provide an excellent source of information on health topics (e. g., corporate behavior, study data) exemplified by articles based on tobacco industry documents. Pharmaceutical and other industry documents appear to have been less used for research, indicating a need for funding for this type of research and well-indexed and curated repositories to provide researchers with ready access to the documents.	[Wieland, L. Susan] Brown Univ, Ctr Evidence Based Med, Providence, RI 02912 USA; [Rutkow, Lainie; Kaufmann, Christopher N.; Mahendraratnam, Nirosha; Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Vedula, S. Swaroop] Johns Hopkins Univ, Baltimore, MD USA; [Rosman, Lori M.; Twose, Claire] Johns Hopkins Univ, William H Welch Med Lib, Baltimore, MD USA	Brown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Wieland, LS (corresponding author), Brown Univ, Ctr Evidence Based Med, Providence, RI 02912 USA.	lswieland@gmail.com		Wieland, Lisa Susan/0000-0003-2157-0603; Twose, Claire/0000-0001-9667-076X; Rutkow, Helaine/0000-0001-6423-7291; Rosman, Lori/0000-0002-6935-1672				Anderson SJ, 2011, TOB CONTROL, V20, pII8, DOI 10.1136/tc.2010.041921; [Anonymous], 2013, FED REG; Applbaum K, 2009, CULT MED PSYCHIAT, V33, P185, DOI 10.1007/s11013-009-9129-3; Bernschneider-Reif S, 2006, PHARMAZIE, V61, P966; Breggin Peter R, 2006, Ethical Hum Psychol Psychiatry, V8, P77, DOI 10.1891/ehpp.8.1.77; Chan AW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8013; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Dickersin K, 2011, J ROY SOC MED, V104, P532, DOI 10.1258/jrsm.2011.11k042; Doshi P, 2013, BMJ OPEN, V3; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Freudenberg N, 2012, J PUBLIC HEALTH POL, V33, P244, DOI 10.1057/jphp.2011.60; Fugh-Berman AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000335; Greene JA, 2005, B HIST MED, V79, P749, DOI 10.1353/bhm.2005.0153; HETHERINGTON J, 1989, PEDIATRICS, V84, P374; Hill KP, 2008, ANN INTERN MED, V149, P251, DOI 10.7326/0003-4819-149-4-200808190-00006; Hurt RD, 2009, MAYO CLIN PROC, V84, P446, DOI 10.1016/S0025-6196(11)60563-6; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Jureidini JN, 2011, ACCOUNT RES, V18, P45, DOI 10.1080/08989621.2011.542683; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Krumholz HM, 2013, ANN INTERN MED, V158, P910, DOI 10.7326/0003-4819-158-12-201306180-00009; Landefeld CS, 2009, NEW ENGL J MED, V360, P103, DOI 10.1056/NEJMp0808659; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; McDaniel PA, 2009, AM J PUBLIC HEALTH, V99, P452, DOI 10.2105/AJPH.2008.138115; McHenry LB, 2008, ACCOUNT RES, V15, P152, DOI 10.1080/08989620802194384; Psaty BM, 2004, JAMA-J AM MED ASSOC, V292, P2622, DOI 10.1001/jama.292.21.2622; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Ross JS, 2010, ARCH INTERN MED, V170, P2035, DOI 10.1001/archinternmed.2010.461; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Spielmans GI, 2009, SOC SCI MED, V69, P14, DOI 10.1016/j.socscimed.2009.05.001; Steinman MA, 2007, PLOS MED, V4, P743, DOI 10.1371/journal.pmed.0040134; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189; Vedula SS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001378; Vedula SS, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-136; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; White J, 2009, ACCOUNT RES, V16, P41, DOI 10.1080/08989620802689847; Woods S, 2011, SCHIZOPHRENIA BULL, V37, P30; World Health Organization, 2004, TOB IND DOC WHAT THE	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94709	10.1371/journal.pone.0094709	http://dx.doi.org/10.1371/journal.pone.0094709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24800999	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800021
J	Yamamoto, S; Sato, H; Tanabe, AS; Hidaka, A; Kadowaki, K; Toju, H				Yamamoto, Satoshi; Sato, Hirotoshi; Tanabe, Akifumi S.; Hidaka, Amane; Kadowaki, Kohmei; Toju, Hirokazu			Spatial Segregation and Aggregation of Ectomycorrhizal and Root-Endophytic Fungi in the Seedlings of Two Quercus Species	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; DARK SEPTATE ENDOPHYTES; COMMUNITY COMPOSITION; INSECT HERBIVORES; COMPETITION; PLANT; HOST; DIVERSITY; ECOLOGY; FOREST	Diverse clades of mycorrhizal and endophytic fungi are potentially involved in competitive or facilitative interactions within host-plant roots. We investigated the potential consequences of these ecological interactions on the assembly process of root-associated fungi by examining the co-occurrence of pairs of fungi in host-plant individuals. Based on massively-parallel pyrosequencing, we analyzed the root-associated fungal community composition for each of the 249 Quercus serrata and 188 Quercus glauca seedlings sampled in a warm-temperate secondary forest in Japan. Pairs of fungi that co-occurred more or less often than expected by chance were identified based on randomization tests. The pyrosequencing analysis revealed that not only ectomycorrhizal fungi but also endophytic fungi were common in the root-associated fungal community. Intriguingly, specific pairs of these ectomycorrhizal and endophytic fungi showed spatially aggregated patterns, suggesting the existence of facilitative interactions between fungi in different functional groups. Due to the large number of fungal pairs examined, many of the observed aggregated/segregated patterns with very low P values (e.g., < 0.005) turned non-significant after the application of a multiple comparison method. However, our overall results imply that the community structures of ectomycorrhizal and endophytic fungi could influence each other through interspecific competitive/facilitative interactions in root. To test the potential of host-plants' control of fungus-fungus ecological interactions in roots, we further examined whether the aggregated/segregated patterns could vary depending on the identity of host plant species. Potentially due to the physiological properties shared between the congeneric host plant species, the sign of hosts' control was not detected in the present study. The pyrosequencing-based randomization analyses shown in this study provide a platform of the high-throughput investigation of fungus-fungus interactions in plant root systems.	[Yamamoto, Satoshi; Sato, Hirotoshi; Kadowaki, Kohmei; Toju, Hirokazu] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Hidaka, Amane] Hokkaido Univ, Filed Sci Ctr Northern Biosphere, Japan Wildlife Res Ctr,Network Ctr, Forest & Grassland Survey Monitoring Sites Projec, Tomakomai, Japan	Kyoto University; Japan Fisheries Research & Education Agency (FRA); Hokkaido University	Yamamoto, S (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto, Japan.	s_yamamoto@terra.zool.kyoto-u.ac.jp	Toju, Hirokazu/T-7355-2019; Sato, Hirotoshi/A-2429-2015; Toju, Hirokazu/S-7307-2017; Kadowaki, Kohmei/K-8117-2019; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Kadowaki, Kohmei/0000-0003-0512-1621; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government [GS014]	Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government	This work was financially supported by the Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese government (to H.T.; GS014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bogale M, 2010, FUNGAL BIOL-UK, V114, P396, DOI 10.1016/j.funbio.2010.02.006; Booth MG, 2004, ECOL LETT, V7, P538, DOI 10.1111/j.1461-0248.2004.00605.x; Borowicz VA, 2001, ECOLOGY, V82, P3057; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chen YL, 2000, NEW PHYTOL, V146, P545, DOI 10.1046/j.1469-8137.2000.00663.x; CHILVERS GA, 1987, NEW PHYTOL, V107, P441, DOI 10.1111/j.1469-8137.1987.tb00195.x; Cho M, 2005, J FOREST RES-JPN, V10, P143, DOI 10.1007/s10310-004-0124-9; Davey ML, 2013, MOL ECOL, V22, P368, DOI 10.1111/mec.12122; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fujihara M, 1996, J VEG SCI, V7, P729, DOI 10.2307/3236384; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Gorzelak MA, 2012, FUNGAL ECOL, V5, P36, DOI 10.1016/j.funeco.2011.08.008; Grelet GA, 2009, NEW PHYTOL, V182, P359, DOI 10.1111/j.1469-8137.2009.02813.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; HATTINGH MJ, 1973, SOIL SCI, V116, P383, DOI 10.1097/00010694-197311000-00007; Hortal S, 2008, MYCORRHIZA, V18, P69, DOI 10.1007/s00572-007-0160-3; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Izzo A, 2006, MYCOLOGIA, V98, P374, DOI 10.3852/mycologia.98.3.374; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Japan Meteorological Agency, 2010, CLIM STAT; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kennedy PG, 2007, J ECOL, V95, P1338, DOI 10.1111/j.1365-2745.2007.01306.x; Kennedy PG, 2009, ECOLOGY, V90, P2098, DOI 10.1890/08-1291.1; Kernaghan G, 2011, MICROB ECOL, V62, P460, DOI 10.1007/s00248-011-9851-6; Koide RT, 2011, ANN FOREST SCI, V68, P45, DOI 10.1007/s13595-010-0006-6; Koide RT, 2005, NEW PHYTOL, V165, P305, DOI 10.1111/j.1469-8137.2004.01216.x; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lantz H, 2011, MYCOLOGIA, V103, P57, DOI 10.3852/10-060; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lindahl B, 1999, NEW PHYTOL, V144, P183, DOI 10.1046/j.1469-8137.1999.00502.x; Mack KML, 2008, OIKOS, V117, P310, DOI 10.1111/j.2007.0030-1299.15973.x; MAMOUN M, 1993, PLANT SOIL, V149, P211, DOI 10.1007/BF00016611; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Oksanen J., **DATA OBJECT**; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006; Pickles BJ, 2012, MOL ECOL, V21, P5110, DOI 10.1111/j.1365-294X.2012.05739.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reininger V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042865; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Saunders M, 2010, EVOL APPL, V3, P525, DOI 10.1111/j.1752-4571.2010.00141.x; Simard SW, 1997, NATURE, V388, P579, DOI 10.1038/41557; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; STONE L, 1992, OECOLOGIA, V91, P419, DOI 10.1007/BF00317632; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tanabe AS, 2012, CLAIDENT SOFTWARE DI; Tanabe AS, 2012, ASSAMS SOFTWARE DIST; Tedersoo L, 2013, NEW PHYTOL, V199, P822, DOI 10.1111/nph.12328; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Toju H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086566; Toju H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078248; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wagg C, 2008, MYCORRHIZA, V18, P103, DOI 10.1007/s00572-007-0157-y; Wang W, 2007, CAN J BOT, V85, P1214, DOI 10.1139/B07-086; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson JM, 1992, INTERACTIONS FUNGAL, P199; Wu B, 1999, MYCORRHIZA, V9, P151, DOI 10.1007/s005720050300	76	25	26	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96363	10.1371/journal.pone.0096363	http://dx.doi.org/10.1371/journal.pone.0096363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801150	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800061
J	Alcaino, J; Romero, I; Niklitschek, M; Sepulveda, D; Rojas, MC; Baeza, M; Cifuentes, V				Alcaino, Jennifer; Romero, Ignacio; Niklitschek, Mauricio; Sepulveda, Dionisia; Cecilia Rojas, Maria; Baeza, Marcelo; Cifuentes, Victor			Functional Characterization of the Xanthophyllomyces dendrorhous Farnesyl Pyrophosphate Synthase and Geranylgeranyl Pyrophosphate Synthase Encoding Genes That Are Involved in the Synthesis of Isoprenoid Precursors	PLOS ONE			English	Article							CAROTENOID BIOSYNTHESIS GENES; DIPHOSPHATE SYNTHASE; PHAFFIA-RHODOZYMA; BETA-CAROTENE; ASTAXANTHIN BIOSYNTHESIS; ISOPENTENYL DIPHOSPHATE; WILD-TYPE; EXPRESSION; CLONING; CONVERSION	The yeast Xanthophyllomyces dendrorhous synthesizes the carotenoid astaxanthin, which has applications in biotechnology because of its antioxidant and pigmentation properties. However, wild-type strains produce too low amounts of carotenoids to be industrially competitive. Considering this background, it is indispensable to understand how the synthesis of astaxanthin is controlled and regulated in this yeast. In this work, the steps leading to the synthesis of the carotenoid precursor geranylgeranyl pyrophosphate (GGPP, C-20) in X. dendrorhous from isopentenyl pyrophosphate (IPP, C-5) and dimethylallyl pyrophosphate (DMAPP, C-5) was characterized. Two prenyl transferase encoding genes, FPS and crtE, were expressed in E. coli. The enzymatic assays using recombinant E. coli protein extracts demonstrated that FPS and crtE encode a farnesyl pyrophosphate (FPP, C-15) synthase and a GGPP-synthase, respectively. X. dendrorhous FPP-synthase produces geranyl pyrophosphate (GPP, C-10) from IPP and DMAPP and FPP from IPP and GPP, while the X. dendrorhous GGPP-synthase utilizes only FPP and IPP as substrates to produce GGPP. Additionally, the FPS and crtE genes were over-expressed in X. dendrorhous, resulting in an increase of the total carotenoid production. Because the parental strain is diploid, the deletion of one of the alleles of these genes did not affect the total carotenoid production, but the composition was significantly altered. These results suggest that the over-expression of these genes might provoke a higher carbon flux towards carotenogenesis, most likely involving an earlier formation of a carotenogenic enzyme complex. Conversely, the lower carbon flux towards carotenogenesis in the deletion mutants might delay or lead to a partial formation of a carotenogenic enzyme complex, which could explain the accumulation of astaxanthin carotenoid precursors in these mutants. In conclusion, the FPS and the crtE genes represent good candidates to manipulate to favor carotenoid biosynthesis in X. dendrorhous.	[Alcaino, Jennifer; Romero, Ignacio; Niklitschek, Mauricio; Sepulveda, Dionisia; Baeza, Marcelo; Cifuentes, Victor] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Cecilia Rojas, Maria] Univ Chile, Fac Ciencias, Dept Quim, Santiago, Chile	Universidad de Chile; Universidad de Chile	Cifuentes, V (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.	vcifuentes@uchile.cl	/C-6686-2008; Alcaino, Jennifer/H-4576-2012	Alcaino, Jennifer/0000-0001-8984-0943	Fondecyt [1100324]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Funding by Fondecyt 1100324. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIO JL, 1995, BIOTECHNOL TECH, V9, P509, DOI 10.1007/BF00159567; Alcaino J, 2012, J AGR FOOD CHEM, V60, P8640, DOI 10.1021/jf302287f; Alcaino J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-169; Alvarez V, 2006, FUNGAL GENET BIOL, V43, P261, DOI 10.1016/j.fgb.2005.12.004; AN GH, 1989, APPL ENVIRON MICROB, V55, P116, DOI 10.1128/AEM.55.1.116-124.1989; ANDREWES AG, 1976, PHYTOCHEMISTRY, V15, P1003, DOI 10.1016/S0031-9422(00)84390-3; BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5; Breitenbach J, 2011, BIOTECHNOL LETT, V33, P755, DOI 10.1007/s10529-010-0495-2; Cantera JJL, 2002, INT J SYST EVOL MICR, V52, P1953, DOI 10.1099/00207713-52-6-1953; CAPLIN BE, 1994, BBA-PROTEIN STRUCT M, V1205, P39, DOI 10.1016/0167-4838(94)90089-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cifuentes V, 1997, ANTON LEEUW INT J G, V72, P111, DOI 10.1023/A:1000200119447; Contreras G, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-84; Fell JW, 1999, J IND MICROBIOL BIOT, V23, P677, DOI 10.1038/sj.jim.2900681; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; GAZIANO JM, 1993, ANN NY ACAD SCI, V691, P148, DOI 10.1111/j.1749-6632.1993.tb26166.x; Goodwin TW, 1984, BIOCH CAROTENOIDS, VII; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Hermosilla G, 2003, ANTON LEEUW INT J G, V84, P279, DOI 10.1023/A:1026090008405; Hoshino TO, 1999, F. HOFFMANN-LA ROCHE AG European Patent Application, Patent No. [EP 0 955 363 A2, 0955363]; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; Kajiwara S, 1997, BIOCHEM J, V324, P421, DOI 10.1042/bj3240421; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KOIKETAKESHITA A, 1995, J BIOL CHEM, V270, P18396, DOI 10.1074/jbc.270.31.18396; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lee PC, 2002, APPL MICROBIOL BIOT, V60, P1, DOI 10.1007/s00253-002-1101-x; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Lichtenthaler HK, 2000, BIOCHEM SOC T, V28, P785, DOI 10.1042/BST0280785; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodato P, 2007, BIOL RES, V40, P73, DOI 10.4067/S0716-97602007000100008; Lodato P, 2004, BIOL RES, V37, P83, DOI 10.4067/S0716-97602004000100009; Loto I, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-235; Marcoleta A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-190; Mekkriengkrai D, 2004, BIOSCI BIOTECH BIOCH, V68, P2360, DOI 10.1271/bbb.68.2360; Misawa N, 2011, CURR OPIN BIOTECH, V22, P627, DOI 10.1016/j.copbio.2011.01.002; Niklitschek M, 2008, BIOL RES, V41, P93, DOI 10.4067/S0716-97602008000100011; Niklitschek Mauricio, 2012, Methods Mol Biol, V898, P219, DOI 10.1007/978-1-61779-918-1_15; Ohnuma S, 1997, J BIOL CHEM, V272, P5192, DOI 10.1074/jbc.272.8.5192; OHNUMA S, 1994, J BIOL CHEM, V269, P14792; Ojima K, 2006, MOL GENET GENOMICS, V275, P148, DOI 10.1007/s00438-005-0072-x; Plochocka D, 2000, BIOCHIMIE, V82, P733, DOI 10.1016/S0300-9084(00)01155-X; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Saito K, 2007, J BIOSCI BIOENG, V103, P575, DOI 10.1263/jbb.103.575; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; SCHIEDT K, 1985, PURE APPL CHEM, V57, P685, DOI 10.1351/pac198557050685; Shang F, 2006, J BIOTECHNOL, V122, P285, DOI 10.1016/j.jbiotec.2005.11.020; Sitthithaworn W, 2001, CHEM PHARM BULL, V49, P197, DOI 10.1248/cpb.49.197; Takaichi S, 2011, MAR DRUGS, V9, P1101, DOI 10.3390/md9061101; van den Brink JM, 2000, MOL GEN GENET, V263, P601, DOI 10.1007/s004380051207; Verdoes JC, 2003, APPL ENVIRON MICROB, V69, P3728, DOI 10.1128/AEM.69.7.3728-3738.2003; Visser H, 2005, METH BIOTEC, V18, P257; Wozniak A, 2011, FEMS YEAST RES, V11, P252, DOI 10.1111/j.1567-1364.2010.00711.x	52	19	20	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96626	10.1371/journal.pone.0096626	http://dx.doi.org/10.1371/journal.pone.0096626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796858	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000107
J	Gupta, P; Sidhartha, E; Girard, MJA; Mari, JM; Wong, TY; Cheng, CY				Gupta, Preeti; Sidhartha, Elizabeth; Girard, Michael J. A.; Mari, Jean Martial; Wong, Tien-Yin; Cheng, Ching-Yu			A Simplified Method to Measure Choroidal Thickness Using Adaptive Compensation in Enhanced Depth Imaging Optical Coherence Tomography	PLOS ONE			English	Article							CENTRAL SEROUS CHORIORETINOPATHY; SD-OCT; CONTRAST; IMAGES; REPRODUCIBILITY; SEGMENTATION; VASCULOPATHY; EYES	Purpose: To evaluate a simplified method to measure choroidal thickness (CT) using commercially available enhanced depth imaging (EDI) spectral domain optical coherence tomography (SD-OCT). Methods: We measured CT in 31 subjects without ocular diseases using Spectralis EDI SD-OCT. The choroid-scleral interface of the acquired images was first enhanced using a post-processing compensation algorithm. The enhanced images were then analysed using Photoshop. Two graders independently graded the images to assess inter-grader reliability. One grader re-graded the images after 2 weeks to determine intra-grader reliability. Statistical analysis was performed using intra-class correlation coefficient (ICC) and Bland-Altman plot analyses. Results: Using adaptive compensation both the intra-grader reliability (ICC: 0.95 to 0.97) and inter-grader reliability (ICC: 0.93 to 0.97) were perfect for all five locations of CT. However, with the conventional technique of manual CT measurements using built-in callipers provided with the Heidelberg explorer software, the intra- (ICC: 0.87 to 0.94) and inter-grader reliability (ICC: 0.90 to 0.93) for all the measured locations is lower. Using adaptive compensation, the mean differences (95% limits of agreement) for intra-and inter-grader sub-foveal CT measurements were -1.3 (-3.33 to 30.8) mu m and -1.2 (-36.6 to 34.2) mu m, respectively. Conclusions: The measurement of CT obtained from EDI SD-OCT using our simplified method was highly reliable and efficient. Our method is an easy and practical approach to improve the quality of choroidal images and the precision of CT measurement.	[Gupta, Preeti; Sidhartha, Elizabeth; Girard, Michael J. A.; Wong, Tien-Yin; Cheng, Ching-Yu] Singapore Eye Res Inst, Singapore, Singapore; [Gupta, Preeti; Sidhartha, Elizabeth; Girard, Michael J. A.; Wong, Tien-Yin; Cheng, Ching-Yu] Singapore Natl Eye Ctr, Singapore, Singapore; [Gupta, Preeti; Sidhartha, Elizabeth; Wong, Tien-Yin; Cheng, Ching-Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Gupta, Preeti; Sidhartha, Elizabeth; Wong, Tien-Yin; Cheng, Ching-Yu] Natl Univ Hlth Syst, Singapore, Singapore; [Girard, Michael J. A.] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore 117548, Singapore; [Mari, Jean Martial] UCL, Fac Engn Sci, Dept Bioengn, London, England; [Wong, Tien-Yin; Cheng, Ching-Yu] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Wong, Tien-Yin; Cheng, Ching-Yu] Duke NUS Grad Med Sch, Off Clin Sci, Ctr Quantitat Med, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; University of London; University College London; National University of Singapore; National University of Singapore	Cheng, CY (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	ching-yu_cheng@nuhs.edu.sg	Girard, Michael/F-9323-2015; Cheng, Ching-Yu/Y-2229-2019; Wong, Tien Yin/AAC-9724-2020	Girard, Michael/0000-0003-4408-5918; Cheng, Ching-Yu/0000-0003-0655-885X; Wong, Tien Yin/0000-0002-8448-1264; Mari, Jean Martial/0000-0002-1169-6547	National Medical Research Council, Singapore [R760/44/2010]; Ministry of Education, Academic Research Funds, Tier 1, Singapore (MJAG)	National Medical Research Council, Singapore(National Medical Research Council, Singapore); Ministry of Education, Academic Research Funds, Tier 1, Singapore (MJAG)(Ministry of Education, Singapore)	This study was supported by a grant (R760/44/2010) from National Medical Research Council, Singapore. Image post-processing techniques were supported by the Ministry of Education, Academic Research Funds, Tier 1, Singapore (MJAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cheung CM, 2013, ACTA OPHTHALMOL; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Duan L, 2012, OPT EXPRESS, V20, P3353, DOI 10.1364/OE.20.003353; Fitzgerald MEC, 2002, EXP EYE RES, V74, P561, DOI 10.1006/exer.2002.1142; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Foin N, 2013, CARDIOVASC REVASCULA, V14, P139, DOI 10.1016/j.carrev.2013.03.007; Foin N, 2013, EUR HEART J-CARD IMG, V14, P85, DOI 10.1093/ehjci/jes151; Fong AHC, 2011, RETINA-J RET VIT DIS, V31, P502, DOI 10.1097/IAE.0b013e3182083beb; Fujiwara T, 2009, AM J OPHTHALMOL, V148, P445, DOI 10.1016/j.ajo.2009.04.029; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; Gomi F, 2008, CURR OPIN OPHTHALMOL, V19, P208, DOI 10.1097/ICU.0b013e3282fb7c33; Grossniklaus HE, 2004, AM J OPHTHALMOL, V137, P496, DOI 10.1016/j.ajo.2003.09.042; Gupta B, 2011, OPHTHALMOLOGICA, V225, P207, DOI 10.1159/000324050; Hee MR, 1998, OPHTHALMOLOGY, V105, P360, DOI 10.1016/S0161-6420(98)93601-6; Ho J, 2011, OPHTHALMOLOGY, V118, P2001, DOI 10.1016/j.ophtha.2011.02.049; Ikuno Y, 2011, INVEST OPHTH VIS SCI, V52, P5536, DOI 10.1167/iovs.10-6811; Ikuno Y, 2009, INVEST OPHTH VIS SCI, V50, P3876, DOI 10.1167/iovs.08-3325; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Kahn KN, 2011, INVEST OPHTH VIS SCI, V52, P7221, DOI 10.1167/iovs.11-8019; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Lin P, 2012, INVEST OPHTH VIS SCI, V53, P1874, DOI 10.1167/iovs.11-9290; Linsenmeier RA, 2000, INVEST OPHTH VIS SCI, V41, P3117; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Mari JM, 2013, INVEST OPHTH VIS SCI, V54, P2238, DOI 10.1167/iovs.12-11327; Maul EA, 2011, OPHTHALMOLOGY, V118, P1571, DOI 10.1016/j.ophtha.2011.01.016; Povazay B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2773728; Rosman M, 2012, CLIN EXP OPHTHALMOL, V40, P557, DOI 10.1111/j.1442-9071.2012.02763.x; Shin JW, 2012, OPHTHALMOLOGY, V119, P1017, DOI 10.1016/j.ophtha.2011.10.029; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tian J, 2012, IEEE ENG MED BIO, P5360, DOI 10.1109/EMBC.2012.6347205; Torzicky T, 2012, OPT EXPRESS, V20, P7564, DOI 10.1364/OE.20.007564; Yamashita T, 2012, INVEST OPHTH VIS SCI, V53, P1102, DOI 10.1167/iovs.11-8836; Yiu G, 2014, JAMA OPHTHALMOL, V132, P174, DOI 10.1001/jamaophthalmol.2013.7288; Zhang L, 2012, INVEST OPHTH VIS SCI, V53, P7510, DOI 10.1167/iovs.12-10311	36	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96661	10.1371/journal.pone.0096661	http://dx.doi.org/10.1371/journal.pone.0096661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797674	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000112
J	Jensen, JH; Willemoes, M; Winther, JR; De Vico, L				Jensen, Jan H.; Willemoes, Martin; Winther, Jakob R.; De Vico, Luca			In Silico Prediction of Mutant HIV-1 Proteases Cleaving a Target Sequence	PLOS ONE			English	Article							MOLECULAR-FORCE FIELD; PROTEIN-PROTEIN DOCKING; VIRUS TYPE-1 PROTEASE; ORBITAL METHOD; SUBSTRATE RECOGNITION; DRUG-RESISTANCE; CLEAVAGE SITES; VIRAL PROTEASE; SPECIFICITY; MMFF94	HIV-1 protease represents an appealing system for directed enzyme re-design, since it has various different endogenous targets, a relatively simple structure and it is well studied. Recently Chaudhury and Gray ( Structure ( 2009) 17: 1636-1648) published a computational algorithm to discern the specificity determining residues of HIV-1 protease. In this paper we present two computational tools aimed at re-designing HIV-1 protease, derived from the algorithm of Chaudhuri and Gray. First, we present an energy-only based methodology to discriminate cleavable and non cleavable peptides for HIV-1 proteases, both wild type and mutant. Secondly, we show an algorithm we developed to predict mutant HIV-1 proteases capable of cleaving a new target substrate peptide, different from the natural targets of HIV-1 protease. The obtained in silico mutant enzymes were analyzed in terms of cleavability and specificity towards the target peptide using the energy-only methodology. We found two mutant proteases as best candidates for specificity and cleavability towards the target sequence.	[Jensen, Jan H.; De Vico, Luca] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Willemoes, Martin; Winther, Jakob R.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	De Vico, L (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.	luca@chem.ku.dk	Jensen, Jan Halborg/G-4338-2010; De Vico, Luca/D-2267-2009; De Vico, Luca/HFZ-7775-2022; Winther, Jakob R./K-4451-2014; Willemoës, Martin/K-4359-2014	Jensen, Jan Halborg/0000-0002-1465-1010; De Vico, Luca/0000-0002-2821-5711; De Vico, Luca/0000-0002-2821-5711; Winther, Jakob R./0000-0001-6995-9154; Willemoës, Martin/0000-0003-1689-2712	Danish Research Council for Technology and Production Sciences (FTP)	Danish Research Council for Technology and Production Sciences (FTP)	Funds were provided by the Danish Research Council for Technology and Production Sciences (FTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvizo O, 2012, PROTEIN SCI, V21, P1029, DOI 10.1002/pro.2086; [Anonymous], PYMOL MOL GRAPH SYST; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chaudhury S, 2009, STRUCTURE, V17, P1636, DOI 10.1016/j.str.2009.10.008; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Davidon WC, 1991, SIAM J OPTIMIZ, V1, P1, DOI 10.1137/0801001; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Fedorov DG, 2004, J CHEM PHYS, V121, P2483, DOI 10.1063/1.1769362; Fedorov DG, 2006, J COMPUT CHEM, V27, P976, DOI 10.1002/jcc.20406; Fedorov DG, 2007, J PHYS CHEM A, V111, P6904, DOI 10.1021/jp0716740; FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Genheden S, 2010, J CHEM THEORY COMPUT, V6, P3558, DOI 10.1021/ct100272s; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Halgren TA, 1996, J COMPUT CHEM, V17, P520, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<520::AID-JCC2>3.0.CO;2-W; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 1996, J COMPUT CHEM, V17, P553, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<553::AID-JCC3>3.0.CO;2-T; Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO;2-Q; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; JASKOLSKI M, 1991, BIOCHEMISTRY-US, V30, P1600, DOI 10.1021/bi00220a023; Johnson Victoria A, 2013, Top Antivir Med, V21, P6; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kolli M, 2009, J VIROL, V83, P11027, DOI 10.1128/JVI.00628-09; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lemmon G, 2012, CHEM BIOL DRUG DES, V79, P888, DOI 10.1111/j.1747-0285.2012.01356.x; Li Q, 2013, FEBS LETT, V587, P1155, DOI 10.1016/j.febslet.2012.12.019; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nakano T, 2002, CHEM PHYS LETT, V351, P475, DOI 10.1016/S0009-2614(01)01416-6; NAVIA MA, 1989, NATURE, V337, P615, DOI 10.1038/337615a0; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ozen A, 2012, J CHEM THEORY COMPUT, V8, P703, DOI 10.1021/ct200668a; Ozen A, 2011, J MOL BIOL, V410, P726, DOI 10.1016/j.jmb.2011.03.053; OSWALD M, 1991, FEBS LETT, V292, P298, DOI 10.1016/0014-5793(91)80888-A; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Prabu-Jeyabalan M, 2004, J VIROL, V78, P12446, DOI 10.1128/JVI.78.22.12446-12454.2004; Prabu-Jeyabalan M, 2002, STRUCTURE, V10, P369, DOI 10.1016/S0969-2126(02)00720-7; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; RIVIERE Y, 1991, NATURE, V350, P625, DOI 10.1038/350625a0; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Sherman W, 2008, CHEM BIOL DRUG DES, V71, P387, DOI 10.1111/j.1747-0285.2008.00659.x; Steinmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044480; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; TOMASSELLI AG, 1993, PROTEIN SCI, V2, P2167, DOI 10.1002/pro.5560021216; TOMASZEK TA, 1992, BIOCHEMISTRY-US, V31, P10153, DOI 10.1021/bi00157a003; TOZSER J, 1991, FEBS LETT, V281, P77, DOI 10.1016/0014-5793(91)80362-7; van Beilen JB, 2002, CURR OPIN BIOTECH, V13, P338, DOI 10.1016/S0958-1669(02)00334-8; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang W, 2001, P NATL ACAD SCI USA, V98, P14937, DOI 10.1073/pnas.251265598; WLODAWER A, 1989, SCIENCE, V245, P616, DOI 10.1126/science.2548279	57	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95833	10.1371/journal.pone.0095833	http://dx.doi.org/10.1371/journal.pone.0095833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796579	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000024
J	Song, SJ; Hu, Y; Gu, XF; Si, FF; Hua, ZY				Song, Sijie; Hu, Ying; Gu, Xianfang; Si, Feifei; Hua, Ziyu			A Novel Newborn Rat Kernicterus Model Created by Injecting a Bilirubin Solution into the Cisterna Magna	PLOS ONE			English	Article							UGT1 LOCUS; GUNN-RATS; BRAIN; ENCEPHALOPATHY; APOPTOSIS; HYPERBILIRUBINEMIA; NEURONS; MEMORY; MICE; HIPPOCAMPUS	Background: Kernicterus still occurs around the world; however, the mechanism of bilirubin neurotoxicity remains unclear, and effective treatment strategies are lacking. To solve these problems, several kernicterus (or acute bilirubin encephalopathy) animal models have been established, but these models are difficult and expensive. Therefore, the present study was performed to establish a novel kernicterus model that is simple and affordable by injecting unconjugated bilirubin solution into the cisterna magna (CM) of ordinary newborn Sprague-Dawley (SD) rats. Methods: On postnatal day 5, SD rat pups were randomly divided into bilirubin and control groups. Then, either bilirubin solution or ddH(2)O (pH = 8.5) was injected into the CM at 10 mu g/g (bodyweight). For model characterization, neurobehavioral outcomes were observed, mortality was calculated, and bodyweight was recorded after bilirubin injection and weaning. Apoptosis in the hippocampus was detected by H&E staining, TUNEL, flow cytometry and Western blotting. When the rats were 28 days old, learning and memory ability were evaluated using the Morris water maze test. Results: The bilirubin-treated rats showed apparently abnormal neurological manifestations, such as clenched fists, opisthotonos and torsion spasms. Bodyweight gain in the bilirubin-treated rats was significantly lower than that in the controls (P<0.001). The early and late mortality of the bilirubin-treated rats were both dramatically higher than those of the controls (P = 0.004 and 0.017, respectively). Apoptosis and necrosis in the hippocampal nerve cells in the bilirubin-treated rats were observed. The bilirubin-treated rats performed worse than the controls on the Morris water maze test. Conclusion: By injecting bilirubin into the CM, we successfully created a new kernicterus model using ordinary SD rats; the model mimics both the acute clinical manifestations and the chronic sequelae. In particular, CM injection is easy to perform; thus, more stable models for follow-up study are available.	[Song, Sijie; Hu, Ying; Gu, Xianfang; Si, Feifei; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China; [Song, Sijie; Si, Feifei; Hua, Ziyu] Chongqing Med Univ, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Song, Sijie; Si, Feifei; Hua, Ziyu] Chongqing Med Univ, Chongqing Key Lab Translat Med Res Cognit Dev & L, Chongqing, Peoples R China; [Song, Sijie; Si, Feifei; Hua, Ziyu] Chongqing Med Univ, Key Lab Pediat Chongqing, Chongqing, Peoples R China; [Song, Sijie; Si, Feifei; Hua, Ziyu] Chongqing Med Univ, Childrens Hosp, Chongqing Int Sci & Technol Cooperat Ctr Child De, Chongqing, Peoples R China; [Hu, Ying] Third Mil Med Univ, Southwest Hosp, Dept Pediat, Chongqing, Peoples R China; [Gu, Xianfang] Childrens Hosp Kaifeng, Dept Neonatol, Kaifeng, Henan, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Army Medical University	Hua, ZY (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing, Peoples R China.	h_ziyu@163.com			National Natural Science Foundation of China [81200459]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81200459). URL: http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDABBARMADA M, 1984, J NEUROPATH EXP NEUR, V43, P45, DOI 10.1097/00005072-198401000-00004; Mejia GB, 2008, J NEUROSCI METH, V168, P35, DOI 10.1016/j.jneumeth.2007.09.003; BLANC WA, 1959, J NEUROPATH EXP NEUR, V18, P165, DOI 10.1097/00005072-195901000-00011; Brites D, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00088; Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919; Chang FY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005876; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Goldberg JE, 1999, J IMMUNOL METHODS, V224, P1, DOI 10.1016/S0022-1759(98)00038-6; Grabow T S, 2001, Curr Pain Headache Rep, V5, P510, DOI 10.1007/s11916-001-0068-0; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; Hanko E, 2005, PEDIATR RES, V57, P179, DOI 10.1203/01.PDR.0000148711.11519.A5; Hemsley KM, 2007, MOL GENET METAB, V90, P313, DOI 10.1016/j.ymgme.2006.10.005; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Johnson L, 2009, J PERINATOL, V29, pS25, DOI 10.1038/jp.2008.211; Johnson LH, 2002, J PEDIATR-US, V140, P396, DOI 10.1067/mpd.2002.123098; Li XD, 2004, LIFE SCI, V74, P1307, DOI 10.1016/j.lfs.2003.08.011; [刘开珍 Liu Kaizhen], 2012, [临床儿科杂志, Journal of Chinical Pediatrics], V30, P840; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Maisels MJ, 2004, PEDIATRICS, V114, P297; Manning D, 2007, ARCH DIS CHILD-FETAL, V92, P342, DOI 10.1136/adc.2006.105361; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MOTTINO AD, 1988, INT J BIOCHEM, V20, P1113, DOI 10.1016/0020-711X(88)90256-X; Nguyen N, 2008, J BIOL CHEM, V283, P7901, DOI 10.1074/jbc.M709244200; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Proescholdt MG, 2000, NEUROSCIENCE, V95, P577; Rainov Nikolai G., 2001, Current Gene Therapy, V1, P367, DOI 10.2174/1566523013348445; Rice AC, 2008, PEDIATR RES, V64, P265, DOI 10.1203/PDR.0b013e31817d9be0; Rodrigues CMP, 2002, HEPATOLOGY, V35, P1186, DOI 10.1053/jhep.2002.32967; ROSE AL, 1979, J NEUROPATH EXP NEUR, V38, P152, DOI 10.1097/00005072-197903000-00006; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Sgro M, 2012, PEDIATRICS, V130, pE886, DOI 10.1542/peds.2012-0253; SHAPIRO SM, 1988, PEDIATR RES, V23, P306, DOI 10.1203/00006450-198803000-00015; Springer S. C., 2012, KERNICTERUS MEDSCAPE; Sunico CR, 2010, J NEUROSCI, V30, P973, DOI 10.1523/JNEUROSCI.3911-09.2010; Watchko JF, 2005, PEDIATR RES, V57, P177, DOI 10.1203/01.PDR.0000150727.50378.EA; Watchko JF, 2006, NEUROMOL MED, V8, P513, DOI 10.1385/NMM:8:4:513; WENNBERG RP, 1986, PEDIATR RES, V20, P789, DOI 10.1203/00006450-198608000-00018; Yang Y, 2003, J ENDOCRINOL, V178, P45, DOI 10.1677/joe.0.1780045; Zhang TJ, 2006, ANESTH ANALG, V102, P1018, DOI 10.1213/01.ane.0000199221.96250.8c	40	10	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96171	10.1371/journal.pone.0096171	http://dx.doi.org/10.1371/journal.pone.0096171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796550	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000044
J	Damasceno, A; Damasceno, BP; Cendes, F				Damasceno, Alfredo; Damasceno, Benito Pereira; Cendes, Fernando			The Clinical Impact of Cerebellar Grey Matter Pathology in Multiple Sclerosis	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; CEREBRAL-CORTEX; LESIONS; ATROPHY; MS; DEMYELINATION; IMPAIRMENT; EXTENT; MRI	Background: The cerebellum is an important site for cortical demyelination in multiple sclerosis, but the functional significance of this finding is not fully understood. Objective: To evaluate the clinical and cognitive impact of cerebellar grey-matter pathology in multiple sclerosis patients. Methods: Forty-two relapsing-remitting multiple sclerosis patients and 30 controls underwent clinical assessment including the Multiple Sclerosis Functional Composite, Expanded Disability Status Scale (EDSS) and cerebellar functional system (FS) score, and cognitive evaluation, including the Paced Auditory Serial Addition Test (PASAT) and the Symbol-Digit Modalities Test (SDMT). Magnetic resonance imaging was performed with a 3T scanner and variables of interest were: brain white-matter and cortical lesion load, cerebellar intracortical and leukocortical lesion volumes, and brain cortical and cerebellar white-matter and grey-matter volumes. Results: After multivariate analysis high burden of cerebellar intracortical lesions was the only predictor for the EDSS (p<0.001), cerebellar FS (p = 0.002), arm function (p = 0.049), and for leg function (p<0.001). Patients with high burden of cerebellar leukocortical lesions had lower PASAT scores (p = 0.013), while patients with greater volumes of cerebellar intracortical lesions had worse SDMT scores (p = 0.015). Conclusions: Cerebellar grey-matter pathology is widely present and contributes to clinical dysfunction in relapsing-remitting multiple sclerosis patients, independently of brain grey-matter damage.	[Damasceno, Alfredo; Damasceno, Benito Pereira; Cendes, Fernando] Univ Campinas UNICAMP, Dept Neurol, Campinas, Brazil	Universidade Estadual de Campinas	Damasceno, A (corresponding author), Univ Campinas UNICAMP, Dept Neurol, Campinas, Brazil.	alfredodamasceno@hotmail.com	Damasceno, Alfredo/D-8137-2016; Cendes, Fernando/C-1301-2012	Cendes, Fernando/0000-0001-9336-9568; Damasceno, Alfredo/0000-0002-7919-3989	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/00885-4, 2013/07559-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(grants numbers 2010/00885-4 and 2013/07559-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson VM, 2011, MULT SCLER J, V17, P1079, DOI 10.1177/1352458511403528; Calabrese M, 2010, J NEUROL NEUROSUR PS, V81, P401, DOI 10.1136/jnnp.2009.177733; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Cerasa A, 2013, J NEUROL, V260, P1358, DOI 10.1007/s00415-012-6805-y; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2012, LANCET NEUROL, V11, P1082, DOI 10.1016/S1474-4422(12)70230-2; Gilmore CP, 2009, J NEUROL NEUROSUR PS, V80, P182, DOI 10.1136/jnnp.2008.148767; Henry RG, 2008, J NEUROL NEUROSUR PS, V79, P1236, DOI 10.1136/jnnp.2007.134825; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kutzelnigg A, 2007, BRAIN PATHOL, V17, P38, DOI 10.1111/j.1750-3639.2006.00041.x; McAuliffe MJ, 2001, P 14 IEEE S COMP BAS; Nielsen AS, 2013, NEUROLOGY, V81, P641, DOI 10.1212/WNL.0b013e3182a08ce8; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramasamy DP, 2009, J NEUROL SCI, V282, P47, DOI 10.1016/j.jns.2008.12.034; Sastre-Garriga J, 2011, MULT SCLER J, V17, P457, DOI 10.1177/1352458510389219; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Tedesco AM, 2011, BRAIN, V134, P3669, DOI 10.1093/brain/awr266; Wattjes MP, 2007, AM J NEURORADIOL, V28, P54	21	39	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96193	10.1371/journal.pone.0096193	http://dx.doi.org/10.1371/journal.pone.0096193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789257	gold, Green Submitted, Green Published			2022-12-27	WOS:000336655700060
J	Liberti, A; Melillo, D; Zucchetti, I; Natale, L; Dishaw, LJ; Litman, GW; De Santis, R; Pinto, MR				Liberti, Assunta; Melillo, Daniela; Zucchetti, Ivana; Natale, Lenina; Dishaw, Larry J.; Litman, Gary W.; De Santis, Rosaria; Pinto, Maria Rosaria			Expression of Ciona intestinalis Variable Region-Containing Chitin-Binding Proteins during Development of the Gastrointestinal Tract and Their Role in Host-Microbe Interactions	PLOS ONE			English	Article							ASCIDIAN HALOCYNTHIA-RORETZI; IMMUNE-TYPE RECEPTOR; LARVAL TISSUES; ORIGIN; GENES; METAMORPHOSIS; AMPHIOXUS; JUVENILE; FATES; STAGE	Variable region-containing chitin-binding proteins (VCBPs) are secreted, immune-type molecules that have been described in both amphioxus, a cephalochordate, and sea squirt, Ciona intestinalis, a urochordate. In adult Ciona, VCBP-A, -B and -C are expressed in hemocytes and the cells of the gastrointestinal tract. VCBP-C binds bacteria in the stomach lumen and functions as an opsonin in vitro. In the present paper the expression of VCBPs has been characterized during development using in situ hybridization, immunohistochemical staining and quantitative polymerase chain reaction (qPCR) technologies. The expression of VCBP-A and -C is detected first in discrete areas of larva endoderm and becomes progressively localized during differentiation in the stomach and intestine, marking the development of gut tracts. In "small adults" (1-2 cm juveniles) expression of VCBP-C persists and VCBP-A gradually diminishes, ultimately replaced by expression of VCBP-B. The expression of VCBP-A and -C in stage 7-8 juveniles, at which point animals have already started feeding, is influenced significantly by challenge with either Gram-positive or -negative bacteria. A potential role for VCBPs in gut-microbiota interactions and homeostasis is indicated.	[Liberti, Assunta; Melillo, Daniela; Zucchetti, Ivana; Natale, Lenina; De Santis, Rosaria; Pinto, Maria Rosaria] Dept Anim Physiol & Evolut, Stn Zool Anton Dohrn, Naples, Italy; [Dishaw, Larry J.; Litman, Gary W.] Univ S Florida, Coll Med, Dept Pediat, St Petersburg, FL 33701 USA	Stazione Zoologica Anton Dohrn di Napoli; State University System of Florida; University of South Florida	Pinto, MR (corresponding author), Dept Anim Physiol & Evolut, Stn Zool Anton Dohrn, Naples, Italy.	mariarosaria.pinto@szn.it	Liberti, Assunta/AAX-1026-2020; Dishaw, Larry/ABZ-9621-2022; Dishaw, Larry J/A-9930-2010	Dishaw, Larry/0000-0002-2705-4573; Dishaw, Larry J/0000-0002-2705-4573	Stazione Zoologica Anton Dohrn; National Institute of Health (NIH) [AI23338]; All Children's Hospital-Johns Hopkins Medicine Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI023338, R01AI023338, R37AI023338] Funding Source: NIH RePORTER	Stazione Zoologica Anton Dohrn; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); All Children's Hospital-Johns Hopkins Medicine Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by Stazione Zoologica Anton Dohrn institutional funds, by the National Institute of Health (NIH), grant AI23338 to GWL, and by an All Children's Hospital-Johns Hopkins Medicine Foundation grant to LJD. AL has been supported by a Stazione Zoologica Anton Dohrn PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Burighel P, 1997, MICROSCOPICAL ANATOM, V15, P221; Cannon JP, 2004, CURR BIOL, V14, pR465, DOI 10.1016/j.cub.2004.06.009; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chiba S, 2004, ZOOL SCI, V21, P285, DOI 10.2108/zsj.21.285; Dishaw LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00096; Dishaw LJ, 2011, P NATL ACAD SCI USA, V108, P16747, DOI 10.1073/pnas.1109687108; Dishaw LJ, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-78; Dufour HD, 2006, P NATL ACAD SCI USA, V103, P8727, DOI 10.1073/pnas.0600805103; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Hirano T, 2000, DEV GENES EVOL, V210, P55, DOI 10.1007/s004270050011; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Marino R, 2002, IMMUNOGENETICS, V53, P1055, DOI 10.1007/s00251-001-0421-9; Mashoof S, 2013, MUCOSAL IMMUNOL, V6, P358, DOI 10.1038/mi.2012.78; Nakazawa K, 2013, DEV DYNAM, V242, P1172, DOI 10.1002/dvdy.24009; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Prada JAH, 2006, NAT IMMUNOL, V7, P875, DOI 10.1038/ni1359; Tanaka KJ, 1996, DEV GENES EVOL, V206, P218, DOI 10.1007/s004270050047; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	23	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94984	10.1371/journal.pone.0094984	http://dx.doi.org/10.1371/journal.pone.0094984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788831	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700023
J	Paxton, KL; Cohen, EB; Paxton, EH; Nemeth, Z; Moore, FR				Paxton, Kristina L.; Cohen, Emily B.; Paxton, Eben H.; Nemeth, Zoltan; Moore, Frank R.			El Nino-Southern Oscillation Is Linked to Decreased Energetic Condition in Long-Distance Migrants	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; REPRODUCTIVE SUCCESS; MIGRATORY SONGBIRD; SPRING MIGRATION; ARRIVAL DATE; CLIMATE; RAINFALL; STOPOVER; FAT; PHENOLOGY	Predicting how migratory animals respond to changing climatic conditions requires knowledge of how climatic events affect each phase of the annual cycle and how those effects carry-over to subsequent phases. We utilized a 17-year migration dataset to examine how El Nino-Southern Oscillation climatic events in geographically different regions of the Western hemisphere carry-over to impact the stopover biology of several intercontinental migratory bird species. We found that migratory birds that over-wintered in South America experienced significantly drier environments during El Nino years, as reflected by reduced Normalized Difference Vegetation Index (NDVI) values, and arrived at stopover sites in reduced energetic condition during spring migration. During El Nino years migrants were also more likely to stopover immediately along the northern Gulf coast of the southeastern U. S. after crossing the Gulf of Mexico in small suboptimal forest patches where food resources are lower and migrant density often greater than larger more contiguous forests further inland. In contrast, NDVI values did not differ between El Nino and La Nina years in Caribbean-Central America, and we found no difference in energetic condition or use of coastal habitats for migrants en route from Caribbean-Central America wintering areas. Birds over-wintering in both regions had consistent median arrival dates along the northern Gulf coast, suggesting that there is a strong drive for birds to maintain their time program regardless of their overall condition. We provide strong evidence that not only is the stopover biology of migratory landbirds influenced by events during the previous phase of their life-cycle, but where migratory birds over-winter determines how vulnerable they are to global climatic cycles. Increased frequency and intensity of ENSO events over the coming decades, as predicted by climatic models, may disproportionately influence long-distance migrants over-wintering in South America.	[Paxton, Kristina L.; Moore, Frank R.] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA; [Cohen, Emily B.] Migratory Bird Ctr, Smithsonian Conservat Biol Inst, Washington, DC USA; [Paxton, Eben H.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI USA; [Nemeth, Zoltan] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of Southern Mississippi; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; United States Department of the Interior; United States Geological Survey; University of California System; University of California Davis	Paxton, KL (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	kpaxton@hawaii.edu	Cohen, Emily/AAB-4246-2020	Cohen, Emily/0000-0002-4978-4278; Nemeth, Zoltan/0000-0001-6164-9952; Paxton, Eben/0000-0001-5578-7689	National Science Foundation [DEB 0554754, IBN 0078189, IOS 844703]	National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by National Science Foundation grants to FRM (DEB 0554754, IBN 0078189, IOS 844703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada JA, 2001, AUK, V118, P191, DOI 10.1642/0004-8038(2001)118[0191:COTRBO]2.0.CO;2; Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Barriocanal C, 2007, ARDEA, V95, P91, DOI 10.5253/078.095.0110; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Berthold P, 1995, CONTROL BIRD MIGRATI; Blem C.R., 1990, Current Ornithology, V7, P59; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Buler JJ, 2011, J ORNITHOL, V152, P101, DOI 10.1007/s10336-010-0640-7; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; ELLEGREN H, 1992, ARDEA, V80, P255; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; GAUTHREA.SA, 1971, AUK, V88, P343, DOI 10.2307/4083884; GAUTHREAUX SA, 1972, WILSON BULL, V84, P136; Giannini A, 2000, J CLIMATE, V13, P297, DOI 10.1175/1520-0442(2000)013<0297:IVOCRE>2.0.CO;2; Gonzalez-Prieto AM, 2013, J ORNITHOL, V154, P1067, DOI 10.1007/s10336-013-0975-y; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Helms CW, 1960, BIRD BANDING, V31, P1, DOI DOI 10.2307/4510793; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; Kelly JF, 2002, AUK, V119, P210, DOI 10.1642/0004-8038(2002)119[0210:DDMGBW]2.0.CO;2; KUENZI AJ, 1991, CONDOR, V93, P869, DOI 10.2307/3247722; Kuznetsova A., 2013, LMERTEST TESTS RANDO; LaManna JA, 2012, AUK, V129, P734, DOI 10.1525/auk.2012.12017; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Mazerolle DF, 2005, J AVIAN BIOL, V36, P155, DOI 10.1111/j.0908-8857.2005.03289.x; McKellar AE, 2013, OECOLOGIA, V172, P595, DOI 10.1007/s00442-012-2520-8; MOLLER AP, 1994, BEHAV ECOL SOCIOBIOL, V35, P115, DOI 10.1007/BF00171501; MOORE F, 1987, OECOLOGIA, V74, P47, DOI 10.1007/BF00377344; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Moore FR, 2005, USDA FOREST SERVICE, P684, DOI DOI 10.3389/FPHYS.2017.00532; Moore FR, 1990, ACT 20 C INT ORN CHR, P1122; Moore Frank R., 2005, P251; Moore Frank R., 1995, P121; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Nott MP, 2002, GLOBAL ECOL BIOGEOGR, V11, P333, DOI 10.1046/j.1466-822X.2002.00296.x; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; PEARSON DL, 1986, BIOTROPICA, V18, P244, DOI 10.2307/2388493; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; POULIN B, 1992, ECOLOGY, V73, P2295, DOI 10.2307/1941476; Pyle P, 1997, IDENTIFICATION GUIDE; Radchuk V, 2013, J ANIM ECOL, V82, P275, DOI 10.1111/j.1365-2656.2012.02029.x; Ridgley R. S., 2003, DIGITAL DISTRIBUTION; Robson D, 2011, J ANIM ECOL, V80, P320, DOI 10.1111/j.1365-2656.2010.01772.x; Rockwell SM, 2012, AUK, V129, P744, DOI 10.1525/auk.2012.12003; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2007, CLIM RES, V35, P123, DOI 10.3354/cr00719; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smith RJ, 2005, J AVIAN BIOL, V36, P117, DOI 10.1111/j.0908-8857.2005.03329.x; Smith RJ, 2003, OECOLOGIA, V134, P325, DOI 10.1007/s00442-002-1152-9; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Strode PK, 2003, GLOBAL CHANGE BIOL, V9, P1137, DOI 10.1046/j.1365-2486.2003.00664.x; Strong AM, 2000, J ANIM ECOL, V69, P883, DOI 10.1046/j.1365-2656.2000.00447.x; Studds CE, 2007, CLIM RES, V35, P115, DOI 10.3354/cr00718; Studds CE, 2011, P ROY SOC B-BIOL SCI, V278, P3437, DOI 10.1098/rspb.2011.0332; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tucker C.J., 2004, GLOBAL INVENTORY MOD; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; Wolfe JD, 2009, AUK, V126, P809, DOI 10.1525/auk.2009.08018	70	29	31	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95383	10.1371/journal.pone.0095383	http://dx.doi.org/10.1371/journal.pone.0095383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788978	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700028
J	Philippot, Q; Deslee, G; Adair-Kirk, TL; Woods, JC; Byers, D; Conradi, S; Dury, S; Perotin, JM; Lebargy, F; Cassan, C; Le Naour, R; Holtzman, MJ; Pierce, RA				Philippot, Quentin; Deslee, Gaetan; Adair-Kirk, Tracy L.; Woods, Jason C.; Byers, Derek; Conradi, Susan; Dury, Sandra; Perotin, Jeanne Marie; Lebargy, Francois; Cassan, Christelle; Le Naour, Richard; Holtzman, Michael J.; Pierce, Richard A.			Increased Iron Sequestration in Alveolar Macrophages in Chronic Obtructive Pulmonary Disease	PLOS ONE			English	Article							OXIDATIVE STRESS	Free iron in lung can cause the generation of reactive oxygen species, an important factor in chronic obstructive pulmonary disease (COPD) pathogenesis. Iron accumulation has been implicated in oxidative stress in other diseases, such as Alzheimer's and Parkinson's diseases, but little is known about iron accumulation in COPD. We sought to determine if iron content and the expression of iron transport and/or storage genes in lung differ between controls and COPD subjects, and whether changes in these correlate with airway obstruction. Explanted lung tissue was obtained from transplant donors, GOLD 2-3 COPD subjects, and GOLD 4 lung transplant recipients, and bronchoalveolar lavage (BAL) cells were obtained from non-smokers, healthy smokers, and GOLD 1-3 COPD subjects. Iron-positive cells were quantified histologically, and the expression of iron uptake (transferrin and transferrin receptor), storage (ferritin) and export (ferroportin) genes was examined by real-time RT-PCR assay. Percentage of iron-positive cells and expression levels of iron metabolism genes were examined for correlations with airflow limitation indices (forced expiratory volume in the first second (FEV1) and the ratio between FEV1 and forced vital capacity (FEV1/FVC)). The alveolar macrophage was identified as the predominant iron-positive cell type in lung tissues. Futhermore, the quantity of iron deposit and the percentage of iron positive macrophages were increased with COPD and emphysema severity. The mRNA expression of iron uptake and storage genes transferrin and ferritin were significantly increased in GOLD 4 COPD lungs compared to donors (6.9 and 3.22 fold increase, respectively). In BAL cells, the mRNA expression of transferrin, transferrin receptor and ferritin correlated with airway obstruction. These results support activation of an iron sequestration mechanism by alveolar macrophages in COPD, which we postulate is a protective mechanism against iron induced oxidative stress.	[Philippot, Quentin; Adair-Kirk, Tracy L.; Byers, Derek; Holtzman, Michael J.; Pierce, Richard A.] Washington Univ, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63130 USA; [Philippot, Quentin; Deslee, Gaetan; Perotin, Jeanne Marie] Univ Hosp, Inst Natl Sante, Reims, France; [Philippot, Quentin; Deslee, Gaetan; Perotin, Jeanne Marie] Univ Hosp, Rech Med Unit 903, Reims, France; [Deslee, Gaetan; Dury, Sandra; Perotin, Jeanne Marie; Lebargy, Francois] Univ Hosp Reims, Dept Pulm Med, Reims, France; [Woods, Jason C.; Conradi, Susan] Washington Univ, Dept Radiol, St Louis, MO USA; [Dury, Sandra; Lebargy, Francois; Cassan, Christelle; Le Naour, Richard] Univ Reims, EA4683, Reims, France	Washington University (WUSTL); CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne; Washington University (WUSTL); Universite de Reims Champagne-Ardenne	Pierce, RA (corresponding author), Washington Univ, Dept Internal Med, Div Pulm & Crit Care Med, St Louis, MO 63130 USA.	rpierce@dom.wustl.edu	DESLEE, Gaëtan/G-2625-2013	DESLEE, Gaëtan/0000-0002-4919-5916; Byers, Derek/0000-0001-7371-9153; Perotin, Jeanne-Marie/0000-0001-7184-3767; LE NAOUR, Richard/0000-0003-1925-6041	NIH [P50HL084922]; Alafi Neuroimaging Laboratory; Hope Center for Neurological Disorders; NIH Neuroscience Blueprint Center Core Grant [P30 NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121791, P50HL084922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alafi Neuroimaging Laboratory; Hope Center for Neurological Disorders; NIH Neuroscience Blueprint Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH P50HL084922 (J.C.W., D.D., M.J.H., R.A.P.), the Alafi Neuroimaging Laboratory, the Hope Center for Neurological Disorders, and NIH Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; Deslee G, 2009, CHEST, V135, P965, DOI 10.1378/chest.08-2257; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Glynos C, 2013, AM J RESP CRIT CARE, V188, P789, DOI 10.1164/rccm.201210-1884OC; Hardin M, 2012, AM J RESP CELL MOL, V47, P203, DOI 10.1165/rcmb.2012-0011OC; Hattotuwa K, 2002, CHEST, V122, P1909, DOI 10.1378/chest.122.6.1909; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kim WJ, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-16; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nelson ME, 1996, AM J RESP CRIT CARE, V153, P1353, DOI 10.1164/ajrccm.153.4.8616566; OLAKANMI O, 1993, J CLIN INVEST, V91, P889, DOI 10.1172/JCI116310; Persson HL, 2013, EXP TOXICOL PATHOL, V65, P81, DOI 10.1016/j.etp.2011.06.004; Rahman I, 2005, CELL BIOCHEM BIOPHYS, V43, P167, DOI 10.1385/CBB:43:1:167; TAKEMOTO K, 1991, INT ARCH OCC ENV HEA, V62, P579, DOI 10.1007/BF00381111; Tanino M, 2002, THORAX, V57, P405, DOI 10.1136/thorax.57.5.405; THOMPSON AB, 1991, J LAB CLIN MED, V117, P493; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; WESSELIUS LJ, 1994, AM J RESP CRIT CARE, V150, P690, DOI 10.1164/ajrccm.150.3.8087339	23	49	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96285	10.1371/journal.pone.0096285	http://dx.doi.org/10.1371/journal.pone.0096285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789352	Green Published, gold			2022-12-27	WOS:000335510600091
J	Freeman, CM; McCubbrey, AL; Crudgington, S; Nelson, J; Martinez, FJ; Han, MK; Washko, GR; Chensue, SW; Arenberg, DA; Meldrum, CA; McCloskey, L; Curtis, JL				Freeman, Christine M.; McCubbrey, Alexandra L.; Crudgington, Sean; Nelson, Joshua; Martinez, Fernando J.; Han, MeiLan K.; Washko, George R., Jr.; Chensue, Stephen W.; Arenberg, Douglas A.; Meldrum, Catherine A.; McCloskey, Lisa; Curtis, Jeffrey L.			Basal Gene Expression by Lung CD4+T Cells in Chronic Obstructive Pulmonary Disease Identifies Independent Molecular Correlates of Airflow Obstruction and Emphysema Extent	PLOS ONE			English	Article							T-CELLS; MEMORY; LYMPHOCYTES; SUBSETS; COPD; INTERLEUKIN-10; POLYMORPHISMS; RESPONSES; SMOKING; STIMULATION	Lung CD4+ T cells accumulate as chronic obstructive pulmonary disease (COPD) progresses, but their role in pathogenesis remains controversial. To address this controversy, we studied lung tissue from 53 subjects undergoing clinically-indicated resections, lung volume reduction, or transplant. Viable single-cell suspensions were analyzed by flow cytometry or underwent CD4+ T cell isolation, followed either by stimulation with anti-CD3 and cytokine/chemokine measurement, or by real-time PCR analysis. In lung CD4+ T cells of most COPD subjects, relative to lung CD4+ T cells in smokers with normal spirometry: (a) stimulation induced minimal IFN-gamma or other inflammatory mediators, but many subjects produced more CCL2; (b) the T effector memory subset was less uniformly predominant, without correlation with decreased IFN-gamma production. Analysis of unstimulated lung CD4+ T cells of all subjects identified a molecular phenotype, mainly in COPD, characterized by markedly reduced mRNA transcripts for the transcription factors controlling T(H)1, T(H)2, T(H)17 and FOXP3+ T regulatory subsets and their signature cytokines. This mRNA-defined CD4+ T cell phenotype did not result from global inability to elaborate mRNA; increased transcripts for inhibitory CD28 family members or markers of anergy; or reduced telomerase length. As a group, these subjects had significantly worse spirometry, but not DLCO, relative to subjects whose lung CD4+ T cells expressed a variety of transcripts. Analysis of mRNA transcripts of unstimulated lung CD4+ T cell among all subjects identified two distinct molecular correlates of classical COPD clinical phenotypes: basal IL-10 transcripts correlated independently and inversely with emphysema extent (but not spirometry); by contrast, unstimulated IFN-gamma transcripts correlated independently and inversely with reduced spirometry (but not reduced DLCO or emphysema extent). Aberrant lung CD4+ T cells polarization appears to be common in advanced COPD, but also exists in some smokers with normal spirometry, and may contribute to development and progression of specific COPD phenotypes.	[Freeman, Christine M.] VA Ann Arbor Healthcare Syst, Res Serv, Ann Arbor, MI USA; [Freeman, Christine M.; Crudgington, Sean; Nelson, Joshua; Martinez, Fernando J.; Han, MeiLan K.; Arenberg, Douglas A.; Meldrum, Catherine A.; McCloskey, Lisa; Curtis, Jeffrey L.] Univ Michigan Hlth Syst, Dept Internal Med, Pulm & Crit Care Med Div, Ann Arbor, MI 48109 USA; [McCubbrey, Alexandra L.; Chensue, Stephen W.; Curtis, Jeffrey L.] Univ Michigan, Grad Program Immunol, Ann Arbor, MI 48109 USA; [Washko, George R., Jr.] Brigham & Womans Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA USA; [Washko, George R., Jr.] Harvard Univ, Boston, MA 02115 USA; [Chensue, Stephen W.] VA Ann Arbor Healthcare Syst, Pathol & Lab Med Serv, Ann Arbor, MI USA; [Chensue, Stephen W.] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA; [Curtis, Jeffrey L.] VA Ann Arbor Healthcare Syst, Med Serv, Pulm & Crit Care Med Sect, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Curtis, JL (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Pulm & Crit Care Med Div, Ann Arbor, MI 48109 USA.	jlcurtis@umich.edu	Arenberg, Douglas/P-7251-2014	Arenberg, Douglas/0000-0001-7707-5092; Curtis, Jeffrey/0000-0001-5191-4847	USPHS [R01 HL082480, T32 AI007413, K23 HL093351, K24 HL04212]; Merit Review Award [1 l01 BX001389]; Research Enhancement Award Program from the Biomedical Laboratory Research & Development Service; Department of Veterans Affairs; Parker B. Francis Fellowship in Pulmonary Research; Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center [P30 CA46952]; Lung Tissue Research Consortium (Clinical Centers) [N01 HR046162]; Michigan Institute for Clinical and Health Research [UL1 RR024986]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL093351, R01HL082480, K24HL004212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007413] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Merit Review Award(US Department of Veterans Affairs); Research Enhancement Award Program from the Biomedical Laboratory Research & Development Service; Department of Veterans Affairs(US Department of Veterans Affairs); Parker B. Francis Fellowship in Pulmonary Research; Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center; Lung Tissue Research Consortium (Clinical Centers); Michigan Institute for Clinical and Health Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by R01 HL082480 (F.J.M., J.L.C.), T32 AI007413 (A. L. M.), K23 HL093351 ( M. K. H.) and K24 HL04212 (F.J.M.) from the USPHS; Merit Review Award 1 l01 BX001389 (C. M. F.) and a Research Enhancement Award Program from the Biomedical Laboratory Research & Development Service (J.L.C.), Department of Veterans Affairs; and a Parker B. Francis Fellowship in Pulmonary Research (G.R.W.). These investigations were also supported in part by the Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center, Grant P30 CA46952; by the Lung Tissue Research Consortium (Clinical Centers), Grant N01 HR046162; and by the Michigan Institute for Clinical and Health Research, Grant UL1 RR024986. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; AUERBACH O, 1972, NEW ENGL J MED, V286, P853, DOI 10.1056/NEJM197204202861601; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Barcelo B, 2006, CLIN EXP IMMUNOL, V145, P474, DOI 10.1111/j.1365-2249.2006.03167.x; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Brooks DG, 2010, P NATL ACAD SCI USA, V107, P3018, DOI 10.1073/pnas.0914500107; Burgess JL, 2004, J OCCUP ENVIRON MED, V46, P1013, DOI 10.1097/01.jom.0000141668.70006.52; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Combe CL, 2005, INFECT IMMUN, V73, P4913, DOI 10.1128/IAI.73.8.4913-4921.2005; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Curtis Jeffrey L, 2007, Proc Am Thorac Soc, V4, P512, DOI 10.1513/pats.200701-002FM; Demeo DL, 2008, AM J RESP CELL MOL, V38, P114, DOI 10.1165/rcmb.2007-0107OC; Di Stefano A, 2009, CLIN EXP IMMUNOL, V157, P316, DOI 10.1111/j.1365-2249.2009.03965.x; Dikopoulos N, 2005, J IMMUNOL, V174, P99, DOI 10.4049/jimmunol.174.1.99; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Freeman CM, 2010, J IMMUNOL, V184, P6504, DOI 10.4049/jimmunol.1000006; Freeman CM, 2009, AM J RESP CRIT CARE, V180, P1179, DOI 10.1164/rccm.200904-0552OC; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; GOLD Executive Committee, 2008, GLOB STRAT DIAGN MAN; Gomez-Martin D, 2010, AUTOIMMUN REV, V9, P454, DOI 10.1016/j.autrev.2009.12.006; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; He JQ, 2007, EUR RESPIR J, V29, P1120, DOI 10.1183/09031936.00002907; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Johannessen A, 2013, AM J RESP CRIT CARE, V187, P602, DOI 10.1164/rccm.201209-1722OC; Kapina MA, 2007, J IMMUNOL, V178, P976, DOI 10.4049/jimmunol.178.2.976; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; Livingstone AM, 2009, IMMUNOL RES, V45, P209, DOI 10.1007/s12026-009-8102-0; Lofdahl MJ, 2008, RESP MED, V102, P1812, DOI 10.1016/j.rmed.2008.06.013; Majo J, 2001, EUR RESPIR J, V17, P946, DOI 10.1183/09031936.01.17509460; Majori M, 1999, J ALLERGY CLIN IMMUN, V103, P458, DOI 10.1016/S0091-6749(99)70471-9; Manichaikul A, 2014, AM J RESP CRIT CARE, V189, P408, DOI 10.1164/rccm.201306-1061OC; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; Mets OM, 2012, AM J ROENTGENOL, V199, P336, DOI 10.2214/AJR.11.7808; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Okada R, 2008, INT IMMUNOL, V20, P1189, DOI 10.1093/intimm/dxn075; Paats MS, 2012, EUR RESPIR J, V40, P330, DOI 10.1183/09031936.00079611; Plumb J, 2009, EUR RESPIR J, V34, P89, DOI 10.1183/09031936.00100708; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; Roos-Engstrand E, 2009, COPD, V6, P112, DOI 10.1080/15412550902755358; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Shan M, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranlsmed.3000154; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Smyth LJC, 2007, CHEST, V132, P156, DOI 10.1378/chest.07-0083; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Sullivan AK, 2005, AM J RESP CRIT CARE, V172, P590, DOI 10.1164/rccm.200410-1332OC; THURLBECK W. M., 1963, THORAX, V18, P59, DOI 10.1136/thx.18.1.59	57	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96421	10.1371/journal.pone.0096421	http://dx.doi.org/10.1371/journal.pone.0096421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805101	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900057
J	Mori, H; Matsuda, KI; Yamawaki, M; Kawata, M				Mori, Hiroko; Matsuda, Ken-Ichi; Yamawaki, Masanaga; Kawata, Mitsuhiro			Estrogenic Regulation of Histamine Receptor Subtype H1 Expression in the Ventromedial Nucleus of the Hypothalamus in Female Rats	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; PANCREATIC HORMONE AMYLIN; GUINEA-PIG BRAIN; SEX-DIFFERENCES; H-1 RECEPTORS; GENE-EXPRESSION; NEURONAL HISTAMINE; FEEDING-BEHAVIOR; ANORECTIC ACTION; ARCUATE NUCLEUS	Female sexual behavior is controlled by central estrogenic action in the ventromedial nucleus of the hypothalamus (VMN). This region plays a pivotal role in facilitating sex-related behavior in response to estrogen stimulation via neural activation by several neurotransmitters, including histamine, which participates in this mechanism through its strong neural potentiating action. However, the mechanism through which estrogen signaling is linked to the histamine system in the VMN is unclear. This study was undertaken to investigate the relationship between estrogen and histamine receptor subtype H1 (H1R), which is a potent subtype among histamine receptors in the brain. We show localization of H1R exclusively in the ventrolateral subregion of the female VMN (vl VMN), and not in the dorsomedial subregion. In the vl VMN, abundantly expressed H1R were mostly colocalized with estrogen receptor a. Intriguingly, H1R mRNA levels in the vl VMN were significantly elevated in ovariectomized female rats treated with estrogen benzoate. These data suggest that estrogen can amplify histamine signaling by enhancing H1R expression in the vl VMN. This enhancement of histamine signaling might be functionally important for allowing neural excitation in response to estrogen stimulation of the neural circuit and may serve as an accelerator of female sexual arousal.	[Mori, Hiroko; Yamawaki, Masanaga] Kyoto Prefectural Univ Med, Dept Med Educ, Kamigyo Ku, Kyoto, Japan; [Matsuda, Ken-Ichi; Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Dept Anat & Neurobiol, Kamigyo Ku, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Mori, H (corresponding author), Kyoto Prefectural Univ Med, Dept Med Educ, Kamigyo Ku, Kyoto, Japan.	mori-h@koto.kpu-m.ac.jp			Ministry of Education, Science, Sports, Culture and Technology, Japan [J122004172]; Grants-in-Aid for Scientific Research [23500580, 24700331] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology, Japan (to HM, #J122004172) http://www.jsps.go.jp/english/e-grants/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALE TL, 1995, J NEUROSCI, V15, P5058; BLAUSTEIN JD, 1989, NEUROENDOCRINOLOGY, V49, P454, DOI 10.1159/000125152; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; CHO BN, 1994, BRAIN RES, V652, P177, DOI 10.1016/0006-8993(94)90336-0; DEVRIES GJ, 1994, J NEUROSCI, V14, P1789, DOI 10.1523/JNEUROSCI.14-03-01789.1994; DONOSO AO, 1979, PSYCHOPHARMACOLOGY, V66, P251, DOI 10.1007/BF00428315; Dupre C, 2010, P NATL ACAD SCI USA, V107, P12311, DOI 10.1073/pnas.1006049107; Easton A, 2004, PHARMACOL BIOCHEM BE, V79, P563, DOI 10.1016/j.pbb.2004.09.014; Eckersell CB, 1998, J NEUROSCI, V18, P3967; Ferretti C, 1998, PHARMACOL BIOCHEM BE, V59, P255, DOI 10.1016/S0091-3057(97)00395-X; GELLER HM, 1981, DEV BRAIN RES, V1, P89, DOI 10.1016/0165-3806(81)90096-1; Ghi P, 1999, PHARMACOL BIOCHEM BE, V64, P761, DOI 10.1016/S0091-3057(99)00143-4; Gonzalez-Flores O, 2011, NEUROCHEM INT, V59, P671, DOI 10.1016/j.neuint.2011.06.013; Gotoh K, 2013, J NEUROCHEM, V125, P588, DOI 10.1111/jnc.12213; Griffin GD, 2008, J COMP NEUROL, V510, P631, DOI 10.1002/cne.21816; Griffin GD, 2010, J COMP NEUROL, V518, P4531, DOI 10.1002/cne.22470; Gu GB, 1999, J NEUROSCI, V19, P3213; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hakansson ML, 1998, J NEUROSCI, V18, P559; Han M, 2008, PSYCHONEUROENDOCRINO, V33, P569, DOI 10.1016/j.psyneuen.2008.01.018; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Inoue I, 1996, P NATL ACAD SCI USA, V93, P13316, DOI 10.1073/pnas.93.23.13316; Kasaoka S, 2005, NUTRITION, V21, P855, DOI 10.1016/j.nut.2004.12.009; Kawata M, 2008, J NEUROENDOCRINOL, V20, P673, DOI 10.1111/j.1365-2826.2008.01727.x; Kow LM, 1998, BEHAV BRAIN RES, V92, P169, DOI 10.1016/S0166-4328(97)00189-7; Lintunen M, 1998, EUR J NEUROSCI, V10, P2287, DOI 10.1046/j.1460-9568.1998.00240.x; Lintunen M, 2002, NEUROBIOL DIS, V9, P94, DOI 10.1006/nbdi.2001.0453; MACLUSKY NJ, 1980, ENDOCRINOLOGY, V106, P192, DOI 10.1210/endo-106-1-192; MEISEL RL, 1987, NEUROENDOCRINOLOGY, V45, P201, DOI 10.1159/000124726; Mollet A, 2003, PEPTIDES, V24, P155, DOI 10.1016/S0196-9781(02)00288-7; Mollet A, 2001, AM J PHYSIOL-REG I, V281, pR1442, DOI 10.1152/ajpregu.2001.281.5.R1442; Mori H, 2008, P NATL ACAD SCI USA, V105, P13632, DOI 10.1073/pnas.0806503105; Mori H, 2010, ENDOCRINOLOGY, V151, P5775, DOI 10.1210/en.2010-0646; Morimoto T, 2001, BEHAV BRAIN RES, V124, P145, DOI 10.1016/S0166-4328(01)00225-X; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; PETERSEN SL, 1993, J NEUROENDOCRINOL, V5, P643, DOI 10.1111/j.1365-2826.1993.tb00534.x; PETERSEN SL, 1995, ENDOCRINOLOGY, V136, P3604, DOI 10.1210/en.136.8.3604; Petersen SL, 1997, MOL BRAIN RES, V52, P32, DOI 10.1016/S0169-328X(97)00194-0; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Popper P, 1996, BRAIN RES, V712, P335, DOI 10.1016/0006-8993(95)01561-2; Quadros PS, 2008, ENDOCRINOLOGY, V149, P3054, DOI 10.1210/en.2007-1133; QuinonesJenab V, 1997, MOL BRAIN RES, V47, P134, DOI 10.1016/S0169-328X(97)00041-7; QuinonesJenab V, 1997, NEUROENDOCRINOLOGY, V65, P9, DOI 10.1159/000127160; RENAUD LP, 1976, BRAIN RES, V115, P339, DOI 10.1016/0006-8993(76)90520-5; ROMANO GJ, 1989, MOL ENDOCRINOL, V3, P1295, DOI 10.1210/mend-3-8-1295; RUBIN BS, 1980, ENDOCRINOLOGY, V106, P504, DOI 10.1210/endo-106-2-504; SAKATA T, 1988, PHYSIOL BEHAV, V44, P539, DOI 10.1016/0031-9384(88)90316-2; SoriaJasso LE, 1997, NEUROSCI LETT, V225, P117, DOI 10.1016/S0304-3940(97)00209-7; TASAKA K, 1989, BRAIN RES BULL, V22, P271, DOI 10.1016/0361-9230(89)90053-1; TENNENT BJ, 1980, HORM BEHAV, V14, P65, DOI 10.1016/0018-506X(80)90016-1; Thomas A, 1999, J NEUROENDOCRINOL, V11, P137; Vizuete ML, 1997, NEUROSCIENCE, V80, P321, DOI 10.1016/S0306-4522(97)00010-9; WHALEN RE, 1974, HORM BEHAV, V5, P157, DOI 10.1016/0018-506X(74)90040-3; Xu M, 2000, ENDOCRINOLOGY, V141, P3319, DOI 10.1210/en.141.9.3319; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006; Zhou J, 2005, P NATL ACAD SCI USA, V102, P14907, DOI 10.1073/pnas.0507440102; Zhou J, 2007, J NEUROPHYSIOL, V98, P3143, DOI 10.1152/jn.00337.2007; ZHOU L, 1995, EUR J PHARMACOL, V278, P271, DOI 10.1016/0014-2999(95)00175-K	60	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96232	10.1371/journal.pone.0096232	http://dx.doi.org/10.1371/journal.pone.0096232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805361	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900039
J	Richardson, ET; Morrow, CD; Kalil, DB; Bekker, LG; Wood, R				Richardson, Eugene T.; Morrow, Carl D.; Kalil, Darryl B.; Bekker, Linda-Gail; Wood, Robin			Shared Air: A Renewed Focus on Ventilation for the Prevention of Tuberculosis Transmission	PLOS ONE			English	Article							SOUTH-AFRICAN COMMUNITY; HIGH HIV; MYCOBACTERIUM-TUBERCULOSIS; AIRBORNE INFECTION; OUTBREAK; SCHOOL; EPIDEMIOLOGY; PREVALENCE; HEALTH; RISK	Background:Despite an improvement in the overall TB cure rate from 40-74% between 1995 and 2011, TB incidence in South Africa continues to increase. The epidemic is notably disquieting in schools because the vulnerable population is compelled to be present. Older learners (age 15-19) are at particular risk given a smear-positive rate of 427 per 100,000 per year and the significant amount of time they spend indoors. High schools are therefore important locations for potential TB infection and thus prevention efforts. Methods and Findings: Using portable carbon dioxide monitors, we measured CO2 in classrooms under non-steady state conditions. The threshold for tuberculosis transmission was estimated using a carbon dioxide-based risk equation. We determined a critical rebreathed fraction of carbon dioxide (f(c)) of 1.6%, which correlates with an indoor CO2 concentration of 1000 ppm. These values correspond with a ventilation rate of 8.6 l/s per person or 12 air exchanges per hour (ACH) for standard classrooms of 180 m(3). Conclusions: Given the high smear positive rate of high-school adolescents in South Africa, the proposal to achieve CO2 levels of 1000ppm through natural ventilation (in the amount 12 ACH) will not only help achieve WHO guidelines for providing children with healthy indoor environments, it will also provide a low-cost intervention for helping control the TB epidemic in areas of high prevalence.	[Richardson, Eugene T.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Richardson, Eugene T.] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Morrow, Carl D.; Kalil, Darryl B.; Bekker, Linda-Gail; Wood, Robin] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	Stanford University; Stanford University; University of Cape Town	Richardson, ET (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	etr@stanford.edu	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386; Richardson, Eugene/0000-0001-8437-0671	Advanced Residency Training at Stanford fellowship, a Stanford Graduate Fellowship in Science and Engineering, and an Epidemiology of Emerging Infections and Bioterrorism training grant [T32 AI052073]; International Epidemiologic Database to Evaluate Aids [5U01AI069924-02]; Cost-Effectiveness of Preventing AIDS Complications (CEPAC) [5R01AI058736-02]; Cape Town Clinical Trials (CT-CTU) for HIV/AIDS Prevention and Treatment (NIH) [5U01 AI069519-02]; Novel Methods to Inform HIV/TB Clinical Trial Development [5R01A1093269-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, U01AI069924, T32AI052073, R01AI093269, U01AI069519] Funding Source: NIH RePORTER	Advanced Residency Training at Stanford fellowship, a Stanford Graduate Fellowship in Science and Engineering, and an Epidemiology of Emerging Infections and Bioterrorism training grant; International Epidemiologic Database to Evaluate Aids; Cost-Effectiveness of Preventing AIDS Complications (CEPAC); Cape Town Clinical Trials (CT-CTU) for HIV/AIDS Prevention and Treatment (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novel Methods to Inform HIV/TB Clinical Trial Development; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	ETR was funded by an Advanced Residency Training at Stanford fellowship, a Stanford Graduate Fellowship in Science and Engineering, and an Epidemiology of Emerging Infections and Bioterrorism training grant (NIAID: T32 AI052073). CDM and RW were funded by the International Epidemiologic Database to Evaluate Aids (NIAID: 5U01AI069924-02); Cost-Effectiveness of Preventing AIDS Complications (CEPAC) (NIH: 5R01AI058736-02); Cape Town Clinical Trials (CT-CTU) for HIV/AIDS Prevention and Treatment (NIH: 5U01 AI069519-02); and Novel Methods to Inform HIV/TB Clinical Trial Development (NIH: 5R01A1093269-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JR, 2014, J INFECT DIS, V210, P597, DOI 10.1093/infdis/jiu138; [Anonymous], ANN REPORTS MED OFFI; ASHRAE, 2010, 6212010 ASHRAE ANSIA; Chen W, 2012, J INT MED RES, V40, P1830, DOI 10.1177/030006051204000521; Conceicao EZE, 2006, INT J VENT, V5, P259; Deparmtent for Education and Skills (DfES), 2006, DFES BUILD B; Dubos R, 1952, WHITE PLAGUE TUBERCU; Engels Friedrich, 1968, CONDITION WORKING CL; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Faccini M, 2013, EMERG INFECT DIS, V19, P485, DOI 10.3201/eid1902.120527; Feher J, 2012, ACAD PR SER BIOM ENG, P1; Furuya Hiroyuki, 2009, Environmental Health and Preventive Medicine, V14, P96, DOI 10.1007/s12199-008-0062-9; Geelen LMJ, 2008, INDOOR AIR, V18, P416, DOI 10.1111/j.1600-0668.2008.00542.x; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Johnstone-Robertson S, 2011, SAMJ S AFR MED J, V101, P809; Lienhardt C, 2001, EPIDEMIOL REV, V23, P288, DOI 10.1093/oxfordjournals.epirev.a000807; Lygizos M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-300; Meintjes G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-72; Mendell MJ, 2013, INDOOR AIR, V23, P515, DOI 10.1111/ina.12042; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Middelkoop K, 2009, J INFECT DIS, V200, P1207, DOI 10.1086/605930; Morawska L, 1995, INDOOR AIR INTEGRATE; NARDELL EA, 1991, AM REV RESPIR DIS, V144, P302, DOI 10.1164/ajrccm/144.2.302; New York State Commission on Ventilation, 1923, REP NEW YORK STAT CO; Noakes CJ, 2009, J R SOC INTERFACE, V6, pS791, DOI 10.1098/rsif.2009.0305.focus; Persily A.K., 1997, ASHRAE T, V103, P193; Phillips L, 2004, PEDIATRICS, V113, pE514, DOI 10.1542/peds.113.6.e514; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; RILEY RL, 1957, AM REV TUBERC PULM, V75, P420; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Santamouris M, 2008, ENERG BUILDINGS, V40, P1833, DOI 10.1016/j.enbuild.2008.04.002; Satish U, 2012, ENVIRON HEALTH PERSP, V120, P1671, DOI 10.1289/ehp.1104789; Simpson J V, 1923, J Hyg (Lond), V22, P164; Smedje G, 2000, ARCH ENVIRON HEALTH, V55, P18, DOI 10.1080/00039890009603380; South Africa Department of Basic Education, 2011, INFR REP; Tans P., 2014, GLOBAL GREENHOUSE GA; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Van Niekerk L, POCKET GUIDE S AFRIC; Wells WF, 1955, AIR HYG ECOL STUDY D; Wood R, 2011, SAMJ, V101, P2009; Wood Robin, 2012, PLoS One, V7, pe39246, DOI 10.1371/journal.pone.0039246; Wood R, 2010, CLIN INFECT DIS, V51, P401, DOI 10.1086/655129; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2021, 10 THREATS GLOB HLTH	44	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96334	10.1371/journal.pone.0096334	http://dx.doi.org/10.1371/journal.pone.0096334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804707	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900050
J	Fels, L; Distl, O				Fels, Lena; Distl, Ottmar			Identification and Validation of Quantitative Trait Loci (QTL) for Canine Hip Dysplasia (CHD) in German Shepherd Dogs	PLOS ONE			English	Article							COMPLEX; RAC1; OSTEOARTHRITIS; HERITABILITY; DOMAIN; ELBOW; MAPK	Canine hip dysplasia (CHD) is the most common hereditary skeletal disorder in dogs. To identify common alleles associated with CHD, we genotyped 96 German Shepherd Dogs affected by mild, moderate and severe CHD and 96 breed, sex, age and birth year matched controls using the Affymetrix canine high density SNP chip. A mixed linear model analysis identified five SNPs associated with CHD scores on dog chromosomes (CFA) 19, 24, 26 and 34. These five SNPs were validated in a by sex, age, birth year and coancestry stratified sample of 843 German Shepherd Dogs including 277 unaffected dogs and 566 CHD-affected dogs. Mean coancestry coefficients among and within cases and controls were <0.1%. Genotype effects of these SNPs explained 20-32% of the phenotypic variance of CHD in German Shepherd Dogs employed for validation. Genome-wide significance in the validation data set could be shown for each one CHD-associated SNP on CFA24, 26 and 34. These SNPs are located within or in close proximity of genes involved in bone formation and related through a joint network. The present study validated positional candidate genes within two previously known quantitative trait loci (QTL) and a novel QTL for CHD in German Shepherd Dogs.	[Fels, Lena; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			Gesellschaft zur Forderung Kynologischer Forschung e.V. (GKF), Bonn, Germany; Breeding Associaton of German Shepherd Dogs (Verein fur Deutsche Schaferhunde e.V., SV), Augsburg, Germany	Gesellschaft zur Forderung Kynologischer Forschung e.V. (GKF), Bonn, Germany; Breeding Associaton of German Shepherd Dogs (Verein fur Deutsche Schaferhunde e.V., SV), Augsburg, Germany	This study was supported by the Gesellschaft zur Forderung Kynologischer Forschung e.V. (GKF), Bonn, Germany, and the Breeding Associaton of German Shepherd Dogs (Verein fur Deutsche Schaferhunde e.V., SV), Augsburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala NS, 2010, J BIOL CHEM, V285, P36745, DOI 10.1074/jbc.M110.124628; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Boichard D, 2002, P 7 WCGALP MONT FRAN; Boyce BF, 2006, CLIN CANCER RES, V12, p6291S, DOI 10.1158/1078-0432.CCR-06-0991; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brennan T, 2011, CALCIFIED TISSUE INT, V89, P396, DOI 10.1007/s00223-011-9531-z; Broeckx BJG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074811; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chowdhury TT, 2008, INFLAMM RES, V57, P306, DOI 10.1007/s00011-007-7126-y; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Hamann H, 2003, J ANIM BREED GENET, V120, P258, DOI 10.1046/j.1439-0388.2003.00395.x; Janutta V, 2006, DEUT TIERARZTL WOCH, V113, P6; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Lavrijsen ICM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087735; Liu L, 2009, BBA-PROTEINS PROTEOM, V1794, P1485, DOI 10.1016/j.bbapap.2009.06.016; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Maki K, 2004, HEREDITY, V92, P402, DOI 10.1038/sj.hdy.6800434; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Miyazaki Tsuyoshi, 2006, Mod Rheumatol, V16, P68; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Stock KF, 2011, J ANIM BREED GENET, V128, P219, DOI 10.1111/j.1439-0388.2010.00901.x; Thouverey C, 2012, CELL MOL LIFE SCI, V69, P3115, DOI 10.1007/s00018-012-0983-8; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wang GY, 2011, J CELL SCI, V124, P3405, DOI 10.1242/jcs.076026; Wang GY, 2005, J BONE MINER RES, V20, P1022, DOI 10.1359/JBMR.050113; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	34	25	25	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96618	10.1371/journal.pone.0096618	http://dx.doi.org/10.1371/journal.pone.0096618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802516	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800092
J	Herzog, C; Steffen, J; Pannatier, EG; Hajdas, I; Brunner, I				Herzog, Claude; Steffen, Jan; Pannatier, Elisabeth Graf; Hajdas, Irka; Brunner, Ivano			Nine Years of Irrigation Cause Vegetation and Fine Root Shifts in a Water-Limited Pine Forest	PLOS ONE			English	Article							NORWAY SPRUCE FOREST; SCOTS PINE; LITTER DECOMPOSITION; CLIMATE EXTREMES; ATMOSPHERIC CO2; TREE MORTALITY; TURNOVER RATES; SOIL-MOISTURE; BEECH FORESTS; RHONE VALLEY	Scots pines (Pinus sylvestris L.) in the inner-Alpine dry valleys of Switzerland have suffered from increased mortality during the past decades, which has been caused by longer and more frequent dry periods. In addition, a proceeding replacement of Scots pines by pubescent oaks (Quercus pubescens Willd.) has been observed. In 2003, an irrigation experiment was performed to track changes by reducing drought pressure on the natural pine forest. After nine years of irrigation, we observed major adaptations in the vegetation and shifts in Scots pine fine root abundance and structure. Irrigation permitted new plant species to assemble and promote canopy closure with a subsequent loss of herb and moss coverage. Fine root dry weight increased under irrigation and fine roots had a tendency to elongate. Structural composition of fine roots remained unaffected by irrigation, expressing preserved proportions of cellulose, lignin and phenolic substances. A shift to a more negative delta C-13 signal in the fine root C indicates an increased photosynthetic activity in irrigated pine trees. Using radiocarbon (C-14) measurement, a reduced mean age of the fine roots in irrigated plots was revealed. The reason for this is either an increase in newly produced fine roots, supported by the increase in fine root biomass, or a reduced lifespan of fine roots which corresponds to an enhanced turnover rate. Overall, the responses belowground to irrigation are less conspicuous than the more rapid adaptations aboveground. Lagged and conservative adaptations of tree roots with decadal lifespans are challenging to detect, hence demanding for long-term surveys. Investigations concerning fine root turnover rate and degradation processes under a changing climate are crucial for a complete understanding of C cycling.	[Herzog, Claude; Steffen, Jan; Pannatier, Elisabeth Graf; Brunner, Ivano] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Herzog, Claude; Hajdas, Irka] ETH, Swiss Fed Inst Technol Zurich, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Herzog, C (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	claude.herzog@wsl.ch	Hajdas, Irka/C-6696-2011; Brunner, Ivano L./J-8661-2014	Hajdas, Irka/0000-0003-2373-2725; Brunner, Ivano L./0000-0003-3436-995X; Herzog, Claude/0000-0003-3241-1077	Swiss National Science Foundation (SNF) [SNF 31003A_149507]; COST Action [FP0803]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); COST Action(European Cooperation in Science and Technology (COST))	This study was funded by the Swiss National Science Foundation (SNF), Grant number: SNF 31003A_149507, additional funding was received from COST Action FP0803 'Belowground C turnover in European Forests'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann D, 2004, FLORA ALPINA HAUPT B; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; Bader MKF, 2013, J ECOL, V101, P1509, DOI 10.1111/1365-2745.12149; Bakker MR, 2009, TREE PHYSIOL, V29, P229, DOI 10.1093/treephys/tpn020; Barber S.A, 1995, SOIL NUTR BIOAVAILAB, V2nd ed.; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; BERG B, 1984, SOIL BIOL BIOCHEM, V16, P609, DOI 10.1016/0038-0717(84)90081-6; Bigler C, 2006, ECOSYSTEMS, V9, P330, DOI 10.1007/s10021-005-0126-2; Bird JA, 2006, BIOGEOCHEMISTRY, V79, P361, DOI 10.1007/s10533-005-5632-y; Black KE, 1998, TREE PHYSIOL, V18, P259; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Broecker WS, 1982, COLUMBIA U TRACERS S; Brunner I, 2013, PLANT SOIL, V362, P357, DOI 10.1007/s11104-012-1313-5; Brunner I, 2009, TREE PHYSIOL, V29, P541, DOI 10.1093/treephys/tpn046; CAHILL DM, 1992, PHYSIOL MOL PLANT P, V40, P315, DOI 10.1016/0885-5765(92)90014-M; Carnicer J, 2011, P NATL ACAD SCI USA, V108, P1474, DOI 10.1073/pnas.1010070108; Cavelier J, 1999, PLANT SOIL, V211, P207, DOI 10.1023/A:1004686204235; Chapin III FS, 2012, PRINCIPLES TERRESTRI, P229; Coleman M, 2007, PLANT SOIL, V299, P195, DOI 10.1007/s11104-007-9375-5; Collet C, 1997, ANN SCI FOREST, V54, P65, DOI 10.1051/forest:19970106; Cornelissen JHC, 1996, J ECOL, V84, P755, DOI 10.2307/2261337; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cubera E, 2012, AGROFOREST SYST, V85, P205, DOI 10.1007/s10457-012-9492-x; Dawes MA, 2011, J ECOL, V99, P383, DOI 10.1111/j.1365-2745.2010.01764.x; Dence C.W., 1992, METHODS LIGNIN CHEM, P33, DOI [DOI 10.1007/978-3-642-74065-7_3, 10.1007/978-3-642-74065-7_3]; DESANTO AV, 1993, SOIL BIOL BIOCHEM, V25, P1423, DOI 10.1016/0038-0717(93)90057-I; DEVISSER PHB, 1994, FOREST ECOL MANAG, V68, P15, DOI 10.1016/0378-1127(94)90134-1; Dobbertin M, 2006, FOREST PATHOL, V36, P309, DOI 10.1111/j.1439-0329.2006.00457.x; Dobbertin M, 2005, PHYTON-ANN REI BOT A, V45, P153; Dobbertin M, 2007, THESCIENTIFICWORLDJO, V7, P231, DOI 10.1100/tsw.2007.58; Dobbertin M, 2010, TREE PHYSIOL, V30, P346, DOI 10.1093/treephys/tpp123; Eilmann B, 2010, PLANT CELL ENVIRON, V33, P1351, DOI 10.1111/j.1365-3040.2010.02153.x; Eissenstat D., 2013, PLANT ROOTS HIDDEN H, P399, DOI DOI 10.1201/B14550-32; Eissenstat DM., 2002, PLANT ROOTS HIDDEN H, V3, P221, DOI DOI 10.1201/9780203909423; Endrulat T, 2010, TREE PHYSIOL, V30, P1515, DOI 10.1093/treephys/tpq090; Ewers BE, 2000, PLANT CELL ENVIRON, V23, P1055, DOI 10.1046/j.1365-3040.2000.00625.x; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Finer L, 2011, FOREST ECOL MANAG, V262, P2008, DOI 10.1016/j.foreco.2011.08.042; Forzieri G, 2014, HYDROL EARTH SYST SC, V18, P85, DOI 10.5194/hess-18-85-2014; Fujii S, 2010, SOIL BIOL BIOCHEM, V42, P2224, DOI 10.1016/j.soilbio.2010.08.022; Gaudinski JB, 2009, GLOBAL CHANGE BIOL, V15, P992, DOI 10.1111/j.1365-2486.2008.01736.x; Gaudinski JB, 2001, OECOLOGIA, V129, P420, DOI 10.1007/s004420100746; Gaudinski JB, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003649; Gaul D, 2009, FUNCT PLANT BIOL, V36, P11, DOI 10.1071/FP08195; Genenger M, 2003, PLANT SOIL, V255, P253, DOI 10.1023/A:1026118101339; Giordano L, 2009, FUNGAL DIVERS, V38, P69; GLASER PH, 1990, J ECOL, V78, P1021, DOI 10.2307/2260950; Graf U, 2010, BOT HELV, V120, P15, DOI 10.1007/s00035-010-0071-3; Grossman JD, 2012, EVOL APPL, V5, P850, DOI 10.1111/j.1752-4571.2012.00263.x; Hacke UG, 2000, OECOLOGIA, V124, P495, DOI 10.1007/PL00008875; Hajdas I, 2008, EISZEITALTER GEGENWA, V57, P2, DOI DOI 10.3285/EG.57.1-2.1; Hartmann H, 2013, NEW PHYTOL, V200, P340, DOI 10.1111/nph.12331; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heiniger U, 2011, FOREST PATHOL, V41, P501, DOI 10.1111/j.1439-0329.2011.00713.x; Hertel D, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12124; Hiltbrunner D, 2013, BIOGEOCHEMISTRY, P1; Jones RH, 2003, OECOLOGIA, V134, P132, DOI 10.1007/s00442-002-1098-y; Joslin JD, 1998, PLANT SOIL, V204, P165, DOI 10.1023/A:1004352008490; Joslin JD, 2001, PLANT SOIL, V228, P201, DOI 10.1023/A:1004866705021; Kakac B, 1977, HDB PHOTOMETRISCHEN; KATTERER T, 1995, FOREST ECOL MANAG, V74, P1, DOI 10.1016/0378-1127(95)03529-J; Kindt R, 2008, BIODIVERSITYR GUI BI; King JS, 2005, OECOLOGIA, V146, P318, DOI 10.1007/s00442-005-0191-4; Konopka B, 2008, DROUGHTS CAUSES EFFE, P167; Kuster TM, 2012, PLANT SOIL, P1; Lacointe A, 2000, ANN FOREST SCI, V57, P521; Landolt E, 1977, VEROFFENTLICHUNG GEO, V64; Lemoine D, 2001, ANN FOR SCI, V58, P723, DOI 10.1051/forest:2001159; Leuschner C, 2004, PLANT SOIL, V258, P43, DOI 10.1023/B:PLSO.0000016508.20173.80; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; Levin I, 2008, SCI TOTAL ENVIRON, V391, P211, DOI 10.1016/j.scitotenv.2007.10.019; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mitchell PJ, 2013, NEW PHYTOL, V197, P862, DOI [10.1111/nph.12064, 10.1111]; Montagnoli A, 2012, ECOL RES, V27, P1015, DOI 10.1007/s11284-012-0981-1; Niklaus PA, 2003, GLOBAL CHANGE BIOL, V9, P585, DOI 10.1046/j.1365-2486.2003.00614.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Osswald W, 2012, ECOL STUD-ANAL SYNTH, V220, P53, DOI 10.1007/978-3-642-30645-7_3; Ostonen I, 2007, PLANT BIOSYST, V141, P426, DOI 10.1080/11263500701626069; Ostonen I, 2005, FOREST ECOL MANAG, V212, P264, DOI 10.1016/j.foreco.2005.03.064; Peter M, 2009, BIODIVERS CONSERV, V18, P547, DOI 10.1007/s10531-008-9521-2; Polomski J, 2006, FOREST PATHOL, V36, P110, DOI 10.1111/j.1439-0329.2006.00437.x; PREGITZER KS, 1993, NEW PHYTOL, V125, P575, DOI 10.1111/j.1469-8137.1993.tb03905.x; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Pregitzer KS, 2008, GLOBAL CHANGE BIOL, V14, P142, DOI 10.1111/j.1365-2486.2007.01465.x; Prescott CE, 2010, BIOGEOCHEMISTRY, V101, P133, DOI 10.1007/s10533-010-9439-0; Pronk AA, 2002, PLANT SOIL, V243, P161, DOI 10.1023/A:1019934508011; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Rebetez M, 2004, THEOR APPL CLIMATOL, V79, P1, DOI 10.1007/s00704-004-0058-3; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Richter AK, 2013, PLANT BIOSYST, V147, P50, DOI 10.1080/11263504.2012.742471; Rigling A, 2013, GLOBAL CHANGE BIOL, V19, P229, DOI 10.1111/gcb.12038; Rigling A, 2010, TREE PHYSIOL, V30, P845, DOI 10.1093/treephys/tpq038; Riley WJ, 2009, NEW PHYTOL, V184, P387, DOI 10.1111/j.1469-8137.2009.02980.x; Rouault G, 2006, ANN FOREST SCI, V63, P613, DOI 10.1051/forest:2006044; Sah SP, 2013, PLANT SOIL, V363, P77, DOI 10.1007/s11104-012-1294-4; Sah SP, 2011, BIOGEOCHEMISTRY, V104, P91, DOI 10.1007/s10533-010-9485-7; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; Schenk HJ, 2008, NEW PHYTOL, V178, P223, DOI 10.1111/j.1469-8137.2008.02427.x; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Smith MD, 2011, J ECOL, V99, P651, DOI 10.1111/j.1365-2745.2011.01833.x; Steudle E, 2000, J EXP BOT, V51, P1531, DOI 10.1093/jexbot/51.350.1531; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Synal HA, 2007, NUCL INSTRUM METH B, V259, P7, DOI 10.1016/j.nimb.2007.01.138; Thimonier A, 2005, ENVIRON MONIT ASSESS, V104, P81, DOI 10.1007/s10661-005-1605-9; Thimonier A, 2010, EUR J FOREST RES, V129, P443, DOI 10.1007/s10342-009-0328-9; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Tierney GL, 2003, GLOBAL CHANGE BIOL, V9, P670, DOI 10.1046/j.1365-2486.2003.00622.x; Trubat R, 2010, J ARID ENVIRON, V74, P491, DOI 10.1016/j.jaridenv.2009.10.007; Trumbore S, 2000, ECOL APPL, V10, P399, DOI 10.1890/1051-0761(2000)010[0399:AOSOMA]2.0.CO;2; Wacker L, 2010, NUCL INSTRUM METH B, V268, P931, DOI 10.1016/j.nimb.2009.10.067; Wermelinger B, 2008, ECOL ENTOMOL, V33, P239, DOI 10.1111/j.1365-2311.2007.00960.x; Werner P, 1985, VEGETATION FINGES SO; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; WORRELL R, 1995, FORESTRY, V68, P93, DOI 10.1093/forestry/68.2.93; Yuan ZY, 2010, CRIT REV PLANT SCI, V29, P204, DOI 10.1080/07352689.2010.483579; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zweifel R, 2012, J EXP BOT, V63, P2565, DOI 10.1093/jxb/err432	122	31	32	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96321	10.1371/journal.pone.0096321	http://dx.doi.org/10.1371/journal.pone.0096321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802642	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800053
J	Jaramillo, N; Fonseca-Gonzalez, I; Chaverra-Rodriguez, D				Jaramillo-O, Nicolas; Fonseca-Gonzalez, Idalyd; Chaverra-Rodriguez, Duverney			Geometric Morphometrics of Nine Field Isolates of Aedes aegypti with Different Resistance Levels to Lambda-Cyhalothrin and Relative Fitness of One Artificially Selected for Resistance	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; BODY-SIZE; DIPTERA-CULICIDAE; THERMAL EXIGENCY; WING LENGTH; MOSQUITO; POPULATIONS; ALBOPICTUS; FECUNDITY; DENSITY	Aedes aegypti, a mosquito closely associated with humans, is the principal vector of dengue virus which currently infects about 400 million people worldwide. Because there is no way to prevent infection, public health policies focus on vector control; but insecticide-resistance threatens them. However, most insecticide-resistant mosquito populations exhibit fitness costs in absence of insecticides, although these costs vary. Research on components of fitness that vary with insecticide-resistance can help to develop policies for effective integrated management and control. We investigated the relationships in wing size, wing shape, and natural resistance levels to lambda-cyhalothrin of nine field isolates. Also we chose one of these isolates to select in lab for resistance to the insecticide. The main life-traits parameters were assessed to investigate the possible fitness cost and its association with wing size and shape. We found that wing shape, more than wing size, was strongly correlated with resistance levels to lambda-cyhalothrin in field isolates, but founder effects of culture in the laboratory seem to change wing shape (and also wing size) more easily than artificial selection for resistance to that insecticide. Moreover, significant fitness costs were observed in response to insecticide-resistance as proved by the diminished fecundity and survival of females in the selected line and the reversion to susceptibility in 20 generations of the non-selected line. As a practical consequence, we think, mosquito control programs could benefit from this knowledge in implementing efficient strategies to prevent the evolution of resistance. In particular, the knowledge of reversion to susceptibility is important because it can help in planning better strategies of insecticide use to keep useful the few insecticide-molecules currently available.	[Jaramillo-O, Nicolas; Fonseca-Gonzalez, Idalyd; Chaverra-Rodriguez, Duverney] Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Inst Biol, Medellin, Colombia	Universidad de Antioquia	Jaramillo, N (corresponding author), Univ Antioquia UdeA, Fac Ciencias Exactas & Nat, Inst Biol, Medellin, Colombia.	nicolas.jaramillo@udea.edu.co	Jaramillo-O, Nicolas/AAU-7706-2021; Chaverra Rodriguez, Duverney/GLV-2686-2022	Jaramillo-O, Nicolas/0000-0001-8885-6732; Chaverra Rodriguez, Duverney/0000-0001-8068-7436; Fonseca-Gonzalez, Idalyd/0000-0003-2999-0047	Colciencias; Universidad de Antioquia, Colombia [1115-343-19131, 360-2006]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia, Colombia	This research was supported by Colciencias (www.colciencias.gov.co) and Universidad de Antioquia (www.udea.edu.co), Colombia, project No. 1115-343-19131, Contract No. 360-2006. The funders had no role in studying design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; [Anonymous], 1925, J ECON ENTOMOL; Antonio GE, 2009, PEST MANAG SCI, V65, P323, DOI 10.1002/ps.1683; Armbruster P, 2002, J MED ENTOMOL, V39, P699, DOI 10.1603/0022-2585-39.4.699; Arnqvist G, 1998, ACTA ZOOL ACAD SCI H, V44, P73; Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013; Bellan SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010165; Berger D, 2012, J ANIM ECOL, V81, P1244, DOI 10.1111/j.1365-2656.2012.02010.x; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Beserra EB, 2006, NEOTROP ENTOMOL, V35, P853, DOI 10.1590/S1519-566X2006000600021; Beserra EB, 2009, IHERINGIA SER ZOOL, V99, P142, DOI 10.1590/S0073-47212009000200004; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Bourguet D, 2013, TRENDS ECOL EVOL, V28, P110, DOI 10.1016/j.tree.2012.09.001; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; Brown ZS, 2013, J ECON ENTOMOL, V106, P366, DOI 10.1603/EC11365; Chan HH, 2013, J MED ENTOMOL, V50, P362, DOI 10.1603/ME12182; Chaverra-Rodriguez D, 2012, REV COLOMB ENTOMOL, V38, P100; DEEVEY ES, 1947, Q REV BIOL, V22, P283, DOI 10.1086/395888; Dujardin JP, 2008, INFECT GENET EVOL, V8, P875, DOI 10.1016/j.meegid.2008.07.011; Dujardin Jean-Pierre Al, 2010, BMC Res Notes, V3, P266, DOI 10.1186/1756-0500-3-266; Duron O, 2006, EVOLUTION, V60, P303, DOI 10.1111/j.0014-3820.2006.tb01108.x; Fitnney DJ, 1971, PROBIT ANAL STAT TRE; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081; FUTUYMA DJ, 1998, EVOLUTIONARY BIOL, P561; Gaspe MS, 2013, INFECT GENET EVOL, V17, P93, DOI 10.1016/j.meegid.2013.03.044; Gomez A, 2011, MEM I OSWALDO CRUZ, V106, P993, DOI 10.1590/S0074-02762011000800015; GROOT H, 1980, AM J TROP MED HYG, V29, P330, DOI 10.4269/ajtmh.1980.29.330; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Henry A, 2010, INFECT GENET EVOL, V10, P207, DOI 10.1016/j.meegid.2009.12.001; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hoy MA, 1998, PHILOS T ROY SOC B, V353, P1787, DOI 10.1098/rstb.1998.0331; Jirakanjanakit N, 2007, TROP MED INT HEALTH, V12, P1354, DOI 10.1111/j.1365-3156.2007.01919.x; Jirakanjanakit N, 2008, INFECT GENET EVOL, V8, P414, DOI 10.1016/j.meegid.2007.05.004; Jirakanjanakit Nuananong, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P858; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Koella JC, 1996, J MED ENTOMOL, V33, P261, DOI 10.1093/jmedent/33.2.261; Kumar S, 2009, TROP BIOMED, V26, P155; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315; PACKER MJ, 1989, ECOL ENTOMOL, V14, P297, DOI 10.1111/j.1365-2311.1989.tb00960.x; Paris M, 2011, ECOTOXICOLOGY, V20, P1184, DOI 10.1007/s10646-011-0663-8; R Core Team, 2012, R LANG ENV STAT COMP; Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117; Reiskind MH, 2012, J INSECT PHYSIOL, V58, P911, DOI 10.1016/j.jinsphys.2012.04.006; REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177; Rohlf F.J., 2013, TPSRELW RELATIVE WAR; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Vargas REM, 2010, INFECT GENET EVOL, V10, P580, DOI 10.1016/j.meegid.2010.01.004; WHO, 1981, WHOVBC818076; WHO, 1998, WHOCDSCPCMAL9812; WHO, 2012, WHOHTMNTDVEW20125; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222	65	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96379	10.1371/journal.pone.0096379	http://dx.doi.org/10.1371/journal.pone.0096379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801598	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800064
J	Orri, M; Paduanello, M; Lachal, J; Falissard, B; Sibeoni, J; Revah-Levy, A				Orri, Massimiliano; Paduanello, Matteo; Lachal, Jonathan; Falissard, Bruno; Sibeoni, Jordan; Revah-Levy, Anne			Qualitative Approach to Attempted Suicide by Adolescents and Young Adults: The (Neglected) Role of Revenge	PLOS ONE			English	Article							DELIBERATE SELF-HARM; BEHAVIOR; CHILDREN; PEOPLE; HEALTH	Background: Suicide by adolescents and young adults is a major public health concern, and repetition of self-harm is an important risk factor for future suicide attempts. Objective: Our purpose is to explore the perspective of adolescents directly involved in suicidal acts. Methods: Qualitative study involving 16 purposively selected adolescents (sex ratio1:1) from 3 different centers. Half had been involved in repeated suicidal acts, and the other half only one. Data were gathered through semistructured interviews and analyzed according to Interpretative Phenomenological Analysis. Results: We found five main themes, organized in two superordinate themes. The first theme (individual dimensions of the suicide attempt) describes the issues and explanations that the adolescents saw as related to themselves; it includes the subthemes: (1) negative emotions toward the self and individual impasse, and (2) the need for some control over their lives. The second main theme (relational dimensions of attempted suicide) describes issues that adolescents mentioned that were related to others and includes three subthemes: (3) perceived impasse in interpersonal relationships, (4) communication, and (5) revenge. Conclusions: Adolescents involved in suicidal behavior are stuck in both an individual and a relational impasse from which there is no exit and no apparent way to reach the other. Revenge can bridge this gap and thus transforms personal distress into a relational matter. This powerful emotion has been neglected by both clinicians and researchers.	[Orri, Massimiliano; Lachal, Jonathan; Falissard, Bruno; Sibeoni, Jordan; Revah-Levy, Anne] Univ Paris Sud, INSERM Res Unit 669, Paris, France; [Orri, Massimiliano; Lachal, Jonathan; Falissard, Bruno; Sibeoni, Jordan; Revah-Levy, Anne] Paris Descartes Univ, Paris, France; [Paduanello, Matteo] Univ Padua, Dept Appl Psychol, Padua, Italy; [Lachal, Jonathan; Sibeoni, Jordan] Cochin Hosp, AP HP, Maison Solenn, Paris, France; [Revah-Levy, Anne] Argenteuil Hosp Ctr, Ctr Soins Psychotherapeut Transit Adolescents, Argenteuil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; University of Padua; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Orri, M (corresponding author), Univ Paris Sud, INSERM Res Unit 669, Paris, France.	massimiliano.orri@inserm.fr	Lachal, Jonathan/G-9444-2014; Orri, Massimiliano/S-9220-2019	Lachal, Jonathan/0000-0002-6282-7359; revah-levy, anne/0000-0003-1805-6275; Paduanello, Matteo/0000-0002-7228-1433; Orri, Massimiliano/0000-0003-1389-2610; Sibeoni, Jordan/0000-0001-9613-5513				[Anonymous], 1960, CARTESIAN MEDITATION; Bergmans Y, 2009, CRISIS, V30, P120, DOI 10.1027/0227-5910.30.3.120; Cash SJ, 2009, CURR OPIN PEDIATR, V21, P613, DOI 10.1097/MOP.0b013e32833063e1; Chitsabesan P, 2003, EUR CHILD ADOLES PSY, V12, P23, DOI 10.1007/s00787-003-0302-x; Connor J, 2009, J ADOLESCENCE, V32, P619, DOI 10.1016/j.adolescence.2008.06.005; Consoli A, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-8; Council of Europe, 2008, CHILD TEEN SUIC EUR; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Everall RD., 2000, CAN J COUNS, V34, P111; Fenaughty J, 2003, J HOMOSEXUAL, V45, P1, DOI 10.1300/J082v45n01_01; Hawton K, 1998, J EPIDEMIOL COMMUN H, V52, P191, DOI 10.1136/jech.52.3.191; Hawton K, 2003, J CHILD PSYCHOL PSYC, V44, P1191, DOI 10.1111/1469-7610.00200; Hawton K, 2007, J CLIN PSYCHIAT, V68, P1574, DOI 10.4088/JCP.v68n1017; Hawton K, 2012, J CHILD PSYCHOL PSYC, V53, P1212, DOI 10.1111/j.1469-7610.2012.02559.x; Herrera A, 2006, SOC SCI MED, V62, P805, DOI 10.1016/j.socscimed.2005.06.055; Hjelmeland H, 2010, SUICIDE LIFE-THREAT, V40, P74, DOI 10.1521/suli.2010.40.1.74; Kaess M, 2012, EVID-BASED MENT HEAL, V15, P66, DOI 10.1136/ebmental-2012-100791; Knoll JL, 2010, J AM ACAD PSYCHIATRY, V38, P87; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; McLane J., 1996, HYPATIA, V11, P107, DOI [DOI 10.1111/j.1527-2001.1996.tb01038.x, 10.1111/j.1527-2001.1996.tb01038.x, DOI 10.1111/J.1527-2001.1996.TB01038.X]; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Patton M. Q., 2001, QUALITATIVE RES EVAL; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Scottish Executive SAH, 2008, EFF INT PREV SUIC SU; Sinclair J, 2005, BRIT MED J, V330, P1112, DOI 10.1136/bmj.38441.503333.8F; Smith J., 2008, DOING SOCIAL PSYCHOL, P229; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Smith JA, 2009, QUAL RES PSYCHOL; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Tyrer P, 2003, PSYCHOL MED, V33, P969, DOI 10.1017/S0033291703008171; World Health Organization, SUIC PREV SUPRE; Zayas L, 2010, SOC SCI MED, V70, P1773, DOI 10.1016/j.socscimed.2010.02.013	32	23	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96716	10.1371/journal.pone.0096716	http://dx.doi.org/10.1371/journal.pone.0096716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802777	gold, Green Published			2022-12-27	WOS:000338029800114
J	Salamanca, HH; Antonyak, MA; Cerione, RA; Shi, H; Lis, JT				Salamanca, H. Hans; Antonyak, Marc A.; Cerione, Richard A.; Shi, Hua; Lis, John T.			Inhibiting Heat Shock Factor 1 in Human Cancer Cells with a Potent RNA Aptamer	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN 90 INHIBITOR; TRANSCRIPTION FACTOR; DNA-BINDING; IN-VIVO; MOLECULAR CHAPERONES; POLYMERASE-III; PHASE-II; DISTINCT; EXPRESSION	Heat shock factor 1 (HSF1) is a master regulator that coordinates chaperone protein expression to enhance cellular survival in the face of heat stress. In cancer cells, HSF1 drives a transcriptional program distinct from heat shock to promote metastasis and cell survival. Its strong association with the malignant phenotype implies that HSF1 antagonists may have general and effective utilities in cancer therapy. For this purpose, we had identified an avid RNA aptamer for HSF1 that is portable among different model organisms. Extending our previous work in yeast and Drosophila, here we report the activity of this aptamer in human cancer cell lines. When delivered into cells using a synthetic gene and strong promoter, this aptamer was able to prevent HSF1 from binding to its DNA regulation elements. At the cellular level, expression of this aptamer induced apoptosis and abolished the colony-forming capability of cancer cells. At the molecular level, it reduced chaperones and attenuated the activation of the MAPK signaling pathway. Collectively, these data demonstrate the advantage of aptamers in drug target validation and support the hypothesis that HSF1 DNA binding activity is a potential target for controlling oncogenic transformation and neoplastic growth.	[Salamanca, H. Hans; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Salamanca, H. Hans] SUNY Upstate Med Univ, Coll Med, Syracuse, NY 13210 USA; [Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Shi, Hua] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Shi, Hua] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Lis, John T.] Dongguk Univ, Dept Biomed Engn, Seoul, South Korea	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Dongguk University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	jtl10@cornell.edu			National Institutes of Health (NIH) [GM25232, CA140730]; Cornell University;  [25232-2351]; NATIONAL CANCER INSTITUTE [R01CA140730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232, P41GM103485] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cornell University; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the National Institutes of Health (NIH) grants (GM25232 to J.T. Lis; CA140730 to J.T. Lis and H. Shi; Minority Supplement #25232-2351 to J.T. Lis and H. H. Salamanca), and Cornell University (Provost Diversity Fellowship to H.H. Salamanca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisht KS, 2003, CANCER RES, V63, P8984; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Czarnecka-Verner E, 2000, PLANT MOL BIOL, V43, P459, DOI 10.1023/A:1006448607740; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Drysdale MJ, 2006, CURR OPIN DRUG DISC, V9, P483; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan XC, 2005, NUCLEIC ACIDS RES, V33, P838, DOI 10.1093/nar/gki212; Fan XC, 2004, P NATL ACAD SCI USA, V101, P6934, DOI 10.1073/pnas.0401523101; Hendrickson AEW, 2012, GYNECOL ONCOL, V124, P210, DOI 10.1016/j.ygyno.2011.10.002; Hong D, 2013, CLIN CANCER RES, V19, P4824, DOI 10.1158/1078-0432.CCR-13-0477; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lebruska LL, 1999, BIOCHEMISTRY-US, V38, P3168, DOI 10.1021/bi982515x; Liu XD, 1997, EMBO J, V16, P6466, DOI 10.1093/emboj/16.21.6466; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mi J, 2006, NUCLEIC ACIDS RES, V34, P3577, DOI 10.1093/nar/gkl482; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Oh WK, 2011, UROLOGY, V78, P626, DOI 10.1016/j.urology.2011.04.041; Ostling P, 2007, J BIOL CHEM, V282, P7077, DOI 10.1074/jbc.M607556200; Richardson PG, 2010, BRIT J HAEMATOL, V150, P428, DOI 10.1111/j.1365-2141.2010.08264.x; Salamanca HH, 2011, NUCLEIC ACIDS RES, V39, P6729, DOI 10.1093/nar/gkr206; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; Shi H, 1999, P NATL ACAD SCI USA, V96, P10033, DOI 10.1073/pnas.96.18.10033; Wang SC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq529; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wurster SE, 2008, RNA, V14, P1037, DOI 10.1261/rna.878908; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Zhao XC, 2006, NUCLEIC ACIDS RES, V34, P3755, DOI 10.1093/nar/gkl470	36	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96330	10.1371/journal.pone.0096330	http://dx.doi.org/10.1371/journal.pone.0096330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800749	Green Published, gold			2022-12-27	WOS:000338029800056
J	Yu, XB; Su, JW; Li, XY; Chen, G				Yu, Xiao-Bo; Su, Jun-Wei; Li, Xiu-Yang; Chen, Gao			Short-Term Effects of Particulate Matter on Stroke Attack: Meta-Regression and Meta-Analyses	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; ACUTE ISCHEMIC-STROKE; HOSPITAL ADMISSIONS; CARDIOVASCULAR-DISEASES; HEMORRHAGIC STROKE; ASSOCIATION; EXPOSURE; MORTALITY; TAIWAN; RISK	Background and Purpose: Currently there are more and more studies on the association between short-term effects of exposure to particulate matter (PM) and the morbidity of stroke attack, but few have focused on stroke subtypes. The objective of this study is to assess the relationship between PM and stroke subtypes attack, which is uncertain now. Methods: Meta-analyses, meta-regression and subgroup analyses were conducted to investigate the association between short-term effects of exposure to PM and the morbidity of different stroke subtypes from a number of epidemiologic studies (from 1997 to 2012). Results: Nineteen articles were identified. Odds ratio (OR) of stroke attack associated with particular matter ("thoracic particles'' [PM10]<10 mu m in aerodynamic diameter, "fine particles'' [PM2.5]<2.5 mu m in aerodynamic diameter) increment of 10 mu g/m(3) was as effect size. PM10 exposure was related to an increase in risk of stroke attack (OR per 10 mu g/m(3) = 1.004, 95%CI: 1.001 similar to 1.008) and PM2.5 exposure was not significantly associated with stroke attack (OR per 10 mu g/m(3) = 0.999, 95%CI: 0.994 similar to 1.003). But when focused on stroke subtypes, PM2.5 (OR per 10 mu g/m(3) = 1.025; 95%CI, 1.001 similar to 1.049) and PM10 (OR per 10 mu g/m(3) = 1.013; 95%CI, 1.001 similar to 1.025) exposure were statistically significantly associated with an increased risk of ischemic stroke attack, while PM2.5 (all the studies showed no significant association) and PM10 (OR per 10 mu g/m(3) = 1.007; 95%CI, 0.992 similar to 1.022) exposure were not associated with an increased risk of hemorrhagic stroke attack. Meta-regression found study design and area were two effective covariates. Conclusion: PM2.5 and PM10 had different effects on different stroke subtypes. In the future, it's worthwhile to study the effects of PM to ischemic stroke and hemorrhagic stroke, respectively.	[Yu, Xiao-Bo; Chen, Gao] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Jun-Wei] Zhejiang Univ, Affiliated Hosp 1, Minist Publ Hlth China, Key Lab Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Xiu-Yang] Zhejiang Univ, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, XY (corresponding author), Zhejiang Univ, Dept Publ Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	lixiuyang@zju.edu.cn; d.chengao@163.com			Hangzhou Science and Technology Bureau [200513231344]; Fundamental Research Funds for the Central Universities [2010QNA7020]; Zhejiang University Undergraduate Zetetic Experiment Project of Public Health; Zhejiang University Student Research Training Program (SRTP); Zhejiang University Public Health Innovative Experiment Project	Hangzhou Science and Technology Bureau; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Zhejiang University Undergraduate Zetetic Experiment Project of Public Health; Zhejiang University Student Research Training Program (SRTP); Zhejiang University Public Health Innovative Experiment Project	This research was supported by a grant from Hangzhou Science and Technology Bureau (Grants 200513231344), the Fundamental Research Funds for the Central Universities (Grants 2010QNA7020), and a grant from Zhejiang University Undergraduate Zetetic Experiment Project of Public Health (2013). Additional support was provided by Zhejiang University Student Research Training Program (SRTP) (2011) and Zhejiang University Public Health Innovative Experiment Project (2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ZJ, 2010, EUR HEART J, V31, P2034, DOI 10.1093/eurheartj/ehq188; Atkinson RW, 2013, EPIDEMIOLOGY, V24, P44, DOI 10.1097/EDE.0b013e318276ccb8; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; Corea F, 2012, NEUROL INT, V4, P44, DOI 10.4081/ni.2012.e11; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Guo Yu-ming, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P1064; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306; Bin J, 2006, J EXPO SCI ENV EPID, V16, P225, DOI 10.1038/sj.jea.7500451; Johnson JYM, 2010, STROKE, V41, P1319, DOI 10.1161/STROKEAHA.110.580571; Kelly FJ, 2003, OCCUP ENVIRON MED, V60, P612, DOI 10.1136/oem.60.8.612; Larrieu S, 2007, SCI TOTAL ENVIRON, V387, P105, DOI 10.1016/j.scitotenv.2007.07.025; Le Tertre A, 2002, J EPIDEMIOL COMMUN H, V56, P773, DOI 10.1136/jech.56.10.773; LEBOWITZ MD, 1995, SCI TOTAL ENVIRON, V168, P109, DOI 10.1016/0048-9697(95)04614-7; Li XY, 2012, CNS NEUROSCI THER, V18, P501, DOI 10.1111/j.1755-5949.2012.00325.x; Liao DP, 1999, ENVIRON HEALTH PERSP, V107, P521, DOI 10.2307/3434393; Linn WS, 2000, ENVIRON HEALTH PERSP, V108, P427, DOI 10.2307/3454383; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Maheswaran R, 2012, STROKE, V43, P22, DOI 10.1161/STROKEAHA.110.610238; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; O'Donnell MJ, 2011, EPIDEMIOLOGY, V22, P422, DOI 10.1097/EDE.0b013e3182126580; Oudin A, 2010, NEUROEPIDEMIOLOGY, V34, P131, DOI 10.1159/000274807; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Tsai SS, 2003, STROKE, V34, P2612, DOI 10.1161/01.STR.0000095564.33543.64; Vidale S, 2010, NEUROL SCI, V31, P179, DOI 10.1007/s10072-009-0206-8; Villeneuve PJ, 2006, EUR J EPIDEMIOL, V21, P689, DOI 10.1007/s10654-006-9050-9; Villeneuve PJ, 2012, SCI TOTAL ENVIRON, V430, P193, DOI 10.1016/j.scitotenv.2012.05.002; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Willocks LJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-227; Wong TW, 1999, OCCUP ENVIRON MED, V56, P679, DOI 10.1136/oem.56.10.679; Wordley J, 1997, OCCUP ENVIRON MED, V54, P108, DOI 10.1136/oem.54.2.108; Ye Yu, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P816	38	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95682	10.1371/journal.pone.0095682	http://dx.doi.org/10.1371/journal.pone.0095682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802512	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800032
J	Isono, T; Chano, T; Kitamura, A; Yuasa, T				Isono, Takahiro; Chano, Tokuhiro; Kitamura, Asuka; Yuasa, Takeshi			Glucose Deprivation Induces G2/M Transition-Arrest and Cell Death in N-GlcNAc(2)-Modified Protein-Producing Renal Carcinoma Cells	PLOS ONE			English	Article							CANCER	Some cancer cells can survive under glucose deprivation within the microenvironment of a tumor. Recently, we reported that N-linked (beta-N-acetylglucosamine)(2) [N-GlcNAc(2)]-modified proteins induce G2/M arrest and cell death under glucose deprivation. Here, we investigated whether such a response to glucose deprivation contributes to the survival of renal cell carcinomas, which are sensitive to nutritional stress. Specifically, we analyzed seven renal carcinoma cell lines. Four of these cell lines produced N-GlcNAc(2)-modified proteins and led G2/M-phase arrest under glucose deprivation, leading to cell death. The remaining three cell lines did not produce N-GlcNAc(2)-modified proteins and undergo G1/S-phase arrest under glucose deprivation, leading to survival. The four dead cell lines displayed significant up-regulation in the UDP-GlcNAc biosynthesis pathway as well as increased phosphorylation of p53, which was not observed in the surviving three cell lines. In addition, the four dead cell lines showed prolonged up-regulated expression of ATF3, which is related to unfolded protein response (UPR), while the surviving three cell lines showed only transient up-regulation of ATF3. In this study, we demonstrated that the renal carcinoma cells which accumulate N-GlcNAc(2)-modified proteins under glucose deprivation do not survive with abnormaly prolonged UPR pathway. By contrast, renal carcinoma cells that do not accumulate N-GlcNAc(2)-modified proteins under these conditions survive. Morover, we demonstrated that buformin, a UPR inhibitor, efficiently reduced cell survival under conditions of glucose deprivation for both sensitive and resistant phenotypes. Further studies to clarify these findings will lead to the development of novel chemotherapeutic treatments for renal cancer.	[Isono, Takahiro; Kitamura, Asuka] Shiga Univ Med Sci, Cent Reseach Lab, Otsu, Shiga 52021, Japan; [Chano, Tokuhiro] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Yuasa, Takeshi] Japanese Fdn Canc Res, Inst Canc, Dept Urol, Tokyo 170, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Japanese Foundation for Cancer Research	Isono, T (corresponding author), Shiga Univ Med Sci, Cent Reseach Lab, Otsu, Shiga 52021, Japan.	isono@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Smoking Research Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan	Smoking Research Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was partly supported by the Smoking Research Foundation (T. Y.) and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (T. C. and T. Y.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busaidy NL, 2012, J CLIN ONCOL, V30, P2919, DOI 10.1200/JCO.2011.39.7356; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; El Mjiyad N, 2011, ONCOGENE, V30, P253, DOI 10.1038/onc.2010.466; Hartmann JT, 1999, ANTICANCER RES, V19, P1541; Hidalgo M, 2006, CLIN CANCER RES, V12, P5755, DOI 10.1158/1078-0432.CCR-06-0118; Isono T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060397; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Matsuo J, 2012, MOL CANCER THER, V11, P1082, DOI 10.1158/1535-7163.MCT-11-0871; Rajapakse AG, 2009, AM J PHYSIOL-HEART C, V296, pH815, DOI 10.1152/ajpheart.00756.2008; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Srinivasan R, 2007, NAT CLIN PRACT UROL, V4, P74, DOI 10.1038/ncpuro0705; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Wu H, 2012, J PATHOL, V227, P189, DOI 10.1002/path.3978	17	18	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96168	10.1371/journal.pone.0096168	http://dx.doi.org/10.1371/journal.pone.0096168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796485	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000043
J	Kobayashi, K; Takahashi, O; Hiratsuka, M; Yamaotsu, N; Hirono, S; Watanabe, Y; Oda, A				Kobayashi, Kana; Takahashi, Ohgi; Hiratsuka, Masahiro; Yamaotsu, Noriyuki; Hirono, Shuichi; Watanabe, Yurie; Oda, Akifumi			Evaluation of Influence of Single Nucleotide Polymorphisms in Cytochrome P450 2B6 on Substrate Recognition Using Computational Docking and Molecular Dynamics Simulation	PLOS ONE			English	Article							AMINO-ACID; SEQUENCES; ENZYMES; P450; SUPERFAMILY; PARAMETERS; MUTANTS; SITES; 2C9	In this study, we investigated the influence of single nucleotide polymorphisms on the conformation of mutated cytochrome P450 ( CYP) 2B6 proteins using molecular dynamics ( MD) simulation. Some of these mutations influence drug metabolism activities, leading to individual variations in drug efficacy and pharmacokinetics. Using computational docking, we predicted the structure of the complex between the antimalarial agent artemether and CYP2B6 whose conformations were obtained by MD simulation. The simulation demonstrated that the entire structure of the protein changes even when a single residue is mutated. Moreover, the structural flexibility is affected by the mutations and it may influence the enzyme activity. The results suggest that some of the inactive mutants cannot recognize artemether due to structural changes caused by the mutation.	[Kobayashi, Kana; Takahashi, Ohgi] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, Sendai, Miyagi, Japan; [Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi, Japan; [Yamaotsu, Noriyuki; Hirono, Shuichi] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo, Japan; [Watanabe, Yurie; Oda, Akifumi] Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan; [Oda, Akifumi] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan	Tohoku Medical & Pharmaceutical University; Tohoku University; Kitasato University; Kanazawa University; Osaka University	Oda, A (corresponding author), Kanazawa Univ, Fac Pharm, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa, Japan.	oda@p.kanazawa-u.ac.jp	ODA, Akifumi/D-8405-2015; Hiratsuka, Masahiro/AAO-8082-2020; Yamaotsu, Noriyuki/AAW-2545-2020	Hiratsuka, Masahiro/0000-0002-3767-7686; Yamaotsu, Noriyuki/0000-0002-4302-1085	Japan Society for the Promotion of Science [23790137]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for scientific research (23790137) from the Japan Society for the Promotion of Science(http:// www. jsps.go.jp/english/index. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-275; [Anonymous], 2008, SPART 08; Bathelt C, 2002, J MOL MODEL, V8, P327, DOI 10.1007/s00894-002-0104-y; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Case D.A., 2008, AMBER10; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570; GOTOH O, 1992, J BIOL CHEM, V267, P83; Hanna IH, 2000, ARCH BIOCHEM BIOPHYS, V376, P206, DOI 10.1006/abbi.2000.1708; Honda M, 2011, DRUG METAB DISPOS, V39, P1860, DOI 10.1124/dmd.111.040352; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Momose Y, 2002, ANN NEUROL, V51, P133, DOI 10.1002/ana.10079; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Nagata N, 2012, J CHEM INF MODEL, V52, P2257, DOI 10.1021/ci300219g; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; Niu RJ, 2011, J MOL MODEL, V17, P2839, DOI 10.1007/s00894-011-0970-2; Oda A, 2005, J COMPUT CHEM, V26, P818, DOI 10.1002/jcc.20221; Oda A, 2004, PHARM RES, V21, P2270, DOI 10.1007/s11095-004-7680-8; Oda A, 2009, J COMPUT CHEM, V30, P2728, DOI 10.1002/jcc.21299; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Shaik S., 2005, CYTOCHROME P450 STRU, P45, DOI DOI 10.1007/0-387-27447-2_2; Skopalik J, 2008, J PHYS CHEM B, V112, P8165, DOI 10.1021/jp800311c; Stresser DM, 1999, DRUG METAB DISPOS, V27, P517; Tu Y, 2008, DRUG METAB DISPOS, V36, P2371, DOI 10.1124/dmd.108.022640; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Watanabe T, 2010, PHARMACOGENET GENOM, V20, P459, DOI 10.1097/FPC.0b013e32833bba0e; Wolkers J, 1998, AQUAT TOXICOL, V44, P103, DOI 10.1016/S0166-445X(98)00063-0; Yamaotsu N, 2008, BIOL PHARM BULL, V31, P1552, DOI 10.1248/bpb.31.1552	31	21	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96789	10.1371/journal.pone.0096789	http://dx.doi.org/10.1371/journal.pone.0096789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796891	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000127
J	Lagrange, PH; Thangaraj, SK; Dayal, R; Deshpande, A; Ganguly, NK; Girardi, E; Joshi, B; Katoch, K; Katoch, VM; Kumar, M; Lakshmi, V; Leportier, M; Longuet, C; Malladi, SVS; Mukerjee, D; Nair, D; Raja, A; Raman, B; Rodrigues, C; Sharma, P; Singh, A; Singh, S; Sodha, A; Kabeer, BSA; Vernet, G; Goletti, D				Lagrange, Philippe H.; Thangaraj, Satheesh K.; Dayal, Rajeshwar; Deshpande, Alaka; Ganguly, Nirmal K.; Girardi, Enrico; Joshi, Beenu; Katoch, Kiran; Katoch, Vishwa M.; Kumar, Manoj; Lakshmi, Vemu; Leportier, Marc; Longuet, Christophe; Malladi, Subbalaxmi V. S.; Mukerjee, Deepali; Nair, Deepthi; Raja, Alamelu; Raman, Balambal; Rodrigues, Camilla; Sharma, Pratibha; Singh, Amit; Singh, Sarman; Sodha, Archana; Kabeer, Basirudeen Syed Ahamed; Vernet, Guy; Goletti, Delia			A Toolbox for Tuberculosis (TB) Diagnosis: An Indian Multi-Centric Study (2006-2008); Evaluation of Serological Assays Based on PGL-Tb1 and ESAT-6/CFP10 Antigens for TB Diagnosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; HUMORAL RESPONSE; IMMUNOLOGICAL DIAGNOSIS; GLYCOLIPID ANTIGENS; ANTIBODY-RESPONSES; MEDIATED IMMUNITY; MYCODOT(TM) TEST; LIPID ANTIGENS; SERODIAGNOSIS	Background: The aim of this multi-centric prospective study in India was to assess the accuracy of a serological test as an additional tool for diagnosing active tuberculosis (ATB). In particular, an assay based on ELISA using a phenolic glycolipid (PGL-Tb1) or a fusion protein (ESAT-6/CFP10) was compared to the tuberculin skin test (TST) and the microbiological results according to HIV status. Methods: Individuals with and without ATB and HIV infection were enrolled. Serology and TST results were analyzed per se and in combination with the microbiological data. Results: Among the 778 ATB patients, 102 were HIV-infected, 316 HIV-uninfected and 360 had an HIV-unknown status. Of the 945 non-ATB subjects, 559 were at low risk (community adults) and 386 at high risk of M. tuberculosis exposure. Among those with ATB, the sensitivity of ELISA-PGL-Tb1 for ATB was higher than that of ELISA-ESAT-6/CFP10, both in HIV-infected (72.3% versus 63.7%, p = 0.29) and HIV-uninfected/HIV-unknown groups (40.5% versus 28.6%; p < 0.0001), whereas the specificity was around 91% for both tests. Sensitivity for ATB increased when the results of the two ELISA were combined, reaching 75.5% in the HIV-infected and 50.9% in the group of HIV-uninfected/HIV-unknown ATB, with a significant decrease of the global specificity (83.9%). Analyzing the ELISA results with the microbiological results, we observed that the sensitivity of both serology tests was independent of the ATB patients' smear microscopy (SM) status and grade. Combining the results of SM with both ELISA, the detection of ATB patients significantly increased (p < 0.0001), particularly in those with extrapulmonary TB (up to 45.1%) or HIV infection (up to 83.3%). No significant association was observed between TST and serology results. Conclusions: In this prospective multi-centric study, the combination of two rapid tests, such as SM and serology, might be useful in detecting ATB, especially in HIV-infected patients.	[Lagrange, Philippe H.] Hop St Louis, Microbiol Serv, Paris, France; [Thangaraj, Satheesh K.; Leportier, Marc] BioMerieux, Marcy Letoile, France; [Thangaraj, Satheesh K.; Leportier, Marc] BioMerieux, New Delhi, India; [Dayal, Rajeshwar; Singh, Amit] SN Med Coll & Hosp, Agra, Uttar Pradesh, India; [Deshpande, Alaka] Sir JJ Grp Govt Hosp & Grant Med Coll, Bombay, Maharashtra, India; [Ganguly, Nirmal K.; Mukerjee, Deepali] Indian Council Med Res, New Delhi, India; [Girardi, Enrico; Goletti, Delia] L Spallanzani Natl Inst Infect Dis, Dept Epidemiol & Preclin Res, Rome, Italy; [Joshi, Beenu; Katoch, Kiran; Katoch, Vishwa M.] Natl JALMA Inst Leprosy & Other Mycrobacterial Di, Agra, Uttar Pradesh, India; [Kumar, Manoj; Singh, Sarman] All India Inst Med Sci, New Delhi, India; [Lakshmi, Vemu; Malladi, Subbalaxmi V. S.] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India; [Longuet, Christophe; Vernet, Guy] Fdn Merieux, Lyon, France; [Nair, Deepthi; Sharma, Pratibha] Safdarjang Hosp, New Delhi, India; [Raja, Alamelu; Raman, Balambal; Kabeer, Basirudeen Syed Ahamed] Natl Inst Res TB, Madras, Tamil Nadu, India; [Rodrigues, Camilla; Sodha, Archana] PD Hinduja Hosp & Med Res Ctr, Microbiol Sect, Bombay, Maharashtra, India	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; bioMerieux; Indian Council of Medical Research (ICMR); IRCCS Lazzaro Spallanzani; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; All India Institute of Medical Sciences (AIIMS) New Delhi; Nizam's Institute of Medical Sciences; Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Lagrange, PH (corresponding author), Hop St Louis, Microbiol Serv, Paris, France.	plagrange@sfr.fr	goletti, delia/AAM-6577-2020; Kabeer, Basirudeen Syed Ahamed/AAQ-7599-2020; Singh, Sarman/AAR-8914-2020; KUMAR, MANOJ/HHC-0782-2022; Singh, Amit/D-3917-2015	Kabeer, Basirudeen Syed Ahamed/0000-0002-7287-1636; Singh, Sarman/0000-0002-0749-9647; Singh, Amit/0000-0003-3012-5245; Goletti, Delia/0000-0001-8360-4376; Girardi, Enrico/0000-0001-8182-5896	Fondation Merieux; "Ricerca Corrente" from the Italian Ministry of Health	Fondation Merieux; "Ricerca Corrente" from the Italian Ministry of Health	Fondation Merieux funded the study. In addition "Ricerca Corrente" from the Italian Ministry of Health partially funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; [Anonymous], 2011, COMM SER TESTS DIAGN; [Anonymous], 2003, BASIC STAT ELECT STA; Antunes A, 2002, RES MICROBIOL, V153, P301, DOI 10.1016/S0923-2508(02)01323-2; Banoo S, 2006, NAT REV MICROBIOL, pS20, DOI 10.1038/nrmicro1570; BARRERA L, 1992, TUBERCLE LUNG DIS, V73, P187, DOI 10.1016/0962-8479(92)90084-W; Boggian K, 1996, J CLIN MICROBIOL, V34, P1854, DOI 10.1128/JCM.34.7.1854-1855.1996; BOTHAMLEY GH, 1995, EUR RESPIR J, V8, pS676; Chan ED, 2000, TUBERCLE LUNG DIS, V80, P131, DOI 10.1054/tuld.2000.0243; Colangeli R, 1999, INT J TUBERC LUNG D, V3, P1127; CRUAUD P, 1990, RES MICROBIOL, V141, P679, DOI 10.1016/0923-2508(90)90062-U; DAFFE M, 1987, EUR J BIOCHEM, V167, P155, DOI 10.1111/j.1432-1033.1987.tb13317.x; DALEINE G, 1995, TUBERCLE LUNG DIS, V76, P234, DOI 10.1016/S0962-8479(05)80011-5; DANIEL TM, 1994, TUBERCLE LUNG DIS, V75, P33, DOI 10.1016/0962-8479(94)90099-X; DANIEL TM, 1987, AM REV RESPIR DIS, V135, P1137; DANIEL TM, 1988, J INFECT DIS, V158, P678, DOI 10.1093/infdis/158.4.678; DAS S, 1992, CLIN EXP IMMUNOL, V89, P402; DAVID HL, 1992, INT J LEPROSY, V60, P208; Dayal R, 2012, INDIAN J PEDIATR, V79, P183, DOI 10.1007/s12098-011-0469-y; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Gennaro ML, 2007, INT J TUBERC LUNG D, V11, P624; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Gong JH, 1998, J CLIN INVEST, V101, P383, DOI 10.1172/JCI318; Harrington JJ, 2000, INT J TUBERC LUNG D, V4, P161; Hoff ST, 2007, CLIN INFECT DIS, V45, P575, DOI 10.1086/520662; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; KROON FP, 1995, CLIN INFECT DIS, V21, P1197, DOI 10.1093/clinids/21.5.1197; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Laal S, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P71; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Lagrange PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043739; Lang ML, 2006, INFECT IMMUN, V74, P803, DOI 10.1128/IAI.74.2.803-809.2006; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; LYONS NF, 1988, LEPROSY REV, V59, P45; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Mathur ML, 1999, INT J TUBERC LUNG D, V3, P732; MCDONOUGH JA, 1992, J LAB CLIN MED, V120, P318; MENZIES D, 2004, TOMANS TUBERCULOSIS, P87; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pal N, 2005, STAT CONCEPTS APPL; PAPA F, 1989, RES MICROBIOL, V140, P569, DOI 10.1016/0923-2508(89)90089-2; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; POUTHIER F, 1994, AIDS, V8, P1277, DOI 10.1097/00002030-199409000-00009; Ratanasuwan W, 1997, INT J TUBERC LUNG D, V1, P259; SALTINI C, 1993, J INFECT DIS, V168, P1409, DOI 10.1093/infdis/168.6.1409; SAVAGE C, 1993, ZBL BAKT-INT J MED M, V278, P49; Schleicher GK, 2002, CLIN CHEM LAB MED, V40, P882, DOI 10.1515/CCLM.2002.156; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Sieling PA, 2000, J IMMUNOL, V164, P4790, DOI 10.4049/jimmunol.164.9.4790; SIMONNEY N, 1995, EUR J CLIN MICROBIOL, V14, P883, DOI 10.1007/BF01691495; Simonney N, 2007, TUBERCULOSIS, V87, P109, DOI 10.1016/j.tube.2006.05.005; Simonney Nancy, 1996, Clin Microbiol Infect, V2, P214; Somi GR, 1999, INT J TUBERC LUNG D, V3, P231; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; Steingart KR, 2007, FUTURE MICROBIOL, V2, P355, DOI 10.2217/17460913.2.4.355; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Stenger S, 1999, CURR OPIN MICROBIOL, V2, P89, DOI 10.1016/S1369-5274(99)80015-0; Stenger S, 2001, SCAND J INFECT DIS, V33, P483, DOI 10.1080/00365540110026584; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; Thangaraj Satheesh K, 2008, STUDY SELECTED M TUB; Theuer C, 1989, AM REV RESP DIS S4, V139; Thompson ML, 2003, BIOSTATISTICS, V4, P341, DOI 10.1093/biostatistics/4.3.341; THYBO S, 1995, TUBERCLE LUNG DIS, V76, P149, DOI 10.1016/0962-8479(95)90558-8; TORGALGARCIA J, 1988, ANN INST PASTEUR MIC, V139, P289, DOI 10.1016/0769-2609(88)90020-8; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; VANDERWERF TS, 1992, MED MICROBIOL IMMUN, V181, P71, DOI 10.1007/BF00189425; VERBON A, 1993, AM REV RESPIR DIS, V148, P378, DOI 10.1164/ajrccm/148.2.378; Wilkins E. G. L., 1994, P367; World Health Organization, 2003, TREATM TUB GUID NAT, P313; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; ZWEIG MH, 1993, CLIN CHEM, V39, P561	81	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96367	10.1371/journal.pone.0096367	http://dx.doi.org/10.1371/journal.pone.0096367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797271	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000336656000069
J	Li, LX; Gong, JH; Zhou, JP				Li, Longxiang; Gong, Jianhua; Zhou, Jieping			Spatial Interpolation of Fine Particulate Matter Concentrations Using the Shortest Wind-Field Path Distance	PLOS ONE			English	Article							LOCALLY VARYING ANISOTROPY; LAND-USE REGRESSION; NEXT-GENERATION; AIR; EXPOSURE; MODELS; PM2.5	Effective assessments of air-pollution exposure depend on the ability to accurately predict pollutant concentrations at unmonitored locations, which can be achieved through spatial interpolation. However, most interpolation approaches currently in use are based on the Euclidean distance, which cannot account for the complex nonlinear features displayed by air-pollution distributions in the wind-field. In this study, an interpolation method based on the shortest path distance is developed to characterize the impact of complex urban wind-field on the distribution of the particulate matter concentration. In this method, the wind-field is incorporated by first interpolating the observed wind-field from a meteorological-station network, then using this continuous wind-field to construct a cost surface based on Gaussian dispersion model and calculating the shortest wind-field path distances between locations, and finally replacing the Euclidean distances typically used in Inverse Distance Weighting (IDW) with the shortest wind-field path distances. This proposed methodology is used to generate daily and hourly estimation surfaces for the particulate matter concentration in the urban area of Beijing in May 2013. This study demonstrates that wind-fields can be incorporated into an interpolation framework using the shortest wind-field path distance, which leads to a remarkable improvement in both the prediction accuracy and the visual reproduction of the wind-flow effect, both of which are of great importance for the assessment of the effects of pollutants on human health.	[Li, Longxiang; Gong, Jianhua; Zhou, Jieping] Chinese Acad Sci, Olymp Sci & Technol Pk CAS, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Gong, Jianhua] Zhejiang CAS Applicat Ctr Geoinformat, Jiashan, Zhejiang, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Zhou, JP (corresponding author), Chinese Acad Sci, Olymp Sci & Technol Pk CAS, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	jpzhou@irsa.ac.cn			Plans of National Sci-Tech Major Special Item [2014ZX10003002]; National Science Foundation of China [41301437, 41371387]; Foundation of the State Key Laboratory of Remote Sensing Sciences in China	Plans of National Sci-Tech Major Special Item; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the State Key Laboratory of Remote Sensing Sciences in China	This work was partially supported by the Plans of National Sci-Tech Major Special Item 2014ZX10003002, the National Science Foundation of China 41301437, the Foundation of the State Key Laboratory of Remote Sensing Sciences in China and the National Science Foundation of China 41371387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain MA, 2007, ATMOS ENVIRON, V41, P3453, DOI 10.1016/j.atmosenv.2006.11.063; Boisvert JB, 2009, MATH GEOSCI, V41, P585, DOI 10.1007/s11004-009-9229-1; Boisvert JB, 2011, STOCH ENV RES RISK A, V25, P1077, DOI 10.1007/s00477-011-0483-7; Boisvert JB, 2011, COMPUT GEOSCI-UK, V37, P495, DOI 10.1016/j.cageo.2010.03.021; Bowman KW, 2013, ATMOS ENVIRON, V80, P571, DOI 10.1016/j.atmosenv.2013.07.007; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Curriero FC, 2006, MATH GEOL, V38, P907, DOI 10.1007/s11004-006-9055-7; de Mesnard L, 2013, COMPUT GEOSCI-UK, V52, P459, DOI 10.1016/j.cageo.2012.11.002; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Engel-Cox J, 2013, ATMOS ENVIRON, V80, P584, DOI 10.1016/j.atmosenv.2013.08.016; Ensor KB, 2013, CIRCULATION, V127, P1192, DOI 10.1161/CIRCULATIONAHA.113.000027; Gardner B, 2003, CAN J FISH AQUAT SCI, V60, P344, DOI 10.1139/F03-025; GOODIN WR, 1980, J APPL METEOROL, V19, P98, DOI 10.1175/1520-0450(1980)019<0098:AOATFC>2.0.CO;2; Goovaerts P, 2000, J HYDROL, V228, P113, DOI 10.1016/S0022-1694(00)00144-X; GREEN AES, 1980, JAPCA J AIR WASTE MA, V30, P773, DOI 10.1080/00022470.1980.10465108; Greenberg JA, 2011, COMPUT GEOSCI-UK, V37, P272, DOI 10.1016/j.cageo.2010.05.012; Hoek G, 2008, ATMOS ENVIRON, V42, P7561, DOI 10.1016/j.atmosenv.2008.05.057; Janssen S, 2008, ATMOS ENVIRON, V42, P4884, DOI 10.1016/j.atmosenv.2008.02.043; Jerrett M, 2005, J EXPO ANAL ENV EPID, V15, P185, DOI 10.1038/sj.jea.7500388; Kanaroglou PS, 2005, ATMOS ENVIRON, V39, P2399, DOI 10.1016/j.atmosenv.2004.06.049; Lee SJ, 2012, ENVIRON HEALTH PERSP, V120, P1727, DOI 10.1289/ehp.1205006; Liao DP, 2006, ENVIRON HEALTH PERSP, V114, P1374, DOI 10.1289/ehp.9169; Liu Y, 2009, ENVIRON HEALTH PERSP, V117, P886, DOI 10.1289/ehp.0800123; Pearce JL, 2009, ATMOS ENVIRON, V43, P2060, DOI 10.1016/j.atmosenv.2008.10.060; Peterson EE, 2006, ENVIRON MONIT ASSESS, V121, P571, DOI 10.1007/s10661-005-9156-7; Peterson EE, 2007, FRESHWATER BIOL, V52, P267, DOI 10.1111/j.1365-2427.2006.01686.x; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Ryan PH, 2007, INHAL TOXICOL, V19, P127, DOI 10.1080/08958370701495998; Seaman NL, 2000, ATMOS ENVIRON, V34, P2231, DOI 10.1016/S1352-2310(99)00466-5; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; Tian J, 2010, REMOTE SENS ENVIRON, V114, P221, DOI 10.1016/j.rse.2009.09.011; Turner DB, 1973, WORKBOOK ATMOSPHERIC; Ver Hoef JM, 2006, ENVIRON ECOL STAT, V13, P449, DOI 10.1007/s10651-006-0022-8; WARNER TT, 1983, J CLIM APPL METEOROL, V22, P394, DOI 10.1175/1520-0450(1983)022<0394:ACOTTO>2.0.CO;2; Zhang A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080969, 10.1371/journal.pone.0063486, 10.1371/journal.pone.0059428, 10.1371/journal.pone.0059254, 10.1371/journal.pone.0064689]; Zou HX, 2012, INT J GEOGR INF SCI, V26, P667, DOI 10.1080/13658816.2011.609488	36	27	31	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96111	10.1371/journal.pone.0096111	http://dx.doi.org/10.1371/journal.pone.0096111			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798197	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000037
J	Ortiz-Ortiz, KJ; Ramirez-Garcia, R; Cruz-Correa, M; Rios-Gonzalez, MY; Ortiz, AP				Ortiz-Ortiz, Karen J.; Ramirez-Garcia, Roberto; Cruz-Correa, Marcia; Rios-Gonzalez, Moraima Y.; Ortiz, Ana Patricia			Effects of Type of Health Insurance Coverage on Colorectal Cancer Survival in Puerto Rico: A Population-Based Study	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; CARE REFORM; ENGLAND; DIAGNOSIS; COHORT; WALES	Colorectal cancer represents a major health problem and an important economic burden in Puerto Rico. In the 1990's, the Commonwealth of Puerto Rico implemented a health care reform through the privatization of the public health system. The goal was to ensure access to health services, eliminate disparities for medically indigent citizens and provide special coverage for high-risk conditions such as cancer. This study estimates the 5-year relative survival rate of colorectal cancer and the relative excess risk of death in Puerto Rico for 2004-2005, by type of health insurance coverage; Government Health Plan vs. Non-Government Health Plan. Colorectal cancer in advanced stages was more common in Government Health Plan patients compared with Non-Government Health Plan patients (44.29% vs. 40.24 had regional extent and 13.58% versus 10.42% had distant involvement, respectively). Government Health Plan patients in the 50-64 (RR = 6.59; CI: 2.85-15.24) and >= 65 (RR = 2.4; CI: 1.72-4.04) age-groups had the greater excess risk of death compared with Non-Government Health Plan patients. Further studies evaluating the interplay of access to health services and the barriers affecting the Government Health Plan population are warranted.	[Ortiz-Ortiz, Karen J.] Univ Puerto Rico, Ctr Comprehens Canc, Puerto Rico Cent Canc Registry, San Juan, PR 00936 USA; [Ortiz-Ortiz, Karen J.; Ramirez-Garcia, Roberto; Rios-Gonzalez, Moraima Y.] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Hlth Serv Adm, San Juan, PR 00936 USA; [Cruz-Correa, Marcia] Univ Puerto Rico, Ctr Comprehens Canc, San Juan, PR 00936 USA; [Ortiz, Ana Patricia] Univ Puerto Rico, Ctr Comprehens Canc, Canc Control & Populat Sci Program, San Juan, PR 00936 USA; [Ortiz, Ana Patricia] Univ Puerto Rico, Grad Sch Publ Hlth, Dept Biostat & Epidemiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Ortiz-Ortiz, KJ (corresponding author), Univ Puerto Rico, Ctr Comprehens Canc, Puerto Rico Cent Canc Registry, San Juan, PR 00936 USA.	karen.ortiz@upr.edu		Ortiz-Ortiz, Karen/0000-0002-0134-9947	National Program of Cancer Registries (NPCR) [5U58-DP 003863-02]; Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico	National Program of Cancer Registries (NPCR); Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico	This work is supported by federal funds from the National Program of Cancer Registries (NPCR Award Number 5U58-DP 003863-02; URL: http://www.cdc.gov/cancer/npcr/), to the Puerto Rico Central Cancer Registry (PRCCR) at the Comprehensive Cancer Center, and by the Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico. The ideas and opinions expressed herein are those of the authors, and endorsement by the PRCCR is not intended nor should it be inferred. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman P, 2011, HLTH SYSTEM ANAL BET; Butler J, 2013, HEALTH POLICY, V112, P148, DOI 10.1016/j.healthpol.2013.03.021; Centers for Disease Control and Prevention, 2012, BEHAV RISK FACT SURV; Centers for Medicare and Medicaid Services (CMS), 2012, FIN REP COMM PUERT R; Chirikos TN, 2007, J HEALTH CARE POOR U, V18, P116, DOI 10.1353/hpu.2007.0006; Coleman MP, 2001, CANCER, V91, P208, DOI 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E; Coleman MP, 2004, BRIT J CANCER, V90, P1367, DOI 10.1038/sj.bjc.6601696; Comision para Evaluar el Sistema de Salud del Estado Libre Asociado de Puerto Rico, 2005, INFORME FINAL EVALUA; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Dickman PW, 2013, STATA COMPUTER PROGR; Figueroa NR, 2012, CANC PUERTO RICO 200, P17; Fritz A, 2000, INT CLASSIFICATION D; Gorey KM, 2011, AM J PUBLIC HEALTH, V101, P112, DOI 10.2105/AJPH.2009.173112; Grann VR, 2003, ARCH INTERN MED, V163, P2123, DOI 10.1001/archinte.163.18.2123; Hansen RP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-49; Hofmarcher M.M., 2007, IMPROVED HLTH SYSTEM; Hulme PA, 1998, J NURS ADMIN, V28, P44, DOI 10.1097/00005110-199802000-00008; Kelsall HL, 2009, SOC SCI MED, V68, P290, DOI 10.1016/j.socscimed.2008.09.070; Lopez-Charneco M, 2013, P R HEALTH SCI J, V32, P68; Mandelblatt JS, 1999, CANCER-AM CANCER SOC, V86, P2378, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2378::AID-CNCR28>3.3.CO;2-C; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; Mattei H, 2013, COMPLETE LIFE TABELS; McDavid K, 2003, ARCH INTERN MED, V163, P2135, DOI 10.1001/archinte.163.18.2135; Morse DE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-391; National Cancer Institute (NCI), 2001, SEER SUMM STAG MAN 2; National Patient Safety Agency (NPSA) and Royal College of General Practitioners (RCGP), 2010, DEL DIAGN CANC THEM; Organization PAH, 2007, HLTH SYST PROF PUERT; Ortiz-Ortiz KJ, 2010, P R HEALTH SCI J, V29, P241; Pan American Health Organization (PAHO) Puerto Rico, 2007, COUNTRIES, V2, P596; Parkin D, 1991, CANC REGISTRATION PR, V95, P159; Perez I, 2011, SALUD TIENE PRECIO; Rachet B, 2010, BRIT J CANCER, V103, P446, DOI 10.1038/sj.bjc.6605752; Ramirez-Garcia R, 2001, P R Health Sci J, V20, P171; Ramirez-Garcia R, 2009, MODULO AUTOINSTRUCCI; Ramirez-Garcia R, 2012, B EC UNIDAD INVESTIG, V9, P1; Smith JK, 2013, J SURG RES, V185, P15, DOI 10.1016/j.jss.2013.05.058; Swaminathan R, 2011, IARC Sci Publ, P7; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; WHO, 2007, EV BUS STRENGTH HLTH, P44; Woods LM, 2006, ANN ONCOL, V17, P5, DOI 10.1093/annonc/mdj007; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; World Health Organization, 2000, WORLD HLTH REP 2000	43	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96746	10.1371/journal.pone.0096746	http://dx.doi.org/10.1371/journal.pone.0096746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24796444	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000123
J	Padiya, R; Chowdhury, D; Borkar, R; Srinivas, R; Bhadra, MP; Banerjee, SK				Padiya, Raju; Chowdhury, Debabrata; Borkar, Roshan; Srinivas, R.; Bhadra, Manika Pal; Banerjee, Sanjay K.			Garlic Attenuates Cardiac Oxidative Stress via Activation of PI3K/AKT/Nrf2-Keap1 Pathway in Fructose-Fed Diabetic Rat	PLOS ONE			English	Article							INSULIN-RESISTANCE; RESVERATROL; PROTECTS	Background: Cardiovascular complication due to diabetes has remained a major cause of death. There is an urgent need to the cardiac complications in diabetes by nutritional or pharmacological agents. Thus the present study was designed to find out the effectiveness of garlic on cardiac complications in insulin-resistant diabetic rats. Methods and Results: SD rats were fed high fructose (65%) diet alone or along with raw garlic homogenate (250 mg/kg/day) or nutrient-matched (65% corn starch) control diet for 8 weeks. Fructose-fed diabetic rats showed cardiac hypertrophy, increased NFkB activity and increased oxidative stress. Administration of garlic significantly decreased (p<0.05) cardiac hypertrophy, NFkB activity and oxidative stress. Although we did not observe any changes in myocardial catalase, GSH and GPx in diabetic heart, garlic administration showed significant (p<0.05) increase in all three antioxidant/enzymes levels. Increased endogenous antioxidant enzymes and gene expression in garlic treated diabetic heart are associated with higher protein expression of Nrf2. Increased myocardial H2S levels, activation of PI3K/Akt pathway and decreased Keap levels in fructose-fed heart after garlic administration might be responsible for higher Nrf2 levels. Conclusion: Our study demonstrates that raw garlic homogenate is effective in reducing cardiac hypertrophy and fructose-induced myocardial oxidative stress through PI3K/AKT/Nrf2-Keap1 dependent pathway.	[Padiya, Raju; Banerjee, Sanjay K.] Indian Inst Chem Technol, Div Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India; [Chowdhury, Debabrata; Bhadra, Manika Pal] Indian Inst Chem Technol, Div Chem Biol, Hyderabad 500007, Andhra Pradesh, India; [Borkar, Roshan; Srinivas, R.] Indian Inst Chem Technol, Natl Ctr Mass Spectrometry, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Banerjee, SK (corresponding author), Indian Inst Chem Technol, Div Med Chem & Pharmacol, Hyderabad 500007, Andhra Pradesh, India.	banerjees74@hotmail.com	BORKAR, ROSHAN M/J-6995-2019	BORKAR, ROSHAN M/0000-0003-1963-7688; , Raju Padiya/0000-0002-9772-9118; Banerjee, Sanjay/0000-0002-0008-0480; Banerjee, Sanjay k/0000-0002-0044-0984	Department of Science and Technology [SR/S0/AS-18/2011]; Ramalingaswami Fellowship; CSIR (UNDO) [BSC0103]	Department of Science and Technology(Department of Science & Technology (India)); Ramalingaswami Fellowship; CSIR (UNDO)	Financial support was provided by Department of Science and Technology (SR/S0/AS-18/2011), Ramalingaswami Fellowship, and CSIR (UNDO, BSC0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagul PK, 2012, PHARMACOL RES, V66, P260, DOI 10.1016/j.phrs.2012.05.003; Banerjee SK, 2010, J MOL CELL CARDIOL, V49, P683, DOI 10.1016/j.yjmcc.2010.06.003; Banerjee Sanjay Kumar, 2002, BMC Pharmacol, V2, P16, DOI 10.1186/1471-2210-2-16; Banerjee SK, 2003, PHYTOTHER RES, V17, P97, DOI 10.1002/ptr.1281; Calvert JW, 2010, ANTIOXID REDOX SIGN, V12, P1203, DOI 10.1089/ars.2009.2882; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Ceriello A, 2002, DIABETES, V51, P1076, DOI 10.2337/diabetes.51.4.1076; Das DK, 2007, AM J PHYSIOL-HEART C, V293, pH2629, DOI 10.1152/ajpheart.00996.2007; Delbosc S, 2005, ATHEROSCLEROSIS, V179, P43, DOI 10.1016/j.atherosclerosis.2004.10.018; Erejuwa OO, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/374037; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Jay D, 2006, FREE RADICAL BIO MED, V40, P183, DOI 10.1016/j.freeradbiomed.2005.06.018; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Milner JA, 2006, J NUTR, V136, p827S, DOI 10.1093/jn/136.3.727S; Padiya Raju, 2013, Recent Pat Food Nutr Agric, V5, P105, DOI 10.2174/18761429113059990002; Padiya R, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-53; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Zhang J, 2011, PEPTIDES, V32, P1415, DOI 10.1016/j.peptides.2011.05.024; Zhang XC, 2005, EXP NEUROL, V191, P318, DOI 10.1016/j.expneurol.2004.10.011	21	102	111	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e94228	10.1371/journal.pone.0094228	http://dx.doi.org/10.1371/journal.pone.0094228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796753	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000006
J	Yang, ZK; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Dong, J; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY				Yang, Zhi-Kai; Han, Qing-Feng; Zhu, Tong-Ying; Ren, Ye-Ping; Chen, Jiang-Hua; Zhao, Hui-Ping; Chen, Meng-Hua; Dong, Jie; Wang, Yue; Hao, Chuan-Ming; Zhang, Rui; Zhang, Xiao-Hui; Wang, Mei; Tian, Na; Wang, Hai-Yan			The Associations between the Family Education and Mortality of Patients on Peritoneal Dialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SOCIAL SUPPORT; HEMODIALYSIS-PATIENTS; TECHNIQUE FAILURE; OUTCOMES; CAREGIVERS; IMPACT; SURVIVAL; EPISODE; UPDATE	Aims: To investigate whether education level of family members predicts all-cause and cardiovascular death and initial-episode peritonitis in patients on peritoneal dialysis (PD). Methods: A total of 2264 patients on chronic PD were collected from seven centers affiliated with the Socioeconomic Status on the Outcome of Peritoneal Dialysis (SSOP) Study. All demographic, socioeconomic and laboratory data of patients and the education level of all family members were recorded at baseline. Multivariate Cox regression was used to calculate the hazard ratio (HR) of all-cause and cardiovascular mortality, and initial-episode peritonitis with adjustments for recognized traditional factors. Results: There were no significant differences in baseline characteristics between patients with (n = 1752) and without (n = 512) complete education information. According to the highest education level of patients' family, included 1752 patients were divided into four groups, i.e. elementary or lower (15%), middle (27%), high (24%) and more than high school (34%). The family highest education (using elementary school or lower group as reference, hazard ratio and 95% confidence interval of middle school group, high school group and more than high school group was 0.68[0.48-0.96], 0.64[0.45-0.91], 0.66[0.48-0.91], respectively) rather than their average education level or patients' or spouse's education was significantly associated with the higher mortality. Neither patients' nor family education level did correlate to the risk for cardiovascular death or initial-episode peritonitis. Conclusions: Family members' education level was found to be a novel predictor of PD outcome. Family, as the main source of health care providers, should be paid more attention in our practice.	[Yang, Zhi-Kai; Dong, Jie; Wang, Hai-Yan] Peking Univ, Key Lab Renal Dis, Minist Educ, Inst Nephrol,Dept Med,Renal Div,Hosp 1,Minist Hlt, Beijing 100871, Peoples R China; [Han, Qing-Feng; Wang, Yue] Peking Univ, Hosp 3, Dept Nephrol, Beijing 100871, Peoples R China; [Zhu, Tong-Ying; Hao, Chuan-Ming] Fudan Univ, Huashan Hosp, Dept Nephrol, Shanghai 200433, Peoples R China; [Ren, Ye-Ping; Zhang, Rui] Harbin Med Univ, Affiliated Hosp 2, Dept Nephrol, Harbin, Heilongjiang, Peoples R China; [Chen, Jiang-Hua; Zhang, Xiao-Hui] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Kidney Dis Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Hui-Ping; Wang, Mei] Peking Univ, Peoples Hosp, Dept Nephrol, Beijing 100871, Peoples R China; [Chen, Meng-Hua; Tian, Na] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Peking University; Peking University; Fudan University; Harbin Medical University; Zhejiang University; Peking University; Ningxia Medical University	Dong, J (corresponding author), Peking Univ, Key Lab Renal Dis, Minist Educ, Inst Nephrol,Dept Med,Renal Div,Hosp 1,Minist Hlt, Beijing 100871, Peoples R China.	dongjie@medmail.com.cn	Dong, Jie/AFM-0048-2022; tian, na/GVR-9226-2022		New Century Excellent Talents from Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from ISN GO RP Committee	New Century Excellent Talents from Education Department, China; Baxer Clinical Research Award from Baxter Corp, China; ISN Research Award from ISN GO RP Committee	This study is in part supported by New Century Excellent Talents from Education Department, China, Baxer Clinical Research Award from Baxter Corp, China and ISN Research Award from ISN GO R&P Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolalu B, 2009, PERITON DIALYSIS INT, V29, P292; Beanlands Heather, 2005, Nephrol Nurs J, V32, P621; Cohen SD, 2007, ADV CHRONIC KIDNEY D, V14, P335, DOI 10.1053/j.ackd.2007.04.007; FARIAS MG, 1994, KIDNEY INT, V46, P1392, DOI 10.1038/ki.1994.410; Griva K, 2013, PERITON DIALYSIS INT, V33, P280, DOI 10.3747/pdi.2011.00308; Horsburgh M E, 1998, ANNA J, V25, P219; Horsburgh ME, 1998, NEPHROL NURS J, V25, P229; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Khan CM, 2013, HEALTH PSYCHOL, V32, P739, DOI 10.1037/a0028609; Kimmel PL, 2000, J AM SOC NEPHROL, V11, P1518, DOI 10.1681/ASN.V1181518; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Martin LC, 2011, CLIN J AM SOC NEPHRO, V6, P1944, DOI 10.2215/CJN.11431210; Mehrotra R, 2012, PERITON DIALYSIS INT, V32, P322, DOI 10.3747/pdi.2011.00084; Molloy GJ, 2008, HEALTH PSYCHOL, V27, P286, DOI 10.1037/0278-6133.27.2.286; Mujais S, 2006, KIDNEY INT, V70, pS21, DOI 10.1038/sj.ki.5001912; Oliver MJ, 2010, NEPHROL DIAL TRANSPL, V25, P2737, DOI 10.1093/ndt/gfq085; Patel SS, 2005, SEMIN DIALYSIS, V18, P98, DOI 10.1111/j.1525-139X.2005.18203.x; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P1480, DOI 10.2215/CJN.01240210; Schaubel DE, 2001, KIDNEY INT, V60, P1517, DOI 10.1046/j.1523-1755.2001.00969.x; Schipper K, 2011, NEPHROL DIAL TRANSPL, V26, P3189, DOI 10.1093/ndt/gfq833; Sezer S, 2013, CLIN NEPHROL, V80, P342, DOI 10.5414/CN107742; Smith SC, 2004, CIRCULATION, V109, P3112, DOI 10.1161/01.CIR.0000133427.35111.67; Stephens MAP, 2013, HEALTH PSYCHOL, V32, P1029, DOI 10.1037/a0030018; Stephens MAP, 2009, HEALTH PSYCHOL, V28, P48, DOI 10.1037/a0012385; Szeto CC, 2008, PERITON DIALYSIS INT, V28, P252; Thong MSY, 2007, NEPHROL DIAL TRANSPL, V22, P845, DOI 10.1093/ndt/gfl700; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Tong A, 2008, NEPHROL DIAL TRANSPL, V23, P3960, DOI 10.1093/ndt/gfn415; Tsai TC, 2006, KIDNEY INT, V70, P1983, DOI 10.1038/sj.ki.5001811; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; Xu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050766; Xu R, 2012, PERITON DIALYSIS INT, V32, P94, DOI 10.3747/pdi.2010.00213; Ye XQ, 2008, J PSYCHOSOM RES, V65, P157, DOI 10.1016/j.jpsychores.2008.04.007	33	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95894	10.1371/journal.pone.0095894	http://dx.doi.org/10.1371/journal.pone.0095894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797080	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000028
J	Doallo, S; Cadaveira, F; Corral, M; Mota, N; Lopez-Caneda, E; Holguin, SR				Doallo, Sonia; Cadaveira, Fernando; Corral, Montserrat; Mota, Nayara; Lopez-Caneda, Eduardo; Rodriguez Holguin, Socorro			Larger Mid-Dorsolateral Prefrontal Gray Matter Volume in Young Binge Drinkers Revealed by Voxel-Based Morphometry	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; LEVEL-DEPENDENT RESPONSE; INDUCED BRAIN IMPAIRMENT; SPATIAL WORKING-MEMORY; FRONTAL-CORTEX; ADOLESCENT ALCOHOL; DECISION-MAKING; DRINKING; ACTIVATION; GENDER	Binge drinking or heavy episodic drinking is a high prevalent pattern of alcohol consumption among young people in several countries. Despite increasing evidence that binge drinking is associated with impairments in executive aspects of working memory (i.e. self-ordered working memory), processes known to depend on the mid-dorsolateral prefrontal cortex (Brodmann areas 46 and 9), less is known about the impact of binge drinking on prefrontal gray matter integrity. Here, we investigated the effects of binge drinking on gray matter volume of mid-dorsolateral prefrontal cortex in youths. We used voxel-based morphometry on the structural magnetic resonance images of subjects reporting a persistent (at least three years) binge drinking pattern of alcohol use (n = 11; age 22.43 +/- 1.03) and control subjects (n = 21; age 22.18 +/- 1.08) to measure differences in gray matter volume between both groups. In a region of interest analysis of the mid-dorsolateral prefrontal cortex, after co-varying for age and gender, we observed significantly larger gray matter volume in the left mid-dorsolateral prefrontal cortex (Brodmann areas 46 and 9) in binge drinkers in comparison with control subjects. Furthermore, there was a significant positive correlation between left mid-dorsolateral prefrontal cortex volume and Self-Ordered Pointing Test (SOPT) total errors score in binge drinkers. The left mid-dorsolateral prefrontal cortex volume also correlated with the quantity and speed of alcohol intake. These findings indicate that a repeated exposure to alcohol -that does not meet criteria for alcohol dependence- throughout post-adolescent years and young adulthood is linked with structural anomalies in mid-dorsolateral prefrontal regions critically involved in executive aspects of working memory.	[Doallo, Sonia; Cadaveira, Fernando; Corral, Montserrat; Mota, Nayara; Lopez-Caneda, Eduardo; Rodriguez Holguin, Socorro] Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Doallo, S (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Psychobiol, Santiago De Compostela, Spain.	sonia.doallo@usc.es	Mota, Nayara/C-8183-2011; Varela, Montserrat Corral/A-6384-2012; Cadaveira, Fernando/ABE-7827-2021; Holguín, Socorro Rodríguez/D-1800-2010; Doallo, Sonia/O-2833-2018; Varela, Montserrat Corral/AEP-7949-2022; Cadaveira, Fernando/C-5981-2011; López Caneda, Eduardo/AAS-2406-2020	Mota, Nayara/0000-0002-5897-7506; Cadaveira, Fernando/0000-0001-6198-1541; Holguín, Socorro Rodríguez/0000-0003-1502-987X; Varela, Montserrat Corral/0000-0003-3068-3415; Cadaveira, Fernando/0000-0001-6198-1541; Doallo, Sonia/0000-0003-4937-4348; Lopez Caneda, Eduardo/0000-0003-1788-1556	Conselleria de Industria e Innovacion, Xunta de Galicia [INCITE08PXIB211015PR]; Ministerio de Ciencia e Innovacion of Spain [EDU2008-03400, PSI2011-22575]; Isidro Parga Pondal program (Xunta de Galicia, Spain)	Conselleria de Industria e Innovacion, Xunta de Galicia(Xunta de Galicia); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Isidro Parga Pondal program (Xunta de Galicia, Spain)(Xunta de Galicia)	This study was supported by a grant from the Conselleria de Industria e Innovacion, Xunta de Galicia (INCITE08PXIB211015PR) and by two grants from the Ministerio de Ciencia e Innovacion of Spain (EDU2008-03400; PSI2011-22575). SD was supported by a postdoctoral contract from the Isidro Parga Pondal program (Xunta de Galicia, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babor TF., 2001, AUDIT ALCOHOL USE DI; Caldwell LC, 2005, ALCOHOL ALCOHOLISM, V40, P194, DOI 10.1093/alcalc/agh134; Campanella S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062260; Cheetham A, 2014, PSYCHOPHARMACOLOGY, DOI 10.10007/s00213-014-3483-8; Crego A, 2012, ALCOHOL, V46, P415, DOI 10.1016/j.alcohol.2011.10.002; Crego A, 2010, DRUG ALCOHOL DEPEN, V109, P45, DOI 10.1016/j.drugalcdep.2009.11.020; Crego A, 2009, ALCOHOL CLIN EXP RES, V33, P1870, DOI 10.1111/j.1530-0277.2009.01025.x; Crews FT, 2000, ALCOHOL CLIN EXP RES, V24, P1712, DOI 10.1111/j.1530-0277.2000.tb01973.x; Curtis CE, 2000, NEUROPSYCHOLOGIA, V38, P1503, DOI 10.1016/S0028-3932(00)00062-2; De Bellis Michael D, 2005, Alcohol Clin Exp Res, V29, P1590, DOI 10.1097/01.alc.0000179368.87886.76; Degoratis LR, 1983, NEUROIMAGE; Ehlers CL, 2007, NEUROTOXICOL TERATOL, V29, P153, DOI 10.1016/j.ntt.2006.11.013; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; Hartley DE, 2004, PHARMACOL BIOCHEM BE, V78, P611, DOI 10.1016/j.pbb.2004.04.027; Hermens DF, 2013, CORTEX, V49, P3, DOI 10.1016/j.cortex.2012.05.021; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; Howell NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074164; Jacobus J, 2009, NEUROTOXICOL TERATOL, V31, P349, DOI 10.1016/j.ntt.2009.07.006; Jacobus J, 2013, ANNU REV CLIN PSYCHO, V9, P703, DOI 10.1146/annurev-clinpsy-050212-185610; Jahanshahi M, 1999, NEUROPSYCHOLOGIA, V37, P181; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lopez-Caneda E, 2013, ALCOHOL ALCOHOLISM, V48, P464, DOI 10.1093/alcalc/agt046; Lopez-Caneda E, 2012, ADDICTION, V107, P1796, DOI 10.1111/j.1360-0443.2012.03908.x; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maurage P, 2012, CLIN NEUROPHYSIOL, V123, P892, DOI 10.1016/j.clinph.2011.09.018; Maurage P, 2013, NEUROIMAGE-CLIN, V3, P218, DOI 10.1016/j.nicl.2013.08.010; Maurage P, 2013, CORTEX, V49, P1155, DOI 10.1016/j.cortex.2012.12.015; Maurage P, 2009, J PSYCHIATR NEUROSCI, V34, P111; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Medina KL, 2008, ALCOHOL CLIN EXP RES, V32, P386, DOI 10.1111/j.1530-0277.2007.00602.x; Montgomery C, 2012, HUM PSYCHOPHARM CLIN, V27, P187, DOI 10.1002/hup.1268; Mota N, 2013, DRUG ALCOHOL DEPEN, V133, P108, DOI 10.1016/j.drugalcdep.2013.05.024; Norman AL, 2011, DRUG ALCOHOL DEPEN, V119, P216, DOI 10.1016/j.drugalcdep.2011.06.019; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Parada M, 2012, ADDICT BEHAV, V37, P167, DOI 10.1016/j.addbeh.2011.09.015; Pascual M, 2007, EUR J NEUROSCI, V25, P541, DOI 10.1111/j.1460-9568.2006.05298.x; Petit G, 2014, ALCOHOL ALCOHOLISM, V49, P198, DOI 10.1093/alcalc/agt172; Petit G, 2013, PSYCHIAT RES, V209, P494, DOI 10.1016/j.psychres.2013.04.005; Petit G, 2012, CLIN NEUROPHYSIOL, V123, P925, DOI 10.1016/j.clinph.2011.10.042; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P873, DOI 10.1073/pnas.90.3.873; PETRIDES M, 1995, J NEUROSCI, V15, P359; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Sanhueza C, 2011, PSICOTHEMA, V23, P209; Scaife JC, 2009, PHARMACOL BIOCHEM BE, V93, P354, DOI 10.1016/j.pbb.2009.05.015; Schweinsburg AD, 2010, ALCOHOL, V44, P111, DOI 10.1016/j.alcohol.2009.09.032; Schweinsburg AD, 2011, ADDICTION, V106, P564, DOI 10.1111/j.1360-0443.2010.03197.x; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Squeglia LM, 2012, J STUD ALCOHOL DRUGS, V73, P749, DOI 10.15288/jsad.2012.73.749; Squeglia Lindsay M, 2012, Psychopharmacology (Berl), V220, P529, DOI 10.1007/s00213-011-2500-4; Squeglia LM, 2011, ALCOHOL CLIN EXP RES, V35, P1831, DOI 10.1111/j.1530-0277.2011.01527.x; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V22, P45; Tapert SF, 1999, J INT NEUROPSYCH SOC, V5, P481, DOI 10.1017/S1355617799566010; Tapert SF, 2004, ALCOHOL CLIN EXP RES, V28, P1577, DOI 10.1097/01.ALC.0000141812.81234.A6; Tapert SF, 2001, ALCOHOL CLIN EXP RES, V25, P236, DOI 10.1097/00000374-200102000-00012; Townshend JM, 2005, ALCOHOL CLIN EXP RES, V29, P317, DOI 10.1097/01.ALC.0000156453.05028.F5; Varela J., 2005, VALIDACION EMPIRICA; Wechsler D, 2003, WAIS 3 ESCALA INTELI; Wetherill RR, 2013, PSYCHOPHARMACOLOGY, V230, P663, DOI 10.1007/s00213-013-3198-2; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Xiao L, 2013, PSYCHOL ADDICT BEHAV, V27, P443, DOI 10.1037/a0027892; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009	71	36	36	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96380	10.1371/journal.pone.0096380	http://dx.doi.org/10.1371/journal.pone.0096380			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789323	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700083
J	Yomogida, Y; Sugiura, M; Akimoto, Y; Miyauchi, CM; Kawashima, R				Yomogida, Yukihito; Sugiura, Motoaki; Akimoto, Yoritaka; Miyauchi, Carlos Makoto; Kawashima, Ryuta			The Neural Basis of Event Simulation: An fMRI Study	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; CONSTRUCTIVE EPISODIC SIMULATION; TEMPORO-PARIETAL JUNCTION; LOBE CONTRIBUTIONS; CORTICAL-LESIONS; SOCIAL COGNITION; BRAIN-REGIONS; FUTURE; COMPREHENSION; MIND	Event simulation (ES) is the situational inference process in which perceived event features such as objects, agents, and actions are associated in the brain to represent the whole situation. ES provides a common basis for various cognitive processes, such as perceptual prediction, situational understanding/prediction, and social cognition (such as mentalizing/trait inference). Here, functional magnetic resonance imaging was used to elucidate the neural substrates underlying important subdivisions within ES. First, the study investigated whether ES depends on different neural substrates when it is conducted explicitly and implicitly. Second, the existence of neural substrates specific to the future-prediction component of ES was assessed. Subjects were shown contextually related object pictures implying a situation and performed several picture-word-matching tasks. By varying task goals, subjects were made to infer the implied situation implicitly/explicitly or predict the future consequence of that situation. The results indicate that, whereas implicit ES activated the lateral prefrontal cortex and medial/lateral parietal cortex, explicit ES activated the medial prefrontal cortex, posterior cingulate cortex, and medial/lateral temporal cortex. Additionally, the left temporoparietal junction plays an important role in the future-prediction component of ES. These findings enrich our understanding of the neural substrates of the implicit/explicit/predictive aspects of ES-related cognitive processes.	[Yomogida, Yukihito] Tamagawa Univ Brain Sci Inst, Tokyo, Japan; [Yomogida, Yukihito] Japan Soc Promot Sci, Tokyo, Japan; [Sugiura, Motoaki; Akimoto, Yoritaka; Miyauchi, Carlos Makoto; Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Dept Funct Brain Imaging, Sendai, Miyagi 980, Japan; [Sugiura, Motoaki] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Smart Ageing Int Res Ctr, Sendai, Miyagi 980, Japan; [Kawashima, Ryuta] Tohoku Univ, Inst Dev Aging & Canc, Div Dev Cognit Neurosci, Sendai, Miyagi 980, Japan	Japan Society for the Promotion of Science; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Yomogida, Y (corresponding author), Tamagawa Univ Brain Sci Inst, Tokyo, Japan.	yukihitoyomogida@gmail.com		Yomogida, Yukihito/0000-0001-5026-4440	MEXT [23011002];  [20N8136]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported by a Grant-in-Aid for JSPS fellows (20N8136) (to YY) and by KAKENHI (23011002) from MEXT (to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2009, NEUROPSYCHOLOGIA, V47, P2222, DOI 10.1016/j.neuropsychologia.2008.10.026; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Barbey AK, 2009, PHILOS T R SOC B, V364, P1291, DOI 10.1098/rstb.2008.0315; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Bargh JA., 1994, HDB SOCIAL COGNITION; Baron-Cohen S, 1999, EUR J NEUROSCI, V11, P1891, DOI 10.1046/j.1460-9568.1999.00621.x; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Botzung A, 2008, BRAIN COGNITION, V66, P202, DOI 10.1016/j.bandc.2007.07.011; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Ferstl EC, 2002, NEUROIMAGE, V17, P1599, DOI 10.1006/nimg.2002.1247; Ferstl EC, 2001, COGNITIVE BRAIN RES, V11, P325, DOI 10.1016/S0926-6410(01)00007-6; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; Gozzi M, 2009, NEUROPSYCHOLOGIA, V47, P2125, DOI 10.1016/j.neuropsychologia.2009.04.002; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hasson U, 2007, CEREB CORTEX, V17, P2899, DOI 10.1093/cercor/bhm016; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2007, NEUROIMAGE, V36, P924, DOI 10.1016/j.neuroimage.2007.03.059; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Jakobs O, 2012, NEUROIMAGE, V60, P2389, DOI 10.1016/j.neuroimage.2012.02.037; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Mitchell JP, 2006, SOC COGN AFFECT NEUR, V1, P49, DOI 10.1093/scan/nsl007; Mitchell JP, 2005, NEUROIMAGE, V28, P757, DOI 10.1016/j.neuroimage.2005.03.011; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; Noonan KA, 2010, J COGNITIVE NEUROSCI, V22, P1597, DOI 10.1162/jocn.2009.21289; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; Ruby P, 2003, EUR J NEUROSCI, V17, P2475, DOI 10.1046/j.1460-9568.2003.02673.x; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Satpute AB, 2006, BRAIN RES, V1079, P86, DOI 10.1016/j.brainres.2006.01.005; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schacter DL, 2009, PHILOS T R SOC B, V364, P1245, DOI 10.1098/rstb.2008.0308; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Summerfield JJ, 2010, NEUROPSYCHOLOGIA, V48, P1501, DOI 10.1016/j.neuropsychologia.2010.01.022; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2009, CEREB CORTEX, V19, P1539, DOI 10.1093/cercor/bhn191; Urgesi C, 2010, NEURON, V65, P309, DOI 10.1016/j.neuron.2010.01.026; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Visser M, 2012, J COGNITIVE NEUROSCI, V24, P1766, DOI 10.1162/jocn_a_00244; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Wagner DD, 2011, CEREB CORTEX, V21, P2788, DOI 10.1093/cercor/bhr074; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Wegner D. M., 1998, HDB SOCIAL PSYCHOL, P446; Whitney C, 2009, NEUROIMAGE, V47, P360, DOI 10.1016/j.neuroimage.2009.04.037; Wicker B, 2003, NEUROPSYCHOLOGIA, V41, P139, DOI 10.1016/S0028-3932(02)00144-6; Yarkoni T, 2008, NEUROIMAGE, V41, P1408, DOI 10.1016/j.neuroimage.2008.03.062	67	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96534	10.1371/journal.pone.0096534	http://dx.doi.org/10.1371/journal.pone.0096534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789353	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700109
J	Zhang, Y; Quan, ZX; Zhao, ZH; Luo, XJ; Tang, K; Li, J; Zhou, X; Jiang, DM				Zhang, Yuan; Quan, Zhengxue; Zhao, Zenghui; Luo, Xiaoji; Tang, Ke; Li, Jie; Zhou, Xu; Jiang, Dianming			Evaluation of Anterior Cervical Reconstruction with Titanium Mesh Cages versus Nano-Hydroxyapatite/Polyamide66 Cages after 1-or 2-Level Corpectomy for Multilevel Cervical Spondylotic Myelopathy: A Retrospective Study of 117 Patients	PLOS ONE			English	Article							SINGLE-LEVEL CORPECTOMY; COMPRESSIVE STRENGTH; TECHNICAL NOTE; SPINE FUSION; FOLLOW-UP; LAMINOPLASTY; DECOMPRESSION; STABILIZATION; COMPLICATIONS; COMPOSITES	Objective: To retrospectively compare the efficacy of the titanium mesh cage (TMC) and the nano-hydroxyapatite/ polyamide66 cage (n-HA/PA66 cage) for 1- or 2-level anterior cervical corpectomy and fusion (ACCF) to treat multilevel cervical spondylotic myelopathy (MCSM). Methods: A total of 117 consecutive patients with MCSM who underwent 1- or 2-level ACCF using a TMC or an n-HA/PA66 cage were studied retrospectively at a mean follow-up of 45.28+/-12.83 months. The patients were divided into four groups according to the level of corpectomy (1- or 2-level corpectomy) and cage type used (TMC or n-HA/PA66 cage). Clinical and radiological parameters were used to evaluate outcomes. Results: At the one-year follow-up, the fusion rate in the n-HA/PA66 group was higher, albeit non-significantly, than that in the TMC group for both 1- and 2-level ACCF, but the fusion rates of the procedures were almost equal at the final follow-up. The incidence of cage subsidence at the final follow-up was significantly higher in the TMC group than in the n-HA/PA66 group for the 1-level ACCF (24% vs. 4%, p = 0.01), and the difference was greater for the 2-level ACCF between the TMC group and the n-HA/PA66 group (38% vs. 5%, p = 0.01). Meanwhile, a much greater loss of fused height was observed in the TMC group compared with the n-HA/PA66 group for both the 1- and 2-level ACCF. All four groups demonstrated increases in C2-C7 Cobb angle and JOA scores and decreases in VAS at the final follow-up compared with preoperative values. Conclusion: The lower incidence of cage subsidence, better maintenance of the height of the fused segment and similar excellent bony fusion indicate that the n-HA/PA66 cage may be a superior alternative to the TMC for cervical reconstruction after cervical corpectomy, in particular for 2-level ACCF.	[Zhang, Yuan; Quan, Zhengxue; Zhao, Zenghui; Luo, Xiaoji; Tang, Ke; Li, Jie; Zhou, Xu; Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Chongqing, Peoples R China	Chongqing Medical University	Quan, ZX (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Chongqing, Peoples R China.	quanzx18@126.com	Zhang, Yuan/AAH-8525-2021	Zhang, Yuan/0000-0002-4839-0218	National Natural Science Foundation of China [81272039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant No. 81272039). URL: http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andaluz N, 2012, J NEUROSURG-SPINE, V16, P2, DOI 10.3171/2011.9.SPINE10430; Bilbao G, 2010, ACTA NEUROCHIR, V152, P1155, DOI 10.1007/s00701-010-0660-3; Chen Y, 2008, J SPINAL DISORD TECH, V21, P489, DOI 10.1097/BSD.0b013e318158de22; Chibbaro S, 2006, J CLIN NEUROSCI, V13, P233, DOI 10.1016/j.jocn.2005.04.011; Daubs MD, 2005, SPINE, V30, P1402, DOI 10.1097/01.brs.0000166526.78058.3c; Dorai Z, 2003, J NEUROSURG, V99, P3, DOI 10.3171/spi.2003.99.1.0003; Edwards CC, 2002, SPINE, V27, P1168, DOI 10.1097/00007632-200206010-00007; Gercek E, 2003, EUR SPINE J, V12, P513, DOI 10.1007/s00586-003-0539-6; Hee HT, 2003, J SPINAL DISORD TECH, V16, P1, DOI 10.1097/00024720-200302000-00001; HERKOWITZ HN, 1988, SPINE, V13, P774, DOI 10.1097/00007632-198807000-00011; Hilibrand AS, 2002, SPINE, V27, P146, DOI 10.1097/00007632-200201150-00005; Huang M, 2003, J MATER SCI-MATER M, V14, P655, DOI 10.1023/A:1024087410890; Kinoshita A, 1999, MINIM INVAS NEUROSUR, V42, P156, DOI 10.1055/s-2008-1053390; Kirkpatrick JS, 1999, SPINE, V24, P1186, DOI 10.1097/00007632-199906150-00003; Kotil K, 2011, TURK NEUROSURG, V21, P606, DOI [10.5137/1019-5149.JTN .4739-11.2, 10.5137/1019-5149.JTN.4739-11.2]; Lee SH, 2008, J CLIN NEUROSCI, V15, P1227, DOI 10.1016/j.jocn.2007.09.019; Lian XF, 2010, EUR SPINE J, V19, P713, DOI 10.1007/s00586-010-1319-8; Lim TH, 2001, SPINE, V26, P951, DOI 10.1097/00007632-200104150-00021; Lin QS, 2012, EUR SPINE J, V21, P474, DOI 10.1007/s00586-011-1961-9; Liu Y, 2012, EUR SPINE J, V21, P2428, DOI 10.1007/s00586-012-2323-y; Lu J, 2008, EUR SPINE J, V17, P129, DOI 10.1007/s00586-007-0518-4; Majd ME, 1999, SPINE, V24, P1604, DOI 10.1097/00007632-199908010-00016; Matz PG, 2009, J NEUROSURG-SPINE, V11, P157, DOI 10.3171/2009.1.SPINE08726; Oh MC, 2009, SPINE, V34, P692, DOI 10.1097/BRS.0b013e318199690a; Rieger A, 2003, NEUROSURGERY, V52, P449, DOI 10.1227/01.NEU.0000043815.31251.5B; Sevki K, 2004, SPINE, V29, P2493, DOI 10.1097/01.brs.0000145412.93407.c3; Song KJ, 2012, EUR SPINE J, V21, P1551, DOI 10.1007/s00586-012-2296-x; Tani T, 2002, SPINE, V27, P2491, DOI 10.1097/00007632-200211150-00013; Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6; WITTENBERG RH, 1990, SPINE, V15, P1073, DOI 10.1097/00007632-199015100-00017; Xu QA, 2010, INT J NANOMED, V5, P331; Yan DL, 2011, ARCH ORTHOP TRAUM SU, V131, P1369, DOI 10.1007/s00402-011-1317-2; Yang X, 2013, INT ORTHOP, V37, P2421, DOI 10.1007/s00264-013-2101-4; Yang X, 2012, ORTHOPEDICS, V35, pE66, DOI 10.3928/01477447-20111122-10; Yu FB, 2013, EUR SPINE J, V22, P2891, DOI 10.1007/s00586-013-2976-1; Zhang Y, 2007, SPINE, V32, P1482, DOI 10.1097/BRS.0b013e318068b30a; Zhao ZH, 2012, J CLIN NEUROSCI, V19, P536, DOI 10.1016/j.jocn.2011.05.043	37	24	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96265	10.1371/journal.pone.0096265	http://dx.doi.org/10.1371/journal.pone.0096265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789144	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700070
J	Jonas, JB; Wang, NL; Xu, J; Wang, YX; You, QS; Yang, DY; Bin Xie, X; Xu, L				Jonas, Jost B.; Wang, Ningli; Xu, Jie; Wang, Ya Xing; You, Qi Sheng; Yang, Diya; Bin Xie, Xiao; Xu, Liang			Diabetic Retinopathy and Estimated Cerebrospinal Fluid Pressure. The Beijing Eye Study 2011	PLOS ONE			English	Article							INTRACRANIAL-PRESSURE; PROGRESSION; POPULATION; HEMORRHAGE; INDEX; CHINA	Purpose: The cerebrospinal fluid pressure (CSFP) is a major determinant of central retinal vein pressure and thus of retinal capillary pressure. We tested the hypothesis whether prevalence and severity of diabetic retinopathy are associated with CSFP. Methods: The population-based Beijing Eye Study 2011 included 3468 individuals with a mean age of 64.6 +/- 9.8 years. A detailed ophthalmic examination was performed including fundus photography for the assessment of diabetic retinopathy according. Based on a previous study with lumbar cerebrospinal fluid pressure (CSFP) measurements, CSFP was calculated as CSFP[mmHg] = 0.44xBody Mass Index[kg/m(2)]+0.16 Diastolic Blood Pressure[mmHg]-0.18xAge[Years] = 1.9]. Results: In binary regression analysis, presence of diabetic retinopathy was significantly associated with higher levels of HbA1c (P<0.001; regression coefficient B:0.25; odds ratio (OR):1.28; 95% confidence interval (CI):1.15,1.43), higher blood concentration of glucose (P<0.001; B:0.40;OR:1.49;95%CI:1.36,1.63), longer known duration of diabetes mellitus (P<0.001; B:0.14;OR:1.15; 95%CI:1.11,1.19), higher systolic blood pressure (P<0.001; B:0.03;OR:1.03;95%CI:1.02,1.04), lower diastolic blood pressure (P<0.001; B:-0.06;OR:0.94;95%CI:0.91,0.97), and higher CSFP (P = 0.002; B:0.13;OR:1.14;95%CI:1.05,1.24). Severity of diabetic retinopathy was significantly associated with higher HbA1c value (P<0.001; standardized coefficient beta: 0.19; correlation coefficient B: 0.07;95%CI:0.05,0.08), higher blood concentration of glucose (P<0.001; beta:0.18;B:0.04;95%CI:0.04,0.05), longer known duration of diabetes mellitus (P<0.001; beta:0.20;B:0.03;95%CI:0.02,0.03), lower level of education (P = 0.001; beta:-0.05;B:-0.02;95%CI:-0.03,-0.01), lower diastolic blood pressure (P = 0.002; beta:-0.08;B:-0.001;95%CI:-0.004,-0.001), higher systolic blood pressure (P = 0.006; beta:0.06;B:0.001;95%CI:0.000,0.001), and higher CSFP (P = 0.006; beta:0.06;B:0.006;95%CI:0.002,0.010). Conclusions: Higher prevalence and severity of diabetic retinopathy were associated with higher estimated CSFP after adjusting for systemic parameters. Higher CSFP through a higher retinal vein pressure may lead to more marked retinal venous congestion and vascular leakage in diabetic retinae.	[Jonas, Jost B.; Xu, Jie; Wang, Ya Xing; You, Qi Sheng; Xu, Liang] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Mannheim, Germany; [Wang, Ningli; Yang, Diya; Bin Xie, Xiao] Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing, Peoples R China	Capital Medical University; Ruprecht Karls University Heidelberg; Capital Medical University	Jonas, JB (corresponding author), Capital Med Univ, Beijing Ophthalmol & Visual Sci Key Lab, Beijing Tongren Eye Ctr, Beijing Inst Ophthalmol, Beijing, Peoples R China.	jost.jonas@medma.uni-heidelberg.de; xlbio1@163.com	Xu, Jie/AIE-0524-2022; You, Qisheng/AAG-7153-2020; xu, jie/GQR-1913-2022; wang, YA XING/K-9671-2016	You, Qisheng/0000-0003-0743-7320; xu, jie/0000-0002-2039-7055; wang, YA XING/0000-0003-2749-7793	Chinese State Natural Sciences Fund [81170890]; National Key Technology R&D Program of the Ministry of Science and Technology [2012BAH05F05, 2013BAH19F04]; Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Chinese State Natural Sciences Fund; National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	This work was supported by the Chinese State Natural Sciences Fund (81170890) and the National Key Technology R&D Program of the Ministry of Science and Technology (Nos. 2012BAH05F05 and 2013BAH19F04). The authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Berdahl JP, 2012, INVEST OPHTH VIS SCI, V53, P1422, DOI 10.1167/iovs.11-8220; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; CLARKE C, 1976, BRIT MED J, V2, P495, DOI 10.1136/bmj.2.6034.495; De Maeyer K, 2007, BRIT J OPHTHALMOL, V91, P869, DOI 10.1136/bjo.2006.109132; Fleming AD, 2010, BRIT J OPHTHALMOL, V94, P706, DOI 10.1136/bjo.2008.149807; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Jonas JB, 2003, BRIT J OPHTHALMOL, V87, P361, DOI 10.1136/bjo.87.3.361-a; JONAS JB, 2014, AM J HYPERTENSION; Jonas JB, 2008, GRAEF ARCH CLIN EXP, V246, P1059, DOI 10.1007/s00417-008-0780-0; Jonas JB, 2007, AM J OPHTHALMOL, V143, P112, DOI 10.1016/j.ajo.2006.09.019; Man REK, 2012, OPHTHALMOLOGY, V119, P1754, DOI 10.1016/j.ophtha.2012.03.021; Medele RJ, 1998, J NEUROSURG, V88, P851, DOI 10.3171/jns.1998.88.5.0851; Park CY, 2012, BRIT J OPHTHALMOL, V96, P151, DOI 10.1136/bjo.2010.198275; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Quigley M, 1999, ARCH OPHTHALMOL-CHIC, V117, P84; Ren RJ, 2012, GRAEF ARCH CLIN EXP, V250, P445, DOI 10.1007/s00417-011-1746-1; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Stodtmeister R, 2013, INVEST OPHTH VIS SCI, V54, P4698, DOI 10.1167/iovs.12-10607; Wang Y, 2006, BRIT J OPHTHALMOL, V90, P353, DOI 10.1136/bjo.2005.081521; Xie XB, 2013, CRIT CARE, V17, DOI 10.1186/cc12841; Xu L, 2006, BRIT J OPHTHALMOL, V90, P1087, DOI 10.1136/bjo.2006.096123	24	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96273	10.1371/journal.pone.0096273	http://dx.doi.org/10.1371/journal.pone.0096273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789334	gold, Green Published			2022-12-27	WOS:000335510600090
J	Xue, DX; Wang, HY; Zhang, T; Liu, JX				Xue, Dong-Xiu; Wang, Hai-Yan; Zhang, Tao; Liu, Jin-Xian			Population Genetic Structure and Demographic History of Atrina pectinata Based on Mitochondrial DNA and Microsatellite Markers	PLOS ONE			English	Article							BROADCAST-SPAWNING BIVALVE; PACIFIC MARGINAL SEAS; PLEISTOCENE ISOLATION; MARINE FISH; EDULIS L.; DISPERSAL; EXPANSION; SOFTWARE; FLOW; DIFFERENTIATION	The pen shell, Atrina pectinata, is one of the commercial bivalves in East Asia and thought to be recently affected by anthropogenic pressure (habitat destruction and/or fishing pressure). Information on its population genetic structure is crucial for the conservation of A. pectinata. Considering its long pelagic larval duration and iteroparity with high fecundity, the genetic structure for A. pectinata could be expected to be weak at a fine scale. However, the unusual oceanography in the coasts of China and Korea suggests potential for restricted dispersal of pelagic larvae and geographical differentiation. In addition, environmental changes associated with Pleistocene sea level fluctuations on the East China Sea continental shelf may also have strongly influenced historical population demography and genetic diversity of marine organisms. Here, partial sequences of the mitochondrial Cytochrome c oxidase subunit I (COI) gene and seven microsatellite loci were used to estimate population genetic structure and demographic history of seven samples from Northern China coast and one sample from North Korea coast. Despite high levels of genetic diversity within samples, there was no genetic differentiation among samples from Northern China coast and low but significant genetic differentiation between some of the Chinese samples and the North Korean sample. A late Pleistocene population expansion, probably after the Last Glacial Maximum, was also demonstrated for A. pectinata samples. No recent genetic bottleneck was detected in any of the eight samples. We concluded that both historical recolonization (through population range expansion and demographic expansion in the late Pleistocene) and current gene flow (through larval dispersal) were responsible for the weak level of genetic structure detected in A. pectinata.	[Xue, Dong-Xiu; Zhang, Tao; Liu, Jin-Xian] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China; [Wang, Hai-Yan] Chinese Acad Sci, Inst Oceanol, Dept Marine Organism Taxon & Phylogeny, Qingdao, Shandong, Peoples R China; [Xue, Dong-Xiu] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, T (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China.	tzhang@qdio.ac.cn; jinxianliu@gmail.com			National Key Technology R&D Program in the 12th Five Year Plan of China [2011BAD13B01, 2011BAD45B01]; 100 Talents Program of the Chinese Academy of Sciences; National Marine Public Welfare Research Project [201305043]	National Key Technology R&D Program in the 12th Five Year Plan of China(National Key Technology R&D Program); 100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Marine Public Welfare Research Project	This work was supported by National Key Technology R&D Program in the 12th Five Year Plan of China (No. 2011BAD13B01 and No. 2011BAD45B01); 100 Talents Program of the Chinese Academy of Sciences to JXL; and the National Marine Public Welfare Research Project (201305043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HS, 2012, GENES GENOM, V34, P681, DOI 10.1007/s13258-012-0091-z; An HS, 2011, INT J MOL SCI, V12, P6024, DOI 10.3390/ijms12096024; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise John C., 1994, pi; Baus E, 2005, MOL ECOL, V14, P3373, DOI 10.1111/j.1365-294X.2005.02681.x; BENZIE JAH, 1992, MAR BIOL, V113, P373, DOI 10.1007/BF00349161; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Cho ES, 2007, MAR BIOTECHNOL, V9, P203, DOI 10.1007/s10126-006-6057-x; Claremont M, 2011, J BIOGEOGR, V38, P1016, DOI 10.1111/j.1365-2699.2011.02482.x; Collin R, 2001, MOL ECOL, V10, P2249, DOI 10.1046/j.1365-294X.2001.01372.x; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crandall ED, 2008, MOL ECOL, V17, P611, DOI 10.1111/j.1365-294X.2007.03600.x; Crandall ED, 2012, MOL BIOL EVOL, V29, P707, DOI 10.1093/molbev/msr227; Diaz-Ferguson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012675; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fievet V, 2007, MOL ECOL, V16, P1847, DOI 10.1111/j.1365-294X.2006.03208.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fu YX, 1997, GENETICS, V147, P915; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hellberg ME, 2002, B MAR SCI, V70, P273; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HUNT A, 1993, MAR ECOL PROG SER, V92, P179, DOI 10.3354/meps092179; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kenchington E, 2003, ICES J MAR SCI, V60, P1172, DOI 10.1016/S1054-3139(03)00136-X; Kenchington EL, 2006, MOL ECOL, V15, P1781, DOI 10.1111/j.1365-294X.2006.02915.x; Kupper C, 2012, MOL ECOL, V21, P5864, DOI 10.1111/mec.12064; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Launey S, 2002, J HERED, V93, P331, DOI 10.1093/jhered/93.5.331; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu JX, 2006, MOL PHYLOGENET EVOL, V40, P712, DOI 10.1016/j.ympev.2006.04.019; Liu JX, 2011, MAR BIOL, V158, P893, DOI 10.1007/s00227-010-1616-0; Liu J, 2011, MOL ECOL, V20, P4332, DOI 10.1111/j.1365-294X.2011.05275.x; Luttikhuizen PC, 2003, J EVOLUTION BIOL, V16, P260, DOI 10.1046/j.1420-9101.2003.00510.x; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Ni LH, 2011, MAR ECOL-EVOL PERSP, V32, P488, DOI 10.1111/j.1439-0485.2011.00436.x; Nielsen EE, 2001, FISH FISH, V2, P328, DOI 10.1046/j.1467-2960.2001.00055.x; Owen EF, 2013, MAR BIOL, V160, P3015, DOI 10.1007/s00227-013-2291-8; Park SDE, 2001, THESIS U DUBLIN; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prakoon W, 2010, MAR BIOTECHNOL, V12, P506, DOI 10.1007/s10126-009-9234-x; Pritchard J. K., 2009, DOCUMENTATION STRUCT, P1; Qiu S., 2000, J FISHERIES CHINA, V24, P28; Rambaut A., 2007, TRACER V1 5; Ridgway G, 2001, SARSIA, V86, P157, DOI 10.1080/00364827.2001.10420471; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Selkoe KA, 2011, MAR ECOL PROG SER, V436, P291, DOI 10.3354/meps09238; TAJIMA F, 1989, GENETICS, V123, P585; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Vadopalas B, 2004, J SHELLFISH RES, V23, P693; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Oppen MJH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003401; Wang PX, 1999, MAR GEOL, V156, P5, DOI 10.1016/S0025-3227(98)00172-8; Wang Z. R., 1997, FAUNA SINICA PHYLUM; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Xiao J, 2010, MAR BIOL, V157, P1767, DOI 10.1007/s00227-010-1449-x; Xu JW, 2009, MOL PHYLOGENET EVOL, V52, P45, DOI 10.1016/j.ympev.2009.02.007; Xu XD, 1999, MAR GEOL, V156, P285, DOI 10.1016/S0025-3227(98)00183-2; Xue DX, 2012, J SHELLFISH RES, V31, P739, DOI 10.2983/035.031.0318; Yu R, 2007, THESIS OCEAN U CHINA; Zhan AB, 2009, MAR BIOTECHNOL, V11, P223, DOI 10.1007/s10126-008-9138-1; Zhang Hong-yun, 2009, Shanghai Haiyang Daxue Xuebao, V18, P623; Zhang J., 2008, THESIS LIAONING NORM; Zhao, 1995, WESTPAC PALEOGEOGRAP, P75	77	30	35	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95436	10.1371/journal.pone.0095436	http://dx.doi.org/10.1371/journal.pone.0095436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789175	Green Published, Green Submitted, gold			2022-12-27	WOS:000335510600037
J	Woodhams, DC; Brandt, H; Baumgartner, S; Kielgast, J; Kupfer, E; Tobler, U; Davis, LR; Schmidt, BR; Bel, C; Hodel, S; Knight, R; McKenzie, V				Woodhams, Douglas C.; Brandt, Hannelore; Baumgartner, Simone; Kielgast, Jos; Kuepfer, Eliane; Tobler, Ursina; Davis, Leyla R.; Schmidt, Benedikt R.; Bel, Christian; Hodel, Sandro; Knight, Rob; McKenzie, Valerie			Interacting Symbionts and Immunity in the Amphibian Skin Mucosome Predict Disease Risk and Probiotic Effectiveness	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; ANTIMICROBIAL PEPTIDES; JANTHINOBACTERIUM-LIVIDUM; BACTERIAL COMMUNITIES; DEFENSE PEPTIDES; CHYTRID FUNGUS; CHYTRIDIOMYCOSIS; HOST; FROG; MICROBIOTA	Pathogenesis is strongly dependent on microbial context, but development of probiotic therapies has neglected the impact of ecological interactions. Dynamics among microbial communities, host immune responses, and environmental conditions may alter the effect of probiotics in human and veterinary medicine, agriculture and aquaculture, and the proposed treatment of emerging wildlife and zoonotic diseases such as those occurring on amphibians or vectored by mosquitoes. Here we use a holistic measure of amphibian mucosal defenses to test the effects of probiotic treatments and to assess disease risk under different ecological contexts. We developed a non-invasive assay for antifungal function of the skin mucosal ecosystem (mucosome function) integrating host immune factors and the microbial community as an alternative to pathogen exposure experiments. From approximately 8500 amphibians sampled across Europe, we compared field infection prevalence with mucosome function against the emerging fungal pathogen Batrachochytrium dendrobatidis. Four species were tested with laboratory exposure experiments, and a highly susceptible species, Alytes obstetricans, was treated with a variety of temperature and microbial conditions to test the effects of probiotic therapies and environmental conditions on mucosome function. We found that antifungal function of the amphibian skin mucosome predicts the prevalence of infection with the fungal pathogen in natural populations, and is linked to survival in laboratory exposure experiments. When altered by probiotic therapy, the mucosome increased antifungal capacity, while previous exposure to the pathogen was suppressive. In culture, antifungal properties of probiotics depended strongly on immunological and environmental context including temperature, competition, and pathogen presence. Functional changes in microbiota with shifts in temperature provide an alternative mechanistic explanation for patterns of disease susceptibility related to climate beyond direct impact on host or pathogen. This nonlethal management tool can be used to optimize and quickly assess the relative benefits of probiotic therapies under different climatic, microbial, or host conditions.	[Woodhams, Douglas C.; Brandt, Hannelore; Baumgartner, Simone; Kuepfer, Eliane; Tobler, Ursina; Davis, Leyla R.; Schmidt, Benedikt R.; Bel, Christian; Hodel, Sandro] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Woodhams, Douglas C.; McKenzie, Valerie] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Kielgast, Jos] Univ Copenhagen, Dept Biol, Sect Freshwater Biol, Copenhagen, Denmark; [Kuepfer, Eliane] Tech Univ Carolo Wilhelmina Braunschweig, Dept Evolutionary Biol, D-38106 Braunschweig, Germany; [Tobler, Ursina; Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Dept Chem & Biochem, BioFrontiers Inst, Boulder, CO 80309 USA	University of Zurich; University of Colorado System; University of Colorado Boulder; University of Copenhagen; Braunschweig University of Technology; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Woodhams, DC (corresponding author), Univ Massachusetts, Dept Biol, Boston, MA 02125 USA.	dwoodhams@gmail.com	Schmidt, Benedikt R./B-8491-2008; Woodhams, Douglas/B-1962-2012; Knight, Rob/D-1299-2010	Schmidt, Benedikt R./0000-0002-4023-1001; Woodhams, Douglas/0000-0003-4559-1046; Knight, Rob/0000-0002-0975-9019	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich; European Union of Aquarium Curators; Schweizer Tierschutz; Zurcher Tierschutz; Claraz Foundation; environment department of the canton St. Gallen; environment department of the canton Zurich; Swiss National Science Foundation [31-125099]; U.S. National Science Foundation Population and Community Ecology Section [DEB 1146284]	Zoological Institute; Forschungskredit of the University of Zurich; Vontobel Stiftung; Janggen-Pohn Stiftung; Basler Stiftung fur biologische Forschung; Stiftung Dr. Joachim De Giacomi; Zoo Zurich; Grun Stadt Zurich; European Union of Aquarium Curators(European Commission); Schweizer Tierschutz; Zurcher Tierschutz; Claraz Foundation; environment department of the canton St. Gallen; environment department of the canton Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. National Science Foundation Population and Community Ecology Section	Financial support came from the Zoological Institute and the Forschungskredit of the University of Zurich, Vontobel Stiftung, Janggen-Pohn Stiftung, Basler Stiftung fur biologische Forschung, Stiftung Dr. Joachim De Giacomi, Zoo Zurich, Grun Stadt Zurich, European Union of Aquarium Curators, Schweizer Tierschutz, Zurcher Tierschutz, Claraz Foundation, the environment departments of the cantons St. Gallen and Zurich, Swiss National Science Foundation (31-125099 to DCW), and U.S. National Science Foundation Population and Community Ecology Section (DEB 1146284 to VJM and RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaz V, 2014, CONSERV BIOL, V28, P213, DOI 10.1111/cobi.12128; Barrios V., 2012, ACTION PLAN CONSERVA; Becker J, 2012, ECOL LETT, V15, P468, DOI 10.1111/j.1461-0248.2012.01759.x; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Britton RA, 2012, TRENDS MICROBIOL, V20, P313, DOI 10.1016/j.tim.2012.04.001; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Burgman MA, 1993, RISK ASSESSMENT CONS; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Conlon JM, 2011, CELL MOL LIFE SCI, V68, P2303, DOI 10.1007/s00018-011-0720-8; Conlon JM, 2009, PEPTIDES, V30, P1069, DOI 10.1016/j.peptides.2009.03.004; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Daum JM, 2012, INFECT GENET EVOL, V12, P1854, DOI 10.1016/j.meegid.2012.07.024; Delplace F, 2002, BIOCHEM J, V363, P457, DOI 10.1042/0264-6021:3630457; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GASCON C, 2007, AMPHIBIAN CONSERVATI; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hoffmann DE, 2013, SCIENCE, V342, P314, DOI 10.1126/science.1244656; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kesarcodi-Watson A, 2008, AQUACULTURE, V274, P1, DOI 10.1016/j.aquaculture.2007.11.019; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Kueneman JG, 2013, MOL ECOL, DOI [10.1111/mec.12510, DOI 10.1111/MEC.12510]; Kung D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087101; Lafferty KD, 2010, SCIENCE, V330, P187, DOI 10.1126/science.1196915; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; Meltser S, 2009, ANIM CONSERV, V13, P44; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Murray KA, 2012, HUM ECOL RISK ASSESS, V18, P200, DOI 10.1080/10807039.2012.632310; Myers JM, 2012, J CHEM ECOL, V38, P958, DOI 10.1007/s10886-012-0170-2; Newman DG, 2010, NEW ZEAL J ZOOL, V37, P121, DOI 10.1080/03014221003685856; Pask JD, 2012, GLOBAL CHANGE BIOL, V18, P1231, DOI 10.1111/j.1365-2486.2011.02622.x; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Roedder Dennis, 2009, Diversity, V1, P52; Rollins-Smith LA, 2002, DEV COMP IMMUNOL, V26, P63, DOI 10.1016/S0145-305X(01)00041-6; Rollins-Smith Louise A., 2011, P92; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Ross EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073056; Salinas I, 2008, FISH SHELLFISH IMMUN, V25, P114, DOI 10.1016/j.fsi.2008.03.011; Schadich E, 2009, LETT APPL MICROBIOL, V49, P384, DOI 10.1111/j.1472-765X.2009.02677.x; Schadich E, 2009, J HERPETOL, V43, P173, DOI 10.1670/08-113R1.1; Schloss PD, 2010, DNA CELL BIOL, V29, P533, DOI 10.1089/dna.2010.1020; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Stockwell MP, 2010, DIS AQUAT ORGAN, V88, P177, DOI 10.3354/dao02165; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Vredenburg V.T., 2011, FUNGAL DIS EMERGING, P342; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Williamson NR, 2007, FUTURE MICROBIOL, V2, P605, DOI 10.2217/17460913.2.6.605; Wilson M., 2005, MICROBIAL INHABITANT; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Woodhams DC, 2012, FUNGAL BIOL-UK, V116, P1203, DOI 10.1016/j.funbio.2012.10.005; Woodhams DC, 2012, DIS AQUAT ORGAN, V98, P11, DOI 10.3354/dao02429	70	122	122	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96375	10.1371/journal.pone.0096375	http://dx.doi.org/10.1371/journal.pone.0096375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24789229	Green Accepted, gold, Green Published			2022-12-27	WOS:000338917300038
J	Ghartey, JP; Smith, BC; Chen, ZG; Buckley, N; Lo, YT; Ratner, AJ; Herold, BC; Burk, RD				Ghartey, Jeny P.; Smith, Benjamin C.; Chen, Zigui; Buckley, Niall; Lo, Yungtai; Ratner, Adam J.; Herold, Betsy C.; Burk, Robert D.			Lactobacillus crispatus Dominant Vaginal Microbiome Is Associated with Inhibitory Activity of Female Genital Tract Secretions against Escherichia coli	PLOS ONE			English	Article							ONSET NEONATAL SEPSIS; WOMEN	Objective: Female genital tract secretions inhibit E. coli ex vivo and the activity may prevent colonization and provide a biomarker of a healthy microbiome. We hypothesized that high E. coli inhibitory activity would be associated with a Lactobacillus crispatus and/or jensenii dominant microbiome and differ from that of women with low inhibitory activity. Study Design: Vaginal swab cell pellets from 20 samples previously obtained in a cross-sectional study of near-term pregnant and non-pregnant healthy women were selected based on having high (> 90% inhibition) or low (< 20% inhibition) anti-E. coli activity. The V6 region of the 16S ribosomal RNA gene was amplified and sequenced using the Illumina HiSeq 2000 platform. Filtered culture supernatants from Lactobacillus crispatus, Lactobacillus iners, and Gardnerella vaginalis were also assayed for E. coli inhibitory activity. Results: Sixteen samples (10 with high and 6 with low activity) yielded evaluable microbiome data. There was no difference in the predominant microbiome species in pregnant compared to non-pregnant women (n = 8 each). However, there were significant differences between women with high compared to low E. coli inhibitory activity. High activity was associated with a predominance of L. crispatus (p < 0.007) and culture supernatants from L. crispatus exhibited greater E. coli inhibitory activity compared to supernatants obtained from L. iners or G. vaginalis. Notably, the E. coli inhibitory activity varied among different strains of L. crispatus. Conclusion: Microbiome communities with abundant L. crispatus likely contribute to the E. coli inhibitory activity of vaginal secretions and efforts to promote this environment may prevent E. coli colonization and related sequelae including preterm birth.	[Ghartey, Jeny P.; Herold, Betsy C.; Burk, Robert D.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Smith, Benjamin C.; Chen, Zigui; Buckley, Niall; Herold, Betsy C.; Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Lo, Yungtai; Burk, Robert D.] Albert Einstein Coll Med, Dept Epidemiol, Bronx, NY 10467 USA; [Lo, Yungtai; Burk, Robert D.] Albert Einstein Coll Med, Dept Populat Hlth, Bronx, NY 10467 USA; [Ratner, Adam J.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Herold, Betsy C.; Burk, Robert D.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Yeshiva University; Albert Einstein College of Medicine	Ghartey, JP (corresponding author), Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA.	jgeorge@montefiore.org	Chen, Zigui/E-8490-2017	Chen, Zigui/0000-0002-8577-1298; Herold, Betsy/0000-0001-9974-0786; Ratner, Adam/0000-0003-1761-794X	National Center for Research Resources [ULI RR025750, KL2RR025749]; National Institutes of Health; United States Public Health Service Grants [AI065309, AI079763, AI072204]; National Cancer Institute: [CA78527, P30CA013330]; NATIONAL CANCER INSTITUTE [U01CA078527, P30CA013330, R01CA078527] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750, KL2RR025749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072204, R21AI079763, R01AI065309, R33AI079763, R56AI072204, R01AI092743] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service Grants(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute:(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Clinical and Translational Science Award Grant ULI RR025750 and KL2RR025749 from the National Center for Research Resources, a component of the National Institutes of Health, United States Public Health Service Grants AI065309 (to BCH), AI079763 (to BCH), and AI072204 (to RDB), the National Cancer Institute: CA78527 (to RDB), and the Einstein Cancer Research Center (P30CA013330) from the National Cancer Institute (to RDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Carey JC, 2005, AM J OBSTET GYNECOL, V192, P1341, DOI 10.1016/j.ajog.2004.12.069; Carey JC, 2003, SEMIN PERINATOL, V27, P212, DOI 10.1016/S0146-0005(03)00020-X; Carey JC, 2000, NEW ENGL J MED, V342, P534, DOI 10.1056/NEJM200002243420802; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Dezzutti CS, 2012, J INFECT DIS, V206, P1931, DOI 10.1093/infdis/jis555; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Ghartey JP, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.025; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Kalyoussef S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049506; Keller MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P194, DOI 10.1097/QAI.0b013e31826867ae; Lin CY, 2011, PEDIATR NEONATOL, V52, P78, DOI 10.1016/j.pedneo.2011.02.001; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Madan RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040415; Madan RP, 2013, UNPUB; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Smith BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040425; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Valore EV, 2006, INFECT IMMUN, V74, P5693, DOI 10.1128/IAI.00524-06	25	68	73	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96659	10.1371/journal.pone.0096659	http://dx.doi.org/10.1371/journal.pone.0096659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805362	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900078
J	Li, Q; Davis, S; Mitchell, P; Dowling, R; Yan, B				Li, Qi; Davis, Stephen; Mitchell, Peter; Dowling, Richard; Yan, Bernard			Proximal Hyperdense Middle Cerebral Artery Sign Predicts Poor Response to Thrombolysis	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; MCA DOT SIGN; INTRAVENOUS THROMBOLYSIS; CT; OCCLUSION; RECANALIZATION; ASSOCIATION; TERRITORY; MARKER	The aim of our study was to compare the rapid neurological improvement after intravenous recombinant tissue-type plasminogen activator (rtPA) in patients with proximal hyperdense middle cerebral artery sign ( p-HMCAS) to those without the sign and those with the distal hyperdense middle cerebral artery sign ( d-HMCAS). Admission and 24 hour non-contrast CT scans of 120 patients with middle cerebral artery ( MCA) territory stroke who were treated with intravenous rtPA were assessed for the presence of p-HMCAS and d-HMCAS. The sign was classified according to the site of occlusion. Rapid neurological improvement was defined as >= 50% improvement in the NIHSS score at 24 hours after thrombolysis. Rapid neurological recovery after thrombolysis was assessed and compared between the subgroups. Rapid neurological recovery was less common in the pooled group of patients with either p-HMCAS or d-HMCAS than those without the sign (p < 0.01). Patients with p- HMCAS were less likely to have rapid neurological recovery than those with d- HMCAS ( p, 0.01). However, there was no difference in early neurological recovery between patients with d-HMCAS and those without any hyperdense sign. Our study showed that poor neurological recovery post rtPA was confined to p-HMCAS and not to d-HMCAS, indicating that these signs have quite different prognostic significance.	[Li, Qi] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Li, Qi; Davis, Stephen; Yan, Bernard] Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia; [Mitchell, Peter; Dowling, Richard] Univ Melbourne, Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic 3050, Australia	Chongqing Medical University; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne	Yan, B (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Neurol, Melbourne, Vic 3050, Australia.	bernard.yan@mh.org.au	Li, Qi/ABE-4182-2021	Li, Qi/0000-0002-9144-148X; Yan, Bernard/0000-0001-8802-9606; Dowling, Richard/0000-0002-4082-8676				Arnold M, 2002, STROKE, V33, P1828, DOI 10.1161/01.STR.0000020713.89227.B7; Arnold M, 2004, CEREBROVASC DIS, V17, P182; Barber PA, 2001, STROKE, V32, P84, DOI 10.1161/01.STR.32.1.84; BASTIANELLO S, 1991, NEURORADIOLOGY, V33, P207, DOI 10.1007/BF00588219; Brown DL, 2004, STROKE, V35, P147, DOI 10.1161/01.STR.000010539.93273.72; Gralla J, 2008, AM J NEURORADIOL, V29, P247, DOI 10.3174/ajnr.A0790; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jensen UR, 2010, CEREBROVASC DIS, V29, P62, DOI 10.1159/000256648; Kamalian S, 2013, STROKE, V44, P3553, DOI 10.1161/STROKEAHA.113.003079; Kharitonova T, 2009, J NEUROL NEUROSUR PS, V80, P273, DOI 10.1136/jnnp.2008.150185; Kim EY, 2008, AM J NEURORADIOL, V29, P359, DOI 10.3174/ajnr.A0800; Leary MC, 2003, STROKE, V34, P2636, DOI 10.1161/01.STR.0000092123.00938.83; Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576; Machumpurath B, 2011, CEREBROVASC DIS, V31, P278, DOI 10.1159/000322564; Manelfe C, 1999, STROKE, V30, P769, DOI 10.1161/01.STR.30.4.769; Mattle HP, 2008, STROKE, V44, P3553; Rosenthal ES, 2008, AM J NEURORADIOL, V29, P1471, DOI 10.3174/ajnr.A1153; Rubiera M, 2006, STROKE, V37, P2301, DOI 10.1161/01.STR.0000237070.80133.1d; Shetty SK, 2006, RADIOLOGY, V241, P315, DOI 10.1148/radiol.2411040573; Somford DM, 2002, RADIOLOGY, V223, P667, DOI 10.1148/radiol.2233011017; TOMSICK TA, 1989, NEURORADIOLOGY, V31, P312, DOI 10.1007/BF00344173; TOMSICK TA, 1994, AM J NEURORADIOL, V15, P16; Tsao JW, 2002, NEUROLOGY, V58, P1512, DOI 10.1212/WNL.58.10.1512; VONKUMMER R, 1995, STROKE, V26, P581, DOI 10.1161/01.STR.26.4.581; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Zou M, 2013, J CLIN NEUROSCI, V20, P984, DOI 10.1016/j.jocn.2012.10.013	26	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96123	10.1371/journal.pone.0096123	http://dx.doi.org/10.1371/journal.pone.0096123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804962	Green Published, gold			2022-12-27	WOS:000335728900036
J	Wang, JY; Wu, PK; Chen, PCH; Yen, CC; Hung, GY; Chen, CF; Hung, SC; Tsai, SF; Liu, CL; Chen, TH; Chen, WM				Wang, Jir-You; Wu, Po-Kuei; Chen, Paul Chih-Hsueh; Yen, Chuen-Chuan; Hung, Giun-Yi; Chen, Cheng-Fong; Hung, Shih-Chieh; Tsai, Shih-Fen; Liu, Chien-Lin; Chen, Tain-Hsiung; Chen, Wei-Ming			Manipulation Therapy Prior to Diagnosis Induced Primary Osteosarcoma Metastasis-From Clinical to Basic Research	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; CELL-PROLIFERATION; MASSAGE THERAPY; MOUSE EPIDERMIS; TUMOR-GROWTH; PROMOTE; COMPLEMENTARY	Osteosarcoma (OS) patients who suffer manipulation therapy (MT) prior to diagnosis resulted in poor prognosis with increasing metastasis or recurrence rate. The aim of the study is to establish an in vivo model to identify the effects of MT on OS. The enrolled 235 OS patients were followed up in this study. In vivo nude mice model with tibia injection of GFP-labeled human OS cells were randomly allocated into MT(+) that with repeated massage on tumor site twice a week and no treatment as MT(2) group. The five-year survival, metastasis and recurrence rates were recorded in clinical subjects. X-ray plainfilm, micro-PET/CT scan, histopathology, serum metalloproteinase 2 (MMP2), metalloproteinase 9 (MMP9) level and human kinase domain insert receptor (KDR) pattern were assayed in mice model. The results showed that patient with MT decreased 5-year survival and higher recurrence or metastasis rate. Compatible with clinical findings, the decreased body weight (30.5 +/- 60.65 g) and an increased tumor volume (8.3 +/- 61.18 mm(3)) in MT(+) mice were observed. The increasing signal intensity over lymph node region of hind limb by micro-PET/CT and the tumor cells were detected in lung and bilateral lymph nodes only in MT(+) group. MMP2 (2.14 +/- 9.8 ng/ml) and MMP9 (25.5 +/- 1.81 ng/ml) were higher in MT(+) group than in MT(2) group (165 +/- 7.8 ng/ml and 16.9 +/- 1.40 ng/ml, individually) as well as KDR expression. Taking clinical observations and in vivo evidence together, MT treatment leads to poor prognosis of primary osteosarcoma; physicians should pay more attention on patients who seek MT before diagnosis.	[Wang, Jir-You; Wu, Po-Kuei; Chen, Cheng-Fong; Hung, Shih-Chieh; Liu, Chien-Lin; Chen, Tain-Hsiung; Chen, Wei-Ming] Taipei Vet Gen Hosp, Dept Orthopaed, Taipei, Taiwan; [Wang, Jir-You; Wu, Po-Kuei; Chen, Paul Chih-Hsueh; Yen, Chuen-Chuan; Hung, Giun-Yi; Chen, Cheng-Fong; Hung, Shih-Chieh; Tsai, Shih-Fen; Liu, Chien-Lin; Chen, Tain-Hsiung; Chen, Wei-Ming] Taipei Vet Gen Hosp, Dept Orthopaed, Therapeut & Res Ctr Musculoskeletal Tumor, Taipei, Taiwan; [Wang, Jir-You; Hung, Shih-Chieh] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Wu, Po-Kuei; Chen, Cheng-Fong; Hung, Shih-Chieh; Liu, Chien-Lin; Chen, Tain-Hsiung; Chen, Wei-Ming] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Wu, Po-Kuei; Chen, Cheng-Fong; Hung, Shih-Chieh; Liu, Chien-Lin; Chen, Tain-Hsiung; Chen, Wei-Ming] Natl Yang Ming Univ, Sch Med, Inst Clin, Taipei 112, Taiwan; [Chen, Paul Chih-Hsueh] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan; [Yen, Chuen-Chuan] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Hung, Giun-Yi] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Dept Pharmacol, Taipei 112, Taiwan; [Tsai, Shih-Fen] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan, Miaoli, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan	Chen, WM (corresponding author), Taipei Vet Gen Hosp, Dept Orthopaed, Taipei, Taiwan.	wmchen@vghtpe.gov.tw	Hung, Giun-Yi/J-4158-2014; Tsai, Shih-Feng/E-3997-2010		Taipei Veterans General Hospital [V100C-108]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work is supported by a grant of Taipei Veterans General Hospital (V100C-108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Kosei, 2012, Sarcoma, V2012, P523432, DOI 10.1155/2012/523432; BERTSCH S, 1976, CELL TISSUE KINET, V9, P445, DOI 10.1111/j.1365-2184.1976.tb01295.x; Bjornland K, 2005, J SURG RES, V127, P151, DOI 10.1016/j.jss.2004.12.016; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Calenda Elaine, 2006, Curr Pain Headache Rep, V10, P270, DOI 10.1007/s11916-006-0031-1; Cassileth BR, 2004, J PAIN SYMPTOM MANAG, V28, P244, DOI 10.1016/j.jpainsymman.2003.12.016; Chandwani KD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/979213; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P2064, DOI 10.1038/sj.bjc.6605482; Collinge William, 2012, Semin Oncol Nurs, V28, P45, DOI 10.1016/j.soncn.2011.11.005; Diaz NM, 2004, AM J SURG PATHOL, V28, P1641, DOI 10.1097/00000478-200412000-00014; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; Ferrari C, 2004, ACTA ORTHOP SCAND, V75, P487, DOI 10.1080/00016470410001295-1; Han J, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-37; Hodgson NA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/456897; Jane SW, 2009, J PAIN SYMPTOM MANAG, V37, P754, DOI 10.1016/j.jpainsymman.2008.04.021; Keir ST, 2011, SUPPORT CARE CANCER, V19, P711, DOI 10.1007/s00520-010-1032-5; Khanna C, 2001, CANCER RES, V61, P3750; Knox LC, 1922, ANN SURG, V75, P129, DOI 10.1097/00000658-192202000-00001; Li IH, 2010, NEUROIMAGE, V49, P1259, DOI 10.1016/j.neuroimage.2009.07.072; Liu F, 2002, HEPATOLOGY, V35, P1314, DOI 10.1053/jhep.2002.33467; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Ma KH, 2009, NEUROIMAGE, V45, P687, DOI 10.1016/j.neuroimage.2008.12.060; MARKS F, 1979, CANCER RES, V39, P4183; Mialou V, 2005, CANCER-AM CANCER SOC, V104, P1100, DOI 10.1002/cncr.21263; Park SY, 2012, J KOREAN SURG SOC, V82, P356, DOI 10.4174/jkss.2012.82.6.356; Sergi C, 2008, EXP GERONTOL, V43, P1039, DOI 10.1016/j.exger.2008.09.009; Sherman Karen J, 2005, BMC Complement Altern Med, V5, P13, DOI 10.1186/1472-6882-5-13; Snoeks TJA, 2011, BONE, V49, P1264, DOI 10.1016/j.bone.2011.09.037; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; SWEETNAM R, 1982, BRIT J HOSP MED, V28, P112; Teng ZZ, 2012, ATHEROSCLEROSIS, V223, P321, DOI 10.1016/j.atherosclerosis.2012.06.015; Thurber GM, 2010, J SURG ONCOL, V102, P758, DOI 10.1002/jso.21735; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; Tomlinson RE, 2013, BONE, V52, P212, DOI 10.1016/j.bone.2012.09.035; Turner RR, 2005, AM J SURG PATHOL, V29, P1254, DOI 10.1097/01.pas.0000173022.95099.ca; Wanchai A, 2012, NURS HEALTH SCI, V14, P339, DOI 10.1111/j.1442-2018.2012.00730.x; Witt F, 2013, TISSUE ENG A; Wu PK, 2010, J BONE JOINT SURG BR, V92B, P1580, DOI 10.1302/0301-620X.92B11.24706; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yu ST, 2010, CANCER RES, V70, P2585, DOI 10.1158/0008-5472.CAN-09-3841	40	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96571	10.1371/journal.pone.0096571	http://dx.doi.org/10.1371/journal.pone.0096571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804772	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900072
J	Castellanos, R; Xie, Q; Zheng, DY; Cvekl, A; Morrow, BE				Castellanos, Raquel; Xie, Qing; Zheng, Deyou; Cvekl, Ales; Morrow, Bernice E.			Mammalian TBX1 Preferentially Binds and Regulates Downstream Targets Via a Tandem T-site Repeat	PLOS ONE			English	Article							TISSUE-SPECIFIC TRANSCRIPTION; DNA-BINDING; BOX GENES; FUNCTIONAL-ANALYSIS; IDENTIFICATION; MUTATIONS; PROTEIN; VERTEBRATE; EXPRESSION; BRACHYURY	Haploinsufficiency or mutation of TBX1 is largely responsible for the etiology of physical malformations in individuals with velo-cardio-facial/DiGeorge syndrome (VCFS/DGS/22q11.2 deletion syndrome). TBX1 encodes a transcription factor protein that contains an evolutionarily conserved DNA binding domain termed the T-box that is shared with other family members. All T-box proteins, examined so far, bind to similar but not identical consensus DNA sequences, indicating that they have specific binding preferences. To identify the TBX1 specific consensus sequence, Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was performed. In contrast to other TBX family members recognizing palindrome sequences, we found that TBX1 preferentially binds to a tandem repeat of 5'-AGGTGTGAAGGTGTGA-3'. We also identified a second consensus sequence comprised of a tandem repeat with a degenerated downstream site. We show that three known human disease-causing TBX1 missense mutations (F148Y, H194Q and G310S) do not alter nuclear localization, or disrupt binding to the tandem repeat consensus sequences, but they reduce transcriptional activity in cell culture reporter assays. To identify Tbx1-downstream genes, we performed an in silico genome wide analysis of potential cis-acting elements in DNA and found strong enrichment of genes required for developmental processes and transcriptional regulation. We found that TBX1 binds to 19 different loci in vitro, which may correspond to putative cis-acting binding sites. In situ hybridization coupled with luciferase gene reporter assays on three gene loci, Fgf8, Bmper, Otog-MyoD, show that these motifs are directly regulated by TBX1 in vitro. Collectively, the present studies establish new insights into molecular aspects of TBX1 binding to DNA. This work lays the groundwork for future in vivo studies, including chromatin immunoprecipitation followed by next generation sequencing (ChIP-Seq) to further elucidate the molecular pathogenesis of VCFS/DGS.	[Castellanos, Raquel; Xie, Qing; Zheng, Deyou; Cvekl, Ales; Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Xie, Qing; Cvekl, Ales] Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10467 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Morrow, BE (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	bernice.morrow@einstein.yu.edu		Morrow, Bernice/0000-0002-8076-4726; Zheng, Deyou/0000-0003-4354-5337	NIH [P01 HD070454, R01 DC05186, R01 EY012200]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH P01 HD070454 (BEM), R01 DC05186 (BEM), and R01 EY012200 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Aggarwal VS, 2006, HUM MOL GENET, V15, P3219, DOI 10.1093/hmg/ddl399; Agulnik SI, 1996, GENETICS, V144, P249; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Beermann F, 2006, GENESIS, V44, P1, DOI 10.1002/gene.20177; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Binnerts ME, 2004, BIOCHEM BIOPH RES CO, V315, P272, DOI 10.1016/j.bbrc.2004.01.048; Birnbaum RY, 2012, HUM MOL GENET, V21, P4930, DOI 10.1093/hmg/dds336; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; BOLLAG RJ, 1994, NAT GENET, V7, P383, DOI 10.1038/ng0794-383; Borycki AG, 1997, CURR BIOL, V7, pR620, DOI 10.1016/S0960-9822(06)00317-4; Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chatterjee S, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-63; Chauhan BK, 2004, NUCLEIC ACIDS RES, V32, P1696, DOI 10.1093/nar/gkh334; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Chen L, 2010, J CELL BIOL, V189, P417, DOI 10.1083/jcb.200912037; Chen LS, 2011, J BIOL CHEM, V286, P18641, DOI 10.1074/jbc.M111.236471; Chesley P, 1935, J EXPT ZOOLOGY, V70, P7; Conley CA, 2000, DEVELOPMENT, V127, P3947; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; Dobrovolskaia-Zavadskaia N, 1927, CR HEBD SOC BIOL, V97, P3; El Omari K, 2011, PROTEINS; El-Amraoui A, 2001, HEARING RES, V158, P151, DOI 10.1016/S0378-5955(01)00312-4; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Gluecksohn-Schoenheimer S, 1938, GENETICS, V23, P573; Grifone R, 2008, DEV DYNAM, V237, P3071, DOI 10.1002/dvdy.21718; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; He ML, 1999, P NATL ACAD SCI USA, V96, P10212, DOI 10.1073/pnas.96.18.10212; Hu TH, 2004, DEVELOPMENT, V131, P5491, DOI 10.1242/dev.01399; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue F, 2008, DEV BIOL, V316, P471, DOI 10.1016/j.ydbio.2008.01.013; Ivins S, 2005, DEV BIOL, V285, P554, DOI 10.1016/j.ydbio.2005.06.026; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kelly RG, 2004, HUM MOL GENET, V13, P2829, DOI 10.1093/hmg/ddh304; Kirstein L, 2000, GENES CELLS, V5, P661, DOI 10.1046/j.1365-2443.2000.00355.x; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Lazebnik MB, 2008, J BIOL CHEM, V283, P11078, DOI 10.1074/jbc.C800049200; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Liao BY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S1; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; McGaughey DM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-8; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Monks DC, 2012, DEV DYNAM, V241, P563, DOI 10.1002/dvdy.23731; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nowotschin S, 2006, DEVELOPMENT, V133, P1565, DOI 10.1242/dev.02309; Packham EA, 2003, HUM MOL GENET, V12, pR37, DOI 10.1093/hmg/ddg077; Prouse MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065132; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schraders M, 2012, AM J HUM GENET, V91, P883, DOI 10.1016/j.ajhg.2012.09.012; Sidhu A, 2008, BIOCHEMISTRY-US, V47, P6809, DOI 10.1021/bi702495m; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Sinha S, 2000, GENE, V258, P15, DOI 10.1016/S0378-1119(00)00417-0; Stoller JZ, 2005, HUM MOL GENET, V14, P885, DOI 10.1093/hmg/ddi081; van Bueren KL, 2010, DEV BIOL, V340, P369, DOI 10.1016/j.ydbio.2010.01.020; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Voss AK, 2012, DEV CELL, V23, P652, DOI 10.1016/j.devcel.2012.07.010; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; White PH, 2005, GENESIS, V42, P193, DOI 10.1002/gene.20140; Wilson V, 2002, GENOME BIOL, V3, P30081, DOI [10.1186/gb-2002-3-6-reviews3008, DOI 10.1186/GB-2002-3-6-REVIEWS3008]; Xie Q, 2011, J BIOL CHEM, V286, P43259, DOI 10.1074/jbc.M111.264580; Yagi H, 2003, LANCET, V362, P1366, DOI 10.1016/S0140-6736(03)14632-6; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	75	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95151	10.1371/journal.pone.0095151	http://dx.doi.org/10.1371/journal.pone.0095151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797903	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000014
J	Lv, T; Liu, YF; Zhang, JP; Xu, L; Zhu, Y; Yin, HK; An, HM; Lin, ZM; Xie, YH; Chen, L				Lv, Tao; Liu, Yanfeng; Zhang, Jianping; Xu, Le; Zhu, Yu; Yin, Hankun; An, Huimin; Lin, Zongming; Xie, Youhua; Chen, Lian			Impact of an Altered PROX1 Expression on Clinicopathology, Prognosis and Progression in Renal Cell Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER PROGRESSION; E-CADHERIN; GENE; METASTASIS; SURVIVAL; INVASION; TUMORS	The transcription factor PROX1 (prospero homeobox 1) has a critical role in the development of various organs, and has been implicated in both oncogenic and tumor-suppressive functions in human cancers. However, the role of PROX1 in the development of renal cell carcinomas (RCCs) has not yet been studied. Here, we reported that PROX1 expression was decreased in human RCC tissues compared with adjacent normal tissues. In RCC tissues, however, poorly differentiated RCC expressed higher PROX1 levels compared with well-differentiated RCC. In addition, the PROX1 immunostaining levels were positively correlated with tumor nuclear grade and lymph node metastasis. Further, high PROX1 expression indicated poor survival for patients. These findings imply that in the different developmental stages of RCC, PROX1 may exert distinct functions according to the specific microenvironment of tumor. Moreover, in vitro experiments revealed that PROX1 overexpression enhanced the proliferation and migration of RCC cells; conversely, PROX1 depletion by siRNA attenuated the proliferation and migration of RCC cells. Collectively, these observations suggest that PROX1 plays an important role in RCC development and progression, and PROX1 may be a novel target for prevention and treatment of RCC.	[Lv, Tao; Zhang, Jianping; Xu, Le; Zhu, Yu; Yin, Hankun; An, Huimin; Lin, Zongming] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Liu, Yanfeng; Xie, Youhua] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOE & MOH, Shanghai 200433, Peoples R China; [Chen, Lian] Fudan Univ, Children Hosp, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Lin, ZM (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	linzongming123@gmail.com; yhxie@fudan.edu.cn; Chen321223@163.com	Xu, Le/HDN-9623-2022		National Natural Science Foundation of China [81372755, 31071143, 31170148]; National Basic Research Program of China [2012CB519002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	The work was supported by National Natural Science Foundation of China (81372755, 31071143, 31170148; http://www.nsfc.gov.cn/) and National Basic Research Program of China (2012CB519002; http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen D, 2014, J UROLOGY, V191, P479, DOI 10.1016/j.juro.2013.08.052; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Dadras SS, 2008, J INVEST DERMATOL, V128, P2798, DOI 10.1038/jid.2008.176; Dudas J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-92; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Elsir T, 2011, BRIT J CANCER, V104, P1747, DOI 10.1038/bjc.2011.162; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Laerm A, 2007, J HEPATOL, V46, P89, DOI 10.1016/j.jhep.2006.07.033; Liu YF, 2013, STAT INTERFACE, V6, P1; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Lu MH, 2012, CLIN CANCER RES, V18, P6416, DOI 10.1158/1078-0432.CCR-12-0832; Martinez-Salamanca JI, 2011, EUR UROL, V59, P120, DOI 10.1016/j.eururo.2010.10.001; Meyer T, 1998, EUR J CANCER, V34, P214, DOI 10.1016/S0959-8049(97)10129-0; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrova TV, 2008, CANCER CELL, V13, P407, DOI 10.1016/j.ccr.2008.02.020; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schneider M, 2006, INT J ONCOL, V28, P883; Shen XD, 2004, AM J PATHOL, V165, P1315, DOI 10.1016/S0002-9440(10)63390-1; Skog M, 2011, BRIT J CANCER, V105, P1346, DOI 10.1038/bjc.2011.297; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Versmold B, 2007, INT J CANCER, V121, P547, DOI 10.1002/ijc.22705; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021; Wei JC, 2008, ANTICANCER RES, V28, P327; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Zinovieva RD, 1996, GENOMICS, V35, P517, DOI 10.1006/geno.1996.0392	28	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95996	10.1371/journal.pone.0095996	http://dx.doi.org/10.1371/journal.pone.0095996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797520	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000031
J	Phillips, JE; Gomer, RH				Phillips, Jonathan E.; Gomer, Richard H.			The p21-Activated Kinase (PAK) Family Member PakD Is Required for Chemorepulsion and Proliferation Inhibition by Autocrine Signals in Dictyostelium discoideum	PLOS ONE			English	Article							REPRESSES CELL-PROLIFERATION; PROTEIN; CHALONE; NEUROGENESIS; CHEMOTAXIS; DOWNSTREAM; DROSOPHILA; POLARITY; GROWTH; SIZE	In Dictyostelium discoideum, the secreted proteins AprA and CfaD function as reporters of cell density and regulate cell number by inhibiting proliferation at high cell densities. AprA also functions to disperse groups of cells at high density by acting as a chemorepellent. However, the signal transduction pathways associated with AprA and CfaD are not clear, and little is known about how AprA affects the cytoskeleton to regulate cell movement. We found that the p21-activated kinase (PAK) family member PakD is required for both the proliferation-inhibiting activity of AprA and CfaD and the chemorepellent activity of AprA. Similar to cells lacking AprA or CfaD, cells lacking PakD proliferate to a higher cell density than wild-type cells. Recombinant AprA and CfaD inhibit the proliferation of wild-type cells but not cells lacking PakD. Like AprA and CfaD, PakD affects proliferation but does not significantly affect growth (the accumulation of mass) on a pernucleus basis. In contrast to wild-type cells, cells lacking PakD are not repelled from a source of AprA, and colonies of cells lacking PakD expand at a slower rate than wild-type cells, indicating that PakD is required for AprA-mediated chemorepulsion. A PakD-GFP fusion protein localizes to an intracellular punctum that is not the nucleus or centrosome, and PakD-GFP is also occasionally observed at the rear cortex of moving cells. Vegetative cells lacking PakD show excessive actin-based filopodia-like structures, suggesting that PakD affects actin dynamics, consistent with previously characterized roles of PAK proteins in actin regulation. Together, our results implicate PakD in AprA/CfaD signaling and show that a PAK protein is required for proper chemorepulsive cell movement in Dictyostelium.	[Phillips, Jonathan E.; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@bio.tamu.edu		Gomer, Richard/0000-0003-2361-4307; Phillips, Jonathan/0000-0001-9896-5895	NIH [GM074990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102280, R01GM074990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM074990. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2009, HFSP J, V3, P194, DOI 10.2976/1.3100548; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Brock DA, 2005, DEVELOPMENT, V132, P4553, DOI 10.1242/dev.02032; BULLOUGH WS, 1964, EXP CELL RES, V36, P192, DOI 10.1016/0014-4827(64)90172-7; Choe JM, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-4; Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Garcia M, 2014, EUKARYOT CELL, V13, P119, DOI 10.1128/EC.00216-13; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Goldberg JM, 2006, PLOS GENET, V2, P291, DOI 10.1371/journal.pgen.0020038; Gomer RH, 2001, NAT REV MOL CELL BIO, V2, P48, DOI 10.1038/35048058; Graf R, 2000, J CELL SCI, V113, P1747; Graf R, 2001, METHOD CELL BIOL, V67, P337; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Herlihy SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059365; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Keizer-Gunnink I, 2007, J CELL BIOL, V177, P579, DOI 10.1083/jcb.200611046; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Kumar A, 2009, J CELL BIOCHEM, V107, P579, DOI 10.1002/jcb.22159; LEBERER E, 1992, EMBO J, V11, P4815, DOI 10.1002/j.1460-2075.1992.tb05587.x; Lee S, 2004, MOL BIOL CELL, V15, P5456, DOI 10.1091/mbc.E04-04-0323; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Phillips JE, 2012, P NATL ACAD SCI USA, V109, P10990, DOI 10.1073/pnas.1206350109; Phillips JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021765; Phillips JE, 2010, EUKARYOT CELL, V9, P1557, DOI 10.1128/EC.00121-10; Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068; Rooney RD, 1996, J BIOL CHEM, V271, P21498, DOI 10.1074/jbc.271.35.21498; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Souopgui J, 2002, EMBO J, V21, P6429, DOI 10.1093/emboj/cdf644; Tang YT, 2008, EUKARYOT CELL, V7, P1758, DOI 10.1128/EC.00210-08; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Vianello F, 2005, J MOL MED, V83, P752, DOI 10.1007/s00109-005-0675-z; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8	45	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96633	10.1371/journal.pone.0096633	http://dx.doi.org/10.1371/journal.pone.0096633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797076	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000108
J	Zhou, X; Chen, JC				Zhou, Xiang; Chen, Jianchang			Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; FATTY-ACID OXIDATION; IDIOPATHIC DILATED CARDIOMYOPATHY; CORONARY-ARTERY-DISEASE; QUALITY-OF-LIFE; ISCHEMIC CARDIOMYOPATHY; DIABETIC-PATIENTS; ENERGY-METABOLISM; SYSTOLIC FUNCTION; ELDERLY-PATIENTS	Background: Whether additional benefit can be achieved with the use of trimetazidine (TMZ) in patients with chronic heart failure (CHF) remains controversial. We therefore performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the effects of TMZ treatment in CHF patients. Methods: We searched PubMed, EMBASE, and Cochrane databases through October 2013 and included 19 RCTs involving 994 CHF patients who underwent TMZ or placebo treatment. Risk ratio (RR) and weighted mean differences (WMD) were calculated using fixed or random effects models. Results: TMZ therapy was associated with considerable improvement in left ventricular ejection fraction (WMD: 7.29%, 95% CI: 6.49 to 8.09, p<0.01) and New York Heart Association classification (WMD: -0.55, 95% CI: -0.81 to -0.28, p<0.01). Moreover, treatment with TMZ also resulted in significant decrease in left ventricular end-systolic volume (WMD: -17.09 ml, 95% CI: -20.15 to -14.04, p, 0.01), left ventricular end-diastolic volume (WMD: -11.24 ml, 95% CI: -14.06 to -8.42, p, 0.01), hospitalization for cardiac causes (RR: 0.43, 95% CI: 0.21 to 0.91, p = 0.03), B-type natriuretic peptide (BNP; WMD: -157.08 pg/ml, 95% CI: -176.55 to -137.62, p<0.01) and C-reactive protein (CRP; WMD: -1.86 mg/l, 95% CI: -2.81 to -0.90, p<0.01). However, there were no significant differences in exercise duration and all-cause mortality between patients treated with TMZ and placebo. Conclusions: TMZ treatment in CHF patients may improve clinical symptoms and cardiac function, reduce hospitalization for cardiac causes, and decrease serum levels of BNP and CRP.	[Zhou, Xiang; Chen, Jianchang] Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Zhou, X (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Cardiol, Suzhou, Jiangsu, Peoples R China.	zhou-xiang@suda.edu.cn						Belardinelli R, 2001, EUR HEART J, V22, P2164, DOI 10.1053/euhj.2001.2653; Belardinelli R, 2008, J CARDIOVASC PHARM, V51, P611, DOI 10.1097/FJC.0b013e31817bdd66; Belardinelli R, 2007, EUR HEART J, V28, P1102, DOI 10.1093/eurheartj/ehm071; BROTTIER L, 1990, EUR HEART J, V11, P207, DOI 10.1093/oxfordjournals.eurheartj.a059685; Cera M, 2010, J CARDIOVASC PHARM T, V15, P24, DOI 10.1177/1074248409356431; Dedkova EN, 2013, J MOL CELL CARDIOL, V59, P41, DOI 10.1016/j.yjmcc.2013.01.016; Di Napoli P, 2005, HEART, V91, P161, DOI 10.1136/hrt.2003.031310; Di Napoli P, 2007, AM HEART J, V154, DOI 10.1016/j.ahj.2007.06.033; El-Kady Taher, 2005, Am J Cardiovasc Drugs, V5, P271, DOI 10.2165/00129784-200505040-00006; Fragasso G, 2006, EUR HEART J, V27, P942, DOI 10.1093/eurheartj/ehi816; Fragasso G, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00415-0; Fragasso G, 2006, J AM COLL CARDIOL, V48, P992, DOI 10.1016/j.jacc.2006.03.060; Fragasso G, 2011, HEART, V97, P1495, DOI 10.1136/hrt.2011.226332; Gao DF, 2011, HEART, V97, P278, DOI 10.1136/hrt.2010.208751; Gunes Y, 2009, HEART VESSELS, V24, P277, DOI 10.1007/s00380-008-1118-x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; Krum H, 2011, LANCET, V378, P713, DOI 10.1016/S0140-6736(11)61038-6; Marazzi G, 2009, ADV THER, V26, P455, DOI 10.1007/s12325-009-0024-7; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosano GMC, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-16; Sisakian H, 2007, ACTA CARDIOL, V62, P493, DOI 10.2143/AC.62.5.2023413; Thrainsdottir IS, 2004, J CARDIOVASC PHARM, V44, P101, DOI 10.1097/00005344-200407000-00014; Tuunanen H, 2008, CIRCULATION, V118, P1250, DOI 10.1161/CIRCULATIONAHA.108.778019; Vitale C, 2004, EUR HEART J, V25, P1814, DOI 10.1016/j.ehj.2004.06.034; Yin RX, 2007, TRANSL RES, V149, P152, DOI 10.1016/j.trsl.2006.11.004; Zhang L, 2012, J AM COLL CARDIOL, V59, P913, DOI 10.1016/j.jacc.2011.11.027; Zhao P, 2013, LIFE SCI, V92, P633, DOI 10.1016/j.lfs.2012.03.015; Zhou X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040424	29	34	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e94660	10.1371/journal.pone.0094660	http://dx.doi.org/10.1371/journal.pone.0094660			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797235	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000009
J	Abdi, J; Mutis, T; Garssen, J; Redegeld, FA				Abdi, Jahangir; Mutis, Tuna; Garssen, Johan; Redegeld, Frank A.			Toll-Like Receptor (TLR)-1/2 Triggering of Multiple Myeloma Cells Modulates Their Adhesion to Bone Marrow Stromal Cells and Enhances Bortezomib-Induced Apoptosis	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED DRUG-RESISTANCE; INFLAMMATION; ACTIVATION; GROWTH; EXPRESSION; CANCER; PATHOGENESIS; COMBINATION; SURVIVAL	In multiple myeloma (MM), the malignant plasma cells usually localize to the bone marrow where they develop drug resistance due to adhesion to stromal cells and various environmental signals. Hence, modulation of this interaction is expected to influence drug sensitivity of MM cells. Toll-like receptor (TLR) ligands have displayed heterogeneous effects on B-cell malignancies and also on MM cells in a few recent studies, but effects on adhesion and drug sensitivity of myeloma cells in the context of bone marrow stromal cells (BMSCs) have never been investigated. In the present study, we explored the modulatory effects of TLR1/2 ligand (Pam3CSK4) on adhesion of human myeloma cells to BMSCs. It is shown that TLR1/2 triggering has opposite effects in different HMCLs on their adhesion to BMSCs. Fravel, L363, UM-6, UM-9 and U266 showed increased adhesion to BMSC in parallel with an increased surface expression of integrin molecules alpha 4 and alpha V beta 3. OPM-1, OPM-2 and NCI-H929 showed a dose-dependent decrease in adhesion upon TLR activation following a downregulation of beta 7 integrin expression. Importantly, TLR1/2 triggering increased cytotoxic and apoptotic effects of bortezomib in myeloma cells independent of the effect on stromal cell adhesion. Moreover, the apoptosis-enhancing effect of Pam3CSK4 paralleled induction of cleaved caspase-3 protein in FACS analysis suggesting a caspase-dependent mechanism. Our findings uncover a novel role of TLR activation in MM cells in the context of bone marrow microenvironment. Stimulation of TLR1/2 bypasses the protective shield of BMSCs and may be an interesting strategy to enhance drug sensitivity of multiple myeloma cells.	[Abdi, Jahangir; Garssen, Johan; Redegeld, Frank A.] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands; [Mutis, Tuna] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center	Redegeld, FA (corresponding author), Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci, Div Pharmacol, Utrecht, Netherlands.	f.a.m.redegeld@uu.nl	garssen, johan/I-7159-2016; Abdi, Jahangir/ABF-9317-2020; Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960; Abdi, Jahangir/0000-0001-5857-7281	Utrecht University	Utrecht University	This research has been funded by the Utrecht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi J, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.17; Abdi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060671; Abdi J, 2011, CRIT REV ONCOL HEMAT, V80, P225, DOI 10.1016/j.critrevonc.2010.12.001; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Bloem AC, 1998, BRIT J HAEMATOL, V100, P166, DOI 10.1046/j.1365-2141.1998.00517.x; Bohnhorst J, 2006, LEUKEMIA, V20, P1138, DOI 10.1038/sj.leu.2404225; Chen KQ, 2007, INT IMMUNOPHARMACOL, V7, P1271, DOI 10.1016/j.intimp.2007.05.016; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Chiron D, 2008, BLOOD, V112, P2205, DOI 10.1182/blood-2008-02-140673; Chiron D, 2009, J IMMUNOL, V182, P4471, DOI 10.4049/jimmunol.0803113; Damiano JS, 2000, LEUKEMIA LYMPHOMA, V38, P71, DOI 10.3109/10428190009060320; Damiano JS, 1999, BLOOD, V93, P1658, DOI 10.1182/blood.V93.5.1658; Demchenko YN, 2010, BLOOD, V115, P3541, DOI 10.1182/blood-2009-09-243535; Gu HT, 2008, MOL CANCER THER, V7, P2298, DOI 10.1158/1535-7163.MCT-08-0186; Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295; Hennessy EJ, 2011, J BIOL CHEM, V286, P25531, DOI 10.1074/jbc.M111.256206; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hung C-H, 2010, J EXP CLIN MED, V2, P297; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klein B, 2010, BLOOD, V115, P3422, DOI 10.1182/blood-2010-01-264796; Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x; Markovina S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-176; MasellisSmith A, 1997, CANCER RES, V57, P930; Mitsiades CS, 2007, HEMATOL ONCOL CLIN N, V21, P1007, DOI 10.1016/j.hoc.2007.08.007; Nefedova Y, 2004, BLOOD, V103, P3503, DOI 10.1182/blood-2003-07-2340; Nefedova Y, 2003, LEUKEMIA, V17, P1175, DOI 10.1038/sj.leu.2402924; Neri P, 2011, BLOOD, V117, P6202, DOI 10.1182/blood-2010-06-292243; Noborio-Hatano K, 2009, ONCOGENE, V28, P231, DOI 10.1038/onc.2008.385; Omagari D, 2009, CLIN EXP IMMUNOL, V156, P294, DOI 10.1111/j.1365-2249.2009.03892.x; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541; Ria T, 2002, HAEMATOLOGICA, V87, P836; Saha MN, 2010, CANCER BIOL THER, V9, P936, DOI 10.4161/cbt.9.11.11882; Sanz-Rodriguez F, 1999, BRIT J HAEMATOL, V107, P825, DOI 10.1046/j.1365-2141.1999.01762.x; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; van de Donk NWCJ, 2002, LEUKEMIA, V16, P1362, DOI 10.1038/sj.leu.2402501; van der Veer MS, 2011, HAEMATOL-HEMATOL J, V96, P284, DOI 10.3324/haematol.2010.030759; Wang XD, 2011, LEUKEMIA LYMPHOMA, V52, P1991, DOI 10.3109/10428194.2011.591004; Werner J, 2012, INNATE IMMUN-LONDON, V18, P55, DOI 10.1177/1753425910392934; Xu Y, 2010, BRIT J HAEMATOL, V150, P543, DOI 10.1111/j.1365-2141.2010.08284.x; Zhang YP, 2009, EUR CYTOKINE NETW, V20, P148, DOI 10.1684/ecn.2009.0156	45	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96608	10.1371/journal.pone.0096608	http://dx.doi.org/10.1371/journal.pone.0096608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794258	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700118
J	Grueneisen, J; Beiderwellen, K; Heusch, P; Buderath, P; Aktas, B; Gratz, M; Forsting, M; Lauenstein, T; Ruhlmann, V; Umutlu, L				Grueneisen, Johannes; Beiderwellen, Karsten; Heusch, Philipp; Buderath, Paul; Aktas, Bahriye; Gratz, Marcel; Forsting, Michael; Lauenstein, Thomas; Ruhlmann, Verena; Umutlu, Lale			Correlation of Standardized Uptake Value and Apparent Diffusion Coefficient in Integrated Whole-Body PET/MRI of Primary and Recurrent Cervical Cancer	PLOS ONE			English	Article							NONMETASTATIC LYMPH-NODES; FDG-PET/CT; COMPUTED-TOMOGRAPHY; PRIMARY-TUMOR; EMISSION-TOMOGRAPHY; WEIGHTED MRI; PREDICTOR; LESIONS; DIFFERENTIATION; FEASIBILITY	Background: To evaluate a potential correlation of the maximum standard uptake value (SUVmax) and the minimum apparent diffusion coefficient (ADC(min)) in primary and recurrent cervical cancer based on integrated PET/MRI examinations. Methods: 19 consecutive patients (mean age 51.6 years; range 30-72 years) with histopathologically confirmed primary cervical cancer (n = 9) or suspected tumor recurrence (n = 10) were prospectively enrolled for an integrated PET/MRI examination. Two radiologists performed a consensus reading in random order, using a dedicated post-processing software. Polygonal regions of interest (ROI) covering the entire tumor lesions were drawn into PET/MR images to assess SUVmax and into ADC parameter maps to determine ADCmin values. Pearson's correlation coefficients were calculated to assess a potential correlation between the mean values of ADC(min) and SUVmax. Results: In 15 out of 19 patients cervical cancer lesions (n = 12) or lymph node metastases (n = 42) were detected. Mean SUVmax (12.5 +/- 6.5) and ADC(min) (644.5 +/- 1797x10(-5) mm(2)/s) values for all assessed tumor lesions showed a significant but weak inverse correlation (R = -20.342, p<0.05). When subdivided in primary and recurrent tumors, primary tumors and associated primary lymph node metastases revealed a significant and strong inverse correlation between SUVmax and ADC(min) (R = -20.692, p<0.001), whereas recurrent cancer lesions did not show a significant correlation. Conclusions: These initial results of this emerging hybrid imaging technique demonstrate the high diagnostic potential of simultaneous PET/MR imaging for the assessment of functional biomarkers, revealing a significant and strong correlation of tumor metabolism and higher cellularity in cervical cancer lesions.	[Grueneisen, Johannes; Beiderwellen, Karsten; Gratz, Marcel; Forsting, Michael; Lauenstein, Thomas; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Heusch, Philipp] Univ Hosp Duesseldorf, Dept Diagnost & Intervent Radiol & Neuroradiol, Dusseldorf, Germany; [Buderath, Paul; Aktas, Bahriye] Univ Hosp Essen, Dept Obstet & Gynecol, Essen, Germany; [Gratz, Marcel] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Ruhlmann, Verena] Univ Hosp Essen, Dept Nucl Med, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Grueneisen, J (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	Johannes.grueneisen@uk-essen.de	Aktas, Bahriye/F-1019-2014; Aktas, Bahriye/AAW-1201-2021	Aktas, Bahriye/0000-0002-5474-051X; Gratz, Marcel/0000-0001-9723-5233				Andrade WP, 2013, EJSO-EUR J SURG ONC, V39, P1358, DOI 10.1016/j.ejso.2013.08.025; Antoch G, 2004, J CLIN ONCOL, V22, P4357, DOI 10.1200/JCO.2004.08.120; Antonsen SL, 2013, GYNECOL ONCOL, V129, P298, DOI 10.1016/j.ygyno.2013.01.019; Beiderwellen K, 2013, EUR J RADIOL, V82, pE669, DOI 10.1016/j.ejrad.2013.07.027; Bipat S, 2003, GYNECOL ONCOL, V91, P59, DOI 10.1016/S0090-8258(03)00409-8; Brendle CB, 2013, RADIOLOGY, V268, P190, DOI 10.1148/radiol.13121838; Brown RS, 1999, J NUCL MED, V40, P556; Buchbender C, 2013, EUR J RADIOL, V82, P877, DOI 10.1016/j.ejrad.2013.01.019; Buerkle A, 2008, CANCER METAST REV, V27, P545, DOI 10.1007/s10555-008-9151-x; Choi BB, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-126; Chung M. K., 2007, ENCY MEASUREMENT STA, V1, P189; Elmi A, 2013, CLIN RADIOL, V68, pE524, DOI 10.1016/j.crad.2013.05.094; Fujii S, 2008, EUR RADIOL, V18, P18, DOI 10.1007/s00330-007-0732-9; Gu J, 2011, MOL IMAGING BIOL, V13, P1020, DOI 10.1007/s11307-010-0433-7; Heusch P, 2013, ROFO-FORTSCHR RONTG, V185, P1059, DOI 10.1055/s-0033-1350110; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Heusch P, 2013, J MAGN RESON IMAGING, V37, P233, DOI 10.1002/jmri.23751; Ho KC, 2009, EUR J NUCL MED MOL I, V36, P200, DOI 10.1007/s00259-008-0936-5; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kershah S, 2013, MOL IMAGING BIOL, V15, P776, DOI 10.1007/s11307-013-0629-8; Kim JK, 2008, J MAGN RESON IMAGING, V28, P714, DOI 10.1002/jmri.21480; Kitajima K, 2009, EUR J NUCL MED MOL I, V36, P362, DOI 10.1007/s00259-008-0956-1; Levy A, 2011, J MAGN RESON IMAGING, V33, P1020, DOI 10.1002/jmri.22546; Liu Y, 2011, GYNECOL ONCOL, V122, P19, DOI 10.1016/j.ygyno.2011.03.023; Martinez-Moller A, 2009, J NUCL MED, V50, P520, DOI 10.2967/jnumed.108.054726; McVeigh PZ, 2008, EUR RADIOL, V18, P1058, DOI 10.1007/s00330-007-0843-3; Mittra E, 2009, EUR J NUCL MED MOL I, V36, P1952, DOI 10.1007/s00259-009-1206-x; Mori T, 2008, J THORAC ONCOL, V3, P358, DOI 10.1097/JTO.0b013e318168d9ed; Naganawa S, 2005, EUR RADIOL, V15, P71, DOI 10.1007/s00330-004-2529-4; Nakajo M, 2012, CLIN NUCL MED, V37, P475, DOI 10.1097/RLU.0b013e318248524a; Nakamura K, 2012, GYNECOL ONCOL, V124, P335, DOI 10.1016/j.ygyno.2011.10.014; Nakamura K, 2012, EUR J NUCL MED MOL I, V39, P283, DOI 10.1007/s00259-011-1978-7; Nensa F, 2013, RADIOLOGY, V268, P366, DOI 10.1148/radiol.13130231; Punwani S, 2011, EUR J RADIOL, V78, P21, DOI 10.1016/j.ejrad.2010.07.028; Rakheja R, 2013, AM J ROENTGENOL, V201, P1115, DOI 10.2214/AJR.13.11304; Rao RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032613; Roh JL, 2009, ORAL ONCOL, V45, P218, DOI 10.1016/j.oraloncology.2008.05.010; Sharma U, 2009, NMR BIOMED, V22, P104, DOI 10.1002/nbm.1245; Thoeny HC, 2012, RADIOLOGY, V263, P19, DOI 10.1148/radiol.11101821; Tomasi G, 2012, CURR OPIN PHARMACOL, V12, P569, DOI 10.1016/j.coph.2012.07.016; Tong AN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0780-8; Varoquaux A, 2013, EUR J NUCL MED MOL I, V40, P842, DOI 10.1007/s00259-013-2351-9; Wong CS, 2012, EUR J RADIOL, V81, P2122, DOI 10.1016/j.ejrad.2011.09.003; Wu XC, 2011, EUR J RADIOL, V79, pE117, DOI 10.1016/j.ejrad.2011.04.062; Xue FY, 2006, GYNECOL ONCOL, V101, P147, DOI 10.1016/j.ygyno.2005.10.005	46	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96751	10.1371/journal.pone.0096751	http://dx.doi.org/10.1371/journal.pone.0096751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804676	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900089
J	Wang, SH; Meng, QM; Dai, JJ; Han, XG; Han, Y; Ding, C; Liu, HW; Yu, SQ				Wang, Shaohui; Meng, Qingmei; Dai, Jianjun; Han, Xiangan; Han, Yue; Ding, Chan; Liu, Haiwen; Yu, Shengqing			Development of an Allele-Specific PCR Assay for Simultaneous Sero-Typing of Avian Pathogenic Escherichia coli Predominant O1, O2, O18 and O78 Strains	PLOS ONE			English	Article							ANTIGEN GENE-CLUSTER; POLYMERASE-CHAIN-REACTION; COMPLETE GENOME SEQUENCE; RAPID DETECTION; IDENTIFICATION; BIOSYNTHESIS	Systemic infections by avian pathogenic Escherichia coli (APEC) are economically devastating to poultry industries worldwide. E. coli strains belonging to serotypes O1, O2, O18 and O78 are preferentially associated with avian colibacillosis. The rfb gene cluster controlling O antigen synthesis is usually various among different E. coli serotypes. In present study, the rfb gene clusters of E. coli serotypes O1, O2, O18 and O78 were characterized and compared. Based on the serotype-specific genes in rfb gene cluster, an allele-specific polymerase chain reaction (PCR) assay was developed. This PCR assay was highly specific and reliable for sero-typing of APEC O1, O2, O18 and O78 strains. The sensitivity of the assay was determined as 10 pg DNA or 10 colony forming units (CFUs) bacteria for serotypes O2 and O18 strains, and 500 pg DNA or 1,000 CFUs bacteria for serotypes O1 and O78 strains. Using this PCR system, APEC isolates and the infected tissue samples were categorized successfully. Furthermore, it was able to differentiate the serotypes for the samples with multi-agglutination in the traditional serum agglutination assay. Therefore, the allele-specific PCR is more simple, rapid and accurate assay for APEC diagnosis, epidemiologic study and vaccine development.	[Wang, Shaohui; Meng, Qingmei; Han, Xiangan; Han, Yue; Ding, Chan; Liu, Haiwen; Yu, Shengqing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Meng, Qingmei; Dai, Jianjun] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Yu, SQ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China.	yus@shvri.ac.cn	Dai, Jianjun/ABB-7353-2021	Han, Xiangan/0000-0001-5625-637X	Chinese Special Fund for Agro-scientific Research in the Public Interest [201303044]; National Natural Science Foundation of China [81201266, 31370045]; Shanghai Veterinary Research Institute [2013JB05]	Chinese Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Veterinary Research Institute	This work was supported by the funds of Chinese Special Fund for Agro-scientific Research in the Public Interest (201303044), the National Natural Science Foundation of China (81201266, 31370045) and The National Basic Fund for Institutes, which is supported by Shanghai Veterinary Research Institute (2013JB05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[白灏 Bai Hao], 2013, [微生物学通报, Microbiology China], V40, P1315; BASTIN DA, 1995, GENE, V164, P17, DOI 10.1016/0378-1119(95)00459-J; Beutin L, 2005, J CLIN MICROBIOL, V43, P703, DOI 10.1128/JCM.43.2.703-710.2005; Beutin L, 2005, J CLIN MICROBIOL, V43, P5143, DOI 10.1128/JCM.43.10.5143-5149.2005; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chen W., 2010, CHINESE J ANIMAL INF, V18, P34; Clermont O, 2007, DIAGN MICR INFEC DIS, V57, P129, DOI 10.1016/j.diagmicrobio.2006.08.007; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; DebRoy C, 2005, APPL ENVIRON MICROB, V71, P4919, DOI 10.1128/AEM.71.8.4919-4924.2005; Ewers C, 2003, BERL MUNCH TIERARZTL, V116, P381; Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Feng L, 2004, J CLIN MICROBIOL, V42, P3799, DOI 10.1128/JCM.42.8.3799-3804.2004; Fratamico PM, 2010, CAN J MICROBIOL, V56, P308, DOI [10.1139/W10-010, 10.1139/w10-010]; Fratamico PM, 2003, J CLIN MICROBIOL, V41, P3379, DOI 10.1128/JCM.41.7.3379-3383.2003; Hu QH, 2011, J MICROBIOL METH, V87, P64, DOI 10.1016/j.mimet.2011.07.007; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kaper JB, 2005, INT J MED MICROBIOL, V295, P355, DOI 10.1016/j.ijmm.2005.06.008; KAUFFMANN F, 1947, J IMMUNOL, V57, P71; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Liu B, 2010, VET MICROBIOL, V142, P373, DOI 10.1016/j.vetmic.2009.10.019; Ma X, 2010, ANIM HUSB VET MED, V42, P20; Mangiamele P, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00026-13; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Paton AW, 1999, J CLIN MICROBIOL, V37, P3362, DOI 10.1128/JCM.37.10.3362-3365.1999; Perelle S, 2002, J APPL MICROBIOL, V93, P758, DOI 10.1046/j.1365-2672.2002.01743.x; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; Shepherd JG, 2000, INFECT IMMUN, V68, P6056, DOI 10.1128/IAI.68.10.6056-6061.2000; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WRIGHT PA, 1990, J PATHOL, V162, P99, DOI 10.1002/path.1711620203; Xie Y, 2006, J INFECT DIS, V194, P358, DOI 10.1086/505429	31	22	29	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96904	10.1371/journal.pone.0096904	http://dx.doi.org/10.1371/journal.pone.0096904			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805368	gold, Green Submitted, Green Published			2022-12-27	WOS:000335728900115
J	Jennings, L; Bertrand, J; Rech, D; Harvey, SA; Hatzold, K; Samkange, CA; Aduda, DSO; Fimbo, B; Cherutich, P; Perry, L; Castor, D; Njeuhmeli, E				Jennings, Larissa; Bertrand, Jane; Rech, Dino; Harvey, Steven A.; Hatzold, Karin; Samkange, Christopher A.; Aduda, Dickens S. Omondi; Fimbo, Bennett; Cherutich, Peter; Perry, Linnea; Castor, Delivette; Njeuhmeli, Emmanuel			Quality of Voluntary Medical Male Circumcision Services during Scale-Up: A Comparative Process Evaluation in Kenya, South Africa, Tanzania and Zimbabwe	PLOS ONE			English	Article							HIV PREVENTION; SAFETY; MEN	Background: The rapid expansion of voluntary medical male circumcision (VMMC) has raised concerns whether health systems can deliver and sustain VMMC according to minimum quality criteria. Methods and Findings: A comparative process evaluation was used to examine data from SYMMACS, the Systematic Monitoring of the Voluntary Medical Male Circumcision Scale-Up, among health facilities providing VMMC across two years of program scale-up. Site-level assessments examined the availability of guidelines, supplies and equipment, infection control, and continuity of care services. Direct observation of VMMC surgeries were used to assess care quality. Two sample tests of proportions and t-tests were used to examine differences in the percent of facilities meeting requisite preparedness standards and the mean number of directly-observed surgical tasks performed correctly. Results showed that safe, high quality VMMC can be implemented and sustained at-scale, although substantial variability was observed over time. In some settings, facility preparedness and VMMC service quality improved as the number of VMMC facilities increased. Yet, lapses in high performance and expansion of considerably deficient services were also observed. Surgical tasks had the highest quality scores, with lower performance levels in infection control, pre-operative examinations, and post-operative patient monitoring and counseling. The range of scale-up models used across countries additionally underscored the complexity of delivering high quality VMMC. Conclusions: Greater efforts are needed to integrate VMMC scale-up and quality improvement processes in sub-Saharan African settings. Monitoring of service quality, not just adverse events reporting, will be essential in realizing the full health impact of VMMC for HIV prevention.	[Jennings, Larissa; Harvey, Steven A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Bertrand, Jane; Perry, Linnea] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Rech, Dino] Ctr HIV & AIDS Prevent Studies, Johannesburg, South Africa; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Samkange, Christopher A.] Univ Zimbabwe, Coll Hlth Sci, Inst Continuing Hlth Educ, Harare, Zimbabwe; [Aduda, Dickens S. Omondi] Impact Res & Dev Org, Kisumu, Kenya; [Fimbo, Bennett] Minist Hlth & Social Welf, Natl AIDS Control Programme, Dar Es Salaam, Tanzania; [Cherutich, Peter] Natl AIDS & Sexually Transmitted Infect Control P, Nairobi, Kenya; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tulane University; University of Zimbabwe; United States Agency for International Development (USAID)	Jennings, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	ljenning@jhsph.edu	Harvey, Steven/AAP-5520-2020	Harvey, Steven/0000-0001-6936-0213	U.S. Agency for International Development (USAID) | Project SEARCH; Johns Hopkins Center for Global Health; USAID [GHH-I-00-07-00032-00]	U.S. Agency for International Development (USAID) | Project SEARCH(United States Agency for International Development (USAID)); Johns Hopkins Center for Global Health; USAID(United States Agency for International Development (USAID))	The article was supported by the U.S. Agency for International Development (USAID) | Project SEARCH, Task Order No. 2, funded by the USAID (www.usaid.gov) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). USAID staff played a role in study design and data analysis, decision to publish, and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID's or the United States government's opinion.	[Anonymous], 2006, WHO M REP 5 6 DEC 20; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2006, B WORLD HEALTH ORGAN, V86, P669; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2013, SYSTEMATIC IN PRESS; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; Edgil D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001128; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Musau P, 2011, J UROLOGY, V186, P1923, DOI 10.1016/j.juro.2011.07.027; Muula Adamson S, 2007, BMC Urol, V7, P4, DOI 10.1186/1471-2490-7-4; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Ngo TD, 2012, HIV AIDS-RES PALLIAT, V4, P37, DOI 10.2147/HIV.S30357; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Rech D, 2013, IMPLICATION IN PRESS; World Health Organization, 2009, MAL CIRC SERV QUAL A	18	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e79524	10.1371/journal.pone.0079524	http://dx.doi.org/10.1371/journal.pone.0079524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801073	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800001
J	Lin, HS; Chen, YJ; Li, JD; Lu, TW; Chang, HH; Hu, CC				Lin, Hsien-Shu; Chen, Yunn-Jy; Li, Jia-Da; Lu, Tung-Wu; Chang, Hau-Hung; Hu, Chih-Chung			Measurement of Mandibular Growth Using Cone-Beam Computed Tomography: A Miniature Pig Model Study	PLOS ONE			English	Article							IMPLANTS	The purpose of this study was to measure the long-term growth of the mandible in miniature pigs using 3D Cone-Beam Computerized Tomography (CBCT). The mandibles of the pigs were scanned monthly over 12 months using CBCT and the 3D mandibular models were reconstructed from the data. Seventeen anatomical landmarks were identified and classified into four groups of line segments, namely anteroposterior, superoinferior, mediolateral and anteroinferior. The inter-marker distances, inter-segmental angles, volume, monthly distance changes and percentage of changes were calculated to describe mandibular growth. The total changes of inter-marker distances were normalized to the initial values. All inter-marker distances increased over time, with the greatest mean normalized total changes in the superoinferior and anteroposterior groups (p < 0.05). Monthly distance changes were greatest during the first four months and then reduced over time. Percentages of inter-marker distance changes were similar among the groups, reaching half of the overall growth around the 4th month. The mandibular volume growth increased non-linearly with time, accelerating during the first five months and slowing during the remaining months. The growth of the mandible was found to be anisotropic and non-homogeneous within the bone and non-linear over time, with faster growth in the ramus than in the body. These growth patterns appeared to be related to the development of the dentition, providing necessary space for the teeth to grow upward for occlusion and for the posterior teeth to erupt.	[Lin, Hsien-Shu; Chen, Yunn-Jy; Chang, Hau-Hung] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan; [Li, Jia-Da; Lu, Tung-Wu; Hu, Chih-Chung] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Lu, Tung-Wu] Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei 10764, Taiwan; [Hu, Chih-Chung] Ming Chih Univ Sci & Technol, Dept Mech Engn, New Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Lu, TW (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	twlu@ntu.edu.tw		CHEN, ALEX YUNN-JY/0000-0002-9329-5922				BANG S, 1967, ARCH ORAL BIOL, V12, P993, DOI 10.1016/0003-9969(67)90094-5; BAREGGI R, 1995, ARCH ORAL BIOL, V40, P119, DOI 10.1016/0003-9969(94)00142-X; BJORK A, 1968, AM J PHYS ANTHROPOL, V29, P243, DOI 10.1002/ajpa.1330290217; BJORK ARNE, 1963, JOUR DENT RES, V42, P400, DOI 10.1177/00220345630420014701; BJORK ARNE, 1955, ACTA ODONTOL SCAND, V13, P9, DOI 10.3109/00016355509028170; Dula K, 1996, EUR J ORAL SCI, V104, P503, DOI 10.1111/j.1600-0722.1996.tb00133.x; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; International Commission on Radiological Protection, 2007, ANN ICRP, V105, P37; Kim Inah, 2012, New Zealand Dental Journal, V108, P9; Koppe Thomas, 1997, Okajimas Folia Anatomica Japonica, V74, P39; Krarup S, 2005, J ANAT, V207, P669, DOI 10.1111/j.1469-7580.2005.00479.x; Kuboki T, 1997, J DENT RES, V76, P1760, DOI 10.1177/00220345970760110701; Leander D., 2011, J INDIAN ORTHOD SOC, V45, P51; Ngan Daniel C S, 2003, Aust Orthod J, V19, P67; Obrez A, 1996, ACTA ANAT, V156, P99; Roberts JA, 2009, BRIT J RADIOL, V82, P35, DOI 10.1259/bjr/31419627; Scaf G, 1997, ORAL SURG ORAL MED O, V83, P41, DOI 10.1016/S1079-2104(97)90089-5; Schulze D, 2004, DENTOMAXILLOFAC RAD, V33, P83, DOI 10.1259/dmfr/28403350; Wei-Ming C, 1999, J CHINESE SOC ANIMAL, V28, P347; Wrixon AD, 2008, J RADIOL PROT, V28, P161, DOI 10.1088/0952-4746/28/2/R02	20	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96540	10.1371/journal.pone.0096540	http://dx.doi.org/10.1371/journal.pone.0096540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801528	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800084
J	Nicolini, P; Ciulla, MM; Malfatto, G; Abbate, C; Mari, D; Rossi, PD; Pettenuzzo, E; Magrini, F; Consonni, D; Lombardi, F				Nicolini, Paola; Ciulla, Michele M.; Malfatto, Gabriella; Abbate, Carlo; Mari, Daniela; Rossi, Paolo D.; Pettenuzzo, Emanuela; Magrini, Fabio; Consonni, Dario; Lombardi, Federico			Autonomic Dysfunction in Mild Cognitive Impairment: Evidence from Power Spectral Analysis of Heart Rate Variability in a Cross-Sectional Case-Control Study	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; VASCULAR RISK-FACTORS; WHITE-MATTER LESIONS; CARDIAC VAGAL TONE; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; SUBCORTICAL HYPERINTENSITIES; CARDIOVASCULAR REGULATION; ANTIDEPRESSANT TREATMENT; ORTHOSTATIC HYPOTENSION	Background: Mild cognitive impairment (MCI) is set to become a major health problem with the exponential ageing of the world's population. The association between MCI and autonomic dysfunction, supported by indirect evidence and rich with clinical implications in terms of progression to dementia and increased risk of mortality and falls, has never been specifically demonstrated. Aim: To conduct a comprehensive assessment of autonomic function in subjects with MCI by means of power spectral analysis (PSA) of heart rate variability (HRV) at rest and during provocative manoeuvres. Methods: This cross-sectional study involved 80 older outpatients (aged >= 65) consecutively referred to a geriatric unit and diagnosed with MCI or normal cognition (controls) based on neuropsychological testing. PSA was performed on 5-minute electrocardiographic recordings under three conditions-supine rest with free breathing (baseline), supine rest with paced breathing at 12 breaths/minute (parasympathetic stimulation), and active standing (orthosympathetic stimulation)-with particular focus on the changes from baseline to stimulation of indices of sympathovagal balance: normalized low frequency (LFn) and high frequency (HFn) powers and the LF/HF ratio. Blood pressure (BP) was measured at baseline and during standing. Given its exploratory nature in a clinical population the study included subjects on medications with a potential to affect HRV. Results: There were no significant differences in HRV indices between the two groups at baseline. MCI subjects exhibited smaller physiological changes in all three HRV indices during active standing, consistently with a dysfunction of the orthosympathetic system. Systolic BP after 10 minutes of standing was lower in MCI subjects, suggesting dysautonomia-related orthostatic BP dysregulation. Conclusions: Our study is novel in providing evidence of autonomic dysfunction in MCI. This is associated with orthostatic BP dysregulation and the ongoing follow-up of the study population will determine its prognostic relevance as a predictor of adverse health outcomes.	[Nicolini, Paola; Abbate, Carlo; Mari, Daniela; Rossi, Paolo D.; Pettenuzzo, Emanuela] Univ Milan, Dept Clin & Community Sci, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy; [Ciulla, Michele M.; Magrini, Fabio; Lombardi, Federico] Univ Milan, Dept Clin & Community Sci, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cardiovasc Dis Unit, Milan, Italy; [Malfatto, Gabriella] Osped San Luca, Ist Auxol Italiano IRCCS, Dept Cardiol, Milan, Italy; [Consonni, Dario] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto Auxologico Italiano; IRCCS Ca Granda Ospedale Maggiore Policlinico	Nicolini, P (corresponding author), Univ Milan, Dept Clin & Community Sci, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy.	paolanikolini@fastwebnet.it	Consonni, Dario/AAM-2947-2020; lombardi, federico/L-1023-2016; Rossi, Paolo Dionigi/GRX-7747-2022; Mari, Daniela/K-5663-2016; Malfatto, G/AAA-7703-2020; CIULLA, MICHELE MARIO/B-9627-2013; Abbate, Carlo/M-3116-2018	Consonni, Dario/0000-0002-8935-3843; lombardi, federico/0000-0003-2424-2509; Rossi, Paolo Dionigi/0000-0002-1202-5454; Mari, Daniela/0000-0002-6950-0789; CIULLA, MICHELE MARIO/0000-0002-6717-6065; Abbate, Carlo/0000-0002-0368-3834	University of Milan	University of Milan	PN was supported by a PhD grant from the University of Milan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelink MW, 2002, CRIT CARE MED, V30, P997, DOI 10.1097/00003246-200205000-00008; AHARONPERETZ J, 1992, ARCH NEUROL-CHICAGO, V49, P919, DOI 10.1001/archneur.1992.00530330041013; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Al Hazzouri AZ, 2014, HYPERTENSION, V63, P181, DOI 10.1161/HYPERTENSIONAHA.113.01888; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ALGOTSSON A, 1995, ACTA NEUROL SCAND, V91, P14; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Allan LM, 2005, DEMENT GERIATR COGN, V19, P140, DOI 10.1159/000082885; Allan LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005521; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; [Anonymous], 2012, FEDERAL INTERAGENCY; [Anonymous], 2011, FUTURO DEMOGRAFICO P; Anzola GP, 2011, ACTA NEUROL SCAND, V124, P403, DOI 10.1111/j.1600-0404.2011.01495.x; Appenzeller O., 1997, AUTONOMIC NERVOUS SY; Arsenault-Lapierre G., 2012, INT J ALZHEIMERS DIS, V2012; Basso A, 1987, Funct Neurol, V2, P189; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bilchick KC, 2006, J CARDIOVASC ELECTR, V17, P691, DOI 10.1111/j.1540-8167.2006.00501.x; Bilge AK, 2005, INT J CLIN PRACT, V59, P306, DOI 10.1111/j.1742-1241.2005.00464.x; Bloomfield DM, 1997, AM HEART J, V134, P316, DOI 10.1016/S0002-8703(97)70140-6; Bohannon AD, 2002, J AM GERIATR SOC, V50, P424, DOI 10.1046/j.1532-5415.2002.50104.x; Bombois S, 2008, STROKE, V39, P2046, DOI 10.1161/STROKEAHA.107.505206; Braak H, 1998, J NEURAL TRANSM-SUPP, P127; Bravi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045666; Brignole M, 2006, AGE AGEING, V35, P46, DOI 10.1093/ageing/aflO86; Britton A, 2008, NEUROEPIDEMIOLOGY, V31, P115, DOI 10.1159/000148257; BROWN TE, 1993, J APPL PHYSIOL, V75, P2310, DOI 10.1152/jappl.1993.75.5.2310; Brown WR, 2011, NEUROPATH APPL NEURO, V37, P56, DOI 10.1111/j.1365-2990.2010.01139.x; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnethon MR, 2002, AM HEART J, V143, P808, DOI 10.1067/mhj.2002.121928; Chang JS, 2010, PROG NEURO-PSYCHOPH, V34, P924, DOI 10.1016/j.pnpbp.2010.04.017; Chen CJ, 2009, CLIN NEUROPHYSIOL, V120, P348, DOI 10.1016/j.clinph.2008.10.155; Costa FV, 2009, HIGH BLOOD PRESS CAR, V16, P167, DOI 10.2165/11530410-000000000-00000; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Dias FLD, 2013, CURR ALZHEIMER RES, V10, P476, DOI 10.2174/1567205011310050003; DAVIDSON RA, 1989, J AM GERIATR SOC, V37, P861, DOI 10.1111/j.1532-5415.1989.tb02267.x; Toledo MADV, 2008, GERIATR GERONTOL INT, V8, P109, DOI 10.1111/j.1447-0594.2008.00456.x; Toledo MAD, 2010, CLIN AUTON RES, V20, P11, DOI 10.1007/s10286-009-0035-0; Debette S, 2007, STROKE, V38, P2924, DOI 10.1161/STROKEAHA.107.488403; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Delano-Wood L, 2012, J ALZHEIMERS DIS, V29, P589, DOI 10.3233/JAD-2012-102103; Delbaere K, 2012, AM J GERIAT PSYCHIAT, V20, P845, DOI 10.1097/JGP.0b013e31824afbc4; Della Sala S, 2003, NEUROL SCI, V24, P10, DOI 10.1007/s100720300015; DERENZI E, 1980, ARCH NEUROL-CHICAGO, V37, P6, DOI 10.1001/archneur.1980.00500500036003; Di Carlo A, 2000, J AM GERIATR SOC, V48, P775, DOI 10.1111/j.1532-5415.2000.tb04752.x; ELMSTAHL S, 1992, AGE AGEING, V21, P301, DOI 10.1093/ageing/21.4.301; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; Folino AF, 2005, INT J CARDIOL, V100, P247, DOI 10.1016/j.ijcard.2004.08.057; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman R, 2011, AUTON NEUROSCI-BASIC, V161, P46, DOI 10.1016/j.autneu.2011.02.004; FREY AW, 1995, Z KARDIOL, V84, P105; Frisoni GB, 1999, AM J EPIDEMIOL, V150, P1031, DOI 10.1093/oxfordjournals.aje.a009927; Galeone F, 2011, INT J GERIATR PSYCH, V26, P695, DOI 10.1002/gps.2583; Galluzzi S, 2009, J GERONTOL A-BIOL, V64, P1312, DOI 10.1093/gerona/glp105; Ganguli M, 2011, ARCH NEUROL-CHICAGO, V68, P761, DOI 10.1001/archneurol.2011.101; Geda YE, 2008, ARCH GEN PSYCHIAT, V65, P1193, DOI 10.1001/archpsyc.65.10.1193; Gentlesk PJ, 2005, AM HEART J, V150, P478, DOI 10.1016/j.ahj.2004.10.031; Geroldi C, 2006, J NEUROL NEUROSUR PS, V77, P1219, DOI 10.1136/jnnp.2005.082651; Gibbons CH, 2006, NEUROLOGY, V67, P28, DOI 10.1212/01.wnl.0000223828.28215.0b; Gilder M, 2008, AUTON NEUROSCI-BASIC, V143, P73, DOI 10.1016/j.autneu.2008.06.002; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Giubilei F, 1998, ALZ DIS ASSOC DIS, V12, P356, DOI 10.1097/00002093-199812000-00017; Graham JE, 1997, LANCET, V349, P1793, DOI 10.1016/S0140-6736(97)01007-6; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guo HY, 2010, HYPERTENS RES, V33, P32, DOI 10.1038/hr.2009.172; Guo ZC, 1997, AM J EPIDEMIOL, V145, P1106; Guzik P, 2008, HYPERTENS RES, V31, P443, DOI 10.1291/hypres.31.443; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hansen AL, 2009, ANXIETY STRESS COPIN, V22, P77, DOI 10.1080/10615800802272251; Havnen A., 2013, CLIN NEUROPSYCHIATRY, V10, P56; Hovland A, 2012, INT J PSYCHOPHYSIOL, V86, P269, DOI 10.1016/j.ijpsycho.2012.10.004; Huang WL, 2013, J CLIN PSYCHOPHARM, V33, P170, DOI 10.1097/JCP.0b013e3182839052; Idiaquez J, 2002, CLIN AUTON RES, V12, P43, DOI 10.1007/s102860200009; IKEDA T, 1994, BRIT J ANAESTH, V73, P479, DOI 10.1093/bja/73.4.479; Iwamoto Y, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-199; JOBERT M, 1995, NEUROPSYCHOBIOLOGY, V31, P204, DOI 10.1159/000119195; Johnsen BH, 2003, J ANXIETY DISORD, V17, P75, DOI 10.1016/S0887-6185(02)00178-0; Joyner MJ, 2008, EXP PHYSIOL, V93, P715, DOI 10.1113/expphysiol.2007.039545; Jung HW, 2013, PULSE, V1, P29, DOI 10.1159/000348622; Kamath M, 1995, HEART RATE VARIABILI, P75; Karas M, 2005, J HYPERTENS, V23, P1251, DOI 10.1097/01.hjh.0000170389.69202.53; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; Kawano Y, 2000, BLOOD PRESS MONIT, V5, P181, DOI 10.1097/00126097-200006000-00007; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kerr WC, 2012, DRUG ALCOHOL REV, V31, P200, DOI 10.1111/j.1465-3362.2011.00374.x; Kikuchi M, 2009, PROG NEURO-PSYCHOPH, V33, P1474, DOI 10.1016/j.pnpbp.2009.08.002; Kim DH, 2006, J AM GERIATR SOC, V54, P1751, DOI 10.1111/j.1532-5415.2006.00940.x; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Koschke M, 2009, PSYCHOSOM MED, V71, P852, DOI 10.1097/PSY.0b013e3181b8bb7a; Laiacona M., 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P209; Laitinen T, 2004, J APPL PHYSIOL, V96, P2333, DOI 10.1152/japplphysiol.00444.2003; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lefrandt JD, 2001, AM J HYPERTENS, V14, P1083, DOI 10.1016/S0895-7061(01)02218-X; Licht CMM, 2010, BIOL PSYCHIAT, V68, P861, DOI 10.1016/j.biopsych.2010.06.032; Lindqvist M, 2007, J HYPERTENS, V25, P169, DOI 10.1097/HJH.0b013e3280104dba; Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061803; Liu-Ambrose TY, 2008, PHYS THER, V88, P1482, DOI 10.2522/ptj.20080117; Lombardi F, 1996, CARDIOVASC RES, V32, P208, DOI 10.1016/0008-6363(96)00116-2; Luck T, 2010, DEMENT GERIATR COGN, V29, P164, DOI 10.1159/000272424; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Mathewson KJ, 2010, INT J PSYCHOPHYSIOL, V76, P123, DOI 10.1016/j.ijpsycho.2010.02.007; MCLEOD DR, 1992, PSYCHOPHARMACOLOGY, V107, P535, DOI 10.1007/BF02245268; Mehagnoul-Schipper DJ, 2000, STROKE, V31, P1615, DOI 10.1161/01.STR.31.7.1615; Mehrabian S, 2010, J NEUROL SCI, V299, P45, DOI 10.1016/j.jns.2010.08.056; Menard S., 1995, SAGE U PAPER SERIES, V07-106; Menezes Antonio da Silva Jr, 2004, Arq Bras Cardiol, V83, P169; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Monaco M, 2013, NEUROL SCI, V34, P749, DOI 10.1007/s10072-012-1130-x; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; MURASE S, 1994, NEUROSCIENCE, V61, P635, DOI 10.1016/0306-4522(94)90440-5; Naglie G, 2006, QUAL LIFE RES, V15, P631, DOI 10.1007/s11136-005-4364-8; Nicolini P, 2012, PACE, V35, P621, DOI 10.1111/j.1540-8159.2012.03335.x; Nobili A, 2011, PHARMACOEPIDEM DR S, V20, P488, DOI 10.1002/pds.2108; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PAGANI M, 1988, J AUTONOM NERV SYST, V23, P143, DOI 10.1016/0165-1838(88)90078-1; Pagani M, 1997, CIRCULATION, V95, P1441; PARATI G, 1995, HYPERTENSION, V25, P1276, DOI 10.1161/01.HYP.25.6.1276; Park KW, 2012, PSYCHIAT RES-NEUROIM, V203, P201, DOI 10.1016/j.pscychresns.2011.12.007; PARMELEE PA, 1995, J AM GERIATR SOC, V43, P130, DOI 10.1111/j.1532-5415.1995.tb06377.x; Pavithran P, 2010, CLIN EXP PHARMACOL P, V37, pE107, DOI 10.1111/j.1440-1681.2009.05295.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2011, NEW ENGL J MED, V364, P2227, DOI 10.1056/NEJMcp0910237; Pfeifer L, 2013, INT PSYCHOGERIATR, V25, P1345, DOI 10.1017/S1041610213000562; Piccirillo G, 1998, INT J CARDIOL, V63, P53, DOI 10.1016/S0167-5273(97)00282-9; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Prencipe M, 2000, J HUM HYPERTENS, V14, P825, DOI 10.1038/sj.jhh.1001117; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; RAIHA I, 1993, ACTA NEUROL SCAND, V87, P286; Rang HD., 1999, PHARMACOLOGY; Reed MJ, 2005, QJM-INT J MED, V98, P87, DOI 10.1093/qjmed/hci018; RICHARDS JE, 1991, PSYCHOPHYSIOLOGY, V28, P43, DOI 10.1111/j.1469-8986.1991.tb03385.x; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Routledge HC, 2002, J CLIN PHARM THER, V27, P85, DOI 10.1046/j.1365-2710.2002.00404.x; Royall DR, 2006, MED HYPOTHESES, V67, P747, DOI 10.1016/j.mehy.2005.10.036; Ruitenberg A, 2001, DEMENT GERIATR COGN, V12, P33, DOI 10.1159/000051233; Ruiz GA, 2000, PACE, V23, P325, DOI 10.1111/j.1540-8159.2000.tb06757.x; Sahin I., 2004, Eur J Intern Med, V15, P225, DOI 10.1016/j.ejim.2004.04.005; Salo TM, 1999, EUR J CLIN PHARMACOL, V55, P191, DOI 10.1007/s002280050617; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schinka JA, 2010, CURR PSYCHIAT REP, V12, P4, DOI 10.1007/s11920-009-0079-9; Schwartz JB, 2008, BRAUNWALDS HEART DIS, P1923; Shah AJ, 2011, PSYCHOSOM MED, V73, P475, DOI 10.1097/PSY.0b013e3182227d6a; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Shell WE, 2012, J CENT NERV SYST DIS, V4, P65, DOI 10.4137/JCNSD.S9381; Sierra C, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/478710; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Spielberger CD, 1970, STATE  TRAIT ANXIETY; Srinivasan K, 2002, CLIN PHYSIOL FUNCT I, V22, P404, DOI 10.1046/j.1475-097X.2002.00450.x; Stein PK, 2005, J CARDIOVASC ELECTR, V16, P13, DOI 10.1046/j.1540-8167.2005.04358.x; Stein PK, 2005, HEART RATE VARIABILI; STRAHAN R, 1972, J CLIN PSYCHOL, V28, P191, DOI 10.1002/1097-4679(197204)28:2<191::AID-JCLP2270280220>3.0.CO;2-G; SUESS PE, 1994, PSYCHOPHYSIOLOGY, V31, P17, DOI 10.1111/j.1469-8986.1994.tb01020.x; Terhardt J, 2013, CLIN NEUROPHARMACOL, V36, P198, DOI 10.1097/WNF.0b013e3182a76fbb; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tonhajzerova I., 2012, HEART RATE VARIABILI, P185; Tsuji H, 1996, J AM COLL CARDIOL, V28, P1539, DOI 10.1016/S0735-1097(96)00342-7; TULEN JHM, 1994, PSYCHOPHARMACOLOGY, V114, P81, DOI 10.1007/BF02245447; Tulen JHM, 1998, J CARDIOVASC PHARM, V32, P183, DOI 10.1097/00005344-199808000-00003; Tuokko H, 2003, ARCH NEUROL-CHICAGO, V60, P577, DOI 10.1001/archneur.60.4.577; Uusitalo ALT, 2007, AM J PHYSIOL-HEART C, V293, pH1013, DOI 10.1152/ajpheart.00475.2006; Vallar G., 1994, Archivio di Psicologia Neurologia e Psichiatria, V55, P827; van Zyl LT, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-12; Vanneste S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059728; WANG SJ, 1994, AGE AGEING, V23, P400, DOI 10.1093/ageing/23.5.400; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wolf DL, 2003, J CLIN PSYCHOPHARM, V23, P51, DOI 10.1097/00004714-200302000-00009; Wu GQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004323; Xie CM, 2012, NEUROIMAGE, V63, P320, DOI 10.1016/j.neuroimage.2012.06.062; Yamasaki F, 1998, AM J CARDIOL, V81, P137, DOI 10.1016/S0002-9149(97)00892-8; Yamasaki Y, 1996, AM J PHYSIOL-HEART C, V271, pH303, DOI 10.1152/ajpheart.1996.271.1.H303; Yang ACC, 2008, J AM GERIATR SOC, V56, P958, DOI 10.1111/j.1532-5415.2008.01662.x; Yasuda G, 2005, DIABETIC MED, V22, P1394, DOI 10.1111/j.1464-5491.2005.01636.x; Zhang Qian, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P610; Zheng JJJ, 2011, STROKE, V42, P2086, DOI 10.1161/STROKEAHA.110.610360; Zulli R, 2005, J AM GERIATR SOC, V53, P2135, DOI 10.1111/j.1532-5415.2005.00508.x	187	38	40	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96656	10.1371/journal.pone.0096656	http://dx.doi.org/10.1371/journal.pone.0096656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801520	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800105
J	Sun, T; Vasek, MJ; Klein, RS				Sun, Tony; Vasek, Michael J.; Klein, Robyn S.			Congenitally Acquired Persistent Lymphocytic Choriomeningitis Viral Infection Reduces Neuronal Progenitor Pools in the Adult Hippocampus and Subventricular Zone	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEUROLOGIC DISEASE; VIRUS-INFECTION; NEUROGENESIS; CELLS; MICE; DIFFERENTIATION; EXPRESSION; CCL2	Lymphocytic choriomeningitis virus (LCMV) can be transmitted through congenital infection, leading to persistent infection of numerous organ systems including the central nervous system (CNS). Adult mice persistently infected with LCMV (LCMV-cgPi mice) exhibit learning deficits, such as poor performance in spatial discrimination tests. Given that deficits in spatial learning have been linked to defects in adult neurogenesis, we investigated the impact of congenital LCMV infection on generation of neuroblasts from neural progenitor cells within neurogenic zones of adult mice. In LCMV-cgPi mice, QPCR and immunohistochemistry detected presence of LCMV glycoprotein-coding RNA and nucleoprotein in the hippocampal dentate gyrus and subventricular zone (SVZ), sites of neurogenesis that harbor populations of neuroblasts. Numbers of neuroblasts were reduced in LCMV-cgPi mice, as determined by IHC quantification, and analysis of BrdU incorporation by flow cytometry revealed lower numbers of BrdU-labeled neuroblasts. Additionally, TUNEL assays performed in situ showed increased numbers of apoptotic cells in the two neurogenic regions. Next, neurosphere cultures were infected in vitro with LCMV and differentiated to create a population of cells that consisted of both transit amplifying cells and neuroblasts. Immunocytochemical and TUNEL assays revealed increased numbers of TUNEL-positive cells that express nestin, suggesting that the drop in numbers of neuroblasts was due to a combination of impaired proliferation and apoptosis of progenitor cells. LCMV-cgPi mice exhibited transcriptional up-regulation several cytokines and chemokines, including gammainterferon inducible chemokines CXCL9 and CXCL10. Chronic up-regulation of these chemokines can facilitate a pro-inflammatory niche that may contribute to defects in neurogenesis.	[Sun, Tony; Vasek, Michael J.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Klein, Robyn S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Klein, RS (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	rklein@dom.wustl.edu		Vasek, Michael/0000-0002-1112-4346	NIH/NINDS [R01NS052632, F31 NS077640]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052632, F31NS077640] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS R01NS052632 (to R.S.K.) and F31 NS077640 (to M.J.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; [Anonymous], 2002, LCMV CTR NERV SYST U; Barton LL, 2001, CLIN INFECT DIS, V33, P370, DOI 10.1086/321897; Bonthius DJ, 2007, ANN NEUROL, V62, P347, DOI 10.1002/ana.21161; Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002; Bonthius DJ, 2007, PLOS PATHOG, V3, P1541, DOI 10.1371/journal.ppat.0030149; Borrow P, 2010, VIRUSES-BASEL, V2, P2443, DOI 10.3390/v2112443; Brot MD, 1997, J NEUROVIROL, V3, P265, DOI 10.3109/13550289709029467; Ciurea A, 1999, PERSISTENCE LYMPHOCY; COLE GA, 1986, MED MICROBIOL IMMUN, V175, P197, DOI 10.1007/BF02122450; Colonna L, 2008, CELL STEM CELL; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; DELATORRE JC, 1991, BRIT MED BULL, V47, P838, DOI 10.1093/oxfordjournals.bmb.a072515; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Guzman-Sanchez F, 2012, J ALZHEIMERS DIS, V30, P779, DOI 10.3233/JAD-2012-120070; JAMIESON BD, 1988, P NATL ACAD SCI USA, V85, P2265, DOI 10.1073/pnas.85.7.2265; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KING CC, 1992, J VIROL, V66, P3155, DOI 10.1128/JVI.66.5.3155-3160.1992; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kunz S, 2006, J VIROL, V80, P9082, DOI 10.1128/JVI.00795-06; Liu MT, 2001, J IMMUNOL, V167, P4091, DOI 10.4049/jimmunol.167.7.4091; Liu XS, 2007, J NEUROSCI RES, V85, P2120, DOI 10.1002/jnr.21359; Mani I, 2009, TOP COMPANION ANIM M, V24, P164, DOI 10.1053/j.tcam.2009.07.002; Mathei C, 2011, J AM GERIATR SOC, V59, P2201, DOI 10.1111/j.1532-5415.2011.03719.x; McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Orr AG, 2010, J MOL NEUROSCI, V41, P89, DOI 10.1007/s12031-009-9293-5; RODRIGUEZ M, 1983, AM J PATHOL, V110, P95; Sharma A, 2002, NEUROBIOL DIS, V11, P246, DOI 10.1006/nbdi.2002.0531; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Tomonaga K, 2004, TRENDS MOL MED, V10, P71, DOI 10.1016/j.molmed.2003.12.001; Tran PB, 2007, J COMP NEUROL, V500, P1007, DOI 10.1002/cne.21229; Turbic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025406; van Marle G, 2004, VIROLOGY, V329, P302, DOI 10.1016/j.virol.2004.08.024; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; von Herrath M, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1910s36	41	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96442	10.1371/journal.pone.0096442	http://dx.doi.org/10.1371/journal.pone.0096442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802239	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800069
J	Gile, GH; Slamovits, CH				Gile, Gillian H.; Slamovits, Claudio H.			Transcriptomic Analysis Reveals Evidence for a Cryptic Plastid in the Colpodellid Voromonas pontica, a Close Relative of Chromerids and Apicomplexan Parasites	PLOS ONE			English	Article							HEME-BIOSYNTHESIS PATHWAY; IRON-SULFUR CLUSTERS; ISOPRENOID BIOSYNTHESIS; SUBCELLULAR-LOCALIZATION; PHYLOGENETIC ANALYSES; GENOME SEQUENCE; METABOLIC MAPS; LIFE-CYCLE; EUK-MPLOC; APICOPLAST	Colpodellids are free-living, predatory flagellates, but their close relationship to photosynthetic chromerids and plastid-bearing apicomplexan parasites suggests they were ancestrally photosynthetic. Colpodellids may therefore retain a cryptic plastid, or they may have lost their plastids entirely, like the apicomplexan Cryptosporidium. To find out, we generated transcriptomic data from Voromonas pontica ATCC 50640 and searched for homologs of genes encoding proteins known to function in the apicoplast, the non-photosynthetic plastid of apicomplexans. We found candidate genes from multiple plastid-associated pathways including iron-sulfur cluster assembly, isoprenoid biosynthesis, and tetrapyrrole biosynthesis, along with a plastid-type phosphate transporter gene. Four of these sequences include the 59 end of the coding region and are predicted to encode a signal peptide and a transit peptide-like region. This is highly suggestive of targeting to a cryptic plastid. We also performed a taxon-rich phylogenetic analysis of small subunit ribosomal RNA sequences from colpodellids and their relatives, which suggests that photosynthesis was lost more than once in colpodellids, and independently in V. pontica and apicomplexans. Colpodellids therefore represent a valuable source of comparative data for understanding the process of plastid reduction in humanity's most deadly parasite.	[Gile, Gillian H.; Slamovits, Claudio H.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University	Gile, GH (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	g.gile@dal.ca	Slamovits, Claudio/E-2591-2011	Slamovits, Claudio/0000-0003-3050-1474	NSERC [386345]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an NSERC Discovery grant (386345) to CHS and an NSERC postdoctoral fellowship to GHG. CHS is a Fellow of the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Bachvaroff TR, 2014, MOL PHYLOGENET EVOL, V70, P314, DOI 10.1016/j.ympev.2013.10.007; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Barta JR, 2006, TRENDS PARASITOL, V22, P463, DOI 10.1016/j.pt.2006.08.001; Baumeister S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019334; Bispo NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059288; Blouin NA, 2012, BIOESSAYS, V34, P226, DOI 10.1002/bies.201100139; Borza T, 2005, EUKARYOT CELL, V4, P253, DOI 10.1128/EC.4.2.253-261.2005; Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; BRUGEROLLE G, 1979, PROTISTOLOGICA, V15, P183; Brugerolle G, 2002, EUR J PROTISTOL, V38, P113, DOI 10.1078/0932-4739-00864; Butterfield ER, 2013, PROTIST, V164, P218, DOI 10.1016/j.protis.2012.09.001; Carreno RA, 1999, PARASITOL RES, V85, P899, DOI 10.1007/s004360050655; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Colleoni C, 2010, MOL BIOL EVOL, V27, P2691, DOI 10.1093/molbev/msq158; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Koning AP, 2004, EUKARYOT CELL, V3, P1198, DOI 10.1128/EC.3.5.1198-1205.2004; Dellibovi-Ragheb TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003227; Denny P, 1998, PROTIST, V149, P51, DOI 10.1016/S1434-4610(98)70009-4; Disch A, 1998, BIOCHEM J, V333, P381, DOI 10.1042/bj3330381; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Eisenreich W, 1998, CHEM BIOL, V5, pR221, DOI 10.1016/S1074-5521(98)90002-3; Ellis KES, 2001, MOL MICROBIOL, V41, P973, DOI 10.1046/j.1365-2958.2001.02588.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Flugge UI, 1999, ANNU REV PLANT PHYS, V50, P27, DOI 10.1146/annurev.arplant.50.1.27; FOISSNER W, 1984, PROTISTOLOGICA, V20, P635; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; Gisselberg JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003655; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grawert T, 2011, CELL MOL LIFE SCI, V68, P3797, DOI 10.1007/s00018-011-0753-z; Grauvogel C, 2007, J MOL EVOL, V65, P725, DOI 10.1007/s00239-007-9053-5; Gschloessl B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-393; Haussig JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067269; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hoef-Emden K, 2005, J MOL EVOL, V60, P183, DOI 10.1007/s00239-004-0089-5; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iida K, 2002, EUR J BIOCHEM, V269, P291, DOI 10.1046/j.0014-2956.2001.02651.x; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Karnataki A, 2007, MOL MICROBIOL, V63, P1653, DOI 10.1111/j.1365-2958.2007.05619.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khan H, 2007, MOL BIOL EVOL, V24, P1832, DOI 10.1093/molbev/msm101; KIVIC PA, 1974, CAN J BOT, V52, P695, DOI 10.1139/b74-089; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Koreny L, 2011, GENOME BIOL EVOL, V3, P359, DOI 10.1093/gbe/evr029; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar B, 2011, INT J PARASITOL, V41, P991, DOI 10.1016/j.ijpara.2011.05.006; Kuvardina ON, 2002, J EUKARYOT MICROBIOL, V49, P498, DOI 10.1111/j.1550-7408.2002.tb00235.x; Laatsch T, 2004, MOL BIOL EVOL, V21, P1318, DOI 10.1093/molbev/msh127; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leander BS, 2006, PROTIST, V157, P45, DOI 10.1016/j.protis.2005.10.002; Leander BS, 2003, J EUKARYOT MICROBIOL, V50, P334, DOI 10.1111/j.1550-7408.2003.tb00145.x; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Lim L, 2010, FEBS LETT, V584, P549, DOI 10.1016/j.febslet.2009.11.097; Linka M, 2008, PLANT PHYSIOL, V148, P1487, DOI 10.1104/pp.108.129478; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Matsuzaki M, 2008, MOL BIOL EVOL, V25, P1167, DOI 10.1093/molbev/msn064; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Myl'nikov AP, 2000, ZOOL ZH, V79, P261; Nair SC, 2011, J EXP MED, V208, P1547, DOI 10.1084/jem.20110039; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; Ong HC, 2010, J PHYCOL, V46, P602, DOI [10.1111/j.1529-8817.2010.00841x, 10.1111/j.1529-8817.2010.00841.x]; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; Parfrey LW, 2011, P NATL ACAD SCI USA, V108, P13624, DOI 10.1073/pnas.1110633108; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Patron NJ, 2007, BIOESSAYS, V29, P1048, DOI 10.1002/bies.20638; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puerta MVS, 2005, DNA RES, V12, P151, DOI 10.1093/dnares/12.2.151; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; Ralph SA, 2004, MOL BIOL EVOL, V21, P2183, DOI 10.1093/molbev/msh233; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Ralph SA, 2001, DRUG RESIST UPDATE, V4, P145, DOI 10.1054/drup.2001.0205; Rao A, 2008, INDIAN J BIOCHEM BIO, V45, P365; Robledo JAF, 2011, INT J PARASITOL, V41, P1217, DOI 10.1016/j.ijpara.2011.07.008; ROUND FE, 1980, BIOSYSTEMS, V12, P61, DOI 10.1016/0303-2647(80)90038-6; Rumpf R, 1996, J PHYCOL, V32, P119, DOI 10.1111/j.0022-3646.1996.00119.x; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; Sanchez-Puerta MV, 2007, PROTIST, V158, P105, DOI 10.1016/j.protis.2006.09.004; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Seeber F, 2010, INT REV CEL MOL BIO, V281, P161, DOI 10.1016/S1937-6448(10)81005-6; Sekiguchi H, 2002, PROTIST, V153, P157, DOI 10.1078/1434-4610-00094; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Simpson AGB, 1996, SYST PARASITOL, V33, P187, DOI 10.1007/BF01531200; Slamovits CH, 2008, MOL BIOL EVOL, V25, P1297, DOI 10.1093/molbev/msn075; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Tartar A, 2003, INT J SYST EVOL MICR, V53, P1719, DOI 10.1099/ijs.0.02559-0; THOMSEN HA, 1995, EUR J PHYCOL, V30, P29, DOI 10.1080/09670269500650781; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Toso MA, 2007, J EUKARYOT MICROBIOL, V54, P66, DOI 10.1111/j.1550-7408.2006.00229.x; Tyra HM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r212; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; Vollmer M, 2001, J BIOL CHEM, V276, P5483, DOI 10.1074/jbc.M009452200; Waller RF, 2003, SCIENCE, V301; Weber APM, 2006, EUKARYOT CELL, V5, P609, DOI 10.1128/EC.5.3.609-612.2006; WEINSTEIN JD, 1983, J BIOL CHEM, V258, P6799; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; Woehle C, 2011, GENOME BIOL EVOL, V3, P1220, DOI 10.1093/gbe/evr100; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; WU B, 2006, THESIS U PENNSYLVANI; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Xu XM, 2011, ANTIOXID REDOX SIGN, V15, P271, DOI 10.1089/ars.2010.3259; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Yuan CL, 2012, EMERG INFECT DIS, V18, P125, DOI 10.3201/eid1801.110716; Zhu G, 2000, MICROBIOL-SGM, V146, P315, DOI 10.1099/00221287-146-2-315	127	20	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96258	10.1371/journal.pone.0096258	http://dx.doi.org/10.1371/journal.pone.0096258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797661	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000052
J	Juul, L; Maindal, HT; Zoffmann, V; Frydenberg, M; Sandbaek, A				Juul, Lise; Maindal, Helle T.; Zoffmann, Vibeke; Frydenberg, Morten; Sandbaek, Annelli			Effectiveness of a Training Course for General Practice Nurses in Motivation Support in Type 2 Diabetes Care: A Cluster-Randomised Trial	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; PERCEIVED COMPETENCE; GLYCEMIC CONTROL; PROBLEM-AREAS; INTERVENTION; DISEASE; QUALITY; ASSOCIATION; AUTONOMY; SCALE	Background: Type 2 diabetes is a common metabolic disease with the potential for prevention of complications. The prevention requires a high level of lasting actions from the patients, which may be burdensome. The aim of this trial was to evaluate the effectiveness of a training course for general practice nurses in motivation support at 18 months follow-up in the affiliated type 2 diabetes population. Methods: Forty general practices with nurse-led diabetes consultations from the area of Aarhus, Denmark were randomised 1:1 to either intervention or usual practice. Intervention practices were offered a 16-hour Self-determination theory - based course including communication training for general practice nurses delivered over 10 months. The affiliated diabetes populations (aged 40-74 years) were identified from registers (intervention n = 2,005; usual n = 2,029). Primary outcomes were register-based glycated haemoglobin (HbA(1c)) -, total cholesterol levels, and well-being measured by the Problem Areas In Diabetes scale (PAID) and the mental component summary score, SF12 (SF12, mcs). Intention-to-treat analyses were performed. Predefined subgroups analyses were performed. Results: The differences between the intervention-and the control practices' mean HbA1c and total cholesterol at follow-up adjusted for baseline values and clustering were respectively: -0.02%-points (95% CI: -0.11 to 0.07; p: 0.67); 0.08 mmol/l (95% CI: 0.01 to 0.15; p:0.02). Differences in median scores adjusted for clustering were for PAID:1.25; p = 0.31 and SF12, mcs: 0.99; p = 0.15. Women in intervention practices differed from women in usual practices on mean HbA1c: -0.12%-points (-0.23 to -0.02; p = 0.02) and SF12, mcs: 2.6; p = 0.01. Conclusions: Offering a training course for general practice nurses in applying the Self-determination theory in current type 2 diabetes care had no effect compared with usual practice measured by HbA1c and total cholesterol levels and the wellbeing at 18 months of follow-up in a comprehensive register-based diabetes population. Subgroup analyses suggested a possible effect in women, which deserves further attention.	[Juul, Lise; Sandbaek, Annelli] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Juul, Lise; Maindal, Helle T.] Aarhus Univ, Dept Publ Hlth, Sect Hlth Promot & Hlth, Aarhus, Denmark; [Zoffmann, Vibeke] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Zoffmann, Vibeke] Oslo Univ Hosp, Nasjonal Kompetansetjeneste Laering & Mestring In, Oslo, Norway; [Frydenberg, Morten] Aarhus Univ, Sect Biostat, Dept Publ Hlth, Aarhus, Denmark	Aarhus University; Aarhus University; Steno Diabetes Center; University of Oslo; Aarhus University	Juul, L (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark.	lise.juul@alm.au.dk	Maindal, Helle Terkildsen/N-8916-2016; Zoffmann, Vibeke/X-7192-2019; Albertin, Paloma C/X-1093-2018	Maindal, Helle Terkildsen/0000-0003-0525-7254; Juul, Lise/0000-0003-3640-7593	Tryg Foundation [7597-08]; UCSF Lundbeck Foundation [FP47/2009]; Health Insurance Foundation [2009B068]; Danish Nurses' Organisation [10/38412]; Aase and Ejnar Danielsens Foundation [10-000408]	Tryg Foundation; UCSF Lundbeck Foundation; Health Insurance Foundation; Danish Nurses' Organisation; Aase and Ejnar Danielsens Foundation	The study was financially supported by The Tryg Foundation (J.no.7597-08), UCSF Lundbeck Foundation (J.no.FP47/2009), The Health Insurance Foundation (J.no.2009B068), The Danish Nurses' Organisation (J.no.10/38412) and Aase and Ejnar Danielsens Foundation (J.no.10-000408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Amsberg S, 2008, INT J NURS STUD, V45, P1319, DOI 10.1016/j.ijnurstu.2007.09.010; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Eigenmann CA, 2009, DIABETIC MED, V26, P425, DOI 10.1111/j.1464-5491.2009.02697.x; El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Heinrich E, 2010, DIABETES RES CLIN PR, V90, P270, DOI 10.1016/j.diabres.2010.09.012; Heo M, 2008, BIOMETRICS, V64, P1256, DOI 10.1111/j.1541-0420.2008.00993.x; Hornsten A, 2005, DIABETES RES CLIN PR, V68, P65, DOI 10.1016/j.diabres.2004.08.003; Hornsten A, 2008, DIABETES RES CLIN PR, V81, P50, DOI 10.1016/j.diabres.2008.02.005; Juul L, 2012, PRIM CARE DIABETES, V6, P221, DOI 10.1016/j.pcd.2012.04.001; Juul L, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-130; Kirkwood B.R., 2003, ESSENTIAL MED STAT, P424; Laakso M, 2001, J INTERN MED, V249, P225, DOI 10.1046/j.1365-2796.2001.00789.x; Levesque CS, 2007, HEALTH EDUC RES, V22, P691, DOI 10.1093/her/cyl148; Maindal HT, 2011, SCAND J PUBLIC HEALT, V39, P262, DOI 10.1177/1403494811402721; Mannucci E, 2009, NUTR METAB CARDIOVAS, V19, P604, DOI 10.1016/j.numecd.2009.03.021; Minet LKR, 2011, DIABETOLOGIA, V54, P1620, DOI 10.1007/s00125-011-2120-x; Patrick H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-18; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Renders CM, 2000, COCHRANE DATABASE SY; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Schwartz D, 2009, J CLIN EPIDEMIOL, V62, P499, DOI 10.1016/j.jclinepi.2009.01.012; Sheldon K.M, 2003, SELF DETERMINATION T, P3; Smelt AFH, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X514819; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760; West DS, 2007, DIABETES CARE, V30, P1081, DOI 10.2337/dc06-1966; Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001; Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58; Williams GC, 1998, DIABETES CARE, V21, P1644, DOI 10.2337/diacare.21.10.1644; Williams GC, 2011, CONTEMP CLIN TRIALS, V32, P535, DOI 10.1016/j.cct.2011.03.002; Williams GC, 2009, DIABETES EDUCATOR, V35, P484, DOI 10.1177/0145721709333856; Zoffmann V, 2006, PATIENT EDUC COUNS, V64, P78, DOI 10.1016/j.pec.2005.11.017; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	38	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96683	10.1371/journal.pone.0096683	http://dx.doi.org/10.1371/journal.pone.0096683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798419	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000118
J	Redmer, T; Welte, Y; Behrens, D; Fichtner, I; Przybilla, D; Wruck, W; Yaspo, ML; Lehrach, H; Schafer, R; Regenbrecht, CRA				Redmer, Torben; Welte, Yvonne; Behrens, Diana; Fichtner, Iduna; Przybilla, Dorothea; Wruck, Wasco; Yaspo, Marie-Laure; Lehrach, Hans; Schaefer, Reinhold; Regenbrecht, Christian R. A.			The Nerve Growth Factor Receptor CD271 Is Crucial to Maintain Tumorigenicity and Stem-Like Properties of Melanoma Cells	PLOS ONE			English	Article							NEURAL CREST; TUMOR MICROENVIRONMENT; EPIGENETIC REGULATION; METASTATIC MELANOMA; CANCER-CELLS; FACTOR-BETA; SOX10; TRANSCRIPTION; CD133; PROMOTES	Background: Large-scale genomic analyses of patient cohorts have revealed extensive heterogeneity between individual tumors, contributing to treatment failure and drug resistance. In malignant melanoma, heterogeneity is thought to arise as a consequence of the differentiation of melanoma-initiating cells that are defined by cell-surface markers like CD271 or CD133. Results: Here we confirmed that the nerve growth factor receptor (CD271) is a crucial determinant of tumorigenicity, stem-like properties, heterogeneity and plasticity in melanoma cells. Stable shRNA mediated knock-down of CD271 in patient-derived melanoma cells abrogated their tumor-initiating and colony-forming capacity. A genome-wide expression profiling and gene-set enrichment analysis revealed novel connections of CD271 with melanoma-associated genes like CD133 and points to a neural crest stem cell (NCSC) signature lost upon CD271 knock-down. In a meta-analysis we have determined a shared set of 271 differentially regulated genes, linking CD271 to SOX10, a marker that specifies the neural crest. To dissect the connection of CD271 and CD133 we have analyzed 10 patient-derived melanoma-cell strains for cell-surface expression of both markers compared to established cell lines MeWo and A375. We found CD271(+) cells in the majority of cell strains analyzed as well as in a set of 16 different patient-derived melanoma metastases. Strikingly, only 2/12 cell strains harbored a CD133(+) sub-set that in addition comprised a fraction of cells of a CD271(+)/CD133(+) phenotype. Those cells were found in the label-retaining fraction and in vitro deduced from CD271(+) but not CD271 knock-down cells. Conclusions: Our present study provides a deeper insight into the regulation of melanoma cell properties and points CD271 out as a regulator of several melanoma-associated genes. Further, our data strongly suggest that CD271 is a crucial determinant of stem-like properties of melanoma cells like colony-formation and tumorigenicity.	[Redmer, Torben; Welte, Yvonne; Przybilla, Dorothea; Wruck, Wasco; Schaefer, Reinhold; Regenbrecht, Christian R. A.] Univ Hosp Berlin, Inst Pathol, Berlin, Germany; [Behrens, Diana; Fichtner, Iduna] Expt Pharmacol & Oncol Berlin Buch GmbH, Berlin, Germany; [Wruck, Wasco; Regenbrecht, Christian R. A.] Univ Hosp Berlin, Lab Funct Genom LFGC, Berlin, Germany; [Yaspo, Marie-Laure; Lehrach, Hans] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Przybilla, Dorothea; Schaefer, Reinhold; Regenbrecht, Christian R. A.] Univ Hosp Berlin, Comprehens Canc Ctr Charite, Berlin, Germany	Max Planck Society	Regenbrecht, CRA (corresponding author), Univ Hosp Berlin, Inst Pathol, Berlin, Germany.	christian.regenbrecht@charite.de	Regenbrecht, Christian RA/S-7715-2016; Schäfer, Reinhold/AAB-5110-2021; Redmer, Torben/ABF-3893-2020	Regenbrecht, Christian RA/0000-0001-9494-5977; Redmer, Torben/0000-0002-0050-9478; Schafer, Reinhold/0000-0001-7952-2124	Federal Ministry of Education and Research, BMBF, Germany [031 5852A]	Federal Ministry of Education and Research, BMBF, Germany(Federal Ministry of Education & Research (BMBF))	This study was supported by the Federal Ministry of Education and Research, BMBF, Germany (No. 031 5852A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Aoki Y, 2003, DEV BIOL, V259, P19, DOI 10.1016/S0012-1606(03)00161-1; Baba T, 2009, ONCOGENE, V28, P209, DOI 10.1038/onc.2008.374; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Betancur P, 2011, DEVELOPMENT, V138, P3689, DOI 10.1242/dev.057836; Boiko Alexander D, 2013, Methods Mol Biol, V961, P253, DOI 10.1007/978-1-62703-227-8_16; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Das SK, 2013, CANCER RES, V73, P844, DOI 10.1158/0008-5472.CAN-12-1681; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dorsky RI, 2000, GENE DEV, V14, P158; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Ho H, 2012, CANCER RES, V72, P5516, DOI 10.1158/0008-5472.CAN-12-0775; John N, 2011, STEM CELLS, V29, P689, DOI 10.1002/stem.607; Kanehira M, 2007, ONCOGENE, V26, P6448, DOI 10.1038/sj.onc.1210466; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Konig A, 2000, MECH DEVELOP, V93, P211, DOI 10.1016/S0925-4773(00)00266-5; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lathia JD, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.80; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Marincola FM, 1996, J IMMUNOTHER, V19, P192, DOI 10.1097/00002371-199605000-00004; MEIER P, 1995, DEV BIOL, V169, P1, DOI 10.1006/dbio.1995.1121; Mundell NA, 2011, DEVELOPMENT, V138, P641, DOI 10.1242/dev.054718; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Prasad MK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-40; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Regenbrecht C, 2008, ECANCERMEDICALSCIENC, V2, DOI 10.3332/ecancer.2008.114; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sanyas I, 2012, DEVELOPMENT, V139, P3633, DOI 10.1242/dev.080051; Satzger I, 2007, AM J SURG PATHOL, V31, P1175, DOI 10.1097/PAS.0b013e3180341ebc; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stolt CC, 2008, NUCLEIC ACIDS RES, V36, P5427, DOI 10.1093/nar/gkn527; Stove C, 2004, ONCOGENE, V23, P5330, DOI 10.1038/sj.onc.1207699; Uchida F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-321; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Xin HW, 2012, STEM CELLS, V30, P591, DOI 10.1002/stem.1061; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yokoyama S, 2006, FEBS J, V273, P1805, DOI 10.1111/j.1742-4658.2006.05200.x; You HN, 2010, HEPATOLOGY, V51, P1635, DOI 10.1002/hep.23544; Zabierowski SE, 2011, PIGM CELL MELANOMA R, V24, P422, DOI 10.1111/j.1755-148X.2011.00847.x	52	74	79	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e92596	10.1371/journal.pone.0092596	http://dx.doi.org/10.1371/journal.pone.0092596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24799129	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336656000001
J	Wijnen, WJ; van der Made, I; van den Oever, S; Hiller, M; de Boer, BA; Picavet, DI; Chatzispyrou, IA; Houtkooper, RH; Tijsen, AJ; Hagoort, J; van Veen, H; Everts, V; Ruijter, JM; Pinto, YM; Creemers, EE				Wijnen, Wino J.; van der Made, Ingeborg; van den Oever, Stephanie; Hiller, Monika; de Boer, Bouke A.; Picavet, Daisy I.; Chatzispyrou, Iliana A.; Houtkooper, Riekelt H.; Tijsen, Anke J.; Hagoort, Jaco; van Veen, Henk; Everts, Vincent; Ruijter, Jan M.; Pinto, Yigal M.; Creemers, Esther E.			Cardiomyocyte-Specific miRNA-30c Over-Expression Causes Dilated Cardiomyopathy	PLOS ONE			English	Article							LARGE GENE LISTS; MITOCHONDRIAL BIOGENESIS; CARDIAC FIBROSIS; HEART-FAILURE; MICRORNAS; HYPERTROPHY; TARGETS; DEFECTS; MIR-133; MIR-30	MicroRNAs (miRNAs) regulate many aspects of cellular function and their deregulation has been implicated in heart disease. MiRNA-30c is differentially expressed in the heart during the progression towards heart failure and in vitro studies hint to its importance in cellular physiology. As little is known about the in vivo function of miRNA-30c in the heart, we generated transgenic mice that specifically overexpress miRNA-30c in cardiomyocytes. We show that these mice display no abnormalities until about 6 weeks of age, but subsequently develop a severely dilated cardiomyopathy. Gene expression analysis of the miRNA-30c transgenic hearts before onset of the phenotype indicated disturbed mitochondrial function. This was further evident by the downregulation of mitochondrial oxidative phosphorylation (OXPHOS) complexes III and IV at the protein level. Taken together these data indicate impaired mitochondrial function due to OXPHOS protein depletion as a potential cause for the observed dilated cardiomyopathic phenotype in miRNA-30c transgenic mice. We thus establish an in vivo role for miRNA-30c in cardiac physiology, particularly in mitochondrial function.	[Wijnen, Wino J.; van der Made, Ingeborg; van den Oever, Stephanie; Hiller, Monika; de Boer, Bouke A.; Tijsen, Anke J.; Hagoort, Jaco; Ruijter, Jan M.; Pinto, Yigal M.; Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Wijnen, Wino J.] Interuniv Cardiol Inst Nederland ICIN NHI, Utrecht, Netherlands; [Picavet, Daisy I.; van Veen, Henk; Everts, Vincent] Univ Amsterdam, Acad Med Ctr, LCAM, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Chatzispyrou, Iliana A.; Houtkooper, Riekelt H.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Creemers, EE (corresponding author), Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	e.e.creemers@amc.uva.nl	Wijnen, Wino/P-4774-2015; Houtkooper, Riekelt/P-5001-2019	Wijnen, Wino/0000-0002-3513-3618; Creemers, Esther/0000-0002-9001-3854; Tijsen, Anke/0000-0002-8030-8894; Houtkooper, Riekelt/0000-0001-9961-0842	Netherlands Organization for Scientific Research (NWO): MEERVOUD [836.12.002]; VENI/ZonMw [91613050]; AMC PhD fellowship; Inter-universitair Cardiologisch Instituut Nederland (ICIN) [08401]; Nederlandse Hartstichting [NHS2007-B167]; Netherlands CardioVascular Research Initiative [CVON 2011-11]	Netherlands Organization for Scientific Research (NWO): MEERVOUD; VENI/ZonMw; AMC PhD fellowship; Inter-universitair Cardiologisch Instituut Nederland (ICIN); Nederlandse Hartstichting; Netherlands CardioVascular Research Initiative	This research was supported by the Netherlands Organization for Scientific Research (NWO): MEERVOUD grant 836.12.002 to EEC, and VENI/ZonMw grant 91613050 to RHH, AMC PhD fellowship to IAC, the Inter-universitair Cardiologisch Instituut Nederland (ICIN project 08401), the Nederlandse Hartstichting (grant NHS2007-B167) and the Netherlands CardioVascular Research Initiative (CVON 2011-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abonnenc M, 2013, CIRC RES, DOI [10.1161/CIRCRE-SAHA.113.302400., DOI 10.1161/CIRCRE-SAHA.113.302400]; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Boon RA, 2013, NATURE, V495, P107, DOI 10.1038/nature11919; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Cannino G, 2007, MITOCHONDRION, V7, P359, DOI 10.1016/j.mito.2007.07.001; Casademont Jordi, 2002, Heart Fail Rev, V7, P131, DOI 10.1023/A:1015372407647; Chen Le, 2011, Congest Heart Fail, V17, P257; Creemers EE, 2011, CARDIOVASC RES, V89, P265, DOI 10.1093/cvr/cvq308; Dai Y, 2013, HYPERTENSION, V61, P751, DOI 10.1161/HYPERTENSIONAHA.111.00654; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; de Boer BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047719; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jentzsch C, 2012, J MOL CELL CARDIOL, V52, P13, DOI 10.1016/j.yjmcc.2011.07.010; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Li HL, 2012, MOL MED REP, V5, P1457, DOI 10.3892/mmr.2012.831; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Marchand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044532; Marin-Garcia J, 2002, J CARD FAIL, V8, P347, DOI 10.1054/jcaf.2002.127774; Matkovich SJ, 2011, CIRC RES, V108, P18, DOI 10.1161/CIRCRESAHA.110.233528; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053950; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2013, METHODS, V59, P32, DOI 10.1016/j.ymeth.2012.08.011; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tijsen AJ, 2012, CARDIOVASC RES, V93, P573, DOI 10.1093/cvr/cvr344; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Ventura FV, 2005, MOL GENET METAB, V86, P344, DOI 10.1016/j.ymgme.2005.07.030; Zhang Y, 2013, MOL CELL ENDOCRINOL, V381, P230, DOI 10.1016/j.mce.2013.08.004; Zhou HJ, 2012, ONCOL REP, V27, P807, DOI 10.3892/or.2011.1574	42	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96290	10.1371/journal.pone.0096290	http://dx.doi.org/10.1371/journal.pone.0096290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789369	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700071
J	Bruno, G; Barutta, F; Landi, A; Perin, PC; Gruden, G				Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella			The Effect of Age and NT-proBNP on the Association of Central Obesity with 6-Years Cardiovascular Mortality of Middle-Aged and Elderly Diabetic People: The Population-Based Casale Monferrato Study	PLOS ONE			English	Article							BODY-MASS INDEX; C-REACTIVE PROTEIN; NATRIURETIC PEPTIDE; WAIST CIRCUMFERENCE; PROSPECTIVE COHORT; FOLLOW-UP; ALL-CAUSE; RISK; WEIGHT; DEATH	Background: Among people with type 2 diabetes the relationship between central obesity and cardiovascular mortality has not been definitely assessed. Moreover, NT-proBNP is negatively associated with central obesity, but no study has examined their combined effect on survival. We have examined these issues in a well-characterized population-based cohort. Methods and Findings: Survival data of 2272 diabetic people recruited in 2000 who had no other chronic disease have been updated to 31 December 2006. NT-proBNP was measured in a subgroup of 1690 patients. Cox proportional hazards modeling was employed to estimate the independent associations between cardiovascular and all-cause mortality and waist circumference. Mean age was 67.9 years, 49.3% were men. Both age and NT-proBNP were negatively correlated with waist circumference (r = -0.11, p < 0.001 and r = -0.07, p = 0.002). Out of 2272 subjects, 520 deaths (221 for CV mortality) occurred during a median follow-up of 5.4 years. Central obesity was not associated with CV mortality (hazard ratio, HR, adjusted for age, sex, diabetes duration, 1.14, 95% CI 0.86-1.52). NTproBNP was a negative confounder and age a strong modifier of this relationship (p for interaction <0.001): age <70 years, fully adjusted model HR = 3.52 (1.17-10.57) and age >= 70 years, HR = 0.80 (0.46-1.40). Respective HRs for all-cause mortality were 1.86 (1.03-3.32) and 0.73 (0.51-1.04). Conclusions: In diabetic people aged 70 years and lower, central obesity was independently associated with increased cardiovascular mortality, independently of the negative effect of NT-proBNP. In contrast, no effect on 6-years survival was evident in diabetic people who have yet survived up to 70 years.	[Bruno, Graziella; Barutta, Federica; Landi, Andrea; Perin, Paolo Cavallo; Gruden, Gabriella] Univ Turin, Dept Med Sci, Turin, Italy	University of Turin	Bruno, G (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	graziella.bruno@unito.it		BRUNO, Graziella/0000-0002-3011-8304	Piedmont Region (Ricerca Sanitaria Finalizzata)	Piedmont Region (Ricerca Sanitaria Finalizzata)	The Casale Monferrato Study is supported by grants from the Piedmont Region (Ricerca Sanitaria Finalizzata 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Bruno G, 2008, NUTR METAB CARDIOVAS, V18, P39, DOI 10.1016/j.numecd.2006.08.007; Bruno G, 2013, DIABETES CARE, V36, P2677, DOI 10.2337/dc13-0353; Bruno G, 2009, DIABETES, V58, P926, DOI 10.2337/db08-0900; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Cheng S, 2011, AM J CARDIOL, V108, P979, DOI 10.1016/j.amjcard.2011.05.033; Chrysant SG, 2013, J AM SOC HYPERTENS, V7, P85, DOI 10.1016/j.jash.2012.11.008; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Eeg-Olofsson K, 2009, DIABETOLOGIA, V52, P65, DOI 10.1007/s00125-008-1190-x; Kalra PR, 2002, INT J CARDIOL, V85, P125, DOI 10.1016/S0167-5273(02)00241-3; Katzmarzyk PT, 2013, DIABETES CARE, V36, P3128, DOI 10.2337/dc13-0219; Kim BH, 2010, J INT MED RES, V38, P1737, DOI 10.1177/147323001003800519; Ko KP, 2012, J EPIDEMIOL, V22, P433, DOI 10.2188/jea.JE20110164; Kyrou I, 2009, DIABETES CARE, V32, pS403, DOI 10.2337/dc09-S348; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Martin J, 2013, CAN J CARDIOL, V29, P969, DOI 10.1016/j.cjca.2012.11.010; Moro C, 2013, AM J PHYSIOL-HEART C, V304, pH358, DOI 10.1152/ajpheart.00704.2012; Nakamura Kazuyo, 2011, Environmental Health and Preventive Medicine, V16, P52, DOI 10.1007/s12199-010-0165-y; Park Seung Jei, 2009, Korean Circ J, V39, P538, DOI 10.4070/kcj.2009.39.12.538; Perotto M, 2013, ACTA DIABETOL, V50, P563, DOI 10.1007/s00592-011-0338-1; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Price GM, 2006, AM J CLIN NUTR, V84, P449; Tarnow L, 2006, DIABETOLOGIA, V49, P2256, DOI 10.1007/s00125-006-0359-4; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Yamada-Goto N, 2013, DIABETES, V62, P1500, DOI 10.2337/db12-0718; Zeller M, 2008, CIRCULATION, V118, P482, DOI 10.1161/CIRCULATIONAHA.107.753483; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96076	10.1371/journal.pone.0096076	http://dx.doi.org/10.1371/journal.pone.0096076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788805	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600072
J	Feldblum, PJ; Odoyo-June, E; Obiero, W; Bailey, RC; Combes, S; Hart, C; Lai, JJ; Fischer, S; Cherutich, P				Feldblum, Paul J.; Odoyo-June, Elijah; Obiero, Walter; Bailey, Robert C.; Combes, Stephanie; Hart, Catherine; Lai, Jaim Jou; Fischer, Shelly; Cherutich, Peter			Safety, Effectiveness and Acceptability of the PrePex Device for Adult Male Circumcision in Kenya	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HIV PREVENTION; SHANG RING; TRIAL; RAKAI; EFFICACY; RISK; MEN	Objective: To assess the safety, effectiveness and acceptability of the PrePex device for adult medical male circumcision (MMC) in routine service delivery in Kenya. Methods: We enrolled 427 men ages 18-49 at one fixed and two outreach clinics. Procedures were performed by trained clinical officers and nurses. The first 50 enrollees were scheduled for six follow-up visits, and remaining men were followed at Days 7 and 42. We recorded adverse events (AEs) and time to complete healing, and interviewed men about acceptability and pain. Results: Placement and removal procedures each averaged between 3 and 4 minutes. Self-reported pain was minimal during placement but was fleetingly intense during removal. The rate of moderate/severe AEs was 5.9% overall (95% confidence interval [CI] 3.8%-8.5%), all of which resolved without sequelae. AEs included 5 device displacements, 2 spontaneous foreskin detachments, and 9 cases of insufficient foreskin removal. Surgical completion of MMC was required for 9 men (2.1%). Among the closely monitored first 50 participants, the probability of complete healing by Day 42 was 0.44 (95% CI 0.30-0.58), and 0.90 by Day 56. A large majority of men was favorable about their MMC procedure and would recommend PrePex to friends and family. Conclusions: The PrePex device was effective for MMC in Kenya, and well-accepted. The AE rate was higher than reported for surgical procedures there, or in previous PrePex studies. Healing time is longer than following surgical circumcision. Provider experience and clearer counseling on post-placement and post-removal care should lead to lower AE rates.	[Feldblum, Paul J.; Combes, Stephanie; Hart, Catherine; Fischer, Shelly] FHI 360, Clin Sci Unit, Durham, NC 27713 USA; [Odoyo-June, Elijah; Obiero, Walter] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Odoyo-June, Elijah] Ctr Dis Control & Prevent Kenya, Nairobi, Kenya; [Obiero, Walter; Bailey, Robert C.] Univ Illinois, Chicago, IL USA; [Lai, Jaim Jou] FHI 360, Quantitat Sci Dept, Durham, NC USA; [Cherutich, Peter] Natl AIDS & STI Control Programme, Nairobi, Kenya	FHI 360; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; FHI 360	Feldblum, PJ (corresponding author), FHI 360, Clin Sci Unit, Durham, NC 27713 USA.	pfeldblum@fhi360.org			Bill & Melinda Gates Foundation [OPP47394]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI082151] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Bill & Melinda Gates Foundation under grant # OPP47394. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001509; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Buwembo DR, 2012, BJU INT, V109, P104, DOI 10.1111/j.1464-410X.2011.10259.x; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2012, B WORLD HEALTH ORGAN, V90, P773, DOI 10.2471/BLT.12.106112; Kiggundu V, 2009, BJU INT, V104, P529, DOI 10.1111/j.1464-410X.2009.08420.x; Kigozi G, 2013, JAIDS-J ACQ IMM DEF, V63, P617, DOI 10.1097/QAI.0b013e3182968dda; Krieger JN, 2007, UROL INT, V78, P235, DOI 10.1159/000099344; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Rech D, 2011, ADVERSE EVENT ACTION; Rogers JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061725; Samuelson J, 2013, JAIDS-J ACQ IMM DEF, V64, P127, DOI 10.1097/QAI.0b013e3182a61dd3; Sokal DC, 2014, JAIDS-J ACQ IMM DEF, V65, P447, DOI 10.1097/QAI.0000000000000061; WHO, 2012, US DEV AD MAL CIRC P; WHO, 2013, GUID US DEV AD MAL C; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; World Health Organization, 2012, FRAM CLIN EV DEV AD; World Health Organization, 2013, M WHO TECHN ADV GROU; World Health Organization, 2013, WHO PREQ MAL CIRC DE	26	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95357	10.1371/journal.pone.0095357	http://dx.doi.org/10.1371/journal.pone.0095357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788898	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600035
J	Kozlowska, M; Tarczewska, A; Jakob, M; Szpotkowski, K; Wojtas, M; Rymarczyk, G; Ozyhar, A				Kozlowska, Malgorzata; Tarczewska, Aneta; Jakob, Michal; Szpotkowski, Kamil; Wojtas, Magdalena; Rymarczyk, Grzegorz; Ozyhar, Andrzej			Calponin-Like Chd64 Is Partly Disordered	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; F-ACTIN-BINDING; CIRCULAR-DICHROISM; ENERGY CONTENT; CH DOMAINS; WEB SERVER; I-TASSER; PROTEIN; TRANSGELIN	20-hydroxyecdysone (20E) and juvenile hormone (JH) signaling pathways interact to regulate insect development. Recently, two proteins, a calponin-like Chd64 and immunophilin FKBP39 have been found to play a pivotal role in the cross-talk between 20E and JH, although the molecular basis of interaction remains unknown. The aim of this work was to identify the structural features that would provide understanding of the role of Chd64 in multiple and dynamic complex that cross-links the signaling pathways. Here, we demonstrate the results of in silico and in vitro analyses of the structural organization of Chd64 from Drosophila melanogaster and its homologue from Tribolium castaneum. Computational analysis predicted the existence of disordered regions on the termini of both proteins, while the central region appeared to be globular, probably corresponding to the calponin homology (CH) domain. In vitro analyses of the hydrodynamic properties of the proteins from analytical size-exclusion chromatography and analytical ultracentrifugation revealed that DmChd64 and TcChd64 had an asymmetrical, elongated shape, which was further confirmed by small angle X-ray scattering (SAXS). The Kratky plot indicated disorderness in both Chd64 proteins, which could possibly be on the protein termini and which would give rise to specific hydrodynamic properties. Disordered tails are often involved in diverse interactions. Therefore, it is highly possible that there are intrinsically disordered regions (IDRs) on both termini of the Chd64 proteins that serve as platforms for multiple interaction with various partners and constitute the foundation for their regulatory function.	[Kozlowska, Malgorzata; Tarczewska, Aneta; Jakob, Michal; Wojtas, Magdalena; Rymarczyk, Grzegorz; Ozyhar, Andrzej] Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland; [Szpotkowski, Kamil] Polish Acad Sci, Inst Bioorgan Chem, Ctr Biocrystallog Res, Poznan, Poland	Wroclaw University of Science & Technology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences	Ozyhar, A (corresponding author), Wroclaw Univ Technol, Fac Chem, Dept Biochem, PL-50370 Wroclaw, Poland.	andrzej.ozyhar@pwr.edu.pl		OZYHAR, Andrzej/0000-0002-5874-784X; Szpotkowski, Kamil/0000-0002-7101-7200	National Science Centre grant [2012/05/B/NZ1/00659]; Polish Ministry of Science; Higher Education for the faculty of Chemistry of Wroclaw University of Technology	National Science Centre grant(National Science Centre, Poland); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); Higher Education for the faculty of Chemistry of Wroclaw University of Technology	This work was supported by National Science Centre grant (2012/05/B/NZ1/00659) and partly by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the faculty of Chemistry of Wroclaw University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 1970, Methods Biochem Anal, V18, P1, DOI 10.1002/9780470110362.ch1; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Banuelos S, 1998, STRUCTURE, V6, P1419, DOI 10.1016/S0969-2126(98)00141-5; Begg GE, 2001, CURR PROTEC PROTEIN; Bernado P., 2010, INSTRUMENTAL ANAL IN, P451; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Carugo KD, 1997, NAT STRUCT BIOL, V4, P175, DOI 10.1038/nsb0397-175; Casey R, 2005, BLAST SEQUENCES AID; DEHAEN C, 1987, ANAL BIOCHEM, V166, P235, DOI 10.1016/0003-2697(87)90570-7; DeLano WL, 2002, PYMOL USERS MANUAL; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Fu Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-600; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Gimona M, 1998, J CELL SCI, V111, P1813; Glatter O., 1982, SMALL ANGLE X RAY SC; HARTWIG JH, 1994, PROTEIN PROFILE, V1, P711; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; ISHAAYA I, 1976, Phytoparasitica, V4, P9, DOI 10.1007/BF02981074; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kelly SM, 1997, BBA-PROTEIN STRUCT M, V1338, P161, DOI 10.1016/S0167-4838(96)00190-2; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kostyukovsky M, 2000, INSECT BIOCHEM MOLEC, V30, P891, DOI 10.1016/S0965-1748(00)00063-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lawson D, 1997, CELL MOTIL CYTOSKEL, V38, P250, DOI 10.1002/(SICI)1097-0169(1997)38:3<250::AID-CM3>3.0.CO;2-9; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Li YP, 2007, J BIOL CHEM, V282, P37605, DOI 10.1074/jbc.M704595200; Liu PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019776; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; McGough A, 1998, CURR OPIN STRUC BIOL, V8, P166, DOI 10.1016/S0959-440X(98)80034-1; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Punta M., 2012, NUCL ACIDS RES; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riddiford LM, 1994, ADV INSECT PHYSL, V24; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Romero, 1997, Genome Inform Ser Workshop Genome Inform, V8, P110; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schroder R, 2008, DEV GENES EVOL, V218, P119, DOI 10.1007/s00427-008-0214-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Voet D., 2005, BIOCHEMISTRY-US; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xue B, 2013, BBA-PROTEINS PROTEOM, V1834, P725, DOI 10.1016/j.bbapap.2013.01.012; Yang ZM, 2007, MOL ENDOCRINOL, V21, P343, DOI 10.1210/me.2006-0104; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96809	10.1371/journal.pone.0096809	http://dx.doi.org/10.1371/journal.pone.0096809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805353	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900099
J	Maniscalco, JM				Maniscalco, John M.			The Effects of Birth Weight and Maternal Care on Survival of Juvenile Steller Sea Lions (Eumetopias jubatus)	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; GALAPAGOS FUR SEALS; POPULATION-DYNAMICS; CAPTURE-RECAPTURE; MIROUNGA-LEONINA; LACTATION STRATEGIES; ATTENDANCE PATTERNS; BEHAVIORAL ECOLOGY; TEMPORAL VARIATION; MODEL SELECTION	Steller sea lions were listed as endangered following a collapse of the western distinct population beginning in the late 1970s. Low juvenile survival has been implicated as a factor in the decline. I conducted a multistate mark-recapture analysis to estimate juvenile survival in an area of the western population where sea lions are showing signs of recovery. Survival for males and females was 80% between 3 weeks and 1 year of age. Approximately 20% of juveniles continued to be nursed by their mothers between ages 1 and 2 and 10% between ages 2 and 3. Survival for juveniles that suckled beyond 1 year was 88.2% and 89.9% to ages 2 and 3, respectively. In contrast, survival for individuals weaned by age 1 was 40.6% for males and 64.2% for females between ages 1 and 2. Birth mass positively influenced survival for juveniles weaned at age 1 but had little effect on individuals continuing to suckle. Cumulative survival to age 4 was double that estimated during the population decline in this region. Evidence suggests that western Steller sea lions utilize a somewhat different maternal strategy than those in the eastern distinct population. Western adult females generally invest more in their pups during the first year but wean offspring by age 1 more often. This results in better survival to age 1, but greater mortality between ages 1 and 3 compared to the eastern population. Different maternal strategies may reflect density dependent pressures of populations at opposite levels of abundance.	Alaska SeaLife Ctr, Dept Sci, Seward, AK 99964 USA		Maniscalco, JM (corresponding author), Alaska SeaLife Ctr, Dept Sci, Seward, AK 99964 USA.	johnm@alaskasealife.org			U.S. federal grant appropriations through the National Marine Fisheries Service - NOAA [NA09NMF4390169]	U.S. federal grant appropriations through the National Marine Fisheries Service - NOAA	This study was funding by U.S. federal grant appropriations through the National Marine Fisheries Service - NOAA Award NA09NMF4390169 (https://grantsonline.rdc.noaa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALVERSON DL, 1992, REV AQUAT SCI, V6, P203; Anderson D. R., 2008, MODEL BASED INFERENC; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; Beauplet G, 2005, J ANIM ECOL, V74, P1160, DOI 10.1111/j.1365-2656.2005.01016.x; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; Bickham JW, 1996, J MAMMAL, V77, P95, DOI 10.2307/1382712; Boltnev AI, 1998, CAN J ZOOL, V76, P843, DOI 10.1139/cjz-76-5-843; Boltnev AI, 2001, J ZOOL, V254, P219, DOI 10.1017/S0952836901000735; Boyd IL, 1990, FUNCTIONAL ECOLOGY, V14, P623; Brandon EAA, 2005, FISH B-NOAA, V103, P246; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Chilvers BL, 2010, J MAMMAL, V91, P758, DOI 10.1644/09-MAMM-A-285.1; Choquet R., 2005, U CARE 2 2 USERS MAN; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; DeMaster D, 2011, RESULTS STELLAR SEA; DEMASTER D, 2002, AKSG0202 U AL SEA GR; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GENTRY RL, 1974, AM ZOOL, V14, P391; Hadley GL, 2007, OIKOS, V116, P601, DOI 10.1111/j.2007.0030-1299.15528.x; Hall AJ, 2001, J ANIM ECOL, V70, P138; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Hennen D, 2006, ECOL APPL, V16, P704, DOI 10.1890/1051-0761(2006)016[0704:ABTASS]2.0.CO;2; Hernandez-Camacho CJ, 2008, J MAMMAL, V89, P1059, DOI 10.1644/07-MAMM-A-404.1; Hoef JMV, 2012, AM STAT, V66, P124, DOI 10.1080/00031305.2012.687494; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Horning M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030173; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Kendall WL, 2003, ECOLOGY, V84, P1058, DOI 10.1890/0012-9658(2003)084[1058:AMCMFM]2.0.CO;2; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; LEE PC, 1991, J ZOOL, V225, P99, DOI 10.1111/j.1469-7998.1991.tb03804.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Loughlin Thomas R., 1997, Society for Marine Mammalogy Special Publication, V3, P159; Lycett JE, 1998, BEHAV ECOL SOCIOBIOL, V42, P49, DOI 10.1007/s002650050410; MAJLUF P, 1992, J ZOOL, V227, P367, DOI 10.1111/j.1469-7998.1992.tb04400.x; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Maniscalco JM, 2009, MAR MAMMAL SCI, V25, P206, DOI 10.1111/j.1748-7692.2008.00247.x; Mathews EA, 2011, MAR MAMMAL SCI, V27, P852, DOI 10.1111/j.1748-7692.2010.00455.x; McMahon CR, 2005, P ROY SOC B-BIOL SCI, V272, P923, DOI 10.1098/rspb.2004.3038; McMahon CR, 2005, MAR ECOL PROG SER, V288, P273, DOI 10.3354/meps288273; McMahon CR, 2004, BEHAV ECOL SOCIOBIOL, V55, P349, DOI 10.1007/s00265-003-0721-1; McMahon CR, 1999, POLAR BIOL, V21, P279, DOI 10.1007/s003000050363; McMahon CR, 2003, WILDLIFE RES, V30, P35, DOI 10.1071/WR01069; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; Melin SR, 2012, MAR MAMMAL SCI, V28, P751, DOI 10.1111/j.1748-7692.2011.00538.x; Merrick R, 1996, NMFSAFSC68 NOAA US D; MERRICK RL, 1995, FISH B-NOAA, V93, P753; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; National Research Council, 2003, DECL STELL SEA LION; NICHOLS JD, 1994, ECOLOGY, V75, P2052, DOI 10.2307/1941610; ORZACK SH, 1989, AM NAT, V133, P901, DOI 10.1086/284959; Pendleton GW, 2006, CAN J ZOOL, V84, P1163, DOI 10.1139/Z06-103; Phillips AV, 2003, J MAMMAL, V84, P524, DOI 10.1644/1545-1542(2003)084<0524:BCUIRB>2.0.CO;2; Pitcher KW, 2007, FISH B-NOAA, V105, P102; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; Proffitt KM, 2010, OIKOS, V119, P1255, DOI 10.1111/j.1600-0706.2009.18098.x; Raum-Suryan KL, 2009, MAR POLLUT BULL, V58, P1487, DOI 10.1016/j.marpolbul.2009.06.004; Raum-Suryan KL, 2004, MAR MAMMAL SCI, V20, P823, DOI 10.1111/j.1748-7692.2004.tb01195.x; RAYMOND MR, 1987, EDUC PSYCHOL MEAS, V47, P13, DOI 10.1177/0013164487471002; Rea L, 2011, 19 BIENN C BIOL MAR; Sandegren FE, 1970, THESIS U ALASKA ANCH; Schulz TM, 2004, MAR MAMMAL SCI, V20, P86, DOI 10.1111/j.1748-7692.2004.tb01142.x; Schulz TM, 2005, ECOL MONOGR, V75, P159, DOI 10.1890/04-0319; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; THOMAS JA, 1983, CAN J ZOOL, V61, P2078, DOI 10.1139/z83-272; TRILLMICH F, 1990, BEHAVIOUR, V114, P3, DOI 10.1163/156853990X00022; TRILLMICH F, 1981, BEHAVIOUR, V78, P21, DOI 10.1163/156853981X00248; Trillmich F, 2008, BEHAV ECOL SOCIOBIOL, V62, P363, DOI 10.1007/s00265-007-0423-1; Trillmich Fritz, 1996, Advances in the Study of Behavior, V25, P533; Trites AW, 2007, FISH OCEANOGR, V16, P46, DOI 10.1111/j.1365-2419.2006.00408.x; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; TRIVERS RL, 1974, AM ZOOL, V14, P249; White GC, 2006, J WILDLIFE MANAGE, V70, P1521, DOI 10.2193/0022-541X(2006)70[1521:MSMATE]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winship AJ, 2001, J MAMMAL, V82, P500, DOI 10.1644/1545-1542(2001)082<0500:GIBSOT>2.0.CO;2; Wolf N, 2008, ECOL APPL, V18, P1932, DOI 10.1890/07-1254.1; York AE, 2008, CAN J ZOOL, V86, P33, DOI 10.1139/Z07-108; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	89	23	23	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96328	10.1371/journal.pone.0096328	http://dx.doi.org/10.1371/journal.pone.0096328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804679	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900049
J	Mern, DS; Beierfuss, A; Fontana, J; Thome, C; Hegewald, AA				Mern, Demissew S.; Beierfuss, Anja; Fontana, Johann; Thome, Claudius; Hegewald, Aldemar A.			Imbalanced Protein Expression Patterns of Anabolic, Catabolic, Anti-Catabolic and Inflammatory Cytokines in Degenerative Cervical Disc Cells: New Indications for Gene Therapeutic Treatments of Cervical Disc Diseases	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; AGE-RELATED-CHANGES; EXTRACELLULAR-MATRIX; NUCLEUS PULPOSUS; ANULUS FIBROSUS; GROWTH-FACTORS; TRANSPLANTATION; PATHOGENESIS; DIFFUSION; AGREEMENT	Degenerative disc disease (DDD) of the cervical spine is common after middle age and can cause loss of disc height with painful nerve impingement, bone and joint inflammation. Despite the clinical importance of these problems, in current publications the pathology of cervical disc degeneration has been studied merely from a morphologic view point using magnetic resonance imaging (MRI), without addressing the issue of biological treatment approaches. So far a wide range of endogenously expressed bioactive factors in degenerative cervical disc cells has not yet been investigated, despite its importance for gene therapeutic approaches. Although degenerative lumbar disc cells have been targeted by different biological treatment approaches, the quantities of disc cells and the concentrations of gene therapeutic factors used in animal models differ extremely. These indicate lack of experimentally acquired data regarding disc cell proliferation and levels of target proteins. Therefore, we analysed proliferation and endogenous expression levels of anabolic, catabolic, ant-catabolic, inflammatory cytokines and matrix proteins of degenerative cervical disc cells in three- dimensional cultures. Preoperative MRI grading of cervical discs was used, then grade III and IV nucleus pulposus (NP) tissues were isolated from 15 patients, operated due to cervical disc herniation. NP cells were cultured for four weeks with low-glucose in collagen I scaffold. Their proliferation rates were analysed using 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide. Their protein expression levels of 28 therapeutic targets were analysed using enzyme-linked immunosorbent assay. During progressive grades of degeneration NP cell proliferation rates were similar. Significantly decreased aggrecan and collagen II expressions (P < 0.0001) were accompanied by accumulations of selective catabolic and inflammatory cytokines (disintegrin and metalloproteinase with thrombospondin motifs 4 and 5, matrix metalloproteinase 3, interleukin-1 beta, interleukin-1 receptor) combined with low expression of anti-catabolic factor (metalloproteinase inhibitor 3) (P < 0.0001). This study might contribute to inhibit inflammatory catabolism of cervical discs.	[Mern, Demissew S.; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Tirol, Austria; [Beierfuss, Anja; Fontana, Johann; Hegewald, Aldemar A.] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Mannheim, Baden Wurttembe, Germany	Medical University of Innsbruck; Ruprecht Karls University Heidelberg	Mern, DS (corresponding author), Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Tirol, Austria.	demissew.shenegelegn-mern@uki.at	, Hegewald/H-2847-2019	, Hegewald/0000-0002-2022-2060; Shenegelegn Mern, Demissew/0000-0001-5893-981X	University Medical Center Mannheim of Heidelberg University	University Medical Center Mannheim of Heidelberg University	The study is funded by University Medical Center Mannheim of Heidelberg University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8; Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x; Christe A, 2005, NEURORADIOLOGY, V47, P721, DOI 10.1007/s00234-005-1412-6; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Gruber HE, 2003, SPINE, V28, P186, DOI 10.1097/00007632-200301150-00017; Hastreiter D, 2001, J ORTHOP RES, V19, P597, DOI 10.1016/S0736-0266(00)00069-3; Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777; Kalb S, 2012, WORLD NEUROSURG, V77, P491, DOI 10.1016/j.wneu.2011.07.014; Kanemoto M, 1996, SPINE, V21, P1, DOI 10.1097/00007632-199601010-00001; Kolstad F, 2005, EUR J RADIOL, V55, P415, DOI 10.1016/j.ejrad.2005.02.005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Liebscher T, 2011, SPINE, V36, P153, DOI 10.1097/BRS.0b013e3181cd588c; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; MAROUDAS A, 1975, J ANAT, V120, P113; Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af; Matsumoto M, 1998, J BONE JOINT SURG BR, V80B, P19, DOI 10.1302/0301-620X.80B1.7929; Meisel HJ, 2007, BIOMOL ENG, V24, P5, DOI 10.1016/j.bioeng.2006.07.002; Mercer S, 1999, SPINE, V24, P619, DOI 10.1097/00007632-199904010-00002; Mercer SR, 1996, MAN THER, V2, P76; Mern DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081467; Mern DS, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term1583, DOI 10.1002/TERM1583]; Millward-Sadler SJ, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2693; Miyazaki M, 2008, J SPINAL DISORD TECH, V21, P288, DOI 10.1097/BSD.0b013e31813c0e59; MODIC MT, 1986, RADIOLOGY, V161, P753, DOI 10.1148/radiology.161.3.3786728; MODIC MT, 1987, RADIOLOGY, V163, P227, DOI 10.1148/radiology.163.1.3823440; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Nerlich AG, 2007, EUR SPINE J, V16, P547, DOI 10.1007/s00586-006-0213-x; Nomura T, 2001, CLIN ORTHOP RELAT R, P94; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roberts S, 2006, EUR SPINE J, V15, pS312, DOI 10.1007/s00586-006-0126-8; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd; Skrzypiec DM, 2007, EUR SPINE J, V16, P1701, DOI 10.1007/s00586-007-0458-z; Soukane DM, 2007, J BIOMECH, V40, P2645, DOI 10.1016/j.jbiomech.2007.01.003; Tolonen J, 2006, EUR SPINE J, V15, P588, DOI 10.1007/s00586-005-0930-6; Weiler C, 2012, Eur Spine J, V21 Suppl 6, pS810, DOI 10.1007/s00586-011-1922-3; Wigfield CC, 2003, J SPINAL DISORD TECH, V16, P441, DOI 10.1097/00024720-200310000-00002; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Zhao CQ, 2011, J ORTHOP RES, V29, P718, DOI 10.1002/jor.21285	47	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96870	10.1371/journal.pone.0096870	http://dx.doi.org/10.1371/journal.pone.0096870			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804684	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900109
J	Ashengo, TA; Hatzold, K; Mahler, H; Rock, A; Kanagat, N; Magalona, S; Curran, K; Christensen, A; Castor, D; Mugurungi, O; Dhlamini, R; Xaba, S; Njeuhmeli, E				Ashengo, Tigistu Adamu; Hatzold, Karin; Mahler, Hally; Rock, Amelia; Kanagat, Natasha; Magalona, Sophia; Curran, Kelly; Christensen, Alice; Castor, Delivette; Mugurungi, Owen; Dhlamini, Roy; Xaba, Sinokuthemba; Njeuhmeli, Emmanuel			Voluntary Medical Male Circumcision (VMMC) in Tanzania and Zimbabwe: Service Delivery Intensity and Modality and Their Influence on the Age of Clients	PLOS ONE			English	Article							HIV PREVENTION; MEN	Background: Scaling up voluntary medical male circumcision (VMMC) to 80% of men aged 15-49 within five years could avert 3.4 million new HIV infections in Eastern and Southern Africa by 2025. Since 2009, Tanzania and Zimbabwe have rapidly expanded VMMC services through different delivery (fixed, outreach or mobile) and intensity (routine services, campaign) models. This review describes the modality and intensity of VMMC services and its influence on the number and age of clients. Methods and Findings: Program reviews were conducted using data from implementing partners in Tanzania (MCHIP) and Zimbabwe (PSI). Key informant interviews (N = 13 Tanzania; N = 8 Zimbabwe) were conducted; transcripts were analyzed using Nvivo. Routine VMMC service data for May 2009-December 2012 were analyzed and presented in frequency tables. A descriptive analysis and association was performed using the z-ratio for the significance of the difference. Key informants in both Tanzania and Zimbabwe believe VMMC scale-up can be achieved by using a mix of service delivery modality and intensity approaches. In Tanzania, the majority of clients served during campaigns (59%) were aged 10-14 years while the majority during routine service delivery (64%) were above 15 (p< 0.0001). In Zimbabwe, significantly more VMMCs were done during campaigns (64%) than during routine service delivery (36%) (p< 0.00001); the difference in the age of clients accessing services in campaign versus non-campaign settings was significant for age groups 10-24 (p< 0.05), but not for older groups. Conclusions: In Tanzania and Zimbabwe, service delivery modalities and intensities affect client profiles in conjunction with other contextual factors such as implementing campaigns during school holidays in Zimbabwe and cultural preference for circumcision at a young age in Tanzania. Formative research needs to be an integral part of VMMC programs to guide the design of service delivery modalities in the face of, or lack of, strong social norms.	[Ashengo, Tigistu Adamu; Curran, Kelly; Christensen, Alice] Maternal & Child Hlth Integrated Program, Washington, DC 20036 USA; [Ashengo, Tigistu Adamu; Curran, Kelly] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hatzold, Karin; Dhlamini, Roy] Populat Serv Int, Harare, Zimbabwe; [Mahler, Hally] MCHIP Tanzania, Dar Es Salaam, Tanzania; [Rock, Amelia; Kanagat, Natasha; Magalona, Sophia] JSI Res & Training Inst Inc, Boston, MA USA; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Mugurungi, Owen; Xaba, Sinokuthemba] Minist Hlth & Child Welf, Harare, Zimbabwe	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Agency for International Development (USAID)	Ashengo, TA (corresponding author), Maternal & Child Hlth Integrated Program, Washington, DC 20036 USA.	Tigi.Adamu@Jhpiego.org		Magalona, Sophia/0000-0003-2050-9376	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development's (USAID's) Maternal and Child Health Integrated Program (MCHIP) [GHS-A-00-08-00002-000]; AIDS Support and Technical Assistance Resources (AIDSTAR-One) Project [GHH-I-00-07-00059-00]	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development's (USAID's) Maternal and Child Health Integrated Program (MCHIP)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); AIDS Support and Technical Assistance Resources (AIDSTAR-One) Project	This review is funded by the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development's (USAID's) Maternal and Child Health Integrated Program (MCHIP), under Cooperative Agreement # GHS-A-00-08-00002-000 and AIDS Support and Technical Assistance Resources (AIDSTAR-One) Project, Sector I, Task Order 1 under contract number GHH-I-00-07-00059-00. Opinions herein are those of the authors and do not necessarily reflect the views of USAID. However, the funder, USAID, played a significant technical role in study design, analysis, decision to publish, and preparation of the manuscript.	AHPRA, 2012, 201112 ANN REP AHPR; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, 19 INT AIDS C WASH; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gilliam FD, 2010, AIDS BEHAV, V14, P1207, DOI 10.1007/s10461-009-9656-5; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hatzold K, 2012, POPULATION SER UNPUB; Mavhu W, 2012, SYSTEMATIC MONITORIN; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Republic of Zimbabwe, 2009, ZIMB NAT HIV AIDS ST; Romer D, 2007, PREV SCI, V8, P89, DOI 10.1007/s11121-007-0064-7; UNAIDS, 2007, MAL CIRC GLOB TRENDS; United Republic of Tanzania Ministry of Health and Social Welfare National AIDS Control Program, 2012, MAL CIRC STAT TANZ; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	18	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e83642	10.1371/journal.pone.0083642	http://dx.doi.org/10.1371/journal.pone.0083642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801882	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800007
J	Biton, YY; Kumar, S; Dunlap, D; Swigon, D				Biton, Yoav Y.; Kumar, Sandip; Dunlap, David; Swigon, David			Lac Repressor Mediated DNA Looping: Monte Carlo Simulation of Constrained DNA Molecules Complemented with Current Experimental Results	PLOS ONE			English	Article							TETHERED-PARTICLE MOTION; ROD-LIKE STRUCTURES; IN-VIVO; COUNTERION CONDENSATION; LENGTH DEPENDENCE; SINGLE-MOLECULE; OPERATOR; SEQUENCE; CONFORMATION; PROTEIN	Tethered particle motion (TPM) experiments can be used to detect time-resolved loop formation in a single DNA molecule by measuring changes in the length of a DNA tether. Interpretation of such experiments is greatly aided by computer simulations of DNA looping which allow one to analyze the structure of the looped DNA and estimate DNA-protein binding constants specific for the loop formation process. We here present a new Monte Carlo scheme for accurate simulation of DNA configurations subject to geometric constraints and apply this method to Lac repressor mediated DNA looping, comparing the simulation results with new experimental data obtained by the TPM technique. Our simulations, taking into account the details of attachment of DNA ends and fluctuations of the looped subsegment of the DNA, reveal the origin of the double-peaked distribution of RMS values observed by TPM experiments by showing that the average RMS value for anti-parallel loop types is smaller than that of parallel loop types. The simulations also reveal that the looping probabilities for the anti-parallel loop types are significantly higher than those of the parallel loop types, even for loops of length 600 and 900 base pairs, and that the correct proportion between the heights of the peaks in the distribution can only be attained when loops with flexible Lac repressor conformation are taken into account. Comparison of the in silico and in vitro results yields estimates for the dissociation constants characterizing the binding affinity between O1 and Oid DNA operators and the dimeric arms of the Lac repressor.	[Biton, Yoav Y.; Swigon, David] Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA; [Kumar, Sandip; Dunlap, David] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University	Biton, YY (corresponding author), Univ Pittsburgh, Dept Math, Pittsburgh, PA 15260 USA.	yoav.y.biton@gmail.com	Kumar, Sandip/P-9922-2015	Kumar, Sandip/0000-0002-2358-2344	Human Frontiers in Science Project [RGP0051/2009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084070] Funding Source: NIH RePORTER	Human Frontiers in Science Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Human Frontiers in Science Project, grant RGP0051/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker NA, 2013, NUCLEIC ACIDS RES, V41, P156, DOI 10.1093/nar/gks1011; BELLOMY GR, 1988, BIOCHEMISTRY-US, V27, P3900, DOI 10.1021/bi00411a002; Benham CJ, 2005, ANNU REV BIOMED ENG, V7, P21, DOI 10.1146/annurev.bioeng.6.062403.132016; BENHAM CJ, 1977, P NATL ACAD SCI USA, V74, P2397, DOI 10.1073/pnas.74.6.2397; Biton YY, 2007, J ELASTICITY, V87, P187, DOI 10.1007/s10659-007-9103-7; Biton YY, 2010, INT J NONLIN MECH, V45, P735, DOI 10.1016/j.ijnonlinmec.2010.05.004; Blumberg S, 2005, BIOPHYS J, V89, P1272, DOI 10.1529/biophysj.105.061242; Bond LM, 2010, NUCLEIC ACIDS RES, V38, P8072, DOI 10.1093/nar/gkq755; Britton LA, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3273453; Coleman BD, 2003, J CHEM PHYS, V118, P7127, DOI 10.1063/1.1559690; Czapla L, 2006, J CHEM THEORY COMPUT, V2, P685, DOI 10.1021/ct060025+; Edelman LM, 2003, BIOPHYS J, V84, P1131, DOI 10.1016/S0006-3495(03)74929-7; ELHASSAN MA, 1995, J MOL BIOL, V251, P648, DOI 10.1006/jmbi.1995.0462; FENLEY MO, 1990, BIOPOLYMERS, V30, P1191, DOI 10.1002/bip.360301305; Finzi L, 2003, METHOD ENZYMOL, V370, P369; FINZI L, 1995, SCIENCE, V267, P378, DOI 10.1126/science.7824935; Frank DE, 1997, J MOL BIOL, V267, P1186, DOI 10.1006/jmbi.1997.0920; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; GOEDDEL DV, 1978, P NATL ACAD SCI USA, V75, P3578, DOI 10.1073/pnas.75.8.3578; Gonzalez O, 2001, THEOR CHEM ACC, V106, P76, DOI 10.1007/s002140100256; Haeusler AR, 2012, NUCLEIC ACIDS RES, V40, P4432, DOI 10.1093/nar/gks019; Han L, 2009, IMA VOL MATH APPL, V150, P123, DOI 10.1007/978-1-4419-0670-0_6; Han L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005621; Hirsh AD, 2011, BIOPHYS J, V101, P718, DOI 10.1016/j.bpj.2011.06.040; KLENIN KV, 1991, J MOL BIOL, V217, P413, DOI 10.1016/0022-2836(91)90745-R; LEVENE SD, 1986, J MOL BIOL, V189, P73, DOI 10.1016/0022-2836(86)90382-7; MANNING GS, 1969, J CHEM PHYS, V51, P924, DOI 10.1063/1.1672157; Manousiouthakis VI, 1999, J CHEM PHYS, V110, P2753, DOI 10.1063/1.477973; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Mehta RA, 1999, J MOL BIOL, V294, P67, DOI 10.1006/jmbi.1999.3244; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Milstein JN, 2011, BIOPOLYMERS, V95, P144, DOI 10.1002/bip.21547; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Muller-Hill, 1996, LAC OPERON; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; Olson WK, 2004, PHILOS T R SOC A, V362, P1403, DOI 10.1098/rsta.2004.1380; Priest DG, 2014, P NATL ACAD SCI USA, V111, P349, DOI 10.1073/pnas.1317817111; RHODES D, 1981, NATURE, V292, P378, DOI 10.1038/292378a0; Ruben GC, 1997, MICROSC RES TECHNIQ, V36, P400, DOI 10.1002/(SICI)1097-0029(19970301)36:5<400::AID-JEMT10>3.0.CO;2-W; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Segall DE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088306; SHIMADA J, 1984, MACROMOLECULES, V17, P689, DOI 10.1021/ma00134a028; SIMONS A, 1984, P NATL ACAD SCI-BIOL, V81, P1624, DOI 10.1073/pnas.81.6.1624; Swigon D, 1998, BIOPHYS J, V74, P2515, DOI 10.1016/S0006-3495(98)77960-3; Swigon D, 2009, MATH DNA STRUCTURE F; Swigon D, 2006, P NATL ACAD SCI USA, V103, P9879, DOI 10.1073/pnas.0603557103; Swigon D, 2008, INT J NONLIN MECH, V43, P1082, DOI 10.1016/j.ijnonlinmec.2008.07.003; Towles KB, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/2/025001; TULLIUS TD, 1985, SCIENCE, V230, P679, DOI 10.1126/science.2996145; Vanzi F, 2006, NUCLEIC ACIDS RES, V34, P3409, DOI 10.1093/nar/gkl393; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; Westcott TP, 1997, J CHEM PHYS, V107, P3967, DOI 10.1063/1.474752; WHITE JH, 1969, AM J MATH, V91, P693, DOI 10.2307/2373348; White JH, 1989, MATH METHODS DNA SEQ, P225; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0; Zurla C, 2006, J PHYS-CONDENS MAT, V18, pS225, DOI 10.1088/0953-8984/18/14/S07	60	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e92475	10.1371/journal.pone.0092475	http://dx.doi.org/10.1371/journal.pone.0092475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800809	Green Accepted, gold, Green Published			2022-12-27	WOS:000338029800017
J	Gourlay-Larour, ML; Pradel, R; Guillemain, M; Guitton, JS; L'Hostis, M; Santin-Janin, H; Caizergues, A				Gourlay-Larour, Marie-Lucile; Pradel, Roger; Guillemain, Matthieu; Guitton, Jean-Sebastien; L'Hostis, Monique; Santin-Janin, Hugues; Caizergues, Alain			Movement Patterns in a Partial Migrant: A Multi-Event Capture-Recapture Approach	PLOS ONE			English	Article							TEAL ANAS-CRECCA; WINTERING DIVING DUCKS; SITE FIDELITY; TEMPORARY EMIGRATION; INDIVIDUAL TURNOVER; ESTIMATING SURVIVAL; DISPERSAL; MODELS; RATES; HETEROGENEITY	Partial migration is a pervasive albeit poorly studied phenomenon by which some individuals of a population migrate while others are residents. It has tremendous consequences on seasonal variations of population size/structure and therefore management. Using a multi-event capture-mark-recapture/recovery (CMR) approach, we assessed seasonal site occupancy, survival and site fidelity of a partially migratory diving duck, the Common pochard (Aythya ferina), in an area potentially including both local breeders and winter visitors. The modelling exercise indeed discriminated two different categories of individuals. First, locally breeding females which had a probability of being present in our study area during winter of 0.41. Females of this category were found to be more faithful to their breeding site than males (breeding site fidelity probabilities of 1 and 0.11, respectively). The second category of birds were winter visitors, which included adults of both sexes, whose probability of being present in the study area during the breeding season was nil, and young of both sexes with a 0.11 probability of being present in the area during the breeding season. All wintering individuals, among which there was virtually no locally breeding male, displayed a high fidelity to our study area from one winter to the next (0.41-0.43). Estimated annual survival rates differed according to age (adults 0.69, young 0.56). For both age classes mortality was higher during late winter/early spring than during summer/early winter. Our study is among the first to show how and under which conditions the multi-event approach can be employed for investigating complex movement patterns encountered in partial migrants, providing a convenient tool for overcoming state uncertainty. It also shows why studying patterns of probability of individual presence/movements in partial migrants is a key towards understanding seasonal variations in numbers.	[Gourlay-Larour, Marie-Lucile; Guitton, Jean-Sebastien; Caizergues, Alain] Off Natl Chasse & Faune Sauvage, Nantes, France; [Gourlay-Larour, Marie-Lucile; L'Hostis, Monique] Univ Nantes Angers Le Mans, Nantes, France; [Pradel, Roger] CNRS, Ctr Ecol Evolut & Fonct, UMR 5175, Montpellier, France; [Guillemain, Matthieu] Off Natl Chasse & Faune Sauvage, Arles, France; [Gourlay-Larour, Marie-Lucile; L'Hostis, Monique] Oniris, Ecole Natl Vet Agroalimentaire & Alimentat Nantes, Nantes, France; [Santin-Janin, Hugues] Off Natl Chasse & Faune Sauvage, Le Perray En Yvelines, France	Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Caizergues, A (corresponding author), Off Natl Chasse & Faune Sauvage, Nantes, France.	alain.caizergues@oncfs.gouv.fr	Pradel, Roger/A-8666-2008	Pradel, Roger/0000-0002-2684-9251; Caizergues, Alain/0000-0001-7246-0469	Office National de la Chasse et de la Faune Sauvage	Office National de la Chasse et de la Faune Sauvage	This work was funded by the Office National de la Chasse et de la Faune Sauvage. The funder had no role in study design and data collection and analysis, decision to publish, or preparation of the manuscript.	Blums P, 2002, J ANIM ECOL, V71, P438, DOI 10.1046/j.1365-2656.2002.00613.x; BLUMS PN, 1983, J WILDLIFE MANAGE, V47, P199, DOI 10.2307/3808067; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham Kenneth P., 1993, P199; BURNHAM KP, 1993, BIOMETRICS, V49, P1194, DOI 10.2307/2532261; Caizergues A, 2011, WILDLIFE BIOL, V17, P373, DOI 10.2981/10-102; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cox DR, 1974, THEORETICAL STAT; Davis BE, 2010, WATERBIRDS, V33, P349, DOI 10.1675/063.033.0311; Devineau O, 2007, DYNAMIQUE GESTION PO; Duriez O, 2009, J APPL ECOL, V46, P144, DOI 10.1111/j.1365-2664.2008.01592.x; Emeriau S, 2009, THESIS U NANTES, P48; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Gauthier G, 2008, CAN J STAT, V36, P59, DOI 10.1002/cjs.5550360107; Gauthreaux SA, 1982, AVIAN BIOL, VVI, P93, DOI DOI 10.1016/B978-0-12-249406-2.50011-3; Gillis EA, 2008, ECOLOGY, V89, P1687, DOI 10.1890/07-1122.1; Gourlay-Larour ML, 2013, J WILDLIFE MANAGE, V77, P477, DOI 10.1002/jwmg.522; Gourlay-Larour ML, 2012, BIRD STUDY, V59, P266, DOI 10.1080/00063657.2012.697867; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Guillemain M, 2002, BIOL CONSERV, V103, P183, DOI 10.1016/S0006-3207(01)00120-3; Guillemain M, 2009, BIRD STUDY, V56, P272, DOI 10.1080/00063650902792122; HARAMIS GM, 1982, J FIELD ORNITHOL, V53, P342; Herring G, 2005, WATERBIRDS, V28, P71, DOI 10.1675/1524-4695(2005)028[0071:HUMAHR]2.0.CO;2; HESTBECK JB, 1991, ECOLOGY, V72, P523, DOI 10.2307/2937193; Hobson KA, 2009, J APPL ECOL, V46, P572, DOI 10.1111/j.1365-2664.2009.01651.x; Keller I, 2009, J ORNITHOL, V150, P483, DOI 10.1007/s10336-008-0367-x; Kendall WL, 1997, ECOLOGY, V78, P563; Ketterson E.D., 1983, Current Ornithology, V1, P357; Ketterson E.D., 1985, MIGRATION MECH ADAPT; Korner-Nievergelt Fraenzi, 2009, Wildfowl, P24; Lebreton JD, 1999, BIRD STUDY, V46, P39; Legagneux P, 2009, J ORNITHOL, V150, P183, DOI 10.1007/s10336-008-0333-7; Liu Y, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.46; Mooij Johan H., 2005, Beitraege zur Jagd- und Wildforschung, V30, P49; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 1996, J ANIM ECOL, V65, P137, DOI 10.2307/5716; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; Nilsson ALK, 2010, NATURWISSENSCHAFTEN, V97, P981, DOI 10.1007/s00114-010-0714-7; Peron G, 2010, ECOLOGY, V91, P3365, DOI 10.1890/09-1525.1; Pledger S, 2003, BIOMETRICS, V59, P786, DOI 10.1111/j.0006-341X.2003.00092.x; Pradel R., 2005, Animal Biodiversity and Conservation, V28, P189; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Pradel R, 1997, J WILDLIFE MANAGE, V61, P816, DOI 10.2307/3802189; Pradel R, 2009, ENVIRON ECOL STAT SE, V3, P781, DOI 10.1007/978-0-387-78151-8_36; Reeber S., 2010, SUIVI ORNITHOLOGIQUE; Reeber S, 2012, SUIVI ORNITHOLOGIQUE; Robertson G, 1999, AUK, V116, P20, DOI 10.2307/4089450; Rodrigues D, 2012, DELAYING START MALLA, P44; Rodrigues DJC, 2001, HUNGARY; Rousselot J.C., 1991, CRITERES DETERMINATI; Schaub M, 2004, ECOLOGY, V85, P2107, DOI 10.1890/03-3110; Schricke V, 2002, GAME WILDLIFE SCI, V19, P143; Scott D.A., 1996, ATLAS ANATIDAE POPUL; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; SUTER W, 1992, ARDEA, V80, P229; Tamisier A., 1999, CAMARGUE CANARDS FOU; Tavecchia G, 2002, WILDLIFE BIOL, V8, P21, DOI 10.2981/wlb.2002.004; WELLER MW, 1965, AUK, V82, P227, DOI 10.2307/4082935; Wilcove D.S., 2008, NO WAY HOME DECLINE; Zwarts L, 2009, WETLANDS BIRDS LIVIN	65	13	13	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96478	10.1371/journal.pone.0096478	http://dx.doi.org/10.1371/journal.pone.0096478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802936	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800075
J	Obrador, E; Valles, SL; Benlloch, M; Sirerol, JA; Pellicer, JA; Alcacer, J; Coronado, JAF; Estrela, JM				Obrador, Elena; Valles, Soraya L.; Benlloch, Maria; Sirerol, J. Antoni; Pellicer, Jose A.; Alcacer, Javier; Coronado, Javier Alcacer-F.; Estrela, Jose M.			Glucocorticoid Receptor Knockdown Decreases the Antioxidant Protection of B16 Melanoma Cells: An Endocrine System-Related Mechanism that Compromises Metastatic Cell Resistance to Vascular Endothelium-Induced Tumor Cytotoxicity	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTATHIONE EFFLUX; GENE-EXPRESSION; REACTIVE OXYGEN; CANCER; P53; PATHWAY; GROWTH; BCL-2; TRANSCRIPTION	We previously reported an interorgan system in which stress-related hormones (corticosterone and noradrenaline), interleukin-6, and glutathione (GSH) coordinately regulate metastatic growth of highly aggressive B16-F10 melanoma cells. Corticosterone, at levels measured in tumor-bearing mice, also induces apoptotic cell death in metastatic cells with low GSH content. In the present study we explored the potential role of glucocorticoids in the regulation of metastatic cell death/ survival during the early stages of organ invasion. Glucocorticoid receptor (GCR) knockdown decreased the expression and activity of gamma-glutamylcysteine synthetase (gamma-GCS), the rate-limiting step in GSH synthesis, in metastatic cells in vivo independent of the tumor location (liver, lung, or subcutaneous). The decrease in gamma-GCS activity was associated with lower intracellular GSH levels. Nrf2-and p53-dependent down-regulation of gamma-GCS was associated with a decrease in the activities of superoxide dismutase 1 and 2, catalase, glutathione peroxidase, and glutathione reductase, but not of the O-2(-) generating NADPH oxidase. The GCR knockdown-induced decrease in antioxidant protection caused a drastic decrease in the survival of metastatic cells during their interaction with endothelial cells, both in vitro and in vivo; only 10% of cancer cells attached to the endothelium survived compared to 90% survival observed in the controls. This very low rate of metastatic cell survival was partially increased (up to 52%) in vivo by inoculating B16-F10 cells preloaded with GSH ester, which enters the cell and delivers free GSH. Taken together, our results indicate that glucocorticoid signaling influences the survival of metastatic cells during their interaction with the vascular endothelium.	[Obrador, Elena; Valles, Soraya L.; Sirerol, J. Antoni; Pellicer, Jose A.; Estrela, Jose M.] Univ Valencia, Dept Physiol, Valencia, Spain; [Benlloch, Maria] San Vicente Martir Catholic Univ, Fac Expt Sci, Valencia, Spain; [Alcacer, Javier; Coronado, Javier Alcacer-F.] Quiron Hosp, Pathol Lab, Valencia, Spain	University of Valencia; Universidad Catolica de Valencia San Vicente Martir	Estrela, JM (corresponding author), Univ Valencia, Dept Physiol, Valencia, Spain.	jose.m.estrela@uv.es	OBRADOR, ELENA/H-4069-2015; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Estrela, Jose/H-4449-2015; Valles, Soraya L./H-9320-2019	OBRADOR, ELENA/0000-0002-5934-5543; Estrela, Jose/0000-0002-2540-9190; Valles, Soraya L./0000-0003-4861-4266	Ministerio de Economia y Competitividad [SAF2012-31565]; Green Molecular S. L. (Scientific Park, University of Valencia, 46980 Paterna), Spain	Ministerio de Economia y Competitividad(Spanish Government); Green Molecular S. L. (Scientific Park, University of Valencia, 46980 Paterna), Spain	This research was supported by a grant (SAF2012-31565) from the Ministerio de Economia y Competitividad (http://www.idi.mineco.gob.es) and by Green Molecular S. L. (Scientific Park, University of Valencia, 46980 Paterna), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Akerboom T P, 1981, Methods Enzymol, V77, P373; ALBERTSSON PA, 1995, CLIN EXP METASTAS, V13, P269, DOI 10.1007/BF00133482; Anasagasti MJ, 1998, HEPATOLOGY, V27, P1249, DOI 10.1002/hep.510270510; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; ASENSI M, 1994, ANAL BIOCHEM, V217, P323, DOI 10.1006/abio.1994.1126; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bartkowiak K, 2012, CANCER MICROENVIRON, V5, P59, DOI 10.1007/s12307-011-0067-6; Benlloch M, 2006, J BIOL CHEM, V281, P69, DOI 10.1074/jbc.M507471200; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Berardi MJ, 2011, CURR OPIN GENET DEV, V21, P59, DOI 10.1016/j.gde.2010.10.001; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; Cadepond F, 1997, ANNU REV MED, V48, P129; Carretero J, 2001, J BIOL CHEM, V276, P25775, DOI 10.1074/jbc.M101148200; Carretero J, 1999, CLIN EXP METASTAS, V17, P567, DOI 10.1023/A:1006725226078; ESKENAZI AE, 1993, J NATL CANCER I, V85, P711, DOI 10.1093/jnci/85.9.711; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Franco R, 2012, ANTIOXID REDOX SIGN, V17, P1694, DOI 10.1089/ars.2012.4553; Gibellini Lara, 2010, Cancers (Basel), V2, P1288, DOI 10.3390/cancers2021288; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Jakobisiak M, 2003, IMMUNOL LETT, V90, P103, DOI 10.1016/j.imlet.2003.08.005; Kalechman Y, 1998, J IMMUNOL, V161, P3536; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kim HJ, 2010, AM J PHYSIOL-RENAL, V298, pF662, DOI 10.1152/ajprenal.00421.2009; KIMURA AK, 1986, JNCI-J NATL CANCER I, V76, P1247; Klemke M, 2007, J CELL PHYSIOL, V212, P368, DOI 10.1002/jcp.21029; Kratschmar DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036774; Leibowitz Brian, 2010, Cancer Biol Ther, V9, P417, DOI 10.4161/cbt.9.6.11392; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; MEISTER A, 1983, SCIENCE, V220, P472, DOI 10.1126/science.6836290; Mena S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-8; Min KJ, 2012, J MOL MED, V90, P309, DOI 10.1007/s00109-011-0821-8; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; New LS, 2008, J CHROMATOGR SCI, V46, P209, DOI 10.1093/chromsci/46.3.209; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Obrador E, 2002, HEPATOLOGY, V35, P74, DOI 10.1053/jhep.2002.30277; Obrador E, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196261; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Ortega A, 2003, J BIOL CHEM, V278, P39591, DOI 10.1074/jbc.M303753200; Ortega AL, 2003, J BIOL CHEM, V278, P13888, DOI 10.1074/jbc.M207140200; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; Ortega Angel L, 2010, Cancers (Basel), V2, P274, DOI 10.3390/cancers2020274; Pourova J, 2010, ACTA PHYSIOL, V198, P15, DOI 10.1111/j.1748-1716.2009.02039.x; Rotblat B, 2012, ONCOTARGET, V3, P1272; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sakakibara H, 2010, EXP ANIM TOKYO, V59, P637, DOI 10.1538/expanim.59.637; Schlossmacher G, 2011, J ENDOCRINOL, V211, P17, DOI 10.1530/JOE-11-0135; Schmidt S, 2004, CELL DEATH DIFFER, V11, pS45, DOI 10.1038/sj.cdd.4401456; Sengupta S, 2004, ANN NY ACAD SCI, V1024, P54, DOI 10.1196/annals.1321.005; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; SHAW LM, 1977, CLIN CHEM, V23, P79; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Valles SL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-72; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yu CL, 1997, CANCER LETT, V116, P191, DOI 10.1016/S0304-3835(97)00186-9; Zhang HQ, 2012, SEMIN CELL DEV BIOL, V23, P722, DOI 10.1016/j.semcdb.2012.03.017; Zhao YN, 2011, MED ONCOL, V28, P1609, DOI 10.1007/s12032-010-9641-x	67	19	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96466	10.1371/journal.pone.0096466	http://dx.doi.org/10.1371/journal.pone.0096466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802641	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800072
J	Li, S; Li, XJ; Coddou, C; Geng, XY; Wei, JL; Sun, JS				Li, Shuo; Li, Xuejing; Coddou, Claudio; Geng, Xuyun; Wei, Junli; Sun, Jinsheng			Molecular Characterization and Expression Analysis of ATP-Gated P2X7 Receptor Involved in Japanese Flounder (Paralichthys olivaceus) Innate Immune Response	PLOS ONE			English	Article							P2X(7) RECEPTOR; DIVALENT-CATIONS; ION SELECTIVITY; ACTIVATION; PORE; SENSITIVITY; INHIBITION; PHYSIOLOGY; MECHANISM; CHANNELS	ATP-gated P2X7 receptor (P2RX7) channel is a key component for purinergic signaling and plays important roles in the innate immune response in mammals. However, the expression, molecular properties and immune significances of P2RX7 in lower vertebrates are still very limited. Here we identified and characterized a novel bony fish P2RX7 homologue cDNA, termed poP2RX7, in Japanese flounder (Paralichthys olivaceus). PoP2RX7 protein shares about 60-88% sequence similarity and 45-78% sequence identity with known vertebrate P2RX7 proteins. Phylogenetic analysis placed poP2RX7 and other P2RX7 proteins within their own cluster apart from other P2RX members. While the functional poP2RX7 channel shares structural features in common with known P2RX7 homologs, electrophysiological studies revealed that BzATP, the more potent agonist for known mammalian and fish P2RX7s, shows similar potency to ATP in poP2RX7 activation. poP2RX7 mRNA constitutively expressed in all examined tissues from unstimulated healthy Japanese flounder with dominant expression in hepatopancreas and the lowest expression in head kidney, trunk kidney, spleen and gill. poP2RX7 mRNA expression, however, was significantly induced in Japanese flounder head kidney primary cells by Poly(I:C) and bacterial endotoxin LPS stimulations. In vivo experiments further revealed that poP2RX7 gene expression was substantially up-regulated by immune challenge with infectious bacteria Edwardsiella tarda and Vibrio anguillarum. Moreover, activation of poP2RX7 results in an increased gene expression of multifunctional cytokines IL-1 beta and IL-6 in the head kidney primary cells. Collectively, we identified and characterized a novel fish P2RX7 homolog which is engaged in Japanese flounder innate immune response probably through modulation of pro-inflammatory cytokines expression.	[Li, Shuo; Li, Xuejing; Sun, Jinsheng] Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China; [Coddou, Claudio] Univ Catolica Norte, Fac Med, Dept Biomed Sci, Coquimbo, Chile; [Geng, Xuyun; Wei, Junli] Tianjin Ctr Control & Prevent Aquat Anim Infect D, Tianjin, Peoples R China	Tianjin Normal University; Universidad Catolica del Norte; Tianjin Center for Disease Control & Prevention	Sun, JS (corresponding author), Tianjin Normal Univ, Coll Life Sci, Tianjin Key Lab Anim & Plant Resistance, Tianjin, Peoples R China.	jssun1965@aliyun.com	Li, Shuo/GXV-6545-2022; Li, Shuo/N-5364-2019	Li, Shuo/0000-0002-5184-3230	Natural Science Foundation of Tianjin [13JCYBJC38300]; Science & Technology Development Fund of Tianjin Education Commission for Higher Education [20130607]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry; FONDECYT Initiation grant from the Chilean government [11121302]; Research Initiation Fund by Tianjin Normal University [5RL120]; National Basic Research Program of China [2012CB114405]; National Key Technology RD Program [2011BAD13B07, 2012AA10A401, 2012AA092205]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); Science & Technology Development Fund of Tianjin Education Commission for Higher Education; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; FONDECYT Initiation grant from the Chilean government(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Research Initiation Fund by Tianjin Normal University; National Basic Research Program of China(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program)	This project was sponsored by grants from the Natural Science Foundation of Tianjin (13JCYBJC38300; http://www.tstc.gov.cn/), the Science & Technology Development Fund of Tianjin Education Commission for Higher Education (20130607; http://www.tjmec.gov.cn/), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (http://fund.cscse.edu.cn/Login.aspx), FONDECYT Initiation grant from the Chilean government (11121302; http://www.fondecyt.cl/), the Research Initiation Fund provided by Tianjin Normal University (5RL120; http://www.tjnu.edu.cn/), the National Basic Research Program of China (2012CB114405; http://program.most.gov.cn/), and National Key Technology R&D Program (2011BAD13B07, 2012AA10A401 and 2012AA092205; http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Castillo C, 2000, J NEUROCHEM, V74, P1529, DOI 10.1046/j.1471-4159.2000.0741529.x; Baraldi PG, 2004, CURR TOP MED CHEM, V4, P1707, DOI 10.2174/1568026043387223; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen LF, 2006, CRIT REV IMMUNOL, V26, P499, DOI 10.1615/CritRevImmunol.v26.i6.30; Chiao CW, 2013, CLIN SCI, V125, P131, DOI 10.1042/CS20120479; Costa HM, 2011, PURINERG SIGNAL, V7, P7, DOI 10.1007/s11302-011-9215-1; Coutinho-Silva R, 2003, IMMUNITY, V19, P403, DOI 10.1016/S1074-7613(03)00235-8; Denlinger LC, 2001, J IMMUNOL, V167, P1871, DOI 10.4049/jimmunol.167.4.1871; Egan TM, 2004, CURR TOP MED CHEM, V4, P821, DOI 10.2174/1568026043451005; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fujiwara Y, 2006, J PHYSIOL-LONDON, V576, P135, DOI 10.1113/jphysiol.2006.115246; Gavala ML, 2013, J LEUKOCYTE BIOL, V94, P759, DOI 10.1189/jlb.0712351; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Guerra AN, 2007, PURINERG SIGNAL, V3, P39, DOI 10.1007/s11302-006-9035-x; He YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057505; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Humphreys BD, 2000, J BIOL CHEM, V275, P26792; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Jiang LH, 2009, EUR BIOPHYS J BIOPHY, V38, P339, DOI 10.1007/s00249-008-0315-y; Kanjanamekanant K, 2013, J PERIODONTAL RES, V48, P169, DOI 10.1111/j.1600-0765.2012.01517.x; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Lee BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035812; Lenertz LY, 2010, BIOCHEMISTRY-US, V49, P4611, DOI 10.1021/bi902083n; Li S, 2014, VET IMMUNOL IMMUNOP, V157, P182, DOI 10.1016/j.vetimm.2013.11.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Castejon G, 2007, MOL IMMUNOL, V44, P1286, DOI 10.1016/j.molimm.2006.05.015; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Paukert M, 2002, FEBS LETT, V513, P253, DOI 10.1016/S0014-5793(02)02324-4; Peng LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052142; Petrou S, 1997, FEBS LETT, V411, P339, DOI 10.1016/S0014-5793(97)00700-X; Ralevic V, 1998, PHARMACOL REV, V50, P413; Santos AA, 2013, IMMUNOBIOLOGY, V218, P1104, DOI 10.1016/j.imbio.2013.03.003; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Virginio C, 1997, NEUROPHARMACOLOGY, V36, P1285, DOI 10.1016/S0028-3908(97)00141-X; Yan ZH, 2008, J GEN PHYSIOL, V132, P563, DOI 10.1085/jgp.200810059; Young MT, 2007, MOL PHARMACOL, V71, P92, DOI 10.1124/mol.106.030163	46	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96625	10.1371/journal.pone.0096625	http://dx.doi.org/10.1371/journal.pone.0096625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796752	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000106
J	Liu, WK; Liu, Q; Chen, DH; Liang, HX; Chen, XK; Chen, MX; Qiu, SY; Yang, ZY; Zhou, R				Liu, Wen Kuan; Liu, Qian; Chen, De Hui; Liang, Huan Xi; Chen, Xiao Kai; Chen, Mei Xin; Qiu, Shu Yan; Yang, Zi Yeng; Zhou, Rong			Epidemiology of Acute Respiratory Infections in Children in Guangzhou: A Three-Year Study	PLOS ONE			English	Article							SYNCYTIAL VIRUS-INFECTION; POLYMERASE-CHAIN-REACTION; INFLUENZA-A H1N1; TRACT INFECTIONS; MYCOPLASMA-PNEUMONIAE; DEVELOPING-COUNTRIES; PARAINFLUENZA VIRUS; VIRAL-INFECTIONS; YOUNG-CHILDREN; HUMAN METAPNEUMOVIRUS	Acute Respiratory Infections (ARI) are some of the most common human diseases worldwide. However, they have a complex and diverse etiology, and the characteristics of the pathogens involved in respiratory infections in developing countries are not well understood. In this work, we analyzed the characteristics of 17 common respiratory pathogens in children (<= 14 years old) with ARI in Guangzhou, southern China over a 3-year period using real-time polymerase chain reaction. Pathogens were identified in 2361/4242 (55.7%) patients, and the positivity rate varied seasonally. Ten of the 17 pathogens investigated showed positivity rates of more than 5%. The most frequently detected pathogens were respiratory syncytial virus (768/2361, 32.5%), influenza A virus (428/2361, 18.1%), enterovirus (138/2361, 13.3%), Mycoplasma pneumoniae (267/2361, 11.3%) and adenovirus (213/2361, 9.0%). Co-pathogens were common and found in 503 of 2361 (21.3%) positive samples. When ranked according to frequency of occurrence, the pattern of co-pathogens was similar to that of the primary pathogens, with the exception of human bocavirus, human coronavirus and human metapneumovirus. Significant differences were found in age prevalence in 10 of the 17 pathogens (p <= 0.009): four basic patterns were observed, A: detection rates increased with age, B: detection rates declined with age, C: the detection rate showed distinct peaks or D: numbers of patients were too low to detect a trend or showed no significant difference among age groups (p>0.05). These data will be useful for planning vaccine research and control strategies and for studies predicting pathogen prevalence.	[Liu, Wen Kuan; Liu, Qian; Liang, Huan Xi; Chen, Xiao Kai; Chen, Mei Xin; Qiu, Shu Yan; Yang, Zi Yeng; Zhou, Rong] Guangzhou Med Univ, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Liu, Wen Kuan; Liu, Qian; Chen, De Hui; Liang, Huan Xi; Chen, Xiao Kai; Chen, Mei Xin; Qiu, Shu Yan; Yang, Zi Yeng; Zhou, Rong] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Zhou, R (corresponding author), Guangzhou Med Univ, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	zhourong@gird.cn		Liu, Wen-Kuan/0000-0003-3020-9158	State Major Infectious Disease Research Program (China Central Government) [2012ZX10004-213]; National Science and technology support program [2012BAI05B01]; Combination Project of Guangdong Province [2010B091000018]; Research Project of Guangzhou Medical University [2012A04]; project of Respiratory Medical R&D Centre of Guangdong Province [2010B080100027]	State Major Infectious Disease Research Program (China Central Government); National Science and technology support program; Combination Project of Guangdong Province; Research Project of Guangzhou Medical University; project of Respiratory Medical R&D Centre of Guangdong Province	The State Major Infectious Disease Research Program (China Central Government, 2012ZX10004-213), National Science and technology support program (2012BAI05B01), The Combination Project of Guangdong Province (2010B091000018), Research Project of Guangzhou Medical University (2012A04), and the project of Respiratory Medical R&D Centre of Guangdong Province (2010B080100027) provided financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABZUG MJ, 1990, PEDIATR INFECT DIS J, V9, P881, DOI 10.1097/00006454-199012000-00005; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; [Anonymous], 2005, PRINCIPLES PRACTICE; BERMAN S, 1991, REV INFECT DIS, V13, pS454; Broor S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000491; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Cherry JD, 1992, TXB PEDIAT INFECT DI, P1670; CLYDE WA, 1993, CLIN INFECT DIS, V17, pS32; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; DENNY FW, 1986, J PEDIATR-US, V108, P635, DOI 10.1016/S0022-3476(86)81034-4; Durbin AP, 2003, CLIN INFECT DIS, V37, P1668, DOI 10.1086/379775; Ebihara T, 2004, J MED VIROL, V72, P304, DOI 10.1002/jmv.10572; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; FOY HM, 1993, CLIN INFECT DIS, V17, pS37, DOI 10.1093/clinids/17.Supplement_1.S37; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; GLEZEN WP, 1984, J INFECT DIS, V150, P851, DOI 10.1093/infdis/150.6.851; GLEZEN WP, 1973, NEW ENGL J MED, V288, P498, DOI 10.1056/NEJM197303082881005; HABLE KA, 1970, MAYO CLIN PROC, V45, P170; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Henrickson Kelly J, 1998, Semin Pediatr Infect Dis, V9, P217, DOI 10.1016/S1045-1870(98)80035-6; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Hsieh YJ, 2010, J MICROBIOL IMMUNOL, V43, P360, DOI 10.1016/S1684-1182(10)60057-6; Ieven M, 1996, J INFECT DIS, V173, P1445, DOI 10.1093/infdis/173.6.1445; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; JENNINGS LC, 1985, NEW ZEAL MED J, V98, P582; Juntti H, 2003, ALLERGY, V58, P878, DOI 10.1034/j.1398-9995.2003.00233.x; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; KELLNER G, 1988, J MED VIROL, V25, P455, DOI 10.1002/jmv.1890250409; KEPFER PD, 1974, AM J CLIN PATHOL, V61, P1; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; LAFORCE FM, 1994, AM J PREV MED, V10, P31, DOI 10.1016/S0749-3797(18)30513-0; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Liu WK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-28; Liu WK, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-345; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Marcos MA, 2009, CURR OPIN INFECT DIS, V22, P143, DOI 10.1097/QCO.0b013e328328cf65; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; MONTO AS, 1989, REV INFECT DIS, V11, P498; MURPHY B, 1980, MED J AUSTRALIA, V1, P22, DOI 10.5694/j.1326-5377.1980.tb134568.x; Nichols WG, 2008, CLIN MICROBIOL REV, V21, P274, DOI 10.1128/CMR.00045-07; Palmer LJ, 2001, AM J RESP CRIT CARE, V163, P37, DOI 10.1164/ajrccm.163.1.2005013; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Portes Silvana A. R., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P337, DOI 10.1590/S0036-46651998000600001; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Robertson SE, 2004, B WORLD HEALTH ORGAN, V82, P914; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Singleton RJ, 2003, PEDIATRICS, V112, P285, DOI 10.1542/peds.112.2.285; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Suzuki Hiroshi, 2003, Journal of Infection and Chemotherapy, V9, P195; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Weber MW, 1998, TROP MED INT HEALTH, V3, P268, DOI 10.1046/j.1365-3156.1998.00213.x; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wolf DG, 2003, J INFECT DIS, V188, P1865, DOI 10.1086/380100	57	63	85	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96674	10.1371/journal.pone.0096674	http://dx.doi.org/10.1371/journal.pone.0096674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797911	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000114
J	Mu, ZJ; Huang, AY; Ni, JP; Xie, DT				Mu, Zhijian; Huang, Aiying; Ni, Jiupai; Xie, Deti			Linking Annual N2O Emission in Organic Soils to Mineral Nitrogen Input as Estimated by Heterotrophic Respiration and Soil C/N Ratio	PLOS ONE			English	Article							N MINERALIZATION; CARBON-DIOXIDE; WATER-TABLE; FLUXES; CO2; OXIDE; PEATLANDS; METHANE; GROSS; CH4	Organic soils are an important source of N2O, but global estimates of these fluxes remain uncertain because measurements are sparse. We tested the hypothesis that N2O fluxes can be predicted from estimates of mineral nitrogen input, calculated from readily-available measurements of CO2 flux and soil C/N ratio. From studies of organic soils throughout the world, we compiled a data set of annual CO2 and N2O fluxes which were measured concurrently. The input of soil mineral nitrogen in these studies was estimated from applied fertilizer nitrogen and organic nitrogen mineralization. The latter was calculated by dividing the rate of soil heterotrophic respiration by soil C/N ratio. This index of mineral nitrogen input explained up to 69% of the overall variability of N2O fluxes, whereas CO2 flux or soil C/N ratio alone explained only 49% and 36% of the variability, respectively. Including water table level in the model, along with mineral nitrogen input, further improved the model with the explanatory proportion of variability in N2O flux increasing to 75%. Unlike grassland or cropland soils, forest soils were evidently nitrogen-limited, so water table level had no significant effect on N2O flux. Our proposed approach, which uses the product of soil-derived CO2 flux and the inverse of soil C/N ratio as a proxy for nitrogen mineralization, shows promise for estimating regional or global N2O fluxes from organic soils, although some further enhancements may be warranted.	[Mu, Zhijian] Southwest Univ, Coll Resources & Environm, Chongqing Key Lab Soil Multiscale Interfacial Pro, Chongqing, Peoples R China; [Huang, Aiying] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Ni, Jiupai; Xie, Deti] Southwest Univ, Coll Resources & Environm, Chongqing Engn Res Ctr Agr Nonpoint Source Pollut, Chongqing, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China	Mu, ZJ (corresponding author), Southwest Univ, Coll Resources & Environm, Chongqing Key Lab Soil Multiscale Interfacial Pro, Chongqing, Peoples R China.	muzj01@gmail.com			National Natural Science Foundation of China [41371211]; National Major Science and Technology Projects for Water Pollution Control and Management [2012ZX07104-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Science and Technology Projects for Water Pollution Control and Management	This research was supported by the National Natural Science Foundation of China (grant number 41371211) and the National Major Science and Technology Projects for Water Pollution Control and Management (grant number 2012ZX07104-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtsson G, 2003, SOIL BIOL BIOCHEM, V35, P143, DOI 10.1016/S0038-0717(02)00248-1; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Chatskikh D, 2007, SOIL TILL RES, V97, P5, DOI 10.1016/j.still.2007.08.004; Danevcic T, 2010, SOIL BIOL BIOCHEM, V42, P1437, DOI 10.1016/j.soilbio.2010.05.004; Frolking S, 2011, ENVIRON REV, V19, P371, DOI [10.1139/A11-014, 10.1139/a11-014]; Garcia-Montiel DC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013830; Goldberg SD, 2010, GLOBAL CHANGE BIOL, V16, P220, DOI 10.1111/j.1365-2486.2009.02015.x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Inubushi K, 2003, CHEMOSPHERE, V52, P603, DOI 10.1016/S0045-6535(03)00242-X; Kader MA, 2010, SOIL USE MANAGE, V26, P494, DOI 10.1111/j.1475-2743.2010.00303.x; Keller M, 2005, EARTH INTERACT, V9; Klemedtsson L, 2005, GLOBAL CHANGE BIOL, V11, P1142, DOI 10.1111/j.1365-2486.2005.00973.x; Klevens J, 2011, QUAL LIFE RES, V20, P1179, DOI 10.1007/s11136-011-9862-2; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luxhoi J, 2006, SOIL SCI SOC AM J, V70, P1121, DOI 10.2136/sssaj2005.0133; Maljanen M, 2010, BIOGEOSCIENCES, V7, P2711, DOI 10.5194/bg-7-2711-2010; Maljanen M, 2012, BIOGEOCHEMISTRY, V108, P199, DOI 10.1007/s10533-011-9591-1; Manzoni S, 2012, NEW PHYTOL, V196, P79, DOI 10.1111/j.1469-8137.2012.04225.x; Mojeremane W, 2012, FORESTRY, V85, P1, DOI 10.1093/forestry/cpr049; Mu ZJ, 2009, SOIL BIOL BIOCHEM, V41, P2593, DOI 10.1016/j.soilbio.2009.09.013; Murphy DV, 2003, ADV AGRON, V79, P69, DOI 10.1016/S0065-2113(02)79002-0; Nicolardot B, 2001, PLANT SOIL, V228, P83, DOI 10.1023/A:1004813801728; Ojanen P, 2010, FOREST ECOL MANAG, V260, P411, DOI 10.1016/j.foreco.2010.04.036; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Regina K, 1999, GLOB CHANGE BIOL, V5, P183, DOI 10.1046/j.1365-2486.1999.00217.x; Rochette P, 2010, EUR J SOIL SCI, V61, P186, DOI 10.1111/j.1365-2389.2009.01222.x; Smith KA, 1998, ATMOS ENVIRON, V32, P3301, DOI 10.1016/S1352-2310(97)00492-5; SOLLINS P, 1984, SOIL BIOL BIOCHEM, V16, P31, DOI 10.1016/0038-0717(84)90122-6; Springob G, 2003, SOIL BIOL BIOCHEM, V35, P629, DOI 10.1016/S0038-0717(03)00052-X; Weslien P, 2009, EUR J SOIL SCI, V60, P311, DOI 10.1111/j.1365-2389.2009.01123.x; Xu XF, 2008, GLOBAL CHANGE BIOL, V14, P1651, DOI 10.1111/j.1365-2486.2008.01595.x; Yan XY, 2005, GLOBAL CHANGE BIOL, V11, P1131, DOI 10.1111/j.1365-2486.2005.00976.x	33	11	12	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96572	10.1371/journal.pone.0096572	http://dx.doi.org/10.1371/journal.pone.0096572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798347	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000098
J	Ye, L; Yang, XS; Guo, ES; Chen, WY; Lu, LL; Wang, Y; Peng, XJ; Yan, TM; Zhou, FY; Liu, ZQ				Ye, Ling; Yang, Xiaoshan; Guo, Enshuang; Chen, Weiying; Lu, Linlin; Wang, Ying; Peng, Xiaojuan; Yan, Tongmeng; Zhou, Fuyan; Liu, Zhongqiu			Sorafenib Metabolism Is Significantly Altered in the Liver Tumor Tissue of Hepatocellular Carcinoma Patient	PLOS ONE			English	Article							HAND-FOOT SYNDROME; UDP-GLUCURONOSYLTRANSFERASE; BREATH TEST; UGT1A9; PHARMACOKINETICS; CYTOCHROME-P450; GLUCURONIDATION; GENE; POLYMORPHISMS; DISPOSITION	Background: Sorafenib, the drug used as first line treatment for hepatocellular carcinoma (HCC), is metabolized by cytochrome P450 (CYP) 3A4-mediated oxidation and uridine diphosphate glucuronosyl transferase (UGT) 1A9-mediated glucuronidation. Liver diseases are associated with reduced CYP and UGT activities, which can considerably affect drug metabolism, leading to drug toxicity. Thus, understanding the metabolism of therapeutic compounds in patients with liver diseases is necessary. However, the metabolism characteristic of sorafenib has not been systematically determined in HCC patients. Methods: Sorafenib metabolism was tested in the pooled and individual tumor hepatic microsomes (THLMs) and adjacent normal hepatic microsomes (NHLMs) of HCC patients (n = 18). Commercial hepatic microsomes (CHLMs) were used as a control. In addition, CYP3A4 and UGT1A9 protein expression in different tissues were measured by Western blotting. Results: The mean rates of oxidation and glucuronidation of sorafenib were significantly decreased in the pooled THLMs compared with those in NHLMs and CHLMs. The maximal velocity (V-max) of sorafenib oxidation and glucuronidation were approximately 25-fold and 2-fold decreased in the pooled THLMs, respectively, with unchanged K-m values. The oxidation of sorafenib in individual THLMs sample was significantly decreased (ranging from 7 to 67-fold) than that in corresponding NHLMs sample. The reduction of glucuronidation in THLMs was observed in 15 out of 18 patients' samples. Additionally, the level of CYP3A4 and UGT1A9 expression were both notably decreased in the pooled THLMs. Conclusions: Sorafenib metabolism was remarkably decreased in THLMs. This result was associated with the down regulation of the protein expression of CYP3A4 and UGT1A9.	[Ye, Ling; Yang, Xiaoshan; Guo, Enshuang; Chen, Weiying; Lu, Linlin; Wang, Ying; Peng, Xiaojuan; Yan, Tongmeng; Liu, Zhongqiu] Southern Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Guangzhou, Guangdong, Peoples R China; [Ye, Ling; Yang, Xiaoshan; Lu, Linlin; Liu, Zhongqiu] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou, Guangdong, Peoples R China; [Guo, Enshuang; Zhou, Fuyan] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou University of Chinese Medicine; Southern Medical University - China	Liu, ZQ (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Guangzhou, Guangdong, Peoples R China.	liuzq@smu.edu.cn	lu, Linlin/K-6600-2016; Liu, Zhongqiu/ABB-8204-2021; Liu, Zhongqiu/AHC-9661-2022; YAN, TONGMENG/AGK-7507-2022	lu, Linlin/0000-0002-9943-2422; Liu, Zhongqiu/0000-0001-6986-9677; 	Key International Joint Research Project of National Natural Science Foundation of China [81120108025]; Science and Information Technology of Guangzhou [2011Y1-00017-6]	Key International Joint Research Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Information Technology of Guangzhou	This work was supported in part by the Key International Joint Research Project of National Natural Science Foundation of China (Grant No. 81120108025) and the Science and Information Technology of Guangzhou (Grant No. 2011Y1-00017-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arns PA, 1997, CLIN PHARMACOL THER, V62, P527, DOI 10.1016/S0009-9236(97)90048-5; Bernard O, 2004, DRUG METAB DISPOS, V32, P775, DOI 10.1124/dmd.32.8.775; Chalasani N, 2001, HEPATOLOGY, V34, P1103, DOI 10.1053/jhep.2001.29306; Chalon SA, 2003, CLIN PHARMACOL THER, V73, P178, DOI 10.1067/mcp.2003.25; Chen J, 2004, PHARM RES-DORDR, V21, P2095, DOI 10.1023/B:PHAM.0000048202.92930.61; Chen J, 2003, J PHARMACOL EXP THER, V304, P1228, DOI 10.1124/jpet.102.046409; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chu D, 2008, ACTA ONCOL, V47, P176, DOI 10.1080/02841860701765675; Chung NM, 2006, ARCH DERMATOL, V142, P1510, DOI 10.1001/archderm.142.11.1510; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Fukuda T, 2012, THER DRUG MONIT, V34, P671, DOI 10.1097/FTD.0b013e3182708f84; Furlan V, 1999, J PHARMACOL EXP THER, V289, P1169; Gardner-Stephen DA, 2008, CURR DRUG METAB, V9, P439, DOI 10.2174/138920008784746409; Gemignani F, 2007, CARCINOGENESIS, V28, P1287, DOI 10.1093/carcin/bgm021; Giannini E, 2002, ALIMENT PHARM THERAP, V16, P717, DOI 10.1046/j.1365-2036.2002.01200.x; Girard H, 2004, PHARMACOGENETICS, V14, P501, DOI 10.1097/01.fpc.0000114754.08559.27; Gomo C, 2011, INVEST NEW DRUG, V29, P1511, DOI 10.1007/s10637-010-9514-3; Houston JB, 2000, DRUG METAB DISPOS, V28, P246; HUET PM, 1983, HEPATOLOGY, V3, P913; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Kolwankar D, 2007, CLIN GASTROENTEROL H, V5, P388, DOI 10.1016/j.cgh.2006.12.021; Letchoumy PV, 2008, ONCOL RES, V17, P75, DOI 10.3727/096504008784523649; LOWN K, 1992, CLIN PHARMACOL THER, V51, P229, DOI 10.1038/clpt.1992.17; Niu Y, 2013, DIG LIVER DIS; Noda S, 2013, CANCER CHEMOTH PHARM, V72, P269, DOI 10.1007/s00280-013-2187-9; Pasanen M, 1997, TOXICOLOGY, V123, P177, DOI 10.1016/S0300-483X(97)00119-4; Peer CJ, 2012, CLIN CANCER RES, V18, P2099, DOI 10.1158/1078-0432.CCR-11-2484; Pique JM, 2002, CLIN PHARMACOKINET, V41, P999, DOI 10.2165/00003088-200241120-00004; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Sandanaraj E, 2008, PHARMACOGENOMICS J, V8, P174, DOI 10.1038/sj.tpj.6500473; Tang L, 2009, MOL PHARMACEUT, V6, P1466, DOI 10.1021/mp8002557; Toide K, 2002, DRUG METAB DISPOS, V30, P613, DOI 10.1124/dmd.30.6.613; Villeneuve JP, 2004, CURR DRUG METAB, V5, P273, DOI 10.2174/1389200043335531; VILLENEUVE JP, 1986, HEPATOLOGY, V6, P928, DOI 10.1002/hep.1840060520; Villeneuve L, 2003, J PHARMACOL EXP THER, V307, P117, DOI 10.1124/jpet.103.054072; Wang Z, 2008, CLIN CANCER RES, V14, P5124, DOI 10.1158/1078-0432.CCR-07-4774; WITASSEK F, 1983, HEPATOLOGY, V3, P415; Wolber C, 2009, J DTSCH DERMATOL GES, V7, P449, DOI 10.1111/j.1610-0387.2009.07017.x; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Yang LQ, 2003, WORLD J GASTROENTERO, V9, P359, DOI 10.3748/wjg.v9.i2.359; Ye L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/941093; Zimmerman EI, 2012, CLIN CANCER RES, V18, P5788, DOI 10.1158/1078-0432.CCR-12-1967	42	50	50	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96664	10.1371/journal.pone.0096664	http://dx.doi.org/10.1371/journal.pone.0096664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797816	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000113
J	Li, SX; Yun, MY; Fernandez, C; Xu, JH; Srinivasan, SR; Chen, W; Berenson, GS				Li, Shengxu; Yun, Miaoying; Fernandez, Camilo; Xu, Jihua; Srinivasan, Sathanur R.; Chen, Wei; Berenson, Gerald S.			Cigarette Smoking Exacerbates the Adverse Effects of Age and Metabolic Syndrome on Subclinical Atherosclerosis: The Bogalusa Heart Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; FRAMINGHAM RISK SCORE; CARDIOVASCULAR-DISEASE; CAROTID ATHEROSCLEROSIS; ULTRASONIC MEASUREMENT; TOBACCO-SMOKE; ALL-CAUSE; MORTALITY; PREDICTION; INSULIN	Age and metabolic syndrome are major risk factors for atherosclerosis. However, limited information is available regarding whether cigarette smoking, another major, modifiable risk factor, has synergistic effects with age and metabolic syndrome on subclinical atherosclerosis, particularly in young adults. This aspect was examined in 1,051 adults (747 whites and 304 blacks; aged 24-43 years) from the Bogalusa Heart Study. General linear models were used to examine the effects of cigarette smoking and its interactive effects with age and metabolic syndrome on carotid intima-media thickness (CIMT). After adjusting for age, race, and sex, current smokers had lower BMI (mean +/- SE: 27.4 +/- 0.4, 29.3 +/- 0.5, and 29.9 +/- 0.3 kg/m(2) in current, former, and never smokers, respectively; p<0.0001) and lower levels of fasting glucose (82.8 +/- 0.9, 89.5 +/- 2.3, and 87.1 +/- 1.1 mg/dL, respectively; p = 0.001) and insulin (10.6 +/- 0.4, 14.2 +/- 1.0, 13.6 +/- 0.6 mu U/ml, respectively; p<0.0001). Despite being lean and having favorable levels of glucose and insulin, current smokers had greater CIMT (0.850 +/- 0.012, 0.808 +/- 0.011, and 0.801 +/- 0.006 mm, respectively; p = 0.0004). Importantly, cigarette smoking showed significant interactions with age and metabolic syndrome on CIMT: Age-related change in CIMT in current smokers was significantly greater (0.013 +/- 0.002 mm/year) than in nonsmokers (former and never smokers combined) (0.008 +/- 0.001 mm/year) (p for interaction = 0.005); the difference in CIMT between those with and without metabolic syndrome was significantly greater in current smokers (0.154 +/- 0.030 mm, p<0.0001) than in nonsmokers (0.031 +/- 0.014 mm, p = 0.03) (p for interaction <0.0001). In conclusion, cigarette smoking significantly exacerbates the adverse effects of age and metabolic syndrome on subclinical atherosclerosis in young adults, which underscores the importance of prevention and cessation of cigarette smoking behavior in the young.	[Li, Shengxu; Yun, Miaoying; Fernandez, Camilo; Xu, Jihua; Srinivasan, Sathanur R.; Chen, Wei; Berenson, Gerald S.] Tulane Univ, Sch Publ Hlth & Trop Med, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70118 USA; [Li, Shengxu; Yun, Miaoying; Fernandez, Camilo; Xu, Jihua; Srinivasan, Sathanur R.; Chen, Wei; Berenson, Gerald S.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Yun, Miaoying] Minzu Univ China, Coll Life & Environm Sci, Beijing, Peoples R China	Tulane University; Tulane University; Minzu University of China	Li, SX (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Tulane Ctr Cardiovasc Hlth, New Orleans, LA 70118 USA.	sli10@tulane.edu			National Institute of Environmental Health Science [5R01ES021724]; National Institute on Aging [2R01AG016592]; Eunice Kennedy Shriver National Institute of Child Health & Human Development [K12HD043451]; American Heart Association [13SDG14650068]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016592] Funding Source: NIH RePORTER	National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Bogalusa Heart Study is supported by grants 5R01ES021724 from National Institute of Environmental Health Science and 2R01AG016592 from the National Institute on Aging. Shengxu Li is a scholar of the Building Interdisciplinary Research in Women's Health program, supported by Award Number K12HD043451 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. Shengxu Li is also partly supported by Grant 13SDG14650068 from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Berenson G, 2006, ETHNIC DIS, V16, pS2; Berenson GS, 1995, AM J MED SCI, V310, pS22, DOI 10.1097/00000441-199512000-00005; Brook DW, 2010, NICOTINE TOB RES, V12, P263, DOI 10.1093/ntr/ntp202; Cao Y, 2011, ARCH INTERN MED, V171, P1956, DOI 10.1001/archinternmed.2011.539; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cho NH, 2009, CLIN ENDOCRINOL, V71, P679, DOI 10.1111/j.1365-2265.2009.03586.x; Costopouzos C, 2008, BIOCHEM PHARMACOL, V75, P1251, DOI 10.1016/j.bcp.2007.10.006; Dratva J, 2013, ATHEROSCLEROSIS, V230, P304, DOI 10.1016/j.atherosclerosis.2013.08.004; Fan Amy Z, 2006, BMC Cardiovasc Disord, V6, P42; Fan M, 2009, AM J HYPERTENS, V22, P281, DOI 10.1038/ajh.2008.349; Frey P, 2011, CURR OPIN CARDIOL, V26, P424, DOI 10.1097/HCO.0b013e328349683d; Ge Z, 2012, J HYPERTENS, V30, P2307, DOI 10.1097/HJH.0b013e328359aa1f; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Henkin L, 1999, ANN EPIDEMIOL, V9, P290, DOI 10.1016/S1047-2797(99)00003-4; Hughes K, 1998, ATHEROSCLEROSIS, V137, P253, DOI 10.1016/S0021-9150(97)00268-2; Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z; Hunt KJ, 2004, CIRCULATION, V110, P1251, DOI 10.1161/01.CIR.0000140762.04598.F9; HUNTER SMD, 1980, PREV MED, V9, P701; Kieltyka L, 2003, ATHEROSCLEROSIS, V170, P125, DOI 10.1016/S0021-9150(03)00244-2; Kim JA, 2013, INT J CARDIOVAS IMAG, V29, P21, DOI 10.1007/s10554-013-0224-8; Li H, 2006, AM J HYPERTENS, V19, P897, DOI 10.1016/j.amjhyper.2006.02.004; Liang LR, 2009, PREV MED, V49, P62, DOI 10.1016/j.ypmed.2009.05.006; Liu L, 2013, AM J CARDIOL, V3; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Onat A, 2012, CLIN BIOCHEM, V45, P37, DOI 10.1016/j.clinbiochem.2011.10.002; Pham TM, 2007, EUR J EPIDEMIOL, V22, P599, DOI 10.1007/s10654-007-9161-y; Reaven GM, 2011, J INTERN MED, V269, P127, DOI 10.1111/j.1365-2796.2010.02325.x; Reaven GM, 2006, AM J CLIN NUTR, V83, P1237, DOI 10.1093/ajcn/83.6.1237; RILEY WA, 1992, STROKE, V23, P1062, DOI 10.1161/01.STR.23.8.1062; Rizvi AA, 2009, AM J MED SCI, V338, P310, DOI 10.1097/MAJ.0b013e3181a4158c; Ruilope LM, 2010, NAT REV NEPHROL, V6, P14, DOI 10.1038/nrneph.2009.205; Simmons RK, 2008, ARCH INTERN MED, V168, P1209, DOI 10.1001/archinte.168.11.1209; Simon A, 2010, ARTERIOSCL THROM VAS, V30, P182, DOI 10.1161/ATVBAHA.109.196980; Stamler J, 2008, JAMA-J AM MED ASSOC, V300, P1343, DOI 10.1001/jama.300.11.1343; Tang R, 2000, J HYPERTENS, V18, P197, DOI 10.1097/00004872-200018020-00010; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; van den Oord SCH, 2013, ATHEROSCLEROSIS, V228, P1, DOI 10.1016/j.atherosclerosis.2013.01.025; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Whitley E, 2012, J AM COLL CARDIOL, V60, P1839, DOI 10.1016/j.jacc.2012.06.047	44	17	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96368	10.1371/journal.pone.0096368	http://dx.doi.org/10.1371/journal.pone.0096368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789040	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700081
J	Schultz, ML; Tecedor, L; Stein, CS; Stamnes, MA; Davidson, BL				Schultz, Mark L.; Tecedor, Luis; Stein, Colleen S.; Stamnes, Mark A.; Davidson, Beverly L.			CLN3 Deficient Cells Display Defects in the ARF1-Cdc42 Pathway and Actin-Dependent Events	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; LINK BATTEN-DISEASE; ENDOTHELIAL-CELLS; EXCHANGE FACTOR; GENE CLN3; PROTEIN; BRAIN; GOLGI; ENDOCYTOSIS; JUVENILE	Juvenile Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL) is a devastating neurodegenerative disease caused by mutations in CLN3, a protein of undefined function. Cell lines derived from patients or mice with CLN3 deficiency have impairments in actin-regulated processes such as endocytosis, autophagy, vesicular trafficking, and cell migration. Here we demonstrate the small GTPase Cdc42 is misregulated in the absence of CLN3, and thus may be a common link to multiple cellular defects. We discover that active Cdc42 (Cdc42-GTP) is elevated in endothelial cells from CLN3 deficient mouse brain, and correlates with enhanced PAK-1 phosphorylation, LIMK membrane recruitment, and altered actin-driven events. We also demonstrate dramatically reduced plasma membrane recruitment of the Cdc42 GTPase activating protein, ARHGAP21. In line with this, GTP-loaded ARF1, an effector of ARHGAP21 recruitment, is depressed. Together these data implicate misregulated ARF1-Cdc42 signaling as a central defect in JNCL cells, which in-turn impairs various cell functions. Furthermore our findings support concerted action of ARF1, ARHGAP21, and Cdc42 to regulate fluid phase endocytosis in mammalian cells. The ARF1-Cdc42 pathway presents a promising new avenue for JNCL therapeutic development.	[Schultz, Mark L.; Davidson, Beverly L.] Univ Iowa, Program Mol & Cellular Biol, Iowa City, IA 52242 USA; [Schultz, Mark L.; Tecedor, Luis; Stein, Colleen S.; Davidson, Beverly L.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Stamnes, Mark A.; Davidson, Beverly L.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA USA; [Davidson, Beverly L.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Program Mol & Cellular Biol, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu		Stamnes, Mark/0000-0002-5869-7985; Davidson, Beverly/0000-0002-3715-6290; Schultz, Mark/0000-0002-3149-4424	National Institutes of Health [NS084424]; Beyond Batten Disease Foundation Fellowship; BDSRA Fellowship; NCL-Stiftung; Roy J. Carver Trust; UI Central Microscopy and Research Facility [1S10RR025439-01]; Gene Transfer Vector Core [DK-54759]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084424] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beyond Batten Disease Foundation Fellowship; BDSRA Fellowship; NCL-Stiftung; Roy J. Carver Trust; UI Central Microscopy and Research Facility; Gene Transfer Vector Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (NS084424), Beyond Batten Disease Foundation Fellowship, BDSRA Fellowship, NCL-Stiftung, the Roy J. Carver Trust, and UI Central Microscopy and Research Facility (1S10RR025439-01) and the Gene Transfer Vector Core (DK-54759). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JP, 2001, J BIOL CHEM, V276, P34148, DOI 10.1074/jbc.M105398200; Autti T, 1997, NEURORADIOLOGY, V39, P371, DOI 10.1007/s002340050427; Autti TH, 2008, J NEUROL, V255, P1226, DOI 10.1007/s00415-008-0891-x; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bosse T, 2007, MOL CELL BIOL, V27, P6615, DOI 10.1128/MCB.00367-07; Calabria AR, 2006, J NEUROCHEM, V97, P922, DOI 10.1111/j.1471-4159.2006.03793.x; Carlen B, 2001, ULTRASTRUCT PATHOL, V25, P285; Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x; Chattopadhyay S, 2002, HUM MOL GENET, V11, P1421, DOI 10.1093/hmg/11.12.1421; Cheng Y, 2013, CURR EYE RES, V38, P128, DOI 10.3109/02713683.2012.738844; Codlin S, 2008, TRAFFIC, V9, P936, DOI 10.1111/j.1600-0854.2008.00735.x; Codlin S, 2009, J CELL SCI, V122, P1163, DOI 10.1242/jcs.038323; Cotman SL, 2012, CLIN LIPIDOL, V7, P79, DOI 10.2217/CLP.11.70; Defazio G, 1997, BRAIN RES BULL, V43, P467, DOI 10.1016/S0361-9230(97)00080-4; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Eliason SL, 2007, J NEUROSCI, V27, P9826, DOI 10.1523/JNEUROSCI.1710-07.2007; Ferri N, 2013, J CARDIOVASC PHARM; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; Gonzalez-Billault C, 2012, CYTOSKELETON, V69, P464, DOI 10.1002/cm.21034; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hehnly H, 2007, FEBS LETT, V581, P2112, DOI 10.1016/j.febslet.2007.01.094; Hehnly H, 2010, TRAFFIC, V11, P1067, DOI 10.1111/j.1600-0854.2010.01082.x; Hehnly H, 2009, MOL BIOL CELL, V20, P4303, DOI 10.1091/mbc.E09-02-0155; Henry EP, 2006, NAT CHEM BIOL, V2, P39, DOI 10.1038/nchembio751; Kama R, 2011, J CELL BIOL, V195, P203, DOI 10.1083/jcb.201102115; Kichina JV, 2010, EXPERT OPIN THER TAR, V14, P703, DOI 10.1517/14728222.2010.492779; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lebrun AH, 2011, MOL MED; Lim MJ, 2006, NEUROPATH APPL NEURO, V32, P469, DOI 10.1111/j.1365-2990.2006.00738.x; Lim MJ, 2007, NEUROBIOL DIS, V25, P239, DOI 10.1016/j.nbd.2006.09.005; Lojewski X, 2013, HUM MOL GENET; Luiro K, 2004, HUM MOL GENET, V13, P3017, DOI 10.1093/hmg/ddh321; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; Mazaki Y, 2012, MOL BIOL CELL, V23, P2457, DOI 10.1091/mbc.E12-01-0062; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Metcalf DJ, 2008, TRAFFIC, V9, P1905, DOI 10.1111/j.1600-0854.2008.00807.x; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Paniagua Bravo A, 2012, CLIN NEURORADIOL; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Perez-Poyato MS, 2011, J INHERIT METAB DIS, V34, P1083, DOI 10.1007/s10545-011-9323-7; Phillips SN, 2005, J NEUROSCI RES, V79, P573, DOI 10.1002/jnr.20367; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Song L, 2003, IN VITRO CELL DEV-AN, V39, P313; Stanimirovic D, 1996, J CELL PHYSIOL, V169, P455; Szul T, 2007, J CELL SCI, V120, P3929, DOI 10.1242/jcs.010769; Tecedor L, 2013, J NEUROSCI, V33, P18065, DOI 10.1523/JNEUROSCI.0498-13.2013; Titus SA, 2009, ANAL BIOCHEM, V394, P30, DOI 10.1016/j.ab.2009.07.003; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Uvebrant P, 1997, NEUROPEDIATRICS, V28, P6, DOI 10.1055/s-2007-973654; van Deurs B, 1980, Int Rev Cytol, V65, P117; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462	59	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96647	10.1371/journal.pone.0096647	http://dx.doi.org/10.1371/journal.pone.0096647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24792215	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700123
J	Xu, TT; Ripp, S; Sayler, GS; Close, DM				Xu, Tingting; Ripp, Steven; Sayler, Gary S.; Close, Dan M.			Expression of a Humanized Viral 2A-Mediated lux Operon Efficiently Generates Autonomous Bioluminescence in Human Cells	PLOS ONE			English	Article							BACTERIAL LUCIFERASE; REPORTER; VECTORS; ASSAY; PCR	Background: Expression of autonomous bioluminescence from human cells was previously reported to be impossible, suggesting that all bioluminescent-based mammalian reporter systems must therefore require application of a potentially influential chemical substrate. While this was disproven when the bacterial luciferase (lux) cassette was demonstrated to function in a human cell, its expression required multiple genetic constructs, was functional in only a single cell type, and generated a significantly reduced signal compared to substrate-requiring systems. Here we investigate the use of a humanized, viral 2A-linked lux genetic architecture for the efficient introduction of an autobioluminescent phenotype across a variety of human cell lines. Methodology/Principal Findings: The lux cassette was codon optimized and assembled into a synthetic human expression operon using viral 2A elements as linker regions. Human kidney, breast cancer, and colorectal cancer cell lines were both transiently and stably transfected with the humanized operon and the resulting autobioluminescent phenotype was evaluated using common imaging instrumentation. Autobioluminescent cells were screened for cytotoxic effects resulting from lux expression and their utility as bioreporters was evaluated through the demonstration of repeated monitoring of single populations over a prolonged period using both a modified E-SCREEN assay for estrogen detection and a classical cytotoxic compound detection assay for the antibiotic Zeocin. Furthermore, the use of self-directed bioluminescent initiation in response to target detection was assessed to determine its amenability towards deployment as fully autonomous sensors. In all cases, bioluminescent measurements were supported with traditional genetic and transcriptomic evaluations. Conclusions/Significance: Our results demonstrate that the viral 2A-linked, humanized lux genetic architecture successfully produced autobioluminescent phenotypes in all cell lines tested without the induction of cytotoxicity. This autobioluminescent phenotype allowed for repeated interrogation of populations and self-directed control of bioluminescent activation with detection limits and EC50 values similar to traditional reporter systems, making the autobioluminescent cells amenable to automated monitoring and significantly reducing the time and cost required to perform bioluminescent workflows.	[Xu, Tingting; Sayler, Gary S.] Oak Ridge Natl Lab, Joint Inst Biol Sci, Oak Ridge, TN USA; [Ripp, Steven; Close, Dan M.] 490 BioTech Inc, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Close, DM (corresponding author), 490 BioTech Inc, Knoxville, TN USA.	dan.close@490BioTech.com	Ripp, Steven/AAU-1225-2021; Ripp, Steven/B-2305-2008; Close, Dan/A-4417-2012	Ripp, Steven/0000-0002-6836-1764; Ripp, Steven/0000-0002-6836-1764; Close, Dan/0000-0003-4790-4448	NIH SBIR program [1R43ES022567-01]; National Institutes of Health, National Cancer Institute, Cancer Imaging Program [CA127745-01]; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [CBET-0853780]; Alternative Research & Development Foundation; Army Defense University Research Instrumentation Program; Directorate For Engineering [1159344] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R21CA127745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R43ES022567, R44ES022567] Funding Source: NIH RePORTER	NIH SBIR program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Cancer Institute, Cancer Imaging Program; National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET)(National Science Foundation (NSF)); Alternative Research & Development Foundation; Army Defense University Research Instrumentation Program; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIH SBIR program, award number 1R43ES022567-01, the National Institutes of Health, National Cancer Institute, Cancer Imaging Program, award number CA127745-01, the National Science Foundation Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET), award number CBET-0853780, the Alternative Research & Development Foundation, and the Army Defense University Research Instrumentation Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Close DM, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3564910; Close DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012441; Constance J, 2010, MOL IMAGING MARKETS; Costa S, 1991, EXPRESSION FUSED BAC; DEWET JR, 1986, METHOD ENZYMOL, V133, P3; Freundlieb S, 2007, CLONTECHNIQUES, P14; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Hollis RP, 2001, FEBS LETT, V506, P140, DOI 10.1016/S0014-5793(01)02905-2; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Legler J, 1999, TOXICOL SCI, V48, P55, DOI 10.1093/toxsci/48.1.55; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; MEIGHEN EA, 1988, ANNU REV MICROBIOL, V42, P151, DOI 10.1146/annurev.mi.42.100188.001055; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MEIGHEN EA, 1979, BIOCHEM BIOPH RES CO, V87, P1080, DOI 10.1016/S0006-291X(79)80018-2; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Promega, 2009, TECHN MAN PGL4 LUC; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Sambrook J., 2001, MOL CLONING LAB MANU; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.1289/ehp.95103s7113; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tinikul R, 2012, J BIOTECHNOL, V162, P346, DOI 10.1016/j.jbiotec.2012.08.018; Verhaegen M, 2002, ANAL CHEM, V74, P4378, DOI 10.1021/ac025742k; VERVOORT J, 1986, BIOCHEMISTRY-US, V25, P8067, DOI 10.1021/bi00372a041; Welham PA, 2009, MOL BIOSYST, V5, P68, DOI 10.1039/b812094c; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu T, 2013, J VISUALIZED EXPT, V18; Yarranton Geoffrey T., 1992, Current Opinion in Biotechnology, V3, P506, DOI 10.1016/0958-1669(92)90078-W	33	30	31	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96347	10.1371/journal.pone.0096347	http://dx.doi.org/10.1371/journal.pone.0096347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788811	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700078
J	Yang, SZ; Wen, X; Zhao, L; Shi, YL; Jin, HJ				Yang, Sizhong; Wen, Xi; Zhao, Liang; Shi, Yulan; Jin, Huijun			Crude Oil Treatment Leads to Shift of Bacterial Communities in Soils from the Deep Active Layer and Upper Permafrost along the China-Russia Crude Oil Pipeline Route	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; CONTAMINATED ARCTIC SOILS; FUNCTIONAL GENE DIVERSITY; MICROBIAL-POPULATIONS; DEGRADING BACTERIUM; REDUCING CONDITIONS; LOW-TEMPERATURE; ARTHROBACTER SP; SP NOV.; DEGRADATION	The buried China-Russia Crude Oil Pipeline (CRCOP) across the permafrost-associated cold ecosystem in northeastern China carries a risk of contamination to the deep active layers and upper permafrost in case of accidental rupture of the embedded pipeline or migration of oil spills. As many soil microbes are capable of degrading petroleum, knowledge about the intrinsic degraders and the microbial dynamics in the deep subsurface could extend our understanding of the application of in-situ bioremediation. In this study, an experiment was conducted to investigate the bacterial communities in response to simulated contamination to deep soil samples by using 454 pyrosequencing amplicons. The result showed that bacterial diversity was reduced after 8-weeks contamination. A shift in bacterial community composition was apparent in crude oil-amended soils with Proteobacteria (esp. alpha-subdivision) being the dominant phylum, together with Actinobacteria and Firmicutes. The contamination led to enrichment of indigenous bacterial taxa like Novosphingobium, Sphingobium, Caulobacter, Phenylobacterium, Alicylobacillus and Arthrobacter, which are generally capable of degrading polycyclic aromatic hydrocarbons (PAHs). The community shift highlighted the resilience of PAH degraders and their potential for in-situ degradation of crude oil under favorable conditions in the deep soils.	[Yang, Sizhong; Zhao, Liang; Shi, Yulan; Jin, Huijun] Chinese Acad Sci, CAREERI, SKLFSE, Lanzhou, Gansu, Peoples R China; [Wen, Xi] Northwest Univ Nationalities, Coll Elect Engn, Lanzhou, Gansu, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Northwest Minzu University	Yang, SZ (corresponding author), Chinese Acad Sci, CAREERI, SKLFSE, Lanzhou, Gansu, Peoples R China.	yangsz@lzb.ac.cn	Zhao, Liang/T-9147-2019	Yang, Sizhong/0000-0001-8417-593X	National Natural Science Foundation of China (NSFC) [40901044, 41171055]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC) (Grant Nos. 40901044 and 41171055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aislabie J, 2001, POLAR BIOL, V24, P308, DOI 10.1007/s003000000210; Aislabie J, 2006, EXTREMOPHILES, V10, P171, DOI 10.1007/s00792-005-0498-4; Aislabie J, 2010, POLAR MICROBIOLOGY: THE ECOLOGY, BIODIVERSITY AND BIOREMEDIATION POTENTIAL OF MICROORGANISMS IN EXTREMELY COLD ENVIRONMENTS, P215; An DS, 2013, GENOME, V56, P612, DOI 10.1139/gen-2013-0083; Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3724, DOI 10.1128/AEM.00518-13; Balkwill D.L., 2006, PROKARYOTES, P605, DOI DOI 10.1007/0-387-30747-8_23; Baraniecki CA, 2002, MICROB ECOL, V43, P44, DOI 10.1007/s00248-001-1019-3; Barnes David L., 2009, V16, P263; Bell TH, 2011, APPL ENVIRON MICROB, V77, P4163, DOI 10.1128/AEM.00172-11; Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Biggar KW, 1998, J COLD REG ENG, V12, P84, DOI 10.1061/(ASCE)0887-381X(1998)12:2(84); BLECHER H, 1981, XENOBIOTICA, V11, P749, DOI 10.3109/00498258109045878; Braddock JF, 1997, ENVIRON SCI TECHNOL, V31, P2078, DOI 10.1021/es960904d; Braz VS, 2005, FEMS MICROBIOL LETT, V251, P289, DOI 10.1016/j.femsle.2005.08.013; Chen BY, 2005, BIOTECHNOL PROGR, V21, P1085, DOI 10.1021/bp050004d; Chuvilin E. M., 2001, Polar Record, V37, P229; Daane LL, 2002, INT J SYST EVOL MICR, V52, P131, DOI 10.1099/00207713-52-1-131; Dalal J, 2010, PEDOBIOLOGIA, V54, P25, DOI 10.1016/j.pedobi.2010.08.004; Det Norske Veritas (DNV), 2003, RUSS PIP OIL SPILL S; Eberspaeaher J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P250, DOI 10.1007/0-387-30745-1_13; Eriksson M, 2003, APPL ENVIRON MICROB, V69, P275, DOI 10.1128/AEM.69.1.275-284.2003; Greer CW, 2010, HDB HYDROCARBON LIPI, P2313, DOI DOI 10.1007/978-3-540-77587-4_168; HAGGBLOM MM, 1992, FEMS MICROBIOL LETT, V103, P29; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hennessee CT, 2010, HDB HYDROCARBON LIPI, P1853; Hu P, 2005, J BACTERIOL, V187, P8437, DOI 10.1128/JB.187.24.8437-8449.2005; Huang WE, 2009, APPL ENVIRON MICROB, V75, P234, DOI 10.1128/AEM.01861-08; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; Jin HJ, 2010, COLD REG SCI TECHNOL, V64, P213, DOI 10.1016/j.coldregions.2009.12.003; Jones D., 1992, PROKARYOTES, V2, P1283; Juck D, 2000, FEMS MICROBIOL ECOL, V33, P241, DOI 10.1111/j.1574-6941.2000.tb00746.x; Kim SI, 2006, ENZYME MICROB TECH, V40, P71, DOI 10.1016/j.enzmictec.2005.10.041; Kryazhevskikh NA, 2013, MICROBIOLOGY+, V82, P29, DOI 10.1134/S0026261713010050; Lan GH, 2011, AFR J BIOTECHNOL, V10, P11004; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lenchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066588; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; LINGENS F, 1985, INT J SYST BACTERIOL, V35, P26, DOI 10.1099/00207713-35-1-26; Lingens F, 1989, Schriftenr Ver Wasser Boden Lufthyg, V80, P39; MacDonald RW, 2000, SCI TOTAL ENVIRON, V254, P93, DOI 10.1016/S0048-9697(00)00434-4; Mannisto MK, 1999, ARCH MICROBIOL, V171, P189, DOI 10.1007/s002030050698; Margesin R, 2004, EXTREMOPHILES, V8, P201, DOI 10.1007/s00792-004-0378-3; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Mazzon RR, 2008, FEMS MICROBIOL LETT, V288, P178, DOI 10.1111/j.1574-6968.2008.01337.x; Meyer S, 1999, MICROBIOL-SGM, V145, P1731, DOI 10.1099/13500872-145-7-1731; Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298; O'Loughlin EJ, 1999, BIODEGRADATION, V10, P93, DOI 10.1023/A:1008309026751; Oksanen J., 2020, VEGAN COMMUNITY ECOL; ONG CJ, 1990, J BACTERIOL, V172, P1448, DOI 10.1128/jb.172.3.1448-1456.1990; Popp N, 2006, MICROBIOL-SGM, V152, P3291, DOI 10.1099/mic.0.29054-0; Pruthi V, 1997, WORLD J MICROB BIOT, V13, P137, DOI 10.1007/BF02770822; R Core Team, 2021, R LANGUAGE ENV STAT; Raivo K, 2012, PHEATMAP PRETTY HEAT; Reinhold-Hurek B, 2000, INT J SYST EVOL MICR, V50, P649, DOI 10.1099/00207713-50-2-649; Rike A. G., 2001, Polar Record, V37, P239; Samanta SK, 1999, APPL MICROBIOL BIOT, V53, P98, DOI 10.1007/s002530051621; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMITT S, 1984, H-S Z PHYSIOL CHEM, V365, P143; SEXSTONE AJ, 1977, CAN J MICROBIOL, V23, P1327, DOI 10.1139/m77-201; Sherry A, 2013, INT BIODETER BIODEGR, V81, P105, DOI 10.1016/j.ibiod.2012.04.009; Singleton DR, 2005, APPL ENVIRON MICROB, V71, P1202, DOI 10.1128/AEM.71.3.1202-1209.2005; Snape I, 2002, CONTAMINANT DISPERSA, P641; Timmis K.N., 2010, HDB HYDROCARBON LIPI; Vilchek G.E., 1997, DISTURBANCE RECOVERY, P411; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williamson CHD, 2013, INVESTIGATION MICROB; Yang SZ, 2010, COLD REG SCI TECHNOL, V64, P271, DOI 10.1016/j.coldregions.2009.11.004; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058	68	114	116	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96552	10.1371/journal.pone.0096552	http://dx.doi.org/10.1371/journal.pone.0096552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794099	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700112
J	Dai, LM; Liu, D; Song, M; Xu, XQ; Xiong, G; Yang, K; Zhang, K; Meng, H; Guo, H; Bai, Y				Dai, Limeng; Liu, Dan; Song, Min; Xu, Xueqing; Xiong, Gang; Yang, Kang; Zhang, Kun; Meng, Hui; Guo, Hong; Bai, Yun			Mutations in the Homeodomain of HOXD13 Cause Syndactyly Type 1-c in Two Chinese Families	PLOS ONE			English	Article							NONSENSE MUTATION; GENETIC HOMOGENEITY; FOOT MALFORMATIONS; UNRELATED FAMILIES; POLYALANINE TRACT; SITE MUTATION; SUBSTITUTION; CONFIRMATION; DUPLICATION; PHENOTYPES	Background: Syndactyly type 1 (SD1) is an autosomal dominant limb malformation characterized in its classical form by complete or partial webbing between the third and fourth fingers and/or the second and third toes. Its four subtypes (a, b, c, and d) are defined based on variable phenotypes, but the responsible gene is yet to be identified. SD1-a has been mapped to chromosome 3p21.31 and SD1-b to 2q34-q36. SD1-c and SD1-d are very rare and, to our knowledge, no gene loci have been identified. Methods and Results: In two Chinese families with SD1-c, linkage and haplotype analyses mapped the disease locus to 2q31-2q32. Copy number variation (CNV) analysis, using array-based comparative genomic hybridization (array CGH), excluded the possibility of microdeletion or microduplication. Sequence analyses of related syndactyly genes in this region identified c. 917G>A (p.R306Q) in the homeodomain of HOXD13 in family A. Analysis on family B identified the mutation c.916C>G (p.R306G) and therefore confirmed the genetic homogeneity. Luciferase assays indicated that these two mutations affected the transcriptional activation ability of HOXD13. The spectrum of HOXD13 mutations suggested a close genotype-phenotype correlation between the different types of HOXD13-Syndactyly. Overlaps of the various phenotypes were found both among and within families carrying the HOXD13 mutation. Conclusions: Mutations (p.R306Q and p.R306G) in the homeodomain of HOXD13 cause SD1-c. There are affinities between SD1-c and synpolydactyly. Different limb malformations due to distinct classes of HOXD13 mutations should be considered as a continuum of phenotypes and further classification of syndactyly should be done based on phenotype and genotype.	[Dai, Limeng; Liu, Dan; Song, Min; Xu, Xueqing; Zhang, Kun; Meng, Hui; Guo, Hong] Third Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Chongqing, Peoples R China; [Xiong, Gang; Yang, Kang; Bai, Yun] Third Mil Med Univ, Dept Thorac & Cardiac Surg, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Guo, H (corresponding author), Third Mil Med Univ, Coll Basic Med Sci, Dept Med Genet, Chongqing, Peoples R China.	guohong02@gmail.com; baiyungene@gmail.com	guo, hong/C-2985-2012	Limeng, Dai/0000-0003-2407-8577	National Natural Science Foundation of China [81171678, 81100068]; Natural Science Foundation Project of CQ CSTC [cstc2011jjA10080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by National Natural Science Foundation of China (No. 81171678 and No. 81100068) and Natural Science Foundation Project of CQ CSTC (No. cstc2011jjA10080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu AN, 1996, HUM MOL GENET, V5, P945, DOI 10.1093/hmg/5.7.945; Bosse K, 2000, AM J HUM GENET, V67, P492, DOI 10.1086/303028; Brison N, 2012, HUM MOL GENET, V21, P2464, DOI 10.1093/hmg/dds060; Brison N, 2012, EUR J MED GENET, V55, P1, DOI 10.1016/j.ejmg.2011.06.003; Caronia G, 2003, DEVELOPMENT, V130, P1701, DOI 10.1242/dev.00396; CASTILLA EE, 1980, AM J MED GENET, V5, P357, DOI 10.1002/ajmg.1320050406; Dai LM, 2013, EUR J PEDIATR, V172, P1467, DOI 10.1007/s00431-013-2071-y; Debeer P, 2002, J MED GENET, V39, P852, DOI 10.1136/jmg.39.11.852; Fantini S, 2009, HUM MOL GENET, V18, P847, DOI 10.1093/hmg/ddn410; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Furniss D, 2009, J MED GENET, V46, P730, DOI 10.1136/jmg.2009.066027; Garcia-Barcelo MM, 2008, AM J MED GENET A, V146A, P3181, DOI 10.1002/ajmg.a.32426; Ghadami M, 2001, AM J MED GENET, V104, P147, DOI 10.1002/ajmg.10061; Gong LC, 2011, EUR J MED GENET, V54, P108, DOI 10.1016/j.ejmg.2010.10.007; Goodman F, 1998, AM J HUM GENET, V63, P992, DOI 10.1086/302070; Goodman FR, 1997, P NATL ACAD SCI USA, V94, P7458, DOI 10.1073/pnas.94.14.7458; HAY S, 1971, AM J EPIDEMIOL, V94, P572, DOI 10.1093/oxfordjournals.aje.a121356; HSU CK, 1965, CHINESE MED J-PEKING, V84, P482; Hu GZ, 1998, MOL CELL BIOL, V18, P6044, DOI 10.1128/MCB.18.10.6044; Jamsheer A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-4; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; Kan S, 2003, AM J MED GENET A, V121A, P69, DOI 10.1002/ajmg.a.20103; Kurban M, 2011, J HUM GENET, V56, P701, DOI 10.1038/jhg.2011.84; Low KJ, 2012, CLIN DYSMORPHOL, V21, P141, DOI 10.1097/MCD.0b013e32835306f0; Malik S, 2008, CLIN GENET, V73, P113, DOI 10.1111/j.1399-0004.2007.00935.x; Malik S, 2012, EUR J HUM GENET, V20, P817, DOI 10.1038/ejhg.2012.14; Malik S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-78; MONTAGU MFA, 1953, AM J HUM GENET, V5, P70; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Nakano K, 2007, INT SURG, V92, P287; Salsi V, 2006, J BIOL CHEM, V281, P1992, DOI 10.1074/jbc.M510900200; SAYLI BS, 1995, J MED GENET, V32, P421, DOI 10.1136/jmg.32.6.421; Shi XY, 2013, GENE, V532, P297, DOI 10.1016/j.gene.2013.09.040; Wajid M, 2009, CLIN GENET, V76, P300, DOI 10.1111/j.1399-0004.2009.01213.x; Wang BB, 2012, CLIN CHIM ACTA, V413, P1049, DOI 10.1016/j.cca.2012.02.015; Xin Q, 2012, GENE, V499, P48, DOI 10.1016/j.gene.2012.02.046; Zhao XL, 2007, AM J HUM GENET, V80, P361, DOI 10.1086/511387; Zhou X, 2013, BONE, V57, P237, DOI 10.1016/j.bone.2013.07.039	38	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96192	10.1371/journal.pone.0096192	http://dx.doi.org/10.1371/journal.pone.0096192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789103	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600084
J	Yang, J; Cai, H; Lv, J; Zhang, K; Leng, HJ; Wang, ZG; Liu, ZJ				Yang, Jun; Cai, Hong; Lv, Jia; Zhang, Ke; Leng, Huijie; Wang, Zhiguo; Liu, Zhongjun			Biomechanical and Histological Evaluation of Roughened Surface Titanium Screws Fabricated by Electron Beam Melting	PLOS ONE			English	Article							POROUS TITANIUM; DENTAL IMPLANTS; DIFFERENTIATION; OSTEOINDUCTION; STRENGTH; BEHAVIOR; REMOVAL; GROWTH; FILMS	Background: Various fabrication methods are used to improve the stability and osseointegration of screws within the host bone. The aim of this study was to investigate whether roughened surface titanium screws fabricated by electron beam melting can provide better stability and osseointegration as compared with smooth titanium screws in sheep cervical vertebrae. Methods: Roughened surface titanium screws, fabricated by electron beam melting, and conventional smooth surface titanium screws were implanted into sheep for 6 or 12 weeks (groups A and B, respectively). Bone ingrowth and implant stability were assessed with three-dimensional imaging and reconstruction, as well as histological and biomechanical tests. Results: No screws in either group showed signs of loosening. Fibrous tissue formation could be seen around the screws at 6 weeks, which was replaced with bone at 12 weeks. Bone volume/total volume, bone surface area/bone volume, and the trabecular number were significantly higher for a define region of interest surrounding the roughened screws than that surrounding the smooth screws at 12 weeks. Indeed, for roughened screws, trabecular number was significantly higher at 12 weeks than at 6 weeks. On mechanical testing, the maximum pullout strength was significantly higher at 12 weeks than at 6 weeks, as expected; however, no significant differences were found between smooth and roughened screws at either time point. The maximum torque to extract the roughened screws was higher than that required for the smooth screws. Conclusions: Electron beam melting is a simple and effective method for producing a roughened surface on titanium screws. After 12 weeks, roughened titanium screws demonstrated a high degree of osseointegration and increased torsional resistance to extraction over smooth titanium screws.	[Yang, Jun; Cai, Hong; Lv, Jia; Zhang, Ke; Leng, Huijie; Wang, Zhiguo; Liu, Zhongjun] Peking Univ, Hosp 3, Dept Orthoped, Beijing 100871, Peoples R China	Peking University	Liu, ZJ (corresponding author), Peking Univ, Hosp 3, Dept Orthoped, Beijing 100871, Peoples R China.	zjliu@bjmu.edu.cn	Lv, Jia/GXH-6941-2022; Leng, Huijie/AGQ-9574-2022	Lv, Jia/0000-0002-2781-6451; Leng, Huijie/0000-0002-4436-061X	Project of Scientific and Technical Plan of Beijing [Z121100005312005]	Project of Scientific and Technical Plan of Beijing	This study was sponsored by the Project of Scientific and Technical Plan of Beijing (Program title: The development of orthopaedic metal implant fabricated by electron beam melting. Program number: Z121100005312005. http://www.bjkw.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9; Aparicio C, 2011, J MECH BEHAV BIOMED, V4, P1672, DOI 10.1016/j.jmbbm.2011.05.005; Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302; Brinkmann J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0034-x; Cai KY, 2010, ACTA BIOMATER, V6, P2314, DOI 10.1016/j.actbio.2009.11.034; Cho SA, 2003, BIOMATERIALS, V24, P3611, DOI 10.1016/S0142-9612(03)00218-7; Choi W, 2002, 49 ANN M ORTH RES SO; Cook S D, 2001, Spine J, V1, P109, DOI 10.1016/S1529-9430(01)00020-1; Cook SD, 2000, J SPINAL DISORD, V13, P230, DOI 10.1097/00002517-200006000-00006; Di Silvestre M, 2007, SPINE, V32, P1655, DOI 10.1097/BRS.0b013e318074d604; Gao MX, 2011, CLIN BIOMECH, V26, P238, DOI 10.1016/j.clinbiomech.2010.10.008; Hansson S, 1999, J BIOMECH, V32, P829, DOI 10.1016/S0021-9290(99)00058-5; Haslauer CM, 2010, MED ENG PHYS, V32, P645, DOI 10.1016/j.medengphy.2010.04.003; Hu Y, 2009, BIOMATERIALS, V30, P3626, DOI 10.1016/j.biomaterials.2009.03.037; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kim YY, 2012, SPINE J, V12, P164, DOI 10.1016/j.spinee.2012.01.014; Ko CC, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.3.FOCUS1052; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lopez-Heredia MA, 2008, J BIOMED MATER RES A, V85A, P664, DOI 10.1002/jbm.a.31468; OHLIN A, 1994, SPINE, V19, P2774, DOI 10.1097/00007632-199412150-00007; Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029; PANJABI MM, 1988, SPINE, V13, P1129, DOI 10.1097/00007632-198810000-00013; Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x; Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/b715355b; Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014; VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326; Wan SY, 2010, EUR SPINE J, V19, P2122, DOI 10.1007/s00586-010-1489-4; Wu JC, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11125; Yang J, 2013, J MATER SCI-MATER M, V24, P2235, DOI 10.1007/s10856-013-4976-4; Yu S, 2011, T NONFERR METAL SOC, V21, P573, DOI 10.1016/S1003-6326(11)60753-X; Yusuf KD, 2013, CASE REPORTS ORTHOPE; Zhao CY, 2010, J BIOMED MATER RES B, V95B, P387, DOI 10.1002/jbm.b.31728	32	19	27	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96179	10.1371/journal.pone.0096179	http://dx.doi.org/10.1371/journal.pone.0096179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788866	gold, Green Published, Green Submitted			2022-12-27	WOS:000338917300031
J	Fagervold, SK; Romano, C; Kalenitchenko, D; Borowski, C; Nunes-Jorge, A; Martin, D; Galand, PE				Fagervold, Sonja K.; Romano, Chiara; Kalenitchenko, Dimitri; Borowski, Christian; Nunes-Jorge, Amandine; Martin, Daniel; Galand, Pierre E.			Microbial Communities in Sunken Wood Are Structured by Wood-Boring Bivalves and Location in a Submarine Canyon	PLOS ONE			English	Article							RARE BIOSPHERE; GEN. NOV.; DEEP; MEMBERS; HABITAT; DEGRADATION; DIVERSITY; GRADIENTS; DATABASE; SYMBIONT	The cornerstones of sunken wood ecosystems are microorganisms involved in cellulose degradation. These can either be free-living microorganisms in the wood matrix or symbiotic bacteria associated with wood-boring bivalves such as emblematic species of Xylophaga, the most common deep-sea woodborer. Here we use experimentally submerged pine wood, placed in and outside the Mediterranean submarine Blanes Canyon, to compare the microbial communities on the wood, in fecal pellets of Xylophaga spp. and associated with the gills of these animals. Analyses based on tag pyrosequencing of the 16S rRNA bacterial gene showed that sunken wood contained three distinct microbial communities. Wood and pellet communities were different from each other suggesting that Xylophaga spp. create new microbial niches by excreting fecal pellets into their burrows. In turn, gills of Xylophaga spp. contain potential bacterial symbionts, as illustrated by the presence of sequences closely related to symbiotic bacteria found in other wood eating marine invertebrates. Finally, we found that sunken wood communities inside the canyon were different and more diverse than the ones outside the canyon. This finding extends to the microbial world the view that submarine canyons are sites of diverse marine life.	[Fagervold, Sonja K.; Kalenitchenko, Dimitri; Galand, Pierre E.] Univ Paris 06, Sorbonne Univ, UMR8222, LECOB,Observ Oceanol, Banyuls Sur Mer, France; [Fagervold, Sonja K.; Kalenitchenko, Dimitri; Galand, Pierre E.] CNRS, UMR 8222, Lab Ecogeochim Environm Benth LECOB, Banyuls Sur Mer, France; [Romano, Chiara; Martin, Daniel] Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Catalunya, Spain; [Borowski, Christian; Nunes-Jorge, Amandine] Max Planck Inst Marine Microbiol, Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Max Planck Society	Galand, PE (corresponding author), Univ Paris 06, Sorbonne Univ, UMR8222, LECOB,Observ Oceanol, Banyuls Sur Mer, France.	pierre.galand@obs-banyuls.fr	Martin, Daniel/G-5232-2010; Romano, Chiara/AAJ-2517-2021; Galand, Pierre/A-1429-2014; Fagervold, Sonja K/G-5609-2013; Romano, Chiara/D-7372-2014; Kalenitchenko, Dimitri/ABF-3371-2020	Martin, Daniel/0000-0001-6350-7384; Romano, Chiara/0000-0001-5078-0082; Galand, Pierre/0000-0002-2238-3247; Romano, Chiara/0000-0001-5078-0082; Kalenitchenko, Dimitri/0000-0002-8316-0784; Nunes-Jorge, Amandine/0000-0002-0007-0653	Agence Nationale de la Recherche (ANR) [ANR-11JSV7-003-01]; PROMETEO [CTM2007-66316-C02-01/MAR]; DOSMARES [CTM2010-21810-C03-03]; Generalitat de Catalunya [2009SRG665]; Max Planck Gesellschaft; German Research Foundation (DFG)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); PROMETEO; DOSMARES; Generalitat de Catalunya(Generalitat de Catalunya); Max Planck Gesellschaft(Max Planck Society); German Research Foundation (DFG)(German Research Foundation (DFG))	The work of PE Galand and SK Fagervold was supported by the Agence Nationale de la Recherche (ANR) project MICADO (ANR-11JSV7-003-01). The present work was developed within the framework of the projects PROMETEO (CTM2007-66316-C02-01/MAR) and DOSMARES (CTM2010-21810-C03-03). This paper is also a contribution of D Martin and C Romano to the CRG 2009SRG665 funded by the Generalitat de Catalunya. ANJ was funded within the DIWOOD research project by the Max Planck Gesellschaft; CB was funded within the Cluster of Excellence "The Ocean in the Earth System" at Marum, Bremen, by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker PT, 2009, CAH BIOL MAR, V50, P343; Bessette S, 2014, J MAR SCI TECH-TAIW, V22, P60, DOI 10.6119/JMST-013-0829-2; Betcher MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045309; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Blanquer A, 2013, ENVIRON MICROBIOL, V15, P3008, DOI 10.1111/1462-2920.12261; Boynton LC, 1927, J BIOL CHEM, V75, P613; Cai M, 2011, SYST APPL MICROBIOL, V34, P321, DOI 10.1016/j.syapm.2011.03.004; Canals M, 2013, PROG OCEANOGR, V118, P1, DOI 10.1016/j.pocean.2013.09.004; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Canals M, 2009, OCEANOGRAPHY, V22, P26, DOI 10.5670/oceanog.2009.03; Cartes JE, 2009, J SEA RES, V61, P244, DOI 10.1016/j.seares.2009.01.005; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; De Leo FC, 2010, P ROY SOC B-BIOL SCI, V277, P2783, DOI 10.1098/rspb.2010.0462; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; DISTEL DL, 1991, APPL ENVIRON MICROB, V57, P2376, DOI 10.1128/AEM.57.8.2376-2382.1991; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Distel DL, 1997, BIOL BULL, V192, P253, DOI 10.2307/1542719; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Duperron S, 2013, FEMS MICROBIOL ECOL, V83, P552, DOI 10.1111/1574-6941.12014; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fagervold SK, 2013, PROG OCEANOGR, V118, P137, DOI 10.1016/j.pocean.2013.07.012; Fagervold SK, 2012, FEMS MICROBIOL ECOL, V82, P616, DOI 10.1111/j.1574-6941.2012.01432.x; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jones WJ, 2006, MAR BIOL, V148, P841, DOI 10.1007/s00227-005-0115-1; Klaus JS, 2007, ENVIRON MICROBIOL, V9, P1291, DOI 10.1111/j.1462-2920.2007.01249.x; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; Luyten YA, 2006, APPL ENVIRON MICROB, V72, P412, DOI 10.1128/AEM.72.1.412-417.2006; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Purchon DR, 1941, MARINE BIOL ASS UK J, V25, P1, DOI DOI 10.1017/S0025315400014259; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Romano C, 2013, PROG OCEANOGR, V118, P175, DOI 10.1016/j.pocean.2013.07.028; Schauer R, 2010, ISME J, V4, P159, DOI 10.1038/ismej.2009.106; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipkema D, 2009, MICROB ECOL, V58, P903, DOI 10.1007/s00248-009-9534-8; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; TESKE A, 1994, J BACTERIOL, V176, P6623, DOI 10.1128/JB.176.21.6623-6630.1994; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; Turner RD, 2000, B MUS COMP ZOOL HARV, V157, P223; Vergin KL, 1998, APPL ENVIRON MICROB, V64, P3075; Vetter EW, 2010, MAR ECOL-EVOL PERSP, V31, P183, DOI 10.1111/j.1439-0485.2009.00351.x; West AJ, 2011, LIMNOL OCEANOGR, V56, P77, DOI 10.4319/lo.2011.56.1.0077; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085; Yucel M, 2013, CHEMOSPHERE, V90, P403, DOI 10.1016/j.chemosphere.2012.07.036; Zbinden M, 2010, FEMS MICROBIOL ECOL, V74, P450, DOI 10.1111/j.1574-6941.2010.00959.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	57	21	21	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96248	10.1371/journal.pone.0096248	http://dx.doi.org/10.1371/journal.pone.0096248			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805961	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900041
J	Drum, M; Kranaster, R; Ewald, C; Blasczyk, R; Marx, A				Drum, Matthias; Kranaster, Ramon; Ewald, Christina; Blasczyk, Rainer; Marx, Andreas			Variants of a Thermus aquaticus DNA Polymerase with Increased Selectivity for Applications in Allele- and Methylation-Specific Amplification	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; REAL-TIME PCR; ACTIVE-SITE; MUTATIONAL ANALYSIS; MISMATCH-EXTENSION; GENETIC-VARIATION; PRIMER EXTENSION; GENOMIC DNA; AMINO-ACID; PHARMACOGENETICS	The selectivity of DNA polymerases is crucial for many applications. For example, high discrimination between the extension of matched versus mismatched primer termini is desired for the detection of a single nucleotide variation at a particular locus within the genome. Here we describe the generation of thermostable mutants of the large fragment of Thermus aquaticus DNA polymerase (KlenTaq) with increased mismatch extension selectivity. In contrast to previously reported much less active KlenTaq mutants with mismatch discrimination abilities, many of the herein discovered mutants show conserved wild-type-like high activities. We demonstrate for one mutant containing the single amino acid exchange R660V the suitability for application in allele-specific amplifications directly from whole blood without prior sample purification. Also the suitability of the mutant for methylation specific amplification in the diagnostics of 5-methyl cytosines is demonstrated. Furthermore, the identified mutant supersedes other commercially available enzymes in human leukocyte antigen (HLA) analysis by sequence-specific primed polymerase chain reactions (PCRs).	[Drum, Matthias; Kranaster, Ramon; Ewald, Christina; Marx, Andreas] Univ Konstanz, Dept Chem, Konstanz Res Sch Chem Biol, Constance, Germany; [Kranaster, Ramon] Univ Konstanz, MyPOLS Biotec, Constance, Germany; [Blasczyk, Rainer] Hannover Med Sch, Inst Transfus Med, Hannover, Germany	University of Konstanz; University of Konstanz; Hannover Medical School	Marx, A (corresponding author), Univ Konstanz, Dept Chem, Konstanz Res Sch Chem Biol, Constance, Germany.	andreas.marx@uni-konstanz.de		Blasczyk, Rainer/0000-0003-3875-3190	University of Konstanz	University of Konstanz	The study was supported by the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 1998, APPL ENVIRON MICROB, V64, P3748; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Biles BD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh174; BLASCO MA, 1995, J BIOL CHEM, V270, P2735, DOI 10.1074/jbc.270.6.2735; Blatter N, 2013, ANGEW CHEM INT EDIT, V52, P11935, DOI 10.1002/anie.201306655; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Erlich H, 2012, TISSUE ANTIGENS, V80, P1, DOI 10.1111/j.1399-0039.2012.01881.x; Feltus FA, 2006, GENOMICS, V87, P572, DOI 10.1016/j.ygeno.2005.12.016; Firth AE, 2005, BIOINFORMATICS, V21, P3314, DOI 10.1093/bioinformatics/bti516; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Germer S, 1999, GENOME RES, V9, P72; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Ginsburg G.S., 2012, GENOMIC PERSONALIZED, V1-2; Gloeckner C, 2007, ANGEW CHEM INT EDIT, V46, P3115, DOI 10.1002/anie.200603987; Gloeckner Christian, 2010, Curr Protoc Chem Biol, V2, P89, DOI 10.1002/9780470559277.ch090183; Guo Z, 1997, NAT BIOTECHNOL, V15, P331, DOI 10.1038/nbt0497-331; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; HAYATSU H, 1970, BIOCHEMISTRY-US, V9, P2858, DOI 10.1021/bi00816a016; Heichman KA, 2012, CLIN CHEM LAB MED, V50, P1707, DOI 10.1515/cclm-2011-0935; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; ISHIKAWA Y, 1995, HUM IMMUNOL, V42, P315, DOI 10.1016/0198-8859(94)00119-B; Johnson MP, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh046; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; Kotsch K, 1999, TISSUE ANTIGENS, V53, P486, DOI 10.1034/j.1399-0039.1999.530505.x; Kranaster R, 2010, BIOTECHNOL J, V5, P224, DOI 10.1002/biot.200900200; Kranaster R, 2009, ANGEW CHEM INT EDIT, V48, P4625, DOI 10.1002/anie.200900953; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawyer F C, 1993, PCR Methods Appl, V2, P275; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Loh E, 2005, DNA REPAIR, V4, P1390, DOI 10.1016/j.dnarep.2005.09.006; Lutz MW, 2011, J ALZHEIMERS DIS, V24, P247, DOI 10.3233/JAD-2010-101765; Marchiori A, 2007, HAEMATOLOGICA, V92, P1107, DOI 10.3324/haematol.10234; McCarthy JJ, 2000, NAT BIOTECHNOL, V18, P505, DOI 10.1038/75360; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Relling MV, 2001, NAT REV CANCER, V1, P99, DOI 10.1038/35101056; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Roses AD, 2002, NAT REV DRUG DISCOV, V1, P541, DOI 10.1038/nrd840; Roses AD, 2002, LIFE SCI, V70, P1471, DOI 10.1016/S0024-3205(01)01532-6; Rudinger NZ, 2007, CHEM BIOL, V14, P185, DOI 10.1016/j.chembiol.2006.11.016; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shi MM, 2001, CLIN CHEM, V47, P164; Shi MM, 1999, MOL DIAGN, V4, P343, DOI 10.1016/S1084-8592(99)80011-3; Shively L, 2003, BIOTECHNIQUES, V34, P498, DOI 10.2144/03343st01; Strerath M, 2005, ANGEW CHEM INT EDIT, V44, P7842, DOI 10.1002/anie.200501444; Strerath M, 2002, J AM CHEM SOC, V124, P11230, DOI 10.1021/ja027060k; Strerath M, 2007, CHEMBIOCHEM, V8, P395, DOI 10.1002/cbic.200600337; Summerer D, 2005, ANGEW CHEM INT EDIT, V44, P4712, DOI 10.1002/anie.200500047; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Syvanen AC, 1999, HUM MUTAT, V13, P1; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Villbrandt B, 1997, PROTEIN ENG, V10, P1281, DOI 10.1093/protein/10.11.1281; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Wartiovaara Anu, 2002, Methods Mol Biol, V187, P57; Wilhelm J, 2003, CHEMBIOCHEM, V4, P1120, DOI 10.1002/cbic.200300662; Wilhelm J, 2002, BIOL CHEM, V383, P1423, DOI 10.1515/BC.2002.161; WU DY, 1989, P NATL ACAD SCI USA, V86, P2757, DOI 10.1073/pnas.86.8.2757	81	13	14	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96640	10.1371/journal.pone.0096640	http://dx.doi.org/10.1371/journal.pone.0096640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800860	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800100
J	Rouyi, C; Baiya, S; Lee, SK; Mahong, B; Jeon, JS; Ketudat-Cairns, JR; Ketudat-Cairns, M				Rouyi, Chen; Baiya, Supaporn; Lee, Sang-Kyu; Mahong, Bancha; Jeon, Jong-Seong; Ketudat-Cairns, James R.; Ketudat-Cairns, Mariena			Recombinant Expression and Characterization of the Cytoplasmic Rice beta-Glucosidase Os1BGlu4	PLOS ONE			English	Article							SALICYLIC-ACID; PURIFICATION; GENE; IDENTIFICATION; RESISTANCE; TOLERANCE; STRESS; SIGNAL	The Os1BGlu4 beta-glucosidase is the only glycoside hydrolase family 1 member in rice that is predicted to be localized in the cytoplasm. To characterize the biochemical function of rice Os1BGlu4, the Os1bglu4 cDNA was cloned and used to express a thioredoxin fusion protein in Escherichia coli. After removal of the tag, the purified recombinant Os1BGlu4 (rOs1BGlu4) exhibited an optimum pH of 6.5, which is consistent with Os1BGlu4's cytoplasmic localization. Fluorescence microscopy of maize protoplasts and tobacco leaf cells expressing green fluorescent protein-tagged Os1BGlu4 confirmed the cytoplasmic localization. Purified rOs1BGlu4 can hydrolyze p-nitrophenyl (pNP)-beta-D-glucoside (pNPGlc) efficiently (k(cat)/K-m = 17.9 mM(-1).s(-1)), and hydrolyzes pNP-beta-D-fucopyranoside with about 50% the efficiency of the pNPGlc. Among natural substrates tested, rOs1BGlu4 efficiently hydrolyzed beta-(1,3)-linked oligosaccharides of degree of polymerization (DP) 2-3, and b-(1,4)-linked oligosaccharide of DP 3-4, and hydrolysis of salicin, esculin and p-coumaryl alcohol was also detected. Analysis of the hydrolysis of pNP-b-cellobioside showed that the initial hydrolysis was between the two glucose molecules, and suggested rOs1BGlu4 transglucosylates this substrate. At 10 mM pNPGlc concentration, rOs1BGlu4 can transfer the glucosyl group of pNPGlc to ethanol and pNPGlc. This transglycosylation activity suggests the potential use of Os1BGlu4 for pNPoligosaccharide and alkyl glycosides synthesis.	[Rouyi, Chen; Ketudat-Cairns, Mariena] Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Muang Dist, Nakhon Ratchasi, Thailand; [Baiya, Supaporn; Ketudat-Cairns, James R.] Suranaree Univ Technol, Inst Sci, Sch Biochem, Muang Dist, Nakhon Ratchasi, Thailand; [Rouyi, Chen] Guizhou Acad Agr Sci, Guizhou Inst Upland Food Crops, Guiyang, Guizhou, Peoples R China; [Lee, Sang-Kyu; Jeon, Jong-Seong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, Gyeonggi, South Korea; [Lee, Sang-Kyu; Jeon, Jong-Seong] Kyung Hee Univ, Crop Biotech Inst, Yongin, Gyeonggi, South Korea; [Jeon, Jong-Seong] Kyung Hee Univ, Dept Plant Mol Syst Biotechnol, Yongin, Gyeonggi, South Korea	Suranaree University of Technology; Suranaree University of Technology; Guizhou Academy of Agricultural Sciences; Kyung Hee University; Kyung Hee University; Kyung Hee University	Ketudat-Cairns, M (corresponding author), Suranaree Univ Technol, Inst Agr Technol, Sch Biotechnol, Muang Dist, Nakhon Ratchasi, Thailand.	ketudat@sut.ac.th	Cairns, James R Ketudat/B-6407-2019; Jeon, Jong-Seong/AAJ-2161-2020; Supaporn, Baiya/AHA-3942-2022	Jeon, Jong-Seong/0000-0001-6221-4993; Supaporn, Baiya/0000-0002-2641-8101; Lee, Sang-Kyu/0000-0002-3367-5229; Ketudat Cairns, James/0000-0003-3042-1626; Ketudat-Cairns, Mariena/0000-0003-2662-6573	Suranaree University of Technology [SUT3-304-54-12-29]; Government of the Kingdom of Thailand; Government of the People's Republic of China [20-606J]; Guizhou International Cooperation Project on Science and Technology, China [QiankehewaiG(2013)7040]; Next Generation BioGreen Program (SSAC) [PJ009484062014]; Rural Development Administration, Korea	Suranaree University of Technology; Government of the Kingdom of Thailand; Government of the People's Republic of China; Guizhou International Cooperation Project on Science and Technology, China; Next Generation BioGreen Program (SSAC); Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by Suranaree University of Technology grant number SUT3-304-54-12-29, support from the 20th Project of The Joint Committee on Scientific and Technical Cooperation between The Government of the Kingdom of Thailand and The Government of the People's Republic of China (No. 20-606J); Guizhou International Cooperation Project on Science and Technology [No. QiankehewaiG(2013)7040], China, and a grant from the Next Generation BioGreen Program (SSAC, PJ009484062014), Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 1998, PHYTOCHEMISTRY, V48, P49, DOI 10.1016/S0031-9422(97)01099-6; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berrin JG, 2002, EUR J BIOCHEM, V269, P249, DOI 10.1046/j.0014-2956.2001.02641.x; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho JI, 2009, PLANT PHYSIOL, V149, P745, DOI 10.1104/pp.108.131227; Chuankhayan P, 2005, PHYTOCHEMISTRY, V66, P1880, DOI 10.1016/j.phytochem.2005.06.024; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Dharmawardhana DP, 1999, PLANT MOL BIOL, V40, P365, DOI 10.1023/A:1006226931512; Durner J, 1997, TRENDS PLANT SCI, V2, P266, DOI 10.1016/S1360-1385(97)86349-2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; Esen A, 1993, SS GLUCOSIDASE OVERV; Gupta R, 2004, NETNGLYC 1 O SERVER; Himeno N, 2013, BIOSCI BIOTECH BIOCH, V77, P934, DOI 10.1271/bbb.120889; Hrmova M, 1996, J BIOL CHEM, V271, P5277, DOI 10.1074/jbc.271.9.5277; Hrmova M, 1998, J BIOL CHEM, V273, P11134, DOI 10.1074/jbc.273.18.11134; Hua YL, 2013, ARCH BIOCHEM BIOPHYS, V537, P39, DOI 10.1016/j.abb.2013.06.005; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kuntothom T, 2009, ARCH BIOCHEM BIOPHYS, V491, P85, DOI 10.1016/j.abb.2009.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luang S, 2013, J BIOL CHEM, V288, P10111, DOI 10.1074/jbc.M112.423533; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Opassiri R, 2004, BIOCHEM J, V379, P125, DOI 10.1042/BJ20031485; Opassiri R, 2003, PLANT SCI, V165, P627, DOI 10.1016/S0168-9452(03)00235-8; Opassiri R, 2007, BIOCHEM J, V408, P241, DOI 10.1042/BJ20070734; Opassiri R, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-33; Opassiri R, 2010, PLANT SCI, V179, P273, DOI 10.1016/j.plantsci.2010.05.013; Seshadri S, 2009, PLANT PHYSIOL, V151, P47, DOI 10.1104/pp.109.139436; Srisomsap C, 1996, J BIOCHEM, V119, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wakuta S, 2011, BIOCHEM BIOPH RES CO, V409, P634, DOI 10.1016/j.bbrc.2011.05.055; Wakuta S, 2010, PHYTOCHEMISTRY, V71, P1280, DOI 10.1016/j.phytochem.2010.04.025; Wang Q, 2002, CHEM MATER, V14, P3232, DOI 10.1021/cm0200137; WANG QP, 1994, J AM CHEM SOC, V116, P11594, DOI 10.1021/ja00104a060; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1	39	26	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96712	10.1371/journal.pone.0096712	http://dx.doi.org/10.1371/journal.pone.0096712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802508	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800112
J	Skovgaard, D; Hasbak, P; Kjaer, A				Skovgaard, Dorthe; Hasbak, Philip; Kjaer, Andreas			BNP Predicts Chemotherapy-Related Cardiotoxicity and Death: Comparison with Gated Equilibrium Radionuclide Ventriculography	PLOS ONE			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; BRAIN NATRIURETIC PEPTIDE; BREAST-CANCER PATIENTS; CHRONIC HEART-FAILURE; OF-THE-LITERATURE; NT-PRO-BNP; CARDIAC-FUNCTION; DOXORUBICIN TREATMENT; BIOCHEMICAL MARKERS; DYSFUNCTION	Cardiotoxicity is a dose-limiting side-effect of cancer chemotherapeutics such as anthracyclines. The drug-induced cardiac toxicity is currently monitored with repeated assessments of the left ventricular ejection fraction (LVEF) using multigated equilibrium radionuclide ventriculography (MUGA) or echocardiography. However, the plasma cardiac biomarker B-type natriuretic peptide (BNP) has been suggested for early identification of cardiac dysfunction. The aim of the study was to compare LVEF obtained by MUGA and plasma BNP as predictors of developing congestive heart failure (CHF) or death in a population of anthracycline-treated cancer patients. Methods: We prospectively followed 333 cancer patients referred to our department for routine monitoring of LVEF with MUGA and measurement of BNP, January-December 2004. Study end points were hospitalization for CHF and death during follow-up 2004-2010. Data were obtained from the Danish National Patient Registry. Results: During follow-up (mean 1,360 days), 21 of the patients were admitted to hospital with a diagnosis of CHF and 194 of the patients died. BNP levels were significantly higher and LVEF lower in the group of patients that developed CHF. Using cut-off points of BNP > 100 pg/ml (HR 5.5; CI 1.8-17.2; p = 0.003) and LVEF < 50% (HR 7.9; CI 3.0-21.4; p < 0.001) both significantly predicted CHF. Using the same cut-off points only BNP (HR 1.9; CI 1.3-2.9; p = 0.002) and not LVEF (HR 1.1; CI 0.7-1.8; p = 0.58) was predictive of overall death. In multivariate Cox analysis both BNP and LVEF were independent predictors of CHF while age remained the only independent predictor of overall death. Conclusion: In cancer patients treated with cardiotoxic chemotherapy both BNP and LVEF can significantly predict subsequent hospitalization with CHF. In addition, BNP and not LVEF has a prognostic value in detecting overall death. This prospective study based on the hitherto largest study population supports BNP as a clinical relevant method for monitoring chemotherapy-related cardiac failure and death.	[Skovgaard, Dorthe; Kjaer, Andreas] Univ Copenhagen, Cluster Mol Imaging, Copenhagen, Denmark; [Skovgaard, Dorthe; Hasbak, Philip; Kjaer, Andreas] Rigshosp, Dept Clin Physiol Nucl Med & PET, DK-2100 Copenhagen, Denmark; [Skovgaard, Dorthe; Hasbak, Philip; Kjaer, Andreas] Univ Copenhagen Hosp, DK-2100 Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Skovgaard, D (corresponding author), Univ Copenhagen, Cluster Mol Imaging, Copenhagen, Denmark.	dskovgaard@dadlnet.dk	Kjaer, Andreas/E-8932-2015	Kjaer, Andreas/0000-0002-2706-5547	John and Birthe Meyer Foundation; A.P.MAller Foundation; Danish Medical Research Council; Danish Heart Foundation; Research Council of Rigshospitalet; Research Foundation of the Capital Region	John and Birthe Meyer Foundation; A.P.MAller Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation; Research Council of Rigshospitalet; Research Foundation of the Capital Region	This work was supported by the John and Birthe Meyer Foundation, the A.P.MAller Foundation, the Danish Medical Research Council, the Danish Heart Foundation, the Research Council of Rigshospitalet and the Research Foundation of the Capital Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch X, 2013, J AM COLL CARDIOL, V61, P2355, DOI 10.1016/j.jacc.2013.02.072; Cardinale D, 2011, HERZ, V36, P325, DOI 10.1007/s00059-011-3453-4; Cardinale Daniela, 2008, Curr Treat Options Cardiovasc Med, V10, P486, DOI 10.1007/s11936-008-0041-x; Daugaard G, 2005, EUR J HEART FAIL, V7, P87, DOI 10.1016/j.ejheart.2004.03.009; Dodos F, 2008, CLIN RES CARDIOL, V97, P318, DOI 10.1007/s00392-007-0633-6; Dolci A, 2008, AM J CLIN PATHOL, V130, P688, DOI 10.1309/AJCPB66LRIIVMQDR; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; Elbl L, 2006, Vnitr Lek, V52, P563; Feola M, 2011, INT J CARDIOL, V148, P194, DOI 10.1016/j.ijcard.2009.09.564; Garrone O, 2012, CARDIOVASC TOXICOL, V12, P135, DOI 10.1007/s12012-011-9149-4; Geiger S, 2012, ONKOLOGIE, V35, P241, DOI 10.1159/000338335; Gutte H, 2010, CLIN PHYSIOL FUNCT I, V30, P466, DOI 10.1111/j.1475-097X.2010.00967.x; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hildebrandt P, 2009, DIS MARKERS, V26, P227, DOI [10.1155/2009/837256, 10.3233/DMA-2009-0632]; Januzzi JL, 2012, ARCH CARDIOVASC DIS, V105, P40, DOI 10.1016/j.acvd.2011.10.007; Kjaer A, 2005, INT J CARDIOL, V99, P301, DOI 10.1016/j.ijcard.2004.02.003; Kouloubinis A, 2007, INT J CARDIOL, V122, P195, DOI 10.1016/j.ijcard.2006.11.076; Kristoffersen US, 2008, HIV MED, V9, P180, DOI 10.1111/j.1468-1293.2007.00531.x; Ky B, 2011, HEART FAIL CLIN, V7, P323, DOI 10.1016/j.hfc.2011.03.002; Lee Ho Sup, 2008, Cancer Res Treat, V40, P121, DOI 10.4143/crt.2008.40.3.121; Lipshultz SE, 2012, J CLIN ONCOL, V30, P1042, DOI 10.1200/JCO.2010.30.3404; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mavinkurve-Groothuis AMC, 2009, PEDIATR BLOOD CANCER, V52, P631, DOI 10.1002/pbc.21913; Mavinkurve-Groothuis AMC, 2008, PEDIATR HEMAT ONCOL, V25, P655, DOI 10.1080/08880010802244001; Meinardi MT, 2001, J CLIN ONCOL, V19, P2746, DOI 10.1200/JCO.2001.19.10.2746; Nousiainen T, 2002, J INTERN MED, V251, P228, DOI 10.1046/j.1365-2796.2002.00951.x; Nousiainen T, 1999, EUR J HAEMATOL, V62, P135; Okumura H, 2000, ACTA HAEMATOL-BASEL, V104, P158, DOI 10.1159/000046508; Pichon MF, 2005, IN VIVO, V19, P567; Poutanen T, 2003, J CLIN ONCOL, V21, P2349, DOI 10.1200/JCO.2003.08.050; Romano S, 2011, BRIT J CANCER, V105, P1663, DOI 10.1038/bjc.2011.439; Sandri MT, 2005, CLIN CHEM, V51, P1405, DOI 10.1373/clinchem.2005.050153; Sawaya H, 2011, AM J CARDIOL, V107, P1375, DOI 10.1016/j.amjcard.2011.01.006; Snowden JA, 2000, BONE MARROW TRANSPL, V26, P309, DOI 10.1038/sj.bmt.1702507; Soker M, 2005, SAUDI MED J, V26, P1197; Vogelsang TW, 2008, INT J CARDIOL, V124, P193, DOI 10.1016/j.ijcard.2007.02.003; Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9	37	63	68	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96736	10.1371/journal.pone.0096736	http://dx.doi.org/10.1371/journal.pone.0096736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800827	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800118
J	Yamamoto, N; Philbeck, JW; Woods, AJ; Gajewski, DA; Arthur, JC; Potolicchio, SJ; Levy, L; Caputy, AJ				Yamamoto, Naohide; Philbeck, John W.; Woods, Adam J.; Gajewski, Daniel A.; Arthur, Joeanna C.; Potolicchio, Samuel J., Jr.; Levy, Lucien; Caputy, Anthony J.			Medial Temporal Lobe Roles in Human Path Integration	PLOS ONE			English	Article							HUMAN SPATIAL NAVIGATION; FREELY MOVING RATS; PLACE-CELL SEQUENCES; ENTORHINAL CORTEX; PREFRONTAL CORTEX; WORKING-MEMORY; HIPPOCAMPAL INVOLVEMENT; ANTIEPILEPTIC DRUGS; EPISODIC MEMORY; VISUAL SPACE	Path integration is a process in which observers derive their location by integrating self-motion signals along their locomotion trajectory. Although the medial temporal lobe (MTL) is thought to take part in path integration, the scope of its role for path integration remains unclear. To address this issue, we administered a variety of tasks involving path integration and other related processes to a group of neurosurgical patients whose MTL was unilaterally resected as therapy for epilepsy. These patients were unimpaired relative to neurologically intact controls in many tasks that required integration of various kinds of sensory self-motion information. However, the same patients (especially those who had lesions in the right hemisphere) walked farther than the controls when attempting to walk without vision to a previewed target. Importantly, this task was unique in our test battery in that it allowed participants to form a mental representation of the target location and anticipate their upcoming walking trajectory before they began moving. Thus, these results put forth a new idea that the role of MTL structures for human path integration may stem from their participation in predicting the consequences of one's locomotor actions. The strengths of this new theoretical viewpoint are discussed.	[Yamamoto, Naohide] Cleveland State Univ, Dept Psychol, Cleveland, OH 44115 USA; [Yamamoto, Naohide; Philbeck, John W.; Woods, Adam J.; Gajewski, Daniel A.; Arthur, Joeanna C.] George Washington Univ, Dept Psychol, Washington, DC 20052 USA; [Philbeck, John W.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Woods, Adam J.] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Cognit Aging & Memory Clin Translat Res Program, Gainesville, FL USA; [Arthur, Joeanna C.] Natl Geospatial Intelligence Agcy, Off Basic & Appl Res, Springfield, VA USA; [Potolicchio, Samuel J., Jr.] George Washington Univ, Med Ctr, Dept Neurol, Washington, DC 20037 USA; [Levy, Lucien] George Washington Univ, Med Ctr, Dept Radiol, Washington, DC 20037 USA; [Caputy, Anthony J.] George Washington Univ, Med Ctr, Dept Neurol Surg, Washington, DC 20037 USA	University System of Ohio; Cleveland State University; George Washington University; University of Wollongong; State University System of Florida; University of Florida; George Washington University; George Washington University; George Washington University	Philbeck, JW (corresponding author), George Washington Univ, Dept Psychol, Washington, DC 20052 USA.	johnp@uow.edu.au	Yamamoto, Naohide/B-7455-2015	Yamamoto, Naohide/0000-0001-9734-7470; Woods, Adam/0000-0002-0786-0236	National Institutes of Health [R01 NS052137]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grant R01 NS052137 to J.W.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 1999, BRAIN COGNITION, V41, P39, DOI 10.1006/brcg.1999.1095; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Alyan S, 1999, BEHAV NEUROSCI, V113, P19, DOI 10.1037/0735-7044.113.1.19; Arthur JC, 2007, EXP BRAIN RES, V183, P557, DOI 10.1007/s00221-007-1075-0; Astur RS, 2002, BEHAV BRAIN RES, V132, P77, DOI 10.1016/S0166-4328(01)00399-0; Berthoz A, 1999, WAYFINDING BEHAVIOR, P328; Billington J, 2010, J EXP PSYCHOL HUMAN, V36, P1495, DOI 10.1037/a0018728; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Bland BH, 2009, INFORMATION PROCESSING BY NEURONAL POPULATIONS, P283; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Bohbot VD, 2002, PHYSIOL RES, V51, pS49; Buckner RL, 2010, ANNU REV PSYCHOL, V61, P27, DOI 10.1146/annurev.psych.60.110707.163508; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Caputy A, 1999, CRANIAL MICROSURGERY, P278; Chen GF, 2013, P NATL ACAD SCI USA, V110, P378, DOI 10.1073/pnas.1215834110; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; Diaz-Asper CM, 2006, J CLIN EXP NEUROPSYC, V28, P1462, DOI 10.1080/13803390500434359; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Feigenbaum JD, 1996, NEUROPSYCHOLOGIA, V34, P163, DOI 10.1016/0028-3932(95)00107-7; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gajewski DA, 2014, J VISION, V14, DOI 10.1167/14.1.20; Gallistel C. R., 1990, ORG LEARNING, Vviii, P648; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hannula DE, 2006, J NEUROSCI, V26, P8352, DOI 10.1523/JNEUROSCI.5222-05.2006; Hartley T, 2007, HIPPOCAMPUS, V17, P34, DOI 10.1002/hipo.20240; Holdstock JS, 2000, NEUROPSYCHOLOGIA, V38, P410, DOI 10.1016/S0028-3932(99)00099-8; Jackson PA, 1998, NEUROBIOL LEARN MEM, V70, P328, DOI 10.1006/nlme.1998.3859; Jacobs J, 2013, NAT NEUROSCI, V16, P1188, DOI 10.1038/nn.3466; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jeneson A, 2012, LEARN MEMORY, V19, P15, DOI 10.1101/lm.024018.111; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kesner RP, 2001, NEUROPSYCHOLOGY, V15, P58, DOI 10.1037/0894-4105.15.1.58; KESNER RP, 1987, NEUROPSYCHOLOGIA, V25, P653, DOI 10.1016/0028-3932(87)90056-X; Killian NJ, 2012, NATURE, V491, P761, DOI 10.1038/nature11587; Kim S, 2013, P NATL ACAD SCI USA, V110, P4732, DOI 10.1073/pnas.1300869110; Kim S, 2011, J NEUROSCI, V31, P2624, DOI 10.1523/JNEUROSCI.5954-10.2011; Kwan P, 2001, LANCET, V357, P216, DOI 10.1016/S0140-6736(00)03600-X; Lee ACH, 2005, NEUROPSYCHOLOGIA, V43, P1, DOI 10.1016/j.neuropsychologia.2004.07.017; Lee ACH, 2005, HIPPOCAMPUS, V15, P782, DOI 10.1002/hipo.20101; Loomis JM, 1999, WAYFINDING BEHAVIOR, P125; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MECK WH, 1984, BEHAV NEUROSCI, V98, P3, DOI 10.1037/0735-7044.98.1.3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mueller SG, 2006, EUR J NEUROL, V13, P256, DOI 10.1111/j.1468-1331.2006.01188.x; MULLER RU, 1989, J NEUROSCI, V9, P4101; MURI RM, 1994, EXP BRAIN RES, V101, P165; Murray EA, 1998, J NEUROSCI, V18, P6568; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OMARA SM, 1994, J NEUROSCI, V14, P6511; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; Pfeiffer BE, 2013, NATURE, V497, P74, DOI 10.1038/nature12112; Philbeck JW, 2008, PERCEPT PSYCHOPHYS, V70, P1459, DOI 10.3758/PP.70.8.1459; Philbeck JW, 2010, BEHAV RES METHODS, V42, P148, DOI 10.3758/BRM.42.1.148; Philbeck JW, 2005, PSICOLOGICA, V26, P7; Philbeck JW, 2004, J COGNITIVE NEUROSCI, V16, P510, DOI 10.1162/089892904323057254; Philbeck JW, 2001, J EXP PSYCHOL HUMAN, V27, P141, DOI 10.1037/0096-1523.27.1.141; Philbeck JW, 2000, NEUROPSYCHOLOGIA, V38, P950, DOI 10.1016/S0028-3932(99)00156-6; Pierrot-Deseilligny C, 2002, ANN NEUROL, V52, P10, DOI 10.1002/ana.10273; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Pulliainen V, 2000, ACTA NEUROL SCAND, V101, P73, DOI 10.1034/j.1600-0404.2000.101002073.x; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; RIESER JJ, 1990, PERCEPTION, V19, P675, DOI 10.1068/p190675; Rieser JJ, 1999, WAYFINDING BEHAVIOR, P168; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Shelton AL, 2009, CURR ISS MEM, P140; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; Shrager Y, 2008, P NATL ACAD SCI USA, V105, P12034, DOI 10.1073/pnas.0805414105; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Surges R, 2008, J NEUROL NEUROSUR PS, V79, P924, DOI 10.1136/jnnp.2007.129387; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1990, J NEUROSCI, V10, P436; Tcheang L, 2011, P NATL ACAD SCI USA, V108, P1152, DOI 10.1073/pnas.1011843108; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Teyler TJ, 2007, HIPPOCAMPUS, V17, P1158, DOI 10.1002/hipo.20350; THOMSON JA, 1983, J EXP PSYCHOL HUMAN, V9, P427, DOI 10.1037/0096-1523.9.3.427; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wiener JM, 2011, EXP BRAIN RES, V208, P61, DOI 10.1007/s00221-010-2460-7; Wiest G, 2000, J VESTIBUL RES-EQUIL, V10, P301; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Wilson MA, 2000, NEW COGNITIVE NEUROS, P589; Wolbers T, 2008, NAT NEUROSCI, V11, P1223, DOI 10.1038/nn.2189; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Worsley CL, 2001, NEUROPSYCHOLOGIA, V39, P452, DOI 10.1016/S0028-3932(00)00140-8; Yamamoto N, 2012, COGN PROCESS, V13, pS365, DOI 10.1007/s10339-012-0462-z	99	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96583	10.1371/journal.pone.0096583	http://dx.doi.org/10.1371/journal.pone.0096583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802000	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800088
J	Adams, VM; Pressey, RL				Adams, Vanessa M.; Pressey, Robert L.			Uncertainties around the Implementation of a Clearing-Control Policy in a Unique Catchment in Northern Australia: Exploring Equity Issues and Balancing Competing Objectives	PLOS ONE			English	Article							BIODIVERSITY; VULNERABILITY; AREAS	Land use change is the most significant driver linked to global species extinctions. In Northern Australia, the landscape is still relatively intact with very low levels of clearing. However, a re-energized political discourse around creating a northern food bowl means that currently intact ecosystems in northern Australia could be under imminent threat from increased land clearing and water extraction. These impacts are likely to be concentrated in a few regions with suitable soils and water supplies. The Daly River Catchment in the Northern Territory is an important catchment for both conservation and development. Land use in the Daly catchment has been subject to clearing guidelines that are largely untested in terms of their eventual implications for the spatial configuration of conservation and development. Given the guidelines are not legislated they might also be removed or revised by subsequent Territory Governments, including the recently-elected one. We examine the uncertainties around the spatial implications of full implementation of the Daly clearing guidelines and their potential effects on equity of opportunity across land tenures and land uses. We also examine how removal of the guidelines could affect conservation in the catchment. We conclude that the guidelines are important in supporting development in the catchment while still achieving conservation goals, and we recommend ways of implementing the guidelines to make best use of available land resources for intensified production.	[Adams, Vanessa M.] Charles Darwin Univ, Northern Australia Natl Environm Res Program Hub, Darwin, NT 0909, Australia; [Adams, Vanessa M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Adams, Vanessa M.; Pressey, Robert L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia	Charles Darwin University; Charles Darwin University; James Cook University	Adams, VM (corresponding author), Charles Darwin Univ, Northern Australia Natl Environm Res Program Hub, Darwin, NT 0909, Australia.	vanessa.adams@cdu.edu.au	Adams, Vanessa M./A-3834-2012	Adams, Vanessa M./0000-0002-3509-7901	Project 1.1 (Catchment to Coast Conservation Planning) under the North Australia Hub of the National Environmental Research Program; Australian Research Council	Project 1.1 (Catchment to Coast Conservation Planning) under the North Australia Hub of the National Environmental Research Program; Australian Research Council(Australian Research Council)	This project was supported by Project 1.1 (Catchment to Coast Conservation Planning) under the North Australia Hub of the National Environmental Research Program. RLP also acknowledges support from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alo CA, 2008, ENVIRON PLANN B, V35, P280, DOI 10.1068/b32091; [Anonymous], [No title captured]; Arnost M, 2013, ABC RURAL; Bryan BA, 2011, ENVIRON MODELL SOFTW, V26, P83, DOI 10.1016/j.envsoft.2010.03.034; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chatto R., 2003, DISTRIBUTION STATUS; DLRM, 2013, VEG MAPP DAL RIV CAT; Franklin DC, 2005, WILDLIFE RES, V32, P399, DOI 10.1071/WR05052; Kennard MJ, 2010, INTERIM REPORT DEP E; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Menon S, 2001, CONSERV BIOL, V15, P501, DOI 10.1046/j.1523-1739.2001.015002501.x; Nel JL, 2009, BIOL CONSERV, V142, P1605, DOI 10.1016/j.biocon.2009.02.031; NRETAS, 2009, REC SIT CONS SIGN BI; Pascoe-Bell A, 2011, IDENTIFICATION POTEN; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pontius RG, 2004, ECOL MODEL, V179, P445, DOI 10.1016/j.ecolmodel.2004.05.010; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Setterfield SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059144; SEWPaC, 2012, INT BIOG REG AUSTR V; Stewart P, 2013, ABC RURAL; Tapp V, 2013, ABC RURAL; Verburg P. H., 2004, GeoJournal, V61, P309, DOI 10.1007/s10708-004-4946-y; Visconti P, 2010, CONSERV LETT, V3, P404, DOI 10.1111/j.1755-263X.2010.00130.x; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Webster T., 2009, NO AUSTR LAND WATER; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; Woinarski J, 2007, NATURE OF NORTHERN AUSTRALIA: NATURAL VALUES, ECOLOGICAL PROCESSES AND FUTURE PROSPECTS, P1; Woinarski JCZ, 2013, LAND, V2, P20, DOI 10.3390/land2010020; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x	32	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96479	10.1371/journal.pone.0096479	http://dx.doi.org/10.1371/journal.pone.0096479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798486	gold, Green Published, Green Accepted			2022-12-27	WOS:000336656000081
J	Kotb, A; Hsieh, S; Wells, GA				Kotb, Ahmed; Hsieh, Shuching; Wells, George A.			The Effect of Telephone Support Interventions on Coronary Artery Disease (CAD) Patient Outcomes during Cardiac Rehabilitation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; FOLLOW-UP INTERVENTION; HOME-BASED EXERCISE; HEART-DISEASE; COUNSELING INTERVENTION; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; HEALTH OPTIONS; CHOICE CHOICE	Background: Cardiac rehabilitation is offered to individuals after cardiac events to aid recovery and reduce the likelihood of further cardiac illness. However, patient participation remains suboptimal and the provision of high quality care to an expanding population of patients with chronic heart conditions is becoming increasingly difficult. A systematic review and meta-analysis was conducted to determine the effect of telephone support interventions compared with standard post-discharge care on coronary artery disease patient outcomes. Methods: The Cochrane Library, MEDLINE, EMBASE, and CINAHL were searched and randomized controlled trials that directly compared telephone interventions with standard post-discharge care in adults following a myocardial infarction or a revascularization procedure were included. Study selection, data extraction and quality assessment were completed independently by two reviewers. Where appropriate, outcome data were combined and analyzed using a random effects model. For each dichotomous outcome, odds ratios (OR) and 95% confidence intervals (CI) were derived for each outcome. For continuous outcomes, weighted mean differences (WMD) and standardized mean differences (SMD) and 95% CI were calculated. Results: 26 studies met the inclusion criteria. No difference was observed in mortality between the telephone group and the group receiving standard care OR 1.12 (0.71, 1.77). The intervention was significantly associated with fewer hospitalizations than the comparison group OR 0.62 (0.40, 0.97). Significantly more participants in the telephone group stopped smoking OR 1.32 (1.07, 1.62); had lower systolic blood pressure WMD -0.22 (-0.40, -0.04); lower depression scores SMD -0.10 (-0.21, -0.00); and lower anxiety scores SMD -0.14 (-0.24, -0.04). However, no significant difference was observed for low-density lipoprotein levels WMD -0.10 (-0.23, 0.03). Conclusions: Compared to standard post-discharge care, regular telephone support interventions may help reduce feelings of anxiety and depression as well as, improve systolic blood pressure control and the likelihood of smoking cessation.	[Kotb, Ahmed; Wells, George A.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Kotb, Ahmed; Hsieh, Shuching; Wells, George A.] Univ Ottawa, Inst Heart, Cardiovasc Res Methods Ctr, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Kotb, A (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	akotb@ottawaheart.ca	Wells, George A/M-4549-2017	Wells, George A/0000-0002-2289-9139; Kotb, Ahmed/0000-0001-5066-2836	Ontario Graduate Scholarship	Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This research was funded by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	[Anonymous], DEF COR ART DIS; Arthur HM, 2002, MED SCI SPORT EXER, V34, P1544, DOI 10.1097/00005768-200210000-00003; Balady GJ, 2007, CIRCULATION, V115, P2675, DOI 10.1161/CIRCULATIONAHA.106.180945; Bambauer KZ, 2005, PSYCHOSOM MED, V67, P539, DOI 10.1097/01.psy.0000171810.37958.61; Barth J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006886; Bazargani RH, 2011, PROCD SOC BEHV, V30, DOI 10.1016/j.sbspro.2011.10.158; BECKIE T, 1989, HEART LUNG, V18, P46; Best JD, 2002, J CLIN EPIDEMIOL, V55; Beswick AD, 2004, HEALTH TECHNOL ASSES, V8, P1; Davies P, 2010, COCHRANE DATABASE SY; Ekici B, 2014, KARDIOL POL, V72, P617, DOI 10.5603/KP.a2014.0023; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; Gallagher R, 2003, HEART LUNG, V32, P79, DOI 10.1067/mhl.2003.19; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Hanssen TA, 2007, EUR J CARDIOV PREV R, V14, P429, DOI 10.1097/HJR.0b013e32801da123; Hanssen TA, 2009, J CLIN NURS, V18, P1334, DOI 10.1111/j.1365-2702.2008.02654.x; Hartford K, 2002, HEART LUNG, V31, P199, DOI 10.1067/mhl.2002.122942; Holmes-Rovner M, 2008, J GEN INTERN MED, V23, P1464, DOI 10.1007/s11606-008-0710-1; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Jolliffe JA, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800, DOI 10.1093/eurheartj/ehm316, DOI 10.1002/14651858.CD001800]; Ma YS, 2010, CHOLESTEROL, DOI 10.1155/2010/383281; McLaughlin TJ, 2005, J GEN INTERN MED, V20, P1084, DOI 10.1111/j.1525-1497.2005.00256.x; MedicineNet, DEF HEART FAIL; Mittag O, 2006, INT J REHABIL RES, V29, P295, DOI 10.1097/MRR.0b013e328010ba9a; National Institute for Health and Clinical Excellence, 2007, MI SEC PREV SEC PREV, V48; Neubeck L, 2009, EUR HEART J, V30, P76; Neubeck L, 2011, EUROPEAN J CARDIOVAS, V18; Neubeck L, 2009, EUR J CARDIOV PREV R, V16, P281, DOI 10.1097/HJR.0b013e32832a4e7a; Redfern J, 2009, HEART, V95, P468, DOI 10.1136/hrt.2008.150870; Redfern J, 2008, J CARDIOPULM REHABIL, V28; Redfern J, 2010, INT J CARDIOL, V145, P481, DOI 10.1016/j.ijcard.2010.04.035; Reid RD, 2007, PATIENT EDUC COUNS, V66, P319, DOI 10.1016/j.pec.2007.01.005; Smith KM, 2011, HEART, V97, P1169, DOI 10.1136/hrt.2010.202036; Smith KM, 2004, EUR J CARDIOV PREV R, V11, P313, DOI 10.1097/01.hjr.0000136414.40017.10; Smith KM, 2007, SUSTAINABILITY EXERC; Stevens B, 1985, THESIS U ALBERTA CAN; Stone JA, 2005, CAN J CARDIOL, V21, p5D; Taylor RS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007130.pub2; Taylor RS, 2004, AM J MED, V116, P682, DOI 10.1016/j.amjmed.2004.01.009; Tranmer JE, 2004, WESTERN J NURS RES, V26, P515, DOI 10.1177/0193945904265690; Vale MJ, 2003, ARCH INTERN MED, V163; VANELDERENVANKEMENADE T, 1994, BRIT J CLIN PSYCHOL, V33, P367, DOI 10.1111/j.2044-8260.1994.tb01133.x; Versteeg H, 2013, J PSYCHOSOM RES, V75, P518, DOI 10.1016/j.jpsychores.2013.10.005; Whalley B, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002902.pub3, 10.1002/14651858.CD002902]	44	31	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96581	10.1371/journal.pone.0096581	http://dx.doi.org/10.1371/journal.pone.0096581			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798429	gold, Green Published			2022-12-27	WOS:000336656000099
J	Luo, AP; Yu, XF; Li, GC; Ma, G; Chen, HY; Ding, F; Li, Y; Liu, ZH				Luo, Aiping; Yu, Xinfeng; Li, Guichang; Ma, Gang; Chen, Hongyan; Ding, Fang; Li, Yi; Liu, Zhihua			Differentiation-Associated Genes Regulated by c-Jun and Decreased in the Progression of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							CORNIFIED ENVELOPE; KERATINOCYTE DIFFERENTIATION; EPIDERMAL DIFFERENTIATION; STRUCTURAL ORGANIZATION; BARRIER FUNCTION; TUMOR PROMOTION; STEM-CELLS; CYSTATIN-A; EXPRESSION; SKIN	Transcription factor c-Jun plays a key role in controlling epithelium cell proliferation, apoptosis and differentiation. However, molecular mechanism and biological functions of c-Jun in squamous differentiation and the progression of esophageal squamous cell carcinoma (ESCC) remain elusive. In this study, we found that c-Jun bound directly to the promoter region, and activated the transcription of differentiation-associated genes including cystatin A, involucrin and SPRR3 in vivo. Ectopic expression of c-Jun enhanced SPRR3 transactivation in KYSE450 cells. Conversely, TAM67, a dominant negative mutant of c-Jun, inhibited SPRR3 transactivation. c-Jun increased expression of SPPR3 mainly via a PKC/JNK pathway in response to TPA in KYSE450 cells. Furthermore, c-Jun was remarkably reduced in esophageal cancer. Interestingly, cystatin A, involucrin and SPRR3 were significantly downregulated as well, and associated with differentiation grade. Expression of c-Jun was correlated with the expression of these genes in normal epithelium and ESCC. Importantly, the expression of these genes was remarkably decreased during the malignant transformation from normal epithelium to low-grade intraepithelial neoplasia (LGIN) or high-grade intraepithelial neoplasia (HGIN). The expression of cystatin A and involucrin was significantly reduced from LGIN to HGIN. These results suggest c-Jun was involved in the regulation of differentiation-associated genes in ESCC. These genes might serve as the potential markers in distinguishing normal epithelium from esophageal squamous intraepithelial neoplasia.	[Luo, Aiping; Ma, Gang; Chen, Hongyan; Ding, Fang; Li, Yi; Liu, Zhihua] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Yu, Xinfeng] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Dept Pharmacol, Beijing, Peoples R China; [Li, Guichang] Chinese Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Dept Med & Biol Control, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Capital Medical University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Liu, ZH (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	liuzh@cicams.ac.cn			National Basic Research Program of China [2011CB504205, 2013CB911004]; National Natural Science Foundation of China [81101740, 81130043, 81201818]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Basic Research Program of China(2011CB504205, 2013CB911004) and National Natural Science Foundation of China (81101740, 81130043, 81201818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Baroni A, 2012, CLIN DERMATOL, V30, P257, DOI 10.1016/j.clindermatol.2011.08.007; BROWN PH, 1994, ONCOGENE, V9, P791; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cooper SJ, 2003, MOL CANCER RES, V1, P848; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Croagh D, 2008, STEM CELL REV, V4, P261, DOI 10.1007/s12015-008-9031-3; Doupe DP, 2012, SCIENCE, V337, P1091, DOI 10.1126/science.1218835; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Geboes K, 1978, Front Gastrointest Res, V3, P1; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Han BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036941; HAWLEYNELSON P, 1988, MOL CARCINOGEN, V1, P202, DOI 10.1002/mc.2940010309; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ishida-Yamamoto A, 1998, EXP DERMATOL, V7, P1, DOI 10.1111/j.1600-0625.1998.tb00295.x; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Jones SJ, 1997, J INVEST DERMATOL, V109, P187, DOI 10.1111/1523-1747.ep12319308; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Lehrbach Dárcio Matenhauer, 2003, Arq. Gastroenterol., V40, P256, DOI 10.1590/S0004-28032003000400011; Licht AH, 2010, J CLIN INVEST, V120, P2307, DOI 10.1172/JCI41749; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Mandard AM, 2000, MUTAT RES-REV MUTAT, V462, P335, DOI 10.1016/S1383-5742(00)00019-3; Mehic D, 2005, J INVEST DERMATOL, V124, P212, DOI 10.1111/j.0022-202X.2004.23558.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MURPHY GF, 1984, J INVEST DERMATOL, V82, P453, DOI 10.1111/1523-1747.ep12260945; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Nagarajan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004179; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Sakamoto K, 2011, HISTOPATHOLOGY, V58, P531, DOI 10.1111/j.1365-2559.2011.03759.x; Seery JP, 2002, J CELL SCI, V115, P1783; Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4; Sevilla LM, 2007, J CELL BIOL, V179, P1599, DOI 10.1083/jcb.200706187; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Takahashi H, 1998, J BIOL CHEM, V273, P17375, DOI 10.1074/jbc.273.28.17375; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Thompson EJ, 2002, CANCER RES, V62, P3044; Wang WC, 2011, HUM PATHOL, V42, P1430, DOI 10.1016/j.humpath.2010.12.009; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yu XF, 2006, BIOCHEM BIOPH RES CO, V342, P286, DOI 10.1016/j.bbrc.2006.01.147; Zhang LQ, 2005, EMBO J, V24, P766, DOI 10.1038/sj.emboj.7600532; Zhang Y, 2008, INT J CANCER, V122, P260, DOI 10.1002/ijc.23104; Zucchini C, 2001, INT J ONCOL, V19, P1133	55	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96610	10.1371/journal.pone.0096610	http://dx.doi.org/10.1371/journal.pone.0096610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796531	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000104
J	Rudzinska, M; Gawel, D; Sikorska, J; Karpinska, KM; Kiedrowski, M; Stepien, T; Marchlewska, M; Czarnocka, B				Rudzinska, Magdalena; Gawel, Damian; Sikorska, Justyna; Karpinska, Kamila M.; Kiedrowski, Miroslaw; Stepien, Tomasz; Marchlewska, Magdalena; Czarnocka, Barbara			The Role of Podoplanin in the Biology of Differentiated Thyroid Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION PROFILES; PREDICTS POOR-PROGNOSIS; CENTRAL-NERVOUS-SYSTEM; LYMPH-NODE METASTASIS; EXTRACELLULAR-MATRIX; MICROARRAY ANALYSIS; ECTOPIC EXPRESSION; TUMOR INVASION	Podoplanin (PDPN), a mucin-type transmembrane glycoprotein specific to the lymphatic system is expressed in a variety of human cancers, and is regarded as a factor promoting tumor progression. The purpose of this study was to elucidate the molecular role of PDPN in the biology of thyroid cancer cells. PDPN expression was evaluated in primary thyroid carcinomas and thyroid carcinoma cell lines by RT-qPCR, Western blotting, IF and IHC. To examine the role of podoplanin in determining a cell's malignant potential (cellular migration, invasion, proliferation, adhesion, motility, apoptosis), a thyroid cancer cell line with silenced PDPN expression was used. We observed that PDPN was solely expressed in the cancer cells of 40% of papillary thyroid carcinoma (PTC) tissues. Moreover, PDPN mRNA and protein were highly expressed in PTC-derived TPC1 and BcPAP cell lines but were not detected in follicular thyroid cancer derived cell lines. PDPN knock-down significantly decreased cellular invasion, and modestly reduced cell migration, while proliferation and adhesion were not affected. Our results demonstrate that PDPN mediates the invasive properties of cells derived from papillary thyroid carcinomas, suggesting that podoplanin might promote PTC progression.	[Rudzinska, Magdalena; Gawel, Damian; Sikorska, Justyna; Karpinska, Kamila M.; Czarnocka, Barbara] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland; [Kiedrowski, Miroslaw] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol, Warsaw, Poland; [Kiedrowski, Miroslaw] Inst Oncol, Warsaw, Poland; [Stepien, Tomasz; Marchlewska, Magdalena] Copernicus Mem Hosp, Dept Gen & Endocrinol Surg, Lodz, Poland	Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Czarnocka, B (corresponding author), Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland.	barbaracmkp@gmail.com	Gawel, Damian/U-4218-2019; Sikorska, Justyna/K-5010-2012; Czarnocka, Barbara/V-1048-2019	Gawel, Damian/0000-0002-1270-5505; Czarnocka, Barbara/0000-0001-7701-760X; Rudzinska-Radecka, Magdalena/0000-0001-9912-2128; Stepien, Tomasz/0000-0003-3569-1932; Kiedrowski, Miroslaw/0000-0003-1361-9286	National Science Center, Poland [2012/07/B/NZ5/02444]	National Science Center, Poland(National Science Centre, Poland)	This work was supported by grant 2012/07/B/NZ5/02444 from The National Science Center, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Breiteneder-Geleff S, 1999, Verh Dtsch Ges Pathol, V83, P270; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Chuang WY, 2009, HISTOL HISTOPATHOL, V24, P1021, DOI 10.14670/HH-24.1021; Chung YS, 2009, THYROID, V19, P241, DOI 10.1089/thy.2008.0244; Cueni LN, 2010, AM J PATHOL, V177, P1004, DOI 10.2353/ajpath.2010.090703; Dumoff KL, 2006, MODERN PATHOL, V19, P708, DOI 10.1038/modpathol.3800580; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Fernandez-Munoz B, 2011, INT J BIOCHEM CELL B, V43, P886, DOI 10.1016/j.biocel.2011.02.010; Frasca F, 2008, ENDOCR-RELAT CANCER, V15, P191, DOI 10.1677/ERC-07-0212; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Gorka B, 2007, BRIT J CANCER, V97, P531, DOI 10.1038/sj.bjc.6603915; Guarino V, 2005, J CLIN ENDOCR METAB, V90, P5270, DOI 10.1210/jc.2005-0271; Hall FT, 2003, ARCH OTOLARYNGOL, V129, P716, DOI 10.1001/archotol.129.7.716; Hansen T, 2007, VIRCHOWS ARCH, V450, P449, DOI 10.1007/s00428-007-0376-9; Inoue H, 2012, J ORAL SCI, V54, P241, DOI 10.2334/josnusd.54.241; ISHIZAKA Y, 1990, BIOCHEM BIOPH RES CO, V168, P402, DOI 10.1016/0006-291X(90)92335-W; Ito T, 2009, LUNG CANCER, V63, P418, DOI 10.1016/j.lungcan.2008.06.008; Ito Y, 2012, WORLD J SURG, V36, P1274, DOI 10.1007/s00268-012-1423-5; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Knauf JA, 2003, ONCOGENE, V22, P4406, DOI 10.1038/sj.onc.1206602; Kreppel M, 2010, VIRCHOWS ARCH, V456, P473, DOI 10.1007/s00428-010-0915-7; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liu DX, 2007, J CLIN ENDOCR METAB, V92, P2264, DOI 10.1210/jc.2006-1613; Lu YM, 2007, CANCER INVEST, V25, P393, DOI 10.1080/07357900701508934; Martin-Villar E, 2005, INT J CANCER, V113, P899, DOI 10.1002/ijc.20656; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Martin-Villar E, 2010, MOL BIOL CELL, V21, P4387, DOI 10.1091/mbc.E10-06-0489; Mashhadiabbas F, 2012, OR SURG OR MED OR PA, V114, P240, DOI 10.1016/j.oooo.2012.04.009; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Mishima K, 2006, ACTA NEUROPATHOL, V111, P563, DOI 10.1007/s00401-006-0033-4; Mitsutake N, 2006, ENDOCRINOLOGY, V147, P1014, DOI 10.1210/en.2005-0280; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Navarro A, 2008, AM J PHYSIOL-LUNG C, V295, pL543, DOI 10.1152/ajplung.90262.2008; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Nixon IJ, 2012, THYROID; Ochoa-Alvarez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041845; Ordonez NG, 2006, ADV ANAT PATHOL, V13, P83, DOI 10.1097/01.pap.0000213007.48479.94; Paes JE, 2008, ENDOCRIN METAB CLIN, V37, P375, DOI 10.1016/j.ecl.2008.01.001; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Rodrigo JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-48; Scholl FG, 2000, LAB INVEST, V80, P1749, DOI 10.1038/labinvest.3780185; Schoppmann SF, 2013, CLIN EXP METASTAS, V30, P441, DOI 10.1007/s10585-012-9549-2; Shen YQ, 2010, J BIOL CHEM, V285, P9649, DOI 10.1074/jbc.M109.047696; Shibahara J, 2006, VIRCHOWS ARCH, V448, P493, DOI 10.1007/s00428-005-0133-x; Shintaku M, 2010, BRAIN TUMOR PATHOL, V27, P23, DOI 10.1007/s10014-009-0262-z; Siironen P, 2005, TUMOR BIOL, V26, P57, DOI 10.1159/000085586; Skubis-Zegadlo J, 2005, BRIT J CANCER, V93, P144, DOI 10.1038/sj.bjc.6602628; Soares P, 2003, ONCOGENE, V22, P4578, DOI 10.1038/sj.onc.1206706; Sugitani I, 2008, SURGERY, V143, P35, DOI 10.1016/j.surg.2007.06.011; Suzuki H, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-287; Takagi S, 2014, INT J CANCER, V134, P2605, DOI 10.1002/ijc.28602; Takeuchi T, 2010, INT J CLIN EXP PATHO, V3, P634; TANAKA J, 1987, VIROLOGY, V161, P62, DOI 10.1016/0042-6822(87)90171-1; Tsuneki M, 2013, LAB INVEST, V93, P921, DOI 10.1038/labinvest.2013.86; Tsuneki M, 2013, VIRCHOWS ARCH, V462, P297, DOI 10.1007/s00428-012-1359-z; Valster A, 2005, METHODS, V37, P208, DOI 10.1016/j.ymeth.2005.08.001; Wang JW, 2003, MOL ENDOCRINOL, V17, P1425, DOI 10.1210/me.2003-0041; Wang SL, 2007, APMIS, V115, P906, DOI 10.1111/j.1600-0463.2007.apm_653.x; WATANABE M, 1990, CANCER RES, V50, P6657; Weng LP, 2001, HUM MOL GENET, V10, P251, DOI 10.1093/hmg/10.3.251; Wetterwald A, 1996, BONE, V18, P125, DOI 10.1016/8756-3282(95)00457-2; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Yasuoka H, 2005, MODERN PATHOL, V18, P1127, DOI 10.1038/modpathol.3800402; Yu HB, 2007, AM J CLIN PATHOL, V128, P776, DOI 10.1309/7P8U659JBJCV6EEU; Yurrita MM, 2014, INT J BIOCHEM CELL B, V46, P68, DOI 10.1016/j.biocel.2013.11.016; Zaydfudim V, 2008, SURGERY, V144, P1070, DOI 10.1016/j.surg.2008.08.034	75	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96541	10.1371/journal.pone.0096541	http://dx.doi.org/10.1371/journal.pone.0096541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797369	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000090
J	Walterson, AM; Smith, DDN; Stavrinides, J				Walterson, Alyssa M.; Smith, Derek D. N.; Stavrinides, John			Identification of a Pantoea Biosynthetic Cluster That Directs the Synthesis of an Antimicrobial Natural Product	PLOS ONE			English	Article							ERWINIA-HERBICOLA EH1087; CAUSAL AGENT; FIRE-BLIGHT; GENE-CLUSTER; HETEROLOGOUS EXPRESSION; ANTIBIOTIC PRODUCTION; BIOLOGICAL-CONTROL; PINK DISEASE; STRAIN E325; AMYLOVORA	Fire Blight is a destructive disease of apple and pear caused by the enteric bacterial pathogen, Erwinia amylovora. E. amylovora initiates infection by colonizing the stigmata of apple and pear trees, and entering the plants through natural openings. Epiphytic populations of the related enteric bacterium, Pantoea, reduce the incidence of disease through competition and antibiotic production. In this study, we identify an antibiotic from Pantoea ananatis BRT175, which is effective against E. amylovora and select species of Pantoea. We used transposon mutagenesis to create a mutant library, screened approximately 5,000 mutants for loss of antibiotic production, and recovered 29 mutants. Sequencing of the transposon insertion sites of these mutants revealed multiple independent disruptions of an 8.2 kb cluster consisting of seven genes, which appear to be coregulated. An analysis of the distribution of this cluster revealed that it was not present in any other of our 115 Pantoea isolates, or in any of the fully sequenced Pantoea genomes, and is most closely related to antibiotic biosynthetic clusters found in three different species of Pseudomonas. This identification of this biosynthetic cluster highlights the diversity of natural products produced by Pantoea.	[Walterson, Alyssa M.; Smith, Derek D. N.; Stavrinides, John] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	University of Regina	Stavrinides, J (corresponding author), Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada.	john.stavrinides@uregina.ca			University of Regina Faculty of Graduate Studies and Research; Rx&D Health Research Foundation; Master's Award from the Canadian Institutes of Health Research; Discovery Grant from the Natural Sciences and Engineering Council of Canada [386654-2010]; LOF from the Canada Foundation for Innovation [28591]; University of Regina Faculty of Science	University of Regina Faculty of Graduate Studies and Research; Rx&D Health Research Foundation; Master's Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Discovery Grant from the Natural Sciences and Engineering Council of Canada(CGIAR); LOF from the Canada Foundation for Innovation; University of Regina Faculty of Science	AW was supported by scholarships from the University of Regina Faculty of Graduate Studies and Research, and awards from the Rx&D Health Research Foundation. DDNS was funded by a Master's Award from the Canadian Institutes of Health Research. This work was funded by a Discovery Grant from the Natural Sciences and Engineering Council of Canada (386654-2010), an LOF from the Canada Foundation for Innovation (28591), and funding from the University of Regina Faculty of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Aleshin VV, 1999, TRENDS BIOCHEM SCI, V24, P133, DOI 10.1016/S0968-0004(99)01367-5; ALEXEYEV MF, 1995, CAN J MICROBIOL, V41, P1053, DOI 10.1139/m95-147; Azad HR, 2000, PLANT DIS, V84, P973, DOI 10.1094/PDIS.2000.84.9.973; Beer S. V., 1984, ACTA HORTIC, V151, P203; Bell AA, 2004, FREQUENCY PATHOGENIC; Bonn WG, 2000, FIRE BLIGHT, P37, DOI 10.1079/9780851992945.0037; Brady CL, 2009, INT J SYST EVOL MICR, V59, P2339, DOI 10.1099/ijs.0.009241-0; Brady SF, 1999, J AM CHEM SOC, V121, P11912, DOI 10.1021/ja992790m; Cha JS, 1997, J PHYTOPATHOL, V145, P313, DOI 10.1111/j.1439-0434.1997.tb00407.x; CHATTERJ.AK, 1969, CAN J MICROBIOL, V15, P640, DOI 10.1139/m69-110; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; Coplin DL, 2002, PLANT DIS, V86, P304, DOI 10.1094/PDIS.2002.86.3.304; COPLIN DL, 1986, J BACTERIOL, V168, P619, DOI 10.1128/jb.168.2.619-623.1986; Cother EJ, 2004, AUSTRALAS PLANT PATH, V33, P495, DOI 10.1071/AP04053; Coutinho TA, 2002, PLANT DIS, V86, P20, DOI 10.1094/PDIS.2002.86.1.20; ELGOORANI MA, 1992, J PHYTOPATHOL, V136, P335, DOI 10.1111/j.1439-0434.1992.tb01316.x; Fucikovsky L, 2006, PHYTOPATHOLOGY, V96, pS37; Giddens SR, 2002, MOL MICROBIOL, V45, P769, DOI 10.1046/j.1365-2958.2002.03048.x; Giddens SR, 2003, ENVIRON MICROBIOL, V5, P1016, DOI 10.1046/j.1462-2920.2003.00506.x; Girard G, 2011, MICROBIOL-SGM, V157, P398, DOI 10.1099/mic.0.043075-0; Gitaitis RD, 1997, PLANT DIS, V81, P1096, DOI 10.1094/PDIS.1997.81.9.1096C; GU ZM, 1992, GENE, V119, P123, DOI 10.1016/0378-1119(92)90076-2; Jin M, 2003, ANGEW CHEM INT EDIT, V42, P2898, DOI 10.1002/anie.200351053; Jin M, 2003, ANGEW CHEM INT EDIT, V42, P2902, DOI 10.1002/anie.200351054; Johnson KB, 2000, FIRE BLIGHT, P319, DOI 10.1079/9780851992945.0319; JOHNSON KB, 1993, PHYTOPATHOLOGY, V83, P995, DOI 10.1094/Phyto-83-995; Kamber T, 2012, TREES-STRUCT FUNCT, V26, P227, DOI 10.1007/s00468-011-0619-x; Kearns LP, 1998, APPL ENVIRON MICROB, V64, P1837; Kido K, 2008, J GEN PLANT PATHOL, V74, P302, DOI 10.1007/s10327-008-0107-3; Magarvey N, 2001, MICROBIOL-SGM, V147, P2103, DOI 10.1099/00221287-147-8-2103; MAKOFF AJ, 1978, MICROBIOL REV, V42, P307, DOI 10.1128/MMBR.42.2.307-328.1978; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marin-Cevada V, 2006, PLANT PATHOL, V55, P294, DOI 10.1111/j.1365-3059.2005.01331.x; Martin JF, 1998, APPL MICROBIOL BIOT, V50, P1, DOI 10.1007/s002530051249; Mavrodi DV, 2013, ENVIRON MICROBIOL, V15, P675, DOI 10.1111/j.1462-2920.2012.02846.x; Nadarasah G, 2014, MICROBIOL-SGM, V160, P602, DOI 10.1099/mic.0.073452-0; Ozaktan H, 2004, BRAZ J MICROBIOL, V35, P224, DOI 10.1590/S1517-83822004000200010; Perez-y-Terron R, 2009, AUSTRALAS PLANT DIS, V4, P96, DOI 10.1071/DN09041; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Pusey PL, 2008, PHYTOPATHOLOGY, V98, P1136, DOI 10.1094/PHYTO-98-10-1136; Pusey PL, 2011, PHYTOPATHOLOGY, V101, P1234, DOI 10.1094/PHYTO-09-10-0253; Resch M, 2012, NUC ACIDS RES, V38, P2485; RIGGLE JH, 1972, CAN J BOTANY, V50, P1077, DOI 10.1139/b72-133; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; Schatz A, 2005, CLIN ORTHOP RELAT R, P3; Sholberg PL, 2008, ACTA HORTIC, V793, P423, DOI 10.17660/ActaHortic.2008.793.64; SLININGER PJ, 1992, APPL MICROBIOL BIOT, V37, P388, DOI 10.1007/BF00210998; Smith D.D.N., 2013, GENOME ANNOUNCEMENTS, V1; Smith DDN, 2013, GENOME ANNOUNC, V1; Smits THM, 2010, J BACTERIOL, V192, P6486, DOI 10.1128/JB.01122-10; Smits THM., 2011, PLOS ONE, V6; THOMSON SV, 1992, P NZ PLAN P, P295, DOI 10.30843/nzpp.1992.45.11243; Vanneste JL, 2008, ACTA HORTIC, V793, P391; Vanneste JL, 2002, ACTA HORTIC, P285, DOI 10.17660/ActaHortic.2002.590.42; Vanneste JL, 2000, ACTA HORTIC, P39; Vrljic M., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P327; Walcott RR, 2002, PLANT DIS, V86, P106, DOI 10.1094/PDIS.2002.86.2.106; Wright SAI, 2006, ACTA HORTIC, P313, DOI 10.17660/ActaHortic.2006.704.45; Wright S. A. I., 1996, Acta Horticulturae, P309; Wright SAI, 2001, APPL ENVIRON MICROB, V67, P284, DOI 10.1128/AEM.67.1.284-292.2001; Wright SAI, 2002, ACTA HORTIC, P237, DOI 10.17660/ActaHortic.2002.590.34	63	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96208	10.1371/journal.pone.0096208	http://dx.doi.org/10.1371/journal.pone.0096208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796857	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000047
J	Yu, Y; Carter, CRJ; Youssef, N; Dyck, JRB; Light, PE				Yu, Yi; Carter, Chris R. J.; Youssef, Nermeen; Dyck, Jason R. B.; Light, Peter E.			Intracellular Long-Chain Acyl CoAs Activate TRPV1 Channels	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; SODIUM-CALCIUM EXCHANGE; COENZYME-A ESTERS; FREE FATTY-ACID; K-ATP CHANNELS; CAPSAICIN RECEPTOR; BINDING-PROTEIN; ION-CHANNEL; PLASMA-GLUCOSE; OBESITY	TRPV1 channels are an important class of membrane proteins that play an integral role in the regulation of intracellular cations such as calcium in many different tissue types. The anionic phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) is a known positive modulator of TRPV1 channels and the negatively charged phosphate groups interact with several basic amino acid residues in the proximal C-terminal TRP domain of the TRPV1 channel. We and other groups have shown that physiological sub-micromolar levels of long-chain acyl CoAs (LC-CoAs), another ubiquitous anionic lipid, can also act as positive modulators of ion channels and exchangers. Therefore, we investigated whether TRPV1 channel activity is similarly regulated by LC-CoAs. Our results show that LC-CoAs are potent activators of the TRPV1 channel and interact with the same PIP2-binding residues in TRPV1. In contrast to PIP2, LC-CoA modulation of TRPV1 is independent of Ca2+ i, acting in an acyl side-chain saturation and chain-length dependent manner. Elevation of LC-CoAs in intact Jurkat T-cells leads to significant increases in agonist-induced Ca2+ i levels. Our novel findings indicate that LC-CoAs represent a new fundamental mechanism for regulation of TRPV1 channel activity that may play a role in diverse cell types under physiological and pathophysiological conditions that alter fatty acid transport and metabolism such as obesity and diabetes.	[Yu, Yi; Carter, Chris R. J.; Youssef, Nermeen; Light, Peter E.] Univ Alberta, Fac Med & Dent, Alberta Diabet Inst, Dept Pharmacol, Edmonton, AB, Canada; [Dyck, Jason R. B.] Univ Alberta, Fac Med & Dent, Dept Pediat, Edmonton, AB, Canada	University of Alberta; University of Alberta	Light, PE (corresponding author), Univ Alberta, Fac Med & Dent, Alberta Diabet Inst, Dept Pharmacol, Edmonton, AB, Canada.	peter.light@ualberta.ca		Dyck, Jason/0000-0002-7045-2884	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was funded by the Canadian Institutes of Health Research and the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Digel M, 2009, MOL CELL BIOCHEM, V326, P23, DOI 10.1007/s11010-008-0003-3; Faergeman NJ, 2002, BIOCHEM J, V368, P679, DOI 10.1042/BJ20021413; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fox JEM, 2004, MOL ENDOCRINOL, V18, P679, DOI 10.1210/me.2003-0431; GOLAY A, 1986, J CLIN ENDOCR METAB, V63, P481, DOI 10.1210/jcem-63-2-481; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; Hamming KSC, 2008, MOL ENDOCRINOL, V22, P2293, DOI 10.1210/me.2008-0053; Harmancey R, 2010, J LIPID RES, V51, P1380, DOI 10.1194/jlr.M001230; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jung J, 1999, J NEUROSCI, V19, P529; Keeble J, 2005, ARTHRITIS RHEUM, V52, P3248, DOI 10.1002/art.21297; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Larsson O, 1996, J BIOL CHEM, V271, P10623, DOI 10.1074/jbc.271.18.10623; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu DY, 2008, HYPERTENS RES, V31, P1989, DOI 10.1291/hypres.31.1989; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Matta JA, 2007, J PHYSIOL-LONDON, V578, P397, DOI 10.1113/jphysiol.2006.121988; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; Musumeci G, 2011, NEUROBIOL DIS, V43, P669, DOI 10.1016/j.nbd.2011.05.018; Nieto-Posadas A, 2012, NAT CHEM BIOL, V8, P78, DOI 10.1038/nchembio.712; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Qin F., 2007, V179, P509; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; REQUERO MA, 1995, FEBS LETT, V357, P75; Riedel MJ, 2006, EMBO J, V25, P4605, DOI 10.1038/sj.emboj.7601321; Riedel MJ, 2005, DIABETES, V54, P2070, DOI 10.2337/diabetes.54.7.2070; Riedel MJ, 2003, DIABETES, V52, P2630, DOI 10.2337/diabetes.52.10.2630; Sabin MA, 2007, PEDIATRICS, V120, pE1426, DOI 10.1542/peds.2007-0189; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; Simonsen AC, 2003, FEBS LETT, V552, P253, DOI 10.1016/S0014-5793(03)00970-0; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suri A, 2008, TRENDS PHARMACOL SCI, V29, P29, DOI 10.1016/j.tips.2007.10.016; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85; Vyklicky L, 2008, PHYSIOL RES, V57, pS59, DOI 10.33549/physiolres.931478; Webster NJ, 2008, ENDOCRINOLOGY, V149, P3679, DOI 10.1210/en.2007-1138; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhu ZM, 2011, PFLUG ARCH EUR J PHY, V461, P211, DOI 10.1007/s00424-010-0902-5	54	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96597	10.1371/journal.pone.0096597	http://dx.doi.org/10.1371/journal.pone.0096597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798548	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000101
J	Christiansen, JH; Christensen, J; Grunbaum, T; Kyllingsbaek, S				Christiansen, Jens H.; Christensen, Jeppe; Grunbaum, Thor; Kyllingsbaek, Soren			A Common Representation of Spatial Features Drives Action and Perception: Grasping and Judging Object Features within Trials	PLOS ONE			English	Article							VISUAL ILLUSIONS; PATIENT DF; DISSOCIATION; REAL; PATHWAYS; VISION; TIME	Spatial features of an object can be specified using two different response types: either by use of symbols or motorically by directly acting upon the object. Is this response dichotomy reflected in a dual representation of the visual world: one for perception and one for action? Previously, symbolic and motoric responses, specifying location, has been shown to rely on a common representation. What about more elaborate features such as length and orientation? Here we show that when motoric and symbolic responses are made within the same trial, the probability of making the same symbolic and motoric response is well above chance for both length and orientation. This suggests that motoric and symbolic responses to length and orientation are driven by a common representation. We also show that, for both response types, the spatial features of an object are processed independently. This finding of matching object-processing characteristics is also in agreement with the idea of a common representation driving both response types.	[Christiansen, Jens H.; Christensen, Jeppe; Kyllingsbaek, Soren] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Grunbaum, Thor] Univ Copenhagen, Dept Media Commun & Cognit, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Christiansen, JH (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	jens.h.christiansen@gmail.com		Kyllingsbaek, Soren/0000-0002-4100-437X; Grunbaum, Thor/0000-0002-6464-8098; Christensen, Jeppe Hoy/0000-0002-6666-8869	 [10-080263];  [10-089757]	; 	URL of funder's website: http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad. Grant numbers: 10-080263 (Intentional action, attention to objects, and working memory) and 10-089757 (Sapere Aude: Modeling Visual Cognition - Perception, Attention, and short-term memory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno N, 2009, NEUROPSYCHOLOGIA, V47, P1421, DOI 10.1016/j.neuropsychologia.2008.10.031; Cardoso-Leite P, 2010, SEEING PERCEIVING, V23, P89, DOI 10.1163/187847510X503588; Cavina-Pratesi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000424; Dyde RT, 2002, EXP BRAIN RES, V144, P518, DOI 10.1007/s00221-002-1065-1; Franz VH, 2000, PSYCHOL SCI, V11, P20, DOI 10.1111/1467-9280.00209; Franz V, 2008, COGN NEUROPSYCHOL, V25, P920, DOI 10.1080/02643290701862449; Ganel T, 2008, CURR BIOL, V18, pR599, DOI 10.1016/j.cub.2008.04.052; Ganel T, 2008, PSYCHOL SCI, V19, P221, DOI 10.1111/j.1467-9280.2008.02071.x; Ganel T, 2008, CURR BIOL, V18, pR1090, DOI 10.1016/j.cub.2008.10.007; Gangopadhyay N., 2010, PERCEPTION ACTION CO, P71; Gegenfurtner KR, 2007, J VISION, V7, DOI 10.1167/7.5.11; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; Goodale MA, 2004, CURR OPIN NEUROBIOL, V14, P203, DOI 10.1016/j.conb.2004.03.002; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Goodale MA, 2011, VISION RES, V51, P1567, DOI 10.1016/j.visres.2010.07.027; Hesse C, 2010, VISION RES, V50, P2642, DOI 10.1016/j.visres.2010.07.026; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kyllingsbaek S, 2007, J EXP PSYCHOL HUMAN, V33, P64, DOI 10.1037/0096-1523.33.1.64; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Milner AD, 2012, TRENDS COGN SCI, V16, P256, DOI 10.1016/j.tics.2012.03.004; Milner D, 2003, TRENDS COGN SCI, V7, P10, DOI 10.1016/S1364-6613(02)00004-9; Mitchell T.M, 2003, MACH LEARN; ONO H, 1967, PERCEPT PSYCHOPHYS, V2, P201, DOI 10.3758/BF03213050; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Schenk T, 2012, TRENDS COGN SCI, V16, P258, DOI 10.1016/j.tics.2012.03.006; Schenk T, 2012, J NEUROSCI, V32, P2013, DOI 10.1523/JNEUROSCI.3413-11.2012; Schenk T, 2011, VISION RES, V51, P812, DOI 10.1016/j.visres.2011.02.003; Schenk T, 2010, COGN NEUROSCI-UK, V1, P52, DOI 10.1080/17588920903388950; Singhal A, 2007, J VISION, V7, DOI 10.1167/7.5.5; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; Stone LS, 2003, J VISION, V3, P725, DOI 10.1167/3.11.7; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518; Westwood DA, 2002, EXP BRAIN RES, V144, P262, DOI 10.1007/s00221-002-1068-y; Westwood DA, 2011, VISION RES, V51, P804, DOI 10.1016/j.visres.2010.10.014; Winer BJ, 1971, STAT PRINCIPLES EXPT	36	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94744	10.1371/journal.pone.0094744	http://dx.doi.org/10.1371/journal.pone.0094744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZS	24788941	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700015
J	Palmer, MV; Thacker, TC; Waters, WR; Robbe-Austerman, S				Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray; Robbe-Austerman, Suelee			Oral Vaccination of White-Tailed Deer (Odocoileus virginianus) with Mycobacterium bovis Bacillus Calmette-Guerin (BCG)	PLOS ONE			English	Article							UNITED-STATES; PULMONARY TUBERCULOSIS; WILDLIFE RESERVOIR; BRUSHTAIL POSSUMS; MICHIGAN; INFECTION; EFFICACY; IDENTIFICATION; IMMUNIZATION; PROTECTION	Wildlife reservoirs of Mycobacterium bovis represent serious obstacles to the eradication of tuberculosis from livestock, particularly cattle. In Michigan, USA tuberculous white-tailed deer transmit M. bovis to other deer and cattle. One approach in dealing with this wildlife reservoir is to vaccinate deer, thus interfering with the intraspecies and interspecies transmission cycles. Thirty-three white-tailed deer were assigned to one of two groups; oral vaccination with 1x10(8) colony-forming units of M. bovis BCG Danish (n = 17); and non-vaccinated (n = 16). One hundred eleven days after vaccination deer were infected intratonsilarly with 300 colony-forming units of virulent M. bovis. At examination, 150 days after challenge, BCG vaccinated deer had fewer gross and microscopic lesions, fewer tissues from which M. bovis could be isolated, and fewer late stage granulomas with extensive liquefactive necrosis. Fewer lesions, especially those of a highly necrotic nature should decrease the potential for dissemination of M. bovis within the host and transmission to other susceptible hosts.	[Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray] Agr Res Serv, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA; [Robbe-Austerman, Suelee] Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Palmer, MV (corresponding author), Agr Res Serv, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	mitchell.palmer@ars.usda.gov	Palmer, Mitchell/R-7091-2018	Palmer, Mitchell/0000-0002-5902-3333	United States Department of Agriculture, Agricultural Research Service	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was funded by the United States Department of Agriculture, Agricultural Research Service. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aldwell FE, 2003, VACCINE, V22, P70, DOI 10.1016/S0264-410X(03)00539-5; Ballesteros C, 2009, VACCINE, V27, P6662, DOI 10.1016/j.vaccine.2009.08.095; Ballesteros C, 2011, EUR J WILDLIFE RES, V57, P749, DOI 10.1007/s10344-010-0483-9; Ballesteros C, 2009, RES VET SCI, V86, P388, DOI 10.1016/j.rvsc.2008.09.003; Ben Salah I, 2008, MICROBIOL-SGM, V154, P3715, DOI 10.1099/mic.0.2008/020164-0; Bolin CA, 1997, J INFECT DIS, V176, P1559, DOI 10.1086/514155; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Cross ML, 2007, VET J, V174, P472, DOI 10.1016/j.tvjl.2006.10.005; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Klerk LM, 2010, VET IMMUNOL IMMUNOP, V137, P84, DOI 10.1016/j.vetimm.2010.04.013; DELISLE GW, 1985, NEW ZEAL VET J, V33, P138, DOI 10.1080/00480169.1985.35198; Griffin J. F. T., 1999, Tubercle and Lung Disease, V79, P135, DOI 10.1054/tuld.1998.0202; Griffin JFT, 2006, VACCINE, V24, P835, DOI 10.1016/j.vaccine.2005.07.033; Griffin JFT, 2000, CLIN INFECT DIS, V30, pS223, DOI 10.1086/313865; Griffin JFT, 2000, VET J, V160, P202, DOI 10.1053/tvjl.2000.0514; Hall PB, 2005, J ZOO WILDLIFE MED, V36, P115, DOI 10.1638/04-028; Harmsen D, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-26; Hines N, 2006, J VET DIAGN INVEST, V18, P243, DOI 10.1177/104063870601800302; Hoft Daniel F., 1996, P269, DOI 10.1016/B978-012410580-5/50021-2; Huard RC, 2003, J CLIN MICROBIOL, V41, P1637, DOI 10.1128/JCM.41.4.1637-1650.2003; Johnson LK, 2008, VET J, V175, P409, DOI 10.1016/j.tvjl.2007.04.021; Kierschner P, 1998, METHODS MOL BIOL MYC, P349; Milian-Suazo F, 2000, AM J VET RES, V61, P90, DOI 10.2460/ajvr.2000.61.90; Miller RA, 2006, AM J VET RES, V67, P604, DOI 10.2460/ajvr.67.4.604; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; O'Brien DJ, 2011, VET MICROBIOL, V151, P179, DOI 10.1016/j.vetmic.2011.02.042; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; O'Brien DJ, 2001, J WILDLIFE DIS, V37, P608, DOI 10.7589/0090-3558-37.3.608; Olsen SC, 2012, CLIN VACCINE IMMUNOL, V19, P886, DOI 10.1128/CVI.00107-12; Palmer MV, 2007, VACCINE, V25, P6589, DOI 10.1016/j.vaccine.2007.06.056; Palmer MV, 2014, TRANSBOUND EMERG DIS, V61, P266, DOI 10.1111/tbed.12032; Palmer MV, 2014, EUR J WILDLIFE RES, V60, P265, DOI 10.1007/s10344-013-0777-9; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; Palmer MV, 2009, ZOONOSES PUBLIC HLTH, V56, P243, DOI 10.1111/j.1863-2378.2008.01198.x; Palmer Mitchell V., 2012, Veterinary Medicine International, P236205, DOI 10.1155/2012/236205; Palmer Mitchell V, 2011, Vet Med Int, V2011, P816345, DOI 10.4061/2011/816345; Palmer MV, 1999, J WILDLIFE DIS, V35, P450, DOI 10.7589/0090-3558-35.3.450; Palmer MV, 2002, VET PATHOL, V39, P334, DOI 10.1354/vp.39-3-334; Ramsey DSL, 2009, TUBERCULOSIS, V89, P163, DOI 10.1016/j.tube.2008.11.002; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Rocke TE, 2008, J WILDLIFE DIS, V44, P930, DOI 10.7589/0090-3558-44.4.930; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Shilang Z, 1985, BIOL DEER PRODUCTION, V22, P154; Slate D, 2005, VIRUS RES, V111, P68, DOI 10.1016/j.virusres.2005.03.012; Thacker TC, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-100; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Turnbull PCB, 2004, VACCINE, V22, P3340, DOI 10.1016/j.vaccine.2004.02.037; von Ruden S, 2008, VET MICROBIOL, V132, P29, DOI 10.1016/j.vetmic.2008.04.022; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002	52	20	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97031	10.1371/journal.pone.0097031	http://dx.doi.org/10.1371/journal.pone.0097031			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804678	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900129
J	Zhang, D; Wang, ZH; Wang, NN; Gao, Y; Liu, Y; Wu, Y; Bai, Y; Zhang, ZB; Lin, XY; Dong, YZ; Ou, XF; Xu, CM; Liu, B				Zhang, Di; Wang, Zhenhui; Wang, Ningning; Gao, Yang; Liu, Ying; Wu, Ying; Bai, Yan; Zhang, Zhibin; Lin, Xiuyun; Dong, Yuzhu; Ou, Xiufang; Xu, Chunming; Liu, Bao			Tissue Culture-Induced Heritable Genomic Variation in Rice, and Their Phenotypic Implications	PLOS ONE			English	Article							POPULATION GENETIC THEORY; TRANSPOSABLE ELEMENTS; CYTOSINE METHYLATION; SOMACLONAL VARIATION; MOLECULAR-SPECTRUM; DNA METHYLATION; RETROTRANSPOSON; ACTIVATION; MUTATIONS; EXPRESSION	Background: Somaclonal variation generally occurs in plants regenerated from tissue culture. However, fundamental issues regarding molecular characteristics, mutation rates and mutation spectra of plant somatic variation as well as their phenotypic relevance have been addressed only recently. Moreover, these studies have reported highly discrepant results in different plant species and even in the same plant genotype. Methodology/principal findings: We investigated heritable genomic variation induced by tissue culture in rice by whole genome re-sequencing of an extensively selfed somaclonal line (TC-reg-2008) and its wild type (WT) donor (cv. Hitomebore). We computed the overall mutation rate, single nucleotide polymorphisms (SNPs), small scale insertions/deletions (Indels) and mobilization of transposable elements (TEs). We assessed chromosomal distribution of the various types of genomic variations, tested correlations between SNPs and Indels, and examined concomitancy between TE activity and its cytosine methylation states. We also performed gene ontology (GO) analysis of genes containing nonsynonymous mutations and large-effect mutations, and assayed effects of the genomic variations on phenotypes under both normal growing condition and several abiotic stresses. We found that heritable somaclonal genomic variation occurred extensively in rice. The genomic variations distributed non-randomly across each of the 12 rice chromosomes, and affected a large number of functional genes. The phenotypic penetrance of the genomic variations was condition-dependent. Conclusions/significance: Tissue culture is a potent means to generate heritable genetic variations in rice, which bear distinct difference at least in space (chromosomal distribution) from those occurred under natural settings. Our findings have provided new information regarding the mutation rate and spectrum as well as chromosomal distribution pattern of somaclonal variation in rice. Our data also suggest that rice possesses a strong capacity to canalize genetic variations under normal growing conditions to maintain phenotypic robustness, which however can be released by certain abiotic stresses to generate variable phenotypes.	[Zhang, Di; Gao, Yang; Liu, Ying; Wu, Ying; Bai, Yan; Zhang, Zhibin; Dong, Yuzhu; Ou, Xiufang; Xu, Chunming; Liu, Bao] NE Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China; [Wang, Zhenhui; Wang, Ningning] Jilin Agr Univ, Fac Agron, Changchun, Peoples R China; [Lin, Xiuyun] Jilin Acad Agr Sci, Changchun, Peoples R China	Northeast Normal University - China; Jilin Agricultural University; Jilin Academy of Agricultural Sciences	Xu, CM (corresponding author), NE Normal Univ, Minist Educ MOE, Key Lab Mol Epigenet, Changchun, Peoples R China.	chunmingnenu@163.com; baoliu@nenu.edu.cn		Liu, Bao/0000-0001-5481-1675; Xu, Chunming/0000-0002-0986-0993; zakaria, seyed moein/0000-0002-0086-1279	State Key Basic Research and Development Plan of China [2013CBA01404]; Program for Introducing Talents to Universities [B07017]	State Key Basic Research and Development Plan of China(National Basic Research Program of China); Program for Introducing Talents to Universities	This work was supported by the State Key Basic Research and Development Plan of China (2013CBA01404) and the Program for Introducing Talents to Universities (#B07017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2005, THEOR APPL GENET, V111, P431, DOI 10.1007/s00122-005-2013-9; Barret P, 2006, GENOME, V49, P1399, DOI 10.1139/G06-109; Batley J, 2003, PLANT PHYSIOL, V132, P84, DOI 10.1104/pp.102.019422; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; BRETTELL RIS, 1991, MOL GEN GENET, V229, P365, DOI 10.1007/BF00267457; Cheng C, 2006, MOL GENET GENOMICS, V276, P378, DOI 10.1007/s00438-006-0141-9; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; HEINZ DJ, 1971, AM J BOT, V58, P257, DOI 10.2307/2441162; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; HIROCHIKA H, 1993, EMBO J, V12, P2521, DOI 10.1002/j.1460-2075.1993.tb05907.x; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Huang J, 2009, GENOMICS, V93, P274, DOI 10.1016/j.ygeno.2008.11.007; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Jiang CF, 2011, CURR BIOL, V21, P1385, DOI 10.1016/j.cub.2011.07.002; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kashkush K, 2007, GENETICS, V177, P1975, DOI 10.1534/genetics.107.080234; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Komatsu M, 2003, PLANT CELL, V15, P1934, DOI 10.1105/tpc.011809; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu ZL, 2004, THEOR APPL GENET, V109, P200, DOI 10.1007/s00122-004-1618-8; Miyao A, 2012, PLANT CELL PHYSIOL, V53, P256, DOI 10.1093/pcp/pcr172; Neelakandan AK, 2012, PLANT CELL REP, V31, P597, DOI 10.1007/s00299-011-1202-z; Ngezahayo F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-91; Nuthikattu S, 2013, PLANT PHYSIOL, V162, P116, DOI 10.1104/pp.113.216481; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; PESCHKE VM, 1991, THEOR APPL GENET, V81, P90, DOI 10.1007/BF00226117; PESCHKE VM, 1987, SCIENCE, V238, P804, DOI 10.1126/science.238.4828.804; Picault N, 2009, PLANT J, V58, P754, DOI 10.1111/j.1365-313X.2009.03813.x; PLANCKAERT F, 1989, GENETICS, V123, P567; POUTEAU S, 1991, EMBO J, V10, P1911, DOI 10.1002/j.1460-2075.1991.tb07717.x; Rhee Y, 2009, MAYDICA, V54, P429; Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Waddington C., 1957, STRATEGY GENES; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Wang XR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-77; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074479	48	46	47	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96879	10.1371/journal.pone.0096879	http://dx.doi.org/10.1371/journal.pone.0096879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804838	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900111
J	Chen, X; Liu, HY; Zhang, T; Liu, YC; Xie, XX; Wang, ZR; Xu, XM				Chen, Xue; Liu, Hongyang; Zhang, Ting; Liu, Yanchun; Xie, Xixiu; Wang, Zhirong; Xu, Xuemei			A Vaccine of L2 Epitope Repeats Fused with a Modified IgG1 Fc Induced Cross-Neutralizing Antibodies and Protective Immunity against Divergent Human Papillomavirus Types	PLOS ONE			English	Article							MINOR CAPSID PROTEIN; ANTIGEN-PRESENTING CELLS; VIRUS-LIKE PARTICLES; SUBCAPSULAR SINUS; LYMPH-NODE; B-CELLS; HUMORAL RESPONSES; SUBUNIT VACCINE; RECEPTOR; HPV	Current human papillomavirus (HPV) major capsid protein L1 virus-like particles (VLPs)-based vaccines in clinic induce strong HPV type-specific neutralizing antibody responses. To develop pan-HPV vaccines, here, we show that the fusion protein E3R4 consisting of three repeats of HPV16 L2 aa 17-36 epitope (E3) and a modified human IgG1 Fc scaffold (R4) induces cross-neutralizing antibodies and protective immunity against divergent HPV types. E3R4 was expressed as a secreted protein in baculovirus expression system and could be simply purified by one step Protein A affinity chromatography with the purity above 90%. Vaccination of E3R4 formulated with Freunds adjuvant not only induced cross-neutralizing antibodies against HPV pseudovirus types 16, 18, 45, 52, 58, 6, 11 and 5 in mice, but also protected mice against vaginal challenges with HPV pseudovirus types 16, 45, 52, 58, 11 and 5 for at least eleven months after the first immunization. Moreover, vaccination of E3R4 formulated with FDA approved adjuvant alum plus monophosphoryl lipid A also induced cross-neutralizing antibodies against HPV types 16, 18 and 6 in rabbits. Thus, our results demonstrate that delivery of L2 antigen as a modified Fc-fusion protein may facilitate pan-HPV vaccine development.	[Chen, Xue; Liu, Hongyang; Zhang, Ting; Liu, Yanchun; Xie, Xixiu; Wang, Zhirong; Xu, Xuemei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Xu, XM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Sch Basic Med,Peking Union Med Coll, Beijing 100730, Peoples R China.	xuemeixu@vip.sina.com			Natural Science Foundation of China [31070813]; Natural Science Foundation of Beijing [7102110]; Key Program of China International Science & Technology Cooperation [2013DFA32430]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Key Program of China International Science & Technology Cooperation	This research was supported by Natural Science Foundation of China (31070813), Natural Science Foundation of Beijing (7102110) and Key Program of China International Science & Technology Cooperation (2013DFA32430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Buck CB, 2005, METH MOLEC MED, V119, P445; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Castanon S, 1999, J VIROL, V73, P4452; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016405; Day PM, 2008, J VIROL, V82, P4638, DOI 10.1128/JVI.00143-08; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Du LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016555; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Embers ME, 2004, VACCINE, V22, P670, DOI 10.1016/j.vaccine.2003.08.037; Fusco WG, 2010, INFECT IMMUN, V78, P3763, DOI 10.1128/IAI.00217-10; Gambhira R, 2007, J VIROL, V81, P13927, DOI 10.1128/JVI.00936-07; Gambhira R, 2007, J VIROL, V81, P11585, DOI 10.1128/JVI.01577-07; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Jagu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055538; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064; Jensen MA, 2007, EUR J IMMUNOL, V37, P1139, DOI 10.1002/eji.200636321; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kemp TJ, 2011, VACCINE, V29, P2011, DOI 10.1016/j.vaccine.2011.01.001; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Konduru K, 2011, VACCINE, V29, P2968, DOI 10.1016/j.vaccine.2011.01.113; LEENAARS PPAM, 1994, VET IMMUNOL IMMUNOP, V40, P225, DOI 10.1016/0165-2427(94)90022-1; LUND J, 1991, J IMMUNOL, V147, P2657; MALLON FM, 1991, AM J VET RES, V52, P1503; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Nakao S, 2012, VIROLOGY, V434, P110, DOI 10.1016/j.virol.2012.09.006; Nieto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039741; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Qi Z, 2010, BIOCHEM BIOPH RES CO, V398, P506, DOI 10.1016/j.bbrc.2010.06.109; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Roden RBS, 2000, VIROLOGY, V270, P254, DOI 10.1006/viro.2000.0272; Rubio I, 2011, VIROLOGY, V409, P348, DOI 10.1016/j.virol.2010.10.017; Rubio I, 2009, VACCINE, V27, P1949, DOI 10.1016/j.vaccine.2009.01.102; Schellenbacher C, 2013, J INVEST DERMATOL, V133, P2706, DOI 10.1038/jid.2013.253; Schellenbacher C, 2009, J VIROL, V83, P10085, DOI 10.1128/JVI.01088-09; Schiller JT, 2012, NAT REV MICROBIOL, V10, P681, DOI 10.1038/nrmicro2872; Slupetzky K, 2007, VACCINE, V25, P2001, DOI 10.1016/j.vaccine.2006.11.049; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; Tumban E, 2013, VACCINE, V31, P4647, DOI 10.1016/j.vaccine.2013.07.052; Tumban E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049751; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; White DM, 2011, INFECT IMMUN, V79, P3388, DOI 10.1128/IAI.00166-11; Xie XX, 2013, ARCH VIROL, V158, P193, DOI 10.1007/s00705-012-1465-x; Xu YF, 2007, J MED MICROBIOL, V56, P907, DOI 10.1099/jmm.0.47073-0; Ye LL, 2011, NAT BIOTECHNOL, V29, P158, DOI 10.1038/nbt.1742; Zaharatos GJ, 2011, VACCINE, V30, P42, DOI 10.1016/j.vaccine.2011.10.056; Zhang MY, 2009, VACCINE, V27, P857, DOI 10.1016/j.vaccine.2008.11.083; Zhang T, 2010, VACCINE, V28, P3479, DOI 10.1016/j.vaccine.2010.02.057	53	11	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95448	10.1371/journal.pone.0095448	http://dx.doi.org/10.1371/journal.pone.0095448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802101	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800029
J	Leftheriotis, G; Kauffenstein, G; Hamel, JF; Abraham, P; Le Saux, O; Willoteaux, S; Henrion, D; Martin, L				Leftheriotis, Georges; Kauffenstein, Gilles; Hamel, Jean Francois; Abraham, Pierre; Le Saux, Olivier; Willoteaux, Serge; Henrion, Daniel; Martin, Ludovic			The Contribution of Arterial Calcification to Peripheral Arterial Disease in Pseudoxanthoma Elasticum	PLOS ONE			English	Article							ANKLE-BRACHIAL INDEX; RISK-FACTORS; INTERMITTENT CLAUDICATION; CARDIOVASCULAR-DISEASE; AORTIC CALCIFICATION; CAROTID-ARTERY; ASSOCIATION; CORONARY; ATHEROSCLEROSIS; MINERALIZATION	Background and aims: The contribution of arterial calcification (AC) in peripheral arterial disease (PAD) and arterial wall compressibility is a matter of debate. Pseudoxanthoma elasticum (PXE), an inherited metabolic disease due to ABCC6 gene mutations, combines elastic fiber fragmentation and calcification in various soft tissues including the arterial wall. Since AC is associated with PAD, a frequent complication of PXE, we sought to determine the role of AC in PAD and arterial wall compressibility in this group of patients. Methods and Results: Arterial compressibility and patency were determined by ankle-brachial pressure index (ABI) in a cohort of 71 PXE patients (mean age 48 +/- SD 14 yrs, 45 women) and compared to 30 controls without PAD. Lower limb arterial calcification (LLAC) was determined by non-contrast enhanced helicoidal CT-scan. A calcification score (Ca-score) was computed for the femoral, popliteal and sub-popliteal artery segments of both legs. Forty patients with PXE had an ABI<0.90 and none had an ABI>1.40. LLAC increased with age, significantly more in PXE subjects than controls. A negative association was found between LLAC and ABI (r = -0.363, p = 0.002). The LLAC was independently associated with PXE and age, and ABI was not linked to cardiovascular risk factors. Conclusions: The presence of AC was associated with PAD and PXE without affecting arterial compressibility. PAD in PXE patients is probably due to proximal obstructive lesions developing independently from cardiovascular risk factors.	[Leftheriotis, Georges; Abraham, Pierre; Willoteaux, Serge; Martin, Ludovic] Univ Hosp Angers, PXE Hlth, Angers, France; [Leftheriotis, Georges; Abraham, Pierre; Willoteaux, Serge; Martin, Ludovic] Univ Hosp Angers, Res Ctr, Angers, France; [Leftheriotis, Georges; Kauffenstein, Gilles; Abraham, Pierre; Henrion, Daniel; Martin, Ludovic] LUNAM Univ, Sch Med, Inserm 1083, UMR CNRS 6214, Angers, France; [Le Saux, Olivier] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Willoteaux, Serge] LUNAM Univ, Sch Med, UPRES 3860, Angers, France; [Hamel, Jean Francois] Univ Hosp Angers, Clin Res Ctr, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite de Franche-Comte; University of Hawaii System; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Leftheriotis, G (corresponding author), Univ Hosp Angers, PXE Hlth, Angers, France.	geleftheriotis@chu-angers.fr	Henrion, Daniel/N-7023-2015; Kauffenstein, Gilles/K-2867-2015; Henrion, Daniel/AAK-1995-2021; Le Saux, Olivier/P-4668-2017; Martin, Ludovic/K-2674-2015; Henrion, Daniel/J-8141-2015	Henrion, Daniel/0000-0003-1094-0285; Kauffenstein, Gilles/0000-0003-4994-8305; Henrion, Daniel/0000-0003-1094-0285; Le Saux, Olivier/0000-0002-5605-3617; Henrion, Daniel/0000-0003-1094-0285	French Society of Vascular Medicine (SFMV); University Hospital of Angers [2010-A00142-37, 2011-A00942-39]; PXE-France Patients' Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108249] Funding Source: NIH RePORTER	French Society of Vascular Medicine (SFMV); University Hospital of Angers; PXE-France Patients' Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	French Society of Vascular Medicine (SFMV), University Hospital of Angers (contract # 2010-A00142-37 and # 2011-A00942-39) and the PXE-France Patients' Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2008, J VASC SURG, V48, P1197, DOI 10.1016/j.jvs.2008.06.005; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Aboyans V, 2011, J VASC SURG, V53, P984, DOI 10.1016/j.jvs.2010.10.054; Aerden D, 2011, ANN VASC SURG, V25, P770, DOI 10.1016/j.avsg.2010.12.025; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison MA, 2004, ARTERIOSCL THROM VAS, V24, P331, DOI 10.1161/01.ATV.0000110786.02097.0c; Allison MA, 2008, J AM COLL CARDIOL, V51, P1292, DOI 10.1016/j.jacc.2007.11.064; Amann K, 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI 10.2215/CJN.02120508; Boutouyrie P, 2001, HYPERTENSION, V38, P1181, DOI 10.1161/hy1101.096108; Brampton C, 2011, CELL CYCLE, V10, P1810, DOI 10.4161/cc.10.11.15681; Campens L, 2013, ARTERIOSCL THROM VAS, V33, P2646, DOI 10.1161/ATVBAHA.113.301901; Chassaing N, 2005, J MED GENET, V42, P881, DOI 10.1136/jmg.2004.030171; DeBakey ME, 2000, AM J CARDIOL, V85, P1045, DOI 10.1016/S0002-9149(00)00694-9; Donas KP, 2007, J VASC INTERV RADIOL, V18, P457, DOI 10.1016/j.jvir.2007.01.011; Germain DP, 2003, ARTERIOSCL THROM VAS, V23, P836, DOI 10.1161/01.ATV.0000067428.19031.28; Herisson F, 2011, ATHEROSCLEROSIS, V216, P348, DOI 10.1016/j.atherosclerosis.2011.02.004; Hu XF, 2003, SURV OPHTHALMOL, V48, P424, DOI 10.1016/S0039-6257(03)00053-5; Ix JH, 2009, J AM COLL CARDIOL, V54, P1176, DOI 10.1016/j.jacc.2009.06.017; Kornet L, 2004, ULTRASOUND MED BIOL, V30, P1041, DOI 10.1016/j.ultrasmedbio.2004.06.004; Kuller LH, 1999, ARTERIOSCL THROM VAS, V19, P2189, DOI 10.1161/01.ATV.19.9.2189; LAURIER D, 1994, J CLIN EPIDEMIOL, V47, P1353, DOI 10.1016/0895-4356(94)90079-5; Le Boulanger G, 2010, AM J MED GENET A, V152A, P118, DOI 10.1002/ajmg.a.33162; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; LEBWOHL M, 1994, J AM ACAD DERMATOL, V30, P103, DOI 10.1016/S0190-9622(08)81894-4; Leftheriotis Georges, 2013, Frontiers in Genetics, V4, P4, DOI 10.3389/fgene.2013.00004; Leftheriotis G, 2011, J VASC SURG, V54, P1390, DOI 10.1016/j.jvs.2011.04.041; Levitzky YS, 2008, AM J CARDIOL, V101, P326, DOI 10.1016/j.amjcard.2007.08.032; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; MAURO MA, 1988, AM J ROENTGENOL, V150, P435, DOI 10.2214/ajr.150.2.435; Morbelli S, 2013, INT J CARDIOVASC IMA; Nasir K, 2007, ARTERIOSCL THROM VAS, V27, P1220, DOI 10.1161/ATVBAHA.107.140079; NELDNER KH, 1988, CLIN DERMATOL, V6, pR8; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Nitschke Y, 2012, AM J HUMAN GENETICS; Ohtake T, 2011, J VASC SURG, V53, P676, DOI 10.1016/j.jvs.2010.09.070; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Rabkin SW, 2012, ANGIOLOGY, V63, P150, DOI 10.1177/0003319711410307; Raptis AE, 2011, INSIGHTS IMAGING, V2, P193, DOI 10.1007/s13244-011-0068-5; Shanahan CM, 1999, CIRCULATION, V100, P2168, DOI 10.1161/01.CIR.100.21.2168; Siskos D, 2012, ANN VASC SURG, V26, DOI 10.1016/j.avsg.2011.07.013; Smith CD, 2008, FOOT ANKLE INT, V29, P185, DOI 10.3113/FAI.2008.0185; Vanakker Olivier M, 2008, Hum Mutat, V29, P205, DOI 10.1002/humu.9514; von Beckerath O, 2008, CIRCULATION, V118, P102, DOI 10.1161/CIRCULATIONAHA.107.760355; WITTEMAN JCM, 1986, LANCET, V2, P1120; Xu HG, 2013, ORTHOP SURG, V5, P40, DOI 10.1111/os.12028; Zuily S, 2012, J AM COLL CARDIOL, V59, P1991, DOI 10.1016/j.jacc.2011.11.067	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96003	10.1371/journal.pone.0096003	http://dx.doi.org/10.1371/journal.pone.0096003			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800819	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800038
J	Macintyre, K; Andrinopoulos, K; Moses, N; Bornstein, M; Ochieng, A; Peacock, E; Bertrand, J				Macintyre, Kate; Andrinopoulos, Katherine; Moses, Natome; Bornstein, Marta; Ochieng, Athanasius; Peacock, Erin; Bertrand, Jane			Attitudes, Perceptions and Potential Uptake of Male Circumcision among Older Men in Turkana County, Kenya Using Qualitative Methods	PLOS ONE			English	Article							HIV PREVENTION; ACCEPTABILITY; KISUMU	Background: In many communities, older men (i.e., over 25 years of age) have not come forward for Voluntary Medical Male Circumcision (VMMC) services. Reasons for low demand among this group of men are not well understood, and may vary across geographic and cultural contexts. This paper examines the facilitators and barriers to VMMC demand in Turkana County, Kenya, with a focus on older men. This is one of the regions targeted by the VMMC program in Kenya because the Turkana ethnic group does not traditionally circumcise, and the rates of HIV and STD transmission are high. Methods and Findings: Twenty focus group discussions and 69 in-depth interviews were conducted with circumcised and uncircumcised men and their partners to elicit their attitudes and perceptions toward male circumcision. The interviews were conducted in urban, peri-urban, and rural communities across Turkana. Our results show that barriers to circumcision include stigma associated with VMMC, the perception of low risk for HIV for older men and their "protection by marriage,'' cultural norms, and a lack of health infrastructure. Facilitators include stigma against not being circumcised (since circumcision is associated with modernity), protection against disease including HIV, and cleanliness. It was also noted that older men should adopt the practice to serve as role models to younger men. Conclusions: Both men and women were generally supportive of VMMC, but overcoming barriers with appropriate communication messages and high quality services will be challenging. The justification of circumcision being a biomedical procedure for protection against HIV will be the most important message for any communication strategy.	[Macintyre, Kate] Aidspan, Nairobi, Kenya; [Macintyre, Kate; Andrinopoulos, Katherine; Peacock, Erin; Bertrand, Jane] Tulane Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Moses, Natome] Oxfam GB, Lodwar, Kenya; [Bornstein, Marta] Learning Act, San Francisco, CA USA; [Ochieng, Athanasius] Minist Publ Hlth & Sanitat, Natl AIDS & STD Control Programme, Nairobi, Kenya	Tulane University	Macintyre, K (corresponding author), Aidspan, Nairobi, Kenya.	kate.macintyre@aidspan.org			Research to Prevention Project, part of USAID's Project SEARCH [GHH-I-DD-07-00032-00]; PEPFAR (USG)	Research to Prevention Project, part of USAID's Project SEARCH(United States Agency for International Development (USAID)); PEPFAR (USG)	The funding for this research came from the Research to Prevention Project, part of USAID's Project SEARCH, Task order no. 2, contract number GHH-I-DD-07-00032-00, and supported through PEPFAR (USG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; District Commissioner Office of the President, 2012, TURK COUNT REP; Edgil D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001128; Gasasira RA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Hayes R, 2010, AIDS, V24, pS81, DOI 10.1097/01.aids.0000390710.04255.2b; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018299; Kelly A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-67; Kenya National AIDS and STD Control Programme, 2007, KEN AIDS IND SURV FI; Kenya National Bureau of Statistics, 2010, KEN POP HOUS CENS; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Moses N, 2011, FACTORS INFLUENCING; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Ochieng A, 2013, DATABASE ALL DONE VM; Onyango T, 2011, MALE CIRCUMCISION CO; Plotkin MK, 2011, UNPEELED MANGO  QUAL; Reed JB, 2012, JAIDS-J ACQ IMM DEF, V60, pS88, DOI 10.1097/QAI.0b013e31825cac4e; Ruto SJO, 2009, ED MARGINAL N KENYA; Schneider J, 2012, AIDS PATIENT CARE ST, V26, P631, DOI 10.1089/apc.2012.0188; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; Westercamp M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015552; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	28	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e83998	10.1371/journal.pone.0083998	http://dx.doi.org/10.1371/journal.pone.0083998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802112	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800009
J	Prabhawathi, V; Boobalan, T; Sivakumar, PM; Doble, M				Prabhawathi, Veluchamy; Boobalan, Thulasinathan; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh			Antibiofilm Properties of Interfacially Active Lipase Immobilized Porous Polycaprolactam Prepared by LB Technique	PLOS ONE			English	Article							LANGMUIR-BLODGETT-FILMS; BACTERIAL ADHESION; HYDROPHOBICITY; ATTACHMENT; SURFACES; ACTIVATION; ADSORPTION; STRATEGIES; MONOLAYERS; STABILITY	Porous biomaterial is the preferred implant due to the interconnectivity of the pores. Chances of infection due to biofilm are also high in these biomaterials because of the presence of pores. Although biofilm in implants contributes to 80% of human infections [1], there are no commercially available natural therapeutics against it. In the current study, glutaraldehyde cross linked lipase was transferred onto a activated porous polycaprolactam surface using Langmuir-Blodgett deposition technique, and its thermostability, slimicidal, antibacterial, biocompatibility and surface properties were studied. There was a 20% increase in the activity of the covalently crosslinked lipase when compared to its free form. This immobilized surface was thermostable and retained activity and stability until 100 degrees C. There was a 2 and 7 times reduction in carbohydrate and 9 and 5 times reduction in biofilm protein of Staphylococcus aureus and Escherichia coli respectively on lipase immobilized polycaprolactam (LIP) when compared to uncoated polycaprolactam (UP). The number of live bacterial colonies on LIP was four times less than on UP. Lipase acted on the cell wall of the bacteria leading to its death, which was confirmed from AFM, fluorescence microscopic images and amount of lactate dehydrogenase released. LIP allowed proliferation of more than 90% of 3T3 cells indicating that it was biocompatible. The fact that LIP exhibits antimicrobial property at the air-water interface to hydrophobic as well as hydrophilic bacteria along with lack of cytotoxicity makes it an ideal biomaterial for biofilm prevention in implants.	[Prabhawathi, Veluchamy; Boobalan, Thulasinathan; Sivakumar, Ponnurengam Malliappan; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Doble, M (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	mukeshd@iitm.ac.in		Sivakumar, Ponnurengam Malliappan/0000-0002-5880-9596; Veluchamy, Prabhawathi/0000-0002-9703-5714; Doble, Mukeshd/0000-0002-4335-0698; THULASINATHAN, BOOBALAN/0000-0002-8786-5001				Amro NA, 2000, LANGMUIR, V16, P2789, DOI 10.1021/la991013x; Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t; Britt DW, 2001, LANGMUIR, V17, P3757, DOI 10.1021/la001240v; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Candan F, 2003, J ETHNOPHARMACOL, V87, P215, DOI 10.1016/S0378-8741(03)00149-1; Chiou SH, 2004, BIOMATERIALS, V25, P197, DOI 10.1016/S0142-9612(03)00482-4; Chui WK, 1997, J MICROENCAPSUL, V14, P51, DOI 10.3109/02652049709056467; Ciston S, 2008, J MEMBRANE SCI, V320, P101, DOI 10.1016/j.memsci.2008.03.065; Clifford JS, 2005, BIOTECHNOL BIOENG, V92, P231, DOI 10.1002/bit.20595; Corpe WA, 1980, ADSORPTION MICROORGA, P105; Costa SA, 2005, ENZYME IMMOBILIZATIO, P301; Dave RN, 2011, ANTIMICROB AGENTS CH, V55, P845, DOI 10.1128/AAC.00477-10; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Doi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049051; EGINTON PJ, 1995, COLLOID SURFACE B, V5, P153, DOI 10.1016/0927-7765(95)01219-9; EMBS F, 1991, ADV MATER, V3, P25, DOI 10.1002/adma.19910030106; FERNANDEZLAFUENTE R, 1993, ENZYME MICROB TECH, V15, P546, DOI 10.1016/0141-0229(93)90016-U; GAINES GL, 1966, INSOLUBLE MONOLAYER; Girard-Egrot AP, 2010, INT J NANOTECHNOL, V7, P753, DOI 10.1504/IJNT.2010.031743; Gupta R, 2004, APPL MICROBIOL BIOT, V64, P763, DOI 10.1007/s00253-004-1568-8; Habash MB, 2000, COLLOID SURFACE B, V19, P13, DOI 10.1016/S0927-7765(00)00131-4; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; Kristensen JB, 2008, BIOTECHNOL ADV, V26, P471, DOI 10.1016/j.biotechadv.2008.05.005; Kumar D., 2012, J MICROBIOL BIOTECHN, V2, P521; Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006; Lin DQ, 2003, BIOTECHNOL BIOENG, V83, P149, DOI 10.1002/bit.10654; MACRITCHIE F, 1977, J COLLOID INTERF SCI, V61, P223, DOI 10.1016/0021-9797(77)90384-8; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; McDaniel C.S, 2009, U.S. Patent, Patent No. [0238811, A1, 0238811, 0238811 A1]; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Miller BF., 1992, ENCY DICT MED NURSIN, V7th ed; NICOLINI C, 1993, BIOCHIM BIOPHYS ACTA, V1158, P273, DOI 10.1016/0304-4165(93)90025-4; Nicolini C, 2008, BIOSYSTEMS, V94, P228, DOI 10.1016/j.biosystems.2008.06.010; Nuhiji E, 2012, ACS APPL MATER INTER, V4, P2912, DOI 10.1021/am300087k; Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003; Petersen MTN, 2001, J BIOTECHNOL, V85, P115, DOI 10.1016/S0168-1656(00)00360-6; Potera C, 2010, ENVIRON HEALTH PERSP, V118, pA288, DOI 10.1289/ehp.118-a288; Prabhawathi V, 2012, IND ENG CHEM RES, V51, P5230, DOI 10.1021/ie2029392; Prasanna SS, 2008, J INDIAN I SCI, V88, P27; Rather PN, 2005, ENVIRON MICROBIOL, V7, P1065, DOI 10.1111/j.1462-2920.2005.00806.x; REIFSTECK F, 1987, J MED MICROBIOL, V24, P65, DOI 10.1099/00222615-24-1-65; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Sanchez-Gonzalez J, 2003, J COLLOID INTERF SCI, V267, P286, DOI 10.1016/S0021-9797(03)00754-9; Sawant SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063311; SCHWARTZ MK, 1966, METHOD ENZYMOL, V9, P294; Sivakumar PM, 2010, COLLOID SURFACE B, V81, P439, DOI 10.1016/j.colsurfb.2010.07.037; Sivakumar PM, 2010, APPL SURF SCI, V256, P6018, DOI 10.1016/j.apsusc.2010.03.112; Sivakumar PM, 2010, CARBOHYD POLYM, V79, P717, DOI 10.1016/j.carbpol.2009.09.027; Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113; Veluchamy P, 2011, J AGR FOOD CHEM, V59, P10869, DOI 10.1021/jf201124v; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zanon NCM, 2012, J COLLOID INTERF SCI, V373, P69, DOI 10.1016/j.jcis.2011.07.095; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zhao Q, 2007, APPL SURF SCI, V253, P8674, DOI 10.1016/j.apsusc.2007.04.044	57	13	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96152	10.1371/journal.pone.0096152	http://dx.doi.org/10.1371/journal.pone.0096152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798482	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000041
J	Shi, LH; Zhang, Z; Yu, AM; Wang, W; Wei, Z; Akhter, E; Maurer, K; Reis, PC; Song, L; Petri, M; Sullivan, KE				Shi, Lihua; Zhang, Zhe; Yu, Angela M.; Wang, Wei; Wei, Zhi; Akhter, Ehtisham; Maurer, Kelly; Reis, Patricia Costa; Song, Li; Petri, Michelle; Sullivan, Kathleen E.			The SLE Transcriptome Exhibits Evidence of Chronic Endotoxin Exposure and Has Widespread Dysregulation of Non-Coding and Coding RNAs	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CIRCULATING ENDOTOXIN; GENE-EXPRESSION; IFN-ALPHA; ALTERNATIVE POLYADENYLATION; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; INTERFERON-ALPHA	Background: Gene expression studies of peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE) have demonstrated a type I interferon signature and increased expression of inflammatory cytokine genes. Studies of patients with Aicardi Goutieres syndrome, commonly cited as a single gene model for SLE, have suggested that accumulation of non-coding RNAs may drive some of the pathologic gene expression, however, no RNA sequencing studies of SLE patients have been performed. This study was designed to define altered expression of coding and non-coding RNAs and to detect globally altered RNA processing in SLE. Methods: Purified monocytes from eight healthy age/gender matched controls and nine SLE patients (with low-moderate disease activity and lack of biologic drug use or immune suppressive treatment) were studied using RNA-seq. Quantitative RT-PCR was used to validate findings. Serum levels of endotoxin were measured by ELISA. Results: We found that SLE patients had diminished expression of most endogenous retroviruses and small nucleolar RNAs, but exhibited increased expression of pri-miRNAs. Splicing patterns and polyadenylation were significantly altered. In addition, SLE monocytes expressed novel transcripts, an effect that was replicated by LPS treatment of control monocytes. We further identified increased circulating endotoxin in SLE patients. Conclusions: Monocytes from SLE patients exhibit globally dysregulated gene expression. The transcriptome is not simply altered by the transcriptional activation of a set of genes, but is qualitatively different in SLE. The identification of novel loci, inducible by LPS, suggests that chronic microbial translocation could contribute to the immunologic dysregulation in SLE, a new potential disease mechanism.	[Shi, Lihua; Maurer, Kelly; Reis, Patricia Costa; Song, Li; Sullivan, Kathleen E.] Childrens Hosp Philadelphia, Div Allergy Immunol, Philadelphia, PA 19104 USA; [Zhang, Zhe; Yu, Angela M.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Wang, Wei; Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Akhter, Ehtisham; Petri, Michelle] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; New Jersey Institute of Technology; Johns Hopkins University	Sullivan, KE (corresponding author), Childrens Hosp Philadelphia, Div Allergy Immunol, Philadelphia, PA 19104 USA.	sullivak@mail.med.upenn.edu	, AndyWei/H-4415-2012	Costa Reis, Patricia/0000-0002-7174-8302; Yu, Angela/0000-0001-5404-594X; Wei, Zhi/0000-0001-6059-4267	NIH [5R01AR058547-05]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR058547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH Grant# 5R01AR058547-05 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2002, J AM SOC NEPHROL, V13, P2869, DOI 10.1097/01.ASN.0000036868.73317.7A; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Beck-Engeser GB, 2009, P NATL ACAD SCI USA, V106, P20865, DOI 10.1073/pnas.0908074106; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CASEY WF, 1992, CRIT CARE MED, V20, P1090, DOI 10.1097/00003246-199208000-00004; Chauhan SK, 2013, J CLIN IMMUNOL, V33, P954, DOI 10.1007/s10875-013-9887-0; Chipumuro E, 2012, FASEB J, V26, P842, DOI 10.1096/fj.11-189498; Csiszar A, 2000, CLIN EXP IMMUNOL, V122, P464, DOI 10.1046/j.1365-2249.2000.01369.x; DeBeaux AC, 1996, SCAND J GASTROENTERO, V31, P43, DOI 10.3109/00365529609104999; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eggleton P, 2010, J CLIN IMMUNOL, V30, P649, DOI 10.1007/s10875-010-9429-y; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Feroze U, 2012, J RENAL NUTR, V22, P317, DOI 10.1053/j.jrn.2011.05.004; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Garrett S, 2008, J IMMUNOL, V180, P5257, DOI 10.4049/jimmunol.180.8.5257; Ghazizadeh S, 1997, J VIROL, V71, P9163, DOI 10.1128/JVI.71.12.9163-9169.1997; Gibbert K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002868; Gorjestani S, 2008, LUPUS, V17, P548, DOI 10.1177/0961203307087982; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; GRANHOLM NA, 1991, CLIN EXP IMMUNOL, V85, P270; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Incoronato M, 2010, CANCER RES, V70, P3638, DOI 10.1158/0008-5472.CAN-09-3341; IZUI S, 1977, J EXP MED, V145, P1115, DOI 10.1084/jem.145.5.1115; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Kondrashov A, 2012, RNA, V18, P2236, DOI 10.1261/rna.032391.112; Koscec M, 1997, J IMMUNOL, V159, P2033; KRIEG AM, 1990, J CLIN INVEST, V86, P809, DOI 10.1172/JCI114778; Kuijpers Taco W, 2002, Eur J Paediatr Neurol, V6 Suppl A, pA59, DOI 10.1053/ejpn.2002.0576; Kuijpers TW, 2002, EUR J PAEDIAT NEU SA, V6, pA77; Kuijpers TW, 2002, EUR J PAEDIAT NEU SA, V6, pA65; Lebon P, 2002, EUR J PAEDIAT NEU SA, V6, pA55; Lebon P, 2002, EUR J PAEDIAT NEU SA, V6, pA77; Lebon Pierre, 2002, Eur J Paediatr Neurol, V6 Suppl A, pA47, DOI 10.1053/ejpn.2002.0574; Lester RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005644; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Mevorach D, 1998, J EXP MED, V188, P2313, DOI 10.1084/jem.188.12.2313; Miller JC, 2009, J GAMBL STUD, V25, P121, DOI 10.1007/s10899-008-9109-5; Miller MA, 2009, ATHEROSCLEROSIS, V203, P494, DOI 10.1016/j.atherosclerosis.2008.06.018; Molad Y, 2010, ANN RHEUM DIS, V69, P175, DOI 10.1136/ard.2008.102780; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Moulton VR, 2013, P NATL ACAD SCI USA, V110, P1845, DOI 10.1073/pnas.1214207110; Moulton VR, 2010, J BIOL CHEM, V285, P12490, DOI 10.1074/jbc.M109.091660; Nagaike T, 2011, MOL CELL, V41, P409, DOI 10.1016/j.molcel.2011.01.022; Nowroozalizadeh S, 2010, J INFECT DIS, V201, P1150, DOI 10.1086/651430; Papewalis C, 2008, J IMMUNOL, V180, P1462, DOI 10.4049/jimmunol.180.3.1462; Petersen T, 2009, J NEUROIMMUNOL, V215, P108, DOI 10.1016/j.jneuroim.2009.08.015; PHILLIPS R, 1985, CLIN IMMUNOL IMMUNOP, V34, P69, DOI 10.1016/0090-1229(85)90008-X; Rahimi H, 2013, LUPUS IN PRESS; Rapoport MJ, 2002, J AUTOIMMUN, V19, P63, DOI 10.1006/jaut.2002.0596; Rho YH, 2011, ARTHRIT CARE RES, V63, P535, DOI 10.1002/acr.20365; Richez C, 2009, J IMMUNOL, V182, P820, DOI 10.4049/jimmunol.182.2.820; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schiffer L, 2008, J IMMUNOL, V180, P1938, DOI 10.4049/jimmunol.180.3.1938; Sharma R, 2003, AM J CARDIOL, V92, P188, DOI 10.1016/S0002-9149(03)00536-8; Shoshan Y, 2001, J IMMUNOL, V167, P5963, DOI 10.4049/jimmunol.167.10.5963; Shui HA, 2007, RHEUMATOLOGY, V46, P1277, DOI 10.1093/rheumatology/kem136; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Steinbach F, 2000, ANN RHEUM DIS, V59, P283, DOI 10.1136/ard.59.4.283; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takase O, 2003, KIDNEY INT, V63, P501, DOI 10.1046/j.1523-1755.2003.00781.x; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Weckerle CE, 2012, ARTHRITIS RHEUM-US, V64, P2947, DOI 10.1002/art.34483; Xu ZY, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.1; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Zhai JX, 2012, MOL BIOL REP, V39, P6763, DOI 10.1007/s11033-012-1501-7; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017; Zhang Z, 2011, GENES IMMUN, V12, P445, DOI 10.1038/gene.2011.17; Zhang Z, 2010, GENES IMMUN, V11, P124, DOI 10.1038/gene.2009.66; Zhang Z, 2011, GENES IMMUN; Zhang Z, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/507475; Zheng L, 2008, J HISTOCHEM CYTOCHEM, V56, P517, DOI 10.1369/jhc.7A7368.2008	81	98	104	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e93846	10.1371/journal.pone.0093846	http://dx.doi.org/10.1371/journal.pone.0093846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796678	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000005
J	Wang, JH; Eguchi, K; Matsumoto, S; Fujiu, K; Komuro, I; Nagai, R; Manabe, I				Wang, Jack H.; Eguchi, Kosei; Matsumoto, Sahohime; Fujiu, Katsuhito; Komuro, Issei; Nagai, Ryozo; Manabe, Ichiro			The omega-3 Polyunsaturated Fatty Acid, Eicosapentaenoic Acid, Attenuates Abdominal Aortic Aneurysm Development via Suppression of Tissue Remodeling	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; VASCULAR CALCIFICATION; CONTROLLED-TRIAL; PROTEIN-KINASE; DOUBLE-BLIND; FISH-OIL; INFLAMMATION; CELLS; DOXYCYCLINE; GELATINASE	Abdominal aortic aneurysm (AAA) is a prevalent vascular disease that can progressively enlarge and rupture with a high rate of mortality. Inflammation and active remodeling of the aortic wall have been suggested to be critical in its pathogenesis. Meanwhile, omega-3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) are known to reduce cardiovascular events, but its role in AAA management remains unclear. Here, we show that EPA can attenuate murine CaCl2-induced AAA formation. Aortas from BALB/c mice fed an EPA-diet appeared less inflamed, were significantly smaller in diameter compared to those from control-diet-fed mice, and had relative preservation of aortic elastic lamina. Interestingly, CT imaging also revealed markedly reduced calcification of the aortas after EPA treatment. Mechanistically, MMP2, MMP9, and TNFSF11 levels in the aortas were reduced after EPA treatment. Consistent with this finding, RAW264.7 macrophages treated with EPA showed attenuated Mmp9 levels after TNF-alpha simulation. These results demonstrate a novel role of EPA in attenuating AAA formation via the suppression of critical remodeling pathways in the pathogenesis of AAAs, and raise the possibility of using EPA for AAA prevention in the clinical setting.	[Wang, Jack H.; Eguchi, Kosei; Matsumoto, Sahohime; Fujiu, Katsuhito; Komuro, Issei; Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Nagai, Ryozo] Jichi Med Univ, Shimotsuke, Tochigi, Japan	University of Tokyo; Jichi Medical University	Nagai, R (corresponding author), Jichi Med Univ, Shimotsuke, Tochigi, Japan.	nagai-tky@umin.ac.jp; manabe-tky@umin.ac.jp	Manabe, Ichiro/E-1529-2014; Manabe, Ichiro/AAE-5105-2021		MEXT KAKENHI [24117703]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Tokyo Biochemical Research Foundation	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Biochemical Research Foundation	This study was supported by MEXT KAKENHI 24117703 (to IM), "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'' (to RN), and research grants from the Tokyo Biochemical Research Foundation (to IM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2006, CIRC RES, V98, P727, DOI 10.1161/01.RES.0000216009.68958.e6; Aikawa E, 2009, CIRCULATION, V119, P1785, DOI 10.1161/CIRCULATIONAHA.108.827972; Allaire E, 1998, J CLIN INVEST, V102, P1413, DOI 10.1172/JCI2909; An WS, 2009, AM J PHYSIOL-RENAL, V297, pF895, DOI 10.1152/ajprenal.00217.2009; BONAA KH, 1990, NEW ENGL J MED, V322, P795, DOI 10.1056/NEJM199003223221202; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Chen JH, 2011, CIRCULATION, V123, P584, DOI 10.1161/CIRCULATIONAHA.110.971853; Chiou AC, 2001, J SURG RES, V99, P371, DOI 10.1006/jsre.2001.6207; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Defawe OD, 2003, CARDIOVASC RES, V60, P205, DOI 10.1016/S0008-6363(03)00513-3; DONADIO JV, 1994, NEW ENGL J MED, V331, P1194, DOI 10.1056/NEJM199411033311804; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Eliason JL, 2005, CIRCULATION, V112, P232, DOI 10.1161/CIRCULATIONAHA.104.517391; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Hu Xueyou, 2010, J Vis Exp, DOI 10.3791/2445; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Matsumoto M, 2008, ATHEROSCLEROSIS, V197, P524, DOI 10.1016/j.atherosclerosis.2007.07.023; Miyake T, 2009, CARDIOVASC RES, V83, P436, DOI 10.1093/cvr/cvp155; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; Norman PE, 2011, J VASC SURG, V53, P274, DOI 10.1016/j.jvs.2010.08.087; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Pradelli L, 2012, CRIT CARE, V16, DOI 10.1186/cc11668; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rughani G, 2012, COCHRANE DATABASE SY, V9; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shen H, 2013, ARTERIOSCL THROM VAS, V33, P2596, DOI 10.1161/ATVBAHA.113.302099; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; SIEGEL CL, 1994, AM J ROENTGENOL, V163, P1123, DOI 10.2214/ajr.163.5.7976888; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Tull SP, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000177; Vammen S, 2001, BRIT J SURG, V88, P1066, DOI 10.1046/j.0007-1323.2001.01845.x; van der Meij E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053882; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711; Wang YT, 2013, ATHEROSCLEROSIS, V226, P29, DOI 10.1016/j.atherosclerosis.2012.09.010; Weintraub NL, 2009, NEW ENGL J MED, V361, P1114, DOI 10.1056/NEJMcibr0905244; Wylie-Sears J, 2011, ARTERIOSCL THROM VAS, V31, P598, DOI 10.1161/ATVBAHA.110.216184; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Yuan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029037	54	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96286	10.1371/journal.pone.0096286	http://dx.doi.org/10.1371/journal.pone.0096286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798452	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000060
J	Fujita, M; Takada, YK; Takada, Y				Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu			The Chemokine Fractalkine Can Activate Integrins without CX3CR1 through Direct Binding to a Ligand-Binding Site Distinct from the Classical RGD-Binding Site	PLOS ONE			English	Article							MEMBRANE-BOUND CHEMOKINE; RECEPTOR CX(3)CR1; MONOCYTE ARREST; CELL-ADHESION; ALPHA-V-BETA-3; FLOW; INFLAMMATION; CLEAVAGE; NEURONS; ALPHA(IIB)BETA(3)	The chemokine domain of fractalkine (FKN-CD) binds to the classical RGD-binding site of alpha v beta 3 and that the resulting ternary complex formation (integrin-FKN-CX3CR1) is critical for CX3CR1 signaling and FKN-induced integrin activation. However, only certain cell types express CX3CR1. Here we studied if FKN-CD can activate integrins in the absence of CX3CR1. We describe that WT FKN-CD activated recombinant soluble alpha v beta 3 in cell-free conditions, but the integrin-binding defective mutant of FKN-CD (K36E/R37E) did not. This suggests that FKN-CD can activate alpha v beta 3 in the absence of CX3CR1 through the direct binding of FKN-CD to alpha v beta 3. WT FKN-CD activated alpha v beta 3 on CX3CR1-negative cells (K562 and CHO) but K36E/R37E did not, suggesting that FKN-CD can activate integrin at the cellular levels in a manner similar to that in cell-free conditions. We hypothesized that FKN-CD enhances ligand binding to the classical RGD-binding site (site 1) through binding to a second binding site (site 2) that is distinct from site 1 in alpha v beta 3. To identify the possible second FKN-CD binding site we performed docking simulation of alpha v beta 3-FKN-CD interaction using alpha v beta 3 with a closed inactive conformation as a target. The simulation predicted a potential FKN-CD-binding site in inactive alpha v beta 3 (site 2), which is located at a crevice between alpha v and beta 3 on the opposite side of site 1 in the alpha v beta 3 headpiece. We studied if FKN-CD really binds to site 2 using a peptide that is predicted to interact with FKN-CD in site 2. Notably the peptide specifically bound to FKN-CD and effectively suppressed integrin activation by FKN-CD. This suggests that FKN-CD actually binds to site 2, and this leads to integrin activation. We obtained very similar results in alpha 4 beta 1 and alpha 5 beta 1. The FKN binding to site 2 and resulting integrin activation may be a novel mechanism of integrin activation and of FKN signaling.	[Fujita, Masaaki; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Takada, Y (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol Biochem & Mol Med, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu		takada, yoshikazu/0000-0001-5481-9589	TRDRP (Tobacco-related disease research program) [18XT-0169]; NIH [CA13015]; DOD [W81XWH-10-1-0312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	TRDRP (Tobacco-related disease research program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by TRDRP (Tobacco-related disease research program) 18XT-0169, NIH CA13015, and DOD W81XWH-10-1-0312 (to YT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; BLYSTONE SD, 1994, J CELL BIOL, V127, P1129, DOI 10.1083/jcb.127.4.1129; Cambien B, 2001, BLOOD, V97, P2031, DOI 10.1182/blood.V97.7.2031; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Cierniewski CS, 1999, J BIOL CHEM, V274, P16923, DOI 10.1074/jbc.274.24.16923; Dorgham K, 2009, J LEUKOCYTE BIOL, V86, P903, DOI 10.1189/jlb.0308158; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Goda S, 2000, J IMMUNOL, V164, P4313, DOI 10.4049/jimmunol.164.8.4313; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Hu DD, 1999, J BIOL CHEM, V274, P4633, DOI 10.1074/jbc.274.8.4633; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kansra V, 2001, J BIOL CHEM, V276, P31831, DOI 10.1074/jbc.M009374200; Legler DF, 2001, J CELL SCI, V114, P1545; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Saegusa J, 2008, J BIOL CHEM, V283, P26107, DOI 10.1074/jbc.M804835200; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Schafer A, 2004, BLOOD, V103, P407, DOI 10.1182/blood-2002-10-3260; Schofield KP, 1998, BLOOD, V91, P3230, DOI 10.1182/blood.V91.9.3230.3230_3230_3238; Smith DF, 2005, AM J PHYSIOL-HEART C, V289, pH1976, DOI 10.1152/ajpheart.00153.2005; Smith ML, 2004, J EXP MED, V200, P935, DOI 10.1084/jem.20040424; Suga H, 2004, J BIOCHEM, V135, P605, DOI 10.1093/jb/mvh058; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Weber C, 2003, J MOL MED, V81, P4, DOI 10.1007/s00109-002-0391-x; Weber KSC, 1999, EUR J IMMUNOL, V29, P700, DOI 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yokoyama K, 1999, BIOCHEMISTRY-US, V38, P5872, DOI 10.1021/bi9827619; Zhang XP, 1998, J BIOL CHEM, V273, P7345, DOI 10.1074/jbc.273.13.7345	45	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96372	10.1371/journal.pone.0096372	http://dx.doi.org/10.1371/journal.pone.0096372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789099	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700082
J	Kongsbak, M; von Essen, MR; Boding, L; Levring, TB; Schjerling, P; Lauritsen, JPH; Woetmann, A; Odum, N; Bonefeld, CM; Geisler, C				Kongsbak, Martin; von Essen, Marina R.; Boding, Lasse; Levring, Trine B.; Schjerling, Peter; Lauritsen, Jens P. H.; Woetmann, Anders; Odum, Niels; Bonefeld, Charlotte M.; Geisler, Carsten			Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4(+) T Cells	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; 1,25-DIHYDROXYVITAMIN D-3; MEDIATED DEGRADATION; NUCLEAR-LOCALIZATION; HUMAN-LYMPHOCYTES; IMMUNE-SYSTEM; X-RECEPTOR; D ANALOGS; EXPRESSION; MODULATION	The active form of vitamin D-3, 1,25(OH)(2)D-3, has significant immunomodulatory properties and is an important determinant in the differentiation of CD4(+) effector T cells. The biological actions of 1,25(OH)(2)D-3 are mediated by the vitamin D receptor (VDR) and are believed to correlate with the VDR protein expression level in a given cell. The aim of this study was to determine if and how 1,25(OH)(2)D-3 by itself regulates VDR expression in human CD4(+) T cells. We found that activated CD4(+) T cells have the capacity to convert the inactive 25(OH)D-3 to the active 1,25(OH)(2)D-3 that subsequently up-regulates VDR protein expression approximately 2-fold. 1,25(OH)(2)D-3 does not increase VDR mRNA expression but increases the half-life of the VDR protein in activated CD4(+) T cells. Furthermore, 1,25(OH)(2)D-3 induces a significant intracellular redistribution of the VDR. We show that 1,25(OH)(2)D-3 stabilizes the VDR by protecting it from proteasomal degradation. Finally, we demonstrate that proteasome inhibition leads to up-regulation of VDR protein expression and increases 1,25(OH)(2)D-3-induced gene activation. In conclusion, our study shows that activated CD4(+) T cells can produce 1,25(OH)(2)D-3, and that 1,25(OH)(2)D-3 induces a 2-fold up-regulation of the VDR protein expression in activated CD4(+) T cells by protecting the VDR against proteasomal degradation.	[Kongsbak, Martin; von Essen, Marina R.; Boding, Lasse; Levring, Trine B.; Lauritsen, Jens P. H.; Woetmann, Anders; Odum, Niels; Bonefeld, Charlotte M.; Geisler, Carsten] Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Bispebjerg Hosp, Inst Sports Med, Dept Orthoped Surg M, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Healthy Aging, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Geisler, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	cge@sund.ku.dk	Schjerling, Peter/F-6194-2011; Geisler, Carsten/A-7056-2012; Woetmann, Anders/AAJ-3171-2020; von Essen, marina/AAG-9686-2021	Schjerling, Peter/0000-0001-7138-3211; Geisler, Carsten/0000-0002-8472-0771; Bonefeld, Charlotte Menne/0000-0002-0523-6229; von Essen, Marina/0000-0001-9367-5020; Kongsbak-Wismann, Martin/0000-0002-3496-9333; Boding, Lasse/0000-0003-4813-2865; Woetmann, Anders/0000-0002-3008-735X	Danish Medical Research Council; Lundbeck Foundation; Novo Nordisk Foundation; A.P. Moller Foundation for the Advancement of Medical Sciences; Novo Nordisk Fonden [NNF12OC0002036] Funding Source: researchfish; The Danish Cancer Society [R72-A4571] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A.P. Moller Foundation for the Advancement of Medical Sciences; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	This work was supported by grants from The Danish Medical Research Council, The Lundbeck Foundation, The Novo Nordisk Foundation, and The A.P. Moller Foundation for the Advancement of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Baeke F, 2010, J STEROID BIOCH MOL; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chen LF, 2005, J IMMUNOL, V174, P6144, DOI 10.4049/jimmunol.174.10.6144; CHEN TL, 1986, J CELL PHYSIOL, V126, P21, DOI 10.1002/jcp.1041260104; Chi YY, 2009, BIOCHEM BIOPH RES CO, V386, P493, DOI 10.1016/j.bbrc.2009.06.061; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; COSTA EM, 1985, ENDOCRINOLOGY, V117, P2203, DOI 10.1210/endo-117-5-2203; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; DAME MC, 1986, BIOCHEMISTRY-US, V25, P4523, DOI 10.1021/bi00364a011; DAVOODI F, 1995, J STEROID BIOCHEM, V54, P147, DOI 10.1016/0960-0760(95)00128-M; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Diaz L, 2011, CYTOKINE, V55, P188, DOI 10.1016/j.cyto.2011.04.013; Dietrich J, 1998, J BIOL CHEM, V273, P26281, DOI 10.1074/jbc.273.41.26281; Dorr J, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-15; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Hsieh JC, 1998, J CELL BIOCHEM, V70, P94, DOI 10.1002/(SICI)1097-4644(19980701)70:1<94::AID-JCB10>3.3.CO;2-Q; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Jaaskelainen T, 2000, J CELL BIOCHEM, V76, P548; Jeffery LE, 2012, J IMMUNOL, V189, P5155, DOI 10.4049/jimmunol.1200786; Jeffery LE, 2009, J IMMUNOL, V183, P5458, DOI 10.4049/jimmunol.0803217; Joseph RW, 2012, HUM IMMUNOL, V73, P693, DOI 10.1016/j.humimm.2012.04.019; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Kaiser MF, 2013, EUR J HAEMATOL, V90, P263, DOI 10.1111/ejh.12069; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; KIZAKI M, 1991, BLOOD, V77, P1238; Klopot A, 2007, J CELL BIOCHEM, V100, P617, DOI 10.1002/jcb.21087; Kongsbak M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00148; Krishnan AV, 2011, VITAMIN D AND CANCER, P53, DOI 10.1007/978-1-4419-7188-3_3; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; Li XY, 1999, MOL ENDOCRINOL, V13, P1686, DOI 10.1210/me.13.10.1686; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; MANGELSDORF DJ, 1987, P NATL ACAD SCI USA, V84, P354, DOI 10.1073/pnas.84.2.354; Masuyama H, 1998, J CELL BIOCHEM, V71, P429, DOI 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Nielsen MM, 2014, J IMMUNOL; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Palmer MT, 2011, J BIOL CHEM, V286, P997, DOI 10.1074/jbc.M110.163790; PAN LC, 1987, J BIOL CHEM, V262, P4670; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Peleg S, 2010, J CELL BIOCHEM, V110, P926, DOI 10.1002/jcb.22606; Pike JW, 2012, REV ENDOCR METAB DIS, V13, P45, DOI 10.1007/s11154-011-9198-9; PROVVEDINI DM, 1989, J CLIN ENDOCR METAB, V68, P774, DOI 10.1210/jcem-68-4-774; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; SANTISOMERE D, 1993, MOL ENDOCRINOL, V7, P833, DOI 10.1210/me.7.7.833; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Thien R, 2005, J ALLERGY CLIN IMMUN, V116, P683, DOI 10.1016/j.jaci.2005.05.013; Tiosano D, 2013, J CLIN ENDOCR METAB, V98, P1685, DOI 10.1210/jc.2012-3858; Urry Z, 2012, EUR J IMMUNOL, V42, P2697, DOI 10.1002/eji.201242370; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; WALTERS MR, 1982, J BIOL CHEM, V257, P7481; Wang YJ, 2010, ARCH BIOCHEM BIOPHYS, V494, P166, DOI 10.1016/j.abb.2009.11.029; WIESE RJ, 1992, J BIOL CHEM, V267, P20082; YU XP, 1991, J BIOL CHEM, V266, P7588; YU XP, 1991, P NATL ACAD SCI USA, V88, P8347, DOI 10.1073/pnas.88.19.8347; Zella JB, 2003, J CELL BIOCHEM, V88, P216, DOI 10.1002/jcb.10347; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	71	51	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96695	10.1371/journal.pone.0096695	http://dx.doi.org/10.1371/journal.pone.0096695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24792400	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700126
J	Chen, L; Zhang, Z; Qiu, JH; Zhang, LL; Luo, XD; Jang, J				Chen, Li; Zhang, Ze; Qiu, Juhui; Zhang, Lingling; Luo, Xiangdong; Jang, Jun			Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ER alpha-Positive Breast Cancer Cells on Hard Substrates	PLOS ONE			English	Article							CYCLE PROGRESSION; PROTEIN; EXPRESSION; BINDING; METASTASIS; RECURRENCE; ACTIVATION; MECHANISM; PREFOLDIN; INTERACTS	Clinical observations have revealed a strong association between estrogen receptor alpha (ER alpha)-positive tumors and the development of bone metastases, however, the mechanism underlying this association remains unknown. We cultured MCF-7 (ER alpha-positive) on different rigidity substrates. Compared with cells grown on more rigid substrates (100 kPa), cells grown on soft substrates (10 kPa) exhibited reduced spreading ability, a lower ratio of cells in the S and G2/M cell cycle phases, and a decreased proliferation rate. Using stable isotope labeling by amino acids (SILAC), we further compared the whole proteome of MCF-7 cells grown on substrates of different rigidity (10 and 100 kPa), and found that the expression of eight members of chaperonin CCT increased by at least 2-fold in the harder substrate. CCT folding activity was increased in the hard substrate compared with the soft substrates. Amplified in breast cancer 1 (AIB1), was identified in CCT immunoprecipitates. CCT folding ability of AIB1 increased on 100-kPa substrate compared with 10- and 30-kPa substrates. Moreover, using mammalian two-hybrid protein-protein interaction assays, we found that the polyglutamine repeat sequence of the AIB1 protein was essential for interaction between CCT zeta and AIB1. CCT zeta-mediated AIB1 folding affects the cell area spreading, growth rate, and cell cycle. The expressions of the c-myc, cyclin D1, and PgR genes were higher on hard substrates than on soft substrate in both MCF-7 and T47D cells. ER alpha and AIB1 could up-regulate the mRNA and protein expression levels of the c-myc, cyclin D1, and PgR genes, and that 17 beta-estradiol could enhance this effects. Conversely, 4-hydroxytamoxifen, could inhibit these effects. Taken together, our studies demonstrate that some ER alpha-positive breast cancer cells preferentially grow on more rigid substrates. CCT-mediated AIB1 folding appears to be involved in the rigidity response of breast cancer cells, which provides novel insight into the mechanisms of bone metastasis.	[Chen, Li; Jang, Jun] Third Mil Med Univ, Southwest Hosp, Breast Dis Ctr, Chongqing, Peoples R China; [Chen, Li; Zhang, Ze; Qiu, Juhui; Zhang, Lingling; Luo, Xiangdong; Jang, Jun] Third Mil Med Univ, Southwest Hosp, Burn Res Inst, Chongqing, Peoples R China; [Chen, Li; Zhang, Ze; Qiu, Juhui; Zhang, Lingling; Luo, Xiangdong] Chongqing Key Lab Dis Prote, Natl Key Lab Trauma & Burns, Chongqing, Peoples R China	Army Medical University; Army Medical University	Luo, XD (corresponding author), Third Mil Med Univ, Southwest Hosp, Burn Res Inst, Chongqing, Peoples R China.	luoxd2005@163.com; jiangjun8086@126.com	zhang, lingling/HDM-2189-2022		National Natural Science Foundation of China [81072157, 81372813]; National High Technology Research and Development Program of China [2011CB710904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by Grants from the National Natural Science Foundation of China (No. 81072157 and 81372813; http://www.nsfc.gov.cn/Portal0/default106.htm). National High Technology Research and Development Program of China grant 2011CB710904 (http://www.most.gov.cn/eng/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldinger I, 2005, PANCREATOLOGY, V5, P370, DOI 10.1159/000086537; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; Chang AK, 2012, ONCOL LETT, V4, P588, DOI 10.3892/ol.2012.803; Chen L, 2009, CANCER LETT, V278, P210, DOI 10.1016/j.canlet.2009.01.008; Chu JE, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/209748; Cimmino F, 2007, J PROTEOME RES, V6, P2550, DOI 10.1021/pr060701g; CLARK GM, 1987, J CLIN ONCOL, V5, P55, DOI 10.1200/JCO.1987.5.1.55; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; DUBIK D, 1992, ONCOGENE, V7, P1587; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fizazi K, 2011, LANCET, V377, P813, DOI 10.1016/S0140-6736(10)62344-6; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gomez-Puertas P, 2004, J MOL RECOGNIT, V17, P85, DOI 10.1002/jmr.654; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Guelcher SA, 2011, CANCER MICROENVIRON, V4, P247, DOI 10.1007/s12307-011-0078-3; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; HENDERSON BE, 1988, CANCER RES, V48, P246; Her C, 2003, CANCER RES, V63, P865; Hess KR, 2003, BREAST CANCER RES TR, V78, P105, DOI 10.1023/A:1022166517963; Hodges LC, 2003, MOL CANCER RES, V1, P300; Karmakar S, 2009, ENDOCRINOLOGY, V150, P1588, DOI 10.1210/en.2008-1001; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Kumar R, 2000, ENDOCR-RELAT CANCER, V7, P257, DOI 10.1677/erc.0.0070257; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Ma G, 2011, INT J BIOL SCI, V7, P664, DOI 10.7150/ijbs.7.664; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nibbe RK, 2009, MOL CELL PROTEOMICS, V8, P827, DOI 10.1074/mcp.M800428-MCP200; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pongtepaditep S, 2012, EUR J MED GENET, V55, P599, DOI 10.1016/j.ejmg.2012.06.013; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Ruppender NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015451; Salmon-Divon M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-415; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Solomayer EF, 2000, BREAST CANCER RES TR, V59, P271, DOI 10.1023/A:1006308619659; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905; Tsuchiya H, 1996, CANCER RES, V56, P2881; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Vos CBJ, 1999, J PATHOL, V187, P279; Wang Y, 2012, BURNS, V38, P414, DOI 10.1016/j.burns.2011.09.002; Wong LJC, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-111; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yokota S, 2001, CELL STRESS CHAPERON, V6, P345, DOI 10.1379/1466-1268(2001)006<0345:IEOCCC>2.0.CO;2; Zwart W, 2011, EMBO J, V30, P4764, DOI 10.1038/emboj.2011.368	52	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96085	10.1371/journal.pone.0096085	http://dx.doi.org/10.1371/journal.pone.0096085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788909	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600074
J	Kobayashi, M; Ohno, T; Ihara, K; Murai, A; Kumazawa, M; Hoshino, H; Iwanaga, K; Iwai, H; Hamana, Y; Ito, M; Ohno, K; Horio, F				Kobayashi, Misato; Ohno, Tamio; Ihara, Kunio; Murai, Atsushi; Kumazawa, Mayumi; Hoshino, Hiromi; Iwanaga, Koichiro; Iwai, Hiroshi; Hamana, Yoshiki; Ito, Mikako; Ohno, Kinji; Horio, Fumihiko			Searching for Genomic Region of High-Fat Diet-Induced Type 2 Diabetes in Mouse Chromosome 2 by Analysis of Congenic Strains	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; SMXA-5 MOUSE; TSOD MOUSE; MICE; OBESITY; ALPHA; EXPRESSION; PROTEIN	SMXA-5 mice are a high-fat diet-induced type 2 diabetes animal model established from non-diabetic SM/J and A/J mice. By using F2 intercross mice between SMXA-5 and SM/J mice under feeding with a high-fat diet, we previously mapped a major diabetogenic QTL (T2dm2sa) on chromosome 2. We then produced the congenic strain (SM.A-T2dm2sa (R0), 20.8-163.0 Mb) and demonstrated that the A/J allele of T2dm2sa impaired glucose tolerance and increased body weight and body mass index in the congenic strain compared to SM/J mice. We also showed that the combination of T2dm2sa and other diabetogenic loci was needed to develop the high-fat diet-induced type 2 diabetes. In this study, to narrow the potential genomic region containing the gene(s) responsible for T2dm2sa, we constructed R1 and R2 congenic strains. Both R1 (69.6-163.0 Mb) and R2 (20.8-128.2 Mb) congenic mice exhibited increases in body weight and abdominal fat weight and impaired glucose tolerance compared to SM/J mice. The R1 and R2 congenic analyses strongly suggested that the responsible genes existed in the overlapping genomic interval (69.6-128.2 Mb) between R1 and R2. In addition, studies using the newly established R1A congenic strain showed that the narrowed genomic region (69.6-75.4 Mb) affected not only obesity but also glucose tolerance. To search for candidate genes within the R1A genomic region, we performed exome sequencing analysis between SM/J and A/J mice and extracted 4 genes (Itga6, Zak, Gpr155, and Mtx2) with non-synonymous coding SNPs. These four genes might be candidate genes for type 2 diabetes caused by gene-gene interactions. This study indicated that one of the genes responsible for high-fat diet-induced diabetes exists in the 5.8 Mb genomic interval on mouse chromosome 2.	[Kobayashi, Misato; Murai, Atsushi; Kumazawa, Mayumi; Hoshino, Hiromi; Iwanaga, Koichiro; Iwai, Hiroshi; Hamana, Yoshiki; Horio, Fumihiko] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan; [Ohno, Tamio] Nagoya Univ, Grad Sch Med, Ctr Promot Med Res & Educ, Div Expt Anim, Nagoya, Aichi 4648601, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 46401, Japan; [Ito, Mikako; Ohno, Kinji] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Horio, F (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan.	horiof@agr.nagoya-u.ac.jp	Ohno, Kinji/H-4020-2012; IHARA, Kunio/D-1952-2011; Ohno, Kinji/ABD-5787-2020; Ito, Mikako/I-1941-2012	Ohno, Kinji/0000-0002-1529-2750; Ohno, Kinji/0000-0002-1529-2750; KOBAYASHI, Misato/0000-0002-2752-6358	JSPS KAKENHI [24380068]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Number 24380068. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Hirayama I, 1999, DIABETES, V48, P1183, DOI 10.2337/diabetes.48.5.1183; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Karunakaran S, 2013, PHYSIOL GENOMICS, V45, P191, DOI 10.1152/physiolgenomics.00159.2012; Kobayashi M, 2006, DIABETOLOGIA, V49, P486, DOI 10.1007/s00125-005-0121-3; Kobayashi M, 2004, BIOSCI BIOTECH BIOCH, V68, P226, DOI 10.1271/bbb.68.226; Liu TC, 2000, BIOCHEM BIOPH RES CO, V274, P811, DOI 10.1006/bbrc.2000.3236; Mizutani S, 2006, MAMM GENOME, V17, P375, DOI 10.1007/s00335-005-0161-5; NISHIMURA M, 1995, MAMM GENOME, V6, P850, DOI 10.1007/BF00292434; Schmidt C, 2008, PHYSIOL GENOMICS, V34, P42, DOI 10.1152/physiolgenomics.00267.2007; Stoehr JP, 2000, DIABETES, V49, P1946, DOI 10.2337/diabetes.49.11.1946; Stoehr JP, 2004, DIABETES, V53, P245, DOI 10.2337/diabetes.53.1.245; Trifonov S, 2010, BIOCHEM BIOPH RES CO, V398, P19, DOI 10.1016/j.bbrc.2010.05.162; Wang JR, 2012, GENETICS, V190, P449, DOI 10.1534/genetics.111.132381; Yogosawa S, 2013, DIABETES, V62, P115, DOI 10.2337/db12-0295	17	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96271	10.1371/journal.pone.0096271	http://dx.doi.org/10.1371/journal.pone.0096271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789282	Green Published, Green Submitted, gold			2022-12-27	WOS:000335510600089
J	Zhao, PW; Jiang, WG; Wang, L; Jiang, ZY; Shan, YX; Jiang, YF				Zhao, Ping-Wei; Jiang, Wei-Guang; Wang, Li; Jiang, Zhen-Yu; Shan, Yu-Xing; Jiang, Yan-Fang			Plasma Levels of IL-37 and Correlation with TNF-alpha, IL-17A, and Disease Activity during DMARD Treatment of Rheumatoid Arthritis	PLOS ONE			English	Article							CYTOMETRIC BEAD ARRAY; ANTIINFLAMMATORY CYTOKINE; PATHOGENESIS; INTERLEUKIN-37; INFLAMMATION; EXPRESSION; ROLES	The aim of this study was to assess the change of IL-37 concentrations in rheumatoid arthritis (RA) patients under Disease-modifying anti-rheumatic drug (DMARD) therapy, and to establish a correlation between Interleukin-37 and pro-inflammatory cytokines in plasma and disease activity. The plasma level of IL-37 was determined using ELISA in 50 newly diagnosed RA patients and 30 healthy controls (HC). Plasma levels of IL-17A, IL-6 and TNF-alpha were measured using flow a cytometric bead array assay. We found that the concentrations of IL-37, as well as IL-17A, IL-6 and TNF-alpha, were higher in plasma of RA patients compared to HCs. Compared to patients who did not respond to DMARD treatment, treatment of patients responsive to DMARDs resulted in down-regulation of IL-17A, IL-6 and TNF-alpha expression. The plasma level of the anti-inflammatory cytokine IL-37 was also decreased in drug responders after DMARD treatment. The plasma level of IL-37 in RA patients was positively correlated with pro-inflammatory cytokines (IL-17A, TNF-alpha) and disease activity (CRP, DAS28) in RA patients. IL-37 expression in RA and during DMARD treatment appears to be controlled by the level of pro-inflammatory cytokines. This results in a strong correlation between plasma levels of IL-37 and disease activity in RA patients.	[Zhao, Ping-Wei; Jiang, Wei-Guang; Wang, Li; Shan, Yu-Xing; Jiang, Yan-Fang] Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China; [Jiang, Zhen-Yu] Jilin Univ, Hosp 1, Dept Rheumatism, Changchun 130023, Peoples R China	Jilin University; Jilin University	Jiang, YF (corresponding author), Jilin Univ, Hosp 1, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Peoples R China.	yanfangjiang@hotmail.com			National Natural Science Foundation of China [30972610, 81273240]; Jilin Province Science and Technology Agency [20110716]; Health Department Research Projects in Jilin Province [2009Z054]; Cutting-edge Science and Interdisciplinary Innovation Projects of Jilin University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Agency; Health Department Research Projects in Jilin Province; Cutting-edge Science and Interdisciplinary Innovation Projects of Jilin University	This study was supported by grants from the National Natural Science Foundation of China (No. 30972610 and 81273240), Jilin Province Science and Technology Agency (No. 20110716), the Health Department Research Projects in Jilin Province (2009Z054) and the Cutting-edge Science and Interdisciplinary Innovation Projects of Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Boraschi D, 2011, EUR CYTOKINE NETW, V22, P127, DOI 10.1684/ecn.2011.0288; Bufler P, 2002, P NATL ACAD SCI USA, V99, P13723, DOI 10.1073/pnas.212519099; Bulau AM, 2011, THESCIENTIFICWORLDJO, V11, P2480, DOI 10.1100/2011/968479; Chu KD, 2013, EXP THER MED, V5, P423, DOI 10.3892/etm.2012.853; Corvaisier M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001395; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Hashizume M, 2011, ARTHRITIS, DOI 10.1155/2011/765624; Kramer JM, 2007, J PERIODONTOL, V78, P1083, DOI 10.1902/jop.2007.060392; Kurebayashi Y, 2013, GENES CELLS, V18, P247, DOI 10.1111/gtc.12039; Lubberts E, 2003, ADV EXP MED BIOL, V520, P194; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Moran EM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2772; Morgan E, 2004, CLIN IMMUNOL, V110, P252, DOI 10.1016/j.clim.2003.11.017; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Park JY, 2007, BULL HOSP JT DIS, V65, pS4; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Sakai N, 2012, J GASTROEN HEPATOL, V27, P1609, DOI 10.1111/j.1440-1746.2012.07187.x; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Simon LS, 2000, INT J CLIN PRACT, V54, P243; Song LJ, 2013, J CLIN IMMUNOL, V33, P111, DOI 10.1007/s10875-012-9791-z; Tarnok A, 2003, CLIN CHEM, V49, P1000, DOI 10.1373/49.6.1000; Tete S, 2012, INT J IMMUNOPATH PH, V25, P31, DOI 10.1177/039463201202500105; van Hamburg JP, 2013, ANN RHEUM DIS; Yusof MYM, 2013, DRUGS, V73, P341, DOI 10.1007/s40265-013-0018-2; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	32	90	98	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95346	10.1371/journal.pone.0095346	http://dx.doi.org/10.1371/journal.pone.0095346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788826	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600034
J	Hartley, S; McArthur, M; Coenen, M; Cabello, M; Covelli, V; Roszczynska-Michta, J; Pitkanen, T; Bickenbach, J; Cieza, A				Hartley, Sally; McArthur, Maggie; Coenen, Michaela; Cabello, Maria; Covelli, Venusia; Roszczynska-Michta, Joanna; Pitkanen, Tuuli; Bickenbach, Jerome; Cieza, Alarcos			Narratives Reflecting the Lived Experiences of People with Brain Disorders: Common Psychosocial Difficulties and Determinants	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; WOMENS EXPERIENCES; MENTAL-DISORDERS; QUALITATIVE RESEARCH; PHYSICAL-ACTIVITY; OLDER-ADULTS; DEPRESSION; PARTICIPATION; PERCEPTIONS	Background: People with brain disorders - defined as both, mental disorders and neurological disorders experience a wide range of psychosocial difficulties (PSDs) (e. g., concentrating, maintaining energy levels, and maintaining relationships). Research evidence is required to show that these PSDs are common across brain disorders. Objectives: To explore and gain deeper understanding of the experiences of people with seven brain disorders (alcohol dependency, depression, epilepsy, multiple sclerosis, Parkinson's disease, schizophrenia, stroke). It examines the common PSDs and their influencing factors. Methods: Seventy seven qualitative studies identified in a systematic literature review and qualitative data derived from six focus groups are used to generate first-person narratives representing seven brain disorders. A theory-driven thematic analysis of these narratives identifies the PSDs and their influencing factors for comparison between the seven disorders. Results: First-person narratives illustrate realities for people with brain disorders facilitating a deeper understanding of their every-day life experiences. Thematic analysis serves to highlight the commonalities, both of PSDs, such as loneliness, anger, uncertainty about the future and problems with work activities, and their determinants, such as work opportunities, trusting relationships and access to self-help groups. Conclusions: The strength of the methodology and the narratives is that they provide the opportunity for the reader to empathise with people with brain disorders and facilitate deeper levels of understanding of the complexity of the relationship of PSDs, determinants and facilitators. The latter reflect positive aspects of the lives of people with brain disorders. The result that many PSDs and their influencing factors are common to people with different brain disorders opens up the door to the possibility of using cross-cutting interventions involving different sectors. This strengthens the message that 'a great deal can be done' to improve the lived experience of persons with brain disorders when medical interventions are exhausted.	[Hartley, Sally; McArthur, Maggie] Univ E Anglia, Fac Med & Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Hartley, Sally] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia; [Hartley, Sally] London Sch Hyg & Trop Med, London WC1, England; [Coenen, Michaela; Cieza, Alarcos] Univ Munich, Dept Med Informat Biometry & Epidemiol IBE, Chair Publ Hlth & Hlth Serv Res, Res Unit Biopsychosocial Hlth, Munich, Germany; [Cabello, Maria] Univ Autonoma Madrid, Fac Med, Inst Salud Carlos III CIBERSAM, Inst Invest Princesa IIS IP, Madrid, Spain; [Covelli, Venusia] Neurol Inst Carlo Besta IRCCS Fdn, Sci Directorate, Neurol Publ Hlth & Disabil Unit, Milan, Italy; [Roszczynska-Michta, Joanna] Inst Neurol & Psychiat, Warsaw, Poland; [Pitkanen, Tuuli] A Clin Fdn A Klin Kasaatio, Helsinki, Finland; [Bickenbach, Jerome; Cieza, Alarcos] Swiss Parapleg Res, Nottwil, Switzerland; [Cieza, Alarcos] Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England	University of East Anglia; University of Sydney; University of London; London School of Hygiene & Tropical Medicine; University of Munich; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; IRCCS Istituto Neurologico Besta; Swiss Paraplegic Research; University of Southampton	Cieza, A (corresponding author), Univ Munich, Dept Med Informat Biometry & Epidemiol IBE, Chair Publ Hlth & Hlth Serv Res, Res Unit Biopsychosocial Hlth, Munich, Germany.	alarcos.cieza@soton.ac.uk	Cabello, Maria/R-5665-2019; Pitkänen, Tuuli/AAH-2204-2020; COVELLI, VENUSIA/AAG-9232-2020	Cabello, Maria/0000-0003-2362-6092; COVELLI, VENUSIA/0000-0002-5965-2658; Pitkanen, Tuuli/0000-0002-2381-9436; Coenen, Michaela/0000-0001-7492-7907	PARADISE Consortium	PARADISE Consortium	Our special thanks go to the participants of the focus groups. We also thank Francesca Albanesi, Elisabeth Linseisen, Blanca Mellor, Itziar Leal, Rui Quintas, Alberto Raggi, Carla Sabariego and Justyna Waszkiewicz for their meaningful contributions regarding data collection and analyses of the focus groups. Finally, we would like to thank the other members of the PARADISE Consortium for their valuable support.	Allan J, 2009, J PSYCHIATR MENT HLT, V16, P865, DOI 10.1111/j.1365-2850.2009.01465.x; Ambrogne JA, 2007, PERSPECT PSYCHIATR C, V43, P84, DOI 10.1111/j.1744-6163.2007.00115.x; Ambrogne Sobczak Janet, 2009, J Am Psychiatr Nurses Assoc, V14, P421, DOI 10.1177/1078390308325577; Gonzalez-Torres MA, 2007, SOC PSYCH PSYCH EPID, V42, P14, DOI 10.1007/s00127-006-0126-3; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Asia Market Research, 2012, BACK TRANSL; Backenstrass M, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-190; Bejerholm Ulrika, 2006, Occup Ther Int, V13, P100, DOI 10.1002/oti.210; Bezdek M, 2006, MED ANTHROPOL Q, V20, P160, DOI 10.1525/maq.2006.20.2.160; Blanchard Amy, 2009, Issues Ment Health Nurs, V30, P764, DOI 10.3109/01612840903225594; Bombois S, 2010, J NUTR HEALTH AGING, V14, P212, DOI 10.1007/s12603-010-0052-7; Borkoles E, 2008, PSYCHOL HEALTH, V23, P427, DOI 10.1080/14768320701205309; Boss TM, 2006, AM J OCCUP THER, V60, P348, DOI 10.5014/ajot.60.3.348; Brems C, 2007, J ASSOC NURSE AIDS C, V18, P12, DOI 10.1016/j.jana.2006.11.002; Brown CG, 2008, J PREV INTERV COMMUN, V35, P33, DOI 10.1300/J005v35n02_04; Buizza Chiara, 2007, Clin Pract Epidemiol Ment Health, V3, P23, DOI 10.1186/1745-0179-3-23; Cabello M, 2012, J AFFECT DISORDERS, V141, P22, DOI 10.1016/j.jad.2011.12.009; Carin-Levy G, 2009, CAN J OCCUP THER, V76, P73, DOI 10.1177/000841740907600204; Cechnicki A, 2011, SOC PSYCH PSYCH EPID, V46, P643, DOI 10.1007/s00127-010-0230-2; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; Dalemans RJP, 2010, INT J LANG COMM DIS, V45, P537, DOI 10.3109/13682820903223633; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Dixon-Woods M, 2006, BMC MED RES METHODOL, P35; Dodd KJ, 2006, DISABIL REHABIL, V28, P1127, DOI 10.1080/09638280500531842; Douglas C, 2008, J NEUROSCI NURS, V40, P158, DOI 10.1097/01376517-200806000-00006; Dyson Jane, 2007, J Fam Health Care, V17, P211; Engberg E, 2012, SPORTS MED, V42, P433, DOI 10.2165/11597610-000000000-00000; Esmail S, 2007, SEX DISABIL, V25, P163, DOI 10.1007/s11195-007-9054-8; Feely M, 2009, J PSYCHIATR MENT HLT, V16, P725, DOI 10.1111/j.1365-2850.2009.01452.x; Finlayson M., 2005, BRIT J OCCUPATIONAL, V68, P117, DOI DOI 10.1177/030802260506800304; Fogarty Margaret, 2005, Issues Ment Health Nurs, V26, P341, DOI 10.1080/01612840590915711; Fong T, 2006, DISABIL REHABIL, V28, P695, DOI 10.1080/09638280500277495; Gisquet E, 2008, SOC SCI MED, V67, P1847, DOI 10.1016/j.socscimed.2008.09.026; Glassel A, 2012, DISABIL REHABIL, V34, P157, DOI 10.3109/09638288.2011.593680; Green J., 2018, QUALITATIVE METHODS, VFourth; Green TL, 2009, INT J NURS STUD, V46, P1194, DOI 10.1016/j.ijnurstu.2009.02.008; Greenhalgh T, 2005, QUAL SAF HEALTH CARE, V14, P443, DOI 10.1136/qshc.2005.014712; Grytten N, 2005, CHRONIC ILLN, V1, P231, DOI 10.1179/174239505X56012; Grytten N, 2006, CHRONIC ILLN, V2, P195, DOI 10.1179/174592006X129482; Hammel KW., 2006, PERSPECTIVES DISABIL; Hill A, 2010, PSYCHIATR REHABIL J, V33, P228, DOI 10.2975/33.3.2010.228.231; Holper L, 2010, J NEUROL, V257, P103, DOI 10.1007/s00415-009-5282-4; Hudson PL, 2006, PALLIATIVE MED, V20, P87, DOI 10.1191/0269216306pm1108oa; Isaksson AK, 2008, J NEUROSCI NURS, V40, P180, DOI 10.1097/01376517-200806000-00009; Isaksson Ann-Kristin, 2006, J Neurosci Nurs, V38, P229; Jakobsson A, 2005, ALCOHOL ALCOHOLISM, V40, P118, DOI 10.1093/alcalc/agh128; Jones D, 2008, DISABIL REHABIL, V30, P1213, DOI 10.1080/09638280701828955; JONES R, 1995, BRIT MED J, V311, P2, DOI 10.1136/bmj.311.6996.2; Kuwabara SA, 2007, GEN HOSP PSYCHIAT, V29, P317, DOI 10.1016/j.genhosppsych.2007.04.001; Latif E, 2013, J MENT HEALTH POLICY, V16, P35; Lencucha R, 2008, AM J PSYCHIATR REHAB, V11, P330, DOI 10.1080/15487760802397645; Levola J, NORDIC J PSYCHIAT, V0, P1; Liu KWD, 2007, AM J OCCUP THER, V61, P543, DOI 10.5014/ajot.61.5.543; Magliano L, 2008, PSYCHIAT SERV, V59, P795, DOI 10.1176/appi.ps.59.7.795; Malcomson KS, 2008, DISABIL REHABIL, V30, P662, DOI 10.1080/09638280701400730; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Martikainen KK, 2006, MOVEMENT DISORD, V21, P2187, DOI 10.1002/mds.21171; Mccabe MP, 2008, DISABIL REHABIL, V30, P600, DOI 10.1080/09638280701400276; Meijer JL, 2013, ASS LIFE EVENTS PREG; Miller C M, 1997, J Neurosci Nurs, V29, P294; Miller N, 2006, AGE AGEING, V35, P614, DOI 10.1093/ageing/afl105; Millward L J, 2005, J Psychiatr Ment Health Nurs, V12, P565, DOI 10.1111/j.1365-2850.2005.00875.x; Moll MF, 2009, REV LAT-AM ENFERM, V17, P995, DOI 10.1590/S0104-11692009000600011; Murray J, 2006, SOC SCI MED, V63, P1363, DOI 10.1016/j.socscimed.2006.03.037; National Institute for Health and Clinical Excellence, 2009, GUID MAN; Nilsagard Y, 2009, DISABIL REHABIL, V31, P1301, DOI 10.1080/09638280802532639; Noblit G HR, 1998, METAETHNOGRAPHY SYNT; Nolan P, 2005, J Psychiatr Ment Health Nurs, V12, P146, DOI 10.1111/j.1365-2850.2004.00806.x; Oehlberg K, 2008, J GERIATR PSYCH NEUR, V21, P123, DOI 10.1177/0891988708316862; Olsson M, 2005, J ADV NURS, V49, P7, DOI 10.1111/j.1365-2648.2004.03258.x; Olsson M, 2008, HEALTH CARE WOMEN IN, V29, P416, DOI 10.1080/07399330701876646; Patel SC, 2012, MANUAL PSYCHIAT NURS; Paterson C, 2005, NATO SCI SER II MATH, V198, P11; Patomella AH, 2009, DISABIL REHABIL, V31, P726, DOI 10.1080/09638280802306539; Phillips LJ, 2006, GERIATR NURS, V27, P362, DOI 10.1016/j.gerinurse.2006.10.012; Pretzer-Aboff I, 2009, REHABIL NURS, V34, P55; Prunty M, 2008, MULT SCLER J, V14, P701, DOI 10.1177/1352458507086103; Quintas R, 2012, EPILEPSY BEHAV, V25, P60, DOI 10.1016/j.yebeh.2012.05.016; Raggi A, 2010, INT J REHABIL RES; Raggi A, 2012, J HEADACHE PAIN, V13, P595, DOI 10.1007/s10194-012-0482-1; Ravenek MJ, 2009, DISABIL REHABIL, V31, P1925, DOI 10.1080/09638280902850261; Raymond JE, 2009, MIDWIFERY, V25, P39, DOI 10.1016/j.midw.2007.01.005; Rice Elizabeth, 2008, ANS Adv Nurs Sci, V31, pE9, DOI 10.1097/01.ANS.0000319568.91631.98; Robison J, 2009, DISABIL REHABIL, V31, P1555, DOI 10.1080/09638280802639327; Rodriguez BF, 2005, J ANXIETY DISORD, V19, P752, DOI 10.1016/j.janxdis.2004.10.002; Samokhvalov AV, 2010, ALCOHOL CLIN EXP RES, V34, P1871, DOI 10.1111/j.1530-0277.2010.01275.x; Sample PL, 2006, EPILEPSY BEHAV, V9, P649, DOI 10.1016/j.yebeh.2006.08.009; Schlichting S, 2007, REV LAT-AM ENFERM, V15, P384, DOI 10.1590/S0104-11692007000300004; Schmid AA, 2009, AM J OCCUP THER, V63, P310, DOI 10.5014/ajot.63.3.310; Shevil E, 2006, DISABIL REHABIL, V28, P779, DOI 10.1080/09638280500387013; Smith C, 2009, DISABIL REHABIL, V31, P685, DOI 10.1080/09638280802273473; Snape D, 2009, EPILEPSY BEHAV, V14, P172, DOI 10.1016/j.yebeh.2008.09.031; Solimeo S, 2008, J GERONTOL B-PSYCHOL, V63, pS42, DOI 10.1093/geronb/63.1.S42; Sweetland J, 2007, MULT SCLER J, V13, P1183, DOI 10.1177/1352458507078414; Switaj P, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-193; Teasdale TW, 2005, BRAIN INJURY, V19, P1049, DOI 10.1080/02699050500110421; Thompson HS, 2009, J CLIN NURS, V18, P1803, DOI 10.1111/j.1365-2702.2008.02694.x; Todres L, 2008, QUAL HEALTH RES, V18, P1566, DOI 10.1177/1049732308324249; Todres Les, 2007, Med Health Care Philos, V10, P53, DOI 10.1007/s11019-006-9012-8; Webb H, 2007, ADDICT RES THEORY, V15, P85, DOI 10.1080/16066350601068675; Wertz MS, 2011, INT J QUAL STUD HEAL, V6, DOI 10.3402/qhw.v6i2.5882; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO, 2001, WHO INT CLASS FUNCT; Wilson SJ, 2005, EPILEPSY BEHAV, V6, P570, DOI 10.1016/j.yebeh.2005.02.015; Wilton R, 2006, SOC SCI MED, V63, P649, DOI 10.1016/j.socscimed.2006.01.022; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; Wollin JA, 2006, INT J PALLIAT NURS, V12, P20, DOI 10.12968/ijpn.2006.12.1.20392; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wressle E, 2007, AUST OCCUP THER J, V54, P131, DOI 10.1111/j.1440-1630.2006.00610.x; Yeh MY, 2008, J CLIN NURS, V17, P921, DOI 10.1111/j.1365-2702.2007.02098.x; Yeh MY, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-76; Yilmaz M, 2008, SCAND J OCCUP THER, V15, P162, DOI 10.1080/11038120802022102; Yilmaz M, 2009, INT J QUAL STUD HEAL, V4, P267, DOI 10.3109/17482620903113112; Yorkston KM, 2007, J COMMUN DISORD, V40, P433, DOI 10.1016/j.jcomdis.2006.10.006	115	24	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96890	10.1371/journal.pone.0096890	http://dx.doi.org/10.1371/journal.pone.0096890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG9HB	24805128	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000335728900113
J	He, QM; Morris, BJ; Grove, JS; Petrovitch, H; Ross, W; Masaki, KH; Rodriguez, B; Chen, RD; Donlon, TA; Willcox, DC; Willcox, BJ				He, Qimei; Morris, Brian J.; Grove, John S.; Petrovitch, Helen; Ross, Webster; Masaki, Kamal H.; Rodriguez, Beatriz; Chen, Randi; Donlon, Timothy A.; Willcox, D. Craig; Willcox, Bradley J.			Shorter Men Live Longer: Association of Height with Longevity and FOXO3 Genotype in American Men of Japanese Ancestry	PLOS ONE			English	Article							BODY-MASS INDEX; MUSCLE STRENGTH; UNITED-STATES; ENERGY-INTAKE; ADULT HEIGHT; TIME-SCALE; FOLLOW-UP; MORTALITY; LIFE; COHORT	Objectives: To determine the relation between height, FOXO3 genotype and age of death in humans. Methods: Observational study of 8,003 American men of Japanese ancestry from the Honolulu Heart Program/Honolulu-Asia Aging Study (HHP/HAAS), a genetically and culturally homogeneous cohort followed for over 40 years. A Cox regression model with age as the time scale, stratified by year of birth, was used to estimate the effect of baseline height on mortality during follow-up. An analysis of height and longevity-associated variants of the key regulatory gene in the insulin/IGF-1 signaling (IIS) pathway, FOXO3, was performed in a HHP-HAAS subpopulation. A study of fasting insulin level and height was conducted in another HHP-HAAS subpopulation. Results: A positive association was found between baseline height and all-cause mortality (RR=1.007; 95% CI 1.003-1.011; P=0.002) over the follow-up period. Adjustments for possible confounding variables reduced this association only slightly (RR=1.006; 95% CI 1.002-1.010; P=0.007). In addition, height was positively associated with all cancer mortality and mortality from cancer unrelated to smoking. A Cox regression model with time-dependent covariates showed that relative risk for baseline height on mortality increased as the population aged. Comparison of genotypes of a longevity-associated single nucleotide polymorphism in FOXO3 showed that the longevity allele was inversely associated with height. This finding was consistent with prior findings in model organisms of aging. Height was also positively associated with fasting blood insulin level, a risk factor for mortality. Regression analysis of fasting insulin level (mIU/L) on height (cm) adjusting for the age both data were collected yielded a regression coefficient of 0.26 (95% CI 0.10-0.42; P=0.001). Conclusion: Height in mid-life is positively associated with mortality, with shorter stature predicting longer lifespan. Height was, moreover, associated with fasting insulin level and the longevity genotype of FOXO3, consistent with a mechanistic role for the IIS pathway.	[He, Qimei; Morris, Brian J.; Grove, John S.; Petrovitch, Helen; Ross, Webster; Masaki, Kamal H.; Rodriguez, Beatriz; Chen, Randi; Donlon, Timothy A.; Willcox, D. Craig; Willcox, Bradley J.] Kuakini Med Ctr, Honolulu Heart Program, Honolulu Asia Aging Study, Honolulu, HI 96817 USA; [He, Qimei; Petrovitch, Helen; Ross, Webster; Willcox, Bradley J.] Vet Affairs Pacific Isl Hlth Care Syst, Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [He, Qimei; Petrovitch, Helen; Ross, Webster; Masaki, Kamal H.; Rodriguez, Beatriz; Willcox, D. Craig; Willcox, Bradley J.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; [Morris, Brian J.] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Grove, John S.; Rodriguez, Beatriz] Univ Hawaii Manoa, Dept Publ Hlth, Honolulu, HI 96822 USA; [Rodriguez, Beatriz] Inst Tecnol Monterrey, Monterrey, Mexico; [Donlon, Timothy A.; Willcox, Bradley J.] Kuakini Med Ctr, Dept Res, Honolulu, HI USA; [Willcox, D. Craig] Okinawa Univ, Dept Human Welf, Ginowan, Okinawa, Japan	Pacific Health Research & Education Institute; University of Hawaii System; University of Sydney; University of Hawaii System; University of Hawaii Manoa; Tecnologico de Monterrey	Morris, BJ (corresponding author), Kuakini Med Ctr, Honolulu Heart Program, Honolulu Asia Aging Study, Phys Off Tower, Honolulu, HI 96817 USA.	brian.morris@sydney.edu.au			National Heart, Lung, and Blood Institute [NO1-HC-05102]; National Institute on Aging (NIA) [NO1-AG-4-2149]; NIA [2U01AG019349, 1R01AG038707, 2R01AG027060]; Office for Research and Development, Department of Veterans Affairs; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027060, R01AG038707, U01AG019349, N01AG042149] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office for Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by contracts NO1-HC-05102 (Honolulu Heart Program) from the National Heart, Lung, and Blood Institute and NO1-AG-4-2149 (Honolulu-Asia Aging Study) from the National Institute on Aging (NIA); grants 2U01AG019349, 1R01AG038707, 2R01AG027060 from the NIA; and support from the Office for Research and Development, Department of Veterans Affairs. The views in this article do not necessarily reflect those of the federal government of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 1998, PEDIATRICS, V102, P602, DOI 10.1542/peds.102.3.602; ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; Barker DJP, 2011, AM J HUM BIOL, V23, P412, DOI 10.1002/ajhb.21165; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bartke A, 2013, PHYSIOL REV, V93, P571, DOI 10.1152/physrev.00006.2012; Bonner J.T., 2006, WHY SIZE MATTERS; Burchfiel CM, 1996, ANN EPIDEMIOL, V6, P490, DOI 10.1016/S1047-2797(96)00103-2; COX DR, 1972, J R STAT SOC B, V34, P187; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Davey SG, 2000, J EPIDEMIOL COMMUNIT, V54, P97; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Hebert PR, 1997, CANCER CAUSE CONTROL, V8, P591, DOI 10.1023/A:1018442329319; HOLZENBERGER M, 1991, ARCH GERONTOL GERIAT, V13, P89, DOI 10.1016/0167-4943(91)90019-M; Huxley J., 1932, PROBLEMS RELATIVE GR; KAGAN A, 1974, J CHRON DIS, V27, P345, DOI 10.1016/0021-9681(74)90014-9; Kagan A., 1996, HONOLULU HEART PROGR; Kemkes-Grottenthaler A, 2005, AM J PHYS ANTHROPOL, V128, P340, DOI 10.1002/ajpa.20146; KERR GR, 1982, GROWTH, V46, P135; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Kuh D, 2002, AM J EPIDEMIOL, V156, P627, DOI 10.1093/aje/kwf099; LEON DA, 1995, J EPIDEMIOL COMMUN H, V49, P5, DOI 10.1136/jech.49.1.5; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; MARMOT MG, 1984, LANCET, V1, P1003; Mizushima Shunsaku, 1992, Nutrition and Health (Bicester), V8, P97; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rantanen T, 2012, AGE, V34, P563, DOI 10.1007/s11357-011-9256-y; Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463; Salaris L, 2012, BIODEMOGR SOC BIOL, V58, P1, DOI 10.1080/19485565.2012.666118; SAMARAS TT, 1992, B WORLD HEALTH ORGAN, V70, P259; Samaras TT, 2003, LIFE SCI, V72, P1781, DOI 10.1016/S0024-3205(02)02503-1; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Singh-Manoux A, 2010, ECON HUM BIOL, V8, P396, DOI 10.1016/j.ehb.2010.03.002; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sue LY, 2009, CANCER EPIDEM BIOMAR, V18, P2842, DOI 10.1158/1055-9965.EPI-09-0087; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Thompson D.W, 1917, GROWTH FORM; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox BJ, 2004, J GERONTOL A-BIOL, V59, P789; WORTH RM, 1970, J CHRON DIS, V23, P389, DOI 10.1016/0021-9681(70)90022-6	43	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94385	10.1371/journal.pone.0094385	http://dx.doi.org/10.1371/journal.pone.0094385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804734	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900011
J	Sugaya, K; Ishihara, Y; Inoue, S; Tsuji, H				Sugaya, Kimihiko; Ishihara, Yoshie; Inoue, Sonoe; Tsuji, Hideo			Characterization of Ubiquitin-Activating Enzyme Uba1 in the Nucleus by Its Mammalian Temperature-Sensitive Mutant	PLOS ONE			English	Article							RNA-POLYMERASE-II; NONPERMISSIVE TEMPERATURE; DNA-REPLICATION; LARGEST SUBUNIT; RE-REPLICATION; CELL MUTANT; TS85 CELLS; S-PHASE; E1; PROTEIN	Temperature-sensitive (ts) CHO-K1 mutant tsTM3 exhibits chromosomal instability and cell-cycle arrest in the S to G(2) phases with decreased DNA synthesis at the nonpermissive temperature, 39 degrees C. Previously, complementation tests with other mutants showed that tsTM3 harbors a genetic defect in the ubiquitin-activating enzyme Uba1. Sequence comparison of the Uba1 gene between wild-type and mutant cells in this study revealed that the mutant phenotype is caused by a G-to-A transition that yields a Met-to-Ile substitution at position 256 in hamster Uba1. The ts defects in tsTM3 were complemented by expression of the wild-type Uba1 tagged with green fluorescent protein. Expression of the Uba1 primarily in the nucleus appeared to rescue tsTM3 cells. Incubation at 39 degrees C resulted in a decrease of nuclear Uba1 in tsTM3 cells, suggesting that loss of Uba1 in the nucleus may lead to the ts defects. Analyses with the fluorescent ubiquitination-based cell cycle indicator revealed that loss of function of Uba1 leads to failure of the ubiquitin system in the nucleus. Incubation at 39 degrees C caused an increase in endogenous geminin in tsTM3 cells. A ts mutation of Uba1 found in tsTM3 cells appears to be a novel mutation reflecting the important roles of Uba1 in nucleus.	[Sugaya, Kimihiko; Ishihara, Yoshie; Inoue, Sonoe; Tsuji, Hideo] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan; [Sugaya, Kimihiko; Ishihara, Yoshie; Inoue, Sonoe; Tsuji, Hideo] Natl Inst Radiol Sci, Fukushima Project Headquarters, Chiba 260, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology	Sugaya, K (corresponding author), Natl Inst Radiol Sci, Res Ctr Radiat Protect, Chiba 260, Japan.	k_sugaya@nirs.go.jp		Sugaya, Kimihiko/0000-0002-7288-5800; Sugaya, Kiminobu/0000-0002-2788-5457	Japan Society for the Promotion of Science [23570012]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 23570012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYUSAWA D, 1992, CELL STRUCT FUNCT, V17, P113, DOI 10.1247/csf.17.113; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Chiu YH, 2007, MOL CELL, V27, P1014, DOI 10.1016/j.molcel.2007.08.020; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; DEVERAUX Q, 1990, J BIOL CHEM, V265, P6323; GRENFELL SJ, 1994, BIOCHEM J, V300, P701, DOI 10.1042/bj3000701; HANDLEYGEARHART PM, 1994, J BIOL CHEM, V269, P33171; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hongo E, 2008, INT J RADIAT BIOL, V84, P778, DOI 10.1080/09553000802345936; HYODO M, 1982, EXP CELL RES, V137, P31, DOI 10.1016/0014-4827(82)90004-0; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kimura H, 1999, MOL CELL BIOL, V19, P5383; Kisielewska J, 2012, DEVELOPMENT, V139, P63, DOI 10.1242/dev.068676; Klotz-Noack K, 2012, J CELL SCI, V125, P2436, DOI 10.1242/jcs.100883; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Lao TT, 2012, J CELL PHYSIOL, V227, P1561, DOI 10.1002/jcp.22870; Marcus M, 1982, PREMATURE CHROMOSOME, P173; MITA S, 1980, EXP CELL RES, V126, P407, DOI 10.1016/0014-4827(80)90280-3; MORI M, 1993, J BIOL CHEM, V268, P16803; Moudry P, 2012, CELL CYCLE, V11, P1573, DOI 10.4161/cc.19978; OHTSUBO M, 1988, BIOCHEM BIOPH RES CO, V153, P1173, DOI 10.1016/S0006-291X(88)81351-2; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salvat C, 2000, EUR J BIOCHEM, V267, P3712, DOI 10.1046/j.1432-1327.2000.01404.x; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Stephen AG, 1996, J BIOL CHEM, V271, P15608, DOI 10.1074/jbc.271.26.15608; Stephen AG, 1997, J BIOL CHEM, V272, P10895; Sugaya K, 1998, MOL GEN GENET, V258, P279, DOI 10.1007/s004380050732; Sugaya K, 2005, EXP CELL RES, V306, P242, DOI 10.1016/j.yexcr.2005.02.017; Sugaya K, 1997, GENE, V194, P267, DOI 10.1016/S0378-1119(97)00204-7; Sugaya K, 2011, RNA BIOL, V8, P488, DOI 10.4161/rna.8.3.14656; Sugaya K, 2006, J CELL SCI, V119, P4944, DOI 10.1242/jcs.03288; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TSUJI H, 1990, SOMAT CELL MOLEC GEN, V16, P461, DOI 10.1007/BF01233196; Yang U, 2012, BIOCHEM BIOPH RES CO, V427, P587, DOI 10.1016/j.bbrc.2012.09.102; ZENG GC, 1984, MOL CELL BIOL, V4, P1815, DOI 10.1128/MCB.4.9.1815	37	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96666	10.1371/journal.pone.0096666	http://dx.doi.org/10.1371/journal.pone.0096666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805847	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900080
J	Boschetti, E; D'Alessandro, R; Bianco, F; Carelli, V; Cenacchi, G; Pinna, AD; Del Gaudio, M; Rinaldi, R; Stanghellini, V; Pironi, L; Rhoden, K; Tugnoli, V; Casali, C; De Giorgio, R				Boschetti, Elisa; D'Alessandro, Roberto; Bianco, Francesca; Carelli, Valerio; Cenacchi, Giovanna; Pinna, Antonio D.; Del Gaudio, Massimo; Rinaldi, Rita; Stanghellini, Vincenzo; Pironi, Loris; Rhoden, Kerry; Tugnoli, Vitaliano; Casali, Carlo; De Giorgio, Roberto			Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy	PLOS ONE			English	Article							CELL GROWTH-FACTOR; DNA DEPLETION; MNGIE; TRANSPLANTATION; CANCER; MODEL; EXPRESSION; DELETIONS; DISORDER; FEATURES	Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive mitochondrial disease associated with mutations in the nuclear TYMP gene. As a result, the thymidine phosphorylase (TP) enzyme activity is markedly reduced leading to toxic accumulation of thymidine and therefore altered mitochondrial DNA. MNGIE is characterized by severe gastrointestinal dysmotility, neurological impairment, reduced life expectancy and poor quality of life. There are limited therapeutic options for MNGIE. In the attempt to restore TP activity, allogenic hematopoietic stem cell transplantation has been used as cellular source of TP. The results of this approach on similar to 20 MNGIE patients showed gastrointestinal and neurological improvement, although the 5-year mortality rate is about 70%. In this study we tested whether the liver may serve as an alternative source of TP. We investigated 11 patients (7M; 35-55 years) who underwent hepatic resection for focal disorders. Margins of normal liver tissue were processed to identify, quantify and localize the TP protein by Western Blot, ELISA, and immunohistochemistry, and to evaluate TYMP mRNA expression by qPCR. Western Blot identified TP in liver with a TP/GAPDH ratio of 0.9 +/- 0.5. ELISA estimated TP content as 0.5 +/- 0.07 ng/mu g of total protein. TP was identified in both nuclei and cytoplasm of hepatocytes and sinusoidal lining cells. Finally, TYMP mRNA was expressed in the liver. Overall, our study demonstrates that the liver is an important source of TP. Orthotopic liver transplantation may be considered as a therapeutic alternative for MNGIE patients.	[Boschetti, Elisa; Bianco, Francesca; Pinna, Antonio D.; Del Gaudio, Massimo; Stanghellini, Vincenzo; Pironi, Loris; Rhoden, Kerry; De Giorgio, Roberto] Univ Bologna, Dept Surg & Med Sci, Bologna, Italy; [Boschetti, Elisa; Carelli, Valerio; Cenacchi, Giovanna; Tugnoli, Vitaliano] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy; [D'Alessandro, Roberto] Univ Bologna, Inst Neurol Sci, Bologna, Italy; [Rinaldi, Rita] St Orsola Malpighi Hosp, Neurol Unit, Bologna, Italy; [Casali, Carlo] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, I-00185 Rome, Italy	University of Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Sapienza University Rome	De Giorgio, R (corresponding author), Univ Bologna, Dept Surg & Med Sci, Bologna, Italy.	roberto.degiorgio@unibo.it	Pinna, Antonio/AAC-6685-2019; Rinaldi, Rita/K-7004-2016; Bianco, Francesca/J-9441-2018; Boschetti, Elisa/J-3684-2016; Stanghellini, Vincenzo/AAC-4604-2022; Pironi, Loris/AAB-9725-2019	Rinaldi, Rita/0000-0002-4564-7284; Boschetti, Elisa/0000-0003-4503-2770; PIRONI, LORIS/0000-0002-1773-8330; CENACCHI, GIOVANNA/0000-0001-5824-3118; CARELLI, VALERIO/0000-0003-4923-6404	Italian Ministry of Health [RF2009]; University of Bologna; "Fondazione Del Monte di Bologna e Ravenna'', Bologna, Italy	Italian Ministry of Health(Ministry of Health, Italy); University of Bologna; "Fondazione Del Monte di Bologna e Ravenna'', Bologna, Italy	This work was partly supported by grants from the Italian Ministry of Health (Ricerca Finalizzata 2009 RF2009) and funds from University of Bologna ( R. De G.). R. De G., V. T. and E. B. were the recipients of grants from "Fondazione Del Monte di Bologna e Ravenna'', Bologna, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S, 2004, CANCER SCI, V95, P851, DOI 10.1111/j.1349-7006.2004.tb02193.x; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Bonotto M, 2013, CLIN BREAST CANCER, V13, P167, DOI 10.1016/j.clbc.2012.10.002; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Fairbanks LD, 2013, J PHARMACEUT BIOMED, V76, P8, DOI 10.1016/j.jpba.2012.12.006; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Filosto M, 2012, J NEUROL, V259, P2699, DOI 10.1007/s00415-012-6572-9; Finkenstedt A, 2013, JIMD REP, V10, P41, DOI 10.1007/8904_2012_199; FOX SB, 1995, J PATHOL, V176, P183, DOI 10.1002/path.1711760212; FRIEDKIN M, 1954, J BIOL CHEM, V207, P245; FRIEDKIN M, 1954, J BIOL CHEM, V207, P257; Giordano C, 2008, AM J PATHOL, V173, P1120, DOI 10.2353/ajpath.2008.080252; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Halter J, 2011, BONE MARROW TRANSPL, V46, P330, DOI 10.1038/bmt.2010.100; Hirano M, 2006, NEUROLOGY, V67, P1458, DOI 10.1212/01.wnl.0000240853.97716.24; Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04; HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721; la Marca G, 2006, J MASS SPECTROM, V41, P586, DOI 10.1002/jms.1013; Lara MC, 2007, BIOSCIENCE REP, V27, P151, DOI 10.1007/s10540-007-9043-2; Lara MC, 2006, NEUROLOGY, V67, P1461, DOI 10.1212/01.wnl.0000239824.95411.52; Marti R, 2005, ANN NEUROL, V58, P649, DOI 10.1002/ana.20615; Marti R, 2003, BIOCHEM BIOPH RES CO, V303, P14, DOI 10.1016/S0006-291X(03)00294-8; MIYADERA K, 1995, CANCER RES, V55, P1687; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; O'Mahony CA, 2012, TEX HEART I J, V39, P874; Papadimitriou A, 1998, NEUROLOGY, V51, P1086, DOI 10.1212/WNL.51.4.1086; Pontarin G, 2006, J BIOL CHEM, V281, P22720, DOI 10.1074/jbc.M604498200; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; Spinazzola A, 2002, J BIOL CHEM, V277, P4128, DOI 10.1074/jbc.M111028200; Toi M, 2005, LANCET ONCOL, V6, P158, DOI 10.1016/S1470-2045(05)01766-3; Torres-Torronteras J, 2011, GENE THER, V18, P795, DOI 10.1038/gt.2011.24; van Triest B, 2000, CLIN CANCER RES, V6, P1063; WALTENBERGER J, 1992, FEBS LETT, V313, P129, DOI 10.1016/0014-5793(92)81428-O; Wu SL, 2013, WORLD J GASTROENTERO, V19, P5981, DOI 10.3748/wjg.v19.i36.5981; Yavuz H, 2007, ARCH NEUROL-CHICAGO, V64, P435, DOI 10.1001/archneur.64.3.435; YOSHIMURA A, 1990, BIOCHIM BIOPHYS ACTA, V1034, P107, DOI 10.1016/0304-4165(90)90160-X	37	32	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96692	10.1371/journal.pone.0096692	http://dx.doi.org/10.1371/journal.pone.0096692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802030	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800109
J	Liang, JM; Luan, YX; Lu, B; Zhang, HB; Luo, YN; Ge, PF				Liang, Jianmin; Luan, Yongxin; Lu, Bin; Zhang, Hongbo; Luo, Yi-nan; Ge, Pengfei			Protection of Ischemic Postconditioning against Neuronal Apoptosis Induced by Transient Focal Ischemia Is Associated with Attenuation of NF-kappa B/p65 Activation	PLOS ONE			English	Article							NF-KAPPA-B; CEREBRAL ISCHEMIA/REPERFUSION INJURY; SIGNALING PATHWAY CONTRIBUTES; TRAUMATIC BRAIN-INJURY; CELL-DEATH; REPERFUSION INJURY; STATUS EPILEPTICUS; INFARCT SIZE; RATS; INHIBITION	Background and Purpose: Accumulating evidences have demonstrated that nuclear factor kappa B/p65 plays a protective role in the protection of ischemic preconditioning and detrimental role in lethal ischemia-induced programmed cell death including apoptosis and autophagic death. However, its role in the protection of ischemic postconditioning is still unclear. Methods: Rat MCAO model was used to produce transient focal ischemia. The procedure of ischemic postconditioning consisted of three cycles of 30 seconds reperfusion/reocclusion of MCA. The volume of cerebral infarction was measured by TTC staining and neuronal apoptosis was detected by TUNEL staining. Western blotting was used to analyze the changes in protein levels of Caspase-3, NF-kappa B/p65, phosphor-NF-kappa B/p65, IkB alpha, phosphor-IkB alpha, Noxa, Bim and Bax between rats treated with and without ischemic postconditioning. Laser scanning confocal microscopy was used to examine the distribution of NF-kappa B/p65 and Noxa. Results: Ischemic postconditioning made transient focal ischemia-induced infarct volume decrease obviously from 38.6% +/- 65.8% to 23.5% +/- 64.3%, and apoptosis rate reduce significantly from 46.5% +/- 66.2 to 29.6% +/- 65.3% at reperfusion 24 h following 2 h focal cerebral ischemia. Western blotting analysis showed that ischemic postconditioning suppressed markedly the reduction of NF-kappa B/p65 in cytoplasm, but elevated its content in nucleus either at reperfusion 6 h or 24 h. Moreover, the decrease of IkBa and the increase of phosphorylated IkB alpha and phosphorylated NF-kappa B/p65 at indicated reperfusion time were reversed by ischemic postconditioning. Correspondingly, proapoptotic proteins Caspase-3, cleaved Caspase-3, Noxa, Bim and Bax were all mitigated significantly by ischemic postconditioning. Confocal microscopy revealed that ischemic postconditioning not only attenuated ischemia-induced translocation of NF-kappa B/p65 from neuronal cytoplasm to nucleus, but also inhibited the abnormal expression of proapoptotic protein Noxa within neurons. Conclusions: We demonstrated in this study that the protection of ischemic postconditioning on neuronal apoptosis caused by transient focal ischemia is associated with attenuation of the activation of NF-kappa B/p65 in neurons.	[Liang, Jianmin; Zhang, Hongbo] Jilin Univ, Hosp 1, Dept Pediat, Changchun 130023, Peoples R China; [Luan, Yongxin; Lu, Bin; Luo, Yi-nan; Ge, Pengfei] Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China; [Liang, Jianmin; Luo, Yi-nan; Ge, Pengfei] Jilin Univ, Hosp 1, Neurosci Res Ctr, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Ge, PF (corresponding author), Jilin Univ, Hosp 1, Dept Neurosurg, Changchun 130023, Peoples R China.	pengfeige@gmail.com			National Nature and Science Foundation [30973110, 81171234]; Science and Technology Department of Jilin Province [20080139]	National Nature and Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Jilin Province	This work was supported by National Nature and Science Foundation (30973110) and (81171234), the Outstanding Youth Grant (20080139) from the Science and Technology Department of Jilin Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Blondeau N, 2001, J NEUROSCI, V21, P4668, DOI 10.1523/JNEUROSCI.21-13-04668.2001; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Chuang YC, 2010, J NEUROSCI RES, V88, P1898, DOI 10.1002/jnr.22369; Clemens JA, 1997, MOL BRAIN RES, V48, P187, DOI 10.1016/S0169-328X(97)00092-2; Danielisova V, 2006, CELL MOL NEUROBIOL, V26, P1181, DOI 10.1007/s10571-006-9034-z; Darling CE, 2005, AM J PHYSIOL-HEART C, V289, pH1618, DOI 10.1152/ajpheart.00055.2005; Ding ZM, 2012, INT J MOL SCI, V13, P6089, DOI 10.3390/ijms13056089; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Feng XD, 2013, MOL MED REP, V7, P1516, DOI 10.3892/mmr.2013.1392; Fischer Uwe M, 2006, Interact Cardiovasc Thorac Surg, V5, P531, DOI 10.1510/icvts.2006.130765; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Han HS, 2003, J CEREBR BLOOD F MET, V23, P589, DOI 10.1097/01.WCB.0000059566.39780.8D; Hu J, 2005, MOL CARCINOGEN, V44, P274, DOI 10.1002/mc.20142; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050764; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Ishihara Y, 2012, J PHARMACOL SCI, V119, P251, DOI 10.1254/jphs.12079FP; Jang ER, 2011, NEUROCHEM INT, V58, P52, DOI 10.1016/j.neuint.2010.10.012; Kim EJ, 2010, TRANSL STROKE RES, V1, P40, DOI 10.1007/s12975-009-0006-8; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Kin H, 2008, SHOCK, V29, P761, DOI 10.1097/SHK.0b013e31815cfd5a; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kong YH, 2013, NEUROCHEM RES, V38, P815, DOI 10.1007/s11064-013-0984-5; Li L, 2013, INFLAMM RES, V62, P387, DOI 10.1007/s00011-013-0590-7; Li WL, 2013, NEUROSCIENCE, V244, P16, DOI 10.1016/j.neuroscience.2013.03.045; Li ZY, 2012, J INT MED RES, V40, P954, DOI 10.1177/147323001204000314; Liang JM, 2013, J INT MED RES, V41, P618, DOI 10.1177/0300060513476587; Liang JM, 2012, INT J MED SCI, V9, P923, DOI 10.7150/ijms.4878; Liu KX, 2009, INTENS CARE MED, V35, P933, DOI 10.1007/s00134-009-1428-1; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Nakai M, 2000, J NEUROCHEM, V74, P647, DOI 10.1046/j.1471-4159.2000.740647.x; Pignataro Giuseppe, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P1; Pizzi M, 2009, FEBS J, V276, P27, DOI 10.1111/j.1742-4658.2008.06767.x; Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011; Ren CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003851; Ryu HJ, 2011, NEUROSCIENCE, V187, P93, DOI 10.1016/j.neuroscience.2011.04.048; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Shen WH, 2003, ACTA PHARMACOL SIN, V24, P1125; Song YS, 2010, J CEREBR BLOOD F MET, V30, P1265, DOI 10.1038/jcbfm.2010.6; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Wang Y, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/124614; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Xiong J, 2011, INFLAMM RES, V60, P547, DOI 10.1007/s00011-010-0303-4; Xu L, 2002, BIOCHEM BIOPH RES CO, V299, P14, DOI 10.1016/S0006-291X(02)02573-1; Xu M, 2012, BRAIN RES, V1454, P48, DOI 10.1016/j.brainres.2012.03.020; Yin LL, 2012, INT J NEUROSCI, V122, P748, DOI 10.3109/00207454.2012.721827; You WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060290; Yuan YJ, 2011, BRAIN RES, V1367, P85, DOI 10.1016/j.brainres.2010.10.017; Zeng M, 2013, BIOCHEM BIOPH RES CO, V436, P180, DOI 10.1016/j.bbrc.2013.05.070; Zhang W, 2005, J CEREBR BLOOD F MET, V25, P30, DOI 10.1038/sj.jcbfm.9600004; Zhao H, 2006, J CEREBR BLOOD F MET, V26, P1114, DOI 10.1038/sj.jcbfm.9600348; Zhou XL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-251	57	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96734	10.1371/journal.pone.0096734	http://dx.doi.org/10.1371/journal.pone.0096734			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800741	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800116
J	Ungethum, L; Chatrou, M; Kusters, D; Schurgers, L; Reutelingsperger, CP				Ungethum, Lisette; Chatrou, Martijn; Kusters, Dennis; Schurgers, Leon; Reutelingsperger, Chris P.			Molecular Imaging of Cell Death in Tumors. Increasing Annexin A5 Size Reduces Contribution of Phosphatidylserine-Targeting Function to Tumor Uptake	PLOS ONE			English	Article							IN-VIVO DETECTION; CANCER-TREATMENT; APOPTOTIC CELLS; BREAST-CANCER; SOLID TUMORS; CHEMOTHERAPY; BINDING; TC-99M-ANNEXIN-V; BIODISTRIBUTION; NANOPARTICLES	Objective: Annexin A5 is a phosphatidylserine binding protein that binds dying cells in vivo. Annexin A5 is a potential molecular imaging agent to determine efficacy of anti-cancer therapy in patients. Its rapid clearance from circulation limits tumor uptake and, hence, its sensitivity. The aim of this study is to determine if non-invasive imaging of cell death in tumors will benefit from increasing circulation time of annexin A5 by increasing its size. Procedures: Annexin A5 size was increased by complexation of biotinylated annexin A5 with Alexa-Fluor680-labeled streptavidin. The non-binding variant of annexin A5, M1234, was used as negative control. The HT29 colon carcinoma xenograft model in NMRI nude mice was used to measure tumor uptake in vivo. Tumor uptake of fluorescent annexin A5-variants was measured using non-invasive optical imaging. Results: The annexin A5-streptavidin complex (4:1, moles: moles, M-w similar to 200 kDa) binds phosphatidylserine-expressing membranes with a Hill-coefficient of 5.7 +/- 0.5 for Ca2+-binding and an EC50 of 0.9 +/- 0.1 mM Ca2+ (EC50 is the Ca2+ concentration required for half maximal binding)(annexin A5: Hill-coefficient 3.9 +/- 0.2, EC50 1.5 +/- 0.2 mM Ca2+). Circulation half-life of annexin A5-streptavidin is +/- 21 minutes (circulation half-life of annexin A5 is +/- 4 min.). Tumor uptake of annexin A5-streptavidin was higher and persisted longer than annexin A5-uptake but depended less on phosphatidylserine binding. Conclusion: Increasing annexin A5 size prolongs circulation times and increases tumor uptake, but decreases contribution of PS-targeting to tumor uptake and abolishes power to report efficacy of therapy.	[Ungethum, Lisette; Chatrou, Martijn; Kusters, Dennis; Schurgers, Leon; Reutelingsperger, Chris P.] Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands	Maastricht University	Ungethum, L (corresponding author), Maastricht Univ, Cardiovasc Res Inst Maastricht, Dept Biochem, Maastricht, Netherlands.	c.reutelingsperger@maastrichtuniversity.nl	Schurgers, Leon/AAT-7100-2021	Schurgers, Leon/0000-0001-7867-6957	European Union [IVA-VLANED-1.20]	European Union(European Commission)	This work was financially supported by the European Union through the grant Euregional PACT II by the Interreg IV program of Grensregio Vlaanderen-Nederland (IVA-VLANED-1.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Belhocine TZ, 2006, CURR CLIN PHARMACOL, V1, P129, DOI 10.2174/157488406776872541; Blankenberg F, 2002, CLIN CANCER RES, V8, P2757; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; Blankenberg FG, 2008, J NUCL MED, V49, p81S, DOI 10.2967/jnumed.107.045898; Boersma HH, 2005, J NUCL MED, V46, P2035; Corsten MF, 2006, CANCER RES, V66, P1255, DOI 10.1158/0008-5472.CAN-05-3000; Davila M, 2008, J THROMB HAEMOST, V6, P1517, DOI 10.1111/j.1538-7836.2008.02987.x; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Green DR, 2012, TRENDS CELL BIOL, V22, P555, DOI 10.1016/j.tcb.2012.08.008; Hoebers FJP, 2008, EUR J NUCL MED MOL I, V35, P509, DOI 10.1007/s00259-007-0624-x; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Kartachova MS, 2008, NUCL MED COMMUN, V29, P39, DOI 10.1097/MNM.0b013e3282f1bc22; Ke S, 2004, J NUCL MED, V45, P108; Kemerink GJ, 2003, J NUCL MED, V44, P947; Kusters DHM, 2012, MOL IMAGING BIOL, V14, P523, DOI 10.1007/s11307-012-0586-7; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2013, ADV DRUG DELIVER REV, V65, P71, DOI 10.1016/j.addr.2012.10.002; Mandl Stefanie J, 2004, Mol Imaging, V3, P1, DOI 10.1162/153535004773861679; Michalski MH, 2011, EUR J NUCL MED MOL I, V38, P358, DOI 10.1007/s00259-010-1569-z; Mira JP, 1997, J BIOL CHEM, V272, P10474; PEARSON JW, 1989, CANCER RES, V49, P3562; Robidoux A, 2010, CLIN BREAST CANCER, V10, P81, DOI 10.3816/CBC.2010.n.011; Rottey S, 2006, J NUCL MED, V47, P1813; Schaper Frederic L W V J, 2013, Cancers (Basel), V5, P550, DOI 10.3390/cancers5020550; Schellenberger E, 2008, SMALL, V4, P225, DOI 10.1002/smll.200700847; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHROIT AJ, 1985, J BIOL CHEM, V260, P5131; Schutters K, 2013, CELL DEATH DIFFER, V20, P49, DOI 10.1038/cdd.2012.107; Schutters K, 2010, APOPTOSIS, V15, P1072, DOI 10.1007/s10495-010-0503-y; Tait JF, 2005, J NUCL MED, V46, P807; Tait JF, 2004, ANAL BIOCHEM, V329, P112, DOI 10.1016/j.ab.2004.02.043; Tait JF, 2008, J NUCL MED, V49, P1573, DOI 10.2967/jnumed.108.052803; Takei T, 2004, J NUCL MED, V45, P2083; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Ungethum L, 2011, J BIOL CHEM, V286, P1903, DOI 10.1074/jbc.M110.163527; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Yang DJ, 2001, CANCER BIOTHER RADIO, V16, P73, DOI 10.1089/108497801750096087; Zhang R, 2011, J NUCL MED, V52, P958, DOI 10.2967/jnumed.110.083220	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96749	10.1371/journal.pone.0096749	http://dx.doi.org/10.1371/journal.pone.0096749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801051	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800121
J	Farley, JH; Eveson, JP; Davis, TLO; Andamari, R; Proctor, CH; Nugraha, B; Davies, CR				Farley, Jessica H.; Eveson, J. Paige; Davis, Tim L. O.; Andamari, Retno; Proctor, Craig H.; Nugraha, Budi; Davies, Campbell R.			Demographic Structure, Sex Ratio and Growth Rates of Southern Bluefin Tuna (Thunnus maccoyii) on the Spawning Ground	PLOS ONE			English	Article							AGE; OTOLITHS	The demographics of the southern bluefin tuna (SBT) Thunnus maccoyii spawning stock were examined through a large-scale monitoring program of the Indonesian longline catch on the spawning ground between 1995 and 2012. The size and age structure of the spawning population has undergone significant changes since monitoring began. There has been a reduction in the relative abundance of larger/older SBT in the catch since the early 2000s, and a corresponding decrease in mean length and age, but there was no evidence of a significant truncation of the age distribution. Pulses of young SBT appear in the catches in the early- and mid-2000s and may be the first evidence of increased recruitment into the spawning stock since 1995. Fish in these two recruitment pulses were spawned around 1991 and 1997. Size-related variations in sex ratio were also observed with female bias for fish less than 170 cm FL and male bias for fish greater than 170 cm FL. This trend of increasing proportion of males with size above 170 cm FL is likely to be related to sexual dimorphism in growth rates as male length-at-age is greater than that for females after age 10 years. Mean length-at-age of fish aged 8-10 years was greater for both males and females on the spawning ground than off the spawning ground, suggesting that size may be the dominant factor determining timing of maturation in SBT. In addition to these direct results, the data and samples from this program have been central to the assessment and management of this internationally harvested stock.	[Farley, Jessica H.; Eveson, J. Paige; Davis, Tim L. O.; Proctor, Craig H.; Davies, Campbell R.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia; [Andamari, Retno] Inst Mariculture Res & Dev, Gondol, Bali, Indonesia; [Nugraha, Budi] Res Inst Tuna Fisheries, Denpasar, Bali, Indonesia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Farley, JH (corresponding author), CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia.	Jessica.Farley@csiro.au	Davies, Campbell R/N-8086-2013; Proctor, Craig/I-3710-2016; Farley, Jessica/E-4957-2014	Davies, Campbell R/0000-0002-2028-1060; Farley, Jessica/0000-0002-5047-746X; Eveson, Paige/0000-0002-1560-2093	CSIRO Wealth from Oceans Flagship; Australian Fisheries Management Authority; Australian Department of Agriculture	CSIRO Wealth from Oceans Flagship(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Fisheries Management Authority; Australian Department of Agriculture(Australian Government)	This work was supported by funding from CSIRO Wealth from Oceans Flagship, the Australian Fisheries Management Authority, and the Australian Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 18 M CCSBT SCI COMM; [Anonymous], 2002, DIR AG EST WORKSH CC; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bravington MV, 2014, FISHERY INDEPENDENT; CAMPANA SE, 1995, T AM FISH SOC, V124, P131, DOI 10.1577/1548-8659(1995)124<0131:GASMFD>2.3.CO;2; CCSBT, 2013, 18 M SCI COMM COMM C; CCSBT, 2013, EST TOT GLOB CATCH S; Clear NP, 2000, FISH B-NOAA, V98, P25; Davis TLO, 2001, FISH B-NOAA, V99, P381; Davis TLO, 1995, INDONESIAN FISH RES, V1, P68; Davis TLO, 1998, 4 CCSBT SCI M 23 31; Davis TLO, 1999, INDONESIAN FISH RES, V5, P50; Evans K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034550; Farley JH, 2007, FISH RES, V83, P151, DOI 10.1016/j.fishres.2006.09.006; Farley JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060577; Farley JH, 1998, FISH B-NOAA, V96, P223; Farley JH, 2001, 2 CCSBT STOCK ASS M; Gunn JS, 2008, FISH RES, V92, P207, DOI 10.1016/j.fishres.2008.01.018; Gunn JS, 1996, 2 CCSBT SCI M 26 AUG; Hillary R, 2012, DEV MANAGEMENT PROCE; Hillary RM, 2011, 16 CCSBT M SCI M 19; Lin Yu-Ting, 2010, Journal of the Fisheries Society of Taiwan, V37, P135; Morton R, 2003, CCSBTESC030932; Patterson H, 2012, 17 M CCSBT SCI COMM; Patterson TA, 2008, FISH OCEANOGR, V17, P352, DOI 10.1111/j.1365-2419.2008.00483.x; Polacheck T, 2004, CAN J FISH AQUAT SCI, V61, P307, DOI 10.1139/F04-005; Proctor C, 2011, PROJECT SUMMARY ACIA; Proctor CH, 2006, 11 CCSBT EXT SCI M 4; Satria F., 2012, 17 CCSBT M SCI M 27; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shingu C, 1978, FSIH STUDY JAP ASS F, V31; Williams AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039318	33	20	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96392	10.1371/journal.pone.0096392	http://dx.doi.org/10.1371/journal.pone.0096392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797529	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000071
J	Hett, A; West, S				Hett, Anne; West, Steven			Inhibition of U4 snRNA in Human Cells Causes the Stable Retention of Polyadenylated Pre-mRNA in the Nucleus	PLOS ONE			English	Article							II TRANSCRIPTIONAL TERMINATION; EXON JUNCTION COMPLEX; POLYMERASE-II; MAMMALIAN-CELLS; END FORMATION; SPLICEOSOME; SPECKLES; EXOSOME; INTRON; EXPORT	Most human pre-mRNAs contain introns that are removed by splicing. Such a complex process needs strict control and regulation in order to prevent the expression of aberrant or unprocessed transcripts. To analyse the fate of pre-mRNAs that cannot be spliced, we inhibited splicing using an anti-sense morpholino (AMO) against U4 snRNA. As a consequence, splicing of several selected transcripts was strongly inhibited. This was accompanied by the formation of enlarged nuclear speckles containing polyadenylated RNA, splicing factors and the nuclear poly(A) binding protein. Consistently, more polyadenylated pre-mRNA could be isolated from nucleoplasmic as well as chromatin-associated RNA fractions following U4 inhibition. Further analysis demonstrated that accumulated pre-mRNAs were stable in the nucleus and that nuclear RNA degradation factors did not re-localise to nuclear speckles following splicing inhibition. The accumulation of pre-mRNA and the formation of enlarged speckles were sensitive to depletion of the 3' end processing factor, CPSF73, suggesting a requirement for poly(A) site processing in this mechanism. Finally, we provide evidence that the pre-mRNAs produced following U4 snRNA inhibition remain competent for splicing, perhaps providing a biological explanation for their stability. These data further characterise processes ensuring the nuclear retention of pre-mRNA that cannot be spliced and suggest that, in some cases, unspliced transcripts can complete splicing sometime after their initial synthesis.	[Hett, Anne; West, Steven] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	West, S (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	steven.west@ed.ac.uk	West, Steven/AAG-4009-2019	West, Steven/0000-0002-7622-9050	Wellcome Trust [088499/Z/09/2, 092076]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by a research career development fellowship from The Wellcome Trust awarded to SW (088499/Z/09/2), a Centre core grant from The Wellcome Trust (092076) and a PhD studentship from The Wellcome Trust awarded to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; BRINGMANN P, 1984, EMBO J, V3, P1357, DOI 10.1002/j.1460-2075.1984.tb01977.x; Brody Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000573; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Daguenet E, 2012, MOL BIOL CELL, V23, P1765, DOI 10.1091/mbc.E12-01-0040; Davidson L, 2014, GENE DEV, V28, P342, DOI 10.1101/gad.231274.113; Davidson L, 2013, NUCLEIC ACIDS RES, V41, P7101, DOI 10.1093/nar/gkt446; Davidson L, 2012, EMBO J, V31, P2566, DOI 10.1038/emboj.2012.101; de Almeida SF, 2010, NUCLEIC ACIDS RES, V38, P8015, DOI 10.1093/nar/gkq703; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dye MJ, 2006, MOL CELL, V21, P849, DOI 10.1016/j.molcel.2006.01.032; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; Eberle AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011540; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Glaunsinger BA, 2010, RNA BIOL, V7, P13, DOI 10.4161/rna.7.1.10255; Gudipati R. K., 2012, MOL CELL; HASHIMOTO C, 1984, NUCLEIC ACIDS RES, V12, P3283, DOI 10.1093/nar/12.7.3283; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Khodor YL, 2012, RNA, V18, P2174, DOI 10.1261/rna.034090.112; Khodor YL, 2011, GENE DEV, V25, P2502, DOI 10.1101/gad.178962.111; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lamond AI, 2011, COLD SPRING HARB PER, V3; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Le Hir H, 2000, GENE DEV, V14, P1098; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Martins SB, 2011, NAT STRUCT MOL BIOL, V18, P1115, DOI 10.1038/nsmb.2124; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552; Oesterreich FC, 2010, MOL CELL, V40, P571, DOI 10.1016/j.molcel.2010.11.004; Pabis M, 2013, RNA, V19, P1054, DOI 10.1261/rna.037069.112; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Schmid M, 2012, MOL CELL; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Sloan KE, 2013, J CELL BIOL, V200, P577, DOI 10.1083/jcb.201207131; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Takemura R, 2011, GENES CELLS, V16, P1035, DOI 10.1111/j.1365-2443.2011.01548.x; Tange TO, 2004, CURR OPIN CELL BIOL, V16, P279, DOI 10.1016/j.ceb.2004.03.012; Tilgner H, 2012, GENOME RES, V22, P1616, DOI 10.1101/gr.134445.111; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; VANKAN P, 1992, EMBO J, V11, P335, DOI 10.1002/j.1460-2075.1992.tb05056.x; VILLARREAL LP, 1983, MOL CELL BIOL, V3, P1381, DOI 10.1128/MCB.3.8.1381; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; WERSIG C, 1990, NUCLEIC ACIDS RES, V18, P6223, DOI 10.1093/nar/18.21.6223; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Wetterberg I, 1996, RNA, V2, P641; Wiegand HL, 2003, P NATL ACAD SCI USA, V100, P11327, DOI 10.1073/pnas.1934877100; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Younis I, 2013, ELIFE, V2, DOI 10.7554/eLife.00780	62	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96174	10.1371/journal.pone.0096174	http://dx.doi.org/10.1371/journal.pone.0096174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796696	Green Published, Green Accepted, gold			2022-12-27	WOS:000336656000045
J	Keleshian, VL; Kellom, M; Kim, HW; Taha, AY; Cheon, Y; Igarashi, M; Rapoport, SI; Rao, JS				Keleshian, Vasken L.; Kellom, Matthew; Kim, Hyung-Wook; Taha, Ameer Y.; Cheon, Yewon; Igarashi, Miki; Rapoport, Stanley I.; Rao, Jagadeesh S.			Neuropathological Responses to Chronic NMDA in Rats Are Worsened by Dietary n-3 PUFA Deprivation but Are Not Ameliorated by Fish Oil Supplementation	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ALPHA-LINOLENIC ACID; FRONTAL-CORTEX; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; DOUBLE-BLIND; UNANESTHETIZED RATS; BRAIN; LIVER; METABOLISM	Background: Dietary long-chain n-3 polyunsaturated fatty acid (PUFA) supplementation may be beneficial for chronic brain illnesses, but the issue is not agreed on. We examined effects of dietary n-3 PUFA deprivation or supplementation, compared with an n-3 PUFA adequate diet (containing alpha-linolenic acid [18: 3 n-3] but not docosahexaenoic acid [DHA, 22: 6n-3]), on brain markers of lipid metabolism and excitotoxicity, in rats treated chronically with NMDA or saline. Methods: Male rats after weaning were maintained on one of three diets for 15 weeks. After 12 weeks, each diet group was injected i.p. daily with saline (1 ml/kg) or a subconvulsive dose of NMDA (25 mg/kg) for 3 additional weeks. Then, brain fatty acid concentrations and various markers of excitotoxicity and fatty acid metabolism were measured. Results: Compared to the diet-adequate group, brain DHA concentration was reduced, while n-6 docosapentaenoic acid (DPA, 22: 5n-6) concentration was increased in the n-3 deficient group; arachidonic acid (AA, 20: 4n-6) concentration was unchanged. These concentrations were unaffected by fish oil supplementation. Chronic NMDA increased brain cPLA(2) activity in each of the three groups, but n-3 PUFA deprivation or fish oil did not change cPLA(2) activity or protein compared with the adequate group. sPLA(2) expression was unchanged in the three conditions, whereas iPLA(2) expression was reduced by deprivation but not changed by supplementation. BDNF protein was reduced by NMDA in N-3 PUFA deficient rats, but protein levels of IL-1 beta, NGF, and GFAP did not differ between groups. Conclusions: N-3 PUFA deprivation significantly worsened several pathological NMDA-induced changes produced in diet adequate rats, whereas n-3 PUFA supplementation did not affect NMDA induced changes. Supplementation may not be critical for this measured neuropathology once the diet has an adequate n-3 PUFA content.	[Keleshian, Vasken L.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Kellom, Matthew] Arizona State Univ, Sch Earth & Space Explorat, Phoenix, AZ USA; [Kim, Hyung-Wook] Sejong Univ, Coll Life Sci, Seoul, South Korea; [Taha, Ameer Y.; Cheon, Yewon; Rapoport, Stanley I.; Rao, Jagadeesh S.] NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA	Virginia Commonwealth University; Arizona State University; Arizona State University-Downtown Phoenix; Sejong University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Rao, JS (corresponding author), NIA, Brain Physiol & Metab Sect, Neurosci Lab, NIH, Bethesda, MD 20892 USA.	jrao@mail.nih.gov	Kellom, Matthew/GNP-5389-2022		Office of Dietary Supplementation awarded [OD-09-085]; intramural program of National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING [ZIAAG000399] Funding Source: NIH RePORTER	Office of Dietary Supplementation awarded; intramural program of National Institute on Aging, NIH; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the Office of Dietary Supplementation awarded to J.S. Rao (Grant #OD-09-085) and the intramural program of National Institute on Aging, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Basselin M, 2008, NEUROCHEM RES, V33, P2229, DOI 10.1007/s11064-008-9700-2; Basselin M, 2006, NEUROPSYCHOPHARMACOL, V31, P1659, DOI 10.1038/sj.npp.1300920; Basselin M, 2010, J LIPID RES, V51, P1049, DOI 10.1194/jlr.M002469; Beezhold BL, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-26; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bondi CO, 2013, BIOL PSYCHIAT; BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; DeMar JC, 2006, J LIPID RES, V47, P172, DOI 10.1194/jlr.M500362-JLR200; DeMar JC, 2004, J NEUROCHEM, V91, P1125, DOI 10.1111/j.1471-4159.2004.02789.x; Denomme J, 2005, J NUTR, V135, P206, DOI 10.1093/jn/135.2.206; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; Dwivedi Y, 2000, J PHARMACOL EXP THER, V295, P244; Ellsworth-Bowers ER, 2012, NUTR RES REV, V25, P180, DOI 10.1017/S0954422412000091; Ertley RN, 2007, BIOL PSYCHIAT, V61, P246, DOI 10.1016/j.biopsych.2006.03.022; Farooqui AA, 2000, J MOL NEUROSCI, V14, P123, DOI 10.1385/JMN:14:3:123; FRANDSEN A, 1990, INT J DEV NEUROSCI, V8, P209, DOI 10.1016/0736-5748(90)90013-R; Frangou S, 2006, BRIT J PSYCHIAT, V188, P46, DOI 10.1192/bjp.188.1.46; Fratesi JA, 2009, APPL PHYSIOL NUTR ME, V34, P1, DOI 10.1139/H08-131; Garrido R, 2003, J NEUROTRAUM, V20, P1201, DOI 10.1089/089771503322584628; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Harbeby E, PROSTAGLANDINS LEUKO, V86, P211; Hassanali Z, 2010, DIABETES OBES METAB, V12, P139, DOI 10.1111/j.1463-1326.2009.01130.x; Igarashi M, 2007, J LIPID RES, V48, P152, DOI 10.1194/jlr.M600396-JLR200; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Key TIJ, 2003, AM J CLIN NUTR, V78, p533S, DOI 10.1093/ajcn/78.3.533S; Kherjee PKM, 2007, PROSTAG LEUKOTR ESS, V77, P233, DOI 10.1016/j.plefa.2007.10.022; Kim HW, 2011, PROSTAG LEUKOTR ESS, V85, P361, DOI 10.1016/j.plefa.2011.08.002; Kris-Etherton PM, 2008, J AM DIET ASSOC, V108, P1125, DOI 10.1016/j.jada.2008.04.025; Lipsky RH, 2005, AMINO ACIDS, V28, P169, DOI 10.1007/s00726-005-0164-2; MacQueen GM, 2001, BEHAV NEUROSCI, V115, P1145, DOI 10.1037//0735-7044.115.5.1145; Ramsden CE, 2013, PAIN, V154, P2441, DOI 10.1016/j.pain.2013.07.028; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Rao JS, 2012, J AFFECT DISORDERS, V136, P63, DOI 10.1016/j.jad.2011.08.017; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; Rapoport SI, 2009, PROSTAG LEUKOTR ESS, V81, P119, DOI 10.1016/j.plefa.2009.05.021; Rosell MS, 2005, AM J CLIN NUTR, V82, P327, DOI 10.1093/ajcn/82.2.327; Ryan AS, 2008, CLIN PEDIATR, V47, P355, DOI 10.1177/0009922807311730; SCOTT BL, 1989, P NATL ACAD SCI USA, V86, P2903, DOI 10.1073/pnas.86.8.2903; Stoll AL, 1999, ARCH GEN PSYCHIAT, V56, P407, DOI 10.1001/archpsyc.56.5.407; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Suzuki H, 2001, WORLD REV NUTR DIET, V88, P68; Taha AY, 2012, PROSTAG LEUKOTR ESS, V87, P91, DOI 10.1016/j.plefa.2012.07.006; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Yagami T, 2006, CURR NEUROPHARMACOL, V4, P87, DOI 10.2174/157015906775203011; Yang HC, 1999, ANAL BIOCHEM, V269, P278, DOI 10.1006/abio.1999.4053; Zimmer L, 2000, NEUROSCI LETT, V284, P25, DOI 10.1016/S0304-3940(00)00950-2	49	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95318	10.1371/journal.pone.0095318	http://dx.doi.org/10.1371/journal.pone.0095318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798187	Green Published, gold			2022-12-27	WOS:000336656000017
J	Ndikuyeze, GH; Gaurnier-Hausser, A; Patel, R; Baldwin, AS; May, MJ; Flood, P; Krick, E; Propert, KJ; Mason, NJ				Ndikuyeze, Georges Habineza; Gaurnier-Hausser, Anita; Patel, Reema; Baldwin, Albert S.; May, Michael J.; Flood, Patrick; Krick, Erika; Propert, Kathleen J.; Mason, Nicola J.			A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; SELECTIVE-INHIBITION; BLOCKS OSTEOCLASTOGENESIS; KINASE; MODEL; EXPRESSION; SURVIVAL; INFLAMMATION; METABOLISM; SUBGROUPS	Activated B-Cell (ABC) Diffuse Large B-Cell Lymphoma (DLBCL) is a common, aggressive and poorly chemoresponsive subtype of DLBCL, characterized by constitutive canonical NF-kappa B signaling. Inhibition of NF-kappa B signaling leads to apoptosis of ABC-DLBCL cell lines, suggesting targeted disruption of this pathway may have therapeutic relevance. The selective IKK inhibitor, NEMO Binding Domain (NBD) peptide effectively blocks constitutive NF-kB activity and induces apoptosis in ABC-DLBCL cells in vitro. Here we used a comparative approach to determine the safety and efficacy of systemic NBD peptide to inhibit constitutive NF-kB signaling in privately owned dogs with spontaneous newly diagnosed or relapsed ABC-like DLBCL. Malignant lymph nodes biopsies were taken before and twenty-four hours after peptide administration to determine biological effects. Intravenous administration of <2 mg/kg NBD peptide was safe and inhibited constitutive canonical NF-kappa B activity in 6/10 dogs. Reductions in mitotic index and Cyclin D expression also occurred in a subset of dogs 24 hours post peptide and in 3 dogs marked, therapeutically beneficial histopathological changes were identified. Mild, grade 1 toxicities were noted in 3 dogs at the time of peptide administration and one dog developed transient subclinical hepatopathy. Long term toxicities were not identified. Pharmacokinetic data suggested rapid uptake of peptide into tissues. No significant hematological or biochemical toxicities were identified. Overall the results from this phase I study indicate that systemic administration of NBD peptide is safe and effectively blocks constitutive NF-kB signaling and reduces malignant B cell proliferation in a subset of dogs with ABC-like DLBCL. These results have potential translational relevance for human ABC-DLBCL.	[Ndikuyeze, Georges Habineza] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Gaurnier-Hausser, Anita] Drexel Univ, Coll Med, Off Profess Studies Hlth Sci, Philadelphia, PA 19104 USA; [Patel, Reema] Antech Diagnost, New Hyde Pk, NY USA; [Baldwin, Albert S.] TheraLogics Inc, Chapel Hill, NC USA; [Baldwin, Albert S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Baldwin, Albert S.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [May, Michael J.] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Flood, Patrick] Univ Alberta, Katz Ctr Pharm & Hlth Res 7 020G, Edmonton, AB, Canada; [Krick, Erika; Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Propert, Kathleen J.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Mason, Nicola J.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Alberta; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Mason, NJ (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA.	nmason@vet.upenn.edu		May, Michael/0000-0002-2485-3716	NIH/The Canine Hereditary Cancer Consortium [1R41AI088870-01A1, UC2 CA148149]; Mari Lowe Center for Comparative Oncology; NATIONAL CANCER INSTITUTE [UC2CA148149] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI088870] Funding Source: NIH RePORTER	NIH/The Canine Hereditary Cancer Consortium; Mari Lowe Center for Comparative Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH 1R41AI088870-01A1 (P.F.), the Mari Lowe Center for Comparative Oncology (N.J.M.) http://research.vet.upenn.edu/marilowe/GeneralInformation/tabid/1886/Default.aspx, and NIH UC2 CA148149/The Canine Hereditary Cancer Consortium (N.J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Katib A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-228; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ankermann T, 2005, CRIT CARE MED, V33, P1384, DOI 10.1097/01.CCM.0000166371.18066.5E; [Anonymous], 2011, VET COMP ONCOL; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Cardozo AK, 2007, BBA-BIOMEMBRANES, V1768, P2222, DOI 10.1016/j.bbamem.2007.06.003; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Dasgupta S, 2004, J IMMUNOL, V173, P1344, DOI 10.4049/jimmunol.173.2.1344; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; De Plaen IG, 2007, PEDIATR RES, V61, P716, DOI 10.1203/pdr.0b013e3180534219; di Meglio P, 2005, ARTHRITIS RHEUM-US, V52, P951, DOI 10.1002/art.20960; Ethridge RT, 2002, J AM COLL SURGEONS, V195, P497, DOI 10.1016/S1072-7515(02)01222-X; Furuta H, 2012, INT J CANCER, V131, pE625, DOI 10.1002/ijc.27435; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; Gaurnier-Hausser A, 2011, CLIN CANCER RES, V17, P4661, DOI 10.1158/1078-0432.CCR-10-3310; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Hayakawa Y, 2009, J GASTROENTEROL, V44, P935, DOI 10.1007/s00535-009-0098-7; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Ianaro A, 2009, CANCER LETT, V274, P331, DOI 10.1016/j.canlet.2008.09.038; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kiessling MK, 2009, CANCER RES, V69, P2365, DOI 10.1158/0008-5472.CAN-08-3221; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lam LT, 2008, P NATL ACAD SCI USA, V105, P20798, DOI 10.1073/pnas.0806491106; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mudaliar MAV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072591; Nadjar A, 2005, NEUROPSYCHOPHARMACOL, V30, P1492, DOI 10.1038/sj.npp.1300755; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Peterson JM, 2011, MOL MED, V17, P508, DOI 10.2119/molmed.2010.00263; Pham LV, 2011, BLOOD, V117, P200, DOI 10.1182/blood-2010-06-290437; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spee B, 2006, J VET INTERN MED, V20, P1085, DOI 10.1892/0891-6640(2006)20[1085:CMAOSI]2.0.CO;2; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Vail DM, 2010, VET COMP ONCOL, V8, P28, DOI 10.1111/j.1476-5829.2009.00200.x; Vail DM, 2009, CLIN CANCER RES, V15, P3503, DOI 10.1158/1078-0432.CCR-08-3113; von Bismarck P, 2012, PULM PHARMACOL THER, V25, P228, DOI 10.1016/j.pupt.2012.03.002	47	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95404	10.1371/journal.pone.0095404	http://dx.doi.org/10.1371/journal.pone.0095404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798348	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000018
J	Yang, HP; Mi, RH; Wang, Q; Wei, XD; Yin, QS; Chen, L; Zhu, XH; Song, YP				Yang, Haiping; Mi, Ruihua; Wang, Qian; Wei, Xudong; Yin, Qingsong; Chen, Lin; Zhu, Xinghu; Song, Yongping			Expression of Neuron-Specific Enolase in Multiple Myeloma and Implications for Clinical Diagnosis and Treatment	PLOS ONE			English	Article							SERUM MARKERS	Objective: To determine the expression of neuron-specific enolase (NSE) in patients with multiple myeloma (MM) and to evaluate its clinical value as a tumor marker and, an indicator of disease progression and treatment efficacy. Methods: Using electrochemiluminescence immunoassay (ECLIA), we measured the serum levels of NSE in 47 healthy subjects (control group), 25 patients with small cell lung cancer (lung cancer group), and 52 patients with MM (MM group). For the MM group, serum NSE levels were measured and other disease indicators and related symptoms were monitored before and after chemotherapy. The relationship between NSE expression and other MM-related factors was analyzed. In addition, immunohistochemical staining was performed on bone marrow biopsy specimens from patients with MM. Results: In the control group, serum NSE levels were within the normal range as previously reported, while the lung cancer group and the untreated MM group exhibited NSE levels that were significantly higher relative to the control group (P<0.05). The difference in NSE expression between the lung cancer group and untreated MM group was statistically significant (P<0.05). NSE levels were significantly decreased in MM patients after chemotherapy and were positively correlated with an MM disease index [beta-2 microglobulin (beta(2)-MG)]. Changes in NSE were not related to the response rate to chemotherapy but rather were correlated with progression-free survival. Conclusions: Patients with MM may have increased serum NSE levels, and changes in NSE may provide insight into treatment efficacy of chemotherapy and disease progression. Perhaps NSE expression is a viable biomarker for MM and can be a useful reference for the design and adjustment of clinical MM treatment programs.	[Yang, Haiping; Mi, Ruihua; Wang, Qian; Wei, Xudong; Yin, Qingsong; Chen, Lin; Zhu, Xinghu; Song, Yongping] Zhengzhou Univ, Tumor Hosp, Dept Hematol, Zhengzhou 450052, Peoples R China; [Yang, Haiping] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Hematol, Zhengzhou, Peoples R China	Zhengzhou University; Henan University of Science & Technology	Wei, XD (corresponding author), Zhengzhou Univ, Tumor Hosp, Dept Hematol, Zhengzhou 450052, Peoples R China.	xudongwei@zzu.edu.cn			National Natural Science Foundation of China [81170520]; Henan Department of Health Provincial-Departmental [2011010014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan Department of Health Provincial-Departmental	This study was supported by the National Natural Science Foundation of China (NO. 81170520) and the Henan Department of Health Provincial-Departmental collaboration project (NO. 2011010014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2009, CLIN HEMATOLOGY, V22, P379; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bredella MA, 2005, AM J ROENTGENOL, V184, P1199, DOI 10.2214/ajr.184.4.01841199; [陈侃侃 CHEN Kankan], 2010, [江苏医药, Jiangsu Medical Journal], V36, P421; Ebert W, 1996, ANTICANCER RES, V16, P2161; Gao W, 2012, J CHINESE GEN PRACTI, V10, P337; Jimbo Junko, 2006, Rinsho Ketsueki, V47, P1381; Jorgensen LGM, 1996, BRIT J CANCER, V74, P463, DOI 10.1038/bjc.1996.383; Lamy PJ, 2000, LUNG CANCER, V29, P197, DOI 10.1016/S0169-5002(00)00113-6; Liu S, 2007, INT J HEMATOL, V85, P49, DOI 10.1532/IJH97.06132; Multiple myeloma working group in China, 2008, CHINESE J INTERNAL M, V47, P869; Nakajima T, 1995, Rinsho Ketsueki, V36, P359; Pinson P, 1997, RESPIRATION, V64, P102; Riley RD, 2004, CLIN CANCER RES, V10, P4, DOI 10.1158/1078-0432.CCR-1051-2; Sharma Ricky A, 2006, Lancet Oncol, V7, P960, DOI 10.1016/S1470-2045(06)70945-7; Song S, 2004, WILLIAMS HEMATOLOGY, P1342; Woertgen C, 2002, ACT NEUR S, V81, P205; [张青云 Zhang Qingyun], 2005, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V28, P728; Zhang Z, 2007, DIAGNOSIS HEMATOLOGI, P232; Zhang Z, 2003, HEMATOLOGY, P1341; 张忆梓, 2012, [中华血液学杂志, Chinese Journal of Hematology], V33, P417	21	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e94304	10.1371/journal.pone.0094304	http://dx.doi.org/10.1371/journal.pone.0094304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796851	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000007
J	Altshuler, AE; Lamadrid, I; Li, DN; Ma, SR; Kurre, L; Schmid-Schonbein, GW; Penn, AH				Altshuler, Angelina E.; Lamadrid, Itze; Li, Diana; Ma, Stephanie R.; Kurre, Leena; Schmid-Schoenbein, Geert W.; Penn, Alexander H.			Transmural Intestinal Wall Permeability in Severe Ischemia after Enteral Protease Inhibition	PLOS ONE			English	Article							FREE FATTY-ACIDS; MATRIX METALLOPROTEINASES; BACTERIAL TRANSLOCATION; INTRALUMINAL GLUCOSE; MUCOSAL PERMEABILITY; CYTOTOXIC MEDIATORS; BLOOD-FLOW; CELL-DEATH; GUT; REPERFUSION	In intestinal ischemia, inflammatory mediators in the small intestine's lumen such as food byproducts, bacteria, and digestive enzymes leak into the peritoneal space, lymph, and circulation, but the mechanisms by which the intestinal wall permeability initially increases are not well defined. We hypothesize that wall protease activity (independent of luminal proteases) and apoptosis contribute to the increased transmural permeability of the intestine's wall in an acutely ischemic small intestine. To model intestinal ischemia, the proximal jejunum to the distal ileum in the rat was excised, the lumen was rapidly flushed with saline to remove luminal contents, sectioned into equal length segments, and filled with a tracer (fluorescein) in saline, glucose, or protease inhibitors. The transmural fluorescein transport was determined over 2 hours. Villi structure and epithelial junctional proteins were analyzed. After ischemia, there was increased transmural permeability, loss of villi structure, and destruction of epithelial proteins. Supplementation with luminal glucose preserved the epithelium and significantly attenuated permeability and villi damage. Matrix metalloproteinase (MMP) inhibitors (doxycycline, GM 6001), and serine protease inhibitor (tranexamic acid) in the lumen, significantly reduced the fluorescein transport compared to saline for 90 min of ischemia. Based on these results, we tested in an in-vivo model of hemorrhagic shock (90 min 30 mmHg, 3 hours observation) for intestinal lesion formation. Single enteral interventions (saline, glucose, tranexamic acid) did not prevent intestinal lesions, while the combination of enteral glucose and tranexamic acid prevented lesion formation after hemorrhagic shock. The results suggest that apoptotic and protease mediated breakdown cause increased permeability and damage to the intestinal wall. Metabolic support in the lumen of an ischemic intestine with glucose reduces the transport from the lumen across the wall and enteral proteolytic inhibition attenuates tissue breakdown. These combined interventions ameliorate lesion formation in the small intestine after hemorrhagic shock.	[Altshuler, Angelina E.; Lamadrid, Itze; Li, Diana; Ma, Stephanie R.; Kurre, Leena; Schmid-Schoenbein, Geert W.; Penn, Alexander H.] Univ Calif San Diego, Inst Engn Med, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Altshuler, AE (corresponding author), Univ Calif San Diego, Inst Engn Med, Dept Bioengn, La Jolla, CA 92093 USA.	aaltshul@ucsd.edu		Penn, Alexander/0000-0002-0774-1835	National Institutes of Health (NIH) [GM-85072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM-85072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler AE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.109; Altshuler AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032672; Baker AJ, 1995, AM J PHYSL; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; BOUNOUS G, 1967, ARCH SURG-CHICAGO, V94, P46; Chang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040087; Chang M, 2012, SHOCK, V37, P297, DOI 10.1097/SHK.0b013e318240b59b; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHIU CJ, 1970, ARCH SURG-CHICAGO, V101, P484; Cui NG, 1996, DIGEST DIS SCI, V41, P405, DOI 10.1007/BF02093836; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; DAUTERIVE AH, 1985, ANN SURG, V201, P198, DOI 10.1097/00000658-198502000-00011; Deitch EA, 2003, SHOCK, V19, P452, DOI 10.1097/01.shk.0000048899.46342.f6; DEITCH EA, 1991, CRIT CARE MED, V19, P785, DOI 10.1097/00003246-199106000-00010; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; DeLano FA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005046; Derikx JPM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003428; FAUST RG, 1966, J CELL PHYSIOL, V67, P149, DOI 10.1002/jcp.1040670117; FLYNN WJ, 1992, J SURG RES, V52, P499, DOI 10.1016/0022-4804(92)90318-T; Fujita S, 2005, DIABETES, V54, P3258, DOI 10.2337/diabetes.54.11.3258; GOLUB LM, 1991, CRIT REV ORAL BIOL M, V2, P297, DOI 10.1177/10454411910020030201; Grootjans J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039638; HAGLUND U, 1994, GUT, V35, pS73, DOI 10.1136/gut.35.1_Suppl.S73; HAGLUND U, 1993, CRIT CARE MED, V21, pS15, DOI 10.1097/00003246-199302001-00004; Hakulinen J, 2006, J BIOL CHEM, V281, P21369, DOI 10.1074/jbc.M602053200; HEBRA A, 1993, J PEDIATR SURG, V28, P362, DOI 10.1016/0022-3468(93)90232-A; Honda K, 2003, INT J EXP PATHOL, V84, P281, DOI 10.1111/j.0959-9673.2003.00364.x; Hu JL, 2005, BIOCHEM PHARMACOL, V70, P535, DOI 10.1016/j.bcp.2005.04.047; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Ishimaru K, 2004, SHOCK, V22, P467, DOI 10.1097/01.shk.0000142253.31006.8c; ISRAEL EJ, 1994, ACTA PAEDIATR, V83, P27, DOI 10.1111/j.1651-2227.1994.tb13238.x; KOSLOSKE AM, 1989, CLIN PERINATOL, V16, P97, DOI 10.1016/S0095-5108(18)30657-2; Kozar RA, 2002, JPEN-PARENTER ENTER, V26, P226, DOI 10.1177/0148607102026004226; LANGER JC, 1992, J PEDIATR SURG, V27, P329, DOI 10.1016/0022-3468(92)90856-3; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Liu WL, 2009, J NEUROCHEM, V108, P811, DOI 10.1111/j.1471-4159.2008.05821.x; MCARDLE AH, 1972, ARCH SURG-CHICAGO, V105, P441; Medina C, 2006, J PHARMACOL EXP THER, V318, P933, DOI 10.1124/jpet.106.103465; MIRKOVITCH V, 1975, RES EXP MED, V166, P183, DOI 10.1007/BF01851184; Mitsuoka H, 2000, P NATL ACAD SCI USA, V97, P1772, DOI 10.1073/pnas.97.4.1772; Mitsuoka H, 2000, SHOCK, V14, P522, DOI 10.1097/00024382-200014050-00005; Moore BA, 2011, GASTROENTEROLOGY, V141, P1283, DOI 10.1053/j.gastro.2011.06.035; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Penn AH, 2008, AM J PHYSIOL-HEART C, V294, pH1779, DOI 10.1152/ajpheart.00902.2007; Penn AH, 2007, SHOCK, V27, P296, DOI 10.1097/01.shk.0000235139.20775.7f; Penn AH, 2011, SHOCK, V36, P251, DOI 10.1097/SHK.0b013e3182236f0f; Qin X, 2012, AM J PHYSIOL-GASTR L, V303, pG969, DOI 10.1152/ajpgi.00290.2012; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; RIEPE SP, 1980, J CLIN INVEST, V66, P314, DOI 10.1172/JCI109859; ROBINSON JWL, 1977, BIOMED EXPRESS, V27, P60; Rosario HS, 2004, AM J PATHOL, V164, P1707, DOI 10.1016/S0002-9440(10)63729-7; Schmid-Schonbein GW, 2007, INT IMMUNOPHARMACOL, V7, P1845, DOI 10.1016/j.intimp.2007.07.015; Seifert WF, 1996, GUT, V39, P114, DOI 10.1136/gut.39.1.114; Steck N, 2012, GUT, V61, P1610, DOI 10.1136/gutjnl-2011-300775; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Sun ZW, 1998, SHOCK, V10, P203, DOI 10.1097/00024382-199809000-00009; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; TAKADA A, 1989, THROMB RES, V55, P717, DOI 10.1016/0049-3848(89)90302-2; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; THORENS B, 1993, ANNU REV PHYSIOL, V55, P591, DOI 10.1146/annurev.ph.55.030193.003111; Unno N, 1998, AM J PHYSIOL-GASTR L, V274, pG700, DOI 10.1152/ajpgi.1998.274.4.G700; Vakonyi T, 1977, Digestion, V15, P295; Wani Imtiaz, 2009, World J Emerg Surg, V4, P46, DOI 10.1186/1749-7922-4-46	63	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96655	10.1371/journal.pone.0096655	http://dx.doi.org/10.1371/journal.pone.0096655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805256	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900077
J	Hall, MP; Hill, M; Zimmermann, B; Sigurjonsson, S; Westemeyer, M; Saucier, J; Demko, Z; Rabinowitz, M				Hall, Megan P.; Hill, Matthew; Zimmermann, Bernhard; Sigurjonsson, Styrmir; Westemeyer, Margaret; Saucier, Jennifer; Demko, Zachary; Rabinowitz, Matthew			Non-Invasive Prenatal Detection of Trisomy 13 Using a Single Nucleotide Polymorphism- and Informatics-Based Approach	PLOS ONE			English	Article							CELL-FREE DNA; FETAL ANEUPLOIDY; CHROMOSOMES 13; DOWN-SYNDROME; POPULATION; DIAGNOSIS; SURVIVAL; MORTALITY; INFANTS	Purpose: To determine how a single nucleotide polymorphism (SNP)-and informatics-based non-invasive prenatal aneuploidy test performs in detecting trisomy 13. Methods: Seventeen trisomy 13 and 51 age-matched euploid samples, randomly selected from a larger cohort, were analyzed. Cell-free DNA was isolated from maternal plasma, amplified in a single multiplex polymerase chain reaction assay that interrogated 19,488 SNPs covering chromosomes 13, 18, 21, X, and Y, and sequenced. Analysis and copy number identification involved a Bayesian-based maximum likelihood statistical method that generated chromosome-and samplespecific calculated accuracies. Results: Of the samples that passed a stringent DNA quality threshold (94.1%), the algorithm correctly identified 15/15 trisomy 13 and 49/49 euploid samples, for 320/320 correct copy number calls. Conclusions: This informatics-and SNP-based method accurately detects trisomy 13-affected fetuses non-invasively and with high calculated accuracy.	[Hall, Megan P.; Hill, Matthew; Zimmermann, Bernhard; Sigurjonsson, Styrmir; Rabinowitz, Matthew] Natera Inc, Dept Res & Dev, San Carlos, CA 94070 USA; [Westemeyer, Margaret; Saucier, Jennifer; Demko, Zachary] Natera Inc, Dept Genet Counseling, San Carlos, CA USA		Rabinowitz, M (corresponding author), Natera Inc, Dept Res & Dev, San Carlos, CA 94070 USA.	mrabinowitz@natera.com		/0000-0002-7300-5027; Zimmermann, Bernhard/0000-0002-5275-4571	Natera Inc.	Natera Inc.	Natera Inc. sponsored the study, and thus was involved in study design, data collection and analysyis, decision to publish, and preparation of the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1459; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P21, DOI 10.1002/uog.12299; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; BATY BJ, 1994, AM J MED GENET, V49, P175, DOI 10.1002/ajmg.1320490204; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; BOYD PA, 1987, LANCET, V2, P425; Buyse ML, 1990, BIRTH DEFECTS ENCY; Carey JC, 2010, MANAGEMENT GENETIC S; Chen EZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021791; Chiu RWK, 2010, CLIN CHEM, V56, P459, DOI 10.1373/clinchem.2009.136507; Choi H, 2013, PRENATAL DIAG, V33, P198, DOI 10.1002/pd.4024; COWEN JM, 1979, J MED GENET, V16, P155, DOI 10.1136/jmg.16.2.155; Crider KS, 2008, AM J MED GENET A, V146A, P820, DOI 10.1002/ajmg.a.32200; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Egan JFX, 2000, OBSTET GYNECOL, V96, P979, DOI 10.1016/S0029-7844(00)01044-9; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Forrester MB, 2003, AM J MED GENET A, V119A, P311, DOI 10.1002/ajmg.a.20151; Griffith CB, 2009, AM J MED GENET A, V149A, P1346, DOI 10.1002/ajmg.a.32883; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Lakovschek IC, 2011, AM J MED GENET A, V155A, P2626, DOI 10.1002/ajmg.a.34284; Liao GJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038154; MANKINEN CB, 1976, J MED GENET, V13, P157, DOI 10.1136/jmg.13.2.157; Mazloom AR, 2013, PRENATAL DIAG, V33, P591, DOI 10.1002/pd.4127; MCFADDEN DE, 1991, AM J MED GENET, V38, P535, DOI 10.1002/ajmg.1320380407; Nicolaides K, 2013, FETAL DIAGNOSIS THER; Nicolaides KH, 2013, PRENATAL DIAG, V33, P575, DOI 10.1002/pd.4103; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Parker MJ, 2003, PRENATAL DIAG, V23, P856, DOI 10.1002/pd.707; PATAU K, 1960, LANCET, V1, P790; Pont SJ, 2006, AM J MED GENET A, V140A, P1749, DOI 10.1002/ajmg.a.31382; Rabinowitz M, 2013, METHOD DETERMINING N; Rabinowitz M, 2012, METHODS NONINVASIVE; Rasmussen SA, 2003, PEDIATRICS, V111, P777, DOI 10.1542/peds.111.4.777; REDHEENDRAN R, 1981, AM J MED GENET, V8, P167, DOI 10.1002/ajmg.1320080207; Samango-Sprouse C, 2013, PRENATAL DIAG, V33, P643, DOI 10.1002/pd.4159; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Spencer K, 2002, PRENATAL DIAG, V22, P877, DOI 10.1002/pd.420; Tsukada K, 2012, CELL BIOCHEM BIOPHYS, V63, P191, DOI 10.1007/s12013-012-9355-0; Vendola C, 2010, AM J MED GENET A, V152A, P360, DOI 10.1002/ajmg.a.33156; Wegrzyn P, 2005, ULTRASOUND OBST GYN, V26, P28, DOI 10.1002/uog.1923; Zimmermann B, 2013, HIGHLY MULTIPLEXED P; Zimmermann B, 2013, HIGHLY MULTIPLEX PCR; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	49	20	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96677	10.1371/journal.pone.0096677	http://dx.doi.org/10.1371/journal.pone.0096677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805989	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900081
J	Yasugi, T; Fischer, A; Jiang, YR; Reichert, H; Knoblich, JA				Yasugi, Tetsuo; Fischer, Anja; Jiang, Yanrui; Reichert, Heinrich; Knoblich, Juergen A.			A Regulatory Transcriptional Loop Controls Proliferation and Differentiation in Drosophila Neural Stem Cells	PLOS ONE			English	Article							PRONEURAL GENE-EXPRESSION; NEUROBLAST SELF-RENEWAL; CENTRAL-NERVOUS-SYSTEM; ACHAETE-SCUTE; OPTIC LOBE; SPINDLE ORIENTATION; ASYMMETRIC DIVISION; BRAIN-DEVELOPMENT; TUMOR-SUPPRESSOR; DNA-BINDING	Neurogenesis is initiated by a set of basic Helix-Loop-Helix (bHLH) transcription factors that specify neural progenitors and allow them to generate neurons in multiple rounds of asymmetric cell division. The Drosophila Daughterless (Da) protein and its mammalian counterparts (E12/E47) act as heterodimerization factors for proneural genes and are therefore critically required for neurogenesis. Here, we demonstrate that Da can also be an inhibitor of the neural progenitor fate whose absence leads to stem cell overproliferation and tumor formation. We explain this paradox by demonstrating that Da induces the differentiation factor Prospero (Pros) whose asymmetric segregation is essential for differentiation in one of the two daughter cells. Da co-operates with the bHLH transcription factor Asense, whereas the other proneural genes are dispensible. After mitosis, Pros terminates Asense expression in one of the two daughter cells. In da mutants, pros is not expressed, leading to the formation of lethal transplantable brain tumors. Our results define a transcriptional feedback loop that regulates the balance between self-renewal and differentiation in Drosophila optic lobe neuroblasts. They indicate that initiation of a neural differentiation program in stem cells is essential to prevent tumorigenesis.	[Yasugi, Tetsuo; Fischer, Anja; Knoblich, Juergen A.] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria; [Jiang, Yanrui; Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Basel	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Yasugi, Tetsuo/N-4913-2015; Knoblich, Juergen A/C-2974-2015	Knoblich, Juergen A/0000-0002-6751-3404	Austrian Academy of Sciences; Austrian Science F [I1281-B19, Z_153_B09]; European Research Council (ERC); EMBO long-term fellowship; JSPS Postdoctoral Fellowship; Austrian Science Fund (FWF) [Z 153] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science F; European Research Council (ERC)(European Research Council (ERC)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); JSPS Postdoctoral Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Work in J.A.K.'s laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF, grants I1281-B19 and Z_153_B09) and an advanced grant of the European Research Council (ERC). Support for T.Y. was provided by EMBO long-term fellowship and JSPS Postdoctoral Fellowship for Research Abroad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; BRAND M, 1993, DEVELOPMENT, V119, P1; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Cheng XY, 2009, J CELL MOL MED, V13, P4377, DOI 10.1111/j.1582-4934.2008.00664.x; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Colonques J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019342; CRONMILLER C, 1987, CELL, V48, P479, DOI 10.1016/0092-8674(87)90198-X; CRONMILLER C, 1993, MECH DEVELOP, V42, P159, DOI 10.1016/0925-4773(93)90005-I; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1; Egger B, 2011, FLY, V5, P237, DOI 10.4161/fly.5.3.15640; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Heng JIT, 2003, BIOESSAYS, V25, P709, DOI 10.1002/bies.10299; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; JARMAN AP, 1993, DEVELOPMENT, V119, P19; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; MARTINBERMUDO MD, 1991, DEVELOPMENT, V113, P445; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Ravanpay AC, 2008, J NEUROSCI RES, V86, P1472, DOI 10.1002/jnr.21615; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; SKEATH JB, 1992, DEVELOPMENT, V114, P939; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Torii MA, 1999, DEVELOPMENT, V126, P443; VAESSIN H, 1994, DEVELOPMENT, V120, P935; VANDOREN M, 1991, DEVELOPMENT, V113, P245; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Yasugi T, 2008, DEVELOPMENT, V135, P1471, DOI 10.1242/dev.019117; Yasugi T, 2010, DEVELOPMENT, V137, P3193, DOI 10.1242/dev.048058	50	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97034	10.1371/journal.pone.0097034	http://dx.doi.org/10.1371/journal.pone.0097034			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804774	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000335728900132
J	Gao, Y; Liu, F; Fang, L; Cai, RL; Zong, CJ; Qi, Y				Gao, Yuan; Liu, Fen; Fang, Lei; Cai, Runlan; Zong, Chuanjie; Qi, Yun			Genkwanin Inhibits Proinflammatory Mediators Mainly through the Regulation of miR-101/MKP-1/MAPK Pathway in LPS-Activated Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; IMMEDIATE-EARLY GENE; RAW 264.7 CELLS; PROTEIN-KINASE PHOSPHATASE-1; IN-VIVO; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY MEDIATORS; RAW-264.7 MACROPHAGES	Genkwanin is one of the major non-glycosylated flavonoids in many herbs with anti-inflammatory activities. Although its anti-inflammatory activity in vivo has been reported, the potential molecular mechanisms remain obscure. In this study, by pharmacological and genetic approaches, we explore the anti-inflammatory effects of genkwanin in LPS-activated RAW264.7 macrophages. Genkwanin potently decreases the proinflammatory mediators, such as iNOS, TNF-alpha, IL-1 beta and IL-6, at the transcriptional and translational levels without cytotoxicity, indicating the excellent anti-inflammatory potency of genkwanin in vitro. Mechanism study shows that genkwanin significantly suppresses the p38- and JNK-mediated AP-1 signaling pathway and increases the mitogen-activated protein kinase (MAPK) phosphatase 1 (MKP-1) expression at the posttranscriptional level. We also confirmed that microRNA-101 (miR-101) is a negative regulator of MKP-1 expression. Moreover, regardless of miR-101-deficient cells or miR-101-abundant cells, the suppression effects of genkwanin on supernatant proinflammatory mediators' levels are far less than that in respective negative control cells, suggesting that genkwanin exerts anti-inflammatory effect mainly through reducing miR-101 production. However, genkwanin can't affect the level of phospho-Akt (p-Akt), indicating that the phosphorylation of Akt may be not responsible for the effect of genkwanin on miR-101 production. We conclude that genkwanin exerts its anti-inflammatory effect mainly through the regulation of the miR-101/MKP-1/MAPK pathway.	[Qi, Yun] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, Y (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	yqi@implad.ac.cn	Fang, Lei/HHN-8887-2022	Fang, Lei/0000-0001-9980-8285	National Natural Science Foundation of China [81274163, 81173645]; Ministry of Science and Technology of the People's Republic of China [2012ZX09301-002-001, 2014ZX09201022-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Nos. 81274163 and 81173645) and National S&T Major Project and Scientific Researchers Aiding Enterprise Item (Nos. 2012ZX09301-002-001 and 2014ZX09201022-006) from the Ministry of Science and Technology of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Altinier G, 2007, J AGR FOOD CHEM, V55, P1718, DOI 10.1021/jf062610+; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Brozic P, 2009, MOL CELL ENDOCRINOL, V301, P229, DOI 10.1016/j.mce.2008.09.004; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Carlson J, 2009, AM J PATHOL, V175, P1564, DOI 10.2353/ajpath.2009.090035; CHARLES CH, 1992, ONCOGENE, V7, P187; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Chen YC, 2001, J CELL BIOCHEM, V82, P537, DOI 10.1002/jcb.1184; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Chung HJ, 2010, J ETHNOPHARMACOL, V130, P450, DOI 10.1016/j.jep.2010.05.020; Cottiglia F, 2001, PHYTOMEDICINE, V8, P302, DOI 10.1078/0944-7113-00036; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; During A, 2013, BIOCHEM PHARMACOL, V86, P1739, DOI 10.1016/j.bcp.2013.10.003; Fan GW, 2013, INFLAMMATION, V36, P1584, DOI 10.1007/s10753-013-9703-2; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Harasstani OA, 2010, INFLAMM RES, V59, P711, DOI 10.1007/s00011-010-0182-8; Huang GC, 2007, INT IMMUNOPHARMACOL, V7, P1054, DOI 10.1016/j.intimp.2007.04.001; Kaneko T, 2009, IN VIVO, V23, P577; Karin M, 2004, ANN RHEUM DIS, V63, P62, DOI 10.1136/ard.2004.028274; Kim AR, 2004, PHYTOTHER RES, V18, P1, DOI 10.1002/ptr.1358; Kraft C, 2003, PHYTOTHER RES, V17, P123, DOI 10.1002/ptr.1066; Lee JY, 2003, J BIOL CHEM, V278, P37041, DOI 10.1074/jbc.M305213200; Li M, 2012, PHYTOTHER RES, V26, P1195, DOI 10.1002/ptr.3680; Lin MW, 2007, BIOCHEM PHARMACOL, V73, P1796, DOI 10.1016/j.bcp.2007.02.009; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Martini ND, 2004, J ETHNOPHARMACOL, V93, P207, DOI 10.1016/j.jep.2004.02.030; Medina EA, 2010, J IMMUNOL, V185, P7562, DOI 10.4049/jimmunol.0903790; Murphy S, 2000, GLIA, V29, P1, DOI 10.1002/(SICI)1098-1136(20000101)29:1<1::AID-GLIA1>3.0.CO;2-N; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Oh YC, 2013, FOOD CHEM TOXICOL, V53, P343, DOI 10.1016/j.fct.2012.12.006; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Pan MH, 2006, BIOCHEM PHARMACOL, V72, P1293, DOI 10.1016/j.bcp.2006.07.039; Park CM, 2011, EUR J PHARMACOL, V660, P454, DOI 10.1016/j.ejphar.2011.04.007; Pelzer LE, 1998, FARMACO, V53, P421, DOI 10.1016/S0014-827X(98)00046-9; Pinho BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024098; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Rodriguez N, 2010, J LEUKOCYTE BIOL, V88, P579, DOI 10.1189/jlb.0210083; Sadhu SK, 2006, J ETHNOPHARMACOL, V108, P371, DOI 10.1016/j.jep.2006.05.024; Smolinski AT, 2003, FOOD CHEM TOXICOL, V41, P1381, DOI 10.1016/S0278-6915(03)00146-7; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; SUH N, 1995, ANTICANCER RES, V15, P233; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; The State Commission of Chinese Pharmacopoeia, 2010, PHARM PEOPL REP CH 1, P148; Theodosiou A, 2002, GENOME BIOL, V3; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; WANG QZ, 1991, LIFE SCI, V49, pPL55, DOI 10.1016/0024-3205(91)90251-6; Wu JJ, 2005, MOL CELL BIOL, V25, P4792, DOI 10.1128/MCB.25.11.4792-4803.2005; Xie CH, 2012, J NUTR BIOCHEM, V23, P1184, DOI 10.1016/j.jnutbio.2011.06.013; Yu YM, 2006, J IMMUNOL, V176, P6194, DOI 10.4049/jimmunol.176.10.6194; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798	61	59	66	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96741	10.1371/journal.pone.0096741	http://dx.doi.org/10.1371/journal.pone.0096741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800851	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800119
J	Hall, DD; Wu, YJ; Domann, FE; Spitz, DR; Anderson, ME				Hall, Duane D.; Wu, Yuejin; Domann, Frederick E.; Spitz, Douglas R.; Anderson, Mark E.			Mitochondrial Calcium Uniporter Activity Is Dispensable for MDA-MB-231 Breast Carcinoma Cell Survival	PLOS ONE			English	Article							CA2+; MICU1; MCU; METABOLISM; GLUCOSE; PROTEIN	Calcium uptake through the mitochondrial Ca2+ uniporter (MCU) is thought to be essential in regulating cellular signaling events, energy status, and survival. Functional dissection of the uniporter is now possible through the recent identification of the genes encoding for MCU protein complex subunits. Cancer cells exhibit many aspects of mitochondrial dysfunction associated with altered mitochondrial Ca2+ levels including resistance to apoptosis, increased reactive oxygen species production and decreased oxidative metabolism. We used a publically available database to determine that breast cancer patient outcomes negatively correlated with increased MCU Ca2+ conducting pore subunit expression and decreased MICU1 regulatory subunit expression. We hypothesized breast cancer cells may therefore be sensitive to MCU channel manipulation. We used the widely studied MDA-MB-231 breast cancer cell line to investigate whether disruption or increased activation of mitochondrial Ca2+ uptake with specific siRNAs and adenoviral overexpression constructs would sensitize these cells to therapy-related stress. MDA-MB-231 cells were found to contain functional MCU channels that readily respond to cellular stimulation and elicit robust AMPK phosphorylation responses to nutrient withdrawal. Surprisingly, knockdown of MCU or MICU1 did not affect reactive oxygen species production or cause significant effects on clonogenic cell survival of MDA-MB-231 cells exposed to irradiation, chemotherapeutic agents, or nutrient deprivation. Overexpression of wild type or a dominant negative mutant MCU did not affect basal cloning efficiency or ceramide-induced cell killing. In contrast, non-cancerous breast epithelial HMEC cells showed reduced survival after MCU or MICU1 knockdown. These results support the conclusion that MDA-MB-231 breast cancer cells do not rely on MCU or MICU1 activity for survival in contrast to previous findings in cells derived from cervical, colon, and prostate cancers and suggest that not all carcinomas will be sensitive to therapies targeting mitochondrial Ca2+ uptake mechanisms.	[Hall, Duane D.; Wu, Yuejin; Anderson, Mark E.] Univ Iowa, Dept Internal Med, Div Cardiovasc Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Domann, Frederick E.; Spitz, Douglas R.; Anderson, Mark E.] Univ Iowa, Free Radical & Radiat Biol Program, Roy J & Lucille A Carver Coll Med, Holden Comprehens Canc Ctr,Dept Radiat Oncol, Iowa City, IA 52242 USA; [Anderson, Mark E.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Domann, FE (corresponding author), Univ Iowa, Free Radical & Radiat Biol Program, Roy J & Lucille A Carver Coll Med, Holden Comprehens Canc Ctr,Dept Radiat Oncol, Iowa City, IA 52242 USA.	frederick-domann@uiowa.edu; douglas-spitz@uiowa.edu; mark-e-anderson@uiowa.edu	Hall, Duane/ACD-6815-2022	Hall, Duane/0000-0003-2228-0966; Spitz, Douglas/0000-0002-1254-8765; Domann, Frederick/0000-0002-0489-2179	American Cancer Society [IRG-77-004-034]; National Institutes of Health (NIH) [R01 CA115438]; NIH [R01 CA182804]; NATIONAL CANCER INSTITUTE [R01CA182804, R01CA115438, P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Grant IRG-77-004-034 (DDH) from the American Cancer Society (http://www.cancer.org), administered through the Holden Comprehensive Cancer Center at the University of Iowa (http://www.uihealthcare.org/HoldenComprehensiveCancerCenter), National Institutes of Health (NIH) R01 CA115438 (FED) and NIH R01 CA182804 (DRS) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Curry MC, 2013, BIOCHEM BIOPH RES CO, V434, P695, DOI 10.1016/j.bbrc.2013.04.015; Dahle J, 2004, CYTOM PART A, V60A, P182, DOI 10.1002/cyto.a.20038; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hadzic T, 2010, FREE RADICAL BIO MED, V48, P1024, DOI 10.1016/j.freeradbiomed.2010.01.018; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Lee WJ, 2006, BIOCH BIOPHYS ACTA; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Marchi S, 2013, CURR BIOL, V23, P58, DOI 10.1016/j.cub.2012.11.026; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Owens KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023846; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SPITZ DR, 1990, BIOCHEM J, V267, P453, DOI 10.1042/bj2670453	31	65	66	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96866	10.1371/journal.pone.0096866	http://dx.doi.org/10.1371/journal.pone.0096866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802861	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800135
J	Njeuhmeli, E; Kripke, K; Hatzold, K; Reed, J; Edgil, D; Jaramillo, J; Castor, D; Forsythe, S; Xaba, S; Mugurungi, O				Njeuhmeli, Emmanuel; Kripke, Katharine; Hatzold, Karin; Reed, Jason; Edgil, Dianna; Jaramillo, Juan; Castor, Delivette; Forsythe, Steven; Xaba, Sinokuthemba; Mugurungi, Owen			Cost Analysis of Integrating the PrePex Medical Device into a Voluntary Medical Male Circumcision Program in Zimbabwe	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; HIV PREVENTION; SCALE-UP; EFFICACY; SAFETY; MEN	Background: Fourteen African countries are scaling up voluntary medical male circumcision (VMMC) for HIV prevention. Several devices that might offer alternatives to the three WHO-approved surgical VMMC procedures have been evaluated for use in adults. One such device is PrePex, which was prequalified by the WHO in May 2013. We utilized data from one of the PrePex field studies undertaken in Zimbabwe to identify cost considerations for introducing PrePex into the existing surgical circumcision program. Methods and Findings: We evaluated the cost drivers and overall unit cost of VMMC at a site providing surgical VMMC as a routine service ("routine surgery site'') and at a site that had added PrePex VMMC procedures to routine surgical VMMC as part of a research study ("mixed study site''). We examined the main cost drivers and modeled hypothetical scenarios with varying ratios of surgical to PrePex circumcisions, different levels of site utilization, and a range of device prices. The unit costs per VMMC for the routine surgery and mixed study sites were $ 56 and $ 61, respectively. The two greatest contributors to unit price at both sites were consumables and staff. In the hypothetical scenarios, the unit cost increased as site utilization decreased, as the ratio of PrePex to surgical VMMC increased, and as device price increased. Conclusions: VMMC unit costs for routine surgery and mixed study sites were similar. Low service utilization was projected to result in the greatest increases in unit price. Countries that wish to incorporate PrePex into their circumcision programs should plan to maximize staff utilization and ensure that sites function at maximum capacity to achieve the lowest unit cost. Further costing studies will be necessary once routine implementation of PrePex-based circumcision is established.	[Njeuhmeli, Emmanuel; Edgil, Dianna; Castor, Delivette] US Agcy Int Dev, Washington, DC 20523 USA; [Kripke, Katharine; Forsythe, Steven] Futures Inst, Hlth Policy Initiat, Washington, DC 20036 USA; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Reed, Jason] Off US Global AIDS Coordinator, Washington, DC USA; [Jaramillo, Juan] Partnership Supply Chain Management Syst, Arlington, VA USA; [Xaba, Sinokuthemba; Mugurungi, Owen] Zimbabwe Minist Hlth & Child Welf, Harare, Zimbabwe	United States Agency for International Development (USAID)	Kripke, K (corresponding author), Futures Inst, Hlth Policy Initiat, Washington, DC 20036 USA.	kkripke@futuresinstitute.org	Forsythe, Steven/AAL-7558-2020; Kripke, Katharine/J-2146-2019	Forsythe, Steven/0000-0002-4409-5991; Kripke, Katharine/0000-0001-8228-4577	PEPFAR (President's Emergency Plan for AIDS Relief) through the USAID | Health Policy Initiative Costing Task Order [GPO-I-00-05-00040-00]	PEPFAR (President's Emergency Plan for AIDS Relief) through the USAID | Health Policy Initiative Costing Task Order(United States Agency for International Development (USAID))	Funding support for this work was provided by PEPFAR (President's Emergency Plan for AIDS Relief) through the USAID | Health Policy Initiative Costing Task Order, contract number GPO-I-00-05-00040-00, beginning July 1, 2010. The Costing Task Order is implemented by Futures Group, in collaboration with the Futures Institute and the Centre for Development and Population Activities. The funder played a significant technical role in study design, analysis, decision to publish, and preparation of the manuscript. The views expressed in this manuscript do not represent the opinion of USAID or the U.S. Government.	[Anonymous], ZIMBABWE SUPPLY CHAI; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027562; Bertrand JT, 2012, SYSTEMATIC MONITORIN; Bitega JP, 2011, JAIDS-J ACQ IMM DEF, V58, pE127, DOI 10.1097/QAI.0b013e3182354e65; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; MORRIS BJ, 2011, BIOMEDICAL ENG THEOR; Mutabazi V, 2013, JAIDS-J ACQ IMM DEF, V63, P315, DOI 10.1097/QAI.0b013e31828e6412; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Obiero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053380; Reed JB, 2012, JAIDS-J ACQ IMM DEF, V60, pS88, DOI 10.1097/QAI.0b013e31825cac4e; UNAIDS, 2013, UNAIDS WORLD AIDS DA; Wamai RG, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-49; WHO, 2013, PROGR SCAL VOL MED M; World Health Organization, 2013, WHO PREQ MAL CIRC DE; World Health Organization Technical Advisory Group on Innovations in Male Circumcision, 2013, EV 2 AD DEV	19	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e82533	10.1371/journal.pone.0082533	http://dx.doi.org/10.1371/journal.pone.0082533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801515	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800004
J	Schlotz, W; Godfrey, KM; Phillips, DI				Schlotz, Wolff; Godfrey, Keith M.; Phillips, David I.			Prenatal Origins of Temperament: Fetal Growth, Brain Structure, and Inhibitory Control in Adolescence	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHRONIC PLACENTAL INSUFFICIENCY; DEFICIT HYPERACTIVITY DISORDER; EFFORTFUL CONTROL; BIRTH-WEIGHT; RESPONSE-INHIBITION; NEURAL BASIS; COGNITIVE CONTROL; DEVELOPMENTAL PSYCHOPATHOLOGY; EXTERNALIZING PROBLEMS	Objective: Individual differences in the temperamental dimension of effortful control are constitutionally based and have been associated with an adverse prenatal developmental environment, with structural brain alterations presenting a potential mechanism. We investigated this hypothesis for anatomically defined brain regions implicated in cognitive and inhibitory motor control. Methods: Twenty-seven 15-16 year old participants with low, medium, or high fetal growth were selected from a longitudinal birth cohort to maximize variation and represent the full normal spectrum of fetal growth. Outcome measures were parent ratings of attention and inhibitory control, thickness and surface area of the orbitofrontal cortex (lateral (LOFC) and medial (MOFC)) and right inferior frontal gyrus (rIFG), and volumetric measures of the striatum and amygdala. Results: Lower birth weight was associated with lower inhibitory control, smaller surface area of LOFC, MOFC and rIFG, lower caudate volume, and thicker MOFC. A mediation model found a significant indirect effect of birth weight on inhibitory control via caudate volume. Conclusions: Our findings support a neuroanatomical mechanism underlying potential long-term consequences of an adverse fetal developmental environment for behavioral inhibitory control in adolescence and have implications for understanding putative prenatal developmental origins of externalizing behavioral problems and self-control.	[Schlotz, Wolff] Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany; [Schlotz, Wolff; Godfrey, Keith M.; Phillips, David I.] MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Schlotz, Wolff] Univ Southampton, Fac Social & Human Sci, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Regensburg; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Schlotz, W (corresponding author), Univ Regensburg, Inst Psychol, D-93053 Regensburg, Germany.	wolff.schlotz@ur.de	Schlotz, Wolff/AAI-9549-2020	Schlotz, Wolff/0000-0003-2356-7766; Godfrey, Keith/0000-0002-4643-0618	Medical Research Council; Wellbeing of Women; German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG SCHL 1708/1-1]; National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; Wessex Medical Research; MRC [MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellbeing of Women(Wellbeing of Women (WoW)); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Institute for Health Research through the NIHR Southampton Biomedical Research Centre; Wessex Medical Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Medical Research Council and Wessex Medical Research. Subjects were drawn from a cohort study originally funded by Wellbeing of Women. WS was supported by German Research Foundation (Deutsche Forschungsgemeinschaft) fellowship grant DFG SCHL 1708/1-1. KMG is supported by the National Institute for Health Research through the NIHR Southampton Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Berglund SK, 2013, PEDIATRICS, V131, P47, DOI 10.1542/peds.2012-0989; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Boes AD, 2009, SOC COGN AFFECT NEUR, V4, P1, DOI 10.1093/scan/nsn035; Brown SM, 2006, EMOTION, V6, P239, DOI 10.1037/1528-3542.6.2.239; Buss C, 2012, P NATL ACAD SCI USA, V109, pE1312, DOI 10.1073/pnas.1201295109; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; Casey BJ, 1997, J AM ACAD CHILD PSY, V36, P374, DOI 10.1097/00004583-199703000-00016; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Cubillo A, 2012, CORTEX, V48, P194, DOI 10.1016/j.cortex.2011.04.007; De Bie HMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024116; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Durston S, 2004, J AM ACAD CHILD PSY, V43, P332, DOI 10.1097/00004583-200403000-00016; Durston S, 2002, DEVELOPMENTAL SCI, V5, pF9, DOI 10.1111/1467-7687.00235; Eisenberg N, 2004, CHILD DEV, V75, P25, DOI 10.1111/j.1467-8624.2004.00652.x; Eisenberg N, 2010, DEV PSYCHOL, V46, P1294, DOI 10.1037/a0020236; Ellis L. K., 2001, REVISION EARLY ADOLE; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fox SE, 2010, CHILD DEV, V81, P28, DOI 10.1111/j.1467-8624.2009.01380.x; Godfrey K, 2001, J BONE MINER RES, V16, P1694, DOI 10.1359/jbmr.2001.16.9.1694; Halmoy A, 2012, BIOL PSYCHIAT, V71, P474, DOI 10.1016/j.biopsych.2011.11.013; Haukvik UK, 2014, SCHIZOPHRENIA BULL, V40, P410, DOI 10.1093/schbul/sbt005; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hultman CM, 2007, J AM ACAD CHILD PSY, V46, P370, DOI 10.1097/01.chi.0000246059.62706.22; Jahfari S, 2011, J NEUROSCI, V31, P6891, DOI 10.1523/JNEUROSCI.5253-10.2011; Jahfari S, 2010, J COGNITIVE NEUROSCI, V22, P1479, DOI 10.1162/jocn.2009.21307; Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077; Lahti J, 2006, J CHILD PSYCHOL PSYC, V47, P1167, DOI 10.1111/j.1469-7610.2006.01661.x; Lengua LJ, 2008, DEV PSYCHOPATHOL, V20, P509, DOI 10.1017/S0954579408000254; Li CSR, 2008, NEUROIMAGE, V41, P1352, DOI 10.1016/j.neuroimage.2008.04.023; Li-Grining CP, 2007, DEV PSYCHOL, V43, P208, DOI 10.1037/0012-1649.43.1.208; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Lou HC, 1996, ACTA PAEDIATR, V85, P1266, DOI 10.1111/j.1651-2227.1996.tb13909.x; Makrides M, 2013, NESTLE NUTR WORKS SE, V74, P211, DOI 10.1159/000348775; Mallard EC, 1998, PEDIATR RES, V43, P262, DOI 10.1203/00006450-199802000-00018; Martel MM, 2012, PERS INDIV DIFFER, V53, P874, DOI 10.1016/j.paid.2012.07.011; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Matsuo K, 2009, HUM BRAIN MAPP, V30, P1188, DOI 10.1002/hbm.20588; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Muennig P, 2009, AM J PUBLIC HEALTH, V99, P1431, DOI 10.2105/AJPH.2008.148353; Nigg JT, 2006, J CHILD PSYCHOL PSYC, V47, P395, DOI 10.1111/j.1469-7610.2006.01612.x; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Olson SL, 2005, DEV PSYCHOPATHOL, V17, P25, DOI 10.1017/S0954579405050029; Ormel J, 2005, PSYCHOL MED, V35, P1825, DOI 10.1017/S0033291705005829; Paus T, 2013, HORM BEHAV, V64, P195, DOI 10.1016/j.yhbeh.2013.04.004; Phua DYL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036502; Qiu AQ, 2012, NEUROIMAGE, V59, P1065, DOI 10.1016/j.neuroimage.2011.09.032; Raikkonen K, 2012, BEST PRACT RES CL EN, V26, P599, DOI 10.1016/j.beem.2012.03.001; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rehn AE, 2004, NEUROSCIENCE, V129, P381, DOI 10.1016/j.neuroscience.2004.07.047; Rifkin-Graboi A, 2013, BIOL PSYCHIAT, V74, P837, DOI 10.1016/j.biopsych.2013.06.019; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; Rothbart MK, 2007, CHILD DEV PERSPECT, V1, P2, DOI 10.1111/j.1750-8606.2007.00002.x; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Schilling C, 2013, HUM BRAIN MAPP, V34, P374, DOI 10.1002/hbm.21446; Schlotz W, 2008, J CHILD PSYCHOL PSYC, V49, P1228, DOI 10.1111/j.1469-7610.2008.01946.x; Schlotz W, 2007, PEDIATRICS, V120, pE1237, DOI 10.1542/peds.2006-3277; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Walhovd KB, 2012, P NATL ACAD SCI USA, V109, P20089, DOI 10.1073/pnas.1208180109; Whittle S, 2008, J AM ACAD CHILD PSY, V47, P682, DOI 10.1097/CHI.0b013e31816bffca; Wiecki TV, 2013, PSYCHOL REV, V120, P329, DOI 10.1037/a0031542; Wiles NJ, 2006, AM J EPIDEMIOL, V163, P829, DOI 10.1093/aje/kwj108	72	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96715	10.1371/journal.pone.0096715	http://dx.doi.org/10.1371/journal.pone.0096715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802625	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000338029800113
J	Wuestenberg, A; Kah, J; Singethan, K; Sirma, H; Keller, AD; Rosal, SRP; Schrader, J; Loscher, C; Volz, T; Bartenschlager, R; Lohmann, V; Protzer, U; Dandri, M; Lohse, AW; Tiegs, G; Sass, G				Wuestenberg, Andrea; Kah, Janine; Singethan, Katrin; Sirma, Hueseyin; Keller, Amelie Dorothea; Rosal, Sergio Rene Perez; Schrader, Joerg; Loscher, Christine; Volz, Tassilo; Bartenschlager, Ralf; Lohmann, Volker; Protzer, Ulrike; Dandri, Maura; Lohse, Ansgar W.; Tiegs, Gisa; Sass, Gabriele			Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin	PLOS ONE			English	Article							COA REDUCTASE INHIBITORS; VIRUS-RNA REPLICATION; HEPATITIS-C; PEGYLATED INTERFERON; COMBINATION THERAPY; DRUG-INTERACTIONS; STATINS; MECHANISM; INFECTION; RIBAVIRIN	Background & Aims: HMG-CoA-reductase-inhibitors (statins) have been shown to interfere with HCV replication in vitro. We investigated the mechanism, requirements and contribution of heme oxygenase-1(HO-1)-induction by statins to interference with HCV replication. Methods: HO-1-induction by fluva-, simva-, rosuva-, atorva-or pravastatin was correlated to HCV replication, using noninfectious replicon systems as well as the infectious cell culture system. The mechanism of HO-1-induction by statins as well as its relevance for interference with HCV replication was investigated using transient or permanent knockdown cell lines. Polyacrylamide(PAA) gels of different density degrees or the Rho-kinase-inhibitor Hydroxyfasudil were used in order to mimic matrix conditions corresponding to normal versus fibrotic liver tissue. Results: All statins used, except pravastatin, decreased HCV replication and induced HO-1 expression, as well as interferon response in vitro. HO-1-induction was mediated by reduction of Bach1 expression and induction of the Nuclear factor (erythroid-derived 2)-like 2 (NRF2) cofactor Krueppel-like factor 2 (KLF2). Knockdown of KLF2 or HO-1 abrogated effects of statins on HCV replication. HO-1-induction and anti-viral effects of statins were more pronounced under cell culture conditions mimicking advanced stages of liver disease. Conclusions: Statin-mediated effects on HCV replication seem to require HO-1-induction, which is more pronounced in a microenvironment resembling fibrotic liver tissue. This implicates that certain statins might be especially useful to support HCV therapy of patients at advanced stages of liver disease.	[Wuestenberg, Andrea; Kah, Janine; Keller, Amelie Dorothea; Rosal, Sergio Rene Perez; Loscher, Christine; Tiegs, Gisa; Sass, Gabriele] Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany; [Singethan, Katrin; Protzer, Ulrike] Tech Univ Munich, Inst Virol, Helmholtz Zentrum Munich, D-80290 Munich, Germany; [Sirma, Hueseyin] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, Hamburg, Germany; [Keller, Amelie Dorothea; Schrader, Joerg; Volz, Tassilo; Dandri, Maura; Lohse, Ansgar W.] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Bartenschlager, Ralf; Lohmann, Volker] Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruprecht Karls University Heidelberg	Sass, G (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Expt Immunol & Hepatol, Hamburg, Germany.	g.sass@uke.de	Lohmann, Volker/H-4211-2019; Dandri, Maura/ABG-4773-2021; Protzer, Ulrike/D-5915-2015; Volz, Tassilo/U-1942-2019; Bartenschlager, Ralf/L-2582-2015	Lohmann, Volker/0000-0001-8719-7608; Dandri, Maura/0000-0002-0073-6689; Protzer, Ulrike/0000-0002-9421-1911; Volz, Tassilo/0000-0003-3120-8958; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft (DFG) [SA 1378/3-1]; Inflammation Regeneration [SFB 841, SFB/TRR77, SI 572/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Inflammation Regeneration	This work was supported by the Deutsche Forschungsgemeinschaft (DFG): grant SA 1378/3-1 to G. S. and M. D.; SFB 841 graduate school "Inflammation & Regeneration" to G. T., SFB/TRR77 (Project 1) to R. B. and V. L., by grant SI 572/3-1 to H. S. and by the Dr. Liselotte Brauns Forschungspreis 2012 to J. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet T, 2008, MICROBES INFECT, V10, P471, DOI 10.1016/j.micinf.2008.01.009; [Anonymous], 2011, INC TEL PACK INS; Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Binder M, 2007, J VIROL, V81, P5270, DOI 10.1128/JVI.00032-07; Blonski W, 2008, CLIN LIVER DIS, V12, P661, DOI 10.1016/j.cld.2008.03.007; Bruno S, 2010, HEPATOLOGY, V51, P388, DOI 10.1002/hep.23340; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Delang L, 2009, HEPATOLOGY, V50, P6, DOI 10.1002/hep.22916; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Fledderus JO, 2008, ARTERIOSCL THROM VAS, V28, P1339, DOI 10.1161/ATVBAHA.108.165811; Forde KA, 2009, WORLD J GASTROENTERO, V15, P5020, DOI 10.3748/wjg.15.5020; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Giguere JF, 2004, J VIROL, V78, P12062, DOI 10.1128/JVI.78.21.12062-12065.2004; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Gueler F, 2007, AM J PATHOL, V170, P1192, DOI 10.2353/ajpath.2007.060782; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Kah J, 2012, ONCOL REP, V28, P1077, DOI 10.3892/or.2012.1860; Kondo C, 2012, J VIRAL HEPATITIS, V19, P615, DOI 10.1111/j.1365-2893.2011.01584.x; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Liu Z, 2009, EUR J PHARM SCI, V38, P215, DOI 10.1016/j.ejps.2009.07.004; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Milazzo L, 2010, J ANTIMICROB CHEMOTH, V65, P735, DOI 10.1093/jac/dkq002; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neuvonen PJ, 2010, CURR OPIN INVEST DR, V11, P323; O'Leary JG, 2007, HEPATOLOGY, V45, P895, DOI 10.1002/hep.21554; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Ramachandran C, 2011, MOL VIS, V17, P1877; Rasmussen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052828; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Sezaki H, 2009, INTERVIROLOGY, V52, P43, DOI 10.1159/000213504; Shan Y, 2004, J BIOL CHEM, V279, P51769, DOI 10.1074/jbc.M409463200; Shan Y, 2007, GASTROENTEROLOGY, V133, P1166, DOI 10.1053/j.gastro.2007.08.002; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Tandra Sweta, 2009, Curr Treat Options Cardiovasc Med, V11, P272; Tang HL, 2009, CLIN SCI, V117, P49, DOI 10.1042/CS20080631; Williams D, 2002, CLIN PHARMACOKINET, V41, P343, DOI 10.2165/00003088-200241050-00003; Ye J, 2003, P NATL ACAD SCI USA, V100, P15865, DOI 10.1073/pnas.2237238100; Zhu ZW, 2010, HEPATOLOGY, V52, P1897, DOI 10.1002/hep.23921	44	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96533	10.1371/journal.pone.0096533	http://dx.doi.org/10.1371/journal.pone.0096533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801208	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800082
J	Zou, YM; Li, SX; Zou, WF; Hu, GM; Zhou, YY; Peng, GY; He, F; Li, B; Ran, PX				Zou, Yimin; Li, Shaoxing; Zou, Weifeng; Hu, Guoping; Zhou, Yumin; Peng, Gongyong; He, Fang; Li, Bing; Ran, Pixin			Upregulation of Gelatinases and Epithelial-Mesenchymal Transition in Small Airway Remodeling Associated with Chronic Exposure to Wood Smoke	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MATRIX METALLOPROTEINASES; CIGARETTE-SMOKE; RESPIRATORY-DISEASES; BASEMENT-MEMBRANE; AGE-CHILDREN; GUINEA-PIGS; COPD; EMPHYSEMA; WOODSMOKE	Background: Peribronchiolar fibrosis is an important feature of small airway remodeling (SAR) in cigarette smoke-induced COPD. The aim of this study was to investigate the role of gelatinases (MMP9, MMP2) and epithelial-mesenchymal transition (EMT) in SAR related to wood smoke (WS) exposure in a rat model. Methods: Forty-eight female Sprague-Dawley rats were randomly divided into the WS group, the cigarette smoke (CS) group and the clean air control group. After 4 to 7 months of smoke exposure, lung tissues were examined with morphometric measurements, immunohistochemistry and Western blotting. Serum MMP9 and TIMP1 concentrations were detected by ELISA. In vitro, primary rat tracheal epithelial cells were stimulated with wood smoke condensate for 7 days. Results: The COPD-like pathological alterations in rats exposed chronically to WS were similar to those exposed to CS; the area of collagen deposition was significantly increased in the small airway walls of those exposed to WS or CS for 7 months. The expression of gelatinases in rats induced by WS or CS exposure was markedly increased in whole lung tissue, and immunohistochemistry showed that MMP9, MMP2 and TIMP1 were primarily expressed in the airway epithelium. The serum levels of MMP9 and TIMP1 were significantly higher in rats secondary to WS or CS exposure. Few cells that double immunostained for E-cadherin and vimentin were observed in the airway subepithelium of rats exposed to WS for 7 months (only 3 of these 8 rats). In vitro, the expression of MMP9 and MMP2 proteins was upregulated in primary rat tracheal epithelial cells following exposure to wood smoke condensate for 7 days by Western blotting; positive immunofluorescent staining for vimentin and type I collagen was also observed. Conclusions: These findings suggest that the upregulation of gelatinases and EMT might play a role in SAR in COPD associated with chronic exposure to wood smoke.	[Zou, Yimin; Li, Shaoxing; Zhou, Yumin; Peng, Gongyong; Ran, Pixin] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zou, Weifeng] Guangzhou Med Univ, Guangzhou Chest Hosp, Guangzhou, Guangdong, Peoples R China; [Hu, Guoping] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [He, Fang; Li, Bing] Guangzhou Med Univ, Res Ctr Expt Med, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University; Guangzhou Medical University	Ran, PX (corresponding author), Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou Inst Resp Dis, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	pxran@vip.163.com	Peng, Gongyong/K-8470-2017		National Natural Science Foundation of China [81170043]; National Natural Science Foundation of Guangdong [S2011020002789]; Ministry of Education of China [2010442311 0001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (81170043), National Natural Science Foundation of Guangdong (S2011020002789), and Doctoral Fund of Ministry of Education of China (2010442311 0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beeh KM, 2003, RESP MED, V97, P634, DOI 10.1053/rmed.2003.1493; Bergeron C, 2007, EUR RESPIR J, V29, P596, DOI 10.1183/09031936.00019906; Borthwick LA, 2009, THORAX, V64, P770, DOI 10.1136/thx.2008.104133; Bracke KR, 2007, CLIN EXP ALLERGY, V37, P1467, DOI 10.1111/j.1365-2222.2007.02808.x; Brajer B, 2008, J PHYSIOL PHARMACOL, V59, P145; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Chen Y, 2008, RESPIROLOGY, V13, P1014, DOI 10.1111/j.1440-1843.2008.01365.x; Cho JY, 2004, AM J RESP CELL MOL, V30, P651, DOI 10.1165/rcmb.2003-0066OC; Daheshia M, 2005, CURR MED RES OPIN, V21, P587, DOI 10.1185/030079905X41417; Deng YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064375; Dix-Cooper L, 2012, NEUROTOXICOLOGY, V33, P246, DOI 10.1016/j.neuro.2011.09.004; Dolhnikoff M, 2009, J ALLERGY CLIN IMMUN, V123, P1090, DOI 10.1016/j.jaci.2009.02.032; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Hanaoka M, 2011, CHEST, V139, P1101, DOI 10.1378/chest.10-0920; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Lagente V, 2010, J MOL CELL CARDIOL, V48, P440, DOI 10.1016/j.yjmcc.2009.09.017; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; Mehra D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052889; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Mishra V, 2003, INT J EPIDEMIOL, V32, P847, DOI 10.1093/ije/dyg240; Montano M, 2004, CHEST, V125, P466, DOI 10.1378/chest.125.2.466; Naeher LP, 2007, INHAL TOXICOL, V19, P67, DOI 10.1080/08958370600985875; Ning W, 2007, AM J RESP CELL MOL, V36, P480, DOI 10.1165/rcmb.2006-0106OC; Oikonomidi S, 2009, CURR MED CHEM, V16, P1214, DOI 10.2174/092986709787846587; Perng DW, 2011, LIFE SCI, V89, P204, DOI 10.1016/j.lfs.2011.06.008; Ramos C, 2009, INHAL TOXICOL, V21, P119, DOI 10.1080/08958370802419145 ; Regalado J, 2006, AM J RESP CRIT CARE, V174, P901, DOI 10.1164/rccm.200503-479OC; Rivera RM, 2008, INT J TUBERC LUNG D, V12, P972; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Selman M, 2003, CHEST, V123, P1633, DOI 10.1378/chest.123.5.1633; Sethi JM, 2000, CLIN CHEST MED, V21, P67, DOI 10.1016/S0272-5231(05)70008-3; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Soltani A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-105; Sukhwinder S, 2011, RESP RES, V12; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; YL L, 2002, BIOCH SOC T, V30	39	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96708	10.1371/journal.pone.0096708	http://dx.doi.org/10.1371/journal.pone.0096708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802298	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800111
J	Huang, CC; Lee, WT; Tsai, ST; Ou, CY; Lo, HI; Wong, TY; Fang, SY; Chen, KC; Huang, JS; Wu, JL; Yen, CJ; Hsueh, WT; Wu, YH; Yang, MW; Lin, FC; Chang, JY; Chang, KY; Wu, SY; Hsiao, JR; Lin, CL; Wang, YH; Weng, YL; Yang, HC; Chang, JS				Huang, Cheng-Chih; Lee, Wei-Ting; Tsai, Sen-Tien; Ou, Chun-Yen; Lo, Hung-i; Wong, Tung-Yiu; Fang, Sheen-Yie; Chen, Ken-Chung; Huang, Jehn-Shyun; Wu, Jiunn-Liang; Yen, Chia-Jui; Hsueh, Wei-Ting; Wu, Yuan-Hua; Yang, Ming-Wei; Lin, Forn-Chia; Chang, Jang-Yang; Chang, Kwang-Yu; Wu, Shang-Yin; Hsiao, Jenn-Ren; Lin, Chen-Lin; Wang, Yi-Hui; Weng, Ya-Ling; Yang, Han-Chien; Chang, Jeffrey S.			Tea Consumption and Risk of Head and Neck Cancer	PLOS ONE			English	Article							UPPER-AERODIGESTIVE TRACT; ORAL-CANCER; ESOPHAGEAL CANCER; COFFEE; ALCOHOL; CAVITY; POLYPHENOLS; SMOKING; TOBACCO; LESIONS	Background: The current study evaluated the association between tea consumption and head and neck cancer (HNC) in Taiwan, where tea is a major agricultural product and a popular beverage. Methods: Interviews regarding tea consumption (frequency, duration, and types) were conducted with 396 HNC cases and 413 controls. Unconditional logistic regression was performed to estimate the odds ratio (OR) and 95% confidence interval (CI) of HNC risk associated with tea drinking, adjusted for sex, age, education, cigarette smoking, betel quid chewing, and alcohol drinking. Results: A reduced HNC risk associated with tea drinking (OR for every cup per day = 0.96, 95% CI: 0.93-0.99; OR for >= 5 cups per day = 0.60, 95% CI: 0.39-0.94) was observed. The association was especially significant for pharyngeal cancer (OR for every cup per day = 0.93, 95% CI: 0.88-0.98; OR for >= 5 cups per day = 0.32, 95% CI: 0.16-0.66). A significant inverse association between HNC and tea consumption was observed particularly for green tea. Conclusions: This study suggests that tea drinking may reduce the risk of HNC. The anticancer property of tea, if proven, may offer a natural chemopreventive measure to reduce the occurrence of HNC.	[Huang, Cheng-Chih; Lee, Wei-Ting; Tsai, Sen-Tien; Ou, Chun-Yen; Lo, Hung-i; Fang, Sheen-Yie; Wu, Jiunn-Liang; Hsiao, Jenn-Ren] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Tainan 70101, Taiwan; [Wong, Tung-Yiu; Chen, Ken-Chung; Huang, Jehn-Shyun] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Stomatol, Tainan 70101, Taiwan; [Yen, Chia-Jui; Chang, Jang-Yang; Chang, Kwang-Yu; Wu, Shang-Yin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med,Div Hematol Oncol, Tainan 70101, Taiwan; [Hsueh, Wei-Ting; Wu, Yuan-Hua; Yang, Ming-Wei; Lin, Forn-Chia] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Radiat Oncol, Tainan 70101, Taiwan; [Chang, Jang-Yang; Chang, Kwang-Yu; Wang, Yi-Hui; Weng, Ya-Ling; Yang, Han-Chien; Chang, Jeffrey S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Lin, Chen-Lin] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Nursing, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital	Chang, JS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.	jeffreychang@nhri.org.tw	Chang, Jang-Yang/D-2099-2010; Chang, Kwang-Yu/G-9161-2011; Chang, Jeffrey Shu-Ming/B-1092-2010; Chang, Jeffrey Shu-Ming/AAR-4161-2020	Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; WU, SHANG-YIN/0000-0003-2914-510X	National Health Research Institutes [CA-102-PP-07]; Establishment of Cancer Research System Excellence Program - Department of Health, Executive Yuan, Taiwan [DOH102-TD-C-111-003, DOH102-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Establishment of Cancer Research System Excellence Program - Department of Health, Executive Yuan, Taiwan	This work was funded by the National Health Research Institutes (CA-102-PP-07) and the Establishment of Cancer Research System Excellence Program funded by the Department of Health, Executive Yuan (DOH102-TD-C-111-003, DOH102-TD-C-111-004), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 2008, WORLD CANC REPORT; BUNDGAARD T, 1995, CANCER CAUSE CONTROL, V6, P57, DOI 10.1007/BF00051681; CHYOU PH, 1995, INT J CANCER, V60, P616, DOI 10.1002/ijc.2910600508; CUMMING RG, 1994, EPIDEMIOLOGY, V5, P116, DOI 10.1097/00001648-199401000-00017; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Ferlay J, 2010, IARC CANCERBASE, V10; FRANCESCHI S, 1992, CANCER, V70, P2227, DOI 10.1002/1097-0142(19921101)70:9&lt;2227::AID-CNCR2820700902&gt;3.0.CO;2-Z; FRANCO EL, 1989, INT J CANCER, V43, P992, DOI 10.1002/ijc.2910430607; Fu JY, 2013, ORAL ONCOL, V49, P918, DOI 10.1016/j.oraloncology.2013.05.002; Galeone C, 2010, CANCER EPIDEM BIOMAR, V19, P1723, DOI 10.1158/1055-9965.EPI-10-0191; Heck JE, 2008, CANCER CAUSE CONTROL, V19, P1329, DOI 10.1007/s10552-008-9204-z; Hildebrand JS, 2013, AM J EPIDEMIOL, V177, P50, DOI 10.1093/aje/kws222; Ide R, 2007, ANN EPIDEMIOL, V17, P821, DOI 10.1016/j.annepidem.2007.04.003; Islami F, 2009, INT J CANCER, V125, P491, DOI 10.1002/ijc.24445; Kapil Umesh, 2005, Asian Pac J Cancer Prev, V6, P202; Kim JW, 2010, CANCER PREV RES, V3, P900, DOI 10.1158/1940-6207.CAPR-09-0131; Lagiou P, 2009, INT J CANCER, V124, P2671, DOI 10.1002/ijc.24246; LAVECCHIA C, 1992, NUTR CANCER, V17, P27, DOI 10.1080/01635589209514170; Li N, 1999, P SOC EXP BIOL MED, V220, P218, DOI 10.1046/j.1525-1373.1999.d01-37.x; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; NOTANI P N, 1987, Nutrition and Cancer, V10, P103; PINTOS J, 1994, EPIDEMIOLOGY, V5, P583, DOI 10.1097/00001648-199411000-00005; Radoi L, 2013, CANCER EPIDEMIOL, V37, P284, DOI 10.1016/j.canep.2013.02.001; Ren JS, 2010, EUR J CANCER, V46, P1873, DOI 10.1016/j.ejca.2010.03.025; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Tavani A, 2003, ORAL ONCOL, V39, P695, DOI 10.1016/S1368-8375(03)00081-2; Thakur VS, 2012, CURR PHARM BIOTECHNO, V13, P191; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002; ZATONSKI W, 1991, CANCER CAUSE CONTROL, V2, P3, DOI 10.1007/BF00052355; ZHENG TZ, 1993, ORAL ONCOL, V29B, P45, DOI 10.1016/0964-1955(93)90010-C	34	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96507	10.1371/journal.pone.0096507	http://dx.doi.org/10.1371/journal.pone.0096507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796481	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000083
J	Campion, CG; Labrie, M; Grosset, AA; St-Pierre, Y				Campion, Carole G.; Labrie, Marilyne; Grosset, Andree-Anne; St-Pierre, Yves			The CCAAT/Enhancer-Binding Protein Beta-2 Isoform (CEBP beta-2) Upregulates Galectin-7 Expression in Human Breast Cancer Cells	PLOS ONE			English	Article							C/EBP-BETA; RETINOIC ACID; MAMMARY-GLAND; TRANSCRIPTION FACTOR; ANIMAL LECTINS; DIFFERENTIATION; OVEREXPRESSION; PROLIFERATION; PROGRESSION; TUMORS	Galectin-7 is considered a gene under the control of p53. However, elevated expression of galectin-7 has been reported in several forms of cancer harboring an inactive p53 pathway. This is especially true for breast cancer where galectin-7 expression is readily expressed in a high proportion in basal-like breast cancer tissues, conferring cancer cells with increased resistance to cell death and metastatic properties. These observations suggest that other transcription factors are capable of inducing galectin-7 expression. In the present work, we have examined the role of CCAAT/enhancer-binding protein beta (C/EBP beta) in inducing expression of galectin-7. C/EBP proteins have been shown to contribute to breast cancer by upregulating pro-metastatic genes. We paid particular attention to C/EBP beta-2 (also known as LAP2), the most transcriptionally active of the C/EBP beta isoforms. Our results showed that ectopic expression of C/EBP beta-2 in human breast cancer cells was sufficient to induce expression of galectin-7 at both the mRNA and protein levels. In silico analysis further revealed the presence of an established CEBP element in the galectin-7 promoter. Mutation of this binding site abolished the transcriptional activity of the galectin-7 promoter. Chromatin immunoprecipitation analysis confirmed that C/EBP beta-2 binds to the endogenous galectin-7 promoter. Analysis of galectin-7 protein expression in normal epithelia and in breast carcinoma by immunohistochemistry further showed the expression pattern of C/EBP beta closely micmicked that of galectin-7, most notably in mammary myoepithelial cells and basal-like breast cancer where galectin-7 is preferentially expressed. Taken together, our findings suggest that C/EBP beta is an important mediator of galectin-7 gene activation in breast cancer cells and highlight the different transcriptional mechanisms controlling galectin-7 in cancer cells.	[Campion, Carole G.; Labrie, Marilyne; Grosset, Andree-Anne; St-Pierre, Yves] Inst Armand Frappier, INRS, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	St-Pierre, Y (corresponding author), Inst Armand Frappier, INRS, Laval, PQ, Canada.	yves.st-pierre@iaf.inrs.ca		St-Pierre, Yves/0000-0002-1948-2041; Labrie, Marilyne/0000-0003-3957-5533	Canadian Institutes for Health Research [MOP-89697]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes for Health Research (Grant No. MOP-89697). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bernerd F, 1999, P NATL ACAD SCI USA, V96, P11329, DOI 10.1073/pnas.96.20.11329; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Campion CG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072468; Chen J, 2004, PROTEOMICS, V4, P2465, DOI 10.1002/pmic.200300762; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Demers M, 2007, CANCER RES, V67, P2824, DOI 10.1158/0008-5472.CAN-06-3891; Demers M, 2010, AM J PATHOL, V176, P3023, DOI 10.2353/ajpath.2010.090876; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; Gruvberger S, 2001, CANCER RES, V61, P5979; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; Lu JX, 1997, MOL CARCINOGEN, V20, P204, DOI 10.1002/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Magnaldo T, 1998, DIFFERENTIATION, V63, P159, DOI 10.1046/j.1432-0436.1998.6330159.x; MAGNALDO T, 1995, DEV BIOL, V168, P259, DOI 10.1006/dbio.1995.1078; Matsui Y, 2007, CANCER RES, V67, P1212, DOI 10.1158/0008-5472.CAN-06-3283; Milde-Langosch K, 2003, BREAST CANCER RES TR, V79, P175, DOI 10.1023/A:1023929504884; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mourskaia AA, 2009, ONCOGENE, V28, P1005, DOI 10.1038/onc.2008.454; Pal R, 2009, BLOOD, V114, P3890, DOI 10.1182/blood-2009-01-201111; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Rorive S, 2002, MODERN PATHOL, V15, P1294, DOI 10.1097/01.MP.0000037306.19083.28; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Seagroves TN, 2000, MOL ENDOCRINOL, V14, P359, DOI 10.1210/me.14.3.359; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887; Zahnow CA, 2001, CANCER RES, V61, P261; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033; Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299; Zhu SY, 1999, MOL CELL BIOL, V19, P7181; Zhu X, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-290	38	11	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95087	10.1371/journal.pone.0095087	http://dx.doi.org/10.1371/journal.pone.0095087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789216	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000336655700025
J	Govindarajan, KA; Freeman, L; Cai, CY; Rahbar, MH; Narayana, PA				Govindarajan, Koushik A.; Freeman, Leorah; Cai, Chunyan; Rahbar, Mohammad H.; Narayana, Ponnada A.			Effect of Intrinsic and Extrinsic Factors on Global and Regional Cortical Thickness	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; MRI; SCHIZOPHRENIA; RELIABILITY; CONSISTENCY; SYSTEM; ADULTS; BRAIN; AGE	Global and regional cortical thicknesses based on T1-weighted magnetic resonance images acquired at 1.5 T and 3 T were measured on a relatively large cohort of 295 subjects using FreeSurfer software. Multivariate regression analysis was performed using Pillai's trace test to determine significant differences in cortical thicknesses measured at these two field strengths. Our results indicate that global cortical thickness is not affected by the field strength or gender. In contrast, the regional cortical thickness was observed to be field dependent. Specifically, the cortical thickness in regions such as parahippocampal, superior temporal, precentral and posterior cingulate is thicker at 3 T than at 1.5 T. In contrast regions such as cuneus and pericalcarine showed higher cortical thickness at 1.5 T than at 3 T. These differences appear to be age-dependent. The differences in regional cortical thickness between field strengths were similar in both genders. Further, male vs. female differences in regional cortical thickness were observed only at 1.5 T and not at 3 T. Our results indicate that magnetic field strength has a significant effect on the estimation of regional, but not global, cortical thickness. In addition, the pulse sequence, scanner type, and spatial resolution do not appear to have significant effect on the measured cortical thickness.	[Govindarajan, Koushik A.; Freeman, Leorah; Narayana, Ponnada A.] Univ Texas Houston, Hlth Sci Ctr, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Cai, Chunyan; Rahbar, Mohammad H.] Univ Texas Houston, Hlth Sci Ctr, Dept Internal Med, Med Sch Houston, Houston, TX 77225 USA; [Rahbar, Mohammad H.] Univ Texas Houston, Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Narayana, PA (corresponding author), Univ Texas Houston, Hlth Sci Ctr, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA.	ponnada.a.narayana@uth.tmc.edu	Govindarajan, Koushik Athreya/L-9758-2019; Kong, A/C-8661-2015	Govindarajan, Koushik/0000-0001-8397-1360	NIH [R01NS078244, S10 RR19186, UL1 TR000371]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH R01NS078244, S10 RR19186, and UL1 TR000371. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAITENBERG V, 1962, J COMP NEUROL, V118, P141, DOI 10.1002/cne.901180202; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Glasser M.F., 2013, NEUROIMAGE; Glasser MF, 2013, NEUROIMAGE, DOI DOI 10.1016/J.NEURO-IMAGE.2013.03.060; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Im K, 2008, CEREB CORTEX, V18, P2181, DOI 10.1093/cercor/bhm244; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Lemaitre H, 2012, NEUROBIOL AGING, V33, pe1; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Lv B, 2010, NEUROIMAGE, V53, P373, DOI 10.1016/j.neuroimage.2010.05.020; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Narayana PA, 2013, NEUROIMAGE-CLIN, V2, P120, DOI 10.1016/j.nicl.2012.11.009; Narr KL, 2001, AM J PSYCHIAT, V158, P244, DOI 10.1176/appi.ajp.158.2.244; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; Olson CL, 1974, J AM STAT ASS, V69, P894; Pfefferbaum A, 2012, NEUROIMAGE, V60, P940, DOI 10.1016/j.neuroimage.2012.01.092; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; Wonderlick JS, 2009, NEUROIMAGE, V44, P1324, DOI 10.1016/j.neuroimage.2008.10.037	31	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96429	10.1371/journal.pone.0096429	http://dx.doi.org/10.1371/journal.pone.0096429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789100	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700091
J	He, F; Zhang, M; Wang, XY; Wu, HC; Shang, XP; Li, FD; Wu, C; Lin, JF; Zhu, BP				He, Fan; Zhang, Meng; Wang, Xinyi; Wu, Haocheng; Shang, Xiaopeng; Li, Fudong; Wu, Chen; Lin, Junfen; Zhu, Bao-Ping			Distinct Risk Profiles for Human Infections with the Influenza A(H7N9) Virus among Rural and Urban Residents: Zhejiang Province, China, 2013	PLOS ONE			English	Article							A H7N9 VIRUS; AVIAN INFLUENZA	Objective: To identify the risk factors and source of infection leading to human infections with the Influenza A(H7N9) virus in urban and rural areas. Methods: We conducted a case-control investigation to identify potential exposures and risk factors. Controls were randomly selected from the same community as the cases using random digit dialing. We used exact conditional logistic regression to evaluate the exposures and risk factors, stratified by urban and rural residence. Results: Buying live or freshly slaughtered poultry from a market was significantly associated with illness onset among both urban [48% of 25 case-patients and 12% of 125 control-persons, adjusted odds ratio (AOR) = 19, 95% CI: 2.3-929] and rural (33% of 18 case-patients and 8.9% of 90 control-persons, AOR = 13, 95% CI: 1.5-infinity) residents. In rural area, tending to home-raised poultry (56% of 18 case-patients and 10% of 90 control-persons, AOR = 57, 95% CI: 7.5-infinity) and existence of a poultry farm in the vicinity of the residence (28% of 18 case-patients and 5.6% of 90 control-persons, AOR = 37, 95% CI: 3.8-infinity) were also significantly associated with disease onset. Presence of underlying medical conditions was a significant risk factor for urban residents (76% of 25 case-patients and 13% of 125 control-persons, AOR = 49, 95% CI: 7.1-2132). Conclusions: Buying live or freshly slaughtered poultry from a market is a risk factor for both urban and rural residents, tending to home-raised poultry and existence of a poultry farm in the vicinity of the residence are risk factors unique for rural residents. The virus might have been in stealth circulation in the poultry population before infecting humans. We recommend strict poultry market management and multisectoral collaboration to identify the extent of poultry infection in China.	[He, Fan; Wang, Xinyi; Wu, Haocheng; Shang, Xiaopeng; Li, Fudong; Wu, Chen; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhang, Meng; Zhu, Bao-Ping] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China; [Zhang, Meng] Dongguan Municipal Ctr Dis Control & Prevent, Dongguan, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention	Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	zjlinjunfen@163.com	Wang, Xinyi/AAE-4342-2019	Zhu, Baoping/0000-0003-0065-0153	Program for Zhejiang Leading Team of Science and Technology Innovation [2011R50021]	Program for Zhejiang Leading Team of Science and Technology Innovation	This study was supported by the Program for Zhejiang Leading Team of Science and Technology Innovation (2011R50021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2013, EURO SURVEILL, V18; [Anonymous], 2013, KANKA NEWS; Bao CJ, 2013, NEW ENGL J MED, V368, P2337, DOI 10.1056/NEJMc1306100; Chen EF, 2013, FRONT MED-PRC, V7, P333, DOI 10.1007/s11684-013-0275-1; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cowling BJ, 2013, LANCET, V382, P129, DOI 10.1016/S0140-6736(13)61171-X; Cox DR., 1970, ANAL BINARY DATA; European Centre for Disease Prevention and Control, 2013, SEV RESP DIS ASS NOV; Fang LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002268; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guan Y, 2013, J INFECT DEV COUNTR, V7, P302, DOI 10.3855/jidc.3675; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Kung NY, 2003, AVIAN DIS, V47, P1037, DOI 10.1637/0005-2086-47.s3.1037; Levy P, 1999, SAMPLING POPULATIONS; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Lu Lu, 2013, Biomed J, V36, P96, DOI 10.4103/2319-4170.113224; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; National Health and Family Planning Commission of the People's Republic of China, 2013, DIAGN TREATM PROT HU; National Health and Family Planning Commission of the People's Republic of China, 2013, BRIEF HUM INF AV INF; Rivers Caitlin, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.264e737b489bef383fbcbaba60daf928; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Tharakaraman K, 2013, CELL, V153, P1486, DOI 10.1016/j.cell.2013.05.034; WHO, 2013, HUM INF AV INFL A H7; Yang SG, 2014, J INFECT DIS, V209, P265, DOI 10.1093/infdis/jit430; Zhang C, 2013, EURO SURVEILL, V18; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379	27	11	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95015	10.1371/journal.pone.0095015	http://dx.doi.org/10.1371/journal.pone.0095015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789082	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700024
J	Floyd, DH; Zhang, Y; Dey, BK; Kefas, B; Breit, H; Marks, K; Dutta, A; Herold-Mende, C; Synowitz, M; Glass, R; Abounader, R; Purow, BW				Floyd, Desiree Hunt; Zhang, Ying; Dey, Bijan K.; Kefas, Benjamin; Breit, Hannah; Marks, Kaitlyn; Dutta, Anindya; Herold-Mende, Christel; Synowitz, Michael; Glass, Rainer; Abounader, Roger; Purow, Benjamin W.			Novel Anti-Apoptotic MicroRNAs 582-5p and 363 Promote Human Glioblastoma Stem Cell Survival via Direct Inhibition of Caspase 3, Caspase 9, and Bim	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; PRECURSOR CELLS; IN-VITRO; CANCER; GLIOMA; DIFFERENTIATION; INDUCE; TUMORS; MIR-21	Glioblastoma is the most common and lethal primary brain tumor. Tumor initiation and recurrence are likely caused by a sub-population of glioblastoma stem cells, which may derive from mutated neural stem and precursor cells. Since CD133 is a stem cell marker for both normal brain and glioblastoma, and to better understand glioblastoma formation and recurrence, we looked for dys-regulated microRNAs in human CD133+ glioblastoma stem cells as opposed to CD133+ neural stem cells isolated from normal human brain. Using FACS sorting of low-passage cell samples followed by microRNA microarray analysis, we found 43 microRNAs that were dys-regulated in common in three separate CD133+ human glioblastomas compared to CD133+ normal neural stem cells. Among these were several microRNAs not previously associated with cancer. We then verified the microRNAs dys-regulated in glioblastoma using quantitative real time PCR and Taqman analysis of the original samples, as well as human GBM stem cell and established cell lines and many human specimens. We show that two candidate oncogenic microRNAs, miR-363 and miR-582-5p, can positively influence glioblastoma survival, as shown by forced expression of the microRNAs and their inhibitors followed by cell number assay, Caspase 3/7 assay, Annexin V apoptosis/fluorescence activated cell sorting, siRNA rescue of microRNA inhibitor treatment, as well as 3 ' UTR mutagenesis to show luciferase reporter rescue of the most successful targets. miR-582-5p and miR-363 are shown to directly target Caspase 3, Caspase 9, and Bim.	[Floyd, Desiree Hunt; Zhang, Ying; Dey, Bijan K.; Kefas, Benjamin; Breit, Hannah; Marks, Kaitlyn; Dutta, Anindya; Abounader, Roger; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Charlottesville, VA 22903 USA; [Floyd, Desiree Hunt; Zhang, Ying; Dey, Bijan K.; Kefas, Benjamin; Breit, Hannah; Marks, Kaitlyn; Dutta, Anindya; Abounader, Roger; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA USA; [Floyd, Desiree Hunt; Zhang, Ying; Dey, Bijan K.; Kefas, Benjamin; Breit, Hannah; Marks, Kaitlyn; Dutta, Anindya; Abounader, Roger; Purow, Benjamin W.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Div Neurosurg Res, Heidelberg, Germany; [Synowitz, Michael] Charite Univ Clin, Clin Neurosurg, Berlin, Germany; [Glass, Rainer] Univ Clin Munich, Munich, Germany	University of Virginia; University of Virginia; University of Virginia; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Abounader, R (corresponding author), Univ Virginia Hlth Syst, Dept Neurol, Div Neurooncol, Charlottesville, VA 22903 USA.	ra6u@virginia.edu	Glass, Rainer/GMW-7952-2022; Dutta, Anindya/P-3203-2016; Synowitz, Michael/G-2596-2012	Dey, Bijan/0000-0001-9386-2475; Dutta, Anindya/0000-0002-4319-0073	NIH [R01 CA136803, R01 NS045209]; NATIONAL CANCER INSTITUTE [R01CA136803, P01CA104106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by two NIH R01s, National Institutes of Health R01 CA136803 (B. Purow) and RO1 NS045209 (R. Abounader). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelastro JM, 2010, MOL CANCER RES, V8, P1105, DOI 10.1158/1541-7786.MCR-09-0383; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Brest P, 2011, ENDOCR-RELAT CANCER, V18, P711, DOI 10.1530/ERC-10-0257; Camidge DR, 2008, EXPERT OPIN BIOL TH, V8, P1167, DOI 10.1517/14712598.8.8.1167 ; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Catania A, 2012, INT J ONCOL, V40, P605, DOI 10.3892/ijo.2011.1305; [CBTRUS C.B.T.R.o.t.U. States], 2010, CBTRUS STAT REP PRIM; Chirasani SR, 2010, BRAIN, V133, P1961, DOI 10.1093/brain/awq128; Christensen K, 2010, J NEUROONCOL; Dirks PB, 2008, PHILOS T R SOC B, V363, P139, DOI 10.1098/rstb.2006.2017; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Ernst A, 2010, ONCOGENE, V29, P3411, DOI 10.1038/onc.2010.83; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Godlewski J, 2010, CELL DEATH DIFFER, V17, P221, DOI 10.1038/cdd.2009.71; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; Hao YB, 2011, CANCER PREV RES, V4, P1073, DOI 10.1158/1940-6207.CAPR-10-0333; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Henriett B, 2011, PITUITARY, V14, P112, DOI 10.1007/s11102-010-0268-x; Huang N, 2012, FEBS LETT, V586, P884, DOI 10.1016/j.febslet.2012.02.017; Hughes P, 2006, CURR DIRECT AUTOIMMU, V9, P74; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Katakowski M, 2010, CANCER INVEST, V28, P1024, DOI 10.3109/07357907.2010.512596; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kefas B, 2010, NEURO-ONCOLOGY, V12, P1102, DOI 10.1093/neuonc/noq080; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Kumar P, 2013, MOL CELL BIOL, V33, P1782; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Lang MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036248; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Misawa A, 2010, ONCOL RES, V19, P23, DOI 10.3727/096504010X12828372551759; Moore LM, 2010, EXPERT OPIN THER TAR, V14, P1247, DOI 10.1517/14728222.2010.527334; Park KJ, 2007, CANCER RES, V67, P7327, DOI 10.1158/0008-5472.CAN-06-4766; Purow B, 2011, J NEURO-ONCOL, V103, P429, DOI 10.1007/s11060-010-0449-5; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Quinones-Hinojosa A, 2007, EXP NEUROL, V205, P313, DOI 10.1016/j.expneurol.2007.03.016; Ren Y, 2010, J BIOMAT SCI-POLYM E, V21, P303, DOI 10.1163/156856209X415828; Sabbagh L, 2004, J IMMUNOL, V173, P5425, DOI 10.4049/jimmunol.173.9.5425; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Shi L, 2010, BRAIN RES, V1352, P255, DOI 10.1016/j.brainres.2010.07.009; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh S, 2007, NEUROSURG CLIN N AM, V18, P31, DOI 10.1016/j.nec.2006.10.014; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weeraratne SD, 2011, NEURO-ONCOLOGY, V13, P165, DOI 10.1093/neuonc/noq179; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Yan XW, 2011, P NATL ACAD SCI USA, V108, P1591, DOI 10.1073/pnas.1018696108; Zeuner A, 2003, BLOOD, V102, P87, DOI 10.1182/blood-2002-08-2369; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang JX, 2010, INT J ONCOL, V36, P913, DOI 10.3892/ijo_00000570; Zhou XA, 2010, ONCOL REP, V24, P195, DOI 10.3892/or_00000846; Zhu QY, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.96	77	82	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96239	10.1371/journal.pone.0096239	http://dx.doi.org/10.1371/journal.pone.0096239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805821	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900040
J	Stech, M; Quast, RB; Sachse, R; Schulze, C; Kubick, DAWS				Stech, Marlitt; Quast, Robert B.; Sachse, Rita; Schulze, Corina; Kubick, Doreen A. Wuestenhagen Stefan			A Continuous-Exchange Cell-Free Protein Synthesis System Based on Extracts from Cultured Insect Cells	PLOS ONE			English	Article							IN-VIVO EXPRESSION; TRANSLATION INITIATION; PLASMINOGEN-ACTIVATOR; MEMBRANE-PROTEINS; DISULFIDE BONDS; CLEAVAGE; IDENTIFICATION; TRANSLOCATION; INHIBITOR; FRAGMENTS	In this study, we present a novel technique for the synthesis of complex prokaryotic and eukaryotic proteins by using a continuous-exchange cell-free (CECF) protein synthesis system based on extracts from cultured insect cells. Our approach consists of two basic elements: First, protein synthesis is performed in insect cell lysates which harbor endogenous microsomal vesicles, enabling a translocation of de novo synthesized target proteins into the lumen of the insect vesicles or, in the case of membrane proteins, their embedding into a natural membrane scaffold. Second, cell-free reactions are performed in a two chamber dialysis device for 48 h. The combination of the eukaryotic cell-free translation system based on insect cell extracts and the CECF translation system results in significantly prolonged reaction life times and increased protein yields compared to conventional batch reactions. In this context, we demonstrate the synthesis of various representative model proteins, among them cytosolic proteins, pharmacological relevant membrane proteins and glycosylated proteins in an endotoxin-free environment. Furthermore, the cell-free system used in this study is well-suited for the synthesis of biologically active tissue-type-plasminogen activator, a complex eukaryotic protein harboring multiple disulfide bonds.	[Stech, Marlitt; Quast, Robert B.; Sachse, Rita] Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam Golm, Potsdam, Germany; [Schulze, Corina] Univ Appl Sci Berlin, Beuth Hsch Tech Berlin, Berlin, Germany	Fraunhofer Gesellschaft; Berliner Hochschule fur Technik; Technical University of Berlin		stefan.kubick@ibmt.fraunhofer.de		Quast, Robert Benjamin/0000-0001-8166-6952	German Ministry of Education and Research (BMBF) [0315942, 0312039]	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research is supported by the German Ministry of Education and Research (BMBF, No. 0315942 and No. 0312039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2005, J BIOSCI BIOENG, V99, P181, DOI 10.1263/jbb.99.181; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Avenaud P, 2004, BIOCHEM BIOPH RES CO, V318, P739, DOI 10.1016/j.bbrc.2004.04.089; BARANOV VI, 1989, GENE, V84, P463, DOI 10.1016/0378-1119(89)90521-0; Bechlars S, 2013, TOXICON, V76, P132, DOI 10.1016/j.toxicon.2013.09.012; Brodel AK, 2013, J BIOTECHNOL, V163, P301, DOI 10.1016/j.jbiotec.2012.11.001; Brodel AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082234; Brodel AK, 2014, BIOTECHNOL BIOENG, V111, P25, DOI 10.1002/bit.25013; BULLEID NJ, 1992, BIOCHEM J, V286, P275, DOI 10.1042/bj2860275; Bushell M, 2000, CELL DEATH DIFFER, V7, P628, DOI 10.1038/sj.cdd.4400699; Bushell M, 2000, EUR J BIOCHEM, V267, P1083, DOI 10.1046/j.1432-1327.2000.01101.x; Chen RH, 2009, PROTEIN EXPRES PURIF, V64, P76, DOI 10.1016/j.pep.2008.10.006; Collen D, 2009, ARTERIOSCL THROM VAS, V29, P1151, DOI 10.1161/ATVBAHA.108.179655; DARBY NJ, 1995, J MOL BIOL, V249, P463, DOI 10.1006/jmbi.1995.0309; Ezure T, 2007, PROTEOMICS, V7, P4424, DOI 10.1002/pmic.200700774; Fenz SF, 2014, BBA-BIOMEMBRANES, V1838, P1382, DOI 10.1016/j.bbamem.2013.12.009; GETHING MJ, 1988, EMBO J, V7, P2731, DOI 10.1002/j.1460-2075.1988.tb03127.x; Gourdon P, 2008, PROTEIN EXPRES PURIF, V58, P103, DOI 10.1016/j.pep.2007.10.017; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Groll U.vonKubickS., 2007, CELL FREE PROTEIN EX, P37; Haberstock S, 2012, PROTEIN EXPRES PURIF, V82, P308, DOI 10.1016/j.pep.2012.01.018; Jiang XP, 2002, FEBS LETT, V514, P290, DOI 10.1016/S0014-5793(02)02383-9; Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Kawasaki T, 2003, EUR J BIOCHEM, V270, P4780, DOI 10.1046/j.1432-1033.2003.03880.x; Kierzek AM, 2001, J BIOL CHEM, V276, P8165, DOI 10.1074/jbc.M006264200; Kim DM, 1999, BIOTECHNOL BIOENG, V66, P180, DOI 10.1002/(SICI)1097-0290(1999)66:3<180::AID-BIT6>3.0.CO;2-S; Kim DM, 1996, BIOTECHNOL PROGR, V12, P645, DOI 10.1021/bp960052l; Kim DY, 2013, BIOTECHNOL PROGR, V29, P165, DOI 10.1002/btpr.1658; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Kubick S, 2003, CELL-FREE PROTEIN EXPRESSION, P209; Kubick S, 2009, CURR TOP MEMBR, V63, P25, DOI 10.1016/S1063-5823(09)63002-7; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; LIN AA, 1993, BIOTECHNOL BIOENG, V42, P339, DOI 10.1002/bit.260420311; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Marissen WE, 2000, J BIOL CHEM, V275, P9314, DOI 10.1074/jbc.275.13.9314; Marissen WE, 1998, MOL CELL BIOL, V18, P7565, DOI 10.1128/MCB.18.12.7565; Merk H, 2012, BIOTECHNIQUES, V53, P153, DOI 10.2144/0000113904; Miot M, 2011, NEW BIOTECHNOL, V28, P277, DOI 10.1016/j.nbt.2010.06.012; Naftzger C, 1996, P NATL ACAD SCI USA, V93, P14809, DOI 10.1073/pnas.93.25.14809; Oh IS, 2006, BIOTECHNOL PROGR, V22, P1225, DOI 10.1021/bp060051l; Oh IS, 2010, BIOPROC BIOSYST ENG, V33, P127, DOI 10.1007/s00449-009-0372-3; Orth JHC, 2011, TOXICON, V57, P199, DOI 10.1016/j.toxicon.2010.11.011; Park CG, 2009, BIOTECHNOL PROGR, V25, P589, DOI 10.1002/btpr.109; Qin M, 2006, BIOPHYS J, V90, P272, DOI 10.1529/biophysj.105.063552; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Ramya R, 2011, CLIN VACCINE IMMUNOL, V18, P1673, DOI 10.1128/CVI.05258-11; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; ROTHBLATT JA, 1986, CELL, V44, P619, DOI 10.1016/0092-8674(86)90271-0; Rouf SA, 1996, BIOTECHNOL ADV, V14, P239, DOI 10.1016/0734-9750(96)00019-5; Sachse R, 2012, ENG LIFE SCI, V12, P1; Sachse R, 2013, ENG LIFE SCI, V13, P39, DOI 10.1002/elsc.201100235; Satoh S, 1999, BIOCHEM J, V342, P65, DOI 10.1042/0264-6021:3420065; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schwarz D, 2007, METHODS, V41, P355, DOI 10.1016/j.ymeth.2006.07.001; Shaklee PM, 2010, CHEMBIOCHEM, V11, P175, DOI 10.1002/cbic.200900669; Sixt BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029565; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Stech M, 2013, ADV BIOCHEM ENG BIOT, V137, P67, DOI 10.1007/10_2013_185; Stech M, 2013, J BIOTECHNOL, V164, P220, DOI 10.1016/j.jbiotec.2012.08.020; Suzuki T, 2007, PROTEOMICS, V7, P1942, DOI 10.1002/pmic.200700237; Suzuki T, 2006, PROTEOMICS, V6, P4486, DOI 10.1002/pmic.200600126; Takai K, 2010, NAT PROTOC, V5, P227, DOI 10.1038/nprot.2009.207; Tarui H, 2001, APPL MICROBIOL BIOT, V55, P446, DOI 10.1007/s002530000534; Tseng YK, 2008, ARCH INSECT BIOCHEM, V68, P206, DOI 10.1002/arch.20242; Van Noorden CJF, 2001, ACTA HISTOCHEM, V103, P241, DOI 10.1078/0065-1281-00601; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Yin G, 2004, BIOTECHNOL BIOENG, V86, P188, DOI 10.1002/bit.10827	73	39	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96635	10.1371/journal.pone.0096635	http://dx.doi.org/10.1371/journal.pone.0096635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804975	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900075
J	Bertrand, JT; Rech, D; Aduda, DO; Frade, S; Loolpapit, M; Machaku, MD; Oyango, M; Mavhu, W; Spyrelis, A; Perry, L; Farrell, M; Castor, D; Njeuhmeli, E				Bertrand, Jane T.; Rech, Dino; Aduda, Dickens Omondi; Frade, Sasha; Loolpapit, Mores; Machaku, Michael D.; Oyango, Mathews; Mavhu, Webster; Spyrelis, Alexandra; Perry, Linnea; Farrell, Margaret; Castor, Delivette; Njeuhmeli, Emmanuel			Systematic Monitoring of Voluntary Medical Male Circumcision Scale-Up: Adoption of Efficiency Elements in Kenya, South Africa, Tanzania, and Zimbabwe	PLOS ONE			English	Article							HIV PREVENTION; UGANDA; MEN	Background: SYMMACS, the Systematic Monitoring of the Voluntary Medical Male Circumcision Scale-up, tracked the implementation and adoption of six elements of surgical efficiency-use of multiple surgical beds, pre-bundled kits, task shifting, task sharing, forceps-guided surgical method, and electrocautery-as standards of surgical efficiency in Kenya, South Africa, Tanzania, and Zimbabwe. Methods and Findings: This multi-country study used two-staged sampling. The first stage sampled VMMC sites: 73 in 2011, 122 in 2012. The second stage involved sampling providers (358 in 2011, 591 in 2012) and VMMC procedures for observation (594 in 2011, 1034 in 2012). The number of VMMC sites increased significantly between 2011 and 2012; marked seasonal variation occurred in peak periods for VMMC. Countries adopted between three and five of the six elements; forceps-guided surgery was the only element adopted by all countries. Kenya and Tanzania routinely practiced task-shifting. South Africa and Zimbabwe used pre-bundled kits with disposable instruments and electrocautery. South Africa, Tanzania, and Zimbabwe routinely employed multiple surgical bays. Conclusions: SYMMACS is the first study to provide data on the implementation of VMMC programs and adoption of elements of surgical efficiency. Findings have contributed to policy change on task-shifting in Zimbabwe, a review of the monitoring system for adverse events in South Africa, an increased use of commercially bundled VMMC kits in Tanzania, and policy dialogue on improving VMMC service delivery in Kenya. This article serves as an overview for five other articles following this supplement.	[Bertrand, Jane T.; Perry, Linnea; Farrell, Margaret] Tulane Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA; [Rech, Dino; Frade, Sasha; Spyrelis, Alexandra] Ctr HIV AIDS Prevent Studies, Johannesburg, South Africa; [Aduda, Dickens Omondi; Loolpapit, Mores; Oyango, Mathews] FHI 360, Nairobi, Kenya; [Machaku, Michael D.] Jhpiego, Dar Es Salaam, Tanzania; [Mavhu, Webster] Dept Community Med UZ, Zimbabwe AIDS Prevent Project, Harare, Zimbabwe; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	Tulane University; Jhpiego; United States Agency for International Development (USAID)	Bertrand, JT (corresponding author), Tulane Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70112 USA.	bertrand@tulane.edu	Frade, Sasha/AAQ-3284-2021	Frade, Sasha/0000-0001-9683-3020; Mavhu, Webster/0000-0003-1881-4398	USAID | Project SEARCH; U.S. Agency for International Development [GHH-I-00-07-00032-00]	USAID | Project SEARCH(United States Agency for International Development (USAID)); U.S. Agency for International Development(United States Agency for International Development (USAID))	The article was supported by USAID | Project SEARCH, Task Order No. 2, funded by the U.S. Agency for International Development (www.usaid.gov) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. USAID staff played a role in study design and data analysis, decision to publish, and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID or United States Government opinion.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, DECREASE HIV PREVALE; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2013, SYST MON VOL MED MAL; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2013, SEX TRANSM INFECT, V89, P345, DOI 10.1136/sextrans-2012-050595; Kuznik A, 2012, TROP DOCT, V42, P5, DOI 10.1258/td.2011.110297; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Rech D, 2013, PLOS MED PEER UNPUB; Sheldon WR, 2012, SEX TRANSM DIS, V39, P567, DOI 10.1097/OLQ.0b013e31824f9eaf; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; World Health Organization, 2009, MAL CIRC SERV QUAL A; World Health Organization, 2007, NEW DAT MAL CIRC HIV; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	18	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e82518	10.1371/journal.pone.0082518	http://dx.doi.org/10.1371/journal.pone.0082518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801374	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800003
J	Kim, M; Jung, S; Kim, SY; Lee, SH; Lee, JH				Kim, Minjoo; Jung, Saem; Kim, Su Yeon; Lee, Sang-Hyun; Lee, Jong Ho			Prehypertension-Associated Elevation in Circulating Lysophosphatidlycholines, Lp-PLA(2) Activity, and Oxidative Stress	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CORONARY-ARTERY-DISEASE; ENDOTHELIAL DYSFUNCTION; CAROTID ATHEROSCLEROSIS; INFLAMMATORY CYTOKINE; PHOSPHOLIPASE A(2); MASS-SPECTROMETRY; LYSOPHOSPHATIDYLCHOLINE; PLASMA; RISK	Prehypertension is a risk factor for atherosclerosis. We investigated alterations in plasma metabolites that are associated with prehypertension. A group of 53 individuals was identified who remained within the range of prehypertension during repeated measurements in a 3-year period. This group was compared with the control group of 53 normotensive subjects who were matched for age and gender. Metabolomic profiles were analyzed with UPLC-LTQ-Orbitrap mass spectrometry. The prehypertensive group showed higher levels of lysophosphatidylcholines (lysoPCs) containing C14:0, C16:1, C16:0, C18:2, C18:1, C18:0, C20:5, C20:4, C20:3, and C22:6, higher circulating Lp-PLA(2) activity, oxidized LDL (ox-LDL), interleukin 6 (IL-6), urinary 8-epi-PGF(2 alpha), and higher brachial-ankle pulse wave velocity (ba-PWV), before and after adjusting for BMI, WHR, smoking, alcohol consumption, serum lipid profiles, glucose, and insulin. LysoPC (16:0) was the most important plasma metabolite for evaluating the difference between control and prehypertensive groups, with a variable important in the projection (VIP) value of 17.173, and it showed a positive and independent association with DBP and SBP. In the prehypertensive group, the levels of lysoPC (16:0) positively and significantly correlated with ox-LDL, Lp-PLA(2) activity, 8-epi-PGF(2 alpha), ba-PWV, and IL-6 before and after adjusting for confounding variables. Prehypertension-associated elevations in lysoPCs, Lp-PLA(2) activity, ox-LDL, urinary 8-epi-PGF(2 alpha), IL-6, and ba-PWV could indicate increased oxidative stress from LpPLA(2)-catalyzed PC hydrolysis during increased LDL oxidation, thereby enhancing proinflammation and arterial stiffness.	[Kim, Minjoo; Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigenom, Seoul 120749, South Korea; [Kim, Minjoo; Jung, Saem; Lee, Jong Ho] Yonsei Univ, Coll Human Ecol, Brain Korea PLUS Project 21, Dept Food & Nutr, Seoul 120749, South Korea; [Kim, Su Yeon; Lee, Jong Ho] Yonsei Univ, Interdisciplinary Course Sci Aging, Seoul 120749, South Korea; [Lee, Sang-Hyun] Natl Hlth Insurance Corp Ilsan Hosp, Dept Family Practice, Goyang, South Korea	Yonsei University; Yonsei University; Yonsei University	Lee, JH (corresponding author), Yonsei Univ, Coll Human Ecol, Dept Food & Nutr, Natl Leading Res Lab Clin Nutrigenet Nutrigenom, Seoul 120749, South Korea.	jhleeb@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [20062005306, 2010-0015017, 2012M3A9C4048762]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This research was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (20062005306, 2010-0015017, and 2012M3A9C4048762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 2007, MOL CELL BIOCHEM, V295, P113, DOI 10.1007/s11010-006-9280-x; Asciutto G, 2013, CARDIOVASC PATHOL, V13; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Chae JS, 2011, ATHEROSCLEROSIS, V218, P499, DOI 10.1016/j.atherosclerosis.2011.06.036; Chen L, 1997, J LIPID RES, V38, P546; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dalekos GN, 1997, J LAB CLIN MED, V129, P300, DOI 10.1016/S0022-2143(97)90178-5; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; De Keyzer D, 2009, ARTERIOSCL THROM VAS, V29, P2041, DOI 10.1161/ATVBAHA.109.196592; Galili O, 2007, AM J PHYSIOL-HEART C, V292, pH904, DOI 10.1152/ajpheart.00628.2006; Glasser SP, 2013, AM J HYPERTENS, V7, P1; Jiang HQ, 2012, J SEP SCI, V35, P483, DOI 10.1002/jssc.201100769; Kim JY, 2013, AGE, V35, P1507, DOI 10.1007/s11357-012-9454-2; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Kim OY, 2010, ATHEROSCLEROSIS, V208, P581, DOI 10.1016/j.atherosclerosis.2009.08.009; Kono N, 2008, J BIOL CHEM, V283, P1628, DOI 10.1074/jbc.M708622200; Kouglas P, 2006, MED SCI MONITOR, V12, pRA5; LEMNE C, 1995, STROKE, V26, P34, DOI 10.1161/01.STR.26.1.34; Liu M, 1998, BIOCHEMISTRY-US, V37, P13626, DOI 10.1021/bi980351e; Liu-Wu Y, 1998, ATHEROSCLEROSIS, V137, P351, DOI 10.1016/S0021-9150(97)00295-5; Loftus N, 2008, RAPID COMMUN MASS SP, V22, P2547, DOI 10.1002/rcm.3640; Malhotra S, 2013, J NUCL CARDIOL, V20, P731, DOI 10.1007/s12350-013-9708-0; Matsumoto T, 2007, CURR MED CHEM, V14, P3209, DOI 10.2174/092986707782793899; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ojala PJ, 2006, BIOCHEMISTRY-US, V45, P14021, DOI 10.1021/bi061657l; Olofsson KE, 2008, BIOCHEM BIOPH RES CO, V370, P348, DOI 10.1016/j.bbrc.2008.03.087; Ou ZJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE683, DOI 10.1152/ajpendo.00136.2012; Paik JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029675; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Shi Y, 2007, ATHEROSCLEROSIS, V191, P54, DOI 10.1016/j.atherosclerosis.2006.05.001; Shim JeeSeon, 2002, Korean Journal of Community Nutrition, V7, P484; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Su TC, 2001, STROKE, V32, P2265, DOI 10.1161/str.32.10.2265; Takabe W, 2004, ARTERIOSCL THROM VAS, V24, P1640, DOI 10.1161/01.ATV.0000134377.17680.26; Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616; Vassalle C, 2004, J INTERN MED, V256, P308, DOI 10.1111/j.1365-2796.2004.01373.x; Wolfram R, 2005, EUR J HEART FAIL, V7, P167, DOI 10.1016/j.ejheart.2004.05.007; Zheng Y, 2013, HYPERTENSION, V62, P398, DOI 10.1161/HYPERTENSIONAHA.113.01166	43	30	34	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96735	10.1371/journal.pone.0096735	http://dx.doi.org/10.1371/journal.pone.0096735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800806	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800117
J	Kwak, JW; Jeong, H; Han, SH; Kim, Y; Son, SM; Mook-Jung, I; Hwang, D; Park, JW				Kwak, Ju-Won; Jeong, Hyobin; Han, Sun-Ho; Kim, Youngkyu; Son, Sung Min; Mook-Jung, Inhee; Hwang, Daehee; Park, Joon Won			Phosphokinase Antibody Arrays on Dendron-Coated Surface	PLOS ONE			English	Article							PROTEIN MICROARRAYS; MASS-SPECTROMETRY; LIGHT-CHAINS; PHOSPHORYLATION; RECEPTOR; DATABASE; PATHWAYS; CLONING; KINASE; MEMORY	Monitoring protein phosphorylation at the cellular level is important to understand the intracellular signaling. Among the phosphoproteomics methods, phosphokinase antibody arrays have emerged as preferred tools to measure well-characterized phosphorylation in the intracellular signaling. Here, we present a dendron-coated phosphokinase antibody array (DPA) in which the antibodies are immobilized on a dendron-coated glass slide. Self-assembly of conically shaped dendrons well-controlled in size and structure resulted in precisely controlled lateral spacing between the immobilized phosphosite-specific antibodies, leading to minimized steric hindrance and improved antigen-antibody binding kinetics. These features increased sensitivity, selectivity, and reproducibility in measured amounts of protein phosphorylation. To demonstrate the utility of the DPA, we generated the phosphorylation profiles of brain tissue samples obtained from Alzheimer's disease (AD) model mice. The analysis of the profiles revealed signaling pathways deregulated during the course of AD progression.	[Kwak, Ju-Won; Park, Joon Won] POSTECH, Dept Chem, Pohang, South Korea; [Jeong, Hyobin; Kim, Youngkyu; Hwang, Daehee] POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Han, Sun-Ho; Son, Sung Min; Mook-Jung, Inhee] Seoul Natl Univ, Dept Biochem & Biomed Sci, Seoul, South Korea; [Hwang, Daehee] DGIST, Inst Basic Sci, Ctr Plant Aging Res, Taegu, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Daegu Gyeongbuk Institute of Science & Technology (DGIST); Institute for Basic Science - Korea (IBS)	Mook-Jung, I (corresponding author), Seoul Natl Univ, Dept Biochem & Biomed Sci, Seoul, South Korea.	inhee@snu.ac.kr; dhwang@dgist.ac.kr; jwpark@postech.ac.kr	Park, Joon Won/F-4694-2013	Park, Joon Won/0000-0003-1432-3161; Son, Sung Min/0000-0002-3536-1952	Institute for Basic Science from Korean MEST, POSCO research fund [CA1308, 2013Y008, 10182KFDA992]; Korean FDA [12182KFDA651];  [NRF-2013-003102];  [NRF-2013M3C7A1069644]	Institute for Basic Science from Korean MEST, POSCO research fund; Korean FDA; ; 	This study was supported by Proteogenomics Project, NRF-2013-003102, NRF-2013M3C7A1069644, and the Institute for Basic Science (CA1308) grants from Korean MEST, POSCO research fund (Project NO. 2013Y008), and 10182KFDA992 and 12182KFDA651 grants from Korean FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaeys I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4365; Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Benters R, 2001, CHEMBIOCHEM, V2, P686, DOI 10.1002/1439-7633(20010903)2:9<686::AID-CBIC686>3.0.CO;2-S; Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8; Chae S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003266; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Chandra H, 2011, EXPERT REV PROTEOMIC, V8, P61, DOI 10.1586/EPR.10.99; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Cretich M, 2004, ANAL BIOCHEM, V332, P67, DOI 10.1016/j.ab.2004.05.041; Cutillas PR, 2005, MOL CELL PROTEOMICS, V4, P1038, DOI 10.1074/mcp.M500078-MCP200; Dai JH, 2006, ANAL CHEM, V78, P135, DOI 10.1021/ac0513966; Dewachter I, 2009, NEUROBIOL DIS, V35, P193, DOI 10.1016/j.nbd.2009.04.003; El-Haibi Christelle P, 2012, J Proteomics Bioinform, V5, P177; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Hernandez F, 2013, J ALZHEIMERS DIS, V33, pS141, DOI 10.3233/JAD-2012-129025; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Hong BJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni109; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kim Taehyun, 2011, Int J Alzheimers Dis, V2011, P857368, DOI 10.4061/2011/857368; Kwak J-W HM, 1999, CDNAS ENCODING MURIN; Kwak JW, 1996, GENE, V173, P257, DOI 10.1016/0378-1119(96)00077-7; Kwak JW, 1996, GENE, V169, P237, DOI 10.1016/0378-1119(95)00807-1; Marwarha G, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-41; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mayya V, 2009, EXPERT REV PROTEOMIC, V6, P605, DOI 10.1586/EPR.09.84; Mizuno S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-52; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oh Soon Jin, 2005, Nucleic Acids Res, V33, pe90; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Ploia C, 2011, J ALZHEIMERS DIS, V26, P315, DOI 10.3233/JAD-2011-110320; Son SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.039; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Wan J, 2010, J NEUROSCI, V30, P6873, DOI 10.1523/JNEUROSCI.0519-10.2010; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang H, 2012, SEMIN CELL DEV BIOL, V23, P872, DOI 10.1016/j.semcdb.2012.05.009	43	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96456	10.1371/journal.pone.0096456	http://dx.doi.org/10.1371/journal.pone.0096456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802362	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800070
J	Mavhu, W; Frade, S; Yongho, AM; Farrell, M; Hatzold, K; Machaku, M; Onyango, M; Mugurungi, O; Fimbo, B; Cherutich, P; Rech, D; Castor, D; Njeuhmeli, E; Bertrand, JT				Mavhu, Webster; Frade, Sasha; Yongho, Ann-Marie; Farrell, Margaret; Hatzold, Karin; Machaku, Michael; Onyango, Mathews; Mugurungi, Owen; Fimbo, Bennett; Cherutich, Peter; Rech, Dino; Castor, Delivette; Njeuhmeli, Emmanuel; Bertrand, Jane T.			Provider Attitudes toward the Voluntary Medical Male Circumcision Scale-Up in Kenya, South Africa, Tanzania and Zimbabwe	PLOS ONE			English	Article								Background: Countries participating in voluntary medical male circumcision (VMMC) scale-up have adopted most of six elements of surgical efficiency, depending on national policy. However, effective implementation of these elements largely depends on providers' attitudes and subsequent compliance. We explored the concordance between recommended practices and providers' perceptions toward the VMMC efficiency elements, in part to inform review of national policies. Methods and Findings: As part of Systematic Monitoring of the VMMC Scale-up (SYMMACS), we conducted a survey of VMMC providers in Kenya, South Africa, Tanzania, and Zimbabwe. SYMMACS assessed providers' attitudes and perceptions toward these elements in 2011 and 2012. A restricted analysis using 2012 data to calculate unadjusted odds ratios and 95% confidence intervals for the country effect on each attitudinal outcome was done using logistic regression. As only two countries allow more than one cadre to perform the surgical procedure, odds ratios looking at country effect were adjusted for cadre effect for these two countries. Qualitative data from open-ended responses were used to triangulate with quantitative analyses. This analysis showed concordance between each country's policies and provider attitudes toward the efficiency elements. One exception was task-shifting, which is not authorized in South Africa or Zimbabwe; providers across all countries approved this practice. Conclusions: The decision to adopt efficiency elements is often based on national policies. The concordance between the policies of each country and provider attitudes bodes well for compliance and effective implementation. However, study findings suggest that there may be need to consult providers when developing national policies.	[Mavhu, Webster] Dept Community Med UZ, Zimbabwe AIDS Prevent Project UZ, Harare, Zimbabwe; [Frade, Sasha; Rech, Dino] Ctr HIV & AIDS Prevent Studies, Johannesburg, South Africa; [Yongho, Ann-Marie; Farrell, Margaret; Bertrand, Jane T.] Tulane Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Hatzold, Karin] Populat Serv Int, Harare, Zimbabwe; [Machaku, Michael] Jhpiego, Dar Es Salaam, Tanzania; [Onyango, Mathews] FHI 360, Kisumu, Kenya; [Mugurungi, Owen] Minist Hlth & Child Welf, Harare, Zimbabwe; [Fimbo, Bennett] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Cherutich, Peter] Natl AIDS STD Control Programme, Nairobi, Kenya; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	Tulane University; Jhpiego; United States Agency for International Development (USAID)	Mavhu, W (corresponding author), Dept Community Med UZ, Zimbabwe AIDS Prevent Project UZ, Harare, Zimbabwe.	wmavhu@gmail.com	Frade, Sasha/AAQ-3284-2021	Frade, Sasha/0000-0001-9683-3020; Mavhu, Webster/0000-0003-1881-4398	USAID | Project SEARCH; President's Emergency Plan for AIDS Relief; U.S. Agency for International Development [GHH-I-00-07-00032-00]	USAID | Project SEARCH(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development(United States Agency for International Development (USAID))	The article was supported by USAID | Project SEARCH, Task Order No. 2, funded by the U.S. Agency for International Development (www.usaid.gov) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). USAID staff played a role in study design and data analysis, decision to publish, and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID or United States Government opinion.	[Anonymous], 2004, MENTAL HLTH SERVICES, DOI [10.1023/b:mhsr.0000024351.12294.65, DOI 10.1023/B:MHSR.0000024351.12294.65, DOI 10.1023/B:MHSR.0000024351.12294.65DISSEMINATIONINPSYCHOTHERAPY145]; BERTRAND JT, 2013, PLOS ONE UNPUB; Creswell J. W., 2014, RES DESIGN QUALITATI; Garland AF, 2003, J BEHAV HEALTH SER R, V30, P393, DOI 10.1007/BF02287427; Grimm P., 2010, WILEY INT ENCY MARKE; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Holland N, 2008, DIS MANAGE, V11, P71, DOI 10.1089/dis.2008.1120007; Manirankunda L, 2012, AIDS EDUC PREV, V24, P456, DOI 10.1521/aeap.2012.24.5.456; Masanja IM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-956; Mavhu W, 2011, AIDS CARE, V23, P52, DOI 10.1080/09540121.2010.490257; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; O'Cathain A, 2009, J MIX METHOD RES, V3, P3, DOI 10.1177/1558689808326272; PERRY L, 2013, PLOS ONE UNPUB; Sheldon WR, 2012, SEX TRANSM DIS, V39, P567, DOI 10.1097/OLQ.0b013e31824f9eaf; Tarimo DS, 2001, TROP MED INT HEALTH, V6, P992, DOI 10.1046/j.1365-3156.2001.00818.x; Wasunna B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-29; WHO and UNAIDS, 2011, PROGR MAL CIRC SCAL; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	18	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e82911	10.1371/journal.pone.0082911	http://dx.doi.org/10.1371/journal.pone.0082911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801632	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800005
J	Thudi, M; Upadhyaya, HD; Rathore, A; Gaur, PM; Krishnamurthy, L; Roorkiwal, M; Nayak, SN; Chaturvedi, SK; Basu, PS; Gangarao, NVPR; Fikre, A; Kimurto, P; Sharma, PC; Sheshashayee, MS; Tobita, S; Kashiwagi, J; Ito, O; Killian, A; Varshney, RK				Thudi, Mahendar; Upadhyaya, Hari D.; Rathore, Abhishek; Gaur, Pooran Mal; Krishnamurthy, Lakshmanan; Roorkiwal, Manish; Nayak, Spurthi N.; Chaturvedi, Sushil Kumar; Basu, Partha Sarathi; Gangarao, N. V. P. R.; Fikre, Asnake; Kimurto, Paul; Sharma, Prakash C.; Sheshashayee, M. S.; Tobita, Satoshi; Kashiwagi, Junichi; Ito, Osamu; Killian, Andrzej; Varshney, Rajeev Kumar			Genetic Dissection of Drought and Heat Tolerance in Chickpea through Genome-Wide and Candidate Gene-Based Association Mapping Approaches	PLOS ONE			English	Article							CICER-ARIETINUM L.; DIVERSITY ASSESSMENT; MEDICAGO-TRUNCATULA; TRAITS; STRESS; MAP; EFFICIENCY; RESOURCE; YIELD; LOCI	To understand the genetic basis of tolerance to drought and heat stresses in chickpea, a comprehensive association mapping approach has been undertaken. Phenotypic data were generated on the reference set (300 accessions, including 211 mini-core collection accessions) for drought tolerance related root traits, heat tolerance, yield and yield component traits from 1-7 seasons and 1-3 locations in India (Patancheru, Kanpur, Bangalore) and three locations in Africa (Nairobi, Egerton in Kenya and Debre Zeit in Ethiopia). Diversity Array Technology (DArT) markers equally distributed across chickpea genome were used to determine population structure and three sub-populations were identified using admixture model in STRUCTURE. The pairwise linkage disequilibrium (LD) estimated using the squared-allele frequency correlations (r(2); when r(2)<0.20) was found to decay rapidly with the genetic distance of 5 cM. For establishing marker-trait associations (MTAs), both genome-wide and candidate gene-sequencing based association mapping approaches were conducted using 1,872 markers (1,072 DArTs, 651 single nucleotide polymorphisms [SNPs], 113 gene-based SNPs and 36 simple sequence repeats [SSRs]) and phenotyping data mentioned above employing mixed linear model (MLM) analysis with optimum compression with P3D method and kinship matrix. As a result, 312 significant MTAs were identified and a maximum number of MTAs (70) was identified for 100-seed weight. A total of 18 SNPs from 5 genes (ERECTA, 11 SNPs; ASR, 4 SNPs; DREB, 1 SNP; CAP2 promoter, 1 SNP and AMDH, 1SNP) were significantly associated with different traits. This study provides significant MTAs for drought and heat tolerance in chickpea that can be used, after validation, in molecular breeding for developing superior varieties with enhanced drought and heat tolerance.	[Thudi, Mahendar; Upadhyaya, Hari D.; Rathore, Abhishek; Gaur, Pooran Mal; Krishnamurthy, Lakshmanan; Roorkiwal, Manish; Nayak, Spurthi N.; Varshney, Rajeev Kumar] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Roorkiwal, Manish; Sharma, Prakash C.] Guru Gobind Singh Indraprastha Univ, Delhi, India; [Chaturvedi, Sushil Kumar; Basu, Partha Sarathi] Indian Inst Pulses Res, Kanpur, Uttar Pradesh, India; [Gangarao, N. V. P. R.] Int Crops Res Inst Semi Arid Trop, Nairobi, Kenya; [Fikre, Asnake] Ethiopian Inst Agr Res, Debre Zeit, Ethiopia; [Kimurto, Paul] Egerton Univ, Egerton, Kenya; [Sheshashayee, M. S.] Univ Agr Sci Bangalore, Bangalore, Karnataka, India; [Tobita, Satoshi] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Kashiwagi, Junichi] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Ito, Osamu] United Nations Univ, Yokohama, Kanagawa, Japan; [Killian, Andrzej] DArT Pty Ltd, Yarralumla, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); GGS Indraprastha University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Pulses Research; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Ethiopian Institute of Agricultural Research (EIAR); Egerton University; University of Agricultural Sciences Bangalore; Japan International Research Center for Agricultural Sciences; Hokkaido University; United Nations University	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Updhayaya, Hari/C-4858-2014; Chaturvedi, Sushil Kumar/AGU-4038-2022; Roorkiwal, Manish/E-9822-2011; Gaur, Pooran/AAR-5729-2021; Varshney, Rajeev K/C-5295-2014; Kimurto, Paul/ABC-3322-2021; Kashiwagi, Junichi/H-9326-2013; THUDI, MAHENDAR/GXA-1578-2022; Gaur, Pooran Mal/ABE-6102-2020	Updhayaya, Hari/0000-0002-5166-6844; Roorkiwal, Manish/0000-0001-6595-281X; Varshney, Rajeev K/0000-0002-4562-9131; THUDI, MAHENDAR/0000-0003-2851-6837; Gaur, Pooran Mal/0000-0002-7086-5873; Nadigatla, Ganga Rao V.P.R/0000-0002-3278-3324	Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme	Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme	This study was undertaken as a part of Tropical Legumes I (TLI- Objective 4: Chickpea) funded by Bill & Melinda Gates Foundation (BMGF) through CGIAR Generation Challenge Programme (http://www.generationcp.org/). This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. DArT Pty. Ltd. provided support in the form of a salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, GEN RESOUR CHROM ENG, V1, P187; Campo S, 2012, J EXP BOT, V63, P983, DOI 10.1093/jxb/err328; Cockram J, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-16; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Degenkolbe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063637; Devasirvatham V, 2012, CROP PASTURE SCI, V63, P419, DOI 10.1071/CP11218; Gaur PM, 2008, FOOD LEGUMES NUTR SE, V2, P39; Hiremath PJ, 2012, PLANT BIOTECHNOL J, V10, P716, DOI 10.1111/j.1467-7652.2012.00710.x; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jain M, 2013, PLANT J, V74, P715, DOI 10.1111/tpj.12173; Jukanti AK, 2012, BRIT J NUTR, V108, pS11, DOI 10.1017/S0007114512000797; Kashiwagi J, 2006, FIELD CROP RES, V95, P171, DOI 10.1016/j.fcr.2005.02.012; Knights EJ, 2007, CHICKPEA BREEDING AND MANAGEMENT, P167, DOI 10.1079/9781845932138.007; Krishnamurthy L, 2013, FIELD CROP RES, V149, P354, DOI 10.1016/j.fcr.2013.05.022; Li DF, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-109; Li YH, 2011, CONSERV GENET, V12, P1145, DOI 10.1007/s10592-011-0216-y; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Nayak SN, 2010, THEOR APPL GENET, V120, P1415, DOI 10.1007/s00122-010-1265-1; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Perrier X., 2003, GENETIC DIVERSITY CU, P3; Petrivalsky M, 2007, J PLANT PHYSIOL, V164, P1410, DOI 10.1016/j.jplph.2007.01.018; Pritchard JK, 2000, GENETICS, V155, P945; Roorkiwal M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00248; Sakiroglu M, 2012, THEOR APPL GENET, V125, P577, DOI 10.1007/s00122-012-1854-2; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Shehzad T, 2009, BREEDING SCI, V59, P217, DOI 10.1270/jsbbs.59.217; Shi C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-52; Somers DJ, 2005, 100 MEMORIAL ISSUE W, P235; Thudi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027275; Toker C, 2007, CHICKPEA BREEDING AND MANAGEMENT, P474, DOI 10.1079/9781845932138.023; Upadhyaya HD, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-106; Upadhyaya HD, 2001, THEOR APPL GENET, V102, P1292, DOI 10.1007/s00122-001-0556-y; Vadez V, 2012, MOL BREEDING, V30, P9, DOI 10.1007/s11032-011-9594-6; Varshney RK, 2014, FUNCT INTEGR GENOMIC, V14, P59, DOI 10.1007/s10142-014-0363-6; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, NAT BIOTECHNOL, V31, P240, DOI 10.1038/nbt.2491; Varshney RK, 2012, J BIOSCIENCES, V37, P811, DOI 10.1007/s12038-012-9228-0; Varshney RK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-523; Wang J, 2006, CROP SCI, V46, P2171, DOI 10.2135/cropsci2006.02.0092; Wilkening S, 2009, GENOMICS, V93, P415, DOI 10.1016/j.ygeno.2008.12.011; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhu C, 2008, PLANT GENOME, V1, P15	50	140	140	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96758	10.1371/journal.pone.0096758	http://dx.doi.org/10.1371/journal.pone.0096758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801366	Green Published, gold			2022-12-27	WOS:000338029800123
J	Chen, H; Ou, QB; Tang, Y; Gao, XH; Wu, LL; Xue, C; Yu, CM; Cui, JT; Diao, YX				Chen, Hao; Ou, Quanbin; Tang, Yi; Gao, Xuhui; Wu, Lili; Xue, Cong; Yu, Chunmei; Cui, Jingteng; Diao, Youxiang			Development and Evaluation of a DAS-ELISA for Rapid Detection of Tembusu Virus Using Monoclonal Antibodies against the Envelope Protein	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; DENGUE VIRUS; REVERSE-TRANSCRIPTION; ENCEPHALITIS-VIRUS; SANDWICH-ELISA; DOMAIN-III; FLAVIVIRUS; DUCKS; CHINA; STRAIN	Since April 2010, Tembusu virus (TMUV) which is a contagious pathogen of waterfowls, causing symptoms of high fever, loss of appetite and fall in egg production, has been reported in east of China. A double antibody sandwich enzyme-linked immunosorbent assay (DAS-ELISA) which detects for TMUV was developed, using two monoclonal antibodies (mAbs) against the TMUV envelope (E) protein. BALB/c mice were immunized with purified recombinant E protein expressed in E. coli. Three hybridoma cell lines designated as 12B1, 10C6 and 2D2, were screened by cell fusion and indirect ELISA for their ability to recognize different linear epitopes on the E protein, and were characterized subsequently. High-affinity mAbs 12B1 and 2D2 were used as capture and detection antibodies, respectively. The reaction conditions for the DAS-ELISA were optimized for TMUV detection. The cross-reactivity of the DAS-ELISA was determined using TMUV, duck plague virus, avian influenza virus subtype H9, Newcastle disease virus, duck hepatitis A virus type 1 and duck reovirus samples. A total of 191 homogenized tissues of field samples were simultaneously detected by DAS-ELISA and by RT-PCR. The former was found to have a high specificity of 99.1% and a sensitivity of 93.1%. These results reveal a positive coincidence between DAS-ELISA and RT-PCR at a coincidence rate of 95.8%. The method developed in this study can be used for the diagnosis of TMUV infection of duck origin.	[Chen, Hao; Ou, Quanbin; Tang, Yi; Gao, Xuhui; Wu, Lili; Xue, Cong; Yu, Chunmei; Cui, Jingteng; Diao, Youxiang] Shandong Agr Univ, Coll Anim Sci & Technol, Poultry Dis Lab, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Diao, YX (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Poultry Dis Lab, Tai An, Shandong, Peoples R China.	yxdiao@126.com	Tang, Yi/AAS-3979-2020		National Natural Science Foundation of China [31272583]; China Agriculture Research System [CARS-43-34]; Modern Agro-industry Technology Research System [nycytx-45-11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Modern Agro-industry Technology Research System	This study was supported by the National Natural Science Foundation of China (31272583), the China Agriculture Research System (CARS-43-34) and the Modern Agro-industry Technology Research System (nycytx-45-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Gao X, 2013, ESTABLISHMENT APPL D; GOLLINS SW, 1986, NATURE, V321, P244, DOI 10.1038/321244a0; GRITSUN TS, 1995, VIRUS RES, V35, P307, DOI 10.1016/0168-1702(94)00090-Y; HEINZ FX, 1986, J BIOL STAND, V14, P133, DOI 10.1016/0092-1157(86)90032-6; KNAPP JS, 1983, J CLIN MICROBIOL, V18, P56, DOI 10.1128/JCM.18.1.56-62.1983; Li LL, 2012, VIRUS GENES, V45, P105, DOI 10.1007/s11262-012-0753-6; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026; Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004; SIEBINGA JT, 1988, ARCH VIROL, V100, P75, DOI 10.1007/BF01310909; Singh RP, 2004, ARCH VIROL, V149, P2155, DOI 10.1007/s00705-004-0366-z; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P336, DOI 10.1111/j.1865-1682.2011.01275.x; Tang Y, 2012, TRANSBOUND EMERG DIS, V59, P208, DOI 10.1111/j.1865-1682.2011.01257.x; Tang Y, 2013, CHARACTERIZATION TEM; Wan CH, 2012, J VIROL, V86, P10912, DOI 10.1128/JVI.01582-12; Wang YL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-553; Wu CW, 2011, APPL MICROBIOL BIOT, V92, P815, DOI 10.1007/s00253-011-3602-y; Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200; Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003; [于春梅 Yu Chunmei], 2012, [中国农业科学, Scientia Agricultura Sinica], V45, P4492; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Yu KX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071319; Yun T, 2012, J VIROL, V86, P3406, DOI 10.1128/JVI.07132-11	27	20	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96366	10.1371/journal.pone.0096366	http://dx.doi.org/10.1371/journal.pone.0096366			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797141	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000068
J	Wang, LF; Zhang, M; Tan, KB; Guo, YL; Tong, HP; Fan, XZ; Fang, KJ; Li, R				Wang, Luofu; Zhang, Miao; Tan, Kaibin; Guo, Yanli; Tong, Haipeng; Fan, Xiaozhou; Fang, Kejing; Li, Rui			Preparation of Nanobubbles Carrying Androgen Receptor siRNA and Their Inhibitory Effects on Androgen-Independent Prostate Cancer when Combined with Ultrasonic Irradiation	PLOS ONE			English	Article							ENHANCED ULTRASOUND; MICROBUBBLES; PATHWAYS; DRUG	Objective: The objective of this study was to investigate nanobubbles carrying androgen receptor (AR) siRNA and their in vitro and in vivo anti-tumor effects, when combined with ultrasonic irradiation, on androgen-independent prostate cancer (AIPC). Materials and Methods: Nanobubbles carrying AR siRNA were prepared using poly-L-lysine and electrostatic adsorption methods. Using C4-2 cell activity as a testing index, the optimal irradiation parameters (including the nanobubble number/cell number ratio, mechanical index [MI], and irradiation time) were determined and used for transfection of three human prostate cancer cell lines (C4-2, LNCaP, and PC-3 cells). The AR expression levels were investigated with RT-PCR and Western blot analysis. Additionally, the effects of the nanobubbles and control microbubbles named SonoVue were assessed via imaging in a C4-2 xenograft model. Finally, the growth and AR expression of seven groups of tumor tissues were assessed using the C4-2 xenograft mouse model. Results: The nanobubbles had an average diameter of 609.5 +/- 15.6 nm and could effectively bind to AR siRNA. Under the optimized conditions of a nanobubble number/cell number ratio of 100: 1, an MI of 1.2, and an irradiation time of 2 min, the highest transfection rates in C4-2, LNCaP, and PC-3 cells were 67.4%, 74.0%, and 63.96%, respectively. In the C4-2 and LNCaP cells, treatment with these binding nanobubbles plus ultrasonic irradiation significantly inhibited cell growth and resulted in the suppression of AR mRNA and protein expression. Additionally, contrast-enhanced ultrasound showed that the nanobubbles achieved stronger signals than the SonoVue control in the central hypovascular area of the tumors. Finally, the anti-tumor effect of these nanobubbles plus ultrasonic irradiation was most significant in the xenograft tumor model compared with the other groups. Conclusion: Nanobubbles carrying AR siRNA could be potentially used as gene vectors in combination with ultrasonic irradiation for the treatment of AIPC.	[Wang, Luofu] Third Mil Med Univ, Daping Hosp, Dept Urol, Chongqing, Peoples R China; [Wang, Luofu] Third Mil Med Univ, Inst Surg Res, Chongqing, Peoples R China; [Zhang, Miao; Guo, Yanli; Tong, Haipeng; Fan, Xiaozhou; Fang, Kejing; Li, Rui] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Tan, Kaibin] Third Mil Med Univ, Xinqiao Hosp, Dept Ultrasound, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Guo, YL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China.	guoyanli71@aliyun.com	Fang, Kejing/ACN-7217-2022		National Natural Science Foundation of China [30970830]; Key Project of the Natural Science Foundation of Chongqing City [cstc2012jjB0072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the Natural Science Foundation of Chongqing City	This study was supported by the National Natural Science Foundation of China (No. 30970830) and Key Project of the Natural Science Foundation of Chongqing City (cstc2012jjB0072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza H, 2011, CANCER SCI, V102, P51, DOI 10.1111/j.1349-7006.2010.01774.x; Bohmer MR, 2009, EUR J RADIOL, V70, P242, DOI 10.1016/j.ejrad.2009.01.051; Chen WS, 2004, J ACOUST SOC AM, V116, P2440, DOI 10.1121/1.1777855; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; Diaz-Lopez R, 2010, BIOMATERIALS, V31, P1723, DOI 10.1016/j.biomaterials.2009.11.044; Endo-Takahashi Y, 2012, INT J PHARMACEUT, V422, P504, DOI 10.1016/j.ijpharm.2011.11.023; Ferrante EA, 2009, J CONTROL RELEASE, V140, P100, DOI 10.1016/j.jconrel.2009.08.001; Haag P, 2005, J STEROID BIOCHEM, V96, P251, DOI 10.1016/j.jsbmb.2005.04.029; Haag P, 2006, J STEROID BIOCHEM, V102, P103, DOI 10.1016/j.jsbmb.2006.09.027; Hernot S, 2008, ADV DRUG DELIVER REV, V60, P1153, DOI 10.1016/j.addr.2008.03.005; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hong MY, 2008, J NUTR BIOCHEM, V19, P848, DOI 10.1016/j.jnutbio.2007.11.006; Hughes MS, 2005, J ACOUST SOC AM, V117, P964, DOI 10.1121/1.1810251; Kornmann LM, 2010, ULTRASOUND MED BIOL, V36, P181, DOI 10.1016/j.ultrasmedbio.2009.09.009; Li HL, 2009, GENE THER, V16, P1146, DOI 10.1038/gt.2009.84; Miao Z, 2011, J 3 MILITARY MED U, V23; Oeffinger BE, 2004, ULTRASONICS, V42, P343, DOI 10.1016/j.ultras.2003.11.011; Pan D, 2009, EUR J RADIOL, V70, P274, DOI 10.1016/j.ejrad.2009.01.042; Rahim A, 2006, ULTRASOUND MED BIOL, V32, P1269, DOI 10.1016/j.ultrasmedbio.2006.04.014; Shiota M, 2011, J MOL ENDOCRINOL, V47, pR25, DOI 10.1530/JME-11-0018; Vandenbroucke RE, 2008, J CONTROL RELEASE, V126, P265, DOI 10.1016/j.jconrel.2007.12.001; Wang D, 2010, CLIN IMAG, V34, P288, DOI 10.1016/j.clinimag.2010.02.009; [汪朝霞 Wang Zhaoxia], 2009, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V25, P101; Watanabe Y, 2008, CANCER SCI, V99, P2525, DOI 10.1111/j.1349-7006.2008.00989.x; Yin TH, 2012, INT J NANOMED, V7, P895, DOI 10.2147/IJN.S28830; Zhang Miao, 2011, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V20, P894; Zhou YF, 2011, WORLD J CLIN ONCOL, V2, P8, DOI 10.5306/wjco.v2.i1.8	27	25	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96586	10.1371/journal.pone.0096586	http://dx.doi.org/10.1371/journal.pone.0096586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798477	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000100
J	Zin, SM; Abbas, M; Abd Majid, A; Ismail, AIM				Zin, Shazalina Mat; Abbas, Muhammad; Abd Majid, Ahmad; Ismail, Ahmad Izani Md			A New Trigonometric Spline Approach to Numerical Solution of Generalized Nonlinear Klien-Gordon Equation	PLOS ONE			English	Article								The generalized nonlinear Klien-Gordon equation plays an important role in quantum mechanics. In this paper, a new three-time level implicit approach based on cubic trigonometric B-spline is presented for the approximate solution of this equation with Dirichlet boundary conditions. The usual finite difference approach is used to discretize the time derivative while cubic trigonometric B-spline is applied as an interpolating function in the space dimension. Several examples are discussed to exhibit the feasibility and capability of the approach. The absolute errors and L-infinity error norms are also computed at different times to assess the performance of the proposed approach and the results were found to be in good agreement with known solutions and with existing schemes in literature.	[Zin, Shazalina Mat; Abbas, Muhammad; Abd Majid, Ahmad; Ismail, Ahmad Izani Md] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Abbas, Muhammad] Univ Malaysia Perlis, Inst Engn Math, Perlis, Malaysia; [Abbas, Muhammad] Univ Sargodha, Dept Math, Sargodha, Pakistan	Universiti Sains Malaysia; Universiti Malaysia Perlis; University of Sargodha	Abbas, M (corresponding author), Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia.	m.abbas@uos.edu.pk	Abbas, Muhammad/K-8190-2019	Abbas, Muhammad/0000-0002-0491-1528; Ahmad Izani, Ismail/0000-0003-1092-5579	FRGS from the School of Mathematical Sciences, Universiti Sains Malaysia [203/PMATHS/6711324]; USM Penang, Malaysia [11800]	FRGS from the School of Mathematical Sciences, Universiti Sains Malaysia; USM Penang, Malaysia	This study was fully supported by FRGS Grant of No. 203/PMATHS/6711324 from the School of Mathematical Sciences, Universiti Sains Malaysia, 11800 USM Penang, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083265; Caglar H, 2006, APPL MATH COMPUT, V175, P72, DOI 10.1016/j.amc.2005.07.019; Chowdhury MSH, 2009, CHAOS SOLITON FRACT, V39, P1928, DOI 10.1016/j.chaos.2007.06.091; Dag I, 2005, APPL MATH COMPUT, V163, P199, DOI 10.1016/j.amc.2004.01.028; De Boor C., 1978, APPL MATH SCI, V27, DOI DOI 10.1007/978-1-4612-6333-3; Deeba E, 1994, J COMPUT PHYS, V124, P442; Dehghan M, 2009, J COMPUT APPL MATH, V230, P400, DOI 10.1016/j.cam.2008.12.011; Dodd R.K., 1982, SOLITON NONLINEAR WA; Guo BY, 1996, COMPUT APPL MATH, V15, P19; Hamid NN, 2010, CUBIC TRIGONOMETRIC, V47, P478; JIMENEZ S, 1990, APPL MATH COMPUT, V35, P61, DOI 10.1016/0096-3003(90)90091-G; Khuri SA, 2010, APPL MATH COMPUT, V216, P1047, DOI 10.1016/j.amc.2010.01.122; Ming W, 1993, J COMPUT PHYS, V108, P296; Rosenberg DUV, 1979, METHODS SOLUTION PAR, V113; Siddiqi SS, 2013, J EGYPTIAN  IN PRESS; Sirendaoreji, 2007, CHAOS SOLITON FRACT, V31, P943, DOI 10.1016/j.chaos.2005.10.048; Wazwaz M, 2006, APPL MATH COMPUT, V167, P1179; Wong YS, 1997, APPL MATH COMPUT, V84, P77, DOI 10.1016/S0096-3003(96)00065-3; Yucel U, 2008, APPL MATH COMPUT, V203, P387, DOI 10.1016/j.amc.2008.04.042	19	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95774	10.1371/journal.pone.0095774	http://dx.doi.org/10.1371/journal.pone.0095774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796483	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000023
J	Cheng, N; Porter, MA; Frick, LW; Nguyen, Y; Hayden, JD; Young, EF; Braunstein, MS; Hull-Ryde, EA; Janzen, WP				Cheng, Nancy; Porter, Melissa A.; Frick, Lloyd W.; Nguyen, Yvonne; Hayden, Jennifer D.; Young, Ellen F.; Braunstein, Miriam S.; Hull-Ryde, Emily A.; Janzen, William P.			Filtration Improves the Performance of a High-Throughput Screen for Anti-Mycobacterial Compounds	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG CANDIDATE; IN-VITRO; GROWTH	The tendency for mycobacteria to aggregate poses a challenge for their use in microplate based assays. Good dispersions have been difficult to achieve in high-throughput screening (HTS) assays used in the search for novel antibacterial drugs to treat tuberculosis and other related diseases. Here we describe a method using filtration to overcome the problem of variability resulting from aggregation of mycobacteria. This method consistently yielded higher reproducibility and lower variability than conventional methods, such as settling under gravity and vortexing.	[Cheng, Nancy; Porter, Melissa A.; Nguyen, Yvonne; Hull-Ryde, Emily A.; Janzen, William P.] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27515 USA; [Hayden, Jennifer D.; Young, Ellen F.; Braunstein, Miriam S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Janzen, William P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Canc Genet Program, Chapel Hill, NC 27599 USA; [Frick, Lloyd W.] DMPK Advisors, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Janzen, WP (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27515 USA.	bjanzen@email.unc.edu			National Institute of Allergy and Infectious Diseases [1R01AI099969]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099969] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases 1R01AI099969. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar I, 2013, LANCET INFECT DIS, V13, P529, DOI 10.1016/S1473-3099(13)70030-6; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bettencourt P, 2010, MICROSCOPY SCI TECHN, P614; Cooper CB, 2013, J MED CHEM, V56, P7755, DOI 10.1021/jm400381v; Davis BD, 1979, MICROBIOLOGY; Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0; Gruppo V, 2006, ANTIMICROB AGENTS CH, V50, P1245, DOI 10.1128/AAC.50.4.1245-1250.2006; KOCH AL, 1968, J THEOR BIOL, V18, P133, DOI 10.1016/0022-5193(68)90174-4; KOCH AL, 1970, ANAL BIOCHEM, V38, P252, DOI 10.1016/0003-2697(70)90174-0; Kumar A, 2012, TB INDIA 2012 REPORT; LAMBRECHT RS, 1988, APPL ENVIRON MICROB, V54, P910, DOI 10.1128/AEM.54.4.910-916.1988; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; LAWRENCE JV, 1977, APPL ENVIRON MICROB, V33, P482, DOI 10.1128/AEM.33.2.482-484.1977; Macarron R, 2009, METHODS MOL BIOL, V565, P1, DOI 10.1007/978-1-60327-258-2_1; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; Meyers PR, 1998, J CLIN MICROBIOL, V36, P2752, DOI 10.1128/JCM.36.9.2752-2754.1998; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Osborne R, 2013, NAT BIOTECHNOL, V31, P89, DOI 10.1038/nbt0213-89; Pathak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034931; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Shin SJ, 2007, J CLIN MICROBIOL, V45, P1941, DOI 10.1128/JCM.02616-06; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Snider GL, 1997, ANN INTERN MED, V126, P237, DOI 10.7326/0003-4819-126-3-199702010-00011; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Tobias HJ, 2005, APPL ENVIRON MICROB, V71, P6086, DOI 10.1128/AEM.71.10.6086-6095.2005; van de Hulst H.C., 1981, LIGHT SCATTERING SMA; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96348	10.1371/journal.pone.0096348	http://dx.doi.org/10.1371/journal.pone.0096348			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788852	gold, Green Submitted, Green Published			2022-12-27	WOS:000336655700079
J	Zhao, HY; Wang, JH; Zhou, YQ; Yang, YD				Zhao, Huiying; Wang, Jihua; Zhou, Yaoqi; Yang, Yuedong			Predicting DNA-Binding Proteins and Binding Residues by Complex Structure Prediction and Application to Human Proteome	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; RIBOSOMAL-RNA-BINDING; AMINO-ACID-SEQUENCES; ENERGY FUNCTION; WEB SERVER; EFFICIENT PREDICTION; FOLD RECOGNITION; RANDOM FOREST; SITES; IDENTIFICATION	As more and more protein sequences are uncovered from increasingly inexpensive sequencing techniques, an urgent task is to find their functions. This work presents a highly reliable computational technique for predicting DNA-binding function at the level of protein-DNA complex structures, rather than low-resolution two-state prediction of DNA-binding as most existing techniques do. The method first predicts protein-DNA complex structure by utilizing the template-based structure prediction technique HHblits, followed by binding affinity prediction based on a knowledge-based energy function (Distance-scaled finite ideal-gas reference state for protein-DNA interactions). A leave-one-out cross validation of the method based on 179 DNA-binding and 3797 non-binding protein domains achieves a Matthews correlation coefficient (MCC) of 0.77 with high precision (94%) and high sensitivity (65%). We further found 51% sensitivity for 82 newly determined structures of DNA-binding proteins and 56% sensitivity for the human proteome. In addition, the method provides a reasonably accurate prediction of DNA-binding residues in proteins based on predicted DNA-binding complex structures. Its application to human proteome leads to more than 300 novel DNA-binding proteins; some of these predicted structures were validated by known structures of homologous proteins in APO forms. The method [SPOT-Seq (DNA)] is available as an on-line server at http://sparks-lab.org.	[Zhao, Huiying; Zhou, Yaoqi; Yang, Yuedong] Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA; [Zhao, Huiying; Wang, Jihua; Zhou, Yaoqi; Yang, Yuedong] Indiana Univ, Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN USA; [Zhao, Huiying] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Wang, Jihua; Zhou, Yaoqi] Shandong Prov Key Lab Funct Macromol Biophy, Dezhou, Shandong, Peoples R China; [Zhou, Yaoqi; Yang, Yuedong] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia; [Zhou, Yaoqi; Yang, Yuedong] Griffith Univ, Sch Informat & Commun Tech, Southport, Qld 4215, Australia	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; QIMR Berghofer Medical Research Institute; Griffith University; Griffith University	Zhou, YQ (corresponding author), Indiana Univ Purdue Univ, Sch Informat, Indianapolis, IN 46202 USA.	yaoqi.zhou@griffith.edu.au; yuedong.yang@griffith.edu.au	Yang, Yuedong/C-9394-2009; Zhou, Yaoqi/B-3284-2009	Yang, Yuedong/0000-0002-6782-2813; Zhou, Yaoqi/0000-0002-9958-5699; zhao, huiying/0000-0001-9134-536X	National Institutes of Health [R01 GM085003]; National Natural Science Foundation of China [61271378]; Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics [SDBP006]; Griffith University eResearch Services Team; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics; Griffith University eResearch Services Team; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health R01 GM085003 to Y.Z., by the National Natural Science Foundation of China 61271378 to J.W., and by funding from Shandong Provincial Key Laboratory of Functional Macromolecular Biophysics SDBP006 to Y.Y. The authors also gratefully acknowledge the support of the Griffith University eResearch Services Team and the use of the High Performance Computing Cluster "Gowonda" to complete this research. This research/project has also been undertaken with the aid of the research cloud resources provided by the Queensland Cyber Infrastructure Foundation (QCIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Andrabi M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-30; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhardwaj N, 2005, NUCLEIC ACIDS RES, V33, P6486, DOI 10.1093/nar/gki949; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Cai YD, 2003, BBA-PROTEINS PROTEOM, V1648, P127, DOI 10.1016/S1570-9639(03)00112-2; Cai YD, 2010, MOL CELLS, V30, P99, DOI 10.1007/s10059-010-0093-0; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chen YC, 2012, NUCLEIC ACIDS RES, V40, pW249, DOI 10.1093/nar/gks481; Comin M, 2009, J COMPUT BIOL, V16, P1577, DOI 10.1089/cmb.2009.0045; Contreras-Moreira B, 2006, BIOINFORMATICS, V22, pE74, DOI 10.1093/bioinformatics/btl215; Dey S, 2012, NUCLEIC ACIDS RES, V40, P7150, DOI 10.1093/nar/gks405; Engelhardt BE, 2011, GENOME RES, V21, P1969, DOI 10.1101/gr.104687.109; FRECH K, 1993, NUCLEIC ACIDS RES, V21, P1655, DOI 10.1093/nar/21.7.1655; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000567; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Huang HL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S47; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Jones S, 2003, NUCLEIC ACIDS RES, V31, P2811, DOI 10.1093/nar/gkg386; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Kuznetsov IB, 2006, PROTEINS, V64, P19, DOI 10.1002/prot.20977; Langlois RE, 2010, NUCLEIC ACIDS RES, V38, P3149, DOI 10.1093/nar/gkq061; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Mariani V, 2011, PROTEINS, V79, P37, DOI 10.1002/prot.23177; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nimrod G, 2010, BIOINFORMATICS, V26, P692, DOI 10.1093/bioinformatics/btq019; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Ozbek P, 2010, NUCLEIC ACIDS RES, V38, pW417, DOI 10.1093/nar/gkq396; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Si JN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S7; Skolnick J, 2004, PROTEINS, V56, P502, DOI 10.1002/prot.20106; Sladek R, 1997, GENOMICS, V45, P320, DOI 10.1006/geno.1997.4939; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Tsuchiya Y, 2005, BIOINFORMATICS, V21, P1721, DOI 10.1093/bioinformatics/bti232; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wang LJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S1; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xiong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028440; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Xu BS, 2009, PROTEINS, V76, P718, DOI 10.1002/prot.22384; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Yang YD, 2012, PROTEINS, V80, P2080, DOI 10.1002/prot.24100; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Yu XJ, 2006, J THEOR BIOL, V240, P175, DOI 10.1016/j.jtbi.2005.09.018; Zhang C, 2005, J MED CHEM, V48, P2325, DOI 10.1021/jm049314d; Zhao HY, 2014, PROTEINS, V82, P640, DOI 10.1002/prot.24441; Zhao HY, 2011, RNA BIOL, V8, P988, DOI 10.4161/rna.8.6.17813; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; Zhou WQ, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-S1-S1	67	22	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96694	10.1371/journal.pone.0096694	http://dx.doi.org/10.1371/journal.pone.0096694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24792350	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700125
J	Akil, O; Hall-Glenn, F; Chang, JL; Li, A; Chang, WH; Lustig, LR; Alliston, T; Hsiao, EC				Akil, Omar; Hall-Glenn, Faith; Chang, Jolie; Li, Alfred; Chang, Wenhan; Lustig, Lawrence R.; Alliston, Tamara; Hsiao, Edward C.			Disrupted Bone Remodeling Leads to Cochlear Overgrowth and Hearing Loss in a Mouse Model of Fibrous Dysplasia	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ENGINEERED G(S)-COUPLED RECEPTOR; MICE LACKING PROSAPOSIN; TEMPORAL BONE; OTIC CAPSULE; OSTEOBLAST EXPRESSION; G(I)-COUPLED RECEPTOR; INNER-EAR; OSTEOPROTEGERIN; OTOSCLEROSIS	Normal hearing requires exquisite cooperation between bony and sensorineural structures within the cochlea. For example, the inner ear secretes proteins such as osteoprotegrin (OPG) that can prevent cochlear bone remodeling. Accordingly, diseases that affect bone regulation can also result in hearing loss. Patients with fibrous dysplasia develop trabecular bone overgrowth resulting in hearing loss if the lesions affect the temporal bones. Unfortunately, the mechanisms responsible for this hearing loss, which could be sensorineural and/or conductive, remain unclear. In this study, we used a unique transgenic mouse model of increased G(s) G-protein coupled receptor (GPCR) signaling induced by expression of an engineered receptor, Rs1, in osteoblastic cells. These ColI(2.3)(+)/Rs1(+) mice showed dramatic bone lesions that histologically and radiologically resembled fibrous dysplasia. We found that ColI(2.3)(+)/Rs1(+) mice showed progressive and severe conductive hearing loss. Ossicular chain impingement increased with the size and number of dysplastic lesions. While sensorineural structures were unaffected, ColI(2.3)(+)/Rs1(+) cochleae had abnormally high osteoclast activity, together with elevated tartrate resistant acid phosphatase (TRAP) activity and receptor activator of nuclear factor kappa-B ligand (Rankl) mRNA expression. ColI(2.3)(+)/Rs1(+) cochleae also showed decreased expression of Sclerostin (Sost), an antagonist of the Wnt signaling pathway that normally increases bone formation. The osteocyte canalicular networks of ColI(2.3)(+)/Rs1(+) cochleae were disrupted and showed abnormal osteocyte morphology. The osteocytes in the ColI(2.3)(+)/Rs1(+) cochleae showed increased expression of matrix metalloproteinase 13 (MMP-13) and TRAP, both of which can support osteocyte-mediated peri-lacunar remodeling. Thus, while the ossicular chain impingement is sufficient to account for the progressive hearing loss in fibrous dysplasia, the deregulation of bone remodeling extends to the cochlea as well. Our findings suggest that factors regulating bone remodeling, including peri-lacunar remodeling by osteocytes, may be useful targets for treating the bony overgrowths and hearing changes of fibrous dysplasia and other bony pathologies.	[Akil, Omar; Chang, Jolie; Lustig, Lawrence R.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94117 USA; [Hall-Glenn, Faith; Alliston, Tamara] Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA USA; [Li, Alfred; Chang, Wenhan] San Francisco VA Med Ctr, Endocrine Unit, San Francisco, CA USA; [Li, Alfred; Chang, Wenhan] San Francisco VA Med Ctr, Bone Imaging Core, San Francisco, CA USA; [Hsiao, Edward C.] Univ Calif San Francisco, Dept Med, Div Endocrinol & Metab, San Francisco, CA USA; [Hsiao, Edward C.] Univ Calif San Francisco, Inst Human Genet, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lustig, LR (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94117 USA.	llustig@ohns.ucsf.edu; tamara.alliston@ucsf.edu; Edward.Hsiao@ucsf.edu		Alliston, Tamara/0000-0001-9992-2897	Hearing Research Inc; NIH [R01 DE019284, K08 AR056299]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR050662, P30AR066262, K08AR056299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021353] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001960] Funding Source: NIH RePORTER	Hearing Research Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Hearing Research Inc (TA, LL), NIH R01 DE019284 (TA), and NIH K08 AR056299 (ECH). The funders had no role in study design, data collection/analysis, decision to publish, or preparation of the manuscript.	Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Akil O, 2012, NEUROSCI RES, V72, P296, DOI 10.1016/j.neures.2012.01.007; Akil O, 2006, J NEUROSCI, V26, P13076, DOI 10.1523/JNEUROSCI.3746-06.2006; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BELANGER LF, 1969, CALC TISS RES, V4, P1, DOI 10.1007/BF02279101; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Chang JL, 2010, EMBO REP, V11, P765, DOI 10.1038/embor.2010.135; Clayton AE, 2004, J LARYNGOL OTOL, V118, P617, DOI 10.1258/0022215041917790; COLE DEC, 1983, AM J MED GENET, V14, P725, DOI 10.1002/ajmg.1320140414; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Cullinane D. M., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P242; Cureoglu S, 2006, AM J OTOLARYNG, V27, P334, DOI 10.1016/j.amjoto.2005.11.001; Cureoglu S, 2010, CURR OPIN OTOLARYNGO, V18, P357, DOI 10.1097/MOO.0b013e32833d11d9; DiCaprio MR, 2005, J BONE JOINT SURG AM, V87A, P1848, DOI 10.2106/JBJS.D.02942; Driver EC, 2009, BIRTH DEFECTS RES C, V87, P212, DOI 10.1002/bdrc.20154; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Hsiao EC, 2008, P NATL ACAD SCI USA, V105, P1209, DOI 10.1073/pnas.0707457105; Hsiao EC, 2010, J BONE MINER RES, V25, P584, DOI 10.1002/jbmr.3; Hsiao EC, 2010, MOL ENDOCRINOL, V24, P621, DOI 10.1210/me.2009-0424; Inoue K, 2006, J BIOL CHEM, V281, P33814, DOI 10.1074/jbc.M607290200; Kao SY, 2013, NEUROBIOL DIS, V56, P25, DOI 10.1016/j.nbd.2013.04.008; Kazakia GJ, 2011, CALCIFIED TISSUE INT, V89, P10, DOI 10.1007/s00223-011-9487-z; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lietman SA, 2013, PEDIATR ENDOCR REV P, V10, P389; Lyford-Pike S, 2012, OTOLARYNG CLIN N AM, V45, P579, DOI 10.1016/j.otc.2012.03.002; MEGERIAN CA, 1995, AM J OTOL, V16, P408; Milovanovic P, 2013, ACS NANO; Morrissey DD, 1997, LARYNGOSCOPE, V107, P1336, DOI 10.1097/00005537-199710000-00008; Papadakis C E, 2000, Ear Nose Throat J, V79, P52; Pollandt K, 2001, VIRCHOWS ARCH, V439, P170, DOI 10.1007/s004280100453; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Qing H, 2009, INT J ORAL SCI, V1, P59, DOI 10.4248/ijos.09019; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Redfern CH, 2000, P NATL ACAD SCI USA, V97, P4826, DOI 10.1073/pnas.97.9.4826; Riddle ND, 2013, ARCH PATHOL LAB MED, V137, P134, DOI 10.5858/arpa.2012.0013-RS; Santos F, 2012, OTOL NEUROTOL, V33, P1562, DOI 10.1097/MAO.0b013e31826bf19b; SORENSEN MS, 1994, ACTA OTO-LARYNGOL, P1; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Tang S, 2012, J BONE MINERAL RES O; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Lierop AH, 2013, J BONE MINER RES, V28, P848, DOI 10.1002/jbmr.1794; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Weinstein LS, 2006, J BONE MINER RES, V21, pP120, DOI 10.1359/JBMR.06S223; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096; Zehnder AF, 2006, LARYNGOSCOPE, V116, P201, DOI 10.1097/01.mlg.0000191466.09210.9a; Zehnder AF, 2005, LARYNGOSCOPE, V115, P172, DOI 10.1097/01.mlg.0000150702.28451.35; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	54	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94989	10.1371/journal.pone.0094989	http://dx.doi.org/10.1371/journal.pone.0094989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788917	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600023
J	Akiyama, T; Shiraishi, T; Qin, JW; Konno, H; Akiyama, N; Shinzawa, M; Miyauchi, M; Takizawa, N; Yanai, H; Ohashi, H; Miyamoto-Sato, E; Yanagawa, H; Yong, WD; Shou, WN; Inoue, J				Akiyama, Taishin; Shiraishi, Takuma; Qin, Junwen; Konno, Hiroyasu; Akiyama, Nobuko; Shinzawa, Miho; Miyauchi, Maki; Takizawa, Nobukazu; Yanai, Hiromi; Ohashi, Hiroyuki; Miyamoto-Sato, Etsuko; Yanagawa, Hiroshi; Yong, Weidong; Shou, Weinian; Inoue, Jun-ichiro			Mitochondria-Nucleus Shuttling FK506-Binding Protein 51 Interacts with TRAF Proteins and Facilitates the RIG-I-Like Receptor-Mediated Expression of Type I IFN	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSES; ANTIVIRAL RESPONSES; BIOLOGICAL FUNCTIONS; SIGNAL-TRANSDUCTION; IMMUNOPHILIN FKBP51; ADAPTER PROTEIN; RNA; INTERFERON; RECOGNITION	Virus-derived double-stranded RNAs (dsRNAs) are sensed in the cytosol by retinoic acid-inducible gene (RIG)-I-like receptors (RLRs). These induce the expression of type I IFN and proinflammatory cytokines through signaling pathways mediated by the mitochondrial antiviral signaling (MAVS) protein. TNF receptor-associated factor (TRAF) family proteins are reported to facilitate the RLR-dependent expression of type I IFN by interacting with MAVS. However, the precise regulatory mechanisms remain unclear. Here, we show the role of FK506-binding protein 51 (FKBP51) in regulating the dsRNA-dependent expression of type I IFN. The binding of FKBP51 to TRAF6 was first identified by "in vitro virus" selection and was subsequently confirmed with a coimmunoprecipitation assay in HEK293T cells. The TRAF-C domain of TRAF6 is required for its interaction, although FKBP51 does not contain the consensus motif for interaction with the TRAF-C domain. Besides TRAF6, we found that FKBP51 also interacts with TRAF3. The depletion of FKBP51 reduced the expression of type I IFN induced by dsRNA transfection or Newcastle disease virus infection in murine fibroblasts. Consistent with this, the FKBP51 depletion attenuated dsRNA-mediated phosphorylations of IRF3 and JNK and nuclear translocation of RelA. Interestingly, dsRNA stimulation promoted the accumulation of FKBP51 in the mitochondria. Moreover, the overexpression of FKBP51 inhibited RLR-dependent transcriptional activation, suggesting a scaffolding function for FKBP51 in the MAVS-mediated signaling pathway. Overall, we have demonstrated that FKBP51 interacts with TRAF proteins and facilitates the expression of type I IFN induced by cytosolic dsRNA. These findings suggest a novel role for FKBP51 in the innate immune response to viral infection.	[Akiyama, Taishin; Shiraishi, Takuma; Qin, Junwen; Konno, Hiroyasu; Akiyama, Nobuko; Shinzawa, Miho; Miyauchi, Maki; Takizawa, Nobukazu; Yanai, Hiromi; Inoue, Jun-ichiro] Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo, Japan; [Qin, Junwen] Minist Educ, Key Lab Regenerat Med, Dept Dev & Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Qin, Junwen] Minist Sci & Technol, Int Base Collaborat Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Qin, Junwen] Jinan Univ, Guangzhou, Guangdong, Peoples R China; [Ohashi, Hiroyuki; Miyamoto-Sato, Etsuko] Univ Tokyo, Inst Med Sci, Div Interactome Med Sci, Minato Ku, Tokyo, Japan; [Yanagawa, Hiroshi] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Yokohama, Kanagawa 223, Japan; [Yong, Weidong; Shou, Weinian] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	University of Tokyo; Jinan University; University of Tokyo; Keio University; Indiana University System; Indiana University Bloomington	Akiyama, T (corresponding author), Univ Tokyo, Inst Med Sci, Div Cellular & Mol Biol, Minato Ku, Tokyo, Japan.	taishin@ims.u-tokyo.ac.jp; jun-i@ims.u-tokyo.ac.jp			Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases from MEXT; Grants-in-Aid for Scientific Research [24390071, 22117002, 26670234] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases from MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Society for the Promotion of Science (T. A.); a Grant-in-Aid for Challenging Exploratory Research (T. A.); a grant for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (J-i.I.); a Grant-in-Aid for Scientific Research on Innovative Areas from MEXT (J-i.I.); and a contract research fund for the Program of Japan Initiative for Global Research Network on Infectious Diseases from MEXT (J-i.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Ferrell J E Jr, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.52.pe1; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Galigniana NM, 2012, J NEUROCHEM, V122, P4, DOI 10.1111/j.1471-4159.2012.07775.x; Gallo LI, 2011, J BIOL CHEM, V286, P30152, DOI 10.1074/jbc.M111.256610; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mikkelsen SS, 2009, J BIOL CHEM, V284, P10774, DOI 10.1074/jbc.M807272200; Miyamoto-Sato E, 2005, GENOME RES, V15, P710, DOI 10.1101/gr.3510505; Miyamoto-Sato E, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng078; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Paz S, 2011, CELL RES, V21, P895, DOI 10.1038/cr.2011.2; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Romano S, 2011, CURR MED CHEM, V18, P5424, DOI 10.2174/092986711798194333; Romano S, 2010, CELL DEATH DIFFER, V17, P145, DOI 10.1038/cdd.2009.115; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tang ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009172; Wang LW, 2011, CURR OPIN PHARMACOL, V11, P360, DOI 10.1016/j.coph.2011.03.008; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamazaki K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000387; Yang K, 2006, MOL BIOL CELL, V17, P1461, DOI 10.1091/mbc.E05-09-0853; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200	47	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95992	10.1371/journal.pone.0095992	http://dx.doi.org/10.1371/journal.pone.0095992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788966	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600062
J	Deng, N; Weaver, JM; Mosmann, TR				Deng, Nan; Weaver, Jason M.; Mosmann, Tim R.			Cytokine Diversity in the Th1-Dominated Human Anti-Influenza Response Caused by Variable Cytokine Expression by Th1 Cells, and a Minor Population of Uncommitted IL-2+IFN gamma-Thpp Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; INFLUENZA-VIRUS INFECTION; CXC CHEMOKINE RECEPTOR-5; GAMMA-SECRETING CELLS; MEMORY STEM-CELLS; MONOALLELIC EXPRESSION; B-CELLS; EFFECTOR; GENE; IL-4	Within overall Th1-like human memory T cell responses, individual T cells may express only some of the characteristic Th1 cytokines when reactivated. In the Th1-oriented memory response to influenza, we have tested the contributions of two potential mechanisms for this diversity: variable expression of cytokines by a uniform population during activation, or different stable subsets that consistently expressed subsets of the Th1 cytokine pattern. To test for short-term variability, in vitro-stimulated influenza-specific human memory CD4+ T cells were sorted according to IL-2 and IFN gamma expression, cultured briefly in vitro, and cytokine patterns measured after restimulation. Cells that were initially IFN gamma+ and either IL-2+ or IL-2- converged rapidly, containing similar proportions of IL-2-IFN gamma+ and IL-2+IFN gamma+ cells after culture and restimulation. Both phenotypes expressed Tbet, and similar patterns of mRNA. Thus variability of IL-2 expression in IFN gamma+ cells appeared to be regulated more by short-term variability than by stable differentiated subsets. In contrast, heterogeneous expression of IFN gamma in IL-2+ influenza-specific T cells appeared to be due partly to stable T cell subsets. After sorting, culture and restimulation, influenza-specific IL-2+IFN gamma- and IL-2+IFN gamma+ cells maintained significantly biased ratios of IFN gamma+ and IFN gamma- cells. IL-2+IFN gamma-cells included both Tbet(lo) and Tbet(hi) cells, and showed more mRNA expression differences with either of the IFN gamma+ populations. To test whether IL-2+IFN gamma-Tbet(lo) cells were Thpp cells (primed but uncommitted memory cells, predominant in responses to protein vaccines), influenza-specific IL-2+IFN gamma- and IL-2+IFN gamma+ T cells were sorted and cultured in Th1- or Th2-generating conditions. Both cell types yielded IFN gamma-secreting cells in Th1 conditions, but only IL-2+IFN gamma- cells were able to differentiate into IL-4-producing cells. Thus expression of IL-2 in the anti-influenza response may be regulated mainly by short term variability, whereas different T cell subsets, Th1 and Thpp, may contribute to variability in IFN gamma expression.	[Deng, Nan; Weaver, Jason M.; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester	Mosmann, TR (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	Tim_Mosmann@urmc.rochester.edu			Rochester Human Immunology Center from the National Institute for Allergy and Infectious Diseases; New York Influenza Center of Excellence from the National Institute for Allergy and Infectious Diseases [HHSN266200700008C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI054953] Funding Source: NIH RePORTER	Rochester Human Immunology Center from the National Institute for Allergy and Infectious Diseases; New York Influenza Center of Excellence from the National Institute for Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Rochester Human Immunology Center (R24AI054953) from the National Institute for Allergy and Infectious Diseases and New York Influenza Center of Excellence (HHSN266200700008C) from the National Institute for Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; ALLAN W, 1990, J IMMUNOL, V144, P3980; Bakocevic N, 2010, J IMMUNOL, V184, P1317, DOI 10.4049/jimmunol.0902277; Bayley JP, 2003, J IMMUNOL, V171, P2349, DOI 10.4049/jimmunol.171.5.2349; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Caserta S, 2010, J IMMUNOL, V185, P6545, DOI 10.4049/jimmunol.1001867; CROFT M, 1991, J IMMUNOL, V146, P4055; Damjanovic D, 2012, CLIN IMMUNOL, V144, P57, DOI 10.1016/j.clim.2012.05.005; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Herve MGD, 2010, J IMMUNOL, V185, P1028, DOI 10.4049/jimmunol.0904209; Derrick SC, 2011, VACCINE; DiethelmOkita BM, 1997, J INFECT DIS, V175, P382, DOI 10.1093/infdis/175.2.382; Divekar AA, 2006, J IMMUNOL, V176, P1465, DOI 10.4049/jimmunol.176.3.1465; Fearon DT, 2006, IMMUNOL REV, V211, P104, DOI 10.1111/j.0105-2896.2006.00390.x; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Gazagne A, 2003, J IMMUNOL METHODS, V283, P91, DOI 10.1016/j.jim.2003.08.013; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Han S, 2010, P NATL ACAD SCI USA, V107, P20453, DOI 10.1073/pnas.1008437107; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Hua LQ, 2013, J VIROL, V87, P11884, DOI 10.1128/JVI.01461-13; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; Jeong YH, 2014, INFECT IMMUN, V82, P132, DOI 10.1128/IAI.00480-13; JUNG T, 1995, EUR J IMMUNOL, V25, P2413, DOI 10.1002/eji.1830250843; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Kruman II, 1996, CELL IMMUNOL, V173, P236, DOI 10.1006/cimm.1996.0273; Lugli E, 2013, NAT PROTOC, V8, P33, DOI 10.1038/nprot.2012.143; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Matesanz F, 2000, EUR J IMMUNOL, V30, P3516, DOI 10.1002/1521-4141(2000012)30:12<3516::AID-IMMU3516>3.0.CO;2-S; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mosmann TR, 2009, IMMUNOL RES; Mozdzanowska K, 2000, J IMMUNOL, V164, P2635, DOI 10.4049/jimmunol.164.5.2635; Nakayama K, 2012, AIDS RES HUM RETROV, V28, P702, DOI [10.1089/aid.2011.0073, 10.1089/AID.2011.0073]; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Paixao T, 2007, IMMUNOL CELL BIOL, V85, P315, DOI 10.1038/sj.icb.7100057; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Rebhahn JA, 2008, COMPUT METH PROG BIO, V92, P54, DOI 10.1016/j.cmpb.2008.06.002; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Rivino L, 2004, J EXP MED, V200, P725, DOI 10.1084/jem.20040774; SAD S, 1994, J IMMUNOL, V153, P3514; Sakai H, 2012, INT IMMUNOL, V24, P5, DOI 10.1093/intimm/dxr088; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Teijaro JR, 2010, J VIROL, V84, P9217, DOI 10.1128/JVI.01069-10; Thaventhiran JED, 2013, CURR OPIN IMMUNOL, V25, P321, DOI 10.1016/j.coi.2013.05.010; Topham DJ, 1998, J VIROL, V72, P882, DOI 10.1128/JVI.72.1.882-885.1998; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Unsoeld H, 2002, J IMMUNOL, V169, P638, DOI 10.4049/jimmunol.169.2.638; Veldhoen M, 2006, J IMMUNOL, V176, P6202, DOI 10.4049/jimmunol.176.10.6202; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XW, 2001, J EXP MED, V194, P1069, DOI 10.1084/jem.194.8.1069; Weaver JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057275; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zaph C, 2006, J IMMUNOL, V177, P511, DOI 10.4049/jimmunol.177.1.511; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326	67	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95986	10.1371/journal.pone.0095986	http://dx.doi.org/10.1371/journal.pone.0095986			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788814	Green Published, Green Submitted, gold			2022-12-27	WOS:000335510600060
J	Fu, XP; Wang, DC; Yin, XL; Du, PC; Kan, BA				Fu, Xiuping; Wang, Duochun; Yin, Xiling; Du, Pengcheng; Kan, Biao			Time Course Transcriptome Changes in Shewanella algae in Response to Salt Stress	PLOS ONE			English	Article							ESCHERICHIA-COLI; ONEIDENSIS MR-1; SHOCK RESPONSE; SP NOV.; HYPERSALINE; REDUCTION; SALINITY; SEA; OSMOADAPTATION; OVEREXPRESSION	Shewanella algae, which produces tetrodotoxin and exists in various seafoods, can cause human diseases, such as spondylodiscitis and bloody diarrhea. In the present study, we focused on the temporal, dynamic process in salt-stressed S. algae by monitoring the gene transcript levels at different time points after high salt exposure. Transcript changes in amino acid metabolism, carbohydrate metabolism, energy metabolism, membrane transport, regulatory functions, and cellular signaling were found to be important for the high salt response in S. algae. The most common strategies used by bacteria to survive and grow in high salt environments, such as Na+ efflux, K+ uptake, glutamate transport and biosynthesis, and the accumulation of compatible solutes, were also observed in S. algae. In particular, genes involved in peptidoglycan biosynthesis and DNA repair were highly and steadily up-regulated, accompanied by rapid and instantaneous enhancement of the transcription of large- and small-ribosome subunits, which suggested that the structural changes in the cell wall and some stressful responses occurred in S. algae. Furthermore, the transcription of genes involved in the tricarboxylic acid (TCA) cycle and the glycolytic pathway was decreased, whereas the transcription of genes involved in anaerobic respiration was increased. These results, demonstrating the multi-pathway reactions of S. algae in response to salt stress, increase our understanding of the microbial stress response mechanisms.	[Fu, Xiuping; Wang, Duochun; Du, Pengcheng; Kan, Biao] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Fu, Xiuping; Wang, Duochun; Du, Pengcheng; Kan, Biao] Univ Tokyo, Collaborat Innovat Ctr Diag & Treatment Infect Di, Bunkyo Ku, Tokyo 113, Japan; [Yin, Xiling] Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 113, Japan	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Tokyo; University of Tokyo	Kan, BA (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	kanbiao@icdc.cn		Yin, Xiling/0000-0002-3942-8210	Priority Project on Infectious Disease Control and Prevention [2012ZX10004215]	Priority Project on Infectious Disease Control and Prevention	This study was supported by the Priority Project on Infectious Disease Control and Prevention (2012ZX10004215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basir N, 2012, J MICROBIOL IMMUNOL, V45, P151, DOI 10.1016/j.jmii.2011.09.007; Dikow RB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-237; EPSTEIN W, 1992, ACTA PHYSIOL SCAND, V146, P193; Gao H., 2011, INT J MICROBIOL, V2011; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gressier M, INT J INFECT DIS S3, V14, pe261; Hase Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065747; Hase Y, 2009, RNA, V15, P1766, DOI 10.1261/rna.1687309; He Z, 2011, APPL ENVIRON MICROB, V76, P1574; Hengge R, 2009, RES MICROBIOL, V160, P667, DOI 10.1016/j.resmic.2009.08.014; Hengge-Aronis R, 2002, J MOL MICROB BIOTECH, V4, P341; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Jiang HC, 2007, ENVIRON MICROBIOL, V9, P2603, DOI 10.1111/j.1462-2920.2007.01377.x; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Kulp TR, 2006, APPL ENVIRON MICROB, V72, P6514, DOI 10.1128/AEM.01066-06; Leblanc L, 2003, CURR MICROBIOL, V46, P157, DOI 10.1007/s00284-002-3837-z; Lefebvre O, 2006, EXTREMOPHILES, V10, P505, DOI 10.1007/s00792-006-0524-1; Li SK, 2006, EXTREMOPHILES, V10, P97, DOI 10.1007/s00792-005-0476-x; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukhopadhyay A, 2006, J BACTERIOL, V188, P4068, DOI 10.1128/JB.01921-05; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; Nandakumar R, 1999, PROTEIN EXPRES PURIF, V15, P155, DOI 10.1006/prep.1998.1005; Nath R, 2011, INDIAN J MED MICROBI, V29, P422, DOI 10.4103/0255-0857.90186; Pagani L, 2003, J CLIN MICROBIOL, V41, P2240, DOI 10.1128/JCM.41.5.2240-2241.2003; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; Shrishrimal K, 2012, HEMODIAL INT, V16, P113, DOI 10.1111/j.1542-4758.2011.00586.x; Skerratt JH, 2002, INT J SYST EVOL MICR, V52, P2101, DOI [10.1099/ijs.0.02351-0, 10.1099/00207713-52-6-2101]; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Van der Heide T, 2000, J BACTERIOL, V182, P203, DOI 10.1128/JB.182.1.203-206.2000; Verma P, 2011, INT J SYST EVOL MICR, V61, P2058, DOI 10.1099/ijs.0.026310-0; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Wang DC, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-15; Wang Yong-Lu, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P836; Yamada M, 2000, J BACTERIOL, V182, P2945, DOI 10.1128/JB.182.10.2945-2952.2000; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x; Zong ZY, 2011, J MED MICROBIOL, V60, P1387, DOI 10.1099/jmm.0.031625-0	42	33	36	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96001	10.1371/journal.pone.0096001	http://dx.doi.org/10.1371/journal.pone.0096001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789066	gold, Green Published, Green Submitted			2022-12-27	WOS:000335510600063
J	Gutierrez-Gil, B; Arranz, JJ; Pong-Wong, R; Garcia-Gamez, E; Kijas, J; Wiener, P				Gutierrez-Gil, Beatriz; Jose Arranz, Juan; Pong-Wong, Ricardo; Garcia-Gamez, Elsa; Kijas, James; Wiener, Pamela			Application of Selection Mapping to Identify Genomic Regions Associated with Dairy Production in Sheep	PLOS ONE			English	Article							MILK-PRODUCTION TRAITS; ARTIFICIAL SELECTION; CANDIDATE GENES; STEAROYL-COENZYME; IDENTIFICATION; SIGNATURES; LOCI; POLYMORPHISM; EXPRESSION; CATTLE	In Europe, especially in Mediterranean areas, the sheep has been traditionally exploited as a dual purpose species, with income from both meat and milk. Modernization of husbandry methods and the establishment of breeding schemes focused on milk production have led to the development of "dairy breeds.'' This study investigated selective sweeps specifically related to dairy production in sheep by searching for regions commonly identified in different European dairy breeds. With this aim, genotypes from 44,545 SNP markers covering the sheep autosomes were analysed in both European dairy and non-dairy sheep breeds using two approaches: (i) identification of genomic regions showing extreme genetic differentiation between each dairy breed and a closely related non-dairy breed, and (ii) identification of regions with reduced variation (heterozygosity) in the dairy breeds using two methods. Regions detected in at least two breeds (breed pairs) by the two approaches (genetic differentiation and at least one of the heterozygosity-based analyses) were labeled as core candidate convergence regions and further investigated for candidate genes. Following this approach six regions were detected. For some of them, strong candidate genes have been proposed (e. g. ABCG2, SPP1), whereas some other genes designated as candidates based on their association with sheep and cattle dairy traits (e. g. LALBA, DGAT1A) were not associated with a detectable sweep signal. Few of the identified regions were coincident with QTL previously reported in sheep, although many of them corresponded to orthologous regions in cattle where QTL for dairy traits have been identified. Due to the limited number of QTL studies reported in sheep compared with cattle, the results illustrate the potential value of selection mapping to identify genomic regions associated with dairy traits in sheep.	[Gutierrez-Gil, Beatriz; Jose Arranz, Juan; Garcia-Gamez, Elsa] Univ Leon, Dpto Prod Anim, E-24071 Leon, Spain; [Pong-Wong, Ricardo; Wiener, Pamela] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Pong-Wong, Ricardo; Wiener, Pamela] Univ Edinburgh, RDSVS, Roslin, Midlothian, Scotland; [Kijas, James] CSIRO, Brisbane, Qld, Australia	Universidad de Leon; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gutierrez-Gil, B (corresponding author), Univ Leon, Dpto Prod Anim, E-24071 Leon, Spain.	beatriz.gutierrez@unileon.es	Arranz, Juan-Jose/H-1225-2015; Kijas, James W/A-4656-2011; Gutierrez, Beatriz/AAU-1711-2021	Arranz, Juan-Jose/0000-0001-9058-131X; Kijas, James W/0000-0002-1417-8278; Pong-Wong, Ricardo/0000-0001-9808-2742; Gutierrez-Gil, Beatriz/0000-0001-7990-5723; Castro-Lopez, Luisa/0000-0001-6356-1794	Spanish Ministry of Economy and Competitiveness [AGL2009-07000]; UK Biotechnology and Biological Sciences Research Council (BBSRC); European Science Foundation [EX/3723]; Spanish Ministry of Economy and Competitiveness (State Secretariat for Research, Development and Innovation); Biotechnology and Biological Sciences Research Council [BBS/E/D/05191132] Funding Source: researchfish; BBSRC [BBS/E/D/05191132] Funding Source: UKRI	Spanish Ministry of Economy and Competitiveness(Spanish Government); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Science Foundation(European Science Foundation (ESF)European Commission); Spanish Ministry of Economy and Competitiveness (State Secretariat for Research, Development and Innovation)(Spanish Government); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge support from the Spanish Ministry of Economy and Competitiveness (Project AGL2009-07000), Institute Strategic Grant funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC) and the financial support of the European Science Foundation through the GENOMIC-RESOURCES Exchange Grant awarded to Beatriz Gutierrez (EX/3723). BGG is funded through the Spanish "Ramon y Cajal'' Programme from the Spanish Ministry of Economy and Competitiveness (State Secretariat for Research, Development and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Alim MA, 2012, MOL BIOL REP, V39, P8733, DOI 10.1007/s11033-012-1733-6; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Barillet F., 1997, P539; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Carta A, 2006, P 8 WORLD C GEN APPL; Debies MT, 2001, J MAMMARY GLAND BIOL, V6, P441, DOI 10.1023/A:1014739131690; DOROW DS, 1993, EUR J BIOCHEM, V213, P701, DOI 10.1111/j.1432-1033.1993.tb17810.x; Dybus A, 2006, ARCH TIERZUCHT, V49, P434, DOI 10.5194/aab-49-434-2006; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Elferink MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032720; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Garcia-Fernandez M, 2011, ANIM GENET, V42, P415, DOI 10.1111/j.1365-2052.2010.02162.x; Garcia-Fernandez M, 2010, J DAIRY SCI, V93, P348, DOI 10.3168/jds.2009-2490; Garcia-Gamez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047782; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gutierrez-Gil B, 2012, ANIM GENET, V43, P654, DOI 10.1111/j.1365-2052.2012.02322.x; Gutierrez-Gil B, 2009, ANIM GENET, V40, P423, DOI 10.1111/j.1365-2052.2009.01856.x; Hayes BJ, 2009, ANIM GENET, V40, P176, DOI 10.1111/j.1365-2052.2008.01815.x; Ida A, 2012, LUCRARI STIINTTIFI Z, V57, P17; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kowalewska-Luczak I, 2013, RES VET SCI, V94, P252, DOI 10.1016/j.rvsc.2012.08.006; Lahlou H, 2012, CANCER RES, V72, P3080, DOI 10.1158/0008-5472.CAN-11-3513; Legge T., 1996, ORIGINS SPREAD AGR P, P238; Li PH, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-6; Maijala K., 1997, GENETICS SHEEP, P539; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; Moioli B, 2007, J DAIRY SCI, V90, P3553, DOI 10.3168/jds.2006-855; Moioli B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-76; Moradi MH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-10; Nafikov RA, 2013, J DAIRY SCI, V96, P6007, DOI 10.3168/jds.2013-6703; Norris BJ, 2008, GENOME RES, V18, P1282, DOI 10.1101/gr.072090.107; Odintsova E, 2003, J CELL SCI, V116, P4557, DOI 10.1242/jcs.00793; Ogorevc J, 2009, ANIM GENET, V40, P832, DOI 10.1111/j.1365-2052.2009.01921.x; Olsen HG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-32; PAYNE RW, 2007, GENSTAT WINDOWS INTR; Pryce JE, 2011, GENETICS, V187, P981, DOI 10.1534/genetics.110.123943; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Raadsma HW, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-45; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schaer DJ, 2006, BLOOD, V107, P373, DOI 10.1182/blood-2005-03-1014; Schwerin M, 2003, GENET SEL EVOL, V35, pS19, DOI 10.1051/gse:2003014; Sheehy PA, 2009, ANIM GENET, V40, P492, DOI 10.1111/j.1365-2052.2009.01862.x; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Sumner-Thomson JM, 2011, J DAIRY SCI, V94, P361, DOI 10.3168/jds.2010-3447; Szatkowska I, 2009, J APPL ANIM RES, V36, P119, DOI 10.1080/09712119.2009.9707044; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiener P, 2011, J HERED, V102, P294, DOI 10.1093/jhered/esr014; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; Wolff GL, 1999, PHYSIOL GENOMICS, V1, P151, DOI 10.1152/physiolgenomics.1999.1.3.151; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Yang TL, 2010, ANN HUM GENET, V74, P11, DOI 10.1111/j.1469-1809.2009.00555.x; Zheng JM, 2006, INFECT IMMUN, V74, P1907, DOI 10.1128/IAI.74.3.1907-1915.2006	62	41	43	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94623	10.1371/journal.pone.0094623	http://dx.doi.org/10.1371/journal.pone.0094623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788864	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600016
J	Kasper, L; Seider, K; Gerwien, F; Allert, S; Brunke, S; Schwarzmuller, T; Ames, L; Zubiria-Barrera, C; Mansour, MK; Becken, U; Barz, D; Vyas, JM; Reiling, N; Haas, A; Haynes, K; Kuchler, K; Hube, B				Kasper, Lydia; Seider, Katja; Gerwien, Franziska; Allert, Stefanie; Brunke, Sascha; Schwarzmueller, Tobias; Ames, Lauren; Zubiria-Barrera, Cristina; Mansour, Michael K.; Becken, Ulrike; Barz, Dagmar; Vyas, Jatin M.; Reiling, Norbert; Haas, Albert; Haynes, Ken; Kuchler, Karl; Hube, Bernhard			Identification of Candida glabrata Genes Involved in pH Modulation and Modification of the Phagosomal Environment in Macrophages	PLOS ONE			English	Article							KAPPA-B ACTIVATION; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; HISTOPLASMA-CAPSULATUM; INVASIVE CANDIDIASIS; IMMUNE-RESPONSE; INNATE IMMUNE; HOST-DEFENSE; MATURATION; EPIDEMIOLOGY	Candida glabrata currently ranks as the second most frequent cause of invasive candidiasis. Our previous work has shown that C. glabrata is adapted to intracellular survival in macrophages and replicates within non-acidified late endosomal-stage phagosomes. In contrast, heat killed yeasts are found in acidified matured phagosomes. In the present study, we aimed at elucidating the processes leading to inhibition of phagosome acidification and maturation. We show that phagosomes containing viable C. glabrata cells do not fuse with pre-labeled lysosomes and possess low phagosomal hydrolase activity. Inhibition of acidification occurs independent of macrophage type (human/murine), differentiation (M1-/M2-type) or activation status (vitamin D-3 stimulation). We observed no differential activation of macrophage MAPK or NF kappa B signaling cascades downstream of pattern recognition receptors after internalization of viable compared to heat killed yeasts, but Syk activation decayed faster in macrophages containing viable yeasts. Thus, delivery of viable yeasts to non-matured phagosomes is likely not triggered by initial recognition events via MAPK or NF kappa B signaling, but Syk activation may be involved. Although V-ATPase is abundant in C. glabrata phagosomes, the influence of this proton pump on intracellular survival is low since blocking V-ATPase activity with bafilomycin A1 has no influence on fungal viability. Active pH modulation is one possible fungal strategy to change phagosome pH. In fact, C. glabrata is able to alkalinize its extracellular environment, when growing on amino acids as the sole carbon source in vitro. By screening a C. glabrata mutant library we identified genes important for environmental alkalinization that were further tested for their impact on phagosome pH. We found that the lack of fungal mannosyltransferases resulted in severely reduced alkalinization in vitro and in the delivery of C. glabrata to acidified phagosomes. Therefore, protein mannosylation may play a key role in alterations of phagosomal properties caused by C. glabrata.	[Kasper, Lydia; Seider, Katja; Gerwien, Franziska; Allert, Stefanie; Brunke, Sascha; Zubiria-Barrera, Cristina; Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Univ Hosp, Ctr Sepsis Control & Care, Integrated Res & Treatment Ctr, Jena, Germany; [Schwarzmueller, Tobias; Kuchler, Karl] Med Univ, Max F Perutz Labs, Dept Med Biochem, Vienna, Austria; [Ames, Lauren; Haynes, Ken] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Mansour, Michael K.; Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Becken, Ulrike] Labs Constant Burg, Paris, France; [Barz, Dagmar] Univ Hosp, Inst Transfus Med, Jena, Germany; [Reiling, Norbert] Res Ctr Borstel, Leibniz Ctr Med & Biosci, Div Microbial Interface Biol, Borstel, Germany; [Haas, Albert] Univ Bonn, Inst Cell Biol, Bonn, Germany; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Exeter; Harvard University; Massachusetts General Hospital; Friedrich Schiller University of Jena; Forschungszentrum Borstel; University of Bonn; Friedrich Schiller University of Jena	Hube, B (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	bernhard.hube@hki-jena.de	Vyas, Jatin/Q-1627-2016; Reiling, Norbert/D-6796-2013; kuchler, karl/AAL-6937-2020; Brunke, Sascha/G-1486-2012	Vyas, Jatin/0000-0002-9985-9565; Reiling, Norbert/0000-0001-6673-4291; kuchler, karl/0000-0003-2719-5955; Brunke, Sascha/0000-0001-7740-4570; Hube, Bernhard/0000-0002-6028-0425	Deutsche Forschungsgemeinschaft [Hu 528/15-1, 16-1, Ha 1929/11-1, Re 1228/5-1, SPP1580]; National Institutes of Health [NIAID 1K08AI110655, 1R01AI079198, 1R01AI092084]; Wellcome Trust [097377/Z/11/Z]; BBSRC [BB/F005210/1];  [FWF-I 746-B11-DACH]; BBSRC [BB/H53146X/1, BB/H53146X/2, BB/F005210/2] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079198, R01AI092084, T32AI007061, R01AI097519, K08AI110655] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [I 746] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/H53146X/2, BB/H53146X/1, BB/F005210/1, BB/F005210/2, BBS/B/10331] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was mainly supported by grants from the Deutsche Forschungsgemeinschaft to B. H. (Hu 528/15-1 and 16-1), A. H. (Ha 1929/11-1) and N.R. (Re 1228/5-1) within the priority program SPP1580 (www.spp1580.uni-bonn.de). Further, this work was in part supported by National Institutes of Health grants NIAID 1K08AI110655 (M. K. M.), 1R01AI079198 (J.M.V.), and 1R01AI092084 (J.M.V.). K. K. was funded by FWF-I 746-B11-DACH. Work in the Haynes lab was supported by grants from The Wellcome Trust (097377/Z/11/Z) and BBSRC (BB/F005210/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup M, 2002, INFECTION, V30, P286, DOI 10.1007/s15010-002-2131-0; Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Bairwa G, 2011, MOL MICROBIOL, V79, P900, DOI 10.1111/j.1365-2958.2010.07496.x; Bartkeviciute D, 2004, FEMS YEAST RES, V4, P833, DOI 10.1016/j.femsyr.2004.03.001; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485, DOI 10.1002/jlb.42.5.485; EISSENBERG LG, 1993, J EXP MED, V177, P1605, DOI 10.1084/jem.177.6.1605; Feldmesser M, 2001, TRENDS MICROBIOL, V9, P273, DOI 10.1016/S0966-842X(01)02035-2; Fernandez-Mora E, 2005, TRAFFIC, V6, P635, DOI 10.1111/j.1600-0854.2005.00304.x; Filler SG, 2006, CURR OPIN MICROBIOL, V9, P333, DOI 10.1016/j.mib.2006.06.005; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Gracey E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069421; Grim SA, 2012, J ANTIMICROB CHEMOTH, V67, P707, DOI 10.1093/jac/dkr511; Gumbo T, 2002, SCAND J INFECT DIS, V34, P817, DOI 10.1080/0036554021000026936; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Haynes K, 2001, TRENDS MICROBIOL, V9, P591, DOI 10.1016/S0966-842X(01)02237-5; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Horn DL, 2009, CLIN INFECT DIS, V48, P1695, DOI 10.1086/599039; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Ibata-Ombetta S, 2001, J LEUKOCYTE BIOL, V70, P149; Ifrim DC, 2014, INFECT IMMUN, V82, P1064, DOI 10.1128/IAI.01189-13; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Jungmann J, 1999, J BIOL CHEM, V274, P6579, DOI 10.1074/jbc.274.10.6579; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kingeter LM, 2012, CELL MOL IMMUNOL, V9, P105, DOI 10.1038/cmi.2011.58; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Lesage P, 1996, MOL CELL BIOL, V16, P1921, DOI 10.1128/mcb.16.5.1921; Lewis RE, 2012, VIRULENCE, V3, P368, DOI 10.4161/viru.20746; MANGELSDORF DJ, 1984, J CELL BIOL, V98, P391, DOI 10.1083/jcb.98.2.391; Mansour MK, 2013, J BIOL CHEM, V288, P16043, DOI 10.1074/jbc.M113.473223; MARODI L, 1993, J CLIN INVEST, V91, P2596, DOI 10.1172/JCI116498; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Naumann M, 2000, BIOCHEM PHARMACOL, V60, P1109, DOI 10.1016/S0006-2952(00)00390-7; Netea MG, 2002, J INFECT DIS, V185, P1483, DOI 10.1086/340511; NEWMAN SL, 1994, J CLIN INVEST, V93, P1422, DOI 10.1172/JCI117119; OTTO V, 1976, INFECT IMMUN, V14, P433, DOI 10.1128/IAI.14.2.433-438.1976; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rai MN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002863; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Roeder A, 2004, J INFECT DIS, V190, P1318, DOI 10.1086/423854; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; ROOK GAW, 1986, IMMUNOLOGY, V57, P159; Schneider B, 2007, TRAFFIC, V8, P226, DOI 10.1111/j.1600-0854.2006.00525.x; Seider K, 2010, CURR OPIN MICROBIOL; Seider K, 2014, EUKARYOT CELL, V13, P170, DOI 10.1128/EC.00262-13; Seider K, 2011, J IMMUNOL, V187, P3072, DOI 10.4049/jimmunol.1003730; Steinbach WJ, 2012, PEDIATR INFECT DIS J, V31, P1252, DOI 10.1097/INF.0b013e3182737427; Strasser JE, 1999, J IMMUNOL, V162, P6148; Tucker SC, 2002, P NATL ACAD SCI USA, V99, P3165, DOI 10.1073/pnas.052702799; Underhill DM, 2005, IMMUNITY, V23, P343, DOI 10.1016/j.immuni.2005.09.011; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vylkova S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003995; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; Welin A, 2008, INFECT IMMUN, V76, P2882, DOI 10.1128/IAI.01549-07; West L, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.478743; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	64	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96015	10.1371/journal.pone.0096015	http://dx.doi.org/10.1371/journal.pone.0096015			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789333	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600065
J	Pan, HH; Chen, CT; Sun, HL; Ku, MS; Liao, PF; Lu, KH; Sheu, JN; Huang, JY; Pai, JY; Lue, KH				Pan, Hui-Hsien; Chen, Chun-Tzu; Sun, Hai-Lun; Ku, Min-Sho; Liao, Pei-Fen; Lu, Ko-Hsiu; Sheu, Ji-Nan; Huang, Jing-Yang; Pai, Jar-Yuan; Lue, Ko-Huang			Comparison of the Effects of Air Pollution on Outpatient and Inpatient Visits for Asthma: A Population-Based Study in Taiwan	PLOS ONE			English	Article							EMERGENCY-ROOM VISITS; COARSE PARTICULATE MATTER; HEALTH-CARE UTILIZATION; HOSPITAL ADMISSIONS; TIME-SERIES; HONG-KONG; RESPIRATORY CONDITIONS; PACIFIC COUNTRIES; DEPARTMENT VISITS; CASE-CROSSOVER	Background: A nationwide asthma survey on the effects of air pollution is lacking in Taiwan. The purpose of this study was to evaluate the time trend and the relationship between air pollution and health care services for asthma in Taiwan. Methods: Health care services for asthma and ambient air pollution data were obtained from the National Health Insurance Research database and Environmental Protection Administration from 2000 through 2009, respectively. Health care services, including those related to the outpatient and inpatient visits were compared according to the concentration of air pollutants. Results: The number of asthma-patient visits to health-care facilities continue to increase in Taiwan. Relative to the respective lowest quartile of air pollutants, the adjusted relative risks (RRs) of the outpatient visits in the highest quartile were 1.10 (P-trend = 0.013) for carbon monoxide (CO), 1.10 (P-trend = 0.015) for nitrogen dioxide (NO2), and 1.20 (P-trend < 0.0001) for particulate matter with an aerodynamic diameter <= 10 mu m (PM10) in the child group (aged 0-18). For adults aged 19-44, the RRs of outpatient visits were 1.13 (P-trend = 0.078) for CO, 1.17 (P-trend = 0.002) for NO2, and 1.13 (P-trend < 0.0001) for PM10. For adults aged 45-64, the RRs of outpatient visits were 1.15 (P-trend = 0.003) for CO, 1.19 (P-trend = 0.0002) for NO2, and 1.10 (P-trend = 0.001) for PM10. For the elderly (aged >= 65), the RRs of outpatient visits in were 1.12 (P-trend = 0.003) for NO2 and 1.10 (P-trend = 0.006) for PM10. For inpatient visits, the RRs across quartiles of CO level were 1.00, 1.70, 1.92, and 1.86 (P-trend = 0.0001) in the child group. There were no significant linear associations between inpatient visits and air pollutants in other groups. Conclusions: There were positive associations between CO levels and childhood inpatient visits as well as NO2, CO and PM10 and outpatient visits.	[Pan, Hui-Hsien; Chen, Chun-Tzu; Sun, Hai-Lun; Ku, Min-Sho; Liao, Pei-Fen; Sheu, Ji-Nan; Lue, Ko-Huang] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan; [Pan, Hui-Hsien; Sun, Hai-Lun; Ku, Min-Sho; Lu, Ko-Hsiu; Sheu, Ji-Nan; Lue, Ko-Huang] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Chun-Tzu; Pai, Jar-Yuan] Chung Shan Med Univ, Dept Hlth Policy & Management, Taichung, Taiwan; [Huang, Jing-Yang] Chung Shan Med Univ, Dept Publ Hlth, Inst Publ Hlth, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University	Lue, KH (corresponding author), Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan.	cshy095@csh.org.tw	廖, 培汾/GLU-8054-2022	Huang, Jing-Yang/0000-0002-0794-9388				Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; Bell ML, 2009, CIRCULATION, V120, P949, DOI 10.1161/CIRCULATIONAHA.109.851113; Bureau of National Health Insurance, 2001, NAT COMPR DIS MAN PR; Cadelis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091136; Chan TC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-26; Chiang Chi-Huei, 2005, J Chin Med Assoc, V68, P204, DOI 10.1016/S1726-4901(09)70208-4; Delamater PL, 2012, SCI TOTAL ENVIRON, V425, P110, DOI 10.1016/j.scitotenv.2012.02.015; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Gasana J, 2012, ENVIRON RES, V117, P36, DOI 10.1016/j.envres.2012.05.001; Gold LS, 2014, RESP MED, V108, P271, DOI 10.1016/j.rmed.2013.12.004; Guo YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042232; Hajat S, 1999, THORAX, V54, P597, DOI 10.1136/thx.54.7.597; Han YY, 2009, PEDIAT ALLERG IMM-UK, V20, P748, DOI 10.1111/j.1399-3038.2009.00871.x; HSIEH KH, 1988, J ASTHMA, V25, P73, DOI 10.3109/02770908809071357; Huang YT, 2009, J FORMOS MED ASSOC, V108, P386, DOI 10.1016/S0929-6646(09)60082-6; Hwang BF, 2010, CHEST, V138, P956, DOI 10.1378/chest.09-2600; Hwang CY, 2010, ACTA DERM-VENEREOL, V90, P589, DOI 10.2340/00015555-0963; Hwang JS, 2002, AM J EPIDEMIOL, V155, P1, DOI 10.1093/aje/155.1.1; Khatri SB, 2009, J ASTHMA, V46, P777, DOI 10.3109/02770900902779284; Kuo HW, 2002, ARCH ENVIRON HEALTH, V57, P194, DOI 10.1080/00039890209602936; Lin M, 2005, PEDIATRICS, V116, pE235, DOI 10.1542/peds.2004-2012; Lipsett M, 1997, ENVIRON HEALTH PERSP, V105, P216, DOI 10.2307/3433245; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Norris G, 1999, ENVIRON HEALTH PERSP, V107, P489, DOI 10.2307/3434632; Qiu H, 2012, ENVIRON HEALTH PERSP, V120, P572, DOI 10.1289/ehp.1104002; Schildcrout JS, 2006, AM J EPIDEMIOL, V164, P505, DOI 10.1093/aje/kwj225; Slaughter JC, 2005, J EXPO ANAL ENV EPID, V15, P153, DOI 10.1038/sj.jea.7500382; Sun HL, 2007, PEDIATR INT, V49, P48, DOI 10.1111/j.1442-200X.2007.02317.x; Sun HL, 2006, AM J EMERG MED, V24, P709, DOI 10.1016/j.ajem.2006.03.006; Takenoue Y, 2012, PEDIATR INT, V54, P762, DOI 10.1111/j.1442-200X.2012.03674.x; Trasande L, 2005, J ALLERGY CLIN IMMUN, V115, P689, DOI 10.1016/j.jaci.2005.01.056; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Villeneuve PJ, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-40; Wang KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075220; Weng Hui-Ching, 2005, Dis Manag, V8, P48, DOI 10.1089/dis.2005.8.48; Wilson AM, 2005, ENVIRON RES, V97, P312, DOI 10.1016/j.envres.2004.07.010; Winquist A, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-70; Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30; Yang CY, 2007, J TOXICOL ENV HEAL A, V70, P111, DOI 10.1080/15287390600755059; Yeh KW, 2011, ASIAN PAC J ALLERGY, V29, P34; Zahran Hatice S., 2011, Morbidity and Mortality Weekly Report, V60, P547	43	53	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96190	10.1371/journal.pone.0096190	http://dx.doi.org/10.1371/journal.pone.0096190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789041	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600083
J	Rummukainen, O; Radun, J; Virtanen, T; Pulkki, V				Rummukainen, Olli; Radun, Jenni; Virtanen, Toni; Pulkki, Ville			Categorization of Natural Dynamic Audiovisual Scenes	PLOS ONE			English	Article							ATTENTIONAL SELECTION; PERCEPTION; SOUNDSCAPES; CONSTRUCTION; MEMORY; WORLD; URBAN; MODEL; GIST	This work analyzed the perceptual attributes of natural dynamic audiovisual scenes. We presented thirty participants with 19 natural scenes in a similarity categorization task, followed by a semi-structured interview. The scenes were reproduced with an immersive audiovisual display. Natural scene perception has been studied mainly with unimodal settings, which have identified motion as one of the most salient attributes related to visual scenes, and sound intensity along with pitch trajectories related to auditory scenes. However, controlled laboratory experiments with natural multimodal stimuli are still scarce. Our results show that humans pay attention to similar perceptual attributes in natural scenes, and a two-dimensional perceptual map of the stimulus scenes and perceptual attributes was obtained in this work. The exploratory results show the amount of movement, perceived noisiness, and eventfulness of the scene to be the most important perceptual attributes in naturalistically reproduced real-world urban environments. We found the scene gist properties openness and expansion to remain as important factors in scenes with no salient auditory or visual events. We propose that the study of scene perception should move forward to understand better the processes behind multimodal scene processing in real-world environments. We publish our stimulus scenes as spherical video recordings and sound field recordings in a publicly available database.	[Rummukainen, Olli; Pulkki, Ville] Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland; [Radun, Jenni; Virtanen, Toni] Univ Helsinki, Inst Behav Sci, Helsinki, Finland	Aalto University; University of Helsinki	Rummukainen, O (corresponding author), Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland.	olli.rummukainen@aalto.fi	Radun, Jenni/AAB-3943-2021; Pulkki, Ville/G-2394-2013; Virtanen, Toni I. O./E-9181-2015	Radun, Jenni/0000-0003-3269-2999; Pulkki, Ville/0000-0003-3460-9677; Virtanen, Toni I. O./0000-0001-5191-2438	European Research Council under the European Community/ERC [240453]; Academy of Finland	European Research Council under the European Community/ERC(European Research Council (ERC)); Academy of Finland(Academy of Finland)	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement No. 240453 and from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ATLASti Scientific Software Development GmbH, 2011, ATL TI V 6; Axelsson O, 2010, J ACOUST SOC AM, V128, P2836, DOI 10.1121/1.3493436; Bonebright T, 2012, 18 INT C AUD DISPL I, P1; Botteldooren D, 2011, UNDERSTANDING URBAN, P1; Botteldooren D., 2012, J ACOUST SOC AM, V131, P3382, DOI [10.1121/1.4708755, DOI 10.1121/1.4708755]; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bregman A.S., 1994, AUDITORY SCENE ANAL; Brockmole JR, 2005, J EXP PSYCHOL HUMAN, V31, P857, DOI 10.1037/0096-1523.31.5.857; Carmi R, 2006, VISION RES, V46, P4333, DOI 10.1016/j.visres.2006.08.019; Castelhano MS, 2008, J EXP PSYCHOL HUMAN, V34, P660, DOI 10.1037/0096-1523.34.3.660; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Coutrot A, 2013, 14 INT WORKSH IM AUD; Coutrot A, 2012, J EYE MOVEMENT RES, V5; Davies WJ, 2013, APPL ACOUST, V74, P224, DOI 10.1016/j.apacoust.2012.05.010; de Leeuw J, 2008, J STAT SOFTW, V31, P1; Dubois D, 2006, ACTA ACUST UNITED AC, V92, P865; Fei-Fei L, 2007, J VISION, V7, DOI 10.1167/7.1.10; FRIEDMAN A, 1979, J EXP PSYCHOL GEN, V108, P316, DOI 10.1037/0096-3445.108.3.316; GAVER WW, 1993, ECOL PSYCHOL, V5, P1, DOI 10.1207/s15326969eco0501_1; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; GOLDSTONE RL, 1994, COGNITION, V52, P125, DOI 10.1016/0010-0277(94)90065-5; Gomez Bolanos J, 2012, AUD ENG SOC 132 CONV, P1; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Hair J. F., 2006, MULTIVARIATE DATA AN; Harding S, 2007, LECT NOTES ARTIF INT, V4840, P399; International Telecommunication Union, 1998, ITU T REC P 911 SUBJ; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Kayser C, 2005, CURR BIOL, V15, P1943, DOI 10.1016/j.cub.2005.09.040; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mather M, 2011, PERSPECT PSYCHOL SCI, V6, P114, DOI 10.1177/1745691611400234; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Nardo D, 2013, HUMAN BRAIN MAPPING, V35, P1; Oksanen J., 2016, R PACKAG; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Peltonen V, 2001, AUD ENG SOC 110 CONV, P1; Pheasant R, 2008, J ACOUST SOC AM, V123, P1446, DOI 10.1121/1.2831735; Pheasant RJ, 2010, J ENVIRON PSYCHOL, V30, P501, DOI 10.1016/j.jenvp.2010.03.006; Politis A, 2011, AUD ENG SOC 131 CONV, P1; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Pulkki V, 2007, J AUDIO ENG SOC, V55, P503; Quigley C, 2007, J EYE MOVEMENT RES, V1; R Core Team, 2018, R LANG ENV STAT COMP; RABINOWITZ GB, 1975, AM J POLIT SCI, V19, P343, DOI 10.2307/2110441; Rouder JN, 2006, CURR DIR PSYCHOL SCI, V15, P9, DOI 10.1111/j.0963-7214.2006.00397.x; Sanocki T, 2013, J EXP PSYCHOL HUMAN, V39, P381, DOI 10.1037/a0030718; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Tardieu J, 2008, APPL ACOUST, V69, P1224, DOI 10.1016/j.apacoust.2007.10.001; TENK (Finnish National Advisory Board on Research Ethics), 2009, ETH PRINC RES HUM SO, P1; TVERSKY B, 1983, COGNITIVE PSYCHOL, V15, P121, DOI 10.1016/0010-0285(83)90006-3; Vilkamo J, 2009, J AUDIO ENG SOC, V57, P709; Vo MLH, 2012, J VISION, V12, DOI 10.1167/12.13.3; Yantis S., 1993, CURR DIR PSYCHOL SCI, V2, P156, DOI [DOI 10.1111/1467-8721.EP10768973, 10.1111/1467, DOI 10.1111/1467]	57	9	9	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95848	10.1371/journal.pone.0095848	http://dx.doi.org/10.1371/journal.pone.0095848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24788808	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600053
J	Blanchard, Z; Mullins, N; Ellipeddi, P; Lage, JM; McKinney, S; El-Etriby, R; Zhang, X; Isokpehi, R; Hernandez, B; ElShamy, WM				Blanchard, Zannel; Mullins, Nicole; Ellipeddi, Pavani; Lage, Janice M.; McKinney, Shawn; El-Etriby, Rana; Zhang, Xu; Isokpehi, Raphael; Hernandez, Brenda; ElShamy, Wael M.			Geminin Overexpression Promotes Imatinib Sensitive Breast Cancer: A Novel Treatment Approach for Aggressive Breast Cancers, Including a Subset of Triple Negative	PLOS ONE			English	Article							ABL TYROSINE KINASE; TOPOISOMERASE-II-ALPHA; AURORA-B KINASE; C-ABL; DNA-REPLICATION; GENE-EXPRESSION; SOLID TUMORS; HISTONE H3; PHOSPHORYLATION; PROTEIN	Breast cancer is the second leading cause of cancer-related deaths in women. Triple negative breast cancer (TNBC) is an aggressive subtype that affects 10-25% mostly African American women. TNBC has the poorest prognosis of all subtypes with rapid progression leading to mortality in younger patients. So far, there is no targeted treatment for TNBC. To that end, here we show that c-Abl is one of several tyrosine kinases that phosphorylate and activate geminin's ability to promote TNBC. Analysis of >800 breast tumor samples showed that geminin is overexpressed in similar to 50% of all tumors. Although c-Abl is overexpressed in similar to 90% of all tumors, it is only nuclear in geminin overexpressing tumors. In geminin-negative tumors, c-Abl is only cytoplasmic. Inhibiting c-Abl expression or activity (using imatinib or nilotinib) prevented geminin Y150 phosphorylation, inactivated the protein, and most importantly converted overexpressed geminin from an oncogene to an apoptosis inducer. In pre-clinical orthotopic breast tumor models, geminin-overexpressing cells developed aneuploid and invasive tumors, which were suppressed when c-Abl expression was blocked. Moreover, established geminin overexpressing orthotopic tumors regressed when treated with imatinib or nilotinib. Our studies support imatinib/nilotonib as a novel treatment option for patients with aggressive breast cancer (including a subset of TNBCs)-overexpressing geminin and nuclear c-Abl.	[Blanchard, Zannel; Mullins, Nicole; Ellipeddi, Pavani; El-Etriby, Rana; ElShamy, Wael M.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Blanchard, Zannel; ElShamy, Wael M.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Lage, Janice M.] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [McKinney, Shawn] Univ Mississippi, Med Ctr, Dept Surg, Jackson, MS 39216 USA; [Zhang, Xu] Univ Mississippi, Med Ctr, Ctr Biostat & Bioinformat, Jackson, MS 39216 USA; [Isokpehi, Raphael] Jackson State Univ, Dept Biol, Ctr Bioinformat & Computat Biol, Jackson, MS USA; [Hernandez, Brenda] Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Jackson State University; Cancer Research Center of Hawaii; University of Hawaii System	ElShamy, WM (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA.	welshamy@umc.edu	ElShamy, Wael M./L-1090-2018; ElShamy, Wael/AAF-2867-2019		American Cancer Society [RSG-09-275-01]; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by a grant from the American Cancer Society, Grant # RSG-09-275-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 1998, MODERN PATHOL, V11, P155; ALLRED DC, 1993, J NATL CANCER I, V85, P200, DOI 10.1093/jnci/85.3.200; Amoui M, 2000, CELL SIGNAL, V12, P637, DOI 10.1016/S0898-6568(00)00107-8; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Blanchard Z, 2011, ONCOTARGET, V2, P1011, DOI 10.18632/oncotarget.363; Chen CX, 2008, HUM IMMUNOL, V69, P501, DOI 10.1016/j.humimm.2008.06.005; Chew HK, 2008, CLIN BREAST CANCER, V8, P511, DOI 10.3816/CBC.2008.n.062; Cipres A, 2007, CELL SIGNAL, V19, P1662, DOI 10.1016/j.cellsig.2007.02.011; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; DeMatteo R, 2009, ANN SURG ONCOL, V16, P799, DOI 10.1245/s10434-009-0316-9; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Duesberg P, 1999, ANTICANCER RES, V19, P4887; ElShamy WM, 2004, NAT CELL BIOL, V6, P954, DOI 10.1038/ncb1171; Engebraaten O, 1999, INT J CANCER, V82, P219, DOI 10.1002/(SICI)1097-0215(19990719)82:2<219::AID-IJC12>3.0.CO;2-#; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Gardner L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2884; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Greenberg S, 2010, CLIN BREAST CANCER, V10, pS20, DOI 10.3816/CBC.2010.s.009; Haruki T, 2011, LUNG CANCER, V71, P356, DOI 10.1016/j.lungcan.2010.06.013; Jing YQ, 2005, ARCH BIOCHEM BIOPHYS, V437, P199, DOI 10.1016/j.abb.2005.03.010; Kadam S, 2004, GENE DEV, V14, P2441; Kimura F, 2013, ACTA CYTOL, V57, P384, DOI 10.1159/000350262; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kulartz M, 2004, BIOCHEM BIOPH RES CO, V315, P1011, DOI 10.1016/j.bbrc.2004.01.164; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Mancini M, 2009, TRAFFIC, V10, P637, DOI 10.1111/j.1600-0854.2009.00897.x; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Matsubara T, 2012, J BIOL CHEM, V287, P5507, DOI 10.1074/jbc.M111.296897; McGarry T, 2011, CELL, V93, P1043; Melo JV, 1996, BLOOD, V88, P2375, DOI 10.1182/blood.V88.7.2375.bloodjournal8872375; Nakuci E, 2006, INT J BIOCHEM CELL B, V38, P1207, DOI 10.1016/j.biocel.2005.12.017; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishihara K, 2009, ONCOL REP, V21, P1189, DOI 10.3892/or_00000340; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; Pantaleo M A, 2007, Minerva Med, V98, P603; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Pishvaian MJ, 2012, CANCER CHEMOTH PHARM, V70, P843, DOI 10.1007/s00280-012-1969-9; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Rappa G, 2011, CANCER CHEMOTH PHARM, V67, P919, DOI 10.1007/s00280-010-1394-x; Reichardt P, 2011, SEMIN ONCOL, V38, pS20, DOI 10.1053/j.seminoncol.2011.01.015; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Salabat MR, 2008, MOL CARCINOGEN, V47, P835, DOI 10.1002/mc.20441; Santos FPS, 2009, LEUKEMIA LYMPHOMA, V50, P16, DOI 10.3109/10428190903383427; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Sistayanarain A, 2006, ANTICANCER RES, V26, P3585; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Thepaut M, 2004, J MOL BIOL, V342, P275, DOI 10.1016/j.jmb.2004.06.065; VANETTEN RA, 1994, J CELL BIOL, V124, P325, DOI 10.1083/jcb.124.3.325; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; WATERFIELD WC, 1978, CANCER, V41, P1235, DOI 10.1002/1097-0142(197804)41:4<1235::AID-CNCR2820410403>3.0.CO;2-8; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamazaki M, 2010, HISTOPATHOLOGY, V56, P883, DOI 10.1111/j.1365-2559.2010.03561.x; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhao H, 2014, ONCOGENE, V33, P1429, DOI 10.1038/onc.2013.84; Zhao HJ, 2010, NEOPLASIA, V12, P214, DOI 10.1593/neo.91576; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	66	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95663	10.1371/journal.pone.0095663	http://dx.doi.org/10.1371/journal.pone.0095663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24789045	Green Submitted, Green Published, gold			2022-12-27	WOS:000338917300016
J	Arilahti, V; Makela, SM; Tynell, J; Julkunen, I; Osterlund, P				Arilahti, Veera; Makela, Sanna M.; Tynell, Janne; Julkunen, Ilkka; Osterlund, Pamela			Novel Avian Influenza A (H7N9) Virus Induces Impaired Interferon Responses in Human Dendritic Cells	PLOS ONE			English	Article							GENE-EXPRESSION; NS1 PROTEIN; IFN-ALPHA; INFECTION; CHINA; TRANSMISSION; MACROPHAGES; FERRETS; MORTALITY; CYTOKINE	In March 2013 a new avian influenza A(H7N9) virus emerged in China and infected humans with a case fatality rate of over 30%. Like the highly pathogenic H5N1 virus, H7N9 virus is causing severe respiratory distress syndrome in most patients. Based on genetic analysis this avian influenza A virus shows to some extent adaptation to mammalian host. In the present study, we analyzed the activation of innate immune responses by this novel H7N9 influenza A virus and compared these responses to those induced by the avian H5N1 and seasonal H3N2 viruses in human monocyte-derived dendritic cells (moDCs). We observed that in H7N9 virus-infected cells, interferon (IFN) responses were weak although the virus replicated as well as the H5N1 and H3N2 viruses in moDCs. H7N9 virus-induced expression of pro-inflammatory cytokines remained at a significantly lower level as compared to H5N1 virus-induced ''cytokine storm'' seen in human moDCs. However, the H7N9 virus was extremely sensitive to the antiviral effects of IFN-alpha and IFN-beta in pretreated cells. Our data indicates that different highly pathogenic avian viruses may show considerable differences in their ability to induce host antiviral responses in human primary cell models such as moDCs. The unexpected appearance of the novel H7N9 virus clearly emphasizes the importance of the global influenza surveillance system. It is, however, equally important to systematically characterize in normal human cells the replication capacity of the new viruses and their ability to induce and respond to natural antiviral substances such as IFNs.	[Arilahti, Veera; Makela, Sanna M.; Tynell, Janne; Julkunen, Ilkka; Osterlund, Pamela] Natl Inst Hlth & Welf, Virol Unit, Helsinki, Finland; [Julkunen, Ilkka] Univ Turku, Dept Virol, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	Osterlund, P (corresponding author), Natl Inst Hlth & Welf, Virol Unit, Helsinki, Finland.	pamela.osterlund@thl.fi	Österlund, Pamela/L-2528-2015; Österlund, Pamela/AGH-9008-2022	Österlund, Pamela/0000-0002-2229-6661; Österlund, Pamela/0000-0002-2229-6661; Julkunen, Ilkka/0000-0003-0165-2564; Avelin, Veera/0000-0003-3117-3732; Tynell, Janne/0000-0001-6930-5230	Research Council for Health [252252, 256159, 255780]; Sigrid Juselius Foundation; Helsinki Graduate Program in Biotechnology and Molecular Biology	Research Council for Health; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Graduate Program in Biotechnology and Molecular Biology	The Academy of Finland supported this work by grants 252252, 256159 and 255780 from the Research Council for Health. This study was also funded by the Sigrid Juselius Foundation and the Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cheung CY, 2012, J INFECT DIS, V206, P640, DOI 10.1093/infdis/jis423; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Cilloniz C, 2010, J VIROL, V84, P7613, DOI 10.1128/JVI.00553-10; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Dortmans JCFM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03058; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Josset L, 2014, MBIO, V5, DOI 10.1128/mBio.01102-13; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Knepper J, 2013, MBIO, V4, DOI 10.1128/mBio.00601-13; Kreijtz JHCM, 2013, VACCINE, V31, P4995, DOI 10.1016/j.vaccine.2013.06.071; Lam TTY, 2013, NATURE, V502, P241, DOI 10.1038/nature12515; Matikainen S, 1996, BLOOD, V88, P114; Matthaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056659; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Ngunjiri JM, 2012, NAT MED, V18, P1456, DOI 10.1038/nm.2879; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Osterlund P, 2012, J VIROL, V86, P11183, DOI 10.1128/JVI.01050-12; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Osterlund PI, 2007, J IMMUNOL, V179, P3434, DOI 10.4049/jimmunol.179.6.3434; Palucka K, 2002, CURR OPIN IMMUNOL, V14, P420, DOI 10.1016/S0952-7915(02)00365-5; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Richard M, 2013, NATURE, V501, P560, DOI 10.1038/nature12476; RONNI T, 1995, J IMMUNOL, V154, P2764; RONNI T, 1993, J IMMUNOL, V150, P1715; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Seo SH, 2004, VIROLOGY, V329, P270, DOI 10.1016/j.virol.2004.08.019; Shi JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077651; Shi Y, 2013, SCIENCE, V342, P243, DOI 10.1126/science.1242917; Thitithanyanont A, 2007, J IMMUNOL, V179, P5220, DOI 10.4049/jimmunol.179.8.5220; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; World Health Organization, 2014, NUMB CONF HUM CAS AV; Wu AP, 2013, CELL HOST MICROBE, V14, P446, DOI 10.1016/j.chom.2013.09.001; Xu LL, 2014, J INFECT DIS, V209, P551, DOI 10.1093/infdis/jit474; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	47	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96350	10.1371/journal.pone.0096350	http://dx.doi.org/10.1371/journal.pone.0096350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804732	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900051
J	Pathak, BK; Mondal, S; Ghosh, AN; Barat, C				Pathak, Bani Kumar; Mondal, Surojit; Ghosh, Amar Nath; Barat, Chandana			The Ribosome Can Prevent Aggregation of Partially Folded Protein Intermediates: Studies Using the Escherichia coli Ribosome	PLOS ONE			English	Article							MOLTEN-GLOBULE STATE; ALPHA-CRYSTALLIN; IN-VITRO; DOMAIN-V; DENATURED/REDUCED LYSOZYME; FOLDING INTERMEDIATE; EXIT TUNNEL; RNA; GROEL; RENATURATION	Background: Molecular chaperones that support folding proteins under non stress condition are classified as chaperone 'foldases' that are distinct from chaperone' holdases' that provide high affinity binding platform for unfolded proteins and prevent their aggregation specifically under stress conditions. Ribosome, the cellular protein synthesis machine can act as a foldase chaperone that can bind unfolded proteins and release them in folding competent state. The peptidyl transferase center (PTC) located in the domain V of the 23S rRNA of Escherichia coli ribosome (bDV RNA) is the chaperoning center of the ribosome. It has been proposed that via specific interactions between the RNA and refolding proteins, the chaperone provides information for the correct folding of unfolded polypeptide chains. Results: We demonstrate using Escherichia coli ribosome and variants of its domain V RNA that the ribosome can bind to partially folded intermediates of bovine carbonic anhydrase II (BCAII) and lysozyme and suppress aggregation during their refolding. Using mutants of domain V RNA we demonstrate that the time for which the chaperone retains the bound protein is an important factor in determining its ability to suppress aggregation and/or support reactivation of protein. Conclusion: The ribosome can behave like a 'holdase' chaperone and has the ability to bind and hold back partially folded intermediate states of proteins from participating in the aggregation process. Since the ribosome is an essential organelle that is present in large numbers in all living cells, this ability of the ribosome provides an energetically inexpensive way to suppress cellular aggregation. Further, this ability of the ribosome might also be crucial in the context that the ribosome is one of the first chaperones to be encountered by a large nascent polypeptide chains that have a tendency to form partially folded intermediates immediately following their synthesis.	[Pathak, Bani Kumar; Mondal, Surojit; Barat, Chandana] St Xaviers Coll, Dept Biotechnol, Kolkata, W Bengal, India; [Ghosh, Amar Nath] Natl Inst Cholera & Enter Dis P 33, Scheme XM, Beleghata, India	St. Xavier's College Kolkata; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Barat, C (corresponding author), St Xaviers Coll, Dept Biotechnol, Kolkata, W Bengal, India.	chandanasgb@yahoo.com			Department of Biotechnology, Government of West Bengal, India [390/(sanc)-BT(Estt.)/RD-6/11]; Department of Science and Technology, Government of India [SERB/F/0643]	Department of Biotechnology, Government of West Bengal, India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work was financially supported by the Department of Biotechnology, Government of West Bengal, India [Grant number 390/(sanc)-BT(Estt.)/RD-6/11]. S.M. is Department of Biotechnology, Government of West Bengal, India, funded research fellow and B.K.P. wishes to acknowledge financial support under Department of Science and Technology, Government of India funded research fellowship scheme [Grant number SERB/F/0643]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; BERA AK, 1994, CURR SCI INDIA, V66, P230; Choi SI, 2009, RNA BIOL, V6, P21, DOI 10.4161/rna.6.1.7441; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; DAS B, 1992, BIOCHEM BIOPH RES CO, V183, P774, DOI 10.1016/0006-291X(92)90550-5; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; DOBSON CM, 1994, TRENDS BIOCHEM SCI, V19, P31, DOI 10.1016/0968-0004(94)90171-6; Fedyukina DV, 2011, ANNU REV BIOPHYS, V40, P337, DOI 10.1146/annurev-biophys-042910-155338; FISCHER B, 1992, PROTEIN ENG, V5, P593, DOI 10.1093/protein/5.6.593; Gladwin ST, 1996, FOLD DES, V1, P407, DOI 10.1016/S1359-0278(96)00057-0; GOLDBERG ME, 1991, BIOCHEMISTRY-US, V30, P2790, DOI 10.1021/bi00225a008; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; IKEGUCHI M, 1986, BIOCHEMISTRY-US, V25, P6965, DOI 10.1021/bi00370a034; KALPAXIS DL, 1986, EUR J BIOCHEM, V154, P267, DOI 10.1111/j.1432-1033.1986.tb09392.x; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; Li J, 1999, J BIOL CHEM, V274, P10790, DOI 10.1074/jbc.274.16.10790; Long KS, 2003, NUCLEIC ACIDS RES, V31, P7208, DOI 10.1093/nar/gkg945; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; O'Brien EP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1850; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; RADFORD SE, 1992, NATURE, V358, P302, DOI 10.1038/358302a0; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Rajaraman K, 1998, BIOCHEM BIOPH RES CO, V249, P917, DOI 10.1006/bbrc.1998.9242; Raman B, 1997, FEBS LETT, V416, P369, DOI 10.1016/S0014-5793(97)01240-4; Raman B, 1996, J BIOL CHEM, V271, P17067, DOI 10.1074/jbc.271.29.17067; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; UVERSKY VN, 1992, FEBS LETT, V314, P89, DOI 10.1016/0014-5793(92)81468-2; Wang CZ, 2010, BIOTECHNOL PROGR, V26, P1073, DOI 10.1002/btpr.407; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; YON JM, 1991, BIOL CELL, V71, P17, DOI 10.1016/0248-4900(91)90047-Q	39	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96425	10.1371/journal.pone.0096425	http://dx.doi.org/10.1371/journal.pone.0096425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805251	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900058
J	Porz, N; Bauer, S; Pica, A; Schucht, P; Beck, J; Verma, RK; Slotboom, J; Reyes, M; Wiest, R				Porz, Nicole; Bauer, Stefan; Pica, Alessia; Schucht, Philippe; Beck, Juergen; Verma, Rajeev Kumar; Slotboom, Johannes; Reyes, Mauricio; Wiest, Roland			Multi-Modal Glioblastoma Segmentation: Man versus Machine	PLOS ONE			English	Article							BRAIN-TUMOR SEGMENTATION; ADJUVANT TEMOZOLOMIDE; RESPONSE ASSESSMENT; RESECTION; SURVIVAL; EXTENT; RADIOTHERAPY; CONCOMITANT; MULTIFORME; NEOPLASMS	Background and Purpose: Reproducible segmentation of brain tumors on magnetic resonance images is an important clinical need. This study was designed to evaluate the reliability of a novel fully automated segmentation tool for brain tumor image analysis in comparison to manually defined tumor segmentations. Methods: We prospectively evaluated preoperative MR Images from 25 glioblastoma patients. Two independent expert raters performed manual segmentations. Automatic segmentations were performed using the Brain Tumor Image Analysis software (BraTumIA). In order to study the different tumor compartments, the complete tumor volume TV (enhancing part plus non-enhancing part plus necrotic core of the tumor), the TV+ (TV plus edema) and the contrast enhancing tumor volume CETV were identified. We quantified the overlap between manual and automated segmentation by calculation of diameter measurements as well as the Dice coefficients, the positive predictive values, sensitivity, relative volume error and absolute volume error. Results: Comparison of automated versus manual extraction of 2-dimensional diameter measurements showed no significant difference (p = 0.29). Comparison of automated versus manual segmentation of volumetric segmentations showed significant differences for TV+ and TV (p < 0.05) but no significant differences for CETV (p > 0.05) with regard to the Dice overlap coefficients. Spearman's rank correlation coefficients (p) of TV+, TV and CETV showed highly significant correlations between automatic and manual segmentations. Tumor localization did not influence the accuracy of segmentation. Conclusions: In summary, we demonstrated that BraTumIA supports radiologists and clinicians by providing accurate measures of cross-sectional diameter-based tumor extensions. The automated volume measurements were comparable to manual tumor delineation for CETV tumor volumes, and outperformed inter-rater variability for overlap and sensitivity.	[Porz, Nicole; Bauer, Stefan; Verma, Rajeev Kumar; Slotboom, Johannes; Wiest, Roland] Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, Support Ctr Adv Neuroimaging, CH-3010 Bern, Switzerland; [Porz, Nicole; Bauer, Stefan; Pica, Alessia; Schucht, Philippe; Beck, Juergen; Verma, Rajeev Kumar; Slotboom, Johannes; Wiest, Roland] Univ Bern, Bern, Switzerland; [Porz, Nicole; Schucht, Philippe; Beck, Juergen] Univ Hosp Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland; [Bauer, Stefan; Reyes, Mauricio] Univ Bern, Inst Surg Technol & Biomech, Bern, Switzerland; [Pica, Alessia] Univ Hosp Bern, Inselspital, Dept Radiat Oncol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Bauer, S (corresponding author), Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, Support Ctr Adv Neuroimaging, CH-3010 Bern, Switzerland.	stefan.bauer@istb.unibe.ch		Beck, Jurgen/0000-0002-7687-6098	Swiss National Science Foundation; Bernese Cancer League; Swiss Cancer League	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bernese Cancer League; Swiss Cancer League	This study was supported by the Swiss National Science Foundation (http://p3.snf.ch/Project-140958), the Bernese Cancer League and the Swiss Cancer League. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D, 1994, BMJ BR MED J, DOI [10.1136/bmj.308.6943, DOI 10.1136/BMJ.308.6943]; Altman D, 1994, BMJ BR MED J, V309, P16104; Bauer S, 2012, SKULL STRIPPING FILT; Bauer S., 2012, P MICCAI BRATS; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Brandsma D, 2009, CURR OPIN NEUROL, V22, P633, DOI 10.1097/WCO.0b013e328332363e; Corso JJ, 2008, IEEE T MED IMAGING, V27, P629, DOI 10.1109/TMI.2007.912817; Criminisi A., 2013, DENSITY FORESTS, P59, DOI [10.1007/978-1-4471-4929-3, DOI 10.1007/978-1-4471-4929-3]; Crum WR, 2006, IEEE T MED IMAGING, V25, P1451, DOI 10.1109/TMI.2006.880587; Deeley MA, 2013, PHYS MED BIOL, V58, P4071, DOI 10.1088/0031-9155/58/12/4071; Deeley MA, 2011, PHYS MED BIOL, V56, P4557, DOI 10.1088/0031-9155/56/14/021; DEVAUX BC, 1993, J NEUROSURG, V78, P767, DOI 10.3171/jns.1993.78.5.0767; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Ellingson BM, 2012, NEURO-ONCOLOGY, V14, P333, DOI 10.1093/neuonc/nor220; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Friedman M, 1952, J AM STAT ASSOC, V32, P675; Perez-Larraya JG, 2012, NEURO-ONCOLOGY, V14, P667, DOI 10.1093/neuonc/nos070; Gooya A, 2012, IEEE T MED IMAGING, V31, P1941, DOI 10.1109/TMI.2012.2210558; Gutman DA, 2013, RADIOLOGY, V267, P560, DOI 10.1148/radiol.13120118; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Heckel F, 2013, COMPUT GRAPH FORUM, V32, P144, DOI 10.1111/cgf.12193; Ibanez L., 2005, ITK SOFTWARE GUIDE; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mazzara GP, 2004, INT J RADIAT ONCOL, V59, P300, DOI 10.1016/j.ijrobp.2004.01.026; Menze B, MULTIMODAL BRAIN TUM; Menze BH, 2010, LECT NOTES COMPUT SC, V6362, P151; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Reuter M, 2014, J NEURO-ONCOL, V118, P123, DOI 10.1007/s11060-014-1403-8; Sanai N, 2011, REV NEUROL-FRANCE, V167, P648, DOI 10.1016/j.neurol.2011.07.004; Schucht P, 2013, J NEUROSURG, V119, P318, DOI 10.3171/2013.5.JNS122235; Seidel K, 2013, J NEUROSURG, V118, P287, DOI 10.3171/2012.10.JNS12895; Seidel K, 2012, NEUROSURGERY, V71, P104, DOI 10.1227/NEU.0b013e31824c02a0; Slotboom J, 2008, INVEST RADIOL, V43, P843, DOI 10.1097/RLI.0b013e3181893605; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tustison N., 2013, MICCAI BRATS WORKSH; Verma R, 2008, ACAD RADIOL, V15, P966, DOI 10.1016/j.acra.2008.01.029; Weltens C, 2001, RADIOTHER ONCOL, V60, P49, DOI 10.1016/S0167-8140(01)00371-1; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Zikic, 2012, P MICCAI BRATS, P1	46	95	98	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96873	10.1371/journal.pone.0096873	http://dx.doi.org/10.1371/journal.pone.0096873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804720	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900110
J	Delgado-Alvarez, DL; Bartnicki-Garcia, S; Seiler, S; Mourino-Perez, RR				Luis Delgado-Alvarez, Diego; Bartnicki-Garcia, Salomon; Seiler, Stephan; Mourino-Perez, Rosa Reyna			Septum Development in Neurospora crassa: The Septal Actomyosin Tangle	PLOS ONE			English	Article							FUNGUS ASPERGILLUS-NIDULANS; V CHITIN SYNTHASE; MOTOR-LIKE DOMAIN; FISSION YEAST; CONTRACTILE RING; CELL-DIVISION; NUCLEAR-DISTRIBUTION; FILAMENTOUS FUNGI; KINASE COT1; CYTOKINESIS	Septum formation in Neurospora crassa was studied by fluorescent tagging of actin, myosin, tropomyosin, formin, fimbrin, BUD-4, and CHS-1. In chronological order, we recognized three septum development stages: 1) septal actomyosin tangle (SAT) assembly, 2) contractile actomyosin ring (CAR) formation, 3) CAR constriction together with plasma membrane ingrowth and cell wall construction. Septation began with the assembly of a conspicuous tangle of cortical actin cables (SAT) in the septation site > 5 min before plasma membrane ingrowth. Tropomyosin and myosin were detected as components of the SAT from the outset. The SAT gradually condensed to form a proto-CAR that preceded CAR formation. During septum development, the contractile actomyosin ring remained associated with the advancing edge of the septum. Formin and BUD-4 were recruited during the transition from SAT to CAR and CHS-1 appeared two min before CAR constriction. Actin patches containing fimbrin were observed surrounding the ingrowing septum, an indication of endocytic activity. Although the trigger of SAT assembly remains unclear, the regularity of septation both in space and time gives us reason to believe that the initiation of the septation process is integrated with the mechanisms that control both the cell cycle and the overall growth of hyphae, despite the asynchronous nature of mitosis in N. crassa.	[Luis Delgado-Alvarez, Diego; Bartnicki-Garcia, Salomon; Mourino-Perez, Rosa Reyna] Ctr Educ Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico; [Seiler, Stephan] Univ Freiburg, Inst Biol Mol Plant Physiol 2, D-79106 Freiburg, Germany; [Seiler, Stephan] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; University of Freiburg; University of Freiburg	Mourino-Perez, RR (corresponding author), Ctr Educ Cient & Educ Super Ensenada, Dept Microbiol, Ensenada, Baja California, Mexico.	rmourino@cicese.mx	Mouriño-Pérez, Rosa Reyna Reyna/F-9192-2014; Bartnicki-Garcia, Salomon/J-3446-2016	Mouriño-Pérez, Rosa Reyna Reyna/0000-0002-7958-2212; Delgado, Diego/0000-0003-4927-8436	Consejo Nacional de Ciencia y Tecnologia-DFG [75306]; CONACYT-Ciencia Basica [134771]; Deutsche Forschungsgemeinschaft DFG [SE-1054/6-1, SE1054/7-1]	Consejo Nacional de Ciencia y Tecnologia-DFG; CONACYT-Ciencia Basica; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by grants from Consejo Nacional de Ciencia y Tecnologia-DFG (75306) to RRMP, CONACYT-Ciencia Basica (134771) to SBG and the Deutsche Forschungsgemeinschaft DFG (SE-1054/6-1, SE1054/7-1) to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603; BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; BRACKER CE, 1967, ANNU REV PHYTOPATHOL, V5, P343, DOI 10.1146/annurev.py.05.090167.002015; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; Calvert MEK, 2011, J CELL BIOL, V195, P799, DOI 10.1083/jcb.201101055; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chant J, 1970, CURR OPIN GENE DEV, V1, P342; CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Dettmann A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002950; Echauri-Espinosa RO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038237; Fajardo-Somera R. A., 2013, 27 FUNG GEN C; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; Gladfelter AS, 2006, CURR OPIN MICROBIOL, V9, P547, DOI 10.1016/j.mib.2006.09.002; Gregory PH, 1984, ECOLOGY PHYSL FUNGAL, P1; Gull K., 1978, FILAMENTOUS FUNGI DE, V3, P78; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2001, CURR OPIN MICROBIOL, V4, P736, DOI 10.1016/S1369-5274(01)00276-4; Heilig Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004306; Heilig Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079464; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Horiuchi H, 2009, MED MYCOL, V47, pS47, DOI 10.1080/13693780802213332; Ichinomiya M, 2005, EUKARYOT CELL, V4, P1125, DOI 10.1128/EC.4.6.1125-1136.2005; Jedd G, 2000, NAT CELL BIOL, V2, P226, DOI 10.1038/35008652; Justa-Schuch D, 2010, MOL MICROBIOL, V76, P220, DOI 10.1111/j.1365-2958.2010.07093.x; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Liu FF, 2008, J CELL BIOL, V180, P325, DOI 10.1083/jcb.200705049; Lord M, 2010, NATURE ED, V3, P53; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Martin SG, 2009, TRENDS CELL BIOL, V19, P447, DOI 10.1016/j.tcb.2009.06.003; Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160; Momany M, 1997, CELL MOTIL CYTOSKEL, V38, P373, DOI 10.1002/(SICI)1097-0169(1997)38:4<373::AID-CM7>3.3.CO;2-L; MOMANY M, 1995, CAN J BOT, V73, pS396; Momany M, 1997, FUNGAL GENET BIOL, V21, P92, DOI 10.1006/fgbi.1997.0967; MOTOYAMA T, 1994, BIOSCI BIOTECH BIOCH, V58, P2254, DOI 10.1271/bbb.58.2254; Motoyama T, 1997, MOL GEN GENET, V253, P520, DOI 10.1007/s004380050353; Mourino-Perez RR, 2006, FUNGAL GENET BIOL, V43, P389, DOI 10.1016/j.fgb.2005.10.007; Mourino-Perez RR, 2013, FUNGAL BIOL REV, V27, P1, DOI 10.1016/j.fbr.2013.02.002; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Rasmussen CG, 2005, EUKARYOT CELL, V4, P1913, DOI 10.1128/EC.4.11.1913-1925.2005; Mourino-Perez RR, 2013, ADV GENET, V83, P99, DOI 10.1016/B978-0-12-407675-4.00003-1; Richthammer C, 2012, MOL MICROBIOL, V85, P716, DOI 10.1111/j.1365-2958.2012.08133.x; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Riquelme Meritxell, 2008, Fungal Biology Reviews, V22, P56, DOI 10.1016/j.fbr.2008.05.003; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Seiler S, 2010, MOL MICROBIOL, V78, P1058, DOI 10.1111/j.1365-2958.2010.07392.x; SERNA L, 1978, J BACTERIOL, V136, P341, DOI 10.1128/JB.136.1.341-351.1978; Si HY, 2012, MOL MICROBIOL, V85, P252, DOI 10.1111/j.1365-2958.2012.08108.x; Si HY, 2010, GENETICS, V185, P166, DOI 10.1534/genetics.110.114165; Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707; Takeshita N, 2005, MOL BIOL CELL, V16, P1961, DOI 10.1091/mbc.E04-09-0761; Takeshita N, 2007, FUNGAL GENET BIOL, V44, P1205, DOI 10.1016/j.fgb.2007.03.006; Trinci A.P.J., 1979, FUNGAL WALL HYPHAL G; TRINCI APJ, 1978, FILAMENTOUS FUNGI, V3, P132; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Vogt N, 2008, MOL BIOL CELL, V19, P4554, DOI 10.1091/mbc.E07-12-1266; Weber I, 2006, PLANT CELL, V18, P225, DOI 10.1105/tpc.105.037341; Wolkow TD, 1996, J CELL SCI, V109, P2179; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Yamada E, 2005, BIOSCI BIOTECH BIOCH, V69, P87, DOI 10.1271/bbb.69.87	73	28	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96744	10.1371/journal.pone.0096744	http://dx.doi.org/10.1371/journal.pone.0096744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800890	gold, Green Published			2022-12-27	WOS:000338029800120
J	Steenken, R; Weber, L; Colonius, H; Diederich, A				Steenken, Rike; Weber, Lars; Colonius, Hans; Diederich, Adele			Designing Driver Assistance Systems with Crossmodal Signals: Multisensory Integration Rules for Saccadic Reaction Times Apply	PLOS ONE			English	Article							AUDITORY-VISUAL INTERACTIONS; SELECTIVE ATTENTION; STIMULUS; WINDOW	Modern driver assistance systems make increasing use of auditory and tactile signals in order to reduce the driver's visual information load. This entails potential crossmodal interaction effects that need to be taken into account in designing an optimal system. Here we show that saccadic reaction times to visual targets (cockpit or outside mirror), presented in a driving simulator environment and accompanied by auditory or tactile accessories, follow some well-known spatiotemporal rules of multisensory integration, usually found under confined laboratory conditions. Auditory nontargets speed up reaction time by about 80 ms. The effect tends to be maximal when the nontarget is presented 50 ms before the target and when target and nontarget are spatially coincident. The effect of a tactile nontarget (vibrating steering wheel) was less pronounced and not spatially specific. It is shown that the average reaction times are well-described by the stochastic "time window of integration'' model for multisensory integration developed by the authors. This two-stage model postulates that crossmodal interaction occurs only if the peripheral processes from the different sensory modalities terminate within a fixed temporal interval, and that the amount of crossmodal interaction manifests itself in an increase or decrease of second stage processing time. A qualitative test is consistent with the model prediction that the probability of interaction, but not the amount of crossmodal interaction, depends on target-nontarget onset asynchrony. A quantitative model fit yields estimates of individual participants' parameters, including the size of the time window. Some consequences for the design of driver assistance systems are discussed.	[Steenken, Rike] Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, D-26111 Oldenburg, Germany; [Weber, Lars] OFFIS, Dept Transportat, Oldenburg, Germany; [Colonius, Hans] Carl von Ossietzky Univ Oldenburg, European Med Sch, Cluster Excellence Hearing4all, Dept Psychol, D-26111 Oldenburg, Germany; [Colonius, Hans] Carl von Ossietzky Univ Oldenburg, European Med Sch, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Diederich, Adele] Jacobs Univ Bremen, Sch Humanities & Social Sci, D-28759 Bremen, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Jacobs University	Steenken, R (corresponding author), Carl von Ossietzky Univ Oldenburg, European Med Sch, Dept Psychol, D-26111 Oldenburg, Germany.	rike.steenken@uni-oldenburg.de	Colonius, Hans/M-3350-2019; Colonius, Hans/D-5668-2011	Colonius, Hans/0000-0002-9733-6939; Colonius, Hans/0000-0002-9733-6939	"Niedersaechsisches Vorab'' of the Volkswagen Foundation; Ministery of Science and Culture of Lower Saxony [ZN2245, ZN2253, ZN2366]	"Niedersaechsisches Vorab'' of the Volkswagen Foundation; Ministery of Science and Culture of Lower Saxony	This work was (partially) supported by the funding initiative "Niedersaechsisches Vorab'' of the Volkswagen Foundation and the Ministery of Science and Culture of Lower Saxony (as part of the project Integrated Modeling for Safe Transportation [IMoST 2]), Grant Number ZN2245, ZN2253, ZN2366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2003, NEUROPSYCHOLOGIA, V41, P1, DOI 10.1016/S0028-3932(02)00139-2; Bell AH, 2006, EXP BRAIN RES, V174, P53, DOI 10.1007/s00221-006-0420-z; Bellinger DB, 2009, TRANSPORT RES F-TRAF, V12, P441, DOI 10.1016/j.trf.2009.08.007; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Colonius H, 2004, J COGNITIVE NEUROSCI, V16, P1000, DOI 10.1162/0898929041502733; Colonius H, 2001, PERCEPT PSYCHOPHYS, V63, P126, DOI 10.3758/BF03200508; Colonius H, 2009, BRAIN TOPOGR, V21, P177, DOI 10.1007/s10548-009-0091-8; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Diederich A, 2008, EXP BRAIN RES, V186, P1, DOI 10.1007/s00221-007-1197-4; Diederich A, 2007, EXP BRAIN RES, V179, P43, DOI 10.1007/s00221-006-0768-0; Diederich A, 2008, BRAIN RES, V1242, P219, DOI 10.1016/j.brainres.2008.05.081; Diederich A, 2007, PERCEPT PSYCHOPHYS, V69, P56, DOI 10.3758/BF03194453; Driver J, 2001, BRIT J PSYCHOL, V92, P53, DOI 10.1348/000712601162103; Ferris T.K., 2006, P HUM FACT ERG SOC A, V50, P406, DOI [10.1177/154193120605000341, DOI 10.1177/154193120605000341]; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Gray R, 2009, ACM T APPL PERCEPT, V6, DOI 10.1145/1462055.1462059; Groh JM, 1996, J NEUROPHYSIOL, V75, P412, DOI 10.1152/jn.1996.75.1.412; HILLS BL, 1980, PERCEPTION, V9, P183, DOI 10.1068/p090183; Ho C, 2013, EXPT BRAIN RES, V227; Ho C., 2008, MULTISENSORY DRIVER; Ho C, 2007, HUM FACTORS, V49, P1107, DOI 10.1518/001872007X249965; Ho C, 2009, EXP BRAIN RES, V195, P261, DOI 10.1007/s00221-009-1778-5; Hughes HC, 1998, VISION RES, V38, P3955, DOI 10.1016/S0042-6989(98)00036-4; Hurts K, 2011, TRANSPORT RES F-TRAF, V14, P300, DOI 10.1016/j.trf.2011.02.003; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Munoz DP, 2004, METH NE FRO NEUROSCI, P55; Otto TU, 2013, J NEUROSCI, V33, P7463, DOI 10.1523/JNEUROSCI.4678-12.2013; Rusch ML, 2013, TRANSPORT RES F-TRAF, V16, P127, DOI 10.1016/j.trf.2012.08.007; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P389, DOI 10.3758/BF03211906; SPENCE C, 2004, CROSSMODAL SPACE CRO, P277; Steenken R, 2008, BRAIN RES, V1220, P150, DOI 10.1016/j.brainres.2007.08.034; Stein BE., 1993, MERGING SENSES; van Atteveldt NM, 2007, CEREB CORTEX, V17, P962, DOI 10.1093/cercor/bhl007; Van Erp JBF, 2004, TRANSPORT RES F-TRAF, V7, P247, DOI 10.1016/j.trf.2004.09.003; Van Wanrooij MM, 2009, EXP BRAIN RES, V198, P425, DOI 10.1007/s00221-009-1815-4; Wallace M. T., 2004, HDB MULTISENSORY PRO, P625	37	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e92666	10.1371/journal.pone.0092666	http://dx.doi.org/10.1371/journal.pone.0092666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24800823	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800018
J	Tian, WL; Wei, T; Li, B; Wang, Z; Zhang, NS; Xie, GH				Tian, Wulin; Wei, Teng; Li, Bin; Wang, Zhe; Zhang, Naisheng; Xie, Guanghong			Pathway of Programmed Cell Death and Oxidative Stress Induced by beta-Hydroxybutyrate in Dairy Cow Abomasum Smooth Muscle Cells and in Mouse Gastric Smooth Muscle	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; ENDOPLASMIC-RETICULUM; KETONE-BODIES; CYTOCHROME-C; DISPLACED ABOMASUM; GROWTH-INHIBITION; INDUCED APOPTOSIS; NUCLEAR ANTIGEN; ACTIVATION; P53	The administration of exogenous beta-hydroxybutyrate (beta-HB), as well as fasting and caloric restriction, is a condition associated with b-HB abundance and decreased appetite in animals. Increased beta-HB and decreased appetite exist simultaneously in some diseases, such as bovine left displaced abomasums (LDA) and human chronic gastritis. However, the effects of beta-HB on stomach injuries have not been explored. To elucidate the possible effects of exogenous beta-HB on the stomach, mice were injected intraperitoneally with beta-HB, and bovine abomasum smooth muscle cells (BSMCs) were treated with different concentrations of beta-HB. We found that beta-HB induced BSMCs endoplasmic reticulum-and mitochondriamediated apoptotic cell death. beta-HB promoted Bax expression and caspase-12, -9, and -3 activation while blocking Bcl-2 expression. beta-HB also promoted AIF, EndoG release and p53 expression. beta-HB acted on key molecules in the apoptotic cell death pathway and increased p38 and c-June NH2-terminal kinase phosphorylation while inhibiting ERK phosphorylation and PCNA expression. beta-HB upregulated P27 and P21 mRNA levels while downregulating cyclin and CDK mRNA levels, arresting the cell cycle. These results suggest that BSMCs treated with b-HB can induce oxidative stress, which can be prevented by intracellular calcium chelators BAPTA/ AM but not antioxidant NAC. Additionally, these results suggest that bHB causes ROS generation through a Ca2+-dependent mechanism and that intracellular Ca2+ levels play a critical role in beta-HB -induced apoptotic cell death. The impact of beta-HB on programmed cell death and oxidative stress in vivo was confirmed in murine experiments. For the first time, we show oxidative stress effects of beta-HB on smooth muscle. We propose that beta-HB is a possible cause of some stomach diseases, including bovine LDA.	[Tian, Wulin; Wei, Teng; Li, Bin; Wang, Zhe; Zhang, Naisheng; Xie, Guanghong] Jilin Univ, Coll Vet Med, Changchun 130023, Peoples R China	Jilin University	Xie, GH (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Peoples R China.	xiegh@jlu.edu.cn			Natural Science Foundation of China [31101865]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The expenses of this work were supported by the Natural Science Foundation of China (31101865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Brookes P, 2002, FREE RADICAL BIO MED, V32, P370, DOI 10.1016/S0891-5849(01)00805-X; Byard RW, 2010, FORENSIC SCI MED PAT, V6, P304, DOI 10.1007/s12024-010-9183-8; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Distelhorst CW, 1998, BLOOD, V91, P731, DOI 10.1182/blood.V91.3.731.731_731_734; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fulop M, 1999, ARCH INTERN MED, V159, P381, DOI 10.1001/archinte.159.4.381; Geishauser T, 1997, AM J VET RES, V58, P1216; Guh JY, 2003, KIDNEY INT, V64, P2041, DOI 10.1046/j.1523-1755.2003.00330.x; Ho SY, 2009, CHEM-BIOL INTERACT, V179, P304, DOI 10.1016/j.cbi.2008.12.015; Ip SW, 2012, INT J UROL, V19, P61, DOI 10.1111/j.1442-2042.2011.02876.x; Jacobson J, 2002, J CELL SCI, V115, P1175; Jacotot E, 1999, ANN NY ACAD SCI, V887, P18, DOI 10.1111/j.1749-6632.1999.tb07919.x; Jain SK, 1998, FREE RADICAL BIO MED, V25, P1083, DOI 10.1016/S0891-5849(98)00140-3; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; LeBlanc SJ, 2005, J DAIRY SCI, V88, P159, DOI 10.3168/jds.S0022-0302(05)72674-6; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin SY, 2009, ANTICANCER RES, V29, P327; Liu ZM, 2007, CELL MOL LIFE SCI, V64, P1428, DOI 10.1007/s00018-007-7107-x; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; MIYACHI K, 1978, J IMMUNOL, V121, P2228; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nagai H, 2007, J BIOCHEM MOL BIOL, V40, P1; Nutt LK, 2002, J BIOL; Pelletier A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1325, DOI 10.1152/ajpendo.00186.2006; Rehage J, 1996, SCHWEIZ ARCH TIERH, V138, P361; Rossi R, 2000, J VET MED A, V47, P9, DOI 10.1046/j.1439-0442.2000.00255.x; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Skinner R, 2009, J PEDIATR SURG, V44, P212, DOI 10.1016/j.jpedsurg.2008.10.042; Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259; Taggart AKP, 2005, J BIOL CHEM, V280, P26649, DOI 10.1074/jbc.C500213200; Tantral L, 2004, CELL BIOCHEM FUNCT, V22, P35, DOI 10.1002/cbf.1050; Turi S, 1997, FREE RADICAL BIO MED, V22, P161, DOI 10.1016/S0891-5849(96)00284-5; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034921; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x	47	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96775	10.1371/journal.pone.0096775	http://dx.doi.org/10.1371/journal.pone.0096775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801711	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800126
J	Adams, TG; Stewart, PA; Blanchar, JC				Adams, Thomas G.; Stewart, Patrick A.; Blanchar, John C.			Disgust and the Politics of Sex: Exposure to a Disgusting Odorant Increases Politically Conservative Views on Sex and Decreases Support for Gay Marriage	PLOS ONE			English	Article							BEHAVIORAL IMMUNE-SYSTEM; SENSITIVITY; LIBERALS; DOMAINS	Disgust has been implicated as a potential causal agent underlying socio-political attitudes and behaviors. Several recent studies have suggested that pathogen disgust may be a causal mechanism underlying social conservatism. However, the specificity of this effect is still in question. The present study tested the effects of disgust on a range of policy preferences to clarify whether disgust is generally implicated in political conservatism across public policy attitudes or is uniquely related to specific content domains. Self-reported socio-political attitudes were compared between participants in two experimental conditions: 1) an odorless control condition, and 2) a disgusting odor condition. In keeping with previous research, the present study showed that exposure to a disgusting odor increased endorsement of socially conservative attitudes related to sexuality. In particular, there was a strong and consistent link between induced disgust and less support for gay marriage.	[Adams, Thomas G.; Blanchar, John C.] Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA; [Stewart, Patrick A.] Univ Arkansas, Dept Polit Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Stewart, PA (corresponding author), Univ Arkansas, Dept Polit Sci, Fayetteville, AR 72701 USA.	pastewar@uark.edu	Blanchar, John/S-6412-2019	Blanchar, John/0000-0001-9726-6320	Department of Political Science at the University of Arkansas	Department of Political Science at the University of Arkansas	The funds used to pay research participants were provided by a small intramural award - the Connor Faculty Fellowship - from the Department of Political Science at the University of Arkansas, which was awarded to Dr. Patrick Stewart. The funders of this award (Sandra and Robert Connor) had no direct involvement in any aspect of the current study.	Atunji BO, 2008, J RES PERS, V42, P1364, DOI 10.1016/j.jrp.2008.04.001; Balzer A, 2011, SOC SCI QUART, V92, P1297, DOI 10.1111/j.1540-6237.2011.00819.x; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Eidelman S, 2012, PERS SOC PSYCHOL B, V38, P808, DOI 10.1177/0146167212439213; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Hatemi P, 2012, PS-POLIT SCI POLIT, V45, P675, DOI 10.1017/S1049096512000686; Helzer EG, 2011, PSYCHOL SCI, V22, P517, DOI 10.1177/0956797611402514; Inbar Y, 2012, SOC PSYCHOL PERS SCI, V3, P537, DOI 10.1177/1948550611429024; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Inbar Y, 2009, EMOTION, V9, P435, DOI 10.1037/a0015960; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Koukounas E, 2001, ARCH SEX BEHAV, V30, P393, DOI 10.1023/A:1010261315767; KRAUT RE, 1982, J PERS SOC PSYCHOL, V42, P853, DOI 10.1037/0022-3514.42.5.853; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Oaten M, 2009, PSYCHOL BULL, V135, P303, DOI 10.1037/a0014823; Olatunji BO, 2012, ASSESSMENT, V19, P205, DOI 10.1177/1073191111432881; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Schaller M., 2011, ADV CULTURE PSYCHOL, V1, P99; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Smith KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025552; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Terrizzi JA, 2010, PERS INDIV DIFFER, V49, P587, DOI 10.1016/j.paid.2010.05.024; Terrizzi Jr JA, 2012, EVOL HUM BEHAV, V34, P99; Toronchuk JA, 2007, COGNITION EMOTION, V21, P1799, DOI 10.1080/02699930701298515; Tybur JM, 2010, EVOL PSYCHOL-US, V8, P599, DOI 10.1177/147470491000800406; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; Wrightsman, 1999, MEASURES POLITICAL A, P59	30	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95572	10.1371/journal.pone.0095572	http://dx.doi.org/10.1371/journal.pone.0095572			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798457	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000020
J	Arsac, JN; Baron, T				Arsac, Jean-Noel; Baron, Thierry			Distinct Transmissibility Features of TSE Sources Derived from Ruminant Prion Diseases by the Oral Route in a Transgenic Mouse Model (TgOvPrP4) Overexpressing the Ovine Prion Protein	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; ATYPICAL SCRAPIE; SHEEP SCRAPIE; MOLECULAR ANALYSIS; MICE; AGENT; INFECTION; FRANCE; BSE; SIMILARITIES	Transmissible spongiform encephalopathies (TSEs) are a group of fatal neurodegenerative diseases associated with a misfolded form of host-encoded prion protein (PrP). Some of them, such as classical bovine spongiform encephalopathy in cattle (BSE), transmissible mink encephalopathy (TME), kuru and variant Creutzfeldt-Jakob disease in humans, are acquired by the oral route exposure to infected tissues. We investigated the possible transmission by the oral route of a panel of strains derived from ruminant prion diseases in a transgenic mouse model (TgOvPrP4) overexpressing the ovine prion protein (A(136)R(154)Q(171)) under the control of the neuron-specific enolase promoter. Sources derived from Nor98, CH1641 or 87V scrapie sources, as well as sources derived from L-type BSE or cattle-passaged TME, failed to transmit by the oral route, whereas those derived from classical BSE and classical scrapie were successfully transmitted. Apart from a possible effect of passage history of the TSE agent in the inocula, this implied the occurrence of subtle molecular changes in the protease-resistant prion protein (PrPres) following oral transmission that can raises concerns about our ability to correctly identify sheep that might be orally infected by the BSE agent in the field. Our results provide proof of principle that transgenic mouse models can be used to examine the transmissibility of TSE agents by the oral route, providing novel insights regarding the pathogenesis of prion diseases.	[Arsac, Jean-Noel; Baron, Thierry] Agence Natl Securite Sanit Alimentat Environm & T, Unite Malad Neurodegenerat, Lyon, France		Baron, T (corresponding author), Agence Natl Securite Sanit Alimentat Environm & T, Unite Malad Neurodegenerat, Lyon, France.	thierry.baron@anses.fr						Arsac JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007300; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron T, 2007, EMERG INFECT DIS, V13, P1887, DOI 10.3201/eid1312.070635; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010310; Bencsik A, 2007, HISTOCHEM CELL BIOL, V127, P531, DOI 10.1007/s00418-007-0276-8; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; BRUCE ME, 1985, J GEN VIROL, V66, P2517, DOI 10.1099/0022-1317-66-12-2517; BURGER D, 1965, J INFECT DIS, V115, P393, DOI 10.1093/infdis/115.4.393; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Crozet C, 2001, EMBO REP, V2, P952, DOI 10.1093/embo-reports/kve204; Crozet C, 2001, J VIROL, V75, P5328, DOI 10.1128/JVI.75.11.5328-5334.2001; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; de Pedro-Cuesta J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-278; Espinosa JC, 2007, J VIROL, V81, P835, DOI 10.1128/JVI.01356-06; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; Fraser JR, 1996, J GEN VIROL, V77, P2663, DOI 10.1099/0022-1317-77-10-2663; Ghani AC, 2002, CR BIOL, V325, P37, DOI 10.1016/S1631-0691(02)01389-6; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Langevin C, 2011, NEUROBIOL DIS, V41, P219, DOI 10.1016/j.nbd.2010.09.010; Mestre-Frances N, 2012, EMERG INFECT DIS, V18, P142, DOI 10.3201/eid1801.111092; Migliore S, 2012, J GEN VIROL, V93, P450, DOI 10.1099/vir.0.035469-0; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; MOULD DL, 1967, J COMP PATHOL, V77, P387, DOI 10.1016/0021-9975(67)90023-0; Nicot S, 2011, J VIROL, V85, P1906, DOI 10.1128/JVI.01872-10; Nicot S, 2010, J GEN VIROL, V91, P570, DOI 10.1099/vir.0.014464-0; OUTRAM GW, 1973, J COMP PATHOL, V83, P19, DOI 10.1016/0021-9975(73)90023-6; Padilla D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001319; Plinston C, 2011, J VIROL, V85, P1174, DOI 10.1128/JVI.01578-10; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Simmons MM, 2011, EMERG INFECT DIS, V17, P848, DOI 10.3201/eid1705.101654; Siso S, 2012, PRION, V6, P174, DOI 10.4161/pri.18990; Stack M, 2009, J GEN VIROL, V90, P764, DOI 10.1099/vir.0.005983-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; Torres JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089722; Vickery CM, 2013, INT J EXP PATHOL, V94, P320, DOI 10.1111/iep.12036; Vulin J, 2011, EMERG INFECT DIS, V17, P55, DOI 10.3201/eid1701.100891; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Yokoyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015450	44	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96215	10.1371/journal.pone.0096215	http://dx.doi.org/10.1371/journal.pone.0096215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797075	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000048
J	Gardell, AM; Qin, Q; Rice, RH; Li, J; Kultz, D				Gardell, Alison M.; Qin, Qin; Rice, Robert H.; Li, Johnathan; Kueltz, Dietmar			Derivation and Osmotolerance Characterization of Three Immortalized Tilapia (Oreochromis mossambicus) Cell Lines	PLOS ONE			English	Article							ORGANIC OSMOLYTES; IN-VITRO; EPIDERMAL-KERATINOCYTES; PROGENITOR-CELL; ROCK INHIBITOR; RAINBOW-TROUT; KIDNEY-CELLS; GLIAL-CELLS; STEM-CELLS; BRAIN	Fish cell cultures are becoming more widely used models for investigating molecular mechanisms of physiological response to environmental challenge. In this study, we derived two immortalized Mozambique tilapia (Oreochromis mossambicus) cell lines from brain (OmB) and lip epithelium (OmL), and compared them to a previously immortalized bulbus arteriosus (TmB) cell line. The OmB and OmL cell lines were generated without or with Rho-associated kinase (ROCK) inhibitor/3T3 feeder layer supplementation. Although both approaches were successful, ROCK inhibitor/feeder layer supplementation was found to offer the advantages of selecting for epithelial-like cell type and decreasing time to immortalization. After immortalization (>= passage 5), we characterized the proteomes of the newly derived cell lines (OmB and OmL) using LCMS and identified several unique cell markers for each line. Subsequently, osmotolerance for each of the three cell lines following acute exposure to elevated sodium chloride was evaluated. The acute maximum osmotolerance of these tilapia cell lines (>700 mOsm/kg) was markedly higher than that of any other known vertebrate cell line, but was significantly higher in the epithelial-like OmL cell line. To validate the physiological relevance of these tilapia cell lines, we quantified the effects of acute hyperosmotic challenge (450 mOsm/kg and 700 mOsm/kg) on the transcriptional regulation of two enzymes involved in biosynthesis of the compatible organic osmolyte, myo-inositol. Both enzymes were found to be robustly upregulated in all three tilapia cell lines. Therefore, the newly established tilapia cells lines represent valuable tools for studying molecular mechanisms involved in the osmotic stress response of euryhaline fish.	[Gardell, Alison M.; Li, Johnathan; Kueltz, Dietmar] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Qin, Qin; Rice, Robert H.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Gardell, AM (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	alison.gardell@gmail.com	, DK/AAU-3163-2021; Rice, Robert/AAP-7813-2021		NSF [IOS-1049780]; NIH from the National Institute for Environmental Health Sciences [P42ES004699-25]; NIEHS/UC Davis Superfund; UC Davis Jastro-Shields Research Fellowship; Division Of Integrative Organismal Systems [1049780] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH from the National Institute for Environmental Health Sciences; NIEHS/UC Davis Superfund; UC Davis Jastro-Shields Research Fellowship; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this study was primarily provided by NSF Grant IOS-1049780 (to D.K.) and NIH Grant P42ES004699-25 from the National Institute for Environmental Health Sciences (to D.K. and R.H.R.). Additional support was provided by NIEHS/UC Davis Superfund for a Pre-doctoral Training Fellowship and a UC Davis Jastro-Shields Research Fellowship (all to A.M.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Agarwal S, 2012, AM J PATHOL, V180, P443, DOI 10.1016/j.ajpath.2011.12.001; ALLENHOFFMANN BL, 1984, P NATL ACAD SCI-BIOL, V81, P7802, DOI 10.1073/pnas.81.24.7802; Boonanuntanasarn S, 2003, BIOCHEM BIOPH RES CO, V310, P1089, DOI 10.1016/j.bbrc.2003.09.127; Boonanuntanasarn S, 2008, J WORLD AQUACULT SOC, V39, P311, DOI 10.1111/j.1749-7345.2008.00167.x; Bryson SP, 2006, MAR BIOTECHNOL, V8, P641, DOI 10.1007/s10126-005-6163-1; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burg MB, 1996, FASEB J, V10, P1598, DOI 10.1096/fasebj.10.14.9002551; Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297; Chi SC, 2005, DIS AQUAT ORGAN, V65, P91, DOI 10.3354/dao065091; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; de Castro AG, 2000, FEBS LETT, V487, P199, DOI 10.1016/S0014-5793(00)02340-1; Deane EE, 2007, GEN COMP ENDOCR, V152, P183, DOI 10.1016/j.ygcen.2006.12.020; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Estelles A, 1996, J BIOL CHEM, V271, P14800, DOI 10.1074/jbc.271.25.14800; Fent K, 2001, TOXICOL IN VITRO, V15, P477, DOI 10.1016/S0887-2333(01)00053-4; Fiess JC, 2007, COMP BIOCHEM PHYS A, V146, P252, DOI 10.1016/j.cbpa.2006.10.027; Fiol DF, 2007, FEBS J, V274, P109, DOI 10.1111/j.1742-4658.2006.05569.x; Fiol DF, 2006, COMP BIOCHEM PHYS D, V1, P344, DOI 10.1016/j.cbd.2006.08.002; Fleischmajer R, 1998, J CELL SCI, V111, P1929; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; Frojdo EM, 2002, COMP BIOCHEM PHYS A, V133, P17, DOI 10.1016/S1095-6433(02)00110-1; Fryer J. L., 1994, Journal of Tissue Culture Methods, V16, P87, DOI 10.1007/BF01404816; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Gardell AM, 2013, J EXP BIOL, V216, P4615, DOI 10.1242/jeb.088906; Green H, 1977, Prog Clin Biol Res, V17, P493; HANDLER JS, 1993, AM J PHYSIOL, V265, pC1449, DOI 10.1152/ajpcell.1993.265.6.C1449; Hartmann C, 1998, J PHARMACEUT BIOMED, V17, P193, DOI 10.1016/S0731-7085(97)00198-2; HEIMANN R, 1983, J CELL PHYSIOL, V117, P362, DOI 10.1002/jcp.1041170311; Irianto J, 2013, BIOPHYS J, V104, P759, DOI 10.1016/j.bpj.2013.01.006; JESERICH G, 1992, DEV BRAIN RES, V67, P27, DOI 10.1016/0165-3806(92)90022-O; Kalujnaia S, 2013, AM J PHYSIOL-REG I, V305, pR369, DOI 10.1152/ajpregu.00044.2013; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; Kirschner N, 2012, ANN NY ACAD SCI, V1257, P158, DOI 10.1111/j.1749-6632.2012.06554.x; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kultz D, 2013, MOL CELL PROTEOMICS, V12, P3962, DOI 10.1074/mcp.M113.029827; Lakra WS, 2011, FISH PHYSIOL BIOCHEM, V37, P1, DOI 10.1007/s10695-010-9411-x; Langbein L, 2002, EUR J CELL BIOL, V81, P419, DOI 10.1078/0171-9335-00270; Lanir Y, 2012, J BIOMECH, V45, P780, DOI 10.1016/j.jbiomech.2011.11.018; Laughlin KM, 2009, DIFFERENTIATION, V78, P35, DOI 10.1016/j.diff.2009.04.001; LEWIS DH, 1985, J FISH DIS, V8, P477, DOI 10.1111/j.1365-2761.1985.tb01283.x; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Mack AF, 2013, J NEUROSCI METH, V212, P269, DOI 10.1016/j.jneumeth.2012.11.003; Macpherson I, 1970, Adv Cancer Res, V13, P169, DOI 10.1016/S0065-230X(08)60166-9; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Mak SK, 2004, J BIOL CHEM, V279, P39075, DOI 10.1074/jbc.M406643200; Mazon AD, 2007, TOXICOLOGY, V230, P53, DOI 10.1016/j.tox.2006.10.027; Miller J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003284; NAKANISHI T, 1988, AM J PHYSIOL, V255, pC181, DOI 10.1152/ajpcell.1988.255.2.C181; Nishiyama T, 2000, J DERMATOL SCI, V24, pS51, DOI 10.1016/S0923-1811(00)00142-0; Ohnishi T, 2007, J BIOL CHEM, V282, P637, DOI 10.1074/jbc.M604474200; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; PARKINSON C, 1987, J FISH BIOL, V31, P239, DOI 10.1111/j.1095-8649.1987.tb05322.x; Petzold A, 2003, J NEUROIMMUNOL, V138, P45, DOI 10.1016/S0165-5728(03)00092-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Rippa AL, 2013, ACTA NATURAE, V5, P22, DOI 10.32607/20758251-2013-5-4-22-33; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sacchi R, 2013, J EXP BIOL, V216, P4626, DOI 10.1242/jeb.093823; Sadray S, 2003, J CHROMATOGR B, V787, P293, DOI 10.1016/S1570-0232(02)00952-2; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Seelan RS, 2009, J BIOL CHEM, V284, P9443, DOI 10.1074/jbc.M900206200; Servili A, 2009, COMP BIOCHEM PHYS A, V152, P245, DOI 10.1016/j.cbpa.2008.10.018; Shamir A, 2001, GENE, V271, P285, DOI 10.1016/S0378-1119(01)00502-9; SIVRON T, 1992, GLIA, V6, P52, DOI 10.1002/glia.440060108; SIZELAND PCB, 1993, KIDNEY INT, V43, P448, DOI 10.1038/ki.1993.66; Stepanenko AA, 2012, CYTOL GENET+, V46, P96, DOI 10.3103/S0095452712020041; STICKNEY RR, 1986, PROG FISH CULT, V48, P161, DOI 10.1577/1548-8640(1986)48&lt;161:TTOSW&gt;2.0.CO;2; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; TOCHER DR, 1990, J NEUROSCI METH, V33, P93, DOI 10.1016/0165-0270(90)90013-6; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Vesterinen HM, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-33; Wang PJ, 2009, COMP BIOCHEM PHYS A, V152, P544, DOI 10.1016/j.cbpa.2008.12.012; Warskulat U, 2004, J INVEST DERMATOL, V123, P516, DOI 10.1111/j.0022-202X.2004.23313.x; Warskulat U, 2008, EXP DERMATOL, V17, P1031, DOI 10.1111/j.1600-0625.2008.00746.x; Warskulat U, 2007, BIOL CHEM, V388, P1345, DOI 10.1515/BC.2007.140; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wei YB, 2009, AQUAC RES, V40, P1523, DOI 10.1111/j.1365-2109.2009.02253.x; Wen CM, 2008, COMP BIOCHEM PHYS A, V149, P167, DOI 10.1016/j.cbpa.2007.11.005; Wen CM, 2010, COMP BIOCHEM PHYS A, V156, P224, DOI 10.1016/j.cbpa.2010.02.003; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018271; Zhou LR, 2003, FISH PHYSIOL BIOCHEM, V29, P255, DOI 10.1007/s10695-004-5262-7	84	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95919	10.1371/journal.pone.0095919	http://dx.doi.org/10.1371/journal.pone.0095919			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797371	Green Published, gold			2022-12-27	WOS:000336656000030
J	Sanchez-Riego, AM; Lopez-Maury, L; Florencio, FJ				Maria Sanchez-Riego, Ana; Lopez-Maury, Luis; Javier Florencio, Francisco			Genomic Responses to Arsenic in the Cyanobacterium Synechocystis sp PCC 6803	PLOS ONE			English	Article							GROUP-2 SIGMA-FACTORS; FERN PTERIS-VITTATA; SP STRAIN PCC-6803; SACCHAROMYCES-CEREVISIAE; EXPRESSION PROFILES; ESCHERICHIA-COLI; PHOSPHATE-TRANSPORT; 2-COMPONENT SYSTEM; LIGHT ACCLIMATION; STRESS	Arsenic is a ubiquitous contaminant and a toxic metalloid which presents two main redox states in nature: arsenite [As III] and arsenate [As V]. Arsenic resistance in Synechocystis sp. strain PCC 6803 is mediated by the arsBHC operon and two additional arsenate reductases encoded by the arsI1 and arsI2 genes. Here we describe the genome-wide responses to the presence of arsenate and arsenite in wild type and mutants in the arsenic resistance system. Both forms of arsenic produced similar responses in the wild type strain, including induction of several stress related genes and repression of energy generation processes. These responses were transient in the wild type strain but maintained in time in an arsB mutant strain, which lacks the arsenite transporter. In contrast, the responses observed in a strain lacking all arsenate reductases were somewhat different and included lower induction of genes involved in metal homeostasis and Fe-S cluster biogenesis, suggesting that these two processes are targeted by arsenite in the wild type strain. Finally, analysis of the arsR mutant strain revealed that ArsR seems to only control 5 genes in the genome. Furthermore, the arsR mutant strain exhibited hypersentivity to nickel, copper and cadmium and this phenotype was suppressed by mutation in arsB but not in arsC gene suggesting that overexpression of arsB is detrimental in the presence of these metals in the media.	[Maria Sanchez-Riego, Ana; Lopez-Maury, Luis; Javier Florencio, Francisco] Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF)	Lopez-Maury, L (corresponding author), Univ Seville, CSIC, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain.	llmaury@ibvf.csic.es; floren@us.es	Florencio, Francisco J/K-7716-2014; Lopez-Maury, Luis/B-3715-2015	Florencio, Francisco J/0000-0002-2068-7861; Lopez-Maury, Luis/0000-0002-3510-0621	Ministerio de Economia y Competitividad (MINECO); European Regional Fund (FEDER) [BFU201015708, E-CLPN09-001]; Junta de Andalucia [BIO-284]; Junta de Ampliacion de Estudios-Doctor contract from Consejo Superior de Investigaciones Cientificas (CSIC); FPU fellowship from the Ministerio de Educacion y Ciencia (MEC)	Ministerio de Economia y Competitividad (MINECO); European Regional Fund (FEDER); Junta de Andalucia(Junta de Andalucia); Junta de Ampliacion de Estudios-Doctor contract from Consejo Superior de Investigaciones Cientificas (CSIC); FPU fellowship from the Ministerio de Educacion y Ciencia (MEC)(German Research Foundation (DFG))	This work was supported by Ministerio de Economia y Competitividad (MINECO) and the European Regional Fund (FEDER) to F. J. F. (grant BFU201015708, and plan E-CLPN09-001) and by Junta de Andalucia (group BIO-284). L.L.- M. was recipient of a Junta de Ampliacion de Estudios-Doctor contract from Consejo Superior de Investigaciones Cientificas (CSIC). A.M.S.R. was recipient of an FPU fellowship from the Ministerio de Educacion y Ciencia (MEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Basturea GN, 2012, J BIOL CHEM, V287, P28816, DOI 10.1074/jbc.C112.394403; Basu P., 2010, MICROBE MAG, V5, P53, DOI DOI 10.1128/MICR0BE.5.53.1; Bernstam L, 2000, J TOXICOL ENV HEAL B, V3, P293, DOI 10.1080/109374000436355; Cameron JC, 2010, PLANT PHYSIOL, V154, P1672, DOI 10.1104/pp.110.162990; Chakrabarty D, 2009, CHEMOSPHERE, V74, P688, DOI 10.1016/j.chemosphere.2008.09.082; Cleiss-Arnold J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-709; Dani SU, 2011, SCI TOTAL ENVIRON, V409, P4889, DOI 10.1016/j.scitotenv.2011.05.044; Dhankher OP, 2006, P NATL ACAD SCI USA, V103, P5413, DOI 10.1073/pnas.0509770102; Dilda PJ, 2008, INT J BIOCHEM CELL B, V40, P1016, DOI 10.1016/j.biocel.2007.11.002; Elias M, 2012, NATURE, V491, P134, DOI 10.1038/nature11517; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; Erb TJ, 2012, SCIENCE, V337, P467, DOI 10.1126/science.1218455; Perez-Perez ME, 2009, J BACTERIOL, V191, P7477, DOI 10.1128/JB.00831-09; Fekry MI, 2011, ACS CHEM BIOL, V6, P127, DOI 10.1021/cb2000023; Foster AW, 2012, J BIOL CHEM, V287, P12142, DOI 10.1074/jbc.M111.338301; Garcia-Dominguez M, 2000, J BACTERIOL, V182, P1507, DOI 10.1128/JB.182.6.1507-1514.2000; Garcia-Dominguez M, 1997, PLANT MOL BIOL, V35, P723, DOI 10.1023/A:1005846626187; Giner-Lamia J, 2012, PLANT PHYSIOL, V159, P1806, DOI 10.1104/pp.112.200659; Gregus Z, 2009, TOXICOL SCI, V110, P282, DOI 10.1093/toxsci/kfp113; Hanaoka M, 2008, PLANT J, V56, P327, DOI 10.1111/j.1365-313X.2008.03600.x; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hervas M, 2012, BIOCHEMISTRY-US, V51, P1178, DOI 10.1021/bi201904p; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Houot L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-350; Huang TL, 2012, PLANT MOL BIOL, V80, P587, DOI 10.1007/s11103-012-9969-z; Imamura S, 2003, FEBS LETT, V554, P357, DOI 10.1016/S0014-5793(03)01188-8; Indriolo E, 2010, PLANT CELL, V22, P2045, DOI 10.1105/tpc.109.069773; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; Jin YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000053; Kamerlin SCL, 2013, Q REV BIOPHYS, V46, P1, DOI 10.1017/S0033583512000157; Kanesaki Y, 2007, PLANT J, V49, P313, DOI 10.1111/j.1365-313X.2006.02959.x; Kim SG, 2012, BBA-PROTEINS PROTEOM, V1824, P392, DOI [10.1016/j.bbapap.2011.10.012, 10.1016/j.bbapap.2011.11.012]; Kulp TR, 2008, SCIENCE, V321, P967, DOI 10.1126/science.1160799; Li B, 2010, BIORESOURCE TECHNOL, V101, P9811, DOI 10.1016/j.biortech.2010.07.043; Li RH, 2003, J BACTERIOL, V185, P6780, DOI 10.1128/JB.185.23.6780-6789.2003; Liu WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042408; Liu ZJ, 2004, BIOCHEM BIOPH RES CO, V316, P1178, DOI 10.1016/j.bbrc.2004.03.003; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Lopez-Maury L, 2003, J BACTERIOL, V185, P5363, DOI 10.1128/JB.185.18.5363-5371.2003; Lopez-Maury L, 2009, J BACTERIOL, V191, P3534, DOI 10.1128/JB.01798-08; Lopez-Redondo ML, 2010, MOL MICROBIOL, V78, P475, DOI 10.1111/j.1365-2958.2010.07348.x; Maciaszczyk-Dziubinska E, 2010, FEBS LETT, V584, P726, DOI 10.1016/j.febslet.2009.12.027; Marteyn B, 2009, MOL MICROBIOL, V71, P520, DOI 10.1111/j.1365-2958.2008.06550.x; Meng YL, 2004, J BIOL CHEM, V279, P18334, DOI 10.1074/jbc.M400037200; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; Murphy JN, 2009, J BACTERIOL, V191, P6722, DOI 10.1128/JB.00801-09; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Norton GJ, 2008, J EXP BOT, V59, P2267, DOI 10.1093/jxb/ern097; ODEN KL, 1994, MOL MICROBIOL, V12, P301, DOI 10.1111/j.1365-2958.1994.tb01018.x; Ordonez E, 2009, J BIOL CHEM, V284, P15107, DOI 10.1074/jbc.M900877200; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Paithoonrangsarid K, 2004, J BIOL CHEM, V279, P53078, DOI 10.1074/jbc.M410162200; Pan XW, 2010, GENETICS, V186, P725, DOI 10.1534/genetics.110.117655; Pandey S, 2012, J PROTEOMICS, V75, P921, DOI 10.1016/j.jprot.2011.10.011; Parvatiyar K, 2005, J BACTERIOL, V187, P4853, DOI 10.1128/JB.187.14.4853-4864.2005; Pitt FD, 2010, J BACTERIOL, V192, P3512, DOI 10.1128/JB.00258-10; Pollari M, 2009, J BACTERIOL, V191, P3992, DOI 10.1128/JB.00132-09; Ramadan D, 2009, BIOCHEMISTRY-US, V48, P424, DOI 10.1021/bi801988x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rodriguez-Gabriel MA, 2005, EUKARYOT CELL, V4, P1396, DOI 10.1128/EC.4.8.1396-1402.2005; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Rupprecht E, 2007, PLANT CELL PHYSL, V51, P1210; Rutherford JC, 1999, J BIOL CHEM, V274, P25827, DOI 10.1074/jbc.274.36.25827; Seino Y, 2009, J BACTERIOL, V191, P1581, DOI 10.1128/JB.01588-08; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Singh AK, 2008, PLANT PHYSIOL, V148, P467, DOI 10.1104/pp.108.123489; Singh AK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-105; Singh AK, 2009, PLANT PHYSIOL, V151, P1596, DOI 10.1104/pp.109.144824; Slaughter DC, 2012, MICROBIOL RES, V167, P151, DOI 10.1016/j.micres.2011.05.007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Takahashi A, 2001, APPL ORGANOMET CHEM, V15, P291, DOI 10.1002/aoc.144; Takahashi T, 2010, J BACTERIOL, V192, P4031, DOI 10.1128/JB.00444-10; Tawfik DS, 2011, BIOCHEMISTRY-US, V50, P1128, DOI 10.1021/bi200002a; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; THIEL T, 1988, J BACTERIOL, V170, P1143, DOI 10.1128/jb.170.3.1143-1147.1988; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Thorsen M, 2007, PHYSIOL GENOMICS, V30, P35, DOI 10.1152/physiolgenomics.00236.2006; Thorsen M, 2012, MOL MICROBIOL, V84, P1177, DOI 10.1111/j.1365-2958.2012.08085.x; Thorsen M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-105; van Lis R, 2013, BBA-BIOENERGETICS, V1827, P176, DOI 10.1016/j.bbabio.2012.08.007; Varvasovszki V, 2003, BIOCHEM BIOPH RES CO, V305, P641, DOI 10.1016/S0006-291X(03)00822-2; Villadangos AF, 2011, MOL MICROBIOL, V82, P998, DOI 10.1111/j.1365-2958.2011.07882.x; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; WILLSKY GR, 1980, J BACTERIOL, V144, P366, DOI 10.1128/JB.144.1.366-374.1980; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; Wysocki R, 2003, BIOCHEM BIOPH RES CO, V304, P293, DOI 10.1016/S0006-291X(03)00584-9; Wysocki R, 1997, J BIOL CHEM, V272, P30061, DOI 10.1074/jbc.272.48.30061; Wysocki R, 2001, MOL MICROBIOL, V40, P1391, DOI 10.1046/j.1365-2958.2001.02485.x; Ye J, 2012, TRENDS PLANT SCI, V17, P155, DOI 10.1016/j.tplants.2011.12.003; Yin XX, 2011, PLANT PHYSIOL, V156, P1631, DOI 10.1104/pp.111.178947; Yoshimura T, 2007, FEBS LETT, V581, P1495, DOI 10.1016/j.febslet.2007.03.010; Zhang YB, 2009, ANTON LEEUW INT J G, V96, P161, DOI 10.1007/s10482-009-9313-z; Zhang Y, 2007, MICROBIOL-SGM, V153, P3713, DOI 10.1099/mic.0.2007/011403-0; Zhao FJ, 2009, NEW PHYTOL, V181, P777, DOI 10.1111/j.1469-8137.2008.02716.x	96	26	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96826	10.1371/journal.pone.0096826	http://dx.doi.org/10.1371/journal.pone.0096826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797411	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000130
J	Cappelli, A; Ulissi, U; Valzano, M; Damiani, C; Epis, S; Gabrielli, MG; Conti, S; Polonelli, L; Bandi, C; Favia, G; Ricci, I				Cappelli, Alessia; Ulissi, Ulisse; Valzano, Matteo; Damiani, Claudia; Epis, Sara; Gabrielli, Maria Gabriella; Conti, Stefania; Polonelli, Luciano; Bandi, Claudio; Favia, Guido; Ricci, Irene			A Wickerhamomyces anomalus Killer Strain in the Malaria Vector Anopheles stephensi	PLOS ONE			English	Article							YEAST PICHIA-ANOMALA; CANDIDACIDAL ANTIIDIOTYPIC ANTIBODIES; AEDES-AEGYPTI DIPTERA; MOSQUITO MIDGUT; TOXIN; PURIFICATION; BIOTECHNOLOGY; BIOCONTROL; ALBICANS; PEPTIDE	The yeast Wickerhamomyces anomalus has been investigated for several years for its wide biotechnological potential, especially for applications in the food industry. Specifically, the antimicrobial activity of this yeast, associated with the production of Killer Toxins (KTs), has attracted a great deal of attention. The strains of W. anomalus able to produce KTs, called "killer" yeasts, have been shown to be highly competitive in the environment. Different W. anomalus strains have been isolated from diverse habitats and recently even from insects. In the malaria mosquito vector Anopheles stephensi these yeasts have been detected in the midgut and gonads. Here we show that the strain of W. anomalus isolated from An. stephensi, namely WaF17.12, is a killer yeast able to produce a KT in a cell-free medium (in vitro) as well as in the mosquito body (in vivo). We showed a constant production of WaF17.12-KT over time, after stimulation of toxin secretion in yeast cultures and reintroduction of the activated cells into the mosquito through the diet. Furthermore, the antimicrobial activity of WaF17.12-KT has been demonstrated in vitro against sensitive microbes, showing that strain WaF17.12 releases a functional toxin. The mosquito-associated yeast WaF17.12 thus possesses an antimicrobial activity, which makes this yeast worthy of further investigations, in view of its potential as an agent for the symbiotic control of malaria.	[Cappelli, Alessia; Ulissi, Ulisse; Valzano, Matteo; Damiani, Claudia; Gabrielli, Maria Gabriella; Favia, Guido; Ricci, Irene] Univ Camerino, Scuola Biosci & Med Vet, I-62032 Camerino, Italy; [Epis, Sara; Bandi, Claudio] Univ Milan, Dipartimento Patol Anim Igiene & Sanita Pubbl Vet, Milan, Italy; [Conti, Stefania; Polonelli, Luciano] Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, I-43100 Parma, Italy	University of Camerino; University of Milan; University of Parma	Ricci, I (corresponding author), Univ Camerino, Scuola Biosci & Med Vet, I-62032 Camerino, Italy.	irene.ricci@unicam.it	Bandi, Claudio/J-7835-2018; Conti, Stefania/N-3558-2015; EPIS, SARA/B-7708-2017; CAPPELLI, ALESSIA/AAU-6203-2020	Bandi, Claudio/0000-0002-0181-4618; Conti, Stefania/0000-0001-9973-8352; EPIS, SARA/0000-0001-8807-4802; Damiani, Claudia/0000-0001-5022-0675; Favia, Guido/0000-0002-4420-8482; Cappelli, Alessia/0000-0003-4553-9360	European Union [281222]; Prin [2009L27YC8_003]; Italian Ministry of Education, University and Research (MIUR); EU [228421]	European Union(European Commission); Prin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme ([FP7/2007-2013] [FP7/2007-2011]) under grant agreement nu 281222 to IR and from Prin 2009 (grant 2009L27YC8_003), from the Italian Ministry of Education, University and Research (MIUR) and by the EU-FP7 Capacities-Infrastructure 2008 (grant 228421) to GF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2004, INSECT BIOCHEM MOLEC, V34, P667, DOI 10.1016/j.ibmb.2004.03.019; Bevan EA, 1963, GEN TOD 11 INT C GEN, V1, P53; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Billker O, 2000, PARASITOLOGY, V120, P547, DOI 10.1017/S0031182099005946; Bushkin GG, 2012, MBIO, V3, DOI 10.1128/mBio.00258-12; Buzzini P, 2001, J CLIN MICROBIOL, V39, P3362, DOI 10.1128/JCM.39.9.3362-3364.2001; CAILLIEZ JC, 1994, MYCOPATHOLOGIA, V126, P173, DOI 10.1007/BF01103772; CAILLIEZ JC, 1992, BIOL CELL, V75, P19, DOI 10.1016/0248-4900(92)90120-P; Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X; Conti S, 2008, NEW MICROBIOL, V31, P143; Corena MD, 2005, J EXP BIOL, V208, P3263, DOI 10.1242/jeb.01739; Fang WG, 2011, SCIENCE, V331, P1074, DOI 10.1126/science.1199115; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Fiori PL, 2006, J ANTIMICROB CHEMOTH, V57, P891, DOI 10.1093/jac/dkl051; Fredlund E, 2002, FEMS YEAST RES, V2, P395, DOI 10.1111/j.1567-1364.2002.tb00109.x; Friel D, 2007, MOL PLANT MICROBE IN, V20, P371, DOI 10.1094/MPMI-20-4-0371; Grevesse C, 2003, PHYTOPATHOLOGY, V93, P1145, DOI 10.1094/PHYTO.2003.93.9.1145; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005; Guyard C, 2002, J ANTIMICROB CHEMOTH, V49, P961, DOI 10.1093/jac/dkf040; Izgu F, 2006, ENZYME MICROB TECH, V39, P669, DOI 10.1016/j.enzmictec.2005.11.024; JIJAKLI MH, 2011, A VANLEEUWENHOEK INT, V99, P93, DOI DOI 10.1007/S10482-010-9541-2; KAGIYAMA S, 1988, AGR BIOL CHEM TOKYO, V52, P1; Koehler S, 2013, J CHEM ECOL, V39, P978, DOI 10.1007/s10886-013-0304-1; LACHANCE MA, 1977, CAN J BIOCHEM CELL B, V55, P1001, DOI 10.1139/o77-149; Lopes CA, 2010, REV ARGENT MICROBIOL, V42, P298, DOI 10.1590/S0325-75412010000400011; Magliani W., 2007, Anti-Infective Agents in Medicinal Chemistry, V6, P263, DOI 10.2174/187152107782023060; Magliani W, 2008, FRONT BIOSCI-LANDMRK, V13, P6920, DOI 10.2741/3199; MAHESHWARI R, 1989, INDIAN J MED RES-A, V89, P396; MOLINA M, 1989, J GEN MICROBIOL, V135, P309; Muccilli S, 2013, YEAST, V30, P33, DOI 10.1002/yea.2935; Olstorpe M, 2011, ANTON LEEUW INT J G, V99, P57, DOI 10.1007/s10482-010-9497-2; Passoth V, 2006, FEMS YEAST RES, V6, P3, DOI 10.1111/j.1567-1364.2005.00004.x; Passoth V, 2003, TOP CURR GENET, V2, P297; Peng Y, 2009, APPL MICROBIOL BIOT, V85, P85, DOI 10.1007/s00253-009-2061-1; POLONELLI L, 1986, J CLIN MICROBIOL, V24, P866, DOI 10.1128/JCM.24.5.866-869.1986; POLONELLI L, 1990, MYCOPATHOLOGIA, V110, P169, DOI 10.1007/BF00437542; Polonelli L, 1997, CLIN DIAGN LAB IMMUN, V4, P142, DOI 10.1128/CDLI.4.2.142-146.1997; POLONELLI L, 1987, J CLIN MICROBIOL, V25, P460, DOI 10.1128/JCM.25.2.460-462.1987; Polonelli L, 2011, ANTON LEEUW INT J G, V99, P35, DOI 10.1007/s10482-010-9496-3; Ricci I, 2011, ENVIRON MICROBIOL, V13, P911, DOI 10.1111/j.1462-2920.2010.02395.x; Ricci I, 2011, ANTON LEEUW INT J G, V99, P43, DOI 10.1007/s10482-010-9532-3; Savoia D, 2006, EXP PARASITOL, V113, P186, DOI 10.1016/j.exppara.2006.01.002; SAWANT AD, 1988, APPL ENVIRON MICROB, V54, P1099, DOI 10.1128/AEM.54.5.1099-1103.1988; Sundh I, 2011, ANTON LEEUW INT J G, V99, P113, DOI 10.1007/s10482-010-9528-z; Toki W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041893; Walker GM, 2011, ANTON LEEUW INT J G, V99, P25, DOI 10.1007/s10482-010-9491-8; Wang L, 2008, DIS AQUAT ORGAN, V80, P211, DOI 10.3354/dao01943; Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001; Wang X, 2007, CURR MICROBIOL, V55, P396, DOI 10.1007/s00284-007-9010-y; Wang XX, 2012, MICROBIOL RES, V167, P558, DOI 10.1016/j.micres.2011.12.001; Xu ZW, 2006, PROTEIN EXPRES PURIF, V47, P118, DOI 10.1016/j.pep.2005.11.025; Zacchi L, 2002, ANN MICROBIOL, V52, P237	53	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95988	10.1371/journal.pone.0095988	http://dx.doi.org/10.1371/journal.pone.0095988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788884	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600061
J	Ellies, DL; Economou, A; Viviano, B; Rey, JP; Paine-Saunders, S; Krumlauf, R; Saunders, S				Ellies, Debra L.; Economou, Androulla; Viviano, Beth; Rey, Jean-Philippe; Paine-Saunders, Stephenie; Krumlauf, Robb; Saunders, Scott			Wise Regulates Bone Deposition through Genetic Interactions with Lrp5	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; DKK1-MEDIATED INHIBITION; BMP ANTAGONIST; DENSITY; MICE; SCLEROSTIN; MUTATION; DIFFERENTIATION; MASS; OSTEOBLAST	In this study using genetic approaches in mouse we demonstrate that the secreted protein Wise plays essential roles in regulating early bone formation through its ability to modulate Wnt signaling via interactions with the Lrp5 co-receptor. In Wise(-/-) mutant mice we find an increase in the rate of osteoblast proliferation and a transient increase in bone mineral density. This change in proliferation is dependent upon Lrp5, as Wise; Lrp5 double mutants have normal bone mass. This suggests that Wise serves as a negative modulator of Wnt signaling in active osteoblasts. Wise and the closely related protein Sclerostin (Sost) are expressed in osteoblast cells during temporally distinct early and late phases in a manner consistent with the temporal onset of their respective increased bone density phenotypes. These data suggest that Wise and Sost may have common roles in regulating bone development through their ability to control the balance of Wnt signaling. We find that Wise is also required to potentiate proliferation in chondrocytes, serving as a potential positive modulator of Wnt activity. Our analyses demonstrate that Wise plays a key role in processes that control the number of osteoblasts and chondrocytes during bone homeostasis and provide important insight into mechanisms regulating the Wnt pathway during skeletal development.	[Ellies, Debra L.; Rey, Jean-Philippe; Krumlauf, Robb] Stowers Inst Med Res, Kansas City, MO USA; [Economou, Androulla; Krumlauf, Robb] Natl Inst Med Res, London NW7 1AA, England; [Viviano, Beth; Paine-Saunders, Stephenie; Saunders, Scott] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Krumlauf, Robb] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA; [Saunders, Scott] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Stowers Institute for Medical Research; MRC National Institute for Medical Research; Washington University (WUSTL); University of Kansas; University of Kansas Medical Center; Washington University (WUSTL)	Saunders, S (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	saunders_s@kids.wustl.edu	Krumlauf, Robb/AAH-5012-2019	Krumlauf, Robb/0000-0001-9102-7927	SIMR funds; MRC; NIH [DK56063, HD39952]; Children's Discovery Institute of Washington University; St. Louis Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056063] Funding Source: NIH RePORTER	SIMR funds; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Discovery Institute of Washington University; St. Louis Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research by DLE and RK was supported by SIMR funds awarded to RK, and the targeted Wise mouse mutants were generated by AE and RK with funding from the MRC. Research by SS was supported by NIH Grants DK56063 and HD39952, as well as funding provided by the Children's Discovery Institute of Washington University and St. Louis Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2013, DEVELOPMENT, V140, P583, DOI 10.1242/dev.085118; Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balemans W, 2007, J BONE MINER RES, V22, P708, DOI 10.1359/JBMR.070211; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; BEIGHTON P, 1977, CLIN GENET, V11, P1; Bhat BM, 2007, GENE, V391, P103, DOI 10.1016/j.gene.2006.12.014; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Collette N. M., 2013, DEV BIOL; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Itasaki N, 2003, DEVELOPMENT, V130, P4295, DOI 10.1242/dev.00674; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kokubu C, 2004, DEVELOPMENT, V131, P5469, DOI 10.1242/dev.01405; Kusu N, 2003, J BIOL CHEM, V278, P24113, DOI 10.1074/jbc.M301716200; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Laurikkala J, 2003, DEV BIOL, V264, P91, DOI 10.1016/j.ydbio.2003.08.011; Leupin O, 2011, J BIOL CHEM, V286, P19489, DOI 10.1074/jbc.M110.190330; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Patel MS, 2002, NEW ENGL J MED, V346, P1572, DOI 10.1056/NEJM200205163462011; Rickels MR, 2005, J BONE MINER RES, V20, P878, DOI 10.1359/JBMR.041223; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; STEIN SA, 1983, NEUROLOGY, V33, P267, DOI 10.1212/WNL.33.3.267; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yanagita M, 2004, BIOCHEM BIOPH RES CO, V316, P490, DOI 10.1016/j.bbrc.2004.02.075; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhang M, 2009, J CELL BIOCHEM, V108, P896, DOI 10.1002/jcb.22319; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008	44	15	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96257	10.1371/journal.pone.0096257	http://dx.doi.org/10.1371/journal.pone.0096257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789067	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600088
J	Tymofiyeva, O; Ziv, E; Barkovich, AJ; Hess, CP; Xu, D				Tymofiyeva, Olga; Ziv, Etay; Barkovich, A. James; Hess, Christopher P.; Xu, Duan			Brain without Anatomy: Construction and Comparison of Fully Network-Driven Structural MRI Connectomes	PLOS ONE			English	Article							CONNECTIVITY; ARCHITECTURE; PARCELLATION	MRI connectomics methods treat the brain as a network and provide new information about its organization, efficiency, and mechanisms of disruption. The most commonly used method of defining network nodes is to register the brain to a standardized anatomical atlas based on the Brodmann areas. This approach is limited by inter-subject variability and can be especially problematic in the context of brain maturation or neuroplasticity (cerebral reorganization after brain damage). In this study, we combined different image processing and network theory methods and created a novel approach that enables atlas-free construction and connection-wise comparison of diffusion MRI-based brain networks. We illustrated the proposed approach in three age groups: neonates, 6-month-old infants, and adults. First, we explored a data-driven method of determining the optimal number of equal-area nodes based on the assumption that all cortical areas of the brain are connected and, thus, no part of the brain is structurally isolated. Second, to enable a connection-wise comparison, alignment to a "reference brain" was performed in the network domain within each group using a matrix alignment algorithm with simulated annealing. The correlation coefficients after pair-wise network alignment ranged from 0.6102 to 0.6673. To test the method's reproducibility, one subject from the 6-month-old group and one from the adult group were scanned twice, resulting in correlation coefficients of 0.7443 and 0.7037, respectively. While being less than 1 due to parcellation and noise, statistically, these values were significantly higher than inter-subject values. Rotation of the parcellation largely explained the variability. Through the abstraction from anatomy, the developed framework allows for a fully network-driven analysis of structural MRI connectomes and can be applied to subjects at any stage of development and with substantial differences in cortical anatomy.	[Tymofiyeva, Olga; Ziv, Etay; Barkovich, A. James; Hess, Christopher P.; Xu, Duan] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Xu, D (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	Duan.Xu@ucsf.edu	Xu, Duan/B-3197-2013; Xu, Duan/GMW-4195-2022	Xu, Duan/0000-0003-0550-4235; Hess, Christopher/0000-0002-5132-5302	National Institutes of Health (NIH) [R01 EB009756, HD072074, NS046432]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046432] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants R01 EB009756, HD072074, and NS046432 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bells S., 2011, P INT SOC MAGN RESON, V19, P678; Brodmann K, 1905, J PSYCHOL NEUROL LEI, V4, P177; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cloutman LL, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00034; Collin G, 2013, NEUROSCIENTIST, V19, P616, DOI 10.1177/1073858413503712; de Reus MA, 2013, NEUROIMAGE, V80, P397, DOI 10.1016/j.neuroimage.2013.03.053; Dennis EL, 2013, NEUROIMAGE, V64, P671, DOI 10.1016/j.neuroimage.2012.09.004; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P., 2005, DIFFUSION MRI BRAIN; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Huang H, 2015, CEREB CORTEX, V25, P1389, DOI 10.1093/cercor/bht335; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Levin HS., 2000, CEREBRAL REORGANIZAT; Li LC, 2013, NEUROIMAGE, V80, P462, DOI 10.1016/j.neuroimage.2013.04.024; Meskaldji DE, 2013, NEUROIMAGE, V80, P416, DOI 10.1016/j.neuroimage.2013.04.084; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Raj A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014832; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O., 2010, NETWORKS BRAIN; Tymofiyeva O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063310; Tymofiyeva O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031029; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zilles K, 2010, NAT REV NEUROSCI, V11, P139, DOI 10.1038/nrn2776; Ziv E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078824	37	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96196	10.1371/journal.pone.0096196	http://dx.doi.org/10.1371/journal.pone.0096196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789312	Green Published, gold			2022-12-27	WOS:000335510600085
J	White, MT; Lwetoijera, D; Marshall, J; Caron-Lormier, G; Bohan, DA; Denholm, I; Devine, GJ				White, Michael T.; Lwetoijera, Dickson; Marshall, John; Caron-Lormier, Geoffrey; Bohan, David A.; Denholm, Ian; Devine, Gregor J.			Negative Cross Resistance Mediated by Co-Treated Bed Nets: A Potential Means of Restoring Pyrethroid-Susceptibility to Malaria Vectors	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; INSECTICIDE RESISTANCE; IMPREGNATED BEDNETS; MOSQUITO NETS; KDR MUTATION; CULICIDAE; DIPTERA; TRANSMISSION; ARABIENSIS; CURTAINS	Insecticide-treated nets and indoor residual spray programs for malaria control are entirely dependent on pyrethroid insecticides. The ubiquitous exposure of Anopheles mosquitoes to this chemistry has selected for resistance in a number of populations. This threatens the sustainability of our most effective interventions but no operationally practicable way of resolving the problem currently exists. One innovative solution involves the co-application of a powerful chemosterilant (pyriproxyfen or PPF) to bed nets that are usually treated only with pyrethroids. Resistant mosquitoes that are unaffected by the pyrethroid component of a PPF/pyrethroid co-treatment remain vulnerable to PPF. There is a differential impact of PPF on pyrethroid-resistant and susceptible mosquitoes that is modulated by the mosquito's behavioural response at co-treated surfaces. This imposes a specific fitness cost on pyrethroid-resistant phenotypes and can reverse selection. The concept is demonstrated using a mathematical model.	[White, Michael T.; Marshall, John] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, London, England; [Lwetoijera, Dickson] Ifakara Hlth Inst, Ifakara, Tanzania; [Caron-Lormier, Geoffrey] Univ Nottingham, Loughborough, Leics, England; [Bohan, David A.] INRA, UMR Agroecol 1347, Pole ECOLDUR, F-21034 Dijon, France; [Denholm, Ian] Univ Hertfordshire, Hatfield AL10 9AB, Herts, England; [Devine, Gregor J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia	Imperial College London; Ifakara Health Institute; University of Nottingham; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Hertfordshire; QIMR Berghofer Medical Research Institute	Devine, GJ (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	greg.devine@qimrberghofer.edu.au	Devine, Gregor J/H-1141-2014; Bohan, David A/D-7992-2012	Devine, Gregor J/0000-0001-6312-0390; Bohan, David A/0000-0001-5656-775X; Denholm, Ian/0000-0001-9797-874X; White, Michael/0000-0002-7472-4138	Bill and Melinda Gates Foundation [OPP52644]; Medical Research Council [MR/J012254/1] Funding Source: researchfish; MRC [MR/J012254/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was partly funded by the Bill and Melinda Gates Foundation (grant ID OPP52644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Corbel V, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-22; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire RK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-12; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Hougard JM, 2003, B ENTOMOL RES, V93, P491, DOI 10.1079/BER2003261; Irish SR, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-17; Khambay BPS, 2001, PEST MANAG SCI, V57, P761, DOI 10.1002/ps.381; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kolaczinski JH, 2004, J MED ENTOMOL, V41, P930, DOI 10.1603/0022-2585-41.5.930; Kolaczinski JH, 2000, B ENTOMOL RES, V90, P125; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Lwetoijera DW, 2014, AM J TROP MED HYG; Maharaj R, 2005, SAMJ S AFR MED J, V95, P871; MartinezTorres D, 1997, PESTIC SCI, V51, P265, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;265::AID-PS626&gt;3.0.CO;2-P; Molineaux L, 2020, GARKI PROJECT RES EP, V8; Mourou JR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-321; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ndiath MO, 2012, PLOS ONE, V7; Norris LC, 2011, J VECTOR ECOL, V36, P411, DOI 10.1111/j.1948-7134.2011.00182.x; Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006; Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045; Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2; Tabashnik B.E., 1990, PESTICIDE RESISTANCE, P153; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; White MT, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-153; Witzig C, 2013, HEREDITY, V110, P389, DOI 10.1038/hdy.2012.112; YAMAMOTO I, 1993, ARCH INSECT BIOCHEM, V22, P277, DOI 10.1002/arch.940220120	44	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95640	10.1371/journal.pone.0095640	http://dx.doi.org/10.1371/journal.pone.0095640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788951	Green Published, Green Submitted, gold			2022-12-27	WOS:000335510600045
J	Andolfo, G; Ferriello, F; Tardella, L; Ferrarini, A; Sigillo, L; Frusciante, L; Ercolano, MR				Andolfo, Giuseppe; Ferriello, Francesca; Tardella, Luca; Ferrarini, Alberto; Sigillo, Loredana; Frusciante, Luigi; Ercolano, Maria Raffaella			Tomato Genome-Wide Transcriptional Responses to Fusarium Wilt and Tomato Mosaic Virus	PLOS ONE			English	Article							DISEASE RESISTANCE; NUCLEOTIDE-BINDING; PLANT; DEFENSE; SUPERFAMILY; METABOLISM; SALICYLATE; SYSTEM; GENES	Since gene expression approaches constitute a starting point for investigating plant-pathogen systems, we performed a transcriptional analysis to identify a set of genes of interest in tomato plants infected with F. oxysporum f.sp. lycopersici (Fol) and Tomato Mosaic Virus (ToMV). Differentially expressed tomato genes upon inoculation with Fol and ToMV were identified at two days post-inoculation. A large overlap was found in differentially expressed genes throughout the two incompatible interactions. However, Gene Ontology enrichment analysis evidenced specific categories in both interactions. Response to ToMV seems more multifaceted, since more than 70 specific categories were enriched versus the 30 detected in Fol interaction. In particular, the virus stimulated the production of an invertase enzyme that is able to redirect the flux of carbohydrates, whereas Fol induced a homeostatic response to prevent the fungus from killing cells. Genomic mapping of transcripts suggested that specific genomic regions are involved in resistance response to pathogen. Coordinated machinery could play an important role in prompting the response, since 60% of pathogen receptor genes (NB-ARC-LRR, RLP,RLK) were differentially regulated during both interactions. Assessment of genomic gene expression patterns could help in building up models of mediated resistance responses.	[Andolfo, Giuseppe; Ferriello, Francesca; Frusciante, Luigi; Ercolano, Maria Raffaella] Univ Naples Federico II, Dept Agr Sci, Portici, Italy; [Tardella, Luca] Univ Roma La Sapienza, Dept Stat Sci, I-00185 Rome, Italy; [Ferrarini, Alberto] Univ Verona, Dipartimento Biotecnol, I-37100 Verona, Italy; [Sigillo, Loredana] Consiglio Ric & Sperimentaz Agr, Ctr Sperimentaz & Certificaz Sementi CRA SCS SS, Rome, Italy	University of Naples Federico II; Sapienza University Rome; University of Verona; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Ercolano, MR (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	ercolano@unina.it	Ercolano, Maria/AAJ-8129-2020; Sigillo, Loredana/AAE-8473-2021; Sigillo, Loredana/AAS-9909-2020; Sigillo, Loredana/ABH-8776-2020	TARDELLA, Luca/0000-0002-5703-3909; Sigillo, Loredana/0000-0002-1475-4570; , Giuseppe/0000-0003-0272-8700	Italian Ministry of Education, University and Research	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This research was carried out within the GenoPOM-PRO Project funded by the Italian Ministry of Education, University and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament K, 2010, PLANT J, V62, P124, DOI 10.1111/j.1365-313X.2010.04132.x; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; [Anonymous], CPVO TP 44 3 TECHN P; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; DETORRES ZM, 2009, PLANT J, V59, P375; Ercolano MR, 2012, PLANT CELL REP, V31, P973, DOI 10.1007/s00299-012-1234-z; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hammond-Kosack KE, 2008, PLANT SIGNAL BEHAV, V3, P993, DOI 10.4161/psb.6292; Handford MG, 2007, J GEN VIROL, V88, P337, DOI 10.1099/vir.0.82376-0; He M, 2012, VIRUS RES, V163, P374, DOI 10.1016/j.virusres.2011.09.006; Herbers K, 2000, MOL PLANT PATHOL, V1, P51, DOI 10.1046/j.1364-3703.2000.00007.x; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Horsfall JG, 1957, DIS PLANT PLANT PATH, V5, P1; Inami K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044101; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kobayashi M, 2011, J PLANT PHYSIOL, V168, P1142, DOI 10.1016/j.jplph.2011.01.002; Koornneef A, 2008, PLANT SIGNAL BEHAV, V3, P543, DOI 10.4161/psb.3.8.6151; Li JJ, 2011, BREEDING SCI, V61, P338, DOI 10.1270/jsbbs.61.338; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Lodha TD, 2012, MOL BIOTECHNOL, V50, P87, DOI 10.1007/s12033-011-9418-2; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Lukasik E, 2009, CURR OPIN PLANT BIOL, V12, P427, DOI 10.1016/j.pbi.2009.03.001; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Ori N, 1997, PLANT CELL, V9, P521, DOI 10.1105/tpc.9.4.521; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Paz-Lago D., 2000, Cultivos Tropicales, V21, P17; R Core Team, 2021, R LANGUAGE ENV STAT; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Sela-Buurlage MB, 2001, MOL GENET GENOMICS, V265, P1104, DOI 10.1007/s004380100509; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x; Zangerl AR, 1997, AM NAT, V150, P491, DOI 10.1086/286077	43	18	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94963	10.1371/journal.pone.0094963	http://dx.doi.org/10.1371/journal.pone.0094963			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804963	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900016
J	Guibinga, GH; Barron, N; Pandori, W				Guibinga, Ghiabe-Henri; Barron, Nikki; Pandori, William			Striatal Neurodevelopment Is Dysregulated in Purine Metabolism Deficiency and Impacts DARPP-32, BDNF/TrkB Expression and Signaling: New Insights on the Molecular and Cellular Basis of Lesch-Nyhan Syndrome	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; GENETIC MOUSE MODEL; HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; DE-NOVO MUTATIONS; TRANSCRIPTIONAL DYSREGULATION; PROTEIN-PHOSPHORYLATION; DOPAMINERGIC-NEURONS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; NERVOUS-SYSTEM	Lesch-Nyhan Syndrome (LNS) is a neurodevelopmental disorder caused by mutations in the gene encoding the purine metabolic enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT). This syndrome is characterized by an array of severe neurological impairments that in part originate from striatal dysfunctions. However, the molecular and cellular mechanisms underlying these dysfunctions remain largely unidentified. In this report, we demonstrate that HPRT-deficiency causes dysregulated expression of key genes essential for striatal patterning, most notably the striatally-enriched transcription factor B-cell leukemia 11b (Bcl11b). The data also reveal that the down-regulated expression of Bcl11b in HPRT-deficient immortalized mouse striatal (STHdh) neural stem cells is accompanied by aberrant expression of some of its transcriptional partners and other striatally-enriched genes, including the gene encoding dopamine-and cAMP-regulated phosphoprotein 32, (DARPP-32). Furthermore, we demonstrate that components of the BDNF/TrkB signaling, a known activator of DARPP-32 striatal expression and effector of Bcl11b transcriptional activation are markedly increased in HPRT-deficient cells and in the striatum of HPRT knockout mouse. Consequently, the HPRT-deficient cells display superior protection against reactive oxygen species (ROS)-mediated cell death upon exposure to hydrogen peroxide. These findings suggest that the purine metabolic defect caused by HPRT-deficiency, while it may provide neuroprotection to striatal neurons, affects key genes and signaling pathways that may underlie the neuropathogenesis of LNS.	[Guibinga, Ghiabe-Henri; Barron, Nikki; Pandori, William] Univ Calif San Diego, Sch Med, Dept Pediat, Div Genet,Rady Childrens Hosp, La Jolla, CA 92093 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Guibinga, GH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, Div Genet,Rady Childrens Hosp, La Jolla, CA 92093 USA.	gguibinga@ucsd.edu			National Institute of Health (NIH) [DK082840]; University of California San Diego; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Diego(University of California System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from the National Institute of Health (NIH), DK082840 and by a research grant from the University of California San Diego, Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlotta P, 2008, J NEUROSCI, V28, P622, DOI 10.1523/JNEUROSCI.2986-07.2008; Borgkvist A, 2007, NEUROSCI BIOBEHAV R, V31, P79, DOI 10.1016/j.neubiorev.2006.03.003; Bowers JM, 2012, DIS MARKERS, V33, P251, DOI [10.3233/DMA-2012-0919, 10.1155/2012/456787]; BROWNING MD, 1985, J NEUROCHEM, V45, P11, DOI 10.1111/j.1471-4159.1985.tb05468.x; Cardenas-Aguayo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053596; Ceballos-Picot I, 2009, HUM MOL GENET, V18, P2317, DOI 10.1093/hmg/ddp164; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Cipriani S, 2010, BIOMARK MED, V4, P701, DOI 10.2217/BMM.10.94; Correia CT, 2010, GENES BRAIN BEHAV, V9, P841, DOI 10.1111/j.1601-183X.2010.00627.x; Desplats PA, 2008, NEUROBIOL DIS, V31, P298, DOI 10.1016/j.nbd.2008.05.005; Ernst M, 1996, NEW ENGL J MED, V334, P1568, DOI 10.1056/NEJM199606133342403; Florian C, 2011, MOL SYNDROMOL, V2, P153, DOI 10.1159/000327329; Fumagalli F, 2006, PHARMACOGENOMICS J, V6, P95, DOI 10.1038/sj.tpj.6500360; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gharbi-Ayachi A, 2010, SCIENCE, V330, P1673, DOI 10.1126/science.1197048; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Guerrini R, 2012, EPILEPSIA, V53, P2067, DOI 10.1111/j.1528-1167.2012.03656.x; Guibinga GH, 2013, HUM MOL GENET, V22, P4502, DOI 10.1093/hmg/ddt298; Guibinga GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063333; Guibinga GH, 2012, HUM MOL GENET, V21, P609, DOI 10.1093/hmg/ddr495; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Hamdan FF, 2010, AM J HUM GENET, V87, P671, DOI 10.1016/j.ajhg.2010.09.017; Hebb ALO, 2008, EUR NEUROPSYCHOPHARM, V18, P339, DOI 10.1016/j.euroneuro.2007.08.002; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Im HI, 2012, TRENDS NEUROSCI, V35, P325, DOI 10.1016/j.tins.2012.01.004; JINNAH HA, 1990, BRAIN RES BULL, V25, P467, DOI 10.1016/0361-9230(90)90239-V; Jinnah HA, 1999, J NEUROCHEM, V72, P225, DOI 10.1046/j.1471-4159.1999.0720225.x; JINNAH HA, 1992, J PHARMACOL EXP THER, V263, P596; JINNAH HA, 1994, J NEUROSCI, V14, P1164; JINNAH HA, 1991, BEHAV NEUROSCI, V105, P1004, DOI 10.1037/0735-7044.105.6.1004; JINNAH HA, 2000, METABOLIC MOL BASES, P2537; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Keilani S, 2012, J NEUROSCI, V32, P6808, DOI 10.1523/JNEUROSCI.5448-11.2012; Kim SH, 2001, J NEURAL TRANSM-SUPP, P263; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Le Novere N, 2008, CELL MOL LIFE SCI, V65, P2125, DOI 10.1007/s00018-008-8150-y; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; Lewers JC, 2008, NEUROSCIENCE, V152, P761, DOI 10.1016/j.neuroscience.2007.10.065; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; Long JE, 2009, J COMP NEUROL, V512, P556, DOI 10.1002/cne.21854; Mahajan SD, 2009, INT REV NEUROBIOL, V88, P199, DOI 10.1016/S0074-7742(09)88008-2; Mancuso JJ, 2010, J NEUROCHEM, V112, P651, DOI 10.1111/j.1471-4159.2009.06488.x; Martin-Ibanez R, 2012, STEM CELLS DEV, V21, P2239, DOI 10.1089/scd.2011.0607; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mastrangelo L, 2012, P NATL ACAD SCI USA, V109, P3377, DOI 10.1073/pnas.1118067109; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Mikolaenko I, 2005, NEUROBIOL DIS, V20, P479, DOI 10.1016/j.nbd.2005.04.005; Motti D, 2012, SEMIN FETAL NEONAT M, V17, P347, DOI 10.1016/j.siny.2012.07.008; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pratt DW, 2012, MOL SYNDROMOL, V3, P284, DOI 10.1159/000345845; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Smith DW, 2000, MOL THER, V1, P486, DOI 10.1006/mthe.2000.0057; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tang B, 2012, HUM MOL GENET, V21, P3097, DOI 10.1093/hmg/dds132; Tang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023691; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Xie KQ, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00049; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042	63	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96575	10.1371/journal.pone.0096575	http://dx.doi.org/10.1371/journal.pone.0096575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804781	Green Published, gold			2022-12-27	WOS:000335728900073
J	Kai, T; Yamazaki, T; Arai, S; Miyazaki, T				Kai, Toshihiro; Yamazaki, Tomoko; Arai, Satoko; Miyazaki, Toru			Stabilization and Augmentation of Circulating AIM in Mice by Synthesized IgM-Fc	PLOS ONE			English	Article							CELL-BINDING CHARACTERISTICS; APOPTOSIS INHIBITOR; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; MOLECULAR-CLONING; NATURAL-HISTORY; MACROPHAGE AIM; SP-ALPHA; OBESITY; INFLAMMATION	Owing to rapid and drastic changes in lifestyle and eating habits in modern society, obesity and obesity-associated diseases are among the most important public health problems. Hence, the development of therapeutic approaches to regulate obesity is strongly desired. In view of previous work showing that apoptosis inhibitor of macrophage (AIM) blocks lipid storage in adipocytes, thereby preventing obesity caused by a high-fat diet, we here explored a strategy to augment circulating AIM levels. We synthesized the Fc portion of the soluble human immunoglobulin (Ig) M heavy chain and found that it formed a pentamer containing IgJ as natural IgM does, and effectively associated with AIM in vitro. When we injected the synthesized Fc intravenously into mice lacking circulating IgM, it associated with endogenous mouse AIM, protecting AIM from renal excretion and preserving the circulating AIM levels. As the synthesized Fc lacked the antigen-recognizing variable region, it provoked no undesired immune response. In addition, a challenge with the Fc-human AIM complex in wild-type mice, which exhibited normal levels of circulating IgM and AIM, successfully maintained the levels of the human AIM in mouse blood. We also observed that the human AIM was effectively incorporated into adipocytes in visceral fat tissue, suggesting its functionality against obesity. Thus, our findings reveal potent strategies to safely increase AIM levels, which could form the basis for developing novel therapies for obesity.	[Kai, Toshihiro; Yamazaki, Tomoko; Arai, Satoko; Miyazaki, Toru] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan; [Miyazaki, Toru] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, S (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan.	sarai@m.u-tokyo.ac.jp; tm@m.u-tokyo.ac.jp		Miyazaki, Toru/0000-0003-3842-4362; Arai, Satoko/0000-0002-6145-8686	Japan Society for the Promotion of Science; CREST; Dainippon Sumitomo Pharma Co., Ltd.; ONSENDO Co., Ltd.; Grants-in-Aid for Scientific Research [25253056] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST(Core Research for Evolutional Science and Technology (CREST)); Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); ONSENDO Co., Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (A) (Japan Society for the Promotion of Science), CREST (JST), research grants by Dainippon Sumitomo Pharma Co., Ltd. and ONSENDO Co., Ltd. (to TM), Grants-in-Aid for Scientific Research (B) (Japan Society for the Promotion of Science) (to SA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Badaru A, 2012, CURR DIABETES REP, V12, P75, DOI 10.1007/s11892-011-0247-2; Blonski W, 2010, WORLD J GASTROENTERO, V16, P3603, DOI 10.3748/wjg.v16.i29.3603; Boes M, 1998, J IMMUNOL, V160, P4776; Cambuli VM, 2010, DIABETES CARE, V33, P820, DOI 10.2337/dc09-1573; Day C P, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS377, DOI 10.1046/j.1440-1746.17.s3.31.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gangadharan B, 2007, CLIN CHEM, V53, P1792, DOI 10.1373/clinchem.2007.089144; Gebe JA, 1997, J BIOL CHEM, V272, P6151, DOI 10.1074/jbc.272.10.6151; Gebe JA, 2000, IMMUNOLOGY, V99, P78, DOI 10.1046/j.1365-2567.2000.00903.x; Gray J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-271; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Hersoug LG, 2007, ALLERGY, V62, P1205, DOI 10.1111/j.1398-9995.2007.01506.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iwamura Y, 2012, BIOCHEM BIOPH RES CO, V422, P476, DOI 10.1016/j.bbrc.2012.05.018; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kim WK, 2008, EXP MOL MED, V40, P677, DOI 10.3858/emm.2008.40.6.677; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Marzullo P, 2010, J CLIN ENDOCR METAB, V95, P3965, DOI 10.1210/jc.2009-2798; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Mori M, 2012, FEBS LETT, V586, P3569, DOI 10.1016/j.febslet.2012.08.017; Moulin CM, 2009, ARQ BRAS ENDOCRINOL, V53, P183, DOI 10.1590/S0004-27302009000200010; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Rosenbloom AL, 2003, DIABETES CARE, V26, P2954, DOI 10.2337/diacare.26.10.2954; Safsten P, 2006, ANAL BIOCHEM, V353, P181, DOI 10.1016/j.ab.2006.01.041; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	39	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97037	10.1371/journal.pone.0097037	http://dx.doi.org/10.1371/journal.pone.0097037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804991	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900133
J	Wolff, G; Balke, JE; Andras, IE; Park, M; Toborek, M				Wolff, Gretchen; Balke, Jordan E.; Andras, Ibolya E.; Park, Minseon; Toborek, Michal			Exercise Modulates Redox-Sensitive Small GTPase Activity in the Brain Microvasculature in a Model of Brain Metastasis Formation	PLOS ONE			English	Article							ENDOTHELIAL TIGHT JUNCTION; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; RAS; CANCER; MECHANISM; TUMOR; RHO; PERMEABILITY; OCCLUDIN	Tumor cell extravasation into the brain requires passage through the blood-brain barrier (BBB). There is evidence that exercise can alter the oxidation status of the brain microvasculature and protect against tumor cell invasion into the brain, although the mechanisms are not well understood. In the current study, we focused on the role of microenvironment generated by exercise and metastasizing tumor cells at the levels of brain microvessels, influencing oxidative stress-mediated responses and activation of redox-sensitive small GTPases. Mature male mice were exercised for four weeks using a running wheel with the average voluntary running distance 9.0 +/- 0.3 km/day. Mice were then infused with 1.0 +/- 10(6) D122 (murine Lewis lung carcinoma) cells into the brain microvasculature, and euthanized either 48 hours (in short-term studies) or 2-3 weeks (in long-term studies) post tumor cell administration. A significant increase in the level of reactive oxygen species was observed following 48 hours or 3 weeks of tumor cells growth, which was accompanied by a reduction in MnSOD expression in the exercised mice. Activation of the small GTPase Rho was negatively correlated with running distance in the tumor cell infused mice. Together, these data suggest that exercise may play a significant role during aggressive metastatic invasion, especially at higher intensities in pre-trained individuals.	[Wolff, Gretchen; Balke, Jordan E.; Andras, Ibolya E.; Park, Minseon; Toborek, Michal] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL USA; [Toborek, Michal] Jerzy Kukuczka Acad Phys Educ, Katowice, Poland	University of Miami; Akademia Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach	Toborek, M (corresponding author), Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL USA.	mtoborek@med.miami.edu			National Institutes of Health/National Cancer Institute [R0CA133257]; NATIONAL CANCER INSTITUTE [R01CA133257] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health/National Cancer Institute (http://www.cancer.gov/) grant R0CA133257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon-Ching JB, 2007, CLIN CANCER RES, V13, P1644, DOI 10.1158/1078-0432.CCR-07-0096; Bakalova R, 2013, CLIN CANCER RES, V19, P2503, DOI 10.1158/1078-0432.CCR-12-3726; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bellot GL, 2013, MITOCHONDRION, V13, P155, DOI 10.1016/j.mito.2012.06.007; BOS JL, 1989, CANCER RES, V49, P4682; Mena AC, 2010, ANTI-CANCER DRUG, V21, pS3, DOI 10.1097/01.cad.0000361534.44052.c5; Carter LG, 2012, AM J PHYSIOL-ENDOC M, V303, pE1061, DOI 10.1152/ajpendo.00213.2012; Chen L, 2009, J NEUROSCI RES, V87, P1718, DOI 10.1002/jnr.21973; Chetram MA, 2013, FRONT BIOL, V8; Davis MF, 2011, FREE RADICAL BIO MED, V51, P565, DOI 10.1016/j.freeradbiomed.2011.05.003; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Eichler AF, 2011, NAT REV CLIN ONCOL, V8, P344, DOI 10.1038/nrclinonc.2011.58; EISENBACH L, 1983, INT J CANCER, V32, P113, DOI 10.1002/ijc.2910320118; Grassian AR, 2011, COLD SH Q B, V76, P313, DOI 10.1101/sqb.2011.76.010967; Gu YT, 2013, NEUROPHARMACOLOGY, V75, P407, DOI 10.1016/j.neuropharm.2013.08.004; Gu YT, 2012, J MOL NEUROSCI, V48, P302, DOI 10.1007/s12031-012-9789-2; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2011, ANTIOXID REDOX SIGN, V14, P689, DOI 10.1089/ars.2009.2984; Heo JY, 2004, BIOCHEMISTRY-US, V43, P2314, DOI 10.1021/bi035275g; Hoyle M, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17140; Jia W, 2013, ANTICANCER RES, V33, P2353; Kamar FG, 2010, SEMIN NEUROL, V30, P217, DOI 10.1055/s-0030-1255225; Kehrli P, 1999, NEUROCHIRURGIE, V45, P357; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Lemanne D, 2013, ONCOLOGY-NY, V27, P580; Marosi K, 2012, NEUROSCIENCE, V226, P21, DOI 10.1016/j.neuroscience.2012.09.001; May AL, 2013, MMWR-MORBID MORTAL W, V62, P120; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Paceli RB, 2012, PATHOL RES PRACT, V208, P377, DOI 10.1016/j.prp.2012.04.006; Park M, 2013, J BIOL CHEM, V288, P33324, DOI 10.1074/jbc.M113.483487; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Radak Z, 2002, ANTIOXID REDOX SIGN, V4, P213, DOI 10.1089/152308602753625979; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Raheem OA, 2013, CURR OPIN UROL; Rahmathulla G, 2012, J ONCOL, V2012, DOI 10.1155/2012/723541; Rios-Arrabal S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-404; Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com; Seelbach M, 2010, ENVIRON HEALTH PERSP, V118, P479, DOI 10.1289/ehp.0901334; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077919; Solomon E, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-129; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Toborek M, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-22; Tochhawng L, 2013, MITOCHONDRION, V13, P246, DOI 10.1016/j.mito.2012.08.002; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Wolff G, 2013, IUBMB LIFE, V65, P565, DOI 10.1002/iub.1169; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4	48	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97033	10.1371/journal.pone.0097033	http://dx.doi.org/10.1371/journal.pone.0097033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804765	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900131
J	He, XF; Liu, LR; Wei, W; Liu, Y; Su, J; Wang, SL; Shen, XL; Yang, XB				He, Xiao-Feng; Liu, Li-Rong; Wei, Wu; Liu, Yi; Su, Jiao; Wang, Su-Lan; Shen, Xu-Liang; Yang, Xian-Bin			Association between the XPG Asp1104His and XPF Arg415Gln Polymorphisms and Risk of Cancer: A Meta-Analysis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM GENES; NON-HODGKIN-LYMPHOMA; DNA-REPAIR; BREAST-CANCER; LUNG-CANCER; BLADDER-CANCER; COLORECTAL-CANCER; ENDOMETRIAL CANCER; POOLED ANALYSIS	Background: The XPG (xeroderma pigmentosum type G) Asp1104His and XPF (xeroderma pigmentosum type F) Arg415Gln polymorphisms had been implicated in cancer susceptibility. The previous published data on the association between XPG Asp1104His and XPF Arg415Gln polymorphisms and cancer risk remained controversial. Methodology/Principal Findings: To derive a more precise estimation of the association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and overall cancer risk, we performed a meta-analysis to investigate the association between cancer susceptibility and XPG Asp1104His (32,162 cases and 39,858 controls from 66 studies) and XPF Arg415Gln polymorphisms (17,864 cases and 20,578 controls from 32 studies) in different inheritance models. We used odds ratios with 95% confidence intervals to assess the strength of the association. Overall, significantly elevated cancer risk was found when all studies were pooled into the meta-analysis of XPG Asp1104His (dominant model: OR = 1.05, 95% CI = 1.00-1.10; Asp/His vs. Asp/Asp: OR = 1.06, 95% CI = 1.01-1.11). In the further stratified and sensitivity analyses, significantly decreased lung cancer risk was found for XPF Arg415Gln (dominant model: OR = 0.82, 95% CI = 0.71-0.96; Arg/Gln versus Arg/Arg: OR = 0.83, 95% CI = 0.71-0.97; additive model: OR = 0.83, 95% CI = 0.72-0.95) and significantly increased other cancer risk was found among hospital-based studies for XPG Asp1104His (dominant model: OR = 1.23, 95% CI = 1.02-1.49). Conclusions/Significance: In summary, this meta-analysis suggests that XPF Arg415Gln polymorphism may be associated with decreased lung cancer risk and XPG Asp1104His may be a low-penetrant risk factor in some cancers development. And larger scale primary studies are required to further evaluate the interaction of XPG Asp1104His and XPF Arg415Gln polymorphisms and cancer risk in specific populations.	[He, Xiao-Feng; Yang, Xian-Bin] Changzhi Med Coll, Peace Hosp, Dept Res, Changzhi, Peoples R China; [Liu, Li-Rong] Guiyang Med Univ, Affiliated Hosp, Dept Clin Biochem, Guiyang, Peoples R China; [Wei, Wu; Wang, Su-Lan; Shen, Xu-Liang] Changzhi Med Coll, Peace Hosp, Dept Hematol, Changzhi, Peoples R China; [Liu, Yi] Southern Med Univ, Nanfang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Su, Jiao] Changzhi Med Coll, Dept Biol Chem, Changzhi, Peoples R China	Changzhi Medical College; Guizhou Medical University; Changzhi Medical College; Southern Medical University - China; Changzhi Medical College	Wei, W (corresponding author), Changzhi Med Coll, Peace Hosp, Dept Hematol, Changzhi, Peoples R China.	weiwuhxf@163.com						Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berhane N, 2012, MOL BIOL REP, V39, P2471, DOI 10.1007/s11033-011-0998-5; Biason P, 2012, PHARMACOGENOMICS J, V12, P476, DOI 10.1038/tpj.2011.33; Bigler J, 2005, CANCER EPIDEM BIOMAR, V14, P2501, DOI 10.1158/1055-9965.EPI-05-0270; Blankenburg S, 2005, EUR J HUM GENET, V13, P253, DOI 10.1038/sj.ejhg.5201296; Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544; Canbay E, 2010, ANTICANCER RES, V30, P1359; Chang JS, 2008, INT J CANCER, V123, P2095, DOI 10.1002/ijc.23801; Cheng HB, 2013, ASIAN PAC J CANCER P, V14, P4083, DOI 10.7314/APJCP.2013.14.7.4083; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; Cui Y, 2006, INT J CANCER, V118, P714, DOI 10.1002/ijc.21413; Davey SG, 1997, LANCET, V350, P1182, DOI DOI 10.1016/S0140-6736(05)63833-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doherty JA, 2011, CANCER EPIDEM BIOMAR, V20, P1873, DOI 10.1158/1055-9965.EPI-11-0119; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Zein R, 2009, CANCER-AM CANCER SOC, V115, P1651, DOI 10.1002/cncr.24205; Figl A, 2010, MUTAT RES-GEN TOX EN, V702, P8, DOI 10.1016/j.mrgentox.2010.06.011; Freidin M. B., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P439; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Garcia-Closas M, 2006, CANCER EPIDEM BIOMAR, V15, P536, DOI 10.1158/1055-9965.EPI-05-0749; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Goncalves FT, 2011, J DERMATOL SCI, V64, P59, DOI 10.1016/j.jdermsci.2011.06.003; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; He XH, 2008, PATHOBIOLOGY, V75, P356, DOI 10.1159/000164220; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill DA, 2006, BLOOD, V108, P3161, DOI 10.1182/blood-2005-01-026690; Hooker S, 2008, PROSTATE CANCER P D, V11, P349, DOI 10.1038/sj.pcan.4501027; Hsu MS, 2010, ANN SURG ONCOL, V17, P760, DOI 10.1245/s10434-009-0802-0; Huang WY, 2006, CANCER EPIDEM BIOMAR, V15, P306, DOI 10.1158/1055-9965.EPI-05-0751; Hung RJ, 2008, CANCER EPIDEM BIOMAR, V17, P3081, DOI 10.1158/1055-9965.EPI-08-0411; Hussain SK, 2009, CANCER EPIDEM BIOMAR, V18, P2304, DOI 10.1158/1055-9965.EPI-09-0233; Ibarrola-Villava M, 2011, EUR J CANCER, V47, P2618, DOI 10.1016/j.ejca.2011.05.011; Jeon HS, 2003, CARCINOGENESIS, V24, P1677, DOI 10.1093/carcin/bgg120; Jorgensen TJ, 2007, BREAST CANCER RES TR, V101, P65, DOI 10.1007/s10549-006-9263-3; Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Krupa R., 2011, Experimental Oncology, V33, P55; Kumar R, 2003, INT J CANCER, V103, P671, DOI 10.1002/ijc.10870; Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672; Li Long-man, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P271, DOI 10.3760/cma.j.issn.1007-3418.2010.04.009; Liu D, 2012, MOL CARCINOGEN, V51, pE83, DOI 10.1002/mc.21862; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; Ma HX, 2012, PHARMACOGENET GENOM, V22, P50, DOI 10.1097/FPC.0b013e32834e3cf6; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKean-Cowdin R, 2009, CANCER EPIDEM BIOMAR, V18, P1118, DOI 10.1158/1055-9965.EPI-08-1078; McWilliams RR, 2008, CANCER RES, V68, P4928, DOI 10.1158/0008-5472.CAN-07-5539; Mechanic LE, 2006, CARCINOGENESIS, V27, P1377, DOI 10.1093/carcin/bgi330; Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Narter KF, 2009, ANTICANCER RES, V29, P1389; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Pan J, 2009, CARCINOGENESIS, V30, P785, DOI 10.1093/carcin/bgp058; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Paszkowska-Szczur K, 2013, INT J CANCER, V133, P1094, DOI 10.1002/ijc.28123; Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257; Rajaraman P, 2008, INT J CANCER, V123, P2713, DOI 10.1002/ijc.23779; Rajaraman P, 2010, NEURO-ONCOLOGY, V12, P37, DOI 10.1093/neuonc/nop012; Romanowicz-Makowska Hanna, 2007, Pol Merkur Lekarski, V22, P200; Rouissi K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-101; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Santos LS, 2013, ONCOL REP, V30, P2458, DOI 10.3892/or.2013.2702; Sanyal S, 2004, CARCINOGENESIS, V25, P729, DOI 10.1093/carcin/bgh058; Shen J, 2006, CANCER EPIDEM BIOMAR, V15, P1614, DOI 10.1158/1055-9965.EPI-06-0218; Shen M, 2005, INT J CANCER, V116, P768, DOI 10.1002/ijc.21117; Shen M, 2007, HAEMATOLOGICA, V92, P1180, DOI 10.3324/haematol.11324; Shen M, 2006, HUM GENET, V119, P659, DOI 10.1007/s00439-006-0177-2; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Smith TR, 2011, CARCINOGENESIS, V32, P1354, DOI 10.1093/carcin/bgr117; Smith TR, 2003, CANCER EPIDEM BIOMAR, V12, P1200; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; Thirumaran RK, 2006, CARCINOGENESIS, V27, P1676, DOI 10.1093/carcin/bgi381; Visapaa JP, 2004, GUT, V53, P871, DOI 10.1136/gut.2003.018994; Wakasugi M, 1997, J BIOL CHEM, V272, P16030, DOI 10.1074/jbc.272.25.16030; Wang LE, 2007, CLIN CANCER RES, V13, P6532, DOI 10.1158/1078-0432.CCR-07-0969; Wang XF, 2013, GENE, V529, P317, DOI 10.1016/j.gene.2013.07.025; Weiss JM, 2005, CANCER EPIDEM BIOMAR, V14, P2524, DOI 10.1158/1055-9965.EPI-05-0414; Weiss JM, 2006, GYNECOL ONCOL, V103, P891, DOI 10.1016/j.ygyno.2006.05.020; Wen H, 2013, ACTAS UROL ESP, V37, P259, DOI 10.1016/j.acuro.2012.04.007; Wen H, 2009, INT UROL NEPHROL, V41, P855, DOI 10.1007/s11255-009-9560-y; Wen Shu-xin, 2006, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V28, P703; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Yu HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041853; Zhu ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036293; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	93	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e88490	10.1371/journal.pone.0088490	http://dx.doi.org/10.1371/journal.pone.0088490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802942	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800015
J	Perry, L; Rech, D; Mavhu, W; Frade, S; Machaku, MD; Onyango, M; Aduda, DSO; Fimbo, B; Cherutich, P; Castor, D; Njeuhmeli, E; Bertrand, JT				Perry, Linnea; Rech, Dino; Mavhu, Webster; Frade, Sasha; Machaku, Michael D.; Onyango, Mathews; Aduda, Dickens S. Omondi; Fimbo, Bennett; Cherutich, Peter; Castor, Delivette; Njeuhmeli, Emmanuel; Bertrand, Jane T.			Work Experience, Job-Fulfillment and Burnout among VMMC Providers in Kenya, South Africa, Tanzania and Zimbabwe	PLOS ONE			English	Article							HEALTH-CARE	Background: Human resource capacity is vital to the scale-up of voluntary medical male circumcision (VMMC) services. VMMC providers are at risk of "burnout'' from performing a single task repeatedly in a high volume work environment that produces long work hours and intense work effort. Methods and findings: The Systematic Monitoring of the Voluntary Medical Male Circumcision Scale-up (SYMMACS) surveyed VMMC providers in Kenya, South Africa, Tanzania, and Zimbabwe in 2011 (n = 357) and 2012 (n = 591). Providers self-reported on their training, work experience, levels of job-fulfillment and work fatigue/burnout. Data analysis included a descriptive analysis of VMMC provider characteristics, and both bivariate and multivariate analyses of factors associated with provider work fatigue/burnout. In 2012, Kenyan providers had worked in VMMC for a median of 31 months compared to South Africa (10 months), Tanzania (15 months), and Zimbabwe (11 months). More than three-quarters (78-99%) of providers in all countries in 2012 reported that VMMC is a personally fulfilling job. However, 67% of Kenyan providers reported starting to experience work fatigue/burnout compared to South Africa (33%), Zimbabwe (17%), and Tanzania (15%). Despite the high level of work fatigue/burnout in Kenya, none of the measured factors (i.e., gender, age, full-time versus part-time status, length of service, number of operations performed, or cadre) were significantly associated with work fatigue/burnout in 2011. In 2012, logistic regression found increases in age (p<.05) and number of months working in VMMC (p<.01) were associated with an increased likelihood of experiencing work fatigue/burnout, while higher career total VMMCs decreased the likelihood of experiencing burnout. Conclusion: Given cross-country differences, further elucidation of cultural and other contextual factors that may influence provider burnout is required. Continuing to emphasize the contribution that providers make in the fight against HIV/AIDS is important.	[Perry, Linnea; Bertrand, Jane T.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA; [Rech, Dino; Frade, Sasha] Ctr HIV & AIDS Prevent Studies, Johannesburg, South Africa; [Mavhu, Webster] Univ Zimbabwe, Coll Hlth Sci, Dept Community Med UZ, Zimbabwe AIDS Prevent Project, Harare, Zimbabwe; [Machaku, Michael D.] Jhpiego, Dar Es Salaam, Tanzania; [Onyango, Mathews] FHI 360, Kisumu, Kenya; [Aduda, Dickens S. Omondi] Impact Res & Dev Org, Kisumu, Kenya; [Fimbo, Bennett] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania; [Cherutich, Peter] Natl AIDS STI Control Programme, Nairobi, Kenya; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	Tulane University; University of Zimbabwe; Jhpiego; United States Agency for International Development (USAID)	Perry, L (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	lperry@tulane.edu	Frade, Sasha/AAQ-3284-2021	Frade, Sasha/0000-0001-9683-3020; Mavhu, Webster/0000-0003-1881-4398	USAID | Project SEARCH, Task Order No. 2 - U. S. Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief	USAID | Project SEARCH, Task Order No. 2 - U. S. Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The article was supported by USAID | Project SEARCH, Task Order No. 2, funded by the U. S. Agency for International Development (www.usaid.gov) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). USAID staff played a role in study design and data analysis, decision to publish, and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID or United States Government opinion.	BARBOUR RS, 1994, SOC SCI MED, V39, P221, DOI 10.1016/0277-9536(94)90331-X; Bertrand J. T., 2013, SYSTEMATIC MONITORIN; Bertrand JT, 2013, PLOS MED PEER UNPUB; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; Felton JS, 1998, OCCUP MED-OXFORD, V48, P237, DOI 10.1093/occmed/48.4.237; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Rech D, 2013, PLOS MED PEER  UNPUB; Rech D, 2012, CTR HIV AIDS PREVENT; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Wagner G, 2007, AIDS PATIENT CARE ST, V21, P871, DOI 10.1089/apc.2007.0008; Waldman JD, 2010, HEALTH CARE MANAGE R, V35, P206, DOI 10.1097/HMR.0b013e3181e3940e; WHO, 2010, CONSIDERATIONS IMPLE; WHO UNAIDS, 2011, PROGR SCAL MAL CIRCU; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	16	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e84215	10.1371/journal.pone.0084215	http://dx.doi.org/10.1371/journal.pone.0084215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802260	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800010
J	Szili, D; Banko, Z; Toth, EA; Nagy, G; Rojkovich, B; Gati, T; Simon, M; Herincs, Z; Sarmay, G				Szili, Daniel; Banko, Zsuzsanna; Toth, Eszter Angela; Nagy, Gyooegy; Rojkovich, Bernadette; Gati, Tamas; Simon, Melinda; Herincs, Zoltan; Sarmay, Gabriella			TGF beta Activated Kinase 1 (TAK1) at the Crossroad of B Cell Receptor and Toll-Like Receptor 9 Signaling Pathways in Human B Cells	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLASS SWITCH RECOMBINATION; I-KAPPA-B; PKC-BETA; TERMINAL DIFFERENTIATION; AUTOIMMUNE-DISEASE; TYROSINE KINASE; T-CELLS; BAFF-R; SURVIVAL	B cell development and activation are regulated by combined signals mediated by the B cell receptor (BCR), receptors for the B-cell activating factor of the tumor necrosis factor family (BAFF-R) and the innate receptor, Toll-like receptor 9 (TLR9). However, the underlying mechanisms by which these signals cooperate in human B cells remain unclear. Our aim was to elucidate the key signaling molecules at the crossroads of BCR, BAFF-R and TLR9 mediated pathways and to follow the functional consequences of costimulation. Therefore we stimulated purified human B cells by combinations of anti-Ig, B-cell activating factor of the tumor necrosis factor family (BAFF) and the TLR9 agonist, CpG oligodeoxynucleotide. Phosphorylation status of various signaling molecules, B cell proliferation, cytokine secretion, plasma blast generation and the frequency of IgG producing cells were investigated. We have found that BCR induced signals cooperate with BAFF-R- and TLR9-mediated signals at different levels of cell activation. BCR and BAFF-as well as TLR9 and BAFF-mediated signals cooperate at NF kappa B activation, while BCR and TLR9 synergistically costimulate mitogen activated protein kinases (MAPKs), ERK, JNK and p38. We show here for the first time that the MAP3K7 (TGF beta activated kinase, TAK1) is responsible for the synergistic costimulation of B cells by BCR and TLR9, resulting in an enhanced cell proliferation, plasma blast generation, cytokine and antibody production. Specific inhibitor of TAK1 as well as knocking down TAK1 by siRNA abrogates the synergistic signals. We conclude that TAK1 is a key regulator of receptor crosstalk between BCR and TLR9, thus plays a critical role in B cell development and activation.	[Szili, Daniel; Banko, Zsuzsanna; Toth, Eszter Angela; Simon, Melinda; Herincs, Zoltan; Sarmay, Gabriella] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Nagy, Gyooegy; Rojkovich, Bernadette; Gati, Tamas] Buda Hosp Hospitaller Bros St John, Budapest, Hungary; [Nagy, Gyooegy] Semmelweis Univ, Dept Rheumatol, H-1085 Budapest, Hungary	Eotvos Lorand University; Semmelweis University	Sarmay, G (corresponding author), Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary.	sarmayg@elte.hu	Nagy, György/W-6254-2019; Sarmay, Gabriella/AAF-3460-2020	Nagy, György/0000-0003-1198-3228; Herincs, Zoltan/0000-0001-9743-1891	Hungarian Scientific Research Fund [OTKA 60760, 104846]; National Development Agency [OTKA CK 80689]; European Union and the European Social Fund [TAMOP 4.2.1./B-09/1/KMR-2010-0003]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Development Agency; European Union and the European Social Fund	This work was supported by the Hungarian Scientific Research Fund (OTKA 60760, /www.otka.hu/ and 104846 and National Development Agency /www.nfu.hu/ OTKA CK 80689 to G. S.); and the European Union and the European Social Fund have provided financial support to the project under the grant agreement no. TAMOP 4.2.1./B-09/1/KMR-2010-0003./www.nfu.hu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Agrawal S, 2011, J CLIN IMMUNOL, V31, P472, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; Binard A, 2008, J AUTOIMMUN, V30, P63, DOI 10.1016/j.jaut.2007.11.001; BIRO A, 1992, EUR J IMMUNOL, V22, P2547, DOI 10.1002/eji.1830221013; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Cancro MP, 2009, NAT REV IMMUNOL, V9, P657, DOI 10.1038/nri2621; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Carter LM, 2013, ARTHRITIS RHEUM; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3; Davidson A, 2010, CURR OPIN IMMUNOL, V22, P732, DOI 10.1016/j.coi.2010.09.010; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Fu LC, 2009, BLOOD, V113, P4627, DOI 10.1182/blood-2008-10-183467; Galligan CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006703; Geffroy-Luseau A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00083; Grimaldi C, 2005, J IMMUNOL, V174, P1775, DOI 10.4049/jimmunol.174.4.1775; Hancz A, 2012, IMMUNOL LETT, V143, P77, DOI 10.1016/j.imlet.2012.02.006; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Iwata S, 2012, J ALLERGY CLIN IMMUN, V129, P1594, DOI 10.1016/j.jaci.2012.03.014; Jackson SM, 2009, BLOOD, V113, P3999, DOI 10.1182/blood-2008-03-145979; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kenny EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074103; Khan WN, 2009, J IMMUNOL, V183, P3561, DOI 10.4049/jimmunol.0800933; Kim HA, 2011, J LEUKOCYTE BIOL, V89, P393, DOI 10.1189/jlb.1209787; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Nakano S, 2008, RHEUMATOLOGY, V47, P145, DOI 10.1093/rheumatology/kem327; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; OGARRA A, 1990, INT IMMUNOL, V2, P821, DOI 10.1093/intimm/2.9.821; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Otipoby KL, 2008, P NATL ACAD SCI USA, V105, P12435, DOI 10.1073/pnas.0805460105; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Peng SL, 2005, CURR OPIN IMMUNOL, V17, P230, DOI 10.1016/j.coi.2005.03.003; Pistoia V, 1997, IMMUNOL TODAY, V18, P343, DOI 10.1016/S0167-5699(97)01080-3; Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schneider P, 2003, IMMUNOL LETT, V88, P57, DOI 10.1016/S0165-2478(03)00050-6; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Su TT, 2002, NAT IMMUNOL, V3, P780, DOI 10.1038/ni823; Swee LK, 2010, IMMUNOL LETT, V131, P40, DOI 10.1016/j.imlet.2010.03.007; Taniguchi F, 2009, MOL CELL ENDOCRINOL, V307, P196, DOI 10.1016/j.mce.2009.04.012; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Treml JF, 2009, CELL BIOCHEM BIOPHYS, V53, P1, DOI 10.1007/s12013-008-9036-1; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wong CK, 2009, J CLIN IMMUNOL, V29, P738, DOI 10.1007/s10875-009-9318-4; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Yamada T, 2005, AM J RESP CELL MOL, V32, P388, DOI 10.1165/rcmb.2004-0317OC; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yi AK, 2003, INT IMMUNOL, V15, P577, DOI 10.1093/intimm/dxg058; Yu Calvin C K, 2003, Curr Dir Autoimmun, V6, P61; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311	73	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96381	10.1371/journal.pone.0096381	http://dx.doi.org/10.1371/journal.pone.0096381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801688	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800065
J	Visram, S; Clarke, C; White, M				Visram, Shelina; Clarke, Charlotte; White, Martin			Making and Maintaining Lifestyle Changes with the Support of a Lay Health Advisor: Longitudinal Qualitative Study of Health Trainer Services in Northern England	PLOS ONE			English	Article							BEHAVIOR-CHANGE; COST-EFFECTIVENESS; EXPERT PATIENTS; BIRTH OUTCOMES; COMMUNITY; INTERVENTION; WORKERS; PROGRAM; PREVENTION; WOMEN	Objective: To explore and document the experiences of those receiving support from a lay health trainer, in order to inform the optimisation and evaluation of such interventions. Design: Longitudinal qualitative study with up to four serial interviews conducted over 12 months. Interviews were transcribed and analysed using the constant comparative approach associated with grounded theory. Participants: 13 health trainers, 5 managers and 26 clients. Setting: Three health trainer services targeting disadvantaged communities in northern England. Results: The final dataset comprised 116 interviews (88 with clients and 28 with staff). Discussions with health trainers and managers revealed a high degree of heterogeneity between the local services in terms of their primary aims and activities. However, these were found to converge over time. There was agreement that health trainer interventions are generally 'person-centred' in terms of being tailored to the needs of individual clients. This led to a range of self-reported outcomes, including behaviour changes, physical health improvements and increased social activity. Factors impacting on the maintenance of lifestyle changes included the cost and timing of health-promoting activities, ill-health or low mood. Participants perceived a need for ongoing access to low cost facilities to ensure that any lifestyle changes can be maintained in the longer term. Conclusions: Health trainers may be successful in terms of supporting people from socio-economically disadvantaged communities to make positive lifestyle changes, as well as achieving other health- related outcomes. This is not a 'one-size-fits-all' approach; commissioners and providers should select the intervention models that best meet the needs of their local populations. By delivering holistic interventions that address multiple lifestyle risks and incorporate relapse prevention strategies, health trainers could potentially have a significant impact on health inequalities. However, rigorous, formal outcome and economic evaluation of the range of health trainer delivery models is needed.	[Visram, Shelina] Univ Durham, Ctr Publ Policy & Hlth, Durham, England; [Visram, Shelina; White, Martin] Newcastle Univ, Fuse UKCRC Ctr Translat Res Publ Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Clarke, Charlotte] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [White, Martin] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Durham University; Newcastle University - UK; University of Edinburgh; Newcastle University - UK	Visram, S (corresponding author), Univ Durham, Ctr Publ Policy & Hlth, Durham, England.	shelina.visram@durham.ac.uk		Visram, Shelina/0000-0001-9576-2689; White, Martin/0000-0002-1861-6757	National Institute for Health Research (NIHR) [RTF/08/01/096]; Fuse, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation, Cancer Research UK, Economic and Social Research Council; Medical Research Council; NIHR; ESRC [ES/G007470/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007470/1] Funding Source: researchfish; Medical Research Council [MR/K02325X/1] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Fuse, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence; British Heart Foundation, Cancer Research UK, Economic and Social Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This manuscript presents research undertaken as part of a doctoral training fellowship awarded to SV by the National Institute for Health Research (NIHR) (RTF/08/01/096). For details, see: http://www.nihrtcc.nhs.uk/nihrfellow/. At the time of conducting the study, CC and MW were funded in part by Fuse, a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council and the NIHR, under the auspices of UKCRC, is gratefully acknowledged. For details, see: http://www.ukcrc.org/researchcoordination/jointfund/publichealth/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Views expressed in the manuscript are those of the authors and do not necessarily represent those of the above named funders.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Andrews JO, 2004, J NURS SCHOLARSHIP, V36, P358, DOI 10.1111/j.1547-5069.2004.04064.x; Baker EA, 1997, HEALTH EDUC BEHAV, V24, P495, DOI 10.1177/109019819702400408; Ball L, 2011, PERSPECT PUBLIC HEAL, V131, P24, DOI 10.1177/1757913910369089; Bambra C., 2010, Journal of Epidemiology & Community Health, V64, P284, DOI 10.1136/jech.2008.082743; Barton G, 2011, J ENVIRON MANAGE, P1; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; Buchan J, 2002, B WORLD HEALTH ORGAN, V80, P575; Buck D., 2012, IMPLICATIONS POLICY; Carr S, 2011, HLTH TECHNOLOGY ASSE, V15; Charmaz K., 2003, INSIDE INTERVIEWING, P311; Chiovitti RF, 2003, J ADV NURS, V44, P427, DOI 10.1046/j.0309-2402.2003.02822.x; Conservative Party, 2010, CONS MAN 2010; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Daniels K, 2005, HEALTH POLICY, V73, P92, DOI 10.1016/j.healthpol.2004.10.006; Department of Health, 2004, CHOOS HLTH MAK HLTH; Donaldson L, 2003, BRIT MED J, V326, P1279, DOI 10.1136/bmj.326.7402.1279; Dorling D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b829; Duckett Stephen J, 2005, Aust Health Rev, V29, P201; Dugdill L, 2009, REFLECT PRACT, V10, P121, DOI 10.1080/14623940802652979; Durantini MR, 2006, PSYCHOL BULL, V132, P212, DOI 10.1037/0033-2909.132.2.212; Eng E, 1997, HEALTH EDUC BEHAV, V24, P413, DOI 10.1177/109019819702400402; Flax VL, 1999, HEALTH EDUC RES, V14, P15, DOI 10.1093/her/14.1.15; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hutchison AJ, 2010, INT J SOC RES METHOD, V13, P283, DOI 10.1080/13645570902996301; Islam MA, 2002, B WORLD HEALTH ORGAN, V80, P445; Lewin SA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub2; Lorig K, 2002, LANCET, V359, P814, DOI 10.1016/S0140-6736(02)07959-X; Macintyre S, 2006, HEALTH EDUC RES, V21, P731, DOI 10.1093/her/cyl015; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Michie S, 2009, J EPIDEMIOL COMMUN H, V63, P610, DOI 10.1136/jech.2008.078725; Michie S, 2008, NHS HLTH TRAINER HDB; MRC (Medical Research Council UK), 2008, DEV EVALUATING COMPL; Murray S, 2009, BMJ-BRIT MED J, V339; Nemcek MA, 2003, PUBLIC HEALTH NURS, V20, P260, DOI 10.1046/j.1525-1446.2003.20403.x; Pennington Mark, 2013, Cost Eff Resour Alloc, V11, P30, DOI 10.1186/1478-7547-11-30; Popay J, 2003, SOCIOL HEALTH ILL, V25, P1, DOI 10.1111/1467-9566.t01-1-00322; Rahman E, 2013, PERSPECT PUBLIC HEAL, V133, P207, DOI 10.1177/1757913913481931; Ratima MM, 1999, AUST NZ J PUBL HEAL, V23, P601, DOI 10.1111/j.1467-842X.1999.tb01544.x; Shilts MK, 2004, AM J HEALTH PROMOT, V19, P81, DOI 10.4278/0890-1171-19.2.81; Shircore R, 2013, HLTH TRAINERS HALF Y; Sinanovic E, 2003, INT J TUBERC LUNG D, V7, pS56; South J, 2006, EVALUATION BRADFORD; South J, 2007, J R SOC PROMO HEALTH, V127, P224, DOI 10.1177/1466424007081791; Springett J., 2007, Critical Public Health, V17, P243, DOI 10.1080/09581590701225854; STEVENS PE, 1994, SOC SCI MED, V39, P1565, DOI 10.1016/0277-9536(94)90008-6; Struthers R, 2003, J RURAL HEALTH, V19, P174, DOI 10.1111/j.1748-0361.2003.tb00559.x; Swider SM, 2002, PUBLIC HEALTH NURS, V19, P11, DOI 10.1046/j.1525-1446.2002.19003.x; THOMSON R, 2003, INT J SOCIAL RES MET, V0006; UKPHA, 2005, CHOOS HLTH LOS HLTH; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Vassilev I, 2011, CHRONIC ILLN, V7, P60, DOI 10.1177/1742395310383338; Visram S, 2006, EVALUATION EARLY ADO; Viswanathan M, 2009, 181 AG HLTH CAR RES; Wanless D., 2004, SECURING GOOD HLTH W; Ward L, 2009, EVALUATION HLTH TRAI; Wilkinson D, 2011, PSYCHOL HEALTH MED, P1; Ziersch A, 2000, SEX TRANSM INFECT, V76, P447, DOI 10.1136/sti.76.6.447	59	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94749	10.1371/journal.pone.0094749	http://dx.doi.org/10.1371/journal.pone.0094749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24801173	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800022
J	Du, T; Ju, GQ; Wu, S; Cheng, ZL; Cheng, J; Zou, XY; Zhang, GY; Miao, S; Liu, GH; Zhu, YJ				Du, Tao; Ju, Guanqun; Wu, Shuai; Cheng, Zhongliang; Cheng, Jun; Zou, Xiangyu; Zhang, Guangyuan; Miao, Shuai; Liu, Guohua; Zhu, Yingjian			Microvesicles Derived from Human Wharton's Jelly Mesenchymal Stem Cells Promote Human Renal Cancer Cell Growth and Aggressiveness through Induction of Hepatocyte Growth Factor	PLOS ONE			English	Article							STROMAL CELLS; TUMOR-GROWTH; MATRIX METALLOPROTEINASES; HORIZONTAL TRANSFER; SIGNALING PATHWAYS; MET; METASTASIS; EXPRESSION; MICRORNAS; MECHANISM	In our previous study, microvesicles (MVs) released from human Wharton's jelly mesenchymal stem cells (hWJ-MSCs) retard the growth of bladder cancer cells. We would like to know if MVs have a similar effect on human renal cell carcinoma (RCC). By use of cell culture and the BALB/c nu/nu mice xeno-graft model, the influence of MVs upon the growth and aggressiveness of RCC (786-0) was assessed. Cell counting kit-8 (CCK-8) assay, incidence of tumor, tumor size, Ki-67 or TUNEL staining was used to evaluate tumor cell growth in vitro or in vivo. Flow cytometry assay (in vitro) or examination of cyclin D1 expression (in vivo) was carried out to determine the alteration of cell cycle. The aggressiveness was analyzed by Wound Healing Assay (in vitro) or MMP-2 and MMP-9 expression (in vivo). AKT/p-AKT, ERK1/2/p-ERK1/2 or HGF/c-MET expression was detected by real-time PCR or western blot. Our data demonstrated that MVs promote the growth and aggressiveness of RCC both in vitro and in vivo. In addition, MVs facilitated the progression of cell cycle from G(0/1) to S. HGF expression in RCC was greatly induced by MVs, associated with activation of AKT and ERK1/2 signaling pathways. RNase pre-treatment abrogated all effects of MVs. In summary, induction of HGF synthesis via RNA transferred by MVs activating AKT and ERK1/2 signaling is one of crucial contributors to the pro-tumor effect.	[Ju, Guanqun; Wu, Shuai; Cheng, Zhongliang; Zou, Xiangyu; Zhang, Guangyuan; Miao, Shuai; Liu, Guohua; Zhu, Yingjian] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Du, Tao] Henan Prov Peoples Hosp, Dept Urol, Zhengzhou, Peoples R China; [Wu, Shuai] Qingdao Municipal Hosp, Dept Urol, Qingdao, Peoples R China; [Cheng, Jun] Nantong Tongzhou Peoples Hosp, Dept Urol, Nantong, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Zhengzhou University; Qingdao Municipal Hospital	Ju, GQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	juguanqun1@163.com; zhuyingjian_sjtu@126.com	Zhang, Guangyuan/AAD-5494-2020		Research Program of Science and Technology Commission of Shanghai Municipality [10411967200]; Shanghai Song-Jiang Health Bureau [2011PD06]; National Natural Science Foundation of China [81170642]; Shanghai Shen Kang Plat-form Grant [SHDC12007206]	Research Program of Science and Technology Commission of Shanghai Municipality; Shanghai Song-Jiang Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Shen Kang Plat-form Grant	This study is supported by grants from the Research Program of Science and Technology Commission of Shanghai Municipality (10411967200) and Shanghai Song-Jiang Health Bureau (2011PD06) and National Natural Science Foundation of China (81170642) and Shanghai Shen Kang Plat-form Grant (SHDC12007206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta JM, 2012, STEM CELLS DEV, V21, P1627, DOI 10.1089/scd.2011.0550; Aune G, 2011, GYNECOL ONCOL, V121, P402, DOI 10.1016/j.ygyno.2010.12.355; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bouffi C, 2009, RHEUMATOLOGY, V48, P1185, DOI 10.1093/rheumatology/kep162; Bruno S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0304; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Du T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt215; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Gatti S, 2011, NEPHROL DIAL TRANSPL, V26, P1474, DOI 10.1093/ndt/gfr015; Han ZP, 2011, J CELL MOL MED, V15, P2343, DOI 10.1111/j.1582-4934.2010.01215.x; Herrera MB, 2010, J CELL MOL MED, V14, P1605, DOI 10.1111/j.1582-4934.2009.00860.x; Hong JS, 2011, J IMMUNOL, V186, P6427, DOI 10.4049/jimmunol.1003449; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Janowska-Wieczorek A, 2001, BLOOD, V98, P3143, DOI 10.1182/blood.V98.10.3143; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Losche W, 2004, PLATELETS, V15, P109, DOI 10.1080/09537100310001649885; Ma PC, 2008, GENE CHROMOSOME CANC, V47, P1025, DOI 10.1002/gcc.20604; Miyata Y, 2006, CLIN CANCER RES, V12, P4876, DOI 10.1158/1078-0432.CCR-06-0362; Nabeshima K, 2000, CANCER RES, V60, P3364; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Navab R, 2009, NEOPLASIA, V11, P1292, DOI 10.1593/neo.09622; Quesenberry PJ, 2010, EXP HEMATOL, V38, P581, DOI 10.1016/j.exphem.2010.03.021; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Ratajczak MZ, 2012, LEUKEMIA, V26, P1166, DOI 10.1038/leu.2011.389; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Rosenthal EL, 1998, CANCER RES, V58, P5221; Rubio D, 2008, EXP CELL RES, V314, P691, DOI 10.1016/j.yexcr.2007.11.017; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Sierra J Rafael, 2011, Ther Adv Med Oncol, V3, pS21, DOI 10.1177/1758834011422557; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhu W, 2012, CANCER LETT, V315, P28, DOI 10.1016/j.canlet.2011.10.002	49	59	61	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96836	10.1371/journal.pone.0096836	http://dx.doi.org/10.1371/journal.pone.0096836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797571	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000131
J	Lourenco, BM; Costa, KM; da Silva, M				Lourenco, Bruna Mendes; Costa, Kaue Machado; da Silva Filho, Manoel			Voice Disorder in Cystic Fibrosis Patients	PLOS ONE			English	Article							AIR-FLOW; QUALITY; THERAPY; DYSPHONIA; SPEAKERS; WOMEN; MEN	Cystic fibrosis is a common autosomal recessive disorder with drastic respiratory symptoms, including shortness of breath and chronic cough. While most of cystic fibrosis treatment is dedicated to mitigating the effects of respiratory dysfunction, the potential effects of this disease on vocal parameters have not been systematically studied. We hypothesized that cystic fibrosis patients, given their characteristic respiratory disorders, would also present dysphonic symptoms. Given that voice disorders can severely impair quality of life, the identification of a potential cystic fibrosis-related dysphonia could be of great value for the clinical evaluation and treatment of this disease. We tested our hypothesis by measuring vocal parameters, using both objective physical measures and the GRBAS subjective evaluation method, in male and female cystic fibrosis patients undergoing conventional treatment and compared them to age and sex matched controls. We found that cystic fibrosis patients had a significantly lower vocal intensity and harmonic to noise ratio, as well as increased levels of jitter and shimmer. In addition, cystic fibrosis patients also showed higher scores of roughness, breathiness and asthenia, as well as a significantly altered general grade of dysphonia. When we segregated the results according to sex, we observed that, as a group, only female cystic fibrosis patients had significantly lower values of harmonic to noise ratio and an abnormal general grade of dysphonia in relation to matched controls, suggesting that cystic fibrosis exerts a more pronounced effect on vocal parameters of women in relation to men. Overall, the dysphonic characteristics of CF patients can be explained by dysfunctions in vocal fold movement and partial upper airway obstruction, potentially caused by the accumulation of mucus and chronic cough characteristic of CF symptomatology. Our results show that CF patients exhibit significant dysphonia and suggest they may potentially benefit from voice therapy as a parallel treatment strategy.	[Lourenco, Bruna Mendes; Costa, Kaue Machado; da Silva Filho, Manoel] Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil; [Lourenco, Bruna Mendes] Fed Univ Para, Joao de Barros Barreto Univ Hosp, BR-66059 Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	da Silva, M (corresponding author), Fed Univ Para, Inst Biol Sci, BR-66059 Belem, Para, Brazil.	manoel@ufpa.br	da Silva Filho, Manoel/C-6684-2013; Costa, Kauê M/H-5574-2012	Costa, Kauê M/0000-0002-5562-6495	Federal University of Para; Joao de Barros Barreto University Hospital	Federal University of Para; Joao de Barros Barreto University Hospital	This study was supported by the Federal University of Para and the Joao de Barros Barreto University Hospital. MSF is a research fellow of the National Council for Research and Development (CNPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's websites: http://www.ufpa.br/, http://www.barrosbarreto.ufpa.br/, http://www.cnpq.br/.	Baken RJ., 2010, CLIN MEASUREMENTS SP; Bhuta T, 2004, J VOICE, V18, P299, DOI 10.1016/j.jvoice.2003.12.004; Cohen SM, 2009, OTOLARYNG CLIN N AM, V42, P107, DOI 10.1016/j.otc.2008.09.010; Deary IJ, 1997, BRIT J HEALTH PSYCH, V2, P333, DOI 10.1111/j.2044-8287.1997.tb00547.x; DeBodt MS, 1997, J VOICE, V11, P74, DOI 10.1016/S0892-1997(97)80026-4; Dehqan A, 2010, J VOICE, V24, P161, DOI 10.1016/j.jvoice.2008.07.005; Ferrand CT, 2000, J VOICE, V14, P17, DOI 10.1016/S0892-1997(00)80091-0; Franca MC, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2011.11.010; Gartner-Schmidt JL, 2013, J VOICE, V27, P210, DOI 10.1016/j.jvoice.2012.11.007; Gibson PG, 2009, PULM PHARMACOL THER, V22, P159, DOI 10.1016/j.pupt.2008.11.005; Grini-Grandval M N, 2002, Rev Laryngol Otol Rhinol (Bord), V123, P311; Hirano M., 1981, CLIN EXAMINATION VOI; Hodge FS, 2001, J VOICE, V15, P503, DOI 10.1016/S0892-1997(01)00050-9; HOLLIEN H, 1962, J SPEECH HEAR RES, V5, P237, DOI 10.1044/jshr.0503.237; Holmberg EB, 2001, J VOICE, V15, P395, DOI 10.1016/S0892-1997(01)00041-8; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; HOLMES LC, 1994, J SPEECH HEAR RES, V37, P789, DOI 10.1044/jshr.3704.789; Kosztyla-Hojna B, 2011, FOLIA HISTOCHEM CYTO, V49, P72, DOI 10.5603/FHC.2011.0011; Lopes LW, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.05.008; Lucero JC, 2005, J ACOUST SOC AM, V117, P1362, DOI 10.1121/1.1853235; Maryn Y, 2009, FOLIA PHONIATR LOGO, V61, P217, DOI 10.1159/000227999; MUELLER PB, 1992, J COMMUN DISORD, V25, P251, DOI 10.1016/0021-9924(92)90019-S; Murry T, 2004, J VOICE, V18, P183, DOI 10.1016/j.jvoice.2003.11.003; Naufel de Felippe Ana Clara, 2006, Braz J Otorhinolaryngol, V72, P659; Nemr K, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.03.005; Omori K., 2011, JPN MED ASS J, V54, P248; Pontes Paulo A. L., 2002, Rev. Bras. Otorrinolaringol., V68, P182, DOI 10.1590/S0034-72992002000200005; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Schindler A, 2013, AURIS NASUS LARYNX, V40, P291, DOI 10.1016/j.anl.2012.08.003; Speyer R, 2008, J VOICE, V22, P565, DOI 10.1016/j.jvoice.2006.10.005; Toran K C, 2009, Kathmandu Univ Med J (KUMJ), V7, P374; Verdonck-de Leeuw IM, 2001, J VOICE, V15, P313, DOI 10.1016/S0892-1997(01)00033-9; Wilson JA, 2002, CLIN OTOLARYNGOL, V27, P179, DOI 10.1046/j.1365-2273.2002.00559.x; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S; Yelken K, 2010, J VOICE, V24, P724, DOI 10.1016/j.jvoice.2009.05.004; YUMOTO E, 1982, J ACOUST SOC AM, V71, P1544, DOI 10.1121/1.387808; Zemanick ET, 2010, J CYST FIBROS, V9, P1, DOI 10.1016/j.jcf.2009.09.003	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96769	10.1371/journal.pone.0096769	http://dx.doi.org/10.1371/journal.pone.0096769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796691	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000125
J	Medina-Echeverz, J; Fioravanti, J; Diaz-Valdes, N; Frank, K; Aranda, F; Gomar, C; Ardaiz, N; Dotor, J; Umansky, V; Prieto, J; Berraondo, P				Medina-Echeverz, Jose; Fioravanti, Jessica; Diaz-Valdes, Nancy; Frank, Kathrin; Aranda, Fernando; Gomar, Celia; Ardaiz, Nuria; Dotor, Javier; Umansky, Viktor; Prieto, Jesus; Berraondo, Pedro			Harnessing High Density Lipoproteins to Block Transforming Growth Factor Beta and to Inhibit the Growth of Liver Tumor Metastases	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; TGF-BETA; T-CELLS; ADENOASSOCIATED VIRUS; SYNTHETIC PEPTIDE; IMMUNE CELLS; GENE-THERAPY; CANCER; PROGRESSION; MELANOMA	Transforming growth factor beta (TGF-beta) is a powerful promoter of cancer progression and a key target for antitumor therapy. As cancer cells exhibit active cholesterol metabolism, high density lipoproteins (HDLs) appear as an attractive delivery system for anticancer TGF beta-inhibitory molecules. We constructed a plasmid encoding a potent TGF-beta-blocking peptide (P144) linked to apolipoprotein A-I (ApoA-I) through a flexible linker (pApoLinkerP144). The ApoLinkerP144 sequence was then incorporated into a hepatotropic adeno-associated vector (AAVApoLinkerP144). The aim was to induce hepatocytes to produce HDLs containing a modified ApoA-I capable of blocking TGF-b. We observed that transduction of the murine liver with pApoLinkerP144 led to the appearance of a fraction of circulating HDL containing the fusion protein. These HDLs were able to attenuate TGF-b signaling in the liver and to enhance IL-12 -mediated IFN-gamma production. Treatment of liver metastasis of MC38 colorectal cancer with AAVApoLinkerP144 resulted in a significant reduction of tumor growth and enhanced expression of IFN-c and GM-CSF in cancerous tissue. ApoLinkerP144 also delayed MC38 liver metastasis in Rag2(-/) (-)IL2r gamma (-/)-immunodeficient mice. This effect was associated with downregulation of TGF-beta target genes essential for metastatic niche conditioning. Finally, in a subset of ret transgenic mice, a model of aggressive spontaneous metastatic melanoma, AAVApoLinkerP144 delayed tumor growth in association with increased CD8(+) T cell numbers in regional lymph nodes. In conclusion, modification of HDLs to transport TGF-b-blocking molecules is a novel and promising approach to inhibit the growth of liver metastases by immunological and non-immunological mechanisms.	[Medina-Echeverz, Jose; Fioravanti, Jessica; Diaz-Valdes, Nancy; Aranda, Fernando; Gomar, Celia; Ardaiz, Nuria; Prieto, Jesus; Berraondo, Pedro] Univ Navarra, Ctr Appl Med Res, Div Hepatol & Gene Therapy, E-31080 Pamplona, Spain; [Diaz-Valdes, Nancy; Frank, Kathrin; Umansky, Viktor] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Diaz-Valdes, Nancy; Frank, Kathrin; Umansky, Viktor] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol Venereol & Allergol, Heidelberg, Germany; [Dotor, Javier] DIGNA Biotech, Madrid, Spain; [Prieto, Jesus] Univ Navarra Clin, Networked Biomed Res Ctr Hepat & Digest Dis, Liver Unit, Pamplona, Spain	University of Navarra; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Navarra	Prieto, J (corresponding author), Univ Navarra, Ctr Appl Med Res, Div Hepatol & Gene Therapy, E-31080 Pamplona, Spain.	jprieto@unav.es; pberraondol@unav.es	Fioravanti, Jessica/AAS-1245-2020; Aranda, Fernando/N-9649-2019; Aranda, Fernando/N-2112-2014; Berraondo, Pedro/J-3154-2012	Fioravanti, Jessica/0000-0001-6263-4306; Aranda, Fernando/0000-0002-9364-474X; Aranda, Fernando/0000-0002-9364-474X; Berraondo, Pedro/0000-0001-7410-1865; Prieto, Jesus/0000-0002-1091-9593	FIMA; UTE project CIMA [IMMUNONET-SOE1/P1/E014]; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria [FIS PI10/00264]; Foundation for Cancer Research [108992]; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; fellowship of Spanish Fondo de Investigacion Sanitaria; Martin Escudero fellowship; Miguel Servet contract from Spanish Fondo de Investigacion Sanitaria	FIMA; UTE project CIMA; Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Foundation for Cancer Research; Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer; fellowship of Spanish Fondo de Investigacion Sanitaria; Martin Escudero fellowship; Miguel Servet contract from Spanish Fondo de Investigacion Sanitaria	This work was supported by the agreement between FIMA and the "UTE project CIMA'', Red de Inmunoterapia IMMUNONET-SOE1/P1/E014, Instituto de Salud Carlos III, Fondo de Investigacion Sanitaria (FIS PI10/00264), Fundacion Mutua Madrilena, Dr. Mildred Scheel Foundation for Cancer Research (grant 108992, to V.U.) and by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer (to V.U.). J. F. and J.M-E. were supported by a fellowship of Spanish Fondo de Investigacion Sanitaria. N.D-V. was supported by a Martin Escudero fellowship. P. B. was supported by a Miguel Servet contract from Spanish Fondo de Investigacion Sanitaria. J.D. was employee of Digna Biotech until June 2013. He has neither rights nor benefits from the data presented in this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abschuetz Oliver, 2012, Cancers (Basel), V4, P490, DOI 10.3390/cancers4020490; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Cao WM, 2004, CANCER RES, V64, P1515, DOI 10.1158/0008-5472.CAN-03-0675; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ezquerro IJ, 2003, CYTOKINE, V22, P12, DOI 10.1016/S1043-4666(03)00101-7; Fioravanti J, 2011, HEPATOLOGY, V53, P1864, DOI 10.1002/hep.24306; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315; Kato M, 1998, ONCOGENE, V17, P1885, DOI 10.1038/sj.onc.1202077; Lacko AG, 2006, CHEMOTHERAPY, V52, P171, DOI 10.1159/000093268; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Melero I, 1999, GENE THER, V6, P1779, DOI 10.1038/sj.gt.3301010; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pussinen PJ, 2000, BIOCHEM J, V349, P559, DOI 10.1042/0264-6021:3490559; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; Schlingensiepen KH, 2006, CYTOKINE GROWTH F R, V17, P129, DOI 10.1016/j.cytogfr.2005.09.002; Sevko A, 2013, J INVEST DERMATOL, V133, P1610, DOI 10.1038/jid.2012.444; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Takaku S, 2010, INT J CANCER, V126, P1666, DOI 10.1002/ijc.24961; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Umansky V, 2008, CANCER RES, V68, P9451, DOI 10.1158/0008-5472.CAN-08-1464; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; Zabala M, 2007, J HEPATOL, V47, P807, DOI 10.1016/j.jhep.2007.07.025	34	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96799	10.1371/journal.pone.0096799	http://dx.doi.org/10.1371/journal.pone.0096799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797128	Green Published, gold			2022-12-27	WOS:000336656000128
J	Sikkel, PC; Tuttle, LJ; Cure, K; Coile, AM; Hixon, MA				Sikkel, Paul C.; Tuttle, Lillian J.; Cure, Katherine; Coile, Ann Marie; Hixon, Mark A.			Low Susceptibility of Invasive Red Lionfish (Pterois volitans) to a Generalist Ectoparasite in Both Its Introduced and Native Ranges	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; GNATHIID ISOPODS; HAEMOGREGARINA-BIGEMINA; HOST-SPECIFICITY; CLEANING BEHAVIOR; PROXIMATE CAUSE; LIFE-CYCLE; REEF; PARASITE; FISH	Escape from parasites in their native range is one of many mechanisms that can contribute to the success of an invasive species. Gnathiid isopods are blood-feeding ectoparasites that infest a wide range of fish hosts, mostly in coral reef habitats. They are ecologically similar to terrestrial ticks, with the ability to transmit blood-borne parasites and cause damage or even death to heavily infected hosts. Therefore, being highly resistant or highly susceptible to gnathiids can have significant fitness consequences for reef-associated fishes. Indo-Pacific red lionfish (Pterois volitans) have invaded coastal habitats of the western tropical and subtropical Atlantic and Caribbean regions. We assessed the susceptibility of red lionfish to parasitic gnathiid isopods in both their native Pacific and introduced Atlantic ranges via experimental field studies during which lionfish and other, ecologically-similar reef fishes were caged and exposed to gnathiid infestation on shallow coral reefs. Lionfish in both ranges had very few gnathiids when compared with other species, suggesting that lionfish are not highly susceptible to infestation by generalist ectoparasitic gnathiids. While this pattern implies that release from gnathiid infestation is unlikely to contribute to the success of lionfish as invaders, it does suggest that in environments with high gnathiid densities, lionfish may have an advantage over species that are more susceptible to gnathiids. Also, because lionfish are not completely resistant to gnathiids, our results suggest that lionfish could possibly have transported blood parasites between their native Pacific and invaded Atlantic ranges.	[Sikkel, Paul C.; Coile, Ann Marie] Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA; [Tuttle, Lillian J.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Cure, Katherine] Univ Guam, Marine Lab, Mangilao, GU 96923 USA; [Cure, Katherine] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Cure, Katherine] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Hixon, Mark A.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA	Arkansas State University; Oregon State University; University of Guam; University of Western Australia; University of Western Australia; University of Hawaii System; University of Hawaii Manoa	Sikkel, PC (corresponding author), Arkansas State Univ, Dept Biol Sci, Jonesboro, AR 72401 USA.	psikkel@astate.edu	Cure, Katherine/I-3126-2019	Tuttle Raz, Lillian/0000-0002-5009-8080	Arkansas State University; National Science Foundation (N.S.F.); American Museum of Natural History; American Academy of Underwater Sciences; U.S. N.S.F. [08-51162, 12-33027]; Division Of Ocean Sciences [1233027] Funding Source: National Science Foundation	Arkansas State University; National Science Foundation (N.S.F.)(National Science Foundation (NSF)); American Museum of Natural History; American Academy of Underwater Sciences; U.S. N.S.F.(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded in part by Arkansas State University; a National Science Foundation (N.S.F.) Graduate Research Fellowship; scholarships from the American Museum of Natural History and the American Academy of Underwater Sciences to LJ Tuttle; and grants from the U.S. N.S.F. (08-51162 and 12-33027, MA Hixon, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Anderson ET, 2010, J AQUAT ANIM HEALTH, V22, P266, DOI 10.1577/H10-029.1; Arnal C, 2000, J FISH BIOL, V57, P1075, DOI 10.1006/jfbi.2000.1371; Bandilla M, 2005, PARASITOLOGY, V130, P169, DOI 10.1017/S0031182004006407; BAUER ON, 1991, J FISH BIOL, V39, P679, DOI 10.1111/j.1095-8649.1991.tb04398.x; BERNADSKY G, 1991, COPEIA, P230; BERRY PF, 1982, MAR ECOL PROG SER, V10, P49, DOI 10.3354/meps010049; Clark KL, 2001, J PARASITOL, V87, P1379, DOI 10.1645/0022-3395(2001)087[1379:HAOTPR]2.0.CO;2; Coile AM, 2013, PARASITOLOGY, V140, P888, DOI 10.1017/S0031182013000097; CORNELL HV, 1993, AM NAT, V141, P847, DOI 10.1086/285512; Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942; Curtis LM, 2013, INT J PARASITOL, V43, P361, DOI 10.1016/j.ijpara.2012.11.012; Davies AJ, 2004, FOLIA PARASIT, V51, P99, DOI 10.14411/fp.2004.015; Davies AJ, 2001, FOLIA PARASIT, V48, P169, DOI 10.14411/fp.2001.029; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Farquharson C, 2012, ZOOTAXA, P47; Fast MD, 2002, DIS AQUAT ORGAN, V52, P57, DOI 10.3354/dao052057; Freshwater DW, 2009, MITOCHONDRIAL CONTRO; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Gendron AD, 2012, BIOL INVASIONS, V14, P367, DOI 10.1007/s10530-011-0083-y; Giorgi MS, 2004, OECOLOGIA, V138, P648, DOI 10.1007/s00442-003-1475-1; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Grutter A, 1996, MAR ECOL PROG SER, V130, P61, DOI 10.3354/meps130061; Grutter AS, 2008, CORAL REEFS, V27, P655, DOI 10.1007/s00338-008-0377-4; Grutter AS, 2001, P ROY SOC B-BIOL SCI, V268, P1361, DOI 10.1098/rspb.2001.1658; GRUTTER AS, 1994, MAR ECOL PROG SER, V115, P21, DOI 10.3354/meps115021; Grutter AS, 1999, NATURE, V398, P672, DOI 10.1038/19443; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; Hadfield KA, 2008, ZOOTAXA, P23, DOI 10.11646/zootaxa.1894.1.2; Hadfield KA, 2009, J MAR BIOL ASSOC UK, V89, P1331, DOI 10.1017/S0025315409000587; HALSTEAD BW, 1955, ANAT REC, V122, P317, DOI 10.1002/ar.1091220304; Harris PD, 1998, PARASITOLOGY, V117, P137, DOI 10.1017/S003118209800287X; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Helfman GS, 2009, DIVERSITY FISHES BIO, P38; Horton T, 2003, J FISH DIS, V26, P401, DOI 10.1046/j.1365-2761.2003.00476.x; Humann P., 2002, REEF FISH IDENTIFICA; Jones CM, 2007, INT J PARASITOL, V37, P927, DOI 10.1016/j.ijpara.2007.01.011; Jones CM, 2005, J FISH BIOL, V66, P860, DOI 10.1111/j.0022-1112.2005.00640.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; KENNEDY CR, 1994, PARASITOLOGY, V109, P187, DOI 10.1017/S0031182000076290; Kulbicki M, 2012, MAR ECOL PROG SER, V446, P189, DOI 10.3354/meps09442; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; McCoy KD, 2001, J EVOLUTION BIOL, V14, P395, DOI 10.1046/j.1420-9101.2001.00290.x; Miller A, 2008, NEW ZEAL J MAR FRESH, V42, P143, DOI 10.1080/00288330809509944; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Morris Jr JA, 2009, 99 NOS NCCOS, V99; Mouritsen KN, 2002, PARASITOLOGY, V124, pS101, DOI 10.1017/S0031182002001476; MUGRIDGE RER, 1983, J FISH DIS, V6, P81, DOI 10.1111/j.1365-2761.1983.tb00054.x; Munday PL, 2003, J FISH BIOL, V62, P976, DOI 10.1046/j.1095-8649.2003.00078.x; Nagel L, 2007, J FISH BIOL, V70, P497, DOI 10.1111/j.1095-8649.2007.01320.x; Penfold R, 2008, MAR ECOL PROG SER, V357, P111, DOI 10.3354/meps07312; Pisanu B, 2010, INT J PARASITOL, V40, P1277, DOI 10.1016/j.ijpara.2010.03.012; Poulin R, 2011, FRESHWATER BIOL, V56, P676, DOI 10.1111/j.1365-2427.2010.02425.x; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Seneviratne SS, 2009, INT J PARASITOL, V39, P995, DOI 10.1016/j.ijpara.2008.12.009; Shakman E, 2009, ACTA PARASITOL, V54, P380, DOI 10.2478/s11686-009-0048-9; Sikkel PC, 2009, CORAL REEFS, V28, P489, DOI 10.1007/s00338-009-0474-z; Sikkel PC, 2006, CORAL REEFS, V25, P683, DOI 10.1007/s00338-006-0154-1; Sikkel PC, 2011, MAR BIOL, V158, P1075, DOI 10.1007/s00227-011-1631-9; Sikkel PC, 2004, ANIM BEHAV, V68, P241, DOI 10.1016/j.anbehav.2003.10.023; Sikkel PC, 2000, MAR ECOL PROG SER, V193, P191, DOI 10.3354/meps193191; Smit NJ, 2004, ADV PARASIT, V58, P289, DOI 10.1016/S0065-308X(04)58005-3; Stapp P, 2009, J ANIM ECOL, V78, P807, DOI 10.1111/j.1365-2656.2009.01541.x; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Tanaka Katsuhiko, 2007, Plankton & Benthos Research, V2, P1, DOI 10.3800/pbr.2.1; Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250; Tompkins DM, 2003, ECOL LETT, V6, P189, DOI 10.1046/j.1461-0248.2003.00417.x; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Vignon M, 2010, ENVIRON BIOL FISH, V87, P1, DOI 10.1007/s10641-009-9553-9; Vignon M, 2009, PARASITOL RES, V104, P775, DOI 10.1007/s00436-008-1254-3; Waldie PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021201; Walker PD, 2008, FOLIA PARASIT, V55, P141, DOI 10.14411/fp.2008.019; Welicky RL, 2013, MAR BIOL, V160, P1607, DOI 10.1007/s00227-013-2213-9; Whiteman EA, 2002, J MAR BIOL ASSOC UK, V82, P655, DOI 10.1017/S0025315402006021; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289	81	34	34	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95854	10.1371/journal.pone.0095854	http://dx.doi.org/10.1371/journal.pone.0095854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796701	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000025
J	Tomasi, D; Volkow, ND				Tomasi, Dardo; Volkow, Nora D.			Mapping Small-World Properties through Development in the Human Brain: Disruption in Schizophrenia	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; RESTING-STATE; LOW-FREQUENCY; TEST-RETEST; NETWORKS; ORGANIZATION; DYNAMICS; MRI; COMORBIDITY; ACTIVATION	Evidence from imaging studies suggests that the human brain has a small-world network topology that might be disrupted in certain brain disorders. However, current methodology is based on global graph theory measures, such as clustering, C, characteristic path length, L, and small-worldness, S, that lack spatial specificity and are insufficient to identify regional brain abnormalities. Here we propose novel ultra-fast methodology for mapping local properties of brain network topology such as local C, L and S (lC, lL and lS) in the human brain at 3-mm isotropic resolution from 'resting-state' magnetic resonance imaging data. Test-retest datasets from 40 healthy children/adolescents were used to demonstrate the overall good reliability of the measures across sessions and computational parameters (intraclass correlation >0.5 for lC and lL) and their low variability across subjects (< 29%). Whereas regions with high local functional connectivity density (lFCD; local degree) in posterior parietal and occipital cortices demonstrated high lC and short lL, subcortical regions (globus pallidus, thalamus, hippocampus and amygdala), cerebellum (lobes and vermis), cingulum and temporal cortex also had high, lS, demonstrating stronger small-world topology than other hubs. Children/adolescents had stronger lFCD, higher lC and longer lL in most cortical regions and thalamus than 74 healthy adults, consistent with pruning of functional connectivity during maturation. In contrast, lFCD, lC and lL were weaker in thalamus and midbrain, and lL was shorter in frontal cortical regions and cerebellum for 69 schizophrenia patients than for 74 healthy controls, suggesting exaggerated pruning of connectivity in schizophrenia. Follow up correlation analyses for seeds in thalamus and midbrain uncovered lower positive connectivity of these regions in thalamus, putamen, cerebellum and frontal cortex (cingulum, orbitofrontal, inferior frontal) and lower negative connectivity in auditory, visual, motor, premotor and somatosensory cortices for schizophrenia patients than for controls, consistent with prior findings of thalamic disconnection in schizophrenia.	[Tomasi, Dardo; Volkow, Nora D.] NIAAA, Bethesda, MD 20892 USA; [Volkow, Nora D.] NIDA, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Tomasi, D (corresponding author), NIAAA, Bethesda, MD 20892 USA.	tomasidg@mail.nih.gov	Tomasi, Dardo/J-2127-2015		National Institutes of Alcohol Abuse and Alcoholism [2RO1AA09481]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009481, ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was accomplished with support from the National Institutes of Alcohol Abuse and Alcoholism (2RO1AA09481). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Aron AR, 2006, NEUROIMAGE, V29, P1000, DOI 10.1016/j.neuroimage.2005.08.010; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Beu M, 2009, J NEUROSCI METH, V176, P263, DOI 10.1016/j.jneumeth.2008.08.036; Bluhm RL, 2007, SCHIZOPHRENIA BULL, V33, P1004, DOI 10.1093/schbul/sbm052; Boksa P, 2012, J PSYCHIATR NEUROSCI, V37, P75, DOI 10.1503/jpn.120007; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Copeland JRM, 1998, SCHIZOPHRENIA BULL, V24, P153, DOI 10.1093/oxfordjournals.schbul.a033307; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; FARKAS T, 1984, ARCH GEN PSYCHIAT, V41, P293; Fitzsimmons J, 2013, CURR OPIN PSYCHIATR, V26, P172, DOI 10.1097/YCO.0b013e32835d9e6a; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Hadley J, 2013, NEUROPSYCHOPHARMACOL, DOI [10.1038/npp.2013.1305, DOI 10.1038/NPP.2013.1305]; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kong J, 2007, NEUROIMAGE, V34, P1171, DOI 10.1016/j.neuroimage.2006.10.019; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Laursen TM, 2009, J CLIN PSYCHIAT, V70, P1432, DOI 10.4088/JCP.08m04807; Linden DEJ, 2011, CEREB CORTEX, V21, P330, DOI 10.1093/cercor/bhq097; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Marenco S, 2012, NEUROPSYCHOPHARMACOL, V37, P499, DOI 10.1038/npp.2011.215; Oertel-Knochel V, 2013, SCHIZOPHR RES, V147, P331, DOI 10.1016/j.schres.2013.04.024; Ottet MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00402; PARK SK, 1988, COMMUN ACM, V31, P1192, DOI 10.1145/63039.63042; Paus Tomas, 2008, Nat Rev Neurosci, V9, P947, DOI 10.1038/nrn2513; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tomasi D., 2012, CEREB CORTEX; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Voineskos AN, 2010, BRAIN, V133, P1494, DOI 10.1093/brain/awq040; VOLKOW ND, 1988, SCHIZOPHR RES, V1, P47, DOI 10.1016/0920-9964(88)90039-4; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V114, P39, DOI 10.1016/S0925-4927(01)00130-5; VOLKOW ND, 1986, J CEREBR BLOOD F MET, V6, P441, DOI 10.1038/jcbfm.1986.77; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yu QB, 2012, CURR TOP MED CHEM, V12, P2415, DOI 10.2174/156802612805289890; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]	74	45	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96176	10.1371/journal.pone.0096176	http://dx.doi.org/10.1371/journal.pone.0096176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788815	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917300030
J	Manning, JR; Ranganath, R; Norman, KA; Blei, DM				Manning, Jeremy R.; Ranganath, Rajesh; Norman, Kenneth A.; Blei, David M.			Topographic Factor Analysis: A Bayesian Model for Inferring Brain Networks from Neural Data	PLOS ONE			English	Article							BLIND SEPARATION	The neural patterns recorded during a neuroscientific experiment reflect complex interactions between many brain regions, each comprising millions of neurons. However, the measurements themselves are typically abstracted from that underlying structure. For example, functional magnetic resonance imaging (fMRI) datasets comprise a time series of three-dimensional images, where each voxel in an image (roughly) reflects the activity of the brain structure(s)-located at the corresponding point in space-at the time the image was collected. FMRI data often exhibit strong spatial correlations, whereby nearby voxels behave similarly over time as the underlying brain structure modulates its activity. Here we develop topographic factor analysis (TFA), a technique that exploits spatial correlations in fMRI data to recover the underlying structure that the images reflect. Specifically, TFA casts each brain image as a weighted sum of spatial functions. The parameters of those spatial functions, which may be learned by applying TFA to an fMRI dataset, reveal the locations and sizes of the brain structures activated while the data were collected, as well as the interactions between those structures.	[Manning, Jeremy R.; Norman, Kenneth A.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Manning, Jeremy R.; Ranganath, Rajesh; Blei, David M.] Princeton Univ, Dept Comp Sci, Princeton, NJ 08544 USA; [Norman, Kenneth A.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Manning, JR (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	manning3@princeton.edu	Manning, Jeremy/H-4617-2019	Manning, Jeremy/0000-0001-7613-4732	NSF/NIH Collaborative Research in Computational Neuroscience Program [NSF IIS-1009542]	NSF/NIH Collaborative Research in Computational Neuroscience Program	This research was supported by the NSF/NIH Collaborative Research in Computational Neuroscience Program, grant number NSF IIS-1009542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop Christopher M., 2006, PATTERN RECOGNITION; COMON P, 1991, SIGNAL PROCESS, V24, P11, DOI 10.1016/0165-1684(91)90080-3; Duchi J, 2011, J MACH LEARN RES, V12, P2121; Friston KJ, 1996, NEUROIMAGE, V4, P97, DOI 10.1006/nimg.1996.0033; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gelman A., 2007, DATA ANAL USING REGR; Gelman A, 2013, BAYESIAN DATA ANAL, V3rd; Gershman SJ, 2011, NEUROIMAGE, V57, P89, DOI 10.1016/j.neuroimage.2011.04.042; Hoffman MD, 2013, J MACH LEARN RES, V14, P1303; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Ranganath R., 2014, ARTIFICIAL INTELLIGE, P814; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Stan Development Team, 2022, STAN US GUID VERS 2; Turk-Browne NB, 2013, SCIENCE, V342, P580, DOI 10.1126/science.1238409; Turner BM, 2013, NEUROIMAGE, V72, P193, DOI 10.1016/j.neuroimage.2013.01.048; Wainwright MJ, 2008, FOUND TRENDS MACH LE, V1, P1, DOI 10.1561/2200000001; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	24	25	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94914	10.1371/journal.pone.0094914	http://dx.doi.org/10.1371/journal.pone.0094914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804795	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900014
J	Smutek, M; Turbasa, M; Sikora, M; Piechota, M; Zajdel, J; Przewlocki, R; Parkitna, JR				Smutek, Magdalena; Turbasa, Mateusz; Sikora, Magdalena; Piechota, Marcin; Zajdel, Joanna; Przewlocki, Ryszard; Parkitna, Jan Rodriguez			A Model of Alcohol Drinking under an Intermittent Access Schedule Using Group-Housed Mice	PLOS ONE			English	Article							INBRED MOUSE STRAINS; ETHANOL-CONSUMPTION; 20-PERCENT ETHANOL; SOCIAL MODULATION; C57BL/6J MICE; PRAIRIE VOLES; RATS; ESCALATION; PREFERENCE; METABOLISM	Here, we describe a new model of voluntary alcohol drinking by group-housed mice. The model employs sensor-equipped cages that track the behaviors of the individual animals via implanted radio chips. After the animals were allowed intermittent access to alcohol (three 24 h intervals every week) for 4 weeks, the proportions of licks directed toward bottles containing alcohol were 50.9% and 39.6% for the male and female mice, respectively. We used three approaches (i.e., quinine adulteration, a progressive ratio schedule and a schedule involving a risk of punishment) to test for symptoms of compulsive alcohol drinking. The addition of 0.01% quinine to the alcohol solution did not significantly affect intake, but 0.03% quinine induced a greater than 5-fold reduction in the number of licks on the alcohol bottles. When the animals were required to perform increasing numbers of instrumental responses to obtain access to the bottle with alcohol (i.e., a progressive ratio schedule), they frequently reached a maximum of 21 responses irrespective of the available reward. Although the mice rarely achieved higher response criteria, the number of attempts was,10 times greater in case of alcohol than water. We have developed an approach for mapping social interactions among animals that is based on analysis of the sequences of entries into the cage corners. This approach allowed us to identify the mice that followed other animals in non-random fashions. Approximately half of the mice displayed at least one interaction of this type. We have not yet found a clear correlation between imitative behavior and relative alcohol preference. In conclusion, the model we describe avoids the limitations associated with testing isolated animals and reliably leads to stable alcohol drinking. Therefore, this model may be well suited to screening for the effects of genetic mutations or pharmacological treatments on alcohol-induced behaviors.	[Smutek, Magdalena; Turbasa, Mateusz; Sikora, Magdalena; Piechota, Marcin; Zajdel, Joanna; Przewlocki, Ryszard; Parkitna, Jan Rodriguez] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Przewlocki, Ryszard] Jagiellonian Univ, Inst Appl Psychol, Dept Neurosci & Neuropsychol, Krakow, Poland	Polish Academy of Sciences; Jagiellonian University	Parkitna, JR (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland.	Jan.Rodriguez@if-pan.krakow.pl	Piechota, Marcin/G-9464-2011; Rodriguez, Jan/I-2910-2012	Rodriguez, Jan/0000-0003-0367-2331; Piechota, Marcin/0000-0003-2468-151X	Polish National Science Centre [2011/03/B/NZ4/02211]	Polish National Science Centre	This work was supported by the grant 2011/03/B/NZ4/02211 from the Polish National Science Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSHULER HL, 1979, DRUG ALCOHOL DEPEN, V4, P333, DOI 10.1016/0376-8716(79)90017-6; Anacker AMJ, 2011, ALCOHOL CLIN EXP RES, V35, P1884, DOI 10.1111/j.1530-0277.2011.01533.x; Anacker AMJ, 2011, ADDICT BIOL, V16, P92, DOI 10.1111/j.1369-1600.2010.00234.x; Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; Crabbe JC, 2012, ALCOHOL ALCOHOLISM, V47, P509, DOI 10.1093/alcalc/ags067; Crabbe JC, 2011, ANN NY ACAD SCI, V1216, P24, DOI 10.1111/j.1749-6632.2010.05895.x; Crabbe JC, 2010, BEHAV GENET, V40, P737, DOI 10.1007/s10519-010-9371-z; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Deehan GA, 2007, ALCOHOL CLIN EXP RES, V31, P1692, DOI 10.1111/j.1530-0277.2007.00466.x; Galsworthy MJ, 2005, BEHAV GENET, V35, P675, DOI 10.1007/s10519-005-3423-9; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Heilig M, 2011, NAT REV NEUROSCI, V12, P670, DOI 10.1038/nrn3110; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Hostetler CM, 2012, PSYCHOPHARMACOLOGY, V224, P121, DOI 10.1007/s00213-012-2836-4; HUBBELL CL, 1991, ALCOHOL, V8, P355, DOI 10.1016/0741-8329(91)90573-F; HUTCHINS DA, 1974, BRIT J PHARMACOL, V51, pP115; Hwa LS, 2011, ALCOHOL CLIN EXP RES, V35, P1938, DOI 10.1111/j.1530-0277.2011.01545.x; KEMPF E, 1984, PROG NEURO-PSYCHOPH, V8, P365, DOI 10.1016/0278-5846(84)90111-8; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Loi B, 2010, ALCOHOL CLIN EXP RES, V34, P2147, DOI 10.1111/j.1530-0277.2010.01311.x; McCulley WD, 2013, ALCOHOL, V47, P187, DOI 10.1016/j.alcohol.2013.01.001; Melendez RI, 2011, ALCOHOL CLIN EXP RES, V35, P652, DOI 10.1111/j.1530-0277.2010.01383.x; MILLER BL, 1979, NEUROPSYCHOBIOLOGY, V5, P11, DOI 10.1159/000117658; Murphy JM, 2002, BEHAV GENET, V32, P363, DOI 10.1023/A:1020266306135; Nowak A, 2013, BEHAV BRAIN RES, V238, P200, DOI 10.1016/j.bbr.2012.10.031; Ouchi H, 2013, BEHAV BRAIN RES, V238, P146, DOI 10.1016/j.bbr.2012.10.029; Panksepp JB, 2011, NEUROSCI BIOBEHAV R, V35, P1864, DOI 10.1016/j.neubiorev.2011.05.013; Parkitna JR, 2013, BIOL PSYCHIAT, V73, P263, DOI 10.1016/j.biopsych.2012.07.019; R Core Team, 2013, LANG ENV STAT COMP; Radwanska K, 2012, ADDICT BIOL, V17, P601, DOI 10.1111/j.1369-1600.2011.00394.x; Rilke O, 1998, PHARMACOL BIOCHEM BE, V59, P891, DOI 10.1016/S0091-3057(97)00509-1; RODGERS DA, 1966, PSYCHOSOM MED, V28, P498, DOI 10.1097/00006842-196607000-00028; Rosenwasser AM, 2013, ADDICT BIOL, V18, P496, DOI 10.1111/j.1369-1600.2012.00481.x; ROSS D, 1976, P W PHARMACOL SOC, V19, P326; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sommer W, 2006, ADDICT BIOL, V11, P289, DOI 10.1111/j.1369-1600.2006.00037.x; Stairs DJ, 2009, PHARMACOL BIOCHEM BE, V92, P377, DOI 10.1016/j.pbb.2009.01.016; Stephens DN, 2010, ADDICT BIOL, V15, P145, DOI 10.1111/j.1369-1600.2009.00193.x; VALZELLI L, 1973, PSYCHOPHARMACOLOGIA, V31, P305, DOI 10.1007/BF00421275; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; WISE RA, 1973, PSYCHOPHARMACOLOGIA, V29, P203, DOI 10.1007/BF00414034; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006	45	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96787	10.1371/journal.pone.0096787	http://dx.doi.org/10.1371/journal.pone.0096787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804807	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900095
J	Tamaki, FK; Textor, LC; Polikarpov, I; Marana, SR				Tamaki, Fabio K.; Textor, Larissa C.; Polikarpov, Igor; Marana, Sandro R.			Sets of Covariant Residues Modulate the Activity and Thermal Stability of GH1 beta-Glucosidases	PLOS ONE			English	Article							SUBSTRATE AGLYCONE SPECIFICITY; CRYSTAL-STRUCTURES; INSIGHTS; PROTEINS; GLYCOSIDASE; MECHANISM; CATALYSIS; BINDING	The statistical coupling analysis of 768 beta-glucosidases from the GH1 family revealed 23 positions in which the amino acid frequencies are coupled. The roles of these covariant positions in terms of the properties of b-glucosidases were investigated by alanine-screening mutagenesis using the fall armyworm Spodoptera frugiperda beta-glycosidase (Sf beta gly) as a model. The effects of the mutations on the Sf beta gly kinetic parameters (k(cat)/K-m) for the hydrolysis of three different p-nitrophenyl beta-glycosides and structural comparisons of several b-glucosidases showed that eleven covariant positions (54, 98, 143, 188, 195, 196, 203, 398, 451, 452 and 460 in Sfbgly numbering) form a layer surrounding the active site of the beta-glucosidases, which modulates their catalytic activity and substrate specificity via direct contact with the active site residues. Moreover, the influence of the mutations on the transition temperature (T-m) of Sfbgly indicated that nine of the coupled positions (49, 62, 143, 188, 223, 278, 309, 452 and 460 in Sfbgly numbering) are related to thermal stability. In addition to being preferentially occupied by prolines, structural comparisons indicated that these positions are concentrated at loop segments of the b-glucosidases. Therefore, due to these common biochemical and structural properties, these nine covariant positions, even without physical contacts among them, seem to jointly modulate the thermal stability of beta-glucosidases.	[Tamaki, Fabio K.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Textor, Larissa C.; Polikarpov, Igor] IFSC USP, Inst Fis, Sao Carlos, SP, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	srmarana@iq.usp.br	Tamaki, Fabio K./L-6024-2013; Marana, Sandro/D-3867-2012; Polikarpov, Igor/D-2575-2012	Tamaki, Fabio K./0000-0003-2515-8202; Marana, Sandro/0000-0002-5117-1921; Polikarpov, Igor/0000-0001-9496-4174	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [08/55914- 9]; CNPq (Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico) [08/57908-1]; Instituto Nacional de Ciencias e Tecnologia para o Bioetanol [574002/2008-1]	Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencias e Tecnologia para o Bioetanol	This project was supported by Fapesp (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Grant 08/55914- 9), CNPq (Conselho Nacional de Desenvolvimento Cienti fico e Tecnologico) and Instituto Nacional de Ciencias e Tecnologia para o Bioetanol (Grants: 08/57908-1 and 574002/2008-1). F.K.T. and L.C.T. are post-docs supported by Fapesp. I.P. and S.R.M. are CNPq research fellows. I.P. is a staff member of the Departamento de Fisica e Informatica - IFSC USP. S. R. M. is a staff member of the Departamento de Bioquimica IQUSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badieyan S, 2012, BIOCHEMISTRY-US, V51, P8907, DOI 10.1021/bi300675x; Berrin JG, 2003, BIOCHEM J, V373, P41, DOI 10.1042/BJ20021876; Burmeister WP, 1997, STRUCTURE, V5, P663, DOI 10.1016/S0969-2126(97)00221-9; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Coutinho P. M., 1999, RECENT ADV CARBOHYDR; Creighton T.E., 1992, PROTEINS STRUCTURES; Czjzek M, 2000, P NATL ACAD SCI USA, V97, P13555, DOI 10.1073/pnas.97.25.13555; FERSHT AR, 1986, TRENDS BIOCHEM SCI, V11, P321, DOI 10.1016/0968-0004(86)90289-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marana SR, 2006, IUBMB LIFE, V58, P63, DOI 10.1080/15216540600617156; Marana SR, 2004, EUR J BIOCHEM, V271, P4169, DOI 10.1111/j.1432-1033.2004.04354.x; Marana SR, 2003, EUR J BIOCHEM, V270, P4866, DOI 10.1046/j.1432-1033.2003.03887.x; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mendonca LMF, 2008, BIOCHIM BIOPHYS ACTA, V1814, P1616; Mendonca LMF, 2011, BBA-PROTEINS PROTEOM, V1814, P1616, DOI 10.1016/j.bbapap.2011.08.012; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Verdoucq L, 2004, J BIOL CHEM, V279, P31796, DOI 10.1074/jbc.M402918200; Watanabe L, 2010, J STRUCT BIOL, V169, P226, DOI 10.1016/j.jsb.2009.10.009; Wiesmann C, 1997, J MOL BIOL, V269, P851, DOI 10.1006/jmbi.1997.1084; Yu WL, 2013, J BIOL CHEM, V288, P14949, DOI 10.1074/jbc.M113.454751	35	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96627	10.1371/journal.pone.0096627	http://dx.doi.org/10.1371/journal.pone.0096627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804841	gold, Green Submitted, Green Published			2022-12-27	WOS:000335728900074
J	Tuchina, O; Groh, KC; Talarico, G; Muller, CHG; Wielsch, N; Hupfer, Y; Svatos, A; Grosse-Wilde, E; Hansson, BS				Tuchina, Oksana; Groh, Katrin C.; Talarico, Giovanni; Mueller, Carsten H. G.; Wielsch, Natalie; Hupfer, Yvonne; Svatos, Ales; Grosse-Wilde, Ewald; Hansson, Bill S.			Morphology and Histochemistry of the Aesthetasc-Associated Epidermal Glands in Terrestrial Hermit Crabs of the Genus Coenobita (Decapoda: Paguroidea)	PLOS ONE			English	Article							ANTENNULAR GROOMING BEHAVIOR; PLEOPOD TEGUMENTAL GLANDS; CARIBBEAN SPINY LOBSTER; OLFACTORY ORGAN; MASS-SPECTROMETRY; SERINE-PROTEASE; LARVAL RELEASE; FINE-STRUCTURE; CRUSTACEA; LAND	Crustaceans have successfully adapted to a variety of environments including fresh-and saltwater as well as land. Transition from an aquatic to a terrestrial lifestyle required adaptations of the sensory equipment of an animal, particularly in olfaction, where the stimulus itself changes from hydrophilic to mainly hydrophobic, air-borne molecules. Hermit crabs Coenobita spp. (Anomura, Coenobitidae) have adapted to a fully terrestrial lifestyle as adults and have been shown to rely on olfaction in order to detect distant food items. We observed that the specialized olfactory sensilla in Coenobita, named aesthetascs, are immersed in a layer of mucous-like substance. We hypothesized that the mucous is produced by antennal glands and affects functioning of the aesthetascs. Using various microscopic and histochemical techniques we proved that the mucous is produced by aesthetasc-associated epidermal glands, which we consider to be modified rosette-type aesthetasc tegumental glands known from aquatic decapods. These epidermal glands in Coenobita are multicellular exocrine organs of the recto-canal type with tubulo-acinar arrangement of the secretory cells. Two distinct populations of secretory cells were clearly distinguishable with light and electron microscopy. At least part of the secretory cells contains specific enzymes, CUB-serine proteases, which are likely to be secreted on the surface of the aesthetasc pad and take part in antimicrobial defense. Proteomic analysis of the glandular tissue corroborates the idea that the secretions of the aesthetasc-associated epidermal glands are involved in immune responses. We propose that the mucous covering the aesthetascs in Coenobita takes part in antimicrobial defense and at the same time provides the moisture essential for odor perception in terrestrial hermit crabs. We conclude that the morphological modifications of the aesthetasc-associated epidermal glands as well as the functional characteristics of their secretions are important adaptations to a terrestrial lifestyle.	[Tuchina, Oksana; Groh, Katrin C.; Grosse-Wilde, Ewald; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany; [Talarico, Giovanni] Ernst Moritz Arndt Univ Greifswald, Inst Legal Med, Dept Forens Toxicol, Greifswald, Germany; [Mueller, Carsten H. G.] Ernst Moritz Arndt Univ Greifswald, Dept Cytol & Evolutionary Biol, Museum & Inst Zool, Greifswald, Germany; [Mueller, Carsten H. G.] Univ Arizona, Dept Neurosci, Tucson, AZ USA; [Wielsch, Natalie; Hupfer, Yvonne; Svatos, Ales] Max Planck Inst Chem Ecol, Res Grp Mass Spectrometry & Prote, Jena, Germany	Max Planck Society; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Arizona; Max Planck Society	Tuchina, O (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	otuchina@ice.mpg.de	Hansson, Bill S/G-2774-2013; Große-Wilde, Ewald/G-5584-2013; Tuchina, Oksana/M-6627-2016; Svatos, Ales/A-3305-2014	Hansson, Bill S/0000-0002-4811-1223; Große-Wilde, Ewald/0000-0002-3760-9835; Tuchina, Oksana/0000-0003-1480-1311; Svatos, Ales/0000-0003-1032-7288	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; ARNAUD J, 1988, J MORPHOL, V197, P21, DOI 10.1002/jmor.1051970103; ARSENAULT AL, 1979, J SUBMICR CYTOL PATH, V11, P193; Barbato JC, 1997, BIOL BULL, V193, P107, DOI 10.2307/1542756; BARKER PL, 1977, J EXP MAR BIOL ECOL, V26, P297, DOI 10.1016/0022-0981(77)90089-2; BARRETT AJ, 1994, METHOD ENZYMOL, V244, P1; BLISS DE, 1968, AM ZOOL, V8, P673; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BRUNET M, 1991, TISSUE CELL, V23, P733, DOI 10.1016/0040-8166(91)90026-P; DOUGHTIE DG, 1982, J MORPHOL, V171, P41, DOI 10.1002/jmor.1051710104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELOFSSON R, 1978, J ULTRA MOL STRUCT R, V64, P14, DOI 10.1016/S0022-5320(78)90003-5; Festoff BW, 1990, PROS NATO ASI SERI A, V191; GHIRADELLA H, 1970, PROTOPLASMA, V69, P145, DOI 10.1007/BF01276656; GHIRADELLA H, 1968, J MORPHOL, V124, P361, DOI 10.1002/jmor.1051240309; GHIRADELLA HT, 1968, AM ZOOL, V8, P603; Glaessner MF, 1969, TREATISE INVERTEBR R, P400; GNATZY W, 1984, CELL TISSUE RES, V236, P729; GORVETT H, 1946, Q J MICROSC SCI, V87, P209; GORVETT H., 1956, PROC ZOOL SOC LONDON, V126, P291; GORVETT H, 1951, Q J MICROSC SCI, V92, P275; GREENAWAY P, 1988, J EXP BIOL, V140, P493; Groh K, FRONT EVOL IN PRESS; GRUNERT U, 1988, CELL TISSUE RES, V251, P95, DOI 10.1007/BF00215452; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; Harzsch S, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-58; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollins B, 2003, J COMP NEUROL, V455, P125, DOI 10.1002/cne.10489; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; Johns ME, 2004, J NEUROBIOL, V61, P377, DOI 10.1002/neu.20056; JOHNSON B, 1987, J CRUSTACEAN BIOL, V7, P288, DOI 10.2307/1548609; JUBERTHIEJUPEAU L, 1978, INT J SPELEOL, V9, P309, DOI 10.5038/1827-806X.9.3.8; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Koczan S., 2012, THESIS FRIEDRICH SCH; Krang AS, 2012, P ROY SOC B-BIOL SCI, V279, P3510, DOI 10.1098/rspb.2012.0596; Levine MZ, 2001, J NEUROBIOL, V49, P277, DOI 10.1002/neu.10010; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; Mûàller CHG., 2011, TREATISE ZOOLOGY ANA, V1, P235; Mueller Carsten H. G., 2009, Soil Organisms, V81, P269; Muller CHG, 2013, ANTHROPOD S IN PRESS; Quennedey A, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P177; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; RIEDER N, 1977, ZOOMORPHOLOGIE, V88, P133, DOI 10.1007/BF01880650; RITTSCHOF D, 1993, AM ZOOL, V33, P487; RITTSCHOF D, 1980, J CHEM ECOL, V6, P103, DOI 10.1007/BF00987531; RITTSCHOF D, 1990, J CHEM ECOL, V16, P1359, DOI 10.1007/BF01021032; RITTSCHOF D, 1985, CHEM SENSES, V10, P567, DOI 10.1093/chemse/10.4.567; RITTSCHOF D, 1986, J CHEM ECOL, V12, P1273, DOI 10.1007/BF01012347; RITTSCHOF D, 1985, AM ZOOL, V25, pA113; RITTSCHOF D, 1980, J CHEM ECOL, V6, P665, DOI 10.1007/BF00987677; RITTSCHOF D, 1990, J CHEM ECOL, V16, P261, DOI 10.1007/BF01021283; Schmidt M, 2005, J EXP BIOL, V208, P233, DOI 10.1242/jeb.01357; Schmidt M, 2006, CELL TISSUE RES, V325, P369, DOI 10.1007/s00441-006-0163-y; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SMALL MP, 1994, J EXP MAR BIOL ECOL, V182, P169, DOI 10.1016/0022-0981(94)90049-3; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Steinbrecht RA, 1999, J INSECT PHYSIOL, V45, P785, DOI 10.1016/S0022-1910(99)00066-9; Stensmyr MC, 2005, CURR BIOL, V15, P116, DOI 10.1016/j.cub.2004.12.069; Stepanyan R, 2005, CELL TISSUE RES, V322, P321, DOI 10.1007/s00441-005-0022-2; STEVENSON J, 1961, BIOL BULL, V121, P554, DOI 10.2307/1539454; TALBOT P, 1993, CRUSTACEAN INTEGUMENT, P151; TALBOT P, 1991, ZOOMORPHOLOGY, V110, P329, DOI 10.1007/BF01668023; TOMASCHKO KH, 1995, EUR J ENTOMOL, V92, P105; Weirich D, 1997, J MORPHOL, V233, P183, DOI 10.1002/(SICI)1097-4687(199708)233:2<183::AID-JMOR7>3.0.CO;2-7; Yonge CM, 1932, P R SOC LOND B-CONTA, V111, P298, DOI 10.1098/rspb.1932.0057	68	18	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96430	10.1371/journal.pone.0096430	http://dx.doi.org/10.1371/journal.pone.0096430			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805352	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900059
J	Usami, M; Iwadare, Y; Kodaira, M; Watanabe, K; Ushijima, H; Tanaka, T; Harada, M; Tanaka, H; Sasaki, Y; Saito, K				Usami, Masahide; Iwadare, Yoshitaka; Kodaira, Masaki; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya; Harada, Maiko; Tanaka, Hiromi; Sasaki, Yoshinori; Saito, Kazuhiko			Did Parents and Teachers Struggle with Child Survivors 20 Months after the 2011 Earthquake and Tsunami in Japan? A Retrospective Observational Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NORWEGIAN CHILDREN; DISASTER	Background: On March 11, 2011, Japan was struck by the earthquake and tsunami. Twenty months after the disaster, we collected information on the difficulties faced by parents and teachers in dealing with the post-traumatic symptoms of child survivors. The aim of this study was to evaluate the relationship between post-traumatic symptoms in children and parents' and teachers' difficulties in dealing with children who survived the huge disaster. Methods: The subjects included 12,524 children from elementary, middle, and junior high schools in Ishinomaki City. The Post Traumatic Stress Symptoms for Children 15 items (PTSSC-15), a self-rating questionnaire on post-traumatic symptoms, was distributed among the children, and Strength and Difficulties Questionnaire (SDQ), a self-rating questionnaire on difficulties in dealing with children, was given to their parents and teachers. With PTSSC-15, a valid response was obtained from 10,909 (89.5%) participants. With SDQ for teachers and parents, valid responses were obtained from 10,577 (86.7%) and 7052 (83.9%) participants, respectively. Results: PTSSC-15 scores were significantly higher (P < 0.001) in girls than in boys from the junior high school. These effect sizes were less than 0.30. Correlations of teachers' SDQ scores and PTSSC-15 scores were significantly low (r < 0.21, P < 0.001) for both genders and all children. Likewise, correlations between SDQ scores assigned by parents (excluding "prosocial behavior'') and PTSSC-15 scores were significantly low (r < 0.21, P < 0.001) for both genders and at all school levels. Conclusion: This study elucidated that the difficulties faced by parents and teachers while dealing with child survivors significantly low correlate with the child's post-traumatic symptoms caused by the 2011 earthquake and tsunami. Thus, it is important that clinicians should not only evaluate post-traumatic symptoms with a self-rating questionnaire but also try to objectively evaluate whether there were day-to-day difficulties caused by the post-traumatic symptoms.	[Usami, Masahide; Iwadare, Yoshitaka; Watanabe, Kyota; Ushijima, Hirokage; Tanaka, Tetsuya] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan; [Kodaira, Masaki; Saito, Kazuhiko] Aiiku Hosp, Imperial Gift Fdn, Dept Child Mental Hlth, Minato Ku, Tokyo, Japan; [Harada, Maiko] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Yamaguchi, Japan; [Tanaka, Hiromi] Tokyo Womens Med Univ, Inst Womens Hlth, Tokyo, Japan; [Sasaki, Yoshinori] Tokyo Metropolitan Tama Med Ctr, Dept Psychiat, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Yamaguchi University; Tokyo Women's Medical University	Usami, M (corresponding author), Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Child & Adolescent Psychiat, Ichikawa, Japan.	usami.masahide@hospk.ncgm.go.jp	Usami, Masahide/G-1404-2015	Usami, Masahide/0000-0002-1145-9971	National Center for Global Health and Medicine 347 [24-108]	National Center for Global Health and Medicine 347	This work was supported by the grant of National Center for Global Health and Medicine 347 (24-108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SM, 2007, J CHILD ADOL PS NURS, V20, P148, DOI 10.1111/j.1744-6171.2007.00105.x; Carballo M, 2005, J ROY SOC MED, V98, P396, DOI 10.1258/jrsm.98.9.396; Chemtob CM, 2008, ARCH PEDIAT ADOL MED, V162, P126, DOI 10.1001/archpediatrics.2007.36; Du YB, 2012, DISASTERS, V36, P495, DOI 10.1111/j.1467-7717.2011.01271.x; Dyb Grete, 2011, Clin Child Psychol Psychiatry, V16, P621, DOI 10.1177/1359104510391048; Hafstad GS, 2011, PSYCHOL TRAUMA-US, V3, P130, DOI 10.1037/a0023236; Jensen TK, 2009, ARCH PEDIAT ADOL MED, V163, P856, DOI 10.1001/archpediatrics.2009.151; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Kato H, 1996, ACTA PSYCHIAT SCAND, V93, P477, DOI 10.1111/j.1600-0447.1996.tb10680.x; Kim BN, 2009, J CLIN PSYCHIAT, V70, P1148, DOI 10.4088/JCP.08m04896; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Matsuishi T, 2008, BRAIN DEV-JPN, V30, P410, DOI 10.1016/j.braindev.2007.12.003; Mullett-Hume E, 2008, AM J ORTHOPSYCHIAT, V78, P103, DOI 10.1037/0002-9432.78.1.103; Piyasil V, 2008, ASEAN J PSYCHIATR, V9, P99; Piyasil Vinadda, 2007, Journal of the Medical Association of Thailand, V90, P2370; Tominaga Y, 2002, HATTATSU SHINRI RINS, V8, p29.36; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; Ularntinon Sirirat, 2008, J Med Assoc Thai, V91 Suppl 3, pS69; Usami M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065398; Usami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050721; WEISAETH L, 1989, ACTA PSYCHIAT SCAND, V80, P63, DOI 10.1111/j.1600-0447.1989.tb05255.x; Weisz J.R., 2001, EUROPEAN CHILD ADOLE, V10, P12, DOI DOI 10.1007/S007870170003; WHO, 2005, TSUN WREAKS MENT HLT; WHO, MENT HLTH ASS POP AF; Wiguna T, 2010, ASIA-PAC PSYCHIAT, V2, P151, DOI 10.1111/j.1758-5872.2010.00079.x	25	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96459	10.1371/journal.pone.0096459	http://dx.doi.org/10.1371/journal.pone.0096459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG9HB	24805783	gold, Green Published			2022-12-27	WOS:000335728900060
J	Vorsino, AE; Fortini, LB; Amidon, FA; Miller, SE; Jacobi, JD; Price, JP; Gon, SO; Koob, GA				Vorsino, Adam E.; Fortini, Lucas B.; Amidon, Fred A.; Miller, Stephen E.; Jacobi, James D.; Price, Jonathan P.; Gon, Sam 'Ohukani'ohi'a, III; Koob, Gregory A.			Modeling Hawaiian Ecosystem Degradation due to Invasive Plants under Current and Future Climates	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; BIOLOGICAL INVASIONS; FORESTS; NICHE; HOTSPOTS; DISTRIBUTIONS; EQUILIBRIUM; INFORMATION; POPULATIONS; PREDICTION	Occupation of native ecosystems by invasive plant species alters their structure and/or function. In Hawaii, a subset of introduced plants is regarded as extremely harmful due to competitive ability, ecosystem modification, and biogeochemical habitat degradation. By controlling this subset of highly invasive ecosystem modifiers, conservation managers could significantly reduce native ecosystem degradation. To assess the invasibility of vulnerable native ecosystems, we selected a proxy subset of these invasive plants and developed robust ensemble species distribution models to define their respective potential distributions. The combinations of all species models using both binary and continuous habitat suitability projections resulted in estimates of species richness and diversity that were subsequently used to define an invasibility metric. The invasibility metric was defined from species distribution models with <0.7 niche overlap (Warrens I) and relatively discriminative distributions (Area Under the Curve.0.8; True Skill Statistic >0.75) as evaluated per species. Invasibility was further projected onto a 2100 Hawaii regional climate change scenario to assess the change in potential habitat degradation. The distribution defined by the invasibility metric delineates areas of known and potential invasibility under current climate conditions and, when projected into the future, estimates potential reductions in native ecosystem extent due to climate-driven invasive incursion. We have provided the code used to develop these metrics to facilitate their wider use (Code S1). This work will help determine the vulnerability of native-dominated ecosystems to the combined threats of climate change and invasive species, and thus help prioritize ecosystem and species management actions.	[Vorsino, Adam E.; Amidon, Fred A.; Miller, Stephen E.] US Fish & Wildlife Serv, Strateg Habitat Conservat Div, Pacific Isl Off, Honolulu, HI 96819 USA; [Fortini, Lucas B.; Jacobi, James D.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Honolulu, HI USA; [Fortini, Lucas B.] Pacific Isl Climate Change Cooperat, Honolulu, HI USA; [Price, Jonathan P.] Univ Hawaii, Dept Geog, Hilo, HI 96720 USA; [Gon, Sam 'Ohukani'ohi'a, III] Nat Conservancy Hawaii, Honolulu, HI USA; [Koob, Gregory A.] Nat Resources Conservat Serv, USDA, Honolulu, HI USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; University of Hawaii System; University Hawaii Hilo; Nature Conservancy; United States Department of Agriculture (USDA)	Vorsino, AE (corresponding author), US Fish & Wildlife Serv, Strateg Habitat Conservat Div, Pacific Isl Off, Honolulu, HI 96819 USA.	Adam_Vorsino@fws.gov		Fortini, Lucas/0000-0002-5781-7295	United States Fish and Wildlife Service	United States Fish and Wildlife Service(US Fish & Wildlife Service)	This work was funded by the United States Fish and Wildlife Service. Employees of the Fish and Wildlife Service analyzed the data, prepared the manuscript, and decided to publish in this journal.	Ahumada Jorge A., 2009, P331; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Asner GP, 2005, P NATL ACAD SCI USA, V102, P4383, DOI 10.1073/pnas.0500823102; Asner GP, 2008, P NATL ACAD SCI USA, V105, P4519, DOI 10.1073/pnas.0710811105; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Bisrat SA, 2012, DIVERS DISTRIB, V18, P648, DOI 10.1111/j.1472-4642.2011.00867.x; Boelman NT, 2007, ECOL APPL, V17, P2137, DOI 10.1890/07-0004.1; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Burton Michele L., 2005, Urban Ecosystems, V8, P93, DOI 10.1007/s11252-005-1421-6; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Catford JA, 2011, DIVERS DISTRIB, V17, P1099, DOI 10.1111/j.1472-4642.2011.00794.x; Colwell R.K., 2009, PRINCET GUIDE ECOL P, V663, P257, DOI DOI 10.1515/9781400833023.257; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Daehler CC, 2005, PERSPECT PLANT ECOL, V7, P203, DOI 10.1016/j.ppees.2005.08.002; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; DAEHLER CC, 2000, BIOL INVASIONS, V2, P93, DOI DOI 10.1023/A:1010002005024; Daly C, 2010, INT J CLIMATOL, V30, P1857, DOI 10.1002/joc.2007; Dukes JS, 2011, ECOL APPL, V21, P1887, DOI 10.1890/11-0111.1; Dukes JS, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P345; Duursma DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084222; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2005, ECOL MODEL, V186, P280, DOI 10.1016/j.ecolmodel.2004.12.007; ELITH J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI [DOI 10.1146/ANNUREV.EC0LSYS.110308.120159, 10.1146/annurev.ecolsys.110308.120159, DOI 10.1146/ANNUREV.ECOLSYS.110308.120159]; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Fortini LB, 2013, TECHNICAL REPORT; Franklin J, 2009, MAPPING SPECIES DIST; Fridley J.D., 2011, ENCY BIOL INVASIONS, P356; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Funk JL, 2005, BIOGEOCHEMISTRY, V76, P441, DOI 10.1007/s10533-005-7657-7; Gallagher RV, 2010, BIOL INVASIONS, V12, P4049, DOI 10.1007/s10530-010-9814-8; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; Guisan A, 2000, PHYTOCOENOLOGIA, V30, P353; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hastie T., 2009, UNSUPERVISED LEARNIN; Hengl T, 2012, PACKAGE PLOTKML; Hijmans R, 2010, DISMO SPECIES DISTRI; Hijmans RJ, 2010, RASTER GEOGRAPHIC AN, pr948; Huang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024733; Hughes RF, 2005, ECOL APPL, V15, P1615, DOI 10.1890/04-0874; Ibanez I, P NIAES INT S TSUK J, P8; Ibanez I, 2008, ECOL APPL, V18, P1664, DOI 10.1890/07-1594.1; Ibanez I, 2009, J APPL ECOL, V46, P1219, DOI 10.1111/j.1365-2664.2009.01736.x; Jones KH, 1998, COMPUT GEOSCI, V24, P315, DOI 10.1016/S0098-3004(98)00032-6; Kou XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023115; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Levine JM, 2000, SCIENCE, V288, P852, DOI 10.1126/science.288.5467.852; Liu C, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P4241; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Loope LL, 1998, CLIMATIC CHANGE, V39, P503, DOI 10.1023/A:1005372118420; Lozier JD, 2011, BIOL INVASIONS, V13, P2409, DOI 10.1007/s10530-011-0052-5; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mascaro J, 2012, ECOL MONOGR, V82, P221, DOI 10.1890/11-1014.1; Mateo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032586; Maune DF, 2010, DIGITAL ELEVATION MO; Mccarthy KP, 2012, CONSERV BIOL, V26, P68, DOI 10.1111/j.1523-1739.2011.01754.x; Mealor BA, 2007, OIKOS, V116, P1493, DOI 10.1111/j.0030-1299.2007.15781.x; O'Donnell J, 2012, GLOBAL CHANGE BIOL, V18, P617, DOI 10.1111/j.1365-2486.2011.02537.x; Ortega-Huerta MA, 2008, REV MEX BIODIVERS, V79, P205; Owen D., 2012, FLA LAW REV, V64, P141; Palmer DD, 2008, HAWAIIS FERNS FERN A; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pau S, 2009, BIODIVERS CONSERV, V18, P3167, DOI 10.1007/s10531-009-9635-1; Penuelas J, 2010, GLOBAL CHANGE BIOL, V16, P2171, DOI 10.1111/j.1365-2486.2009.02054.x; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Piedallu C, 2008, AGR FOREST METEOROL, V148, P1696, DOI 10.1016/j.agrformet.2008.06.001; PIELOU E C, 1969, P286; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Price J.P., 2012, 20121192 US GEOL SUR; R Core Team, 2021, R LANGUAGE ENV STAT; Rejmanek M., 1989, BIOL INVASIONS GLOBA, P369; Ricciardi A, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P225; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; Simberloff D, 2013, INVASIVE SPECIES WHA; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Sullivan MJP, 2012, METHODS ECOL EVOL, V3, P870, DOI 10.1111/j.2041-210X.2012.00219.x; Thuiller W., 2014, PACKAGE BIOMOD2 ENSE; Trotta-Moreu N, 2010, ENVIRON ENTOMOL, V39, P42, DOI 10.1603/EN08179; Tweiten MA, 2014, J VEG SCI, V25, P734, DOI 10.1111/jvs.12112; U.S. Fish and Wildlife Service, 2001, FED REGISTER, V66, P63752; U. S. Fish and Wildlife Service, 2012, FED REGISTER, V181, P57647; U.S. Fish and Wildlife Service, 2003, FED REGISTER, V68, P9116; U.S. Fish and Wildlife Service, 2004, FED REGISTER, V69, P18499; U.S. Fish and Wildlife Service, 2003, FED REGISTER, V68, P17430; U. S. Fish and Wildlife Service, 1977, FED REGISTER, V184, P47840; U.S. Fish and Wildlife Service, 2003, FED REGISTER, V68, P28054; U.S. Fish and Wildlife Service, 1984, FED REGISTER, V49, P47397; U.S. Fish and Wildlife Service, 2002, FED REGISTER, V67, P54026; U.S. Fish and Wildlife Service, 2003, FED REGISTER, V68, P34710; U.S. Fish and Wildlife Service, 2008, FED REGISTER, V73, P73794; U. S. Fish and Wildlife Service, 2012, FED REGISTER, V201, P63927; U. S. Fish and Wildlife Service, 1977, FED REGISTER, V155, P40685; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V70, P18960; U.S. Fish and Wildlife Service, 1983, FED REGISTER, V48, P46328; U. S. Fish and Wildlife Service, 2012, FED REGISTER, V112, P34464; Vaclavik T, 2012, DIVERS DISTRIB, V18, P73, DOI 10.1111/j.1472-4642.2011.00854.x; Vitousek PM, 2010, PAC SCI, V64, P359, DOI 10.2984/64.3.359; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wei T, 2013, CORRPLOT VISUALIZATI; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; Yelenik SG, 2013, NATURE, V503, P517, DOI 10.1038/nature12798; Zenni RD, 2013, OIKOS, V122, P801, DOI 10.1111/j.1600-0706.2012.00254.x; Zhang CX, 2012, MON WEATHER REV, V140, P3259, DOI 10.1175/MWR-D-11-00260.1; Ziegler AC, 2002, HAWAIIAN NATURAL HIS; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	125	39	42	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95427	10.1371/journal.pone.0095427	http://dx.doi.org/10.1371/journal.pone.0095427			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805254	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900018
J	Bu, WM; Pereira, LM; Eckenhoff, RG; Yuki, K				Bu, Weiming; Pereira, Luis M.; Eckenhoff, Roderic G.; Yuki, Koichi			Stereoselectivity of Isoflurane in Adhesion Molecule Leukocyte Function-Associated Antigen-1	PLOS ONE			English	Article							ANESTHETIC ISOFLURANE; LFA-1-DEFICIENT MICE; GABA(A) RECEPTOR; OPTICAL ISOMERS; BINDING PROTEIN; INTEGRIN LFA-1; I-DOMAIN; T-CELL; CRYSTAL; ALPHA	Background: Isoflurane in clinical use is a racemate of S- and R-isoflurane. Previous studies have demonstrated that the effects of S-isoflurane on relevant anesthetic targets might be modestly stronger (less than 2-fold) than R-isoflurane. The X-ray crystallographic structure of the immunological target, leukocyte function-associated antigen-1 (LFA-1) with racemic isoflurane suggested that only S-isoflurane bound specifically to this protein. If so, the use of specific isoflurane enantiomers may have advantage in the surgical settings where a wide range of inflammatory responses is expected to occur. Here, we have further tested the hypothesis that isoflurane enantioselectivity is apparent in solution binding and functional studies. Methods: First, binding of isoflurane enantiomers to LFA-1 was studied using 1-aminoanthracene (1-AMA) displacement assays. The binding site of each enantiomer on LFA-1 was studied using the docking program GLIDE. Functional studies employed the flow-cytometry based ICAM binding assay. Results: Both enantiomers decreased 1-AMA fluorescence signal (at 520 nm), indicating that both competed with 1-AMA and bound to the alpha L I domain. The docking simulation demonstrated that both enantiomers bound to the LFA-1 "lovastatin site.'' ICAM binding assays showed that S-isoflurane inhibited more potently than R-isoflurane, consistent with the result of 1-AMA competition assay. Conclusions: In contrast with the x-ray crystallography, both enantiomers bound to and inhibited LFA-1. S-isoflurane showed slight preference over R-isoflurane.	[Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Pereira, Luis M.; Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Pereira, Luis M.; Yuki, Koichi] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA.	yuki.koichi@gmail.com		Eckenhoff, Roderic/0000-0002-5581-746X	NIH [P01GM55876, K08GM101345]; CHMC anesthesia foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM101345, P01GM055876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHMC anesthesia foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by NIH P01GM55876, K08GM101345, CHMC anesthesia foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranat I, 2002, NAT REV DRUG DISCOV, V1, P753, DOI 10.1038/nrd915; Badell IR, 2010, J CLIN INVEST, V120, P4520, DOI 10.1172/JCI43895; Boehncke WH, 2007, BIOL-TARGETS THER, V1, P301; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Carbo C, 2013, J ANESTH, V27, P261, DOI 10.1007/s00540-012-1508-1; Dickinson R, 2000, ANESTHESIOLOGY, V93, P837, DOI 10.1097/00000542-200009000-00035; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, 1998, MOL PHARMACOL, V54, P610; Eger EI, 1997, ANESTH ANALG, V85, P188, DOI 10.1097/00000539-199707000-00033; Emoto M, 2003, J IMMUNOL, V171, P584, DOI 10.4049/jimmunol.171.2.584; FRANKS NP, 1991, SCIENCE, V254, P427, DOI 10.1126/science.1925602; Gaillard T, 2007, J MOL BIOL, V374, P231, DOI 10.1016/j.jmb.2007.07.006; GRAF BM, 1994, ANESTHESIOLOGY, V81, P129, DOI 10.1097/00000542-199407000-00019; HALL AC, 1994, BRIT J PHARMACOL, V112, P906, DOI 10.1111/j.1476-5381.1994.tb13166.x; HARRIS B, 1992, EUR J PHARMACOL, V217, P215, DOI 10.1016/0014-2999(92)90875-5; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; HUANG CG, 1993, J ORG CHEM, V58, P7382, DOI 10.1021/jo00078a015; JONES MV, 1993, J NEUROPHYSIOL, V70, P1339, DOI 10.1152/jn.1993.70.4.1339; Lea WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007150; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; LYSKO GS, 1994, EUR J PHARMACOL, V263, P25, DOI 10.1016/0014-2999(94)90519-3; Miyamoto M, 2003, J IMMUNOL, V170, P5228, DOI 10.4049/jimmunol.170.10.5228; MOODY EJ, 1994, ANESTHESIOLOGY, V81, P124, DOI 10.1097/00000542-199407000-00018; MOODY EJ, 1993, BRAIN RES, V615, P101, DOI 10.1016/0006-8993(93)91119-D; Nau C, 2002, ANESTHESIOLOGY, V97, P497; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Paliwal A, 2007, BBA-MOL CELL BIOL L, V1771, P55, DOI 10.1016/j.bbalip.2006.10.002; PFEIFFER CC, 1956, SCIENCE, V124, P29, DOI 10.1126/science.124.3210.29; Poston RS, 2000, TRANSPLANTATION, V69, P2005, DOI 10.1097/00007890-200005270-00006; Prince JE, 2001, J IMMUNOL, V166, P7362, DOI 10.4049/jimmunol.166.12.7362; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; QUINLAN JJ, 1995, ANESTHESIOLOGY, V83, P611, DOI 10.1097/00000542-199509000-00021; Reisman NM, 2011, BLOOD, V118, P5851, DOI 10.1182/blood-2011-04-347252; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimazawa R, 2008, J HEALTH SCI, V54, P23, DOI 10.1248/jhs.54.23; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Svergun DI, 1997, PROTEINS, V27, P110; Takagi J, 2002, BIOCHEMISTRY-US, V41, P4339, DOI 10.1021/bi016047u; Tanner JW, 2001, BIOCHEMISTRY-US, V40, P5075, DOI 10.1021/bi001428d; Turgeon NA, 2010, AM J TRANSPLANT, V10, P2082, DOI 10.1111/j.1600-6143.2010.03212.x; URBANOVA M, 1991, BIOCHEMISTRY-US, V30, P10479, DOI 10.1021/bi00107a016; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Xu Y, 1996, BIOPHYS J, V70, P532, DOI 10.1016/S0006-3495(96)79599-1; Yuki K, 2013, ANESTH ANALG; Yuki K, 2012, FASEB J; Yuki K, 2011, ANESTH ANALG, V112, P830, DOI 10.1213/ANE.0b013e31820dcabb; Yuki K, 2008, FASEB J, V22, P4109, DOI 10.1096/fj.08-113324; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908	50	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96649	10.1371/journal.pone.0096649	http://dx.doi.org/10.1371/journal.pone.0096649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801074	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800102
J	Cheng, YZ; Wang, F; Wen, J; Shi, YK				Cheng, Yongzhong; Wang, Fang; Wen, Jin; Shi, Yingkang			Risk Factors of Post-Traumatic Stress Disorder (PTSD) after Wenchuan Earthquake: A Case Control Study	PLOS ONE			English	Article							ADULT SURVIVORS; FEMALE VETERANS; CHECKLIST; TRAUMA; HEALTH; PREVALENCE; PREDICTORS; SYMPTOMS; CHINA	Background: Few clues were found in the literature about the independent risk factors for PTSD among earthquake survivors in Sichuan province three years after the 2008 earthquake. Ours was the first case-control study with matching factors of age and distance from the epicenter among survivors age 16 years or older, three years after the catastrophe. Objectives: To identify independent risk factors for PTSD among earthquake survivors. Methods: We performed a population-based matched case-control study. The cases were drawn from earthquake areas three years after the Wenchuan earthquake, including 113 cases who met positive criteria for PTSD symptoms according to the PCL-C (PTSD Checklist-Civilian Version) score and 452 controls who did not meet the criteria. Cases and controls were matched individually by birth year (+ three years) and the town they lived in when the earthquake occurred. Results: Independent risk factors for PTSD symptoms included two-week disease prevalence (odds ratio [OR], 1.92; 95% confidence interval [CI], 1.18-3.13), witnessing someone being killed in the earthquake (OR, 2.04; 95%CI, 1.17-3.58), having no regular income after the earthquake (OR, 0.52; 95%CI, 0.28-0.98), receiving mental health support only one time after the earthquake (OR, 2.43; 95%CI, 1.09-5.42) and lower social support (lower PSSS score) (OR, 0.95; 95%CI, 0.93-0.97). Conclusion: Earthquake experience, suffering from physical illnesses, lack of stable income, and lower social support were associated with PTSD symptoms.	[Cheng, Yongzhong; Wen, Jin; Shi, Yingkang] Sichuan Univ, West China Hosp, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China; [Cheng, Yongzhong] Sichuan Univ, West China Hosp, Dept Operat Management, Chengdu 610064, Peoples R China; [Wang, Fang] Shuangliu Ctr Dis Control & Prevent CDC, Chengdu, Peoples R China	Sichuan University; Sichuan University	Wen, J (corresponding author), Sichuan Univ, West China Hosp, Dept Hosp Management & Hlth Policy, Chengdu 610064, Peoples R China.	44584302@qq.com; huaxiwenjin@163.com			National Natural Science Foundation of China [81072376, 71131006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (Grant No. 81072376 and 71131006; http://www.nsfc.gov.cn/Portal0/default152.htm) financially supported this study. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agustini EN, 2011, J PSYCHIATR MENT HLT, V18, P543, DOI 10.1111/j.1365-2850.2011.01702.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Friedman M.J., 1995, NEUROBIOLOGICAL CLIN, P507; Fu Y, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-1; Guo J, 2014, J ANXIETY DISORD, V28, P75, DOI 10.1016/j.janxdis.2013.12.001; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; Hsu CC, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200207000-00022; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Kun P, 2013, PUBLIC HEALTH, V127, P644, DOI 10.1016/j.puhe.2013.04.018; Kun P, 2009, DEPRESS ANXIETY, V26, P1134, DOI 10.1002/da.20612; Lang AJ, 2003, J TRAUMA STRESS, V16, P257, DOI 10.1023/A:1023796007788; Ma XH, 2011, PSYCHIAT RES, V189, P385, DOI [10.1016/j.psychres.2010.12.016, 10.1016/j.psychres.2011.02.016]; Patacchioli FR, 2001, J ENDOCRINOL INVEST, V24, P173, DOI 10.1007/BF03343838; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Schnurr P P, 1999, Semin Clin Neuropsychiatry, V4, P295; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Wang L, 2009, PSYCHOL REP, V105, P879, DOI 10.2466/PR0.105.3.879-885; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wen J, 2011, M REC WENCH EARTHQ; Wen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043081; Xu JP, 2012, PSYCHIAT CLIN NEUROS, V66, P210, DOI 10.1111/j.1440-1819.2012.02331.x; Yehuda R, 1996, BIOL PSYCHIAT, V40, P79, DOI 10.1016/0006-3223(95)00451-3; Zhang Z, 2011, PUBLIC HEALTH, V125, P293, DOI 10.1016/j.puhe.2010.12.008; Zhou XB, 2013, COMPR PSYCHIAT, V54, P493, DOI 10.1016/j.comppsych.2012.12.010	30	29	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96644	10.1371/journal.pone.0096644	http://dx.doi.org/10.1371/journal.pone.0096644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24800944	gold, Green Published			2022-12-27	WOS:000338029800101
J	Gong, L; Chen, XR; Liu, CL; Jin, FL; Hu, QB				Gong, Liang; Chen, Xiurun; Liu, Chenglan; Jin, Fengliang; Hu, Qiongbo			Gene Expression Profile of Bombyx mori Hemocyte under the Stress of Destruxin A	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; MYCOTOXIN DESTRUXIN; IMMUNE-RESPONSE; PROTEIN; DEPSIPEPTIDES; BIOSYNTHESIS; INSECTICIDES; MOSQUITO; FUNGI; TOLL	Destruxin A (DA) is a cyclo-peptidic mycotoxin from the entomopathogenic fungus Metarhizium anisopliae. To uncover potential genes associated with its molecular mechanisms, a digital gene expression (DGE) profiling analysis was used to compare differentially expressed genes in the hemocytes of silkworm larvae treated with DA. Ten DGE libraries were constructed, sequenced, and assembled, and the unigenes with least 2.0-fold difference were further analyzed. The numbers of up-regulated genes were 10, 20, 18, 74 and 8, as well as the numbers of down-regulated genes were 0, 1, 8, 13 and 3 at 1, 4, 8, 12 and 24 h post treatment, respectively. Totally, the expression of 132 genes were significantly changed, among them, 1, 3 and 12 genes were continually up-regulated at 4, 3 and 2 different time points, respectively, while 1 gene was either up or down-regulated continually at 2 different time points. Furthermore, 68 genes were assigned to one or multiple gene ontology (GO) terms and 89 genes were assigned to specific Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthology. In-depth analysis identified that these genes putatively involved in insecticide resistance, cell apoptosis, and innate immune defense. Finally, twenty differentially expressed genes were randomly chosen and validated by quantitative real-time PCR (qRT-PCR). Our studies provide insights into the toxic effect of this microbial insecticide on silkworm's hemocytes, and are helpful to better understanding of the molecular mechanisms of DA as a biological insecticide.	[Gong, Liang; Chen, Xiurun; Liu, Chenglan; Jin, Fengliang; Hu, Qiongbo] South China Agr Univ, Coll Nat Resource & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, QB (corresponding author), South China Agr Univ, Coll Nat Resource & Environm, Guangzhou, Guangdong, Peoples R China.	hqbscau@126.com			National Natural Science Foundation of China [31272057]; National High Technology Research and Development Program ('863' Program) of China [2012AA101505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program ('863' Program) of China(National High Technology Research and Development Program of China)	This research is supported by the National Natural Science Foundation of China (31272057) and National High Technology Research and Development Program ('863' Program) of China (2012AA101505). The authors cordially thank Dr. Ye Mingqiang (Sericulture & Agri-food Research Institute, Guangdong Academy of Agricultural Science, Guangzhou 510640, China) for his kindly grant of silkworm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri B, 1999, BIOCONTROL SCI TECHN, V9, P487, DOI 10.1080/09583159929451; Ao JQ, 2008, MOL IMMUNOL, V45, P543, DOI 10.1016/j.molimm.2007.05.019; Asano T, 2013, INSECT BIOCHEM MOLEC, V43, P344, DOI 10.1016/j.ibmb.2013.01.001; Che Y, 2001, J NAT PROD, V64, P555, DOI 10.1021/np000547r; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Enserink M, 2005, SCIENCE, V308, P1531; Fan JQ, 2013, J INTEGR AGR, V12, P101; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hu QB, 2007, J APPL ENTOMOL, V131, P262, DOI 10.1111/j.1439-0418.2007.01159.x; Hu QB, 2006, TOXICON, V48, P491, DOI 10.1016/j.toxicon.2006.06.018; Hu QB, 2009, TOXICON, V53, P115, DOI 10.1016/j.toxicon.2008.10.019; Hunter DM, 2001, B ENTOMOL RES, V91, P93; James RR, 2012, J INVERTEBR PATHOL, V109, P175, DOI 10.1016/j.jip.2011.12.005; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kanzok SM, 2006, TRENDS PARASITOL, V22, P49, DOI 10.1016/j.pt.2005.12.008; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Larsen Peter E, 2012, BMC Res Notes, V5, P275, DOI 10.1186/1756-0500-5-275; Liao PC, 2008, BIOCHEM BIOPH RES CO, V376, P637, DOI 10.1016/j.bbrc.2008.08.161; Liu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081980; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Meng X, 2011, TOXICON, V58, P327, DOI 10.1016/j.toxicon.2011.06.002; Morais RP, 2010, J BRAZIL CHEM SOC, V21, P2262, DOI 10.1590/S0103-50532010001200013; MUROI M, 1994, BIOCHEM BIOPH RES CO, V205, P1358, DOI 10.1006/bbrc.1994.2815; Nakagawa H, 2003, BONE, V33, P443, DOI 10.1016/S8756-3282(03)00201-1; Oppert B, 1996, INSECT BIOCHEM MOLEC, V26, P571, DOI 10.1016/S0965-1748(96)00013-6; PAIS M, 1981, PHYTOCHEMISTRY, V20, P715, DOI 10.1016/0031-9422(81)85160-6; Pal S, 2007, J BIOL CHEM, V282, P8969, DOI 10.1074/jbc.M605927200; Park JA, 2012, J INVERTEBR PATHOL, V110, P382, DOI 10.1016/j.jip.2012.04.015; Pedras MSC, 2002, PHYTOCHEMISTRY, V59, P579, DOI 10.1016/S0031-9422(02)00016-X; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Rieber N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066621; Ruiz-Sanchez E, 2010, TOXICON, V56, P1043, DOI 10.1016/j.toxicon.2010.07.012; Ruiz-Sanchez E, 2010, TOXICON, V55, P1162, DOI 10.1016/j.toxicon.2010.01.006; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Shakya Barkha, 2012, Toxicol Int, V19, P301, DOI 10.4103/0971-6580.103673; Shi WB, 2004, BIOL CONTROL, V30, P165, DOI 10.1016/j.biocontrol.2004.01.017; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; TISSIERES A, 1974, J MOL BIOL, V84, P389, DOI 10.1016/0022-2836(74)90447-1; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tounou AK, 2003, BIOCONTROL SCI TECHN, V13, P715, DOI 10.1080/09583150310001606534; Vey A, 2002, J INVERTEBR PATHOL, V80, P177, DOI 10.1016/S0022-2011(02)00104-0; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Wang Q, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-9; Wang SJ, 2013, INSECT BIOCHEM MOLEC, V43, P533, DOI 10.1016/j.ibmb.2013.03.004; Yi F, 2012, MOLECULES, V17, P7533, DOI 10.3390/molecules17067533; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang J, 2008, INSECT MOL BIOL, V17, P209, DOI 10.1111/j.1365-2583.2008.00796.x	52	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96170	10.1371/journal.pone.0096170	http://dx.doi.org/10.1371/journal.pone.0096170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801594	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800045
J	Hamlin, JK; Baron, AS				Hamlin, J. Kiley; Baron, Andrew S.			Agency Attribution in Infancy: Evidence for a Negativity Bias	PLOS ONE			English	Article							GOAL-DIRECTED ACTIONS; PREVERBAL INFANTS; PERCEPTION; MIND; PERSPECTIVE; INTENTIONS; IMITATION; COGNITION; ILLUSION; OTHERS	Adults tend to attribute agency and intention to the causes of negative outcomes, even if those causes are obviously mechanical. Is this over-attribution of negative agency the result of years of practice with attributing agency to actual conspecifics, or is it a foundational aspect of our agency-detection system, present in the first year of life? Here we present two experiments with 6-month-old infants, in which they attribute agency to a mechanical claw that causes a bad outcome, but not to a claw that causes a good outcome. Control experiments suggest that the attribution stems directly from the negativity of the outcome, rather than from physical cues present in the stimuli. Together, these results provide evidence for striking developmental continuity in the attribution of agency to the causes of negative outcomes.	[Hamlin, J. Kiley; Baron, Andrew S.] Univ British Columbia, Departent Psychol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Hamlin, JK (corresponding author), Univ British Columbia, Departent Psychol, Vancouver, BC V5Z 1M9, Canada.	kiley.hamlin@psych.ubc.ca			Natural Science and Engineering Research Council of Canada (NSERC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Natural Science and Engineering Research Council of Canada (NSERC) to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Anan Y, 2009, EMOTION, V9, P123, DOI 10.1037/a0014607; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1994, CAH PSYCHOL COGN, V13, P724; Barrett J.L., 2004, WHY WOULD ANYONE BEL; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Biro S, 2007, DEVELOPMENTAL SCI, V10, P379, DOI 10.1111/j.1467-7687.2006.00544.x; Boyer Pascal, 2001, RELIG EXPLAINED EVOL; Camilleri JA, 2010, EVOL PSYCHOL-US, V8, P303; Carey S., 1994, MAPPING MIND DOMAIN, P169, DOI DOI 10.1017/CB09780511752902.008; Casstevens R.M., 2007, JHAB JAVA HABITUATIO; Csibra G, 2008, COGNITION, V107, P705, DOI 10.1016/j.cognition.2007.08.001; Epley N, 2008, SOC COGNITION, V26, P143, DOI 10.1521/soco.2008.26.2.143; Geraci A, 2011, DEVELOPMENTAL SCI, V14, P1012, DOI 10.1111/j.1467-7687.2011.01048.x; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Gilbert DT, 2000, J PERS SOC PSYCHOL, V79, P690, DOI 10.1037/0022-3514.79.5.690; Guthrie Stewart E., 1993, FACES CLOUDS; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2013, COGNITION, V128, P451, DOI 10.1016/j.cognition.2013.04.004; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P186, DOI 10.1177/0963721412470687; Hamlin JK, 2013, DEVELOPMENTAL SCI, V16, P209, DOI 10.1111/desc.12017; Hamlin JK, 2012, COGNITIVE DEV, V27, P227, DOI 10.1016/j.cogdev.2012.05.005; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hamlin JK, 2009, INFANCY, V14, P579, DOI 10.1080/15250000903144215; Haselton MG, 2000, J PERS SOC PSYCHOL, V78, P81, DOI 10.1037/0022-3514.78.1.81; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hume D., 1757, 4 DISSERTATIONS; Johnson SC, 2001, COGNITIVE DEV, V16, P637, DOI 10.1016/S0885-2014(01)00043-0; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; JONES EE, 1965, ADV EXP SOC PSYCHOL, V2, P219; Kanouse D. E., 1971, ATTRIBUTION PERCEIV; Kinzler KD, 2008, COGNITION, V107, P775, DOI 10.1016/j.cognition.2007.09.005; Klin A, 2000, J CHILD PSYCHOL PSYC, V41, P831, DOI 10.1111/1469-7610.00671; Knobe J, 2005, TRENDS COGN SCI, V9, P357, DOI 10.1016/j.tics.2005.06.011; Knobe J, 2003, PHILOS PSYCHOL, V16, P309, DOI 10.1080/09515080307771; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; LEGERSTEE M, 1992, EARLY DEV PARENTING, V1, P59, DOI DOI 10.1002/EDP; Legerstee M, 2008, INFANT BEHAV DEV, V31, P81, DOI 10.1016/j.infbeh.2007.07.006; Leslie A.M., 1994, MAPPING MIND DOMAIN, P119, DOI [10.1017/cbo9780511752902.006, DOI 10.1017/CBO9780511752902.006]; Leslie AM, 2006, PSYCHOL SCI, V17, P421, DOI 10.1111/j.1467-9280.2006.01722.x; Luczak H, 2003, ERGONOMICS, V46, P1361, DOI 10.1080/00140130310001610883; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; Luo YY, 2011, DEVELOPMENTAL SCI, V14, P453, DOI 10.1111/j.1467-7687.2010.00995.x; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; MELTZOFF AN, 1994, INFANT BEHAV DEV, V17, P83, DOI 10.1016/0163-6383(94)90024-8; Meltzoff AN, 2007, DEVELOPMENTAL SCI, V10, P126, DOI 10.1111/j.1467-7687.2007.00574.x; Morewedge CK, 2009, J EXP PSYCHOL GEN, V138, P535, DOI 10.1037/a0016796; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Muentener P, 2010, COGNITIVE PSYCHOL, V61, P63, DOI 10.1016/j.cogpsych.2010.02.001; Nesse RM, 2001, ANN NY ACAD SCI, V935, P75; Newman GE, 2010, P NATL ACAD SCI USA, V107, P17140, DOI 10.1073/pnas.0914056107; Norenzayan A, 2006, PERS SOC PSYCHOL B, V32, P174, DOI 10.1177/0146167205280251; Piaget Jean, 1929, CHILDS CONCEPTION WO; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; PREMACK D, 1990, COGNITION, V36, P1, DOI 10.1016/0010-0277(90)90051-K; Pun A, 2013, BIENN M SOC RES CHIL; Rakison DH, 2001, PSYCHOL BULL, V127, P209, DOI 10.1037//0033-2909.127.2.209; Rosset E, 2008, COGNITION, V108, P771, DOI 10.1016/j.cognition.2008.07.001; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Ruffman T, 2012, BRIT J DEV PSYCHOL, V30, P87, DOI 10.1111/j.2044-835X.2011.02045.x; Rutherford MD, 2006, J AUTISM DEV DISORD, V36, P983, DOI 10.1007/s10803-006-0136-8; Shimizu YA, 2004, DEVELOPMENTAL SCI, V7, P425, DOI 10.1111/j.1467-7687.2004.00362.x; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; TAYLOR SE, 1991, PSYCHOL BULL, V110, P67, DOI 10.1037/0033-2909.110.1.67; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Ward AF, 2013, PSYCHOL SCI, V24, P1437, DOI 10.1177/0956797612472343; Waytz A, 2010, J PERS SOC PSYCHOL, V99, P410, DOI 10.1037/a0020240; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	73	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96112	10.1371/journal.pone.0096112	http://dx.doi.org/10.1371/journal.pone.0096112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24801144	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800042
J	Hidaka, Y; Operario, D; Tsuji, H; Takenaka, M; Kimura, H; Kamakura, M; Ichikawa, S				Hidaka, Yasuharu; Operario, Don; Tsuji, Hiroyuki; Takenaka, Mie; Kimura, Hirokazu; Kamakura, Mitsuhiro; Ichikawa, Seiichi			Prevalence of Sexual Victimization and Correlates of Forced Sex in Japanese Men Who Have Sex with Men	PLOS ONE			English	Article							HIV-INFECTION; INTERNET; AFRICA; STRESS; HEALTH; INDIA; RISK	Studies of men who have sex with men (MSM) in diverse geographic and cultural contexts have identified health challenges affecting this population. MSM might be particularly vulnerable to sexual victimization and forced sex. The aim of this research study was to examine prevalence of sexual victimization and correlates of forced sex among Japanese MSM. We recruited a sample of 5,731 Japanese MSM who completed an internet-administered survey. Participants reported on history of different types of sexual victimization, unprotected anal sex, other health risk behaviors, exposure to gay-related teasing and bullying, depression, and suicidality. Over one-fifth of the sample (21.4%) reported experiencing at least one form of sexual victimization, and 8.7% reported a history of forced sex. MSM who had ever experienced forced sex were significantly more likely to report experiencing psychological risks (depression OR = 1.55, 95% CI = 1.28-1.89; attempted suicide OR = 2.25, 95% CI = 1.81-2.81; other forms of bullying OR = 1.38, 95% CI = 1.13-1.68) and other behavioral risks (unprotected anal sex OR = 1.56, 95% CI = 1.29-1.90; sex venue attendance OR = 1.27, 95% CI = 1.04-1.54; methamphetamine use OR = 1.57, 95% CI = 1.05-1.36), compared to MSM who had not experienced forced sex. Efforts to develop holistic and integrated health services for Japanese MSM are warranted, particularly related to psychosocial determinants of HIV prevention. However, due to cultural factors that emphasize familial and social relations and that stigmatize same-sex behavior, Japanese MSM might experience challenges to seeking social support and health services. Interventions must be provided in safe and non-judgmental settings where Japanese MSM feel comfortable disclosing their health and social support needs.	[Hidaka, Yasuharu] Takarazuka Univ, Sch Nursing, Osaka, Japan; [Operario, Don] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Tsuji, Hiroyuki] Japanese Fdn AIDS Prevent, Osaka, Japan; [Takenaka, Mie] Kansai AIDS Council, Osaka, Japan; [Kimura, Hirokazu] Hlth & Social Welf Bur, Yokohama, Kanagawa, Japan; [Kamakura, Mitsuhiro] Keio Univ, Grad Sch Hlth Management, Fujisawa, Kanagawa, Japan; [Ichikawa, Seiichi] Nagoya City Univ, Sch Nursing, Nagoya, Aichi, Japan	Brown University; Keio University; Nagoya City University	Hidaka, Y (corresponding author), Takarazuka Univ, Sch Nursing, Osaka, Japan.	y-hidaka@takara-univ.ac.jp			Ministry of Health, Labour and Welfare of Japan; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810] Funding Source: NIH RePORTER	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a Grant-in-Aid for AIDS Research from the Ministry of Health, Labour and Welfare of Japan in 2005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebajo Sylvia B, 2012, Afr J Reprod Health, V16, P21; Asthana S, 2001, SOC SCI MED, V52, P707, DOI 10.1016/S0277-9536(00)00167-2; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Birnbaum MH, 2004, ANNU REV PSYCHOL, V55, P803, DOI 10.1146/annurev.psych.55.090902.141601; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Deuba K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058099; DiStefano AS, 2008, QUAL HEALTH RES, V18, P1429, DOI 10.1177/1049732308322605; Fergusson DM, 2013, CHILD ABUSE NEGLECT, V37, P664, DOI 10.1016/j.chiabu.2013.03.013; Gilmour S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043473; Hidaka Y, 2006, J EPIDEMIOL COMMUN H, V60, P962, DOI 10.1136/jech.2005.045336; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Latypov A, 2013, CENT ASIAN SURV, V32, P52, DOI 10.1080/02634937.2013.768059; Laurent E, 2005, J HOMOSEXUAL, V48, P163, DOI 10.1300/J082v48n03_09; Lloyd S, 2012, AIDS EDUC PREV, V24, P228, DOI 10.1521/aeap.2012.24.3.228; Logie CH, 2012, SOC SCI MED, V74, P1261, DOI 10.1016/j.socscimed.2012.01.008; Longfield K, 2007, CULT HEALTH SEX, V9, P473, DOI 10.1080/13691050601161864; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; MHLW, 2012, HEIS 24 NEND KOB ROD; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Vu L, 2012, AIDS BEHAV, V16, P717, DOI 10.1007/s10461-011-9948-4; Waldner-Haugrud L K, 1995, Violence Vict, V10, P203	27	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95675	10.1371/journal.pone.0095675	http://dx.doi.org/10.1371/journal.pone.0095675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802357	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800031
J	Xu, CH; Yu, LK; Hao, KK				Xu, Chun-Hua; Yu, Li-Ke; Hao, Ke-Ke			Serum YKL-40 Level Is Associated with the Chemotherapy Response and Prognosis of Patients with Small Cell Lung Cancer	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST-CANCER; POOR SURVIVAL; TUMOR-MARKER; ANGIOGENESIS; BIOMARKER; CEA	This study was to explore the association between the serum YKL-40 level and the clinical characteristics, the response to chemotherapy and prognosis in small cell lung cancer (SCLC). Serum YKL-40 levels were detected and compared in 120 patients with SCLC pre- and post-chemotherapy, and in 40 healthy controls. Receiver operating characteristics (ROC) curves were adopted for diagnosis and calculation of area under ROC curve in SCLC. The Kaplan-Meier method, univariate and multivariate Cox regression analysis were used to analyze the correlation between pre-chemotherapy serum YKL-40 levels and progression-free survival (PFS) and overall survival (OS). The pre-chemotherapy serum YKL-40 levels were significantly higher than those of the controls (p<0.001). The post-chemotherapy serum YKL-40 levels in the SCLC cases were lower than pre-chemotherapy serum YKL-40 levels in these cases (p = 0.026). The patients with high serum YKL-40 showed a poorer response to chemotherapy than those patients with low serumYKL-40 (p = 0.031). Univariate analysis revealed that SCLC patients with high serum YKL-40 had a shorter PFS and OS than those with low serum YKL-40 (HR of 1.74, p = 0.033; HR of 1.33, p = 0.001). Cox multivariate analysis indicated that YKL-40 was an independent prognostic indicator of PFS and OS (HR of 1.12, p = 0.029; HR of 1.84, p = 0.025). Kaplan-Meier survival curves further confirmed that patients with low serum YKL-40 have longer PFS and OS (p = 0.016 and p = 0.041, respectively). These results suggest that YKL-40 is a potential prognostic marker of chemotherapy response in SCLC.	[Xu, Chun-Hua; Yu, Li-Ke; Hao, Ke-Ke] First Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Xu, Chun-Hua; Yu, Li-Ke; Hao, Ke-Ke] Nanjing Chest Hosp, Nanjing, Jiangsu, Peoples R China; [Xu, Chun-Hua; Yu, Li-Ke; Hao, Ke-Ke] Clin Ctr Nanjing Resp Dis, Nanjing, Jiangsu, Peoples R China		Yu, LK (corresponding author), First Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	yulike_doctor@163.com			Nanjing Medical Science and Technique Development Foundation	Nanjing Medical Science and Technique Development Foundation	This work was supported in part by a grant from "Twelve-Five Plan'' the Major Program of Nanjing Medical Science and Technique Development Foundation (Molecular Mechanism Study on Metastasis and Clinical Efficacy Prediction of Non-small Cell Lung Cancer) (LK-Yu). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barata J F, 2007, REV PORT PNEUMOL, V13, P587; Bi J, 2009, HUM PATHOL, V40, P1790, DOI 10.1016/j.humpath.2009.07.005; Chen ZG, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-10; Choi IK, 2010, ACTA ONCOL, V49, P861, DOI 10.3109/02841861003631503; Dupont J, 2004, J CLIN ONCOL, V22, P3330, DOI 10.1200/JCO.2004.09.112; Free CM, 2007, LUNG CANCER, V57, P222, DOI 10.1016/j.lungcan.2007.03.006; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Gronlund B, 2006, INT J BIOL MARKER, V21, P141, DOI 10.1177/172460080602100302; Grunnet M, 2012, LUNG CANCER, V76, P138, DOI 10.1016/j.lungcan.2011.11.012; Hogdall EVS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-8; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Johansen JS, 2004, LUNG CANCER-J IASLC, V46, P333, DOI 10.1016/j.lungcan.2004.05.010; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Maddison P, 2010, LUNG CANCER, V70, P335, DOI 10.1016/j.lungcan.2010.03.002; Mitsuhashi A, 2009, ANN ONCOL, V20, P71, DOI 10.1093/annonc/mdn552; Mylin AK, 2009, INT J CANCER, V124, P1492, DOI 10.1002/ijc.24110; Okamura K, 2013, LUNG CANCER, V80, P45, DOI 10.1016/j.lungcan.2013.01.002; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Schmidt H, 2006, J CLIN ONCOL, V24, P798, DOI 10.1200/JCO.2005.03.7960; Schultz NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067059; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thom I, 2010, CANCER-AM CANCER SOC, V116, P4114, DOI 10.1002/cncr.25196; Tufman A, 2010, CANCER BIOMARK, V6, P123, DOI 10.3233/CBM-2009-0124; van Meerbeeck JP, 2011, LANCET, V378, P1741, DOI 10.1016/S0140-6736(11)60165-7; Wang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051127; Yamac D, 2008, ADV THER, V25, P801, DOI 10.1007/s12325-008-0082-2; Zou L, 2010, BRAZ J MED BIOL RES, V43, P1232, DOI 10.1590/S0100-879X2010007500133	29	20	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96384	10.1371/journal.pone.0096384	http://dx.doi.org/10.1371/journal.pone.0096384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801872	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800066
J	Xu, T; Gu, L; Choi, MJ; Kim, RJ; Suh, MC; Kang, H				Xu, Tao; Gu, Lili; Choi, Min Ji; Kim, Ryeo Jin; Suh, Mi Chung; Kang, Hunseung			Comparative Functional Analysis of Wheat (Triticum aestivum) Zinc Finger-Containing Glycine-Rich RNA-Binding Proteins in Response to Abiotic Stresses	PLOS ONE			English	Article							COLD ADAPTATION PROCESS; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; CHAPERONE ACTIVITY; RECOGNITION MOTIF; MESSENGER-RNA; SHOCK DOMAIN; ORYZA-SATIVA; PLANTS; CSPA	Although the functional roles of zinc finger-containing glycine-rich RNA-binding proteins (RZs) have been characterized in several plant species, including Arabidopsis thaliana and rice (Oryza sativa), the physiological functions of RZs in wheat (Triticum aestivum) remain largely unknown. Here, the functional roles of the three wheat RZ family members, named TaRZ1, TaRZ2, and TaRZ3, were investigated using transgenic Arabidopsis plants under various abiotic stress conditions. Expression of TaRZs was markedly regulated by salt, dehydration, or cold stress. The TaRZ1 and TaRZ3 proteins were localized to the nucleus, whereas the TaRZ2 protein was localized to the nucleus, endoplasmic reticulum, and cytoplasm. Germination of all three TaRZ-expressing transgenic Arabidopsis seeds was retarded compared with that of wild-type seeds under salt stress conditions, whereas germination of TaRZ2- or TaRZ3-expressing transgenic Arabidopsis seeds was retarded under dehydration stress conditions. Seedling growth of TaRZ1-expressing transgenic plants was severely inhibited under cold or salt stress conditions, and seedling growth of TaRZ2-expressing plants was inhibited under salt stress conditions. By contrast, expression of TaRZ3 did not affect seedling growth of transgenic plants under any of the stress conditions. In addition, expression of TaRZ2 conferred freeze tolerance in Arabidopsis. Taken together, these results suggest that different TaRZ family members play various roles in seed germination, seedling growth, and freeze tolerance in plants under abiotic stress.	[Xu, Tao; Gu, Lili; Choi, Min Ji; Kang, Hunseung] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Kwangju, South Korea; [Kim, Ryeo Jin; Suh, Mi Chung] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Bioenergy Sci & Technol, Kwangju, South Korea	Chonnam National University; Chonnam National University	Kang, H (corresponding author), Chonnam Natl Univ, Coll Agr & Life Sci, Dept Plant Biotechnol, Kwangju, South Korea.	hskang@jnu.ac.kr	Xu, Tao/AAP-4529-2020; Kang, Hunseung/AAE-9912-2020	Xu, Tao/0000-0002-6962-3404; 	Next-Generation BioGreen21 Program, Rural Development Administration, Republic of Korea [PJ00820303]; Mid-career Researcher Program through a National Research Foundation of Korea grant - Ministry of Education, Science and Technology [2011-0017357]	Next-Generation BioGreen21 Program, Rural Development Administration, Republic of Korea; Mid-career Researcher Program through a National Research Foundation of Korea grant - Ministry of Education, Science and Technology	This work was supported by grants from the Next-Generation BioGreen21 Program (PJ00820303), Rural Development Administration, Republic of Korea, and by a grant from the Mid-career Researcher Program through a National Research Foundation of Korea grant funded by the Ministry of Education, Science and Technology (2011-0017357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 1998, TRENDS PLANT SCI, V3, P15, DOI 10.1016/S1360-1385(97)01151-5; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Bechtold N, 1998, METH MOL B, V82, P259; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; Jiang WN, 1997, J BIOL CHEM, V272, P196; Jung HJ, 2013, J PLANT BIOL, V56, P123, DOI 10.1007/s12374-013-0906-8; Jung JH, 2011, PLANT CELL REP, V30, P1881, DOI 10.1007/s00299-011-1095-x; Kang H, 2013, TRENDS PLANT SCI, V18, P100, DOI 10.1016/j.tplants.2012.08.004; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kim JS, 2008, PLANT J, V55, P455, DOI 10.1111/j.1365-313X.2008.03518.x; Kim JY, 2007, PLANT J, V50, P439, DOI 10.1111/j.1365-313X.2007.03057.x; Kim JY, 2010, PLANT CELL ENVIRON, V33, P759, DOI 10.1111/j.1365-3040.2009.02101.x; Kim WY, 2010, PLANT PHYSIOL BIOCH, V48, P866, DOI 10.1016/j.plaphy.2010.08.013; Kim YO, 2007, PLANT CELL PHYSIOL, V48, P1170, DOI 10.1093/pcp/pcm087; Kim YO, 2006, PLANT CELL PHYSIOL, V47, P793, DOI 10.1093/pcp/pcj047; Kim YO, 2005, PLANT J, V42, P890, DOI 10.1111/j.1365-313X.2005.02420.x; Kwak KJ, 2005, J EXP BOT, V56, P3007, DOI 10.1093/jxb/eri298; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Semrad K., 2011, BIOCH RES INTERNAT, P1, DOI [10.1155/2011/532908, DOI 10.1155/2011/532908]; Simpson GG, 1996, PLANT MOL BIOL, V32, P1, DOI 10.1007/BF00039375; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Xu T, 2013, PHYTOCHEMISTRY, V94, P28, DOI 10.1016/j.phytochem.2013.05.019	26	19	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96877	10.1371/journal.pone.0096877	http://dx.doi.org/10.1371/journal.pone.0096877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800811	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800137
J	Bowden, SD; Hopper-Chidlaw, AC; Rice, CJ; Ramachandran, VK; Kelly, DJ; Thompson, A				Bowden, Steven D.; Hopper-Chidlaw, Amanda C.; Rice, Christopher J.; Ramachandran, Vinoy K.; Kelly, David J.; Thompson, Arthur			Nutritional and Metabolic Requirements for the Infection of HeLa Cells by Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; GENE-EXPRESSION; PHOSPHOENOLPYRUVATE; TRANSPORT; INVASION; MUTANTS; GLUCOSE; PHOSPHORYLATION; MACROPHAGES	Salmonella is the causative agent of a spectrum of human and animal diseases ranging from gastroenteritis to typhoid fever. It is a food - and water - borne pathogen and infects via ingestion followed by invasion of intestinal epithelial cells and phagocytic cells. In this study we employed a mutational approach to define the nutrients and metabolic pathways required by Salmonella enterica serovar Typhimurium during infection of a human epithelial cell line ( HeLa). We deleted the key glycolytic genes, pfkA and pfkB to show that S. Typhimurium utilizes glycolysis for replication within HeLa cells; however, glycolysis was not absolutely essential for intracellular replication. Using S. Typhimurium strains deleted for genes encoding components of the phosphotransferase system and glucose transport, we show that glucose is a major substrate required for the intracellular replication of S. Typhimurium in HeLa cells. We also deleted genes encoding enzymes involved in the utilization of gluconeogenic substrates and the glyoxylate shunt and show that neither of these pathways were required for intracellular replication of S. Typhimurium within HeLa cells.	[Bowden, Steven D.; Hopper-Chidlaw, Amanda C.; Ramachandran, Vinoy K.; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Bowden, Steven D.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan; [Ramachandran, Vinoy K.] Univ Oxford, Dept Plant Sci, Oxford, England; [Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; Nara Institute of Science & Technology; University of Oxford; University of Sheffield	Thompson, A (corresponding author), Inst Food Res, Norwich Res Pk, Norwich NR4 7UA, Norfolk, England.	arthur.thompson@ifr.ac.uk			BBSRC [BB/D004810/1, BB/J001627/1/]; Biotechnology and Biological Sciences Research Council [BB/J001007/1, BB/J001627/1, BB/D004810/1] Funding Source: researchfish; BBSRC [BB/J001627/1, BB/J001007/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to the BBSRC for funding this work (Grant BB/D004810/1 TO AT and BB/J001627/1/to AT and DJK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy J, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-5; Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; Altier C, 2005, J MICROBIOL, V43, P85; Bowden SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013871; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Brumell JH, 1999, CURR BIOL, V9, pR277, DOI 10.1016/S0960-9822(99)80178-X; Cabrera R, 2006, ACTA CRYSTALLOGR F, V62, P935, DOI 10.1107/S1744309106032246; CARRILLO.G, 1970, J BACTERIOL, V102, P524; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P206; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEATH A, 1993, RES MICROBIOL, V144, P529, DOI 10.1016/0923-2508(93)90002-J; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eriksson S, 2000, CELL MICROBIOL, V2, P239, DOI 10.1046/j.1462-5822.2000.00051.x; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; FRAENKEL DG, 1996, ESCHERICHIA COLI SAL, P189; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; HENDERSON PJF, 1977, BIOCHEM J, V162, P309, DOI 10.1042/bj1620309; HOSONO K, 1995, BIOSCI BIOTECH BIOCH, V59, P256, DOI 10.1271/bbb.59.256; Jones BD, 2005, J MICROBIOL, V43, P110; Klumpp J, 2007, MICROBIOL-SGM, V153, P1207, DOI 10.1099/mic.0.2006/004747-0; Knodler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084681; KOTLARZ D, 1975, BIOCHIM BIOPHYS ACTA, V381, P257, DOI 10.1016/0304-4165(75)90232-9; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Paterson GK, 2009, MICROB PATHOGENESIS, V46, P261, DOI 10.1016/j.micpath.2009.01.008; Portillo FGD, 2001, MICROBES INFECT, V3, P1305, DOI 10.1016/S1286-4579(01)01491-5; POSTMA PW, 1977, J BACTERIOL, V129, P630, DOI 10.1128/JB.129.2.630-639.1977; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; REPHAELI AW, 1980, J BIOL CHEM, V255, P8585; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; RYPNIEWSKI WR, 1989, J MOL BIOL, V207, P805, DOI 10.1016/0022-2836(89)90246-5; SAIER MH, 1975, J BIOL CHEM, V250, P7078; SMITH HO, 1967, VIROLOGY, V31, P207, DOI 10.1016/0042-6822(67)90164-X; SMYER JR, 1989, ARCH MICROBIOL, V153, P26, DOI 10.1007/BF00277536; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; STOCK JB, 1982, J BIOL CHEM, V257, P4543; Szeto J, 2009, INFECT IMMUN, V77, P996, DOI 10.1128/IAI.01275-08; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; VANDERVLAG J, 1995, MOL GEN GENET, V248, P236, DOI 10.1007/BF02190806; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WILSON RB, 1987, J BACTERIOL, V169, P3029, DOI 10.1128/jb.169.7.3029-3034.1987; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	51	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96266	10.1371/journal.pone.0096266	http://dx.doi.org/10.1371/journal.pone.0096266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797930	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000336656000055
J	De Salvo, M; Raimondi, L; Vella, S; Adesso, L; Ciarapica, R; Verginelli, F; Pannuti, A; Citti, A; Boldrini, R; Milano, GM; Cacchione, A; Ferrari, A; Collini, P; Rosolen, A; Bisogno, G; Alaggio, R; Inserra, A; Locatelli, M; Stifani, S; Screpanti, I; Miele, L; Locatelli, F; Rota, R				De Salvo, Maria; Raimondi, Lavinia; Vella, Serena; Adesso, Laura; Ciarapica, Roberta; Verginelli, Federica; Pannuti, Antonio; Citti, Arianna; Boldrini, Renata; Milano, Giuseppe M.; Cacchione, Antonella; Ferrari, Andrea; Collini, Paola; Rosolen, Angelo; Bisogno, Gianni; Alaggio, Rita; Inserra, Alessandro; Locatelli, Mattia; Stifani, Stefano; Screpanti, Isabella; Miele, Lucio; Locatelli, Franco; Rota, Rossella			Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALVEOLAR RHABDOMYOSARCOMA; INHIBITION; EXPRESSION; DIFFERENTIATION; SURVIVAL; PATHWAY; PROTEIN	Rhabdomyosarcoma (RMS) is a pediatric myogenic-derived soft tissue sarcoma that includes two major histopathological subtypes: embryonal and alveolar. The majority of alveolar RMS expresses PAX3-FOXO1 fusion oncoprotein, associated with the worst prognosis. RMS cells show myogenic markers expression but are unable to terminally differentiate. The Notch signaling pathway is a master player during myogenesis, with Notch1 activation sustaining myoblast expansion and Notch3 activation inhibiting myoblast fusion and differentiation. Accordingly, Notch1 signaling is up-regulated and activated in embryonal RMS samples and supports the proliferation of tumor cells. However, it is unable to control their differentiation properties. We previously reported that Notch3 is activated in RMS cell lines, of both alveolar and embryonal subtype, and acts by inhibiting differentiation. Moreover, Notch3 depletion reduces PAX3-FOXO1 alveolar RMS tumor growth in vivo. However, whether Notch3 activation also sustains the proliferation of RMS cells remained unclear. To address this question, we forced the expression of the activated form of Notch3, Notch3IC, in the RH30 and RH41 PAX3-FOXO1-positive alveolar and in the RD embryonal RMS cell lines and studied the proliferation of these cells. We show that, in all three cell lines tested, Notch3IC over-expression stimulates in vitro cell proliferation and prevents the effects of pharmacological Notch inhibition. Furthermore, Notch3IC further increases RH30 cell growth in vivo. Interestingly, knockdown of Notch canonical ligands JAG1 or DLL1 in RMS cell lines decreases Notch3 activity and reduces cell proliferation. Finally, the expression of Notch3IC and its target gene HES1 correlates with that of the proliferative marker Ki67 in a small cohort of primary PAX-FOXO1 alveolar RMS samples. These results strongly suggest that high levels of Notch3 activation increase the proliferative potential of RMS cells.	[De Salvo, Maria; Raimondi, Lavinia; Vella, Serena; Adesso, Laura; Ciarapica, Roberta; Verginelli, Federica; Milano, Giuseppe M.; Cacchione, Antonella; Locatelli, Franco; Rota, Rossella] IRCCS, Osped Pediat Bambino Gesu, Dept Oncohematol, Rome, Italy; [Pannuti, Antonio; Miele, Lucio] Louisiana State Univ, Hlth Sci Ctr, Stanley Scott Canc Ctr, New Orleans, LA USA; [Pannuti, Antonio; Miele, Lucio] Louisiana Canc Res Consortium, New Orleans, LA USA; [Citti, Arianna; Boldrini, Renata] IRCCS, Osped Pediat Bambino Gesu, Dept Pathol, Rome, Italy; [Ferrari, Andrea] Fdn IRCCS Ist Nazl Tumori, Pediat Oncol Unit, Milan, Italy; [Collini, Paola] Fdn IRCCS Ist Nazl Tumori, Anat Pathol Unit 2, Milan, Italy; [Rosolen, Angelo; Bisogno, Gianni] Univ Padua, Dept Pediat, Oncohematol Unit, Padua, Italy; [Alaggio, Rita] Univ Padua, Dept Pathol, I-35100 Padua, Italy; [Inserra, Alessandro] IRCCS, Osped Pediat Bambino Gesu, Dept Surg, Rome, Italy; [Locatelli, Mattia] IRCCS, Osped Pediat Bambino Gesu, Dept Sci Directorate, Rome, Italy; [Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada; [Screpanti, Isabella] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Locatelli, Franco] Univ Pavia, Dipartimento Sci Pediat, I-27100 Pavia, Italy	IRCCS Bambino Gesu; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; IRCCS Bambino Gesu; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Padua; University of Padua; IRCCS Bambino Gesu; IRCCS Bambino Gesu; McGill University; Sapienza University Rome; University of Pavia	Rota, R (corresponding author), IRCCS, Osped Pediat Bambino Gesu, Dept Oncohematol, Rome, Italy.	rossella.rota@opbg.net	Vella, Serena/N-7179-2019; verginelli, federica/HGU-3834-2022; Collini, Paola/K-7354-2016; milano, giuseppe maria/AAH-9219-2019; Rota, Rossella/AAB-2497-2019; alaggio, rita/AAC-2348-2019; Raimondi, Lavinia/K-4085-2016; Adesso, Laura/AAA-7708-2020; Ferrari, Andrea/R-1028-2016; Locatelli, Mattia/AAA-6241-2020; Vella, Serena/K-6451-2016; Cacchione, Antonella/AAB-5726-2020; Inserra, Alessandro/H-3120-2012; Bisogno, Gianni/K-9282-2016	Vella, Serena/0000-0001-9477-9294; verginelli, federica/0000-0002-8762-8815; Collini, Paola/0000-0002-6158-210X; milano, giuseppe maria/0000-0002-0250-6043; Rota, Rossella/0000-0002-9408-7711; alaggio, rita/0000-0003-3915-3816; Raimondi, Lavinia/0000-0001-9394-2002; Adesso, Laura/0000-0003-2121-4924; Ferrari, Andrea/0000-0002-4724-0517; Vella, Serena/0000-0001-9477-9294; Miele, Lucio/0000-0002-5853-7287; cacchione, antonella/0000-0003-4901-9952; Bisogno, Gianni/0000-0003-4462-5523; Stifani, Stefano/0000-0002-2376-7701	AIRC (Associazione Italiana Ricerca sul Cancro) [10338]; Ricerca Corrente (Ministero della Salute); AIRC (progetto speciale 5xmille); MIUR (Ministero dell'Istruzione, Universita e della Ricerca, progetto di rilevante interesse nazionale, PRIN); NCI (National Cancer Institute) [P01 1666009]	AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Ricerca Corrente (Ministero della Salute)(Ministry of Health, Italy); AIRC (progetto speciale 5xmille)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministero dell'Istruzione, Universita e della Ricerca, progetto di rilevante interesse nazionale, PRIN); NCI (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by grants from AIRC (Associazione Italiana Ricerca sul Cancro) project #10338 and Ricerca Corrente (Ministero della Salute) to RR; AIRC (progetto speciale 5xmille), MIUR (Ministero dell'Istruzione, Universita e della Ricerca, progetto di rilevante interesse nazionale, PRIN) and Ricerca Corrente (Ministero della Salute) to FL; NCI (National Cancer Institute) P01 1666009 to LM and AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Belyea BC, 2011, CLIN CANCER RES, V17, P7324, DOI 10.1158/1078-0432.CCR-11-1004; Buas MF, 2010, J BIOL CHEM, V285, P1249, DOI 10.1074/jbc.M109.046441; Cao LA, 2010, CANCER RES, V70, P6497, DOI 10.1158/0008-5472.CAN-10-0582; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Crose LES, 2012, CLIN CANCER RES, V18, P3780, DOI 10.1158/1078-0432.CCR-10-3063; Dahlqvist C, 2003, DEVELOPMENT, V130, P6089, DOI 10.1242/dev.00834; Davicioni E, 2010, J CLIN ONCOL, V28, P1240, DOI 10.1200/JCO.2008.21.1268; Gagan J, 2012, J BIOL CHEM, V287, P40360, DOI 10.1074/jbc.M112.378414; Giovannini C, 2009, J HEPATOL, V50, P969, DOI 10.1016/j.jhep.2008.12.032; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Graziani I, 2008, CANCER RES, V68, P9678, DOI 10.1158/0008-5472.CAN-08-0969; Hoemann CD, 2000, MOL CELL BIOL, V20, P3831, DOI 10.1128/MCB.20.11.3831-3842.2000; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Joshi I, 2009, BLOOD, V113, P1689, DOI 10.1182/blood-2008-03-147967; Kitzmann M, 2006, J CELL PHYSIOL, V208, P538, DOI 10.1002/jcp.20688; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2002, J CELL SCI, V115, P1095; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Lee MH, 2011, CANCER RES, V71, P3921, DOI 10.1158/0008-5472.CAN-10-3358; Loeb DM, 2008, SURG CLIN N AM, V88, P615, DOI 10.1016/j.suc.2008.03.008; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Missiaglia E, 2012, J CLIN ONCOL, V30, P1670, DOI 10.1200/JCO.2011.38.5591; Nagao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039268; Parham DM, 2006, ARCH PATHOL LAB MED, V130, P1454; Raimondi L, 2012, CELL DEATH DIFFER, V19, P871, DOI 10.1038/cdd.2011.171; Ramirez-Peinado S, 2011, CANCER RES, V71, P6796, DOI 10.1158/0008-5472.CAN-11-0759; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Roma J, 2011, CLIN CANCER RES, V17, P505, DOI 10.1158/1078-0432.CCR-10-0166; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Wen YF, 2012, MOL CELL BIOL, V32, P2300, DOI 10.1128/MCB.06753-11; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Williamson D, 2010, J CLIN ONCOL, V28, P2151, DOI 10.1200/JCO.2009.26.3814; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Yamaguchi N, 2008, CANCER RES, V68, P1881, DOI 10.1158/0008-5472.CAN-07-1597	42	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96238	10.1371/journal.pone.0096238	http://dx.doi.org/10.1371/journal.pone.0096238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797362	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000050
J	Garcia, CP; Burchardt, AD; Carvalho, RN; Gilliland, D; Antonio, DC; Rossi, F; Lettieri, T				Garcia, Cesar Pascual; Burchardt, Alina D.; Carvalho, Raquel N.; Gilliland, Douglas; Antonio, Diana C.; Rossi, Francois; Lettieri, Teresa			Detection of Silver Nanoparticles inside Marine Diatom Thalassiosira pseudonana by Electron Microscopy and Focused Ion Beam	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; GOLD NANOPARTICLES; CELL; TOXICITY; EXPOSURE	In the following article an electron/ion microscopy study will be presented which investigates the uptake of silver nanoparticles (AgNPs) by the marine diatom Thalassiosira pseudonana, a primary producer aquatic species. This organism has a characteristic silica exoskeleton that may represent a barrier for the uptake of some chemical pollutants, including nanoparticles (NPs), but that presents a technical challenge when attempting to use electron-microscopy (EM) methods to study NP uptake. Here we present a convenient method to detect the NPs interacting with the diatom cell. It is based on a fixation procedure involving critical point drying which, without prior slicing of the cell, allows its inspection using transmission electron microscopy. Employing a combination of electron and ion microscopy techniques to selectively cut the cell where the NPs were detected, we are able to demonstrate and visualize for the first time the presence of AgNPs inside the cell membrane.	[Garcia, Cesar Pascual; Gilliland, Douglas; Antonio, Diana C.; Rossi, Francois] European Commiss, Joint Res Ctr, Inst Hlth & Consumer Protect, Ispra, VA, Italy; [Burchardt, Alina D.; Carvalho, Raquel N.; Lettieri, Teresa] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, Ispra, VA, Italy; [Burchardt, Alina D.] FU Berlin, Fachbereich Biol Chem Pharm, Berlin, Germany; [Antonio, Diana C.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Antonio, Diana C.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	European Commission Joint Research Centre; EC JRC ISPRA Site; European Commission Joint Research Centre; EC JRC ISPRA Site; Free University of Berlin; Universidade de Aveiro; Universidade de Aveiro	Garcia, CP (corresponding author), CRP Gabriel Lippman, Belvaux, Luxembourg.	pascual@lippmann.lu; teresa.lettieri@jrc.ec.europa.eu	Pascual Garcia, Cesar/M-4731-2015	Pascual Garcia, Cesar/0000-0002-0526-2507; Lettieri, Teresa/0000-0002-3363-9666	European Commission DG Joint Research Centre	European Commission DG Joint Research Centre(European CommissionEuropean Commission Joint Research Centre)	This project has been funded by the European Commission DG Joint Research Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson L, 2009, DEEP-SEA RES PT II, V56, P1369, DOI 10.1016/j.dsr2.2008.11.031; Bhatta H, 2009, J NANOSCI NANOTECHNO, V9, P6760, DOI 10.1166/jnn.2009.2020; Bopp SK, 2007, GENE, V396, P293, DOI 10.1016/j.gene.2007.03.013; Bozzola J. J, 1999, ELECT MICROSCOPY PRI; Burchardt AD, 2012, ENVIRON SCI TECHNOL, V46, P11336, DOI 10.1021/es300989e; Carvalho RN, 2011, AQUAT TOXICOL, V101, P244, DOI 10.1016/j.aquatox.2010.10.004; Davis AK, 2006, EUKARYOT CELL, V5, P1157, DOI 10.1128/EC.00042-06; Denys L, 2004, ECOL INDIC, V4, P255, DOI 10.1016/j.ecolind.2004.06.001; Drobne D, 2007, MICROSC RES TECHNIQ, V70, P895, DOI 10.1002/jemt.20494; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P9004, DOI 10.1021/es901706j; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; Farkas J, 2011, AQUAT TOXICOL, V101, P117, DOI 10.1016/j.aquatox.2010.09.010; Garcia CP, 2013, SCI REP, V3, P1623; Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Heymann JAW, 2009, J STRUCT BIOL, V166, P1, DOI 10.1016/j.jsb.2008.11.005; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Hildebrand M, 2009, J STRUCT BIOL, V166, P316, DOI 10.1016/j.jsb.2009.02.014; Kwok KWH, 2012, AQUAT TOXICOL, V120, P59, DOI 10.1016/j.aquatox.2012.04.012; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Linsinger TPJ., 2012, 25404 EUR EN; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Losic D, 2007, J POROUS MAT, V14, P61, DOI 10.1007/s10934-006-9009-y; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Miao AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015196; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Pletikapic G, 2012, J MOL RECOGNIT, V25, P309, DOI 10.1002/jmr.2177; Potapova M, 2007, ECOL INDIC, V7, P48, DOI 10.1016/j.ecolind.2005.10.001; Rocha A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-5; Rovira L, 2012, MAR POLLUT BULL, V64, P500, DOI 10.1016/j.marpolbul.2012.01.005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrand AM, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/23/235104; Shah NB, 2011, MOL PHARMACEUT, V8, P176, DOI 10.1021/mp1002587; Stuart EJE, 2013, NANOSCALE, V5, P174, DOI 10.1039/c2nr33146b; Sumbayev VV, 2013, SMALL, V9, P472, DOI 10.1002/smll.201201528; Svetlicic V, 2013, INT J MOL SCI, V14, P20064, DOI 10.3390/ijms141020064; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; University of Alabama, 2014, FIX SEM; Wang MJ, 2011, AQUAT TOXICOL, V101, P377, DOI 10.1016/j.aquatox.2010.11.014; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yang WR, 2011, ANALYST, V136, P42, DOI 10.1039/c0an00602e	47	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96078	10.1371/journal.pone.0096078	http://dx.doi.org/10.1371/journal.pone.0096078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797958	Green Published, gold			2022-12-27	WOS:000336656000035
J	Nescerecka, A; Rubulis, J; Vital, M; Juhna, T; Hammes, F				Nescerecka, Alina; Rubulis, Janis; Vital, Marius; Juhna, Talis; Hammes, Frederik			Biological Instability in a Chlorinated Drinking Water Distribution Network	PLOS ONE			English	Article							ASSIMILABLE ORGANIC-CARBON; ESCHERICHIA-COLI O157; DISTRIBUTION-SYSTEM; FRESH-WATER; FLOW-CYTOMETRY; FULL-SCALE; BACTERIAL REGROWTH; MICROBIAL-GROWTH; DISSOLVED ATP; SUPPLY-SYSTEM	The purpose of a drinking water distribution system is to deliver drinking water to the consumer, preferably with the same quality as when it left the treatment plant. In this context, the maintenance of good microbiological quality is often referred to as biological stability, and the addition of sufficient chlorine residuals is regarded as one way to achieve this. The full-scale drinking water distribution system of Riga (Latvia) was investigated with respect to biological stability in chlorinated drinking water. Flow cytometric (FCM) intact cell concentrations, intracellular adenosine tri-phosphate (ATP), heterotrophic plate counts and residual chlorine measurements were performed to evaluate the drinking water quality and stability at 49 sampling points throughout the distribution network. Cell viability methods were compared and the importance of extracellular ATP measurements was examined as well. FCM intact cell concentrations varied from 5x10(3) cells mL 21 to 4.66x10(5) cells mL(-1) in the network. While this parameter did not exceed 2.1x10(4) cells mL(-1) in the effluent from any water treatment plant, 50% of all the network samples contained more than 1.06x10(5) cells mL(-1). This indisputably demonstrates biological instability in this particular drinking water distribution system, which was ascribed to a loss of disinfectant residuals and concomitant bacterial growth. The study highlights the potential of using cultivation-independent methods for the assessment of chlorinated water samples. In addition, it underlines the complexity of full-scale drinking water distribution systems, and the resulting challenges to establish the causes of biological instability.	[Nescerecka, Alina; Rubulis, Janis; Juhna, Talis] Riga Tech Univ, Dept Water Engn & Technol, Riga, Latvia; [Nescerecka, Alina; Vital, Marius; Hammes, Frederik] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Environm Microbiol, Dubendorf, Switzerland	Riga Technical University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Hammes, F (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Dept Environm Microbiol, Dubendorf, Switzerland.	frederik.hammes@eawag.ch	Juhna, Talis/AAX-4974-2021	Juhna, Talis/0000-0001-5985-704X; Rubulis, Janis/0000-0003-4694-5977; Nescerecka, Alina/0000-0003-4689-2545	EU project "TECHNEAU" [018320]; NMS-CH project "BioWater: Assessment of biological stability in drinking water distribution networks with chlorine residuals" [Sciex-N-7 12.265]	EU project "TECHNEAU"; NMS-CH project "BioWater: Assessment of biological stability in drinking water distribution networks with chlorine residuals"	The authors acknowledge the financial support of the EU project "TECHNEAU" (Nr. 018320) and the NMS-CH project "BioWater: Assessment of biological stability in drinking water distribution networks with chlorine residuals" (Sciex-N-7 12.265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun EN, 1999, J AM WATER WORKS ASS, V91, P62; AZAM F, 1977, NATURE, V267, P696, DOI 10.1038/267696a0; Berney M, 2008, WATER RES, V42, P4010, DOI 10.1016/j.watres.2008.07.017; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Boe-Hansen R, 2002, WATER RES, V36, P4477, DOI 10.1016/S0043-1354(02)00191-4; Bucheli-Witschel M, 2012, WATER RES, V46, P4246, DOI 10.1016/j.watres.2012.05.008; Cowan DA, 2007, POLAR BIOL, V30, P1599, DOI 10.1007/s00300-007-0324-9; Delahaye E, 2003, WATER RES, V37, P3689, DOI 10.1016/S0043-1354(03)00288-4; Douterelo I, 2014, WATER RES, V54, P100, DOI 10.1016/j.watres.2014.01.049; Eichler S, 2006, APPL ENVIRON MICROB, V72, P1858, DOI 10.1128/AEM.72.3.1858-1872.2006; Francisque A, 2009, WATER RES, V43, P1075, DOI 10.1016/j.watres.2008.11.030; Friedman M, 2002, J AM WATER WORKS ASS, V94, P48; Glasmacher A., 2003, HETEROTROPHIC PLATE; Gregori G, 2001, APPL ENVIRON MICROB, V67, P4662, DOI 10.1128/AEM.67.10.4662-4670.2001; Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009; Hammes F, 2010, WATER RES, V44, P3915, DOI 10.1016/j.watres.2010.04.015; Hammes F, 2010, J WATER SUPPLY RES T, V59, P31, DOI 10.2166/aqua.2010.052; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Jjemba P. K., 2010, GUIDANCE DOCUMENT MI; Juhna T, 2007, APPL ENVIRON MICROB, V73, P7456, DOI 10.1128/AEM.00845-07; Lautenschlager K, 2013, WATER RES, V47, P3015, DOI 10.1016/j.watres.2013.03.002; Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032; LeChevallier M. W., 2004, WATER TREATMENT PATH; LECHEVALLIER MW, 1991, APPL ENVIRON MICROB, V57, P857, DOI 10.1128/AEM.57.3.857-862.1991; LeChevallier MW, 1996, APPL ENVIRON MICROB, V62, P2201, DOI 10.1128/AEM.62.7.2201-2211.1996; Lehtola MJ, 2006, WATER RES, V40, P2151, DOI 10.1016/j.watres.2006.04.010; Lisle JT, 1999, LETT APPL MICROBIOL, V29, P42, DOI 10.1046/j.1365-2672.1999.00572.x; Liu G, 2013, WATER RES, V47, P2719, DOI 10.1016/j.watres.2013.02.035; Liu W, 2002, WATER RES, V36, P891, DOI 10.1016/S0043-1354(01)00296-2; Manuel CM, 2007, WATER RES, V41, P551, DOI 10.1016/j.watres.2006.11.007; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Mezule L., 2013, Drinking Water and Engineering Science, V6, P25; Niquette P, 2001, WATER RES, V35, P675, DOI 10.1016/S0043-1354(00)00303-1; Nocker A, 2007, J MICROBIOL METH, V70, P252, DOI 10.1016/j.mimet.2007.04.014; Pinto AJ, 2012, ENVIRON SCI TECHNOL, V46, P8851, DOI 10.1021/es302042t; Polanska M, 2005, WATER RES, V39, P2259, DOI 10.1016/j.watres.2005.04.015; Prevost M, 1998, WATER RES, V32, P1393, DOI 10.1016/S0043-1354(97)00388-6; Ramseier MK, 2011, WATER RES, V45, P2002, DOI 10.1016/j.watres.2010.12.002; Ramseier MK, 2011, WATER RES, V45, P1490, DOI 10.1016/j.watres.2010.11.016; RIEMANN B, 1979, FRESHWATER BIOL, V9, P481, DOI 10.1111/j.1365-2427.1979.tb01532.x; RITTMANN BE, 1984, J AM WATER WORKS ASS, V76, P106; Rossman L.A., 2000, EPANET 2 USERS MANUA; Rubulis J, 2011, ONLINE MEASUREMENT U, P1488, DOI [10.1061/41203(425)133, DOI 10.1061/41203(425)133]; Shi L, 2007, CYTOM PART A, V71A, P592, DOI 10.1002/cyto.a.20402; SIEBEL E, 2008, DRINK WATER ENG SCI, V1, P1, DOI DOI 10.5194/DWESD-1-71-2008; Srinivasan S, 2008, WATER RES, V42, P3393, DOI 10.1016/j.watres.2008.04.025; Tsai YP, 2005, BIOFOULING, V21, P267, DOI 10.1080/08927010500398633; Van Der Kooij, 1990, DRINKING WATER MICRO; Van Der Kooij D, 2000, WATER AIR SOIL POLL, V123, P25, DOI 10.1023/A:1005288720291; van der Kooij D, 2003, WATER SCI TECHNOL, V47, P83, DOI 10.2166/wst.2003.0287; van der Wielen PWJJ, 2010, WATER RES, V44, P4860, DOI 10.1016/j.watres.2010.07.016; VANDERKOOIJ D, 1992, J AM WATER WORKS ASS, V84, P57, DOI 10.1002/j.1551-8833.1992.tb07305.x; Venkateswaran K, 2003, J MICROBIOL METH, V52, P367, DOI 10.1016/S0167-7012(02)00192-6; Vital M, 2008, ENVIRON MICROBIOL, V10, P2387, DOI 10.1111/j.1462-2920.2008.01664.x; Vital M, 2007, MICROBIOL-SGM, V153, P1993, DOI 10.1099/mic.0.2006/005173-0; Vital M, 2012, WATER RES, V46, P4665, DOI 10.1016/j.watres.2012.06.010; Vital M, 2010, APPL ENVIRON MICROB, V76, P6477, DOI 10.1128/AEM.00794-10; Weinrich LA, 2010, WATER RES, V44, P5367, DOI 10.1016/j.watres.2010.06.035	58	79	84	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96354	10.1371/journal.pone.0096354	http://dx.doi.org/10.1371/journal.pone.0096354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796923	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000067
J	Zhao, ZQ; Cheng, XM; Wang, YB; Han, R; Li, L; Xiang, T; He, LH; Long, HX; Zhu, B; He, Y				Zhao, Zhongquan; Cheng, Xiaoming; Wang, Yubo; Han, Rui; Li, Li; Xiang, Tong; He, Luhang; Long, Haixia; Zhu, Bo; He, Yong			Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis	PLOS ONE			English	Article							BREAST-CANCER; TGF-BETA; E-CADHERIN; PROTEIN EXPRESSION; TUMOR PROGRESSION; STAT3 ACTIVATION; POOR-PROGNOSIS; CELLS; INFLAMMATION; EMT	Objective: Epithelial-mesenchymal transition (EMT) plays an important role in cancer tumorigenesis. However, the underlying mechanisms of EMT in lung adenocarcinoma, and how this process might be inhibited, remain to be explored. This study investigated the role of IL-6 in lung adenocarcinoma cell EMT and explored the potential effects of metformin on this process. Methods: Invasion assay and MTT assay was performed to determine cell invasion and cell proliferation. Western blotting, immunofluorescence, real-time PCR, ELISA, and immunohistochemistry were performed to detect the expression of IL-6, E-cadherin, Vimentin, and p-STAT3. Results: We discovered that IL-6, via STAT3 phosphorylation, could promote lung adenocarcinoma cell invasion via EMT in vitro. This was supported by the inverse correlation between E-cadherin and IL-6 expression, positive correlation between IL-6 and vimentin mRNA expression and between STAT3 phosphorylation and IL-6 expression in tumor tissues. Importantly, metformin inhibited tumor growth and distant metastases in tumor-bearing nude mice and reversed IL-6-induced EMT both in vitro and in vivo. Furthermore, we found that blockade of STAT3 phosphorylation might be the underlying mechanism of metformin inhibition of IL-6-induced EMT. Conclusions: Collectively, our present results show that enhanced IL-6 expression, via STAT3 phosphorylation, is a mechanism of EMT in lung adenocarcinoma. We found that metformin could inhibit IL-6-induced EMT possibly by blocking STAT3 phosphorylation.	[Zhao, Zhongquan; Xiang, Tong; He, Luhang; Long, Haixia; Zhu, Bo] Third Mil Med Univ, Inst Canc, Xinqiao Hosp, Chongqing, Peoples R China; [Zhao, Zhongquan] Fuzhhou Gen Hosp Nanjing Mil Commond, Dept Oncol, Fuzhou, Peoples R China; [Cheng, Xiaoming] Third Mil Med Univ, Inst Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China; [Wang, Yubo; Han, Rui; Li, Li; He, Yong] Third Mil Med Univ, Daping Hosp, Dept Resp Med, Chongqing, Peoples R China; [Zhu, Bo] Third Mil Med Univ, Biomed Anal Ctr, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University	Zhu, B (corresponding author), Third Mil Med Univ, Inst Canc, Xinqiao Hosp, Chongqing, Peoples R China.	oncology_bozhu@yahoo.com.cn; zhaozhonquan@sina.com			National Natural Science Foundation of China [81172113, 81071912, 31270845, 81222031]; Chongqing Science Technology Commission [CSTC 2011BB5021]; Chinese "863" Program [2012AA02A201]; National Key Basic Research Program of China [2012CB526603, 2010CB529404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Science Technology Commission(Natural Science Foundation Project of CQ CSTC); Chinese "863" Program(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China)	This work is supported by the National Natural Science Foundation of China (No. 81172113, No. 81071912, No. 31270845, No. 81222031), the Chongqing Science Technology Commission (CSTC 2011BB5021), the Chinese "863" Program (No. 2012AA02A201) and National Key Basic Research Program of China (No. 2012CB526603 and No. 2010CB529404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Berstein LM, 2012, MED ONCOL, V29, P1308, DOI 10.1007/s12032-011-9840-0; Bhola NE, 2013, J CLIN INVEST, V123, P1348, DOI 10.1172/JCI65416; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Cufi S, 2010, CELL CYCLE, V9, P4461, DOI 10.4161/cc.9.22.14048; De Vita F, 1998, J EXP CLIN CANC RES, V17, P413; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; Dohadwala M, 2010, OTOLARYNG HEAD NECK, V142, P753, DOI 10.1016/j.otohns.2010.01.034; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Huang C, 2011, NEOPLASMA, V58, P396, DOI 10.4149/neo_2011_05_396; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Katsumata N, 1996, CLIN CANCER RES, V2, P553; Kida H, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22653; Koh E, 2012, INT J SURG PATHOL, V20, P233, DOI 10.1177/1066896911436274; Li HL, 2014, AM J PHYSIOL-ENDOC M, V306, pE197, DOI 10.1152/ajpendo.00202.2013; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Martin-Castillo B, 2010, CELL CYCLE, V9, P1057, DOI 10.4161/cc.9.6.10994; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Miao Y, 2013, PATHOL ONCOL RES, V19, P281, DOI 10.1007/s12253-012-9580-2; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Mimeault M, 2007, ANN ONCOL, V18, P1605, DOI 10.1093/annonc/mdm070; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Nerstedt A, 2010, DIABETOLOGIA, V53, P2406, DOI 10.1007/s00125-010-1856-z; Oka S, 2012, ANTICANCER RES, V32, P861; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; See AP, 2012, J NEURO-ONCOL, V110, P359, DOI 10.1007/s11060-012-0981-6; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Soltermann A, 2008, CLIN CANCER RES, V14, P7430, DOI 10.1158/1078-0432.CCR-08-0935; Soria G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-130; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tischler V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-127; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yamaji H, 2004, CANCER IMMUNOL IMMUN, V53, P786, DOI 10.1007/s00262-004-0533-9; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yin T, 2007, J SURG RES, V141, P196, DOI 10.1016/j.jss.2006.09.027	49	79	85	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95884	10.1371/journal.pone.0095884	http://dx.doi.org/10.1371/journal.pone.0095884			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24789104	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917300021
J	Calton, MA; Lee, D; Sundaresan, S; Mendus, D; Leu, R; Wangsawihardja, F; Johnson, KR; Mustapha, M				Calton, Melissa A.; Lee, Dasom; Sundaresan, Srividya; Mendus, Diana; Leu, Rose; Wangsawihardja, Felix; Johnson, Kenneth R.; Mustapha, Mirna			A Lack of Immune System Genes Causes Loss in High Frequency Hearing but Does Not Disrupt Cochlear Synapse Maturation in Mice	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; NATURAL-KILLER-CELLS; GUINEA-PIG COCHLEA; OUTER HAIR-CELLS; MHC CLASS-I; DBA/2J MICE; OLIVOCOCHLEAR INNERVATION; POSTNATAL MATURATION; EFFERENT SYNAPSES; AFFERENT-FIBERS	Early cochlear development is marked by an exuberant outgrowth of neurites that innervate multiple targets. The establishment of mature cochlear neural circuits is, however, dependent on the pruning of inappropriate axons and synaptic connections. Such refinement also occurs in the central nervous system (CNS), and recently, genes ordinarily associated with immune and inflammatory processes have been shown to play roles in synaptic pruning in the brain. These molecules include the major histocompatibility complex class I (MHCI) genes, H2-K-b and H2-D-b, and the complement cascade gene, C1qa. Since the mechanisms involved in synaptic refinement in the cochlea are not well understood, we investigated whether these immune system genes may be involved in this process and whether they are required for normal hearing function. Here we report that these genes are not necessary for normal synapse formation and refinement in the mouse cochlea. We further demonstrate that C1qa expression is not necessary for normal hearing in mice but the lack of expression of H2-K-b and H2-D-b causes hearing impairment. These data underscore the importance of the highly polymorphic family of MHCI genes in hearing in mice and also suggest that factors and mechanisms regulating synaptic refinement in the cochlea may be distinct from those in the CNS.	[Calton, Melissa A.; Lee, Dasom; Sundaresan, Srividya; Mendus, Diana; Leu, Rose; Wangsawihardja, Felix; Mustapha, Mirna] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Johnson, Kenneth R.] Jackson Lab, Bar Harbor, ME 04609 USA	Stanford University; Jackson Laboratory	Mustapha, M (corresponding author), Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	mirnam@stanford.edu			National Institute in Deafness and other Communicative Disorders [R01 DC09590, P30 DC010363, R01 DC004301]; Stanford Medical School Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004301, P30DC010363, R01DC009590] Funding Source: NIH RePORTER	National Institute in Deafness and other Communicative Disorders; Stanford Medical School Dean's Postdoctoral Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by research and core grants from the National Institute in Deafness and other Communicative Disorders: R01 DC09590 (Dr. Mirna Mustapha), P30 DC010363 (Dr. Stefan Heller, Stanford University), R01 DC004301 (Dr. Kenneth R. Johnson, Jackson Laboratory) and by a Stanford Medical School Dean's Postdoctoral Fellowship (awarded to Melissa A. Calton). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Barclay M, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-33; Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; BROWN MC, 1987, J COMP NEUROL, V260, P591, DOI 10.1002/cne.902600411; BROWN MC, 1987, J COMP NEUROL, V260, P605, DOI 10.1002/cne.902600412; Bruce LL, 1997, INT J DEV NEUROSCI, V15, P671, DOI 10.1016/S0736-5748(96)00120-7; Bruce LL, 2000, J COMP NEUROL, V423, P532, DOI 10.1002/1096-9861(20000731)423:3<532::AID-CNE14>3.0.CO;2-T; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; COLE KS, 1992, BRAIN RES, V575, P223; Datwani A, 2009, NEURON, V64, P463, DOI 10.1016/j.neuron.2009.10.015; Fang Q, 2012, JARO-J ASSOC RES OTO, V13, P173, DOI 10.1007/s10162-011-0302-3; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; HAFIDI A, 1993, INT J DEV NEUROSCI, V11, P507, DOI 10.1016/0736-5748(93)90024-8; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Huang LC, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-38; Johnson KR, 2008, GENOMICS, V92, P219, DOI 10.1016/j.ygeno.2008.06.007; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; LENOIR M, 1980, ANAT EMBRYOL, V160, P253, DOI 10.1007/BF00305106; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; LIBERMAN MC, 1980, HEARING RES, V3, P189, DOI 10.1016/0378-5955(80)90046-5; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIBERMAN MC, 1982, J ACOUST SOC AM, V72, P1441, DOI 10.1121/1.388677; Liu Q, 2007, J NEUROPHYSIOL, V98, P2215, DOI 10.1152/jn.00284.2007; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; ROMAND MR, 1990, J ELECTRON MICR TECH, V15, P144, DOI 10.1002/jemt.1060150206; Rueda J, 2003, NEUROSCI RES, V45, P401, DOI 10.1016/S0168-0102(03)00009-9; Schott E, 2003, J EXP MED, V198, P1213, DOI 10.1084/jem.20030918; Shin JB, 2010, J NEUROSCI, V30, P9683, DOI 10.1523/JNEUROSCI.1541-10.2010; Simmons DD, 1996, J COMP NEUROL, V370, P551, DOI 10.1002/(SICI)1096-9861(19960708)370:4<551::AID-CNE10>3.0.CO;2-M; Simmons DD, 1996, DEV BRAIN RES, V95, P213; Stephan AH, 2013, J NEUROSCI, V33, P13460, DOI 10.1523/JNEUROSCI.1333-13.2013; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; UZIEL A, 1983, DEV BRAIN RES, V7, P295, DOI 10.1016/0165-3806(83)90186-4; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Xia AP, 2007, JARO-J ASSOC RES OTO, V8, P447, DOI 10.1007/s10162-007-0092-9	46	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94549	10.1371/journal.pone.0094549	http://dx.doi.org/10.1371/journal.pone.0094549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804771	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900012
J	Fu, Y; Qiao, LP; Cao, YM; Zhou, XZ; Liu, Y; Ye, XQ				Fu, Yu; Qiao, Liping; Cao, Yuming; Zhou, Xiaozhou; Liu, Yu; Ye, Xingqian			Structural Elucidation and Antioxidant Activities of Proanthocyanidins from Chinese Bayberry (Myrica rubra Sieb. et Zucc.) Leaves	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PHENOLIC-COMPOUNDS; PEANUT SKINS; IDENTIFICATION; CHROMATOGRAPHY; PROCYANIDINS; OLIGOMERS; POLYMERIZATION; FLAVONOIDS; PLASMA	Proanthocyanidins in Chinese bayberry leaves (PCBLs) were qualitatively analyzed. NMR data suggest that PCBLs are mostly composed of (epi) gallocatechin gallate units. Matrix-assisted laser desorption time-of-flight MS data indicate 95 possible prodelphinidin structures, ranging from dimers to tridecamers. Preparative normal-phase HPLC and further analysis by reverse-phase HPLC together with electrospray ionization MS enabled detection of 20 compounds, including seven newly identified compounds in Chinese bayberry leaves. The antioxidant capacity of PCBLs was evaluated by (1,1-diphenyl-2-picryl-hydrazyl), ferric-reducing antioxidant power, and oxygen radical absorption capacity assays. The EC50 of DPPH radical scavenging activities (as 50% decrease in the initial DPPH concentration) were 7.60 mu g. The FRAP and ORAC values were 8859.336 +/- 978.39 and 12991.61 +/- 1553.34 mu mol Trolox equivalents per gram, respectively. The results indicate the high antioxidant potency of PCBLs.	[Fu, Yu; Qiao, Liping; Cao, Yuming; Zhou, Xiaozhou; Ye, Xingqian] Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc,Fuli Inst Food Sci, Dept Food Sci & Nutr,Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Yu] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, XQ (corresponding author), Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc,Fuli Inst Food Sci, Dept Food Sci & Nutr,Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	psu@zju.edu.cn			Chinese National Key Technologies R&D Program of 12th Five-year Plan [2012BAD31B06]; Province Key Science and Technology Innovation Team Project [2010R50032, 2012T2T123]	Chinese National Key Technologies R&D Program of 12th Five-year Plan; Province Key Science and Technology Innovation Team Project	This project was supported by the Chinese National Key Technologies R&D Program of 12th Five-year Plan (2012BAD31B06) and the Province Key Science and Technology Innovation Team Project (2010R50032, 2012T2T123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 1998, FREE RADICAL BIO MED, V24, P1355, DOI 10.1016/S0891-5849(97)00458-9; Bao JS, 2005, J AGR FOOD CHEM, V53, P2327, DOI 10.1021/jf048312z; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Cespedes CL, 2010, FOOD CHEM, V119, P886, DOI 10.1016/j.foodchem.2009.07.045; Chen KunSong, 2004, Horticultural Reviews, V30, P83, DOI 10.1002/9780470650837.ch3; CZOCHANSKA Z, 1980, J CHEM SOC PERK T 1, P2278, DOI 10.1039/p19800002278; Davis AL, 1996, MAGN RESON CHEM, V34, P887, DOI 10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U; Dinelli G, 2011, J CHROMATOGR A, V1218, P7670, DOI 10.1016/j.chroma.2011.05.065; Feghali K, 2012, J AGR FOOD CHEM, V60, P5728, DOI 10.1021/jf203304v; Fu C, 2007, J AGR FOOD CHEM, V55, P7689, DOI 10.1021/jf071166n; Gu HF, 2008, FOOD RES INT, V41, P208, DOI 10.1016/j.foodres.2007.11.011; Gu LW, 2003, J MASS SPECTROM, V38, P1272, DOI 10.1002/jms.541; Hammerstone JF, 1999, J AGR FOOD CHEM, V47, P490, DOI 10.1021/jf980760h; Hellstrom J, 2007, J AGR FOOD CHEM, V55, P157, DOI 10.1021/jf062441t; Jaiswal R, 2012, J MASS SPECTROM, V47, P502, DOI 10.1002/jms.2954; Karioti A, 2011, J AGR FOOD CHEM, V59, P6412, DOI 10.1021/jf2011535; Khanal RC, 2009, J FOOD SCI, V74, pH52, DOI 10.1111/j.1750-3841.2009.01063.x; Kim KK, 2012, INT J ONCOL, V40, P227, DOI 10.3892/ijo.2011.1198; Kimura H, 2011, J CHROMATOGR A, V1218, P7704, DOI 10.1016/j.chroma.2011.07.024; Koga K, 2013, J FOOD SCI, V78, pH105, DOI 10.1111/1750-3841.12001; Li CM, 2010, J AGR FOOD CHEM, V58, P9033, DOI 10.1021/jf102552b; Li HJ, 2007, ANAL CHEM, V79, P1739, DOI 10.1021/ac061823v; Liu YX, 2010, MOLECULES, V15, P7763, DOI 10.3390/molecules15117763; Masuda T, 2010, BIOSCI BIOTECH BIOCH, V74, P212, DOI 10.1271/bbb.90697; Monagas M, 2007, J AGR FOOD CHEM, V55, P8498, DOI 10.1021/jf071780z; Monagas M, 2009, J AGR FOOD CHEM, V57, P10590, DOI 10.1021/jf901391a; Monagas M, 2010, J PHARMACEUT BIOMED, V51, P358, DOI 10.1016/j.jpba.2009.03.035; Prior RL, 2005, PHYTOCHEMISTRY, V66, P2264, DOI 10.1016/j.phytochem.2005.03.025; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Gonzalez-Centeno MR, 2012, J AGR FOOD CHEM, V60, P11850, DOI 10.1021/jf303047k; Rosales-Castro M, 2012, HOLZFORSCHUNG, V66, P577, DOI 10.1515/hf-2011-0157; Ruiz-Valdiviezo VM, 2009, GAYANA BOT, V66, P206; Sarnoski PJ, 2012, J FOOD SCI, V77, pM242, DOI 10.1111/j.1750-3841.2012.02652.x; Sarnoski PJ, 2012, FOOD CHEM, V131, P927, DOI 10.1016/j.foodchem.2011.09.081; SEIFTER S, 1950, ARCH BIOCHEM, V25, P191; Shoji T, 2006, J CHROMATOGR A, V1102, P206, DOI 10.1016/j.chroma.2005.10.065; Song XY, 2010, MOL CARCINOGEN, V49, P450, DOI 10.1002/mc.20616; Spranger I, 2008, FOOD CHEM, V108, P519, DOI 10.1016/j.foodchem.2007.11.004; Sun BS, 1998, J AGR FOOD CHEM, V46, P4267, DOI 10.1021/jf980366j; Sun WX, 2003, J MASS SPECTROM, V38, P438, DOI 10.1002/jms.456; Tatsuno T, 2012, BIOL PHARM BULL, V35, P909, DOI 10.1248/bpb.35.909; Tong Y, 2009, ARCH PHARM RES, V32, P527, DOI 10.1007/s12272-009-1408-6; Valls J, 2009, J CHROMATOGR A, V1216, P7143, DOI 10.1016/j.chroma.2009.07.030; Wang SJ, 2010, PLANTA MED, V76, P1492, DOI 10.1055/s-0030-1249780; Yang HH, 2011, FOOD CHEM, V128, P1128, DOI 10.1016/j.foodchem.2011.03.118; Yang HH, 2011, J AGR FOOD CHEM, V59, P1622, DOI 10.1021/jf103918v; Yao WR, 2011, J AGR FOOD CHEM, V59, P5312, DOI 10.1021/jf200211m; Yokozawa T., 2012, EVIDENCE BASED COMPL; Zhang SM, 2009, HORTSCIENCE, V44, P487, DOI 10.21273/HORTSCI.44.2.487	49	39	44	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96162	10.1371/journal.pone.0096162	http://dx.doi.org/10.1371/journal.pone.0096162			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805126	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900037
J	Westman, G; Berglund, D; Widen, J; Ingelsson, M; Korsgren, O; Lannfelt, L; Sehlin, D; Lidehall, AK; Eriksson, BM				Westman, Gabriel; Berglund, David; Widen, Johan; Ingelsson, Martin; Korsgren, Olle; Lannfelt, Lars; Sehlin, Dag; Lidehall, Anna-Karin; Eriksson, Britt-Marie			Increased Inflammatory Response in Cytomegalovirus Seropositive Patients with Alzheimer's Disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SIMPLEX-VIRUS TYPE-1; BETA-AMYLOID PEPTIDE; CD8(+) T-CELLS; APOLIPOPROTEIN-E; COGNITIVE IMPAIRMENT; SYSTEMIC INFLAMMATION; ELDERLY PERSONS; INFECTION; DEMENTIA	Alzheimer's disease (AD) has been associated with increased local inflammation in the affected brain regions, and in some studies also with elevated levels of proinflammatory cytokines in peripheral blood. Cytomegalovirus (CMV) is known to promote a more effector-oriented phenotype in the T-cell compartment, increasing with age. The aim of this study was to investigate the inflammatory response of peripheral blood mononuclear cells (PBMCs) from AD patients and non-demented (ND) controls. Using a multiplex Luminex xMAP assay targeting GM-CSF, IFN-gamma, IL-1 beta, IL-2, IL-4, IL-5, IL-6, IL-8, IP-10 and TNF-alpha, cytokine profiles from PBMCs were analysed after stimulation with anti-CD3/CD28 beads, CMV pp65 peptide mix or amyloid beta (A beta) protofibrils, respectively. CMV seropositive AD subjects presented with higher IFN-gamma levels after anti-CD3/ CD28 and CMV pp65 but not after Ab stimulation, compared to CMV seropositive ND controls. When analysing IFN-gamma response to anti-CD3/CD28 stimulation on a subgroup level, CMV seropositive AD subjects presented with higher levels compared to both CMV seronegative AD and CMV seropositive ND subjects. Taken together, our data from patients with clinically manifest AD suggest a possible role of CMV as an inflammatory promoter in AD immunology. Further studies of AD patients at earlier stages of disease, could provide better insight into the pathophysiology.	[Westman, Gabriel; Widen, Johan; Eriksson, Britt-Marie] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Berglund, David; Korsgren, Olle; Lidehall, Anna-Karin] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ingelsson, Martin; Lannfelt, Lars; Sehlin, Dag] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Westman, G (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	gabriel.westman@medsci.uu.se		Berglund, David/0000-0001-8623-0939; Widen, Johan/0000-0001-9186-2607; Sehlin, Dag/0000-0002-9430-3859; Korsgren, Olle/0000-0002-8524-9547	Family Ohlinder-Nielsen's Foundation; Uppsala University; Landstinget i Uppsala lan; Swedish Research Council; Swedish Brain Foundation; Swedish Alzheimer Foundation; Swedish Society of Medicine	Family Ohlinder-Nielsen's Foundation; Uppsala University; Landstinget i Uppsala lan; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; Swedish Alzheimer Foundation; Swedish Society of Medicine	This work was funded by grants from The Family Ohlinder-Nielsen's Foundation, Uppsala University, Landstinget i Uppsala lan, Swedish Research Council (2006-2822, 2006-6326 and 2006-3464), Swedish Brain Foundation, Swedish Alzheimer Foundation and Swedish Society of Medicine, to whom we all express our gratitude. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Aiello AE, 2008, J INFECT DIS, V197, P34, DOI 10.1086/524144; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; Ball MJ, 2012, ALZHEIMERS DEMENT; Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224; Bartlett DB, 2012, AGING CELL, V11, P912, DOI 10.1111/j.1474-9726.2012.00849.x; Beydoun HA, 2010, INT J INFECT DIS, V14, pE154, DOI 10.1016/j.ijid.2009.12.007; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Carbone I, 2013, NEUROBIOL AGING; Derhovanessian E, 2011, J GEN VIROL, V92, P2746, DOI 10.1099/vir.0.036004-0; Di Carlo M, 2010, EUR BIOPHYS J BIOPHY, V39, P877, DOI 10.1007/s00249-009-0439-8; Englund H, 2007, J NEUROCHEM, V103, P334, DOI 10.1111/j.1471-4159.2007.04759.x; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Haan MN, 2008, NEUROBIOL AGING, V29, P1774, DOI 10.1016/j.neurobiolaging.2007.04.020; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Hoozemans JJM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-171; Ingelsson M, 2004, NEUROLOGY, V62, P925, DOI 10.1212/01.WNL.0000115115.98960.37; Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kobayashi N, 2013, BIOCHEM BIOPH RES CO, V430, P907, DOI 10.1016/j.bbrc.2012.12.054; Letenneur L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003637; Lidehall AK, 2005, J CLIN IMMUNOL, V25, P473, DOI 10.1007/s10875-005-5372-8; Lin WR, 2002, J PATHOL, V197, P395, DOI 10.1002/path.1127; Lin WR, 2002, NEUROBIOL DIS, V9, P82, DOI 10.1006/nbdi.2001.0465; Lurain NS, 2013, J INFECT DIS, V208, P564, DOI 10.1093/infdis/jit210; Marz W, 2004, EUR HEART J, V25, P2109, DOI 10.1016/j.ehj.2004.08.024; MICHAUD M, 2013, J AM MED DIR ASS; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Rocha NP, 2012, MOL CELL NEUROSCI, V49, P77, DOI 10.1016/j.mcn.2011.09.005; Rontu R, 2006, CLIN ENDOCRINOL, V64, P265, DOI 10.1111/j.1365-2265.2006.02455.x; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Stowe RP, 2012, J MED VIROL, V84, P1797, DOI 10.1002/jmv.23397; Strandberg TE, 2003, STROKE, V34, P2126, DOI 10.1161/01.STR.0000086754.32238.DA; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tabaton M, 2010, EXP NEUROL, V221, P18, DOI 10.1016/j.expneurol.2009.09.002; Tarter KD, 2014, J INFECT DIS, V209, P837, DOI 10.1093/infdis/jit616; van Exel E, 2009, ARCH GEN PSYCHIAT, V66, P1263, DOI 10.1001/archgenpsychiatry.2009.146; Walker S, 2007, TRANSPL INFECT DIS, V9, P165, DOI 10.1111/j.1399-3062.2006.00199.x; Westman G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077921; Wozniak Matthew A, 2010, Ther Adv Neurol Disord, V3, P141, DOI 10.1177/1756285610370069	42	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96779	10.1371/journal.pone.0096779	http://dx.doi.org/10.1371/journal.pone.0096779			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804776	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900093
J	Xu, L; Zhong, NJ; Xie, YY; Huang, HL; Jiang, GB; Liu, YJ				Xu, Li; Zhong, Nan-Jing; Xie, Yang-Yin; Huang, Hong-Liang; Jiang, Guang-Bin; Liu, Yun-Jun			Synthesis, Characterization, In Vitro Cytotoxicity, and Apoptosis-Inducing Properties of Ruthenium( II) Complexes	PLOS ONE			English	Article							DEOXYRIBONUCLEIC-ACID; ANTICANCER ACTIVITY; DNA; BINDING; RU(II); 9,10-ANTHRACENEDICARBOXALDEHYDE; CANCER	Two new Ru(II) complexes, [Ru(bpy)(2)(FAMP)](ClO4)(2) 1 and 2, are synthesized and characterized by elemental analysis, electrospray mass spectrometry, and 1 H nuclear magnetic resonance. The in vitro cytotoxicities and apoptosis-inducing properties of these complexes are extensively studied. Complexes 1 and 2 exhibit potent antiproliferative activities against a panel of human cancer cell lines. The cell cycle analysis shows that complexes 1 and 2 exhibit effective cell growth inhibition by triggering G0/G1 phase arrest and inducing apoptosis by mitochondrial dysfunction. The in vitro DNA binding properties of the two complexes are investigated by different spectrophotometric methods and viscosity measurements.	[Xu, Li] Guangdong Pharmaceut Univ, Sch Chem & Chem Engn, Zhongshan, Peoples R China; [Zhong, Nan-Jing] Guangdong Pharmaceut Univ, Sch Food Sci, Zhongshan, Peoples R China; [Xie, Yang-Yin; Jiang, Guang-Bin; Liu, Yun-Jun] Guangdong Pharmaceut Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China; [Huang, Hong-Liang] Guangdong Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University	Xu, L (corresponding author), Guangdong Pharmaceut Univ, Sch Chem & Chem Engn, Zhongshan, Peoples R China.	xuli473@163.com; lyjche@163.com	Huang, Hongliang/GYI-9500-2022	Huang, Hongliang/0000-0003-0887-5621	National Nature Science Foundation of China [21301034, 31070858]; National Science Foundation of Guangdong Province [S2013040014083]; Guangdong Pharmaceutical University	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Pharmaceutical University	This work was supported by the National Nature Science Foundation of China (No. 21301034, 31070858), the National Science Foundation of Guangdong Province (S2013040014083) and Guangdong Pharmaceutical University for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON JK, 1984, J AM CHEM SOC, V106, P2466, DOI 10.1021/ja00320a058; Bratsos I, 2007, CHIMIA, V61, P692, DOI 10.2533/chimia.2007.692; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; CITARELLA RV, 1982, CANCER RES, V42, P440; Clarke MJ, 2003, COORDIN CHEM REV, V236, P207, DOI 10.1016/S0010-8545(02)00311-9; COHEN G, 1969, BIOPOLYMERS, V8, P45, DOI 10.1002/bip.1969.360080105; FRIEDMAN AE, 1990, J AM CHEM SOC, V112, P4960, DOI 10.1021/ja00168a052; Gasser G, 2011, J MED CHEM, V54, P3, DOI 10.1021/jm100020w; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Grau-Campistany A, 2013, MOL PHARMACEUT, V10, P1964, DOI 10.1021/mp300723b; Gupta RK, 2013, INORG CHEM, V52, P3687, DOI 10.1021/ic302196v; Han MJ, 2007, J PHYS CHEM C, V111, P16577, DOI 10.1021/jp075194k; Hartinger CG, 2008, CURR MED CHEM, V15, P2574, DOI 10.2174/092986708785908978; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; KLANDERMAN BH, 1966, J ORG CHEM, V31, P2618, DOI 10.1021/jo01346a038; Liao GL, 2012, CHEM COMMUN, V48, P10781, DOI 10.1039/c2cc36039j; Liu YA, 2011, EUR J INORG CHEM, P1974, DOI 10.1002/ejic.201000968; Lo KKW, 2008, INORG CHEM, V47, P200, DOI 10.1021/ic701735q; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; Meng X, 2007, CANCER RES, V69, P5458; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEYHART GA, 1993, J AM CHEM SOC, V115, P4423, DOI 10.1021/ja00064a001; Palanimuthu D, 2013, J MED CHEM, V56, P722, DOI 10.1021/jm300938r; Paw W, 1997, INORG CHEM, V36, P2287, DOI 10.1021/ic9610851; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; REICHMANN ME, 1954, J AM CHEM SOC, V76, P3047, DOI 10.1021/ja01640a067; SATYANARAYANA S, 1993, BIOCHEMISTRY-US, V32, P2573, DOI 10.1021/bi00061a015; SATYANARAYANA S, 1992, BIOCHEMISTRY-US, V31, P9319, DOI 10.1021/bi00154a001; Smith GS, 2011, DALTON T, V40, P10793, DOI 10.1039/c1dt11007a; Sorenson J R, 1989, Prog Med Chem, V26, P437, DOI 10.1016/S0079-6468(08)70246-7; SULLIVAN BP, 1978, INORG CHEM, V17, P3334, DOI 10.1021/ic50190a006; TSELEPIKALOULI E, 1989, J INORG BIOCHEM, V37, P271, DOI 10.1016/0162-0134(89)85002-0; WOLFE A, 1987, BIOCHEMISTRY-US, V26, P6392, DOI 10.1021/bi00394a013; Zhang HY, 2011, MAR DRUGS, V9, P1502, DOI 10.3390/md9091502	34	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96082	10.1371/journal.pone.0096082	http://dx.doi.org/10.1371/journal.pone.0096082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804832	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900035
J	Hatzold, K; Mavhu, W; Jasi, P; Chatora, K; Cowan, FM; Taruberekera, N; Mugurungi, O; Ahanda, K; Njeuhmeli, E				Hatzold, Karin; Mavhu, Webster; Jasi, Phineas; Chatora, Kumbirai; Cowan, Frances M.; Taruberekera, Noah; Mugurungi, Owen; Ahanda, Kim; Njeuhmeli, Emmanuel			Barriers and Motivators to Voluntary Medical Male Circumcision Uptake among Different Age Groups of Men in Zimbabwe: Results from a Mixed Methods Study	PLOS ONE			English	Article							ACCEPTABILITY; PREVENTION	Background: We conducted quantitative and qualitative studies to explore barriers and motivating factors to VMMC for HIV prevention, and to assess utilization of existing VMMC communication channels. Methods and Findings: A population-based survey was conducted with 2350 respondents aged 15-49. Analysis consisted of descriptive statistics and bivariate analysis between circumcision and selected demographics. Logistic regression was used to determine predictors of male circumcision uptake compared to intention to circumcise. Focus group discussions (FGDs) were held with men purposively selected to represent a range of ethnicities. 68% and 53% of female/male respondents, respectively, had heard about VMMC for HIV prevention, mostly through the radio (71%). Among male respondents, 11.3% reported being circumcised and 49% reported willingness to undergo VMMC. Factors which men reported motivated them to undergo VMMC included HIV/STI prevention (44%), improved hygiene (26%), enhanced sexual performance (6%) and cervical cancer prevention for partner (6%). Factors that deterred men from undergoing VMMC included fear of pain (40%), not believing that they were at risk of HIV (18%), lack of partner support (6%). Additionally, there were differences in motivators and barriers by age. FGDs suggested additional barriers including fear of HIV testing, partner refusal, reluctance to abstain from sex and myths and misconceptions. Conclusions: VMMC demand-creation messages need to be specifically tailored for different ages and should emphasize non-HIV prevention benefits, such as improved hygiene and sexual appeal, and need to address men's fear of pain. Promoting VMMC among women is crucial as they appear to have considerable influence over men's decision to get circumcised.	[Hatzold, Karin; Jasi, Phineas; Chatora, Kumbirai] Populat Serv Int, Harare, Zimbabwe; [Mavhu, Webster; Cowan, Frances M.] Ctr Sexual Hlth & HIV AIDS Res CeSHHAR, Harare, Zimbabwe; [Mavhu, Webster; Cowan, Frances M.] UCL, Ctr Sexual Hlth & HIV Res, London, England; [Taruberekera, Noah] Populat Serv Int, Washington, DC USA; [Mugurungi, Owen] Minist Hlth & Child Welf, Harare, Zimbabwe; [Ahanda, Kim; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	University of London; University College London; United States Agency for International Development (USAID)	Hatzold, K (corresponding author), Populat Serv Int, Harare, Zimbabwe.	khatzold@psi-zim.co.zw		Mavhu, Webster/0000-0003-1881-4398; Cowan, Frances/0000-0003-3087-4422	PEPFAR through the USAID [674-A-00-10-00081-00]; PSI	PEPFAR through the USAID(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); PSI	This review is funded by PEPFAR through the USAID under a Cooperative Agreement # 674-A-00-10-00081-00 with PSI. The opinions herein are those of the authors and do not necessarily reflect the views of USAID. However, the funder USAID played a significant technical role in study design, analysis, decision to publish, and preparation of the manuscript.	Albert LM, 2011, AIDS CARE, V23, P1578, DOI 10.1080/09540121.2011.579939; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Bertrand JT, 2012, SYSTEMATIC MONITORIN; Green J, 2009, QUALITATIVE METHODS; Halperin DT, 2005, SEX TRANSM DIS, V32, P238, DOI 10.1097/01.olq.0000149782.47456.5b; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Hershfield L, 2004, CHANGING BEHAV PRACT; International Initiative for Impact Evaluation, 2013, SCOP REP INT INCR DE; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Mavhu W, 2011, TROP MED INT HEALTH, V16, P589, DOI 10.1111/j.1365-3156.2011.02744.x; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; UNDP, 2012, ZIMB MILL DEV GOALS; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO and UNAIDS, 2011, PROGR MAL CIRC SCAL; WHO/UNAIDS, 2009, GUID IND MAL CIRC PR; Zimbabwe Central Statistical Office, 2007, ZIMB DEM HLTH SURV Z; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2	20	72	73	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e85051	10.1371/journal.pone.0085051	http://dx.doi.org/10.1371/journal.pone.0085051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802746	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800013
J	Kumar, M; Gantasala, NP; Roychowdhury, T; Thakur, PK; Banakar, P; Shukla, RN; Jones, MGK; Rao, U				Kumar, Mukesh; Gantasala, Nagavara Prasad; Roychowdhury, Tanmoy; Thakur, Prasoon Kumar; Banakar, Prakash; Shukla, Rohit N.; Jones, Michael G. K.; Rao, Uma			De Novo Transcriptome Sequencing and Analysis of the Cereal Cyst Nematode, Heterodera avenae	PLOS ONE			English	Article							NEUROPEPTIDE GENE FAMILIES; PLANT-PARASITIC NEMATODES; ESOPHAGEAL GLAND-CELLS; ROOT-LESION NEMATODE; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; CHORISMATE MUTASE; MOLECULAR CHARACTERIZATION; GLOBODERA-PALLIDA; PHARYNGEAL GLAND	The cereal cyst nematode (CCN, Heterodera avenae) is a major pest of wheat (Triticum spp) that reduces crop yields in many countries. Cyst nematodes are obligate sedentary endoparasites that reproduce by amphimixis. Here, we report the first transcriptome analysis of two stages of H. avenae. After sequencing extracted RNA from pre parasitic infective juvenile and adult stages of the life cycle, 131 million Illumina high quality paired end reads were obtained which generated 27,765 contigs with N50 of 1,028 base pairs, of which 10,452 were annotated. Comparative analyses were undertaken to evaluate H. avenae sequences with those of other plant, animal and free living nematodes to identify differences in expressed genes. There were 4,431 transcripts common to H. avenae and the free living nematode Caenorhabditis elegans, and 9,462 in common with more closely related potato cyst nematode, Globodera pallida. Annotation of H. avenae carbohydrate active enzymes (CAZy) revealed fewer glycoside hydrolases (GHs) but more glycosyl transferases (GTs) and carbohydrate esterases (CEs) when compared to M. incognita. 1,280 transcripts were found to have secretory signature, presence of signal peptide and absence of transmembrane. In a comparison of genes expressed in the pre-parasitic juvenile and feeding female stages, expression levels of 30 genes with high RPKM (reads per base per kilo million) value, were analysed by qRT-PCR which confirmed the observed differences in their levels of expression levels. In addition, we have also developed a user-friendly resource, Heterodera transcriptome database (HATdb) for public access of the data generated in this study. The new data provided on the transcriptome of H. avenae adds to the genetic resources available to study plant parasitic nematodes and provides an opportunity to seek new effectors that are specifically involved in the H. avenae-cereal host interaction.	[Kumar, Mukesh; Gantasala, Nagavara Prasad; Thakur, Prasoon Kumar; Banakar, Prakash; Rao, Uma] Indian Agr Res Inst, Div Nematol, New Delhi 110012, India; [Roychowdhury, Tanmoy] Jawaharlal Nehru Univ, Sch Computat & Integrat Sci, New Delhi 110067, India; [Jones, Michael G. K.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Shukla, Rohit N.] Bionivid Technol P Ltd, Bangalore, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Jawaharlal Nehru University, New Delhi; Murdoch University	Rao, U (corresponding author), Indian Agr Res Inst, Div Nematol, New Delhi 110012, India.	umarao@iari.res.in	banakar, prakash/Q-1204-2019; Jones, Michael G.K./M-5932-2013; Roychowdhury, Tanmoy/AAZ-7889-2021	Jones, Michael G.K./0000-0001-5002-0227; thakur, prasoon kumar/0000-0003-2217-9008; Shukla, Rohit/0000-0001-8279-5377; Roychowdhury, Tanmoy/0000-0002-1187-1720	Department of Biotechnology, Government of India under the Indo-Australia Strategic Research fund [PR12678]; Australia-India Strategic Research Fund [BF030027]	Department of Biotechnology, Government of India under the Indo-Australia Strategic Research fund; Australia-India Strategic Research Fund(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors would like to thank the Department of Biotechnology, Government of India for financial support under the Indo-Australia Strategic Research fund (PR12678). M. G. K. Jones thanks the Australia-India Strategic Research Fund (BF030027) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alkharouf NW, 2007, EXP PARASITOL, V115, P247, DOI 10.1016/j.exppara.2006.09.009; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Barker WC, 2000, NUCLEIC ACIDS RES, V28, P41, DOI 10.1093/nar/28.1.41; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown RH, 1987, PRINCIPLES PRACTICE, Vxiv; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castagnone-Sereno P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-598; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOPER AF, 1970, J NEMATOL, V2, P305; Cotton JA, 2014, GENOME BIOL, V15, pR43, DOI DOI 10.1186/gb-2014-15-3-r43; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Davis EL, 2004, TRENDS PARASITOL, V20, P134, DOI 10.1016/j.pt.2004.01.005; Davis EL, 2008, CURR OPIN PLANT BIOL, V11, P360, DOI 10.1016/j.pbi.2008.04.003; De Boer JM, 2002, MOL PLANT PATHOL, V3, P261, DOI 10.1046/j.1364-3703.2002.00122.x; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; DSCa Pankaj, 1998, PATHOLOGICAL PROBLEM, P95; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Evgen'ev MB, 2005, CYTOGENET GENOME RES, V110, P510, DOI 10.1159/000084984; Farias LP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001510; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gao B, 2001, INT J PARASITOL, V31, P1617, DOI 10.1016/S0020-7519(01)00300-9; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gheysen G, 2002, ANNU REV PHYTOPATHOL, V40, P191, DOI 10.1146/annurev.phyto.40.121201.093719; Goellner M, 2001, PLANT CELL, V13, P2241, DOI 10.1105/tpc.13.10.2241; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Husson SJ, 2007, PROG NEUROBIOL, V82, P33, DOI 10.1016/j.pneurobio.2007.01.006; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jones D, 2004, CUTIS, V74, P17; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Jones JT, 2003, MOL PLANT PATHOL, V4, P43, DOI 10.1046/j.1364-3703.2003.00140.x; JONES MGK, 1981, ANN APPL BIOL, V97, P353, DOI 10.1111/j.1744-7348.1981.tb05122.x; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kimber MJ, 2005, PARASITOLOGY, V131, pS129, DOI 10.1017/S0031182005009157; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li C, 2005, PARASITOLOGY, V131, pS109, DOI 10.1017/S0031182005009376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Maizels RM, 2000, INT J PARASITOL, V30, P495, DOI 10.1016/S0020-7519(00)00022-9; Matthews BF, 2004, J NEMATOL, V36, P457; McVeigh P, 2005, INT J PARASITOL, V35, P1043, DOI 10.1016/j.ijpara.2005.05.010; Miller HT, 2008, PUBLIC ADM PUBLIC PO, V134, P13; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; Mitreva M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r75; Mokabli A, 2001, NEMATOLOGY, V3, P171, DOI 10.1163/156854101750236303; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; Nicol P, 2012, INT J PARASITOL, V42, P225, DOI 10.1016/j.ijpara.2011.11.010; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Papolu PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080603; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Qin L, 2000, MOL PLANT MICROBE IN, V13, P830, DOI 10.1094/MPMI.2000.13.8.830; Rao U, 2013, BIOINFORMATION, V9, P67, DOI 10.6026/97320630009067; Rehman S, 2009, MOL PLANT MICROBE IN, V22, P330, DOI 10.1094/MPMI-22-3-0330; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Replogle A, 2013, MOL PLANT MICROBE IN, V26, P87, DOI 10.1094/MPMI-05-12-0118-FI; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Rose PW, 2011, NUCLEIC ACIDS RES, V39, pD392, DOI 10.1093/nar/gkq1021; Sela N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r59; Shingles J, 2007, EXP PARASITOL, V115, P114, DOI 10.1016/j.exppara.2006.07.008; Smit A, 1996, REPEATMASKER OPEN 30; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Tateno Y, 2002, NUCLEIC ACIDS RES, V30, P27, DOI 10.1093/nar/30.1.27; Tytgat T, 2004, MOL PLANT MICROBE IN, V17, P846, DOI 10.1094/MPMI.2004.17.8.846; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Vanholme B, 2006, PARASITOL RES, V98, P414, DOI 10.1007/s00436-005-0029-3; Vanholme B, 2004, GENE, V332, P13, DOI [10.1016/j.gene.2004.02.024, 10.1016/j.gnee.2004.02.024]; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang XH, 2001, MOL PLANT MICROBE IN, V14, P536, DOI 10.1094/MPMI.2001.14.4.536; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wieczorek K, 2006, PLANT SIGNAL BEHAV, V1, P223, DOI 10.4161/psb.1.5.3426; WYSS U, 1992, NETH J PLANT PATHOL, V98, P165, DOI 10.1007/BF01974483; Yan GP, 2010, PHYTOPATHOLOGY, V100, P216, DOI 10.1094/PHYTO-100-3-0216; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	95	46	46	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96311	10.1371/journal.pone.0096311	http://dx.doi.org/10.1371/journal.pone.0096311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802510	Green Published, gold			2022-12-27	WOS:000338029800052
J	Nouri, S; Arevalo, R; Falk, BW; Groves, RL				Nouri, Shahideh; Arevalo, Rafael; Falk, Bryce W.; Groves, Russell L.			Genetic Structure and Molecular Variability of Cucumber mosaic virus Isolates in the United States	PLOS ONE			English	Article							RNA REPLICATION PROTEINS; COAT PROTEIN; BIOLOGICAL VARIATION; NATURAL-POPULATIONS; SYMPTOM EXPRESSION; RECOMBINATION; PLANT; EVOLUTION; TRANSMISSION; SELECTION	Cucumber mosaic virus (CMV) has a worldwide distribution and the widest host range of any known plant virus. From 2000 to 2012, epidemics of CMV severely affected the production of snap bean (Phaseulos vulgaris L.) in the Midwest and Northeastern United States. Virus diversity leading to emergence of new strains is often considered a significant factor in virus epidemics. In addition to epidemics, new disease phenotypes arising from genetic exchanges or mutation can compromise effectiveness of plant disease management strategies. Here, we captured a snapshot of genetic variation of 32 CMV isolates collected from different regions of the U. S including new field as well as historic isolates. Nucleotide diversity (p) was low for U. S. CMV isolates. Sequence and phylogenetic analyses revealed that CMV subgroup I is predominant in the US and further showed that the CMV population is a mixture of subgroups IA and IB. Furthermore, phylogenetic analysis suggests likely reassortment between subgroups IA and IB within five CMV isolates. Based on phylogenetic and computational analysis, recombination between subgroups I and II as well as IA and IB in RNA 3 was detected. This is the first report of recombination between CMV subgroups I and II. Neutrality tests illustrated that negative selection was the major force operating upon the CMV genome, although some positively selected sites were detected for all encoded proteins. Together, these data suggest that different regions of the CMV genome are under different evolutionary constraints. These results also delineate composition of the CMV population in the US, and further suggest that recombination and reassortment among strain subgroups does occur but at a low frequency, and point towards CMV genomic regions that differ in types of selection pressure.	[Nouri, Shahideh] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Arevalo, Rafael] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Groves, Russell L.] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Groves, RL (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	groves@entomology.wisc.edu		Yan, Zhiyong/0000-0001-8253-0694	University of Wisconsin; Midwest Food Processors Association	University of Wisconsin; Midwest Food Processors Association	This work was partially supported by a combination of Hatch Formula 142 founding (University of Wisconsin) and the Midwest Food Processors Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2011, PHYTOPATHOLOGY, V101, P1136, DOI 10.1094/PHYTO-01-11-0017; Ali A, 2006, J VIROL, V80, P8345, DOI 10.1128/JVI.00568-06; Aranda MA, 1997, J MOL EVOL, V44, P81, DOI 10.1007/PL00006124; BOCCARD F, 1993, VIROLOGY, V193, P563, DOI 10.1006/viro.1993.1165; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bonnet J, 2005, VIROLOGY, V332, P359, DOI 10.1016/j.virol.2004.11.017; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Canto T, 1997, VIROLOGY, V237, P237, DOI 10.1006/viro.1997.8804; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Chen YF, 2007, VIRUS GENES, V35, P405, DOI 10.1007/s11262-007-0094-z; Chen YK, 2002, J VIROL, V76, P4119, DOI 10.1128/JVI.76.8.4119-4124.2002; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; DING SW, 1994, VIROLOGY, V198, P593, DOI 10.1006/viro.1994.1071; Domingo E, 1988, BOCA RATON; Eiras M, 2004, J PLANT PATHOL, V86, P61; Escriu F, 2007, PLOS PATHOG, V3, P67, DOI 10.1371/journal.ppat.0030008; Fraile A, 1997, J VIROL, V71, P934, DOI 10.1128/JVI.71.2.934-940.1997; Gallitelli D, 2000, VIRUS RES, V71, P9, DOI 10.1016/S0168-1702(00)00184-2; Garcia-Arenal F, 2000, VIRUS RES, V71, P1, DOI 10.1016/S0168-1702(00)00183-0; Garcia-Arenal F, 2001, ANNU REV PHYTOPATHOL, V39, P157, DOI 10.1146/annurev.phyto.39.1.157; German TL, 2004, P 2004 MIDW FOOD PRO; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Glasa M, 2002, ARCH VIROL, V147, P563, DOI 10.1007/s007050200006; Grau CR, 2002, P WIS FERT AGL PEST, V41, P248; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAYES RJ, 1990, CELL, V63, P363, DOI 10.1016/0092-8674(90)90169-F; HOLLAND JJ, 1992, CURR TOP MICROBIOL, V176, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KAO CC, 1992, J VIROL, V66, P7293, DOI 10.1128/JVI.66.12.7293-7302.1992; Kobori Takashi, 2002, Journal of General Plant Pathology, V68, P81, DOI 10.1007/PL00013059; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Koundal V, 2011, BIOCHEM GENET, V49, P25, DOI 10.1007/s10528-010-9382-8; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larsen RC, 2002, ANN REP BEAN IMPROV, V45, P36; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Lewsey MG, 2010, PLANT SIGNAL BEHAV, V5, P705, DOI 10.4161/psb.5.6.11643; Li HY, 2004, J VIROL, V78, P10582, DOI 10.1128/JVI.78.19.10582-10587.2004; Lin HX, 2004, J VIROL, V78, P6666, DOI 10.1128/JVI.78.12.6666-6675.2004; Lin HX, 2003, J GEN VIROL, V84, P249, DOI 10.1099/vir.0.18673-0; Liu YY, 2009, ACTA VIROL, V53, P89, DOI 10.4149/av_2009_02_89; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Morse S.S., 1994, EVOLUTIONARY BIOL VI; MOSSOP DW, 1977, VIROLOGY, V81, P177, DOI 10.1016/0042-6822(77)90071-X; Moury B, 2004, MOL BIOL EVOL, V21, P1602, DOI 10.1093/molbev/msh164; Moury B, 2002, J GEN VIROL, V83, P2563, DOI 10.1099/0022-1317-83-10-2563; Nault B.A., 2006, P 2006 EMP STAT FRUI, P74; OReilly EK, 1997, J VIROL, V71, P7526, DOI 10.1128/JVI.71.10.7526-7532.1997; OWEN J, 1988, VIROLOGY, V166, P495, DOI 10.1016/0042-6822(88)90520-X; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; PEDEN KWC, 1973, VIROLOGY, V53, P487, DOI 10.1016/0042-6822(73)90232-8; PERRY KL, 1994, VIROLOGY, V205, P591, DOI 10.1006/viro.1994.1686; Perry KL, 1998, VIROLOGY, V242, P204, DOI 10.1006/viro.1998.8991; Perry KL, 1992, J GEN VIROL; Pierrugues O, 2007, J GEN VIROL, V88, P2852, DOI 10.1099/vir.0.83077-0; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; RIZOS H, 1992, J GEN VIROL, V73, P2099, DOI 10.1099/0022-1317-73-8-2099; ROBINSON DJ, 1987, J GEN VIROL, V68, P2551, DOI 10.1099/0022-1317-68-10-2551; RODRIGUEZALVARADO G, 1995, PLANT DIS, V79, P450, DOI 10.1094/PD-79-0450; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roossinck MJ, 2002, J VIROL, V76, P3382, DOI 10.1128/JVI.76.7.3382-3387.2002; Roossinck MJ, 1999, J VIROL, V73, P6752, DOI 10.1128/JVI.73.8.6752-6758.1999; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schirmer A, 2005, J GEN VIROL, V86, P2897, DOI 10.1099/vir.0.81167-0; SCHWINGHAMER MW, 1977, VIROLOGY, V79, P88, DOI 10.1016/0042-6822(77)90337-3; Sclavounos AP, 2006, EUR J PLANT PATHOL, V115, P163, DOI 10.1007/s10658-006-0010-8; Shi BJ, 2008, NUCLEIC ACIDS RES, V36, P1057, DOI 10.1093/nar/gkm1036; SHINTAKU MH, 1992, PLANT CELL, V4, P751, DOI 10.1105/tpc.4.7.751; Smith TJ, 2000, J VIROL, V74, P7578, DOI 10.1128/JVI.74.16.7578-7586.2000; Sulistyowati E, 2004, AUSTRALAS PLANT PATH, V33, P505, DOI 10.1071/AP04054; SUZUKI M, 1995, J GEN VIROL, V76, P1791, DOI 10.1099/0022-1317-76-7-1791; Takeshita M, 2001, ARCH VIROL, V146, P697, DOI 10.1007/s007050170140; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsompana M, 2005, MOL ECOL, V14, P53, DOI 10.1111/j.1365-294X.2004.02392.x; WAHYUNI WS, 1992, PLANT PATHOL, V41, P282, DOI 10.1111/j.1365-3059.1992.tb02350.x; Webster RG, 1995, MOL BASIS VIRUS EVOL, P531; WHITE PS, 1995, VIROLOGY, V207, P334, DOI 10.1006/viro.1995.1088	87	34	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96582	10.1371/journal.pone.0096582	http://dx.doi.org/10.1371/journal.pone.0096582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801880	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800087
J	Qiu, Z; Jiang, H; Ding, J; Hu, Y; Shang, X				Qiu, Z.; Jiang, H.; Ding, J.; Hu, Y.; Shang, X.			Pollen and Phytolith Evidence for Rice Cultivation and Vegetation Change during the Mid-Late Holocene at the Jiangli Site, Suzhou, East China (vol 9, 2014)	PLOS ONE			English	Correction														Qiu, Zhenwei/0000-0001-5751-5476				Qiu ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086816; 2014, PLOS ONE, V9, P97395, DOI DOI 10.1371/JOURNAL.PONE.0097541	2	2	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e97541	10.1371/journal.pone.0097541	http://dx.doi.org/10.1371/journal.pone.0097541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801163	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800142
J	Taillebois, E; Beloula, A; Quinchard, S; Jaubert-Possamai, S; Daguin, A; Servent, D; Tagu, D; Thany, SH; Tricoire-Leignel, H				Taillebois, Emiliane; Beloula, Abdelhamid; Quinchard, Sophie; Jaubert-Possamai, Stephanie; Daguin, Antoine; Servent, Denis; Tagu, Denis; Thany, Steeve H.; Tricoire-Leignel, Helene			Neonicotinoid Binding, Toxicity and Expression of Nicotinic Acetylcholine Receptor Subunits in the Aphid Acyrthosiphon pisum	PLOS ONE			English	Article							MYZUS-PERSICAE HEMIPTERA; REAL-TIME PCR; ALPHA-BUNGAROTOXIN BINDING; PEACH-POTATO APHID; INSECT MEMBRANES; MUSCA-DOMESTICA; GENES; NORMALIZATION; THIAMETHOXAM; IDENTIFICATION	Neonicotinoid insecticides act on nicotinic acetylcholine receptor and are particularly effective against sucking pests. They are widely used in crops protection to fight against aphids, which cause severe damage. In the present study we evaluated the susceptibility of the pea aphid Acyrthosiphon pisum to the commonly used neonicotinoid insecticides imidacloprid (IMI), thiamethoxam (TMX) and clothianidin (CLT). Binding studies on aphid membrane preparations revealed the existence of high and low-affinity binding sites for [H-3]-IMI (Kd of 0.16 +/- 0.04 nM and 41.7 +/- 5.9 nM) and for the nicotinic antagonist [I-125]-alpha- bungarotoxin (Kd of 0.008 +/- 0.002 nM and 1.135 +/- 0.213 nM). Competitive binding experiments demonstrated that TMX displayed a higher affinity than IMI for [I-125]-alpha-bungarotoxin binding sites while CLT affinity was similar for both [I-125]-alpha-bungarotoxin and [H-3]-IMI binding sites. Interestingly, toxicological studies revealed that at 48 h, IMI (LC50 = 0.038 mu g/ml) and TMX (LC50 = 0.034 mu g/ml) were more toxic than CLT (LC50 = 0.118 mu g/ml). The effect of TMX could be associated to its metabolite CLT as demonstrated by HPLC/MS analysis. In addition, we found that aphid larvae treated either with IMI, TMX or CLT showed a strong variation of nAChR subunit expression. Using semi-quantitative PCR experiments, we detected for all insecticides an increase of Apisum alpha 10 and Apisum beta 1 expressions levels, whereas Apisum beta 2 expression decreased. Moreover, some other receptor subunits seemed to be differently regulated according to the insecticide used. Finally, we also demonstrated that nAChR subunit expression differed during pea aphid development. Altogether these results highlight species specificity that should be taken into account in pest management strategies.	[Taillebois, Emiliane; Beloula, Abdelhamid; Quinchard, Sophie; Thany, Steeve H.; Tricoire-Leignel, Helene] Univ Angers, Lab Recepteurs & Canaux Ion Membranaires RCIM, UPRES EA 2647, USC INRA 1330,SFR QUASAV 4207, Angers, France; [Jaubert-Possamai, Stephanie; Tagu, Denis] INRA, UMR 1349, Inst Genet Environm & Protect Plantes, Le Rheu, France; [Daguin, Antoine] Grp Interprofess Rech Prod Agropharmaceut, Angers, France; [Servent, Denis] CEA, Inst Biol & Technol iBiTecS, Serv Ingn Mol Prot SIMOPRO, Gif Sur Yvette, France	INRAE; Universite d'Angers; INRAE; CEA; UDICE-French Research Universities; Universite Paris Saclay	Thany, SH (corresponding author), Univ Angers, Lab Recepteurs & Canaux Ion Membranaires RCIM, UPRES EA 2647, USC INRA 1330,SFR QUASAV 4207, Angers, France.	steeve.thany@univ-angers.fr	Tricoire-Leignel, Hélène/ABG-2320-2020	Tricoire-Leignel, Hélène/0000-0002-2881-2962; quinchard, sophie/0000-0002-2137-8374; taillebois, emiliane/0000-0003-1675-9196; Tagu, Denis/0000-0002-6320-8648; THANY, Steeve/0000-0002-4333-177X; Servent, Denis/0000-0002-0774-1691	French Institute for Agricultural Research (INRA); Department 'Sante des Plantes et Environnement (SPE)': USC RCIM/UMR BIO3P; French 'Ministere de la Recherche et de l'Enseignement Superieur'	French Institute for Agricultural Research (INRA); Department 'Sante des Plantes et Environnement (SPE)': USC RCIM/UMR BIO3P; French 'Ministere de la Recherche et de l'Enseignement Superieur'	This work was supported by a specific grant from the French Institute for Agricultural Research (INRA), the Department 'Sante des Plantes et Environnement (SPE)': USC RCIM/UMR BIO3P. E. Taillebois acknowledges the French 'Ministere de la Recherche et de l'Enseignement Superieur' for financial support in the framework of Ph.D grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Benzidane Y, 2010, PEST MANAG SCI, V66, P1351, DOI 10.1002/ps.2022; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dale RP, 2010, INSECT MOL BIOL, V19, P141, DOI 10.1111/j.1365-2583.2009.00975.x; Dedryver CA, 2010, CR BIOL, V333, P539, DOI 10.1016/j.crvi.2010.03.009; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Foster SP, 2008, PEST MANAG SCI, V64, P1111, DOI 10.1002/ps.1648; Gao JR, 2007, INSECT MOL BIOL, V16, P325, DOI 10.1111/j.1365-2583.2007.00730.x; Grauso M, 2002, GENETICS, V160, P1519; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Johnson DR, 2005, APPL ENVIRON MICROB, V71, P3866, DOI 10.1128/AEM.71.7.3866-3871.2005; Kayser H, 2004, PEST MANAG SCI, V60, P945, DOI 10.1002/ps.919; Lansdell SJ, 2000, NEUROPHARMACOLOGY, V39, P671, DOI 10.1016/S0028-3908(99)00170-7; Le Trionnaire G, 2008, BIOL CELL, V100, P441, DOI 10.1042/BC20070135; Li J, 2010, INSECT BIOCHEM MOLEC, V40, P17, DOI 10.1016/j.ibmb.2009.12.003; Lind RJ, 1999, INSECT BIOCHEM MOLEC, V29, P979, DOI 10.1016/S0965-1748(99)00074-0; Lind RJ, 1998, PESTIC BIOCHEM PHYS, V62, P3, DOI 10.1006/pest.1998.2364; Markussen MDK, 2010, PEST MANAG SCI, V66, P1257, DOI 10.1002/ps.2007; McCulloch RS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-36; Miao J, 2013, PEST MANAG SCI; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Sadeghi A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.6501; Shi XB, 2011, PEST MANAG SCI, V67, P1528, DOI 10.1002/ps.2207; Slater R, 2012, PEST MANAG SCI, V68, P634, DOI 10.1002/ps.2307; Smith RD, 2003, BIOTECHNIQUES, V34, P88, DOI 10.2144/03341st05; SUMIKAWA K, 1992, J BIOL CHEM, V267, P6286; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Wellmann H, 2004, PEST MANAG SCI, V60, P959, DOI 10.1002/ps.920; Wiesner P, 2000, J BIOCHEM MOL TOXIC, V14, P221, DOI 10.1002/(SICI)1099-0461(2000)14:4<221::AID-JBT7>3.0.CO;2-6; Yu XL, 2011, ARCH INSECT BIOCHEM, V77, P163, DOI 10.1002/arch.20432; Zhang AG, 2000, J NEUROCHEM, V75, P1294, DOI 10.1046/j.1471-4159.2000.751294.x; Zhang NJ, 2004, NEUROSCI LETT, V371, P56, DOI 10.1016/j.neulet.2004.08.040; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	38	34	38	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96669	10.1371/journal.pone.0096669	http://dx.doi.org/10.1371/journal.pone.0096669			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801634	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800106
J	Verkoeijen, PPJL; Bouwmeester, S				Verkoeijen, Peter P. J. L.; Bouwmeester, Samantha			Does Intuition Cause Cooperation?	PLOS ONE			English	Article							REPLICABILITY; REPLICATIONS; PSYCHOLOGY; CRISIS	Recently, researchers claimed that people are intuitively inclined to cooperate with reflection causing them to behave selfishly. Empirical support for this claim came from experiments using a 4-player public goods game with a marginal return of 0.5 showing that people contributed more money to a common project when they had to decide quickly (i.e., a decision based on intuition) than when they were instructed to reflect and decide slowly. This intuitive-cooperation effect is of high scientific and practical importance because it argues against a central assumption of traditional economic and evolutionary models. The first experiment of present study was set up to examine the generality of the intuitive-cooperation effect and to further validate the experimental task producing the effect. In Experiment 1, we investigated Amazon Mechanical Turk (AMT) workers' contributions to a 4-player public goods game with a marginal return of 0.5 while we manipulated the knowledge about the other players' contribution to the public goods game (contribution known vs. contribution unknown), the identity of the other players (humans vs. computers randomly generating contributions) and the time constraint (time pressure/intuition vs. forced delay/reflection). However, the results of Experiment 1 failed to reveal an intuitive-cooperation effect. Furthermore, four subsequent direct replications attempts with AMT workers (Experiments 2a, 2b, 2c and Experiment 3, which was conducted with naive/inexperienced participants) also failed to demonstrate intuitive-cooperation effects. Taken together, the results of the present study could not corroborate the idea that people are intuitively cooperative, hence suggesting that the theoretical relationship between intuition and cooperation should be further scrutinized.	[Verkoeijen, Peter P. J. L.; Bouwmeester, Samantha] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands	Erasmus University Rotterdam	Verkoeijen, PPJL (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	verkoeijen@fsw.eur.nl						Cumming G., 2013, UNDERSTANDING NEW ST; Koole SL, 2012, PERSPECT PSYCHOL SCI, V7, P608, DOI 10.1177/1745691612462586; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P531, DOI 10.1177/1745691612463401; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2014, NAT COMMUN  IN PRESS; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194	12	74	75	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96654	10.1371/journal.pone.0096654	http://dx.doi.org/10.1371/journal.pone.0096654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801381	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800104
J	Wang, XX; Wang, K; Li, XZ; Zhai, LQ; Qu, CX; Zhao, Y; Liu, ZR; Wang, HZ; An, QJ; Jing, LW; Wang, XH				Wang, Xiao-Xia; Wang, Kang; Li, Xiao-Zhong; Zhai, Li-Qin; Qu, Chong-Xiao; Zhao, Yan; Liu, Zhi-Rong; Wang, Hui-Zhen; An, Qi-Jun; Jing, Li-Wei; Wang, Xu-Hong			Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo	PLOS ONE			English	Article							E-CADHERIN; OVEREXPRESSION; EXPRESSION; INVASION; CANCER; RAC1; PROLIFERATION; ADHESION; CDC42	IQGAP1 is a scaffolding protein that can regulate several distinct signaling pathways. The accumulating evidence has demonstrated that IQGAP1 plays an important role in tumorigenesis and tumor progression. However, the function of IQGAP1 in esophageal squamous cell carcinoma (ESCC) has not been thoroughly investigated. In the present study, we showed that IQGAP1 was overexpressed in ESCC tumor tissues, and its overexpression was correlated with the invasion depth of ESCC. Importantly, by using RNA interference (RNAi) technology we successfully silenced IQGAP1 gene in two ESCC cell lines, EC9706 and KYSE150, and for the first time found that suppressing IQGAP1 expression not only obviously reduced the tumor cell growth, migration and invasion in vitro but also markedly inhibited the tumor growth, invasion, lymph node and lung metastasis in xenograft mice. Furthermore, Knockdown of IQGAP1 expression in ESCC cell lines led to a reversion of epithelial to mesenchymal transition (EMT) progress. These results suggest that IQGAP1 plays crucial roles in regulating ESCC occurrence and progression. IQGAP1 silencing may therefore develop into a promising novel anticancer therapy.	[Wang, Xiao-Xia; Wang, Kang; Zhao, Yan; Liu, Zhi-Rong; Wang, Hui-Zhen] Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Peoples R China; [Li, Xiao-Zhong; An, Qi-Jun] Shanxi Prov Peoples Hosp, Dept Emergency, Taiyuan, Peoples R China; [Zhai, Li-Qin; Qu, Chong-Xiao] Shanxi Prov Peoples Hosp, Dept Pathol, Taiyuan, Peoples R China; [Jing, Li-Wei] Shanxi Med Univ, Dept Stat, Taiyuan, Peoples R China; [Wang, Xu-Hong] Shanxi Canc Hosp, Dept Surg, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi People's Hospital; Shanxi People's Hospital; Shanxi Medical University	Wang, XX (corresponding author), Shanxi Med Univ, Dept Biochem & Mol Biol, Taiyuan, Peoples R China.	wxiaoxia99007@126.com			National Natural Science Foundation of China [81372676, 30973401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Science Foundation of China (numbers 81372676 and 30973401) (http://www.nsfc.gov.cn/nsfc/cen/xxgk/slzz.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Chen F, 2010, EXP MOL MED, V42, P477, DOI 10.3858/emm.2010.42.7.049; Dong PX, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-77; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Hayashi H, 2010, INT J CANCER, V126, P2563, DOI 10.1002/ijc.24987; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Kim H, 2011, FEBS LETT, V585, P723, DOI 10.1016/j.febslet.2011.01.041; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lin DC, 2009, DIS ESOPHAGUS, V22, P9, DOI 10.1111/j.1442-2050.2008.00845.x; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu Z, 2010, CLIN CANCER RES, V16, P6009, DOI 10.1158/1078-0432.CCR-10-1627; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Osman MA, 2010, THESCIENTIFICWORLDJO, V10, P944, DOI 10.1100/tsw.2010.85; Qi YJ, 2012, J PROTEOMICS, V75, P3129, DOI 10.1016/j.jprot.2012.04.025; Takemoto H, 2001, INT J CANCER, V91, P783, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1121>3.0.CO;2-Z; Walch A, 2008, MODERN PATHOL, V21, P544, DOI 10.1038/modpathol.2008.3; Wang XX, 2013, HEPATOB PANCREAT DIS, V12, P540, DOI 10.1016/S1499-3872(13)60085-5; Wang YP, 2008, EXP MOL PATHOL, V85, P122, DOI 10.1016/j.yexmp.2008.06.001; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048917	27	16	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96501	10.1371/journal.pone.0096501	http://dx.doi.org/10.1371/journal.pone.0096501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800852	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800079
J	Zhu, ZH; Chen, J; Xiong, JW; Peng, JR				Zhu, Zhihui; Chen, Jun; Xiong, Jing-Wei; Peng, Jinrong			Haploinsufficiency of Def Activates p53-Dependent TGF beta Signalling and Causes Scar Formation after Partial Hepatectomy	PLOS ONE			English	Article							ZEBRAFISH DANIO-RERIO; LIVER-REGENERATION; IN-VIVO; INFLAMMATION; GROWTH; INJURY; CELLS; MACROPHAGES; EXPRESSION; REPAIR	The metazoan liver exhibits a remarkable capacity to regenerate lost liver mass without leaving a scar following partial hepatectomy (PH). Whilst previous studies have identified components of several different signaling pathways that are essential for activation of hepatocyte proliferation during liver regeneration, the mechanisms that enable such regeneration to occur without accompanying scar formation remain poorly understood. Here we use the adult zebrafish liver, which can regenerate within two weeks following PH, as a new genetic model to address this important question. We focus on the role of Digestive-organ-expansion-factor (Def), a nucleolar protein which has recently been shown to complex with calpain3 (Capn3) to mediate p53 degradation specifically in the nucleolus, in liver regeneration. Firstly, we show that Def expression is up-regulated in the wild-type liver following amputation, and that the def(hi429/+) heteroozygous mutant (def(+/-)) suffers from haploinsufficiency of Def in the liver. We then show that the expression of pro-inflammatory cytokines is up-regulated in the def(+/-) liver, which leads to distortion of the migration and the clearance of leukocytes after PH. Transforming growth factor beta (TGF beta) signalling is thus activated in the wound epidermis in def(+/-) due to a prolonged inflammatory response, which leads to fibrosis at the amputation site. Fibrotic scar formation in def(+/-) is blocked by the over-expression of Def, by the loss-of-function of p53, and by treatment with anti-inflammation drug dexamethasone or TGF beta-signalling inhibitor SB431542. We finally show that the Def- p53 pathway suppresses fibrotic scar formation, at least in part, through the regulation of the expression of the pro-inflammatory factor, high-mobility group box 1. We conclude that the novel Def- p53 nucleolar pathway functions specifically to prevent a scar formation at the amputation site in a normal amputated liver.	[Zhu, Zhihui; Peng, Jinrong] Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xiong, Jing-Wei] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Zhejiang University; Zhejiang University; Peking University	Peng, JR (corresponding author), Zhejiang Univ, Coll Anim Sci, Minist Educ, Key Lab Mol Anim Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	pengjr@zju.edu.cn	Xiong, Jing-Wei/A-7113-2011	Peng, Jinrong/0000-0002-0793-4848	973 Program [2012CB944550]; National Natural Science Foundation of China [31330050]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported financially by the "973 Program'' (2012CB944550) and the National Natural Science Foundation of China (31330050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, HEPATOLOGY, V41, P1046, DOI 10.1002/hep.20665; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bhattacharyya S, 2007, BLOOD, V109, P4313, DOI 10.1182/blood-2006-10-048215; Charette JM, 2010, RNA, V16, P2156, DOI 10.1261/rna.2359810; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Curado S, 2010, SEMIN LIVER DIS, V30, P288, DOI 10.1055/s-0030-1255357; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Ho DM, 2006, DEV BIOL, V295, P730, DOI 10.1016/j.ydbio.2006.03.050; Huang H, 2008, DEVELOPMENT, V135, P3209, DOI 10.1242/dev.024406; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; Korzh S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-84; Lalani I, 1997, ANN ALLERG ASTHMA IM, V79, P469, DOI 10.1016/S1081-1206(10)63052-9; Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126; Masuzaki R, 2013, WOUND REPAIR REGEN, V21, P122, DOI 10.1111/j.1524-475X.2012.00868.x; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Radtke S, 2010, J CELL SCI, V123, P947, DOI 10.1242/jcs.065326; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schachtrup C, 2011, CELL CYCLE, V10, P1764, DOI 10.4161/cc.10.11.15828; Shin DH, 2012, MECH DEVELOP, V128, P525, DOI 10.1016/j.mod.2012.01.005; Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4; Tao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058858; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Tao T, 2009, J GENET GENOMICS, V36, P325, DOI 10.1016/S1673-8527(08)60121-6; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Yan HX, 2013, J HEPATOL, V59, P762, DOI 10.1016/j.jhep.2013.05.029; Yang SL, 2011, ENDOCRINOLOGY, V152, P4706, DOI 10.1210/en.2011-1306; Zhang Y, 2008, J IMMUNOL, V181, P2155, DOI 10.4049/jimmunol.181.3.2155	42	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96576	10.1371/journal.pone.0096576	http://dx.doi.org/10.1371/journal.pone.0096576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801718	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800086
J	Vik, A; Anonsen, JH; Aas, FE; Hegge, FT; Roos, N; Koomey, M; Aspholm, M				Vik, Ashild; Anonsen, Jan Haug; Aas, Finn Erik; Hegge, Finn Terje; Roos, Norbert; Koomey, Michael; Aspholm, Marina			Type IV Pilus Assembly Proficiency and Dynamics Influence Pilin Subunit Phospho-Form Macro- and Microheterogeneity in Neisseria gonorrhoeae	PLOS ONE			English	Article							LINKED PROTEIN GLYCOSYLATION; EPITHELIAL-CELL ADHERENCE; HAEMOPHILUS-INFLUENZAE; NATURAL TRANSFORMATION; PHOSPHOETHANOLAMINE TRANSFERASE; PSEUDOMONAS-AERUGINOSA; MULTICELLULAR BEHAVIOR; PATHOGENIC NEISSERIA; CAMPYLOBACTER-JEJUNI; SALMONELLA-ENTERICA	The PilE pilin subunit protein of the gonococcal Type IV pilus (Tfp) colonization factor undergoes multisite, covalent modification with the zwitterionic phospho-form modification phosphoethanolamine (PE). In a mutant lacking the pilin-like PilV protein however, PilE is modified with a mixture of PE and phosphocholine (PC). Moreover, intrastrain variation of PilE PC modification levels have been observed in backgrounds that constitutively express PptA (the protein phospho-form transferase A) required for both PE and PC modification. The molecular basis underlying phospho-form microheterogeneity in these instances remains poorly defined. Here, we examined the effects of mutations at numerous loci that disrupt or perturb Tfp assembly and observed that these mutants phenocopy the pilV mutant vis a vis phospho-form modification status. Thus, PC modification appears to be directly or indirectly responsive to the efficacy of pilin subunit interactions. Despite the complexity of contributing factors identified here, the data favor a model in which increased retention in the inner membrane may act as a key signal in altering phospho-form modification. These results also provide an alternative explanation for the variation in PilE PC levels observed previously and that has been assumed to be due to phase variation of pptA. Moreover, mass spectrometry revealed evidence for mono-and di-methylated forms of PE attached to PilE in mutants deficient in pilus assembly, directly implicating a methyltransferase-based pathway for PC synthesis in N. gonorrhoeae.	[Vik, Ashild; Anonsen, Jan Haug; Aas, Finn Erik; Hegge, Finn Terje; Roos, Norbert; Koomey, Michael; Aspholm, Marina] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway; [Vik, Ashild; Anonsen, Jan Haug; Aas, Finn Erik; Hegge, Finn Terje; Koomey, Michael; Aspholm, Marina] Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo; University of Oslo	Aspholm, M (corresponding author), Norwegian Univ Life Sci, Sect Food Safety, Dept Food Safety & Infect Biol, Oslo, Norway.	marina.aspholm@nmbu.no	Aspholm, Marina/ABB-5298-2020; Anonsen, Jan Haug/H-8786-2016	Aspholm, Marina/0000-0003-3175-6022; Anonsen, Jan Haug/0000-0003-0304-3404; Koomey, Michael/0000-0001-5844-2344	Research Council of Norway [166931, 183613, 183814]; Department of Molecular Biosciences and Center for Molecular Biology; Neurosciences of the University of Oslo	Research Council of Norway(Research Council of Norway); Department of Molecular Biosciences and Center for Molecular Biology; Neurosciences of the University of Oslo	This research was supported in part by Research Council of Norway grants 166931, 183613, and 183814, the Department of Molecular Biosciences and Center for Molecular Biology and Neurosciences of the University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Aas FE, 2007, MOL MICROBIOL, V65, P607, DOI 10.1111/j.1365-2958.2007.05806.x; Aas FE, 2007, MOL MICROBIOL, V63, P69, DOI 10.1111/j.1365-2958.2006.05482.x; Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Ambur OH, 2007, J BACTERIOL, V189, P2077, DOI 10.1128/JB.01408-06; Anonsen JH, 2012, INFECT IMMUN, V80, P22, DOI 10.1128/IAI.05920-11; Borud B, 2010, J BACTERIOL, V192, P2816, DOI 10.1128/JB.00101-10; Campbell HA, 2001, BBA-MOL CELL BIOL L, V1534, P85, DOI 10.1016/S1388-1981(01)00174-3; CLOSE TJ, 1982, GENE, V20, P305, DOI 10.1016/0378-1119(82)90048-8; Cox AD, 2003, J BACTERIOL, V185, P3270, DOI 10.1128/JB.185.11.3270-3277.2003; Cullen TW, 2012, J BIOL CHEM, V287, P3326, DOI 10.1074/jbc.M111.321737; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Drake SL, 1995, MOL MICROBIOL, V18, P975, DOI 10.1111/j.1365-2958.1995.18050975.x; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009; HAAS R, 1987, P NATL ACAD SCI USA, V84, P9079, DOI 10.1073/pnas.84.24.9079; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Horiuchi T, 1998, J BACTERIOL, V180, P4613, DOI 10.1128/JB.180.17.4613-4620.1998; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Jen FEC, 2013, BIOCHEM BIOPH RES CO, V431, P808, DOI 10.1016/j.bbrc.2012.12.088; KOOMEY M, 1991, MOL MICROBIOL, V5, P279, DOI 10.1111/j.1365-2958.1991.tb02108.x; Lee H, 2004, J BACTERIOL, V186, P4124, DOI 10.1128/JB.186.13.4124-4133.2004; Lewis LA, 2009, INFECT IMMUN, V77, P1112, DOI 10.1128/IAI.01280-08; MACDONALD DL, 1993, CAN J MICROBIOL, V39, P500, DOI 10.1139/m93-071; Mackinnon FG, 2002, MOL MICROBIOL, V43, P931, DOI 10.1046/j.1365-2958.2002.02754.x; Marceau M, 1998, MOL MICROBIOL, V27, P705, DOI 10.1046/j.1365-2958.1998.00706.x; Naessan CL, 2008, J BACTERIOL, V190, P387, DOI 10.1128/JB.00765-07; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Park HSM, 2002, INFECT IMMUN, V70, P3891, DOI 10.1128/IAI.70.7.3891-3903.2002; Park HSM, 2001, MOL MICROBIOL, V42, P293, DOI 10.1046/j.1365-2958.2001.02629.x; PASLOSKE BL, 1989, J BACTERIOL, V171, P2142, DOI 10.1128/jb.171.4.2142-2147.1989; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Rahman MM, 2000, MICROBIOL-UK, V146, P1901, DOI 10.1099/00221287-146-8-1901; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Serino L, 2002, MOL MICROBIOL, V43, P437, DOI 10.1046/j.1365-2958.2002.02755.x; SUD IJ, 1975, J BACTERIOL, V124, P713, DOI 10.1128/JB.124.2.713-717.1975; Swords WE, 2000, MOL MICROBIOL, V37, P13, DOI 10.1046/j.1365-2958.2000.01952.x; Takahashi H, 2008, INFECT IMMUN, V76, P5777, DOI 10.1128/IAI.00676-08; Tamayo R, 2005, FEMS IMMUNOL MED MIC, V43, P249, DOI 10.1016/j.femsim.2004.08.007; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Vik A, 2012, MOL MICROBIOL, V85, P1166, DOI 10.1111/j.1365-2958.2012.08166.x; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Warren MJ, 2003, INFECT IMMUN, V71, P6892, DOI 10.1128/IAI.71.12.6892-6898.2003; Weiser JN, 1998, J EXP MED, V187, P631, DOI 10.1084/jem.187.4.631; Weiser JN, 1998, INFECT IMMUN, V66, P4263; Weiser JN, 1997, INFECT IMMUN, V65, P943, DOI 10.1128/IAI.65.3.943-950.1997; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	53	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96419	10.1371/journal.pone.0096419	http://dx.doi.org/10.1371/journal.pone.0096419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797914	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000074
J	Xu, ZP; Dong, YL; Wang, H; Culley, DJ; Marcantonio, ER; Crosby, G; Tanzi, RE; Zhang, YY; Xie, ZC				Xu, Zhipeng; Dong, Yuanlin; Wang, Hui; Culley, Deborah J.; Marcantonio, Edward R.; Crosby, Gregory; Tanzi, Rudolph E.; Zhang, Yiying; Xie, Zhongcong			Peripheral Surgical Wounding and Age-Dependent Neuroinflammation in Mice	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; MAJOR NONCARDIAC SURGERY; ALZHEIMERS-DISEASE; IMPAIRMENT; LEVOBUPIVACAINE; INFLAMMATION; ACTIVATION; MECHANISMS; ANESTHESIA; IBUPROFEN	Post-operative cognitive dysfunction is associated with morbidity and mortality. However, its neuropathogenesis remains largely to be determined. Neuroinflammation and accumulation of beta-amyloid (Ab) have been reported to contribute to cognitive dysfunction in humans and cognitive impairment in animals. Our recent studies have established a pre-clinical model in mice, and have found that the peripheral surgical wounding without the influence of general anesthesia induces an age-dependent A beta accumulation and cognitive impairment in mice. We therefore set out to assess the effects of peripheral surgical wounding, in the absence of general anesthesia, on neuroinflammation in mice with different ages. Abdominal surgery under local anesthesia was established in 9 and 18 month-old mice. The levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), Iba1 positive cells (the marker of microglia activation), CD33, and cognitive function in mice were determined. The peripheral surgical wounding increased the levels of TNF-alpha, IL-6, and Iba1 positive cells in the hippocampus of both 9 and 18 month-old mice, and age potentiated these effects. The peripheral surgical wounding increased the levels of CD33 in the hippocampus of 18, but not 9, month-old mice. Finally, anti-inflammatory drug ibuprofen ameliorated the peripheral surgical wounding-induced cognitive impairment in 18 month-old mice. These data suggested that the peripheral surgical wounding could induce an age-dependent neuroinflammation and elevation of CD33 levels in the hippocampus of mice, which could lead to cognitive impairment in aged mice. Pending further studies, anti-inflammatory therapies may reduce the risk of postoperative cognitive dysfunction in elderly patients.	[Xu, Zhipeng; Dong, Yuanlin; Wang, Hui; Zhang, Yiying; Xie, Zhongcong] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA 02129 USA; [Xu, Zhipeng; Dong, Yuanlin; Wang, Hui; Tanzi, Rudolph E.; Zhang, Yiying; Xie, Zhongcong] Harvard Univ, Sch Med, Charlestown, MA USA; [Wang, Hui] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesia, Beijing, Peoples R China; [Culley, Deborah J.; Crosby, Gregory] Brigham & Womens Hosp, Dept Anesthesia, Boston, MA 02115 USA; [Culley, Deborah J.; Crosby, Gregory] Harvard Univ, Sch Med, Boston, MA USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med, Boston, MA 02215 USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Primary Care, Boston, MA 02215 USA; [Marcantonio, Edward R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gerontol, Boston, MA 02215 USA; [Tanzi, Rudolph E.] Massachusetts Gen Hosp, Dept Neurol, MassGeneral Inst Neurodegenerat Dis, Genet & Aging Res Unit, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Capital Medical University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Xie, ZC (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Geriatr Anesthesia Res Unit, Charlestown, MA 02129 USA.	zxie@mgh.harvard.edu	Marcantonio, Edward R/U-3929-2017; Tanzi, Rudolph/AAE-9622-2019; Crosby, Gregory/N-6578-2019	Marcantonio, Edward R/0000-0002-2911-4250; Tanzi, Rudolph/0000-0002-7032-1454; Dong, Yuanlin/0000-0002-4760-0519	National Institutes of Health grants (Bethesda, Maryland) [R21 AG029856, R21 AG038994, R01 GM088801, R01 AG041274]; American Geriatrics Society Jahnigen Award (New York, NY); Investigator-Initiated Research Grant from Alzheimer's Association (Chicago, IL); Cure Alzheimer's Fund; Midcareer Investigator Award in Patient-Oriented Research from the National Institute on Aging [K24 AG035075]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG035075, R01AG041274, P50AG005134, R21AG038994, R21AG029856] Funding Source: NIH RePORTER	National Institutes of Health grants (Bethesda, Maryland); American Geriatrics Society Jahnigen Award (New York, NY); Investigator-Initiated Research Grant from Alzheimer's Association (Chicago, IL); Cure Alzheimer's Fund; Midcareer Investigator Award in Patient-Oriented Research from the National Institute on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health grants (Bethesda, Maryland) (R21 AG029856, R21 AG038994, R01 GM088801 and R01 AG041274); American Geriatrics Society Jahnigen Award (New York, NY); Investigator-Initiated Research Grant from Alzheimer's Association (Chicago, IL) and Cure Alzheimer's Fund to ZX. EM is supported by a Midcareer Investigator Award in Patient-Oriented Research from the National Institute on Aging [K24 AG035075]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Cauli O, 2009, J NEUROSCI RES, V87, P1369, DOI 10.1002/jnr.21947; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Duman U, 2010, WORLD J GASTROENTERO, V16, P2537, DOI 10.3748/wjg.v16.i20.2537; Griciuc A, 2013, NEURON; Hocker J, 2009, ANESTHESIOLOGY, V110, P1068, DOI 10.1097/ALN.0b013e31819dad92; Huang YH, 2013, J SURG RES, V184, P989, DOI 10.1016/j.jss.2013.03.074; Liu LL, 2000, J AM GERIATR SOC, V48, P405, DOI 10.1111/j.1532-5415.2000.tb04698.x; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Sliva J, 2009, NEUROENDOCRINOL LETT, V30, P352; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Terrando N, 2011, MAYO CLIN PROC, V86, P885, DOI 10.4065/mcp.2011.0332; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; von Gunten S, 2006, FASEB J, V20, P601, DOI 10.1096/fj.05-5401hyp; Wan Y, 2010, CRIT CARE MED; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Willuweit A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007931; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Xu ZP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03766; Zhang XQ, 2013, J NEUROSCI, V33, P17737, DOI 10.1523/JNEUROSCI.2049-13.2013	25	39	43	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96752	10.1371/journal.pone.0096752	http://dx.doi.org/10.1371/journal.pone.0096752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796537	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000124
J	Chen, AL; Liu, CY; Chen, CH; Wang, JF; Liao, YC; Chang, CH; Tsai, MH; Hwu, KK; Chen, KY				Chen, Ai-Lin; Liu, Chu-Yin; Chen, Chien-Hua; Wang, Jaw-Fen; Liao, Yu-Chen; Chang, Chia-Hui; Tsai, Mong-Hsun; Hwu, Kae-Kang; Chen, Kai-Yi			Reassessment of QTLs for Late Blight Resistance in the Tomato Accession L3708 Using a Restriction Site Associated DNA (RAD) Linkage Map and Highly Aggressive Isolates of Phytophthora infestans	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DENSITY GENETIC-MAP; LYCOPERSICON PIMPINELLIFOLIUM; SOLANUM-PIMPINELLIFOLIUM; SNP DISCOVERY; UNITED-STATES; PH-3 GENE; CONSTRUCTION; MARKERS; GENOME	Tomato late blight caused by the oomycete pathogen Phytophthora infestans (Mont.) de Bary is a major threat to tomato production in cool and wet environments. Intensified outbreaks of late blight have been observed globally from the 1980s, and are associated with migration of new and more aggressive populations of P. infestans in the field. The objective of this study was to reassess late blight resistance in the wild tomato accession L3708 (Solanum pimpinellifolium L.) against pathogens of different aggressiveness. An F-2:3 genetic mapping population was developed using L3708 as the paternal parent. Two isolates of P. infestans, Pi39A and Pi733, were used for inoculation. Pi733 is a highly aggressive genotype that defeats three known late blight resistance genes, Ph-1, Ph-2, and Ph-5t in tomato. In contrast, Pi39A is a less aggressive genotype that defeats only Ph-1. Restriction site Associated DNA Sequencing (RAD-Seq) technology was used to massively sequence 90 bp nucleotides adjacent to both sides of PstI restriction enzyme cutting sites in the genome for all individuals in the genetic mapping population. The RAD-seq data were used to construct a genetic linkage map containing 440 single nucleotide polymorphism markers. Quantitative trait locus (QTL) analysis identified a new disease-resistant QTL specific to Pi733 on chromosome 2. The Ph-3 gene located on chromosome 9 could be detected whichever isolates were used. This study demonstrated the feasibility and efficiency of RAD-Seq technology for conducting a QTL mapping experiment using an F-2:3 mapping population, which allowed the identification of a new late blight resistant QTL in tomato.	[Chen, Ai-Lin; Liu, Chu-Yin; Hwu, Kae-Kang; Chen, Kai-Yi] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Chen, Chien-Hua; Wang, Jaw-Fen] AVRDC, World Vegetable Ctr, Tainan, Taiwan; [Liao, Yu-Chen; Chang, Chia-Hui] Known You Seed Co LTD, Kaohsiung, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Ctr Biotechnol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chen, KY (corresponding author), Natl Taiwan Univ, Dept Agron, Taipei, Taiwan.	kaiychen@ntu.edu.tw		CHEN, KAI-YI/0000-0002-6211-0198; TSAI, MONG-HSUN/0000-0001-8777-5818	Council of Agriculture, Executive Yuan, Taiwan R.O.C. [99AS-5.3.1-ST-a8, 100AS-5.3.1-ST-a9, 101AS-6.1.1-ST-a4]; National Taiwan University [99R70444, 102R350145]	Council of Agriculture, Executive Yuan, Taiwan R.O.C.; National Taiwan University(National Taiwan University)	This work was supported by grants from the Council of Agriculture, Executive Yuan, Taiwan R.O.C. (Grant No. 99AS-5.3.1-ST-a8, 100AS-5.3.1-ST-a9, and 101AS-6.1.1-ST-a4) to KKH and KYC; and grants from the National Taiwan University (Grant No. 99R70444 and 102R350145) to KYC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVRDC, 2005, 2005 PROGR REP, P49; AVRDC, 2002, 2002 PROGR REP, P12; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Black L. L., 1996, Phytopathology, V86, pS24; Brouwer DJ, 2004, THEOR APPL GENET, V108, P628, DOI 10.1007/s00122-003-1469-8; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; Causse M, 2001, THEOR APPL GENET, V102, P273, DOI 10.1007/s001220051644; Chen CH, 2008, PLANT DIS, V92, P751, DOI 10.1094/PDIS-92-5-0751; Chunwongse J, 2002, J HORTIC SCI BIOTECH, V77, P281, DOI 10.1080/14620316.2002.11511493; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; FLOR HH, 1955, PHYTOPATHOLOGY, V45, P680; Foolad MR, 1998, MOL BREEDING, V4, P519, DOI 10.1023/A:1009648112491; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gavino PD, 2000, PLANT DIS, V84, P731, DOI 10.1094/PDIS.2000.84.7.731; Goodwin SB, 1998, PHYTOPATHOLOGY, V88, P939, DOI 10.1094/PHYTO.1998.88.9.939; Grandillo S, 1996, THEOR APPL GENET, V92, P935, DOI 10.1007/BF00224033; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Haldane JBS, 1919, J GENET, V8, P299; Kim MJ, 2006, J AM SOC HORTIC SCI, V131, P637, DOI 10.21273/JASHS.131.5.637; Lennon NJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r15; Li JM, 2011, EUPHYTICA, V179, P427, DOI 10.1007/s10681-010-0340-7; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Merk HL, 2012, EUPHYTICA, V187, P63, DOI 10.1007/s10681-012-0729-6; Moreau P, 1998, MOL PLANT MICROBE IN, V11, P259, DOI 10.1094/MPMI.1998.11.4.259; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Nowicki M, 2012, PLANT DIS, V96, P4, DOI 10.1094/PDIS-05-11-0458; Peirce L. C., 1971, REP TOMATO GENET COO, V21, P30; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shirasawa K, 2010, THEOR APPL GENET, V121, P731, DOI 10.1007/s00122-010-1344-3; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Smart CD, 2007, PLANT DIS, V91, P1045, DOI 10.1094/PDIS-91-8-1045; TANKSLEY SD, 1992, GENETICS, V132, P1141; Thoquet P, 1996, MOL PLANT MICROBE IN, V9, P826, DOI 10.1094/MPMI-9-0826; Truong HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037565; van der Knaap E, 2003, THEOR APPL GENET, V107, P139, DOI 10.1007/s00122-003-1224-1; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Villalta I, 2005, THEOR APPL GENET, V110, P881, DOI 10.1007/s00122-004-1906-3; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Yang HX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064799, 10.1371/journal.pone.0064058]; Zhang CZ, 2013, THEOR APPL GENET, V126, P2643, DOI 10.1007/s00122-013-2162-1; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	50	24	24	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96417	10.1371/journal.pone.0096417	http://dx.doi.org/10.1371/journal.pone.0096417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788810	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700089
J	Iba, Y; Sano, S; Mutterlose, J				Iba, Yasuhiro; Sano, Shin-ichi; Mutterlose, Joerg			The Early Evolutionary History of Belemnites: New Data from Japan	PLOS ONE			English	Article								Belemnites (Order Belemnitida), a very successful group of Mesozoic coleoid cephalopods, dominated the world's oceans throughout the Jurassic and Cretaceous. According to the current view, the phylogenetically earliest belemnites are known from the lowermost Jurassic (Hettangian, 201-199 Ma) of northern Europe. They are of low diversity and have small sized rostra without clear grooves. Their distribution is restricted to this area until the Pliensbachian (191-183 Ma). Here we describe two new belemnite taxa of the Suborder Belemnitina from the Sinemurian (199-191 Ma) of Japan: Nipponoteuthis katana gen et sp. nov., which represents the new family Nipponoteuthidae, and Eocylindroteuthis (?) yokoyamai sp. nov. This is the first reliable report of Sinemurian belemnites outside of Europe and the earliest record of typical forms of Belemnitina in the world. The Sinemurian belemnites from Japan have small to large rostra with one deep and long apical groove. Morphologically these forms are completely different from coeval European genera of Hettangian-Sinemurian age. These new findings suggest that three groups of Belemnitina existed in the Hettangian-Sinemurian: 1) European small forms, 2) Japanese very large forms, and 3) the typical forms with a distinctive apical groove, reported here. The Suborder Belemnitina therefore did not necessarily originate in the Hettangian of northern Europe. The new material from Japan documents that the suborder Belemnitina had a much higher diversity in the early Jurassic than previously thought, and it also shows strong endemisms from the Sinemurian onwards.	[Iba, Yasuhiro] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan; [Sano, Shin-ichi] Fukui Prefectural Dinosaur Museum, Katsuyama, Japan; [Mutterlose, Joerg] Ruhr Univ Bochum, Inst Geol Mineral & Geophys, Bochum, Germany	Hokkaido University; Ruhr University Bochum	Iba, Y (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido, Japan.	iba@mail.sci.hokudai.ac.jp			Japan Society for the Promotion of Science [23840002, 25800285]; MEXT; German Research Foundation [Mu 667/43-1]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); German Research Foundation(German Research Foundation (DFG))	This research was financially supported by the Japan Society for the Promotion of Science (grant 23840002 and 25800285 to YI) (http://www.jsps.go.jp/english/), the MEXT grant for Tenure Tracking system (http://www.mext.go.jp/), and the German Research Foundation (Mu 667/43-1) (http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blakey R, 2010, MOLLEWIDE PLATE TECT; Chen T., 1982, P282; Christensen Walter Kegel, 2002, Berliner Palaeobiologische Abhandlungen, V1, P18; Doyle P., 1993, P229; Doyle P., 1994, University of Kansas Paleontological Contributions New Series, V5, P1; DOYLE P, 1988, Norsk Polarinstitutt Skrifter, P1; Doyle P, 1991, MONOGRAPH PALA 2 587, V145, P50; Doyle Peter, 1994, Palaeopelagos Special Publication, V1, P109; Dzyuba O.S., 2011, Novosti Paleontologii i Stratigrafii, V16-17, P103; Iba Y, 2012, GEOLOGY, V40, P911, DOI 10.1130/G33402.1; Iba Y, 2011, GEOLOGY, V39, P483, DOI 10.1130/G31724.1; Jeletzky J.A., 1966, U KANSAS PALEONTOLOG, V7, P1; Jeletzky JA, 1980, GEOL SUR CANADA B, V338, P59; Kostak M., 2004, GEOLINES, V18, P59; Mutterlose J, 1998, PALAEOGEOGR PALAEOCL, V144, P161, DOI 10.1016/S0031-0182(98)00081-9; Riegraf W., 1998, Fossilium Catalogus Animalia, V135, P5; Riegraf W., 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V169, P128; Sachs V., 1975, T I GEOLOGIYA GEOFIZ, V239, P1; SATO T, 1991, NEWSL STRATIGR, V24, P81; Sato T., 1956, Journal of the Geological Society of Japan, V62, P490; Schlegelmilch R, 1988, BELEMNITEN SUDDEUTSC; Shiino Y, 2011, ISL ARC, V20, P203, DOI 10.1111/j.1440-1738.2011.00760.x; STEVENS G. R., 1965, NEW ZEAL DEP SCI IND RES GEOL SURV PALEONTOL BULL, V(36), P1; TAKAHASHI H, 1969, Science Reports of the Tohoku University Second Series (Geology), V41, P1; Weis R, 2007, B SOC PALEONTOL 1, V24, P181; Weis Robert, 2012, Palaeodiversity, P13; Weis Robert, 2007, Acta Universitatis Carolinae Geologica, V49, P181; Wu S, 1982, CONTRIBUTION GEOLOGY, V10, P113; Zhu K.-y., 1984, Acta Palaeontologica Sinica, V23, P300; Zittel K. A. v., 1895, GRUNDZUGE PALAEONTOL	30	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95632	10.1371/journal.pone.0095632	http://dx.doi.org/10.1371/journal.pone.0095632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788872	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700034
J	Timsit, YE; Negishi, M				Timsit, Yoav E.; Negishi, Masahiko			Coordinated Regulation of Nuclear Receptor CAR by CCRP/DNAJC7, HSP70 and the Ubiquitin-Proteasome System	PLOS ONE			English	Article							CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; HEAT-SHOCK PROTEINS; HEPG2 CELLS; MOUSE-LIVER; ANDROSTANE RECEPTOR; SYNERGISTIC ACTIVATION; MOLECULAR CHAPERONES; PRIMARY HEPATOCYTES; GENE-TRANSCRIPTION; ESTROGEN-RECEPTOR	The constitutive active/androstane receptor (CAR) plays an important role as a coordinate transcription factor in the regulation of various hepatic metabolic pathways for chemicals such as drugs, glucose, fatty acids, bilirubin, and bile acids. Currently, it is known that in its inactive state, CAR is retained in the cytoplasm in a protein complex with HSP90 and the tetratricopeptide repeat protein cytosoplasmic CAR retention protein (CCRP). Upon activation by phenobarbital (PB) or the PB-like inducer 1,4-bis[2-(3,5-dichloropyridyloxy)]-benzene (TCPOBOP), CAR translocates into the nucleus. We have identified two new components to the cytoplasmic regulation of CAR: ubiquitin-dependent degradation of CCRP and protein-protein interaction with HSP70. Treatment with the proteasome inhibitor MG132 (5 mu M) causes CAR to accumulate in the cytoplasm of transfected HepG2 cells. In the presence of MG132, TCPOBOP increases CCRP ubiquitination in HepG2 cells co-expressing CAR, while CAR ubiquitination was not detected. MG132 treatment of HepG2 also attenuated of TCPOBOP-induced CAR transcriptional activation on reporter constructs which contain CAR-binding DNA elements derived from the human CYP2B6 gene. The elevation of cytoplasmic CAR protein with MG132 correlated with an increase of HSP70, and to a lesser extent HSP60. Both CCRP and CAR were found to interact with endogenous HSP70 in HepG2 cells by immunoprecipitation analysis. Induction of HSP70 levels by heat shock also increased cytoplasmic CAR levels, similar to the effect of MG132. Lastly, heat shock attenuated TCPOBOP-induced CAR transcriptional activation, also similar to the effect of MG132. Collectively, these data suggest that ubiquitin-proteasomal regulation of CCRP and HSP70 are important contributors to the regulation of cytoplasmic CAR levels, and hence the ability of CAR to respond to PB or PB-like inducers.	[Timsit, Yoav E.; Negishi, Masahiko] Natl Inst Environm Hlth Sci, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), Natl Inst Environm Hlth Sci, Pharmacogenet Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928; Timsit, Yoav/0000-0002-9100-2460	NIH [Z01ES1005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH Intramural Reseach program:: Z01ES1005-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Chen T, 2013, BIOCHEM J, V458, P96; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; Columbano A, 2005, HEPATOLOGY, V42, P1118, DOI 10.1002/hep.20883; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; DeFranco DB, 1998, J STEROID BIOCHEM, V65, P51, DOI 10.1016/S0960-0760(97)00177-5; Diller KR, 2006, ANNU REV BIOMED ENG, V8, P403, DOI 10.1146/annurev.bioeng.7.060804.100449; ELLISON MJ, 1991, J BIOL CHEM, V266, P21150; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Fu MF, 2003, J STEROID BIOCHEM, V85, P133, DOI 10.1016/S0960-0760(03)00223-1; Hatakeyama S, 2004, GENES CELLS, V9, P533, DOI 10.1111/j.1356-9597.2004.00742.x; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Honkakoski P, 1996, J BIOL CHEM, V271, P9746, DOI 10.1074/jbc.271.16.9746; Honkakoski P, 1998, J BIOCHEM MOL TOXIC, V12, P3; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Hosseinpour F, 2007, FEBS LETT, V581, P4937, DOI 10.1016/j.febslet.2007.09.024; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Inoue K, 2008, J BIOL CHEM, V283, P10425, DOI 10.1074/jbc.M800729200; Inoue K, 2006, BIOCHEM J, V398, P125, DOI 10.1042/BJ20060109; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kaiser P, 2005, METHOD ENZYMOL, V399, P243, DOI 10.1016/S0076-6879(05)99016-2; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069; Koike C, 2005, FEBS LETT, V579, P6733, DOI 10.1016/j.febslet.2005.10.070; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Reid G, 2002, CELL MOL LIFE SCI, V59, P821, DOI 10.1007/s00018-002-8470-2; Salminen WF, 1996, TOXICOL APPL PHARM, V141, P117; Schueller G, 2001, ANTICANCER RES, V21, P295; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Sueyoshi T, 2008, MOL PHARMACOL, V73, P1113, DOI 10.1124/mol.107.042960; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Swales K, 2005, J BIOL CHEM, V280, P3458, DOI 10.1074/jbc.M411318200; Tateishi Y, 2004, EMBO J, V23, P4813, DOI 10.1038/sj.emboj.7600472; Tien ES, 2007, J PHARMACOL EXP THER, V320, P307, DOI 10.1124/jpet.106.112706; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; TROTTIER E, 1995, GENE, V158, P263, DOI 10.1016/0378-1119(94)00916-G; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1; Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yamamoto Y, 2008, DRUG METAB DISPOS, V36, P1189, DOI 10.1124/dmd.108.020628; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Zhou MY, 1996, J BIOL CHEM, V271, P24769, DOI 10.1074/jbc.271.40.24769	56	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96092	10.1371/journal.pone.0096092	http://dx.doi.org/10.1371/journal.pone.0096092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789201	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700056
J	Reibring, CG; El Shahawy, M; Hallberg, K; Kannius-Janson, M; Nilsson, J; Parkkila, S; Sly, WS; Waheed, A; Linde, A; Gritli-Linde, A				Reibring, Claes-Goran; El Shahawy, Maha; Hallberg, Kristina; Kannius-Janson, Marie; Nilsson, Jeanette; Parkkila, Seppo; Sly, William S.; Waheed, Abdul; Linde, Anders; Gritli-Linde, Amel			Expression Patterns and Subcellular Localization of Carbonic Anhydrases Are Developmentally Regulated during Tooth Formation	PLOS ONE			English	Article							CREST-DERIVED MELANOCYTES; RAT INCISOR; ENAMEL MATURATION; EPITHELIAL-CELLS; PH REGULATION; IMMUNOHISTOCHEMICAL LOCALIZATION; 3-DIMENSIONAL ORGANIZATION; ODONTOGENIC ORGAN; TUBULAR LYSOSOMES; DENTAL EPITHELIUM	Carbonic anhydrases (CAs) play fundamental roles in several physiological events, and emerging evidence points at their involvement in an array of disorders, including cancer. The expression of CAs in the different cells of teeth is unknown, let alone their expression patterns during odontogenesis. As a first step towards understanding the role of CAs during odontogenesis, we used immunohistochemistry, histochemistry and in situ hybridization to reveal hitherto unknown dynamic distribution patterns of eight CAs in mice. The most salient findings include expression of CAII/Car2 not only in maturation-stage ameloblasts (MA) but also in the papillary layer, dental papilla mesenchyme, odontoblasts and the epithelial rests of Malassez. We uncovered that the latter form lace-like networks around incisors; hitherto these have been known to occur only in molars. All CAs studied were produced by MA, however CAIV, CAIX and CARPXI proteins were distinctly enriched in the ruffled membrane of the ruffled MA but exhibited a homogeneous distribution in smooth-ended MA. While CAIV, CAVI/Car6, CAIX, CARPXI and CAXIV were produced by all odontoblasts, CAIII distribution displayed a striking asymmetry, in that it was virtually confined to odontoblasts in the root of molars and root analog of incisors. Remarkably, from initiation until near completion of odontogenesis and in several other tissues, CAXIII localized mainly in intracellular punctae/vesicles that we show to overlap with LAMP-1- and LAMP-2-positive vesicles, suggesting that CAXIII localizes within lysosomes. We showed that expression of CAs in developing teeth is not confined to cells involved in biomineralization, pointing at their participation in other biological events. Finally, we uncovered novel sites of CA expression, including the developing brain and eye, the olfactory epithelium, melanoblasts, tongue, notochord, nucleus pulposus and sebaceous glands. Our study provides important information for future single or multiple gene targeting strategies aiming at deciphering the function of CAs during odontogenesis.	[Reibring, Claes-Goran; El Shahawy, Maha; Hallberg, Kristina; Linde, Anders; Gritli-Linde, Amel] Univ Gothenburg, Sahlgrenska Acad, Dept Oral Biochem, Gothenburg, Sweden; [El Shahawy, Maha] Menia Univ, Dept Oral Biol, Al Minya, Egypt; [Kannius-Janson, Marie; Nilsson, Jeanette] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Parkkila, Seppo] Univ Tampere & Fimlab, Tampere Univ Hosp, Sch Med, Tampere, Finland; [Parkkila, Seppo] Univ Tampere & Fimlab, Tampere Univ Hosp, BioMediTech, Tampere, Finland; [Sly, William S.; Waheed, Abdul] St Louis Univ, Sch Med, St Louis, MO USA	University of Gothenburg; Egyptian Knowledge Bank (EKB); Minia University; University of Gothenburg; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Saint Louis University	Gritli-Linde, A (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Oral Biochem, Gothenburg, Sweden.	amel@odontologi.gu.se	Kannius Janson, Marie/M-3052-2015; Wahhed, Abdul/AAA-3099-2020; Nilsson, Jeanette/M-3051-2015	Parkkila, Seppo/0000-0001-7323-8536; El Shahawy, Maha/0000-0001-7122-1191	Swedish Research Council-Medicine [20614]; Thureus Foundation; Swedish Institute; TUA Vastra Gotaland Region; Institute of Odontology, Sahlgrenska Academy at the University of Gothenburg	Swedish Research Council-Medicine(Swedish Research Council); Thureus Foundation; Swedish Institute; TUA Vastra Gotaland Region; Institute of Odontology, Sahlgrenska Academy at the University of Gothenburg	This work was supported by the Swedish Research Council-Medicine (grant 20614) (www.vr.se); the Thureus Foundation; The Swedish Institute (www.si.se); TUA Vastra Gotaland Region; and the Institute of Odontology, Sahlgrenska Academy at the University of Gothenburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WHF, 1915, J MORPHOL, V26, P43, DOI 10.1002/jmor.1050260103; ANDERSON RE, 1982, ANAT REC, V204, P9, DOI 10.1002/ar.1092040103; Angerer L.M., 1992, IN SITU HYBRIDIZATIO, P15; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Aspatwar A, 2013, J ENZYM INHIB MED CH, V28, P1129, DOI 10.3109/14756366.2012.727813; Awad M, 2002, SAUDI MED J, V23, P25; Bosley TM, 2011, BRAIN, V134, P3499, DOI 10.1093/brain/awr302; Bronckers AL, 2009, I EXP ZOOLOG B, V312, P293; Bronckers ALJJ, 2012, BONE, V50, P901, DOI 10.1016/j.bone.2011.12.019; BROWN D, 1990, P NATL ACAD SCI USA, V87, P7457, DOI 10.1073/pnas.87.19.7457; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Callahan JW, 2009, J PROTEOMICS, V72, P23, DOI 10.1016/j.jprot.2008.11.007; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; DOGTEROM AA, 1983, J DENT RES, V62, P789, DOI 10.1177/00220345830620070201; Dou HW, 2004, J HISTOCHEM CYTOCHEM, V52, P1377, DOI 10.1369/jhc.3A6228.2004; Frank RM, 1967, STRUCTURAL CHEMICAL, V1, P399; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; GARANT PR, 1968, ARCH ORAL BIOL, V13, P1167, DOI 10.1016/0003-9969(68)90073-3; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; GHANDOUR MS, 1992, P NATL ACAD SCI USA, V89, P6823, DOI 10.1073/pnas.89.15.6823; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Gut MO, 2002, GASTROENTEROLOGY, V123, P1889, DOI 10.1053/gast.2002.37052; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harju AK, 2013, J ENZYM INHIB MED CH, V28, P231, DOI 10.3109/14756366.2012.700640; Hassan MI, 2013, BIOORGAN MED CHEM, V21, P1570, DOI 10.1016/j.bmc.2012.04.044; Hilvo M, 2004, J HISTOCHEM CYTOCHEM, V52, P1313, DOI 10.1369/jhc.3A6225.2004; Huang XF, 2009, DEV BIOL, V334, P22, DOI 10.1016/j.ydbio.2009.06.034; Inatomi J, 2004, PFLUG ARCH EUR J PHY, V448, P438, DOI 10.1007/s00424-004-1278-1; Innocenti A, 2004, BIOORG MED CHEM LETT, V14, P5435, DOI 10.1016/j.bmcl.2004.07.086; IRITANI N, 1974, ARCH BIOCHEM BIOPHYS, V164, P357, DOI 10.1016/0003-9861(74)90042-3; JOSEPHSEN K, 1977, J ANAT, V124, P45; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Lacruz RS, 2010, BIOCHEM BIOPH RES CO, V393, P883, DOI 10.1016/j.bbrc.2010.02.116; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; Lehtonen J, 2004, J BIOL CHEM, V279, P2719, DOI 10.1074/jbc.M308984200; LESTER KS, 1969, J ULTRA MOL STRUCT R, V27, P63, DOI 10.1016/S0022-5320(69)90020-3; LEWIS SE, 1988, P NATL ACAD SCI USA, V85, P1962, DOI 10.1073/pnas.85.6.1962; LIN HM, 1994, CALCIFIED TISSUE INT, V55, P38, DOI 10.1007/BF00310167; LISTGARTEN MA, 1975, J PERIODONTAL RES, V10, P197, DOI 10.1111/j.1600-0765.1975.tb00025.x; Liu M, 2007, P NATL ACAD SCI USA, V104, P371, DOI 10.1073/pnas.0609870104; LOE H, 1961, ARCH ORAL BIOL, V3, P176, DOI 10.1016/0003-9969(61)90135-2; Luan XH, 2006, DEV DYNAM, V235, P1167, DOI 10.1002/dvdy.20674; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; LYONS GE, 1991, DEVELOPMENT, V111, P233; Margolis DS, 2008, CALCIFIED TISSUE INT, V82, P66, DOI 10.1007/s00223-007-9098-x; Melcher AE, 1980, ORBANS ORAL HISTOLOG, P204; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Mori K, 1999, J BIOL CHEM, V274, P15701, DOI 10.1074/jbc.274.22.15701; Mummery IH, 1921, DENT COSMOS, V63, P1207; Nagelhus EA, 2005, P NATL ACAD SCI USA, V102, P8030, DOI 10.1073/pnas.0503021102; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554; Ochrietor JD, 2005, EXP EYE RES, V81, P492, DOI 10.1016/j.exer.2005.03.010; Ogilvie JM, 2007, P NATL ACAD SCI USA, V104, P8514, DOI 10.1073/pnas.0702899104; Pan PW, 2012, TRANSGENIC RES, V21, P163, DOI 10.1007/s11248-011-9520-z; Pan PW, 2011, TRANSGENIC RES, V20, P675, DOI 10.1007/s11248-010-9441-2; PARKKILA S, 1990, J HISTOCHEM CYTOCHEM, V38, P941, DOI 10.1177/38.7.2113069; PARKKILA S, 1994, GUT, V35, P646, DOI 10.1136/gut.35.5.646; Pastorekova S, 2004, J ENZYM INHIB MED CH, V19, P199, DOI 10.1080/14756360410001689540; REITAN KAARE, 1961, ACTA ODONTOL SCAND, V19, P443, DOI 10.3109/00016356109043400; REITH EJ, 1981, J ANAT, V133, P381; RIKIHISA Y, 1985, ANAT REC, V211, P1, DOI 10.1002/ar.1092110102; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SALAMA AH, 1990, ARCH ORAL BIOL, V35, P119, DOI 10.1016/0003-9969(90)90173-8; SALAMA AH, 1989, J HISTOCHEM CYTOCHEM, V37, P801, DOI 10.1177/37.6.2542393; SALAMA AH, 1991, AM J ANAT, V190, P279, DOI 10.1002/aja.1001900308; SASAKI T, 1984, HISTOCHEMISTRY, V80, P263, DOI 10.1007/BF00495775; Schneider HP, 2013, P NATL ACAD SCI USA, V110, P1494, DOI 10.1073/pnas.1221213110; SELVIG KNUT A., 1963, ACTA ODONTOL SCAND, V21, P175, DOI 10.3109/00016356308993957; Shah GN, 2005, P NATL ACAD SCI USA, V102, P16771, DOI 10.1073/pnas.0508449102; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; SMITH CE, 1975, AM J ANAT, V142, P403, DOI 10.1002/aja.1001420402; SMITH CE, 1975, ANAT RECORD, V183, P523, DOI 10.1002/ar.1091830405; SMITH CE, 1995, INT J DEV BIOL, V39, P153; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; SMITH CE, 1975, AM J ANAT, V142, P431, DOI 10.1002/aja.1001420403; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; SPICER SS, 1990, AM J ANAT, V187, P55, DOI 10.1002/aja.1001870107; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; SUGIMOTO T, 1988, J DENT RES, V67, P1271, DOI 10.1177/00220345880670100501; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Taniuchi K, 2002, MOL BRAIN RES, V109, P207, DOI 10.1016/S0169-328X(02)00563-6; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2001, Adv Dent Res, V15, P14; Toyosawa S, 1989, J Osaka Univ Dent Sch, V29, P72; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; WARSHAWSKY H, 1974, ANAT RECORD, V179, P423, DOI 10.1002/ar.1091790403; WISTRAND PJ, 1986, INVEST OPHTH VIS SCI, V27, P419; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Yang ZL, 2005, HUM MOL GENET, V14, P255, DOI 10.1093/hmg/ddi023	96	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96007	10.1371/journal.pone.0096007	http://dx.doi.org/10.1371/journal.pone.0096007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789143	gold, Green Published, Green Submitted			2022-12-27	WOS:000335510600064
J	Ruf, CG; Port, M; Schmelz, HU; Wagner, W; Muller, F; Senf, S; Matthies, C; Muller-Myhsok, B; Meineke, V; Abend, M				Ruf, Christian G.; Port, Matthias; Schmelz, Hans-Ulrich; Wagner, Walter; Mueller, Felix; Senf, Sven; Matthies, Cord; Mueller-Myhsok, Bertram; Meineke, Viktor; Abend, Michael			Clinically Apparent and Occult Metastasized Seminoma: Almost Indistinguishable on the Transcriptional Level	PLOS ONE			English	Article							GERM-CELL TUMORS; STAGE-I SEMINOMA; TESTICULAR SEMINOMA; PROGNOSTIC-FACTORS; GENE-EXPRESSION; MICRORNAS; SURVEILLANCE; CANCER; MANAGEMENT; DIAGNOSIS	Purpose: The aim of the present study was to examine the biological differences between seminomas with occult and clinically apparent metastases at the time of diagnosis of the primary tumor to gain insight into the biology of these tumors and facilitate the identification of novel predictors of seminoma metastasis. Materials and Methods: Total RNA including small RNAs was isolated from testicular tumors of patients with pure seminoma presenting with lymphogenic metastasis (n = 5, clinical stage IIb/c) and occult metastasis (n = 5, clinical stage I). The regulation of biological processes was examined (1) throughout the mRNA transcriptome (whole genome microarrays, 8660 K Array, Agilent with 4 samples/group) and (2) the miRNA transcriptome employing small RNA next generation sequencing (SOLID, Life Technologies with 5 samples/group). Protein coding genes (mRNAs) and small RNAs showing a significant (>= 2-fold) difference between the groups were identified. Finally (3), we examined 95 candidate miRNAs in 36 apparent metastasized and another 5 occult metastasized seminoma using logistic regression analysis. Results: Among 19,596 genes, on average 12,894 mRNAs appeared expressed (65.8%, SD+/-2.4; range, 62.0-69.3%) and 16.99x10(6)/13.94x10(6) small RNA reads were identified for apparent/occult metastasized seminoma. These reads on average convert into 9,901/9,675 small RNAs including 422/404 mature microRNAs. None of these mRNAs/small RNAs met our selection criteria for candidate genes. From 95 candidate miRNAs 44 appeared expressed, with 3 of them showing weak but significant (p = 0.05) differences among both groups. Conclusions: Occult and apparent metastasized seminomas are biologically almost indistinguishable and probably represent no separate tumor entities. These findings may simplify future research on seminoma metastasis.	[Ruf, Christian G.; Wagner, Walter; Mueller, Felix; Matthies, Cord] Fed Armed Forces Hosp, Dept Urol, Hamburg, Germany; [Ruf, Christian G.; Port, Matthias; Schmelz, Hans-Ulrich; Mueller, Felix; Senf, Sven; Meineke, Viktor; Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany; [Port, Matthias] Univ Hosp Hannover, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, Hannover, Germany; [Schmelz, Hans-Ulrich] Fed Armed Forces Cent Hosp, Dept Urol, Koblenz, Germany; [Mueller-Myhsok, Bertram] Max Plank Inst Psychiat, Munich, Germany	Max Planck Society	Ruf, CG (corresponding author), Fed Armed Forces Hosp, Dept Urol, Hamburg, Germany.	michaelabend@bundeswehr.org		Port, Matthias/0000-0002-8496-5883	German Ministry of Defense	German Ministry of Defense	This work was supported by the German Ministry of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers P, 2012, ACTAS UROL ESP, V36, P127, DOI [10.1016/j.acuro.2011.06.017, 10.1016/j.acuroe.2012.05.002]; Baggerly KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-144; Chen KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003481; Dieckmann KP, 2012, BRIT J CANCER, V107, P1754, DOI 10.1038/bjc.2012.469; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Kollmannsberger C, 2011, ANN ONCOL, V22, P808, DOI 10.1093/annonc/mdq466; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; Mette Sakso Mortensen MGG, 2013, J CLIN ONCOLOGY OF S, V31; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Port M, 2012, HEALTH PHYS, V103, P159, DOI 10.1097/HP.0b013e31824ac318; Port M, 2011, UROL ONCOL-SEMIN ORI, V29, P764, DOI 10.1016/j.urolonc.2009.08.008; Profumo Valentina, 2013, Critical Reviews in Oncogenesis, V18, P341; Ruf CG, 2013, J UROL; Ruf CG, 2013, UROL ONCOL; Ruf CG, 2012, BJU INT, V110, pE14, DOI 10.1111/j.1464-410X.2011.10778.x; Valdevenito JP, 2007, UROLOGY, V70, P777, DOI 10.1016/j.urology.2007.05.020; VONDERMAASE H, 1993, EUR J CANCER, V29A, P1931, DOI 10.1016/0959-8049(93)90446-M; Warde P, 1997, J UROLOGY, V157, P1705, DOI 10.1016/S0022-5347(01)64839-0; Warde P, 2002, J CLIN ONCOL, V20, P4448, DOI 10.1200/JCO.2002.01.038	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95009	10.1371/journal.pone.0095009	http://dx.doi.org/10.1371/journal.pone.0095009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788992	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600024
J	Shen, J; Yin, JY; Li, XP; Liu, ZQ; Wang, Y; Chen, J; Qu, J; Xu, XJ; McLeod, HL; He, YJ; Xia, K; Jia, YW; Zhou, HH				Shen, Jie; Yin, Ji-Ye; Li, Xiang-Ping; Liu, Zhao-Qian; Wang, Ying; Chen, Juan; Qu, Jian; Xu, Xiao-Jing; McLeod, Howard Lewis; He, Yi-Jing; Xia, Kun; Jia, Yuan-Wei; Zhou, Hong-Hao			The Prognostic Value of Altered eIF3a and Its Association with p27 in Non-Small Cell Lung Cancers	PLOS ONE			English	Article							PLATINUM-BASED CHEMOTHERAPY; CISPLATIN SENSITIVITY; CYCLE; P150; OVEREXPRESSION; CARCINOMA; EXPRESSION; P27(KIP1); P170	Background: Over-expressed eukaryotic initiation factor 3a (eIF3a) in non-small cell lung cancer (NSCLC) contributed to cisplatin sensitivity. However, the role of eIF3a in oncogenesis was still controversial. This study was designed to investigate the prognostic impact of eIF3a and p27 in radically resected NSCLC patients. Methods: The expression levels of subcellular eIF3a and p27 were evaluated immunohistochemically in 537 radically resected NSCLC samples, and another cohort of 210 stage II NSCLC patients. Disease specific survival (DSS) and disease free survival (DFS) were analyzed by Kaplan-Meier method and Cox regression model. Results: The subcellular expression of eIF3a was strongly correlated with status of p27 (Spearman rank coefficient correlation for cytoplasmic eIF3a and p27 = 0.653, for nuclear staining = 0.716). Moreover, survival analysis revealed favorable prognostic impact of nuclear eIF3a, p27, and the combination high nuclear staining on NSCLC (Hazards Ratio = 0.360, 95% CI = 0.109-0.782, P = 0.028). In addition, interaction research between biomarkers and chemotherapy status disclosed cisplatin-based regimen trend to prolong DSS of stage II NSCLC patients with high eIF3a-C (P = 0.036) and low p27-N (P = 0.031). Conclusions: Our findings suggested altered eIF3a expression closely correlated with p27 status, and the association was of prognostic value for resected NSCLC. Altered expression of eIF3a and p27 predicted prognosis of NSCLC independently.	[Shen, Jie; Yin, Ji-Ye; Li, Xiang-Ping; Liu, Zhao-Qian; Wang, Ying; Chen, Juan; Qu, Jian; Xu, Xiao-Jing; He, Yi-Jing; Zhou, Hong-Hao] Cent South Univ, Inst Clin Pharmacol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Shen, Jie; Yin, Ji-Ye; Li, Xiang-Ping; Liu, Zhao-Qian; Wang, Ying; Chen, Juan; Qu, Jian; Xu, Xiao-Jing; He, Yi-Jing; Zhou, Hong-Hao] Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 8, Hunan, Peoples R China; [Shen, Jie; Jia, Yuan-Wei] Wannan Med Coll, Yijishan Hosp, Dept Clin Pharm, Wuhu, Anhui, Peoples R China; [McLeod, Howard Lewis] Univ S Florida, H Lee Moffitt Canc Ctr, Personalized Med Inst, Tampa, FL 33682 USA; [Xia, Kun] Cent South Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University; Wannan Medical College; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Central South University	Liu, ZQ (corresponding author), Cent South Univ, Inst Clin Pharmacol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	liuzhaoqian63@126.com	Yin, Ji-Ye/AAE-6794-2020; li, xiang/GWM-6319-2022; XIA, KUN/AAO-3525-2020; McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232; Liu, Zhaoqian/0000-0003-0428-3928; Yin, Ji-Ye/0000-0002-1244-5045	National High-tech R&D Program of China 863 Program [2012AA02A517]; Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China [20110162110034]; National Natural Science Foundation of China [30873089, 81173129, 81202595]; Hunan Provincial Natural Science Foundation [12JJ7006]; Anhui Provincial Natural Science Foundation [1408085MH163]	National High-tech R&D Program of China 863 Program(National High Technology Research and Development Program of China); Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation(Natural Science Foundation of Hunan Province); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was supported by National High-tech R&D Program of China 863 Program Grant 2012AA02A517 (Z. Liu), Program for the Special Scientific Research Foundation of Doctor Disciplines in University of Ministry of Education of China Grant 20110162110034 (Z. Liu), National Natural Science Foundation of China Grants 30873089, 81173129 (Z. Liu), 81202595 (J. Yin), Hunan Provincial Natural Science Foundation 12JJ7006 (Z. Liu), Anhui Provincial Natural Science Foundation 1408085MH163 (J. Shen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blagosklonny MV, 2002, CELL CYCLE, V1, P391, DOI 10.4161/cc.1.6.262; Borriello A, 2011, EXPERT OPIN THER TAR, V15, P677, DOI 10.1517/14728222.2011.561318; Chen GP, 1999, INT J CANCER, V84, P95, DOI 10.1002/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N; Chen GP, 2004, INT J CANCER, V112, P393, DOI 10.1002/ijc.20443; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Dellas A, 1998, CANCER, V83, P1376, DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1; Dong ZZ, 2009, EXP CELL RES, V315, P1889, DOI 10.1016/j.yexcr.2009.03.009; Dong ZZ, 2004, ONCOGENE, V23, P3790, DOI 10.1038/sj.onc.1207465; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Filipits M, 2007, J CLIN ONCOL, V25, P2735, DOI 10.1200/JCO.2006.08.2867; Fu WW, 2013, CHINESE J INORG CHEM, V29, P654, DOI 10.3969/j.issn.1001-4861.2013.00.099; Haybaeck J, 2010, ANTICANCER RES, V30, P1047; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee J, 2009, EXP MOL MED, V41, P765, DOI 10.3858/emm.2009.41.11.102; Liu RY, 2011, ONCOGENE, V30, P4814, DOI 10.1038/onc.2011.189; Liu RY, 2013, MOL CANCER THER, V12, P2157, DOI 10.1158/1535-7163.MCT-12-1190; Pincheira R, 2001, BRIT J CANCER, V84, P1520, DOI 10.1054/bjoc.2001.1828; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spilka R, 2012, J ONCOL, V2012, DOI 10.1155/2012/901956; Vallieres E, 2012, THORAX, V67, P1097, DOI 10.1136/thoraxjnl-2011-201043; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Xu XJ, 2013, LUNG CANCER, V79, P65, DOI 10.1016/j.lungcan.2012.10.005; Yin JY, 2011, CLIN CANCER RES, V17, P4600, DOI 10.1158/1078-0432.CCR-10-2591	26	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96008	10.1371/journal.pone.0096008	http://dx.doi.org/10.1371/journal.pone.0096008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24789280	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917300023
J	Higgs, ND; Gates, AR; Jones, DOB				Higgs, Nicholas D.; Gates, Andrew R.; Jones, Daniel O. B.			Fish Food in the Deep Sea: Revisiting the Role of Large Food-Falls	PLOS ONE			English	Article							SHARK RHINCODON-TYPUS; WHALE-FALL; SCAVENGER ASSEMBLAGES; MONTEREY CANYON; OSEDAX; ECOLOGY; BIOLOGY; CARCASSES; ATLANTIC; WORMS	The carcasses of large pelagic vertebrates that sink to the seafloor represent a bounty of food to the deep-sea benthos, but natural food-falls have been rarely observed. Here were report on the first observations of three large `fish-falls' on the deep-sea floor: a whale shark (Rhincodon typus) and three mobulid rays (genus Mobula). These observations come from industrial remotely operated vehicle video surveys of the seafloor on the Angola continental margin. The carcasses supported moderate communities of scavenging fish (up to 50 individuals per carcass), mostly from the family Zoarcidae, which appeared to be resident on or around the remains. Based on a global dataset of scavenging rates, we estimate that the elasmobranch carcasses provided food for mobile scavengers over extended time periods from weeks to months. No evidence of whale-fall type communities was observed on or around the carcasses, with the exception of putative sulphide-oxidising bacterial mats that outlined one of the mobulid carcasses. Using best estimates of carcass mass, we calculate that the carcasses reported here represent an average supply of carbon to the local seafloor of 0.4 mg m(-2) d(-1), equivalent to,similar to 4% of the normal particulate organic carbon flux. Rapid flux of high-quality labile organic carbon in fish carcasses increases the transfer efficiency of the biological pump of carbon from the surface oceans to the deep sea. We postulate that these food-falls are the result of a local concentration of large marine vertebrates, linked to the high surface primary productivity in the study area.	[Higgs, Nicholas D.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Gates, Andrew R.; Jones, Daniel O. B.] Natl Oceanog Ctr, SERPENT Project, Southampton, Hants, England	University of Plymouth; NERC National Oceanography Centre	Higgs, ND (corresponding author), Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England.	nicholas.higgs@plymouth.ac.uk	Gates, Andrew R/I-4321-2012; Higgs, Nicholas D/GYU-4071-2022; Jones, Daniel/A-3412-2009	Gates, Andrew R/0000-0002-2798-5044; Higgs, Nicholas D/0000-0001-8029-1001; Jones, Daniel/0000-0001-5218-1649	Plymouth University Marine Institute; NERC through the SERPENT Project; Natural Environment Research Council [noc010009] Funding Source: researchfish; NERC [noc010009] Funding Source: UKRI	Plymouth University Marine Institute; NERC through the SERPENT Project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Nicholas Higgs was supported by a Research Fellowship from the Plymouth University Marine Institute (www.plymouth.ac.uk/marine). Andrew Gates was funded by NERC through the SERPENT Project (www.serpentproject.com). Daniel Jones was funded for this work as part of the NERC Marine Environmental Mapping Programme MAREMAP (www.maremap.ac.uk). BP (www.bp.com/) provided resources for the study in the form of the video data and authorised its use for publication. The funders had no role in study design, data analysis, or preparation of the manuscript.	Amon DJ, 2013, DEEP-SEA RES PT II, V92, P87, DOI 10.1016/j.dsr2.2013.01.028; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; Billett DSM, 2010, DEEP-SEA RES PT II, V57, P1406, DOI 10.1016/j.dsr2.2009.02.001; Braby CE, 2007, DEEP-SEA RES PT I, V54, P1773, DOI 10.1016/j.dsr.2007.05.014; BRITTON JC, 1994, OCEANOGR MAR BIOL, V32, P369; BUTMAN CA, 1995, CONSERV BIOL, V9, P462, DOI 10.1046/j.1523-1739.1995.9020462.x; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Davison PC, 2013, PROG OCEANOGR, V116, P14, DOI 10.1016/j.pocean.2013.05.013; DEVADOSS P, 1984, Indian Journal of Fisheries, V31, P156; Drazen JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049332; Ferry LA, 1997, DEEP-SEA RES PT I, V44, P521, DOI 10.1016/S0967-0637(96)00120-3; Fujikura K, 2006, ZOOL SCI, V23, P733, DOI 10.2108/zsj.23.733; Glover AG, 2005, P ROY SOC B-BIOL SCI, V272, P2587, DOI 10.1098/rspb.2005.3275; Goffredi SK, 2008, ISME J, V2, P204, DOI 10.1038/ismej.2007.103; Goffredi SK, 2004, DEEP-SEA RES PT I, V51, P1295, DOI 10.1016/j.dsr.2004.05.009; Graham RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036834; Hardman-Mountford NJ, 2003, PROG OCEANOGR, V59, P181, DOI 10.1016/j.pocean.2003.10.001; Heezen BC, 1972, US FACE DEEP, P1; HESSLER RR, 1978, DEEP-SEA RES, V25, P1029, DOI 10.1016/0146-6291(78)90585-4; Higgs ND, 2011, BIOL BULL-US, V221, P307, DOI 10.1086/BBLv221n3p307; Higgs ND, 2011, P ROY SOC B-BIOL SCI, V278, P9, DOI 10.1098/rspb.2010.1267; HOGLER JA, 1994, PALAIOS, V9, P42, DOI 10.2307/3515077; HOUSTON KA, 1986, MAR BIOL, V92, P563, DOI 10.1007/BF00392516; Hsu HH, 2012, J FISH BIOL, V80, P1595, DOI 10.1111/j.1095-8649.2012.03234.x; ISAACS JD, 1975, SCI AM, V233, P85; Jamieson AJ, 2011, J FISH BIOL, V79, P205, DOI 10.1111/j.1095-8649.2011.03014.x; JANNASCH HW, 1978, OCEANUS, V21, P50; Janssen F, 2000, DEEP-SEA RES PT II, V47, P2999, DOI 10.1016/S0967-0645(00)00056-4; Johnson SB, 2010, BIOL BULL-US, V219, P166, DOI 10.1086/BBLv219n2p166; Jones EG, 1998, P ROY SOC B-BIOL SCI, V265, P1119, DOI 10.1098/rspb.1998.0407; Kaim A, 2008, ACTA PALAEONTOL POL, V53, P97, DOI 10.4202/app.2008.0106; Kemp KM, 2006, MAR ECOL PROG SER, V310, P65, DOI 10.3354/meps310065; Kiel S, 2006, P ROY SOC B-BIOL SCI, V273, P2625, DOI 10.1098/rspb.2006.3620; Lebrato M, 2009, LIMNOL OCEANOGR, V54, P1197, DOI 10.4319/lo.2009.54.4.1197; Lindsay Dhugal J., 2003, JAMSTEC Journal of Deep Sea Research, V22, P1; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P1573, DOI 10.1016/j.dsr.2010.09.003; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P918, DOI 10.1016/j.dsr.2010.04.006; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; MARTILL DM, 1991, NATURE, V351, P193, DOI 10.1038/351193a0; MCALLISTER DE, 1981, CAN J FISH AQUAT SCI, V38, P821, DOI 10.1139/f81-110; McClain CR, 2012, P NATL ACAD SCI USA, V109, P15366, DOI 10.1073/pnas.1208976109; NOTARBARTOLODISCIARA G, 1988, FISH B-NOAA, V86, P45; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; Pope EC, 2010, REV FISH BIOL FISHER, V20, P471, DOI 10.1007/s11160-009-9155-9; Pyenson ND, 2007, BIOLOGY LETT, V3, P709, DOI 10.1098/rsbl.2007.0342; Rabouille C, 2009, DEEP-SEA RES PT II, V56, P2223, DOI 10.1016/j.dsr2.2009.04.005; Raymond E, 2010, 12 INT DEEP SEA BIOL, P153; Robison BH, 2005, SCIENCE, V308, P1609, DOI 10.1126/science.1109104; Rohner CA, 2013, MAR ECOL PROG SER, V482, P153, DOI 10.3354/meps10290; Rouse GW, 2011, BIOL LETTERS, V7, P736, DOI 10.1098/rsbl.2011.0202; Rouse GW, 2009, MAR BIOL, V156, P395, DOI 10.1007/s00227-008-1091-z; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; Sancho G, 2005, DEEP-SEA RES PT I, V52, P837, DOI 10.1016/j.dsr.2004.12.002; Schafer W, 1972, ECOLOGY PALAEOECOLOG, P10; Schuller D, 2004, EARTH PLANET SC LETT, V218, P277, DOI 10.1016/S0012-821X(03)00690-3; Sequeira A, 2012, DIVERS DISTRIB, V18, P504, DOI 10.1111/j.1472-4642.2011.00853.x; SMITH CR, 1994, PALAIOS, V9, P3, DOI 10.2307/3515074; Smith CR, 2002, CAH BIOL MAR, V43, P293; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; SMITH CR, 1992, OCEANUS, V35, P74; SMITH CR, 1985, DEEP-SEA RES, V32, P417, DOI 10.1016/0198-0149(85)90089-5; SMITH CR, 1989, NATURE, V341, P27, DOI 10.1038/341027a0; Smith CR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P286; Smith KL, 1999, SCIENCE, V284, P1174, DOI 10.1126/science.284.5417.1174; SQUIRES RL, 1991, NATURE, V349, P574, DOI 10.1038/349574a0; Stehmann M, 1981, FAO SPECIES IDENTIFI, V5, P1; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; STOCKTON WL, 1982, DEEP-SEA RES, V29, P157, DOI 10.1016/0198-0149(82)90106-6; Stroud EM, 2014, OCEAN COAST MANAGE, V97, P50, DOI 10.1016/j.ocecoaman.2013.01.006; Treude T, 2009, MAR ECOL PROG SER, V382, P1, DOI 10.3354/meps07972; Turner R.D., 1977, Bulletin Am malac Union, V1977, P13; TURNER RD, 1973, SCIENCE, V180, P1377, DOI 10.1126/science.180.4093.1377; Tweddle Denis, 2008, Smithiana Bulletin, P3; VANBENNEKOM AJ, 1984, NETH J SEA RES, V17, P149, DOI 10.1016/0077-7579(84)90047-4; Venkatesan V, 2008, MARINE FISHERIES INF, V198, P19; Wada H, 2002, JAPAN MARINE SCI TEC, V10, P38; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Weir CR, 2011, AFR J MAR SCI, V33, P1, DOI 10.2989/1814232X.2011.572333; Weir Caroline R., 2012, Marine Biodiversity Records, V5, pe26, DOI 10.1017/S1755267212000061; Weir Caroline R., 2010, Marine Biodiversity Records, V3, pe50; Witte U, 1999, MAR ECOL PROG SER, V183, P139, DOI 10.3354/meps183139; WOLFF T, 1979, SARSIA, V64, P117, DOI 10.1080/00364827.1979.10411373; Zeeberg J, 2006, FISH RES, V78, P186, DOI 10.1016/j.fishres.2006.01.012	85	60	61	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96016	10.1371/journal.pone.0096016	http://dx.doi.org/10.1371/journal.pone.0096016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804731	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900031
J	Lim, L; Banwell, C; Bain, C; Banks, E; Seubsman, SA; Kelly, M; Yiengprugsawan, V; Sleigh, A				Lim, Lynette; Banwell, Cathy; Bain, Chris; Banks, Emily; Seubsman, Sam-ang; Kelly, Matthew; Yiengprugsawan, Vasoontara; Sleigh, Adrian			Sugar Sweetened Beverages and Weight Gain over 4 Years in a Thai National Cohort - A Prospective Analysis	PLOS ONE			English	Article							PREVENTING CHILDHOOD OBESITY; CONSUMPTION; TRIAL	Introduction: Sugar sweetened beverages (SSBs) are implicated in the rising prevalence of obesity and diet-related chronic diseases worldwide. However, little is known about their contribution to weight gain in Asian populations. This study aimed to investigate weight change associated with SSB consumption between 2005 and 2009 in a large national cohort of Thai university students. Methods: Questionnaire data were collected from a large Thai cohort (the Thai Health-Risk Transition: a National Cohort Study). The analysis was based on responses from 59 283 of the 60 569 (98%) cohort members who had valid SSB consumption and weight variables in 2005 and 2009. The relationship between SSB consumption in 2005 and self-reported weight change was analysed using multiple linear regression models controlled for socio-demographic, activity and (non-validated) dietary factors shown to influence weight. Results: Higher frequency of SSB consumption in 2005 was significantly associated with greater weight gain between 2005 and 2009 in all age groups and in both sexes (p<0.0001); persons who consumed SSBs at least once a day in 2005 gained 0.5 kg more than those who consumed SSBs less than once a month. The estimated weight gain for the average person in the sample was 1.9 kg (95% C I 1.95-1.96). The difference in weight gain between those who increased their consumption frequency (, once a month to. once per day) between 2005 and 2009 compared to those who maintained it was 0.3 kgs, while persons who reduced their consumption frequency (once a day to. once a month) gained 0.2 kgs less than those whose consumption remained unchanged. Conclusion: SSB consumption is independently associated with weight gain in the Thai population. Research and health promotion in Thailand and other economically transitioning countries should focus on reducing their contribution to population weight gain and to diet-related chronic diseases.	[Lim, Lynette; Banwell, Cathy; Bain, Chris; Banks, Emily; Seubsman, Sam-ang; Kelly, Matthew; Yiengprugsawan, Vasoontara; Sleigh, Adrian] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Seubsman, Sam-ang] Sukhothai Thammithirat Open Univ, Nonthaburi, Thailand; [Bain, Chris] Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia	Australian National University; Sukhothai Thammathirat Open University; QIMR Berghofer Medical Research Institute	Banwell, C (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia.	Cathy.Banwell@anu.edu.au	Yiengprugsawan, Vasoontara/N-7072-2013; Yiengprugsawan, Vas Sbirakos/G-3176-2011; sleigh, adrian/J-4540-2019; Kelly, Matthew/ABC-1069-2020	Yiengprugsawan, Vasoontara/0000-0001-9101-4704; Yiengprugsawan, Vas Sbirakos/0000-0001-9101-4704; sleigh, adrian/0000-0001-8443-7864; Kelly, Matthew/0000-0001-7963-2139; Banwell, Cathy/0000-0001-6808-1052; Banks, Emily/0000-0002-4617-1302; Seubsman, Sam-ang/0000-0002-7451-3218	International Collaborative Research Grants Scheme	International Collaborative Research Grants Scheme	This study was supported by the International Collaborative Research Grants Scheme with joint grants from the Wellcome Trust UK (GR071587MA) (http://www.wellcome.ac.uk/) and the Australian NHMRC (268055) and by a global health grant from the NHMRC (585426) (http://www.nhmrc.gov.au/). No employees of either funder were involved in the any aspect of the research.	Aekplakorn W., 2011, REPORT THAI NATL HLT; Aekplakorn W, 2007, OBESITY, V15, P3113, DOI 10.1038/oby.2007.371; Allotey P, 2011, LANCET, V377, P450, DOI 10.1016/S0140-6736(10)61856-9; Banwell C, 2009, J EPIDEMIOL COMMUN H, V63, P366, DOI 10.1136/jech.2008.080820; Banwell C., 2012, WEIGHT MODERNITY INT; British Soft Drinks Association, 2012, 2012 UK SOFT DRINKS; Chavasit V, 2013, OBES REV, V14, P96, DOI 10.1111/obr.12091; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Deerochanawong C, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-11; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Esterl M., 2013, WALL STREET J; Euromonitor, 2012, SOFT DRINKS THAIL EX; FAO, 2006, DIET EN CONS COUNTR; Feliciano J, 2013, FEMSAS LATEST ACQUIS; Graham JW., 2012, MISSING DATA; Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2007, BMJ-BRIT MED J, V335, P762, DOI 10.1136/bmj.39342.571806.55; James W, 2007, OBESITY REV S1, V9, P6; Jordan S, 2012, J EPIDEMIOL COMMUN H, V66, P75, DOI 10.1136/jech.2010.113043; Kahara P, 2009, MARKETING RES COCA C; Lim Lynette Ly, 2009, Popul Health Metr, V7, P15, DOI 10.1186/1478-7954-7-15; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nam S, 2009, FORBES; National Statistical Office and Office of Agricultural Economics of the Kingdom of Thailand, 2012, FOOD INS ASS NAT SUB; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Seubsman Sam-Ang, 2011, BMC Res Notes, V4, P166, DOI 10.1186/1756-0500-4-166; Simopoulos AP, 2013, NUTRIENTS, V5, P411, DOI 10.3390/nu5020411; Sleigh AC, 2008, INT J EPIDEMIOL, V37, P266, DOI 10.1093/ije/dym161; The Nation, 2006, NATION; Ungchusak C, 2005, 8 WORLD C PREV DENT; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Wilbulpolprasert S, 2011, THAILAND HLTH PROFIL; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	40	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95309	10.1371/journal.pone.0095309	http://dx.doi.org/10.1371/journal.pone.0095309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG9HB	24805125	Green Published, gold			2022-12-27	WOS:000335728900017
J	Lin, HH; Yin, XY; Lunetta, KL; Dupuis, J; McManus, DD; Lubitz, SA; Magnani, JW; Joehanes, R; Munson, PJ; Larson, MG; Levy, D; Ellinor, PT; Benjamin, EJ				Lin, Honghuang; Yin, Xiaoyan; Lunetta, Kathryn L.; Dupuis, Josee; McManus, David D.; Lubitz, Steven A.; Magnani, Jared W.; Joehanes, Roby; Munson, Peter J.; Larson, Martin G.; Levy, Daniel; Ellinor, Patrick T.; Benjamin, Emelia J.			Whole Blood Gene Expression and Atrial Fibrillation: The Framingham Heart Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; FAMILIAL AGGREGATION; RISK-FACTOR; DISEASE; HYPOXIA; PREVALENCE; NETWORKS; HYPERTENSION; POLYMORPHISM	Background: Atrial fibrillation (AF) involves substantial electrophysiological, structural and contractile remodeling. We hypothesize that characterizing gene expression might uncover important pathways related to AF. Methods and Results: We performed genome-wide whole blood transcriptomic profiling (Affymetrix Human Exon 1.0 ST Array) of 2446 participants (mean age 66 +/- 9 years, 55% women) from the Offspring cohort of Framingham Heart Study. The study included 177 participants with prevalent AF, 143 with incident AF during up to 7 years follow up, and 2126 participants with no AF. We identified seven genes statistically significantly up-regulated with prevalent AF. The most significant gene, PBX1 (P=2.8x10(-7)), plays an important role in cardiovascular development. We integrated differential gene expression with gene-gene interaction information to identify several signaling pathways possibly involved in AF-related transcriptional regulation. We did not detect any statistically significant transcriptomic associations with incident AF. Conclusion: We examined associations of gene expression with AF in a large community-based cohort. Our study revealed several genes and signaling pathways that are potentially involved in AF-related transcriptional regulation.	[Lin, Honghuang] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02215 USA; [Lin, Honghuang; Yin, Xiaoyan; Lunetta, Kathryn L.; Dupuis, Josee; McManus, David D.; Joehanes, Roby; Munson, Peter J.; Larson, Martin G.; Levy, Daniel; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Lin, Honghuang; Yin, Xiaoyan; Lunetta, Kathryn L.; Dupuis, Josee; McManus, David D.; Joehanes, Roby; Munson, Peter J.; Larson, Martin G.; Levy, Daniel; Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Lunetta, Kathryn L.; Dupuis, Josee] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiol, Worcester, MA USA; [McManus, David D.] Univ Massachusetts, Sch Med, Div Epidemiol, Dept Quantitat Hlth Sci, Worcester, MA USA; [Lubitz, Steven A.; Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; [Joehanes, Roby; Munson, Peter J.] NIH, Math & Stat Comp Lab, Ctr Informat Technol, Bethesda, MD 20892 USA; [Joehanes, Roby; Munson, Peter J.; Levy, Daniel] NHLBI, Populat Sci Branch, Div Intramural Res, Bethesda, MD 20892 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Ellinor, Patrick T.] Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Ellinor, Patrick T.] Harvard Univ, Sch Med, Boston, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Boston University; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University; Boston University	Lin, HH (corresponding author), Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA 02215 USA.	hhlin@bu.edu	Benjamin, Emelia/E-7103-2011; Levy, Daniel/ABF-6873-2021; Lin, Honghuang/A-3269-2019; Levy, Daniel/ABB-2752-2021	Benjamin, Emelia/0000-0003-4076-2336; Levy, Daniel/0000-0003-1843-8724; Lin, Honghuang/0000-0003-3043-3942; Dupuis, Josee/0000-0003-2871-3603; Lunetta, Kathryn/0000-0002-9268-810X; Ellinor, Patrick/0000-0002-2067-0533	NIH [R01HL092577, R01HL104156, K24HL105780, KL2RR031981]; American Heart Association Awards [13EIA14220013, 09FTF2190028]; Intramural Research Program of National Heart, Lung, and Blood Institute (Levy); National Heart, Lung, and Blood Institute [N01-HC-25195, 6R01-NS 17950]; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000266] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006001, R01HL104156, K24HL105780, R01HL092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Awards(American Heart Association); Intramural Research Program of National Heart, Lung, and Blood Institute (Levy); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIH grants R01HL092577 (Ellinor and Benjamin), R01HL104156, K24HL105780 (Ellinor), KL2RR031981 (McManus), American Heart Association Awards 13EIA14220013 (Ellinor) and 09FTF2190028 (Magnani), and the Intramural Research Program of National Heart, Lung, and Blood Institute (Levy). The Framingham Heart Study is supported by National Heart, Lung, and Blood Institute contract N01-HC-25195 and 6R01-NS 17950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; ALBRITTON LM, 1992, GENOMICS, V12, P430, DOI 10.1016/0888-7543(92)90431-Q; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornstad JL, 2012, CARDIOVASC RES, V93, P100, DOI 10.1093/cvr/cvr294; Brundel BJJM, 1999, CARDIOVASC RES, V42, P443, DOI 10.1016/S0008-6363(99)00045-0; Calvert JW, 2006, J APPL PHYSIOL, V101, P853, DOI 10.1152/japplphysiol.00268.2006; Carnes CA, 2001, CIRC RES, V89, pE32, DOI 10.1161/hh1801.097644; Cervero J, 2012, THROMB HAEMOSTASIS, V108, P742, DOI 10.1160/TH12-05-0285; Chang CP, 2008, DEVELOPMENT, V135, P3577, DOI 10.1242/dev.022350; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Cowley MJ, 2012, NUCLEIC ACIDS RES, V40, pD862, DOI 10.1093/nar/gkr967; Darbar D, 2003, J AM COLL CARDIOL, V41, P2185, DOI 10.1016/S0735-1097(03)00465-0; Darbar D, 2007, HEART RHYTHM, V4, P743, DOI 10.1016/j.hrthm.2007.02.006; Dernellis J, 2001, ACTA CARDIOL, V56, P375, DOI 10.2143/AC.56.6.2005701; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Ellinor PT, 2005, HUM GENET, V118, P179, DOI 10.1007/s00439-005-0034-8; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Gao M, 2013, EXP THER MED, V5, P1239, DOI 10.3892/etm.2013.949; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Goette A, 2000, J AM COLL CARDIOL, V35, P1669, DOI 10.1016/S0735-1097(00)00611-2; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Heerdt PM, 2012, J MOL CELL CARDIOL, V53, P350, DOI 10.1016/j.yjmcc.2012.05.010; Hyun C, 2006, VET J, V171, P245, DOI 10.1016/j.tvjl.2005.02.008; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Joehanes R, 2013, ARTERIOSCL THROM VAS, V33, P1418, DOI 10.1161/ATVBAHA.112.301169; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Lin HH, 2014, HEART RHYTHM, V11, P266, DOI 10.1016/j.hrthm.2013.10.051; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Matkovich SJ, 2010, CIRC RES, V106, P1459, DOI 10.1161/CIRCRESAHA.110.217513; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; MORILLO CA, 1995, CIRCULATION, V91, P1588, DOI 10.1161/01.CIR.91.5.1588; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Schulze-Topphoff U, 2013, J EXP MED, V210, P1301, DOI 10.1084/jem.20121611; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Stankunas K, 2008, CIRC RES, V103, P702, DOI 10.1161/CIRCRESAHA.108.175489; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Thijssen VLJL, 2002, CARDIOVASC RES, V54, P427, DOI 10.1016/S0008-6363(02)00260-2; Van Gelder IC, 1999, J CARDIOVASC ELECTR, V10, P552; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836; Yang ZY, 2009, HUM MUTAT, V30, P328, DOI 10.1002/humu.20891	54	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96794	10.1371/journal.pone.0096794	http://dx.doi.org/10.1371/journal.pone.0096794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805109	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900097
J	Nance, T; Smith, KS; Anaya, V; Richardson, R; Ho, L				Nance, T.; Smith, K. S.; Anaya, V; Richardson, R.; Ho, L.			Transcriptome Analysis Reveals Differential Splicing Events in IPF Lung Tissue (vol 9, pg e92111, 2014)	PLOS ONE			English	Correction														Montgomery, Stephen/0000-0002-5200-3903; Pala, Mauro/0000-0002-3165-5291				Nance T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092111	1	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97550	10.1371/journal.pone.0097550	http://dx.doi.org/10.1371/journal.pone.0097550			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805851	Green Published, gold			2022-12-27	WOS:000335728900138
J	Alcala-Diaz, JF; Delgado-Lista, J; Perez-Martinez, P; Garcia-Rios, A; Marin, C; Quintana-Navarro, GM; Gomez-Luna, P; Camargo, A; Almaden, Y; Caballero, J; Tinahones, FJ; Ordovas, JM; Perez-Jimenez, F; Lopez-Miranda, J				Alcala-Diaz, Juan F.; Delgado-Lista, Javier; Perez-Martinez, Pablo; Garcia-Rios, Antonio; Marin, Carmen; Quintana-Navarro, Gracia M.; Gomez-Luna, Purificacion; Camargo, Antonio; Almaden, Yolanda; Caballero, Javier; Tinahones, Francisco J.; Ordovas, Jose M.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose			Hypertriglyceridemia Influences the Degree of Postprandial Lipemic Response in Patients with Metabolic Syndrome and Coronary Artery Disease: From the Cordioprev Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; NONFASTING TRIGLYCERIDES; OXIDATIVE STRESS; LIPID-METABOLISM; HEART-DISEASE; RISK; MEN; ATHEROSCLEROSIS; METAANALYSIS; DIETARY	Objective: To determine whether metabolic syndrome traits influence the postprandial lipemia response of coronary patients, and whether this influence depends on the number of MetS criteria. Materials and Methods: 1002 coronary artery disease patients from the CORDIOPREV study were submitted to an oral fat load test meal with 0.7 g fat/ kg body weight (12% saturated fatty acids, 10% polyunsaturated fatty acids, 43% monounsaturated fatty acids), 10% protein and 25% carbohydrates. Serial blood test analyzing lipid fractions were drawn at 0, 1, 2, 3 and 4 hours during the postprandial state. Total and incremental area under the curves of the different postprandial parameters were calculated following the trapezoid rule to assess the magnitude of change during the postprandial state Results: Postprandial lipemia response was directly related to the presence of metabolic syndrome. We found a positive association between the number of metabolic syndrome criteria and the response of postprandial plasma triglycerides (p< 0.001), area under the curve of triglycerides (p<0.001) and incremental area under the curve of triglycerides (p<0.001). However, the influence of them on postprandial triglycerides remained statistically significant only in those patients without basal hypertriglyceridemia. Interestingly, in stepwise multiple linear regression analysis with the AUC of triglycerides as the dependent variable, only fasting triglycerides, fasting glucose and waist circumference appeared as significant independent (P<0.05) contributors. The multiple lineal regression (R) was 0.77, and fasting triglycerides showed the greatest effect on AUC of triglycerides with a standardized coefficient of 0.75. Conclusions: Fasting triglycerides are the major contributors to the postprandial triglycerides levels. MetS influences the postprandial response of lipids in patients with coronary heart disease, particularly in non-hypertriglyceridemic patients.	[Alcala-Diaz, Juan F.; Delgado-Lista, Javier; Perez-Martinez, Pablo; Garcia-Rios, Antonio; Marin, Carmen; Quintana-Navarro, Gracia M.; Gomez-Luna, Purificacion; Camargo, Antonio; Almaden, Yolanda; Perez-Jimenez, Francisco; Lopez-Miranda, Jose] Univ Cordoba, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Lipidos & Arteriosclerosis,Dept Med, Cordoba, Spain; [Alcala-Diaz, Juan F.; Delgado-Lista, Javier; Perez-Martinez, Pablo; Garcia-Rios, Antonio; Marin, Carmen; Gomez-Luna, Purificacion; Camargo, Antonio; Almaden, Yolanda; Perez-Jimenez, Francisco; Lopez-Miranda, Jose] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Caballero, Javier] Hosp Univ Reina Sofia, Dept Anal Clin, Cordoba, Spain; [Tinahones, Francisco J.] Inst Salud Carlos III, CIBEROBN, Hosp Virgen Victoria, Malaga, Spain; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] Inst Madrileno Estudios Avanzados Alimentac IMDEA, Madrid, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Tufts University; United States Department of Agriculture (USDA)	Lopez-Miranda, J (corresponding author), Univ Cordoba, Hosp Univ Reina Sofia, Inst Maimonides Invest Biomed Cordoba IMIBIC, Unidad Lipidos & Arteriosclerosis,Dept Med, Cordoba, Spain.	jlopezmir@uco.es	Tinahones, Francisco José/AAB-2882-2020; Caballero-Villarraso, Javier/AAC-3434-2019; Lopez-Miranda, Jose/Y-8306-2019; Camargo, Antonio/G-9720-2015; Jimenez, Francisco Perez/AAJ-9559-2021; Alcala-Diaz, Juan Francisco/F-5329-2016; Alcala-Diaz, Juan F./Q-4455-2019; Marin Hinojosa, Carmen/AFO-1294-2022; Ordovas, Jose/B-8727-2013	Caballero-Villarraso, Javier/0000-0003-0571-5147; Lopez-Miranda, Jose/0000-0002-8844-0718; Camargo, Antonio/0000-0002-0415-4184; Alcala-Diaz, Juan Francisco/0000-0002-4572-3611; Alcala-Diaz, Juan F./0000-0002-4572-3611; Marin Hinojosa, Carmen/0000-0003-2884-4806; Ordovas, Jose/0000-0002-7581-5680; QUINTANA-NAVARRO, GRACIA MARIA/0000-0003-4413-4062; Perez Martinez, Pablo/0000-0001-7716-8117; Delgado Lista, Francisco Javier/0000-0002-2982-2716; Tinahones, Francisco J/0000-0001-6871-4403; Perez Jimenez, Francisco/0000-0001-9808-1280; Perez-Jimenez, Francisco/0000-0001-7499-7681	Fundacion Patrimonio Comunal Olivarero; Junta de Andalucia (Consejeria de Salud, Consejeria de Agricultura y Pesca; Consejeria de Innovacion, Ciencia y Empresa); Diputaciones de Jaen y Cordoba; Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud; Ministerio de Ciencia e Innovacion [AGL2009-122270, FIS PI10/01041, PI10/02412]; Ministerio de Economia y Competitividad [AGL2012/39615]; Consejeria de Economia; Proyectos de Investigacion de Excelencia; Junta de Andalucia [AGR922, PI0193/09]; Consejeria de Salud; Consejeria de Innovacion Ciencia y Empresa [CVI-7450]; ISCIII (Programa Rio-Hortega); Nicolas Monardes Programme; Consejeria de Salud-SAS (Junta de Andalucia);  [0118/08];  [PI-0252/09];  [PI-0058/10]	Fundacion Patrimonio Comunal Olivarero; Junta de Andalucia (Consejeria de Salud, Consejeria de Agricultura y Pesca(Junta de Andalucia); Consejeria de Innovacion, Ciencia y Empresa); Diputaciones de Jaen y Cordoba; Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Consejeria de Economia; Proyectos de Investigacion de Excelencia; Junta de Andalucia(Junta de Andalucia); Consejeria de Salud; Consejeria de Innovacion Ciencia y Empresa; ISCIII (Programa Rio-Hortega)(Instituto de Salud Carlos III); Nicolas Monardes Programme; Consejeria de Salud-SAS (Junta de Andalucia)(Junta de Andalucia); ; ; 	The CORDIOPREV study is supported from Fundacion Patrimonio Comunal Olivarero, Junta de Andalucia (Consejeria de Salud, Consejeria de Agricultura y Pesca, Consejeria de Innovacion, Ciencia y Empresa), Diputaciones de Jaen y Cordoba, Centro de Excelencia en Investigacion sobre Aceite de Oliva y Salud and Ministerio de Medio Ambiente, Medio Rural y Marino, Gobierno de Espana Also supported in part by research grants from the Ministerio de Ciencia e Innovacion (AGL2009-122270 to J L-M, FIS PI10/01041 to P P-M, PI10/02412 to F P-J); Ministerio de Economia y Competitividad (AGL2012/39615 to J L-M); Consejeria de Economia, Innovacion y Ciencia, Proyectos de Investigacion de Excelencia, Junta de Andalucia (AGR922 to F P-J); Consejeria de Salud, Junta de Andalucia (PI0193/09 to J L-M), 0118/08 to F F-J, PI-0252/09 to J D-L, and PI-0058/10 to P P-M; Consejeria de Innovacion Ciencia y Empresa (CVI-7450 to J L-M. JF Alcala-Diaz is supported by a research contract of ISCIII (Programa Rio-Hortega). Y Almaden is a senior researcher supported by the Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia). The CIBEROBN is an initiative of the Instituto de Salud Carlos III, Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour A, 2008, ATHEROSCLEROSIS SUPP, V9, P39, DOI 10.1016/j.atherosclerosissup.2008.05.007; Alipour A, 2007, BIOCHEM SOC T, V35, P466, DOI 10.1042/BST0350466; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bravo E, 2007, BIOCHEM SOC T, V35, P459, DOI 10.1042/BST0350459; CABEZAS MC, 1994, EUR J CLIN INVEST, V24, P669, DOI 10.1111/j.1365-2362.1994.tb01059.x; Delgado-Lista J, 2010, ARTERIOSCL THROM VAS, V30, P1051, DOI 10.1161/ATVBAHA.109.202580; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; GROOT PHE, 1991, ARTERIOSCLER THROMB, V11, P653, DOI 10.1161/01.ATV.11.3.653; Grundy Scott M, 2006, Clin Cornerstone, V8 Suppl 1, pS21, DOI 10.1016/S1098-3597(06)80005-0; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Halkes CJM, 2001, INT J OBESITY, V25, P1767, DOI 10.1038/sj.ijo.0801831; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P237, DOI 10.1016/j.atherosclerosis.2011.09.047; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012; KARPE F, 1994, ATHEROSCLEROSIS, V106, P83, DOI 10.1016/0021-9150(94)90085-X; Klop B, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/947417; Kolovou Genovefa D, 2005, Lipids Health Dis, V4, P21, DOI 10.1186/1476-511X-4-21; Kolovou GD, 2006, MATURITAS, V55, P19, DOI 10.1016/j.maturitas.2006.01.002; Lairon D, 2011, CURR VASC PHARMACOL, V9, P309, DOI 10.2174/157016111795495576; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Lopez-Miranda J, 2007, BRIT J NUTR, V98, P458, DOI 10.1017/S000711450774268X; Lupattelli G, 2002, AM HEART J, V143, P733, DOI 10.1067/mhj.2002.120302; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Yubero-Serrano EM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.53; Mente A, 2010, J AM COLL CARDIOL, V55, P2390, DOI 10.1016/j.jacc.2009.12.053; Mihas C, 2011, CURR VASC PHARMACOL, V9, P271, DOI 10.2174/157016111795495530; Miller M, 2003, J INVEST MED, V51, P50, DOI 10.2310/6650.2003.33544; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nordestgaard BG, 2011, CURR VASC PHARMACOL, V9, P281; Ntyintyane LM, 2008, QJM-INT J MED, V101, P111, DOI 10.1093/qjmed/hcm137; O'Keefe JH, 2007, AM J CARDIOL, V100, P899, DOI 10.1016/j.amjcard.2007.03.107; OMEARA NM, 1992, J CLIN ENDOCR METAB, V75, P465, DOI 10.1210/jc.75.2.465; PATSCH JR, 1992, ARTERIOSCLER THROMB, V12, P1336, DOI 10.1161/01.ATV.12.11.1336; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Skalicky J, 2008, CLIN CHEM LAB MED, V46, P499, DOI 10.1515/CCLM.2008.096; Teramura M, 2007, J ATHEROSCLER THROMB, V14, P172, DOI 10.5551/jat.E505; van Oostrom AJHHM, 2003, J LIPID RES, V44, P576, DOI 10.1194/jlr.M200419-JLR200; van Wijk JPH, 2003, METABOLISM, V52, P1043, DOI 10.1016/S0026-0495(03)00106-9; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	40	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96297	10.1371/journal.pone.0096297	http://dx.doi.org/10.1371/journal.pone.0096297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802225	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800050
J	Jullig, M; Yip, S; Xu, AM; Smith, G; Middleditch, M; Booth, M; Babor, R; Beban, G; Murphy, R				Juellig, Mia; Yip, Shelley; Xu, Aimin; Smith, Greg; Middleditch, Martin; Booth, Michael; Babor, Richard; Beban, Grant; Murphy, Rinki			Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes	PLOS ONE			English	Article							INSULIN-RESISTANCE; BARIATRIC SURGERY; GUT MICROBIOTA; SERUM RETINOL-BINDING-PROTEIN-4; GLUCOSE-METABOLISM; CITRATE METABOLISM; OBESITY; CHILDREN; MARKERS; TISSUE	Background: Bypass of foregut secreted factors promoting insulin resistance is hypothesized to be one of the mechanisms by which resolution of type 2 diabetes (T2D) follows roux-en-y gastric bypass (GBP) surgery. Aim: To identify insulin resistance-associated proteins and metabolites which decrease more after GBP than after sleeve gastrectomy (SG) prior to diabetes remission. Methods: Fasting plasma from 15 subjects with T2D undergoing GBP or SG was analyzed by proteomic and metabolomic methods 3 days before and 3 days after surgery. Subjects were matched for age, BMI, metformin therapy and glycemic control. Insulin resistance was calculated using homeostasis model assessment (HOMA-IR). For proteomics, samples were depleted of abundant plasma proteins, digested with trypsin and labeled with iTRAQ isobaric tags prior to liquid chromatography-tandem mass spectrometry analysis. Metabolomic analysis was performed using gas chromatography-mass spectrometry. The effect of the respective bariatric surgery on identified proteins and metabolites was evaluated using two-way analysis of variance and appropriate post-hoc tests. Results: HOMA-IR improved, albeit not significantly, in both groups after surgery. Proteomic analysis yielded seven proteins which decreased significantly after GBP only, including Fetuin-A and Retinol binding protein 4, both previously linked to insulin resistance. Significant decrease in Fetuin-A and Retinol binding protein 4 after GBP was confirmed using ELISA and immunoassay. Metabolomic analysis identified significant decrease of citrate, proline, histidine and decanoic acid specifically after GBP. Conclusion: Greater early decrease was seen for Fetuin-A, Retinol binding protein 4, and several metabolites after GBP compared to SG, preceding significant weight loss. This may contribute to enhanced T2D remission observed following foregut bypass procedures.	[Juellig, Mia; Middleditch, Martin] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Juellig, Mia; Middleditch, Martin] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Yip, Shelley; Murphy, Rinki] Univ Auckland, Dept Med, Auckland, New Zealand; [Xu, Aimin] Univ Hong Kong, Dept Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Smith, Greg] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia; [Booth, Michael] North Shore Hosp, Dept Surg, Auckland, New Zealand; [Babor, Richard] Middlemore Hosp, Dept Surg, Auckland 6, New Zealand; [Beban, Grant] Auckland City Hosp, Dept Surg, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Hong Kong; University of New South Wales Sydney; Auckland City Hospital	Murphy, R (corresponding author), Univ Auckland, Dept Med, Auckland, New Zealand.	R.Murphy@auckland.ac.nz			Jens Henrick Jensen fund; NovoNordisk Diabetes grant fund	Jens Henrick Jensen fund; NovoNordisk Diabetes grant fund	This work was supported by the Jens Henrick Jensen fund and the NovoNordisk Diabetes grant fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbatini F, 2010, SURG ENDOSC, V24, P1005, DOI 10.1007/s00464-009-0715-9; Adeva MM, 2012, AMINO ACIDS, V43, P171, DOI 10.1007/s00726-011-1088-7; Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Aron-Wisnewsky J, 2012, NAT REV GASTRO HEPAT, V9, P590, DOI 10.1038/nrgastro.2012.161; Blonder J, 2011, ELECTROPHORESIS, V32, P1541, DOI 10.1002/elps.201000585; Brix JM, 2010, J CLIN ENDOCR METAB, V95, P4877, DOI 10.1210/jc.2010-0148; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Christou GA, 2012, HORM METAB RES, V44, P6, DOI 10.1055/s-0031-1295491; Cummings DE, 2009, INT J OBESITY, V33, pS33, DOI 10.1038/ijo.2009.15; Cummings DE, 2007, SURG OBES RELAT DIS, V3, P109, DOI 10.1016/j.soard.2007.02.003; Cupisti A, 2007, BIOMED PHARMACOTHER, V61, P86, DOI 10.1016/j.biopha.2006.09.012; DEVILLIERS DC, 1966, METABOLIS, V15, P458, DOI 10.1016/0026-0495(66)90088-6; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Friedrich N, 2012, J ENDOCRINOL, V215, P29, DOI 10.1530/JOE-12-0120; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gomez-Ambrosi J, 2008, CLIN ENDOCRINOL, V69, P208, DOI 10.1111/j.1365-2265.2007.03156.x; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; GROOP LC, 1991, J CLIN ENDOCR METAB, V72, P96, DOI 10.1210/jcem-72-1-96; Gunduz FO, 2011, DIABETES METAB J, V35, P523, DOI 10.4093/dmj.2011.35.5.523; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Isken F, 2006, HORM METAB RES, V38, P543, DOI 10.1055/s-2006-949528; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jullig M, 2010, PROTEOMICS, V10, P3367, DOI 10.1002/pmic.201000276; Khoo CM, 2013, ANN SURG; Kong LC, 2013, AM J CLIN NUTR, V98, P16, DOI 10.3945/ajcn.113.058743; Li HK, 2008, J PROTEOME RES, V7, P4775, DOI 10.1021/pr800352k; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Merrell Karen, 2004, J Biomol Tech, V15, P238; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Mori K, 2012, ADV CLIN CHEM, V56, P175, DOI 10.1016/B978-0-12-394317-0.00010-8; Mutch DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007905; Oberbach A, 2012, J LAPAROENDOSC ADV S, V22, P184, DOI 10.1089/lap.2011.0115; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Ou HY, 2011, CLIN ENDOCRINOL, V75, P450, DOI 10.1111/j.1365-2265.2011.04070.x; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Patil DP, 2012, J BIOSCIENCES, V37, P647, DOI 10.1007/s12038-012-9244-0; Peterli R, 2009, ANN SURG, V250, P234, DOI 10.1097/SLA.0b013e3181ae32e3; Petrescu O, 2005, INT J OBESITY, V29, P196, DOI 10.1038/sj.ijo.0802868; Rao RS, 2012, OBES REV, V13, P316, DOI 10.1111/j.1467-789X.2011.00955.x; Reinehr T, 2008, J CLIN ENDOCR METAB, V93, P4479, DOI 10.1210/jc.2008-1505; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Sjostrom L, 2008, INT J OBESITY, V32, pS93, DOI 10.1038/ijo.2008.244; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Tuttolomondo A, 2010, ATHEROSCLEROSIS, V208, P290, DOI 10.1016/j.atherosclerosis.2009.07.032; Wang Haichao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000884; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yip S, 2014, OBES SURG, V24, P62, DOI 10.1007/s11695-013-1043-7	50	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96489	10.1371/journal.pone.0096489	http://dx.doi.org/10.1371/journal.pone.0096489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800810	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800077
J	Petris, G; Bestagno, M; Arnoldi, F; Burrone, OR				Petris, Gianluca; Bestagno, Marco; Arnoldi, Francesca; Burrone, Oscar R.			New Tags for Recombinant Protein Detection and O-Glycosylation Reporters	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; ROTAVIRUS NSP5; SECRETORY PATHWAY; AB2 ANTIBODIES; IN-VIVO; PURIFICATION; PHOSPHORYLATION; CELLS; IDENTIFICATION; ACTIVATION	Monoclonal antibodies (mAbs), because of their unique specificity, are irreplaceable tools for scientific research. Precise mapping of the antigenic determinants allows the development of epitope tagging approaches to be used with recombinant proteins for several purposes. Here we describe a new family of tags derived from the epitope recognized by a single highly specific mAb (anti-roTag mAb), which was obtained from a pool of mAbs reacting with the rotavirus nonstructural protein 5 (NSP5). The variable regions of the anti-roTag mAb were identified and their binding capacity verified upon expression as a single-chain/miniAb. The minimal epitope, termed roTag, was identified as a 10 amino acid sequence (SISSSIFKNE). The affinity of the anti-roTag/roTag interaction was found to be comparable to that of the anti-SV5/ SV5 tag interaction. roTag was successfully used for detection of several recombinant cytosolic, secretory and membrane proteins. Two additional variants of roTag of 10 and 13 amino acids containing O-glycosylation susceptible sites (termed OG-tag and roTagO) were constructed and characterised. These tags were useful to detect proteins passing through the Golgi apparatus, the site of O-glycosylation.	[Petris, Gianluca; Bestagno, Marco; Arnoldi, Francesca; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Arnoldi, Francesca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste	Burrone, OR (corresponding author), Int Ctr Genet Engn & Biotechnol, Padriciano 99, I-34012 Trieste, Italy.	burrone@icgeb.org	Petris, Gianluca/N-9754-2018; Arnoldi, Francesca/AAQ-6859-2021; ARNOLDI, Francesca/K-5020-2016	Petris, Gianluca/0000-0002-2420-6359; ARNOLDI, Francesca/0000-0003-0651-5526	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy [RBFR08HSWG]; ICGEB pre-doctoral fellowship	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy; ICGEB pre-doctoral fellowship	F.A. was supported by a FIRB-Futuro in Ricerca grant (RBFR08HSWG) funded by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy. G.P. was partially supported by an ICGEB pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova I, 1996, J GEN VIROL, V77, P2059, DOI 10.1099/0022-1317-77-9-2059; Arnoldi F, 2009, FUTURE VIROL, V4, P185, DOI 10.2217/17460794.4.2.185; Bin Song K, 1998, Biotechnol Appl Biochem, V28 ( Pt 2), P163; Campagna M, 2005, J GEN VIROL, V86, P1481, DOI 10.1099/vir.0.80598-0; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Chu HY, 2013, CURR TOP MICROBIOL, V372, P235, DOI 10.1007/978-3-642-38919-1_12; Covitz KMY, 1998, BIOCHEMISTRY-US, V37, P15214, DOI 10.1021/bi981128k; Crowe J, 1994, Methods Mol Biol, V31, P371; de Mello RA, 2013, WORLD J GASTROENTERO, V19, P6165, DOI 10.3748/wjg.v19.i37.6165; Di Niro R, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-46; Eichwald C, 2004, P NATL ACAD SCI USA, V101, P16304, DOI 10.1073/pnas.0406691101; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; ESTES MK, 1979, J VIROL, V31, P810, DOI 10.1128/JVI.31.3.810-815.1979; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Fattore L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-180; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GRAHAM A, 1987, J GEN VIROL, V68, P115, DOI 10.1099/0022-1317-68-1-115; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Harlow E., 1988, ANTIBODIES LAB MANUA; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kaldalu N, 2000, BIOTECHNIQUES, V28, P456, DOI 10.2144/00283st02; KIM JS, 1993, PROTEIN SCI, V2, P348; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Li EQ, 1997, PROTEIN ENG, V10, P731, DOI 10.1093/protein/10.6.731; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Lopez-Requena A, 2007, MOL IMMUNOL, V44, P3070, DOI 10.1016/j.molimm.2007.01.020; Lopez-Requena A, 2007, MOL IMMUNOL, V44, P2915, DOI 10.1016/j.molimm.2007.01.010; Lopez-Requena A, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00159; MACARTHUR H, 1984, J VIROL, V52, P483, DOI 10.1128/JVI.52.2.483-491.1984; MARGULIES DH, 1976, CELL, V8, P405, DOI 10.1016/0092-8674(76)90153-7; Marth JD, 2008, NAT REV IMMUNOL, V8, P874, DOI 10.1038/nri2417; Martin-Mateos MA, 2007, ALLERGOL IMMUNOPATH, V35, P145, DOI 10.1157/13108225; Nilsson J, 1997, PROTEIN EXPRES PURIF, V11, P1, DOI 10.1006/prep.1997.0767; NYGREN PA, 1994, TRENDS BIOTECHNOL, V12, P184, DOI 10.1016/0167-7799(94)90080-9; Park SH, 2008, J IMMUNOL METHODS, V331, P27, DOI 10.1016/j.jim.2007.10.012; Petris G, 2014, J BIOL CHEM, V289, P1, DOI 10.1074/jbc.M113.512368; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; PRICKETT KS, 1989, BIOTECHNIQUES, V7, P580; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Reichel CL, 2000, DOMEST ANIM ENDOCRIN, V18, P337, DOI 10.1016/S0739-7240(00)00054-0; Sambrook J., 2002, MOL CLONING LAB MANU; Simmons CP, 2007, PLOS MED, V4, P928, DOI 10.1371/journal.pmed.0040178; Sotelo PH, 2010, VIRUS RES, V149, P104, DOI 10.1016/j.virusres.2009.12.006; Stricklett PK, 1998, GENE, V215, P415; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; VANDERSPEK J, 1994, LEUKEMIA, V8, pS144; Vecchi L, 2012, J BIOL CHEM, V287, P20007, DOI 10.1074/jbc.M112.355107; Wang LF, 1996, GENE, V169, P53, DOI 10.1016/0378-1119(95)00795-4; Sun WP, 2007, CELL MOL IMMUNOL, V4, P209; Yin J, 2005, P NATL ACAD SCI USA, V102, P15815, DOI 10.1073/pnas.0507705102; Zhang WW, 1996, MOL BIOCHEM PARASIT, V78, P79, DOI 10.1016/S0166-6851(96)02612-6	54	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96700	10.1371/journal.pone.0096700	http://dx.doi.org/10.1371/journal.pone.0096700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802141	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800110
J	Pu, JT; Wang, ZM; Gu, SC; Fuhrman, C; Leader, JK; Meng, X; Tedrow, J; Sciurba, FC				Pu, Jiantao; Wang, Zhimin; Gu, Suicheng; Fuhrman, Carl; Leader, Joseph K.; Meng, Xin; Tedrow, John; Sciurba, Frank C.			Pulmonary Fissure Integrity and Collateral Ventilation in COPD Patients	PLOS ONE			English	Article							LUNG-VOLUME-REDUCTION; HIGH-RESOLUTION CT; ADVANCED EMPHYSEMA; LOBE; HYPERINFLATION; APPEARANCE; ANATOMY; SURGERY	Purpose: To investigate whether the integrity (completeness) of pulmonary fissures affects pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Materials and Methods: A dataset consisting of 573 CT exams acquired on different subjects was collected from a COPD study. According to the global initiative for chronic obstructive lung disease (GOLD) criteria, these subjects (examinations) were classified into five different subgroups, namely non-COPD (222 subjects), GOLD-I (83 subjects), GOLD-II (141 subjects), GOLD-III (63 subjects), and GOLD-IV (64 subjects), in terms of disease severity. An available computer tool was used to aid in an objective and efficient quantification of fissure integrity. The correlations between fissure integrity, and pulmonary functions (e. g., FEV1, and FEV1/ FVC) and COPD severity were assessed using Pearson and Spearman's correlation coefficients, respectively. Results: For the five sub-groups ranging from non-COPD to GOLD-IV, the average integrities of the right oblique fissure (ROF) were 81.8%, 82.4%, 81.8%, 82.8%, and 80.2%, respectively; the average integrities of the right horizontal fissure (RHF) were 62.6%, 61.8%, 62.1%, 62.2%, and 62.3%, respectively; the average integrities of the left oblique fissure (LOF) were 82.0%, 83.2%, 81.7%, 82.0%, and 78.4%, respectively; and the average integrities of all fissures in the entire lung were 78.0%, 78.6%, 78.1%, 78.5%, and 76.4%, respectively. Their Pearson correlation coefficients with FEV1 and FE1/ FVC range from 0.027 to 0.248 with p values larger than 0.05. Their Spearman correlation coefficients with COPD severity except GOLD-IV range from -0.013 to -0.073 with p values larger than 0.08. Conclusion: There is no significant difference in fissure integrity for patients with different levels of disease severity, suggesting that the development of COPD does not change the completeness of pulmonary fissures and incomplete fissures alone may not contribute to the collateral ventilation.	[Pu, Jiantao; Wang, Zhimin; Gu, Suicheng; Fuhrman, Carl; Leader, Joseph K.; Meng, Xin] Univ Pittsburgh, Dept Radiol, Imaging Res Ctr, Pittsburgh, PA 15260 USA; [Pu, Jiantao] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Pu, Jiantao] Xi An Jiao Tong Univ, Sch Med, Dept Radiol, Affiliated Hosp 1, Xian 710049, Shaanxi Provide, Peoples R China; [Tedrow, John; Sciurba, Frank C.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Xi'an Jiaotong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pu, JT (corresponding author), Univ Pittsburgh, Dept Radiol, Imaging Res Ctr, Pittsburgh, PA 15260 USA.	puj@upmc.edu	Sciurba, Frank/AAZ-9339-2021	sciurba, frank/0000-0001-7468-2225	National Heart, Lung, and Blood Institute of the National Institutes of Health [RO1 HL096613, P50 CA090440, P50 HL084948]; Bonnie J. Addario Lung Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA090440] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096613, P50HL084948] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bonnie J. Addario Lung Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health to the University of Pittsburgh under Grants and RO1 HL096613, P50 CA090440, P50 HL084948, and the Bonnie J. Addario Lung Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz A, 2004, J THORAC IMAG, V19, P186, DOI 10.1097/01.rti.0000131590.74658.24; BERKMEN T, 1994, AM J ROENTGENOL, V162, P1287, DOI 10.2214/ajr.162.6.8191982; BERKMEN YM, 1989, RADIOLOGY, V170, P647, DOI 10.1148/radiology.170.3.2916016; Cetti EJ, 2006, THORAX, V61, P371, DOI 10.1136/thx.2006.060509; Criner GJ, 2011, AM J RESP CRIT CARE, V184, P881, DOI 10.1164/rccm.201103-0455CI; Criner GJ, 2011, CLIN CHEST MED, V32, P379, DOI 10.1016/j.ccm.2011.02.014; Davis SD, 2000, RADIOLOGY, V216, P97, DOI 10.1148/radiology.216.1.r00jl4797; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Gatta D, 2013, INT J CHRONIC OBSTR, V8, P169, DOI 10.2147/COPD.S38320; Gompelmann D, 2013, RESPIRATION, V85, P515, DOI 10.1159/000348269; Gompelmann D, 2012, RESPIRATION, V83, P400, DOI 10.1159/000336239; Higuchi T, 2006, THORAX, V61, P409, DOI 10.1136/thx.2005.051219; HOGG JC, 1969, J CLIN INVEST, V48, P421, DOI 10.1172/JCI105999; LAMBERT MW, 1955, J PATHOL BACTERIOL, V70, P311, DOI 10.1002/path.1700700206; Lubner MG, 2008, RADIOLOGY, V247, P589, DOI 10.1148/radiol.2472050864; MACKLEM PT, 1978, NEW ENGL J MED, V298, P49, DOI 10.1056/NEJM197801052980112; Magnussen H, 2012, THORAX, V67, P302, DOI 10.1136/thoraxjnl-2011-201038; Mahmut M, 2007, J COMPUT ASSIST TOMO, V31, P956, DOI 10.1097/rct.0b013e3180500d23; MARTIN HB, 1966, J APPL PHYSIOL, V21, P1443, DOI 10.1152/jappl.1966.21.5.1443; MATSUOKA Y, 1990, Nippon Acta Radiologica, V50, P1504; MORRELL NW, 1993, AM REV RESPIR DIS, V147, P535, DOI 10.1164/ajrccm/147.3.535; OTSUJI H, 1993, RADIOLOGY, V187, P541, DOI 10.1148/radiology.187.2.8475304; Petrovic M, 2012, INT J CHRONIC OBSTR, V7, P797, DOI 10.2147/COPD.S23784; Pu JT, 2010, MED PHYS, V37, P4661, DOI 10.1118/1.3475937; Pu JT, 2009, IEEE T MED IMAGING, V28, P1986, DOI 10.1109/TMI.2009.2027117; Pu JT, 2009, IEEE T MED IMAGING, V28, P710, DOI 10.1109/TMI.2008.2010441; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; TERRY PB, 1978, NEW ENGL J MED, V298, P10, DOI 10.1056/NEJM197801052980103	29	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96631	10.1371/journal.pone.0096631	http://dx.doi.org/10.1371/journal.pone.0096631			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800803	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800097
J	Rech, D; Bertrand, JT; Thomas, N; Farrell, M; Reed, J; Frade, S; Samkange, C; Obiero, W; Agot, K; Mahler, H; Castor, D; Njeuhmeli, E				Rech, Dino; Bertrand, Jane T.; Thomas, Nicholas; Farrell, Margaret; Reed, Jason; Frade, Sasha; Samkange, Christopher; Obiero, Walter; Agot, Kawango; Mahler, Hally; Castor, Delivette; Njeuhmeli, Emmanuel			Surgical Efficiencies and Quality in the Performance of Voluntary Medical Male Circumcision (VMMC) Procedures in Kenya, South Africa, Tanzania, and Zimbabwe	PLOS ONE			English	Article							POSTPARTUM TUBAL-LIGATION; NURSE-MIDWIVES; MEN	Introduction: This analysis explores the association between elements of surgical efficiency in voluntary medical male circumcision (VMMC), quality of surgical technique, and the amount of time required to conduct VMMC procedures in actual field settings. Efficiency outcomes are defined in terms of the primary provider's time with the client (PPTC) and total elapsed operating time (TEOT). Methods: Two serial cross-sectional surveys of VMMC sites were conducted in Kenya, Republic of South Africa, Tanzania and Zimbabwe in 2011 and 2012. Trained clinicians observed quality of surgical technique and timed 9 steps in the VMMC procedure. Four elements of efficiency (task-shifting, task-sharing [of suturing], rotation among multiple surgical beds, and use of electrocautery) and quality of surgical technique were assessed as explanatory variables. Mann Whitney and Kruskal Wallis tests were used in the bivariate analysis and linear regression models for the multivariate analyses to test the relationship between these five explanatory variables and two outcomes: PPTC and TEOT. The VMMC procedure TEOT and PPTC averaged 23-25 minutes and 6-15 minutes, respectively, across the four countries and two years. The data showed time savings from task-sharing in suturing and use of electrocautery in South Africa and Zimbabwe (where task-shifting is not authorized). After adjusting for confounders, results demonstrated that having a secondary provider complete suturing and use of electrocautery reduced PPTC. Factors related to TEOT varied by country and year, but task-sharing of suturing and/or electrocautery were significant in two countries. Quality of surgical technique was not significantly related to PPTC or TEOT, except for South Africa in 2012 where higher quality was associated with lower TEOT. Conclusions: SYMMACS data confirm the efficiency benefits of task-sharing of suturing and use of electrocautery for decreasing TEOT. Reduced TEOT and PPTC in high volume setting did not result in decreased quality of surgical care.	[Rech, Dino; Frade, Sasha] Ctr HIV & AIDS Prevent Studies, Johannesburg, South Africa; [Bertrand, Jane T.; Thomas, Nicholas; Farrell, Margaret] Tulane Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA USA; [Reed, Jason] US Dept State, Washington, DC 20520 USA; [Samkange, Christopher] Univ Zimbabwe, Coll Hlth Sci, Inst Continuing Hlth Educ, Harare, Zimbabwe; [Obiero, Walter] Natl Reprod Hlth Soc, Kisumu, Kenya; [Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Mahler, Hally] Jhpiego, Dar Es Salaam, Tanzania; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	Tulane University; University of Zimbabwe; Jhpiego; United States Agency for International Development (USAID)	Rech, D (corresponding author), Ctr HIV & AIDS Prevent Studies, Johannesburg, South Africa.	dino@chaps.org.za	Frade, Sasha/AAQ-3284-2021	Frade, Sasha/0000-0001-9683-3020	U.S. Agency for International Development [GHH-I-00-07-00032-00]; Johns Hopkins Center for Global Health; USAID | Project SEARCH	U.S. Agency for International Development(United States Agency for International Development (USAID)); Johns Hopkins Center for Global Health; USAID | Project SEARCH(United States Agency for International Development (USAID))	The article was supported by USAID | Project SEARCH, Task Order No. 2, funded by the U.S. Agency for International Development (www. usaid. gov) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). USAID staff played a role in study design and data analysis, decision to publish, and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID or United States Government opinion.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2013, PLOS MED; Bertrand JT, 2013, PLOS MED PEER UNPUB; Bhandari A, 2008, HEALTH AFFAIR, V27, P964, DOI 10.1377/hlthaff.27.4.964; Curran K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001129; Dickson KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001133; DUSITSIN N, 1980, LANCET, V1, P638; EREN N, 1983, STUD FAMILY PLANN, V14, P43, DOI 10.2307/1965401; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Galukande Moses, 2012, Pan Afr Med J, V13, P88; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Hankins C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001127; Lissouba P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000309; Machado NO, 2010, JSLS-J SOC LAPAROEND, V14, P547, DOI 10.4293/108680810X12924466008286; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Massarweh NN, 2006, J AM COLL SURGEONS, V202, P520, DOI 10.1016/j.jamcollsurg.2005.11.017; Mwandi Z, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001130; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Organization WH, 2009, MALE CIRCUMCISION SE; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; Prager S, 2012, INT J GYNECOL OBSTET, V117, P243, DOI 10.1016/j.ijgo.2012.01.013; Rech D, 2013, PLOS MED; SATYAPAN S, 1983, STUD FAMILY PLANN, V14, P115, DOI 10.2307/1966065; Shen Wen T, 2005, Asian J Surg, V28, P86, DOI 10.1016/S1015-9584(09)60268-2; VAZ MD, 1992, INT J GYNECOL OBSTET, V38, pS37, DOI 10.1016/0020-7292(92)90028-H; Walker R, 2001, INT J NURS STUD, V38, P25, DOI 10.1016/S0020-7489(00)00057-2; WHITE SM, 1987, LANCET, V2, P612; WHO, 2010, CONS IMPL MOD OPTIM; WHO UNAIDS, 2011, PROGR SCAL MAL CIRC	30	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e84271	10.1371/journal.pone.0084271	http://dx.doi.org/10.1371/journal.pone.0084271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802412	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800011
J	Zhang, DY; Yin, YP; Feng, TJ; Hong, FC; Jiang, N; Wang, BX; Chen, XS				Zhang, Dong-Yan; Yin, Yue-Ping; Feng, Tie-Jian; Hong, Fu-Chang; Jiang, Ning; Wang, Bao-Xi; Chen, Xiang-Sheng			HPV Infections among MSM in Shenzhen, China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; AGE-SPECIFIC PREVALENCE; HIV-INFECTION; RISK-FACTORS; MEN; SEX; DETERMINANTS; CANCER; BURDEN	Background: An increasing incidence of anal cancer among men, especially men who have sex with men (MSM) suggests a need to better understand anal human papillomavirus (HPV) infection among this group. Methods: A cross-sectional study was conducted among MSM in Shenzhen, China. Blood was collected for HIV serological testing and syphilis serological screening, and anal swabs were collected for HPV genotyping. Difference of HPV prevalence between HIV seropositive and HIV seronegative MSM was assessed by chi-square test. Factors associated with anal canal HPV infection were assessed by univariate and multivariate logistic regression. Results: A total of 408 MSM were recruited. HIV and HPV prevalence were 6.9% and 36.4%, respectively. HPV was detected in the anal canal in 71.4% of the HIV-positive MSM and in 33.8% of the HIV-negative MSM (P<0.001). Oncogenic types were seen more often in anal specimens of HIV-positive MSM than in specimens of HIV-negative MSM (P = 0.001). The HPV genotypes detected most frequently were HPV06 (8.2%), HPV16 (7.2%), HPV11 (6.4%), HPV18 (4.7%), HPV58 (4.7%), and HPV52 (4.2%). Conclusions: In this study, HIV positive MSM had a higher burden of HPV infection, especially oncogenic HPV infection. HPV types 52 and 58 were as popular as those types designed for the currently available vaccine (HPV6, 11, 16, 18).	[Zhang, Dong-Yan; Yin, Yue-Ping; Jiang, Ning; Wang, Bao-Xi; Chen, Xiang-Sheng] Chinese Acad Med Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Dong-Yan; Yin, Yue-Ping; Jiang, Ning; Wang, Bao-Xi; Chen, Xiang-Sheng] Peking Union Med Coll, Inst Dermatol, Nanjing, Jiangsu, Peoples R China; [Yin, Yue-Ping; Jiang, Ning; Wang, Bao-Xi; Chen, Xiang-Sheng] China CDC, Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China; [Feng, Tie-Jian; Hong, Fu-Chang] Shenzhen Ctr Chron Dis Control & Prevent, Shenzhen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College	Chen, XS (corresponding author), Chinese Acad Med Sci, Nanjing, Jiangsu, Peoples R China.	chenxs@ncstdlc.org			China National Science Research [2008ZX10001-005]; National science and technology [2009ZX10004-904]	China National Science Research; National science and technology	The study was supported by a grant from the Mega Project of China National Science Research for the 11th Five-Year Plan (2008ZX10001-005). Additional funding was received from National science and technology major special project- jiangsu provincial demonstration project on infectious diseases control and prevention (Grant No: 2009ZX10004-904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 2011, MMWR-MORBID MORTAL W, V60, P1705; Chen XX, 2011, INT J VIROLOGY, V18, P101; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Denny LA, 2012, VACCINE, V30, pF168, DOI 10.1016/j.vaccine.2012.06.045; Dona MG, 2012, J CLIN VIROL, V54, P185, DOI 10.1016/j.jcv.2012.02.014; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Frisch M, 2003, AM J EPIDEMIOL, V157, P966, DOI 10.1093/aje/kwg067; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Joseph DA, 2008, CANCER-AM CANCER SOC, V113, P2892, DOI 10.1002/cncr.23744; La Torre G, 2007, VACCINE, V25, P8352, DOI 10.1016/j.vaccine.2007.09.027; Li HM, 2012, J MED VIROL, V84, P798, DOI 10.1002/jmv.23264; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; van der Snoek EM, 2003, SEX TRANSM DIS, V30, P639, DOI 10.1097/01.OLQ.0000079520.04451.59; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035983; Zhang XJ, 2013, AIDS BEHAV, V17, P1129, DOI 10.1007/s10461-011-0085-x	25	13	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96364	10.1371/journal.pone.0096364	http://dx.doi.org/10.1371/journal.pone.0096364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801331	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800062
J	Ding, X; Yang, Y; Han, BD; Du, CZ; Xu, NQ; Huang, HW; Cai, T; Zhang, AQ; Han, ZG; Zhou, WP; Chen, L				Ding, Xiao; Yang, Yuan; Han, Baoda; Du, Chengzhi; Xu, Naiqing; Huang, Huanwei; Cai, Tao; Zhang, Aiqun; Han, Ze-Guang; Zhou, Weiping; Chen, Liang			Transcriptomic Characterization of Hepatocellular Carcinoma with CTNNB1 Mutation	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; HEPATITIS-B-VIRUS; BETA-CATENIN; UNITED-STATES; HEPATOCARCINOGENESIS; TRENDS; MICE; CARCINOGENESIS; PATHOGENESIS	Purpose: Hepatocellular carcinoma (HCC) is the sixth most common solid tumor worldwide and the third leading cause of cancer-related death. HCC is a particularly serious threat to the Chinese population. Although many molecular alterations are known to be involved in the tumorigenesis of hepatocytes, no systemic survey has examined the somatic mutations in HCC samples from Chinese patients. Our goal was to elucidate somatic mutations in Chinese HCC patients and investigate the possible molecular mechanisms involved in tumorigenesis. Experimental Design: A total of 110 hepatitis B virus (HBV)-positive HCC samples and 46 HBV-negative HCC samples were genotyped for hot-spot mutations in the CSF1R, CTNNB1, KRAS, BRAF, NRAS, ERBB2, MET, PIK3CA, JAK1, and SMO genes. The transcriptomes of the CTNNB1 mutation-positive HCC samples from the HBV-positive patients (CB+ HCC) were compared to adjacent non-cancerous livers, and significantly altered genes were functionally validated in vitro. Results: CTNNB1 mutations accounted for the majority of the mutations detected in our study. A slightly higher mutation rate was found in the HBV-positive patients than in their negative counterparts. A distinct pattern of CTNNB1 mutation was detected in these two populations, and drastic changes at the transcriptomic level were detected in the CB+ tumors compared to adjacent non-cancerous livers. Potential tumor suppressors (FoxA3 and Onecut1) and oncogenes (MAFG and SSX1) were functionally validated. Conclusions: Our work is the first systemic characterization of oncogenic mutations in HCC samples from Chinese patients. Targeting the Wnt-beta-catenin pathway may represent a valid treatment option for Chinese HCC patients. Our work also suggests that targeting ONECUT1, FOXA3, SSX1, and MAFG may be a valid treatment option for CTNNB1 mutation positive HCC patients.	[Ding, Xiao; Han, Baoda; Du, Chengzhi; Xu, Naiqing; Huang, Huanwei; Cai, Tao] Natl Inst Biol Sci, Beijing, Peoples R China; [Yang, Yuan; Zhou, Weiping] Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Zhang, Aiqun] Gen Hosp Peoples Liberat Army 301 Hosp, Beijing, Peoples R China; [Han, Ze-Guang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Chen, Liang] Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing, Peoples R China	National Institute of Biological Sciences, Beijing; Naval Medical University; Shanghai Jiao Tong University; National Institute of Biological Sciences, Beijing	Zhou, WP (corresponding author), Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China.	ehphwp@126.com; chenliang@nibs.ac.cn	Zhou, Weiping/AGI-5344-2022	Han, Ze-Guang/0000-0002-1018-1752; Chen, Liang/0000-0001-7300-6604	Chinese Ministry of Science and Technology [2011CB812401]; Beijing Municipal Government; National S&T Major Project for Infectious Diseases of China [2012ZX10002-017]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government; National S&T Major Project for Infectious Diseases of China	This work was funded by Chinese Ministry of Science and Technology grant 2011CB812401, and the Beijing Municipal Government. This work was supported by National S&T Major Project for Infectious Diseases of China (No. 2012ZX10002-017) (to A. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Delgado E, 2013, CURR CANCER DRUG TAR, V13, P867; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kalinina O, 2013, MUTAT RES-GEN TOX EN, V755, P90, DOI 10.1016/j.mrgentox.2013.06.019; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Luo RH, 2005, WORLD J GASTROENTERO, V11, P4431; Micsenyi A, 2004, GASTROENTEROLOGY, V126, P1134, DOI 10.1053/j.gastro.2003.12.047; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Pez F, 2013, J HEPATOL, V59, P1107, DOI 10.1016/j.jhep.2013.07.001; Shiraha H, 2013, INT J ONCOL, V42, P1133, DOI 10.3892/ijo.2013.1829; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Thakur R, 2013, J CELL MOL MED, V17, P449, DOI 10.1111/jcmm.12033; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wong CM, 2001, CANCER-AM CANCER SOC, V92, P136, DOI 10.1002/1097-0142(20010701)92:1<136::AID-CNCR1301>3.0.CO;2-R; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x	25	63	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95307	10.1371/journal.pone.0095307	http://dx.doi.org/10.1371/journal.pone.0095307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798046	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000016
J	Maejima, T; Inoue, T; Kanki, Y; Kohro, T; Li, GL; Ohta, Y; Kimura, H; Kobayashi, M; Taguchi, A; Tsutsumi, S; Iwanari, H; Yamamoto, S; Aruga, H; Dong, SL; Stevens, JF; Poh, HM; Yamamoto, K; Kawamura, T; Mimura, I; Suehiro, JI; Sugiyama, A; Kaneki, K; Shibata, H; Yoshinaka, Y; Doi, T; Asanuma, A; Tanabe, S; Tanaka, T; Minami, T; Hamakubo, T; Sakai, J; Nozaki, N; Aburatani, H; Nangaku, M; Ruan, X; Tanabe, H; Ruan, YJ; Ihara, S; Endo, A; Kodama, T; Wada, Y				Maejima, Takashi; Inoue, Tsuyoshi; Kanki, Yasuharu; Kohro, Takahide; Li, Guoliang; Ohta, Yoshihiro; Kimura, Hiroshi; Kobayashi, Mika; Taguchi, Akashi; Tsutsumi, Shuichi; Iwanari, Hiroko; Yamamoto, Shogo; Aruga, Hirofumi; Dong, Shoulian; Stevens, Junko F.; Poh, Huay Mei; Yamamoto, Kazuki; Kawamura, Takeshi; Mimura, Imari; Suehiro, Jun-ichi; Sugiyama, Akira; Kaneki, Kiyomi; Shibata, Haruki; Yoshinaka, Yasunobu; Doi, Takeshi; Asanuma, Akimune; Tanabe, Sohei; Tanaka, Toshiya; Minami, Takashi; Hamakubo, Takao; Sakai, Juro; Nozaki, Naohito; Aburatani, Hiroyuki; Nangaku, Masaomi; Ruan, Xiaoan; Tanabe, Hideyuki; Ruan, Yijun; Ihara, Sigeo; Endo, Akira; Kodama, Tatsuhiko; Wada, Youichiro			Direct Evidence for Pitavastatin Induced Chromatin Structure Change in the KLF4 Gene in Endothelial Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; TRANSCRIPTION FACTOR; PROINFLAMMATORY ACTIVATION; CHROMOSOME CONFORMATION; TARGETED DELETION; INFLAMMATION; STATINS; BIOLOGY; ATHEROSCLEROSIS; INHIBITORS	Statins exert atheroprotective effects through the induction of specific transcriptional factors in multiple organs. In endothelial cells, statin-dependent atheroprotective gene up-regulation is mediated by Kruppel-like factor (KLF) family transcription factors. To dissect the mechanism of gene regulation, we sought to determine molecular targets by performing microarray analyses of human umbilical vein endothelial cells (HUVECs) treated with pitavastatin, and KLF4 was determined to be the most highly induced gene. In addition, it was revealed that the atheroprotective genes induced with pitavastatin, such as nitric oxide synthase 3 (NOS3) and thrombomodulin (THBD), were suppressed by KLF4 knockdown. Myocyte enhancer factor-2 (MEF2) family activation is reported to be involved in pitavastatin-dependent KLF4 induction. We focused on MEF2C among the MEF2 family members and identified a novel functional MEF2C binding site 148 kb upstream of the KLF4 gene by chromatin immunoprecipitation along with deep sequencing (ChIP-seq) followed by luciferase assay. By applying whole genome and quantitative chromatin conformation analysis {chromatin interaction analysis with paired end tag sequencing (ChIA-PET), and real time chromosome conformation capture (3C) assay}, we observed that the MEF2C-bound enhancer and transcription start site (TSS) of KLF4 came into closer spatial proximity by pitavastatin treatment. 3D-Fluorescence in situ hybridization (FISH) imaging supported the conformational change in individual cells. Taken together, dynamic chromatin conformation change was shown to mediate pitavastatin-responsive gene induction in endothelial cells.	[Maejima, Takashi; Inoue, Tsuyoshi; Kanki, Yasuharu; Kohro, Takahide; Ohta, Yoshihiro; Kobayashi, Mika; Taguchi, Akashi; Tsutsumi, Shuichi; Iwanari, Hiroko; Yamamoto, Shogo; Yamamoto, Kazuki; Kawamura, Takeshi; Mimura, Imari; Suehiro, Jun-ichi; Sugiyama, Akira; Kaneki, Kiyomi; Tanaka, Toshiya; Minami, Takashi; Hamakubo, Takao; Sakai, Juro; Aburatani, Hiroyuki; Ihara, Sigeo; Kodama, Tatsuhiko; Wada, Youichiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Maejima, Takashi; Shibata, Haruki; Yoshinaka, Yasunobu; Doi, Takeshi; Asanuma, Akimune; Tanabe, Sohei] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan; [Inoue, Tsuyoshi; Mimura, Imari; Nangaku, Masaomi] Univ Tokyo, Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, Tokyo 113, Japan; [Kohro, Takahide] Univ Tokyo, Grad Sch Med, Dept Translat Res Healthcare & Clin Sci, Bunkyo Ku, Tokyo, Japan; [Li, Guoliang; Poh, Huay Mei] Jackson Lab Genom Med, Farmington, CT USA; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Aruga, Hirofumi; Dong, Shoulian; Stevens, Junko F.] Thermo Fisher Sci, San Francisco, CA USA; [Nozaki, Naohito] Mab Inst Inc, N Adv Ctr Sci & Technol, Sapporo, Hokkaido, Japan; [Ruan, Xiaoan] Genome Inst Singapore, Singapore, Singapore; [Tanabe, Hideyuki] Grad Univ Adv Studies Sokendai, Sch Adv Sci, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Endo, Akira] Biopharm Res Labs Inc, Koganei, Tokyo, Japan; [Wada, Youichiro] Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Kowa Company, Ltd.; University of Tokyo; University of Tokyo; Jackson Laboratory; Osaka University; Thermo Fisher Scientific; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Graduate University for Advanced Studies - Japan; University of Tokyo	Kimura, H (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	hkimura@fbs.osaka-u.ac.jp; kodama@lsbm.org; ywada-tky@umin.ac.jp	Li, Guoliang/D-8014-2012; Doi, Takeshi/GLS-9636-2022; Kimura, Hiroshi/B-9524-2015	Li, Guoliang/0000-0003-1601-6640; Kimura, Hiroshi/0000-0003-0854-083X; Yamamoto, Kazuki/0000-0001-6231-0475; Sakai, Juro/0000-0003-4043-1035	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Japan Society for the Promotion of Science [23659050, 22310117]; Ministry of Education, Culture, Sports, Science and Technology, Japan [23125503]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26116708, 26860627] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was provided a grant by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program),'' initiated by the Council for Science and Technology Policy (CSTP). This work was supported by Grant-in-Aid for Scientific Research (B) 22310117, Grant-in-Aid for Exploratory Research 23659050, from the Japan Society for the Promotion of Science, and Grant-in-Aid for Scientific Research on Innovative Areas 23125503 from the Ministry of Education, Culture, Sports, Science and Technology, Japan. A part of this work was supported by Platform for Dynamic Approaches to Living System from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Han JH, 2000, TRENDS CARDIOVAS MED, V10, P19, DOI 10.1016/S1050-1738(00)00039-6; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang Shuying, 2003, Nucl Recept, V1, P5, DOI 10.1186/1478-1336-1-5; Jougasaki M, 2010, BRIT J PHARMACOL, V159, P1294, DOI 10.1111/j.1476-5381.2009.00612.x; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kojima A, 1999, J CHROMATOGR B, V724, P173, DOI 10.1016/S0378-4347(98)00523-4; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lin Q, 1998, DEVELOPMENT, V125, P4565; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200; Sabatine MS, 2008, ARTERIOSCL THROM VAS, V28, P562, DOI 10.1161/ATVBAHA.107.156653; Schonbeck U, 2004, CIRCULATION, V109, P18, DOI 10.1161/01.CIR.0000129505.34151.23; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sen-Banerjee S, 2005, CIRCULATION, V112, P720, DOI 10.1161/CIRCULATIONAHA.104.525774; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Shakya K, 2010, ADV EXP MED BIOL, V680, P139, DOI 10.1007/978-1-4419-5913-3_16; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Teramoto T, 2009, J ATHEROSCLER THROMB, V16, P654, DOI 10.5551/jat.1719; Tozawa H, 2011, MOL CELL BIOL, V31, P2196, DOI 10.1128/MCB.01430-10; Villarreal G, 2010, BIOCHEM BIOPH RES CO, V391, P984, DOI 10.1016/j.bbrc.2009.12.002; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005	40	28	29	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96005	10.1371/journal.pone.0096005	http://dx.doi.org/10.1371/journal.pone.0096005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797675	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000032
J	Williams, K; Christensen, J; Rappsilber, J; Nielsen, AL; Johansen, JV; Helin, K				Williams, Kristine; Christensen, Jesper; Rappsilber, Juri; Nielsen, Anders Laerke; Johansen, Jens Vilstrup; Helin, Kristian			The Histone Lysine Demethylase JMJD3/KDM6B Is Recruited to p53 Bound Promoters and Enhancer Elements in a p53 Dependent Manner	PLOS ONE			English	Article							JMJD3 CONTRIBUTES; DEVELOPMENTAL REGULATORS; INK4A-ARF LOCUS; TARGET GENES; DNA-DAMAGE; POLYCOMB; INK4A/ARF; UTX; EXPRESSION; BINDING	The JmjC domain-containing protein JMJD3/KDM6B catalyses the demethylation of H3K27me3 and H3K27me2. JMJD3 appears to be highly regulated at the transcriptional level and is upregulated in response to diverse stimuli such as differentiation inducers and stress signals. Accordingly, JMJD3 has been linked to the regulation of different biological processes such as differentiation of embryonic stem cells, inflammatory responses in macrophages, and induction of cellular senescence via regulation of the INK4A-ARF locus. Here we show here that JMJD3 interacts with the tumour suppressor protein p53. We find that the interaction is dependent on the p53 tetramerization domain. Following DNA damage, JMJD3 is transcriptionally upregulated and by performing genome-wide mapping of JMJD3, we demonstrate that it binds genes involved in basic cellular processes, as well as genes regulating cell cycle, response to stress and apoptosis. Moreover, we find that JMJD3 binding sites show significant overlap with p53 bound promoters and enhancer elements. The binding of JMJD3 to p53 target sites is increased in response to DNA damage, and we demonstrate that the recruitment of JMJD3 to these sites is dependent on p53 expression. Therefore, we propose a model in which JMJD3 is recruited to p53 responsive elements via its interaction with p53 and speculate that JMJD3 could act as a fail-safe mechanism to remove low levels of H3K27me3 and H3K27me2 to allow for efficient acetylation of H3K27.	[Williams, Kristine; Christensen, Jesper; Johansen, Jens Vilstrup; Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Williams, Kristine; Christensen, Jesper; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Nielsen, Anders Laerke] Novo Nordisk AS, Biopharmaceut Res Unit, Malov, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Edinburgh; Novo Nordisk; University of Copenhagen	Helin, K (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	kristian.helin@bric.ku.dk	Williams, Kristine/AAA-5662-2022; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022	Williams, Kristine/0000-0002-1198-6552; Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Vilstrup Johansen, Jens/0000-0001-7094-6801	Novo Nordisk Foundation; Danish Cancer Society; Danish National Research Foundation; Excellence Program of the University of Copenhagen	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Excellence Program of the University of Copenhagen	The work in the Helin lab was supported by grants from the Novo Nordisk Foundation, the Danish Cancer Society, the Danish National Research Foundation, and the Excellence Program of the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Akdemir KC, 2014, NUCLEIC ACIDS RES, V42, P205, DOI 10.1093/nar/gkt866; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Ene CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051407; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li MM, 2012, MOL CELL, V46, P30, DOI 10.1016/j.molcel.2012.01.020; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Sola S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018421; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vandamme J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002647; Vernimmen D, 2011, GENE DEV, V25, P1583, DOI 10.1101/gad.16985411; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006	65	70	70	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96545	10.1371/journal.pone.0096545	http://dx.doi.org/10.1371/journal.pone.0096545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797517	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000091
J	Woudstra, P; Damman, P; Kuijt, WJ; Kikkert, WJ; Grundeken, MJ; van Brussel, PM; Stroobants, AK; van Straalen, JP; Fischer, JC; Koch, KT; Henriques, JPS; Piek, JJ; Tijssen, JGP; de Winter, RJ				Woudstra, Pier; Damman, Peter; Kuijt, Wichert J.; Kikkert, Wouter J.; Grundeken, Maik J.; van Brussel, Peter M.; Stroobants, An K.; van Straalen, Jan P.; Fischer, Johan C.; Koch, Karel T.; Henriques, Jose P. S.; Piek, Jan J.; Tijssen, Jan G. P.; de Winter, Robbert J.			Admission Lipoprotein-Associated Phospholipase A(2) Activity Is Not Associated with Long-Term Clinical Outcomes after ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY; PLASMA; ACETYLHYDROLASE; DARAPLADIB; MORTALITY; DISEASE; TRIAL; RISK; IDENTIFICATION	Background: Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity is a biomarker predicting cardiovascular diseases in a real-world. However, the prognostic value in patients undergoing primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) on long-term clinical outcomes is unknown. Methods: Lp-PLA(2) activity was measured in samples obtained prior to pPCI from consecutive STEMI patients in a high-volume intervention center from 2005 until 2007. Five years all-cause mortality was estimated with the Kaplan-Meier method and compared among tertiles of Lp-PLA(2) activity during complete follow-up and with a landmark at 30 days. In a subpopulation clinical endpoints were assessed at three years. The prognostic value of Lp-PLA(2), in addition to the Thrombolysis In Myocardial Infarction or multimarker risk score, was assessed in multivariable Cox regression. Results: The cohort (n = 987) was divided into tertiles (low <144, intermediate 144-179, and high >179 nmol/min/mL). Among the tertiles differences in baseline characteristics associated with long-term mortality were observed. However, no significant differences in five years mortality in association with Lp-PLA(2) activity levels were found; intermediate versus low Lp-PLA(2) (HR 0.97; CI 95% 0.68-1.40; p = 0.88) or high versus low Lp-PLA(2) (HR 0.75; CI 95% 0.51-1.11; p = 0.15). Both in a landmark analysis and after adjustments for the established risk scores and selection of cases with biomarkers obtained, non-significant differences among the tertiles were observed. In the subpopulation no significant differences in clinical endpoints were observed among the tertiles. Conclusion: Lp-PLA(2) activity levels at admission prior to pPCI in STEMI patients are not associated with the incidence of short and/or long-term clinical endpoints. Lp-PLA(2) as an independent and clinically useful biomarker in the risk stratification of STEMI patients still remains to be proven.	[Woudstra, Pier; Damman, Peter; Kuijt, Wichert J.; Kikkert, Wouter J.; Grundeken, Maik J.; van Brussel, Peter M.; Koch, Karel T.; Henriques, Jose P. S.; Piek, Jan J.; Tijssen, Jan G. P.; de Winter, Robbert J.] Univ Amsterdam, Acad Med Ctr, Ctr Heart, NL-1105 AZ Amsterdam, Netherlands; [Stroobants, An K.; van Straalen, Jan P.; Fischer, Johan C.] Univ Amsterdam, Acad Med Ctr, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	de Winter, RJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Heart, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.j.dewinter@amc.uva.nl	Damman, Peter/D-9469-2018; Woudstra, Pier/GLV-0473-2022	Woudstra, Pier/0000-0002-5870-9923; Henriques, Jose PS/0000-0002-8969-7929	Heart Center, Academic Medical Center - University of Amsterdam	Heart Center, Academic Medical Center - University of Amsterdam	The Lp-PLA2 sample kits were provided by Anton Jansen, diaDexus Inc. The work was funded by the Heart Center, Academic Medical Center - University of Amsterdam. The Lp-PLA2 sample kits were provided by Anton Jansen, diaDexus Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirati E, 2012, CIRC RES, V111, P1336, DOI 10.1161/CIRCRESAHA.111.262477; Biasucci LM, 2011, J AM COLL CARDIOL, V57, P37, DOI 10.1016/j.jacc.2010.07.039; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Bogaty P, 2008, J AM COLL CARDIOL, V51, P2339, DOI 10.1016/j.jacc.2008.03.019; Damman P, 2011, J AM COLL CARDIOL, V57, P29, DOI 10.1016/j.jacc.2010.06.053; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Gerber Y, 2006, ARTERIOSCL THROM VAS, V26, P2517, DOI 10.1161/01.ATV.0000240406.89440.0c; Kampinga MA, 2012, CLIN CHEM, V58, P1063, DOI 10.1373/clinchem.2011.177675; Kikkert WJ, 2013, CIRC-CARDIOVASC INTE, V6, P391, DOI 10.1161/CIRCINTERVENTIONS.113.000425; Kikkert WJ, 2013, THROMB HAEMOSTASIS, V109, P961, DOI 10.1160/TH12-10-0726; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Mallat Z, 2010, CIRCULATION, V122, P2183, DOI 10.1161/CIRCULATIONAHA.110.936393; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Nicholls SJ, 2011, CARDIOVASC DRUGS THE; O'Donoghue M, 2006, CIRCULATION, V113, P1745, DOI 10.1161/CIRCULATIONAHA.105.612630; O'Donoghue ML, 2011, AM HEART J, V162, P613, DOI 10.1016/j.ahj.2011.07.018; Oldgren J, 2007, EUR HEART J, V28, P699, DOI 10.1093/eurheartj/ehl565; Rosenson RS, 2009, LANCET, V373, P649, DOI 10.1016/S0140-6736(09)60403-7; Ryu SK, 2012, CIRCULATION; Serruys PW, 2008, CIRCULATION, V118, P1172, DOI 10.1161/CIRCULATIONAHA.108.771899; Smit JJJ, 2008, AM J CARDIOL, V101, P446, DOI 10.1016/j.amjcard.2007.09.088; Stankovic S, 2012, CLIN LAB, V58, P1135, DOI 10.7754/Clin.Lab.2012.111102; Stein EA, 2012, CLIN CHEM, V58, P814, DOI 10.1373/clinchem.2012.183475; Thompson A, 2010, LANCET, V375, P1536, DOI 10.1016/S0140-6736(10)60319-4; TSELEPIS AD, 1995, ARTERIOSCL THROM VAS, V15, P1764, DOI 10.1161/01.ATV.15.10.1764; White H, 2010, AM HEART J, V160, P655, DOI 10.1016/j.ahj.2010.07.006; Yamada Y, 1998, METABOLISM, V47, P177, DOI 10.1016/S0026-0495(98)90216-5; Yamada Y, 2000, ATHEROSCLEROSIS, V150, P209, DOI 10.1016/S0021-9150(99)00385-8	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96251	10.1371/journal.pone.0096251	http://dx.doi.org/10.1371/journal.pone.0096251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788873	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600087
J	Lv, J; Pan, Y; Li, X; Cheng, DF; Liu, S; Shi, HC; Zhang, YF				Lv, Jing; Pan, Yu; Li, Xiao; Cheng, Dengfeng; Liu, Shuai; Shi, Hongcheng; Zhang, Yifan			The Imaging of Insulinomas Using a Radionuclide-Labelled Molecule of the GLP-1 Analogue Liraglutide: A New Application of Liraglutide	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PREOPERATIVE LOCALIZATION; ENDOSCOPIC ULTRASONOGRAPHY; NEUROENDOCRINE TUMORS; DIABETIC-PATIENTS; HEALTHY-SUBJECTS; IN-VITRO; EXENDIN-4; RECEPTOR; SOMATOSTATIN	Objective: This study explores a new, non-invasive imaging method for the specific diagnosis of insulinoma by providing an initial investigation of the use of I-125-labelled molecules of the glucagon-like peptide-1 (GLP-1) analogue liraglutide for in vivo and in vitro small-animal SPECT/CT (single-photon emission computed tomography/computed tomography) imaging of insulinomas. Methods: Liraglutide was labelled with I-125 by the Iodogen method. The labelled I-125-liraglutide compound and insulinoma cells from the INS-1 cell line were then used for in vitro saturation and competitive binding experiments. In addition, in a nude mouse model, the use of I-125-liraglutide for the in vivo small-animal SPECT/CT imaging of insulinomas and the resulting distribution of radioactivity across various organs were examined. Results: The labelling of liraglutide with I-125 was successful, yielding a labelling rate of approximately 95% and a radiochemical purity of greater than 95%. For the binding between I-125-liraglutide and the GLP-1 receptor on the surface of INS-1 cells, the equilibrium dissociation constant (Kd) was 128.8630.4 nmol/L(N = 3), and the half-inhibition concentration (IC50) was 542.4 +/- 187.5 nmol/L(N = 3). Small-animal SPECT/CT imaging with I-125-liraglutide indicated that the tumour imaging was clearest at 90 min after the I-125-liraglutide treatment. An examination of the in vivo distribution of radioactivity revealed that at 90 min after the I-125-liraglutide treatment, the target/non-target (T/NT) ratio for tumour and muscle tissue was 4.83 +/- 1.30(N = 3). Our study suggested that I-125-liraglutide was predominantly metabolised and cleared by the liver and kidneys. Conclusion: The radionuclide I-125-liraglutide can be utilised for the specificimaging of insulinomas, representing a new non-invasive approach for the in vivo diagnosis of insulinomas.	[Lv, Jing; Pan, Yu; Liu, Shuai; Zhang, Yifan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China; [Li, Xiao; Cheng, Dengfeng; Shi, Hongcheng] Fudan Univ, Sch Med, Zhongshan Hosp, Dept Nucl Med, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; Fudan University	Zhang, YF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Nucl Med, Shanghai 200030, Peoples R China.	zhang_yifan@126.com	Zhang, Yifan/AGT-8799-2022	Yifan, Zhang/0000-0001-6488-6232; Pan, Yu/0000-0002-3917-8688	National Natural Science Foundation of China [81171367]; Innovation Program of Shanghai Municipal Education Commission [12YZ041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This study was supported by grants from the National Natural Science Foundation of China (No.81171367, http://isisn.nsfc.gov.cn/egrantweb) and the Innovation Program of Shanghai Municipal Education Commission(No.12YZ041, http://www.shmec.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LC, 2011, EUR J RADIOL, V80, P675, DOI 10.1016/j.ejrad.2010.09.014; Balon HR, 2001, J NUCL MED, V42, P1134; Chen J, 2007, PROTEIN PEPTIDE LETT, V14, P19, DOI 10.2174/092986607779117272; Cho YM, 2014, ANNU REV PHYSIOL, V76, P535, DOI 10.1146/annurev-physiol-021113-170315; Christ E, 2009, J CLIN ENDOCR METAB, V94, P4398, DOI 10.1210/jc.2009-1082; de Herder W W, 2005, J Endocrinol Invest, V28, P132; Deacon CF, 2009, VASC HEALTH RISK MAN, V5, P199; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gotthardt M, 2002, EUR J NUCL MED MOL I, V29, P597, DOI 10.1007/s00259-002-0761-1; Gough SCL, 2012, DIABETES OBES METAB, V14, P33, DOI 10.1111/j.1463-1326.2012.01576.x; Grant CS, 2005, BEST PRACT RES CL GA, V19, P783, DOI 10.1016/j.bpg.2005.05.008; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Joseph AJ, 2013, ENDOCR PRACT, V19, P602, DOI 10.4158/EP12122.OR; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kiesewetter DO, 2012, EUR J NUCL MED MOL I, V39, P463, DOI 10.1007/s00259-011-1980-0; Korner Meike, 2012, Front Endocrinol (Lausanne), V3, P158, DOI 10.3389/fendo.2012.00158; KRENNING EP, 1989, LANCET, V1, P242; La Rosa S, 2013, ENDOCR PATHOL, V24, P213, DOI 10.1007/s12022-013-9262-y; Nakamura T, 2014, LAB INVEST, V94, P63, DOI 10.1038/labinvest.2013.133; NORTON JA, 1990, ANN SURG, V212, P615, DOI 10.1097/00000658-199011000-00009; Ravi K, 2007, ANN ROY COLL SURG, V89, P212, DOI 10.1308/003588407X179008; Reubi JC, 2003, EUR J NUCL MED MOL I, V30, P781, DOI 10.1007/s00259-003-1184-3; Russell-Jones D, 2009, MOL CELL ENDOCRINOL, V297, P137, DOI 10.1016/j.mce.2008.11.018; Tan EH, 2011, WORLD J CLIN ONCOL, V2, P28, DOI 10.5306/wjco.v2.i1.28; Tucker ON, 2006, BRIT J SURG, V93, P264, DOI 10.1002/bjs.5280; Versari A, 2010, CLIN NUCL MED, V35, P321, DOI 10.1097/RLU.0b013e3181d6677c; Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P220, DOI 10.1210/jc.2002-021053; Vilsboll T, 2007, EXPERT OPIN INV DRUG, V16, P231, DOI 10.1517/13543784.16.2.231; Wild D, 2006, J NUCL MED, V47, P2025; Wu HF, 2013, NUCL MED COMMUN, V34, P701, DOI 10.1097/MNM.0b013e3283614187	33	5	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96833	10.1371/journal.pone.0096833	http://dx.doi.org/10.1371/journal.pone.0096833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805918	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900102
J	Barenco, PVC; Lourenco, EV; Cunha, JP; Almeida, KC; Roque-Barreira, MC; Silva, DAO; Araujo, ECB; Coutinho, LB; Oliveira, MC; Mineo, TWP; Mineo, JR; Silva, NM				Czarnewski Barenco, Paulo Victor; Lourenco, Elaine Vicente; Cunha-Junior, Jair Pereira; Almeida, Karine Cristine; Roque-Barreira, Maria Cristina; Oliveira Silva, Deise Aparecida; Borges Araujo, Ester Cristina; Coutinho, Loyane Bertagnolli; Oliveira, Mario Cezar; Patriarca Mineo, Tiago Wilson; Mineo, Jose Roberto; Silva, Neide Maria			Toxoplasma gondii 70 kDa Heat Shock Protein: Systemic Detection Is Associated with the Death of the Parasites by the Immune Response and Its Increased Expression in the Brain Is Associated with Parasite Replication	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; AVIAN IGY ANTIBODIES; EGG-YOLK ANTIBODIES; IN-VIVO; MURINE TOXOPLASMOSIS; RECOMBINANT ANTIGENS; INFECTED MICE; HEAT-SHOCK-PROTEIN-70; HSP70; VIRULENCE	The heat shock protein of Toxoplasma gondii (TgHSP70) is a parasite virulence factor that is expressed during T. gondii stage conversion. To verify the effect of dexamethasone (DXM)-induced infection reactivation in the TgHSP70-specific humoral immune response and the presence of the protein in the mouse brain, we produced recombinant TgHSP70 and anti-TgHSP70 IgY antibodies to detect the protein, the specific antibody and levels of immune complexes (ICs) systemically, as well as the protein in the brain of resistant (BALB/c) and susceptible (C57BL/6) mice. It was observed higher TgHSP70-specific antibody titers in serum samples of BALB/c compared with C57BL/6 mice. However, the susceptible mice presented the highest levels of TgHSP70 systemically and no detection of specific ICs. The DXM treatment induced increased parasitism and lower inflammatory changes in the brain of C57BL/6, but did not interfere with the cerebral parasitism in BALB/c mice. Additionally, DXM treatment decreased the serological TgHSP70 concentration in both mouse lineages. C57BL/6 mice presented high expression of TgHSP70 in the brain with the progression of infection and under DXM treatment. Taken together, these data indicate that the TgHSP70 release into the bloodstream depends on the death of the parasites mediated by the host immune response, whereas the increased TgHSP70 expression in the brain depends on the multiplication rate of the parasite.	[Czarnewski Barenco, Paulo Victor; Almeida, Karine Cristine; Borges Araujo, Ester Cristina; Coutinho, Loyane Bertagnolli; Oliveira, Mario Cezar; Silva, Neide Maria] Univ Fed Uberlandia, Inst Biomed Sci, Immunopathol Lab, BR-38400 Uberlandia, MG, Brazil; [Lourenco, Elaine Vicente; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Cellular & Mol Biol, Ribeirao Preto, SP, Brazil; [Cunha-Junior, Jair Pereira] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunotechnol & Immunochem, BR-38400 Uberlandia, MG, Brazil; [Oliveira Silva, Deise Aparecida; Patriarca Mineo, Tiago Wilson; Mineo, Jose Roberto] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol, BR-38400 Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Silva, NM (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Immunopathol Lab, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil.	nmsilva@icbim.ufu.br	Roque-Barreira, Maria-Cristina/A-4552-2008; Silva, Neide/C-7813-2013; Mineo, Jose R/B-4151-2009; SILVA, NEIDE MARIA/AAQ-7995-2020; Barenco, Paulo Victor/A-2221-2015; Mineo, Tiago W. P./B-4153-2009	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Silva, Neide/0000-0002-3615-1340; Mineo, Jose R/0000-0002-9010-7228; Mineo, Tiago W. P./0000-0002-2339-2743; Pereira da Cunha Junior, Jair/0000-0001-6182-4298; Borges Araujo, Ester Cristina/0000-0001-7053-6757; Oliveira, Mario/0000-0002-0678-6011; Czarnewski, Paulo/0000-0001-8150-4021	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-04312-10]; Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), grant APQ-04312-10, Conselho Nacional de Pesquisa Cientifica e Tecnologica (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA EM, 1993, J IMMUNOL METHODS, V160, P207, DOI 10.1016/0022-1759(93)90179-B; Aosai F, 2006, CELL STRESS CHAPERON, V11, P13, DOI 10.1379/CSC-138R.1; Aosai F, 2002, CELL STRESS CHAPERON, V7, P357, DOI 10.1379/1466-1268(2002)007<0357:TGDHSP>2.0.CO;2; Barbosa BF, 2007, PLACENTA, V28, P624, DOI 10.1016/j.placenta.2006.10.011; Bartley PM, 2006, PARASITOLOGY, V133, P421, DOI 10.1017/S0031182006000539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brujeni GN, 2012, APPL BIOCHEM BIOTECH, V167, P14, DOI 10.1007/s12010-012-9648-1; Cai YC, 2012, PARASITOL INT, V61, P385, DOI 10.1016/j.parint.2012.01.008; Chaves-Borges Flavia A., 1999, Revista do Instituto de Medicina Tropical de Sao Paulo, V41, P329, DOI 10.1590/S0036-46651999000600001; Chen M, 2003, INT IMMUNOL, V15, P39, DOI 10.1093/intimm/dxg004; Coutinho LB, 2012, INT J PARASITOL, V42, P341, DOI 10.1016/j.ijpara.2012.01.006; Cruse JC, 2010, ATLAS IMMUNOLOGY, P285; da Silva RC, 2010, EXP PARASITOL, V125, P409, DOI 10.1016/j.exppara.2010.04.003; de Medeiros B C, 2001, Transpl Infect Dis, V3, P24, DOI 10.1034/j.1399-3062.2001.003001024.x; Djurkovic-Djakovic O, 2001, ACTA PROTOZOOL, V40, P99; Djurkovic-Djakovic O, 2012, EXP PARASITOL, V131, P372, DOI 10.1016/j.exppara.2012.05.006; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Everson G T, 2003, Minerva Chir, V58, P725; Ferreira A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040391; Gatkowska J, 2006, EXP PARASITOL, V114, P220, DOI 10.1016/j.exppara.2006.03.011; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; GAZZINELLI RT, 1991, J IMMUNOL, V146, P286; GAZZINELLI RT, 1993, J IMMUNOL, V151, P3672; Holec-Gasior L, 2013, CLIN VACCINE IMMUNOL, V20, P1343, DOI 10.1128/CVI.00117-13; Kang Ki-Man, 2006, Korean Journal of Parasitology, V44, P209, DOI 10.3347/kjp.2006.44.3.209; Kovacs-Nolan J, 2012, ANNU REV FOOD SCI T, V3, P163, DOI 10.1146/annurev-food-022811-101137; LAPPIN MR, 1993, AM J VET RES, V54, P415; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyons RE, 1998, INT J PARASITOL, V28, P1041, DOI 10.1016/S0020-7519(98)00074-5; LYONS RE, 1995, PARASITE IMMUNOL, V17, P353, DOI 10.1111/j.1365-3024.1995.tb00902.x; Ma GY, 2009, EXP PARASITOL, V122, P41, DOI 10.1016/j.exppara.2009.01.011; Mahittikorn A, 2010, EXP PARASITOL, V124, P225, DOI 10.1016/j.exppara.2009.10.003; Mun HS, 2005, INFECT IMMUN, V73, P4634, DOI 10.1128/IAI.73.8.4634-4642.2005; Mun HS, 2000, CELL STRESS CHAPERON, V5, P328, DOI 10.1379/1466-1268(2000)005<0328:TGHAAD>2.0.CO;2; Mun HS, 1999, MICROBIOL IMMUNOL, V43, P471, DOI 10.1111/j.1348-0421.1999.tb02430.x; Nicoll S, 1997, J MED MICROBIOL, V46, P263, DOI 10.1099/00222615-46-3-263; Pauly D, 2009, POULTRY SCI, V88, P281, DOI 10.3382/ps.2008-00323; Reichard U., 2007, P153, DOI 10.1016/B978-012369542-0/50009-X; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sathasivam S, 2008, NAT CLIN PRACT NEURO, V4, P317, DOI 10.1038/ncpneuro0810; Shin JH, 2003, J MED MICROBIOL, V52, P217, DOI 10.1099/jmm.0.04978-0; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Silva DAO, 2007, VET PARASITOL, V143, P234, DOI 10.1016/j.vetpar.2006.08.028; Silva NM, 2010, EXP PARASITOL, V126, P167, DOI 10.1016/j.exppara.2010.04.019; Silva NM, 2009, EXP PARASITOL, V123, P65, DOI 10.1016/j.exppara.2009.05.011; Silva NM, 1998, INFECT IMMUN, V66, P3959, DOI 10.1128/IAI.66.8.3959-3963.1998; Spillner E, 2012, BIOLOGICALS, V40, P313, DOI 10.1016/j.biologicals.2012.05.003; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Takashima Y, 2008, INT J PARASITOL, V38, P601, DOI 10.1016/j.ijpara.2007.09.017; VANKNAPEN F, 1985, J CLIN MICROBIOL, V22, P645, DOI 10.1128/JCM.22.4.645-650.1985; Wananukul Siriwan, 2013, Journal of the Medical Association of Thailand, V96, P1135; Weiss LM, 1998, INFECT IMMUN, V66, P3295, DOI 10.1128/IAI.66.7.3295-3302.1998; Weiss LM, 2009, INT J PARASITOL, V39, P895, DOI 10.1016/j.ijpara.2009.02.004	55	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96527	10.1371/journal.pone.0096527	http://dx.doi.org/10.1371/journal.pone.0096527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801069	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800081
J	Deng, XH; Cheng, YD; Yang, X; Li, S; Zhao, RZ; Liu, K; Liu, JL; Cao, Q; Qin, C; Shao, PF; Meng, XX; Li, J; Lu, Q; Yin, CJ				Deng, Xiaheng; Cheng, Yidong; Yang, Xiao; Li, Shuang; Zhao, Ruizhe; Liu, Kang; Liu, Jinliang; Cao, Qiang; Qin, Chao; Shao, Pengfei; Meng, Xiaoxin; Li, Jie; Lu, Qiang; Yin, Changjun			Meta-Analysis Reveals a Lack of Association between UGT2B17 Deletion Polymorphism and Tumor Susceptibility	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE 2B17; PROSTATE-CANCER; GENE DELETION; LUNG-CANCER; RISK; GLUCURONIDATION; DETOXIFICATION; PHENOTYPE; GENOTYPE	Purpose: UGT2B17 is a vital member of the UGT2 family and functions as a detoxification enzyme which catalyzes the glucuronidation of lipophilic compounds. Accumulating evidences implicates that it may contribute to the susceptibility of tumor risk. Identification of a UGT2B17 deletion polymorphism has attracted studies to evaluate the association between the UGT2B17 deletion polymorphism and tumor risk in diverse populations. However, the available results are conflicting. Methods: A meta-analysis based on 14 studies from 10 publications including 5,732 cases and 5,112 controls was performed. Published literature from PubMed, EMBASE and Web of Science was pooled and the crude odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of the associations. Results: Conclusively, our results indicate that individuals with a UGT2B17 deletion polymorphism were associated with tumor risks (OR = 1.29, 95% CI = 1.03-1.63, P<0.001) in a recessive model. However, after excluding two studies for their heterogeneity, the result then demonstrated that the UGT2B17 deletion polymorphism was not associated with tumor risks (OR = 1.118, 95% CI = 0.938-1.332, P>0.1). A subgroup analysis based on tumor type, sex or race did not show significant results. Conclusion: These results suggest that the UGT2B17 deletion polymorphism is not associated with tumor risks.	[Deng, Xiaheng; Cheng, Yidong; Yang, Xiao; Li, Shuang; Zhao, Ruizhe; Liu, Kang; Liu, Jinliang; Cao, Qiang; Qin, Chao; Shao, Pengfei; Meng, Xiaoxin; Li, Jie; Lu, Qiang; Yin, Changjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Lu, Q (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Jiangsu, Peoples R China.	doctorlvqiang@sina.com	Cao, Qiang/K-2349-2019	Yang, Xiao/0000-0002-5429-9162; Lu, Qiang/0000-0003-3589-2507	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81171963, 81201571]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, and by the National Natural Science Foundation of China [Grant number 81171963 and 81201571]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amira N, 2002, INT J CANCER, V101, P293, DOI 10.1002/ijc.10561; Angstadt AY, 2013, CANCER-AM CANCER SOC, V119, P2477, DOI 10.1002/cncr.28009; Benhamou S, 2002, CARCINOGENESIS, V23, P1343, DOI 10.1093/carcin/23.8.1343; Cai L, 2012, PROTEIN PEPTIDE LETT, V19, P62, DOI 10.2174/092986612798472848; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eskandari-Nasab E, 2012, MOL BIOL REP, V39, P10531, DOI 10.1007/s11033-012-1938-8; Gallagher CJ, 2007, CANCER DETECT PREV, V31, P310, DOI 10.1016/j.cdp.2007.07.005; Gallagher CJ, 2007, CANCER EPIDEM BIOMAR, V16, P823, DOI 10.1158/1055-9965.EPI-06-0823; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gruber M, 2013, CANCER EPIDEMIOL, V37, P625, DOI 10.1016/j.canep.2013.06.004; Gruber M, 2013, BLOOD, V121, P1175, DOI 10.1182/blood-2012-08-447359; Gueraud F, 1998, GEN PHARMACOL, V31, P683, DOI 10.1016/S0306-3623(98)00114-1; Guillemette C, 2003, PHARMACOGENOMICS J, V3, P136, DOI 10.1038/sj.tpj.6500171; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Karypidis AH, 2008, PHARMACOGENOMICS J, V8, P147, DOI 10.1038/sj.tpj.6500449; Lau J, 2007, ANN INTERN MED, V127, P820; Lazarus P, 2005, PHARMACOGENET GENOM, V15, P769, DOI 10.1097/01.fpc.0000175596.52443.ef; Lea IA, 2007, CARCINOGENESIS, V28, P1851, DOI 10.1093/carcin/bgm176; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043821; Liu F, 2011, MUTAGENESIS, V26, P573, DOI 10.1093/mutage/ger018; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; MIDGETTE AS, 1994, MED DECIS MAKING, V14, P108, DOI 10.1177/0272989X9401400203; Nagar S, 2006, ONCOGENE, V25, P1659, DOI 10.1038/sj.onc.1209375; Olsson M, 2008, PROSTATE, V68, P571, DOI 10.1002/pros.20700; Park J, 2006, CANCER EPIDEM BIOMAR, V15, P1473, DOI 10.1158/1055-9965.EPI-06-0141; Park JY, 2007, UROLOGY, V70, P374, DOI 10.1016/j.urology.2007.03.001; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Ren Q, 2000, DRUG METAB DISPOS, V28, P1352; Setlur SR, 2010, CANCER EPIDEM BIOMAR, V19, P229, DOI 10.1158/1055-9965.EPI-09-1018; Swanson C, 2007, J CLIN ENDOCR METAB, V92, P4878, DOI 10.1210/jc.2007-0359; TEPHLY TR, 1990, TRENDS PHARMACOL SCI, V11, P276, DOI 10.1016/0165-6147(90)90008-V; Terakura S, 2005, BRIT J HAEMATOL, V129, P221, DOI 10.1111/j.1365-2141.2005.05427.x; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Zheng Z, 2002, DRUG METAB DISPOS, V30, P397, DOI 10.1124/dmd.30.4.397	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96812	10.1371/journal.pone.0096812	http://dx.doi.org/10.1371/journal.pone.0096812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802609	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800132
J	Islam, MA; Sundaraj, K; Ahmad, RB; Sundaraj, S; Ahamed, NU; Ali, MA				Islam, Md. Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Sundaraj, Sebastian; Ahamed, Nizam Uddin; Ali, Md. Asraf			Cross-Talk in Mechanomyographic Signals from the Forearm Muscles during Sub-Maximal to Maximal Isometric Grip Force	PLOS ONE			English	Article							SURFACE ELECTROMYOGRAPHY; EXTENSOR; FREQUENCY	Purpose: This study aimed: i) to examine the relationship between the magnitude of cross-talk in mechanomyographic (MMG) signals generated by the extensor digitorum (ED), extensor carpi ulnaris (ECU), and flexor carpi ulnaris (FCU) muscles with the sub-maximal to maximal isometric grip force, and with the anthropometric parameters of the forearm, and ii) to quantify the distribution of the cross-talk in the MMG signal to determine if it appears due to the signal component of intramuscular pressure waves produced by the muscle fibers geometrical changes or due to the limb tremor. Methods: Twenty, right-handed healthy men (mean +/- SD: age = 26.7 +/- 3.83 y; height = 174.47 +/- 6.3 cm; mass = 72.79 +/- 14.36 kg) performed isometric muscle actions in 20% increment from 20% to 100% of the maximum voluntary isometric contraction (MVIC). During each muscle action, MMG signals generated by each muscle were detected using three separate accelerometers. The peak cross-correlations were used to quantify the cross-talk between two muscles. Results: The magnitude of cross-talk in the MMG signals among the muscle groups ranged from, R-x,y(2) = 2.45-62.28%. Linear regression analysis showed that the magnitude of cross-talk increased linearly (r(2) = 0.857-0.90) with the levels of grip force for all the muscle groups. The amount of cross-talk showed weak positive and negative correlations (r(2) = 0.016-0.216) with the circumference and length of the forearm respectively, between the muscles at 100% MVIC. The cross-talk values significantly differed among the MMG signals due to: limb tremor (MMG(TF)), slow firing motor unit fibers (MMG(SF)) and fast firing motor unit fibers (MMG(FF)) between the muscles at 100% MVIC (p<0.05, eta(2) = 0.47-0.80). Significance: The results of this study may be used to improve our understanding of the mechanics of the forearm muscles during different levels of the grip force.	[Islam, Md. Anamul; Sundaraj, Kenneth; Ahmad, R. Badlishah; Ahamed, Nizam Uddin; Ali, Md. Asraf] Univ Malaysia Perlis, AI Rehab Res Grp, Arau, Perlis, Malaysia; [Sundaraj, Sebastian] Malaysian Minist Hlth, Klang, Selangor, Malaysia	Universiti Malaysia Perlis; Kementerian Kesihatan Malaysia	Islam, MA (corresponding author), Univ Malaysia Perlis, AI Rehab Res Grp, Arau, Perlis, Malaysia.	anamulsialm.phd@gmail.com	Ahamed, Nizam Uddin/J-6248-2012; Ahmad, Badlishah/A-4703-2019; Sundaraj, Kenneth/AAD-1783-2019; Ahmad, RB/U-3211-2019; Rather, R A/J-3509-2019	Ahamed, Nizam Uddin/0000-0003-0497-7356; Ahmad, Badlishah/0000-0002-4862-2728; Sundaraj, Kenneth/0000-0001-7221-0072; Ahmad, RB/0000-0002-4862-2728; Islam, Md. Anamul/0000-0001-6214-7081; Ali, Dr. Md Asraf/0000-0002-4732-5529				BARRY D T, 1992, Electromyography and Clinical Neurophysiology, V32, P35; Basmajian J.V., 1985, MUSCLES ALIVE THEIR; Beck T. W., 2010, TECHNICAL ASPECTS SU, P95; Beck TW, 2007, J ELECTROMYOGR KINES, V17, P1, DOI 10.1016/j.jelekin.2005.12.002; Beck TW, 2010, HUM MOVEMENT SCI, V29, P165, DOI 10.1016/j.humov.2009.11.005; Boron W., 2008, MED PHYSL; Christakos CN, 2006, J NEUROPHYSIOL, V95, P53, DOI 10.1152/jn.00051.2005; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer J T, 2003, Electromyogr Clin Neurophysiol, V43, P293; Ebersole KT, 2001, ISOKINET EXERC SCI, V9, P11, DOI 10.3233/IES-2001-0058; Farina D, 2002, MUSCLE NERVE, V26, P681, DOI 10.1002/mus.10256; Hagg GM, 1997, CLIN BIOMECH, V12, P39, DOI 10.1016/S0268-0033(96)00049-6; IAIZZO P A, 1992, Electromyography and Clinical Neurophysiology, V32, P359; Islam MA, 2013, IEEE SENS J, V13, P2499, DOI 10.1109/JSEN.2013.2255982; Islam MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058902; Jaskolska A, 2004, J ELECTROMYOGR KINES, V14, P217, DOI 10.1016/j.jelekin.2003.08.001; Keenan KG, 2007, J APPL PHYSIOL, V102, P1193, DOI 10.1152/japplphysiol.00491.2006; Kong YK, 2010, J ELECTROMYOGR KINES, V20, P1223, DOI 10.1016/j.jelekin.2010.08.001; Lowery MM, 2003, J APPL PHYSIOL, V94, P1324, DOI 10.1152/japplphysiol.00698.2002; McAuley JH, 2000, BRAIN, V123, P1545, DOI 10.1093/brain/123.8.1545; Mogk JPM, 2003, J ELECTROMYOGR KINES, V13, P63, DOI 10.1016/S1050-6411(02)00071-8; ORIZIO C, 1989, EUR J APPL PHYSIOL O, V58, P528, DOI 10.1007/BF02330708; Orizio C, 2006, MECHANOMYOGRAPHY WIL, P1; Perotto A., 2005, ANATOMICAL GUIDE ELE; Riek S, 2000, J ELECTROMYOGR KINES, V10, P249, DOI 10.1016/S1050-6411(00)00017-1; SOLOMONOW M, 1990, Electromyography and Clinical Neurophysiology, V30, P141; Tarata MT, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-3; WEE A S, 1989, Electromyography and Clinical Neurophysiology, V29, P333; WINTER DA, 1994, J ELECTROMYOGR KINES, V4, P15, DOI 10.1016/1050-6411(94)90023-X; Yung M, 2013, J ELECTROMYOGR KINES, V23, P664, DOI 10.1016/j.jelekin.2013.01.001	30	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96628	10.1371/journal.pone.0096628	http://dx.doi.org/10.1371/journal.pone.0096628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802858	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800095
J	Kawaji, T; Inoue, T; Hara, R; Eiki, D; Ando, Y; Tanihara, H				Kawaji, Takahiro; Inoue, Toshihiro; Hara, Ryuhei; Eiki, Daisuke; Ando, Yukio; Tanihara, Hidenobu			Long-Term Outcomes and Complications of Trabeculectomy for Secondary Glaucoma in Patients with Familial Amyloidotic Polyneuropathy	PLOS ONE			English	Article							OCULAR DECOMPRESSION RETINOPATHY; TRANSTHYRETIN SYNTHESIS; LIVER-TRANSPLANTATION; FILTRATION SURGERY; PIGMENT-EPITHELIUM; MANIFESTATIONS; REVISION; BLEBS	Objective: Secondary glaucoma is a serious complication in patients with transthyretin (TTR)-related familial amyloidotic polyneuropathy (FAP). We assessed the long-term outcomes and complications of trabeculectomy with mitomycin C (MMC) for secondary glaucoma associated with FAP. Methods: Medical case records of Kumamoto University Hospital were retrospectively reviewed. Twenty-one eyes of 13 patients (10 with FAP ATTR Val30Met; 3 with FAP ATTR Tyr114Cys) underwent trabeculectomy with MMC and follow-up of at least 2 years. The primary outcome measure was Kaplan-Meier survival, with failure of this treatment being defined as an intraocular pressure (IOP) of <= 5 mm Hg or >= 22 mm Hg on two consecutive visits or as additional operations needed to reduce IOP. Secondary outcome measures included complications, bleb characteristics, and additional postoperative interventions required. Results: The mean postoperative follow-up period was 5.7 years (range, 2.2-12.7 years). Kaplan-Meier analysis indicated probabilities of success of 0.76, 0.67, and 0.53 at 1, 2, and 3 years after operation, respectively. Significant complications included ocular decompression retinopathy in 7 eyes (33%) and bleb encapsulation in 10 eyes (48%). Twelve eyes (57%) needed additional surgery, such as bleb revision or trabeculectomy with MMC, to reduce IOP. Conclusions: Trabeculectomy with MMC may not be optimal for patients with FAP-related glaucoma and may have several significant complications.	[Kawaji, Takahiro; Inoue, Toshihiro; Hara, Ryuhei; Eiki, Daisuke; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Ando, Yukio] Kumamoto Univ, Dept Neurol, Fac Life Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University	Kawaji, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	kawag@white.plala.or.jp	Kawaji, Takahiro/AAH-2481-2020	Ando, Yukio/0000-0001-7115-9105; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [23390403, 23791993, 23791994]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Number 23390403, 23791993, 23791994. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand N, 2007, J GLAUCOMA, V16, P456, DOI 10.1097/IJG.0b013e31803bbb30; ANDO E, 1992, GRAEF ARCH CLIN EXP, V230, P1, DOI 10.1007/BF00166754; Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057; CAVALLARO T, 1990, INVEST OPHTH VIS SCI, V31, P497; COHEN JS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1612; FECHTNER RD, 1992, ARCH OPHTHALMOL-CHIC, V110, P965, DOI 10.1001/archopht.1992.01080190071032; FELDMAN RM, 1989, OPHTHALMOLOGY, V96, P336, DOI 10.1016/S0161-6420(89)32887-9; FUTA R, 1984, JPN J OPHTHALMOL, V28, P289; Hara R, 2010, ARCH OPHTHALMOL-CHIC, V128, P206, DOI 10.1001/archophthalmol.2009.390; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; Iwach AG, 2003, OPHTHALMOLOGY, V110, P734, DOI 10.1016/S0161-6420(02)01978-4; Kawaji T, 2005, OPHTHALMOLOGY, V112, P2212, DOI 10.1016/j.ophtha.2005.05.028; Kawaji T, 2005, EXP EYE RES, V81, P306, DOI 10.1016/j.exer.2005.02.003; Kawaji T, 2010, OPHTHALMOLOGY, V117, P552, DOI 10.1016/j.ophtha.2009.07.042; Kimura A, 2003, ARCH OPHTHALMOL-CHIC, V121, P351, DOI 10.1001/archopht.121.3.351; Koga T, 2003, AM J OPHTHALMOL, V135, P188, DOI 10.1016/S0002-9394(02)01838-X; Monteiro FA, 2006, J NEUROCHEM, V97, P151, DOI 10.1111/j.1471-4159.2006.03716.x; OPHIR A, 1992, EYE, V6, P348, DOI 10.1038/eye.1992.71; SANDGREN O, 1995, SURV OPHTHALMOL, V40, P173, DOI 10.1016/S0039-6257(95)80025-5; Sandgren O, 2008, ACTA OPHTHALMOL, V86, P520, DOI 10.1111/j.1600-0420.2007.01098.x; SILVAARAUJO AC, 1993, GRAEF ARCH CLIN EXP, V231, P131, DOI 10.1007/BF00920934; Sousa MM, 2001, J NEUROSCI, V21, P7576, DOI 10.1523/JNEUROSCI.21-19-07576.2001; Takihara Y, 2009, AM J OPHTHALMOL, V147, P912, DOI 10.1016/j.ajo.2008.11.015; Wakita M, 2006, BRIT J OPHTHALMOL, V90, P515, DOI 10.1136/bjo.2005.082735; Yarangumeli A, 2004, J GLAUCOMA, V13, P251, DOI 10.1097/00061198-200406000-00014	25	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96324	10.1371/journal.pone.0096324	http://dx.doi.org/10.1371/journal.pone.0096324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802803	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800054
J	Chen, GX; Zheng, S; Qin, S; Zhong, ZM; Wu, XH; Huang, ZP; Li, W; Ding, RT; Yu, H; Chen, JT				Chen, Guo-Xian; Zheng, Shuai; Qin, Shuai; Zhong, Zhao-Ming; Wu, Xiu-Hua; Huang, Zhi-Ping; Li, Wei; Ding, Ruo-Ting; Yu, Hui; Chen, Jian-Ting			Effect of Low-Magnitude Whole-Body Vibration Combined with Alendronate in Ovariectomized Rats: A Random Controlled Osteoporosis Prevention Study	PLOS ONE			English	Article							POSTMENOPAUSAL BONE LOSS; LOW-LEVEL; MECHANICAL SIGNALS; MUSCLE STRENGTH; DOUBLE-BLIND; IN-VIVO; RESORPTION; FRACTURE; MARKERS; WOMEN	Background: Alendronate (ALE) is a conventional drug used to treat osteoporosis. Low-magnitude whole-body vibration (WBV) exercise has been developed as a potential treatment for osteoporosis. The aim of this study was to investigate whether low-magnitude WBV could enhance the protective effect of ALE on bone properties in ovariectomized rats. Methods: A total of 128 Sprague-Dawley rats were randomly divided into five groups (SHAM, OVX+VEH, OVX+WBV, OVX + ALE, OVX+ WBV+ALE). The level of WBV applied was 0.3 g at 45-55 Hz for 20 min/day, 5 day/week and for 3 months. ALE was administered in dose of 1 mg/Kg once a week. Every four weeks eight rats from each group were sacrificed and their blood and both tibiae were harvested. The expression of osteocalcin and CTX in serum was measured by enzyme-linked immunosorbent assay (ELISA) and the tibiae were subjected to metaphyseal three-point bending and mu CT analysis. Results: Osteocalcin rose after ovariectomy and was not appreciably changed by either alendronate or WBV alone or in combination. Alendronate treatment significantly prevented an increase in CTX. WBV alone treatment did not alter this effect. Compared with the OVX+WBV group, nearly all tested indices such as the BV/TV, TV apparent, Tb.N, Tb.Th, and Conn.D were higher in the OVX+ALE group at week 12. Compared with the OVX+WBV group, certain tested indices such as BV/TV, TV apparent, Tb.N, and Con.D, were higher in the OVX+WBV+ALE group at week 12. At week 12, tibiae treated with WBV+ALE exhibited a significantly higher Fmax compared to the OVX+VEH group, and a significant difference was also found in energy absorption between the OVX+WBV+ALE and OVX+VEH groups. Conclusions: Compared with the WBV, ALE was more effective at preventing bone loss and improved the trabecular architecture. However, WBV enhanced the effect of alendronate in ovariectomized rats by inducing further improvements in trabecular architecture.	[Chen, Guo-Xian; Zheng, Shuai; Zhong, Zhao-Ming; Wu, Xiu-Hua; Huang, Zhi-Ping; Li, Wei; Ding, Ruo-Ting; Yu, Hui; Chen, Jian-Ting] Southern Med Univ, Nanfang Hosp, Dept Orthoped Spinal Surg, Guangzhou, Guangdong, Peoples R China; [Chen, Guo-Xian] First Hosp Putian City, Dept Orthoped, Putian City, Fujian Province, Peoples R China; [Qin, Shuai] Peoples Hosp Zhuhai, Dept Ophthalmol, Zhuhai, Peoples R China	Southern Medical University - China	Chen, JT (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthoped Spinal Surg, Guangzhou, Guangdong, Peoples R China.	chenjt99@tom.com			National Natural Science Foundation of China [81000785, 81272042]; Natural Science Foundation of Guangdong Province [S2012040006830, S2012010008875]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported in part by the National Natural Science Foundation of China (No. 81000785, 81272042), and by the Natural Science Foundation of Guangdong Province (No. S2012040006830, S2012010008875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercromby AFJ, 2007, MED SCI SPORT EXER, V39, P1794, DOI 10.1249/mss.0b013e3181238a0f; AKESSON K, 1995, J BONE MINER RES, V10, P1823; Barbier A, 1999, J BONE MINER METAB, V17, P37, DOI 10.1007/s007740050061; Bauss F, 2002, J RHEUMATOL, V29, P2200; BOONEKAMP PM, 1986, BONE MINER, V1, P27; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bovenzi M, 2005, G Ital Med Lav Ergon, V27, P58; Boyd SK, 2006, BONE, V39, P854, DOI 10.1016/j.bone.2006.04.017; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; Cardinale M, 2005, BRIT J SPORT MED, V39, P585, DOI 10.1136/bjsm.2005.016857; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; FLEISCH H, 1987, BONE, V8, pS23; FROST HM, 1982, METAB BONE DIS RELAT, V4, P217, DOI 10.1016/0221-8747(82)90031-5; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; GOODSHIP AE, 1979, J BONE JOINT SURG AM, V61, P539, DOI 10.2106/00004623-197961040-00008; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Iwamoto Jun, 2003, Keio Journal of Medicine, V52, P230; KANNUS P, 1995, LANCET, V346, P50, DOI 10.1016/S0140-6736(95)92679-8; Kharode Yogendra P., 2008, V455, P111, DOI 10.1007/978-1-59745-104-8_8; Kushida K, 2002, CURR THER RES CLIN E, V63, P606, DOI 10.1016/S0011-393X(02)80065-0; LANYON LE, 1984, CALCIFIED TISSUE INT, V36, pS56, DOI 10.1007/BF02406134; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; MARIE PJ, 1985, BONE, V6, P193, DOI 10.1016/8756-3282(85)90053-5; Marin PJ, 2010, J STRENGTH COND RES, V24, P548, DOI 10.1519/JSC.0b013e3181c09d22; Masud T, 2003, AGING CLIN EXP RES, V15, P89; Miyakoshi N, 2003, OSTEOPOROSIS INT, V14, P1007, DOI 10.1007/s00198-003-1510-4; Nelson CM, 2005, IND HEALTH, V43, P472, DOI 10.2486/indhealth.43.472; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; RAISZ LG, 1989, ANNU REV MED, V40, P251; REGINSTER JY, 1989, LANCET, V2, P1469; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Rosen HN, 2000, CALCIFIED TISSUE INT, V66, P100, DOI 10.1007/PL00005830; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2004, J BONE MINER RES, V19, P343, DOI 10.1359/JBMR.0301251; Rubin C, 2006, AGE AGEING, V35, P32, DOI 10.1093/ageing/afl082; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; Santos-Filho S. D., 2010, FIEP B, V80, P875; SCHENK R, 1973, CALC TISS RES, V11, P196, DOI 10.1007/BF02547219; SCHENK R, 1986, CALCIFIED TISSUE INT, V38, P342, DOI 10.1007/BF02555748; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Shiraki M, 1990, OSTEOPOROSIS INT, V10, P183; SMITH ML, 1989, CALCIFIED TISSUE INT, V44, P74, DOI 10.1007/BF02556464; STORM T, 1990, NEW ENGL J MED, V322, P1265, DOI 10.1056/NEJM199005033221803; Stuermer EK, 2010, LANGENBECK ARCH SURG, V395, P163, DOI 10.1007/s00423-008-0436-x; Sturmer EK, 2006, J BONE MINER RES, V21, P89, DOI 10.1359/JBMR.050913; THOMPSON DD, 1990, J BONE MINER RES, V5, P279, DOI 10.1002/jbmr.5650050312; Valimaki MJ, 2007, CLIN THER, V29, P1937, DOI 10.1016/j.clinthera.2007.09.017; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; WATTS NB, 1990, NEW ENGL J MED, V323, P73, DOI 10.1056/NEJM199007123230201; Wenger KH, 2010, BONE, V47, P746, DOI 10.1016/j.bone.2010.07.014; Woolf AD, 2002, OSTEOPOROSIS INT, V13, pS84; Xie LQ, 2008, J APPL PHYSIOL, V104, P1056, DOI 10.1152/japplphysiol.00764.2007; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012	57	20	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96181	10.1371/journal.pone.0096181	http://dx.doi.org/10.1371/journal.pone.0096181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796785	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000046
J	Giesbert, S; Siegmund, U; Schumacher, J; Kokkelink, L; Tudzynski, P				Giesbert, Sabine; Siegmund, Ulrike; Schumacher, Julia; Kokkelink, Leonie; Tudzynski, Paul p			Functional Analysis of BcBem1 and Its Interaction Partners in Botrytis cinerea: Impact on Differentiation and Virulence	PLOS ONE			English	Article							GRAY MOLD FUNGUS; CELL POLARITY; CLAVICEPS-PURPUREA; NADPH OXIDASES; SMALL GTPASES; PROTEIN BEM1; YEAST; MORPHOGENESIS; COMPONENT; FORMIN	In phytopathogenic fungi the establishment and maintenance of polarity is not only essential for vegetative growth and differentiation, but also for penetration and colonization of host tissues. We investigated orthologs of members of the yeast polarity complex in the grey mould fungus Botrytis cinerea: the scaffold proteins Bem1 and Far1, the GEF (guanine nucleotide exchange factor) Cdc24, and the formin Bni1 (named Sep1 in B. cinerea). BcBem1 does not play an important role in regular hyphal growth, but has significant impact on spore formation and germination, on the establishment of conidial anastomosis tubes (CATs) and on virulence. As in other fungi, BcBem1 interacts with the GEF BcCdc24 and the formin BcSep1, indicating that in B. cinerea the apical complex has a similar structure as in yeast. A functional analysis of BcCdc24 suggests that it is essential for growth, since it was not possible to obtain homokaryotic deletion mutants. Heterokaryons of Delta cdc24 (supposed to exhibit reduced bccdc24 transcript levels) already show a strong phenotype: an inability to penetrate the host tissue, a significantly reduced growth rate and malformation of conidia, which tend to burst as observed for Delta bcbem1. Also the formin BcSep1 has significant impact on hyphal growth and development, whereas the role of the putative ortholog of the yeast scaffold protein Far1 remains open: Delta bcfar1 mutants have no obvious phenotypes.	[Giesbert, Sabine; Siegmund, Ulrike; Schumacher, Julia; Kokkelink, Leonie; Tudzynski, Paul p] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany	University of Munster	Tudzynski, P (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany.	tudzyns@uni-muenster.de	Schumacher, Julia/B-9142-2019	Schumacher, Julia/0000-0001-9120-9675; Luth, Leonie/0000-0002-0113-476X	DFG Trilateral program [Tu50/15]	DFG Trilateral program	Funding provided by DFG Trilateral program Tu50/15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Tabares I, 2008, J CELL SCI, V121, P2824, DOI 10.1242/jcs.026286; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Araujo-Palomares CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027148; Banuett F, 2008, FUNGAL GENET BIOL, V45, pS3, DOI 10.1016/j.fgb.2008.05.012; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Butty AC, 1998, SCIENCE, V282, P1511, DOI 10.1126/science.282.5393.1511; CARDENAS ME, 1994, EMBO J, V13, P5944, DOI 10.1002/j.1460-2075.1994.tb06940.x; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Choquer M, 2007, FEMS MICROBIOL LETT, V277, P1, DOI 10.1111/j.1574-6968.2007.00930.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Dub AM, 2013, EUKARYOT CELL, V12, P1609, DOI 10.1128/EC.00160-13; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; France YE, 2006, J CELL SCI, V119, P876, DOI 10.1242/jcs.02849; Giesbert S, 2012, MOL PLANT MICROBE IN, V25, P481, DOI 10.1094/MPMI-07-11-0199; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Guo SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006089; Harren K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041761; Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007; Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474; HARRIS SD, 1994, GENETICS, V136, P517; Harris SD, 2006, INT REV CYTOL, V251, P41, DOI 10.1016/S0074-7696(06)51002-2; Harrison JC, 2001, NAT CELL BIOL, V3, P417, DOI 10.1038/35070104; Herrmann A, 2014, EUKARYOTIC IN PRESS; James P, 1996, GENETICS, V144, P1425; KANGATHARALINGAM N, 1984, CURR MICROBIOL, V10, P99, DOI 10.1007/BF01575767; Kayano Y, 2013, FUNGAL GENET BIOL, V56, P87, DOI 10.1016/j.fgb.2013.05.001; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Kokkelink L, 2011, FUNGAL GENET BIOL, V48, P1012, DOI 10.1016/j.fgb.2011.07.007; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Leeder AC, 2008, FUNGAL GENET BIOL, V45, P897, DOI 10.1016/j.fgb.2007.12.001; Lichius A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030372, 10.1371/journal.pone.0042565]; Liu R, 2010, BBA-MOL CELL RES, V1803, P207, DOI 10.1016/j.bbamcr.2008.09.016; Mourino-Perez RR, 2013, FUNGAL BIOL REV, V27, P1, DOI 10.1016/j.fbr.2013.02.002; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Roca MG, 2012, FUNGAL BIOL-UK, V116, P379, DOI 10.1016/j.funbio.2011.12.007; Rolke Y, 2004, MOL PLANT PATHOL, V5, P17, DOI 10.1111/j.1364-3703.2004.00201.x; Rolke Y, 2008, MOL MICROBIOL, V68, P405, DOI 10.1111/j.1365-2958.2008.06159.x; Rui O, 2007, MOL PLANT PATHOL, V8, P173, DOI 10.1111/J.1364-3703.2007.00383.X; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Schurg T, 2012, MOL MICROBIOL, V86, P349, DOI 10.1111/j.1365-2958.2012.08197.x; Schurmann J, 2013, MOL PLANT MICROBE IN, V26, P1151, DOI 10.1094/MPMI-03-13-0064-R; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356; Siegmund U, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055879, 10.1371/annotation/84c258cf-4f98-43d8-a4f0-7032cba36f22]; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Staats M, 2012, EUKARYOT CELL, V11, P1413, DOI 10.1128/EC.00164-12; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tenberge KB, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P67; Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Virag A, 2006, MYCOL RES, V110, P4, DOI 10.1016/j.mycres.2005.09.005; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wendland J, 2001, GENETICS, V157, P601; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200; Zheng L, 2000, MOL PLANT MICROBE IN, V13, P724, DOI 10.1094/MPMI.2000.13.7.724	67	21	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95172	10.1371/journal.pone.0095172	http://dx.doi.org/10.1371/journal.pone.0095172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797931	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000015
J	Liu, T; Chen, YY; Chao, LF; Wang, SQ; Wu, W; Dai, SP; Wang, F; Fan, Q; Zhou, RC				Liu, Ting; Chen, Yunyun; Chao, Lifang; Wang, Shuqiong; Wu, Wei; Dai, Seping; Wang, Feng; Fan, Qiang; Zhou, Renchao			Extensive Hybridization and Introgression between Melastoma candidum and M-sanguineum	PLOS ONE			English	Article							DIFFERENTIAL INTROGRESSION; HYBRID ZONE; SPECIATION; INDIVIDUALS; ADAPTATION; STAMENS; FLOWERS; MARKERS	Natural hybridization can lead to various evolutionary outcomes in plants, including hybrid speciation and interspecific gene transfer. It can also cause taxonomic problems, especially in plant genera containing multiple species. In this study, the hybrid status of Melastoma affine, the most widespread taxon in this genus, and introgression between its putative parental species, M. candidum and M. sanguineum, were assessed on two sites, Hainan and Guangdong, using 13 SSR markers and sequences of a chloroplast intergenic spacer. Bayesian-based STRUCTURE analysis detected two most likely distinct clusters for the three taxa, and 76.0% and 73.9% of the morphologically identified individuals of M. candidum and M. sanguineum were correctly assigned, respectively. 74.5% of the M. affine individuals had a membership coefficient to either parental species between 0.1 and 0.9, suggesting admixture between M. candidum and M. sanguineum. Furthermore, NewHybrids analysis suggested that most individuals of M. affine were F2 hybrids or backcross hybrids to M. candidum, and that there was extensive introgression between M. candidum and M. sanguineum. These SSR data thus provides convincing evidence for hybrid origin of M. affine and extensive introgression between M. candidum and M. sanguineum. Chloroplast DNA results were consistent with this conclusion. Much higher hybrid frequency on the more disturbed Guangdong site suggests that human disturbance might offer suitable habitats for the survival of hybrids, a hypothesis that is in need of further testing.	[Liu, Ting; Chao, Lifang; Wang, Shuqiong; Fan, Qiang; Zhou, Renchao] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Ting; Chao, Lifang; Wang, Shuqiong; Fan, Qiang; Zhou, Renchao] Sun Yat Sen Univ, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yunyun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Wei] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Dai, Seping] Guangzhou Inst Landscape Gardening, Guangzhou, Guangdong, Peoples R China; [Wang, Feng] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Jinan University	Zhou, RC (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	zhrench@mail.sysu.edu.cn	Wang, Feng/I-8263-2019		National Natural Science Foundation of China [31170213, 91231106]; SRF for ROCS; SEM; Chang Hungta Science Foundation of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); SRF for ROCS(Scientific Research Foundation for the Returned Overseas Chinese Scholars); SEM; Chang Hungta Science Foundation of Sun Yat-sen University	This study is supported by grants from the National Natural Science Foundation of China (31170213 and 91231106), SRF for ROCS, SEM, and Chang Hungta Science Foundation of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Anderson EC, 2002, GENETICS, V160, P1217; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Arnold Michael L., 2009, Journal of Biology (London), V8, P82, DOI 10.1186/jbiol176; Brelsford A, 2009, EVOLUTION, V63, P3050, DOI 10.1111/j.1558-5646.2009.00777.x; Chapman MA, 2013, MOL BIOL EVOL, V30, P2553, DOI 10.1093/molbev/mst168; Chen C., 2007, FLORA CHINA, V13, P360; Chen J., 1984, FLORA REIPUBLICAE PO, V53, P152; Dai SP, 2012, BIOCHEM SYST ECOL, V41, P136, DOI 10.1016/j.bse.2011.12.010; Dobzhansky T., 1937; Don D, 1823, MEMOIRS WERNERIAN NA, V4, P288; Doyle J. J., 1987, PHYTOCHEM B, P11; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hoban SM, 2009, BIOL LETTERS, V5, P324, DOI 10.1098/rsbl.2009.0031; HUANG S-F, 1991, Taiwania, V36, P117; Lamont BB, 2003, J EVOLUTION BIOL, V16, P551, DOI 10.1046/j.1420-9101.2003.00548.x; Larson EL, 2013, EVOLUTION, V67, P3653, DOI 10.1111/evo.12205; Liu T, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200294; Lu GuoHui, 2009, Biodiversity Science, V17, P174, DOI 10.3724/SP.J.1003.2009.08317; Luo Z, 2008, FUNCT ECOL, V22, P794, DOI 10.1111/j.1365-2435.2008.01444.x; Luo Zhong-lai, 2005, Journal of Tropical and Subtropical Botany, V13, P536; Luo ZL, 2009, J SYST EVOL, V47, P43, DOI 10.1111/j.1759-6831.2009.00002.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Meyer K, 2001, BLUMEA, V46, P351; Payseur BA, 2010, MOL ECOL RESOUR, V10, P806, DOI 10.1111/j.1755-0998.2010.02883.x; Pritchard JK, 2000, GENETICS, V155, P945; RIESEBERG LH, 1993, CRIT REV PLANT SCI, V12, P213, DOI 10.1080/713608045; Seminoff JA, 2003, B MAR SCI, V73, P643; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Sun M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019671; Twyford AD, 2012, HEREDITY, V108, P179, DOI 10.1038/hdy.2011.68; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vallender R, 2007, MOL ECOL, V16, P2017, DOI 10.1111/j.1365-294X.2007.03282.x; Wagner W.L., 1999, BISHOP MUSEUM SPECIA, V1; Wallace LE, 2006, AM J BOT, V93, P1001, DOI 10.3732/ajb.93.7.1001; WHITTAKER RJ, 1994, J BIOGEOGR, V21, P245, DOI 10.2307/2845528	38	23	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96680	10.1371/journal.pone.0096680	http://dx.doi.org/10.1371/journal.pone.0096680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797959	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000115
J	Pittman, SJ; Monaco, ME; Friedlander, AM; Legare, B; Nemeth, RS; Kendall, MS; Poti, M; Clark, RD; Wedding, LM; Caldow, C				Pittman, Simon J.; Monaco, Mark E.; Friedlander, Alan M.; Legare, Bryan; Nemeth, Richard S.; Kendall, Matthew S.; Poti, Matthew; Clark, Randall D.; Wedding, Lisa M.; Caldow, Chris			Fish with Chips: Tracking Reef Fish Movements to Evaluate Size and Connectivity of Caribbean Marine Protected Areas	PLOS ONE			English	Article							REGION-WIDE DECLINES; CORAL-REEFS; SPAWNING AGGREGATIONS; RESERVE NETWORKS; RED HIND; PATTERNS; CONSERVATION; PERSPECTIVE; ANIMALS; SCIENCE	Coral reefs and associated fish populations have experienced rapid decline in the Caribbean region and marine protected areas (MPAs) have been widely implemented to address this decline. The performance of no-take MPAs (i.e., marine reserves) for protecting and rebuilding fish populations is influenced by the movement of animals within and across their boundaries. Very little is known about Caribbean reef fish movements creating a critical knowledge gap that can impede effective MPA design, performance and evaluation. Using miniature implanted acoustic transmitters and a fixed acoustic receiver array, we address three key questions: How far can reef fish move? Does connectivity exist between adjacent MPAs? Does existing MPA size match the spatial scale of reef fish movements? We show that many reef fishes are capable of traveling far greater distances and in shorter duration than was previously known. Across the Puerto Rican Shelf, more than half of our 163 tagged fish (18 species of 10 families) moved distances greater than 1 km with three fish moving more than 10 km in a single day and a quarter spending time outside of MPAs. We provide direct evidence of ecological connectivity across a network of MPAs, including estimated movements of more than 40 km connecting a nearshore MPA with a shelf-edge spawning aggregation. Most tagged fish showed high fidelity to MPAs, but also spent time outside MPAs, potentially contributing to spillover. Three-quarters of our fish were capable of traveling distances that would take them beyond the protection offered by at least 40-64% of the existing eastern Caribbean MPAs. We recommend that key species movement patterns be used to inform and evaluate MPA functionality and design, particularly size and shape. A re-scaling of our perception of Caribbean reef fish mobility and habitat use is imperative, with important implications for ecology and management effectiveness.	[Pittman, Simon J.; Monaco, Mark E.; Kendall, Matthew S.; Poti, Matthew; Clark, Randall D.; Wedding, Lisa M.; Caldow, Chris] US Natl Ocean & Atmospher Adm, Ctr Coastal Monitoring & Assessment, Silver Spring, MD 20910 USA; [Pittman, Simon J.; Legare, Bryan; Nemeth, Richard S.] Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI USA; [Pittman, Simon J.] Univ Plymouth, Ctr Marine & Coastal Policy Res, Inst Marine, Plymouth PL4 8AA, Devon, England; [Friedlander, Alan M.] Univ Hawaii Manoa, Dept Biol, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Legare, Bryan] Texas Parks & Wildlife, Dickinson Marine Lab, Dickinson, TX USA; [Wedding, Lisa M.] Stanford Univ, Ctr Ocean Solut, Woods Inst Environm, Monterey, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of the Virgin Islands; University of Plymouth; University of Hawaii System; University of Hawaii Manoa; Stanford University	Pittman, SJ (corresponding author), US Natl Ocean & Atmospher Adm, Ctr Coastal Monitoring & Assessment, Silver Spring, MD 20910 USA.	simon.pittman@noaa.gov	Wedding, Lisa/GRY-3972-2022	Wedding, Lisa/0000-0002-3782-915X; Pittman, Simon/0000-0002-4113-6970	National Science Foundation's Virgin Islands Experimental Program to Stimulate Competitive Research [0814417]; University of the Virgin Islands Center for Marine and Environmental Studies (CMES); Puerto Rico Sea Grant [R-31-1-06]; NOAA Saltonstall-Kennedy [NA09NMF4270068]; NOAA [NA08NOS4260348]; USGS State Partnership Program [07ERAG0078]; EPSCoR [0814417] Funding Source: National Science Foundation	National Science Foundation's Virgin Islands Experimental Program to Stimulate Competitive Research; University of the Virgin Islands Center for Marine and Environmental Studies (CMES); Puerto Rico Sea Grant; NOAA Saltonstall-Kennedy; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); USGS State Partnership Program; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	SJP, MEM, AMF and LMW were supported by U.S. National Park Service, NOAA Center for Coastal Monitoring and Assessment (CCMA) and NOAA Coral Reef Conservation Program. BL was supported by University of the Virgin Islands. RSN was supported by the National Science Foundation's Virgin Islands Experimental Program to Stimulate Competitive Research (0814417) and the University of the Virgin Islands Center for Marine and Environmental Studies (CMES). The UVI acoustic array was supported by grants from Puerto Rico Sea Grant (R-31-1-06), NOAA Saltonstall-Kennedy (NA09NMF4270068), NOAA cooperative agreement (NA08NOS4260348), and USGS State Partnership Program (07ERAG0078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala AC, 2005, CAN J FISH AQUAT SCI, V62, P98, DOI 10.1139/F04-176; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bolden SK, 2000, FISH B-NOAA, V98, P642; Bostrom C, 2011, MAR ECOL PROG SER, V427, P191, DOI 10.3354/meps09051; Botsford LW, 2003, ECOL APPL, V13, pS25; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Devillers R, 2015, AQUAT CONSERV, V25, P480, DOI 10.1002/aqc.2445; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Grober-Dunsmore R, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P493, DOI 10.1007/978-90-481-2406-0_14; Grothues TM, 2009, REV-METHODS TECHNOL, V9, P77, DOI 10.1007/978-1-4020-9640-2_5; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Guarderas AP, 2008, CONSERV BIOL, V22, P1630, DOI 10.1111/j.1523-1739.2008.01023.x; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Hitt S, 2011, ENVIRON BIOL FISH, V92, P525, DOI 10.1007/s10641-011-9875-2; Hitt S, 2011, MAR ECOL PROG SER, V427, P275, DOI 10.3354/meps09093; Kobara S, 2013, OCEANOGR MAR BIOL, V51, P281; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Lee KA, 2014, AQUATIC CONSERV, DOI [10.1002/aqc.243, DOI 10.1002/AQC.243]; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Moffitt EA, 2009, ECOL APPL, V19, P1835, DOI 10.1890/08-1101.1; Monaco ME, 2009, P 11 INT COR REEF S; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mumby PJ, 2006, BIOL CONSERV, V128, P215, DOI 10.1016/j.biocon.2005.09.042; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nemeth R. S., 2006, P GULF CARIBBEAN FIS, V57, P543; Nemeth RS, 2007, ENVIRON BIOL FISH, V78, P365, DOI 10.1007/s10641-006-9161-x; Nemeth RS, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P73, DOI 10.1007/978-90-481-2406-0_4; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Olds AD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1040, DOI 10.1111/geb.12072; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Pina-Amargos F., 2009, Endangered Species Research, V7, P243, DOI 10.3354/esr00192; Pittman SJ, 2011, MAR ECOL PROG SER, V427, P187, DOI 10.3354/meps09139; Pittman SJ, 2003, ADV MAR BIOL, V44, P205, DOI 10.1016/S0065-2881(03)44004-2; Popple ID, 2005, J FISH BIOL, V67, P981, DOI 10.1111/j.1095-8649.2005.00797.x; Roberts Callum M., 2002, Natural Resource Modeling, V15, P487; Roberts CM, 2003, ECOL APPL, V13, pS199; Roberts CM, 2000, B MAR SCI, V66, P581; Rosenberg DK, 1997, BIOSCIENCE, V47, P677, DOI 10.2307/1313208; Russ GR, 2011, ECOL APPL, V21, P241, DOI 10.1890/09-1197.1; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sale PF, 1998, AUST J ECOL, V23, P202, DOI 10.1111/j.1442-9993.1998.tb00721.x; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Turgeon K, 2010, ECOLOGY, V91, P3332, DOI 10.1890/09-2015.1	51	66	66	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96028	10.1371/journal.pone.0096028	http://dx.doi.org/10.1371/journal.pone.0096028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797815	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000033
J	Rexiati, M; Mutalifu, A; Azhati, B; Wang, WG; Yang, HL; Sheyhedin, I; Wang, YJ				Rexiati, Mulati; Mutalifu, Abudurezhake; Azhati, Baihetiya; Wang, Wenguang; Yang, Honglin; Sheyhedin, Ilyar; Wang, Yujie			Diagnosis and Surgical Treatment of Renal Hydatid Disease: a Retrospective Analysis of 30 Cases	PLOS ONE			English	Article							CYSTIC ECHINOCOCCOSIS; CLINICAL MANAGEMENT; EXPERIENCE; KIDNEY; SCLEROTHERAPY; COMMUNITIES; ASPIRATION; ULTRASOUND; THERAPY; SURGERY	Echinococcosis (CE) is an infection which is caused by the larval stage of a tapeworm and is endemic in stockbreeding regions of developing countries. The kidney is the most commonly affected organ in the urinary tract. However, reports on renal hydatid disease are limited in the literature, and usually there are no specific clinical characteristics and promising operative methods. The purpose of this study is to assess the most appropriate surgical technique for the patient with urinary tract CE. We retrospectively analyzed thirty patients with renal hydatid cysts who received different surgical treatments in the urology department of the First Affiliated Hospital of Xinjiang Medical University from February 1985 to April 2010. Twenty patients were males and ten were females. The diagnostic accuracy was 74%, 87.5%, and 66.6% respectively by using of ultrasound, CT, and laboratory tests. Thirty patients were followed up for 1-15 years after surgery. One patient experienced a recurrence of renal CE. The ultrasound, CT, and immunological tests are an important means of diagnosis. The surgical treatment principle of renal hydatid should be based on residual renal function, hydatid cyst size, number, location, and surgical techniques to determine the surgical plan to retain the renal function.	[Rexiati, Mulati; Mutalifu, Abudurezhake; Azhati, Baihetiya; Wang, Wenguang; Wang, Yujie] Xin Jiang Med Univ, Affiliated Hosp 1, Dept Urol, Urumqi, Xin Jiang, Peoples R China; [Yang, Honglin] Yili Friendship Hosp, Yi Ning, Xin Jiang, Peoples R China; [Sheyhedin, Ilyar] Xinjiang Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University	Sheyhedin, I (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Urumqi, Xinjiang, Peoples R China.	sheyhidinelyar@163.com; wangyujieuc@163.com			National Natural Science Foundaion of China [1160088]	National Natural Science Foundaion of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundaion of China, grant number: 1160088 ( http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch- list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif Sajad Hussain, 2008, Int J Surg, V6, P448, DOI 10.1016/j.ijsu.2008.08.003; Bradley M, 2001, T ROY SOC TROP MED H, V95, P72, DOI 10.1016/S0035-9203(01)90338-4; Brunetti E, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001146; Brunetti E, 2010, ACTA TROP, V114, P1, DOI 10.1016/j.actatropica.2009.11.001; Cretu CM, 2012, CHIRURGIA-BUCHAREST, V107, P15; Echinococcosis WIWGo, 1996, B WORLD HEALTH ORGAN, V74, P12; El Sheikh A, 2011, HEPATO-GASTROENTEROL, V58, P336; Esposito C, 1998, SURG ENDOSC-ULTRAS, V12, P177, DOI 10.1007/s004649900624; Fazeli F, 2009, UROLOGY, V73, P999, DOI 10.1016/j.urology.2008.10.049; Fekak H, 2003, ANN UROL, V37, P85, DOI 10.1016/S0003-4401(03)00026-3; Gogus C, 2003, J UROLOGY, V169, P186, DOI 10.1016/S0022-5347(05)64064-5; GOGUS O, 1991, BRIT J UROL, V68, P466, DOI 10.1111/j.1464-410X.1991.tb15386.x; Hanna RM, 1996, AM J ROENTGENOL, V167, P781, DOI 10.2214/ajr.167.3.8751700; HOLMBERG G, 1994, SCAND J UROL NEPHROL, V28, P35, DOI 10.3109/00365599409180467; Horchani A, 2000, EUR UROL, V38, P461, DOI 10.1159/000020325; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047667; IMANI F, 1977, J RADIOL ELEC MED N, V58, P135; Ishimitsu DN, 2010, RADIOGRAPHICS, V30, P334, DOI 10.1148/rg.302095149; Junghanss T, 2008, AM J TROP MED HYG, V79, P301, DOI 10.4269/ajtmh.2008.79.301; Kalinova K, 2007, J IMAB ANN P; Kilinc M, 2008, INT UROL NEPHROL, V40, P609, DOI 10.1007/s11255-007-9316-5; Li TY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001364; Macpherson CNL, 2003, ACTA TROP, V85, P253, DOI 10.1016/S0001-706X(02)00213-9; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Motie MR, 2010, INDIAN J SURG, V72, P448, DOI 10.1007/s12262-010-0163-8; Nemes A, 2006, INT J CARDIOVAS IMAG, V22, P647, DOI 10.1007/s10554-006-9089-4; Ohkawa M., 1993, International Urology and Nephrology, V25, P37, DOI 10.1007/BF02552252; Olut Ali I., 2005, Korean Journal of Parasitology, V43, P15, DOI 10.3347/kjp.2005.43.1.15; Onur K, 2005, EUR J RADIOL EXTRA, V54, P3; Ozbey I, 2002, J INT MED RES, V30, P346; Ozbey Iss, 2001, International Urology and Nephrology, V33, P329, DOI 10.1023/A:1015209106436; Piskun G, 1999, J LAPAROENDOSC ADV A, V9, P361, DOI 10.1089/lap.1999.9.361; Shukla S, 2009, INDIAN J PATHOL MICR, V52, P213, DOI 10.4103/0377-4929.48921; Song XH, 2007, POSTGRAD MED J, V83, P536, DOI 10.1136/pgmj.2007.057166; Stojkovic M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001880; Turgut AT, 2009, AM J ROENTGENOL, V192, P462, DOI 10.2214/AJR.08.1129; Turgut Ahmet Tuncay, 2008, Ultrasound Q, V24, P17, DOI 10.1097/RUQ.0b013e318168f0d1; Xing Y, 2011, INT J CARDIOVAS IMAG, V27, P97, DOI 10.1007/s10554-011-9958-3; Yang YR, 2008, TROP MED INT HEALTH, V13, P1086, DOI 10.1111/j.1365-3156.2008.02101.x; Yasawy MI, 2011, WORLD J GASTROENTERO, V17, P646, DOI 10.3748/wjg.v17.i5.646; Yildirim M, 2006, ANN TROP MED PARASIT, V100, P137, DOI 10.1179/13648590678560; Yilmaz Y, 2006, INT J UROL, V13, P1162, DOI 10.1111/j.1442-2042.2006.01482.x; Zmerli S, 2001, WORLD J SURG, V25, P68, DOI 10.1007/s002680020009	43	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96602	10.1371/journal.pone.0096602	http://dx.doi.org/10.1371/journal.pone.0096602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796329	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000102
J	Yuan, DD; Ran, YJ; Liu, Q; Zhang, YH; Li, HY; Li, PL; Zhu, DL				Yuan, Dandan; Ran, Yajuan; Liu, Qian; Zhang, Yanhua; Li, Huiying; Li, Peiling; Zhu, Daling			Enhancement of the HIF-1 alpha/15-LO/15-HETE Axis Promotes Hypoxia-Induced Endothelial Proliferation in Preeclamptic Pregnancy	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; ANGIOGENIC FACTORS; 15-HYDROXYEICOSATETRAENOIC ACID; IN-VIVO; PATHOPHYSIOLOGY; CELLS; HYPERTENSION; PATHOGENESIS; TROPHOBLAST; HIF-1-ALPHA	Preeclampsia (PE) is an extremely serious condition in pregnant women and the leading cause of maternal and fetal morbidity and mortality. Despite active research, the etiological factors of this disorder remain elusive. The increased release of 15-hydroxyeicosatetraenoic acid (15-HETE) in the placenta of preeclamptic patients has been studied, but its exact role in PE pathogenesis remains unknown. Mounting evidence shows that PE is associated with placental hypoxia, impaired placental angiogenesis, and endothelial dysfunction. In this study, we confirmed the upregulated expression of hypoxiainducible factor 1 alpha (HIF-1 alpha) and 15-lipoxygenase-1/2 (15-LO-1/2) in patients with PE. Production of the arachidonic acid metabolite, 15-HETE, also increased in the preeclamptic placenta, which suggests enhanced activation of the HIF-1 alpha-15-LO-15-HETE axis. Furthermore, this study is the first to show that the umbilical cord of preeclamptic women contains significantly higher serum concentrations of 15-HETE than that of healthy pregnant women. The results also show that expression of 15-LO-1/2 is upregulated in both human umbilical vein endothelial cells (HUVECs) collected from preeclamptic women and in those cultured under hypoxic conditions. Exogenous 15-HETE promotes the migration of HUVECs and in vitro tube formation and promotes cell cycle progression from the G0/G1 phase to the G2/M + S phase, whereas the 15-LO inhibitor, NDGA, suppresses these effects. The HIF-1 alpha/15-LO/15-HETE pathway is therefore significantly associated within the pathology of PE.	[Yuan, Dandan; Liu, Qian; Zhang, Yanhua; Li, Peiling] Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin, Peoples R China; [Ran, Yajuan; Zhu, Daling] Harbin Med Univ Daqing, Coll Pharm, Dept Biopharmaceut Sci, Daqing, Peoples R China; [Li, Huiying] Mudanjiang Med Coll, Hongqi Hosp, Dept Obstet & Gynecol, Mudanjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Mudanjiang Medical University	Li, PL (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Harbin, Peoples R China.	peiley@126.com; dalingz@yahoo.com			National Natural Science Foundation of China [331071007]; Youth Science Foundation of Heilongjiang Province [QC2010078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation of China (DZ, No. 331071007) and Youth Science Foundation of Heilongjiang Province (QL, No. QC2010078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashur-Fabian O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037273; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Drost JT, 2010, MATURITAS, V67, P321, DOI 10.1016/j.maturitas.2010.08.002; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Foidart JM, 2009, J REPROD IMMUNOL, V82, P106, DOI 10.1016/j.jri.2009.09.001; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Iwagaki S, 2004, GYNECOL ENDOCRINOL, V18, P263, DOI 10.1080/0951359042000196277; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Johnson RD, 1998, AM J OBSTET GYNECOL, V178, P54, DOI 10.1016/S0002-9378(98)70626-X; Karthikeyan Vellore J, 2011, Front Biosci (Elite Ed), V3, P1100; Kleinrouweler CE, 2012, BJOG-INT J OBSTET GY, V119, P778, DOI 10.1111/j.1471-0528.2012.03311.x; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Laresgoiti-Servitje E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099861; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Ma J, 2012, J LIPID RES, V53, P1093, DOI 10.1194/jlr.M024398; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McKeeman GC, 2004, AM J OBSTET GYNECOL, V191, P1240, DOI 10.1016/j.ajog.2004.03.004; Myatt L, 2006, J PHYSIOL-LONDON, V572, P25, DOI 10.1113/jphysiol.2006.104968; Myers JE, 2013, BJOG-INT J OBSTET GY, V120, P1215, DOI 10.1111/1471-0528.12195; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reilly KB, 2004, J BIOL CHEM, V279, P9440, DOI 10.1074/jbc.M303857200; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Sane David C., 2004, Angiogenesis, V7, P193, DOI 10.1007/s10456-004-2699-3; Sankar KD, 2012, ANAT CELL BIOL, V45, P86, DOI 10.5115/acb.2012.45.2.86; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Semenza CL, 2001, PEDIATR RES, V49, P614, DOI 10.1203/00006450-200105000-00002; Shenoy V, 2010, TRENDS ENDOCRIN MET, V21, P529, DOI 10.1016/j.tem.2010.05.002; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang YG, 2012, PROSTAG LEUKOTR ESS, V86, P79, DOI 10.1016/j.plefa.2011.10.006; Warrington JP, 2013, HYPERTENSION, V62, P666, DOI 10.1161/HYPERTENSIONAHA.113.00588; Yao L, 2012, PROSTAG OTH LIPID M, V99, P96, DOI 10.1016/j.prostaglandins.2012.09.001; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149	39	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96510	10.1371/journal.pone.0096510	http://dx.doi.org/10.1371/journal.pone.0096510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796548	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000084
J	Ecochard-Dugelay, E; Beliah, M; Boisson, C; Perreaux, F; de Laveaucoupet, J; Labrune, P; Epaud, R; Ducou-Lepointe, H; Bouyer, J; Gajdos, V				Ecochard-Dugelay, Emmanuelle; Beliah, Muriel; Boisson, Caroline; Perreaux, Francis; de Laveaucoupet, Jocelyne; Labrune, Philippe; Epaud, Ralph; Ducou-Lepointe, Hubert; Bouyer, Jean; Gajdos, Vincent			Impact of Chest Radiography for Children with Lower Respiratory Tract Infection: A Propensity Score Approach	PLOS ONE			English	Article							ACUTE BRONCHIOLITIS; PNEUMONIA; PRINCIPLES; MANAGEMENT; DIAGNOSIS	Background: Management of acute respiratory tract infection varies substantially despite this being a condition frequently encountered in pediatric emergency departments. Previous studies have suggested that the use of antibiotics was higher when chest radiography was performed. However none of these analyses had considered the inherent indication bias of observational studies. Objective: The aim of this work was to assess the relationship between performing chest radiography and prescribing antibiotics using a propensity score analysis to address the indication bias due to non-random radiography assignment. Methods: We conducted a prospective study of 697 children younger than 2 years of age who presented during the winter months of 2006-2007 for suspicion of respiratory tract infection at the Pediatric Emergency Department of an urban general hospital in France (Paris suburb). We first determined the individual propensity score (probability of having a chest radiography according to baseline characteristics). Then we assessed the relation between radiography and antibiotic prescription using two methods: adjustment and matching on the propensity score. Results: We found that performing a chest radiography lead to more frequent antibiotic prescription that may be expressed as OR = 2.3, CI [1.3-4.1], or as an increased use of antibiotics of 18.6% [0.08-0.29] in the group undergoing chest radiography. Conclusion: Chest radiography has a significant impact on the management of infants admitted for suspicion of respiratory tract infection in a pediatric emergency department and may lead to unnecessary administration of antibiotics.	[Ecochard-Dugelay, Emmanuelle; Bouyer, Jean; Gajdos, Vincent] INSERM, CESP Ctr Res Epidemiol & Populat Hlth, Reprod & Child Dev Team, U1018, Le Kremlin Bicetre, France; [Beliah, Muriel; Boisson, Caroline; Perreaux, Francis; Labrune, Philippe; Gajdos, Vincent] Hop Antoine Beclere, AP HP, Dept Paediat, Clamart, France; [de Laveaucoupet, Jocelyne] Hop Antoine Beclere, AP HP, Dept Radiol, Clamart, France; [Epaud, Ralph] Ctr Hosp Intercommunal, AP HP, Dept Paediat, Creteil, France; [Ducou-Lepointe, Hubert] Hop Trousseau, AP HP, Dept Paediat Radiol, F-75571 Paris, France; [Labrune, Philippe; Bouyer, Jean; Gajdos, Vincent] Univ Paris 11, Le Kremlin Bicetre, France; [Epaud, Ralph] Univ Paris Est, Creteil, Val De Marne, France; [Ducou-Lepointe, Hubert] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Sorbonne Universite	Gajdos, V (corresponding author), Univ Paris 11, Le Kremlin Bicetre, France.	vincent.gajdos@abc.aphp.fr	bouyer, jean/G-2717-2013	bouyer, jean/0000-0003-4861-0783	French Society of Pediatric	French Society of Pediatric	This work was supported by a research grant from the French Society of Pediatric. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Blackstone EH, 2002, J THORAC CARDIOV SUR, V123, P8, DOI 10.1067/mtc.2002.120329; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Christakis DA, 2005, PEDIATRICS, V115, P878, DOI 10.1542/peds.2004-1299; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DABBOUS IA, 1966, PEDIATRICS, V37, P477; Etard C, 2010, EXPOSITION POPULATIO; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Kwiatkowski F, 2007, B CANCER, V94, P680; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Liu LL, 2004, PEDIATR PULM, V37, P243, DOI 10.1002/ppul.10425; Mathews B, 2009, PEDIATRICS, V124, pE29, DOI 10.1542/peds.2008-2062; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Neuman MI, 2011, PEDIATRICS, V128, P246, DOI 10.1542/peds.2010-3367; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rothrock SG, 2001, PEDIATR EMERG CARE, V17, P240, DOI 10.1097/00006565-200108000-00003; Royston P., 2008, MULTIVARIABLE MODEL; Schuh S, 2007, J PEDIATR-US, V150, P429, DOI 10.1016/j.jpeds.2007.01.005; Swingler GH, 1998, LANCET, V351, P404, DOI 10.1016/S0140-6736(97)07013-X; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Weitzen S, 2004, PHARMACOEPIDEM DR S, V13, P841, DOI 10.1002/pds.969; Willson DF, 2001, PEDIATRICS, V108, P851, DOI 10.1542/peds.108.4.851; Yong JHE, 2009, PEDIATR PULM, V44, P122, DOI 10.1002/ppul.20948	26	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96189	10.1371/journal.pone.0096189	http://dx.doi.org/10.1371/journal.pone.0096189			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788944	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700059
J	Stone, AEL; Mitchell, A; Brownell, J; Miklin, DJ; Golden-Mason, L; Polyak, SJ; Gale, MJ; Rosen, HR				Stone, Amy E. L.; Mitchell, Angela; Brownell, Jessica; Miklin, Daniel J.; Golden-Mason, Lucy; Polyak, Stephen J.; Gale, Michael J., Jr.; Rosen, Hugo R.			Hepatitis C Virus Core Protein Inhibits Interferon Production by a Human Plasmacytoid Dendritic Cell Line and Dysregulates Interferon Regulatory Factor-7 and Signal Transducer and Activator of Transcription (STAT) 1 Protein Expression	PLOS ONE			English	Article							CHRONIC HCV INFECTION; IFN-ALPHA PRODUCTION; RIG-I; ANTIVIRAL RESPONSE; RECOGNITION; THERAPY; IRF-7; GC1QR; INDUCTION; LIGAND	Plasmacytoid Dendritic Cells (pDCs) represent a key immune cell population in the defense against viruses. pDCs detect viral pathogen associated molecular patterns (PAMPs) through pattern recognition receptors (PRR). PRR/PAMP interactions trigger signaling events that induce interferon (IFN) production to initiate local and systemic responses. pDCs produce Type I and Type III (IFNL) IFNs in response to HCV RNA. Extracellular HCV core protein (Core) is found in the circulation in chronic infection. This study defined how Core modulates PRR signaling in pDCs. Type I and III IFN expression and production following exposure to recombinant Core or beta-galactosiade was assessed in human GEN2.2 cells, a pDC cell line. Core suppressed type I and III IFN production in response to TLR agonists and the HCV PAMP agonist of RIG-I. Core suppression of IFN induction was linked with decreased IRF-7 protein levels and increased non-phosphorylated STAT1 protein. Circulating Core protein interferes with PRR signaling by pDCs to suppress IFN production. Strategies to define and target Core effects on pDCs may serve to enhance IFN production and antiviral actions against HCV.	[Stone, Amy E. L.; Mitchell, Angela; Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA; [Stone, Amy E. L.; Mitchell, Angela; Golden-Mason, Lucy; Rosen, Hugo R.] Natl Jewish Hlth, Denver, CO USA; [Stone, Amy E. L.; Mitchell, Angela; Miklin, Daniel J.; Golden-Mason, Lucy; Rosen, Hugo R.] Univ Colorado, Dept Med, Hepatitis C Ctr, Div Gastroenterol & Hepatol, Denver, CO 80202 USA; [Brownell, Jessica; Polyak, Stephen J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Gale, Michael J., Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Rosen, Hugo R.] Denver Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Denver; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Rosen, HR (corresponding author), Univ Colorado, Integrated Dept Immunol, Denver, CO 80202 USA.	Hugo.Rosen@UCDENVER.edu	Stone, Amy/T-7852-2019; Mitchell, Angela M/GQB-5477-2022; Mitchell, Angela/AAB-9956-2022	Golden-Mason, Lucy/0000-0003-3347-4192; STONE, AMY E/0000-0002-9140-6510; Mitchell, Angela/0000-0003-1955-5850; Golden-Mason, Lucy/0000-0002-2087-4405; Gale, Michael/0000-0002-6332-7436; Miklin, Daniel/0000-0002-3864-3672	NIH [U19 AI 1066328]; VA Merit Review grant; NIH/NCATS Colorado CTSI [TL1 TR000155]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066328, F31AI010663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review grant(US Department of Veterans Affairs); NIH/NCATS Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH U19 AI 1066328, a VA Merit Review grant and NIH/NCATS Colorado CTSI Grant Number TL1 TR000155. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Florentin J, 2012, BLOOD, V120, P4544, DOI 10.1182/blood-2012-02-413286; Fortin C, 2013, J IMMUNOL, V191, P363, DOI 10.4049/jimmunol.1202714; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Hagberg N, 2011, J IMMUNOL, V186, P5085, DOI 10.4049/jimmunol.1003349; Hillyer P, 2012, IMMUNOL CELL BIOL, V90, P774, DOI 10.1038/icb.2011.109; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kim HJ, 2011, INSECT MOL BIOL, V20, P723, DOI 10.1111/j.1365-2583.2011.01102.x; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Kumagai Y, 2009, J IMMUNOL, V182, P3960, DOI 10.4049/jimmunol.0804315; Lambotin M, 2010, J VIROL, V84, P8964, DOI 10.1128/JVI.00517-10; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Megjugorac NJ, 2009, J LEUKOCYTE BIOL, V86, P1359, DOI 10.1189/jlb.0509347; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; POLYAK SJ, 2011, HEPATITIS C VIRUSES; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Ray RB, 2001, FEMS MICROBIOL LETT, V202, P149, DOI 10.1111/j.1574-6968.2001.tb10796.x; Raychoudhuri A, 2010, J VIROL, V84, P10991, DOI 10.1128/JVI.00900-10; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; Soffredini R, 2004, AM J GASTROENTEROL, V99, P1738, DOI 10.1111/j.1572-0241.2004.30396.x; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Szabo G, 2005, IMMUNOBIOLOGY, V210, P237, DOI 10.1016/j.imbio.2005.05.018; Tacke RS, 2011, J BIOL CHEM, V286, P10847, DOI 10.1074/jbc.M110.217653; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P7431, DOI 10.1073/pnas.1002301107; Wertheimer AM, 2004, HEPATOLOGY, V40, P335, DOI 10.1002/hep.20306; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yao ZQ, 2004, J VIROL, V78, P6409, DOI 10.1128/JVI.78.12.6409-6419.2004; Yin ZW, 2012, J IMMUNOL, V189, P2735, DOI 10.4049/jimmunol.1102038	46	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95627	10.1371/journal.pone.0095627	http://dx.doi.org/10.1371/journal.pone.0095627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788809	Green Submitted, gold, Green Published			2022-12-27	WOS:000335510600044
J	Birdno, MJ; Tang, W; Dostrovsky, JO; Hutchison, WD; Grill, WM				Birdno, Merrill J.; Tang, Wei; Dostrovsky, Jonathan O.; Hutchison, William D.; Grill, Warren M.			Response of Human Thalamic Neurons to High-Frequency Stimulation	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; SUBTHALAMIC NUCLEUS STIMULATION; GUINEA-PIG; GLOBUS-PALLIDUS; ELECTRICAL-STIMULATION; CELLULAR MECHANISMS; INDUCED INHIBITION; SUBSTANTIA-NIGRA; BURST ACTIVITY; FIRING MODE	Thalamic deep brain stimulation (DBS) is an effective treatment for tremor, but the mechanisms of action remain unclear. Previous studies of human thalamic neurons to noted transient rebound bursting activity followed by prolonged inhibition after cessation of high frequency extracellular stimulation, and the present study sought to identify the mechanisms underlying this response. Recordings from 13 thalamic neurons exhibiting low threshold spike (LTS) bursting to brief periods of extracellular stimulation were made during surgeries to implant DBS leads in 6 subjects with Parkinson's disease. The response immediately after cessation of stimulation included a short epoch of burst activity, followed by a prolonged period of silence before a return to LTS bursting. A computational model of a population of thalamocortical relay neurons and presynaptic axons terminating on the neurons was used to identify cellular mechanisms of the observed responses. The model included the actions of neuromodulators through inhibition of a non-pertussis toxin sensitive K+ current (I-KL), activation of a pertussis toxin sensitive K+ current (I-KG), and a shift in the activation curve of the hyperpolarization-activated cation current (I-h). The model replicated well the measured responses, and the prolonged inhibition was associated most strongly with changes in IKG while modulation of IKL or Ih had minimal effects on post-stimulus inhibition suggesting that neuromodulators released in response to high frequency stimulation are responsible for mediating the post-stimulation bursting and subsequent long duration silence of thalamic neurons. The modeling also indicated that the axons of the model neurons responded robustly to suprathreshold stimulation despite the inhibitory effects on the soma. The findings suggest that during DBS the axons of thalamocortical neurons are activated while the cell bodies are inhibited thus blocking the transmission of pathological signals through the network and replacing them with high frequency regular firing.	[Birdno, Merrill J.; Grill, Warren M.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Grill, Warren M.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Grill, Warren M.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Grill, Warren M.] Duke Univ, Dept Surg, Durham, NC USA; [Tang, Wei; Dostrovsky, Jonathan O.; Hutchison, William D.] Duke Univ, Dept Physiol, Durham, NC USA; [Dostrovsky, Jonathan O.; Hutchison, William D.] Toronto Western Res Inst, Toronto, ON, Canada	Duke University; Duke University; Duke University; Duke University; Duke University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Grill, WM (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	warren.grill@duke.edu		Grill, Warren/0000-0001-5240-6588	US NIH [R01 NS040894]; Canadian Institutes of Health Research [MOP-42505]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040894] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by US NIH R01 NS040894 www.nih.gov and the Canadian Institutes of Health Research MOP-42505 http://www.cihr-irsc.gc. ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; ANDO N, 1995, J NEUROPHYSIOL, V73, P2470, DOI 10.1152/jn.1995.73.6.2470; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Birdno MJ, 2008, NEUROTHERAPEUTICS, V5, P14, DOI 10.1016/j.nurt.2007.10.067; Birdno MJ, 2007, J NEUROPHYSIOL, V98, P1675, DOI 10.1152/jn.00547.2007; Birdno MJ, 2012, J NEUROPHYSIOL, V107, P364, DOI 10.1152/jn.00906.2010; Breit S, 2004, CELL TISSUE RES, V318, P275, DOI 10.1007/s00441-004-0936-0; Chang SY, 2012, MAYO CLIN PROC, V87, P760, DOI 10.1016/j.mayocp.2012.05.006; Darian-Smith I, 1996, Adv Anat Embryol Cell Biol, V133, P1; DESCHENES M, 1990, EUR J NEUROSCI, V2, P140, DOI 10.1111/j.1460-9568.1990.tb00406.x; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Dostrovsky JO, 2002, 6214 SOC NEUR; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Grill Warren M., 2001, Thalamus & Related Systems, V1, P269, DOI 10.1016/S1472-9288(01)00025-5; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Hershey T, 2003, NEUROLOGY, V61, P816, DOI 10.1212/01.WNL.0000083991.81859.73; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hodaie M, 2006, BRAIN RES, V1115, P1, DOI 10.1016/j.brainres.2006.07.085; Kuncel AM, 2007, IEEE T NEUR SYS REH, V15, P190, DOI 10.1109/TNSRE.2007.897004; Kuncel AM, 2006, MOVEMENT DISORD, V21, P1920, DOI 10.1002/mds.21087; Lafreniere-Roula M, 2010, EXP BRAIN RES, V205, P251, DOI 10.1007/s00221-010-2362-8; Lee KH, 2005, J NEUROSURG, V103, P538, DOI 10.3171/jns.2005.103.3.0538; Lee KM, 2011, HISTORY OF THE KOREAN LANGUAGE, P13; Levy R, 2007, NEUROSURGERY, V60, P277, DOI 10.1227/01.NEU.0000255389.85161.03; Liu LD, 2012, J NEUROPHYSIOL, V108, P5, DOI 10.1152/jn.00527.2011; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; MCCORMICK DA, 1992, J NEUROSCI, V12, P278; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; MCCORMICK DA, 1991, J NEUROSCI, V11, P3188; MCCORMICK DA, 1987, J PHYSIOL-LONDON, V392, P147, DOI 10.1113/jphysiol.1987.sp016774; MCCORMICK DA, 1987, J NEUROSCI, V7, P742; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; PAPE HC, 1992, J PHYSIOL-LONDON, V447, P729, DOI 10.1113/jphysiol.1992.sp019026; Radhakrishnan V, 1999, PAIN, V80, P567, DOI 10.1016/S0304-3959(98)00248-6; Sato F, 1997, J COMP NEUROL, V388, P613, DOI 10.1002/(SICI)1096-9861(19971201)388:4<613::AID-CNE9>3.0.CO;2-5; Steriade M, 1997, THALAMUS ORG FUNCTIO, V1; TASKER RR, 1995, NEUROSURG CLIN N AM, V6, P73; Ushe M, 2004, MOVEMENT DISORD, V19, P1163, DOI 10.1002/mds.20231; Wei XFF, 2005, J NEURAL ENG, V2, P139, DOI 10.1088/1741-2560/2/4/010; Windels F, 2005, J NEUROSCI, V25, P5079, DOI 10.1523/JNEUROSCI.0360-05.2005; Windels F, 2003, J NEUROSCI RES, V72, P259, DOI 10.1002/jnr.10577; Zhao YB, 2004, CHINESE MED J-PEKING, V117, P1304	46	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96026	10.1371/journal.pone.0096026	http://dx.doi.org/10.1371/journal.pone.0096026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804767	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900032
J	Tilney, PM; van Wyk, AE; van der Merwe, CF				Tilney, Patricia M.; van Wyk, Abraham E.; van der Merwe, Chris F.			The Epidermal Cell Structure of the Secondary Pollen Presenter in Vangueria infausta (Rubiaceae: Vanguerieae) Suggests a Functional Association with Protruding Onci in Pollen Grains	PLOS ONE			English	Article							XYLOGLUCAN; GERMINATION; MORPHOLOGY; WALLS; POLYSACCHARIDES; PLANTS; KEETIA; WELL	Secondary pollen presentation is a well-known phenomenon in the Rubiaceae with particularly conspicuous pollen presenters occurring in the tribe Vanguerieae. These knob-like structures are formed by a modification of the upper portion of the style and stigma, together known as the stylar head complex. In the flower bud and shortly before anthesis, the anthers surrounding the stylar head complex dehisce and release pollen grains which adhere to the pollen presenter. The epidermal cells of the pollen presenter facing the anthers are radially elongated with a characteristic wall thickening encircling the anticlinal walls of each cell towards the distal end. These cells were studied in the pollen presenter of Vangueria infausta using electron and light microscopy in conjunction with histochemical tests and immunohistochemical methods. Other prominent thickenings of the cell wall were also observed on the distal and proximal walls. All these thickenings were found to be rich in pectin and possibly xyloglucan. The terms ''thickenings of Igersheim'' and ''bands of Igersheim'' are proposed to refer, respectively, to these wall structures in general and those encircling the anticlinal walls of each cell near the distal end. The epidermal cells have an intricate ultrastructure with an abundance of organelles, including smooth and rough endoplasmic reticulum, Golgi apparatus, mitochondria and secretory vesicles. This indicates that these cells are likely to have an active physiological role. The pollen grains possess prominent protruding onci and observations were made on their structure and development. Walls of the protruding onci are also rich in pectin. Pectins are hydrophilic and known to be involved in the dehydration and rehydration of pollen grains. We hypothesise that the thickenings of Igersheim, as well as the protruding onci of the pollen grains, are functionally associated and part of the adaptive syndrome of secondary pollen presentation, at least in the Vanguerieae.	[Tilney, Patricia M.] Univ Johannesburg, Dept Bot & Plant Biotechnol, Johannesburg, South Africa; [van Wyk, Abraham E.; van der Merwe, Chris F.] Univ Pretoria, Dept Plant Sci, ZA-0002 Pretoria, South Africa	University of Johannesburg; University of Pretoria	Tilney, PM (corresponding author), Univ Johannesburg, Dept Bot & Plant Biotechnol, Auckland Pk, Johannesburg, South Africa.	pmtilney@uj.ac.za	van Wyk, Abraham/A-2181-2008	van Wyk, Abraham/0000-0002-0437-3272	National Research Foundation (NRF) [77457]; University of Pretoria	National Research Foundation (NRF); University of Pretoria	The work was funded by a National Research Foundation grant (NRF 77457) awarded to PMT. AEVW and CFVDM were funded by the University of Pretoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, Current Trends in Polymer Science, V8, P27; Bredenkamp CL, 1999, BOT J LINN SOC, V129, P223, DOI 10.1111/j.1095-8339.1999.tb00502.x; Brett CT, 1996, PHYSL BIOCH PLANT CE; Bridson D. M., 1998, RUBIACEAE 2, V5, P211; Buckeridge MS, 2010, PLANT PHYSIOL, V154, P1017, DOI 10.1104/pp.110.158642; Buda GJ, 2009, PLANT J, V60, P378, DOI 10.1111/j.1365-313X.2009.03960.x; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; CONSIDINE JA, 1979, PROTOPLASMA, V99, P347, DOI 10.1007/BF01275807; Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Erdtman G., 1952, POLLEN MORPHOLOGY PL, P1; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; Geldner N, 2013, ANNU REV PLANT BIOL, V64, P531, DOI 10.1146/annurev-arplant-050312-120050; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; HESLOPHARRISON J, 1985, J CELL SCI, V73, P135; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; HESLOPHARRISON Y, 1986, ACTA BOT NEERL, V35, P265, DOI 10.1111/j.1438-8677.1986.tb01289.x; Hornatowska J., 2005, 872005 STFI PACKF; HOWELL GJ, 1993, AUST J BOT, V41, P417, DOI 10.1071/BT9930417; IGERSHEIM A, 1993, PLANT SYST EVOL, V187, P175, DOI 10.1007/BF00994098; IGERSHEIM A, 1993, OPERA BOT BELG, V6, P51; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; Katifori E, 2010, P NATL ACAD SCI USA, V107, P7635, DOI 10.1073/pnas.0911223107; KOOIMAN P., 1960, ACTA BOT NEELANDICA, V9, P208; KOOIMAN P, 1960, RECL TRAV CHIM PAY B, V79, P675; KOOIMAN P, 1957, NATURE, V179, P107, DOI 10.1038/179107a0; Kosaraju SL, 2005, CRIT REV FOOD SCI, V45, P251, DOI 10.1080/10408690490478091; Kuang YF, 2012, GRANA, V51, P253, DOI 10.1080/00173134.2012.660984; Kuang YF, 2008, REV PALAEOBOT PALYNO, V151, P123, DOI 10.1016/j.revpalbo.2008.03.003; Ladd PG, 1998, AUST J BOT, V46, P479, DOI 10.1071/BT97038; Ladd PG, 1996, AUST J BOT, V44, P447, DOI 10.1071/BT9960447; LADD PG, 1994, BOT J LINN SOC, V115, P165, DOI 10.1006/bojl.1994.1040; Lantz H, 2004, BOT J LINN SOC, V146, P257, DOI 10.1111/j.1095-8339.2004.00338.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; Matthews ML, 1999, ANN BOT-LONDON, V83, P385, DOI 10.1006/anbo.1998.0837; O'Brien TP, 1981, STUDY PLANT STRUCTUR, DOI DOI 10.2307/2259948; O'Neill M. A., 2003, PLANT CELL WALL, P1, DOI DOI 10.1002/9781119312994.APR0067; PAYNE W W, 1972, Grana, V12, P93; POTGIETER MJ, 1992, BOT BULL ACAD SINICA, V33, P295; Pryor L. D., 1976, The biology of Eucalypts.; Puff C, 1996, OPERA BOT BELG, V7, P369; Roberts K, 1990, CURR OPIN CELL BIOL, V2, P920, DOI 10.1016/0955-0674(90)90093-T; SAENGER W, 1984, NATURWISSENSCHAFTEN, V71, P31, DOI 10.1007/BF00365977; Satter RL., 1990, PULVINUS MOTOR ORGAN; Skottsberg C, 1945, ARK BOT A, V32A, P1; Tilney PM, 2009, BOTHALIA, V39, P165, DOI 10.4102/abc.v39i2.242; Tilney PM, 1997, GRANA, V36, P249, DOI 10.1080/00173139709362614; TINE MAS, 2000, REV BRASILEIRA BOT, V23, P415; van Wyk B., 2013, FIELD GUIDE TREES SO; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Yeo P. F., 1993, SECONDARY POLLEN PRE; YORK WS, 1990, CARBOHYD RES, V200, P9, DOI 10.1016/0008-6215(90)84179-X; Yuguchi Y, 2005, MACROMOL RAPID COMM, V26, P1315, DOI 10.1002/marc.200500283	55	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96405	10.1371/journal.pone.0096405	http://dx.doi.org/10.1371/journal.pone.0096405			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804803	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900055
J	Wang, H; Li, X; Nakane, S; Liu, S; Ishikawa, H; Iwamoto, A; Matsuda, Z				Wang, Hongyun; Li, Xiao; Nakane, Shuhei; Liu, Shujun; Ishikawa, Hirohito; Iwamoto, Aikichi; Matsuda, Zene			Co-Expression of Foreign Proteins Tethered to HIV-1 Envelope Glycoprotein on the Cell Surface by Introducing an Intervening Second Membrane-Spanning Domain	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODY; VIRAL MEMBRANE; NONNEUTRALIZING ANTIBODY; VIRION INFECTIVITY; ESCHERICHIA-COLI; DIVERSE STRAINS; T-CELLS; FUSION	The envelope glycoprotein (Env) of human immunodeficiency virus type I (HIV-1) mediates membrane fusion. To analyze the mechanism of HIV-1 Env-mediated membrane fusion, it is desirable to determine the expression level of Env on the cell surface. However, the quantification of Env by immunological staining is often hampered by the diversity of HIV-1 Env and limited availability of universal antibodies that recognize different Envs with equal efficiency. To overcome this problem, here we linked a tag protein called HaloTag at the C-terminus of HIV-1 Env. To relocate HaloTag to the cell surface, we introduced a second membrane-spanning domain (MSD) between Env and HaloTag. The MSD of transmembrane protease serine 11D, a type II transmembrane protein, successfully relocated HaloTag to the cell surface. The surface level of Env can be estimated indirectly by staining HaloTag with a specific membrane-impermeable fluorescent ligand. This tagging did not compromise the fusogenicity of Env drastically. Furthermore, fusogenicity of Env was preserved even after the labeling with the ligands. We have also found that an additional foreign peptide or protein such as C34 or neutralizing single- chain variable fragment (scFv) can be linked to the C-terminus of the HaloTag protein. Using these constructs, we were able to determine the required length of C34 and critical residues of neutralizing scFv for blocking membrane fusion, respectively.	[Wang, Hongyun; Li, Xiao; Nakane, Shuhei; Liu, Shujun; Ishikawa, Hirohito; Matsuda, Zene] Chinese Acad Sci, Inst Biophys, China Japan Joint Lab Struct Virol & Immunol, Beijing 100080, Peoples R China; [Li, Xiao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Nakane, Shuhei; Ishikawa, Hirohito; Iwamoto, Aikichi; Matsuda, Zene] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo, Japan; [Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Div Infect Dis, Adv Clin Res Ctr, Tokyo, Japan	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Tokyo; University of Tokyo	Matsuda, Z (corresponding author), Chinese Acad Sci, Inst Biophys, China Japan Joint Lab Struct Virol & Immunol, Beijing 100080, Peoples R China.	zmatsuda@ims.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology for Program of Japan Initiative for Global Research Network on Infectious Diseases	Ministry of Education, Culture, Sports, Science, and Technology for Program of Japan Initiative for Global Research Network on Infectious Diseases	This work was supported by a contract research fund from the Ministry of Education, Culture, Sports, Science, and Technology for Program of Japan Initiative for Global Research Network on Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Atanasiu D, 2013, J VIROL, V87, P11332, DOI 10.1128/JVI.01700-13; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Caffrey M, 2011, TRENDS MICROBIOL, V19, P191, DOI 10.1016/j.tim.2011.02.001; CHEN SY, 1994, P NATL ACAD SCI USA, V91, P5932, DOI 10.1073/pnas.91.13.5932; DASH B, 1994, J GEN VIROL, V75, P1389, DOI 10.1099/0022-1317-75-6-1389; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; Dogo-Isonagie C, 2012, J BIOL CHEM, V287, P15076, DOI 10.1074/jbc.M111.332361; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Garg H, 2011, CURR TOP MED CHEM, V11, P2947, DOI 10.2174/156802611798808479; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Gustchina E, 2005, J MED CHEM, V48, P3036, DOI 10.1021/jm049026h; Huarte N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052740; Ishikawa H, 2012, PROTEIN ENG DES SEL, V25, P813, DOI 10.1093/protein/gzs051; Jorgensen ML, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-9; KNAPPIK A, 1993, BIO-TECHNOL, V11, P77, DOI 10.1038/nbt0193-77; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Lee SJ, 2006, AIDS RES HUM RETROV, V22, P874, DOI 10.1089/aid.2006.22.874; Lee SJ, 2004, J IMMUNOL, V173, P4618, DOI 10.4049/jimmunol.173.7.4618; Lineberger JE, 2002, J VIROL, V76, P3522, DOI 10.1128/JVI.76.7.3522-3533.2002; Liu SJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-100; Liu SW, 2004, CURR PHARM DESIGN, V10, P1827, DOI 10.2174/1381612043384466; Long YF, 2011, PROTEIN CELL, V2, P369, DOI 10.1007/s13238-011-1051-0; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Miller KD, 2005, PROTEIN EXPRES PURIF, V42, P255, DOI 10.1016/j.pep.2005.04.015; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Mulampaka SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019941; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Nieba L, 1997, PROTEIN ENG, V10, P435, DOI 10.1093/protein/10.4.435; Ofek G, 2010, J VIROL, V84, P2955, DOI 10.1128/JVI.02257-09; Otteken A, 1996, J VIROL, V70, P3407, DOI 10.1128/JVI.70.6.3407-3415.1996; Pang Wei, 2009, Antivir Chem Chemother, V20, P1, DOI 10.3851/IMP1369; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sakaguchi N, 2005, J IMMUNOL, V174, P4485, DOI 10.4049/jimmunol.174.8.4485; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Sugaya M, 2007, J INVEST DERMATOL, V127, P1436, DOI 10.1038/sj.jid.5700736; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Teeranaipong P, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18723; Weiss Carol D, 2003, AIDS Rev, V5, P214; Wen M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-79; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhang XZ, 2011, SCI CHINA LIFE SCI, V54, P1042, DOI 10.1007/s11427-011-4244-0; Zhou P, 1998, J IMMUNOL, V160, P1489; Zwick MB, 2003, J VIROL, V77, P5863, DOI 10.1128/JVI.77.10.5863-5876.2003	54	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96790	10.1371/journal.pone.0096790	http://dx.doi.org/10.1371/journal.pone.0096790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804933	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900096
J	Weiss, A; Herman, T; Giladi, N; Hausdorff, JM				Weiss, Aner; Herman, Talia; Giladi, Nir; Hausdorff, Jeffrey M.			Objective Assessment of Fall Risk in Parkinson's Disease Using a Body-Fixed Sensor Worn for 3 Days	PLOS ONE			English	Article							SPATIOTEMPORAL GAIT PARAMETERS; STEP WIDTH VARIABILITY; AMBULATORY ACTIVITY; PHYSICAL-ACTIVITY; OLDER-ADULTS; PEOPLE; DYSFUNCTION; VALIDATION; DISORDERS; DYNAMICS	Background: Patients with Parkinson's disease (PD) suffer from a high fall risk. Previous approaches for evaluating fall risk are based on self-report or testing at a given time point and may, therefore, be insufficient to optimally capture fall risk. We tested, for the first time, whether metrics derived from 3 day continuous recordings are associated with fall risk in PD. Methods and Materials: 107 patients (Hoehn & Yahr Stage: 2.6 +/- 0.7) wore a small, body-fixed sensor (3D accelerometer) on lower back for 3 days. Walking quantity (e. g., steps per 3-days) and quality (e. g., frequency-derived measures of gait variability) were determined. Subjects were classified as fallers or non-fallers based on fall history. Subjects were also followed for one year to evaluate predictors of the transition from non-faller to faller. Results: The 3 day acceleration derived measures were significantly different in fallers and non-fallers and were significantly correlated with previously validated measures of fall risk. Walking quantity was similar in the two groups. In contrast, the fallers walked with higher step-to-step variability, e. g., anterior-posterior width of the dominant frequency was larger (p = 0.012) in the fallers (0.78 +/- 0.17 Hz) compared to the non-fallers (0.71 +/- 0.07 Hz). Among subjects who reported no falls in the year prior to testing, sensor-derived measures predicted the time to first fall (p = 0.0034), whereas many traditional measures did not. Cox regression analysis showed that anterior-posterior width was significantly (p = 0.0039) associated with time to fall during the follow-up period, even after adjusting for traditional measures. Conclusions/Significance: These findings indicate that a body-fixed sensor worn continuously can evaluate fall risk in PD. This sensor-based approach was able to identify transition from non-faller to faller, whereas many traditional metrics were not successful. This approach may facilitate earlier detection of fall risk and may in the future, help reduce high costs associated with falls.	[Weiss, Aner; Herman, Talia; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel; [Giladi, Nir] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, IL-69978 Tel Aviv, Israel; [Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Harvard University; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine	Hausdorff, JM (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel.	jhausdor@tlvmc.gov.il	Giladi, Nir/AAU-8660-2020	Giladi, Nir/0000-0003-1482-8522	European Commission [288878]; Michael J. Fox Foundation for Parkinson's Research; Israel Science Foundation; NIH/NIA [5R21AG034227]; NATIONAL INSTITUTE ON AGING [R21AG034227] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); Michael J. Fox Foundation for Parkinson's Research; Israel Science Foundation(Israel Science Foundation); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The European Commission (Contract. 288878), Michael J. Fox Foundation for Parkinson's Research, the Israel Science Foundation, and the NIH/NIA (5R21AG034227) provided support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Ashburn A, 2001, GERONTOLOGY, V47, P277, DOI 10.1159/000052812; Ashburn A, 2001, AGE AGEING, V30, P47, DOI 10.1093/ageing/30.1.47; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; Bohnen NI, 2009, NEUROLOGY, V73, P1670, DOI 10.1212/WNL.0b013e3181c1ded6; Boonstra TA, 2008, CURR OPIN NEUROL, V21, P461, DOI 10.1097/WCO.0b013e328305bdaf; Brach JS, 2008, GAIT POSTURE, V27, P431, DOI 10.1016/j.gaitpost.2007.05.016; Brach Jennifer S, 2005, J Neuroeng Rehabil, V2, P21, DOI 10.1186/1743-0003-2-21; Brach JS, 2001, J AM GERIATR SOC, V49, P1646, DOI 10.1046/j.1532-5415.2001.t01-1-49274.x; Chastin SFM, 2010, MOVEMENT DISORD, V25, P2114, DOI 10.1002/mds.23146; Dobkin BH, 2013, CURR OPIN NEUROL, V26, P602, DOI 10.1097/WCO.0000000000000026; Dobkin BH, 2011, NEUROREHAB NEURAL RE, V25, P788, DOI 10.1177/1545968311425908; Fiordelli M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2430; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2003, J GERIATR PSYCH NEUR, V16, P53, DOI 10.1177/0891988702250580; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Herman T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055193; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Kelsey JL, 2012, J AM GERIATR SOC, V60, P517, DOI 10.1111/j.1532-5415.2011.03834.x; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Latt MD, 2009, J GERONTOL A-BIOL, V64, P700, DOI 10.1093/gerona/glp009; Lim I, 2008, MOVEMENT DISORD, V23, P2411, DOI 10.1002/mds.22209; Lord S, 2008, GAIT POSTURE, V27, P357, DOI 10.1016/j.gaitpost.2007.04.001; Lord S, 2013, J NEUROL, V260, P2964, DOI 10.1007/s00415-013-7037-5; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Lord S, 2013, J GERONTOL A-BIOL, V68, P820, DOI 10.1093/gerona/gls255; Mirelman A, 2013, MOVEMENT DISORD, V28, P1683, DOI 10.1002/mds.25587; Mirelman A, 2011, ANN NEUROL, V69, P193, DOI 10.1002/ana.22165; Moe-Nilssen R, 2005, GAIT POSTURE, V21, P164, DOI 10.1016/j.gaitpost.2004.01.013; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Moe-Nilssen R, 2010, GAIT POSTURE, V32, P98, DOI 10.1016/j.gaitpost.2010.03.019; Moore ST, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-82; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Paraschiv-Ionescu A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02019; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Rochester L, 2012, J NEUROL, V259, P1081, DOI 10.1007/s00415-011-6301-9; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Stevens JA, 1997, ANN EPIDEMIOL, V7, P54, DOI 10.1016/S1047-2797(96)00110-X; van Hees VT, 2009, OBESITY, V17, P1287, DOI 10.1038/oby.2009.55; Verghese J, 2008, J AM GERIATR SOC, V56, P1244, DOI 10.1111/j.1532-5415.2008.01758.x; Verghese J, 2007, J NEUROL NEUROSUR PS, V78, P929, DOI 10.1136/jnnp.2006.106914; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; Weiss A, 2011, NEUROREHAB NEURAL RE, V25, P810, DOI 10.1177/1545968311424869; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; YACK HJ, 1993, J GERONTOL, V48, pM225, DOI 10.1093/geronj/48.5.M225; Yarnall A, 2011, MOVEMENT DISORD, V26, P2496, DOI 10.1002/mds.23932; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	57	143	144	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96675	10.1371/journal.pone.0096675	http://dx.doi.org/10.1371/journal.pone.0096675			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801889	Green Published, gold			2022-12-27	WOS:000338029800108
J	Wenzel, U; Taubert, M; Ragert, P; Krug, J; Villringer, A				Wenzel, Uwe; Taubert, Marco; Ragert, Patrick; Krug, Juergen; Villringer, Arno			Functional and Structural Correlates of Motor Speed in the Cerebellar Anterior Lobe	PLOS ONE			English	Article							FORCE-VELOCITY RELATIONSHIP; SIMPLE SPIKE DISCHARGE; MOVEMENT VELOCITY; FIBER-TYPE; MEDIAN FREQUENCY; BRAIN STRUCTURE; MUSCLE FORCE; REPRESENTATION; PLASTICITY; NETWORKS	In athletics, motor performance is determined by different abilities such as technique, endurance, strength and speed. Based on animal studies, motor speed is thought to be encoded in the basal ganglia, sensorimotor cortex and the cerebellum. The question arises whether there is a unique structural feature in the human brain, which allows "power athletes'' to perform a simple foot movement significantly faster than "endurance athletes''. We acquired structural and functional brain imaging data from 32 track-and-field athletes. The study comprised of 16 "power athletes'' requiring high speed foot movements (sprinters, jumpers, throwers) and 16 endurance athletes (distance runners) which in contrast do not require as high speed foot movements. Functional magnetic resonance imaging (fMRI) was used to identify speed specific regions of interest in the brain during fast and slow foot movements. Anatomical MRI scans were performed to assess structural grey matter volume differences between athletes groups (voxel based morphometry). We tested maximum movement velocity of plantarflexion (PF-V-max) and acquired electromyographical activity of the lateral and medial gastrocnemius muscle. Behaviourally, a significant difference between the two groups of athletes was noted in PF-V-max and fMRI indicates that fast plantarflexions are accompanied by increased activity in the cerebellar anterior lobe. The same region indicates increased grey matter volume for the power athletes compared to the endurance counterparts. Our results suggest that speed-specific neuro-functional and -structural differences exist between power and endurance athletes in the peripheral and central nervous system.	[Wenzel, Uwe; Krug, Juergen] Univ Leipzig, Inst Training Sci & Gen Kinesiol, D-04109 Leipzig, Germany; [Taubert, Marco; Ragert, Patrick; Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Leipzig University; Max Planck Society	Wenzel, U (corresponding author), Univ Leipzig, Inst Training Sci & Gen Kinesiol, D-04109 Leipzig, Germany.	uwe.wenzel@uni-leipzig.de	Ragert, Patrick/AAI-7290-2020	Villringer, Arno/0000-0003-2604-2404	German Max Planck Society; ESF (Europaischer Sozialfonds) [100154877, 2000373598]	German Max Planck Society(Max Planck Society); ESF (Europaischer Sozialfonds)(European Commission)	This study was funded by the German Max Planck Society. To publish this article, the authors acknowledge support from the ESF (Europaischer Sozialfonds, Project: 100154877 ID: 2000373598). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 2000, SCI AM, V283, P48, DOI 10.1038/scientificamerican0900-48; Andersen LL, 2005, J APPL PHYSIOL, V99, P87, DOI 10.1152/japplphysiol.00091.2005; Anderson BJ, 2011, DEV PSYCHOBIOL, V53, P456, DOI 10.1002/dev.20563; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basmajian J., 1985, MUSCLES ALIVE THEIR; Boreham C, 2006, PHYSL TRAINING, P117; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Carroll TJ, 2002, J PHYSIOL-LONDON, V544, P641, DOI 10.1113/jphysiol.2002.024463; Coltz JD, 1999, J NEUROSCI, V19, P1782; Cronin JB, 2003, J STRENGTH COND RES, V17, P148; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; del Olmo MF, 2006, EUR J APPL PHYSIOL, V96, P722, DOI 10.1007/s00421-006-0153-5; Di X, 2012, BRAIN CONNECT, V2, P225, DOI 10.1089/brain.2011.0050; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Ebner TJ, 2011, CEREBELLUM, V10, P683, DOI 10.1007/s12311-010-0243-0; Farina D, 2002, J APPL PHYSIOL, V92, P235, DOI 10.1152/jappl.2002.92.1.235; Gaser C, 2003, J NEUROSCI, V23, P9240; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; GORZA L, 1988, J PHYSIOL-LONDON, V402, P627, DOI 10.1113/jphysiol.1988.sp017226; GRIMBY L, 1984, J PHYSIOL-LONDON, V346, P195, DOI 10.1113/jphysiol.1984.sp015016; HAMADA I, 1981, BRAIN RES, V230, P384, DOI 10.1016/0006-8993(81)90420-0; Harrison AJ, 2004, J STRENGTH COND RES, V18, P473; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hewitt AL, 2011, J NEUROPHYSIOL, V106, P2232, DOI 10.1152/jn.00886.2010; Hodson-Tole EF, 2008, J EXP BIOL, V211, P1882, DOI 10.1242/jeb.014407; HOFFER JA, 1981, SCIENCE, V213, P466, DOI 10.1126/science.7244644; Hutchins R, 1998, ISOKINET EXERC SCI, V7, P75, DOI 10.3233/IES-1998-0020; Jancke L, 2012, J COGNITIVE NEUROSCI, V24, P1447, DOI 10.1162/jocn_a_00227; KERNELL D, 1993, NEURAL ASPECTS OF HUMAN MOVEMENT, P12; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; Latash M., 2008, NEUROPHYSIOLOGICAL B, V2nd; Lattier G, 2003, J STRENGTH COND RES, V17, P514; Lee SSM, 2009, J EXP BIOL, V212, P3700, DOI 10.1242/jeb.031096; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; MANO N, 1980, J NEUROPHYSIOL, V43, P713, DOI 10.1152/jn.1980.43.3.713; McNaughton S, 2004, EXP BRAIN RES, V154, P470, DOI 10.1007/s00221-003-1677-0; Newton JM, 2008, NEUROIMAGE, V43, P136, DOI 10.1016/j.neuroimage.2008.07.001; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Pette D, 1999, MUSCLE NERVE, V22, P666, DOI 10.1002/(SICI)1097-4598(199906)22:6<666::AID-MUS3>3.0.CO;2-Z; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Sale D, 2003, STRENGTH POWER SPORT, P281; SALE DG, 1987, EXERCISE SPORT SCI R, V15, P95; Sawilowsky SS, 2005, J MOD APPL STAT METH, V4, P598, DOI 10.22237/jmasm/1130804700; Schlerf JE, 2010, J NEUROPHYSIOL, V103, P3330, DOI 10.1152/jn.01117.2009; SCHWARTZ AB, 1993, J NEUROPHYSIOL, V70, P28, DOI 10.1152/jn.1993.70.1.28; Seagrave L, 2000, IAAF REGIONAL DEV CT, V17, P21; Shave R, 2006, PHYSL TRAINING, P61; SIMONEAU JA, 1995, FASEB J, V9, P1091, DOI 10.1096/fasebj.9.11.7649409; Tamaki H, 1997, EUR J APPL PHYSIOL O, V75, P1; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Taubert M, 2010, J NEUROSCI, V30, P11670, DOI 10.1523/JNEUROSCI.2567-10.2010; Tipton CM, 2006, ACSMS ADV EXERCISE P, P144; Trinastic JP, 2010, BRAIN IMAGING BEHAV, V4, P121, DOI 10.1007/s11682-010-9091-2; Turner RS, 1998, J NEUROPHYSIOL, V80, P2162, DOI 10.1152/jn.1998.80.4.2162; Turner RS, 2003, J NEUROPHYSIOL, V90, P3958, DOI 10.1152/jn.00323.2003; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Victor A, 2010, DTSCH ARZTEBL INT, V107, P50, DOI [10.3238/arztebl.2009.0050, 10.3238/arztebl.2010.0050]; von Tscharner V, 2003, J ELECTROMYOGR KINES, V13, P253, DOI 10.1016/S1050-6411(02)00111-6; Wang B, 2013, NEUROIMAGE, V65, P476, DOI 10.1016/j.neuroimage.2012.10.007; Wrbaskiae N, 2009, J ELECTROMYOGR KINES, V92, pe14; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; [No title captured]	62	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96871	10.1371/journal.pone.0096871	http://dx.doi.org/10.1371/journal.pone.0096871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800742	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800136
J	Zeng, C; Gomez-Mestre, I; Wiens, JJ				Zeng, Cen; Gomez-Mestre, Ivan; Wiens, John J.			Evolution of Rapid Development in Spadefoot Toads Is Unrelated to Arid Environments	PLOS ONE			English	Article							GLOBAL PATTERNS; LARVAL DEVELOPMENT; CLIMATE-CHANGE; RE-EVOLUTION; GENOME SIZE; GREAT TITS; C-VALUE; PLASTICITY; FROGS; DIVERSIFICATION	The extent to which species' life histories evolve to match climatic conditions is a critical question in evolutionary biology and ecology and as human activities rapidly modify global climate. GIS-based climatic data offer new opportunities to rigorously test this question. Superficially, the spadefoot toads of North America (Scaphiopodidae) seem to offer a classic example of adaptive life-history evolution: some species occur in extremely dry deserts and have evolved the shortest aquatic larval periods known among anurans. However, the relationships between the climatic conditions where spadefoots occur and the relevant life-history traits have not been explicitly tested. Here, we analyzed these relationships using GISbased climatic data, published life-history data, and a time-calibrated phylogeny for pelobatoid frogs. Surprisingly, we find no significant relationships between life-history variables and precipitation or aridity levels where these species occur. Instead, rapid development in pelobatoids is strongly related to their small genome sizes and to phylogeny.	[Zeng, Cen] Univ Munich, Dept Biol 2, Munich, Germany; [Gomez-Mestre, Ivan] CSIC, Ecol Evolut & Dev Grp, Donana Biol Stn, Seville, Spain; [Wiens, John J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA	University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Arizona	Wiens, JJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	wiensj@email.arizona.edu	Gomez-Mestre, Ivan/F-8226-2014	Gomez-Mestre, Ivan/0000-0003-0094-8195; Wiens, John/0000-0003-4243-1127	Elite Researcher Training Program of the Ministry of Education of China	Elite Researcher Training Program of the Ministry of Education of China(Ministry of Education, China)	The authors thank the Elite Researcher Training Program of the Ministry of Education of China for funds allowing C. Zeng to visit J.J.W. and work on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backmann K., 1972, Quarterly Journal of the Florida Academy of Sciences, V35, P225; Bazazi S, 2012, BEHAV ECOL SOCIOBIOL, V66, P879, DOI 10.1007/s00265-012-1336-1; Bonett RM, 2014, EVOLUTION, V68, P466, DOI 10.1111/evo.12274; Buchholz DR, 2002, COPEIA, P180, DOI 10.1643/0045-8511(2002)002[0180:EPODIS]2.0.CO;2; Buckley LB, 2007, P ROY SOC B-BIOL SCI, V274, P1167, DOI 10.1098/rspb.2006.0436; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camper JD, 1993, GENET LIFE SCI ADV, V12, P79; Conant R., 1998, FIELD GUIDE REPTILES, V3rd; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Garcia-Paris M, 2003, MOL PHYLOGENET EVOL, V28, P12, DOI 10.1016/S1055-7903(03)00036-8; GOIN OB, 1968, COPEIA, P532, DOI 10.2307/1442021; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gomez-Mestre I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084266; Gomez-Mestre I, 2012, EVOLUTION, V66, P3687, DOI 10.1111/j.1558-5646.2012.01715.x; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HORNER HA, 1983, J CELL SCI, V63, P135; Husby A, 2009, P ROY SOC B-BIOL SCI, V276, P1845, DOI 10.1098/rspb.2008.1937; IUCN, 2012, IUCN RED LIST THREAT; Jockusch EL, 1997, P ROY SOC B-BIOL SCI, V264, P597, DOI 10.1098/rspb.1997.0085; Kulkarni SS, 2011, J EVOLUTION BIOL, V24, P2445, DOI 10.1111/j.1420-9101.2011.02370.x; Lambert SM, 2013, EVOLUTION, V67, P2614, DOI 10.1111/evo.12130; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; MAYHEW WW, 1965, AM MIDL NAT, V74, P95, DOI 10.2307/2423123; Morey S, 2000, ECOLOGY, V81, P1736, DOI 10.2307/177320; Morey SR, 2004, OIKOS, V104, P172, DOI 10.1111/j.0030-1299.2004.12623.x; NEWMAN RA, 1987, OECOLOGIA, V71, P301, DOI 10.1007/BF00377299; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; OELDORF E, 1978, Z ZOOL SYST EVOL, V16, P216; Orme D, 2012, CAPER COMP ANAL PHYL; Oufiero CE, 2011, EVOLUTION, V65, P3590, DOI 10.1111/j.1558-5646.2011.01405.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL M, 1992, P ROY SOC B-BIOL SCI, V249, P119, DOI 10.1098/rspb.1992.0093; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pfennig DW, 2010, EVOLUTION, V64, P2331, DOI 10.1111/j.1558-5646.2010.01005.x; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pyron RA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1622; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rocek Z, 2000, AMPHIBIAN BIOL, V4, P1333; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Roff Derek, 2002, pi; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stearns S.C., 1992, pi; Stebbins R. C., 2003, FIELD GUIDE W REPTIL; Tieleman BI, 2002, P ROY SOC LOND B BIO, P207; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Wiens JJ, 2007, AM NAT, V170, pS86, DOI 10.1086/519396; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wiens JJ, 2011, EVOLUTION, V65, P1283, DOI 10.1111/j.1558-5646.2011.01221.x; Wright A, 1949, HDB FROGS TOADS US C; Yuan W, 2000, NATURWISSENSCHAFTEN, V87, P417, DOI 10.1007/s001140050753	57	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96637	10.1371/journal.pone.0096637	http://dx.doi.org/10.1371/journal.pone.0096637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800832	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800099
J	Belenky, NM; Cole, SR; Pence, BW; Itemba, D; Maro, V; Whetten, K				Belenky, Nadya M.; Cole, Stephen R.; Pence, Brian W.; Itemba, Dafrosa; Maro, Venance; Whetten, Kathryn			Depressive Symptoms, HIV Medication Adherence, and HIV Clinical Outcomes in Tanzania: A Prospective, Observational Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; WOMEN; AIDS; PROGRESSION; MORTALITY; PHQ-9; CD4; ASSOCIATION; INFECTION	Depressive symptoms have been shown to independently affect both antiretroviral therapy (ART) adherence and HIV clinical outcomes in high-income countries. We examined the prospective relationship between depressive symptoms and adherence, virologic failure, and suppressed immune function in people living with HIV/AIDS in Tanzania. Data from 403 study participants who were on stable ART and engaged in HIV clinical care were analyzed. We assessed crude and adjusted associations of depressive symptoms and ART adherence, both at baseline and at 12 months, using logistic regression. We used logistic generalized estimating equations to assess the association and 95% confidence intervals (CI) between depressive symptoms and both virologic failure and suppressed immune function. Ten percent of participants reported moderate or severe depressive symptoms at baseline and 31% of participants experienced virologic failure (>150 copies/ml) over two years. Depressive symptoms were associated with greater odds of reported medication nonadherence at both baseline (Odds Ratio [OR] per 1-unit increase = 1.18, 95% CI [1.12, 1.24]) and 12 months (OR = 1.08, 95% CI [1.03, 1.14]). By contrast, increases in depressive symptom score were inversely related to both virologic failure (OR = 0.93, 95% CI [0.87, 1.00]) and immune system suppression (OR = 0.88, 95% CI [0.79, 0.99]), though the association between depressive symptoms and clinical outcomes was less precise than for the association with nonadherence. Findings indicate a positive association between depressive symptoms and nonadherence, and also an inverse relationship between depressive symptoms and clinical outcomes, possibly due to informative loss to follow-up.	[Belenky, Nadya M.; Cole, Stephen R.; Pence, Brian W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Pence, Brian W.; Whetten, Kathryn] Duke Univ, Ctr Hlth Policy & Inequal Res, Duke Global Hlth Inst, Dept Community & Family Med, Durham, NC USA; [Itemba, Dafrosa] Tanzania Women Res Fdn, Moshi, Tanzania; [Maro, Venance] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Kilimanjaro Christian Medical Centre	Belenky, NM (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA.	nbelenky@email.unc.edu		Belenky, Nadya/0000-0002-9286-3473	National Institute of Mental Health [5R01MH078756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518, P30AI050410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078756] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by grant 5R01MH078756 from the National Institute of Mental Health (www.nimh.nih.gov). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuya AO, 2006, J AFFECT DISORDERS, V96, P89, DOI 10.1016/j.jad.2006.05.021; Anastos K, 2005, JAIDS-J ACQ IMM DEF, V39, P537; Antelman G, 2007, JAIDS-J ACQ IMM DEF, V44, P470, DOI 10.1097/QAI.0b013e31802f1318; Bouhnik AD, 2005, ANTIVIR THER, V10, P53; Cook JA, 2004, AM J PUBLIC HEALTH, V94, P1133, DOI 10.2105/AJPH.94.7.1133; EVANS DL, 1989, PSYCHOPHARMACOL BULL, V25, P319; Gonzalez JS, 2011, JAIDS-J ACQ IMM DEF, V58, P181, DOI [10.1097/QAI.0B013E31822D490A, 10.1097/QAI.0b013e31822d490a]; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Ickovics JR, 2002, JAIDS-J ACQ IMM DEF, V31, pS98, DOI 10.1097/00126334-200212153-00002; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ironson G, 2005, PSYCHOSOM MED, V67, P1013, DOI 10.1097/01.psy.0000188569.58998.c8; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Leserman J, 1999, PSYCHOSOM MED, V61, P397, DOI 10.1097/00006842-199905000-00021; Leserman J, 2007, AM J PSYCHIAT; Liu HH, 2006, JAIDS-J ACQ IMM DEF, V41, P315, DOI 10.1097/01.qai.0000197071.77482.6e; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Nakimuli-Mpungu E, 2012, AIDS BEHAV, V16, P2101, DOI 10.1007/s10461-011-0087-8; Pence BW, 2012, PLOS ONE, V7, P1932; Rao D, 2012, AIDS BEHAV, V16, P711, DOI 10.1007/s10461-011-9915-0; Saxena S, 2006, WORLD PSYCHIATRY, V5, P179; Schneider MF, 2005, AIDS, V19, P2009, DOI 10.1097/01.aids.0000189864.90053.22; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Wilson TE, 2002, CLIN INFECT DIS, V34, P529, DOI 10.1086/338397; World Health Organization (WHO), 2005, MENT HLTH ATL	25	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95469	10.1371/journal.pone.0095469	http://dx.doi.org/10.1371/journal.pone.0095469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798428	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000019
J	Helm, O; Mennrich, R; Petrick, D; Goebel, L; Freitag-Wolf, S; Roder, C; Kalthoff, H; Rocken, C; Sipos, B; Kabelitz, D; Schafer, H; Oberg, HH; Wesch, D; Sebens, S				Helm, Ole; Mennrich, Ruben; Petrick, Domantas; Goebel, Lisa; Freitag-Wolf, Sandra; Roeder, Christian; Kalthoff, Holger; Roecken, Christoph; Sipos, Bence; Kabelitz, Dieter; Schaefer, Heiner; Oberg, Hans-Heinrich; Wesch, Daniela; Sebens, Susanne			Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; FOXP3 EXPRESSION; CARCINOMA-CELLS; UP-REGULATION; CANCER; L1CAM; MICROENVIRONMENT; INFILTRATION; PREVALENCE; INSIGHTS	Pancreatic ductal adenocarcinoma (PDAC) is characterized by an extensive stroma being also present in chronic pancreatitis (CP). Using immunohistochemistry, the stroma of CP and PDAC was comprehensively analyzed and correlated with epithelial/carcinoma-related alterations and clinicopathological patient characteristics. While there were no significant differences between CP and PDAC regarding the distribution of CD3+ T cells and alpha-SMA+ fibroblasts, proportions of CD4+ and CD8+ T cells were significantly lower and numbers of CD25+(CD4+) and FoxP3+(CD4+) regulatory T cells were greater in PDAC compared with CP. Macrophages were more prevalent in CP, but localized more closely to carcinoma cells in PDAC, as were cd-T cells. Duct-related FoxP3 and L1CAM expression increased from CP to PDAC, while vimentin expression was similarly abundant in both diseases. Moreover, stromal and epithelial compartments of well-differentiated tumors and CPs shared considerable similarities, while moderately and poorly differentiated tumors significantly differed from CP tissues. Analysis of 27 parameters within each pancreatic disease revealed a significant correlation of i) CD4+ and FoxP3+ CD4+ T cells with FoxP3 expression in PDAC cells, ii) alpha-SMA+ fibroblasts with L1CAM expression and proliferation in PDAC cells, iii) CD3 and CD8 expression with gamma delta-TCR expression in both pancreatic diseases and iv) CD68+ and CD163+ macrophages with vimentin expression in PDAC cells. High expression of FoxP3, vimentin and L1CAM in PDAC cells as well as a tumor-related localization of macrophages each tended to correlate with higher tumor grade. Multivariate survival analysis revealed a younger age at time of surgery as a positive prognostic marker for PDAC patients with the most frequently operated disease stage T3N1M0. Overall this study identified several interrelationships between stroma and epithelial/carcinoma cells in PDACs but also in CP, which in light of previous experimental data strongly support the view that the inflammatory stroma contributes to malignancy-associated alterations already in precursor cells during CP.	[Helm, Ole; Mennrich, Ruben; Goebel, Lisa; Sebens, Susanne] Grp Inflammatory Carcinogenesis, Inst Expt Med, Kiel, Germany; [Petrick, Domantas; Kabelitz, Dieter; Oberg, Hans-Heinrich; Wesch, Daniela] Inst Immunol, Kiel, Germany; [Freitag-Wolf, Sandra] Inst Med Informat & Stat, Kiel, Germany; [Roeder, Christian; Kalthoff, Holger] Inst Expt Canc Res, Kiel, Germany; [Roecken, Christoph] Univ Kiel, Inst Pathol, Kiel, Germany; [Sipos, Bence] Univ Tubingen, Inst Pathol, Tubingen, Germany; [Schaefer, Heiner] Dept Internal Med 1, Lab Mol Gastroenterol & Hepatol, Kiel, Germany	University of Kiel; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sebens, S (corresponding author), Grp Inflammatory Carcinogenesis, Inst Expt Med, UKSH Campus Kiel, Kiel, Germany.	mueerkoe@1med.uni-kiel.de	Sebens, Susanne/C-1222-2010; Kabelitz, Dieter/A-2757-2010; Roeder, Christian/F-1068-2010; Wesch, Daniela/C-1940-2019; Schäfer, Heiner/C-1055-2011; Kabelitz, Dieter/AAB-4199-2021; Kalthoff, Holger/B-1618-2010; Röcken, Christoph/A-9239-2010; Oberg, Hans-Heinrich/C-3994-2019	Roeder, Christian/0000-0001-7881-9110; Wesch, Daniela/0000-0001-6509-208X; Röcken, Christoph/0000-0002-6989-8002; Oberg, Hans-Heinrich/0000-0002-8354-3494	Deutsche Forschungsgemeinschaft (DFG)-Cluster of Excellence "Inflammation at Interfaces"; DFG-Pancreas Cancer Consortium-Kiel	Deutsche Forschungsgemeinschaft (DFG)-Cluster of Excellence "Inflammation at Interfaces"(German Research Foundation (DFG)); DFG-Pancreas Cancer Consortium-Kiel	"This work was supported by the Deutsche Forschungsgemeinschaft (DFG)-funded Cluster of Excellence "Inflammation at Interfaces", and the DFG-funded Pancreas Cancer Consortium-Kiel (DK, DW, HK, HS, SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.''	Ben QW, 2010, ANN SURG ONCOL, V17, P2213, DOI 10.1245/s10434-010-0955-x; Bergmann F, 2010, ONCOL REP, V24, P909, DOI 10.3892/or_00000936; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Emmrich J, 1998, DIGESTION, V59, P192, DOI 10.1159/000007488; Esposito I, 2012, PATHOLOGE, V33, P189, DOI 10.1007/s00292-012-1673-x; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fujita H, 2010, PANCREAS; Gardian K, 2012, J CANCER, V3, P285, DOI 10.7150/jca.4537; Geismann C, 2009, CANCER RES, V69, P4517, DOI 10.1158/0008-5472.CAN-08-3493; Hartel M, 2004, WORLD J SURG, V28, P818, DOI 10.1007/s00268-004-7147-4; Helm O, 2014, INT J CANC; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Kabelitz D, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23304; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kiefel H, 2012, CARCINOGENESIS, V33, P1919, DOI 10.1093/carcin/bgs220; Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832; Kim M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053630; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Kurahara H, 2013, PANCREAS, V42, P155, DOI 10.1097/MPA.0b013e318254f2d1; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Meraviglia S, 2010, CURR MOL MED, V10, P719, DOI 10.2174/156652410793384150; Murkoster SS, 2007, ONCOGENE, V26, P2759, DOI 10.1038/sj.onc.1210076; Muerkoster S, 2004, CANCER RES, V64, P1331, DOI 10.1158/0008-5472.CAN-03-1860; Oberg HH, 2014, CANC RES; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Protti MP, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00210; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Schafer H, 2012, CARCINOGENESIS, V33, P84, DOI 10.1093/carcin/bgr262; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Shojaei H, 2009, CANCER RES, V69, P8710, DOI 10.1158/0008-5472.CAN-09-1602; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138	37	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e94357	10.1371/journal.pone.0094357	http://dx.doi.org/10.1371/journal.pone.0094357			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797069	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000008
J	Maeda, H; Shigoka, M; Wang, YC; Fu, YX; Wesson, RN; Lin, Q; Montgomery, RA; Enzan, H; Sun, ZL				Maeda, Hiromichi; Shigoka, Masatoshi; Wang, Yongchun; Fu, Yingxin; Wesson, Russell N.; Lin, Qing; Montgomery, Robert A.; Enzan, Hideaki; Sun, Zhaoli			Disappearance of GFP-Positive Hepatocytes Transplanted into the Liver of Syngeneic Wild-Type Rats Pretreated with Retrorsine	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LENTIVIRAL VECTORS; HEPATIC-INJURY; LONG-TERM; IN-VIVO; REPOPULATION; DIFFERENTIATION; REPLACEMENT; MECHANISMS; EXPRESSION	Background and Aim: Green fluorescent protein (GFP) is a widely used molecular tag to trace transplanted cells in rodent liver injury models. The differing results from various previously reported studies using GFP could be attributed to the immunogenicity of GFP. Methods: Hepatocytes were obtained from GFP-expressing transgenic (Tg) Lewis rats and were transplanted into the livers of wild-type Lewis rats after they had undergone a partial hepatectomy. The proliferation of endogenous hepatocytes in recipient rats was inhibited by pretreatment with retrorsine to enhance the proliferation of the transplanted hepatocytes. Transplantation of wild-type hepatocytes into GFP-Tg rat liver was also performed for comparison. Results: All biopsy specimens taken seven days after transplantation showed engraftment of transplanted hepatocytes, with the numbers of transplanted hepatocytes increasing until day 14. GFP-positive hepatocytes in wild-type rat livers were decreased by day 28 and could not be detected on day 42, whereas the number of wild-type hepatocytes steadily increased in GFP-Tg rat liver. Histological examination showed degenerative change of GFP-positive hepatocytes and the accumulation of infiltrating cells on day 28. PCR analysis for the GFP transgene suggested that transplanted hepatocytes were eliminated rather than being retained along with the loss of GFP expression. Both modification of the immunological response using tacrolimus and bone marrow transplantation prolonged the survival of GFP-positive hepatocytes. In contrast, host immunization with GFP-positive hepatocytes led to complete loss of GFP-positive hepatocytes by day 14. Conclusion: GFP-positive hepatocytes isolated from GFP-Tg Lewis rats did not survive long term in the livers of retrorsine-pretreated wild-type Lewis rats. The mechanism underlying this phenomenon most likely involves an immunological reaction against GFP. The influence of GFP immunogenicity on cell transplantation models should be considered in planning in vivo experiments using GFP and in interpreting their results.	[Maeda, Hiromichi; Shigoka, Masatoshi; Wang, Yongchun; Fu, Yingxin; Wesson, Russell N.; Lin, Qing; Montgomery, Robert A.; Sun, Zhaoli] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Maeda, Hiromichi] Kochi Med Sch, Dept Surg, Nankoku, Kochi, Japan; [Maeda, Hiromichi] Kochi Med Sch, Canc Treatment Ctr, Nankoku, Kochi, Japan; [Enzan, Hideaki] Chikamori Hosp, Kochi, Kochi, Japan	Johns Hopkins University; Kochi University; Kochi University	Maeda, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA.	hmaeda@kochi-u.ac.jp; zsun2@jhmi.edu		Lin, Qing/0000-0002-8890-800X	Kochi Organization for Medical Reformation and Renewal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007713] Funding Source: NIH RePORTER	Kochi Organization for Medical Reformation and Renewal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Kochi Organization for Medical Reformation and Renewal (http://www.kochi-mrr.or.jp/) to HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avital I, 2002, SURGERY, V132, P384, DOI 10.1067/msy.2002.125785; Bottcher JP, 2011, DIGEST DIS, V29, P384, DOI 10.1159/000329801; CAI X, 1992, TRANSPL P, V24, P1403; Follenzi A, 2004, BLOOD, V103, P3700, DOI 10.1182/blood-2003-09-3217; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Han B, 2009, TRANSPLANTATION, V87, P1, DOI 10.1097/TP.0b013e3181919212; Ichinohe N, 2012, CELL TRANSPLANT, V21, P11, DOI 10.3727/096368911X580626; Inoue H, 2005, BIOCHEM BIOPH RES CO, V329, P288, DOI 10.1016/j.bbrc.2005.01.132; KOBAYASHI E, 1994, TRANSPL P, V26, P1960; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Laconi S, 2001, AM J PATHOL, V158, P771, DOI 10.1016/S0002-9440(10)64019-9; Li J, 2012, HEPATOLOGY, V56, P1044, DOI 10.1002/hep.25722; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Maeda H, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-446; Masson S, 2004, STEM CELLS, V22, P897, DOI 10.1634/stemcells.22-6-897; Mizuno Keisuke, 2008, J Med Dent Sci, V55, P101; Muraca M, 2007, GUT, V56, P1725, DOI 10.1136/gut.2007.127969; Oertel M, 2003, HEPATOLOGY, V37, P994, DOI 10.1053/jhep.2003.50183; Ohnuma K, 2008, FRONT BIOSCI-LANDMRK, V13, P2299, DOI 10.2741/2844; Popp FC, 2007, STEM CELLS, V25, P639, DOI 10.1634/stemcells.2006-0515; SAKR MF, 1991, HEPATOLOGY, V13, P947, DOI 10.1002/hep.1840130524; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Sgodda M, 2007, EXP CELL RES, V313, P2875, DOI 10.1016/j.yexcr.2007.05.020; Taghizadeh RR, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/453590; Watanabe H, 2007, BIOCHEM BIOPH RES CO, V354, P841, DOI 10.1016/j.bbrc.2006.12.236	28	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95880	10.1371/journal.pone.0095880	http://dx.doi.org/10.1371/journal.pone.0095880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796859	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000027
J	Pereira, LB; Vicentini, R; Ottoboni, LMM				Pereira, Leticia Bianca; Vicentini, Renato; Ottoboni, Laura M. M.			Changes in the Bacterial Community of Soil from a Neutral Mine Drainage Channel	PLOS ONE			English	Article							MICROBIAL COMMUNITY; ACID; DIVERSITY; MICROORGANISMS; ENVIRONMENT; SEDIMENT; RESOURCE; TREES	Mine drainage is an important environmental disturbance that affects the chemical and biological components in natural resources. However, little is known about the effects of neutral mine drainage on the soil bacteria community. Here, a high-throughput 16S rDNA pyrosequencing approach was used to evaluate differences in composition, structure, and diversity of bacteria communities in samples from a neutral drainage channel, and soil next to the channel, at the Sossego copper mine in Brazil. Advanced statistical analyses were used to explore the relationships between the biological and chemical data. The results showed that the neutral mine drainage caused changes in the composition and structure of the microbial community, but not in its diversity. The Deinococcus/Thermus phylum, especially the Meiothermus genus, was in large part responsible for the differences between the communities, and was positively associated with the presence of copper and other heavy metals in the environmental samples. Other important parameters that influenced the bacterial diversity and composition were the elements potassium, sodium, nickel, and zinc, as well as pH. The findings contribute to the understanding of bacterial diversity in soils impacted by neutral mine drainage, and demonstrate that heavy metals play an important role in shaping the microbial population in mine environments.	[Pereira, Leticia Bianca; Vicentini, Renato; Ottoboni, Laura M. M.] Univ Estadual Campinas, UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, Campinas, SP, Brazil	Universidade Estadual de Campinas	Ottoboni, LMM (corresponding author), Univ Estadual Campinas, UNICAMP, Ctr Mol Biol & Genet Engn CBMEG, Campinas, SP, Brazil.	ottoboni@unicamp.br	Vicentini, Renato/C-5967-2012; Pereira, Leticia/C-5446-2019	Pereira, Leticia/0000-0001-9261-5544; Vicentini, Renato/0000-0002-0527-1083	CNPq/Vale [550240/2010-1]; FAPESP [FAPESP 2012/05429-2]	CNPq/Vale; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by CNPq/Vale grant 550240/2010-1. LBP received a fellowship from FAPESP (FAPESP 2012/05429-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Banks D, 1997, ENVIRON GEOL, V32, P157, DOI 10.1007/s002540050204; Bouskill NJ, 2010, ECOTOXICOLOGY, V19, P317, DOI 10.1007/s10646-009-0414-2; Bruneel O, 2006, APPL ENVIRON MICROB, V72, P551, DOI 10.1128/AEM.72.1.551-556.2006; Camargo AO, 2009, METHODS CHEM ANAL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chodak M, 2013, APPL SOIL ECOL, V64, P7, DOI 10.1016/j.apsoil.2012.11.004; da Costa M.S., 2006, PROKARYOTES, VVolume 7, P797; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Govarthanan M, 2013, CHEMOSPHERE, V90, P2267, DOI 10.1016/j.chemosphere.2012.10.038; Gray NF, 1997, ENVIRON GEOL, V30, P62, DOI 10.1007/s002540050133; Guo ZH, 2009, BIORESOURCE TECHNOL, V100, P3831, DOI 10.1016/j.biortech.2009.02.043; Halter D, 2011, RES MICROBIOL, V162, P877, DOI 10.1016/j.resmic.2011.06.001; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jain RK, 2009, MINENVIS, V63, P1; Jalali M, 2013, ENVIRON MONIT ASSESS, V185, P537, DOI 10.1007/s10661-012-2573-5; Johnson DB, 2012, FEMS MICROBIOL ECOL, V81, P2, DOI 10.1111/j.1574-6941.2011.01293.x; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Kock D, 2008, APPL ENVIRON MICROB, V74, P5211, DOI 10.1128/AEM.00649-08; Kuang JL, 2013, ISME J, V7, P1038, DOI 10.1038/ismej.2012.139; Kunito T, 1999, ECOTOX ENVIRON SAFE, V44, P174, DOI 10.1006/eesa.1999.1820; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Liao M, 2007, ECOTOX ENVIRON SAFE, V66, P217, DOI 10.1016/j.ecoenv.2005.12.013; Lindsay MBJ, 2009, APPL GEOCHEM, V24, P2212, DOI 10.1016/j.apgeochem.2009.09.012; Liu Y, 2011, BIORESOURCE TECHNOL, V102, P9388, DOI 10.1016/j.biortech.2011.05.095; Mackenzie R, 2013, EXTREMOPHILES, V17, P123, DOI 10.1007/s00792-012-0499-z; Masoud W, 2011, INT DAIRY J, V21, P142, DOI 10.1016/j.idairyj.2010.10.007; Masurat P, 2005, J APPL MICROBIOL, V98, P727, DOI 10.1111/j.1365-2672.2004.02519.x; Mendez MO, 2008, APPL ENVIRON MICROB, V74, P3899, DOI 10.1128/AEM.02883-07; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miransari M, 2013, ACTA PHYSIOL PLANT, V35, P3075, DOI 10.1007/s11738-013-1338-2; Mori K, 2012, INT J SYST EVOL MICR, V62, P112, DOI 10.1099/ijs.0.028654-0; Cardenas JP, 2010, APPL MICROBIOL BIOT, V88, P605, DOI 10.1007/s00253-010-2795-9; Pancholi DA, 2009, MINENVIS, V63, P6; Reis MP, 2013, EXTREMOPHILES, V17, P301, DOI 10.1007/s00792-013-0517-9; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Sanchez-Andrea I, 2011, APPL ENVIRON MICROB, V77, P6085, DOI 10.1128/AEM.00654-11; Serkebaeva YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063994; *STATSOFT INC, 2003, STATISTICA DAT AN SO; Streten-Joyce C, 2013, SCI TOTAL ENVIRON, V443, P65, DOI 10.1016/j.scitotenv.2012.10.024; Sun MY, 2013, ENVIRON MICROBIOL, V15, P2517, DOI 10.1111/1462-2920.12133; Tian B, 2010, TRENDS MICROBIOL, V18, P512, DOI 10.1016/j.tim.2010.07.007; U.S. Environmental Protection Agency (EPA), 1986, 846 EPA SW; Woese CR, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 1, THIRD EDITION, P3, DOI 10.1007/0-387-30741-9_1; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	48	33	34	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96605	10.1371/journal.pone.0096605	http://dx.doi.org/10.1371/journal.pone.0096605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796430	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000103
J	Venter, G; Oerlemans, FTJJ; Wijers, M; Willemse, M; Fransen, JAM; Wieringa, B				Venter, Gerda; Oerlemans, Frank T. J. J.; Wijers, Mietske; Willemse, Marieke; Fransen, Jack A. M.; Wieringa, Be			Glucose Controls Morphodynamics of LPS-Stimulated Macrophages	PLOS ONE			English	Article							UNOPSONIZED PSEUDOMONAS-AERUGINOSA; ATP HYDROLYSIS; PERITONEAL-MACROPHAGES; METABOLIC-INHIBITORS; MOUSE MACROPHAGES; BINDING PROTEINS; CREATINE-KINASE; ARP2/3 COMPLEX; ACTIN NETWORK; PHAGOCYTOSIS	Macrophages constantly undergo morphological changes when quiescently surveying the tissue milieu for signs of microbial infection or damage, or after activation when they are phagocytosing cellular debris or foreign material. These morphofunctional alterations require active actin cytoskeleton remodeling and metabolic adaptation. Here we analyzed RAW 264.7 and Maf-DKO macrophages as models to study whether there is a specific association between aspects of carbohydrate metabolism and actin-based processes in LPS-stimulated macrophages. We demonstrate that the capacity to undergo LPS-induced cell shape changes and to phagocytose complement-opsonized zymosan (COZ) particles does not depend on oxidative phosphorylation activity but is fueled by glycolysis. Different macrophage activities like spreading, formation of cell protrusions, as well as phagocytosis of COZ, were thereby strongly reliant on the presence of low levels of extracellular glucose. Since global ATP production was not affected by rewiring of glucose catabolism and inhibition of glycolysis by 2-deoxy-D-glucose and glucose deprivation had differential effects, our observations suggest a non-metabolic role for glucose in actin cytoskeletal remodeling in macrophages, e. g. via posttranslational modification of receptors or signaling molecules, or other effects on the machinery that drives actin cytoskeletal changes. Our findings impute a decisive role for the nutrient state of the tissue microenvironment in macrophage morphodynamics.	[Venter, Gerda; Oerlemans, Frank T. J. J.; Wijers, Mietske; Willemse, Marieke; Fransen, Jack A. M.; Wieringa, Be] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Wieringa, B (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands.	b.wieringa@ncmls.ru.nl	Wieringa, Berend/A-5346-2011; Wijers-Rouw, Mietske/G-4456-2016; Fransen, Jack/E-8924-2010	Wieringa, Berend/0000-0001-9192-8020; Fransen, Jack/0000-0002-0571-7639; Venter, Gerda/0000-0002-8043-2203				Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028536; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Attanasio F, 2011, EUR J CELL BIOL, V90, P115, DOI 10.1016/j.ejcb.2010.05.004; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bernstein BW, 2003, J NEUROSCI, V23, P1; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; CARLIER MF, 1991, J BIOL CHEM, V266, P1; Chang EJ, 2008, NAT MED, V14, P966, DOI 10.1038/nm.1860; CIFARELLI A, 1979, RES EXP MED, V174, P197, DOI 10.1007/BF01851332; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Crevenna AH, 2013, J BIOL CHEM; Culic O, 1997, AM J PHYSIOL-CELL PH, V273, pC205, DOI 10.1152/ajpcell.1997.273.1.C205; Dalle-Donne I, 2001, FREE RADICAL BIO MED, V31, P1624, DOI 10.1016/S0891-5849(01)00749-3; DANIEL JL, 1986, EUR J BIOCHEM, V156, P677, DOI 10.1111/j.1432-1033.1986.tb09631.x; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Drescher B, 2003, IMMUNOLOGY, V110, P335, DOI 10.1046/j.1365-2567.2003.01743.x; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Garg R, 2011, J BIO CHEM; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Guest CB, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-42; Hallett MA, 2003, AM J PHYSIOL-CELL PH, V285, pC129, DOI 10.1152/ajpcell.00007.2003; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; Hung R-J, 2011, SCIENCE; Ingerman E, 2013, J CELL BIOL, V200, P619, DOI 10.1083/jcb.201211069; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Jia ZJ, 2005, J BIOL CHEM, V280, P30564, DOI 10.1074/jbc.M501754200; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; Kleveta G, 2012, J CELL BIOCHEM, V113, P80, DOI 10.1002/jcb.23330; Kong L, 2008, CELL RES, V18, P745, DOI 10.1038/cr.2008.65; Kowluru A, 1996, J CLIN INVEST, V98, P540, DOI 10.1172/JCI118822; Kress H, 2007, P NATL ACAD SCI USA, V104, P11633, DOI 10.1073/pnas.0702449104; Kuiper JWP, 2008, PLOS BIOL, V6, P568, DOI 10.1371/journal.pbio.0060051; Kuiper JWP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005030; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; KVARSTEIN B, 1969, SCAND J CLIN LAB INV, V24, P271, DOI 10.3109/00365516909080162; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; LOIKE JD, 1979, J BIOL CHEM, V254, P9558; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MAZUR MT, 1977, J CELL BIOL, V75, P185, DOI 10.1083/jcb.75.1.185; MICHL J, 1976, J EXP MED, V144, P1465, DOI 10.1084/jem.144.6.1465; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nevins AK, 2003, AM J PHYSIOL-CELL PH, V285, pC698, DOI 10.1152/ajpcell.00093.2003; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; PAGLIARO L, 1988, J CELL BIOL, V107, P981, DOI 10.1083/jcb.107.3.981; PAGLIARO L, 1992, J CELL BIOL, V118, P859, DOI 10.1083/jcb.118.4.859; PARADISI F, 1979, Ricerca in Clinica e in Laboratorio, V9, P47; PEASE JE, 1993, BIOCHEM MOL BIOL INT, V31, P719; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riley JK, 2006, J BIOL CHEM, V281, P6010, DOI 10.1074/jbc.M506982200; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Romero S, 2007, J BIOL CHEM, V282, P8435, DOI 10.1074/jbc.M609886200; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; SPEERT DP, 1992, J CLIN INVEST, V90, P1085, DOI 10.1172/JCI115924; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tochio T, 2010, J DERMATOL SCI, V58, P123, DOI 10.1016/j.jdermsci.2010.02.012; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Valsecchi F, 2012, BBA-BIOENERGETICS, V1817, P1925, DOI 10.1016/j.bbabio.2012.03.006; van Horssen R, 2013, CELL MOL LIFE SCI, P1; van Horssen R, 2009, J BIOL CHEM, V284, P1620, DOI 10.1074/jbc.M806974200; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vonna L, 2007, EUR BIOPHYS J BIOPHY, V36, P145, DOI 10.1007/s00249-006-0118-y; Waingeh VF, 2006, BIOPHYS J, V90, P1371, DOI 10.1529/biophysj.105.070052; Wang ZX, 2007, J BIOL CHEM, V282, P9536, DOI 10.1074/jbc.M610553200; Williams LM, 2000, J IMMUNOL, V164, P2028, DOI 10.4049/jimmunol.164.4.2028; Wong SYC, 1999, INFECT IMMUN, V67, P16, DOI 10.1128/IAI.67.1.16-21.1999; Xiong YG, 2010, BIOPHYS J, V98, P2136, DOI 10.1016/j.bpj.2010.01.059	85	45	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96786	10.1371/journal.pone.0096786	http://dx.doi.org/10.1371/journal.pone.0096786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796786	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000126
J	Wang, DM; He, FY; Lv, ZJ; Li, DW				Wang, Dongmei; He, Fengyuan; Lv, Zhenjiang; Li, Dengwu			Phytochemical Composition, Antioxidant Activity and HPLC Fingerprinting Profiles of Three Pyrola Species from Different Regions	PLOS ONE			English	Article							QUALITY ASSESSMENT; CONSTITUENTS; METABOLISM	The present study was performed to investigate the variation of phytochemical composition, antioxidant activity and High Performance Liquid Chromatography (HPLC) fingerprinting profiles of three Pyrola species. Thirteen samples (eight P. decorata, three P. calliantha and two P. renifolia) were collected from different regions in China. The tannin, hyperoside and quercetin contents of all samples were determined by reverse-phase HPLC and varied within the range 9.77-34.75, 0.34-2.16 and 0.062-0.147 mg/g dry weigh, respectively. Total flavonoid content was evaluated and varied within the range 16.22-37.82 mg/g dry weight. Antioxidant activity was determined by DPPH assay, with IC50 ranging from 7.96 to 50.33 mg/ml, ABTS center dot(+) and FRAP assay, within the range 612.66-1021.05 and 219.64-398.12 mu mol equiv. Trolox/g, respectively. These results revealed that there were significant variations in phytochemical profiles and antioxidant activity among all samples. Due to the higher phytochemical content and significant antioxidant activity, P. calliantha was selected as the most valuable species, and the P. calliantha sample from Left banner of Alxa even possessed the strongest antioxidant activity among all the thirteen samples. Futhermore, Emei Mountain was proved to be the most suitable region for producing P. decorata. Moreover, in order to further evaluate the diversities and quality of Pyrola, HPLC fingerprint analysis coupled with hierarchical cluster and discrimination analyses were introduced to establish a simple, rapid and effective method for accurate identification, classification and quality assessment of Pyrola. Thirteen samples were divided into three groups consistent with their morphological classification. Two types of discriminant functions were generated and the ratio of discrimination was 100%. This method can identify different species of Pyrola and the same species from different regions of origin. Also, it can be used to compare and control the quality of Pyrola and other natural products prepared from them.	[Wang, Dongmei; He, Fengyuan; Lv, Zhenjiang; Li, Dengwu] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Li, DW (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	dengwuli@163.com			fundamental research funds for the central universities [QN2011077]; special fund for forestry scientific research in the public interest of China [200904004]	fundamental research funds for the central universities(Fundamental Research Funds for the Central Universities); special fund for forestry scientific research in the public interest of China	This work was supported by the program from the fundamental research funds for the central universities (QN2011077) and special fund for forestry scientific research in the public interest of China (200904004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Salces RM, 2005, FOOD CHEM, V91, P91, DOI 10.1016/j.foodchem.2004.05.049; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bergeron C, 1998, PHYTOCHEMISTRY, V49, P233, DOI 10.1016/S0031-9422(97)00878-9; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; *CHIN PHARM COMM, 2005, PHARM CHIN; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Li BY, 2004, ANAL CHIM ACTA, V514, P69, DOI 10.1016/j.aca.2004.03.041; Liu MJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-67; Lu Zhen-Jiang, 2012, Chinese Journal of Plant Ecology, V36, P992, DOI 10.3724/SP.J.1258.2012.00992; Luo DQ, 2004, CHINESE TRADITIONAL, V34, P463; [吕振江 Lv Zhenjiang], 2013, [西北林学院学报, Journal of Northwest Forestry College], V28, P126; Peng L, 2011, FOOD CHEM, V125, P1064, DOI 10.1016/j.foodchem.2010.09.079; Ptitsyn LR, 2011, FITOTERAPIA, V82, P1285, DOI 10.1016/j.fitote.2011.09.005; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Robards K, 1999, FOOD CHEM, V66, P401, DOI 10.1016/S0308-8146(99)00093-X; Shi XM, 2008, WORLD J MICROB BIOT, V24, P2443, DOI 10.1007/s11274-008-9766-7; Wang SS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-321; Yamashita CI, 2005, APPL RADIAT ISOTOPES, V63, P841, DOI 10.1016/j.apradiso.2005.05.045; Yang DF, 2007, CHROMATOGRAPHIA, V66, P509, DOI 10.1365/s10337-007-0359-7; Yang J, 2007, J SEP SCI, V30, P1276, DOI 10.1002/jssc.200600389; Yang LC, 2013, J AGR FOOD CHEM, V61, P1772, DOI 10.1021/jf3042825; Yao XH, 2013, IND CROP PROD, V49, P247, DOI 10.1016/j.indcrop.2013.04.058; Zhang DY, 2013, FOOD CHEM, V141, P2213, DOI 10.1016/j.foodchem.2013.05.045; Zhao KJ, 2003, J AGR FOOD CHEM, V51, P2576, DOI 10.1021/jf026178h; Zhao Y, 2012, FOOD CHEM, V134, P180, DOI 10.1016/j.foodchem.2012.02.090	27	20	21	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96329	10.1371/journal.pone.0096329	http://dx.doi.org/10.1371/journal.pone.0096329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796694	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000065
J	Zhang, H; Xu, XQ; Chen, Y; Qiu, YL; Liu, X; Liu, BF; Zhang, GS				Zhang, Heng; Xu, Xiangqing; Chen, Yin; Qiu, Yinli; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen			Synthesis and Evaluation of Fluorine-Substituted Phenyl Acetate Derivatives as Ultra-Short Recovery Sedative/Hypnotic Agents	PLOS ONE			English	Article							METHOXYCARBONYL-ETOMIDATE; ANESTHETIC AGENTS	Background: Soft drugs are molecules that are purposefully designed to be rapidly metabolized (metabolically labile). In anesthesia, the soft drug is useful because it enables precise titration to effect and rapid recovery, which might allow swift and clear-headed recovery of consciousness and early home readiness. Propofol may cause delayed awakening after prolonged infusion. Propanidid and AZD3043 have a different metabolic pathway compared to propofol, resulting in a short-acting clinical profile. Fluorine imparts a variety of properties to certain medicines, including an enhanced absorption rate and improved drug transport across the blood-brain barrier. We hypothesized that the introduction of fluorine to the frame structure of propanidid and AZD3043 would further accelerate the swift and clear-headed recovery of consciousness. To test this hypothesis, we developed a series of fluorine-containing phenyl acetate derivatives. Methodology/Principal Findings: Fluorine-containing phenyl acetate derivatives were synthesized, and their hypnotic potencies and durations of LORR following bolus or infusion administration were determined in mice, rats and rabbits. The metabolic half-lives in the blood of various species were determined chromatographically. In vitro radioligand binding and c-aminobutyric acidA (GABAA) receptor electrophysiology studies were performed. Among the 12 synthesized fluorine-containing phenyl acetate derivatives, compound 5j induced comparable duration of LORR with AZD3043, but more rapid recovery than AZD3043, propanidid and propofol. The time of compound 5j to return to walk and behavioral recovery are approximately reduced by more than 50% compared to AZD3043 in mice and rats and rabbits. The HD50 of compound 5j decreased with increasing animal size. Conclusions/Significance: The rapid recovery might make compound 5j suitable for precise titration and allow swift and clear-headed recovery of consciousness and early home readiness.	[Zhang, Heng; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen] Huazhong Univ Sci & Technol, Wuhan 430074, Peoples R China; [Xu, Xiangqing; Chen, Yin; Qiu, Yinli; Zhang, Guisen] Jiangsu Nhwa Pharmaceut Co Ltd, Xuzhou, Peoples R China	Huazhong University of Science & Technology	Zhang, GS (corresponding author), Huazhong Univ Sci & Technol, Wuhan 430074, Peoples R China.	gszhang@mail.hust.edu.cn			Jiangsu Nhwa Pharmaceutical Co., Ltd.	Jiangsu Nhwa Pharmaceutical Co., Ltd.	This study was supported by Jiangsu Nhwa Pharmaceutical Co., Ltd., which played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Anderson A, 2001, J MED CHEM, V44, P3582, DOI 10.1021/jm010903i; Atucha E, 2009, BIOORG MED CHEM LETT, V19, P4284, DOI 10.1016/j.bmcl.2009.05.065; Bohm HJ, 2004, CHEMBIOCHEM, V5, P637, DOI 10.1002/cbic.200301023; Butini S, 2009, J MED CHEM, V52, P151, DOI 10.1021/jm800689g; Chen Y, 2013, J MED CHEM, V56, P4671, DOI 10.1021/jm400408r; Chen Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035186; CHRISTMAS D, 1984, ANAESTHESIA, V39, P470, DOI 10.1111/j.1365-2044.1984.tb07318.x; CONWAY CM, 1970, BRIT J ANAESTH, V42, P249, DOI 10.1093/bja/42.3.249; Cotten JF, 2009, ANESTHESIOLOGY, V111, P240, DOI 10.1097/ALN.0b013e3181ae63d1; Craig RM, 1997, INT J PHARMACEUT, V159, P191; Egan TD, 2012, ANESTHESIOLOGY, V116, P1267, DOI 10.1097/ALN.0b013e31825685a6; Egan TD, 2009, ANESTHESIOLOGY, V111, P229, DOI 10.1097/ALN.0b013e3181ae8460; Filler R, 2009, FUTURE MED CHEM, V1, P777, DOI 10.4155/FMC.09.65; GLEN JB, 1979, BRIT J ANAESTH, V51, P819, DOI 10.1093/bja/51.9.819; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Husain SS, 2012, ANESTHESIOLOGY, V117, P1027, DOI 10.1097/ALN.0b013e31826d3bef; Kilpatrick GJ, 2007, ANESTHESIOLOGY, V107, P60, DOI 10.1097/01.anes.0000267503.85085.c0; Sneyd JR, 2010, BRIT J ANAESTH, V105, P246, DOI 10.1093/bja/aeq190; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Zhou H, 1998, CHEM REAGENT, V20, P314; Zolle IM, 2008, J MED CHEM, V51, P2244, DOI 10.1021/jm800012w	21	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96518	10.1371/journal.pone.0096518	http://dx.doi.org/10.1371/journal.pone.0096518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796695	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000085
J	Kellman, PJ; Mnookin, JL; Erlikhman, G; Garrigan, P; Ghose, T; Mettler, E; Charlton, D; Dror, IE				Kellman, Philip J.; Mnookin, Jennifer L.; Erlikhman, Gennady; Garrigan, Patrick; Ghose, Tandra; Mettler, Everett; Charlton, David; Dror, Itiel E.			Forensic Comparison and Matching of Fingerprints: Using Quantitative Image Measures for Estimating Error Rates through Understanding and Predicting Difficulty	PLOS ONE			English	Article							PERCEPTION; COGNITION	Latent fingerprint examination is a complex task that, despite advances in image processing, still fundamentally depends on the visual judgments of highly trained human examiners. Fingerprints collected from crime scenes typically contain less information than fingerprints collected under controlled conditions. Specifically, they are often noisy and distorted and may contain only a portion of the total fingerprint area. Expertise in fingerprint comparison, like other forms of perceptual expertise, such as face recognition or aircraft identification, depends on perceptual learning processes that lead to the discovery of features and relations that matter in comparing prints. Relatively little is known about the perceptual processes involved in making comparisons, and even less is known about what characteristics of fingerprint pairs make particular comparisons easy or difficult. We measured expert examiner performance and judgments of difficulty and confidence on a new fingerprint database. We developed a number of quantitative measures of image characteristics and used multiple regression techniques to discover objective predictors of error as well as perceived difficulty and confidence. A number of useful predictors emerged, and these included variables related to image quality metrics, such as intensity and contrast information, as well as measures of information quantity, such as the total fingerprint area. Also included were configural features that fingerprint experts have noted, such as the presence and clarity of global features and fingerprint ridges. Within the constraints of the overall low error rates of experts, a regression model incorporating the derived predictors demonstrated reasonable success in predicting objective difficulty for print pairs, as shown both in goodness of fit measures to the original data set and in a cross validation test. The results indicate the plausibility of using objective image metrics to predict expert performance and subjective assessment of difficulty in fingerprint comparisons.	[Kellman, Philip J.; Erlikhman, Gennady; Mettler, Everett] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Mnookin, Jennifer L.] Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA; [Garrigan, Patrick] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Ghose, Tandra] Tech Univ Kaiserslautern, Dept Psychol, Kaiserslautern, Germany; [Dror, Itiel E.] Kings Coll London, Inst Cognit Neurosci, London WC2R 2LS, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Saint Joseph's University; University of Kaiserslautern; University of London; King's College London; University College London	Erlikhman, G (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	gennady@ucla.edu	Dror, Itiel/AAV-9123-2021; Dror, Itiel/V-3195-2019	Dror, Itiel/0000-0003-4866-209X; Erlikhman, Gennady/0000-0002-9594-2660	National Institute of Justice (NIJ) [2009-DN-BX-K225]	National Institute of Justice (NIJ)	This research was supported by a grant by the National Institute of Justice (NIJ), (research grant #2009-DN-BX-K225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Ashbaugh D.R, 1999, CRC SER PR CRIM; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D, 2012, LME4 LINEAR MIXED EF; Booth G, 1994, INT470 USDA FOR SERV; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Chatterjee S., 1991, BIOMETRICAL J, DOI DOI 10.1002/BIMJ.4710340613; Cole SA, 2005, J LAW POLICY, V28, P109; Dixon P, 2008, J MEM LANG, V59, P447, DOI 10.1016/j.jml.2007.11.004; Dror I. E., 2009, JURIMETRICS J LAW SC, V50, P93; Dror i.E., 2010, LAW PROBAB RISK, V9, P47, DOI DOI 10.1093/LPR/MGP031; Dror I.E., 2006, J FORENSIC IDENTIFIC, V56, P600, DOI DOI 10.1016/S1355-0306(98)72118-5; Dror IE, 2006, FORENSIC SCI INT, V156, P74, DOI 10.1016/j.forsciint.2005.10.017; Dror I, 2008, J FORENSIC SCI, V53, P900, DOI 10.1111/j.1556-4029.2008.00762.x; Dror IE, 2008, APPL COGNITIVE PSYCH, V22, P573, DOI 10.1002/acp.1383; Dror IE, 2010, PSYCHON B REV, V17, P161, DOI 10.3758/PBR.17.2.161; Faigman DL, 2012, MODERN SCI EVIDENCE, V5; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2013, ARM DATA ANAL USING; Gibson Eleanor Jack, 1969, PRINCIPLES PERCEPTUA; Hall LJ, 2008, FORENSIC SCI INT, V181, P36, DOI 10.1016/j.forsciint.2008.08.008; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Kassin SM, 2013, J APPL RES MEM COGN, V2, P42, DOI 10.1016/j.jarmac.2013.01.001; Kellman P. J., 2002, STEVENS HDB EXPT PSY, V3, P259; Kellman PJ, 2013, PSYCHOL LEARN MOTIV, V58, P117, DOI 10.1016/B978-0-12-407237-4.00004-9; Kellman PJ, 2009, PHYS LIFE REV, V6, P53, DOI 10.1016/j.plrev.2008.12.001; Koehler JJ, 2008, HASTINGS LAW J, V59, P1077; Maltoni D., 2009, HDB FINGERPRINT RECO; Marcon JL, 2009, AAI3358893 U TEX; Mnookin Jennifer, 2008, LAW PROBAB RISK, V7, P127, DOI DOI 10.1093/LPR/MGM022; Mnookin JL, 2008, EPISTEME-J INDIV SOC, V5, P343, DOI 10.3366/E1742360008000440; National Research Council of the National Academies, 2009, STRENGTH FOR SCI US; Neter J., 1996, APPL LINEAR STAT MOD; Pulsifer DP, 2013, FORENSIC SCI INT, V231, P204, DOI 10.1016/j.forsciint.2013.05.003; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Tangen JM, 2011, PSYCHOL SCI, V22, P995, DOI 10.1177/0956797611414729; Thompson Matthew B., 2010, P HUM FACTORS ERGONO, V54, P478; Ulery BT, 2011, P NATL ACAD SCI USA, V108, P7733, DOI 10.1073/pnas.1018707108; Zuur Alain F., 2009, P1	44	22	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e94617	10.1371/journal.pone.0094617	http://dx.doi.org/10.1371/journal.pone.0094617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788812	Green Published, gold			2022-12-27	WOS:000336655700014
J	Martinez-Gomez, D; Mielke, GI; Menezes, AM; Goncalves, H; Barros, FC; Hallal, PC				Martinez-Gomez, David; Mielke, Gregore I.; Menezes, Ana M.; Goncalves, Helen; Barros, Fernando C.; Hallal, Pedro C.			Active Commuting Throughout Adolescence and Central Fatness before Adulthood: Prospective Birth Cohort Study	PLOS ONE			English	Article							CHILDRENS PHYSICAL-ACTIVITY; CARDIOVASCULAR RISK; SCHOOL TRANSPORT; FITNESS; PREVALENCE; ADIPOSITY; STATEMENT; CHILDHOOD; YOUTH	Background: Active commuting is a good opportunity to accumulate physical activity (PA) across the lifespan that potentially might influence central body fat. We aimed to examine the prospective associations of active commuting at 11, 15 and 18 years of age with central body fat at 18 years. Methods: Participants were part of a large birth cohort study in Pelotas, Brazil (n = 3,649 participants). Active commuting, leisure-time PA and income were self-reported at 11, 15 and 18 years. Waist circumference and trunk fat mass were collected at 18 years with the use of a 3-dimensional photonic scanner and dual-energy X-ray absorptiometry, respectively. Results: Active commuting at 11 years was not prospectively associated with central body fat. However, we found that active commuting at 15 and 18 years were prospectively and cross-sectionally associated with central body fat variables, respectively, in boys but not in girls. Also, boys in the highest tertile of accumulated active commuting (i.e., average of active commuting at 11, 13 and 18 years) were associated with 22.09 cm (95%CI: -3.24; -0.94) of waist circumference and -1.11 kg (95%CI: -1.74; -0.48) of trunk fat mass compared to boys in the lowest tertile. Analyses on changes in tertiles of active commuting from 11 and 15 years to 18 years with central body fat variables at 18 years showed that boys who remained consistently in the highest tertile or moved to a higher tertile had lower levels of central body fat compared to those consistently in the lowest tertile. Conclusions: Active commuting throughout adolescence in boys, especially during middle and late adolescence, is associated with lower levels in central fatness before adulthood.	[Martinez-Gomez, David] Autonomous Univ Madrid, Fac Teacher Training & Educ, Dept Phys Educ Sports & Human Movement, E-28049 Madrid, Spain; [Mielke, Gregore I.; Menezes, Ana M.; Goncalves, Helen; Barros, Fernando C.; Hallal, Pedro C.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Rio Grande Do S, Brazil	Autonomous University of Madrid; Universidade Federal de Pelotas	Martinez-Gomez, D (corresponding author), Autonomous Univ Madrid, Fac Teacher Training & Educ, Dept Phys Educ Sports & Human Movement, E-28049 Madrid, Spain.	d.martinez@uam.es	Gonçalves, Helen/P-2381-2018; Gonçalves, Helen/M-1603-2017; Mielke, Gregore I/E-2141-2014; Hallal, Pedro C/A-3249-2011; Menezes, Ana MB/G-7266-2012	Gonçalves, Helen/0000-0001-6470-3352; Mielke, Gregore I/0000-0002-3043-2715; Hallal, Pedro C/0000-0003-1470-6461; Menezes, Ana MB/0000-0002-2996-9427; Barros, Fernando/0000-0001-5973-1746	Santander Bank; Wellcome Trust; European Union; Brazilian National Program for Centers of Excellence (PRONEX); National Research Council (CNPq); Ministry of Health	Santander Bank; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Brazilian National Program for Centers of Excellence (PRONEX); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health	DMG received a scholarship from the Santander Bank for a brief stay in the Federal University of Pelotas, Brazil. The cohort study is supported by the Wellcome Trust. The initial phases of the cohort were funded by the European Union and the Brazilian National Program for Centers of Excellence (PRONEX), National Research Council (CNPq), and Ministry of Health. None of these organizations influenced the study design; the collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the manuscript for publication.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Andersen LB, 2009, SCAND J MED SCI SPOR, V19, P406, DOI 10.1111/j.1600-0838.2008.00803.x; Andersen LB, 2011, J PHYS ACT HEALTH, V8, P1025, DOI 10.1123/jpah.8.8.1025; Bastos JP, 2008, J PHYS ACT HEALTH, V5, P777, DOI 10.1123/jpah.5.6.777; Camhi SM, 2010, INT J PEDIATR OBES, V5, P122, DOI 10.3109/17477160903111763; Chillon P, 2012, PREV MED, V55, P108, DOI 10.1016/j.ypmed.2012.05.019; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davison K. K., 2008, Preventing Chronic Disease, V5, pA100; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Furie GL, 2012, AM J PREV MED, V43, P621, DOI 10.1016/j.amepre.2012.06.034; Hamer M, 2008, PREV MED, V46, P9, DOI 10.1016/j.ypmed.2007.03.006; Hoehner CM, 2012, AM J PREV MED, V42, P571, DOI 10.1016/j.amepre.2012.02.020; Hume C, 2009, AM J PREV MED, V36, P195, DOI 10.1016/j.amepre.2008.10.011; Kwasniewska M, 2010, PREV MED, V51, P482, DOI 10.1016/j.ypmed.2010.09.003; Larouche R, 2011, PEDIATR EXERC SCI, V23, P322, DOI 10.1123/pes.23.3.322; Lee MC, 2008, J PHYS ACT HEALTH, V5, P930, DOI 10.1123/jpah.5.6.930; Lubans DR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-5; Martinez-Gomez D, 2011, PUBLIC HEALTH NUTR, V14, P1779, DOI 10.1017/S1368980010003253; Mota J, 2007, ANN HUM BIOL, V34, P273, DOI 10.1080/03014460701308615; Ostergaard L, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-91; Ostergaard L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001307; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pizarro AN, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-12; Shephard RJ, 2008, SPORTS MED, V38, P751, DOI 10.2165/00007256-200838090-00004; Telama R, 2005, AM J PREV MED, V28, P267, DOI 10.1016/j.amepre.2004.12.003; US Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A, P7; van Sluijs EMF, 2009, PREV MED, V48, P519, DOI 10.1016/j.ypmed.2009.03.002; Victora CG, 2008, INT J EPIDEMIOL, V37, P704, DOI 10.1093/ije/dym177; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Wells JCK, 2008, INT J OBESITY, V32, P232, DOI 10.1038/sj.ijo.0803727; World Health Organization, 2004, GUID DRINK WAT QUAL, P1, DOI DOI 10.1037/E333612004-001	33	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96634	10.1371/journal.pone.0096634	http://dx.doi.org/10.1371/journal.pone.0096634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24791780	gold, Green Submitted, Green Published			2022-12-27	WOS:000336655700120
J	Patra, J; Jha, P; Rehm, J; Suraweera, W				Patra, Jayadeep; Jha, Prabhat; Rehm, Juegen; Suraweera, Wilson			Tobacco Smoking, Alcohol Drinking, Diabetes, Low Body Mass Index and the Risk of Self-Reported Symptoms of Active Tuberculosis: Individual Participant Data (IPD) Meta-Analyses of 72,684 Individuals in 14 High Tuberculosis Burden Countries	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; POPULATION; MORTALITY; HEALTH; INDIA; SUPPLEMENTATION; EPIDEMIOLOGY; PREVALENCE; MORBIDITY; REGIONS	Background: The effects of multiple exposures on active tuberculosis (TB) are largely undetermined. We sought to establish a dose-response relationship for smoking, drinking, and body mass index (BMI) and to investigate the independent and joint effects of these and diabetes on the risk of self-reported symptoms of active TB disease. Methods and Findings: We analyzed 14 national studies in 14 high TB-burden countries using self-reports of blood in cough/phlegm and cough lasting >= 3 weeks in the last year as the measures of symptoms of active TB. The random effect estimates of the relative risks (RR) between active TB and smoking, drinking, diabetes, and BMI, 18.5 kg/m(2) were reported for each gender. Floating absolute risks were used to examine dyads of exposure. Adjusted for age and education, the risks of active TB were significantly associated with diabetes and BMI, 18.5 kg/m(2) in both sexes, with ever drinking in men and with ever smoking in women. Stronger dose-response relationships were seen in women than in men for smoking amount, smoking duration and drinking amount but BMI, 18.5 kg/m(2) showed a stronger dose-response relationship in men. In men, the risks from joint exposures were statistically significant for diabetics with BMI, 18.5 kg/m(2) (RR = 6.4), diabetics who smoked (RR = 3.8), and diabetics who drank alcohol (RR = 3.2). The risks from joint risk factors were generally larger in women than in men, with statistically significant risks for diabetics with BMI, 18.5 kg/m(2) (RR = 10.0), diabetics who smoked (RR = 5.4) and women with BMI<18.5 kg/m(2) who smoked (RR = 5.0). These risk factors account for 61% of male and 34% of female estimated TB incidents in these 14 countries. Conclusions: Tobacco, alcohol, diabetes, and low BMI are significant individual risk factors but in combination are associated with triple or quadruple the risk of development of recent active TB. These risk factors might help to explain the wide variation in TB across countries.	[Patra, Jayadeep; Jha, Prabhat; Suraweera, Wilson] St Michaels Hosp, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Patra, Jayadeep; Jha, Prabhat; Rehm, Juegen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juegen] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Patra, J (corresponding author), St Michaels Hosp, Ctr Global Hlth Res, 30 Bond St, Toronto, ON M5B 1W8, Canada.	patraj@smh.ca	Suraweera, Wilson MG/O-8962-2014	Suraweera, Wilson/0000-0001-9673-5746	US National Institutes of Health [R01-TW05991-01, TW07939-01]; Canadian Institutes of Health Research [IEG-53506]; Bill & Melinda Gates Foundation [57350]; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is supported by grants from the US National Institutes of Health (R01-TW05991-01 and TW07939-01), Canadian Institutes of Health Research (IEG-53506), and the Bill & Melinda Gates Foundation (57350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 2002, CHEST, V121, P932, DOI 10.1378/chest.121.3.932; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; Andreotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004426; [Anonymous], GLOB TUB CONTR WHO R; AYLES H, 2009, PLOS ONE, V4; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Boelaert JR, 2003, LANCET, V362, P1243, DOI 10.1016/S0140-6736(03)14529-1; Bothamley GH, 2005, THORAX, V60, P527, DOI 10.1136/thx.2004.036012; British Association for Parenteral and Enteral Nutrition Malnutrition Advisory Group, 2000, GUID DET MAN MALN 20; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Chan J., 1997, Journal of Nutritional Immunology, V5, P11, DOI 10.1300/J053v05n01_03; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gajalakshmi V, 2009, INT J EPIDEMIOL, V38, P1018, DOI 10.1093/ije/dyp225; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; ICF International, 2012, DEM HLTH SURV 2004 1; International Diabetes Federation, 2009, INT DIAB FED DIAB AT; International Institute for Population Sciences, 2007, INT J HEALTH CARE Q, V18, P765; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Kumar A, 2013, TROP MED INT HEALTH, V18, P636, DOI 10.1111/tmi.12084; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Mason CM, 2004, INFECT IMMUN, V72, P2556, DOI 10.1128/IAI.72.5.2556-2563.2004; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Millwood IY, 2013, INT J EPIDEMIOL, V42, P816, DOI 10.1093/ije/dyt078; Okura Y, 2004, J CLIN EPIDEMIOL, V57, P1096, DOI 10.1016/j.jclinepi.2004.04.005; Pai M, 2007, EXPERT REV ANTI-INFE, V5, P385, DOI 10.1586/14787210.5.3.385; Paton NI, 2004, AM J CLIN NUTR, V80, P460, DOI 10.1093/ajcn/80.2.460; Pednekar MS, 2008, AM J EPIDEMIOL, V167, P330, DOI 10.1093/aje/kwm293; Pednekar MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039443; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; RAO RH, 1984, DIABETES CARE, V7, P595, DOI 10.2337/diacare.7.6.595; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Razak F, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001367; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Rook GAW, 1996, ANNU REV MICROBIOL, V50, P259, DOI 10.1146/annurev.micro.50.1.259; Rosen MJ, 2006, CHEST, V129, p197S, DOI 10.1378/chest.129.1_suppl.197S; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; Szabo G, 2012, ALCOHOL HEALTH RES W, V21, P30; Thomas A, 2005, INT J TUBERC LUNG D, V9, P556; THOMPSON KH, 1995, NUTR RES, V15, P1377, DOI 10.1016/0271-5317(95)02012-K; TVERDAL A, 1986, EUR J RESPIR DIS, V69, P355; Ustun TB, 2003, WORLD HLTH SURVEYS H, P797; Villamor E, 2008, J INFECT DIS, V197, P1499, DOI 10.1086/587846; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; World Health Organization, WORLD HLTH SURV 2003; World Health Organization, 2007, WHO UN MON TB TOB CO	62	43	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96433	10.1371/journal.pone.0096433	http://dx.doi.org/10.1371/journal.pone.0096433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789311	gold, Green Submitted, Green Published			2022-12-27	WOS:000336655700093
J	Lazo, MD; Bernabe-Ortiz, A; Pinto, ME; Ticse, R; Malaga, G; Sacksteder, K; Miranda, JJ; Gilman, RH				de los Angeles Lazo, Maria; Bernabe-Ortiz, Antonio; Pinto, Miguel E.; Ticse, Ray; Malaga, German; Sacksteder, Katherine; Jaime Miranda, J.; Gilman, Robert H.			Diabetic Peripheral Neuropathy in Ambulatory Patients with Type 2 Diabetes in a General Hospital in a Middle Income Country: A Cross-Sectional Study	PLOS ONE			English	Article							PREVALENCE; MELLITUS; POLYNEUROPATHY; MORTALITY	Aim: We aimed to estimate the morbidity rate and associated factors for diabetic peripheral neuropathy (DPN) in a low-middle income country setting. Methods: Cross-sectional study, data was gathered at Peru's Ministry of Health national specialized hospital for endocrinological conditions through standardized interviews, anthropometric measurements and blood tests for glycated haemoglobin (HbA1c). DPN was evaluated using two techniques: the Semmes-Weinstein monofilament test and the diabetic neuropathy symptom score. Overall prevalence and 95% confidence intervals (95% CI) were calculated. Potential factors related to DPN explored included body mass index, years with disease (<10 vs. >= 10 years), glycaemic control (HbA1c <7% vs. >= 7%), microalbuminuria, retinopathy, and current pharmacological treatment. Multivariable analysis was performed using Poisson analysis to calculate prevalence ratios. Results: DPN was observed in 73/129 (56.6%) patients. In multivariable analysis adjusted by age and sex, the prevalence ratio of neuropathy was 1.4 times higher (95% CI 1.07-1.88) in patients who took insulin plus metformin compared to patients who used one treatment alone, and 1.4 higher (95% CI 1.02-1.93) in patients with >= 10 years of disease compared to those with a shorter duration of disease. Also we found some characteristics in foot evaluation associated to neuropathy such as deformities (p<0.001), onychomycosis (p = 0.012), abnormal Achilles reflex (p<0.001), pain perception (p<0.001) and vibration perception (p<0.001). Conclusion: DPN is highly frequent among patients with diabetes in a national specialized facility from Peru. Associated factors to DPN included being a diabetic patient for over ten years, and receiving insulin plus metformin	[de los Angeles Lazo, Maria; Bernabe-Ortiz, Antonio; Malaga, German; Jaime Miranda, J.; Gilman, Robert H.] Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru; [de los Angeles Lazo, Maria; Malaga, German] Univ Peruana Cayetano Heredia, Unidad Conocimiento & Evidencia, Lima, Peru; [Pinto, Miguel E.; Ticse, Ray; Malaga, German; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Pinto, Miguel E.; Ticse, Ray] Hosp Nacl Cayetano Heredia, Serv Endocrinol, Lima, Peru; [Sacksteder, Katherine; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Miranda, JJ (corresponding author), Univ Peruana Cayetano Heredia, CRON Ctr Excellence Chron Dis, Lima, Peru.	Jaime.Miranda@upch.pe		Miranda, J. Jaime/0000-0002-4738-5468; Malaga, German/0000-0002-7828-300X; Bernabe-Ortiz, Antonio/0000-0002-6834-1376; TICSE, RAY/0000-0002-4568-5723	National Heart, Lung, and Blood Institute Global Health Initiative [268200900033C]; Medical Research Council [MR/K007467/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	National Heart, Lung, and Blood Institute Global Health Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ML, ABO, KS, GM, JJM, RHG are affiliated with the CRONICAS Centre of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases (Project Number 268200900033C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Bos M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-387; Boulton AJM, 2008, DIABETES CARE, V31, P1679, DOI 10.2337/dc08-9021; Chan JCN, 2009, DIABETES CARE, V32, P227, DOI 10.2337/dc08-0435; Chuang LM, 2002, DIABETIC MED, V19, P978, DOI 10.1046/j.1464-5491.2002.00833.x; Chung JO, 2011, DIABETES METAB J, V35, P390, DOI 10.4093/dmj.2011.35.4.390; Currie CJ, 2013, J CLIN ENDOCR METAB, V98, P668, DOI 10.1210/jc.2012-3042; Janghorbani M, 2006, ACTA NEUROL SCAND, V114, P384, DOI 10.1111/j.1600-0404.2006.00716.x; Karvestedt L, 2011, J DIABETES COMPLICAT, V25, P97, DOI 10.1016/j.jdiacomp.2010.04.001; Kiani J, 2013, ARCH IRAN MED, V16, P17, DOI 013161/AIM.006; Ko SH, 2012, DIABETES METAB J, V36, P6, DOI 10.4093/dmj.2012.36.1.6; MCNEELY MJ, 1995, DIABETES CARE, V18, P216, DOI 10.2337/diacare.18.2.216; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Menchaca-Diaz R, 2012, GAC MED MEX, V148, P34; *MIN SAL PER, 2007, RES MIN; Mold JW, 2004, J AM BOARD FAM PRACT, V17, P309, DOI 10.3122/jabfm.17.5.309; Ollendorf DA, 1998, DIABETES CARE, V21, P1240, DOI 10.2337/diacare.21.8.1240; Palumbo P.J, 1985, DIABETES AM DIABETES; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Tentolouris N, 2004, DIABETES CARE, V27, P1598, DOI 10.2337/diacare.27.7.1598; Ibarra RCT, 2012, REV MED CHILE, V140, P1126, DOI 10.4067/S0034-98872012000900004; Tres GS, 2007, ARQ BRAS ENDOCRINOL, V51, P987, DOI 10.1590/S0004-27302007000600014	23	16	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95403	10.1371/journal.pone.0095403	http://dx.doi.org/10.1371/journal.pone.0095403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789071	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600036
J	Jain, A; Fuller, S; Backus, BT				Jain, Anshul; Fuller, Stuart; Backus, Benjamin T.			Cue-Recruitment for Extrinsic Signals after Training with Low Information Stimuli	PLOS ONE			English	Article							LOCATION; MOTION; EXPERIENCE; PERCEPTION; BIASES; SHAPE	Cue-recruitment occurs when a previously ineffective signal comes to affect the perceptual appearance of a target object, in a manner similar to the trusted cues with which the signal was put into correlation during training [1,2]. Jain, Fuller and Backus [3] reported that extrinsic signals, those not carried by the target object itself, were not recruited even after extensive training. However, recent studies have shown that training using weakened trusted cues can facilitate recruitment of intrinsic signals [4-7]. The current study was designed to examine whether extrinsic signals can be recruited by putting them in correlation with weakened trusted cues. Specifically, we tested whether an extrinsic visual signal, the rotary motion direction of an annulus of random dots, and an extrinsic auditory signal, direction of an auditory pitch glide, can be recruited as cues for the rotation direction of a Necker cube. We found learning, albeit weak, for visual but not for auditory signals. These results extend the generality of the cue-recruitment phenomenon to an extrinsic signal and provide further evidence that the visual system learns to use new signals most quickly when other, long-trusted cues are unavailable or unreliable.	[Jain, Anshul; Fuller, Stuart; Backus, Benjamin T.] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10036 USA	State University of New York (SUNY) System; SUNY Optometry	Jain, A (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10036 USA.	anshuljjain@gmail.com			NIH [R01-EY013988]; NSF [BCS-0810944]; NATIONAL EYE INSTITUTE [R01EY013988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the NIH R01-EY013988 (www.nih.gov) and NSF BCS-0810944 (www.nsf.gov) grants to B.T.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; Adams-Bedford J, 2013, J VISION, V13; Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Backus B. T., 2011, SENSORY CUE INTEGRAT; Backus BT, 2007, VISION RES, V47, P919, DOI 10.1016/j.visres.2006.12.008; Backus BT, 2009, J VISION, V9, DOI 10.1167/9.1.6; Champion RA, 2007, J VIS, V7, P11; Di Luca M, 2010, CURR BIOL, V20, P1860, DOI 10.1016/j.cub.2010.09.047; DOSHER BA, 1986, VISION RES, V26, P973, DOI 10.1016/0042-6989(86)90154-9; EBY DW, 1989, PERCEPTION, V18, P427, DOI 10.1068/p180427; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Freeman ED, 2006, VISION RES, V46, P4007, DOI 10.1016/j.visres.2006.07.008; Garcia J., 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Gilroy LA, 2004, NAT NEUROSCI, V7, P921, DOI 10.1038/nn1297; Harrison SJ, 2010, VISION RES, V50, P1905, DOI 10.1016/j.visres.2010.06.013; Harrison S, 2010, J VISION, V10, DOI 10.1167/10.6.23; Harrison SJ, 2012, J VISION, V12, DOI 10.1167/12.3.15; Harrison SJ, 2011, VISION RES, V51, P978, DOI 10.1016/j.visres.2011.02.011; Jain A, 2010, J VIS, V10; Jain A, 2013, VISION RES, V82, P13, DOI 10.1016/j.visres.2013.02.006; Jain A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013295; Jain A, 2008, J VISION, V8, DOI 10.1167/8.15.7; Kerrigan IS, 2013, COGNITION, V127, P99, DOI 10.1016/j.cognition.2012.12.011; Klink PC, 2009, J VISION, V9, DOI 10.1167/9.10.20; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Michel MM, 2007, J VISION, V7, DOI 10.1167/7.1.4; Michna ML, 2008, J VISION, V8, DOI 10.1167/8.5.10; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; van Dam LCJ, 2010, J VISION, V10, DOI 10.1167/10.8.15	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96383	10.1371/journal.pone.0096383	http://dx.doi.org/10.1371/journal.pone.0096383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804788	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900053
J	Judd, LM; Menheniott, TR; Ling, H; Jackson, CB; Howlett, M; Kalantzis, A; Priebe, W; Giraud, AS				Judd, Louise M.; Menheniott, Treve R.; Ling, Hui; Jackson, Cameron B.; Howlett, Meegan; Kalantzis, Anastasia; Priebe, Waldemar; Giraud, Andrew S.			Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo	PLOS ONE			English	Article							CONSTITUTIVE ACTIVATION; SIGNAL TRANSDUCER; STAT3 ACTIVATION; CORECEPTOR GP130; MUTANT MICE; MOUSE MODEL; CELL-LINES; APOPTOSIS; EXPRESSION; CARCINOMA	Signal Transducer and Activator of Transcription-3 (STAT3) is constitutively activated in many cancers where it promotes growth, inflammation, angiogenesis and inhibits apoptosis. We have shown that STAT3 is constitutively activated in human gastric cancer, and that chronic IL-11-driven STAT3 transcriptional activity induces gastric tumourigenesis in the gp130(757FF) mouse model of gastric cancer development. Here we show that treatment of human AGS gastric cancer cells with the Janus Kinase (JAK) inhibitor WP1066 dose-, and time-dependently inhibits STAT3 phosphorylation, in conjunction with reduced JAK2 phosphorylation, reduced proliferation and increased apoptosis. In addition, application of intraperitoneal WP1066 for 2 weeks, reduced gastric tumour volume by 50% in the gp130(757FF) mouse coincident with reduced JAK2 and STAT3 activation compared with vehicle-treated, littermate controls. Gastric tumours from WP1066-treated mice had reduced polymorphonuclear inflammation, coincident with inhibition of numerous proinflammatory cytokines including IL11, IL-6 and IL-1 beta, as well as the growth factors Reg1 and amphiregulin. These results show that WP1066 can block proliferation, reduce inflammation and induce apoptosis in gastric tumour cells by inhibiting STAT3 phosphorylation, and that many cytokines and growth factors that promote gastric tumour growth are regulated by STAT3-dependent mechanisms. WP1066 may form the basis for future therapeutics against gastric cancer.	[Judd, Louise M.; Menheniott, Treve R.; Jackson, Cameron B.; Howlett, Meegan; Kalantzis, Anastasia; Giraud, Andrew S.] Murdoch Childrens Res Inst, Infect & Immun Div, Parkville, Vic, Australia; [Priebe, Waldemar] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Ling, Hui] Univ South China, Dept Pathol, Hengyang, Hunan, Peoples R China; [Ling, Hui] Univ South China, Canc Res Inst, Hengyang, Hunan, Peoples R China	Murdoch Children's Research Institute; University of Texas System; UTMD Anderson Cancer Center; University of South China; University of South China	Giraud, AS (corresponding author), Murdoch Childrens Res Inst, Infect & Immun Div, Parkville, Vic, Australia.	andrew.giraud@mcri.edu.au	Menheniott, Treve/D-7964-2015	Menheniott, Treve/0000-0003-2349-8238; Howlett, Meegan/0000-0003-4332-6572; Ling, Hui/0000-0002-0066-6801; Judd, Louise/0000-0003-3613-4839	NHMRC Australia [509165]; NIH/NCI USA; SPORE [P50 CA093459-06]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia); NIH/NCI USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SPORE	This project was supported by funds from; NHMRC Australia (www.nhmrc.gov.au) project grant # 509165 NIH/NCI USA (nih.gov; www. cancer. gov) melanoma SPORE P50 CA093459-06, NIH/NCI USA (nih. gov; www. cancer. gov) brain SPORE 2 P50 CA127001-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaskovich MA, 2003, CANCER RES, V63, P1270; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chen FL, 2008, DIGEST DIS SCI, V53, P181, DOI 10.1007/s10620-007-9841-1; COOK PW, 1992, CANCER RES, V52, P3224; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; Ferrajoli A, 2007, CANCER RES, V67, P11291, DOI 10.1158/0008-5472.CAN-07-0593; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; Hatiboglu MA, INT J CANC, V131, P8; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Howlett M, 2005, GASTROENTEROLOGY, V129, P1005, DOI 10.1053/j.gastro.2005.06.068; Howlett M, 2012, GUT, V61, P1398, DOI 10.1136/gutjnl-2011-300539; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Hutchins AP, 2013, NUCLEIC ACIDS RES, V41, P2155, DOI 10.1093/nar/gks1300; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; Jackson CB, 2007, J PATHOL, V213, P140, DOI 10.1002/path.2218; Judd LM, 2004, GASTROENTEROLOGY, V126, P196, DOI 10.1053/j.gastro.2003.10.066; Judd LM, 2006, GASTROENTEROLOGY, V131, P1073, DOI 10.1053/j.gastro.2006.07.018; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Kneissl J, 2012, INT J ONCOL, V41, P733, DOI 10.3892/ijo.2012.1479; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Lee KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030786; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Mora L B, 2001, Cancer Control, V8, P551; Mora LB, 2002, CANCER RES, V62, P6659; NORMANNO N, 1994, P NATL ACAD SCI USA, V91, P2790, DOI 10.1073/pnas.91.7.2790; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Oshima H, 2011, CANCER SCI, V102, P713, DOI 10.1111/j.1349-7006.2011.01847.x; Ristimaki A, 1997, CANCER RES, V57, P1276; Romani L, 1996, J EXP MED, V183, P1345, DOI 10.1084/jem.183.4.1345; Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z; Samanta A, 2011, LEUKEMIA, V25, P463, DOI 10.1038/leu.2010.287; Sekikawa A, 2005, GASTROENTEROLOGY, V128, P642, DOI 10.1053/j.gastro.2004.12.045; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Takaishi S, 2007, CANCER SCI, V98, P284, DOI 10.1111/j.1349-7006.2007.00392.x; Tebbutt NC, 2002, NAT MED, V8, P1089, DOI 10.1038/nm763; Tian ZJ, 2004, CELL RES, V14, P141, DOI 10.1038/sj.cr.7290213; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Verstovsek S, 2008, CLIN CANCER RES, V14, P788, DOI 10.1158/1078-0432.CCR-07-0524; Xiong H, 2013, INT J CANC IN PRESS; Yakata Y, 2007, INT J ONCOL, V30, P437; YIN TG, 1994, EXP HEMATOL, V22, P467; Zaki MH, 2011, TRENDS IMMUNOL, V32, P171, DOI 10.1016/j.it.2011.02.002	49	77	85	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95993	10.1371/journal.pone.0095993	http://dx.doi.org/10.1371/journal.pone.0095993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804649	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900029
J	Mascher, M; Gerlach, N; Gahrtz, M; Bucher, M; Scholz, U; Dresselhaus, T				Mascher, Martin; Gerlach, Nina; Gahrtz, Manfred; Bucher, Marcel; Scholz, Uwe; Dresselhaus, Thomas			Sequence and Ionomic Analysis of Divergent Strains of Maize Inbred Line B73 with an Altered Growth Phenotype	PLOS ONE			English	Article							SPONTANEOUS MUTATIONS; GENOME; ASSOCIATION; RESOURCE; MYCORRHIZA; DIVERSITY; RESPONSES; SYMBIOSIS; SPECTRUM; DATABASE	Maize (Zea mays) is the most widely grown crop species in the world and a classical model organism for plant research. The completion of a high-quality reference genome sequence and the advent of high-throughput sequencing have greatly empowered re-sequencing studies in maize. In this study, plants of maize inbred line B73 descended from two different sets of seed material grown for several generations either in the field or in the greenhouse were found to show a different growth phenotype and ionome under phosphate starvation conditions and moreover a different responsiveness towards mycorrhizal fungi of the species Glomus intraradices (syn: Rhizophagus irregularis). Whole genome re-sequencing of individuals from both sets and comparison to the B73 reference sequence revealed three cryptic introgressions on chromosomes 1, 5 and 10 in the line grown in the greenhouse summing up to a total of 5,257 single-nucleotide polymorphisms (SNPs). Transcriptome sequencing of three individuals from each set lent further support to the location of the introgression intervals and confirmed them to be fixed in all sequenced individuals. Moreover, we identified.120 genes differentially expressed between the two B73 lines. We thus have found a nearly-isogenic line (NIL) of maize inbred line B73 that is characterized by an altered growth phenotype under phosphate starvation conditions and an improved responsiveness towards symbiosis with mycorrhizal fungi. Through next-generation sequencing of the genomes and transcriptomes we were able to delineate exact introgression intervals. Putative de novo mutations appeared approximately uniformly distributed along the ten maize chromosomes mainly representing G: C ->. A: T transitions. The plant material described in this study will be a valuable tool both for functional studies of genes differentially expressed in both B73 lines and for research on growth behavior especially in response to symbiosis between maize and mycorrhizal fungi.	[Mascher, Martin; Scholz, Uwe] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Cytogenet & Genome Anal, Stadt Seeland, Germany; [Gerlach, Nina; Bucher, Marcel] Univ Cologne, Inst Bot, Cologne Bioctr, Cluster Excellence Plant Sci CEPLAS, Cologne, Germany; [Gahrtz, Manfred; Dresselhaus, Thomas] Univ Regensburg, Biochem Zentrum Regensburg, D-93053 Regensburg, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Cologne; University of Regensburg	Dresselhaus, T (corresponding author), Univ Regensburg, Biochem Zentrum Regensburg, Univ Str 31, D-93053 Regensburg, Germany.	thomas.dresselhaus@ur.de	Gahrtz, Manfred/N-1905-2018; Bucher, Marcel/D-4596-2013	Bucher, Marcel/0000-0003-1680-9413; Scholz, Uwe/0000-0001-6113-3518; Mascher, Martin/0000-0001-6373-6013	German Federal Ministry of Education and Research (BMBF) in the frame of OPTIMAS [FKZ 0315430]	German Federal Ministry of Education and Research (BMBF) in the frame of OPTIMAS(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) in the frame of OPTIMAS [FKZ 0315430]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORKING MYCORRHIZAS; Casieri L, 2012, PLANTA, V235, P1431, DOI 10.1007/s00425-012-1645-7; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Colmsee C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-245; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Devaiah BN, 2009, MOL PLANT, V2, P43, DOI 10.1093/mp/ssn081; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; DOONER HK, 1991, ANNU REV GENET, V25, P173, DOI 10.1146/annurev.ge.25.120191.001133; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fester T, 2011, OECOLOGIA, V167, P913, DOI 10.1007/s00442-011-2037-6; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Jansa J, 2003, AGRONOMIE, V23, P481, DOI 10.1051/agro:2003013; Kaeppler SM, 2000, CROP SCI, V40, P358, DOI 10.2135/cropsci2000.402358x; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LU S, 1994, PLANT SOIL, V158, P119, DOI 10.1007/BF00007924; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; McFarland JW, 2010, ECOSYSTEMS, V13, P177, DOI 10.1007/s10021-009-9309-6; Miclaus M, 2011, GENETICS, V189, P1271, DOI 10.1534/genetics.111.133918; Milberg P, 1997, NEW PHYTOL, V137, P665, DOI 10.1046/j.1469-8137.1997.00870.x; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pegoraro C., 2011, Journal of Crop Science and Biotechnology, V14, P85, DOI 10.1007/s12892-010-0119-3; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; Sawers RJH, 2008, TRENDS PLANT SCI, V13, P93, DOI 10.1016/j.tplants.2007.11.006; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Strack D, 2003, J CHEM ECOL, V29, P1955, DOI 10.1023/A:1025695032113; Subramanian KS, 1997, MYCORRHIZA, V7, P25, DOI 10.1007/s005720050159; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ware D, 2002, NUCLEIC ACIDS RES, V30, P103, DOI 10.1093/nar/30.1.103; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhao W, 2006, NUCLEIC ACIDS RES, V34, pD752, DOI 10.1093/nar/gkj011	45	10	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96782	10.1371/journal.pone.0096782	http://dx.doi.org/10.1371/journal.pone.0096782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804793	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900094
J	Saleem, S; Ruggles, PH; Abbott, WK; Carney, GE				Saleem, Sehresh; Ruggles, Patrick H.; Abbott, Wiley K.; Carney, Ginger E.			Sexual Experience Enhances Drosophila melanogaster Male Mating Behavior and Success	PLOS ONE			English	Article							COURTSHIP SONG; CUTICULAR HYDROCARBONS; PHEROMONE; RESPONSES; DOPAMINE; SENSITIVITY; COMPETITION; PERCEPTION; MODULATION; SELECTION	Competition for mates is a wide-spread phenomenon affecting individual reproductive success. The ability of animals to adjust their behaviors in response to changing social environment is important and well documented. Drosophila melanogaster males compete with one another for matings with females and modify their reproductive behaviors based on prior social interactions. However, it remains to be determined how male social experience that culminates in mating with a female impacts subsequent male reproductive behaviors and mating success. Here we show that sexual experience enhances future mating success. Previously mated D. melanogaster males adjust their courtship behaviors and out-compete sexually inexperienced males for copulations. Interestingly, courtship experience alone is not sufficient in providing this competitive advantage, indicating that copulation plays a role in reinforcing this social learning. We also show that females use their sense of hearing to preferentially mate with experienced males when given a choice. Our results demonstrate the ability of previously mated males to learn from their positive sexual experiences and adjust their behaviors to gain a mating advantage. These experienced-based changes in behavior reveal strategies that animals likely use to increase their fecundity in natural competitive environments.	[Saleem, Sehresh; Ruggles, Patrick H.; Abbott, Wiley K.; Carney, Ginger E.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Carney, GE (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	gcarney@bio.tamu.edu			National Science Foundation [IOS-1121517]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (IOS-1121517 to G. E. C.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. www.nsf.gov.	Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Anderson P, 2007, CHEM SENSES, V32, P483, DOI 10.1093/chemse/bjm017; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Berg HC, 2000, PHYS TODAY, V53, P24, DOI 10.1063/1.882934; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P435, DOI 10.1146/annurev.ne.09.030186.002251; Certel Sarah J, 2012, Cold Spring Harb Protoc, V2012, P319, DOI 10.1101/pdb.prot068130; Davis RL, 2011, NEURON, V70, P8, DOI 10.1016/j.neuron.2011.03.012; Fernandez MD, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000541; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dukas R, 2004, BEHAV ECOL, V15, P695, DOI 10.1093/beheco/arh068; Dukas R, 2005, ANIM BEHAV, V69, P1203, DOI 10.1016/j.anbehav.2004.08.012; Dukas R, 2012, ANIM BEHAV, V84, P1427, DOI 10.1016/j.anbehav.2012.09.010; Dukas R, 2010, ANIM BEHAV, V80, P913, DOI 10.1016/j.anbehav.2010.08.017; Dussaubat C, 2013, J INVERTEBR PATHOL, V113, P42, DOI 10.1016/j.jip.2013.01.002; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Ejima A, 2012, NATURE, V489, P38, DOI 10.1038/489038a; Ellis LL, 2009, J EVOLUTION BIOL, V22, P2183, DOI 10.1111/j.1420-9101.2009.01834.x; Etnier SA, 2000, AM J BOT, V87, P29, DOI 10.2307/2656682; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Farine JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040396; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1982, GENETICS, V102, P771; Gil M, 2013, PSYCHONEUROENDOCRINO, V38, P1688, DOI 10.1016/j.psyneuen.2013.02.002; Giurfa M, 2003, CURR OPIN NEUROBIOL, V13, P726, DOI 10.1016/j.conb.2003.10.015; Gleason JM, 2005, BEHAV GENET, V35, P265, DOI 10.1007/s10519-005-3219-y; Grant RA, 2010, J ZOOL, V281, P263, DOI 10.1111/j.1469-7998.2010.00700.x; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; Grillet M, 2006, P ROY SOC B-BIOL SCI, V273, P315, DOI 10.1098/rspb.2005.3332; Groh Claudia, 2010, Front Biosci (Schol Ed), V2, P268; Guerrieri F, 2012, J EXP BIOL, V215, P2334, DOI 10.1242/jeb.060988; HIRSCH HVB, 1994, J EXP BIOL, V195, P1; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Kawecki TJ, 2010, POPUL ECOL, V52, P15, DOI 10.1007/s10144-009-0174-0; Keleman K, 2012, NATURE, V489, P145, DOI 10.1038/nature11345; Kikuchi A, 2012, DEV NEUROSCI-BASEL, V34, P533, DOI 10.1159/000346266; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Kujtan L, 2009, ANIM BEHAV, V78, P549, DOI 10.1016/j.anbehav.2009.05.026; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Loyau A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00768; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; MARKOW TA, 1978, NATURE, V276, P821, DOI 10.1038/276821a0; Medioni J., 1988, NATO ASI Series Series H Cell Biology, V19, P419; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Murthy M, 2010, CURR OPIN NEUROBIOL, V20, P281, DOI 10.1016/j.conb.2010.02.016; Pan YF, 2014, CELL, V156, P236, DOI 10.1016/j.cell.2013.11.041; Pan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021144; PIERCE JD, 1991, J COMP PSYCHOL, V105, P165, DOI 10.1037/0735-7036.105.2.165; Polejack A, 2007, REV BRAS ENTOMOL, V51, P82, DOI 10.1590/S0085-56262007000100014; Rybak F, 2002, P ROY SOC B-BIOL SCI, V269, P695, DOI 10.1098/rspb.2001.1919; Sarin S, 2009, P ROY SOC B-BIOL SCI, V276, P4323, DOI 10.1098/rspb.2009.1294; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; Tauber E, 2002, J INSECT BEHAV, V15, P109, DOI 10.1023/A:1014488330548; Trott AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046025; Tsuji Y, 2013, PRIMATES, V54, P201, DOI 10.1007/s10329-013-0359-1; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037	73	29	29	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96639	10.1371/journal.pone.0096639	http://dx.doi.org/10.1371/journal.pone.0096639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805129	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900076
J	Agopian, AJ; Mitchell, LE; Glessner, J; Bhalla, AD; Sewda, A; Hakonarson, H; Goldmuntz, E				Agopian, A. J.; Mitchell, Laura E.; Glessner, Joseph; Bhalla, Angela D.; Sewda, Anshuman; Hakonarson, Hakon; Goldmuntz, Elizabeth			Genome-Wide Association Study of Maternal and Inherited Loci for Conotruncal Heart Defects	PLOS ONE			English	Article							FOLATE METABOLISM GENES; CHROMOSOME 22Q11 DELETION; ENVIRONMENT INTERACTIONS; POTASSIUM CHANNEL; SEPTAL-DEFECT; IDENTIFIES 2; RISK; PARENT; VARIANTS; MALFORMATIONS	Conotruncal and related heart defects (CTDs) are a group of serious and relatively common birth defects. Although both maternal and inherited genotypes are thought to play a role in the etiology of CTDs, few specific genetic risk factors have been identified. To determine whether common variants acting through the genotype of the mother (e. g. via an in utero effect) or the case are associated with CTDs, we conducted a genome-wide association study of 750 CTD case-parent triads, with follow-up analyses in 358 independent triads. Log-linear analyses were used to assess the association of CTDs with the genotypes of both the mother and case. No association achieved genomewide significance in either the discovery or combined (discovery+follow-up) samples. However, three loci with p-values suggestive of association (p<10(-5)) in the discovery sample had p-values <0.05 in the follow-up sample and p-values in the combined data that were lower than in the discovery sample. These included suggestive association with an inherited intergenic variant at 20p12.3 (rs6140038, combined p = 1.0x10(-5)) and an inherited intronic variant in KCNJ4 at 22q13.1 (rs2267386, combined p = 9.8x10(-6)), as well as with a maternal variant in SLC22A24 at 11q12.3 (rs11231379, combined p = 4.2x10(-6)). These observations suggest novel candidate loci for CTDs, including loci that appear to be associated with the risk of CTDs via the maternal genotype, but further studies are needed to confirm these associations.	[Agopian, A. J.; Mitchell, Laura E.; Bhalla, Angela D.; Sewda, Anshuman] Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Hakonarson, Hakon; Goldmuntz, Elizabeth] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goldmuntz, Elizabeth] Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Glessner, Joseph; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Mitchell, LE (corresponding author), Univ Texas Houston, Sch Publ Hlth, Ctr Human Genet, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	laura.e.mitchell@uth.tmc.edu	Sewda, Anshuman/ABH-6847-2020	Sewda, Anshuman/0000-0002-2272-5382; Glessner, Joseph/0000-0001-5131-2811	National Institutes of Health (NIH); National Heart, Lung, and Blood Institute [HL74731]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [5P01HD070454]; National Center for Research Resources [UL1RR024134]; Children's Hospital of Philadelphia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Children's Hospital of Philadelphia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (NIH) and National Heart, Lung, and Blood Institute [HL74731], Eunice Kennedy Shriver National Institute of Child Health and Human Development [5P01HD070454], and the National Center for Research Resources [UL1RR024134]. GWAS genotyping was funded by an Institutional Development Fund to The Center for Applied Genomics from The Children's Hospital of Philadelphia. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agopian AJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-117; Botto LD, 2007, BIRTH DEFECTS RES A, V79, P714, DOI 10.1002/bdra.20403; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Cordell HJ, 2013, NAT GENET, V45, P822, DOI 10.1038/ng.2637; Cordell HJ, 2013, HUM MOL GENET, V22, P1473, DOI 10.1093/hmg/dds552; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Doolin MT, 2002, AM J HUM GENET, V71, P1222, DOI 10.1086/344209; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Ferencz C, 1997, GENETIC ENV RISK FAC, P124; Flaquer A, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-44; Goldmuntz E, 1998, J AM COLL CARDIOL, V32, P492, DOI 10.1016/S0735-1097(98)00259-9; Goldmuntz E, 2008, CIRC-CARDIOVASC GENE, V1, P126, DOI 10.1161/CIRCGENETICS.108.796342; Griebsch I, 2007, INT J TECHNOL ASSESS, V23, P192, DOI 10.1017/S0266462307070304; Hobbs CA, 2010, OBSTET GYNECOL, V116, P316, DOI 10.1097/AOG.0b013e3181e80979; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu ZB, 2013, NAT GENET, V45, P818, DOI 10.1038/ng.2636; Jacobsson JA, 2007, GENOMICS, V90, P595, DOI 10.1016/j.ygeno.2007.03.017; Jensen LE, 2004, BIRTH DEFECTS RES A, V70, P396, DOI 10.1002/bdra.20023; Karakose E, 2010, J CELL SCI, V123, P2353, DOI 10.1242/jcs.064600; Kwiatkowska J, 2007, KARDIOL POL, V65, P32; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Long J, 2011, BIRTH DEFECTS RES A, V91, P879, DOI 10.1002/bdra.22849; Lupo PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/630940; Lupo PJ, 2011, BIRTH DEFECTS RES A, V91, P61, DOI 10.1002/bdra.20745; Martin JA, 2005, PEDIATRICS, V115, P619, DOI 10.1542/peds.2004-2695; Martinelli M, 2011, EUR J ORAL SCI, V119, P193, DOI 10.1111/j.1600-0722.2011.00824.x; McElhinney DB, 2003, PEDIATRICS, V112, pE472, DOI 10.1542/peds.112.6.e472; McElhinney DB, 2001, J AM COLL CARDIOL, V37, P2114, DOI 10.1016/S0735-1097(01)01286-4; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mitchell LE, 2010, BIRTH DEFECTS RES A, V88, P48, DOI 10.1002/bdra.20622; NORA JJ, 1983, PROG MED GENET, V5, P91; Oyen N, 2009, CIRCULATION, V120, P295, DOI 10.1161/CIRCULATIONAHA.109.857987; Pecherzewska Roza, 2009, Postepy Biochem, V55, P66; PERIER F, 1994, P NATL ACAD SCI USA, V91, P6240, DOI 10.1073/pnas.91.13.6240; Perry LW, 1993, PERSPECTIVES PEDIAT, V1993, P33; Peyvandi S, 2013, PEDIATR CARDIOL, V34, P1687, DOI 10.1007/s00246-013-0694-4; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Shaw GM, 2005, AM J MED GENET A, V138A, P21, DOI 10.1002/ajmg.a.30924; Shi M, 2012, AM J MED GENET A, V158A, P784, DOI 10.1002/ajmg.a.35257; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; van der Zanden LFM, 2012, J UROLOGY, V188, P2354, DOI 10.1016/j.juro.2012.08.033; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; WULFSBERG EA, 1991, CLIN GENET, V40, P12; Yamada M, 1999, DEV BIOL, V215, P48, DOI 10.1006/dbio.1999.9419; Yan XJ, 2009, J MOL BIOL, V392, P967, DOI 10.1016/j.jmb.2009.07.060; Yoon PW, 1997, ARCH PEDIAT ADOL MED, V151, P1096, DOI 10.1001/archpedi.1997.02170480026004; Zhu HP, 2012, AM J MED GENET A, V158A, P1124, DOI 10.1002/ajmg.a.35313	55	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96057	10.1371/journal.pone.0096057	http://dx.doi.org/10.1371/journal.pone.0096057			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800985	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800041
J	Hong, YA; Lim, JH; Kim, MY; Kim, TW; Kim, Y; Yang, KS; Park, HS; Choi, SR; Chung, S; Kim, HW; Kim, HW; Choi, BS; Chang, YS; Park, CW				Hong, Yu Ah; Lim, Ji Hee; Kim, Min Young; Kim, Tae Woo; Kim, Yaeni; Yang, Keun Suk; Park, Hoon Suk; Choi, Sun Ryoung; Chung, Sungjin; Kim, Hyung Wook; Kim, Hye Won; Choi, Bum Soon; Chang, Yoon Sik; Park, Cheol Whee			Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1 alpha in db/db Mice	PLOS ONE			English	Article							HIGH-FAT DIET; ENZYME GENE-EXPRESSION; RECEPTOR-ALPHA; DIABETIC-NEPHROPATHY; ERR-ALPHA; INFLAMMATORY MEDIATORS; OXIDATIVE STRESS; PGC-1-ALPHA; AMPK; PHOSPHORYLATION	Peroxisome proliferator-activated receptor (PPAR)-alpha, a lipid-sensing transcriptional factor, serves an important role in lipotoxicity. We evaluated whether fenofibrate has a renoprotective effect by ameliorating lipotoxicity in the kidney. Eight-week-old male C57BLKS/J db/m control and db/db mice, divided into four groups, received fenofibrate for 12 weeks. In db/db mice, fenofibrate ameliorated albuminuria, mesangial area expansion and inflammatory cell infiltration. Fenofibrate inhibited accumulation of intra-renal free fatty acids and triglycerides related to increases in PPAR alpha expression, phosphorylation of AMP-activated protein kinase (AMPK), and activation of Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha)-estrogen-related receptor (ERR)-1 alpha-phosphorylated acetyl-CoA carboxylase (pACC), and suppression of sterol regulatory element-binding protein (SREBP)-1 and carbohydrate regulatory element-binding protein (ChREBP)-1, key downstream effectors of lipid metabolism. Fenofibrate decreased the activity of phosphatidylinositol-3 kinase (PI3K)-Akt phosphorylation and FoxO3a phosphorylation in kidneys, increasing the B cell leukaemia/lymphoma 2 (BCL-2)/BCL-2-associated X protein (BAX) ratio and superoxide dismutase (SOD) 1 levels. Consequently, fenofibrate recovered from renal apoptosis and oxidative stress, as reflected by 24 hr urinary 8-isoprostane. In cultured mesangial cells, fenofibrate prevented high glucose-induced apoptosis and oxidative stress through phosphorylation of AMPK, activation of PGC-1 alpha-ERR-1 alpha, and suppression of SREBP-1 and ChREBP-1. Our results suggest that fenofibrate improves lipotoxicity via activation of AMPK-PGC-1 alpha-ERR-1 alpha-FoxO3a signaling, showing its potential as a therapeutic modality for diabetic nephropathy.	[Hong, Yu Ah] Korea Univ, Guro Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Lim, Ji Hee; Kim, Min Young; Kim, Tae Woo; Kim, Yaeni; Yang, Keun Suk; Park, Hoon Suk; Choi, Sun Ryoung; Chung, Sungjin; Kim, Hyung Wook; Choi, Bum Soon; Chang, Yoon Sik; Park, Cheol Whee] Catholic Univ Korea, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Kim, Hye Won] Catholic Univ Korea, Dept Rehabil Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Catholic University of Korea	Park, CW (corresponding author), Catholic Univ Korea, Dept Internal Med, Div Nephrol, Seoul, South Korea.	cheolwhee@hanmail.net	SR, Choi/GRJ-6326-2022; Hong, Yu Ah/AAB-7055-2020; choi, sun ryoung/AGZ-1893-2022	choi, sun ryoung/0000-0002-9668-3349	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111055]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A3020151]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by grants of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (C.W.P.; A111055) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (H.W.K.; 2012R1A1A3020151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Guardia D, 2010, CARDIOVASC RES, V87, P449, DOI 10.1093/cvr/cvq080; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Buler M, 2012, J BIOL CHEM, V287, P1847, DOI 10.1074/jbc.M111.302356; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Chung HW, 2012, NEPHROL DIAL TRANSPL, V27, P2213, DOI 10.1093/ndt/gfr613; Decleves AE, 2010, NAT REV NEPHROL, V6, P371, DOI 10.1038/nrneph.2010.57; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Frier BC, 2011, AM J PHYSIOL-REG I, V300, pR212, DOI 10.1152/ajpregu.00367.2010; Goya K, 2004, ARTERIOSCL THROM VAS, V24, P658, DOI 10.1161/01.ATV.0000118682.58708.78; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Ishigaki N, 2007, BIOCHEM BIOPH RES CO, V364, P502, DOI 10.1016/j.bbrc.2007.10.038; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kim J, 2007, EXP EYE RES, V84, P886, DOI 10.1016/j.exer.2007.01.009; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Kitada M, 2011, EXP DIABETES RES, V2011, P9081; Moore DD, 2012, CELL METAB, V15, P615, DOI 10.1016/j.cmet.2012.03.016; MOORHEAD JF, 1982, LANCET, V2, P1309; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Murakami H, 2006, BIOCHEM BIOPH RES CO, V341, P973, DOI 10.1016/j.bbrc.2006.01.052; Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Olmos Y, 2009, J BIOL CHEM, V284, P14476, DOI 10.1074/jbc.M807397200; Ouali F, 1998, AM J PHYSIOL-RENAL, V275, pF777, DOI 10.1152/ajprenal.1998.275.5.F777; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rangwala SM, 2007, BIOCHEM BIOPH RES CO, V357, P231, DOI 10.1016/j.bbrc.2007.03.126; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Ruan XZ, 2004, BIOCHEM SOC T, V32, P88, DOI 10.1042/BST0320088; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shin SJ, 2009, HYPERTENS RES, V32, P835, DOI 10.1038/hr.2009.107; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715	47	19	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96147	10.1371/journal.pone.0096147	http://dx.doi.org/10.1371/journal.pone.0096147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801481	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800044
J	MacKay, JC; James, JS; Cayer, C; Kent, P; Anisman, H; Merali, Z				MacKay, Jennifer Christine; James, Jonathan Stewart; Cayer, Christian; Kent, Pamela; Anisman, Hymie; Merali, Zul			Protracted Effects of Juvenile Stressor Exposure Are Mitigated by Access to Palatable Food	PLOS ONE			English	Article							ADULT MALE RATS; INSULIN-RESISTANCE; GLUCOSE-INTOLERANCE; BEHAVIORAL DESPAIR; SOCIAL-ISOLATION; EATING BEHAVIOR; OBESITY; RESPONSES; DIET; ADOLESCENTS	Stressor experiences during the juvenile period may increase vulnerability to anxiety and depressive-like symptoms in adulthood. Stressors may also promote palatable feeding, possibly reflecting a form of self-medication. The current study investigated the short-and long-term consequences of a stressor applied during the juvenile period on anxiety-and depressive-like behavior measured by the elevated plus maze (EPM), social interaction and forced swim test (FST). Furthermore, the effects of stress on caloric intake, preference for a palatable food and indices of metabolic syndrome and obesity were assessed. Male Wistar rats exposed to 3 consecutive days of variable stressors on postnatal days (PD) 27-29, displayed elevated anxiety-like behaviors as adults, which could be attenuated by consumption of a palatable high-fat diet. However, consumption of a palatable food in response to a stressor appeared to contribute to increased adiposity.	[MacKay, Jennifer Christine; James, Jonathan Stewart; Cayer, Christian; Kent, Pamela; Merali, Zul] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Merali, Zul] Univ Ottawa, Dept Psychiat, Ottawa, ON K1N 6N5, Canada; [Merali, Zul] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada; [MacKay, Jennifer Christine; James, Jonathan Stewart; Cayer, Christian; Kent, Pamela; Merali, Zul] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Carleton University; University of Ottawa	Merali, Z (corresponding author), Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada.	Zul.Merali@uottawa.ca			Canadian Institute for Health Research [275228]; Canadian Health Research Institutes doctoral Canada Graduate Scholarship awarded	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Health Research Institutes doctoral Canada Graduate Scholarship awarded	This project was funded by an operating grant (Application No. 275228) from the Canadian Institute for Health Research (CIHR: http://www.cihr-irsc.gc.ca) awarded to Zul Merali, and by a Canadian Health Research Institutes doctoral Canada Graduate Scholarship awarded to J. Christine MacKay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfeldt MC, 2011, DIABETES, V60, P2506, DOI 10.2337/db11-0083; Akyol A, 2012, BRIT J NUTR, V107, P964, DOI 10.1017/S0007114511003916; Avital A, 2006, BRAIN RES BULL, V68, P419, DOI 10.1016/j.brainresbull.2005.09.015; Avital A, 2005, INT J NEUROPSYCHOPH, V8, P163, DOI 10.1017/S1461145704004808; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bingham B, 2011, PSYCHONEUROENDOCRINO, V36, P249, DOI 10.1016/j.psyneuen.2010.07.015; Buwalda B, 2001, PHYSIOL BEHAV, V73, P371, DOI 10.1016/S0031-9384(01)00493-0; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Cerf ME, 2007, MED SCI MONITOR, V13, pRA12; Christiansen AM, 2011, PHYSIOL BEHAV, V103, P111, DOI 10.1016/j.physbeh.2011.01.015; Coccurello R, 2009, NEUROSCI BIOBEHAV R, V33, P537, DOI 10.1016/j.neubiorev.2008.05.018; Correa A, 2003, BRAIN RES BULL, V62, P197, DOI 10.1016/j.brainresbull.2003.09.013; Cruz ML, 2005, ANNU REV NUTR, V25, P435, DOI 10.1146/annurev.nutr.25.050304.092625; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Dallman MF, 2005, BRAIN BEHAV IMMUN, V19, P275, DOI 10.1016/j.bbi.2004.11.004; de Ferranti S, 2008, CLIN CHEM, V54, P945, DOI 10.1373/clinchem.2007.100156; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DESS NK, 1992, PHYSIOL BEHAV, V52, P115, DOI 10.1016/0031-9384(92)90440-D; DEUSTER PA, 1992, MED SCI SPORT EXER, V24, P72, DOI 10.1249/00005768-199201000-00013; Dube L, 2005, PHYSIOL BEHAV, V86, P559, DOI 10.1016/j.physbeh.2005.08.023; EINON DF, 1977, DEV PSYCHOBIOL, V10, P123, DOI 10.1002/dev.420100205; Fachin A, 2008, APPETITE, V51, P592, DOI 10.1016/j.appet.2008.04.016; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; FONE KCF, 1991, BRAIN RES, V544, P118, DOI 10.1016/0006-8993(91)90892-Y; Foster MT, 2009, ENDOCRINOLOGY, V150, P2325, DOI 10.1210/en.2008-1426; Freedman DS, 1999, PEDIATRICS, V103, P1175, DOI 10.1542/peds.103.6.1175; Friedman JM, 2003, SCIENCE, V299, P856, DOI 10.1126/science.1079856; Garg N, 2011, BIOCHEM BIOPH RES CO, V413, P476, DOI 10.1016/j.bbrc.2011.08.123; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Greaves-Lord K, 2007, ACTA PSYCHIAT SCAND, V116, P137, DOI 10.1111/j.1600-0447.2007.01001.x; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; International Obesity Task Force, 2010, OB GLOB EP; Jacobson-Pick S, 2008, INT J NEUROPSYCHOPH, V11, P891, DOI 10.1017/S1461145708008559; Jacobson-Pick S, 2011, BEHAV BRAIN RES, V216, P365, DOI 10.1016/j.bbr.2010.08.016; Jacobson-Pick S, 2010, BEHAV BRAIN RES, V214, P268, DOI 10.1016/j.bbr.2010.05.036; Jee SH, 2005, YONSEI MED J, V46, P449, DOI 10.3349/ymj.2005.46.4.449; Kallen VL, 2008, DEPRESS ANXIETY, V25, P131, DOI 10.1002/da.20287; KANT GJ, 1993, PHYSIOL BEHAV, V54, P499, DOI 10.1016/0031-9384(93)90242-8; Korner J, 2003, NEW ENGL J MED, V349, P926, DOI 10.1056/NEJMp038114; Kriketos AD, 2004, DIABETES CARE, V27, P2033, DOI 10.2337/diacare.27.8.2033; la Fleur SE, 2005, ENDOCRINOLOGY, V146, P2193, DOI 10.1210/en.2004-1603; Levin BE, 1996, AM J PHYSIOL-REG I, V270, pR456, DOI 10.1152/ajpregu.1996.270.2.R456; Macht M, 2008, APPETITE, V50, P1, DOI 10.1016/j.appet.2007.07.002; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Markus R, 2000, PHYSIOL BEHAV, V70, P333, DOI 10.1016/S0031-9384(00)00265-1; Marti O, 1996, EUR J ENDOCRINOL, V135, P703, DOI 10.1530/eje.0.1350703; McCormick CM, 2010, PROG NEURO-PSYCHOPH, V34, P756, DOI 10.1016/j.pnpbp.2009.09.019; O'Connor DB, 2008, HEALTH PSYCHOL, V27, pS20, DOI 10.1037/0278-6133.27.1.S20; Pecoraro N, 2004, ENDOCRINOLOGY, V145, P3754, DOI 10.1210/en.2004-0305; Pervanidou P, 2011, INT J PEDIATR OBES, V6, P21, DOI 10.3109/17477166.2011.615996; PinhasHamiel O, 1996, J PEDIATR-US, V129, P319; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; SCHILLER GD, 1992, BRAIN RES BULL, V28, P821, DOI 10.1016/0361-9230(92)90267-2; Shaibi GQ, 2008, J PEDIATR-US, V152, P171, DOI 10.1016/j.jpeds.2007.08.010; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Spruijt-Metz D, 2011, J RES ADOLESCENCE, V21, P129, DOI 10.1111/j.1532-7795.2010.00719.x; Strack AM, 1997, AM J PHYSIOL-REG I, V272, pR840, DOI 10.1152/ajpregu.1997.272.3.R840; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Taylor J. R., 1997, INTRO ERROR ANAL; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Toledo-Rodriguez Maria, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/71203; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Toth E, 2008, BEHAV BRAIN RES, V190, P135, DOI 10.1016/j.bbr.2008.02.012; Ulrich-Lai YM, 2007, ENDOCRINOLOGY, V148, P1823, DOI 10.1210/en.2006-1241; Ulrich-Lai YM, 2011, PHYSIOL BEHAV, V103, P104, DOI 10.1016/j.physbeh.2010.12.011; Ulrich-Lai YM, 2010, P NATL ACAD SCI USA, V107, P20529, DOI 10.1073/pnas.1007740107; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Winer B.J., 1962, STAT PRINCIPLES EXPT; Woods SC, 2000, NUTRITION, V16, P894, DOI 10.1016/S0899-9007(00)00454-8; Young JB, 2000, AM J PHYSIOL-REG I, V279, pR1745, DOI 10.1152/ajpregu.2000.279.5.R1745; Zeeni N, 2013, STRESS, V16, P211, DOI 10.3109/10253890.2012.708952; Zellner DA, 2006, PHYSIOL BEHAV, V87, P789, DOI 10.1016/j.physbeh.2006.01.014	79	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96573	10.1371/journal.pone.0096573	http://dx.doi.org/10.1371/journal.pone.0096573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801635	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800085
J	Madanecki, P; Nozell, S; Ochocka, R; Collawn, JF; Bartoszewski, R				Madanecki, Piotr; Nozell, Susan; Ochocka, Renata; Collawn, James F.; Bartoszewski, Rafal			RNAdigest: A Web-Based Tool for the Analysis and Prediction of Structure - Specific RNAse Digestion Results	PLOS ONE			English	Article							SECONDARY STRUCTURE; MESSENGER-RNA; CONSTRAINTS	Despite recent developments in analyzing RNA secondary structures, relatively few RNA structures have been determined. To date, many investigators have relied on the traditional method of using structure-specific RNAse enzymes to probe RNA secondary structures. However, if these data were combined with novel computational approaches, investigators would have an informative and valuable tool for RNA structural analysis. To this end, we created the web server "RNAdigest.'' RNAdigest uses mfold RNA structural models in order to predict the results of RNAse digestion experiments. Furthermore, RNAdigest also utilizes both RNA sequence and the experimental digestion patterns to formulate the constraints for predicting secondary structures of the RNA. Thus, RNAdigest allows for the structural interpretation of RNAse digestion experiments. Overall, RNAdigest simplifies RNAse digestion result analyses while allowing for the identification of unique fragments. These unique fragments can then be used for testing predicted mfold structures and for designing structural-specific DNA/RNA probes.	[Madanecki, Piotr; Ochocka, Renata; Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland; [Nozell, Susan; Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA	Fahrenheit Universities; Medical University Gdansk; University of Alabama System; University of Alabama Birmingham	Bartoszewski, R (corresponding author), Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland.	rafalbar@gumed.edu.pl	Bartoszewski, Rafal A/D-6311-2011	Bartoszewski, Rafal A/0000-0002-2864-6757; Collawn, James/0000-0002-2528-2759	National Science Center OPUS Program [DEC-2011/03/B/NZ3/04387]; National Institutes of Health [NIH 5RO1 DK060065-10, NIH NCI R01CA138517]; NATIONAL CANCER INSTITUTE [R01CA138517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060065] Funding Source: NIH RePORTER	National Science Center OPUS Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Science Center OPUS Program [DEC-2011/03/B/NZ3/04387 (to R. B.)]; and by the National Institutes of Health [NIH 5RO1 DK060065-10 (to J.F.C.), and NIH NCI R01CA138517 (to S.N.)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Cho BR, 2008, B KOREAN CHEM SOC, V29, P1063; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; Hajiaghayi M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-22; HODGSON RAJ, 1994, NUCLEIC ACIDS RES, V22, P1620, DOI 10.1093/nar/22.9.1620; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; QUIGLEY GJ, 1984, NUCLEIC ACIDS RES, V12, P347, DOI 10.1093/nar/12.1Part1.347; SCHULZ VP, 1990, J MOL BIOL, V211, P427, DOI 10.1016/0022-2836(90)90363-Q; Seetin Matthew G, 2012, Methods Mol Biol, V905, P99, DOI 10.1007/978-1-61779-949-5_8; Vojnovic S, 2010, ARCH BIOL SCI, V62, P515, DOI 10.2298/ABS1003515V; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Washietl S, 2012, NUCLEIC ACIDS RES, V40, P4261, DOI 10.1093/nar/gks009; ZARITSKY A, 1991, COMPUT APPL BIOSCI, V7, P57; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	16	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96759	10.1371/journal.pone.0096759	http://dx.doi.org/10.1371/journal.pone.0096759			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801507	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800124
J	Margaliot, M; Sontag, ED; Tuller, T				Margaliot, Michael; Sontag, Eduardo D.; Tuller, Tamir			Entrainment to Periodic Initiation and Transition Rates in a Computational Model for Gene Translation	PLOS ONE			English	Article							NONOPTIMAL CODON USAGE; CELL-CYCLE; MESSENGER-RNA; SYNONYMOUS MUTATIONS; MOLECULAR MOTORS; STEADY-STATES; PROTEIN; EXPRESSION; SEQUENCE; DETERMINANTS	Periodic oscillations play an important role in many biomedical systems. Proper functioning of biological systems that respond to periodic signals requires the ability to synchronize with the periodic excitation. For example, the sleep/wake cycle is a manifestation of an internal timing system that synchronizes to the solar day. In the terminology of systems theory, the biological system must entrain or phase-lock to the periodic excitation. Entrainment is also important in synthetic biology. For example, connecting several artificial biological systems that entrain to a common clock may lead to a well-functioning modular system. The cell-cycle is a periodic program that regulates DNA synthesis and cell division. Recent biological studies suggest that cell-cycle related genes entrain to this periodic program at the gene translation level, leading to periodically-varying protein levels of these genes. The ribosome flow model (RFM) is a deterministic model obtained via a mean-field approximation of a stochastic model from statistical physics that has been used to model numerous processes including ribosome flow along the mRNA. Here we analyze the RFM under the assumption that the initiation and/or transition rates vary periodically with a common period T. We show that the ribosome distribution profile in the RFM entrains to this periodic excitation. In particular, the protein synthesis pattern converges to a unique periodic solution with period T. To the best of our knowledge, this is the first proof of entrainment in a mathematical model for translation that encapsulates aspects such as initiation and termination rates, ribosomal movement and interactions, and non-homogeneous elongation speeds along the mRNA. Our results support the conjecture that periodic oscillations in tRNA levels and other factors related to the translation process can induce periodic oscillations in protein levels, and may suggest a new approach for re-engineering genetic systems to obtain a desired, periodic, protein synthesis rate.	[Margaliot, Michael] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Margaliot, Michael; Tuller, Tamir] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Sontag, Eduardo D.] Rutgers State Univ, Dept Math, Piscataway, NJ USA; [Sontag, Eduardo D.] Rutgers State Univ, Canc Inst New Jersey, Piscataway, NJ USA; [Tuller, Tamir] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Tel Aviv University	Tuller, T (corresponding author), Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	tamirtul@post.tau.ac.il	Sontag, Eduardo D/J-4420-2012	Sontag, Eduardo D/0000-0001-8020-5783; Tuller, Tamir/0000-0003-4194-7068	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086881, R01GM100473] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitken CE, 2010, ANNU REV BIOPHYS, V39, P491, DOI 10.1146/annurev.biophys.093008.131427; Angeli D, 2003, IEEE T AUTOMAT CONTR, V48, P1684, DOI 10.1109/TAC.2003.817920; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bahir I, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.71; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Berger F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208101; Betton JM, 2003, CURR PROTEIN PEPT SC, V4, P73, DOI 10.2174/1389203033380359; Blythe RA, 2007, J PHYS A-MATH THEOR, V40, pR333, DOI 10.1088/1751-8113/40/46/R01; Border K.C., 1989, FIXED POINT THEOREMS; Bruce A., 2002, MOL BIOL CELL, V4th ed.; BULMER M, 1991, GENETICS, V129, P897; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chai Y, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041928; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chou T, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/11/116601; Chowdhury D, 1999, CURR SCI INDIA, V77, P411; Chowdhury D, 2005, PHYS LIFE REV, V2, P318, DOI 10.1016/j.plrev.2005.09.001; Ciandrini L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002866; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Comeron JM, 2006, P NATL ACAD SCI USA, V103, P6940, DOI 10.1073/pnas.0510638103; Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9; Culver GM, 2000, METHOD ENZYMOL, V318, P446; Dana A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002755; Dana A, 2012, J COMPUT BIOL, V19, P200, DOI 10.1089/cmb.2011.0275; DANPURE CJ, 1995, TRENDS CELL BIOL, V5, P230, DOI 10.1016/S0962-8924(00)89016-9; Deneke C, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/046008; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrari PL, 2011, J STAT PHYS, V144, P1123, DOI 10.1007/s10955-011-0318-4; Ferrell JE, 2011, CELL, V144, P874, DOI 10.1016/j.cell.2011.03.006; Forni F, 2014, DIFFERENTIAL LYAPUNO; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Frenkel-Morgenstern M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.3; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HEINRICH R, 1980, J THEOR BIOL, V86, P279, DOI 10.1016/0022-5193(80)90008-9; HEWER GA, 1974, P AM MATH SOC, V44, P151, DOI 10.2307/2039246; Higareda-Mendoza AE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-10; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; John A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.108001; Jovic A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001040; Kapon R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/3/036001; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klumpp S, 2003, J STAT PHYS, V113, P233, DOI 10.1023/A:1025778922620; Kochetov AV, 2006, MOL BIOL+, V40, P705, DOI 10.1134/S0026893306050049; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lohmiller W, 1998, AUTOMATICA, V34, P683, DOI 10.1016/S0005-1098(98)00019-3; MACDONAL.CT, 1968, BIOPOLYMERS, V6, P1, DOI 10.1002/bip.1968.360060102; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Margaliot M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0267; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1724, DOI 10.1109/TCBB.2012.120; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1545, DOI 10.1109/TCBB.2012.88; Mitarai N, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056011; Moreno-Risueno MA, 2010, SCIENCE, V329, P1306, DOI 10.1126/science.1191937; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Pearson CE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002018; Petrov A, 2011, CURR OPIN STRUC BIOL, V21, P137, DOI 10.1016/j.sbi.2010.11.007; Plata G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r98; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Popkov V, 2001, J PHYS A-MATH GEN, V34, pL45, DOI 10.1088/0305-4470/34/6/103; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; Racle J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003240; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Reuveni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002127; Russo G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000739; Schadschneider A, 2011, STOCHASTIC TRANSPORT IN COMPLEX SYSTEMS: FROM MOLECULES TO VEHICLES, P1; Schmeing TM, 2011, NAT STRUCT MOL BIOL, V18, P432, DOI 10.1038/nsmb.2003; Schmidt MW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100117; Shah P, 2013, CELL, V153, P1589, DOI 10.1016/j.cell.2013.05.049; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; Shah P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001128; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Sharma AK, 2011, J THEOR BIOL, V289, P36, DOI 10.1016/j.jtbi.2011.08.023; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Shaw LB, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021910; Singh A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.38; SMILLIE J, 1984, SIAM J MATH ANAL, V15, P530, DOI 10.1137/0515040; Smith H. L., 1995, MATH SURVEYS MONOGRA, V41, DOI DOI 10.1090/SURV/041; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Srinivasa S, 2012, IEEE T MOBILE COMPUT, V11, P618, DOI 10.1109/TMC.2011.96; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Stueber D, 1984, J EMBO, V3; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Tabak J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001124; Tabareau N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000637; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Toettcher JE, 2010, P NATL ACAD SCI USA, V107, P17047, DOI 10.1073/pnas.1005615107; Tripathy G, 1998, PHYS REV E, V58, P1911, DOI 10.1103/PhysRevE.58.1911; Tuller T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r110; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Uemura S, 2010, NATURE, V464, P1012, DOI 10.1038/nature08925; van Weringh A, 2011, MOL BIOL EVOL, V28, P1827, DOI 10.1093/molbev/msr005; VIDYASAGAR M, 1978, J MATH ANAL APPL, V62, P90, DOI 10.1016/0022-247X(78)90221-4; Vidyasagar M., 1978, NONLINEAR SYSTEMS AN; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Warnecke T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.94; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Zarai Y, 2013, IEEE ACM T COMPUT BI, V10, P1322, DOI 10.1109/TCBB.2013.120; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; ZHANG SP, 1994, J THEOR BIOL, V170, P339, DOI 10.1006/jtbi.1994.1196; Zhang ZG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.101; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	123	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96039	10.1371/journal.pone.0096039	http://dx.doi.org/10.1371/journal.pone.0096039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800863	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800040
J	Yi, JH; Wang, D; Li, ZY; Hu, J; Niu, XF; Liu, XL				Yi, Jian-Hua; Wang, Dong; Li, Zhi-Yong; Hu, Jun; Niu, Xiao-Feng; Liu, Xiao-Lin			C-Reactive Protein as a Prognostic Factor for Human Osteosarcoma: A Meta-Analysis and Literature Review	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; LEVEL PREDICTS PROGNOSIS; POOR-PROGNOSIS; BREAST-CANCER; LUNG-CANCER; GASTRIC-CANCER; PREOPERATIVE ELEVATION; PROSTATE-CANCER; METASTATIC OSTEOSARCOMA; COLORECTAL-CARCINOMA	Background: Osteosarcoma most common primary bone cancer in growing adolescents and young adults. The prognostic role of C-reactive protein (CRP) in patients with osteosarcoma is not fully investigated. The purpose of this study is to perform a meta-analysis and literature review on the role of CRP in osteosarcoma and to assess the potential role of serum CRP as a prognostic factor for patients with osteosarcoma. Methods: A detailed literature search was made in Medline for related research publications written in English. Methodological quality of the studies was also evaluated. The data were extracted and assessed by two reviewers independently. Analysis of pooled data were performed, risk ratio (RR) and corresponding confidence intervals (CIs) were calculated and summarized respectively. Results: Final analysis of 397 patients from 2 eligible studies was performed. Combined RR of CRP expression suggested that the raised serum CRP level had an adverse prognostic effect on overall survival of patients with osteosarcoma (n = 397 in 2 studies; RR = 0.35; 95% CI: 0.18-0.68; p = 0.002). In the uni- and multivariate survival analysis, response rate and CRP levels were the only independent prognostic variables. Conclusions: The results of this meta-analysis suggest that CRP expression confers a worse prognosis in patients with osteosarcoma. Large prospective studies are necessary to provide solid data to confirm the prognostic significance of CRP.	[Yi, Jian-Hua; Wang, Dong; Li, Zhi-Yong; Hu, Jun; Niu, Xiao-Feng; Liu, Xiao-Lin] Sun Yat Sen Univ Guangzhou, Affiliated Hosp 1, Upper Limb Orthoped Dept Huang Pu Award, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Li, ZY (corresponding author), Sun Yat Sen Univ Guangzhou, Affiliated Hosp 1, Upper Limb Orthoped Dept Huang Pu Award, Guangzhou, Guangdong, Peoples R China.	zhiyongli01@yeah.net						Al Murri AM, 2006, BRIT J CANCER, V94, P227, DOI 10.1038/sj.bjc.6602922; Albuquerque K V, 1995, Eur J Surg Oncol, V21, P504, DOI 10.1016/S0748-7983(95)96935-7; Alkhateeb AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051379; Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Allin KH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2891; Andersson BA, 2014, J CANCER RES CLIN, V140, P515, DOI 10.1007/s00432-014-1592-8; ASANO T, 1993, J IMMUNOTHER, V14, P286, DOI 10.1097/00002371-199311000-00006; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beer TM, 2008, CANCER, V112, P2377, DOI 10.1002/cncr.23461; Cha-Molstad H, 2000, J IMMUNOL, V165, P4592, DOI 10.4049/jimmunol.165.8.4592; Cha-Molstad H, 2007, MOL IMMUNOL, V44, P2933, DOI 10.1016/j.molimm.2007.01.015; Chen HH, 2011, CLIN OTOLARYNGOL, V36, P147, DOI 10.1111/j.1749-4486.2011.02274.x; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; Chung YC, 2003, EUR J GASTROEN HEPAT, V15, P369, DOI 10.1097/00042737-200304000-00006; Cota GF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002195; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; de Martino M, 2013, BJU INT, V111, pE348, DOI 10.1111/bju.12067; DEODHAR SD, 1989, CLEV CLIN J MED, V56, P126; Devaraj S, 2009, CLIN CHEM, V55, P229, DOI 10.1373/clinchem.2008.108886; DUNN D, 1977, CANCER-AM CANCER SOC, V40, P3054, DOI 10.1002/1097-0142(197712)40:6<3054::AID-CNCR2820400644>3.0.CO;2-A; Eggers H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0705-6; Elahi MM, 2004, NUTR CANCER, V48, P171, DOI 10.1207/s15327914nc4802_6; Feng JF, 2013, ONCOTARGETS THER, V6, P1147, DOI 10.2147/OTT.S50039; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Funovics PT, 2011, INT ORTHOP, V35, P1529, DOI 10.1007/s00264-011-1208-8; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gagnon B, 2010, BRIT J CANCER, V102, P1113, DOI 10.1038/sj.bjc.6605603; Gakis G, 2011, BJU INT, V108, P1800, DOI 10.1111/j.1464-410X.2011.10234.x; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Gockel I, 2006, WORLD J GASTROENTERO, V12, P3746, DOI 10.3748/wjg.v12.i23.3746; Guillem P, 2005, DIS ESOPHAGUS, V18, P146, DOI 10.1111/j.1442-2050.2005.00474.x; Guo SC, 2012, BBA-REV CANCER, V1825, P207, DOI 10.1016/j.bbcan.2012.01.002; Han YJ, 2011, INT J BIOL MARKER, V26, P209, DOI 10.5301/JBM.2011.8872; Hefler LA, 2008, CLIN CANCER RES, V14, P710, DOI 10.1158/1078-0432.CCR-07-1044; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Hong S, 2012, YONSEI MED J, V53, P111, DOI 10.3349/ymj.2012.53.1.111; Hribal ML, 2013, CURR PHARM DES; Ito K, 2011, J UROLOGY, V186, P430, DOI 10.1016/j.juro.2011.03.113; Ito M, 2011, UROLOGY, V78, P1131, DOI 10.1016/j.urology.2011.07.1416; Jansson AF, 2009, ARTHRITIS RHEUM, V60, P1152, DOI 10.1002/art.24402; Jialal I, 2004, HYPERTENSION, V44, P6, DOI 10.1161/01.HYP.0000130484.20501.df; Karakiewicz PI, 2007, CANCER-AM CANCER SOC, V110, P1241, DOI 10.1002/cncr.22896; Kaya M, 2000, CLIN CANCER RES, V6, P572; Khandavilli SD, 2009, ORAL ONCOL, V45, P912, DOI 10.1016/j.oraloncology.2009.03.015; KLEINERMAN ES, 1995, J IMMUNOTHER, V17, P181, DOI 10.1097/00002371-199504000-00007; KLEINERMAN ES, 1992, J CLIN ONCOL, V10, P1310, DOI 10.1200/JCO.1992.10.8.1310; Koch A, 2009, J THORAC ONCOL, V4, P326, DOI 10.1097/JTO.0b013e31819578c8; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; Komai Y, 2007, BJU INT, V99, P77, DOI 10.1111/j.1464-410X.2006.06497.x; KUSHNER I, 2006, AM J MED, V119; Lyu YX, 2013, TRANSPL INFECT DIS, V15, P290, DOI 10.1111/tid.12055; Mahmoud Fade Aziz, 2002, Curr Oncol Rep, V4, P250, DOI 10.1007/s11912-002-0023-1; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; McCall P, 2011, CANCER BIOMARK, V10, P91, DOI 10.3233/CBM-2012-0236; Mialou V, 2005, CANCER-AM CANCER SOC, V104, P1100, DOI 10.1002/cncr.21263; Mohri Y, 2012, ANTICANCER RES, V32, P4581; Mulrooney DA, 2013, PEDIATR BLOOD CANCER, V60, P1703, DOI 10.1002/pbc.24610; Naito S, 2013, UROLOGY, V82, P846, DOI 10.1016/j.urology.2013.06.035; Nakamura T, 2013, BONE JOINT J, V95B, P411, DOI 10.1302/0301-620X.95B3.30344; Nakamura T, 2012, CANCER-AM CANCER SOC, V118, P1055, DOI 10.1002/cncr.26353; Nishikawa T, 2008, J IMMUNOL, V180, P3492, DOI 10.4049/jimmunol.180.5.3492; Nozoe T, 2001, AM J SURG, V182, P197, DOI 10.1016/S0002-9610(01)00684-5; Nozoe T, 2008, SURG TODAY, V38, P597, DOI 10.1007/s00595-007-3680-8; Nozoe T, 2011, SURG TODAY, V41, P510, DOI 10.1007/s00595-009-4297-x; O'Dowd C, 2010, J THORAC ONCOL, V5, P988, DOI 10.1097/JTO.0b013e3181da78f9; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Peng TI, 2012, J PINEAL RES, V52, P93, DOI 10.1111/j.1600-079X.2011.00923.x; PEPYS MB, 1981, LANCET, V1, P653; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Pine JK, 2009, EJSO-EUR J SURG ONC, V35, P605, DOI 10.1016/j.ejso.2008.12.002; Pond GR, 2012, BJU INT, V110, pE461, DOI 10.1111/j.1464-410X.2012.11148.x; Prins RC, 2012, UROL ONCOL-SEMIN ORI, V30, P33, DOI 10.1016/j.urolonc.2009.11.012; Provisor AJ, 1997, J CLIN ONCOL, V15, P76, DOI 10.1200/JCO.1997.15.1.76; Sadikovic Bekim, 2013, Methods Mol Biol, V973, P227, DOI 10.1007/978-1-62703-281-0_15; Saito K, 2012, BJU INT, V110, P1478, DOI 10.1111/j.1464-410X.2012.11153.x; Saito K, 2009, EUR UROL, V55, P1145, DOI 10.1016/j.eururo.2008.10.012; Sanjay P, 2012, J PANCREAS, V13, P199; Schwartsburd PM, 2003, CANCER METAST REV, V22, P95, DOI 10.1023/A:1022220219975; Schwinger W, 2005, ANN ONCOL, V16, P1199, DOI 10.1093/annonc/mdi226; Shimada H, 2003, J SURG ONCOL, V83, P248, DOI 10.1002/jso.10275; Shimura T, 2012, ANTICANCER RES, V32, P491; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; Smith Gary Robert, 2004, J Inflamm (Lond), V1, P3, DOI 10.1186/1476-9255-1-3; Steffens S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-399; Szalai AJ, 2000, INFECT IMMUN, V68, P5652, DOI 10.1128/IAI.68.10.5652-5656.2000; SZALAI AJ, 1995, J IMMUNOL, V155, P2557; Szkandera J, 2013, BR J CANC; Takasu C, 2013, HEPATO-GASTROENTEROL, V60, P507, DOI 10.5754/hge11425; Terlizzi M, 2014, PHARM THER; Toiyama Y, 2013, ONCOL LETT, V5, P1881, DOI 10.3892/ol.2013.1308; Tomita M, 2012, ANTICANCER RES, V32, P3535; Trapani S, 2000, SEMIN ARTHRITIS RHEU, V29, P348, DOI 10.1053/sarh.2000.5752; Venugopal SK, 2005, CURR OPIN NEPHROL HY, V14, P33, DOI 10.1097/00041552-200501000-00006; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Voleti B, 2005, J IMMUNOL, V175, P3386, DOI 10.4049/jimmunol.175.5.3386; Wang CY, 2009, RADIOTHER ONCOL, V92, P270, DOI 10.1016/j.radonc.2009.01.002; Wang Chia-Siu, 2009, Chang Gung Med J, V32, P471; Wong VKH, 2007, BRIT J CANCER, V96, P222, DOI 10.1038/sj.bjc.6603558; Woo Y, 2012, J SURG ONCOL, V105, P405, DOI 10.1002/jso.22129; Yoshida S, 2008, BJU INT, V101, P978, DOI 10.1111/j.1464-410X.2007.07408.x; Zeng YC, 2012, TUMOR BIOL, V33, P891, DOI 10.1007/s13277-012-0330-6; Zhang DX, 1996, J BIOL CHEM, V271, P9503, DOI 10.1074/jbc.271.16.9503; Zhu LM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00230; Zimmerman MA, 2003, ARCH SURG-CHICAGO, V138, P220, DOI 10.1001/archsurg.138.2.220	107	52	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94632	10.1371/journal.pone.0094632	http://dx.doi.org/10.1371/journal.pone.0094632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800842	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800019
J	Dichamp, I; Seite, P; Agius, G; Barbarin, A; Beby-Defaux, A				Dichamp, Isabelle; Seite, Paule; Agius, Gerard; Barbarin, Alice; Beby-Defaux, Agnes			Human Papillomavirus 16 Oncoprotein E7 Stimulates UBF1-Mediated rDNA Gene Transcription, Inhibiting a p53-Independent Activity of p14(ARF)	PLOS ONE			English	Article							RNA-POLYMERASE-I; ARF TUMOR-SUPPRESSOR; TYPE-16 E7; BINDING PROTEIN; FACTOR UBF; CYCLIN-E; ACTIVATION; E6; PHOSPHORYLATION; TARGET	High-risk human papillomavirus oncoproteins E6 and E7 play a major role in HPV-related cancers. One of the main functions of E7 is the degradation of pRb, while E6 promotes the degradation of p53, inactivating the p14(ARF)-p53 pathway. pRb and p14(ARF) can repress ribosomal DNA (rDNA) transcription in part by targeting the Upstream Binding Factor 1 (UBF1), a key factor in the activation of RNA polymerase I machinery. We showed, through ectopic expression and siRNA silencing of p14(ARF) and/or E7, that E7 stimulates UBF1-mediated rDNA gene transcription, partly because of increased levels of phosphorylated UBF1, preventing the inhibitory function of p14(ARF). Unexpectedly, activation of rDNA gene transcription was higher in cells co-expressing p14(ARF) and E7, compared to cells expressing E7 alone. We did not find a difference in P-UBF1 levels that could explain this data. However, p14(ARF) expression induced E7 to accumulate into the nucleolus, where rDNA transcription takes place, providing an opportunity for E7 to interact with nucleolar proteins involved in this process. GST-pull down and co-immunoprecipitation assays showed interactions between p14(ARF), UBF1 and E7, although p14(ARF) and E7 are not able to directly interact. Co-expression of a pRb-binding-deficient mutant (E7C24G) and p14(ARF) resulted in EC24G nucleolar accumulation, but not in a significant higher activation of rDNA transcription, suggesting that the inactivation of pRb is involved in this phenomenon. Thus, p14(ARF) fails to prevent E7-mediated UBF1 phosphorylation, but could facilitate nucleolar pRb inactivation by targeting E7 to the nucleolus. While others have reported that p19(ARF), the mouse homologue of p14(ARF), inhibits some functions of E7, we showed that E7 inhibits a p53-independent function of p14(ARF). These results point to a mutually functional interaction between p14(ARF) and E7 that might partly explain why the sustained p14(ARF) expression observed in most cervical pre-malignant lesions and malignancies may be ineffective.	[Dichamp, Isabelle; Agius, Gerard; Beby-Defaux, Agnes] Ctr Hosp Univ Poitiers, Fac Med & Pharm, Unite Virol, Poitiers, France; [Seite, Paule; Barbarin, Alice; Beby-Defaux, Agnes] Univ Poitiers, Equipe Emergente 2RCT Recepteurs Regulat Cellules, Poitiers, France	CHU Poitiers; Universite de Poitiers; Universite de Poitiers	Beby-Defaux, A (corresponding author), Ctr Hosp Univ Poitiers, Fac Med & Pharm, Unite Virol, Poitiers, France.	agnes.beby-defaux@chu-poitiers.fr	Barbarin, Alice/GSE-2933-2022	Barbarin, Alice/0000-0003-1593-065X; Seite, Paule/0000-0002-7809-7610	University of Poitiers	University of Poitiers	This work was funded by the University of Poitiers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi R, 2011, J VIROL, V85, P8208, DOI 10.1128/JVI.00114-11; Apicelli AJ, 2008, MOL CELL BIOL, V28, P1068, DOI 10.1128/MCB.00484-07; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Ayrault O, 2004, ONCOGENE, V23, P8097, DOI 10.1038/sj.onc.1207968; Baldwin A, 2006, J VIROL, V80, P6669, DOI 10.1128/JVI.02497-05; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Bulten J, 2006, GYNECOL ONCOL, V101, P487, DOI 10.1016/j.ygyno.2005.11.036; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Ganzenmueller T, 2008, VIROLOGY, V372, P313, DOI 10.1016/j.virol.2007.11.006; Garcia MA, 2006, EMBO J, V25, P4284, DOI 10.1038/sj.emboj.7601302; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; He WX, 2003, J VIROL, V77, P10566, DOI 10.1128/JVI.77.19.10566-10574.2003; Humbey O, 2008, CANCER RES, V68, P9608, DOI 10.1158/0008-5472.CAN-08-2263; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Kao CF, 2004, J BIOMED SCI, V11, P72, DOI 10.1159/000075291; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Lessard F, 2010, MOL CELL, V38, P539, DOI 10.1016/j.molcel.2010.03.015; Lindstrom MS, 2006, CELL BIOCHEM BIOPHYS, V46, P79, DOI 10.1385/CBB:46:1:79; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Martin LG, 1998, J VIROL, V72, P975, DOI 10.1128/JVI.72.2.975-985.1998; Massimi P, 1997, J GEN VIROL, V78, P2607, DOI 10.1099/0022-1317-78-10-2607; MAZZARELLI JM, 1995, ONCOGENE, V11, P1859; McCloskey R, 2010, J VIROL, V84, P5131, DOI 10.1128/JVI.01965-09; McLaughlin-Drubin ME, 2013, P NATL ACAD SCI USA, V110, P16175, DOI 10.1073/pnas.1310432110; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Pan W, 2003, ONCOGENE, V22, P5496, DOI 10.1038/sj.onc.1206857; Raychaudhuri S, 2009, CANCER RES, V69, P2057, DOI 10.1158/0008-5472.CAN-08-3468; Rizos H, 2006, J BIOL CHEM, V281, P38080, DOI 10.1074/jbc.M609405200; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Saporita AJ, 2011, CANCER RES, V71, P6708, DOI 10.1158/0008-5472.CAN-11-1472; Sauer K, 1995, Prog Cell Cycle Res, V1, P125; Sekaric P, 2007, ONCOGENE, V26, P6261, DOI 10.1038/sj.onc.1210462; Shamanin VA, 2008, J VIROL, V82, P3912, DOI 10.1128/JVI.02466-07; Shen J, 2011, BIOCHEM J, V434, P275, DOI 10.1042/BJ20101163; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; STOREY A, 1988, EMBO J, V7, P1815, DOI 10.1002/j.1460-2075.1988.tb03013.x; Sugimoto M, 2003, MOL CELL, V11, P415, DOI 10.1016/S1097-2765(03)00057-1; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tsoumpou I, 2009, CANCER TREAT REV, V35, P210, DOI 10.1016/j.ctrv.2008.10.005; Vazquez-Vega S, 2010, CANCER BIOMARK, V8, P341, DOI [10.3233/CBM-2010-0223, 10.3233/CBM-2011-0223]; VOIT R, 1995, NUCLEIC ACIDS RES, V23, P2593, DOI 10.1093/nar/23.14.2593; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang HD, 1998, MOL CELL BIOL, V18, P7086, DOI 10.1128/MCB.18.12.7086; Wang JL, 2005, MODERN PATHOL, V18, P629, DOI 10.1038/modpathol.3800308; Zatsepina O, 1997, ONCOGENE, V14, P1137, DOI 10.1038/sj.onc.1200946; ZERFASS K, 1995, J VIROL, V69, P6389, DOI 10.1128/JVI.69.10.6389-6399.1995; Zhai WG, 1997, GENE DEV, V11, P1605, DOI 10.1101/gad.11.12.1605; Zhai WG, 1999, MOL CELL BIOL, V19, P2791; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	57	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96136	10.1371/journal.pone.0096136	http://dx.doi.org/10.1371/journal.pone.0096136			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798431	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000039
J	Drury, PP; Davidson, JO; van den Heuij, LG; Wassink, G; Gunn, ER; Booth, LC; Bennet, L; Gunn, AJ				Drury, Paul P.; Davidson, Joanne O.; van den Heuij, Lotte G.; Wassink, Guido; Gunn, Eleanor R.; Booth, Lindsea C.; Bennet, Laura; Gunn, Alistair J.			Status Epilepticus after Prolonged Umbilical Cord Occlusion Is Associated with Greater Neural Injury Fetal Sheep at Term-Equivalent	PLOS ONE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; CONNEXIN HEMICHANNEL BLOCKADE; BRAIN-INJURY; PERINATAL ASPHYXIA; CEREBRAL-ISCHEMIA; MATTER INJURY; BLOOD-FLOW; SEIZURES; LAMBS; HYPOTHERMIA	The majority of pre-clinical studies of hypoxic-ischemic encephalopathy at term-equivalent have focused on either relatively mild insults, or on functional paradigms of cerebral ischemia or hypoxia-ischemia/hypotension. There is surprisingly little information on the responses to single, severe 'physiological' insults. In this study we examined the evolution and pattern of neural injury after prolonged umbilical cord occlusion (UCO). 36 chronically instrumented fetal sheep at 125-129 days gestational age (term = 147 days) were subjected to either UCO until mean arterial pressure was <= 8 mmHg (n = 29), or sham occlusion (n = 7). Surviving fetuses were killed after 72 hours for histopathologic assessment with acid-fuchsin thionine. After UCO, 11 fetuses died with intractable hypotension and 5 ewes entered labor and were euthanized. The remaining 13 fetuses showed marked EEG suppression followed by evolving seizures starting at 5.8 (6.8) hours (median (interquartile range)). 6 of 13 developed status epilepticus, which was associated with a transient secondary increase in cortical impedance (a measure of cytotoxic edema, p<0.05). All fetuses showed moderate to severe neuronal loss in the hippocampus and the basal ganglia but mild cortical cell loss (p<0.05 vs sham occlusion). Status epilepticus was associated with more severe terminal hypotension (p<0.05) and subsequently, greater neuronal loss (p<0.05). In conclusion, profound UCO in term-equivalent fetal sheep was associated with delayed seizures, secondary cytotoxic edema, and subcortical injury, consistent with the predominant pattern after peripartum sentinel events at term. It is unclear whether status epilepticus exacerbated cortical injury or was simply a reflection of a longer duration of asphyxia.	[Drury, Paul P.; Davidson, Joanne O.; van den Heuij, Lotte G.; Wassink, Guido; Gunn, Eleanor R.; Booth, Lindsea C.; Bennet, Laura; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Fetal Physiol & Neurosci Grp, Auckland 1, New Zealand; [Booth, Lindsea C.] Univ Melbourne, Howard Florey Inst, Melbourne, Vic, Australia; [Gunn, Alistair J.] Starship Childrens Hosp, Auckland, New Zealand	University of Auckland; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Starship Children's Hospital	Gunn, AJ (corresponding author), Univ Auckland, Dept Physiol, Fetal Physiol & Neurosci Grp, Auckland 1, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Bennet, Laura/0000-0002-4336-7596; Davidson, Joanne/0000-0002-6781-4258; Gunn, Alistair/0000-0003-0656-7035; Booth, Lindsea/0000-0003-3093-5766	Health Research Council of New Zealand; Auckland Medical Research Foundation; New Zealand Neurological Foundation W& B Miller Doctoral Scholarship	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; New Zealand Neurological Foundation W& B Miller Doctoral Scholarship	This study was supported by the Health Research Council of New Zealand and the Auckland Medical Research Foundation. P Drury is supported by the New Zealand Neurological Foundation W& B Miller Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Barkovich AJ, 2006, AM J NEURORADIOL, V27, P533; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P427; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Bennet L, 1999, J PHYSIOL-LONDON, V517, P247, DOI 10.1111/j.1469-7793.1999.0247z.x; Bernal AL, 2003, BJOG-INT J OBSTET GY, V110, P39, DOI 10.1016/S1470-0328(03)00023-5; Bjorkman ST, 2010, NEUROSCIENCE, V166, P157, DOI 10.1016/j.neuroscience.2009.11.067; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Davidson JO, 2013, EXP NEUROL, V248, P301, DOI 10.1016/j.expneurol.2013.06.026; Davidson JO, 2012, INT J MOL SCI, V13, P6303, DOI 10.3390/ijms13056303; Davidson JO, 2012, ANN NEUROL, V71, P121, DOI 10.1002/ana.22654; DAWES GS, 1959, J PHYSIOL-LONDON, V146, P516, DOI 10.1113/jphysiol.1959.sp006208; de Vries LS, 2010, ARCH DIS CHILD-FETAL, V95, pF220, DOI 10.1136/adc.2008.148205; DeHaan HH, 1997, PEDIATR RES, V41, P96, DOI 10.1203/00006450-199701000-00015; Drury PP, 2013, EXP PHYSIOL, V98, P699, DOI 10.1113/expphysiol.2012.069989; Drury PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039273; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; DUNNIHOO DR, 1973, AM J OBSTET GYNECOL, V116, P648, DOI 10.1016/S0002-9378(15)33129-X; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Geddes R, 2001, DEV NEUROSCI-BASEL, V23, P180, DOI 10.1159/000046140; Glass HC, 2011, J PEDIATR-US, V159, P731, DOI 10.1016/j.jpeds.2011.07.015; GLUCKMAN PD, 1983, J DEV PHYSIOL, V5, P101; Gonzalez H, 2005, J CEREBR BLOOD F MET, V25, P911, DOI 10.1038/sj.jcbfm.9600087; Gunn A J, 2006, NeuroRx, V3, P154, DOI 10.1007/BF03207046; Gunn AJ, 2000, AM J OBSTET GYNECOL, V183, P1564, DOI 10.1067/mob.2000.108084; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Haaland K, 1997, PEDIATR RES, V41, P505, DOI 10.1203/00006450-199704000-00009; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Ikeda T, 1998, AM J OBSTET GYNECOL, V178, P24, DOI 10.1016/S0002-9378(98)70621-0; Jensen EC, 2010, AM J PHYSIOL-REG I, V298, pR700, DOI 10.1152/ajpregu.00474.2009; LAWLER FH, 1982, AM J PHYSIOL, V243, pR433, DOI 10.1152/ajpregu.1982.243.3.R433; Lynch NE, 2012, EPILEPSIA, V53, P549, DOI 10.1111/j.1528-1167.2011.03401.x; MALLARD EC, 1993, PEDIATR RES, V33, P61, DOI 10.1203/00006450-199301000-00013; McBride MC, 2000, NEUROLOGY, V55, P506, DOI 10.1212/WNL.55.4.506; Miller SP, 2002, NEUROLOGY, V58, P542, DOI 10.1212/WNL.58.4.542; NEVANDER G, 1985, ANN NEUROL, V18, P281, DOI 10.1002/ana.410180303; Okereafor A, 2008, PEDIATRICS, V121, P906, DOI 10.1542/peds.2007-0770; Pisani F, 2007, NEUROLOGY, V69, P2177, DOI 10.1212/01.wnl.0000295674.34193.9e; Robertson NJ, 2013, BRAIN, V136, P90, DOI 10.1093/brain/aws285; SCHER MS, 1993, EPILEPSIA, V34, P284, DOI 10.1111/j.1528-1157.1993.tb02412.x; Shah PS, 2009, AM J PERINAT, V26, P39, DOI 10.1055/s-0028-1095185; TAN WKM, 1992, ANN NEUROL, V32, P677, DOI 10.1002/ana.410320511; THORNBERG E, 1995, ARCH DIS CHILD-FETAL, V72, pF39, DOI 10.1136/fn.72.1.F39; Thorngren-Jerneck K, 2001, J NEUROSCI RES, V66, P844, DOI 10.1002/jnr.10051; VANBEL F, 1994, PEDIATR RES, V35, P329; Wibbens B, 2005, AM J OBSTET GYNECOL, V193, P803, DOI 10.1016/j.ajog.2005.01.058; Wibbens B, 2001, RELATIONSHIP CHANGES; Wibbens B, 2007, AM J PHYSIOL-REG I, V293, pR1287, DOI 10.1152/ajpregu.00373.2007; WILLIAMS CE, 1990, PEDIATR RES, V27, P561, DOI 10.1203/00006450-199006000-00004; WILLIAMS CJ, 1991, BRIT MED J, V303, P516, DOI 10.1136/bmj.303.6801.516; Wirrell EC, 2001, PEDIATR RES, V50, P445, DOI 10.1203/00006450-200110000-00005; YEO CL, 1994, J PAEDIATR CHILD H, V30, P129, DOI 10.1111/j.1440-1754.1994.tb00596.x	55	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96530	10.1371/journal.pone.0096530	http://dx.doi.org/10.1371/journal.pone.0096530			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797081	Green Published, gold			2022-12-27	WOS:000336656000088
J	Huppert, LA; Ramsdell, TL; Chase, MR; Sarracino, DA; Fortune, SM; Burton, BM				Huppert, Laura A.; Ramsdell, Talia L.; Chase, Michael R.; Sarracino, David A.; Fortune, Sarah M.; Burton, Briana M.			The ESX System in Bacillus subtilis Mediates Protein Secretion	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; BIOFILM FORMATION; ESAT-6; TRANSCRIPTION; ATTENUATION; SPORULATION; EXPRESSION; VIRULENCE; PLASMIDS; REVEALS	Esat-6 protein secretion systems (ESX or Ess) are required for the virulence of several human pathogens, most notably Mycobacterium tuberculosis and Staphylococcus aureus. These secretion systems are defined by a conserved FtsK/SpoIIIE family ATPase and one or more WXG100 family secreted substrates. Gene clusters coding for ESX systems have been identified amongst many organisms including the highly tractable model system, Bacillus subtilis. In this study, we demonstrate that the B. subtilis yuk/yue locus codes for a nonessential ESX secretion system. We develop a functional secretion assay to demonstrate that each of the locus gene products is specifically required for secretion of the WXG100 virulence factor homolog, YukE. We then employ an unbiased approach to search for additional secreted substrates. By quantitative profiling of culture supernatants, we find that YukE may be the sole substrate that depends on the FtsK/SpoIIIE family ATPase for secretion. We discuss potential functional implications for secretion of a unique substrate.	[Huppert, Laura A.; Burton, Briana M.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ramsdell, Talia L.; Chase, Michael R.; Fortune, Sarah M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sarracino, David A.] Thermo Fisher Sci, BRIMS Unit, Cambridge, MA USA	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Thermo Fisher Scientific	Burton, BM (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	bburton@mcb.harvard.edu	Huppert, Laura/AAQ-8994-2021	Fortune, Sarah/0000-0001-7565-9975	Harvard University Milton Fund (BMB); HHMI Physician Scientist Early Career Award (SMF); Hood Foundation (SMF); NIH [1DP20D001378]	Harvard University Milton Fund (BMB); HHMI Physician Scientist Early Career Award (SMF); Hood Foundation (SMF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Harvard University Milton Fund (BMB) (www.harvard.edu), an HHMI Physician Scientist Early Career Award (SMF) (www.hhmi.org), The Hood Foundation (SMF) (http://hria.org/tmfservices.html), and by NIH grant 1DP20D001378 (SMF) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Anderson M, 2011, J BACTERIOL, V193, P1583, DOI 10.1128/JB.01096-10; Baptista C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067840; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Burts ML, 2008, MOL MICROBIOL, V69, P736, DOI 10.1111/j.1365-2958.2008.06324.x; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chen YH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-219; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Coros A, 2008, MOL MICROBIOL, V69, P794, DOI 10.1111/j.1365-2958.2008.06299.x; Cutting S., 1990, MOL BIOL METHODS BAC; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; Desvaux P, 2004, PROG UROL, V14, P512; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Economou A, 2006, MOL MICROBIOL, V62, P308, DOI 10.1111/j.1365-2958.2006.05377.x; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Fujita M, 2000, GENES CELLS, V5, P79, DOI 10.1046/j.1365-2443.2000.00307.x; Fyans JK, 2012, MOL PLANT PATHOL; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Garti-Levi S, 2013, J BACTERIOL, V195, P1475, DOI 10.1128/JB.02160-12; Garufi G, 2008, J BACTERIOL, V190, P7004, DOI 10.1128/JB.00458-08; GRYCZAN TJ, 1978, J BACTERIOL, V134, P318, DOI 10.1128/JB.134.1.318-329.1978; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; Marchadier E, 2011, PROTEOMICS, V11, P2981, DOI 10.1002/pmic.201000791; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Raghavan S, 2008, NATURE, V454, P717, DOI 10.1038/nature07219; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Robinson C, 2011, BBA-BIOMEMBRANES, V1808, P876, DOI 10.1016/j.bbamem.2010.11.023; Rosch TC, 2014, APPL ENVIRON MICROB, V80, P1349, DOI 10.1128/AEM.03154-13; Rosenberg A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041921; RUIZ A, 1982, SABOURAUDIA, V20, P21; Sambrook J., 2006, CONDENSED PROTOCOLS; San Roman SA, 2010, MICROBIOL-SGM, V156, P1719, DOI 10.1099/mic.0.037069-0; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sao-Jose C, 2004, J BACTERIOL, V186, P8337, DOI 10.1128/JB.186.24.8337-8346.2004; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Sutcliffe IC, 2011, ANTON LEEUW INT J G, V99, P127, DOI 10.1007/s10482-010-9507-4; VANPITTIUS NCG, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-10-RESEARCH0044; Xia YF, 2011, FEMS MICROBIOL LETT, V322, P99, DOI 10.1111/j.1574-6968.2011.02336.x; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	57	34	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96267	10.1371/journal.pone.0096267	http://dx.doi.org/10.1371/journal.pone.0096267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798022	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000056
J	Selvakumar, A; Antony, C; Singhal, J; Tiwari, BK; Singh, Y; Natarajan, K				Selvakumar, Arti; Antony, Cecil; Singhal, Jhalak; Tiwari, Brijendra K.; Singh, Yogendra; Natarajan, Krishnamurthy			Reciprocal Regulation of Reactive Oxygen Species and Phospho-CREB Regulates Voltage Gated Calcium Channel Expression during Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							DENDRITIC CELLS; MACROPHAGES; ACTIVATION; PROTEIN	Our previous work has demonstrated the roles played by L-type Voltage Gated Calcium Channels (VGCC) in regulating Mycobacterium tuberculosis (M. tb) survival and pathogenesis. Here we decipher mechanisms and pathways engaged by the pathogen to regulate VGCC expression in macrophages. We show that M. tb and its antigen Rv3416 use phospho-CREB (pCREB), Reactive Oxygen Species (ROS), Protein Kinase C (PKC) and Mitogen Activated Protein Kinase (MAPK) to modulate VGCC expression in macrophages. siRNA mediated knockdown of MyD88, IRAK1, IRAK2 or TRAF6 significantly inhibited antigen mediated VGCC expression. Inhibiting Protein Kinase C (PKC) or MEK-ERK1/2 further increased VGCC expression. Interestingly, inhibiting intracellular calcium release upregulated antigen mediated VGCC expression, while inhibiting extracellular calcium influx had no significant effect. siRNA mediated knockdown of transcription factors c-Jun, SOX5 and CREB significantly inhibited Rv3416 mediated VGCC expression. A dynamic reciprocal cross-regulation between ROS and pCREB was observed that in turn governed VGCC expression with ROS playing a limiting role in the process. Further dissection of the mechanisms such as the interplay between ROS and pCREB would improve our understanding of the regulation of VGCC expression during M. tb infection.	[Selvakumar, Arti; Antony, Cecil; Singhal, Jhalak; Natarajan, Krishnamurthy] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India; [Tiwari, Brijendra K.; Singh, Yogendra] CSIR Inst Genom & Integrat Biol, Delhi, India	University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Selvakumar, A (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Infect Dis Immunol Lab, Delhi 110007, India.	sarti.selvakumar@gmail.com; knatarajan@acbr.du.ac.in	Tiwari, Brijesh Kumar/K-6227-2013; Singhal, Jhalak/GRE-9090-2022; Antony, Cecil/O-7733-2017	Tiwari, Brijesh Kumar/0000-0002-4834-6831; Antony, Cecil/0000-0001-7622-4586	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The study was funded by grants from the Department of Biotechnology, Ministry of Science and Technology, Government of India to KN and YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Advani MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044245; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Gupta D, 2010, J IMMUNOL, V184, P5444, DOI 10.4049/jimmunol.0903283; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811; Matza D, 2008, IMMUNITY, V28, P64, DOI 10.1016/j.immuni.2007.11.020; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Nejatbakhsh N, 2011, ACTA PHARMACOL SIN, V32, P741, DOI 10.1038/aps.2011.64; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; Roeder A, 2004, J INFECT DIS, V190, P1318, DOI 10.1086/423854; Singhal J, 2012, J BIOL CHEM, V287, P11108, DOI 10.1074/jbc.M111.300319; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wieland H, 2006, FEMS IMMUNOL MED MIC, V47, P296, DOI 10.1111/j.1574-695X.2006.00092.x; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Zheng ZL, 2002, J PHYSIOL-LONDON, V540, P397, DOI 10.1113/jphysiol.2001.013464	30	10	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96427	10.1371/journal.pone.0096427	http://dx.doi.org/10.1371/journal.pone.0096427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797940	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000075
J	Hillman, NH; Gisslen, T; Polglase, GR; Kallapur, SG; Jobe, AH				Hillman, Noah H.; Gisslen, Tate; Polglase, Graeme R.; Kallapur, Suhas G.; Jobe, Alan H.			Ventilation-Induced Increases in EGFR Ligand mRNA Are Not Altered by Intra-Amniotic LPS or Ureaplasma in Preterm Lambs	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; EPIDERMAL-GROWTH-FACTOR; RESPIRATORY-DISTRESS-SYNDROME; FETAL SHEEP; BRONCHOALVEOLAR LAVAGE; FACTOR-ALPHA; LUNG; GENE; AMPHIREGULIN; PULMONARY	Chorioamnionitis and mechanical ventilation are associated with bronchopulmonary dysplasia (BPD) in preterm infants. Mechanical ventilation at birth activates both inflammatory and acute phase responses. These responses can be partially modulated by previous exposure to intra-amniotic (IA) LPS or Ureaplasma parvum (UP). Epidermal growth factor receptor (EGFR) ligands participate in lung development, and angiotensin converting enzyme (ACE) 1 and ACE2 contribute to lung inflammation. We asked whether brief mechanical ventilation at birth altered EGFR and ACE pathways and if antenatal exposure to IA LPS or UP could modulate these effects. Ewes were exposed to IA injections of UP, LPS or saline multiple days prior to preterm delivery at 85% gestation. Lambs were either immediately euthanized or mechanically ventilated for 2 to 3 hr. IA UP and LPS cause modest changes in the EGFR ligands amphiregulin (AREG), epiregulin (EREG), heparin binding epidermal growth factor (HB-EGF), and betacellulin (BTC) mRNA expression. Mechanical ventilation greatly increased mRNA expression of AREG, EREG, and HB-EGF, with no additional increases resulting from IA LPS or UP. With ventilation AREG and EREG mRNA localized to cells in terminal airspace. EGFR mRNA also increased with mechanical ventilation. IA UP and LPS decreased ACE1 mRNA and increased ACE2 mRNA, resulting in a 4 fold change in the ACE1/ACE2 ratio. Mechanical ventilation with large tidal volumes increased both ACE1 and ACE2 expression. The alterations seen in ACE with IA exposures and EGFR pathways with mechanical ventilation may contribute to the development of BPD in preterm infants.	[Hillman, Noah H.; Gisslen, Tate] St Louis Univ, Div Neonatol, St Louis, MO 63103 USA; [Hillman, Noah H.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA; [Polglase, Graeme R.; Kallapur, Suhas G.; Jobe, Alan H.] Univ Western Australia, Sch Women & Infants Hlth, Perth, WA 6009, Australia; [Polglase, Graeme R.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia	Saint Louis University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; Monash University	Hillman, NH (corresponding author), St Louis Univ, Div Neonatol, St Louis, MO 63103 USA.	Hillman@slu.edu		Polglase, Graeme/0000-0002-8906-614X	National Institute of Health [R01-HD072842, K08-HL097085, R01-HD12714, R01-HD57869]; Women's and Infants' Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072842, R01HD057869] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012714] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097085] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Women's and Infants' Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institute of Health R01-HD072842 (AHJ), K08-HL097085 (NHH), R01-HD12714 (AHJ), R01-HD57869 (SGK), and the Women's and Infants' Research Foundation. TG is at University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Been JV, 2010, J PEDIATR-US, V156, P10, DOI 10.1016/j.jpeds.2009.07.044; Been JV, 2010, PEDIATR RES, V67, P83, DOI 10.1203/PDR.0b013e3181c13276; Blanchet S, 2004, AM J RESP CELL MOL, V30, P421, DOI 10.1165/rcmb.2003-0281RC; CATTERTON WZ, 1979, PEDIATR RES, V13, P104, DOI 10.1203/00006450-197902000-00004; Collins JJP, 2010, AM J PHYSIOL-LUNG C, V299, pL852, DOI 10.1152/ajplung.00183.2010; Dolinay T, 2006, PHYSIOL GENOMICS, V26, P68, DOI 10.1152/physiolgenomics.00110.2005; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Fischer HS, 2013, PEDIATRICS, V132, pE1351, DOI 10.1542/peds.2013-1880; Fukumoto J, 2010, AM J PHYSIOL-LUNG C, V298, pL131, DOI 10.1152/ajplung.90576.2008; Gisslen T, 2013, INNATE IMMUN; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hillman NH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-151; IDELL S, 1987, CHEST, V91, P52, DOI 10.1378/chest.91.1.52; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ince DA, 2010, GENET TEST MOL BIOMA, V14, P643, DOI 10.1089/gtmb.2010.0072; Jobe AH, 2000, AM J OBSTET GYNECOL, V182, P401, DOI 10.1016/S0002-9378(00)70231-6; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491; Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779; Kramer BW, 2007, AM J PHYSIOL-LUNG C, V293, pL345, DOI 10.1152/ajplung.00003.2007; Lasaitiene D, 2004, CLIN PHYSIOL FUNCT I, V24, P65, DOI 10.1046/j.1475-0961.2003.00530.x; Lin CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053817; Manzo ND, 2012, AM J RESP CELL MOL, V47, P349, DOI 10.1165/rcmb.2011-0257OC; Marchetti A, 2005, J CLIN ONCOL, V23, P857, DOI 10.1200/JCO.2005.08.043; Matsuda A, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-76; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Moss TJM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.065; Nogueira-Silva C, 2012, MOL MED, V18, P231, DOI 10.2119/molmed.2011.00210; Ortiz LA, 2002, AM J PHYSIOL-LUNG C, V282, pL1209, DOI 10.1152/ajplung.00144.2001; Polglase GR, 2010, PEDIATR RES, V67, P630, DOI 10.1203/PDR.0b013e3181dbbd18; RAABERG L, 1995, PEDIATR RES, V37, P175, DOI 10.1203/00006450-199502000-00009; Rey-Parra GJ, 2012, J MOL MED, V90, P637, DOI 10.1007/s00109-012-0859-2; Satar M, 2012, J MATERN-FETAL NEO M, V25, P1712, DOI 10.3109/14767058.2012.663017; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; Wang F, 2009, CYTOKINE, V48, P246, DOI 10.1016/j.cyto.2009.08.001; Wang YL, 2009, J PHYSIOL-LONDON, V587, P1739, DOI 10.1113/jphysiol.2008.163899; Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987; Yerrapureddy A, 2010, CELL PHYSIOL BIOCHEM, V25, P113, DOI 10.1159/000272056; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824	45	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96087	10.1371/journal.pone.0096087	http://dx.doi.org/10.1371/journal.pone.0096087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788984	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917300025
J	Villa, P; Roebroeks, W				Villa, Paola; Roebroeks, Wil			Neandertal Demise: An Archaeological Analysis of the Modern Human Superiority Complex	PLOS ONE			English	Article							MIDDLE STONE-AGE; MODERN HUMAN COLONIZATION; TENFOLD POPULATION INCREASE; DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; POST-HOWIESONS POORT; HUMAN-EVOLUTION; WESTERN-EUROPE; SOUTH-AFRICA; EARLIEST EVIDENCE	Neandertals are the best-studied of all extinct hominins, with a rich fossil record sampling hundreds of individuals, roughly dating from between 350,000 and 40,000 years ago. Their distinct fossil remains have been retrieved from Portugal in the west to the Altai area in central Asia in the east and from below the waters of the North Sea in the north to a series of caves in Israel in the south. Having thrived in Eurasia for more than 300,000 years, Neandertals vanished from the record around 40,000 years ago, when modern humans entered Europe. Modern humans are usually seen as superior in a wide range of domains, including weaponry and subsistence strategies, which would have led to the demise of Neandertals. This systematic review of the archaeological records of Neandertals and their modern human contemporaries finds no support for such interpretations, as the Neandertal archaeological record is not different enough to explain the demise in terms of inferiority in archaeologically visible domains. Instead, current genetic data suggest that complex processes of interbreeding and assimilation may have been responsible for the disappearance of the specific Neandertal morphology from the fossil record.	[Villa, Paola] Univ Colorado Museum, Boulder, CO 80309 USA; [Villa, Paola] Univ Bordeaux 1, UMR 5199, F-33405 Talence, France; [Villa, Paola] Univ Witwatersrand, Sch Geog & Environm Studies, Johannesburg, South Africa; [Roebroeks, Wil] Leiden Univ, Fac Archaeol, Leiden, Netherlands	University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; Leiden University; Leiden University - Excl LUMC	Villa, P (corresponding author), Univ Colorado Museum, Boulder, CO 80309 USA.	villap@colorado.edu		Roebroeks, Wil/0000-0002-5075-6899	National Science Foundation [BCS 1118143]; Netherlands Organization for Scientific Research (N.W.O) [SP128-548]	National Science Foundation(National Science Foundation (NSF)); Netherlands Organization for Scientific Research (N.W.O)(Netherlands Organization for Scientific Research (NWO))	Research by P.V. was funded by the National Science Foundation grant BCS 1118143. Both P. V. and W. R. were supported by the Netherlands Organization for Scientific Research (N.W.O, SP128-548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Aubert M, 2012, J HUM EVOL, V63, P704, DOI 10.1016/j.jhevol.2012.07.006; Bachellerie F., 2007, PALEO, V19, P259; Balari Sergio, 2011, Int J Evol Biol, V2011, P382679, DOI 10.4061/2011/382679; Banks WE, 2013, J HUM EVOL, V64, P39, DOI 10.1016/j.jhevol.2012.10.001; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bar-Yosef O, 1998, CAMB ARCHAEOL J, V8, P141, DOI 10.1017/S0959774300001815; Bar-Yosef O, 2013, QUATERN INT, V285, P30, DOI 10.1016/j.quaint.2011.07.043; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bar-Yosef O, 1999, AM ANTHROPOL, V101, P322, DOI 10.1525/aa.1999.101.2.322; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Botha R., 2009, CRADLE LANGUAGE, P93; Botha R, 2008, LANG COMMUN, V28, P197, DOI 10.1016/j.langcom.2007.05.002; Botha R, 2010, CAMB ARCHAEOL J, V20, P345, DOI 10.1017/S0959774310000454; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brantingham PJ, 2006, CURR ANTHROPOL, V47, P435, DOI 10.1086/503062; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Cann RL, 2013, SCIENCE, V341, P465, DOI 10.1126/science.1242899; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Caron F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021545; Conard NJ, 2010, P NATL ACAD SCI USA, V107, P7621, DOI 10.1073/pnas.1001458107; Condemi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059781; Crevecoeur I, 2010, J HUM EVOL, V59, P641, DOI 10.1016/j.jhevol.2010.07.022; d'Errico F, 1998, CURR ANTHROPOL, V39, pS1, DOI 10.1086/204689; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; D'Errico F, 2003, EVOL ANTHROPOL, V12, P188, DOI 10.1002/evan.10113; d'Errico F, 2012, QUATERN INT, V259, P59, DOI 10.1016/j.quaint.2011.03.039; Ding QL, 2014, MOL BIOL EVOL, V31, P683, DOI 10.1093/molbev/mst260; Dogandzic T, 2013, J HUM EVOL, V64, P311, DOI 10.1016/j.jhevol.2013.01.005; Douka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072931; Faith JT, 2013, J HUM EVOL, V65, P715, DOI 10.1016/j.jhevol.2013.09.001; Faivre JP, 2012, LITHIC TECHNOL, V37, P5, DOI 10.1179/lit.2012.37.1.5; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Fu QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032473; Gamble C, 2011, NATURE, V479, P294, DOI 10.1038/479294a; Gibbons A, 2014, SCIENCE, V343, P1417, DOI 10.1126/science.343.6178.1417; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grun R, 2003, J HUM EVOL, V45, P155, DOI 10.1016/S0047-2484(03)00102-7; Grunberg JM, 2002, J HUM EVOL, V76, P15; Guerin G, 2013, J HUM EVOL, V64, P314, DOI 10.1016/j.jhevol.2013.01.006; Guibert P., 2008, SOC PALEOLITHIQUE GR, V47, P19; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Higham T, 2006, P NATL ACAD SCI USA, V103, P553, DOI 10.1073/pnas.0510005103; Higham T, 2011, FARMING, V2011, P1; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Higham T, 2011, NATURE, V479, P521, DOI 10.1038/nature10484; Hockett B, 2005, QUATERN INT, V137, P21, DOI 10.1016/j.quaint.2004.11.017; HOWELLS WW, 1976, J HUM EVOL, V5, P477, DOI 10.1016/0047-2484(76)90088-9; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P13471, DOI 10.1073/pnas.1211082109; Hublin JJ, 2011, P NATL ACAD SCI USA, V108, pE277, DOI 10.1073/pnas.1105710108; Hublin JJ, 1996, NATURE, V381, P224, DOI 10.1038/381224a0; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Joris O., 2006, AXE AGE ACHEULIAN TO, P287; Joris O., 2004, BERICHTE R MISCH GER, V84, P49; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; Klein RG, 2013, P NATL ACAD SCI USA, V110, P10910, DOI 10.1073/pnas.1304750110; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Koller J., 2001, EUR J ARCHAEOL, V4, P385, DOI DOI 10.3346/jkms.2014.29.12.1597; Lombard M, 2012, QUATERN INT, V270, P140, DOI 10.1016/j.quaint.2012.02.033; Lowe J, 2012, P NATL ACAD SCI USA, V109, P13532, DOI 10.1073/pnas.1204579109; Marean C.W., 2005, TOOLS SYMBOLS EARLY, P333; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 1999, EVOL ANTHROPOL, V8, P22, DOI 10.1002/(SICI)1520-6505(1999)8:1<22::AID-EVAN7>3.0.CO;2-F; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McBrearty S, 2012, NATURE, V491, P531, DOI 10.1038/nature11751; Mellars P, 1999, CURR ANTHROPOL, V40, P341, DOI 10.1086/200024; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2005, EVOL ANTHROPOL, V14, P12, DOI 10.1002/evan.20037; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; MELLARS P, 1989, CURR ANTHROPOL, V30, P349, DOI 10.1086/203755; Mellars P, 1998, MEM CALIF ACAD SCI, P89; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Mellars P, 2011, SCIENCE, V333, P623, DOI 10.1126/science.1206930; Mellars P, 2010, P NATL ACAD SCI USA, V107, P20147, DOI 10.1073/pnas.1014588107; Mendez FL, 2013, MOL BIOL EVOL, V30, P798, DOI 10.1093/molbev/mst004; Modugno F, 2006, RAPID COMMUN MASS SP, V20, P1787, DOI 10.1002/rcm.2507; Morin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032856; Nash DJ, 2013, J HUM EVOL, V64, P280, DOI 10.1016/j.jhevol.2013.01.010; O'Connell James F., 2006, P43; Palmer F, 2007, MITTEILUNGEN GESELLS, V16, P75; Pearce E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0168; Peresani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068572; Petraglia MD, 2012, QUATERN INT, V258, P119, DOI 10.1016/j.quaint.2011.07.042; Pienaar M, 2008, S AFR J SCI, V104, P65; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Richter D, 2013, J ARCHAEOL SCI, V40, P1176, DOI 10.1016/j.jas.2012.09.003; Rink WJ, 2001, GEOARCHAEOLOGY, V16, P701, DOI 10.1002/gea.1017; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Rougier H, 2007, P NATL ACAD SCI USA, V104, P1165, DOI 10.1073/pnas.0610538104; Roussel M., 2011, NORMES VARIATIONS PR, V385, P513; Ruff C.B., 2002, TRABALHOS ARQUEOLOGI, V22, P435; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Schmider B., 2002, AURIGNACIEN GROTTE R; Shea J.J., 2010, PALAEOANTHROPOLOGY, V2010, P100; Shea JJ, 2003, J WORLD PREHIST, V17, P313, DOI 10.1023/B:JOWO.0000020194.01496.fe; Shea JJ, 2009, VERTEBR PALEOBIOL PA, P189, DOI 10.1007/978-1-4020-9699-0_14; Slimak L, 2008, J ARCHAEOL SCI, V35, P2204, DOI 10.1016/j.jas.2008.02.005; SMITH FH, 1989, YEARB PHYS ANTHROPOL, V32, P35; Smith FH, 2011, GEN ANTHR, V18, P1; Smith FH, 2013, J ANTHROPOL RES, V69, P167, DOI 10.3998/jar.0521004.0069.202; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Speth J., 2012, FARMING, V2012, P1; Straus LG, 2005, QUATERN INT, V137, P47, DOI 10.1016/j.quaint.2004.11.019; Stringer C, 2012, NATURE, V485, P33, DOI 10.1038/485033a; Taborin Y, 1998, CURR ANTHROPOL, V39, P28; Tostevin G., 2007, RETHINKING HUMAN REV, P341; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Videan EN, 2006, AM J PRIMATOL, V68, P745, DOI 10.1002/ajp.20265; Villa P, 2005, QUATERN INT, V126, P223, DOI 10.1016/j.quaint.2004.03.001; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; White M, 2012, EUR J ARCHAEOL, V15, P1; White R., 2002, GALL PREHIST, V34, P257; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wynn T, 2008, AM SCI, V96, P44, DOI 10.1511/2008.69.44; Wynn Thomas, 2011, Int J Evol Biol, V2011, P741357, DOI 10.4061/2011/741357; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106; Zilhao J, 2013, DYNAMICS LEARNING NE, V1, P21; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	150	144	145	3	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96424	10.1371/journal.pone.0096424	http://dx.doi.org/10.1371/journal.pone.0096424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AL1WP	24789039	gold, Green Submitted, Green Published			2022-12-27	WOS:000338917300041
J	Brondani, LA; Assmann, TS; de Souza, BM; Boucas, AP; Canani, LH; Crispim, D				Brondani, Leticia A.; Assmann, Tais S.; de Souza, Bianca M.; Boucas, Ana P.; Canani, Luis H.; Crispim, Daisy			Meta-Analysis Reveals the Association of Common Variants in the Uncoupling Protein (UCP) 1-3 Genes with Body Mass Index Variability	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; 45-BP INSERTION/DELETION POLYMORPHISM; INSULIN-RESISTANCE; PROMOTER POLYMORPHISM-866G/A; COMMON-866G/A POLYMORPHISM; BETA-3-ADRENERGIC RECEPTOR; ALA55VAL POLYMORPHISM; A-3826G POLYMORPHISM; JAPANESE INDIVIDUALS; MUTATIONAL ANALYSIS	Background: The relationship between uncoupling protein (UCP) 1-3 polymorphisms and susceptibility to obesity has been investigated in several genetic studies. However, the impact of these polymorphisms on obesity is still under debate, with contradictory results being reported. Until this date, no meta-analysis evaluated the association of UCP polymorphisms with body mass index (BMI) variability. Thus, this paper describe a meta-analysis conducted to evaluate if the -3826A/G (UCP1); 866G/A, Ala55Val and Ins/Del (UCP2) and -55C/T (UCP3) polymorphisms are associated with BMI changes. Methods: A literature search was run to identify all studies that investigated associations between UCP1-3 polymorphisms and BMI. Weighted mean differences (WMD) were calculated for different inheritance models. Results: Fifty-six studies were eligible for inclusion in the meta-analysis. Meta-analysis results showed that UCP2 55Val/Val genotype was associated with increased BMI in Europeans [Random Effect Model (REM) WMD 0.81, 95% Cl 0.20, 1.41]. Moreover, the UCP2 Ins allele and UCP3-55T/T genotype were associated with increased BMI in Asians [REM WMD 0.46, 95% Cl 0.09, 0.83 and Fixed Effect Model (FEM) WMD 1.63, 95% Cl 0.25, 3.01]. However, a decreased BMI mean was observed for the UCP2-866 A allele in Europeans under a dominant model of inheritance (REM WMD 20.18, 95% Cl 20.35, 20.01). There was no significant association of the UCP1-3826A/G polymorphism with BMI mean differences. Conclusions: The meta-analysis detected a significant association between the UCP2-866G/A, Ins/Del, Ala55Val and UCP355C/T polymorphisms and BMI mean differences.	[Brondani, Leticia A.; Assmann, Tais S.; de Souza, Bianca M.; Boucas, Ana P.; Canani, Luis H.; Crispim, Daisy] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil; [Brondani, Leticia A.; Assmann, Tais S.; de Souza, Bianca M.; Boucas, Ana P.; Canani, Luis H.; Crispim, Daisy] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Crispim, D (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil.	dcmoreira@hcpa.ufrgs.br	Crispim, Daisy/R-5170-2019; Assmann, Tais/AAC-4026-2020; Canani, Luis H/G-9686-2012	Crispim, Daisy/0000-0001-5095-9269; Canani, Luis H/0000-0002-1813-4491; Boucas, Ana Paula/0000-0002-1563-1513; Assmann, Tais/0000-0001-9114-8243	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partially supported by grants from the Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundo de Incentivo a Pesquisa e Eventos (FIPE) at the Hospital de Clinicas de Porto Alegre and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akrami SM, 2007, HUM BIOL, V79, P103, DOI 10.1353/hub.2007.0019; Alonso A, 2005, ANN NUTR METAB, V49, P183, DOI 10.1159/000086883; Andersen G, 2013, INT J OBESITY, V37, P175, DOI 10.1038/ijo.2012.22; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Berentzen T, 2005, INT J OBESITY, V29, P93, DOI 10.1038/sj.ijo.0802841; Bielinski SJ, 2008, ACTA DIABETOL, V45, P179, DOI 10.1007/s00592-008-0039-6; Brondani LA, 2014, METAB SYNDR RELAT D, V12, P16, DOI 10.1089/met.2013.0077; Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001; Bulotta A, 2005, J CLIN ENDOCR METAB, V90, P1176, DOI 10.1210/jc.2004-1072; Cha MH, 2006, METABOLISM, V55, P578, DOI 10.1016/j.metabol.2005.11.012; Chen HH, 2007, OBES SURG, V17, P926, DOI 10.1007/s11695-007-9171-6; D'Adamo M, 2004, DIABETES, V53, P1905, DOI 10.2337/diabetes.53.7.1905; Dalgaard LT, 1999, DIABETOLOGIA, V42, P1413, DOI 10.1007/s001250051312; Dalgaard LT, 2001, J CLIN ENDOCR METAB, V86, P1398, DOI 10.1210/jc.86.3.1398; Dalgaard LT, 2003, OBES RES, V11, P1420, DOI 10.1038/oby.2003.191; de Luis DA, 2007, ANN NUTR METAB, V51, P374, DOI 10.1159/000107685; de Souza BM, 2012, EXP EYE RES, V94, P49, DOI 10.1016/j.exer.2011.11.004; de Souza BM, 2011, ARQ BRAS ENDOCRINOL, V55, P239, DOI 10.1590/S0004-27302011000400001; Dhall M, 2012, ETHNIC DIS, V22, P181; Drummond EM, 2013, CURR OPIN CLIN NUTR, V16, P392, DOI 10.1097/MCO.0b013e3283620f45; Duarte NL, 2003, OBES RES, V11, P512, DOI 10.1038/oby.2003.72; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esterbauer H, 2000, J BIOL CHEM, V275, P36394, DOI 10.1074/jbc.M005713200; Esterbauer H, 2001, NAT GENET, V28, P178, DOI 10.1038/88911; Evans D, 2000, INT J OBESITY, V24, P1239, DOI 10.1038/sj.ijo.0801402; Fang Qi-chen, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P485; Fisler JS, 2006, NUTR METABOLISM, V3, DOI 10.1186/1743-7075-3-38; Fukuyama K, 2006, BIOCHEM BIOPH RES CO, V339, P1212, DOI 10.1016/j.bbrc.2005.11.140; Hamada T, 2008, MED SCI MONITOR, V14, pCR107; Hamada T, 2008, METABOLISM, V57, P410, DOI 10.1016/j.metabol.2007.10.019; Hayakawa T, 1999, METABOLISM, V48, P636, DOI 10.1016/S0026-0495(99)90063-X; Heidari J, 2010, ARCH IRAN MED, V13, P384, DOI 010135/AIM.004; Heilbronn LK, 2000, DIABETOLOGIA, V43, P242, DOI 10.1007/s001250050036; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ji QH, 2004, J HYPERTENS, V22, P97, DOI 10.1097/00004872-200401000-00018; Jia JJ, 2009, OBES REV, V10, P519, DOI 10.1111/j.1467-789X.2009.00569.x; Jia JJ, 2010, MOL BIOL REP, V37, P1513, DOI 10.1007/s11033-009-9550-2; Jun HS, 2009, OBESITY, V17, P355, DOI 10.1038/oby.2008.531; Kiec-Wilk B, 2002, J PHYSIOL PHARMACOL, V53, P477; Kotani K, 2008, ARCH MED RES, V39, P142, DOI 10.1016/j.arcmed.2007.07.002; Lapice E, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-68; Le Fur S, 2004, DIABETES, V53, P235, DOI 10.2337/diabetes.53.1.235; Lee YH, 2008, BIOCHEM BIOPH RES CO, V371, P767, DOI 10.1016/j.bbrc.2008.04.144; Liu XQ, 2012, BIOCHEM GENET, V50, P784, DOI 10.1007/s10528-012-9520-6; Luan JA, 2001, INT J EPIDEMIOL, V30, P1035, DOI 10.1093/ije/30.5.1035; Mancini FP, 2003, CLIN ENDOCRINOL, V59, P817, DOI 10.1046/j.1365-2265.2003.01926.x; Martinez-Hervas S, 2012, EUR J CLIN INVEST, V42, P171, DOI 10.1111/j.1365-2362.2011.02570.x; Meirhaeghe A, 2000, DIABETOLOGIA, V43, P1424, DOI 10.1007/s001250051549; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Mitchell NS, 2011, PSYCHIAT CLIN N AM, V34, P717, DOI 10.1016/j.psc.2011.08.005; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moustafa JS, 2014, NAT REV ENDOCRINOL, V10, P4; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Nagai N, 2011, INT J OBESITY, V35, P1050, DOI 10.1038/ijo.2010.261; Nakano T, 2006, J MED INVESTIG, V53, P218, DOI 10.2152/jmi.53.218; Nan C, 2012, EUR J EPIDEMIOL, V27, P247, DOI 10.1007/s10654-012-9678-6; Ochoa MC, 2007, MOL GENET METAB, V92, P351, DOI 10.1016/j.ymgme.2007.07.011; Oguzkan-Balci S, 2013, J PEDIATR ENDOCR MET, V26, P277, DOI 10.1515/jpem-2012-0267; Oh HH, 2004, METABOLISM, V53, P1054, DOI 10.1016/j.metabol.2004.02.014; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Papazoglou D, 2012, METAB SYNDR RELAT D, V10, P307, DOI 10.1089/met.2012.0003; Qian L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058939; Ramis JM, 2004, METABOLISM, V53, P1411, DOI 10.1016/j.metabol.2004.06.006; Reis AF, 2004, MOL GENET METAB, V82, P339, DOI 10.1016/j.ymgme.2004.06.008; Ricquier D, 2005, P NUTR SOC, V64, P47, DOI 10.1079/PNS2004408; Rosmond R, 2003, INT J OBESITY, V27, P1141, DOI 10.1038/sj.ijo.0802397; Rosmond R, 2002, BBA-MOL BASIS DIS, V1588, P103, DOI 10.1016/S0925-4439(02)00152-7; Sale Michele M, 2007, BMC Endocr Disord, V7, P1, DOI 10.1186/1472-6823-7-1; Sasahara M, 2004, DIABETES, V53, P482, DOI 10.2337/diabetes.53.2.482; Schaffler A, 1999, EUR J CLIN INVEST, V29, P770; Sesti G, 2003, DIABETES, V52, P1280, DOI 10.2337/diabetes.52.5.1280; Shen HQ, 2006, OBESITY, V14, P656, DOI 10.1038/oby.2006.74; Shihara N, 2001, INT J OBESITY, V25, P761, DOI 10.1038/sj.ijo.0801629; Sramkova D, 2007, EXP CLIN ENDOCR DIAB, V115, P303, DOI 10.1055/s-2007-977732; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Binh TQ, 2011, J GENET, V90, P1; Urhammer SA, 1997, J CLIN ENDOCR METAB, V82, P4069, DOI 10.1210/jc.82.12.4069; Urhammer SA, 1997, DIABETOLOGIA, V40, P1227, DOI 10.1007/s001250050811; Valve R, 1998, DIABETOLOGIA, V41, P357, DOI 10.1007/s001250050915; Yanovski JA, 2000, AM J CLIN NUTR, V71, P1405; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zietz B, 2001, EXP CLIN ENDOCR DIAB, V109, P102, DOI 10.1055/s-2001-14829; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	84	71	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96411	10.1371/journal.pone.0096411	http://dx.doi.org/10.1371/journal.pone.0096411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804925	Green Published, gold			2022-12-27	WOS:000335728900056
J	Hill, JW; Thompson, JF; Carter, MB; Edwards, BS; Sklar, LA; Rosenberg, GA				Hill, Jeff W.; Thompson, Jeffrey F.; Carter, Mark B.; Edwards, Bruce S.; Sklar, Larry A.; Rosenberg, Gary A.			Identification of Isoxsuprine Hydrochloride as a Neuroprotectant in Ischemic Stroke through Cell-Based High-Throughput Screening	PLOS ONE			English	Article							DISEASE; DAMAGE	Stroke is a leading cause of death and disability and treatment options are limited. A promising approach to accelerate the development of new therapeutics is the use of high-throughput screening of chemical libraries. Using a cell-based high-throughput oxygen-glucose deprivation (OGD) model, we evaluated 1,200 small molecules for repurposed application in stroke therapy. Isoxsuprine hydrochloride was identified as a potent neuroprotective compound in primary neurons exposed to OGD. Isoxsuprine, a beta(2)-adrenergic agonist and NR2B subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonist, demonstrated no loss of efficacy when administered up to an hour after reoxygenation in an in vitro stroke model. In an animal model of transient focal ischemia, isoxsuprine significantly reduced infarct volume compared to vehicle (137 +/- 18 mm(3) versus 279 +/- 25 mm(3), p, 0.001). Isoxsuprine, a peripheral vasodilator, was FDA approved for the treatment of cerebrovascular insufficiency and peripheral vascular disease. Our demonstration of the significant and novel neuroprotective action of isoxsuprine hydrochloride in an in vivo stroke model and its history of human use suggest that isoxsuprine may be an ideal candidate for further investigation as a potential stroke therapeutic.	[Hill, Jeff W.; Thompson, Jeffrey F.; Rosenberg, Gary A.] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA; [Carter, Mark B.; Edwards, Bruce S.; Sklar, Larry A.] Univ New Mexico, Hlth Sci Ctr, Ctr Mol Discovery, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	Hill, JW (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA.	jwhill@salud.unm.edu			DHHS/NIH/NCRR, University of New Mexico, Clinical and Translational Science Center (CTSC) [1 UL1RR031977-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031977] Funding Source: NIH RePORTER	DHHS/NIH/NCRR, University of New Mexico, Clinical and Translational Science Center (CTSC); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by DHHS/NIH/NCRR grant # 1 UL1RR031977-01, The University of New Mexico, Clinical and Translational Science Center (CTSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison M, 2012, NAT BIOTECHNOL, V30, P571, DOI 10.1038/nbt0712-571a; BEART PM, 1991, NEUROSCI LETT, V124, P187, DOI 10.1016/0304-3940(91)90090-G; Belloli C, 2000, EQUINE VET J, V32, P119, DOI 10.2746/042516400777591543; Beraki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069233; Briones-Garduno J C, 1997, Gac Med Mex, V133, P403; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Culmsee C, 2004, STROKE, V35, P1197, DOI 10.1161/01.STR.0000125855.17686.6d; Culmsee C, 1999, NEUROCHEM INT, V35, P47, DOI 10.1016/S0197-0186(99)00032-7; Eissa A, 2012, J CLIN PHARM THER, V37, P620, DOI 10.1111/j.1365-2710.2012.01366.x; Elliott J., 1995, EQUINE VET J S, V19, P101; Giorgino FL, 2010, ARZNEIMITTELFORSCH, V60, P415, DOI 10.1055/s-0031-1296305; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gogas KR, 2006, CURR OPIN PHARMACOL, V6, P68, DOI 10.1016/j.coph.2005.11.001; Hill JW, 2012, NEUROSCIENCE, V220, P277, DOI 10.1016/j.neuroscience.2012.06.019; HUSSAIN SMA, 1976, PRACTITIONER, V216, P222; Junker V, 2002, EUR J PHARMACOL, V446, P25, DOI 10.1016/S0014-2999(02)01814-9; LISH PM, 1960, J PHARMACOL EXP THER, V129, P438; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Semkova I, 1996, BRAIN RES, V717, P44, DOI 10.1016/0006-8993(95)01567-1; Wang JKT, 2006, P NATL ACAD SCI USA, V103, P10461, DOI 10.1073/pnas.0600930103; Wesseling H, 1975, Vasa, V4, P168	21	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96761	10.1371/journal.pone.0096761	http://dx.doi.org/10.1371/journal.pone.0096761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804769	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900092
J	Huang, WY; Zhao, M; Wei, N; Wang, XX; Cao, HQ; Du, Q; Liang, ZC				Huang, Weiyan; Zhao, Mei; Wei, Na; Wang, Xiaoxia; Cao, Huqing; Du, Quan; Liang, Zicai			Site-Specific RNase A Activity Was Dramatically Reduced in Serum from Multiple Types of Cancer Patients	PLOS ONE			English	Article							RIBONUCLEASE-ACTIVITY; PANCREATIC-CANCER; A SUPERFAMILY; HOST-DEFENSE; PURIFICATION; DIAGNOSIS; SIRNA; STABILITY; SEQUENCE; TUMOURS	Potent RNase activities were found in the serum of mammals but the physiological function of the RNases was never well illustrated, largely due to the caveats in methods of RNase activity measurement. None of the existing methods can distinguish between RNases with different target specificities. A systematic study was recently carried out in our lab to investigate the site-specificity of serum RNases on double-stranded RNA substrates, and found that serum RNases cleave double- stranded RNAs predominantly at 5 '-U/A-3 ' and 5 '-C/A-3 ' dinucleotide sites, in a manner closely resembling RNase A. Based on this finding, a FRET assay was developed in the current study to measure this site-specific serum RNase activity in human samples using a double stranded RNA substrate. We demonstrated that the method has a dynamic range of 10(-5) mg/ml- 10(-1) mg/ml using serial dilution of RNase A. The sera of 303 cancer patients were subjected to comparison with 128 healthy controls, and it was found that serum RNase activities visualized with this site-specific double stranded probe were found to be significantly reduced in patients with gastric cancer, liver cancer, pancreatic cancer, esophageal cancer, ovary cancer, cervical cancer, bladder cancer, kidney cancer and lung cancer, while only minor changes were found in breast and colon cancer patients. This is the first report using double stranded RNA as probe to quantify site-specific activities of RNase A in a serum. The results illustrated that RNase A might be further evaluated to determine if it can serve as a new class of biomarkers for certain cancer types.	[Huang, Weiyan; Wei, Na; Wang, Xiaoxia; Cao, Huqing; Liang, Zicai] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Zhao, Mei] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Zhao, Mei] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhao, Mei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Du, Quan] Peking Univ, Sch Pharmaceut Sci, Inst Mol Med, Beijing 100871, Peoples R China; [Du, Quan] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; Peking University	Du, Q (corresponding author), Peking Univ, Sch Pharmaceut Sci, Inst Mol Med, Beijing 100871, Peoples R China.	quan.du@pku.edu.cn			Beijing Natural Science Foundation [5132015]; National Basic Research Program of China [2011CBA01102]; National High-tech R&D Program of China [2012AA022501]; Guangdong Science and Technology Department [2011B090400478]; Department of Education of China [20090001110052, 200800010019]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China); National High-tech R&D Program of China; Guangdong Science and Technology Department; Department of Education of China	This work was supported by Beijing Natural Science Foundation (5132015), National Basic Research Program of China (2011CBA01102), National High-tech R&D Program of China (2012AA022501), fund from Guangdong Science and Technology Department (2011B090400478) and the Department of Education of China (20090001110052 and 200800010019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI K, 1978, CANCER RES, V38, P2163; AKAGI K, 1976, BIOCHIM BIOPHYS ACTA, V442, P368, DOI 10.1016/0005-2787(76)90311-7; Ardelt W, 2008, CURR PHARM BIOTECHNO, V9, P215, DOI 10.2174/138920108784567245; Ardelt W, 2009, EUR J PHARMACOL, V625, P181, DOI 10.1016/j.ejphar.2009.06.067; BARDON A, 1976, CLIN CHIM ACTA, V67, P231, DOI 10.1016/0009-8981(76)90331-4; Beintema JJ, 1998, CELL MOL LIFE SCI, V54, P825, DOI 10.1007/s000180050211; BENARTZI H, 1992, P NATL ACAD SCI USA, V89, P927, DOI 10.1073/pnas.89.3.927; Choung S, 2006, BIOCHEM BIOPH RES CO, V342, P919, DOI 10.1016/j.bbrc.2006.02.049; Costanzi J, 2005, CANCER INVEST, V23, P643, DOI 10.1080/07357900500283143; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, P2705, DOI 10.1093/nar/gkg393; Dyer KD, 2006, MOL DIVERS, V10, P585, DOI 10.1007/s11030-006-9028-2; Funakoshi A, 1978, Gastroenterol Jpn, V13, P390; HIRS CHW, 1960, J BIOL CHEM, V235, P633; Hong JM, 2010, FASEB J, V24, P4844, DOI 10.1096/fj.09-142398; HUMPHREY RL, 1977, CANCER RES, V37, P2015; Kelemen BR, 1999, NUCLEIC ACIDS RES, V27, P3696, DOI 10.1093/nar/27.18.3696; KEMMER TP, 1991, INT J PANCREATOL, V8, P23; Kocic G, 2005, PEDIATR DIABETES, V6, P155, DOI 10.1111/j.1399-543X.2005.00122.x; KOTTEL RH, 1978, BRIT J CANCER, V38, P280, DOI 10.1038/bjc.1978.199; KURIHARA M, 1984, CANCER RES, V44, P2240; LEDOUX L, 1955, NATURE, V176, P36, DOI 10.1038/176036a0; LEDOUX L, 1955, NATURE, V175, P258, DOI 10.1038/175258b0; MARABELLA P C, 1976, Journal of Surgical Oncology, V8, P501, DOI 10.1002/jso.2930080609; PETERSON LM, 1979, P NATL ACAD SCI USA, V76, P2630, DOI 10.1073/pnas.76.6.2630; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Turner JJ, 2007, MOL BIOSYST, V3, P43, DOI 10.1039/b611612d; Volkov AA, 2009, OLIGONUCLEOTIDES, V19, P191, DOI 10.1089/oli.2008.0162; Wang L, 2006, WORLD J GASTROENTERO, V12, P6949, DOI 10.3748/wjg.v12.i43.6949; WARSHAW AL, 1980, AM J SURG, V139, P27, DOI 10.1016/0002-9610(80)90225-1; Wu HJ, 1998, J BIOL CHEM, V273, P2532, DOI 10.1074/jbc.273.5.2532	34	13	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96490	10.1371/journal.pone.0096490	http://dx.doi.org/10.1371/journal.pone.0096490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805924	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900062
J	Min, T; Fang, F; Ge, H; Shi, YN; Luo, ZR; Yao, YC; Grierson, D; Yin, XR; Chen, KS				Min, Ting; Fang, Fang; Ge, Hang; Shi, Yan-na; Luo, Zheng-rong; Yao, Yun-cong; Grierson, Donald; Yin, Xue-ren; Chen, Kun-song			Two Novel Anoxia-Induced Ethylene Response Factors That Interact with Promoters of Deastringency-Related Genes from Persimmon	PLOS ONE			English	Article							END RULE PATHWAY; MYB TRANSCRIPTION FACTOR; DE-ASTRINGENCY; FRUIT; KIWIFRUIT; HYPOXIA; BIOSYNTHESIS; ARABIDOPSIS; ACCUMULATION; ACETALDEHYDE	A hypoxic environment is generally undesirable for most plants and stimulates anaerobic metabolism. It is a beneficial treatment, however, for the removal of astringency from persimmon to improve the fruit quality after harvest. High soluble tannins (SCTs) content is one of most important causes of astringency. High CO2 (95%) treatment effectively reduced SCTs in both "Mopan'' and "Gongcheng-shuishi'' persimmon fruit by causing increases in acetaldehyde. Using RNA-seq and realtime PCR, twelve ethylene response factor genes (DkERF11-22) were isolated and characterized, to determine those responsive to high CO2 treatment. Only two genes, DkERF19 and DkERF22, showed trans-activation effects on the promoters of deastringency-related genes pyruvate decarboxylase genes (DkPDC2 and DkPDC3) and the transcript levels of these genes was enhanced by hypoxia. Moreover, DkERF19 and the previously isolated DkERF9 had additive effects on activating the DkPDC2 promoter. Taken together, these results provide further evidence that transcriptome changes in the level of DkERF mRNAs regulate deastringency-related genes and their role in the mechanism of persimmon fruit deastringency is discussed.	[Min, Ting; Fang, Fang; Ge, Hang; Shi, Yan-na; Grierson, Donald; Yin, Xue-ren; Chen, Kun-song] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310003, Zhejiang, Peoples R China; [Luo, Zheng-rong] Huazhong Agr Univ, Minist Educ, Key Lab Hort Plant Biol, Wuhan, Peoples R China; [Yao, Yun-cong] Beijing Agr Univ, Dept Plant Sci & Technol, Beijing 100094, Peoples R China; [Grierson, Donald] Univ Nottingham, Sch Biosci, Plant & Crop Sci Div, Loughborough, Leics, England	Zhejiang University; Huazhong Agricultural University; Beijing University of Agriculture; University of Nottingham	Yin, XR (corresponding author), Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	xuerenyin@zju.edu.cn	Ge, Hang/GZB-0729-2022; Yin, Xue-ren/B-3893-2008	Yin, Xue-ren/0000-0002-1282-4432; Luo, Zhengrong/0000-0001-5083-7368	National Natural Science Foundation of China [31101507, 31372114, 31030052]; Special Fund for Agro-scientific Research in the Public Interest [201203047]; 111 project; Fundamental Research Funds for the Central Universities [2013FZA6010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; 111 project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (no. 31101507; no. 31372114; no. 31030052), the Special Fund for Agro-scientific Research in the Public Interest (no. 201203047), the 111 project, and the Fundamental Research Funds for the Central Universities (no. 2013FZA6010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; Chapman NH, 2012, PLANT PHYSIOL, V159, P1644, DOI 10.1104/pp.112.200634; Chung MY, 2010, PLANT J, V64, P936, DOI 10.1111/j.1365-313X.2010.04384.x; Del Bubba M, 2009, J FOOD COMPOS ANAL, V22, P668, DOI 10.1016/j.jfca.2009.02.015; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gibbs DJ, 2011, NATURE, V479, P415, DOI 10.1038/nature10534; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Kuang JF, 2012, J EXP BOT, V63, P441, DOI 10.1093/jxb/err290; Latocha P, 2014, POSTHARVEST BIOL TEC, V88, P21, DOI 10.1016/j.postharvbio.2013.09.005; Li M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058745, 10.1371/journal.pone.0078500, 10.1371/journal.pone.0059582, 10.1371/journal.pone.0079955]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Licausi F, 2011, NATURE, V479, P419, DOI 10.1038/nature10536; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Liu XF, 2013, PLANT MOL BIOL REP, V31, P1474, DOI 10.1007/s11105-013-0621-0; MATSUO T, 1977, PLANT CELL PHYSIOL, V18, P17; Mcrae JM, 2011, MOLECULES, V16, P2348, DOI 10.3390/molecules16032348; Merchante C, 2013, CURR OPIN PLANT BIOL, V16, P554, DOI 10.1016/j.pbi.2013.08.001; Min T, 2012, J EXP BOT, V63, P6393, DOI 10.1093/jxb/ers296; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; PESIS E, 1984, J FOOD SCI, V49, P896, DOI 10.1111/j.1365-2621.1984.tb13236.x; Salvador A, 2007, POSTHARVEST BIOL TEC, V46, P181, DOI 10.1016/j.postharvbio.2007.05.003; Sasidharan R, 2011, PLANT CELL, V23, P4173, DOI 10.1105/tpc.111.093880; Taira S, 2001, J JPN SOC FOOD SCI, V48, P684, DOI 10.3136/nskkk.48.684; Taira S, 1997, POSTHARVEST BIOL TEC, V12, P265, DOI 10.1016/S0925-5214(97)00064-1; TANAKA T, 1994, J CHEM SOC PERK T 1, P3013, DOI 10.1039/p19940003013; Wang RZ, 1997, ACTA HORTIC, P43; Wang Y, 2013, POSTHARVEST BIOL TEC, V83, P72, DOI 10.1016/j.postharvbio.2013.03.015; Xiao YY, 2013, J EXP BOT, V64, P2499, DOI 10.1093/jxb/ert108; YAMADA M, 1994, J JPN SOC HORTIC SCI, V63, P485, DOI 10.2503/jjshs.63.485; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Yin XR, 2008, J EXP BOT, V59, P2097, DOI 10.1093/jxb/ern067; Yin XR, 2013, POSTHARVEST BIOL TEC, V83, P27, DOI 10.1016/j.postharvbio.2013.03.012; Yin XR, 2012, PLANTA, V235, P895, DOI 10.1007/s00425-011-1553-2; Yin XR, 2010, PLANT PHYSIOL, V153, P1280, DOI 10.1104/pp.110.157081	36	48	55	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97043	10.1371/journal.pone.0097043	http://dx.doi.org/10.1371/journal.pone.0097043			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805136	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900134
J	Tewari, R; Patzewitz, EM; Poulin, B; Stewart, L; Baker, DA				Tewari, Rita; Patzewitz, Eva-Maria; Poulin, Benoit; Stewart, Lindsay; Baker, David A.			Development of a Transgenic Plasmodium berghei Line (Pb-pfpkg) Expressing the P. falciparum cGMP-Dependent Protein Kinase, a Novel Antimalarial Drug Target	PLOS ONE			English	Article							MALARIA PARASITES; CYSTEINE PROTEASE; RODENT MALARIA; LIFE-CYCLE; STAGE; ERYTHROCYTES; TRANSMISSION; PKG	With the inevitable selection of resistance to antimalarial drugs in treated populations, there is a need for new medicines to enter the clinic and new targets to progress through the drug discovery pipeline. In this study we set out to develop a transgenic rodent model for testing inhibitors of the Plasmodium falciparum cyclic GMP-dependent kinase in vivo. A model was needed that would allow us to investigate whether differences in amino acid sequence of this enzyme between species influences in vivo efficacy. Here we report the successful development of a transgenic P. berghei line in which the cyclic GMP-dependent protein kinase (PKG) was replaced by the P. falciparum orthologue. We demonstrate that the P. falciparum orthologue was able to functionally complement the endogenous P. berghei pkg gene throughout blood stage development and early sexual development. However, subsequent development in the mosquito was severely compromised. We show that this is due to a defect in the female lineage of the transgenic by using genetic crosses with both male and female deficient P. berghei lines. This defect could be due to expression of a female-specific target in the mosquito stages of P. berghei that cannot be phosphorylated by the P. falciparum kinase. Using a previously reported anticoccidial inhibitor of the cyclic GMP-dependent protein kinase, we show no difference in in vivo efficacy between the transgenic and control P. berghei lines. This in vivo model will be useful for screening future generations of cyclic GMPdependent protein kinase inhibitors and allowing us to overcome any species-specific differences in the enzyme primary sequence that would influence in vivo efficacy in the rodent model. The approach will also be applicable to in vivo testing of other antimalarial compounds where the target is known.	[Tewari, Rita; Patzewitz, Eva-Maria; Poulin, Benoit] Univ Nottingham, Ctr Genet & Genom, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [Stewart, Lindsay; Baker, David A.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, Fac Infect & Trop Dis, London WC1, England	University of Nottingham; University of London; London School of Hygiene & Tropical Medicine	Tewari, R (corresponding author), Univ Nottingham, Ctr Genet & Genom, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2RD, England.	rita.tewari@nottingham.ac.uk; david.baker@lshtm.ac.uk	Tewari, Rita/M-5698-2014	Baker, David/0000-0002-5490-8933; Tewari, Rita/0000-0003-3943-1847	Medical Research Council [G1000779]; Wellcome Trust [094752]; MRC Investigator Award [G0900109]; MRC [G0900278, MR/K011782/1]; Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish; Medical Research Council [G0900109, G0900278, MR/K011782/1] Funding Source: researchfish; BBSRC [BB/D02014X/1] Funding Source: UKRI; MRC [G0900109, G1000779] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC Investigator Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Medical Research Council to D.A.B. and L.S. (DPFS grant Ref: G1000779) and by Wellcome Trust for support to D.A.B. (Project Grant Ref: 094752). RT is grateful for funding by MRC Investigator Award (G0900109) and MRC project grants [G0900278, MR/K011782/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Deng WS, 2002, MOL MICROBIOL, V44, P1141, DOI 10.1046/j.1365-2958.2002.02948.x; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Donald RGK, 2002, EUKARYOT CELL, V1, P317, DOI 10.1128/EC.1.3.317-328.2002; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Hopp CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048206; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; PETERS W, 1975, ANN TROP MED PARASIT, V69, P155, DOI 10.1080/00034983.1975.11686997; Singh A, 2002, BIOCHEM J, V368, P273, DOI 10.1042/BJ20020753; Singh A, 2007, PROTEIN ENG DES SEL, V20, P171, DOI 10.1093/protein/gzm009; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96923	10.1371/journal.pone.0096923	http://dx.doi.org/10.1371/journal.pone.0096923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805991	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900118
J	Zhang, ZH; Hua, F; Liu, T; Zhao, Y; Li, J; Yang, RF; Yang, CX; Zhou, L				Zhang, Zhonghuan; Hua, Fei; Liu, Ting; Zhao, Yong; Li, Jun; Yang, Ruifu; Yang, Changxi; Zhou, Lei			A Double-Taper Optical Fiber-Based Radiation Wave Other than Evanescent Wave in All-Fiber Immunofluorescence Biosensor for Quantitative Detection of Escherichia coli O157: H7	PLOS ONE			English	Article							ANTIBODY-BASED SENSORS; LISTERIA-MONOCYTOGENES; PROBES; IMMUNOSENSOR; GUIDES; CELLS; PO2	Cylindrical or taper-and-cylinder combination optical fiber probe based on evanescent wave has been widely used for immunofluorescence biosensor to detect various analytes. In this study, in contrast to the contradiction between penetration depth and analyte diameter of optical fiber probe-based evanescent wave, we demonstrate that double-taper optical fiber used in a radiation wave-based all-fiber immunofluorescence biosensor (RWAIB) can detect micron-scale analytes using Escherichia coli O157: H7 as representative target. Finite-difference time-domain method was used to compare the properties of evanescent wave and radiation wave (RW). Ray-tracing model was formulated to optimize the taper geometry of the probe. Based on a commercial multi- mode fiber, a double-taper probe was fabricated and connected with biosensor through a ``ferrule connector'' optical fiber connector. The RWAIB configuration was accomplished using commercial multi- mode fibers and fiber-based devices according to the ``all- fiber'' method. The standard sample tests revealed that the sensitivity of the proposed technique for E. coli O157: H7 detection was 10(3) cfu center dot mL(-1). Quantitation could be achieved within the concentration range of 10(3) cfu center dot mL(-1) to 10(7) cfu center dot mL(-1). No non-specific recognition to ten kinds of food-borne pathogens was observed. The results demonstrated that based on the double-taper optical fiber RWAIB can be used for the quantitative detection of micron-scale targets, and RW sensing is an alternative for traditional evanescent wave sensing during the fabrication of fiber-optic biosensors.	[Zhang, Zhonghuan; Liu, Ting; Li, Jun; Yang, Changxi] Tsinghua Univ, Dept Precis Instruments, State Key Lab Precis Measurement Technol & Instru, Beijing 100084, Peoples R China; [Hua, Fei; Zhao, Yong; Yang, Ruifu; Zhou, Lei] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Lab Analyt Microbiol, Beijing, Peoples R China; [Hua, Fei] Taishan Med Univ, Dept Aetiol, Tai An, Shandong, Peoples R China	Tsinghua University; Beijing Institute of Microbiology & Epidemiology; Shandong First Medical University & Shandong Academy of Medical Sciences	Yang, CX (corresponding author), Tsinghua Univ, Dept Precis Instruments, State Key Lab Precis Measurement Technol & Instru, Beijing 100084, Peoples R China.	cxyang@tsinghua.edu.cn; ammszhoulei@aliyun.com	Yang, Ruifu/A-2273-2011	Yang, Ruifu/0000-0003-3219-7269; Yang, Changxi/0000-0002-9972-6965	National Natural Science Foundation of China [81000774]; Major National Science and Technology Programs of China [2011ZX10004, 2012ZX1004801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Programs of China	This work was supported by the National Natural Science Foundation of China (Grant No. 81000774) and the Major National Science and Technology Programs of China (Grant Nos. 2011ZX10004 and 2012ZX1004801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2005, BIOSENS BIOELECTRON, V20, P1312, DOI 10.1016/j.bios.2004.04.026; ANKIEWICZ A, 1982, J OPT SOC AM, V72, P198, DOI 10.1364/JOSA.72.000198; Bharadwaj R, 2011, BIOSENS BIOELECTRON, V26, P3367, DOI 10.1016/j.bios.2010.12.014; Cao WQ, 2006, SENSOR ACTUAT B-CHEM, V119, P363, DOI 10.1016/j.snb.2005.12.034; Foti A, 2013, PLASMONICS, V8, P13, DOI 10.1007/s11468-012-9371-3; Geng T, 2004, APPL ENVIRON MICROB, V70, P6138, DOI 10.1128/AEM.70.10.6138-6146.2004; GLOGE D, 1971, APPL OPTICS, V10, P2252, DOI 10.1364/AO.10.002252; GOLDEN JP, 1994, IEEE T BIO-MED ENG, V41, P585, DOI 10.1109/10.293246; Haber LH, 2004, J MICROSC-OXFORD, V214, P27, DOI 10.1111/j.0022-2720.2004.01308.x; Hewitt BM, 2012, ENVIRON SCI TECHNOL, V46, P5414, DOI 10.1021/es300164p; Holford TRJ, 2012, BIOSENS BIOELECTRON, V34, P12, DOI 10.1016/j.bios.2011.10.023; Horvath R, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862756; Horvath R, 2003, OPT LETT, V28, P1233, DOI 10.1364/OL.28.001233; Horvath R, 2002, APPL PHYS B-LASERS O, V74, P383, DOI 10.1007/s003400200823; Horvath R, 2008, BIOSENS BIOELECTRON, V24, P799, DOI 10.1016/j.bios.2008.06.059; Jung CC, 2003, IEEE SENS J, V3, P352, DOI 10.1109/JSEN.2003.815775; Lazarev A, 2003, REV SCI INSTRUM, V74, P3679, DOI 10.1063/1.1589583; Long F, 2008, BIOSENS BIOELECTRON, V23, P952, DOI 10.1016/j.bios.2007.09.013; LUBBERS DW, 1975, Z NATURFORSCH C, V30, P532; LUBBERS DW, 1977, Z NATURFORSCH C, V32, P133; Lucotti A, 2007, APPL SPECTROSC, V61, P260, DOI 10.1366/000370207780220921; MIRABELLA FM, 1985, APPL SPECTROSC REV, V21, P45, DOI 10.1080/05704928508060428; Muramatsu H, 1999, J MICROSC-OXFORD, V194, P383, DOI 10.1046/j.1365-2818.1999.00509.x; Mynbaev D. K., 2001, FIBER OPTIC COMMUNIC; Ohk SH, 2013, FOOD MICROBIOL, V33, P166, DOI 10.1016/j.fm.2012.09.013; Pesapane A, 2010, J RAMAN SPECTROSC, V41, P256, DOI 10.1002/jrs.2451; Skottrup PD, 2008, BIOSENS BIOELECTRON, V24, P339, DOI 10.1016/j.bios.2008.06.045; Stockle R, 1999, APPL PHYS LETT, V75, P160, DOI 10.1063/1.124305; Taitt CR, 2005, BIOSENS BIOELECTRON, V20, P2470, DOI 10.1016/j.bios.2004.10.026; Turner D., 1983, US patent, Patent No. [4,469,554, 4469554]; Wang CW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3523368; Wei H, 2007, SENSOR ACTUAT B-CHEM, V123, P204, DOI 10.1016/j.snb.2006.08.010; Wolfbeis OS, 2008, ANAL CHEM, V80, P4269, DOI 10.1021/ac800473b	33	5	6	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e95429	10.1371/journal.pone.0095429	http://dx.doi.org/10.1371/journal.pone.0095429			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805354	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900019
J	Jeandron, A; Ensink, JHJ; Thamsborg, SM; Dalsgaard, A; Sengupta, ME				Jeandron, Aurelie; Ensink, Jeroen H. J.; Thamsborg, Stig M.; Dalsgaard, Anders; Sengupta, Mita E.			A Quantitative Assessment Method for Ascaris Eggs on Hands	PLOS ONE			English	Article							HELMINTH INFECTIONS; SUUM EGGS; WASTE-WATER; PRECISION; ACCURACY; FLOTAC; RISK	The importance of hands in the transmission of soil transmitted helminths, especially Ascaris and Trichuris infections, is under-researched. This is partly because of the absence of a reliable method to quantify the number of eggs on hands. Therefore, the aim of this study was to develop a method to assess the number of Ascaris eggs on hands and determine the egg recovery rate of the method. Under laboratory conditions, hands were seeded with a known number of Ascaris eggs, air dried and washed in a plastic bag retaining the washing water, in order to determine recovery rates of eggs for four different detergents (cationic [benzethonium chloride 0.1% and cetylpyridinium chloride CPC 0.1%], anionic [7X 1% quadrafos, glycol ether, and dioctyl sulfoccinate sodium salt] and non-ionic [Tween80 0.1% -polyethylene glycol sorbitan monooleate]) and two egg detection methods (McMaster technique and FLOTAC). A modified concentration McMaster technique showed the highest egg recovery rate from bags. Two of the four diluted detergents (benzethonium chloride 0.1% and 7X 1%) also showed a higher egg recovery rate and were then compared with de-ionized water for recovery of helminth eggs from hands. The highest recovery rate (95.6%) was achieved with a hand rinse performed with 7X 1%. Washing hands with de-ionized water resulted in an egg recovery rate of 82.7%. This washing method performed with a low concentration of detergent offers potential for quantitative investigation of contamination of hands with Ascaris eggs and of their role in human infection. Follow-up studies are needed that validate the hand washing method under field conditions, e.g. including people of different age, lower levels of contamination and various levels of hand cleanliness.	[Jeandron, Aurelie; Ensink, Jeroen H. J.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Thamsborg, Stig M.; Dalsgaard, Anders; Sengupta, Mita E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark	University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen	Jeandron, A (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	aurelie.jeandron@lshtm.ac.uk		Thamsborg, Stig Milan/0000-0003-3304-7422	Sanitation and Hygiene Applied Research for Equity (SHARE) consortium - DFID	Sanitation and Hygiene Applied Research for Equity (SHARE) consortium - DFID	This study was supported by the Sanitation and Hygiene Applied Research for Equity (SHARE) consortium, funded by DFID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bowman DD, 2003, WATER RES, V37, P2063, DOI 10.1016/S0043-1354(02)00597-3; Brownell SA, 2006, APPL ENVIRON MICROB, V72, P2178, DOI 10.1128/AEM.72.3.2178-2184.2006; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; Ekejindu Ekechukwu AC, 2005, J BIOMED INVEST, V3, P16; Ekpo UF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000146; Ensink JHJ, 2008, AM J TROP MED HYG, V79, P561, DOI 10.4269/ajtmh.2008.79.561; Fung ICH, 2009, T ROY SOC TROP MED H, V103, P215, DOI 10.1016/j.trstmh.2008.08.003; Gaspard P. G., 1994, Revue des Sciences de l'Eau, V7, P367; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; JORGENSEN RJ, 1978, ACTA VET SCAND, V19, P147; Kampf G, 2006, APPL ENVIRON MICROB, V72, P3856, DOI 10.1128/AEM.02746-05; Khanum H, 2011, J LIFE EARTH SCI, V5; Larsen MN, 1999, PARASITOLOGY, V119, P209, DOI 10.1017/S0031182099004503; Levecke B, 2012, VET PARASITOL, V188, P194, DOI 10.1016/j.vetpar.2012.03.017; Nguyen Thi Viet Hoa, 2010, Tropical Medicine and Health, V38, P75, DOI 10.2149/tmh.2010-02; Nordin A, 2009, APPL ENVIRON MICROB, V75, P662, DOI 10.1128/AEM.01250-08; OKSANEN A, 1990, ACTA VET SCAND, V31, P393; Olsen A, 2001, J BIOSOC SCI, V33, P569, DOI 10.1017/S0021932001005697; Ozumba A, 2010, S E NIGERIA, P288; Roepstorff A., 1998, EPIDEMIOLOGY DIAGNOS; Romanenko N. A., 2006, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P60; RUDOLFS W, 1951, SEWAGE IND WASTES, V23, P853; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; Trang DT, 2007, TROP MED INT HEALTH, V12, P82, DOI 10.1111/j.1365-3156.2007.01945.x; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	26	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96731	10.1371/journal.pone.0096731	http://dx.doi.org/10.1371/journal.pone.0096731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802859	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000338029800115
J	Testa, G; Gamba, P; Badilli, U; Gargiulo, S; Maina, M; Guina, T; Calfapietra, S; Biasi, F; Cavalli, R; Poli, G; Leonarduzzi, G				Testa, Gabriella; Gamba, Paola; Badilli, Ulya; Gargiulo, Simona; Maina, Marco; Guina, Tina; Calfapietra, Simone; Biasi, Fiorella; Cavalli, Roberta; Poli, Giuseppe; Leonarduzzi, Gabriella			Loading into Nanoparticles Improves Quercetin's Efficacy in Preventing Neuroinflammation Induced by Oxysterols	PLOS ONE			English	Article							LIVER-X RECEPTORS; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; AMYLOID-BETA; ANTIINFLAMMATORY CYTOKINES; CHOLESTEROL HOMEOSTASIS; OXIDATION-PRODUCTS; APOLIPOPROTEIN-E; BLOOD-BRAIN; INFLAMMATION	Chronic inflammatory events appear to play a fundamental role in Alzheimer's disease (AD)-related neuropathological changes, and to result in neuronal dysfunction and death. The inflammatory responses observed in the AD brain include activation and proliferation of glial cells, together with up-regulation of inflammatory mediators and of free radicals. Along with glial cells, neurons themselves can also react and contribute to neuroinflammatory changes in the AD brain, by serving as sources of inflammatory mediators. Because excess cholesterol cannot be degraded in the brain, it must be excreted from that organ as cholesterol oxidation products (oxysterols), in order to prevent its accumulation. Among risk factors for this neurodegenerative disease, a mechanistic link between altered cholesterol metabolism and AD has been suggested; oxysterols appear to be the missing linkers between the two, because of their neurotoxic effects. This study shows that 24-hydroxycholesterol, 27-hydroxycholesterol, and 7b-hydroxycholesterol, the three oxysterols potentially implicated in AD pathogenesis, induce some pro-inflammatory mediator expression in human neuroblastoma SH-SY5Y cells, via Toll-like receptor-4/cyclooxygenase-2/membrane bound prostaglandin E synthase (TLR4/COX-2/mPGES-1); this clearly indicates that oxysterols may promote neuroinflammatory changes in AD. To confirm this evidence, cells were incubated with the anti-inflammatory flavonoid quercetin; remarkably, its anti-inflammatory effects in SH-SY5Y cells were enhanced when it was loaded into beta-cyclodextrin-dodecylcarbonate nanoparticles, versus cells pretreated with free quercetin. The goal of loading quercetin into nanoparticles was to improve its permeation across the blood-brain barrier into the brain, and its bioavailability to reach target cells. The findings show that this drug delivery system might be a new therapeutic strategy for preventing or reducing AD progression.	[Testa, Gabriella; Gamba, Paola; Gargiulo, Simona; Maina, Marco; Guina, Tina; Calfapietra, Simone; Biasi, Fiorella; Poli, Giuseppe; Leonarduzzi, Gabriella] Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy; [Badilli, Ulya] Ankara Univ, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey; [Cavalli, Roberta] Univ Turin, Dept Drug Sci & Technol, Turin, Italy	University of Turin; Ankara University; University of Turin	Leonarduzzi, G (corresponding author), Univ Turin, Dept Clin & Biol Sci, Orbassano, Italy.	gabriella.leonarduzzi@unito.it	Badıllı, Ulya/AAF-3184-2020; Leonarduzzi, Gabriella/AAA-6575-2019; Gamba, Paola/AAA-6585-2019	Testa, Gabriella/0000-0002-2835-2804; LEONARDUZZI, Gabriella Marisa/0000-0002-3422-821X; GAMBA, Paola Francesca/0000-0003-2715-5435	Italian Ministry of University [Prin 2009]; CRT Foundation, Torino; University of Torino, Italy	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR)); CRT Foundation, Torino; University of Torino, Italy	The authors thank the Italian Ministry of University (Prin 2009), the CRT Foundation, Torino, and the University of Torino, Italy for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abildayeva K, 2006, J BIOL CHEM, V281, P12799, DOI 10.1074/jbc.M601019200; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Ansari MA, 2009, J NUTR BIOCHEM, V20, P269, DOI 10.1016/j.jnutbio.2008.03.002; Aye ILMH, 2012, MOL HUM REPROD, V18, P341, DOI 10.1093/molehr/gas001; Azizi G, 2012, IMMUNOPHARM IMMUNOT, V34, P881, DOI 10.3109/08923973.2012.705292; Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Bhamra MS, 2012, ELECTROPHORESIS, V33, P3598, DOI 10.1002/elps.201200161; Bhullar KS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/891748; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Bjorkhem I, 2006, ACTA NEUROL SCAND, V114, P43, DOI 10.1111/j.1600-0404.2006.00684.x; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bureau G, 2008, J NEUROSCI RES, V86, P403, DOI 10.1002/jnr.21503; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Cao GQ, 2007, CURR ALZHEIMER RES, V4, P179, DOI 10.2174/156720507780362173; Cavalli R, 2007, J INCL PHENOM MACRO, V57, P657, DOI 10.1007/s10847-006-9269-9; Cavalli R, 2007, INT J PHARMACEUT, V339, P197, DOI 10.1016/j.ijpharm.2007.03.001; Cavalli R, 2009, J CONTROL RELEASE, V137, P116, DOI 10.1016/j.jconrel.2009.04.004; Chavez-Sanchez L, 2010, HUM IMMUNOL, V71, P737, DOI 10.1016/j.humimm.2010.05.005; Chopra K, 2011, EXPERT OPIN THER TAR, V15, P535, DOI 10.1517/14728222.2011.557363; Colton CA, 2010, CNS NEUROL DISORD-DR, V9, P174, DOI 10.2174/187152710791012053; Conductier G, 2010, J NEUROIMMUNOL, V224, P93, DOI 10.1016/j.jneuroim.2010.05.010; Dafnis I, 2012, NEUROSCIENCE, V210, P21, DOI 10.1016/j.neuroscience.2012.03.013; Dajas Federico, 2013, Central Nervous System Agents in Medicinal Chemistry, V13, P30; Dhawan S, 2011, J PHARM PHARMACOL, V63, P342, DOI 10.1111/j.2042-7158.2010.01225.x; Doggui S, 2012, THER DELIV, V3, P1025, DOI 10.4155/tde.12.84; Drouin-Ouellet J, 2012, TRENDS PHARMACOL SCI, V33, P542, DOI 10.1016/j.tips.2012.07.002; Dugas B, 2010, EUR J NUTR, V49, P435, DOI 10.1007/s00394-010-0102-2; Faria A, 2010, CELL MOL BIOL LETT, V15, P234, DOI 10.2478/s11658-010-0006-4; Ferrera P, 2008, NEUROCHEM RES, V33, P1509, DOI 10.1007/s11064-008-9623-y; Gamba P, 2014, AGING CELL, V13, P561, DOI 10.1111/acel.12206; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gamba P, 2011, AGING CELL, V10, P403, DOI 10.1111/j.1474-9726.2011.00681.x; Ghosh A, 2009, LIFE SCI, V84, P75, DOI 10.1016/j.lfs.2008.11.001; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Haanstra KG, 2013, J IMMUNOL, V190, P1961, DOI 10.4049/jimmunol.1202490; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Ho L, 2010, EXPERT REV PROTEOMIC, V7, P579, DOI 10.1586/EPR.10.69; Holmes C, 2013, NEUROPATH APPL NEURO, V39, P51, DOI 10.1111/j.1365-2990.2012.01307.x; Holmes C, 2011, BIOCHEM SOC T, V39, P898, DOI 10.1042/BST0390898; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Jayasena T, 2013, AGEING RES REV, V12, P867, DOI 10.1016/j.arr.2013.06.003; Johnston H, 2011, BIOCHEM SOC T, V39, P886, DOI 10.1042/BST0390886; Kim WS, 2009, J ALZHEIMERS DIS, V16, P121, DOI 10.3233/JAD-2009-0944; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Kolsch H, 2001, J NEURAL TRANSM, V108, P475, DOI 10.1007/s007020170068; Kolsch H, 2000, NEUROCHEM INT, V36, P507, DOI 10.1016/S0197-0186(99)00157-6; Leonarduzzi G, 2010, CURR MED CHEM, V17, P74, DOI 10.2174/092986710789957760; Leoni V, 2003, J LIPID RES, V44, P793, DOI 10.1194/jlr.M200434-JLR200; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; Mandel Silvia A, 2012, Front Biosci (Schol Ed), V4, P581; Mascia C, 2010, FREE RADICAL BIO MED, V49, P2049, DOI 10.1016/j.freeradbiomed.2010.09.033; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Morello F, 2009, ATHEROSCLEROSIS, V207, P38, DOI 10.1016/j.atherosclerosis.2009.04.001; Nelson TJ, 2005, J BIOL CHEM, V280, P7377, DOI 10.1074/jbc.M409071200; Ong WY, 2010, MOL NEUROBIOL, V41, P299, DOI 10.1007/s12035-010-8099-3; Panzenboeck U, 2006, INT J BIOCHEM CELL B, V38, P1314, DOI 10.1016/j.biocel.2006.01.013; Park L, 2011, P NATL ACAD SCI USA, V108, P5063, DOI 10.1073/pnas.1015413108; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; Prunet C, 2006, CYTOM PART A, V69A, P359, DOI 10.1002/cyto.a.20272; Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Quintanilla RA, 2012, ARCH MED RES, V43, P632, DOI 10.1016/j.arcmed.2012.10.016; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Sahni JK, 2011, J CONTROL RELEASE, V152, P208, DOI 10.1016/j.jconrel.2010.11.033; Saint-Pol J, 2013, BRAIN RES, V1517, P1, DOI 10.1016/j.brainres.2013.04.008; Saint-Pol J, 2012, J ALZHEIMERS DIS, V30, P489, DOI 10.3233/JAD-2012-112090; Scheepens A, 2010, GENES NUTR, V5, P75, DOI 10.1007/s12263-009-0148-z; Sodhi RK, 2013, PHARMACOL RES, V72, P45, DOI 10.1016/j.phrs.2013.03.008; Sottero B, 2009, CURR MED CHEM, V16, P685, DOI 10.2174/092986709787458353; Steffensen KR, 2013, EXPERT OPIN THER TAR, V17, P977, DOI 10.1517/14728222.2013.806490; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Terwel D, 2011, J NEUROSCI, V31, P7049, DOI 10.1523/JNEUROSCI.6546-10.2011; Testa G, 2012, FREE RADICAL BIO MED, V53, P1708, DOI 10.1016/j.freeradbiomed.2012.08.581; Vafeiadou K., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P211, DOI 10.2174/187153007781662521; Vaya J, 2007, J NEUROCHEM, V102, P1727, DOI 10.1111/j.1471-4159.2007.04689.x; Vejux A, 2009, MOL ASPECTS MED, V30, P153, DOI 10.1016/j.mam.2009.02.006; Von Bernhardi R, 2007, NEUROTOX RES, V12, P215, DOI 10.1007/BF03033906; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	87	62	63	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96795	10.1371/journal.pone.0096795	http://dx.doi.org/10.1371/journal.pone.0096795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802026	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800128
J	Abade, L; Macdonald, DW; Dickman, AJ				Abade, Leandro; Macdonald, David W.; Dickman, Amy J.			Using Landscape and Bioclimatic Features to Predict the Distribution of Lions, Leopards and Spotted Hyaenas in Tanzania's Ruaha Landscape	PLOS ONE			English	Article							PANTHERA-PARDUS; PREY PREFERENCES; BEHAVIORAL-ADJUSTMENTS; CARNIVORE CONSERVATION; SPECIES DISTRIBUTIONS; SELECTING THRESHOLDS; HABITAT-SUITABILITY; PRESENCE-ABSENCE; FEMALE LEOPARDS; AFRICAN LIONS	Tanzania's Ruaha landscape is an international priority area for large carnivores, supporting over 10% of the world's lions and important populations of leopards and spotted hyaenas. However, lack of ecological data on large carnivore distribution and habitat use hinders the development of effective carnivore conservation strategies in this critical landscape. Therefore, the study aimed to (i) identify the most significant ecogeographical variables influencing the potential distribution of lions, leopards and spotted hyaenas across the Ruaha landscape; (ii) identify zones with highest suitability for harbouring those species; and (iii) use species distribution modelling algorithms (SDMs) to define important areas for conservation of large carnivores. Habitat suitability was calculated based on environmental features from georeferenced presence-only carnivore location data. Potential distribution of large carnivores appeared to be strongly influenced by water availability; highly suitable areas were situated close to rivers and experienced above average annual precipitation. Net primary productivity and tree cover also exerted some influence on habitat suitability. All three species showed relatively narrow niche breadth and low tolerance to changes in habitat characteristics. From 21,050 km 2 assessed, 8.1% (1,702 km(2)) emerged as highly suitable for all three large carnivores collectively. Of that area, 95.4% (1,624 km(2)) was located within 30 km of the Park-village border, raising concerns about human-carnivore conflict. This was of particular concern for spotted hyaenas, as they were located significantly closer to the Park boundary than lions and leopards. This study provides the first map of potential carnivore distribution across the globally important Ruaha landscape, and demonstrates that SDMs can be effective for understanding large carnivore habitat requirements in poorly sampled areas. This approach could have relevance for many other important wildlife areas that only have limited, haphazard presence-only data, but which urgently require strategic conservation planning.	[Abade, Leandro; Macdonald, David W.; Dickman, Amy J.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England; [Dickman, Amy J.] Ruaha Carnivore Project, Iringa, Tanzania	University of Oxford	Macdonald, DW (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England.	david.macdonald@zoo.ox.ac.uk			Robertson Foundation; Recanati-Kaplan Foundation; SeaWorld Busch Gardens Conservation Fund; St. Louis Zoo WildCare Institute	Robertson Foundation; Recanati-Kaplan Foundation; SeaWorld Busch Gardens Conservation Fund; St. Louis Zoo WildCare Institute	L.A.'s studies were funded by a grant to D.W.M. from the Robertson Foundation. The wider project was funded by grants to A.D. from the Recanati-Kaplan Foundation, the SeaWorld Busch Gardens Conservation Fund and the St. Louis Zoo WildCare Institute. A.D. holds a Kaplan Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Augustine DJ, 1998, J WILDLIFE MANAGE, V62, P1165, DOI 10.2307/3801981; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme G, 2007, ANIM BEHAV, V74, P589, DOI 10.1016/j.anbehav.2006.12.014; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Basille M, 2009, ECOGRAPHY, V32, P683, DOI 10.1111/j.1600-0587.2009.05712.x; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bowyer R. Terry, 2005, P342; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Bradley BA, 2008, J BIOGEOGR, V35, P1158, DOI 10.1111/j.1365-2699.2008.01928.x; Braunisch V, 2008, ECOL MODEL, V214, P153, DOI 10.1016/j.ecolmodel.2008.02.001; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Cabeza M, 2004, J APPL ECOL, V41, P252, DOI 10.1111/j.0021-8901.2004.00905.x; Clark CM, 2007, ECOL LETT, V10, P596, DOI 10.1111/j.1461-0248.2007.01053.x; Cooper SM, 1999, AFR J ECOL, V37, P149, DOI 10.1046/j.1365-2028.1999.00161.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; Dickman A. J., 2008, THESIS U COLL LONDON; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Drake JM, 2009, THEOR ECOL-NETH, V2, P189, DOI 10.1007/s12080-009-0050-8; Eastman J.R., 2012, IDRISI SELVA TUTORIA; Elbroch LM, 2012, BIOL LETTERS, V8, P776, DOI 10.1098/rsbl.2012.0423; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Environmental Systems Research Institute (ESRI), 2012, ARCGIS 10 1; ESA, 2009, ESA GLOBC PROJ; FAO Africover, 2004, TANZ RIV AFR; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hazzah L, 2009, BIOL CONSERV, V142, P2428, DOI 10.1016/j.biocon.2009.06.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Hunter L, 2013, LEOPARD PANTHERA PAR; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IUCN, 2007, REG CONS STRAT CHEET; IUCN, 2009, CAT 2 NAT PARK WORLD; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Karatzoglou A., 2006, J STAT SOFTW, V15, P1, DOI [https://doi.org/10.18637/jss.v015.i09, DOI 10.18637/JSS.V015.I09]; Kendall CI, 2011, ORYX, V45, P28, DOI 10.1017/S0030605310000359; Kolowski JM, 2009, J ZOOL, V277, P23, DOI 10.1111/j.1469-7998.2008.00505.x; Krebs CJ, 2001, BIOSCIENCE, V51, P25, DOI 10.1641/0006-3568(2001)051[0025:WDTYCO]2.0.CO;2; Kunkel KE, 2012, ANIMAL CONSERVATION; Leverette TL, 2005, ERLANGEN EARTH C SER, P467, DOI 10.1007/3-540-27673-4_23; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Loe LE, 2005, J ANIM ECOL, V74, P579, DOI 10.1111/j.1365-2656.2005.00987.x; Loveridge A., 2009, AFRICAN LION DISTRIB; Loveridge Andrew J., 2010, P283; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Mills MGL, 2001, CONSERV BIOL SER, V5, P467; Mosser A, 2009, ECOL LETT, V12, P1050, DOI 10.1111/j.1461-0248.2009.01359.x; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2002, AFR J ECOL, V40, P120, DOI 10.1046/j.1365-2028.2002.00343.x; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pettorelli N, 2005, BIOL LETT-UK, V1, P24, DOI 10.1098/rsbl.2004.0262; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pita R, 2009, AGR ECOSYST ENVIRON, V132, P57, DOI 10.1016/j.agee.2009.02.008; Pitman RT, 2012, J ZOOL, V288, P222, DOI 10.1111/j.1469-7998.2012.00945.x; Pouteau R, 2012, ECOL INFORM, V9, P37, DOI 10.1016/j.ecoinf.2012.03.003; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; R Core Team, 2012, R LANG ENV STAT COMP; Ray JC, 2005, CONSERVATION PRIORIT; Riggio J, 2012, BIODIVERS CONSERV, P1; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Schadt S, 2002, J APPL ECOL, V39, P189, DOI 10.1046/j.1365-2664.2002.00700.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; SOSOVELE H, 2002, SOCIOECONOMIC ROOT C; Steyn V, 2009, S AFR J WILDL RES, V39, P126, DOI 10.3957/056.039.0203; TAWIRI, 2009, TANZ CARN CONS ACT P; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Townshend J.R.G., 2011, VEGETATION CONTINUOU; USGS, 2000, USGS GLCF 3 ARCS FIL; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; Valeix M, 2012, J APPL ECOL, V49, P73, DOI 10.1111/j.1365-2664.2011.02099.x; Valeix M, 2010, LANDSCAPE ECOL, V25, P337, DOI 10.1007/s10980-009-9425-x; Varela S, 2009, J BIOGEOGR, V36, P1645, DOI 10.1111/j.1365-2699.2009.02125.x; Walsh M, 2000, DEV COMMUNITY WILDLI; Wang Xuezhi, 2008, Acta Ecologica Sinica, V28, P821; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Watts HE, 2009, J MAMMAL, V90, P461, DOI 10.1644/08-MAMM-A-136.1; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829; Yirga G, 2013, MAMM BIOL, V78, P193, DOI 10.1016/j.mambio.2012.09.001; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0; Zarco-Gonzalez MM, 2013, BIOL CONSERV, V159, P80, DOI 10.1016/j.biocon.2012.11.007; Zarco-Gonzalez MM, 2012, HUM ECOL, V40, P631, DOI 10.1007/s10745-012-9505-4	113	32	32	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96261	10.1371/journal.pone.0096261	http://dx.doi.org/10.1371/journal.pone.0096261			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797792	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000053
J	Ayoglu, B; Szarka, E; Huber, K; Orosz, A; Babos, F; Magyar, A; Hudecz, F; Rojkovich, B; Gati, T; Nagy, G; Schwenk, JM; Sarmay, G; Prechl, J; Nilsson, P; Papp, K				Ayoglu, Burcu; Szarka, Eszter; Huber, Krisztina; Orosz, Anita; Babos, Fruzsina; Magyar, Anna; Hudecz, Ferenc; Rojkovich, Bernadette; Gati, Tamas; Nagy, Gyoergy; Schwenk, Jochen M.; Sarmay, Gabriella; Prechl, Jozsef; Nilsson, Peter; Papp, Krisztian			Bead Arrays for Antibody and Complement Profiling Reveal Joint Contribution of Antibody Isotypes to C3 Deposition	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ARTHRITIS-SPECIFIC AUTOANTIBODIES; RHEUMATOID-ARTHRITIS; NASOPHARYNGEAL CARCINOMA; CITRULLINATED PROTEINS; ALLOGRAFT RECIPIENTS; ANTIGEN MICROARRAYS; HLA ALLOANTIBODIES; NUCLEAR ANTIGEN-1; ACTIVATION	The development of antigen arrays has provided researchers with great tools to identify reactivities against self or foreign antigens from body fluids. Yet, these approaches mostly do not address antibody isotypes and their effector functions even though these are key points for a more detailed understanding of disease processes. Here, we present a bead array-based assay for a multiplexed determination of antigen-specific antibody levels in parallel with their properties for complement activation. We measured the deposition of C3 fragments from serum samples to reflect the degree of complement activation via all three complement activation pathways. We utilized the assay on a bead array containing native and citrullinated peptide antigens to investigate the levels of IgG, IgM and IgA autoantibodies along with their complement activating properties in serum samples of 41 rheumatoid arthritis patients and 40 controls. Our analysis revealed significantly higher IgG reactivity against the citrullinated fibrinogen beta and filaggrin peptides as well as an IgA reactivity that was exclusive for citrullinated fibrinogen b peptide and C3 deposition in rheumatoid arthritis patients. In addition, we characterized the humoral immune response against the viral EBNA-1 antigen to demonstrate the applicability of this assay beyond autoimmune conditions. We observed that particular buffer compositions were demanded for separate measurement of antibody reactivity and complement activation, as detection of antigen-antibody complexes appeared to be masked due to C3 deposition. We also found that rheumatoid factors of IgM isotype altered C3 deposition and introduced false-positive reactivities against EBNA-1 antigen. In conclusion, the presented bead-based assay setup can be utilized to profile antibody reactivities and immune-complex induced complement activation in a high-throughput manner and could facilitate the understanding and diagnosis of several diseases where complement activation plays role in the pathomechanism.	[Ayoglu, Burcu; Schwenk, Jochen M.; Nilsson, Peter; Papp, Krisztian] KTH Royal Inst Technol, Sch Biotechnol, SciLifeLab, Stockholm, Sweden; [Szarka, Eszter; Huber, Krisztina; Orosz, Anita; Sarmay, Gabriella] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Babos, Fruzsina; Magyar, Anna; Hudecz, Ferenc] MTA ELTE Res Grp Peptide Chem, Budapest, Hungary; [Hudecz, Ferenc] Eotvos Lorand Univ, Dept Organ Chem, Budapest, Hungary; [Rojkovich, Bernadette; Gati, Tamas; Nagy, Gyoergy] Polyclin Hospitaller Bros St John God, Dept Rheumatol, Budapest, Hungary; [Nagy, Gyoergy] Semmelweis Univ, Sch Med, Dept Genet Cell & Immunobiol, Budapest, Hungary; [Prechl, Jozsef; Papp, Krisztian] MTA ELTE Immunol Res Grp, Budapest, Hungary; [Prechl, Jozsef] Diagnosticum Ltd, Budapest, Hungary	Royal Institute of Technology; SciLifeLab; Eotvos Lorand University; Eotvos Lorand University; Semmelweis University	Nilsson, P (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, SciLifeLab, Stockholm, Sweden.	peter.nilsson@scilifelab.se; pkrisz5@gmail.com	Sarmay, Gabriella/AAF-3460-2020; Schwenk, Jochen M/F-1730-2010; Nagy, György/W-6254-2019; Nilsson, Peter/E-4547-2010; Schwenk, Jochen/AAS-4164-2021; Prechl, Jozsef/B-2094-2009	Schwenk, Jochen M/0000-0001-8141-8449; Nagy, György/0000-0003-1198-3228; Nilsson, Peter/0000-0002-4657-8532; Schwenk, Jochen/0000-0001-8141-8449; Papp, Krisztian/0000-0003-0619-8233; Venkatasubramanian, Siddharth/0000-0002-5860-0768; /0000-0001-7843-2960; Prechl, Jozsef/0000-0003-3859-4353	Hungarian Academy of Sciences; Hungarian Scientific Research Fund [OTKA-PD 104779, OTKA-NK 104846]; ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Knut and Alice Wallenberg Foundation; SciLifeLab Stockholm	Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems)(Vinnova); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); SciLifeLab Stockholm	This work was supported by the Hungarian Academy of Sciences, the Hungarian Scientific Research Fund (OTKA-PD 104779 and OTKA-NK 104846), ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems), the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences, the Knut and Alice Wallenberg Foundation and SciLifeLab Stockholm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Ayoglu B, 2013, MOL CELL PROTEOMICS, V12, P2657, DOI 10.1074/mcp.M112.026757; Bartos A, 2009, BIOPOLYMERS, V92, P110, DOI 10.1002/bip.21141; Chen G, 2011, HUM IMMUNOL, V72, P849, DOI 10.1016/j.humimm.2011.07.001; Drobin Kimi, 2013, Methods Mol Biol, V1023, P137, DOI 10.1007/978-1-4614-7209-4_8; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fachiroh J, 2004, J INFECT DIS, V190, P53, DOI 10.1086/421245; Babos F, 2013, BIOCONJUGATE CHEM, V24, P817, DOI 10.1021/bc400073z; GIOUDPAQUET M, 1987, ANN RHEUM DIS, V46, P65, DOI 10.1136/ard.46.1.65; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; HENLE G, 1979, CLIN EXP IMMUNOL, V36, P415; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; JONSSON T, 1993, ANN RHEUM DIS, V52, P161, DOI 10.1136/ard.52.2.161; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; MATHEW A, 1994, CLIN IMMUNOL IMMUNOP, V71, P164, DOI 10.1006/clin.1994.1067; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Miersch S, 2013, J PROTEOMICS, V94, P486, DOI 10.1016/j.jprot.2013.10.018; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Okroj M, 2007, ANN MED, V39, P517, DOI 10.1080/07853890701477546; Papp K, 2007, MOL CELL PROTEOMICS, V6, P133, DOI 10.1074/mcp.T600036-MCP200; Papp K, 2012, J IMMUNOL METHODS, V375, P75, DOI 10.1016/j.jim.2011.09.009; Pratesi F, 2006, ARTHRITIS RHEUM-US, V54, P733, DOI 10.1002/art.21629; Prechl J, 2010, TRENDS IMMUNOL, V31, P133, DOI 10.1016/j.it.2010.01.004; Price JV, 2013, J CLIN INVEST, V123, P5135, DOI 10.1172/JCI70231; Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861; Schellekens GA, 1998, J CLIN INVEST, V101, P273, DOI 10.1172/JCI1316; Sebbag M, 2006, EUR J IMMUNOL, V36, P2250, DOI 10.1002/eji.200535790; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; SEINO J, 1993, CLIN EXP IMMUNOL, V94, P291; SHMERLING RH, 1991, AM J MED, V91, P528, DOI 10.1016/0002-9343(91)90190-9; SIMON M, 1993, J CLIN INVEST, V92, P1387, DOI 10.1172/JCI116713; Smith JD, 2007, AM J TRANSPLANT, V7, P2809, DOI 10.1111/j.1600-6143.2007.01991.x; Szarka E, 2013, IMMUNOLOGY; Team R. D. C, 2011, R LANG ENV STAT COMP; Trouw LA, 2009, ARTHRITIS RHEUM-US, V60, P1923, DOI 10.1002/art.24622; Visser H, 1996, ANN RHEUM DIS, V55, P157, DOI 10.1136/ard.55.3.157; Wahrmann M, 2006, AM J TRANSPLANT, V6, P1033, DOI 10.1111/j.1600-6143.2006.01285.x; Wahrmann M, 2005, HUM IMMUNOL, V66, P526, DOI 10.1016/j.humimm.2004.12.007; Wahrmann M, 2003, J IMMUNOL METHODS, V275, P149, DOI 10.1016/S0022-1759(03)00012-7; Wahrmann M, 2009, TRANSPL INT, V22, P982, DOI 10.1111/j.1432-2277.2009.00912.x; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	45	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96403	10.1371/journal.pone.0096403	http://dx.doi.org/10.1371/journal.pone.0096403			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797804	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000073
J	Pravetoni, M; Vervacke, JS; Distefano, MD; Tucker, AM; Laudenbach, M; Pentel, PR				Pravetoni, Marco; Vervacke, Jeffrey S.; Distefano, Mark D.; Tucker, Ashli M.; Laudenbach, Megan; Pentel, Paul R.			Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; TOLL-LIKE RECEPTORS; B-CELLS; PERTUSSIS VACCINATION; SMOKING-CESSATION; NICOTINE VACCINE; COCAINE VACCINE; BREAST-CANCER; IMMUNOGENICITY; SAFETY	Vaccination against the highly abused prescription opioid oxycodone has shown pre-clinical efficacy for blocking oxycodone effects. The current study further evaluated a candidate vaccine composed of oxycodone derivatized at the C6 position (6OXY) conjugated to the native keyhole limpet hemocyanin (nKLH) carrier protein. To provide an oxycodone vaccine formulation suitable for human studies, we studied the effect of alternative carriers and adjuvants on the generation of oxycodone-specific serum antibody and B cell responses, and the effect of immunization on oxycodone distribution and oxycodone-induced antinociception in mice and rats. 6OXY conjugated to tetanus toxoid (TT) or a GMP grade KLH dimer (dKLH) was as effective as 6OXY conjugated to the nKLH decamer in mice and rats, while the 6OXY hapten conjugated to a TT-derived peptide was not effective in preventing oxycodone-induced antinociception in mice. Immunization with 6OXY-TT s.c. absorbed on alum adjuvant provided similar protection to 6OXY-TT administered i.p. with Freund's adjuvant in rats. The toll-like receptor 4 (TLR4) agonist monophosphoryl lipid A (MPLA) adjuvant, alone or in combination with alum, offered no advantage over alum alone for generating oxycodone-specific serum antibodies or 6OXY-specific antibody secreting B cells in mice vaccinated with 6OXY-nKLH or 6OXY-TT. The immunogenicity of oxycodone vaccines may be modulated by TLR4 signaling since responses to 6OXY-nKLH in alum were decreased in TLR4-deficient mice. These data suggest that TT, nKLH and dKLH carriers provide consistent 6OXY conjugate vaccine immunogenicity across species, strains and via different routes of administration, while adjuvant formulations may need to be tailored to individual immunogens or patient populations.	[Pravetoni, Marco; Tucker, Ashli M.; Laudenbach, Megan; Pentel, Paul R.] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Pravetoni, Marco; Pentel, Paul R.] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Pravetoni, Marco] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA; [Vervacke, Jeffrey S.; Distefano, Mark D.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pravetoni, M (corresponding author), Minneapolis Med Res Fdn Inc, Minneapolis, MN 55404 USA.	prave001@umn.edu		Vervacke, Jeffrey/0000-0002-9903-6219; Pravetoni, Marco/0000-0003-1036-0184	National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) [DA034487]; Minneapolis Medical Research Foundation Career Award; NIH NIDA [DA026300]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026300, R21DA034487] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Minneapolis Medical Research Foundation Career Award; NIH NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) DA034487 (Pravetoni), a Minneapolis Medical Research Foundation Career Award (Pravetoni) and a NIH NIDA DA026300 (Pentel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATL SURVEY DRUG USE; [Anonymous], 2012, WORLD DRUG REP 2012; Anton B, 2006, VACCINE, V24, P3232, DOI 10.1016/j.vaccine.2006.01.047; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Bremer PT, 2012, J MED CHEM, V55, P10776, DOI 10.1021/jm301262z; Cai X, 2013, MOL PHARM; Chen XY, 2012, VACCINE, V31, P159, DOI 10.1016/j.vaccine.2012.10.069; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; de Villiers S. H., 2013, VACCINE; Gilewski TA, 2007, CLIN CANCER RES, V13, P2977, DOI 10.1158/1078-0432.CCR-06-2189; Grondahl-Yli-Hannuksela K, 2012, J INFECT DIS, V205, P1214, DOI 10.1093/infdis/jis182; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; Hu Y, 2013, HUM VACCIN IMMUNOTHE, V10; Kimman TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003665; Kosten TR, 2002, VACCINE, V20, P1196, DOI 10.1016/S0264-410X(01)00425-X; Lebrec H, 2013, J IMMUNOTOXICOL; Livingston PO, 2006, HUM VACCINES, V2, P137, DOI 10.4161/hv.2941; Lockner JW, 2013, BIOORG MED CHEM LETT, V23, P975, DOI 10.1016/j.bmcl.2012.12.048; Martell BA, 2009, ARCH GEN PSYCHIAT, V66, P1116, DOI 10.1001/archgenpsychiatry.2009.128; Matyas GR, 2013, VACCINE, V31, P2804, DOI 10.1016/j.vaccine.2013.04.027; Matyas GR, 2013, VACCINE; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; McCluskie MJ, 2013, INT IMMUNOPHARMACOL, V16, P50, DOI 10.1016/j.intimp.2013.03.021; Miles D, 2011, ONCOLOGIST, V16, P1092, DOI 10.1634/theoncologist.2010-0307; Musselli C, 2001, J CANCER RES CLIN, V127, pR20, DOI 10.1007/BF01470995; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Picciotto MR, 1998, PHYSIOL REV, V78, P1131, DOI 10.1152/physrev.1998.78.4.1131; Pravetoni M, 2012, BIOCHEM PHARMACOL, V83, P543, DOI 10.1016/j.bcp.2011.11.004; Pravetoni M, 2012, J PHARM EXP THER; Pravetoni M, 2013, J MED CHEM, V56, P915, DOI 10.1021/jm3013745; Pryde DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076557; Sanderson SD, 2003, INT IMMUNOPHARMACOL, V3, P137, DOI 10.1016/S1567-5769(02)00260-6; Schellenberger MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038329; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Shen XY, 2012, CLIN PHARMACOL THER, V91, P60, DOI 10.1038/clpt.2011.281; Taylor J. J, 2014, J IMMUNOL METHODS; Taylor JJ, 2012, J EXP MED, V209, P2065, DOI 10.1084/jem.20112272; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tsukamoto H, 2013, J IMMUNOL, V190, P195, DOI 10.4049/jimmunol.1201047; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Yamakawa N, 2013, INT IMMUNOL, V25, P45, DOI 10.1093/intimm/dxs084	44	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96547	10.1371/journal.pone.0096547	http://dx.doi.org/10.1371/journal.pone.0096547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797666	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000092
J	Ruel, G; Levesque, JF; Stocks, N; Sirois, C; Kroger, E; Adams, RJ; Doucet, M; Taylor, AW				Ruel, Guillaume; Levesque, Jean-Frederic; Stocks, Nigel; Sirois, Caroline; Kroger, Edeltraut; Adams, Robert J.; Doucet, Marieve; Taylor, Anne W.			Understanding the Evolution of Multimorbidity: Evidences from the North West Adelaide Health Longitudinal Study (NWAHS)	PLOS ONE			English	Article							POOR GLYCEMIC CONTROL; PREVALENCE; ASTHMA; CARE; COMORBIDITY; DISORDERS; ANXIETY; IMPACT; RISK; COPD	Objective: The aim of this study is to describe the evolution of multimorbidity. Study Design and Setting: Data from 1854 South Australians who participated in the North West Adelaide longitudinal Health Study(NWAHS) was collected between baseline (2000-2002) and follow-up (2008-2010). Status for eight chronic diseases (CDs) was determined by biomedical measurement or self-report. Chronic disease (CD) mean age of occurrence and order of appearance was investigated. Results: The prevalence of multimorbidity increased from 32% to 64% during the 7.8 +/- 1.1 years of follow-up. The estimated mean age of onset of a new CD was significantly older for hypertension, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) and younger for hypercholesterolemia, asthma and other mental problem. Hypercholesterolemia was more likely to develop as a first than as a subsequent CD (39%vs. 16%, p<0.0001) while CVD (1%vs. 5%, p<0.0001), diabetes (5%vs. 11%, p<0.001) and COPD (6%vs. 16%, p<0.0001) were less likely. The presence of mood disorders at baseline was associated with an increased risk of developing other mental disorders (36%vs. 12%, p<0.0001), diabetes (18%vs. 9%, p<0.01) and asthma (30%vs. 21%, p<0.05). Conclusion: Longitudinal data could be used to study the evolution of multimorbidity and could provide information on CDs mean age of occurrence, order of appearance and impact on the development of future CDs.	[Ruel, Guillaume] Minist Sante & Serv Sociaux, Quebec City, PQ, Canada; [Ruel, Guillaume; Sirois, Caroline; Kroger, Edeltraut; Doucet, Marieve] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Ruel, Guillaume; Taylor, Anne W.] Univ Adelaide, Adelaide, SA, Australia; [Levesque, Jean-Frederic] Bur Hlth Informat, Chatswood, NSW, Australia; [Levesque, Jean-Frederic] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Stocks, Nigel] Univ Adelaide, Discipline Gen Practice, Adelaide, SA, Australia; [Sirois, Caroline] Univ Quebec, Dept Sci Infirm, Rimouski, PQ G5L 3A1, Canada; [Kroger, Edeltraut] Univ Laval, Dept Pharm, Quebec City, PQ, Canada; [Adams, Robert J.] Univ Adelaide, Hlth Observ, Adelaide, SA, Australia; [Doucet, Marieve] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada	Institut national de sante publique du Quebec (INSPQ); University of Adelaide; Universite de Montreal; University of Adelaide; University of Quebec; Laval University; University of Adelaide; Laval University	Ruel, G (corresponding author), Minist Sante & Serv Sociaux, Quebec City, PQ, Canada.	guillaumeruel4@hotmail.com	Adams, Robert/Z-3197-2019; Levesque, Jean-Frederic/ABH-7122-2020; Taylor, Anne w/F-5708-2010; Sirois, Caroline/I-1829-2019	Levesque, Jean-Frederic/0000-0002-5418-8593; Taylor, Anne w/0000-0002-4422-7974; Sirois, Caroline/0000-0003-3294-7883; Stocks, Nigel/0000-0002-9018-0361; Kroger, Edeltraut/0000-0002-5653-3979	Fonds de recherche du Quebec - Sante; Jean-Frederic Levesque; Fonds recherche Quebec - Sante	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Jean-Frederic Levesque; Fonds recherche Quebec - Sante	Guillaume Ruel is the awardee of a postdoctoral training award from from Fonds de recherche du Quebec - Sante and Jean-Frederic Levesque is an awardee of a Junior 1 clinical scientist award from Fonds recherche Quebec - Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2006, CHEST, V129, P285, DOI 10.1378/chest.129.2.285; AIHW, 2010, AUSTR HLTH 2010; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Andersohn F, 2009, AM J PSYCHIAT, V166, P591, DOI 10.1176/appi.ajp.2008.08071065; Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8; Appleton SL, 2005, J ALLERGY CLIN IMMUN, V116, P976, DOI 10.1016/j.jaci.2005.08.034; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Broemeling Anne-Marie, 2008, Healthc Q, V11, P70; Ceretta LB, 2012, ACTA DIABETOL; Chen Y, 2010, EVID-BASED MENT HEAL, V13, P30, DOI 10.1136/ebmh.13.1.30; Chittleborough CR, 2006, QUAL LIFE RES, V15, P687, DOI 10.1007/s11136-005-3570-8; Chittleborough CR, 2009, AUST HEALTH REV, V33, P107, DOI 10.1071/AH090107; Diederichs CP, 2012, J CLIN EPIDEMIOL, V65, P679, DOI 10.1016/j.jclinepi.2011.11.006; Fessler MB, 2009, J ALLERGY CLIN IMMUN, V124, P967, DOI 10.1016/j.jaci.2009.08.005; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2006, ANN FAM MED, V4, P417, DOI 10.1370/afm.528; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Fuchs FD, 2012, VASC HEALTH RISK MAN, V8, P437, DOI 10.2147/VHRM.S32585; Gadermann AM, 2012, DEPRESS ANXIETY, V29, P797, DOI 10.1002/da.21924; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Grant Janet F, 2006, Epidemiol Perspect Innov, V3, P4, DOI 10.1186/1742-5573-3-4; Grant JF, 2009, INT J EPIDEMIOL, V38, P1479, DOI 10.1093/ije/dyn262; Grigsby AB, 2002, J PSYCHOSOM RES, V53, P1053, DOI 10.1016/S0022-3999(02)00417-8; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Harrison C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067494; Jani BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074610; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim TB, 2012, RESP CARE, V57, P1248, DOI 10.4187/respcare.01232; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Librero J, 1999, J CLIN EPIDEMIOL, V52, P171, DOI 10.1016/S0895-4356(98)00160-7; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Marengoni A, 2009, J INTERN MED, V265, P288, DOI 10.1111/j.1365-2796.2008.02017.x; Misso NLA, 2005, EUR RESPIR J, V26, P257, DOI 10.1183/09031936.05.00006705; O'Donnell DE, 2003, CAN RESP J SA, V10, p11A; Roberts RG, 2012, J AFFECT DISORDERS, V142, pS80, DOI 10.1016/S0165-0327(12)70012-5; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Ruel G, 2013, CLIN NUTR IN PRESS; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schafer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045390; Sinnige J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079641; Taylor AW, 2013, J CLIN EPIDEMIOL, V66, P461, DOI 10.1016/j.jclinepi.2012.06.021; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Taylor AW, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-11; Vaidyanathan U, 2011, COMPR PSYCHIAT, V52, P527, DOI 10.1016/j.comppsych.2010.10.006; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Whalley B, 2012, INT J BEHAV MED; Wilon D, 2005, CHEST, V128, P2035, DOI 10.1378/chest.128.4.2035; Wong A, 2011, J CLIN EPIDEMIOL, V64, P1109, DOI 10.1016/j.jclinepi.2010.12.011; World Health Organisation, 2011, NONC DIS NCD PROF	51	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96291	10.1371/journal.pone.0096291	http://dx.doi.org/10.1371/journal.pone.0096291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798485	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000061
J	Vervoort, E; Vervliet, B; Bennett, M; Baeyens, F				Vervoort, Ellen; Vervliet, Bram; Bennett, Marc; Baeyens, Frank			Generalization of Human Fear Acquisition and Extinction within a Novel Arbitrary Stimulus Category	PLOS ONE			English	Article							EQUIVALENCE CLASSES; CONSEQUENTIAL FUNCTIONS; CONDITIONED FEAR; AVOIDANCE; DISCRIMINATION; ACCORDANCE; PARADIGM; EXPOSURE; ANXIETY; RETURN	Adaptive anxiety relies on a balance between the generalization of fear acquisition and fear extinction. Research on fear (extinction) generalization has focused mostly on perceptual similarity, thereby ignoring the importance of conceptual stimulus relations in humans. The present study used a laboratory procedure to create de novo conceptual categories of arbitrary stimuli and investigated fear and extinction generalization among these stimuli. A matching-to-sample task produced two four-member categories of abstract figures. Next, a member from one category was coupled with an aversive electrical stimulation, while a member from the other category was presented alone. As expected, conditioned fear responses generalized to the other members of the first category (skin conductance and online shock-expectancy). Subsequent extinction of the conditioned member also generalized to the other members. However, extinguishing a non-conditioned member failed to reduce fear of the conditioned member itself. We conclude that fears generalize readily across conceptually related stimuli, but that the degree of extinction generalization depends on the stimulus subjected to extinction.	[Vervoort, Ellen; Vervliet, Bram; Bennett, Marc; Baeyens, Frank] Univ Leuven, Fac Psychol & Educ Sci, Ctr Psychol Learning & Expt Psychopathol, Louvain, Belgium	KU Leuven	Vervoort, E (corresponding author), Univ Leuven, Fac Psychol & Educ Sci, Ctr Psychol Learning & Expt Psychopathol, Louvain, Belgium.	ellen.vervoort@ppw.kuleuven.be	Vervliet, Bram/AAE-6276-2019	Vervliet, Bram/0000-0002-5904-4257	KU Leuven Research Fund; KU Leuven Centre for Excellence grant [PF/10/005]	KU Leuven Research Fund(KU Leuven); KU Leuven Centre for Excellence grant	This research was supported by a PhD scholarship of the KU Leuven Research Fund, and by a KU Leuven Centre for Excellence grant PF/10/005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustson EM, 1997, J BEHAV THER EXP PSY, V28, P181, DOI 10.1016/S0005-7916(97)00008-6; Barlow DH, 2004, ANXIETY ITS DISORDER; Beckers T, 2013, BIOL PSYCHOL, V92, P90, DOI 10.1016/j.biopsycho.2011.12.015; Craske MG., 2006, FEAR LEARNING BASIC, DOI DOI 10.1037/11474-000; DOUGHER MJ, 1994, J EXP ANAL BEHAV, V62, P331, DOI 10.1901/jeab.1994.62-331; Dunsmoor JE, 2011, LEARN MEMORY, V18, P156, DOI 10.1101/lm.2016411; DYMOND S, 1995, J EXP ANAL BEHAV, V64, P163, DOI 10.1901/jeab.1995.64-163; Dymond S, 2013, ADV RELATIONAL FRAME, P199; Dymond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047539; Dymond S, 2009, BEHAV ANALYST, V32, P7, DOI 10.1007/BF03392173; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Greenway DE, 1996, PSYCHOL REC, V46, P131, DOI 10.1007/BF03395167; Hall G, 1996, ANIM LEARN BEHAV, V24, P233, DOI 10.3758/BF03198973; HAYES SC, 1991, J EXP ANAL BEHAV, V56, P119, DOI 10.1901/jeab.1991.56-119; Hayes SC., 2001, RELATIONAL FRAME THE, DOI [10.1007/b108413, DOI 10.1007/B108413]; Hermans D., 2013, HDB COGNITION EMOTIO, P117; Lang P.J., 1993, PERSPECTIVES ANGER E, V6, P109; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lissek S, 2008, BEHAV RES THER, V46, P678, DOI 10.1016/j.brat.2008.02.005; MINEKA S, 1979, PSYCHOL BULL, V86, P985, DOI 10.1037/0033-2909.86.5.985; PEARCE JM, 1987, PSYCHOL REV, V94, P61, DOI 10.1037/0033-295X.94.1.61; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Roche BT, 2008, PSYCHOL REC, V58, P443, DOI 10.1007/BF03395628; Valverde MR, 2009, J EXP ANAL BEHAV, V92, P85, DOI 10.1901/jeab.2009.92-85; Rowe MK, 1998, BEHAV RES THER, V36, P701, DOI 10.1016/S0005-7967(97)10016-X; SIDMAN M, 1982, J EXP ANAL BEHAV, V37, P5, DOI 10.1901/jeab.1982.37-5; Sidman M., 1994, EQUIVALENCE RELATION; Spruyt A, 2010, EXP PSYCHOL, V57, P36, DOI 10.1027/1618-3169/a000005; Vervliet B, 2005, BEHAV RES THER, V43, P357, DOI 10.1016/j.brat.2004.02.005; Vervliet B, 2004, LEARN MEMORY, V11, P555, DOI 10.1101/lm.77404; Vervliet B, 2007, BEHAV RES THER, V45, P375, DOI 10.1016/j.brat.2006.01.009; Vervliet B, 2006, EXP PSYCHOL, V53, P132, DOI 10.1027/1618-3169.53.2.132; Vervliet B, 2014, NEUROBIOL LEARN MEM, V113, P143, DOI 10.1016/j.nlm.2013.10.002; Vervliet B, 2010, BEHAV RES THER, V48, P38, DOI 10.1016/j.brat.2009.09.005; WULFERT E, 1988, J EXP ANAL BEHAV, V50, P125, DOI 10.1901/jeab.1988.50-125	35	62	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96569	10.1371/journal.pone.0096569	http://dx.doi.org/10.1371/journal.pone.0096569			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798047	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000096
J	Monesson-Olson, BD; Browning-Kamins, J; Aziz-Bose, R; Kreines, F; Trapani, JG				Monesson-Olson, Bryan D.; Browning-Kamins, Jenna; Aziz-Bose, Razina; Kreines, Fabiana; Trapani, Josef G.			Optical Stimulation of Zebrafish Hair Cells Expressing Channelrhodopsin-2	PLOS ONE			English	Article							GOLDFISH MAUTHNER CELL; LATERAL LINE NERVES; TRANSDUCTION CHANNELS; RIBBON SYNAPSE; MECHANOTRANSDUCER CHANNEL; LARVAL ZEBRAFISH; AFFERENT NEURONS; COHERENT MOTION; LOCALIZATION; LATENCY	Vertebrate hair cells are responsible for the high fidelity encoding of mechanical stimuli into trains of action potentials (spikes) in afferent neurons. Here, we generated a transgenic zebrafish line expressing Channelrhodopsin-2 (ChR2) under the control of the hair-cell specific myo6b promoter, in order to examine the role of the mechanoelectrical transduction (MET) channel in sensory encoding in afferent neurons. We performed in vivo recordings from afferent neurons of the zebrafish lateral line while activating hair cells with either mechanical stimuli from a waterjet or optical stimuli from flashes of similar to 470-nm light. Comparison of the patterns of encoded spikes during 100-ms stimuli revealed no difference in mean first spike latency between the two modes of activation. However, there was a significant increase in the variability of first spike latency during optical stimulation as well as an increase in the mean number of spikes per stimulus. Next, we compared encoding of spikes during hair-cell stimulation at 10, 20, and 40-Hz. Consistent with the increased variability of first spike latency, we saw a significant decrease in the vector strength of phase-locked spiking during optical stimulation. These in vivo results support a physiological role for the MET channel in the high fidelity of first spike latency seen during encoding of mechanical sensory stimuli. Finally, we examined whether remote activation of hair cells via ChR2 activation was sufficient to elicit escape responses in free-swimming larvae. In transgenic larvae, 100-ms flashes of similar to 470-nm light resulted in escape responses that occurred concomitantly with field recordings indicating Mauthner cell activity. Altogether, the myo6b: ChR2 transgenic line provides a platform to investigate hair-cell function and sensory encoding, hair-cell sensory input to the Mauthner cell, and the ability to remotely evoke behavior in free-swimming zebrafish.	[Monesson-Olson, Bryan D.; Trapani, Josef G.] Amherst Coll, Dept Biol, Amherst, MA 01002 USA; [Browning-Kamins, Jenna; Aziz-Bose, Razina; Kreines, Fabiana; Trapani, Josef G.] Amherst Coll, Neurosci Program, Amherst, MA 01002 USA	Amherst College; Amherst College	Trapani, JG (corresponding author), Amherst Coll, Dept Biol, Amherst, MA 01002 USA.	jtrapani@amherst.edu	Kreines, Fabiana/AAV-8837-2020	Trapani, Josef/0000-0002-6898-649X; Sugai, Jenna/0000-0002-6145-4909	SOMAS-URM grant through the Howard Hughes Medical Institute [52005120]; National Science Foundation [DUE-0930153]	SOMAS-URM grant through the Howard Hughes Medical Institute; National Science Foundation(National Science Foundation (NSF))	Partial support to JGT was provided by a SOMAS-URM grant through the Howard Hughes Medical Institute (Grant No. 52005120) and the National Science Foundation (Grant No. DUE-0930153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.somasprogram.org.	Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; EATOCK RA, 1987, J NEUROSCI, V7, P2821; EATON RC, 1977, J NEUROBIOL, V8, P151, DOI 10.1002/neu.480080207; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2151, DOI 10.1152/jn.1998.80.4.2151; FABER DS, 1975, BRAIN RES, V96, P349, DOI 10.1016/0006-8993(75)90746-5; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Fettiplace R, 2009, PFLUG ARCH EUR J PHY, V458, P1115, DOI 10.1007/s00424-009-0683-x; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Furukawa S, 2002, J NEUROPHYSIOL, V87, P1749, DOI 10.1152/jn.00491.2001; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; Heil P, 2004, CURR OPIN NEUROBIOL, V14, P461, DOI 10.1016/j.conb.2004.07.002; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; Issa FA, 2011, J EXP BIOL, V214, P1028, DOI 10.1242/jeb.048876; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Karavitaki KD, 2010, J NEUROSCI, V30, P9051, DOI 10.1523/JNEUROSCI.4864-09.2010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; KORN H, 1975, BRAIN RES, V96, P342, DOI 10.1016/0006-8993(75)90745-3; KORN H, 1974, CR ACAD SCI D NAT, V279, P413; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Liao JC, 2012, J NEUROPHYSIOL, V107, P2615, DOI 10.1152/jn.01108.2011; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; PRUGH JIP, 1982, J EXP BIOL, V101, P83; Pujol-Marti J, 2010, DEV DYNAM, V239, P1919, DOI 10.1002/dvdy.22320; Ricci AJ, 2005, J NEUROSCI, V25, P7831, DOI 10.1523/JNEUROSCI.1127-05.2005; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Safieddine S, 2012, ANNU REV NEUROSCI, V35, P509, DOI 10.1146/annurev-neuro-061010-113705; Schnee ME, 2011, NEURON, V70, P326, DOI 10.1016/j.neuron.2011.01.031; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Smedemark-Margulies N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00018; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; STOMMEL EW, 1980, J CELL BIOL, V87, P652, DOI 10.1083/jcb.87.3.652; Tan XD, 2008, HEARING RES, V235, P90, DOI 10.1016/j.heares.2007.10.002; Trapani JG, 2010, METHOD CELL BIOL, V100, P219, DOI 10.1016/B978-0-12-384892-5.00008-6; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Umeda K, 2013, NEUROSCI RES, V75, P69, DOI 10.1016/j.neures.2012.08.010; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Zampini V, 2010, J PHYSIOL-LONDON, V588, P187, DOI 10.1113/jphysiol.2009.181917; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	50	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96641	10.1371/journal.pone.0096641	http://dx.doi.org/10.1371/journal.pone.0096641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24791934	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700121
J	Xiao, LY; Chang, AK; Zang, MX; Bi, HL; Li, SJ; Wang, M; Xing, XR; Wu, HJ				Xiao, Liyun; Chang, Alan K.; Zang, Ming-Xi; Bi, Hailian; Li, Shujing; Wang, Miao; Xing, Xinrong; Wu, Huijian			Induction of the CLOCK Gene by E2-ER alpha Signaling Promotes the Proliferation of Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; TRANSCRIPTIONAL ACTIVITY; ER-ALPHA; CIRCADIAN CLOCK; UP-REGULATION; SHIFT-WORK; EXPRESSION; PER2; SUMOYLATION; BINDING	Growing genetic and epidemiological evidence suggests a direct connection between the disruption of circadian rhythm and breast cancer. Moreover, the expression of several molecular components constituting the circadian clock machinery has been found to be modulated by estrogen-estrogen receptor alpha (E2-ER alpha) signaling in ER alpha-positive breast cancer cells. In this study, we investigated the regulation of CLOCK expression by ER alpha and its roles in cell proliferation. Immunohistochemical analysis of human breast tumor samples revealed high expression of CLOCK in ER alpha-positive breast tumor samples. Subsequent experiments using ER alpha-positive human breast cancer cell lines showed that both protein and mRNA levels of CLOCK were up-regulated by E2 and ER alpha. In these cells, E2 promoted the binding of ER alpha to the EREs (estrogen-response elements) of CLOCK promoter, thereby up-regulating the transcription of CLOCK. Knockdown of CLOCK attenuated cell proliferation in ERa-positive breast cancer cells. Taken together, these results demonstrated that CLOCK could be an important gene that mediates cell proliferation in breast cancer cells.	[Xiao, Liyun; Chang, Alan K.; Bi, Hailian; Li, Shujing; Wang, Miao; Xing, Xinrong; Wu, Huijian] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China; [Wu, Huijian] Dalian Univ Technol, Sch Life Sci & Med, Panjin, Peoples R China; [Zang, Ming-Xi] Zhengzhou Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Zhengzhou 450052, Peoples R China	Dalian University of Technology; Dalian University of Technology; Zhengzhou University	Wu, HJ (corresponding author), Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China.	wuhj@dlut.edu.cn			National Nature Science Foundation of China [31171353, 31271500]; (973 Program) from the Ministry of Science and Technology of China [2011CB504201]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); (973 Program) from the Ministry of Science and Technology of China(National Basic Research Program of China)	This research was supported by grants(31171353, 31271500 to HW) from the National Nature Science Foundation of China and grants (973 Program 2011CB504201 to HW) from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; BERCHUCK A, 1989, CANCER RES, V49, P2091; Berger CE, 2012, J BIOL CHEM, V287, P30117, DOI 10.1074/jbc.M112.367326; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; Duguay D, 2009, CHRONOBIOL INT, V26, P1479, DOI 10.3109/07420520903497575; Fujita N, 2004, MOL ENDOCRINOL, V18, P2937, DOI 10.1210/me.2004-0258; Funabashi T, 2000, J NEUROENDOCRINOL, V12, P521, DOI 10.1046/j.1365-2826.2000.00481.x; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Gery S, 2007, ONCOGENE, V26, P7916, DOI 10.1038/sj.onc.1210585; Gruber CJ, 2004, TRENDS ENDOCRIN MET, V15, P73, DOI 10.1016/j.tem.2004.01.008; Hansen J, 2006, CANCER CAUSE CONTROL, V17, P531, DOI 10.1007/s10552-005-9006-5; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; He PJ, 2007, J ENDOCRINOL, V194, P511, DOI 10.1677/JOE-07-0172; Hong YD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023046; Joshi SR, 2011, MOL ENDOCRINOL, V25, P980, DOI 10.1210/me.2010-0302; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; Kuske B, 2006, ENDOCR-RELAT CANCER, V13, P1121, DOI 10.1677/erc.1.01257; Le TP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071355; Lee JY, 2013, NUCLEIC ACIDS RES, V41, P5614, DOI 10.1093/nar/gkt222; Li S, 2013, ONCOGENE, V32, P4883, DOI 10.1038/onc.2012.518; Li SJ, 2012, BIOL CELL, V104, P287, DOI 10.1111/boc.201100116; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035030; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Marsaud V, 2003, MOL ENDOCRINOL, V17, P2013, DOI 10.1210/me.2002-0269; McDonnell DP, 2005, CLIN CANCER RES, V11, p871S; McDonnell DP, 2004, MATURITAS, V48, pS7, DOI 10.1016/j.maturitas.2004.03.006; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Miyoshi Y, 2010, MED MOL MORPHOL, V43, P193, DOI 10.1007/s00795-010-0514-3; Nakamura TJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1025, DOI 10.1152/ajpendo.90392.2008; Nakamura TJ, 2005, J NEUROSCI RES, V82, P622, DOI 10.1002/jnr.20677; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perrin JS, 2006, P NATL ACAD SCI USA, V103, P5591, DOI 10.1073/pnas.0601310103; Platet N, 2004, CRIT REV ONCOL HEMAT, V51, P55, DOI 10.1016/j.critrevonc.2004.02.001; Rossetti S, 2012, CELL CYCLE, V11, P3691, DOI 10.4161/cc.21946; Rossetti S, 2012, CELL CYCLE, V11, P350, DOI 10.4161/cc.11.2.18792; Sahar S, 2007, CELL CYCLE, V6, P1329, DOI 10.4161/cc.6.11.4295; Sanchez AM, 2010, MOL ENDOCRINOL, V24, P2114, DOI 10.1210/me.2010-0252; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Tyson JJ, 2011, NAT REV CANCER, V11, P523, DOI 10.1038/nrc3081; Viswanathan AN, 2007, CANCER RES, V67, P10618, DOI 10.1158/0008-5472.CAN-07-2485; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang M, 2008, DNA CELL BIOL, V27, P307, DOI 10.1089/dna.2007.0692; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Wijayaratne AL, 2001, J BIOL CHEM, V276, P35684, DOI 10.1074/jbc.M101097200; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Xing XR, 2012, J CELL PHYSIOL, V227, P3812, DOI 10.1002/jcp.24092; Yang C, 2013, MOL CANCER, V12, DOI [10.1186/1476-4598-1112-1121, DOI 10.1186/1476-4598-1112-1121]; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yu EJ, 2013, ONCOGENE, V32, P4160, DOI 10.1038/onc.2012.420; Zhang Y, 2010, J BIOL CHEM, V285, P28604, DOI 10.1074/jbc.M110.149658; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388	63	49	51	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95878	10.1371/journal.pone.0095878	http://dx.doi.org/10.1371/journal.pone.0095878			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789043	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700042
J	Haller, G; Li, P; Esch, C; Hsu, S; Goate, AM; Steinbach, JH				Haller, Gabe; Li, Ping; Esch, Caroline; Hsu, Simon; Goate, Alison M.; Steinbach, Joe Henry			Functional Characterization Improves Associations between Rare Non-Synonymous Variants in CHRNB4 and Smoking Behavior	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; DEPENDENCE; RISK; EXPRESSION; SUBTYPES; CURRENTS; BLOCK	Smoking is the leading cause of preventable death worldwide. Accordingly, effort has been devoted to determining the genetic variants that contribute to smoking risk. Genome-wide association studies have identified several variants in nicotinic acetylcholine receptor genes that contribute to nicotine dependence risk. We previously undertook pooled sequencing of the coding regions and flanking sequence of the CHRNA5, CHRNA3, CHRNB4, CHRNA6 and CHRNB3 genes and found that rare missense variants at conserved residues in CHRNB4 are associated with reduced risk of nicotine dependence among African Americans. We identified 10 low frequency (< 5%) non-synonymous variants in CHRNB4 and investigated functional effects by co-expression with normal alpha 3 or alpha 4 subunits in human embryonic kidney cells. Voltage-clamp was used to obtain acetylcholine and nicotine concentration-response curves and qRT-PCR, western blots and cell-surface ELISAs were performed to assess expression levels. These results were used to functionally weight genetic variants in a gene-based association test. We find that there is a highly significant correlation between carrier status weighted by either acetylcholine EC50 (beta = 0.67, r(2) = 0.017, P = 2X10(-4)) or by response to low nicotine (beta = -0.29, r(2) = 0.02, P = 6x10(-5)) when variants are expressed with the a3 subunit. In contrast, there is no significant association when carrier status is unweighted (beta= -0.04, r(2) = 0.0009, P = 0.54). These results highlight the value of functional analysis of variants and the advantages to integrating such data into genetic studies. They also suggest that an increased sensitivity to low concentrations of nicotine is protective from the risk of developing nicotine dependence.	[Haller, Gabe; Hsu, Simon; Goate, Alison M.] Washington Univ, Dept Psychiat, St Louis, MO USA; [Haller, Gabe; Goate, Alison M.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Li, Ping; Esch, Caroline; Steinbach, Joe Henry] Washington Univ, Dept Anesthesiol, St Louis, MO 63130 USA; [Steinbach, Joe Henry] Washington Univ, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Steinbach, JH (corresponding author), Washington Univ, Dept Anesthesiol, St Louis, MO 63130 USA.	jhs@morpheus.wustl.edu		Haller, Gabriel/0000-0002-3884-5776; Hsu, Simon/0000-0002-0799-3549; Goate, Alison/0000-0002-0576-2472	National Institute of Neurological Diseases and Stroke [NS22356]; National Cancer Institute [CA89392]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant from the National Institute of Neurological Diseases and Stroke NS22356 (JHS) and a grant from the National Cancer Institute CA89392 (AMG, PI: L Bierut). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddick CG, 2011, BIOCHEM PHARMACOL, V82, P828, DOI 10.1016/j.bcp.2011.04.019; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2011, NEURON, V69, P618, DOI 10.1016/j.neuron.2011.02.015; Bracamontes JR, 2008, J BIOL CHEM, V283, P26128, DOI 10.1074/jbc.M801292200; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; FAGERSTROM KO, 1989, J BEHAV MED, V12, P159, DOI 10.1007/BF00846549; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Glick SD, 2008, EUR J PHARMACOL, V599, P91, DOI 10.1016/j.ejphar.2008.09.038; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Haller G, 2013, HUM MOL GEN IN PRESS; Haller G, 2012, HUM MOL GENET, V21, P647, DOI 10.1093/hmg/ddr498; Harpsoe K, 2013, J BIOL CHEM, V288, P2559, DOI 10.1074/jbc.M112.436337; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; IFUNE CK, 1993, J PHYSIOL-LONDON, V463, P431, DOI 10.1113/jphysiol.1993.sp019603; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Liang Y, 2005, NEUROGENETICS, V6, P37, DOI 10.1007/s10048-004-0199-7; MACONOCHIE DJ, 1995, J GEN PHYSIOL, V106, P113, DOI 10.1085/jgp.106.1.113; McClure-Begley TD, 2014, J PHARMACOL EXP THER, V348, P410, DOI 10.1124/jpet.113.209767; Moriconi C, 2011, PFLUG ARCH EUR J PHY, V461, P225, DOI 10.1007/s00424-010-0905-2; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Richards CI, 2011, J BIOL CHEM, V286, P31241, DOI 10.1074/jbc.M111.256024; Rose JE, 2010, P NATL ACAD SCI USA, V107, P5190, DOI 10.1073/pnas.0909184107; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sarginson JE, 2011, AM J MED GENET B, V156B, P275, DOI 10.1002/ajmg.b.31155; Sheffield EB, 2000, NEUROPHARMACOLOGY, V39, P2591, DOI 10.1016/S0028-3908(00)00138-6; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Wang JC, 2009, MOL PSYCHIATR, V14, P501, DOI 10.1038/mp.2008.42; Wilking JA, 2010, PHARMACOGENET GENOM, V20, P121, DOI 10.1097/FPC.0b013e3283369347; Xie PX, 2011, BIOL PSYCHIAT, V70, P528, DOI 10.1016/j.biopsych.2011.04.017	39	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96753	10.1371/journal.pone.0096753	http://dx.doi.org/10.1371/journal.pone.0096753			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804708	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900090
J	O'Callaghan, J; Wells, J; Richardson, S; Holmes, H; Yu, YC; Walker-Samuel, S; Siow, B; Lythgoe, MF				O'Callaghan, James; Wells, Jack; Richardson, Simon; Holmes, Holly; Yu, Yichao; Walker-Samuel, Simon; Siow, Bernard; Lythgoe, Mark F.			Is Your System Calibrated? MRI Gradient System Calibration for Pre-Clinical, High-Resolution Imaging	PLOS ONE			English	Article							GEOMETRIC DISTORTION	High-field, pre-clinical MRI systems are widely used to characterise tissue structure and volume in small animals, using high resolution imaging. Both applications rely heavily on the consistent, accurate calibration of imaging gradients, yet such calibrations are typically only performed during maintenance sessions by equipment manufacturers, and potentially with acceptance limits that are inadequate for phenotyping. To overcome this difficulty, we present a protocol for gradient calibration quality assurance testing, based on a 3D-printed, open source, structural phantom that can be customised to the dimensions of individual scanners and RF coils. In trials on a 9.4 T system, the gradient scaling errors were reduced by an order of magnitude, and displacements of greater than 100 mm, caused by gradient non-linearity, were corrected using a post-processing technique. The step-by-step protocol can be integrated into routine pre-clinical MRI quality assurance to measure and correct for these errors. We suggest that this type of quality assurance is essential for robust pre-clinical MRI experiments that rely on accurate imaging gradients, including small animal phenotyping and diffusion MR.	[O'Callaghan, James; Wells, Jack; Richardson, Simon; Holmes, Holly; Yu, Yichao; Walker-Samuel, Simon; Siow, Bernard; Lythgoe, Mark F.] UCL Ctr Adv Biomed Imaging, Div Med, London, England; [Richardson, Simon; Siow, Bernard] UCL Ctr Med Image Comp, London, England	University of London; University College London; University of London; University College London	O'Callaghan, J (corresponding author), UCL Ctr Adv Biomed Imaging, Div Med, London, England.	james.ocallaghan.10@ucl.ac.uk	Siow, Bernard/ABC-4414-2020; Holmes, Holly/Q-4675-2016	Siow, Bernard/0000-0002-8687-8783; Holmes, Holly/0000-0001-8832-8171; Wells, Jack/0000-0002-4171-3539; Lythgoe, Mark/0000-0002-4945-0171	UK Medical Research Council Doctoral Training Grant Studentship; Medical Research Council [MR/J013110/1]; NC3Rs studentship award; Wellcome Trust; MRC [MR/J013110/1] Funding Source: UKRI; Cancer Research UK [16463] Funding Source: researchfish; National Centre for the Replacement [NC/K500276/1] Funding Source: researchfish	UK Medical Research Council Doctoral Training Grant Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NC3Rs studentship award(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Centre for the Replacement	JO'C was supported by the UK Medical Research Council Doctoral Training Grant Studentship. JW was supported by the Medical Research Council (MR/J013110/1). HH was supported by an NC3Rs studentship award. SWS is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin LN, 2007, MED PHYS, V34, P388, DOI 10.1118/1.2402331; Bammer R, 2003, MAGNET RESON MED, V50, P560, DOI 10.1002/mrm.10545; Cleary JO, 2011, NEUROIMAGE, V56, P974, DOI 10.1016/j.neuroimage.2011.01.082; Cleary JO, 2011, NEUROIMAGE, V54, P769, DOI 10.1016/j.neuroimage.2010.07.039; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Doran SJ, 2005, PHYS MED BIOL, V50, P1343, DOI 10.1088/0031-9155/50/7/001; Gunter JL, 2009, MED PHYS, V36, P2193, DOI 10.1118/1.3116776; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Ourselin S, 2001, IMAGE VISION COMPUT, V19, P25, DOI 10.1016/S0262-8856(00)00052-4; Ourselin S., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P140; Reinsberg SA, 2005, PHYS MED BIOL, V50, P2651, DOI 10.1088/0031-9155/50/11/014; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Stanescu T, 2010, J APPL CLIN MED PHYS, V11, P200, DOI 10.1120/jacmp.v11i1.2961; Wang D, 2004, MAGN RESON IMAGING, V22, P1211, DOI 10.1016/j.mri.2004.08.012; Wang D, 2004, MAGN RESON IMAGING, V22, P1223, DOI 10.1016/j.mri.2004.08.014; Wang DM, 2004, MAGN RESON IMAGING, V22, P529, DOI 10.1016/j.mri.2004.01.008; Wu YC, 2007, J COMPUT ASSIST TOMO, V31, P984, DOI 10.1097/rct.0b013e31805152fa; Yoshimaru E, 2014, MAGN RESON MED, V71, P880, DOI 10.1002/mrm.24678	19	20	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96568	10.1371/journal.pone.0096568	http://dx.doi.org/10.1371/journal.pone.0096568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804737	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900071
J	Powell, AD; Saintot, PP; Gill, KK; Bharathan, A; Buck, SC; Morris, G; Jiruska, P; Jefferys, JGR				Powell, Andrew D.; Saintot, Pierre-Philippe; Gill, Kalbinder K.; Bharathan, Ashtami; Buck, S. Caroline; Morris, Gareth; Jiruska, Premysl; Jefferys, John G. R.			Reduced Gamma Oscillations in a Mouse Model of Intellectual Disability: A Role for Impaired Repetitive Neurotransmission?	PLOS ONE			English	Article							RETARDATION PROTEIN OLIGOPHRENIN-1; GABAERGIC TRANSMISSION; NETWORK OSCILLATIONS; SYNAPTIC PLASTICITY; INTERNEURONS; MEMORY; RHO; HIPPOCAMPUS; ENDOCYTOSIS; MECHANISMS	Intellectual disability affects 2-3% of the population; mutations of the X-chromosome are a major cause of moderate to severe cases. The link between the molecular consequences of the mutation and impaired cognitive function remains unclear. Loss of function mutations of oligophrenin-1 (OPHN1) disrupt Rho-GTPase signalling. Here we demonstrate abnormal neurotransmission at CA3 synapses in hippocampal slices from Ophn1(-/y) mice, resulting from a substantial decrease in the readily releasable pool of vesicles. As a result, synaptic transmission fails at high frequencies required for oscillations associated with cognitive functions. Both spontaneous and KA-induced gamma oscillations were reduced in Ophn1(-/y) hippocampal slices. Spontaneous oscillations were rapidly rescued by inhibition of the downstream signalling pathway of oligophrenin-1. These findings suggest that the intellectual disability due to mutations of oligophrenin-1 results from a synaptopathy and consequent network malfunction, providing a plausible mechanism for the learning disabilities. Furthermore, they raise the prospect of drug treatments for affected individuals.	[Powell, Andrew D.; Saintot, Pierre-Philippe; Gill, Kalbinder K.; Bharathan, Ashtami; Buck, S. Caroline; Morris, Gareth; Jiruska, Premysl; Jefferys, John G. R.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Jiruska, Premysl] Acad Sci Czech Republ, Inst Physiol, Dept Dev Epileptol, Prague, Czech Republic; [Jiruska, Premysl] Charles Univ Prague, Dept Neurol, Sch Med 2, Prague, Czech Republic	University of Birmingham; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague	Powell, AD (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	a.d.powell@bham.ac.uk	Jefferys, John G R/AAF-1164-2021; Jiruska, Premysl/C-4001-2012; Powell, Andrew/A-7472-2010	Jefferys, John G R/0000-0003-0106-4412; Jiruska, Premysl/0000-0003-4955-8577; Morris, Gareth/0000-0003-2469-5102	Wellcome Trust [074771/Z/04/Z]; University of Birmingham Studentships	Wellcome Trust(Wellcome TrustEuropean Commission); University of Birmingham Studentships	This work was supported by a Wellcome Trust grant to JGRJ (074771/Z/04/Z), and University of Birmingham Studentships to PPS, KKG, AB, SCB, and GM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SC, 2002, INVEST OPHTH VIS SCI, V43, P978; Andersson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040906; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar-Eroglu C, 2007, INT J PSYCHOPHYSIOL, V64, P39, DOI 10.1016/j.ijpsycho.2006.07.007; Bianchi V, 2009, HUM MOL GENET, V18, P105, DOI 10.1093/hmg/ddn321; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Brown JT, 2006, NEUROPHARMACOLOGY, V50, P47, DOI 10.1016/j.neuropharm.2005.07.017; Buzsaki G, 2003, NEUROSCIENCE, V116, P201, DOI 10.1016/S0306-4522(02)00669-3; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Dulong C, 2014, INT J ONCOL, V44, P539, DOI 10.3892/ijo.2013.2214; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Fukuda T, 2000, J NEUROSCI, V20, P1519; Gelsomino G, 2013, CEREB CORTEX, V23, P531, DOI 10.1093/cercor/bhs026; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Grice SJ, 2001, NEUROREPORT, V12, P2697, DOI 10.1097/00001756-200108280-00021; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Hanson JE, 2013, NEUROPSYCHOPHARMACOL, V38, P1221, DOI 10.1038/npp.2013.19; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Khelfaoui M, 2007, J NEUROSCI, V27, P9439, DOI 10.1523/JNEUROSCI.2029-07.2007; Khelfaoui M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0160; Khelfaoui M, 2009, HUM MOL GENET, V18, P2575, DOI 10.1093/hmg/ddp189; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Ma JY, 2000, BEHAV BRAIN RES, V111, P1, DOI 10.1016/S0166-4328(00)00138-8; Mathew SS, 2008, J NEUROSCI, V28, P725, DOI 10.1523/JNEUROSCI.3625-07.2008; McNally JM, 2011, NEUROSCIENCE, V199, P51, DOI 10.1016/j.neuroscience.2011.10.015; Middleton S, 2008, P NATL ACAD SCI USA, V105, P18572, DOI 10.1073/pnas.0809302105; Monteggia LM, 2009, BIOL PSYCHIAT, V65, P204, DOI 10.1016/j.biopsych.2008.10.036; Nakano-Kobayashi A, 2009, CURR BIOL, V19, P1133, DOI 10.1016/j.cub.2009.05.022; Palhalmi J, 2004, NEUROPHARMACOLOGY, V47, P381, DOI 10.1016/j.neuropharm.2004.04.010; Pietersen AN, 2009, EUR J NEUROSCI; Posey HT, 1951, AM J MENT DEF, V55, P515; Powell AD, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219907; Rosenzweig ES, 1997, HIPPOCAMPUS, V7, P549, DOI 10.1002/(SICI)1098-1063(1997)7:5<549::AID-HIPO10>3.0.CO;2-0; Saponara S, 2012, BIOCHEM PHARMACOL, V84, P1055, DOI 10.1016/j.bcp.2012.07.025; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Traub RD, 2003, P NATL ACAD SCI USA, V100, P1370, DOI 10.1073/pnas.0337529100; Traub RD, 1998, PROG NEUROBIOL, V55, P563, DOI 10.1016/S0301-0082(98)00020-3; Trevino M, 2007, J NEUROSCI, V27, P251, DOI 10.1523/JNEUROSCI.3815-06.2007; Vreugdenhil M, 2005, NEUROSCIENCE, V132, P1151, DOI 10.1016/j.neuroscience.2005.01.025; Vreugdenhil M, 2003, J NEUROPHYSIOL, V89, P1414, DOI 10.1152/jn.00576.2002; Zlomuzica A, 2010, PHYSIOL BEHAV, V101, P245, DOI 10.1016/j.physbeh.2010.05.007	50	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95871	10.1371/journal.pone.0095871	http://dx.doi.org/10.1371/journal.pone.0095871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800744	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338029800036
J	Vassen, L; Beauchemin, H; Lemsaddek, W; Krongold, J; Trudel, M; Moroy, T				Vassen, Lothar; Beauchemin, Hugues; Lemsaddek, Wafaa; Krongold, Joseph; Trudel, Marie; Moeroey, Tarik			Growth Factor Independence 1b (Gfi1b) Is Important for the Maturation of Erythroid Cells and the Regulation of Embryonic Globin Expression	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; TRANSCRIPTIONAL REPRESSOR GFI1; HEMATOPOIETIC STEM-CELLS; LINEAGE DECISION; TARGET GENE; GFI-1B; DIFFERENTIATION; GATA-1; MICE; LYMPHOMAGENESIS	Growth factor independence 1b (GFI1B) is a DNA binding repressor of transcription with vital functions in hematopoiesis. Gfi1b-null embryos die at midgestation very likely due to defects in erythro-and megakaryopoiesis. To analyze the full functionality of Gfi1b, we used conditionally deficient mice that harbor floxed Gfi1b alleles and inducible (Mx-Cre, Cre-ERT) or erythroid specific (EpoR-Cre) Cre expressing transgenes. In contrast to the germline knockout, EpoR-Cre mediated erythroid specific ablation of Gfi1b allows full gestation, but causes perinatal lethality with very few mice surviving to adulthood. Both the embryonic deletion of Gfi1b by EpoR-Cre and the deletion in adult mice by Mx-Cre or Cre-ERT leads to reduced numbers of erythroid precursors, perturbed and delayed erythroid maturation, anemia and extramedullary erythropoiesis. Global expression analyses showed that the Hba-x, Hbb-bh1 and Hbb-y embryonic globin genes were upregulated in Gfi1b deficient TER119(+) fetal liver cells over the gestation period from day 12.5-17.5 p.c. and an increased level of Hbb-bh1 and Hbb-y embryonic globin gene expression was even maintained in adult Gfi1b deficient mice. While the expression of Bcl11a, a regulator of embryonic globin expression was not affected by Gfi1b deficiency, the expression of Gata1 was reduced and the expression of Sox6, also involved in globin switch, was almost entirely lost when Gfi1b was absent. These findings establish Gfi1b as a regulator of embryonic globin expression and embryonic and adult erythroid maturation.	[Vassen, Lothar; Beauchemin, Hugues; Lemsaddek, Wafaa; Krongold, Joseph; Trudel, Marie; Moeroey, Tarik] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Moeroey, Tarik] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Krongold, Joseph; Moeroey, Tarik] McGill Univ, Div Expt Med, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University	Moroy, T (corresponding author), Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada.	Tarik.Moroy@ircm.qc.ca		Trudel, Marie/0000-0003-0057-2669; Krongold, Joseph/0000-0001-9100-7459	Canadian Institutes of Health Research [MOP - 111247]; Canadian Foundation for Innovation; Canadian Blood Services/Canadian Institutes of Health Research [210399]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Blood Services/Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (MOP - 111247) and the Canadian Foundation for Innovation and the Canadian Blood Services/Canadian Institutes of Health Research (210399) to M. T. T. M. holds the Canada Research Chair (Tier 1) in Hematopoiesis and Immune Cell Differentiation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chowdhury AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053666; D'Souza S, 2011, BLOOD, V118, P6871, DOI 10.1182/blood-2011-04-346775; Doan LL, 2004, NUCLEIC ACIDS RES, V32, P2508, DOI 10.1093/nar/gkh570; Emig D, 2010, NUCLEIC ACIDS RES, V38, pW755, DOI 10.1093/nar/gkq405; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; Gellert P, 2012, NUCLEIC ACIDS RES, V40, P2414, DOI 10.1093/nar/gkr1110; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Hernandez A, 2010, ANN HEMATOL, V89, P759, DOI 10.1007/s00277-009-0900-x; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huang DY, 2005, NUCLEIC ACIDS RES, V33, P5331, DOI 10.1093/nar/gki838; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Ikonomi P, 2000, GENE, V261, P277, DOI 10.1016/S0378-1119(00)00510-2; Jegalian AG, 2002, J BIOL CHEM, V277, P2345, DOI 10.1074/jbc.M105575200; Joshi A, 2013, EXP HEMATOL, V41, P354, DOI 10.1016/j.exphem.2012.11.008; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Khandanpour C, 2013, CANCER CELL, V23, P200, DOI 10.1016/j.ccr.2013.01.011; Khandanpour C, 2012, BLOOD, V120, P4006, DOI 10.1182/blood-2011-02-334722; Khandanpour C, 2011, STEM CELLS, V29, P376, DOI 10.1002/stem.575; Khandanpour C, 2010, BLOOD, V116, P5149, DOI 10.1182/blood-2010-04-280305; Khandanpour C, 2010, BLOOD, V115, P2462, DOI 10.1182/blood-2009-08-239822; Kok CH, 2013, LEUKEMIA, V27, P1427, DOI 10.1038/leu.2013.47; Koldehoff M, 2013, CANCER GENE THER, V20, P421, DOI 10.1038/cgt.2013.31; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuo YY, 2007, MOL CELL BIOL, V27, P4261, DOI 10.1128/MCB.02212-06; Laurent B, 2012, J CELL SCI, V125, P993, DOI 10.1242/jcs.095877; Laurent B, 2010, BLOOD, V115, P687, DOI 10.1182/blood-2009-06-230094; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Randrianarison-Huetz V, 2010, BLOOD, V115, P2784, DOI 10.1182/blood-2009-09-241752; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; Schmidt T, 1998, ONCOGENE, V17, P2661, DOI 10.1038/sj.onc.1202191; Schulz D, 2012, J EXP MED, V209, P187, DOI 10.1084/jem.20110645; Sprussel A, 2012, LEUKEMIA, V26, P2039, DOI 10.1038/leu.2012.157; Suzuki M, 2013, GENES CELLS; Vassen L, 2005, NUCLEIC ACIDS RES, V33, P987, DOI 10.1093/nar/gki243; Vassen L, 2007, BLOOD, V109, P2356, DOI 10.1182/blood-2006-06-030031; Vassen L, 2012, AM J BLOOD RES, V2, P228; Vassen L, 2009, INT J HEMATOL, V89, P422, DOI 10.1007/s12185-009-0286-5; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xu W, 2007, BLOOD, V109, P4406, DOI 10.1182/blood-2006-08-043331; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046286; Zini R, 2012, EXP HEMATOL, V40, P1043, DOI 10.1016/j.exphem.2012.08.003; Zornig M, 1996, ONCOGENE, V12, P1789	49	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96636	10.1371/journal.pone.0096636	http://dx.doi.org/10.1371/journal.pone.0096636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800817	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800098
J	Yu, Q; Li, XT; Zhao, X; Liu, XL; Ikeo, K; Gojobori, T; Liu, QX				Yu, Qi; Li, Xiao-Tong; Zhao, Xiao; Liu, Xun-Li; Ikeo, Kazuho; Gojobori, Takashi; Liu, Qing-Xin			Coevolution of Axon Guidance Molecule Slit and Its Receptor Robo	PLOS ONE			English	Article							CORRELATED EVOLUTION; POSITIVE SELECTION; PROTEINS; LIGAND; REPELLENT; MIGRATION; INSIGHTS; GENE	Coevolution is important for the maintenance of the interaction between a ligand and its receptor during evolution. The interaction between axon guidance molecule Slit and its receptor Robo is critical for the axon repulsion in neural tissues, which is evolutionarily conserved from planarians to humans. However, the mechanism of coevolution between Slit and Robo remains unclear. In this study, we found that coordinated amino acid changes took place at interacting sites of Slit and Robo by comparing the amino acids at these sites among different organisms. In addition, the high level correlation between evolutionary rate of Slit and Robo was identified in vertebrates. Furthermore, the sites under positive selection of slit and robo were detected in the same lineage such as mosquito and teleost. Overall, our results provide evidence for the coevolution between Slit and Robo.	[Yu, Qi; Li, Xiao-Tong; Zhao, Xiao; Liu, Xun-Li; Liu, Qing-Xin] Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China; [Ikeo, Kazuho; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol & DNA Data Bank Japan, Mishima, Shizuoka 411, Japan	Shandong Agricultural University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Liu, QX (corresponding author), Shandong Agr Univ, Lab Dev Genet, Tai An, Shandong, Peoples R China.	liuqingxin@sdau.edu.cn	Li, xiaotong/GYV-4890-2022; yu, qi/Q-5819-2018; 李, 晓童/AEL-7247-2022	yu, qi/0000-0003-2605-5328; 李, 晓童/0000-0001-6890-2068	National Basic Research Program of China [2012CB114600]; National Natural Science Foundation of China [31240037, 31301951]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2012CB114600, http://www.973.gov.cn/English/Index.aspx) and National Natural Science Foundation of China (31240037, 31301951, http://www.nsfc.gov.cn/publish/portal1/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer K, 2011, CARCINOGENESIS, V32, P935, DOI 10.1093/carcin/bgr059; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Camurri L, 2005, MOL CELL NEUROSCI, V30, P485, DOI 10.1016/j.mcn.2005.07.014; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028; Fryxell KJ, 1996, TRENDS GENET, V12, P364, DOI 10.1016/S0168-9525(96)80020-5; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hughes AL, 2012, MOL PHYLOGENET EVOL, V63, P617, DOI 10.1016/j.ympev.2012.02.003; Hutson LD, 2003, DEV DYNAM, V228, P358, DOI 10.1002/dvdy.10386; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li Y, 2005, J MOL ENDOCRINOL, V35, P411, DOI 10.1677/jme.1.01798; Liu QX, 2007, MOL BIOL EVOL, V24, P1458, DOI 10.1093/molbev/msm073; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; MacMullin A, 2006, DEV BIOL, V293, P154, DOI 10.1016/j.ydbio.2006.01.027; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Ozdinler PH, 2002, J NEUROSCI, V22, P4540, DOI 10.1523/JNEUROSCI.22-11-04540.2002; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Preacher K. J., 2002, CALCULATION TEST DIF; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Shields DC, 1996, J IMMUNOL, V156, P1062; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiwary BK, 2013, NEUROENDOCRINOLOGY, V97, P242, DOI 10.1159/000342694; Yamamoto H, 2011, DEV GROWTH DIFFER, V53, P300, DOI 10.1111/j.1440-169X.2010.01234.x; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	34	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94970	10.1371/journal.pone.0094970	http://dx.doi.org/10.1371/journal.pone.0094970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801615	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800025
J	Zhang, T; Zhang, YY; Zhang, CQ; Tang, F; Li, HK; Zhang, Q; Lin, HY; Wu, S; Liu, YX; Xue, FZ				Zhang, Tao; Zhang, Yongyuan; Zhang, Chengqi; Tang, Fang; Li, Hongkai; Zhang, Qian; Lin, Haiyan; Wu, Shuo; Liu, Yanxun; Xue, Fuzhong			Prediction of Metabolic Syndrome by Non-Alcoholic Fatty Liver Disease in Northern Urban Han Chinese Population: A Prospective Cohort Study	PLOS ONE			English	Article							INSULIN-RESISTANCE; RISK; INFLAMMATION; PREVALENCE; STEATOHEPATITIS; ASSOCIATION; SHANGHAI; ALPHA	Objectives: To explore the relationship between non-alcoholic fatty liver disease (NAFLD) and the metabolic syndrome (MetS), and evaluate the value of NAFLD as a marker for predicting the risk of MetS in a large scale prospective cohort from northern urban Han Chinese population. Materials and Methods: A total of 17,920 MetS-free at baseline cohort members was included in the current study between 2005 and 2011. The baseline characteristics of the cohort were compared by NAFLD status at baseline, MetS status after follow-up. Cox proportional hazards models were used to estimate the unadjusted or adjusted hazard ratios (HRs) for NAFLD at baseline predicting the risk of MetS. Results: 2,183 (12.18%) new cases of MetS occurred between 2005 and 2011. In unadjusted model, HRs (95% CIs) for NAFLD predicting MetS was 3.65 (3.35, 3.97). After adjusting the confounding factors of age, gender, the metabolic factors, smoke and exercise, the HRs (95% CIs) was 1.70 (1.55, 1.87). Gender difference was observed, adjusted HRs (95% CIs) of NAFLD for predicting MetS were 2.06(1.72, 2.46) and 1.55(1.39, 1.72) in female and male population, respectively. Moreover, 163 participants developed MetS among participants without any MetS component at baseline, and its adjusted HRs was still significant, 1.87 (1.12, 3.13). Conclusion: The present study indicates that NAFLD is an independent risk factor for predicting the risk of MetS in northern urban Han Chinese population, and the people with NAFLD should initiate weight and dietary control to prevent the occurrence of MetS.	[Zhang, Tao; Li, Hongkai; Zhang, Qian; Wu, Shuo; Liu, Yanxun; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China; [Zhang, Yongyuan] Shandong Univ, Qilu Hosp, Dept Med, Jinan 250100, Peoples R China; [Zhang, Chengqi; Tang, Fang] Shandong Prov QianFoShan Hosp, Hlth Management Ctr, Jinan, Peoples R China; [Lin, Haiyan] Shandong Univ, Ctr Hlth Management, Prov Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020; Zhang, Tao/K-3238-2019; zhang, chi/GRX-3610-2022	Zhang, Tao/0000-0003-1048-4443; Xue, Fuzhong/0000-0003-0378-7956	National Nature Science Fund of China [81302514]; Independent Innovation Foundation of Shandong University, IIFSDU [2012GN045]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University, IIFSDU	This work was supported by grants from the National Nature Science Fund (No. 81302514) of China and the Independent Innovation Foundation of Shandong University, IIFSDU (No. 2012GN045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Angelico F, 2005, J CLIN ENDOCR METAB, V90, P1578, DOI 10.1210/jc.2004-1024; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Athyros VG, 2006, CURR MED RES OPIN, V22, P873, DOI 10.1185/030079906X104696; Bhatia LS, 2012, EUR HEART J, V33, P1190, DOI 10.1093/eurheartj/ehr453; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Fan JG, 2005, J GASTROEN HEPATOL, V20, P1825, DOI 10.1111/j.1440-1746.2005.04058.x; Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042; Fan JG, 2007, J GASTROEN HEPATOL, V22, P1086, DOI 10.1111/j.1440-1746.2006.04781.x; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Grundy SM, 2003, JAMA-J AM MED ASSOC, V290, P3000, DOI 10.1001/jama.290.22.3000; Gill HK, 2006, WORLD J GASTROENTERO, V12, P345, DOI 10.3748/wjg.v12.i3.345; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Karnikowski M, 2007, SAO PAULO MED J, V125, P333, DOI 10.1590/S1516-31802007000600006; Kwon YM, 2012, AM J GASTROENTEROL, V107, P1852, DOI 10.1038/ajg.2012.314; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lu Yan-hui, 2006, Zhonghua Yi Xue Za Zhi, V86, P386; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Mohan V, 2009, DIABETES RES CLIN PR, V84, P84, DOI 10.1016/j.diabres.2008.11.039; Musso G, 2008, DIABETES CARE, V31, P562, DOI 10.2337/dc07-1526; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Pagano C, 2005, EUR J ENDOCRINOL, V152, P113, DOI 10.1530/eje.1.01821; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Ryoo JH, 2013, ATHEROSCLEROSIS, V227, P398, DOI 10.1016/j.atherosclerosis.2013.01.002; Salamone F, 2010, J HEPATOL, V53, P1146, DOI 10.1016/j.jhep.2010.06.013; Sanyal AJ, 2003, AM J GASTROENTEROL, V98, P2064, DOI [10.1016/S0002-9270(03)00551-3, 10.1111/j.1572-0241.2003.07640.x]; Schunk D, 2008, ASTA-ADV STAT ANAL, V92, P101, DOI 10.1007/s10182-008-0053-6; Smits MM, 2013, J GASTROEN HEPATOL, V28, P664, DOI 10.1111/jgh.12106; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Valenti L, 2002, GASTROENTEROLOGY, V122, P274, DOI 10.1053/gast.2002.31065; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Zeng MD, 2008, J DIGEST DIS, V9, P108, DOI 10.1111/j.1751-2980.2008.00331.x	38	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96651	10.1371/journal.pone.0096651	http://dx.doi.org/10.1371/journal.pone.0096651			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801211	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800103
J	Brown, DI; Lassegue, B; Lee, M; Zafari, R; Long, JS; Saavedra, HI; Griendling, KK				Brown, David I.; Lassegue, Bernard; Lee, Minyoung; Zafari, Rostam; Long, James S.; Saavedra, Harold I.; Griendling, Kathy K.			Poldip2 Knockout Results in Perinatal Lethality, Reduced Cellular Growth and Increased Autophagy of Mouse Embryonic Fibroblasts	PLOS ONE			English	Article							DNA-POLYMERASE-DELTA; INTERACTING PROTEIN-38; DAMAGE RESPONSE; BINDING-PROTEIN; SENESCENCE; PDIP38; CANCER; GENE; ANTIGEN; CELLS	Polymerase-delta interacting protein 2 (Poldip2) is an understudied protein, originally described as a binding partner of polymerase delta and proliferating cell nuclear antigen (PCNA). Numerous roles for Poldip2 have been proposed, including mitochondrial elongation, DNA replication/repair and ROS production via Nox4. In this study, we have identified a novel role for Poldip2 in regulating the cell cycle. We used a Poldip2 gene-trap mouse and found that homozygous animals die around the time of birth. Poldip2-/- embryos are significantly smaller than wild type or heterozygous embryos. We found that Poldip2-/- mouse embryonic fibroblasts (MEFs) exhibit reduced growth as measured by population doubling and growth curves. This effect is not due to apoptosis or senescence; however, Poldip2-/- MEFs have higher levels of the autophagy marker LC3b. Measurement of DNA content by flow cytometry revealed an increase in the percentage of Poldip2-/- cells in the G1 and G2/M phases of the cell cycle, accompanied by a decrease in the percentage of S-phase cells. Increases in p53 S20 and Sirt1 were observed in passage 2 Poldip2-/- MEFs. In passage 4/5 MEFs, Cdk1 and CyclinA2 are downregulated in Poldip2-/- cells, and these changes are reversed by transfection with SV40 large T-antigen, suggesting that Poldip2 may target the E2F pathway. In contrast, p21(CIP1) is increased in passage 4/5 Poldip2-/- MEFs and its expression is unaffected by SV40 transfection. Overall, these results reveal that Poldip2 is an essential protein in development, and underline its importance in cell viability and proliferation. Because it affects the cell cycle, Poldip2 is a potential novel target for treating proliferative conditions such as cancer, atherosclerosis and restenosis.	[Brown, David I.; Lassegue, Bernard; Lee, Minyoung; Zafari, Rostam; Long, James S.; Griendling, Kathy K.] Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA; [Saavedra, Harold I.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA	Emory University; Emory University	Griendling, KK (corresponding author), Emory Univ, Sch Med, Div Cardiol, Dept Med, Atlanta, GA 30322 USA.	kgriend@emory.edu	Brown, David/H-3175-2016; Brown, David I/H-4842-2013	Brown, David/0000-0001-7914-5971; Lassegue, Bernard/0000-0003-4924-6506; Griendling, Kathy/0000-0002-9456-8582; Brown, David/0000-0002-2539-4419	National Institutes of Health (NIH) [HL38206, HL095070]; NATIONAL CANCER INSTITUTE [R01CA151521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038206, P01HL095070, R01HL038206, R37HL038206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) HL38206 and HL095070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Aggarwal BB, 2004, ANTICANCER RES, V24, P2783; AKIYAMA T, 1992, P NATL ACAD SCI USA, V89, P7900, DOI 10.1073/pnas.89.17.7900; Arakaki N, 2006, BBA-GEN SUBJECTS, V1760, P1364, DOI 10.1016/j.bbagen.2006.05.012; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Cheng XL, 2005, J BIOCHEM, V138, P673, DOI 10.1093/jb/mvi169; d'Alencon E, 2003, J BACTERIOL, V185, P2967, DOI 10.1128/JB.185.9.2967-2971.2003; Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152; Duda SH, 2006, J ENDOVASC THER, V13, P701, DOI 10.1583/05-1704.1; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Grinchuk OV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S9; Klaile E, 2008, CELL CYCLE, V7, P3180, DOI 10.4161/cc.7.20.6813; Klaile E, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701807200; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Liu L, 2003, J BIOL CHEM, V278, P10041, DOI 10.1074/jbc.M208694200; Luo Y, 2011, EXP GERONTOL, V46, P860, DOI 10.1016/j.exger.2011.07.005; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Maga G, 2013, P NATL ACAD SCI USA, V110, P18850, DOI 10.1073/pnas.1308760110; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Senderowicz AM, 2000, JNCI-J NATL CANCER I, V92, P376, DOI 10.1093/jnci/92.5.376; Sutliff RL, 2013, ARTERIOSCLER THROMB; Sutliff RL, 2013, ARTERIOSCL THROM VAS, V33, P2154, DOI 10.1161/ATVBAHA.113.301913; Tissier A, 2010, DNA REPAIR, V9, P922, DOI 10.1016/j.dnarep.2010.04.010; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wong A, 2013, CELL CYCLE, V12, P3184, DOI 10.4161/cc.26221; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002	30	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96657	10.1371/journal.pone.0096657	http://dx.doi.org/10.1371/journal.pone.0096657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797518	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000111
J	Chen, W; Li, Y; Wang, Q; Wang, N; Wu, YF				Chen, Wang; Li, Yan; Wang, Qiang; Wang, Nan; Wu, Yunfeng			Comparative Genome Analysis of Wheat Blue Dwarf Phytoplasma, an Obligate Pathogen That Causes Wheat Blue Dwarf Disease in China	PLOS ONE			English	Article							SINGLE-CELL; PROTEIN; SEQUENCE; INSECT; IDENTIFICATION; ANNOTATION; PREDICTION; BACTERIUM; STRAINS; PROGRAM	Wheat blue dwarf (WBD) disease is an important disease that has caused heavy losses in wheat production in northwestern China. This disease is caused by WBD phytoplasma, which is transmitted by Psammotettix striatus. Until now, no genome information about WBD phytoplasma has been published, seriously restricting research on this obligate pathogen. In this paper, we report a new sequencing and assembling strategy for phytoplasma genome projects. This strategy involves differential centrifugation, pulsed-field gel electrophoresis, whole genome amplification, shotgun sequencing, de novo assembly, screening of contigs from phytoplasma and the connection of phytoplasma contigs. Using this scheme, the WBD phytoplasma draft genome was obtained. It was comprised of six contigs with a total size of 611,462 bp, covering similar to 94% of the chromosome. Five-hundred-twenty-five protein-coding genes, two operons for rRNA genes and 32 tRNA genes were identified. Comparative genome analyses between WBD phytoplasma and other phytoplasmas were subsequently carried out. The results showed that extensive arrangements and inversions existed among the WBD, OY-M and AY-WB phytoplasma genomes. Most protein-coding genes in WBD phytoplasma were found to be homologous to genes from other phytoplasmas; only 22 WBD-specific genes were identified. KEGG pathway analysis indicated that WBD phytoplasma had strongly reduced metabolic capabilities. However, 46 transporters were identified, which were involved with dipeptides/oligopeptides, spermidine/putrescine, cobalt and Mn/Zn transport, and so on. A total of 37 secreted proteins were encoded in the WBD phytoplasma chromosome and plasmids. Of these, three secreted proteins were similar to the reported phytoplasma virulence factors TENGU, SAP11 and SAP54. In addition, WBD phytoplasma possessed several proteins that were predicted to play a role in its adaptation to diverse environments. These results will provide clues for research on the pathogenic mechanisms of WBD phytoplasma and will also provide a perspective about the genome sequencing of other phytoplasmas and obligate organisms.	[Chen, Wang; Li, Yan; Wang, Qiang; Wang, Nan; Wu, Yunfeng] Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Pest Integrated Pest Management Crop, State Key Lab Crop Stress Biol Arid Areas,Minist, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wu, YF (corresponding author), Northwest A&F Univ, Coll Plant Protect, Key Lab Crop Pest Integrated Pest Management Crop, State Key Lab Crop Stress Biol Arid Areas,Minist, Yangling, Shaanxi, Peoples R China.	wuyf@nwafu.edu.cn			National Natural Science Foundation of China [31371913]; 111 project from the Ministry of Education of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project from the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (grant number: 31371913), the 111 project from the Ministry of Education of China (grant number: B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-529; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chanda PK, 2009, J BASIC MICROB, V49, P205, DOI 10.1002/jobm.200800065; Chen W, 2014, J PLANT PAT IN PRESS, V96; Chen W, 2013, MICROBIOLOGY CHINA, V40, P5; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Chung WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062770; Coskun S, 2007, PRENATAL DIAG, V27, P297, DOI 10.1002/pd.1667; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Frank AC, 2000, BIOINFORMATICS, V16, P560, DOI 10.1093/bioinformatics/16.6.560; Hoshi A, 2009, P NATL ACAD SCI USA, V106, P6416, DOI 10.1073/pnas.0813038106; Husemann P, 2010, BIOINFORMATICS, V26, P570, DOI 10.1093/bioinformatics/btp690; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kloda Anna, 2002, Archaea, V1, P35, DOI 10.1155/2002/419261; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Miura C, 2012, GENE, V510, P107, DOI 10.1016/j.gene.2012.09.001; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Saccardo F, 2012, MICROBIOL-SGM, V158, P2805, DOI 10.1099/mic.0.061432-0; Silva Z, 2005, J BACTERIOL, V187, P1210, DOI 10.1128/JB.187.4.1210-1218.2005; Sugio A, 2011, P NATL ACAD SCI USA, V108, pE1254, DOI 10.1073/pnas.1105664108; Takaya A, 2004, INFECT IMMUN, V72, P1364, DOI 10.1128/IAI.72.3.1364-1373.2004; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Ventura M, 2007, APPL ENVIRON MICROB, V73, P4695, DOI 10.1128/AEM.02496-06; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Wu YF, 2010, PLANT DIS, V94, P977, DOI 10.1094/PDIS-94-8-0977; Zhang CP, 2010, THESIS NW A F U YANG; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; Zhang QinFeng, 1996, Acta Phytophylacica Sinica, V23, P107	42	21	28	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96436	10.1371/journal.pone.0096436	http://dx.doi.org/10.1371/journal.pone.0096436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798075	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000076
J	Mittal, R; Wagener, M; Breed, ER; Liang, Z; Yoseph, BP; Burd, EM; Farris, AB; Coopersmith, CM; Ford, ML				Mittal, Rohit; Wagener, Maylene; Breed, Elise R.; Liang, Zhe; Yoseph, Benyam P.; Burd, Eileen M.; Farris, Alton B., III; Coopersmith, Craig M.; Ford, Mandy L.			Phenotypic T Cell Exhaustion in a Murine Model of Bacterial Infection in the Setting of Pre-Existing Malignancy	PLOS ONE			English	Article							IMMUNE SUPPRESSION; TUMOR MICROENVIRONMENT; INHIBITORY RECEPTORS; OVARIAN-CANCER; ANTIGEN LOSS; EXPRESSION; DIFFERENTIATION; MORTALITY; ESCAPE; SEPSIS	While much of cancer immunology research has focused on anti-tumor immunity both systemically and within the tumor microenvironment, little is known about the impact of pre-existing malignancy on pathogen-specific immune responses. Here, we sought to characterize the antigen-specific CD8(+) T cell response following a bacterial infection in the setting of pre-existing pancreatic adenocarcinoma. Mice with established subcutaneous pancreatic adenocarcinomas were infected with Listeria monocytogenes, and antigen-specific CD8(+) T cell responses were compared to those in control mice without cancer. While the kinetics and magnitude of antigen-specific CD8(+) T cell expansion and accumulation was comparable between the cancer and non-cancer groups, bacterial antigen-specific CD8(+) T cells and total CD4(+) and CD8(+) T cells in cancer mice exhibited increased expression of the coinhibitory receptors BTLA, PD-1, and 2B4. Furthermore, increased inhibitory receptor expression was associated with reduced IFN-gamma and increased IL-2 production by bacterial antigen-specific CD8(+) T cells in the cancer group. Taken together, these data suggest that cancer's immune suppressive effects are not limited to the tumor microenvironment, but that pre-existing malignancy induces phenotypic exhaustion in T cells by increasing expression of coinhibitory receptors and may impair pathogen-specific CD8(+) T cell functionality and differentiation.	[Mittal, Rohit; Wagener, Maylene; Breed, Elise R.; Liang, Zhe; Yoseph, Benyam P.; Coopersmith, Craig M.; Ford, Mandy L.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Mittal, Rohit; Breed, Elise R.; Liang, Zhe; Yoseph, Benyam P.; Coopersmith, Craig M.] Emory Univ, Sch Med, Emory Ctr Crit Care, Atlanta, GA USA; [Wagener, Maylene; Ford, Mandy L.] Emory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA USA; [Burd, Eileen M.; Farris, Alton B., III] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Ford, ML (corresponding author), Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA.	mshawve@emory.edu	Farris, Alton Brad/S-6041-2017; Breed, Elise/G-2547-2017	Farris, Alton Brad/0000-0001-5534-7763; Breed, Elise/0000-0001-6468-8463	United States National Institutes of Health General Medical Sciences [T32GM095442, R01GM104323, R01GM072808, R01AI104699]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM095442, R01GM104323, R01GM072808] Funding Source: NIH RePORTER	United States National Institutes of Health General Medical Sciences; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States National Institutes of Health General Medical Sciences: T32GM095442 (CMC), R01GM104323 (CMC), R01GM072808 (CMC and MLF), and R01AI104699 (MLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P448; Baniyash M, 2013, CANC IMMUNOL IMMUNOT; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Campoli M, 2002, VACCINE, V20, pA40, DOI 10.1016/S0264-410X(02)00386-9; Cui W, 2009, VACCINE, V27, P2177, DOI 10.1016/j.vaccine.2009.01.088; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; del Campo AB, 2012, TISSUE ANTIGENS, V79, P147, DOI 10.1111/j.1399-0039.2011.01831.x; Derre L, 2010, J CLIN INVEST, V120, P157, DOI 10.1172/JCI40070; Ferrone S, 2007, SURG ONCOL CLIN N AM, V16, P755, DOI 10.1016/j.soc.2007.08.004; Floyd TL, 2011, J IMMUNOL, V186, P2033, DOI 10.4049/jimmunol.1003015; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fox AC, 2011, J IMMUNOL, V187, P1950, DOI 10.4049/jimmunol.1003391; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Goding SR, 2013, J IMMUNOL, V190, P4899, DOI 10.4049/jimmunol.1300271; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Karakatsanis S, 2013, HEMATOL ONCOL; Keppler SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040865; Khong HT, 2004, J IMMUNOTHER, V27, P184, DOI 10.1097/00002371-200405000-00002; Krempski J, 2011, J IMMUNOL, V186, P6905, DOI 10.4049/jimmunol.1100274; Liyanage UK, 2006, J IMMUNOTHER, V29, P416, DOI 10.1097/01.cji.0000205644.43735.4e; Mook P, 2011, EMERG INFECT DIS, V17, P38, DOI 10.3201/eid1701.101174; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Pages F, 2011, SEMIN IMMUNOPATHOL, V33, P317, DOI 10.1007/s00281-011-0278-4; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Paulos CM, 2010, J CLIN INVEST, V120, P76, DOI 10.1172/JCI41811; Preston CC, 2011, IMMUNOTHERAPY-UK, V3, P539, DOI [10.2217/IMT.11.20, 10.2217/imt.11.20]; Rangwala S, 2011, BRIT J DERMATOL, V165, P953, DOI 10.1111/j.1365-2133.2011.10507.x; Riches JC, 2013, BLOOD, V121, P1612, DOI 10.1182/blood-2012-09-457531; Sarkar S, 2007, J IMMUNOL, V179, P6704, DOI 10.4049/jimmunol.179.10.6704; Schlaphoff V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002045; Schmidt HH, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24962; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; van der Windt GJW, 2010, INFECT IMMUN, V78, P115, DOI 10.1128/IAI.00949-09; Viehl CT, 2006, ANN SURG ONCOL, V13, P1252, DOI 10.1245/s10434-006-9015-y; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson DC, 2008, J IMMUNOL, V180, P5935, DOI 10.4049/jimmunol.180.9.5935; Yang BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063261; Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877; Ye J, 2013, CANC RES	47	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e93523	10.1371/journal.pone.0093523	http://dx.doi.org/10.1371/journal.pone.0093523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796533	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000004
J	Torrente, M; Guetg, A; Sass, JO; Arps, L; Ruckstuhl, L; Camargo, SMR; Verrey, F				Torrente, Marta; Guetg, Adriano; Sass, Joern Oliver; Arps, Lisa; Ruckstuhl, Lisa; Camargo, Simone M. R.; Verrey, Francois			Amino Acids Regulate Transgene Expression in MDCK Cells	PLOS ONE			English	Article							CANINE KIDNEY-CELLS; MAMMALIAN-CELLS; GENE-EXPRESSION; TRANSPORTER SLC6A19; ADAPTIVE REGULATION; HARTNUP DISORDER; EPITHELIAL-CELLS; SYSTEM-A; CULTURES; ARGININE	Gene expression and cell growth rely on the intracellular concentration of amino acids, which in metazoans depends on extracellular amino acid availability and transmembrane transport. To investigate the impact of extracellular amino acid concentrations on the expression of a concentrative amino acid transporter, we overexpressed the main kidney proximal tubule luminal neutral amino acid transporter B-0 AT1-collectrin (SLC6A19-TMEM27) in MDCK cell epithelia. Exogenously expressed proteins co-localized at the luminal membrane and mediated neutral amino acid uptake. However, the transgenes were lost over few cell culture passages. In contrast, the expression of a control transgene remained stable. To test whether this loss was due to inappropriately high amino acid uptake, freshly transduced MDCK cell lines were cultivated either with physiological amounts of amino acids or with the high concentration found in standard cell culture media. Expression of exogenous transporters was unaffected by physiological amino acid concentration in the media. Interestingly, mycoplasma infection resulted in a significant increase in transgene expression and correlated with the rapid metabolism of L-arginine. However, L-arginine metabolites were shown to play no role in transgene expression. In contrast, activation of the GCN2 pathway revealed by an increase in eIF2 alpha phosphorylation may trigger transgene derepression. Taken together, high extracellular amino acid concentration provided by cell culture media appears to inhibit the constitutive expression of concentrative amino acid transporters whereas L-arginine depletion by mycoplasma induces the expression of transgenes possibly via stimulation of the GCN2 pathway.	[Torrente, Marta; Guetg, Adriano; Arps, Lisa; Ruckstuhl, Lisa; Camargo, Simone M. R.; Verrey, Francois] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Torrente, Marta; Guetg, Adriano; Arps, Lisa; Ruckstuhl, Lisa; Camargo, Simone M. R.; Verrey, Francois] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Sass, Joern Oliver] Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University Children's Hospital Zurich	Verrey, F (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	verrey@access.uzh.ch		Camargo, Simone/0000-0003-0091-7380; Verrey, Francois/0000-0003-3250-9824	Swiss NSF [31-130471/1]; National Centre of Competence in Research (NCCR)	Swiss NSF(Swiss National Science Foundation (SNSF)); National Centre of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF))	The laboratory of FV is supported by Swiss NSF grant 31-130471/1 and the National Centre of Competence in Research (NCCR) Kidney. CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Ban H, 2004, INT J MOL MED, V13, P537; Bauch C, 2003, J BIOL CHEM, V278, P1316, DOI 10.1074/jbc.M210449200; Bauch C, 2002, AM J PHYSIOL-RENAL, V283, pF181, DOI 10.1152/ajprenal.00212.2001; Bauchart-Thevret C, 2010, AM J PHYSIOL-ENDOC M, V299, pE899, DOI 10.1152/ajpendo.00068.2010; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Broadhead CL, 1998, TOXICOL IN VITRO, V12, P209, DOI 10.1016/S0887-2333(97)00113-6; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Danilczyk U, 2006, NATURE, V444, P1088, DOI 10.1038/nature05475; Dillon Brian J, 2002, Med Sci Monit, V8, pBR248; Drexler HG, 2002, CYTOTECHNOLOGY, V39, P75, DOI 10.1023/A:1022913015916; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Hyatt SL, 1997, J BIOL CHEM, V272, P19951, DOI 10.1074/jbc.272.32.19951; Hyde R, 2001, BIOCHEM J, V355, P563, DOI 10.1042/bj3550563; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Kilberg MS, 2012, ADV NUTR, V3, P295, DOI 10.3945/an.112.001891; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; Kimball SR, 2002, J NUTR, V132, P883; Kleta R, 2004, NAT GENET, V36, P999, DOI 10.1038/ng1405; Kratschmar DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036774; Ling R, 2001, BBA-BIOMEMBRANES, V1512, P15, DOI 10.1016/S0005-2736(01)00310-8; MISFELDT DS, 1976, P NATL ACAD SCI USA, V73, P1212, DOI 10.1073/pnas.73.4.1212; Palmisano I, 2012, P NATL ACAD SCI USA, V109, pE2284, DOI 10.1073/pnas.1202174109; Romeo E, 2006, AM J PHYSIOL-RENAL, V290, pF376, DOI 10.1152/ajprenal.00286.2005; Rudnick G, 2013, PFLUGERS ARCH EUR J; SCHIMKE RT, 1963, J BACTERIOL, V86, P195, DOI 10.1128/JB.86.2.195-206.1963; Scott L, 2000, BRIT J CANCER, V83, P800, DOI 10.1054/bjoc.2000.1353; Seow HF, 2004, NAT GENET, V36, P1003, DOI 10.1038/ng1406; Simpson NH, 1998, BIOTECHNOL BIOENG, V59, P90, DOI 10.1002/(SICI)1097-0290(19980705)59:1<90::AID-BIT12>3.0.CO;2-6; Sood R, 2000, GENETICS, V154, P787; STANBRIDGE E, 1971, BACTERIOL REV, V35, P206, DOI 10.1128/MMBR.35.2.206-227.1971; Summa V, 2004, J PHYSIOL-LONDON, V555, P355, DOI 10.1113/jphysiol.2003.054270; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tumer E, 2013, J BIOL CHEM, V288, P33813, DOI 10.1074/jbc.M113.482760; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96823	10.1371/journal.pone.0096823	http://dx.doi.org/10.1371/journal.pone.0096823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797296	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000336656000129
J	Zhang, MM; He, JQ; Hou, JB; Wu, J; Sun, M; Cui, JJ; Tian, JT; Jiang, MM; Yu, B				Zhang, Maomao; He, Jieqiong; Hou, Jingbo; Wu, Jian; Sun, Meng; Cui, Jinjin; Tian, Jiangtian; Jiang, Miaomiao; Yu, Bo			The Immunosuppressant Protosappanin A Diminished Recipient T Cell Migration into Allograft via Inhibition of IP-10 in Rat Heart Transplant	PLOS ONE			English	Article							RECEPTOR-GENE-EXPRESSION; CAESALPINIA-SAPPAN; ACUTE REJECTION; ANTIINFLAMMATORY ACTIVITY; CHEMOKINE CXCL10; KAPPA-B; CXCR3; ACTIVATION; RECRUITMENT; PROMOTER	The immunosuppressant Protosappanin A (PrA), isolated from the medicinal herb, promotes cardiac allograft survival, diminishes inflammatory cell infiltration, and inhibits interferon c-induced protein 10 kDa (IP-10) mRNA expression in rats cardiac grafts. Binding of the chemokine IP-10 to its cognate receptor, CXCR3, plays crucial roles in allograft immunity, especially by mediating the recruitment of effector T cells to allografted tissues. In this study, we attempted to determine whether PrA-mediated inhibition of IP-10 contributes to the effect of reduced T cell infiltration into cardiac allograft within a rat model. Administration of PrA (25 mg/kg daily) via oral gavage following heart transplantation significantly reduced the increase of IP-10 mRNA level in allograft and prevented IP-10 secretion by peripheral blood mononuclear cells (PBMC) isolated from recipient rats seven days posttransplantation. Furthermore, in vitro experiments demonstrated that PrA addition to control PBMC prevented IP-10 secretion. Chemotactic migration assays were utilized to evaluate recipient T cell migration towards PBMC supernatant. PrA administration impaired PBMC supernatant-induced T cell migration. Additional in vitro experiments revealed that PrA slightly reduced naive T cell migration towards chemokines. The presence of IP-10 in PBMC supernatant prevented PrA from reducing T cell migration in PrA-treated recipients. Neither CXCR3 chemokine ligand Mig nor non-CXCR3 chemokine ligand SDF-1 had any effect on T cell migration in PrA-treated recipients. The addition of anti-CXCR3 antibody restored PrA-mediated inhibition of T cell migration. Immunofluorescence microscopy showed that IP-10 was expressed mainly in CD68 positive infiltrating monocytes. Furthermore, PrA consistently reduced CXCR3(+)T cell infiltration into cardiac allografts. The reduced intensity of CXCR3 staining in PrA-treated allografts contributed to the previously depressed naive T cell migrating activity induced by PrA. Collectively, these data indicate that PrA inhibition of IP-10 activity reduced recipient T cell migration and infiltration of cardiac allografts, thus partially explaining the immunosuppressive effect of PrA.	[Zhang, Maomao; He, Jieqiong; Hou, Jingbo; Wu, Jian; Sun, Meng; Cui, Jinjin; Tian, Jiangtian; Yu, Bo] Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Maomao; He, Jieqiong; Hou, Jingbo; Wu, Jian; Cui, Jinjin; Jiang, Miaomiao; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Yu, B (corresponding author), Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China.	yubodr@163.com			Foundation of Heilongjiang Educational Committee [12531286]; National Nature Science Foundation of China [81200180]; New Teachers' Fund for Doctor Stations, Ministry of Education [20122307120021]; Science and technology talent Foundation of Harbin [RC2008QN003003]; Heilongjiang Province Nature Foundation of Great Subject [ZJY03-7]; Foundation for New Century Excellent Talents in Heilongjiang Province [1154-NCET-009]; Post-doctoral Foundation of China [2011M501065]; Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University), Ministry of Education [KF201211]	Foundation of Heilongjiang Educational Committee; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund for Doctor Stations, Ministry of Education; Science and technology talent Foundation of Harbin; Heilongjiang Province Nature Foundation of Great Subject; Foundation for New Century Excellent Talents in Heilongjiang Province(Program for New Century Excellent Talents in University (NCET)); Post-doctoral Foundation of China(China Postdoctoral Science Foundation); Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University), Ministry of Education	Project was supported by The Foundation of Heilongjiang Educational Committee (12531286), National Nature Science Foundation of China (81200180), New Teachers' Fund for Doctor Stations, Ministry of Education (20122307120021), Science and technology talent Foundation of Harbin (RC2008QN003003), the Heilongjiang Province Nature Foundation of Great Subject (ZJY03-7), Foundation for New Century Excellent Talents in Heilongjiang Province (1154-NCET-009), Post-doctoral Foundation of China (2011M501065), and Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University), Ministry of Education (KF201211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini C, 2001, AM J PATHOL, V158, P1703, DOI 10.1016/S0002-9440(10)64126-0; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Crescioli C, 2009, TRANSPLANTATION, V87, P249, DOI 10.1097/TP.0b013e3181919f5d; El-Sawy T, 2002, CURR OPIN IMMUNOL, V14, P562, DOI 10.1016/S0952-7915(02)00382-5; Fahmy NM, 2003, TRANSPLANTATION, V75, P2044, DOI 10.1097/01.TP.0000069601.73079.94; Fahmy NM, 2003, TRANSPLANTATION, V75, P72, DOI 10.1097/00007890-200301150-00013; Gomez-Lopez N, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S8; Guerreiro Rita, 2011, Acta Med Port, V24 Suppl 4, P967; Hancock WW, 2003, CURR OPIN IMMUNOL, V15, P479, DOI 10.1016/S0952-7915(03)00103-1; Hancock WW, 2001, J EXP MED, V193, P975, DOI 10.1084/jem.193.8.975; Kim EC, 2005, AM J CHINESE MED, V33, P405, DOI 10.1142/S0192415X05003016; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; Liu AL, 2009, PLANTA MED, V75, P337, DOI 10.1055/s-0028-1112208; Liu MT, 2001, J IMMUNOL, V167, P4091, DOI 10.4049/jimmunol.167.7.4091; Mao YY, 2011, J CLIN IMMUNOL, V31, P414, DOI 10.1007/s10875-010-9500-8; Melter M, 2001, CIRCULATION, V104, P2558, DOI 10.1161/hc4601.098010; Min BS, 2012, BIOORG MED CHEM LETT, V22, P7436, DOI 10.1016/j.bmcl.2012.10.055; Morita K, 2001, J IMMUNOL, V167, P2979, DOI 10.4049/jimmunol.167.5.2979; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Peperzak V, 2013, J IMMUNOL, V191, P3025, DOI 10.4049/jimmunol.1202222; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sauty A, 2001, J IMMUNOL, V167, P7084, DOI 10.4049/jimmunol.167.12.7084; Schenk AD, 2008, CLIN LAB MED, V28, P441, DOI 10.1016/j.cll.2008.07.004; Uppaluri R, 2008, TRANSPLANTATION, V86, P137, DOI 10.1097/TP.0b013e31817b8e4b; Wang J, 2008, HEPATOB PANCREAT DIS, V7, P45; Wang YZ, 2011, J ETHNOPHARMACOL, V136, P271, DOI 10.1016/j.jep.2011.04.061; Wu J, 2008, TRANSPL P, V40, P3719, DOI 10.1016/j.transproceed.2008.06.097; Wu J, NAUNYN SCHMIEDEBERGS, V381, P83; Wu SQ, 2011, J ETHNOPHARMACOL, V138, P364, DOI 10.1016/j.jep.2011.09.011; Zhang MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066336; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937; Zhang Z, 2004, GASTROENTEROLOGY, V126, P809, DOI 10.1053/j.gastro.2003.12.014; Zhang Z, 2002, J IMMUNOL, V168, P3205, DOI 10.4049/jimmunol.168.7.3205; Zhu J, 2006, WORLD J GASTROENTERO, V12, P4156, DOI 10.3748/wjg.v12.i26.4156	36	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96138	10.1371/journal.pone.0096138	http://dx.doi.org/10.1371/journal.pone.0096138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798458	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000040
J	Feigelson, HS; Zeng, C; Pawloski, PA; Onitilo, AA; Richards, CS; Johnson, MA; Kauffman, TL; Webster, J; Nyirenda, C; Alexander, GL; Hwang, C; Cross, D; McCarty, CA; Davis, RL; Schwarzkopf, D; Williams, AE; Honda, S; Daida, Y; Kushi, LH; Delate, T; Goddard, KAB				Feigelson, Heather Spencer; Zeng, Chan; Pawloski, Pamala A.; Onitilo, Adedayo A.; Richards, C. Sue; Johnson, Monique A.; Kauffman, Tia L.; Webster, Jennifer; Nyirenda, Carsie; Alexander, Gwen L.; Hwang, Clara; Cross, Deanna; McCarty, Catherine A.; Davis, Robert L.; Schwarzkopf, Denise; Williams, Andrew E.; Honda, Stacey; Daida, Yihe; Kushi, Lawrence H.; Delate, Thomas; Goddard, Katrina A. B.		CERGEN Study Team	Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample	PLOS ONE			English	Article							MUTATIONS; CETUXIMAB; NONINFERIORITY; CHEMOTHERAPY; ONCOLOGY; THERAPY; BENEFIT; TRIALS	Purpose: Epidermal growth factor receptor (EGFR) inhibitors are approved for treating metastatic colorectal cancer (CRC); KRAS mutation testing is recommended prior to treatment. We conducted a non-inferiority analysis to examine whether KRAS testing has impacted survival in CRC patients. Patients and Methods: We included 1186 metastatic CRC cases from seven health plans. A cutpoint of July, 2008, was used to define two KRAS testing time period groups: "pre-testing'' (n = 760 cases) and "post-testing'' (n = 426 cases). Overall survival (OS) was estimated, and the difference in median OS between the groups was calculated. The lower bound of the one-sided 95% confidence interval (CI) for the difference in survival was used to test the null hypothesis of post-testing inferiority. Multivariable Cox regression models were constructed to adjust for covariates. Results: The median unadjusted OS was 15.4 months (95% CI: 14.0-17.5) and 12.8 months (95% CI: 10.0-15.2) in the pre- and post-testing groups, respectively. The OS difference was -2.6 months with one-sided 95% lower confidence bound of -5.13 months, which was less than the non-inferiority margin (-5.0 months, unadjusted p = 0.06), leading to a failure to reject inferiority of OS in the post-testing period. In contrast, in the adjusted analysis, OS non-inferiority was identified in the post-testing period (p = 0.001). Sensitivity analyses using cutpoints before and after July, 2008, also met the criteria for non-inferiority. Conclusion: Implementation of KRAS testing did not influence CRC OS. Our data support the use of KRAS testing to guide administration of EGFR inhibitors for treatment of metastatic CRC without diminished OS.	[Feigelson, Heather Spencer; Zeng, Chan; Nyirenda, Carsie] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80231 USA; [Pawloski, Pamala A.] HealthPartners Inst Educ & Res, Bloomington, MN USA; [Onitilo, Adedayo A.] Marshfield Clin Weston Ctr, Dept Hematol Oncol, Weston, WI USA; [Onitilo, Adedayo A.; Cross, Deanna] Marshfield Clin Res Fdn, Weston, WI USA; [Onitilo, Adedayo A.] Univ Queensland, Sch Populat Hlth, Clin Epidemiol Unit, Brisbane, Qld, Australia; [Richards, C. Sue; Johnson, Monique A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Kauffman, Tia L.; Webster, Jennifer; Schwarzkopf, Denise; Goddard, Katrina A. B.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Alexander, Gwen L.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Hwang, Clara] Henry Ford Hlth Syst, Div Hematol Oncol, Dept Internal Med, Detroit, MI USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Davis, Robert L.] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN USA; [Williams, Andrew E.; Honda, Stacey; Daida, Yihe] Kaiser Permanente Hawaii, Ctr Hlth Res, Honolulu, HI USA; [Kushi, Lawrence H.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Delate, Thomas] Kaiser Permanente Colorado, Dept Pharm, Denver, CO USA	Kaiser Permanente; HealthPartners Institute for Education & Research; University of Queensland; Oregon Health & Science University; Kaiser Permanente; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; University of Tennessee System; University of Tennessee Health Science Center; Kaiser Permanente; Kaiser Permanente; Kaiser Permanente	Feigelson, HS (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80231 USA.	heather.s.feigelson@kp.org	Hwang, Clara/AAF-5302-2022; Hwang, Clara/AFJ-8520-2022	Hwang, Clara/0000-0002-0998-323X; Hwang, Clara/0000-0002-0998-323X; Kushi, Lawrence/0000-0001-9136-1175; McCarty, Catherine/0000-0003-1089-0142	National Cancer Institute [5UC2CA148471, U24 CA171524, U19 CA079689]; NATIONAL CANCER INSTITUTE [U19CA079689, U24CA171524, UC2CA148471, RC2CA148471] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG007243] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by resources developed through a grant from the National Cancer Institute (5UC2CA148471) and was conducted at multiple sites of the HMO Cancer Research Network (CRN). The CRN is supported through grants from the National Cancer Institute (U24 CA171524 and U19 CA079689). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; American Cancer Society, 2012, CANC FACTS FIG 2010; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Feigelson Heather Spencer, 2012, BMC Res Notes, V5, P196, DOI 10.1186/1756-0500-5-196; Hornbrook MC, 2005, J NATL CANC I MONOGR, V35, P12, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI033; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lin JS, 2011, AM J CANCER RES, V1, P650; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Tanaka S, 2012, CLIN CANCER RES, V18, P1837, DOI 10.1158/1078-0432.CCR-11-1653; Tunes da Silva G, 2009, BIOL BLOOD MARROW S, V15, P120, DOI 10.1016/j.bbmt.2008.10.004; U.S. Food and Drug Administration, 2010, CET ERB PAN VECT; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; WAGNER EH, 2005, J NATL CANC I MONOGR, V35, P3, DOI DOI 10.1093/JNCIMONOGRAPHS/LGI032; Webster J, 2013, CANCER EPIDEM BIOMAR, V22, P91, DOI 10.1158/1055-9965.EPI-12-0545; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97	21	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e94977	10.1371/journal.pone.0094977	http://dx.doi.org/10.1371/journal.pone.0094977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788807	Green Published, Green Submitted, gold			2022-12-27	WOS:000335510600022
J	Grangeiro, A; Escuder, MM; Cassanote, AJF; Souza, RA; Kalichman, AO; Veloso, V; Ikeda, MLR; Barcellos, NT; Brites, C; Tupinanbas, U; Lucena, NO; da Silva, CL; Lacerda, HR; Grinsztejn, B; Castilho, EA				Grangeiro, Alexandre; Escuder, Maria Mercedes; Flores Cassanote, Alex Jones; Souza, Rosa Alencar; Kalichman, Artur O.; Veloso, Valdilea; Rodrigues Ikeda, Maria Leticia; Barcellos, Nemora Tregnago; Brites, Carlos; Tupinanbas, Unai; Lucena, Noaldo O.; da Silva, Carlos Lima; Lacerda, Heloisa Ramos; Grinsztejn, Beatriz; Castilho, Euclides Ayres			The HIV-Brazil Cohort Study: Design, Methods and Participant Characteristics	PLOS ONE			English	Article							RIO-DE-JANEIRO; ANTIRETROVIRAL TREATMENT; UNIVERSAL ACCESS; DRUG-RESISTANCE; AIDS TREATMENT; SURVIVAL; HIV/AIDS; INDIVIDUALS; CHALLENGES; DEATH	Background: The HIV-Brazil Cohort Study was established to analyze the effectiveness of combination antiretroviral therapy (cART) and the impact of this treatment on morbidity, quality of life (QOL) and mortality. The study design, patients' profiles and characteristics of cART initiation between 2003 and 2010 were described. Methodology/Principal Findings: Since 2003, the HIV-Brazil Cohort has been following HIV-infected adults receiving cART at 26 public health care facilities, using routine clinical care data and self-reported QOL questionnaires. When not otherwise available, data are obtained from national information systems. The main outcomes of interest are diseases related or unrelated to HIV; suppression of viral replication; adverse events; virological, clinical and immunological failures; changes in the cART; and mortality. For the 5,061 patients who started cART between 2003 and 2010, the median follow-up time was 4.1 years (IQR 2.2-5.9 years) with an 83.4% retention rate. Patient profiles were characterized by a predominance of men (male/female ratio 1.7:1), with a mean age of 36.9 years (SD 9.9 years); 55.2% had been infected with HIV via heterosexual contact. The majority of patients (53.4%) initiated cART with a CD4(+) T-cell count <= 200 cells/mm(3). The medications most often used in the various treatment regimens were efavirenz (59.7%) and lopinavir/ritonavir (18.2%). The proportion of individuals achieving viral suppression within the first 12 months of cART use was 77.4% (95% CI 76.1-78.6). Nearly half (45.4%) of the patients presented HIV-related clinical manifestations after starting cART, and the AIDS mortality rate was 13.9 per 1,000 person-years. Conclusions/Significance: Results from cART use in the daily practice of health services remain relatively unknown in low- and middle-income countries, and studies with the characteristics of the HIV-Brazil Cohort contribute to minimizing these shortcomings, given its scope and patient profile, which is similar to that of the AIDS epidemic in the country.	[Grangeiro, Alexandre; Castilho, Euclides Ayres] Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil; [Escuder, Maria Mercedes] Sao Paulo State Dept Hlth, Hlth Inst, Sao Paulo, Brazil; [Flores Cassanote, Alex Jones] Univ Sao Paulo, Sch Med, Postgrad Program Infect & Parasit Dis, Sao Paulo, Brazil; [Souza, Rosa Alencar; Kalichman, Artur O.] Sao Paulo State Dept Hlth, STD AIDS Referral & Training Ctr, Sao Paulo, Brazil; [Veloso, Valdilea; Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil; [Rodrigues Ikeda, Maria Leticia; Barcellos, Nemora Tregnago] Rio Grande do Sul State Dept Hlth, Care & Treatment Clin Partenon Sanat, Porto Alegre, RS, Brazil; [Brites, Carlos] Univ Fed Bahia, Edgar Santos Univ Hosp Complex, Salvador, BA, Brazil; [Tupinanbas, Unai] Univ Fed Minas Gerais, Sch Med, Belo Horizonte, MG, Brazil; [Lucena, Noaldo O.] Amazonas State Dept Hlth, Trop Med Fdn, Manaus, Amazonas, Brazil; [da Silva, Carlos Lima] Bahia State Dept Hlth, State Ctr Diag Treatment & Res, Salvador, BA, Brazil; [Lacerda, Heloisa Ramos] Univ Fed Pernambuco, Recife, PE, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Federal de Minas Gerais; Universidade Federal de Pernambuco	Grangeiro, A (corresponding author), Univ Sao Paulo, Sch Med, Dept Prevent Med, Sao Paulo, Brazil.	ale.grangeiro@gmail.com	Brites, Carlos/D-1353-2013; DE CASTILHO, EUCLIDES AYRES/K-7906-2016	Brites, Carlos/0000-0002-4673-6991; ikeda, maria leticia/0000-0002-2727-2298; Castilho, Euclides/0000-0002-7352-8784	Brazilian National Council for Scientific and Technological Development; Brazilian National Ministry of Health; Pan American Health Organization; STD/AIDS Referral and Training Centre of the Sao Paulo State Department of Health; Evandro Chagas Clinical Research Institute of the Oswaldo Cruz Foundation	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian National Ministry of Health; Pan American Health Organization; STD/AIDS Referral and Training Centre of the Sao Paulo State Department of Health; Evandro Chagas Clinical Research Institute of the Oswaldo Cruz Foundation	The study is funded by the Brazilian National Council for Scientific and Technological Development, the Brazilian National Ministry of Health, the Pan American Health Organization, the STD/AIDS Referral and Training Centre of the Sao Paulo State Department of Health and the Evandro Chagas Clinical Research Institute of the Oswaldo Cruz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencastro PR, 2011, AIDS PATIENT CARE ST, V25, P627, DOI 10.1089/apc.2010.0360; Silva ACAL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/186850; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Veras MADM, 2011, CAD SAUDE PUBLICA, V27, pS104, DOI 10.1590/S0102-311X2011001300011; Grangeiro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014585; Greco DB, 2007, AIDS, V21, pS37, DOI 10.1097/01.aids.0000279705.24428.a3; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Guibu IA, 2011, CAD SAUDE PUBLICA, V27, pS79, DOI 10.1590/S0102-311X2011001300009; Hacker MA, 2007, CAD SAUDE PUBLICA, V23, pS345, DOI 10.1590/S0102-311X2007001500003; Hofer CB, 2004, JAIDS-J ACQ IMM DEF, V36, P967, DOI 10.1097/00126334-200408010-00011; Inocencio LA, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-20; Rezende ELLF, 2010, BRAZ J INFECT DIS, V14, P558, DOI [10.1016/S1413-8670(10)70112-4, 10.1590/S1413-86702010000600003]; Malta M, 2009, JAIDS-J ACQ IMM DEF, V52, P629, DOI 10.1097/QAI.0b013e3181b31b8a; Maruza M, 2012, INT J TUBERC LUNG D, V16, P618, DOI 10.5588/ijtld.11.0110; Medeiros Roseane, 2002, Braz J Infect Dis, V6, P298, DOI 10.1590/S1413-86702002000600005; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Okie S, 2006, NEW ENGL J MED, V354, P1977, DOI 10.1056/NEJMp068069; Pacheco AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001531; Portela MC, 2006, REV SAUDE PUBL, V40, P70, DOI 10.1590/S0034-89102006000800010; Ribeiro FA, 2012, BRAZ J INFECT DIS, V16, P27, DOI 10.1590/S1413-86702012000100005; Soares MA, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406003-00003; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024	24	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95673	10.1371/journal.pone.0095673	http://dx.doi.org/10.1371/journal.pone.0095673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789106	Green Published, gold, Green Submitted			2022-12-27	WOS:000335510600046
J	Esposti, M; Chouaia, B; Comandatore, F; Crotti, E; Sassera, D; Lievens, PMJ; Daffonchio, D; Bandi, C				Degli Esposti, Mauro; Chouaia, Bessem; Comandatore, Francesco; Crotti, Elena; Sassera, Davide; Lievens, Patricia Marie-Jeanne; Daffonchio, Daniele; Bandi, Claudio			Evolution of Mitochondria Reconstructed from the Energy Metabolism of Living Bacteria	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CYTOCHROME-C-OXIDASE; NITRITE REDUCTION; ORIGIN; PROTEIN; NITRATE; GENES; OXYGEN; BC(1); ASSIMILATION	The ancestors of mitochondria, or proto-mitochondria, played a crucial role in the evolution of eukaryotic cells and derived from symbiotic alpha-proteobacteria which merged with other microorganisms -the basis of the widely accepted endosymbiotic theory. However, the identity and relatives of proto-mitochondria remain elusive. Here we show that methylotrophic alpha-proteobacteria could be the closest living models for mitochondrial ancestors. We reached this conclusion after reconstructing the possible evolutionary pathways of the bioenergy systems of proto-mitochondria with a genomic survey of extant alpha-proteobacteria. Results obtained with complementary molecular and genetic analyses of diverse bioenergetic proteins converge in indicating the pathway stemming from methylotrophic bacteria as the most probable route of mitochondrial evolution. Contrary to other a-proteobacteria, methylotrophs show transition forms for the bioenergetic systems analysed. Our approach of focusing on these bioenergetic systems overcomes the phylogenetic impasse that has previously complicated the search for mitochondrial ancestors. Moreover, our results provide a new perspective for experimentally re-evolving mitochondria from extant bacteria and in the future produce synthetic mitochondria.	[Degli Esposti, Mauro; Lievens, Patricia Marie-Jeanne] Italian Inst Technol, Genoa, Italy; [Chouaia, Bessem; Crotti, Elena; Daffonchio, Daniele] Univ Milan, Dept Food Environm & Evolutionary Sci, Milan, Italy; [Comandatore, Francesco; Sassera, Davide; Bandi, Claudio] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	Istituto Italiano di Tecnologia - IIT; University of Milan; University of Milan	Esposti, M (corresponding author), Italian Inst Technol, Genoa, Italy.	mauro.degliesposti@iit.it	Daffonchio, Daniele/AAF-4922-2019; Bandi, Claudio/J-7835-2018	Daffonchio, Daniele/0000-0003-0947-925X; Bandi, Claudio/0000-0002-0181-4618; chouaia, bessem/0000-0003-0726-7237; Sassera, Davide/0000-0003-0442-5252; Degli Esposti, Mauro/0000-0002-0977-119X; Crotti, Elena/0000-0002-3466-8274	BIODESERT [245746]; Italian Ministry of Education, University and Research (MIUR)	BIODESERT; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been partially supported by the project BIODESERT GA-245746 "Biotechnology from Desert Microbial Extremophiles for Supporting Agriculture Research Potential in Tunisia and Southern Europe'' ( European Union) and the Prin 2009 ( grant 009L27YC8_003), from the Italian Ministry of Education, University and Research (MIUR). Work at IIT has been sustained by intramural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek A, 2011, CAN J MICROBIOL, V57, P49, DOI [10.1139/W10-099, 10.1139/w10-099]; Andersson SGE, 2003, PHILOS T R SOC B, V358, P165, DOI 10.1098/rstb.2002.1193; Atteia A, 2009, MOL BIOL EVOL, V26, P1533, DOI 10.1093/molbev/msp068; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Bratton MR, 1999, BIOCHEMISTRY-US, V38, P16236, DOI 10.1021/bi9914107; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Brochier-Armanet C, 2009, MOL BIOL EVOL, V26, P285, DOI 10.1093/molbev/msn246; Budd A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00401; Burger G, 2013, GENOME BIOL EVOL, V5, P418, DOI 10.1093/gbe/evt008; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chouaia B, 2014, GENOME BIOL IN PRESS; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Cunningham L, 1997, MOL MICROBIOL, V24, P579, DOI 10.1046/j.1365-2958.1997.3561728.x; Dam B, 2012, J BACTERIOL, V194, P6008, DOI 10.1128/JB.01446-12; Davidov Y, 2006, ENVIRON MICROBIOL, V8, P2179, DOI 10.1111/j.1462-2920.2006.01101.x; de Graaf RM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-514; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Esser L, 2008, J BIOL CHEM, V283, P2846, DOI 10.1074/jbc.M708608200; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024857; Georgiades K, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-6; Gomez-Manzo S, 2010, J BACTERIOL, V192, P5718, DOI 10.1128/JB.00589-10; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Gribaldo S, 2010, NAT REV MICROBIOL, V8, P743, DOI 10.1038/nrmicro2426; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296; Hung CL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S14; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kim SW, 2009, APPL ENVIRON MICROB, V75, P2652, DOI 10.1128/AEM.02536-08; Kolling DJ, 2007, STRUCTURE, V15, P29, DOI 10.1016/j.str.2006.11.012; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lau E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056993; Lebrun E, 2006, MOL BIOL EVOL, V23, P1180, DOI 10.1093/molbev/msk010; Lee SJ, 2013, NATURE, V494, P380, DOI 10.1038/nature11880; LIN JT, 1994, J BACTERIOL, V176, P2551, DOI 10.1128/JB.176.9.2551-2559.1994; Liu XM, 1998, J BACTERIOL, V180, P6154; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Margulis L, 1996, P NATL ACAD SCI USA, V93, P1071, DOI 10.1073/pnas.93.3.1071; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Mohan SB, 2004, FEMS MICROBIOL ECOL, V49, P433, DOI 10.1016/j.femsec.2004.04.012; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Noor MR, 2012, BBA-BIOENERGETICS, V1817, P638, DOI 10.1016/j.bbabio.2011.08.004; Ouchane S, 2005, MOL MICROBIOL, V57, P261, DOI 10.1111/j.1365-2958.2005.04685.x; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Refojo PN, 2010, BBA-BIOENERGETICS, V1797, P1869, DOI 10.1016/j.bbabio.2010.04.012; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Sakurai K, 2011, MICROBIOL-SGM, V157, P899, DOI 10.1099/mic.0.045906-0; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Searcy DG, 2003, CELL RES, V13, P229, DOI 10.1038/sj.cr.7290168; Shih PM, 2013, P NATL ACAD SCI USA, V110, P12355, DOI 10.1073/pnas.1305813110; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Simmons SS, 2011, BIOINFORM BIOL INSIG, V5, P115, DOI 10.4137/BBI.S7316; Simon J, 2013, BBA-BIOENERGETICS, V1827, P114, DOI 10.1016/j.bbabio.2012.07.005; Slot JC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001097; Sousa FL, 2012, BBA-BIOENERGETICS, V1817, P629, DOI 10.1016/j.bbabio.2011.09.020; Starkenburg SR, 2008, APPL ENVIRON MICROB, V74, P2852, DOI 10.1128/AEM.02311-07; Stewart JJ, 2011, PLANT MOL BIOL, V77, P565, DOI 10.1007/s11103-011-9831-8; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; Takaya N, 2009, BIOSCI BIOTECH BIOCH, V73, P1, DOI 10.1271/bbb.80487; Tamas I, 2010, J BACTERIOL, V192, P4532, DOI 10.1128/JB.00656-10; Thiergart T, 2012, GENOME BIOL EVOL, V4, P466, DOI 10.1093/gbe/evs018; ThonyMeyer L, 1997, MICROBIOL MOL BIOL R, V61, P337; Torriani SFF, 2008, FUNGAL GENET BIOL, V45, P628, DOI 10.1016/j.fgb.2007.12.005; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Valas RE, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-30; Vlaeminck SE, 2011, ENVIRON MICROBIOL, V13, P283, DOI 10.1111/j.1462-2920.2010.02345.x; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; YANG D, 1985, P NATL ACAD SCI USA, V82, P4443, DOI 10.1073/pnas.82.13.4443; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993; Zhang Y, 2011, COORDIN CHEM REV, V255, P1206, DOI 10.1016/j.ccr.2011.02.016; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	89	32	32	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96566	10.1371/journal.pone.0096566	http://dx.doi.org/10.1371/journal.pone.0096566			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804722	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900070
J	Fofaria, NM; Kim, SH; Srivastava, SK				Fofaria, Neel M.; Kim, Sung-Hoon; Srivastava, Sanjay K.			Piperine Causes G1 Phase Cell Cycle Arrest and Apoptosis in Melanoma Cells through Checkpoint Kinase-1 Activation	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; DNA-DAMAGE RESPONSE; INDUCTION; 3,3'-DIINDOLYLMETHANE; CURCUMIN; PRB	In this study, we determined the cytotoxic effects of piperine, a major constituent of black and long pepper in melanoma cells. Piperine treatment inhibited the growth of SK MEL 28 and B16 F0 cells in a dose and time-dependent manner. The growth inhibitory effects of piperine were mediated by cell cycle arrest of both the cell lines in G1 phase. The G1 arrest by piperine correlated with the down-regulation of cyclin D1 and induction of p21. Furthermore, this growth arrest by piperine treatment was associated with DNA damage as indicated by phosphorylation of H2AX at Ser139, activation of ataxia telangiectasia and rad3-related protein (ATR) and checkpoint kinase 1 (Chk1). Pretreatment with AZD 7762, a Chk1 inhibitor not only abrogated the activation of Chk1 but also piperine mediated G1 arrest. Similarly, transfection of cells with Chk1 siRNA completely protected the cells from G1 arrest induced by piperine. Piperine treatment caused down-regulation of E2F1 and phosphorylation of retinoblastoma protein (Rb). Apoptosis induced by piperine was associated with down-regulation of XIAP, Bid (full length) and cleavage of Caspase-3 and PARP. Furthermore, our results showed that piperine treatment generated ROS in melanoma cells. Blocking ROS by tiron protected the cells from piperine mediated cell cycle arrest and apoptosis. These results suggest that piperine mediated ROS played a critical role in inducing DNA damage and activation of Chk1 leading to G1 cell cycle arrest and apoptosis.	[Fofaria, Neel M.; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; [Fofaria, Neel M.; Srivastava, Sanjay K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX USA; [Kim, Sung-Hoon; Srivastava, Sanjay K.] Kyung Hee Univ, Dept Pathol, Coll Korean Med, Canc Prevent Mat Dev Res Ctr, Seoul, South Korea	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Kyung Hee University	Srivastava, SK (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA.	sanjay.srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020	kim, sunghoon/0000-0002-1570-3230	National Cancer Institute [R01 CA129038]; NATIONAL CANCER INSTITUTE [R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by R01 grant CA129038 (to S. K. S.) awarded by National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 1996, CANCER RES, V56, P5475; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Cann KL, 2007, BIOCHEM CELL BIOL, V85, P663, DOI 10.1139/O07-135; Chen CY, 2008, FOOD CHEM TOXICOL, V46, P2476, DOI 10.1016/j.fct.2008.04.016; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Halaban R, 2000, J EXP MED, V191, P1005, DOI 10.1084/jem.191.6.1005; Kandala PK, 2012, J PHARMACOL EXP THER, V341, P24, DOI 10.1124/jpet.111.188706; Kandala PK, 2010, MOL PHARMACOL, V78, P297, DOI 10.1124/mol.110.063750; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kong WX, 2011, TOXICOLOGY, V290, P271, DOI 10.1016/j.tox.2011.10.006; Markovic SN, 2009, GIORN ITAL DERMAT V, V144, P1; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Sahu RP, 2009, BRIT J CANCER, V100, P1425, DOI 10.1038/sj.bjc.6605039; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Samson LD, 2012, MOL SYST BIOL, V31, P1; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Smith J, 2010, ADV CANCER RES, V108, P73, DOI 10.1016/S0065.230X(10)08002.4; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; von Willebrand M, 2003, CANCER RES, V63, P1420; Wattanathorn J, 2008, FOOD CHEM TOXICOL, V46, P3106, DOI 10.1016/j.fct.2008.06.014; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	29	69	70	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94298	10.1371/journal.pone.0094298	http://dx.doi.org/10.1371/journal.pone.0094298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804719	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900010
J	Harl, J; Duda, M; Kruckenhauser, L; Sattmann, H; Haring, E				Harl, Josef; Duda, Michael; Kruckenhauser, Luise; Sattmann, Helmut; Haring, Elisabeth			In Search of Glacial Refuges of the Land Snail Orcula dolium (Pulmonata, Orculidae) - An Integrative Approach Using DNA Sequence and Fossil Data	PLOS ONE			English	Article							LOESS-PALEOSOL SEQUENCE; PLEISTOCENE GLACIATIONS; GASTROPODA; STYLOMMATOPHORA; DIFFERENTIATION; PHYLOGEOGRAPHY; INFERENCE; EUROPE; POLYMORPHISM; EVOLUTION	Harboring a large number of endemic species, the Alps and the Western Carpathians are considered as major centers of biodiversity. Nonetheless, the general opinion until the turn of the millennium was that both Central European mountain regions did not provide suitable habitat during the Last Glacial Maximum, but were colonized later from southern refuges. However, recent molecular genetic studies provide new evidence for peripheral Alpine refuges. We studied the phylogeography of the calciphilous land snail O. dolium across its distribution in the Alps and the Western Carpathians to assess the amount of intraspecific differentiation and to detect potential glacial refuges. A partial sequence of the mitochondrial COI was analyzed in 373 specimens from 135 sampling sites, and for a subset of individuals, partial sequences of the mitochondrial 16S and the nuclear histone H3 and H4 were sequenced. A molecular clock analysis was combined with a reconstruction of the species' geographic range history to estimate how its lineages spread in the course of time. In order to obtain further information on the species' past distribution, we also screened its extensive Pleistocene fossil record. The reconstruction of geographic range history suggests that O. dolium is of Western Carpathian origin and diversified already around the Miocene-Pliocene boundary. The fossil record supports the species' presence at more than 40 sites during the last glacial and earlier cold periods, most of them in the Western Carpathians and the Pannonian Basin. The populations of O. dolium display a high genetic diversity with maximum intraspecific p-distances of 18.4% (COI) and 14.4% (16S). The existence of various diverged clades suggests the survival in several geographically separated refuges. Moreover, the sequence patterns provide evidence of multiple migrations between the Alps and the Western Carpathians. The results indicate that the Southern Calcareous Alps were probably colonized only during the Holocene.	[Harl, Josef; Kruckenhauser, Luise; Haring, Elisabeth] Museum Nat Hist Vienna, Cent Res Labs, Vienna, Austria; [Harl, Josef; Haring, Elisabeth] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Duda, Michael; Sattmann, Helmut] Museum Nat Hist Vienna, Dept Invertebrate Zool, Vienna, Austria	University of Vienna	Harl, J (corresponding author), Museum Nat Hist Vienna, Cent Res Labs, Vienna, Austria.	harl_josef@hotmail.com	Kruckenhauser, Luise/M-3567-2018	Kruckenhauser, Luise/0000-0001-8708-4347; Harl, Josef/0000-0002-4915-3943	Austrian Science Fund [19592- B17]; Freunde des Naturhistorischen Museums Wien	Austrian Science Fund(Austrian Science Fund (FWF)); Freunde des Naturhistorischen Museums Wien	This project was funded by the Austrian Science Fund (FWF, Proj.-No. 19592- B17) and the "Freunde des Naturhistorischen Museums Wien''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, QUATERN INT, V243, P183, DOI 10.1016/j.quaint.2010.11.016; Armbruster GFJ, 2005, J MOLLUS STUD, V71, P339, DOI 10.1093/mollus/eyi038; Arrebola J, 2012, N W J ZOOL, V8; Benke M, 2009, MOL ECOL, V18, P890, DOI 10.1111/j.1365-294X.2008.04073.x; Cadahia L, 2014, J ZOOL SYST IN PRESS; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duda M, 2011, J MOLLUS STUD, V77, P30, DOI 10.1093/mollus/eyq037; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frank C., 2006, PLIO PLEISTOZANE HOL; Frank Christa, 2011, Eiszeitalter und Gegenwart, V60, P126; Fukoh L., 1995, MALACOLOGICAL NEWSLE, V1, P1; Gittenberger E, 2004, MOL PHYLOGENET EVOL, V30, P64, DOI 10.1016/S1055-7903(03)00182-9; Greve C, 2010, MOL PHYLOGENET EVOL, V57, P572, DOI 10.1016/j.ympev.2010.08.021; Haase M, 2003, J ZOOL SYST EVOL RES, V41, P175, DOI 10.1046/j.1439-0469.2003.00208.x; Haase M, 2009, J ZOOL SYST EVOL RES, V47, P105, DOI 10.1111/j.1439-0469.2008.00488.x; Haase M, 2013, J MOLLUS STUD, V79, P241, DOI 10.1093/mollus/eyt017; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harl J, 2011, ARCH MOLLUSKENKD, V140, P175, DOI 10.1127/arch.moll/1869-0963/140/175-199; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Holdhaus K., 1954, Abhandlungen der Zoologisch-Botanischen Gesellschaft in Wien Jena, V18, P1; Hovorka D, 1993, MITTEILUNGEN OSTERRE, V86, P33; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hupuczi J, 2010, CENT EUR J GEOSCI, V2, P57, DOI 10.2478/v10085-009-0048-x; Ivy-Ochs S, 2008, J QUATERNARY SCI, V23, P559, DOI 10.1002/jqs.1202; KLEMM W., 1974, DENKSCHRIFTEN STERRE, V117, P1; Kruckenhauser L., 2011, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V112, P173; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lisicky MJ, 1991, MOLLUSCA SLOVENSKA; Lozek V., 1964, Rozpravy ustred Ust geol, V31, P1; Lozek V, 2001, QUATERN INT, V76-7, P141, DOI 10.1016/S1040-6182(00)00098-7; Lozek Vojien, 2006, Sbornik Geologickych Ved Antropozoikum, V26, P73; Marazzi S., 2005, ATLANTE OROGRAFICO A; Markovic SB, 2005, GEOL CARPATH, V56, P545; Markovic SB, 2008, J QUATERNARY SCI, V23, P73, DOI 10.1002/jqs.1124; Markovic Slobodan B., 2004, Quaternaire, V15, P361; Mitrovic Biljana, 2007, Geoloshki Anali Balkanskoga Poluostrva, V68, P81; Moine O, 2005, BOREAS, V34, P363, DOI 10.1080/03009480510013060; Molnar D, 2010, CENT EUR J GEOSCI, V2, P52, DOI 10.2478/v10085-009-0045-0; Muttoni G, 2003, GEOLOGY, V31, P989, DOI 10.1130/G19445.1; Pinceel J, 2005, MOL ECOL, V14, P1133, DOI 10.1111/j.1365-294X.2005.02479.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A., 2007, TRACER V1 5; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Robles Fernando, 2009, Iberus, V27, P99; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Scheel BM, 2012, MOL ECOL, V21, P3794, DOI 10.1111/j.1365-294X.2012.05649.x; Sommer RS, 2009, J BIOGEOGR, V36, P2013, DOI 10.1111/j.1365-2699.2009.02187.x; Sumegi P, 2011, QUATERN INT, V240, P181, DOI 10.1016/j.quaint.2011.05.005; Sumegi P, 2002, QUATERN INT, V91, P53, DOI 10.1016/S1040-6182(01)00102-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tribsch A, 2003, TAXON, V52, P477, DOI 10.2307/3647447; vanHusen D, 1997, QUATERN INT, V38-9, P109, DOI 10.1016/S1040-6182(96)00017-1; Watanabe Y, 2001, MOL ECOL, V10, P2635, DOI 10.1046/j.0962-1083.2001.01388.x; Weigand AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037089; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; ZAGWIJN WH, 1992, QUATERNARY SCI REV, V11, P583, DOI 10.1016/0277-3791(92)90015-Z; ZIMMERMANN STEPHAN, 1932, ARCH NATURGESCH [ZEITSCHR WISS ZOOL ABT B], V1, P1	62	27	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96012	10.1371/journal.pone.0096012	http://dx.doi.org/10.1371/journal.pone.0096012			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804706	gold, Green Published			2022-12-27	WOS:000335728900030
J	Hong, JK; Kim, HJ; Cho, JC				Hong, Jin-Kyung; Kim, Hye-Jin; Cho, Jae-Chang			Novel PCR Primers for the Archaeal Phylum Thaumarchaeota Designed Based on the Comparative Analysis of 16S rRNA Gene Sequences	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; PHYLOGENETIC CHARACTERIZATION; MESOPHILIC CRENARCHAEOTA; GENOME SEQUENCE; AMOA GENES; DIVERSITY; BACTERIA; ABUNDANCE; SOIL; COMMUNITIES	Based on comparative phylogenetic analysis of 16S rRNA gene sequences deposited in an RDP database, we constructed a local database of thaumarchaeotal 16S rRNA gene sequences and developed a novel PCR primer specific for the archaeal phylum Thaumarchaeota. Among 9,727 quality-filtered (chimeral-checked, size > 1.2 kb) archaeal sequences downloaded from the RDP database, 1,549 thaumarchaeotal sequences were identified and included in our local database. In our study, Thaumarchaeota included archaeal groups MG-I, SAGMCG-I, SCG, FSCG, RC, and HWCG-III, forming a monophyletic group in the phylogenetic tree. Cluster analysis revealed 114 phylotypes for Thaumarchaeota. The majority of the phylotypes (66.7%) belonged to the MG-I and SCG, which together contained most (93.9%) of the thaumarchaeotal sequences in our local database. A phylum-directed primer was designed from a consensus sequence of the phylotype sequences, and the primer's specificity was evaluated for coverage and tolerance both in silico and empirically. The phylum-directed primer, designated THAUM-494, showed > 90% coverage for Thaumarchaeota and < 1% tolerance to non-target taxa, indicating high specificity. To validate this result experimentally, PCRs were performed with THAUM-494 in combination with a universal archaeal primer (ARC917R or 1017FAR) and DNAs from five environmental samples to construct clone libraries. THAUM-494 showed a satisfactory specificity in empirical studies, as expected from the in silico results. Phylogenetic analysis of 859 cloned sequences obtained from 10 clone libraries revealed that > 95% of the amplified sequences belonged to Thaumarchaeota. The most frequently sampled thaumarchaeotal subgroups in our samples were SCG, MG-I, and SAGMCG-I. To our knowledge, THAUM-494 is the first phylum-level primer for Thaumarchaeota. Furthermore, the high coverage and low tolerance of THAUM-494 will make it a potentially valuable tool in understanding the phylogenetic diversity and ecological niche of Thaumarchaeota.	[Cho, Jae-Chang] Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea; Hankuk Univ Foreign Studies, Dept Environm Sci, Yongin, South Korea	Hankuk University Foreign Studies; Hankuk University Foreign Studies	Cho, JC (corresponding author), Hankuk Univ Foreign Studies, Inst Environm Sci, Yongin, South Korea.	chojc@hufs.ac.kr			NRF [NRF-2012R1A1A2004270]; GRRC [GRRCHUFS-2013-B02]; KEITI [20130005501]; HUFS [HUFS-2014]	NRF; GRRC; KEITI; HUFS	This work was supported by a research grant from the NRF (grant no. NRF-2012R1A1A2004270). J. - K. Hong was supported in part by GRRC (program no. GRRCHUFS-2013-B02) and KEITI (GAIA project no. 20130005501). H. -J. Kim was supported in part by HUFS (program no. HUFS-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Auguet JC, 2012, ISME J, V6, P1786, DOI 10.1038/ismej.2012.33; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Beman JM, 2006, APPL ENVIRON MICROB, V72, P7767, DOI 10.1128/AEM.00946-06; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Brochier-Armanet C, 2012, ISME J, V6, P227, DOI [10.1038/ismej.2011.145, 10.1038/ismej.2012.110]; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Coolen MJL, 2007, ENVIRON MICROBIOL, V9, P1001, DOI 10.1111/j.1462-2920.2006.01227.x; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Gubry-Rangin C, 2011, P NATL ACAD SCI USA, V108, P21206, DOI 10.1073/pnas.1109000108; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Guy L, 2011, TRENDS MICROBIOL, V19, P580, DOI 10.1016/j.tim.2011.09.002; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Heijs SK, 2007, MICROB ECOL, V53, P384, DOI 10.1007/s00248-006-9172-3; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Hong JK, 2012, J MICROBIOL BIOTECHN, V22, P771, DOI 10.4014/jmb.1112.12004; Hu AY, 2011, MICROB ECOL, V62, P549, DOI 10.1007/s00248-011-9866-z; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; JUKES T H, 1969, P21; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Loy A, 2002, APPL ENVIRON MICROB, V68, P5064, DOI 10.1128/AEM.68.10.5064-5081.2002; Martin-Cuadrado AB, 2008, ISME J, V2, P865, DOI 10.1038/ismej.2008.40; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; Nelson KA, 2009, APPL ENVIRON MICROB, V75, P4211, DOI 10.1128/AEM.00201-09; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Nunoura T, 2005, ENVIRON MICROBIOL, V7, P1967, DOI 10.1111/j.1462-2920.2005.00881.x; Nunoura T, 2011, NUCLEIC ACIDS RES, V39, P3204, DOI 10.1093/nar/gkq1228; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Offre P, 2011, ENV MICROBIOL REP, V3, P245, DOI 10.1111/j.1758-2229.2010.00217.x; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Perevalova AA, 2008, APPL ENVIRON MICROB, V74, P7620, DOI 10.1128/AEM.00972-08; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Pitcher A, 2011, ISME J, V5, P1896, DOI 10.1038/ismej.2011.60; Purkhold U, 2000, APPL ENVIRON MICROB, V66, P5368, DOI 10.1128/AEM.66.12.5368-5382.2000; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sakai S, 2007, APPL ENVIRON MICROB, V73, P4326, DOI 10.1128/AEM.03008-06; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schleper C, 1998, J BACTERIOL, V180, P5003, DOI 10.1128/JB.180.19.5003-5009.1998; Schleper C, 2010, ADV MICROB PHYSIOL, V57, P1, DOI 10.1016/B978-0-12-381045-8.00001-1; Simon HM, 2000, ENVIRON MICROBIOL, V2, P495, DOI 10.1046/j.1462-2920.2000.00131.x; Sintes E, 2013, ENVIRON MICROBIOL, V15, P1647, DOI 10.1111/j.1462-2920.2012.02801.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang SF, 2009, APPL ENVIRON MICROB, V75, P4216, DOI 10.1128/AEM.01761-08; WOESE CR, 1978, J MOL EVOL, V11, P245, DOI 10.1007/BF01734485; Yagi JM, 2010, ISME J, V4, P131, DOI 10.1038/ismej.2009.101; Zhalnina K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00210	80	7	7	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96197	10.1371/journal.pone.0096197	http://dx.doi.org/10.1371/journal.pone.0096197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805255	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900038
J	Roy, P; Bandyopadhyay, A				Roy, Priti; Bandyopadhyay, Amitabha			Spatio-Temporally Restricted Expression of Cell Adhesion Molecules during Chicken Embryonic Development	PLOS ONE			English	Article							DENDRITIC SELF-AVOIDANCE; N-CADHERIN; PRIMARY CILIUM; PROTOCADHERIN; MOVEMENTS; XENOPUS; IDENTIFICATION; SUPERFAMILY; CARTILAGE; INTERACTS	Differential cell adhesive properties are known to regulate important developmental events like cell sorting and cell migration. Cadherins and protocadherins are known to mediate these cellular properties. Though a large number of such molecules have been predicted, their characterization in terms of interactive properties and cellular roles is far from being comprehensive. To narrow down the tissue context and collect correlative evidence for tissue specific roles of these molecules, we have carried out whole-mount in situ hybridization based RNA expression study for seven cadherins and four protocadherins. In developing chicken embryos (HH stages 18, 22, 26 and 28) cadherins and protocadherins are expressed in tissue restricted manner. This expression study elucidates precise expression domains of cell adhesion molecules in the context of developing embryos. These expression domains provide spatio-temporal context in which the function of these genes can be further explored.	[Roy, Priti; Bandyopadhyay, Amitabha] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Roy, P (corresponding author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.	pritiroy.india@gmail.com; abandopa@iitk.ac.in		Bandyopadhyay, Amitabha/0000-0002-0429-438X	Department of Biotechnology, India [BT/PR9360/BRB/10/551/2007]; Council for Scientific and Industrial Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant (BT/PR9360/BRB/10/551/2007) from Department of Biotechnology, India to AB. PR was supported by fellowship from Council for Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMALEK ET, 1950, J MORPHOL, V86, P599, DOI 10.1002/jmor.1050860305; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; Bradley RS, 1998, CURR BIOL, V8, P325, DOI 10.1016/S0960-9822(98)70132-0; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Cho EA, 1998, DEVELOPMENT, V125, P803; Dahl U, 2002, MOL CELL BIOL, V22, P1474, DOI 10.1128/MCB.22.5.1474-1487.2002; Delic S, 2012, NEUROPATH APPL NEURO, V38, P201, DOI 10.1111/j.1365-2990.2011.01207.x; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dietrich S, 1997, DEVELOPMENT, V124, P3895; Emond MR, 2011, J CELL BIOL, V195, P1115, DOI 10.1083/jcb.201108115; FONTE VG, 1971, J CELL BIOL, V49, P226, DOI 10.1083/jcb.49.1.226; Gillespie PG, 2009, CELL, V139, P33, DOI 10.1016/j.cell.2009.09.010; Goto S, 1998, J AM SOC NEPHROL, V9, P1234; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Hiruma T, 2003, J ANAT, V203, P539, DOI 10.1046/j.1469-7580.2003.00245.x; Homayouni R, 2001, BIOCHEM BIOPH RES CO, V289, P539, DOI 10.1006/bbrc.2001.5998; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1985, SCIENCE, V230, P745, DOI 10.1126/science.2414845; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kim SH, 1998, DEVELOPMENT, V125, P4681; Kim SH, 2000, CURR BIOL, V10, P821, DOI 10.1016/S0960-9822(00)00580-7; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuroda H, 2002, DEV BIOL, V244, P267, DOI 10.1006/dbio.2002.0589; LEE CH, 1995, DEV BIOL, V171, P363, DOI 10.1006/dbio.1995.1288; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Marchong MN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000923; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Hoang P, 2013, CELL RES, V23, P323, DOI 10.1038/cr.2012.137; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Reynolds AB, 1996, EXP CELL RES, V225, P328, DOI 10.1006/excr.1996.0183; Roy P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063670; Sakaguchi H, 2009, CURR OPIN OTOLARYNGO, V17, P388, DOI 10.1097/MOO.0b013e3283303472; SANO K, 1993, EMBO J, V12, P2249, DOI 10.1002/j.1460-2075.1993.tb05878.x; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; VESTWEBER D, 1985, DEV BIOL, V112, P213, DOI 10.1016/0012-1606(85)90135-6; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Whitfield JF, 2008, CELL SIGNAL, V20, P1019, DOI 10.1016/j.cellsig.2007.12.001; Wilcox CS, 1985, KIDNEY PHYSL PATHOPH, P985; YOSHIDA C, 1982, CELL, V28, P217, DOI 10.1016/0092-8674(82)90339-7; Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5; Zhao WF, 2006, DEV DYNAM, V235, P3327, DOI 10.1002/dvdy.20987; Zimmerman K., 1898, ARCH MIKROSK ANAT, V52, P552, DOI [10.1007/BF02975837, DOI 10.1007/BF02975837]	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96837	10.1371/journal.pone.0096837	http://dx.doi.org/10.1371/journal.pone.0096837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24806091	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900103
J	McKinnon, JE; Mailliard, RB; Swindells, S; Wilkin, TJ; Borowski, L; Roper, JM; Bastow, B; Kearney, M; Wiegand, A; Mellors, JW; Rinaldo, CR				McKinnon, John E.; Mailliard, Robbie B.; Swindells, Susan; Wilkin, Timothy J.; Borowski, LuAnn; Roper, Jillian M.; Bastow, Barbara; Kearney, Mary; Wiegand, Ann; Mellors, John W.; Rinaldo, Charles R.		A5201 Study Team	Baseline Natural Killer and T Cell Populations Correlation with Virologic Outcome after Regimen Simplification to Atazanavir/Ritonavir Alone (ACTG 5201)	PLOS ONE			English	Article							LOPINAVIR-RITONAVIR MONOTHERAPY; MAINTENANCE ANTIRETROVIRAL THERAPY; HIV-1 INFECTION; INDUCTION THERAPY; 2 NUCLEOSIDES; 50 COPIES/ML; NK CELLS; TRIAL; SUPPRESSION; RECEPTORS	Objectives: Simplified maintenance therapy with ritonavir-boosted atazanavir (ATV/r) provides an alternative treatment option for HIV-1 infection that spares nucleoside analogs (NRTI) for future use and decreased toxicity. We hypothesized that the level of immune activation (IA) and recovery of lymphocyte populations could influence virologic outcomes after regimen simplification. Methods: Thirty-four participants with virologic suppression >= 48 weeks on antiretroviral therapy (2 NRTI plus protease inhibitor) were switched to ATV/r alone in the context of the ACTG 5201 clinical trial. Flow cytometric analyses were performed on PBMC isolated from 25 patients with available samples, of which 24 had lymphocyte recovery sufficient for this study. Assessments included enumeration of T-cells (CD4/CD8), natural killer (NK) (CD3(+)CD56(+)CD16(+)) cells and cell-associated markers (HLA-DR, CD's 38/69/94/95/158/279). Results: Eight of the 24 patients had at least one plasma HIV-1 RNA level (VL) > 50 copies/mL during the study. NK cell levels below the group median of 7.1% at study entry were associated with development of VL > 50 copies/mL following simplification by regression and survival analyses (p = 0.043 and 0.023), with an odds ratio of 10.3 (95% CI: 1.92-55.3). Simplification was associated with transient increases in naive and CD25(+) CD4(+) T-cells, and had no impact on IA levels. Conclusions: Lower NK cell levels prior to regimen simplification were predictive of virologic rebound after discontinuation of nucleoside analogs. Regimen simplification did not have a sustained impact on markers of IA or T lymphocyte populations in 48 weeks of clinical monitoring.	[McKinnon, John E.] Henry Ford Hosp Syst, Detroit, MI 48202 USA; [Mailliard, Robbie B.; Borowski, LuAnn; Mellors, John W.; Rinaldo, Charles R.] Univ Pittsburgh, Pittsburgh, PA USA; [Swindells, Susan] Univ Nebraska Med Ctr, Omaha, NE USA; [Wilkin, Timothy J.] Weill Cornell Med Coll, New York, NY USA; [Roper, Jillian M.] George Washington Univ, Washington, DC USA; [Bastow, Barbara] Social & Sci Syst Inc, Silver Spring, MD USA; [Kearney, Mary; Wiegand, Ann] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA	Henry Ford Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Nebraska System; University of Nebraska Medical Center; Cornell University; George Washington University; Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	McKinnon, JE (corresponding author), Henry Ford Hosp Syst, Detroit, MI 48202 USA.	jmckinn3@hfhs.org	Mailiiard, Robbie/M-9723-2015	Mailliard, Robbie/0000-0001-5501-503X; Meier, Jeffery/0000-0001-9491-1697; Kearney, Mary/0000-0003-3839-6576	NIH grants from the National Center for Research Resources (NCRR) [1KL2-RR024154-03, UL1 RR024153]; National Cancer Institute (SAIC) [2sXS119]; NIH grant from the National Institute of Allergy and Infectious Diseases [AI069450];  [1R21-AI084423-02];  [U01-AI35041];  [U01-AI068636];  [R37-AI41870]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154, UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069450, U01AI068636, R21AI084423, UM1AI069419, R37AI041870, UM1AI069450, UM1AI069494, UM1AI068636, U01AI035041, U01AI069423, UM1AI069415, UM1AI106701] Funding Source: NIH RePORTER	NIH grants from the National Center for Research Resources (NCRR); National Cancer Institute (SAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH grant from the National Institute of Allergy and Infectious Diseases; ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support for this manuscript was received for JEM from NIH grants 1KL2-RR024154-03, UL1 RR024153 from the National Center for Research Resources (NCRR) and 1R21-AI084423-02. RBM has received financial support from U01-AI35041, U01-AI068636 and R37-AI41870. JWM has received financial support from the National Cancer Institute (SAIC contract 2sXS119). SS was supported by NIH grant AI069450 from the National Institute of Allergy and Infectious Diseases. CRR has received support from U01-AI35041 and U01-AI068636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Alter G, 2007, J INFECT DIS, V195, P1452, DOI 10.1086/513878; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Arribas JR, 2009, JAIDS-J ACQ IMM DEF, V51, P147, DOI 10.1097/QAI.0b013e3181a56de5; Arribas JR, 2005, JAIDS-J ACQ IMM DEF, V40, P280, DOI 10.1097/01.qai.0000180077.59159.f4; Barker E, 2007, AIDS, V21, P2363, DOI 10.1097/QAD.0b013e3282f1d658; Berger CT, 2011, CURR OPIN HIV AIDS, V6, P208, DOI 10.1097/COH.0b013e3283457798; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Bjorkstrom NK, 2010, TRENDS IMMUNOL, V31, P401, DOI 10.1016/j.it.2010.08.003; Brunetta E, 2009, BLOOD, V114, P3822, DOI 10.1182/blood-2009-06-226332; Cameron DW, 2008, J INFECT DIS, V198, P234, DOI 10.1086/589622; Cameron W, 2006, 2 YEAR RANDOMIZED CO; Chakrabarti LA, 2010, CURR OPIN IMMUNOL, V22, P488, DOI 10.1016/j.coi.2010.06.006; Costa P, 2001, AIDS, V15, P965, DOI 10.1097/00002030-200105250-00004; De Maria A, 2003, EUR J IMMUNOL, V33, P2410, DOI 10.1002/eji.200324141; Delaugerre C, 2009, ANTIMICROB AGENTS CH, V53, P2934, DOI 10.1128/AAC.01643-08; Doyle T, 2012, CLIN INFECT DIS, V54, P724, DOI 10.1093/cid/cir936; Gathe Jr JC, 2007, SINGLE AGENT THERAPY; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Johansson SE, 2010, CLIN IMMUNOL, V134, P158, DOI 10.1016/j.clim.2009.10.001; Kahlert C, 2004, AIDS, V18, P955, DOI 10.1097/00002030-200404090-00017; Katlama C, 2003, HIV Med, V4, P79, DOI 10.1046/j.1468-1293.2003.00139.x; LaValley MP, 2008, CIRCULATION, V117, P2395, DOI 10.1161/CIRCULATIONAHA.106.682658; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; McKinnon JE, 2009, ANTIVIR THER, V14, P1; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perez-Valero I, 2011, CURR OPIN INFECT DIS, V24, P7, DOI 10.1097/QCO.0b013e3283422cdf; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Pulido F.SerranoO, 2009, 12 EACS C COL 11 14; Pulido F, 2008, AIDS, V22, pF1, DOI 10.1097/QAD.0b013e3282f4243b; Pulido F, 2009, ANTIVIR THER, V14, P195; Reijers MHE, 2001, AIDS, V15, P129, DOI 10.1097/00002030-200101050-00022; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Swindells S, 2006, JAMA-J AM MED ASSOC, V296, P806, DOI 10.1001/jama.296.7.806; Tiemessen CT, 2010, J INFECT DIS, V202, P1444, DOI 10.1086/656535; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Vieillard V, 2010, JAIDS-J ACQ IMM DEF, V53, P564, DOI 10.1097/QAI.0b013e3181d0c5b4; Wilkin TJ, 2009, J INFECT DIS, V199, P866, DOI 10.1086/597119; Wong AHW, 2010, AIDS RES HUM RETROV, V26, P459, DOI 10.1089/aid.2009.0176	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95524	10.1371/journal.pone.0095524	http://dx.doi.org/10.1371/journal.pone.0095524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802242	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000338029800030
J	Saint-Geniez, M; Ghelfi, E; Liang, XL; Yu, CW; Spencer, C; Abend, S; Hotamisligil, G; Cataltepe, S				Saint-Geniez, Magali; Ghelfi, Elisa; Liang, Xiaoliang; Yu, Chenwei; Spencer, Carrie; Abend, Stephanie; Hotamisligil, Gokhan; Cataltepe, Sule			Fatty Acid Binding Protein 4 Deficiency Protects against Oxygen-Induced Retinopathy in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PREMATURITY; ANGIOGENESIS; AP2; MOUSE; BEVACIZUMAB; VEGF; CELLS; NEOVASCULARIZATION; ATHEROSCLEROSIS	Retinopathy of prematurity (ROP) is a leading cause of blindness in children worldwide due to increasing survival rates of premature infants. Initial suppression, followed by increased production of the retinal vascular endothelial growth factor-A (VEGF) expression are key events that trigger the pathological neovascularization in ROP. Fatty acid binding protein 4 (FABP4) is an intracellular lipid chaperone that is induced by VEGF in a subset of endothelial cells. FABP4 exhibits a pro-angiogenic function in cultured endothelial cells and in airway microvasculature, but whether it plays a role in modulation of retinal angiogenesis is not known. We hypothesized that FABP4 deficiency could ameliorate pathological retinal vascularization and investigated this hypothesis using a well-characterized mouse model of oxygen-induced retinopathy (OIR). We found that FABP4 was not expressed in retinal vessels, but was present in resident macrophages/microglial cells and endothelial cells of the hyaloid vasculature in the immature retina. While FABP4 expression was not required for normal development of retinal vessels, FABP4 expression was upregulated and localized to neovascular tufts in OIR. FABP4(-/-) mice demonstrated a significant decrease in neovessel formation as well as a significant improvement in physiological revascularization of the avascular retinal tissues. These alterations in retinal vasculature were accompanied by reduced endothelial cell proliferation, but no effect on apoptosis or macrophage/microglia recruitment. FABP4(-/-) OIR samples demonstrated decreased expression of genes involved in angiogenesis, such as Placental Growth Factor, and angiopoietin 2. Collectively, our findings suggest FABP4 as a potential target of pathologic retinal angiogenesis in proliferative retinopathies.	[Saint-Geniez, Magali; Spencer, Carrie; Abend, Stephanie] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02115 USA; [Ghelfi, Elisa; Liang, Xiaoliang; Yu, Chenwei; Cataltepe, Sule] Brigham & Womens Hosp, Dept Neonatol, Boston, MA 02115 USA; [Ghelfi, Elisa; Liang, Xiaoliang; Yu, Chenwei; Cataltepe, Sule] Harvard Univ, Sch Med, Boston, MA USA; [Hotamisligil, Gokhan] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Saint-Geniez, M (corresponding author), Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA 02115 USA.	magali.saintgeniez@schepens.harvard.edu	SAINT-GENIEZ, MAGALI/P-3509-2019	SAINT-GENIEZ, MAGALI/0000-0001-9897-138X; Yu, Danny/0000-0002-8997-8560	National Institutes of Health [R21 EY021873]; OneSight Research Foundation; NATIONAL EYE INSTITUTE [R01EY023682, R21EY021873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OneSight Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health Grant R21 EY021873 (to SC and MSG) and OneSight Research Foundation (to SC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TITLE ERROR; Bremer DL, 2012, J AAPOS, V16, P449, DOI 10.1016/j.jaapos.2012.06.011; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Cao RH, 2010, P NATL ACAD SCI USA, V107, P856, DOI 10.1073/pnas.0911661107; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cataltepe O, 2012, NEUROPATH APPL NEURO, V38, P400, DOI 10.1111/j.1365-2990.2011.01237.x; Chen Jing, 2007, Angiogenesis, V10, P133, DOI 10.1007/s10456-007-9066-0; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Davies M, 2006, MOL VIS, V12, P467; Deissler HL, 2013, GRAEF ARCH CLIN EXP, V251, P2345, DOI 10.1007/s00417-013-2393-5; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Feng YX, 2009, CELL PHYSIOL BIOCHEM, V23, P277, DOI 10.1159/000218174; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Furuhashi M, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/642612; Ghelfi E, 2013, AM J PATHOL, V182, P1425, DOI 10.1016/j.ajpath.2012.12.009; Ghelfi E, 2011, AM J RESP CELL MOL, V45, P550, DOI 10.1165/rcmb.2010-0376OC; Girona J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081914; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Jalali S, 2013, ARCH DIS CHILD-FETAL, V98, pF327, DOI 10.1136/archdischild-2012-302365; Kataoka K, 2011, INVEST OPHTH VIS SCI, V52, P1431, DOI 10.1167/iovs.10-5798; Kaur C, 2013, J NEUROIMMUNE PHARM, V8, P66, DOI 10.1007/s11481-012-9347-2; Kowalczuk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017462; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Lim LS, 2011, NEW ENGL J MED, V364, P2360, DOI 10.1056/NEJMc1103460; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Patel RD, 2012, ARCH OPHTHALMOL-CHIC, V130, P801, DOI 10.1001/archophthalmol.2011.1802; Saino-Saito S, 2009, CELL TISSUE RES, V338, P191, DOI 10.1007/s00441-009-0862-2; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Vander Veen DK, 2011, J AAPOS, V15, P536, DOI 10.1016/j.jaapos.2011.07.017; Wheeler DT, 2011, OPHTHALMOLOGY, V118, P1145, DOI 10.1016/j.ophtha.2010.09.031; Yonekura H, 1999, J BIOL CHEM, V274, P35172, DOI 10.1074/jbc.274.49.35172; Zhang L, 2003, CANCER RES, V63, P3403	41	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96253	10.1371/journal.pone.0096253	http://dx.doi.org/10.1371/journal.pone.0096253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802082	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800049
J	Zhan, AB; Xiong, W; He, S; MacIsaac, HJ				Zhan, Aibin; Xiong, Wei; He, Song; MacIsaac, Hugh J.			Influence of Artifact Removal on Rare Species Recovery in Natural Complex Communities Using High-Throughput Sequencing	PLOS ONE			English	Article							BIODIVERSITY; CONSEQUENCES	Large-scale high-throughput sequencing techniques are rapidly becoming popular methods to profile complex communities and have generated deep insights into community biodiversity. However, several technical problems, especially sequencing artifacts such as nucleotide calling errors, could artificially inflate biodiversity estimates. Sequence filtering for artifact removal is a conventional method for deleting error-prone sequences from high-throughput sequencing data. As rare species represented by low-abundance sequences in datasets may be sensitive to artifact removal process, the influence of artifact removal on rare species recovery has not been well evaluated in natural complex communities. Here we employed both internal (reliable operational taxonomic units selected from communities themselves) and external (indicator species spiked into communities) references to evaluate the influence of artifact removal on rare species recovery using 454 pyrosequencing of complex plankton communities collected from both freshwater and marine habitats. Multiple analyses revealed three clear patterns: 1) rare species were eliminated during sequence filtering process at all tested filtering stringencies, 2) more rare taxa were eliminated as filtering stringencies increased, and 3) elimination of rare species intensified as biomass of a species in a community was reduced. Our results suggest that cautions be applied when processing high-throughput sequencing data, especially for rare taxa detection for conservation of species at risk and for rapid response programs targeting non-indigenous species. Establishment of both internal and external references proposed here provides a practical strategy to evaluate artifact removal process.	[Zhan, Aibin; Xiong, Wei; He, Song] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; [Zhan, Aibin; MacIsaac, Hugh J.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of Windsor	Zhan, AB (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, POB 934, Beijing, Peoples R China.	zhanaibin@hotmail.com	Zhan, Aibin/A-7240-2011; macisaac, hugh/AAE-3742-2020		One-Three-Five Program of the Research Center for Eco-Environmental Sciences [YSW2013B02]; Chinese Academy of Sciences; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC Canadian Aquatic Invasive Species Network (CAISN); NSERC	One-Three-Five Program of the Research Center for Eco-Environmental Sciences; Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canadian Aquatic Invasive Species Network (CAISN); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the One-Three-Five Program (YSW2013B02) of the Research Center for Eco-Environmental Sciences and 100 Talents Program of the Chinese Academy of Sciences to A.Z., by Discovery grants from Natural Sciences and Engineering Research Council of Canada (NSERC), the NSERC Canadian Aquatic Invasive Species Network (CAISN), and an NSERC Discovery Accelerator Supplement to H.J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2649; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Creer S, 2010, MOL ECOL, V19, P2829, DOI 10.1111/j.1365-294X.2010.04670.x; De Leon KB, 2012, MICROB ECOL, V64, P499, DOI 10.1007/s00248-012-0043-9; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Zhan AB, 2008, MOL ECOL RESOUR, V8, P790, DOI 10.1111/j.1755-0998.2007.02066.x; Zhan AB, 2014, MOL ECOL RESOUR, V14, P1049, DOI 10.1111/1755-0998.12254; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037	26	30	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96928	10.1371/journal.pone.0096928	http://dx.doi.org/10.1371/journal.pone.0096928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800821	Green Published, gold			2022-12-27	WOS:000338029800138
J	Burotto, M; Wilkerson, J; Stein, W; Motzer, R; Bates, S; Fojo, T				Burotto, Mauricio; Wilkerson, Julia; Stein, Wilfred; Motzer, Robert; Bates, Susan; Fojo, Tito			Continuing a Cancer Treatment Despite Tumor Growth May Be Valuable: Sunitinib in Renal Cell Carcinoma as Example	PLOS ONE			English	Article							INTERFERON-ALPHA; ACQUIRED-RESISTANCE; DOUBLE-BLIND; SURVIVAL; PROGRESSION; EVEROLIMUS; SORAFENIB; AXITINIB; FAILURE; DISEASE	Background: The US FDA and the EMA have approved seven agents for the treatment of renal cell carcinoma, primarily based on differences in progression-free survival (PFS). Because PFS is an arbitrary endpoint we hypothesized that an analysis would demonstrate the growth rate of tumors remained constant at the time of RECIST-defined disease progression. Methods: We previously estimated the growth (g) and regression (d) rates and the stability of g using data from the Phase III trial comparing sunitinib and interferon. Results: Sufficient data were available and rate constants statistically valid in 321 of 374 patients randomized to sunitinib. Median d was 0.0052 days(-1); in 53 patients no tumor growth was recorded. Median g was 0.00082 days(-1) and was stable for a median of 275 days on therapy, remaining stable beyond 300, 600 and 900 days in 122, 65 and 27 patients, respectively. A possible increase in g while receiving sunitinib could be discerned in only 18 of 321 patients. Given a median g of 0.00082 days 21 the estimated median time to a second progression were sunitinib continued past RECIST-defined progression was 7.3 months. At 100, 200, and 300 days after starting therapy, an estimated 47%, 27%, and 13% of tumor remains sunitinib sensitive and could explain a RECIST-defined response to a new TKI. Conclusion: Prolonged stability of g with sunitinib suggests continued sunitinib beyond RECIST-defined progression may provide a beneficial outcome. Randomized trials in patients whose disease has "progressed" on sunitinib are needed to test this hypothesis.	[Burotto, Mauricio; Wilkerson, Julia; Stein, Wilfred; Bates, Susan; Fojo, Tito] NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Stein, Wilfred] Hebrew Univ Jerusalem, Jerusalem, Israel; [Motzer, Robert] Mem Sloan Kettering Canc Ctr, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Memorial Sloan Kettering Cancer Center	Burotto, M (corresponding author), NCI, Med Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mauricio.burottopichun@nih.gov	Bates, Susan/AFP-9514-2022	Wilkerson, Julia/0000-0002-6965-0867; Motzer, Robert/0000-0001-6925-2327	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010620] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvo E, 2012, EUR J CANCER, V48, P333, DOI 10.1016/j.ejca.2011.11.027; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Fojo AT, 2012, CANCER RES, V72, P5151, DOI 10.1158/0008-5472.CAN-12-0733; Goldberg SB, 2013, ONCOLOGIST, V18, P1214, DOI 10.1634/theoncologist.2013-0168; Goss PE, 2013, LANCET ONCOL, V14, P391, DOI 10.1016/S1470-2045(13)70048-2; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Kang YK, 2013, LANCET ONCOL, V14, P1175, DOI 10.1016/S1470-2045(13)70453-4; Korn RL, 2013, CLIN CANCER RES, V19, P2607, DOI 10.1158/1078-0432.CCR-12-2934; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Ou SHI, 2014, ANN ONCOL, V25, P415, DOI 10.1093/annonc/mdt572; Oxnard GR, 2012, JNCI-J NATL CANCER I, V104, P1534, DOI 10.1093/jnci/djs353; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Stein WD, 2008, ONCOLOGIST, V13, P1046, DOI 10.1634/theoncologist.2008-0075; Stein WD, 2008, ONCOLOGIST, V13, P1055, DOI 10.1634/theoncologist.2008-0016; Stein WD, 2012, CLIN CANCER RES, V18, P2374, DOI 10.1158/1078-0432.CCR-11-2275; Stein WD, 2011, CLIN CANCER RES, V17, P907, DOI 10.1158/1078-0432.CCR-10-1762; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Villaruz LC, 2013, CLIN CANCER RES, V19, P2629, DOI 10.1158/1078-0432.CCR-12-2935; von Minckwitz G, 2009, J CLIN ONCOL, V27, P1999, DOI 10.1200/JCO.2008.19.6618	26	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96316	10.1371/journal.pone.0096316	http://dx.doi.org/10.1371/journal.pone.0096316			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796484	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000063
J	Ding, XB; Jin, SQ; Niu, XY; Ren, H; Fu, SK; Li, Q				Ding, Xibing; Jin, Shuqing; Niu, Xiaoyin; Ren, Hao; Fu, Shukun; Li, Quan			A Comparison of the Analgesia Efficacy and Side Effects of Paravertebral Compared with Epidural Blockade for Thoracotomy: An Updated Meta-Analysis	PLOS ONE			English	Article							INTERCOSTAL NERVE CRYOANALGESIA; POSTTHORACOTOMY PAIN MANAGEMENT; ASSISTED THORACOSCOPIC SURGERY; PATIENT-CONTROLLED ANALGESIA; ARTERY-BYPASS-SURGERY; POSTOPERATIVE ANALGESIA; RANDOMIZED-TRIALS; THORACIC-SURGERY; DOUBLE-BLIND; BUPIVACAINE	Objective: The most recent systematic review and metaanalysis comparing the analgesic efficacy and side effects of paravertebral and epidural blockade for thoracotomy was published in 2006. Nine well-designed randomized trials with controversial results have been published since then. The present report constitutes an updated meta-analysis of this issue. Summary of Background: Thoracotomy is a major surgical procedure and is associated with severe postoperative pain. Epidural analgesia is the gold standard for postthoracotomy pain management, but has its limitations and contraindications, and paravertebral blockade is increasingly popular. However, it has not been decided whether the analgesic effect of the two methods is comparable, or whether paravertebral blockade leads to a lower incidence of adverse side effects after thoracotomy. Methods: Two reviewers independently searched the databases PubMed, EMBASE, and the Cochrane Library (last performed on 1 February, 2013) for reports of studies comparing postthoracotomy epidural analgesia and paravertebral blockade. The same individuals independently extracted data from the appropriate studies. Result: Eighteen trials involving 777 patients were included in the current analysis. There was no significant difference in pain scores between paravertebral blockade and epidural analgesia at 48, 24, 48 hours, and the rates of pulmonary complications and morphine usage during the first 24 hours were also similar. However, paravertebral blockade was better than epidural analgesia in reducing the incidence of urinary retention (p, 0.0001), nausea and vomiting (p = 0.01), hypotension (p, 0.00001), and rates of failed block were lower in the paravertebral blockade group (p = 0.01). Conclusions: This metaanalysis showed that PVB can provide comparable pain relief to traditional EPI, and may have a better sideeffect profile for pain relief after thoracic surgery. Further highpowered randomized trials are to need to determine whether PVB truly offers any advantages over EPI.	[Ding, Xibing; Jin, Shuqing; Fu, Shukun; Li, Quan] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Anesthesiol, Shanghai 200092, Peoples R China; [Ding, Xibing; Jin, Shuqing; Niu, Xiaoyin; Ren, Hao; Li, Quan] Tongji Univ, Sch Med, East Hosp, Dept Anesthesiol, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Li, Q (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Anesthesiol, Shanghai 200092, Peoples R China.	quanligene@126.com			National Natural Science Foundation [81270135]; Shanghai Education Committee Key Project [13ZZ024]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Education Committee Key Project	This study was supported financially by the National Natural Science Foundation (81270135) and Shanghai Education Committee Key Project (13ZZ024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreae MH, 2012, COCHRANE DB SYST REV, V17, P10; Arendt Katherine, 2008, Rev Obstet Gynecol, V1, P49; Bimston DN, 1999, SURGERY, V126, P650, DOI 10.1016/S0039-6060(99)70118-2; Bulger EM, 2004, SURGERY, V136, P426, DOI 10.1016/j.surg.2004.05.019; Casati A, 2006, EUR J ANAESTH, V23, P999, DOI 10.1017/S0265021506001104; Davies RG, 2006, BRIT J ANAESTH, V96, P418, DOI 10.1093/bja/ael020; De Cosmo G, 2002, ACTA MED ROM, V40, P340; Dhole S, 2001, J CARDIOTHOR VASC AN, V15, P288, DOI 10.1053/jcan.2001.23271; EASON MJ, 1979, ANAESTHESIA, V34, P638, DOI 10.1111/j.1365-2044.1979.tb06363.x; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Esme H, 2012, EUR J CARDIO-THORAC, V41, P10, DOI 10.1016/j.ejcts.2011.03.056; Fibla JJ, 2009, EUR J CARDIO-THORAC, V36, P901, DOI 10.1016/j.ejcts.2009.05.041; Fortier S, 2012, EUR J ANAESTH, V29, P524, DOI 10.1097/EJA.0b013e328357e5a1; Garutti I, 2009, EUR J CARDIO-THORAC, V35, P829, DOI 10.1016/j.ejcts.2009.01.025; Grant RP, 1999, J CARDIOTHOR VASC AN, V13, P355, DOI 10.1016/S1053-0770(99)90277-X; Grider JS, 2012, J CARDIOTHOR VASC AN, V26, P83, DOI 10.1053/j.jvca.2011.09.003; Gulbahara G, 2010, EUR J CARDIO-THORAC, V37, P467, DOI 10.1016/j.ejcts.2009.05.057; Hansdottir V, 2006, ANESTHESIOLOGY, V104, P142, DOI 10.1097/00000542-200601000-00020; Helms O, 2011, EUR J CARDIO-THORAC, V40, P902, DOI 10.1016/j.ejcts.2011.01.067; Hill SE, 2006, ANESTHESIOLOGY, V104, P1047, DOI 10.1097/00000542-200605000-00022; Horlocker TT, 2003, ORTHOPEDICS, V26, pS243; Hotta K, 2011, J CARDIOTHOR VASC AN, V25, P1009, DOI 10.1053/j.jvca.2011.07.026; Hura G, 2006, EUR J ANAESTH, V23, P658, DOI 10.1017/S0265021506000561; Joshi GP, 2008, ANESTH ANALG, V107, P1026, DOI 10.1213/01.ane.0000333274.63501.ff; Ju H, 2008, EUR J PAIN, V12, P378, DOI 10.1016/j.ejpain.2007.07.011; Kaiser AM, 1998, ANN THORAC SURG, V66, P367, DOI 10.1016/S0003-4975(98)00448-2; Kanazi GE, 2012, EUR J ANAESTH, V29, P186, DOI 10.1097/EJA.0b013e32834fcef7; Karmakar MK, 2001, ANESTHESIOLOGY, V95, P771, DOI 10.1097/00000542-200109000-00033; KAVANAGH BP, 1994, ANESTHESIOLOGY, V81, P737, DOI 10.1097/00000542-199409000-00028; Kaya FN, 2012, J CARDIOTHOR VASC AN, V26, P90, DOI 10.1053/j.jvca.2011.09.008; Lang SA, 2002, ANESTHESIOLOGY, V97, P521, DOI 10.1097/00000542-200208000-00037; Leaver A, 2006, RANDOMIZED TRIAL COM; Liang YX, 2012, J ANESTH, V26, P393, DOI 10.1007/s00540-012-1325-6; Luketich JD, 2005, ANN THORAC SURG, V79, P1845, DOI 10.1016/j.athoracsur.2004.10.055; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; MATTHEWS PJ, 1989, BRIT J ANAESTH, V62, P204, DOI 10.1093/bja/62.2.204; Mehta Y, 2008, ANN CARD ANAESTH, V11, P91, DOI 10.4103/0971-9784.41576; Messina M, 2009, MINERVA ANESTESIOL, V75, P616; Mohta M, 2009, J TRAUMA, V66, P1096, DOI 10.1097/TA.0b013e318166d76d; Mustola ST, 2011, ANN THORAC SURG, V91, P869, DOI 10.1016/j.athoracsur.2010.11.014; PERTTUNEN K, 1995, BRIT J ANAESTH, V75, P541, DOI 10.1093/bja/75.5.541; Pintaric TS, 2011, REGION ANESTH PAIN M, V36, P256, DOI 10.1097/AAP.0b013e3182176f42; Plumis WA, 2006, ACTA ANAESTH SCAND, V50, P804; Richardson J, 1999, BRIT J ANAESTH, V83, P387, DOI 10.1093/bja/83.3.387; Ryu HG, 2011, CLIN J PAIN, V27, P304, DOI 10.1097/AJP.0b013e3181fd5187; SABANATHAN S, 1988, ANN THORAC SURG, V46, P425, DOI 10.1016/S0003-4975(10)64657-7; Sabanathan S, 1990, J R Coll Surg Edinb, V35, P144; Schnabel A, 2010, BRIT J ANAESTH, V105, P842, DOI 10.1093/bja/aeq265; Soto RG, 2003, ANN THORAC SURG, V75, P1349, DOI 10.1016/S0003-4975(02)04647-7; Thavaneswaran P, 2010, ANESTH ANALG, V110, P1740, DOI 10.1213/ANE.0b013e3181da82c8; Yazigi A, 2012, ANN CARD ANAESTH, V15, P32, DOI 10.4103/0971-9784.91479	51	67	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96233	10.1371/journal.pone.0096233	http://dx.doi.org/10.1371/journal.pone.0096233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797238	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000049
J	Johnson, DF; Malone, LL; Zalwango, S; Oketcho, JM; Chervenak, KA; Thiel, B; Mayanja-Kizza, H; Stein, CM; Boom, WH; Lancioni, CL				Johnson, Denise F.; Malone, LaShaunda L.; Zalwango, Sarah; Oketcho, Joy Mukisa; Chervenak, Keith A.; Thiel, Bonnie; Mayanja-Kizza, Harriet; Stein, Catherine M.; Boom, W. Henry; Lancioni, Christina L.		Tuberculosis Res Unit	Tuberculin Skin Test Reversion following Isoniazid Preventive Therapy Reflects Diversity of Immune Response to Primary Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							T-CELL RESPONSES; HEALTH-CARE WORKERS; LATENT TUBERCULOSIS; HOUSEHOLD CONTACTS; M. TUBERCULOSIS; KAMPALA; CONVERSION; SENSITIVITY; EXPOSURE	Rationale: Healthy household contacts (HHC) of individuals with Tuberculosis (TB) with Tuberculin Skin Test (TST) conversions are considered to harbor latent Mycobacterium tuberculosis (Mtb), and at risk for TB. The immunologic, clinical, and public health implications of TST reversions that occur following Isoniazid preventive therapy (IPT) remain controversial. Objectives: To measure frequency of TST reversion following IPT, and variation in interferon-gamma (IFN-gamma) responses to Mtb, in healthy Ugandan TB HHC with primary Mtb infection evidenced by TST conversion. Methods: Prospective cohort study of healthy, HIV-uninfected, TST-negative TB HHC with TST conversions. Repeat TST was performed 12 months following conversion (3 months following completion of 9 month IPT course) to assess for stable conversion vs. reversion. Whole blood IFN-gamma responses to Mtb antigen 85B (MtbA85B) and whole Mtb bacilli (wMtb) were measured in a subset (n = 27 and n = 42, respectively) at enrollment and TST conversion, prior to initiation of IPT. Results: Of 122 subjects, TST reversion was noted in 25 (20.5%). There were no significant differences in demographic, clinical, or exposure variables between reverters and stable converters. At conversion, reverters had significantly smaller TST compared to stable converters (13.7 mm vs 16.4 mm, respectively; p = 0.003). At enrollment, there were no significant differences in IFN-gamma responses to MtbA85B or wMTB between groups. At conversion, stable converters demonstrated significant increases in IFN-gamma responses to Ag85B and wMtb compared to enrollment (p = 0.001, p < 0.001, respectively), while there were no significant changes among reverters. Conclusions: TST reversion following IPT is common following primary Mtb infection and associated with unique patterns of Mtb-induced IFN-gamma production. We have demonstrated that immune responses to primary Mtb infection are heterogeneous, and submit that prospective longitudinal studies of cell mediated immune responses to Mtb infection be prioritized to identify immune phenotypes protective against development of TB disease.	[Johnson, Denise F.; Malone, LaShaunda L.; Chervenak, Keith A.; Thiel, Bonnie; Boom, W. Henry] Case Western Reserve Univ, TB Res Unit TBRU, Cleveland, OH 44106 USA; [Zalwango, Sarah; Oketcho, Joy Mukisa; Mayanja-Kizza, Harriet] Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda; [Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Stein, Catherine M.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lancioni, Christina L.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Case Western Reserve University; Case Western Reserve University; Makerere University; Case Western Reserve University; Oregon Health & Science University	Lancioni, CL (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, 3181 Sw Sam Jackson Pk Rd, Portland, OR 97201 USA.	Lancioni@ohsu.edu	Stein, Catherine/P-9498-2019; Mayanja-Kizza, Harriet/AAM-5372-2020	Stein, Catherine/0000-0002-9763-5023; Mayanja-Kizza, Harriet/0000-0002-9297-6208; Joloba, Moses/0000-0002-0334-9983; MUGERWA, MICHEAL/0000-0001-8591-7544; Lancioni, Christina/0000-0002-0821-1211	US NIAID [HHSN266200700022C/N01-AI-70022]	US NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Federal funds from US NIAID, under contract HHSN266200700022C/N01-AI-70022 supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1959, DIS CHEST, V35, P348; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; ARNEIL AS, 1974, CAN J PUBLIC HEALTH, V65, P197; ATUK NO, 1971, J AMER MED ASSOC, V218, P1795; CAUTHEN CM, 1994, AM J RESP CRIT CARE, V149, P1597, DOI 10.1164/ajrccm.149.6.8004319; Chee CBE, 2007, AM J RESP CRIT CARE, V175, P282, DOI 10.1164/rccm.200608-1109OC; Chiunda A, 2012, IMPACT GEOGRAPHIC DI; DAHLSTROM AW, 1960, DIS CHEST, V38, P599, DOI 10.1378/chest.38.6.599; DANIEL TM, 1967, AM REV RESPIR DIS, V95, P500; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Enarson DA, 1998, CLIN TUBERCULOSIS, P35; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FELTEN MK, 1989, AM REV RESPIR DIS, V140, P1001, DOI 10.1164/ajrccm/140.4.1001; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Fine PEM, 1999, INT J TUBERC LUNG D, V3, P962; Friedman LN, 2006, INFECT CONT HOSP EP, V27, P436, DOI 10.1086/503690; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; GREEN GM, 1981, AM REV RESPIR DIS, V123, P1; Guwatudde D, 2003, B WORLD HEALTH ORGAN, V81, P799; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; HOUK VN, 1968, ARCH ENVIRON HEALTH, V16, P46, DOI 10.1080/00039896.1968.10665013; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Lee SW, 2011, EUR RESPIR J, V37, P1447, DOI 10.1183/09031936.00089510; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahan CS, 2012, AM J TROP MED HYG, V86, P690, DOI 10.4269/ajtmh.2012.11-0553; Mandalakas AM, 2013, PEDIATR INFECT DIS J, V32, pE111, DOI 10.1097/INF.0b013e31827d77b7; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Pai M, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-7; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; PEREZSTABLE EJ, 1988, AM REV RESPIR DIS, V137, P801, DOI 10.1164/ajrccm/137.4.801; Tufariello JM, 2003, LANCET INFECT DIS, V3, P578, DOI 10.1016/S1473-3099(03)00741-2; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; Wilkinson KA, 2006, J INFECT DIS, V193, P354, DOI 10.1086/499311; World Health Organization, 2013, WHOHTMTB201315	37	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96613	10.1371/journal.pone.0096613	http://dx.doi.org/10.1371/journal.pone.0096613			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796677	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000105
J	Seifert, LI; de Castro, F; Marquart, A; Gaedke, U; Weithoff, G; Vos, M				Seifert, Linda I.; de Castro, Francisco; Marquart, Arnim; Gaedke, Ursula; Weithoff, Guntram; Vos, Matthijs			Heated Relations: Temperature-Mediated Shifts in Consumption across Trophic Levels	PLOS ONE			English	Article							FUNCTIONAL-RESPONSE; CLIMATE-CHANGE; FOOD-CHAINS; PREY; POPULATION; COLEOPTERA; PHENOLOGY; DYNAMICS; IMPACT; HYMENOPTERA	A rise in temperature will intensify the feeding links involving ectotherms in food webs. However, it is unclear how the effects will quantitatively differ between the plant-herbivore and herbivore-carnivore interface. To test how warming could differentially affect rates of herbivory and carnivory, we studied trophic interaction strength in a food chain comprised of green algae, herbivorous rotifers and carnivorous rotifers at 10, 15, 20 and 25 degrees C. We found significant warming-induced changes in feeding by both herbivorous and carnivorous rotifers, but these responses occurred at different parts of the entire temperature gradient. The strongest response of the per capita herbivore's ingestion rate occurred due to an increase in temperature from 15 to 20 degrees C (1.9 fold: from 834 to 1611 algal cells per h(-1)) and of the per capita carnivore's ingestion rate from 20 to 25 degrees C (1.6 fold: from 1.5 to 2.5 prey h(-1)). Handling time, an important component of a consumer's functional response, significantly decreased from 15 to 20 degrees C in herbivorous rotifers. In contrast, it decreased from 20 to 25 degrees C in carnivorous rotifers. Attack rates significantly and strongly increased from 10 to 25 degrees C in the herbivorous animals, but not at all in the carnivores. Our results exemplify how the relative forces of top-down control exerted by herbivores and carnivores may strongly shift under global warming. But warming, and its magnitude, are not the only issue: If our results would prove to be representative, shifts in ectotherm interactions will quantitatively differ when a 5 degrees C increase starts out from a low, intermediate or high initial temperature. This would imply that warming could have different effects on the relative forces of carnivory and herbivory in habitats differing in average temperature, as would exist at different altitudes and latitudes.	[Seifert, Linda I.; de Castro, Francisco; Marquart, Arnim; Gaedke, Ursula; Weithoff, Guntram; Vos, Matthijs] Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany; [de Castro, Francisco] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Gaedke, Ursula] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Vos, Matthijs] Leiden Univ, CML, Inst Environm Sci, Leiden, Netherlands	University of Potsdam; Queens University Belfast; Leiden University; Leiden University - Excl LUMC	Seifert, LI (corresponding author), Univ Potsdam, Dept Ecol & Ecosyst Modelling, Potsdam, Germany.	linda.seifert@uni-potsdam.de	de Castro, Francisco/G-2213-2011	de Castro, Francisco/0000-0001-8834-3363; Marquart, Arnim/0000-0002-3447-2669	DFG (Deutsche Forschungsgemeinschaft); Beaufort Marine Research Award; Strategy for Science Technology and Innovation - Marine Institute, funded under the Marine Research Sub-Programme of the Irish National Development Plan	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Beaufort Marine Research Award; Strategy for Science Technology and Innovation - Marine Institute, funded under the Marine Research Sub-Programme of the Irish National Development Plan	This work was funded through a DFG (Deutsche Forschungsgemeinschaft) grant to MV. FC acknowledges support from the Beaufort Marine Research Award for the salary for FC carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the Irish National Development Plan 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, ECOLOGY, V77, P1125, DOI 10.2307/2265581; Altwegg R, 2006, EVOL ECOL RES, V8, P115; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Beisner BE, 1997, CAN J FISH AQUAT SCI, V54, P586, DOI 10.1139/cjfas-54-3-586; Beisner BE, 1996, FRESHWATER BIOL, V35, P219, DOI 10.1046/j.1365-2427.1996.00492.x; Beisner BE, 1997, FUNCT ECOL, V11, P112, DOI 10.1046/j.1365-2435.1997.00062.x; BELEHRADEK J, 1957, ANNU REV PHYSIOL, V19, P59, DOI 10.1146/annurev.ph.19.030157.000423; Binzer A, 2012, PHILOS T R SOC B, V367, P2935, DOI 10.1098/rstb.2012.0230; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Case T. J, 2000, ILLUSTRATED GUIDE TH; CAVE RD, 1989, ENTOMOPHAGA, V34, P3, DOI 10.1007/BF02372581; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Dell AI, 2011, P NATL ACAD SCI USA, V108, P10591, DOI 10.1073/pnas.1015178108; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; FLINN PW, 1991, ENVIRON ENTOMOL, V20, P872, DOI 10.1093/ee/20.3.872; Fussmann GE, 2005, ECOLOGY, V86, P2924, DOI 10.1890/04-1107; GALKOVSKAJA GA, 1987, HYDROBIOLOGIA, V147, P307, DOI 10.1007/BF00025759; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; HALBACH U, 1970, OECOLOGIA, V4, P176, DOI 10.1007/BF00377100; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Huston MA, 2003, SCIENCE, V299, P512, DOI 10.1126/science.299.5606.512; Jankowski T, 2006, LIMNOL OCEANOGR, V51, P815, DOI 10.4319/lo.2006.51.2.0815; Juliano Steven A., 1993, P159; Kratina P, 2012, ECOLOGY, V93, P1421, DOI 10.1890/11-1595.1; Kratina P, 2009, OECOLOGIA, V159, P425, DOI 10.1007/s00442-008-1225-5; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lundberg P, 2000, ECOL LETT, V3, P465, DOI 10.1046/j.1461-0248.2000.00170.x; MACK TP, 1982, ENVIRON ENTOMOL, V11, P46, DOI 10.1093/ee/11.1.46; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Menon A, 2002, J STORED PROD RES, V38, P463, DOI 10.1016/S0022-474X(01)00050-9; OATEN A, 1975, AM NAT, V109, P289, DOI 10.1086/282998; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Peters R.H., 1984, MANUAL METHODS ASSES, V17, P336; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rombough P, 2003, NATURE, V424, P268, DOI 10.1038/424268a; Sentis A, 2013, ECOLOGY, V94, P1675, DOI 10.1890/12-2107.1; Sentis A, 2013, GLOBAL CHANGE BIOL, V19, P833, DOI 10.1111/gcb.12094; Sentis A, 2012, OECOLOGIA, V169, P1117, DOI 10.1007/s00442-012-2255-6; Smolinsky R, 2014, J THERM BIOL, V39, P12, DOI 10.1016/j.jtherbio.2013.11.004; Solomon S., 2007, CLIMATE CHANGE 2007; TUDA M, 1995, OECOLOGIA, V103, P283, DOI 10.1007/BF00328616; Vasseur DA, 2005, AM NAT, V166, P184, DOI 10.1086/431285; Vijverberg J, 2006, FRESHWATER BIOL, V51, P756, DOI 10.1111/j.1365-2427.2006.01528.x; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Voigt W, 2003, ECOLOGY, V84, P2444, DOI 10.1890/02-0266; Vucic-Pestic O, 2011, GLOBAL CHANGE BIOL, V17, P1301, DOI 10.1111/j.1365-2486.2010.02329.x; Wagner A, 2007, OECOLOGIA, V151, P351, DOI 10.1007/s00442-006-0554-5; Wieser W., 1973, EFFECTS TEMPERATURE; Winder M, 2004, GLOBAL CHANGE BIOL, V10, P1844, DOI 10.1111/j.1365-2486.2004.00849.x; Xia JY, 2003, ENVIRON ENTOMOL, V32, P151, DOI 10.1603/0046-225X-32.1.151	55	19	19	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95046	10.1371/journal.pone.0095046	http://dx.doi.org/10.1371/journal.pone.0095046			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797506	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000011
J	Jin, FJ; Li, S; Zheng, K; Zhuo, CQ; Ma, KQ; Chen, MY; Wang, QL; Zhang, PZ; Fan, JL; Ren, Z; Wang, YF				Jin, Fujun; Li, Shen; Zheng, Kai; Zhuo, Cuiqin; Ma, Kaiqi; Chen, Maoyun; Wang, Qiaoli; Zhang, Peizhuo; Fan, Jianglin; Ren, Zhe; Wang, Yifei			Silencing Herpes Simplex Virus Type 1 Capsid Protein Encoding Genes by siRNA: A Promising Antiviral Therapeutic Approach	PLOS ONE			English	Article							RNA INTERFERENCE; ACYCLOVIR; REPLICATION; UL26; VP26; LOCALIZATION; EXPRESSION; RESISTANCE; INFECTION; PRODUCTS	Herpes simplex virus type 1 (HSV-1), a member of the herpesviridae, causes a variety of human viral diseases globally. Although a series of antiviral drugs are available for the treatment of infection and suppression of dissemination, HSV-1 remains highly prevalent worldwide. Therefore, the development of novel antiviral agents with different mechanisms of action is a matter of extreme urgency. During the proliferation of HSV-1, capsid assembly is essential for viral growth, and it is highly conserved in all HSV-1 strains. In this study, small interfering RNAs (siRNAs) against the HSV-1 capsid protein were screened to explore the influence of silencing capsid expression on the replication of HSV-1. We designed and chemically synthesized siRNAs for the capsid gene and assessed their inhibitory effects on the expression of target mRNA and the total intracellular viral genome loads by quantitative real-time PCR, as well as on the replication of HSV-1 via plaque reduction assays and electron microscopy. Our results showed that siRNA was an effective approach to inhibit the expression of capsid protein encoding genes including UL18, UL19, UL26, UL26.5, UL35 and UL38 in vitro. Interference of capsid proteins VP23 (UL18) and VP5 (UL19) individually or jointly greatly affected the replication of clinically isolated acyclovir-resistant HSV-1 as well as HSV-1/F and HSV-2/333. Plaque numbers and intracellular virions were significantly reduced by simultaneous knockdown of UL18 and UL19. The total intracellular viral genome loads were also significantly decreased in the UL18 and UL19 knockdown groups compared with the viral control. In conclusion, interfering with UL18 and UL19 gene expression could inhibit HSV-1 replication efficiently in vitro. Our research offers new targets for an RNA interference-based therapeutic strategy against HSV-1.	[Jin, Fujun; Zheng, Kai; Zhuo, Cuiqin; Ma, Kaiqi; Chen, Maoyun; Wang, Qiaoli; Ren, Zhe; Wang, Yifei] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou Jinan Biomed Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Jin, Fujun; Zhuo, Cuiqin; Chen, Maoyun] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Li, Shen; Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi, Japan; [Zhang, Peizhuo] Shanghai GenePharma Co Ltd, Shanghai, Peoples R China	Jinan University; Jinan University; University of Yamanashi	Ren, Z (corresponding author), Jinan Univ, Natl Engn Res Ctr Genet Med, Guangzhou Jinan Biomed Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China.	rz62@163.com; twang-yf@163.com	Zheng, Kai/AAT-8994-2021	Zheng, Kai/0000-0001-9275-1239; Jin, Fujun/0000-0002-7314-0085; Fan, Jianglin/0000-0002-1737-6130	Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period [SQ2011SF12B02099]; National High Technology Research and Development Program of China (863 Program) [2012AA02A405]; National Natural Science Foundation of China [81274170]; marine fishery science and technology promotion programme of Guangdong province [A201301C06]; Major Platform Project Funds of Administration of Ocean and Fisheries of Guangdong province [GD2012-D01-002]	Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); marine fishery science and technology promotion programme of Guangdong province; Major Platform Project Funds of Administration of Ocean and Fisheries of Guangdong province	This work was supported by the Key Projects in the National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (SQ2011SF12B02099), the National High Technology Research and Development Program of China (863 Program)(2012AA02A405), the National Natural Science Foundation of China (81274170), the marine fishery science and technology promotion programme of Guangdong province (A201301C06), and the Major Platform Project Funds of Administration of Ocean and Fisheries of Guangdong province (GD2012-D01-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduino PG, 2008, J ORAL PATHOL MED, V37, P107, DOI 10.1111/j.1600-0714.2007.00586.x; Bacon TH, 2003, CLIN MICROBIOL REV, V16, P114, DOI 10.1128/CMR.16.1.114-128.2003; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Bhuyan PK, 2004, J VIROL, V78, P10276, DOI 10.1128/JVI.78.19.10276-10281.2004; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; BOOY FP, 1994, P NATL ACAD SCI USA, V91, P5652, DOI 10.1073/pnas.91.12.5652; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Burrel S, 2013, J CLIN VIROL, V58, P321, DOI 10.1016/j.jcv.2013.05.001; Chi JHI, 2000, J VIROL, V74, P1468, DOI 10.1128/JVI.74.3.1468-1476.2000; Coen DM, 2003, NAT REV DRUG DISCOV, V2, P278, DOI 10.1038/nrd1065; DESAI P, 1993, J VIROL, V67, P1357, DOI 10.1128/JVI.67.3.1357-1364.1993; DESAI P, 1994, J VIROL, V68, P5365, DOI 10.1128/JVI.68.9.5365-5374.1994; Dougherty RM., 1964, TECHNIQUES EXPT VIRO, P183; Duan F, 2012, CLIN EXP OPHTHALMOL, V40, P195, DOI 10.1111/j.1442-9071.2011.02668.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GIBSON W, 1972, J VIROL, V10, P1044, DOI 10.1128/JVI.10.5.1044-1052.1972; Henaff D, 2013, J VIROL, V87, P4895, DOI 10.1128/JVI.03292-12; Homa FL, 1997, REV MED VIROL, V7, P107, DOI 10.1002/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Kim HS, 2011, J VIROL, V85, P12698, DOI 10.1128/JVI.05791-11; Krautwald M, 2008, J GEN VIROL, V89, P1346, DOI 10.1099/vir.0.83652-0; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Lingappa VR, 2013, CURR PHARM BIOTECHNO, V14, P513, DOI 10.2174/13892010113149990201; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LJUNGMAN P, 1990, J INFECT DIS, V162, P244, DOI 10.1093/infdis/162.1.244; Vicentini FTMD, 2013, PHARM RES-DORDR, V30, P915, DOI 10.1007/s11095-013-0971-1; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; NEWCOMB WW, 1994, J VIROL, V68, P6059, DOI 10.1128/JVI.68.9.6059-6063.1994; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; Person S, 1998, VIROLOGY, V242, P193, DOI 10.1006/viro.1997.9005; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; POTTAGE JC, 1995, INFECT AGENT DIS, V4, P115; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rixon FJ, 1996, J GEN VIROL, V77, P2251, DOI 10.1099/0022-1317-77-9-2251; Robinson JL, 2012, EXPERT REV ANTI-INFE, V10, P675, DOI [10.1586/eri.12.55, 10.1586/ERI.12.55]; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Stevenson M, 2004, NEW ENGL J MED, V351, P1772, DOI 10.1056/NEJMra045004; Sundaram GSM, 2012, ORG LETT, V14, P3568, DOI 10.1021/ol300728a; TATMAN JD, 1994, J GEN VIROL, V75, P1101, DOI 10.1099/0022-1317-75-5-1101; THOMSEN DR, 1994, J VIROL, V68, P2442, DOI 10.1128/JVI.68.4.2442-2457.1994; THOMSEN DR, 1995, J VIROL, V69, P3690, DOI 10.1128/JVI.69.6.3690-3703.1995; van Velzen M, 2012, J INFECT DIS, V205, P1539, DOI 10.1093/infdis/jis237; Wadhwa R, 2004, MUTAT RES-REV MUTAT, V567, P71, DOI 10.1016/j.mrrev.2004.06.002; Wang Y, 2011, J CLIN VIROL, V52, P107, DOI 10.1016/j.jcv.2011.06.009; Weinberg A, 2007, J CLIN VIROL, V38, P139, DOI 10.1016/j.jcv.2006.08.023; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Wilson AC, 2012, TRENDS MICROBIOL, V20, P604, DOI 10.1016/j.tim.2012.08.005; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Zhe R, 2008, ARCH VIROL, V153, P1401, DOI 10.1007/s00705-008-0110-1; Zhong MG, 2013, RSC ADV, V3, P313, DOI 10.1039/c2ra21464d; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026	52	23	25	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96623	10.1371/journal.pone.0096623	http://dx.doi.org/10.1371/journal.pone.0096623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794394	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700119
J	Kwan, JC; Tianero, MDB; Donia, MS; Wyche, TP; Bugni, TS; Schmidt, EW				Kwan, Jason C.; Tianero, Ma Diarey B.; Donia, Mohamed S.; Wyche, Thomas P.; Bugni, Tim S.; Schmidt, Eric W.			Host Control of Symbiont Natural Product Chemistry in Cryptic Populations of the Tunicate Lissoclinum patella	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; COLONIAL ASCIDIANS; PROCHLORON; SEQUENCE; PEPTIDE; EVOLUTION; GENE; PHYLOGEOGRAPHY; MITOGENOMICS; METABOLITES	Natural products (secondary metabolites) found in marine invertebrates are often thought to be produced by resident symbiotic bacteria, and these products appear to play a major role in the symbiotic interaction of bacteria and their hosts. In these animals, there is extensive variation, both in chemistry and in the symbiotic bacteria that produce them. Here, we sought to answer the question of what factors underlie chemical variation in the ocean. As a model, we investigated the colonial tunicate Lissoclinum patella because of its rich and varied chemistry and its broad geographic range. We sequenced mitochondrial cytochrome c oxidase 1 (COXI) genes, and found that animals classified as L. patella fall into three phylogenetic groups that may encompass several cryptic species. The presence of individual natural products followed the phylogenetic relationship of the host animals, even though the compounds are produced by symbiotic bacteria that do not follow host phylogeny. In sum, we show that cryptic populations of animals underlie the observed chemical diversity, suggesting that the host controls selection for particular secondary metabolite pathways. These results imply novel approaches to obtain chemical diversity from the oceans, and also demonstrate that the diversity of marine natural products may be greatly impacted by cryptic local extinctions.	[Kwan, Jason C.; Tianero, Ma Diarey B.; Donia, Mohamed S.; Schmidt, Eric W.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Wyche, Thomas P.; Bugni, Tim S.] Univ Wisconsin, Div Pharmaceut Sci, Madison, WI USA	Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison	Schmidt, EW (corresponding author), Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA.	ews1@utah.edu	Kwan, Jason/F-9589-2010; Kwan, Jason/S-3497-2019	Kwan, Jason/0000-0001-9933-1536; Kwan, Jason/0000-0001-9933-1536	National Institutes of Health [GM092009]; National Science Foundation [0910812]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health Grant GM092009 and is based on work supported in part by National Science Foundation Grant 0910812 (Future Grid compute grid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Behrendt L, 2012, ISME J, V6, P1222, DOI 10.1038/ismej.2011.181; Bock DG, 2012, P ROY SOC B-BIOL SCI, V279, P2377, DOI 10.1098/rspb.2011.2610; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; Carroll AR, 1996, AUST J CHEM, V49, P659, DOI 10.1071/CH9960659; CORLEY DG, 1988, J AM CHEM SOC, V110, P7920, DOI 10.1021/ja00231a078; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Donia MS, 2006, NAT CHEM BIOL, V2, P729, DOI 10.1038/nchembio829; Donia MS, 2011, P NATL ACAD SCI USA, V108, pE1423, DOI 10.1073/pnas.1111712108; Donia MS, 2011, CHEMBIOCHEM, V12, P1230, DOI 10.1002/cbic.201000780; Donia MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017897; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; Gissi C, 2004, J MOL EVOL, V58, P376, DOI 10.1007/s00239-003-2559-6; Gissi C, 2010, MOL BIOL EVOL, V27, P211, DOI 10.1093/molbev/msp234; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hirose E, 2000, ZOOL SCI, V17, P233, DOI 10.2108/zsj.17.233; Hirose E, 2009, BACTERIOL RES DEV, P161; Hirose M, 2010, ZOOL SCI, V27, P959, DOI 10.2108/zsj.27.959; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Houssen WE, 2010, CHEMBIOCHEM, V11, P1803, DOI 10.1002/cbic.201000230; Iannelli F, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-155; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; Jones AC, 2011, P NATL ACAD SCI USA, V108, P8815, DOI 10.1073/pnas.1101137108; Kott Patricia, 2001, Memoirs of the Queensland Museum, V47, P1; Krzywinski M, 2012, BRIEF BIOINFORM, V13, P627, DOI 10.1093/bib/bbr069; Kuhl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00402; Kwan JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080822; Kwan JC, 2012, P NATL ACAD SCI USA, V109, P20655, DOI 10.1073/pnas.1213820109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McIntosh JA, 2010, J AM CHEM SOC, V132, P15499, DOI 10.1021/ja1067806; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Perez-Portela R, 2008, ZOOLOGY, V111, P163, DOI 10.1016/j.zool.2007.06.006; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RASHID MA, 1995, J NAT PRODUCTS, V58, P594, DOI 10.1021/np50118a020; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt EW, 2009, METHOD ENZYMOL, V458, P575, DOI 10.1016/S0076-6879(09)04823-X; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-534; Smith KF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030473; Stach T, 2010, MOL PHYLOGENET EVOL, V55, P860, DOI 10.1016/j.ympev.2010.03.011; Tarjuelo I, 2004, MOL ECOL, V13, P3125, DOI 10.1111/j.1365-294X.2004.02306.x; Tarjuelo I, 2001, MAR BIOL, V139, P455; Tianero MDB, 2012, J AM CHEM SOC, V134, P418, DOI 10.1021/ja208278k; White J, 2011, ROUTL FILM GUIDEBOOK, P1; Worheide G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-24; Worheide G, 2002, MOL ECOL, V11, P1753, DOI 10.1046/j.1365-294X.2002.01570.x; Yokobori S, 2005, MOL PHYLOGENET EVOL, V34, P273, DOI 10.1016/j.ympev.2004.10.002; Yokobori S, 2003, J MOL EVOL, V57, P574, DOI 10.1007/s00239-003-2511-9; Yokobori S, 1999, GENETICS, V153, P1851; Yokobori S, 2006, MOL PHYLOGENET EVOL, V40, P8, DOI 10.1016/j.ympev.2005.11.025	61	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e95850	10.1371/journal.pone.0095850	http://dx.doi.org/10.1371/journal.pone.0095850			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788869	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700041
J	Shibuya, KC; Goel, VK; Xiong, W; Sham, JG; Pollack, SM; Leahy, AM; Whiting, SH; Yeh, MM; Yee, C; Riddell, SR; Pillarisetty, VG				Shibuya, Kendall C.; Goel, Vikas K.; Xiong, Wei; Sham, Jonathan G.; Pollack, Seth M.; Leahy, Allison M.; Whiting, Samuel H.; Yeh, Matthew M.; Yee, Cassian; Riddell, Stanley R.; Pillarisetty, Venu G.			Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment	PLOS ONE			English	Article							T-CELLS; TUMOR MICROENVIRONMENT; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; SUPPRESSOR-CELLS; BONE-MARROW; TH17 CELLS; CANCER; CARCINOMA; GEMCITABINE	Objective: The immune response to pancreatic ductal adenocarcinoma (PDA) may play a role in defining its uniquely aggressive biology; therefore, we sought to clearly define the adaptive immune infiltrate in PDA. Design: We used immunohistochemistry and flow cytometry to characterize the immune infiltrate in human PDA and compared our findings to the patients' peripheral blood. Results: In contrast to the myeloid cell predominant infiltrate seen in murine models, T cells comprised the majority of the hematopoietic cell component of the tumor stroma in human PDA. Most intratumoral CD8(+) T cells exhibited an antigen-experienced effector memory cell phenotype and were capable of producing IFN-gamma. CD4(+) regulatory T cells (Treg) and IL-17 producing T helper cells were significantly more prevalent in tumor than in blood. Consistent with the association with reduced survival in previous studies, we observed higher frequencies of both myeloid cells and Treg in poorly differentiated tumors. The majority of intratumoral T cells expressed the co-inhibitory receptor programmed death-1 (PD-1), suggesting one potential mechanism through which PDA may evade antitumor immunity. Successful multimodal neoadjuvant therapy altered the immunoregulatory balance and was associated with reduced infiltration of both myeloid cells and Treg. Conclusion: Our data show that human PDA contains a complex mixture of inflammatory and regulatory immune cells, and that neoadjuvant therapy attenuates the infiltration of intratumoral cells associated with immunosuppression and worsened survival.	[Shibuya, Kendall C.; Pollack, Seth M.; Yee, Cassian; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Pollack, Seth M.; Whiting, Samuel H.; Yeh, Matthew M.; Yee, Cassian; Riddell, Stanley R.] Univ Washington, Dept Med, Seattle, WA USA; [Xiong, Wei; Yeh, Matthew M.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Goel, Vikas K.; Sham, Jonathan G.; Pillarisetty, Venu G.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Leahy, Allison M.] Seattle Canc Care Alliance, Seattle, WA USA; [Xiong, Wei] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Cancer Care Alliance; University of Calgary	Pillarisetty, VG (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	vgp@uw.edu	Pillarisetty, Venu/AAF-4425-2020; Pollack, Seth/ABI-1013-2020	Pillarisetty, Venu/0000-0002-1162-9643; 	NIH Cancer Center Support Grant [NIH R01 CA114536]; Fred Hutchinson/University of Washington Cancer Consortium; University of Washington Department of Surgery Research Reinvestment Fund; NATIONAL CANCER INSTITUTE [R01CA114536, K23CA175167] Funding Source: NIH RePORTER	NIH Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred Hutchinson/University of Washington Cancer Consortium; University of Washington Department of Surgery Research Reinvestment Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH Cancer Center Support Grant, NIH R01 CA114536 (SRR), Fred Hutchinson/University of Washington Cancer Consortium Startup Funding (VGP), and the University of Washington Department of Surgery Research Reinvestment Fund (VGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Crippa S, 2012, SURGERY, V152, pS112, DOI 10.1016/j.surg.2012.05.017; Fine RL, 2008, CANCER CHEMOTH PHARM, V61, P167, DOI 10.1007/s00280-007-0473-0; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Garnett CT, 2008, CLIN CANCER RES, V14, P3536, DOI 10.1158/1078-0432.CCR-07-4025; Geng L, 2008, J CANCER RES CLIN, V134, P1021, DOI 10.1007/s00432-008-0364-8; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Gnerlich JL, 2010, J IMMUNOL, V185, P4063, DOI 10.4049/jimmunol.0902609; Haeno H, 2012, CELL, V148, P362, DOI 10.1016/j.cell.2011.11.060; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; He SB, 2011, INT J MOL SCI, V12, P7424, DOI 10.3390/ijms12117424; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Homma Y, 2014, CLIN TRANSL ONCOL, V16, P330, DOI 10.1007/s12094-013-1079-0; Ikemoto T, 2006, PANCREAS, V33, P386, DOI 10.1097/01.mpa.0000240275.68279.13; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Katz SC, 2013, ANN SURG ONCOL, V20, P946, DOI 10.1245/s10434-012-2668-9; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Liyanage UK, 2006, J IMMUNOTHER, V29, P416, DOI 10.1097/01.cji.0000205644.43735.4e; Lyford-Pike S, 2013, CANCER RES, V73, P1733, DOI 10.1158/0008-5472.CAN-12-2384; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Plate JMD, 2005, CANCER IMMUNOL IMMUN, V54, P915, DOI 10.1007/s00262-004-0638-1; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Ryschich E, 2005, CLIN CANCER RES, V11, P498; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Schmitz-Winnenthal FH, 2005, CANCER RES, V65, P10079, DOI 10.1158/0008-5472.CAN-05-1098; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vincent J, 2010, CANCER RES, P3052; Vonderheide RH, 2013, CURR OPIN IMMUNOL, V25, P200, DOI 10.1016/j.coi.2013.01.006; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yoon HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042274	43	92	97	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96565	10.1371/journal.pone.0096565	http://dx.doi.org/10.1371/journal.pone.0096565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794217	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700114
J	Starossom, SC; Veremeyko, T; Dukhinova, M; Yung, AWY; Ponomarev, ED				Starossom, Sarah C.; Veremeyko, Tatyana; Dukhinova, Marina; Yung, Amanda W. Y.; Ponomarev, Eugene D.			Glatiramer Acetate (Copaxone) Modulates Platelet Activation and Inhibits Thrombin-Induced Calcium Influx: Possible Role of Copaxone in Targeting Platelets during Autoimmune Neuroinflammation	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; INFLAMMATION	Background: Glatiramer acetate (GA, Copaxone, Copolymer-1) is an FDA approved drug for the treatment of MS and it is very effective in suppressing neuroinflammation in experimental autoimmune encephalitis (EAE), an animal model of MS. Although this drug was designed to inhibit pathogenic T cells, the exact mechanism of EAE/MS suppression by GA is still not well understood. Previously we presented evidence that platelets become activated and promote neuroinflammation in EAE, suggesting a possible pathogenic role of platelets in MS and EAE. We hypothesized that GA could inhibit neuroinflammation by affecting not only immune cells but also platelets. Methodology/Principal Findings: We investigated the effect of GA on the activation of human platelets in vitro: calcium influx, platelet aggregation and expression of activation markers. Our results in human platelets were confirmed by in-vitro and in-vivo studies of modulation of functions of platelets in mouse model. We found that GA inhibited thrombin-induced calcium influx in human and mouse platelets. GA also decreased thrombin-induced CD31, CD62P, CD63, and active form of aIIbb3 integrin surface expression and formation of platelet aggregates for both mouse and human platelets, and prolonged the bleeding time in mice by 2.7-fold. In addition, we found that GA decreased the extent of macrophage activation induced by co-culture of macrophages with platelets. Conclusions: GA inhibited the activation of platelets, which suggests a new mechanism of GA action in suppression of EAE/MS by targeting platelets and possibly preventing their interaction with immune cells such as macrophages. Furthermore, the reduction in platelet activation by GA may have additional cardiovascular benefits to prevent thrombosis.	[Starossom, Sarah C.; Ponomarev, Eugene D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA; [Starossom, Sarah C.] Charite, Inst Med Immunol & NeuroCure, D-13353 Berlin, Germany; [Veremeyko, Tatyana; Dukhinova, Marina; Yung, Amanda W. Y.; Ponomarev, Eugene D.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chinese University of Hong Kong	Ponomarev, ED (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	eponomarev@cuhk.edu.hk	Dukhinova, Marina/ABF-9506-2021; Dukhinova, Marina/P-8167-2019; Ponomarev, Eugene D./K-1546-2013	Dukhinova, Marina/0000-0001-8118-9439; Ponomarev, Eugene D./0000-0002-0871-8522; Yung, Amanda WY/0000-0003-4265-9324; Starossom, Sarah/0000-0001-7935-9910	National Institute of Health Research [RO1 NS071039-01A1]; Lui Che Woo Institute of Innovative Medicine (LCWIIM) fund, BRAIN-Cognitive Disorders Program [8303111]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071039] Funding Source: NIH RePORTER	National Institute of Health Research(National Institute for Health Research (NIHR)); Lui Che Woo Institute of Innovative Medicine (LCWIIM) fund, BRAIN-Cognitive Disorders Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institute of Health Research Grant RO1 NS071039-01A1 and the Lui Che Woo Institute of Innovative Medicine (LCWIIM) fund, BRAIN-Cognitive Disorders Program (Project# 8303111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begum-Haque S, 2010, J NEUROIMMUNOL, V219, P47, DOI 10.1016/j.jneuroim.2009.11.016; Behari M, 2013, INT J NEUROSCI, V123, P287, DOI 10.3109/00207454.2012.751534; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Bosca I, 2006, J NEUROL, V253, P1370, DOI 10.1007/s00415-006-0233-9; CHRONOS NAF, 1993, CIRCULATION, V88, P2035, DOI 10.1161/01.CIR.88.5.2035; Elgart GW, 1997, J AM ACAD DERMATOL, V37, P553, DOI 10.1016/S0190-9622(97)70170-1; Greene TK, 2010, J THROMB HAEMOST, V8, P2820, DOI 10.1111/j.1538-7836.2010.04084.x; Horstman LL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-10; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Johnson KP, 2010, EXPERT OPIN DRUG MET, V6, P643, DOI 10.1517/17425251003752715; Johnson KP, 2000, MULT SCLER J, V6, P255, DOI 10.1191/135245800678827806; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Lang PA, 2008, NAT MED, V14, P756, DOI 10.1038/nm1780; Langer H., 2013, THROMB HAEMOST, V110; Langer HF, 2012, CIRC RES, V110, P1202, DOI 10.1161/CIRCRESAHA.111.256370; Lenting PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012174; Liu J, 2007, EUR J IMMUNOL, V37, P3143, DOI 10.1002/eji.200737398; Mantovani A, 2013, NAT IMMUNOL, V14, P768, DOI 10.1038/ni.2666; Moroi M, 1996, BLOOD, V88, P2081, DOI 10.1182/blood.V88.6.2081.bloodjournal8862081; Nakano Y, 2002, CARDIOVASC RES, V53, P634, DOI 10.1016/S0008-6363(01)00410-2; Scull CM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-53; Segal JB, 2006, J THROMB HAEMOST, V4, P2377, DOI 10.1111/j.1538-7836.2006.02147.x; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Sheremata WA, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-27; Sotnikov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058979; Stefanini L, 2014, BLOOD; Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; WRIGHT HP, 1965, LANCET, V2, P1109	29	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96256	10.1371/journal.pone.0096256	http://dx.doi.org/10.1371/journal.pone.0096256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788965	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700069
J	Pronin, A; Levay, K; Velmeshev, D; Faghihi, M; Shestopalov, VI; Slepak, VZ				Pronin, Alexey; Levay, Konstantin; Velmeshev, Dmitry; Faghihi, Mohammad; Shestopalov, Valery I.; Slepak, Vladlen Z.			Expression of Olfactory Signaling Genes in the Eye	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MARKER PROTEIN; SYSTEM; TOPHAT; GOLF	Purpose: To advance our understanding how the outer eye interacts with its environment, we asked which cellular receptors are expressed in the cornea, focusing on G protein-coupled receptors. Methods: Total RNA from the mouse cornea was subjected to next-generation sequencing using the Illumina platform. The data was analyzed with TopHat and CuffLinks software packages. Expression of a representative group of genes detected by RNA-seq was further analyzed by RT-PCR and in situ hybridization using RNAscope technology and fluorescent microscopy. Results: We generated more than 46 million pair-end reads from mouse corneal RNA. Bioinformatics analysis revealed that the mouse corneal transcriptome reconstructed from these reads represents over 10,000 gene transcripts. We identified 194 GPCR transcripts, of which 96 were putative olfactory receptors. RT-PCR analysis confirmed the presence of several olfactory receptors and related genes, including olfactory marker protein and the G protein associated with olfaction, G alpha olf. In situ hybridization showed that mRNA for olfactory marker protein, G alpha olf and possibly some olfactory receptors were found in the corneal epithelial cells. In addition to the corneal epithelium, G alpha olf was present in the ganglionic and inner nuclear layers of the retina. One of the olfactory receptors, Olfr558, was present primarily in vessels of the eye co-stained with antibodies against alpha-smooth muscle actin, indicating expression in arterioles. Conclusions: Several species of mRNA encoding putative olfactory receptors and related genes are expressed in the mouse cornea and other parts of the eye indicating they may play a role in sensing chemicals in the ocular environment.	[Pronin, Alexey; Levay, Konstantin; Slepak, Vladlen Z.] Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; [Velmeshev, Dmitry; Faghihi, Mohammad] Univ Miami, Sch Med, Dept Psychiat & Behav Sci, Miami, FL USA; [Pronin, Alexey; Shestopalov, Valery I.] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL USA	University of Miami; University of Miami; Bascom Palmer Eye Institute; University of Miami	Pronin, A (corresponding author), Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA.	a.pronin@med.miami.edu; vslepak@med.miami.edu	Shestopalov, Valery/AAE-9838-2020; Faghihi, Mohammad Ali/AAD-7159-2020; Faghihi, Mohammad Ali/AAH-3139-2019	Faghihi, Mohammad Ali/0000-0002-8330-9067; Shestopalov, Valery/0000-0002-1568-6637; Velmeshev, Dmitry/0000-0002-6491-7307	NIH [EY021517, EY018666, P30 EY014801]; RPB; NATIONAL EYE INSTITUTE [R01EY018666, R01EY021517, R21EY017991, P30EY014801] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RPB(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY021517 (VIS), EY018666 (VZS), P30 EY014801 and RPB unrestricted grant to U. Miami Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Allen JA, 2011, ANNU REV PHARMACOL, V51, P117, DOI 10.1146/annurev-pharmtox-010510-100553; BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Bazan HEP, 2002, PROG RETIN EYE RES, V21, P449, DOI 10.1016/S1350-9462(02)00011-3; Buiakova OI, 1996, P NATL ACAD SCI USA, V93, P9858, DOI 10.1073/pnas.93.18.9858; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Foster SR, 2013, PHARM THERAPEUTICS; Ghoghawala SY, 2008, INVEST OPHTH VIS SCI, V49, P1857, DOI 10.1167/iovs.07-0925; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; HERVE D, 1995, MOL BRAIN RES, V32, P125, DOI 10.1016/0169-328X(95)00070-9; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kenchegowda S, 2010, J LIPID RES, V51, P879, DOI 10.1194/jlr.R001347; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lee AC, 2011, J NEUROSCI, V31, P2974, DOI 10.1523/JNEUROSCI.5067-10.2011; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Liu SH, 2007, INVEST OPHTH VIS SCI, V48, P2987, DOI 10.1167/iovs.06-0880; Manteniotis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079523; Matsunami H, 2009, ANN NY ACAD SCI, V1170, P153, DOI 10.1111/j.1749-6632.2009.03888.x; McIntyre JC, 2008, CHEM SENSES, V33, P825, DOI 10.1093/chemse/bjn061; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pearlman E, 2008, OCUL SURF, V6, P108, DOI 10.1016/S1542-0124(12)70279-3; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Pullar CE, 2007, J CELL PHYSIOL, V211, P261, DOI 10.1002/jcp.20934; Redfern RL, 2010, EXP EYE RES, V90, P679, DOI 10.1016/j.exer.2010.03.012; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; TANAKA H, 1985, J CELL PHYSIOL, V123, P191, DOI 10.1002/jcp.1041230206; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu Y, 2010, GENOMICS, V96, P281, DOI 10.1016/j.ygeno.2010.08.003	38	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e96435	10.1371/journal.pone.0096435	http://dx.doi.org/10.1371/journal.pone.0096435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24789354	Green Published, gold, Green Submitted			2022-12-27	WOS:000338917300042
J	Grosso, G; Pajak, A; Marventano, S; Castellano, S; Galvano, F; Bucolo, C; Drago, F; Caraci, F				Grosso, Giuseppe; Pajak, Andrzej; Marventano, Stefano; Castellano, Sabrina; Galvano, Fabio; Bucolo, Claudio; Drago, Filippo; Caraci, Filippo			Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; ETHYL-EICOSAPENTAENOIC ACID; PLACEBO-CONTROLLED TRIAL; SUPPLEMENTATION LOWERS INFLAMMATION; MILD COGNITIVE IMPAIRMENT; FISH-OIL SUPPLEMENTATION; PRELIMINARY DOUBLE-BLIND; QUALITY-OF-LIFE; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE	Background: Despite omega-3 polyunsaturated fatty acids (PUFA) supplementation in depressed patients have been suggested to improve depressive symptomatology, previous findings are not univocal. Objectives: To conduct an updated meta-analysis of randomized controlled trials (RCTs) of omega-3 PUFA treatment of depressive disorders, taking into account the clinical differences among patients included in the studies. Methods: A search on MEDLINE, EMBASE, PsycInfo, and the Cochrane Database of RCTs using omega-3 PUFA on patients with depressive symptoms published up to August 2013 was performed. Standardized mean difference in clinical measure of depression severity was primary outcome. Type of omega-3 used (particularly eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and omega-3 as mono-or adjuvant therapy was also examined. Meta-regression analyses assessed the effects of study size, baseline depression severity, trial duration, dose of omega-3, and age of patients. Results: Meta-analysis of 11 and 8 trials conducted respectively on patients with a DSM-defined diagnosis of major depressive disorder (MDD) and patients with depressive symptomatology but no diagnosis of MDD demonstrated significant clinical benefit of omega-3 PUFA treatment compared to placebo (standardized difference in random-effects model 0.56 SD [95% CI: 0.20, 0.92] and 0.22 SD [95% CI: 0.01, 0.43], respectively; pooled analysis was 0.38 SD [95% CI: 0.18, 0.59]). Use of mainly EPA within the preparation, rather than DHA, influenced final clinical efficacy. Significant clinical efficacy had the use of omega-3 PUFA as adjuvant rather than mono-therapy. No relation between efficacy and study size, baseline depression severity, trial duration, age of patients, and study quality was found. Omega-3 PUFA resulted effective in RCTs on patients with bipolar disorder, whereas no evidence was found for those exploring their efficacy on depressive symptoms in young populations, perinatal depression, primary disease other than depression and healthy subjects. Conclusions: The use of omega-3 PUFA is effective in patients with diagnosis of MDD and on depressive patients without diagnosis of MDD.	[Grosso, Giuseppe; Castellano, Sabrina; Galvano, Fabio; Bucolo, Claudio; Drago, Filippo] Univ Catania, Sect Pharmacol & Biochem, Dept Clin & Mol Biomed, Catania, Italy; [Pajak, Andrzej] Jagiellonian Univ, Coll Med, Dept Epidemiol & Populat Studies, Krakow, Poland; [Marventano, Stefano] Univ Catania, Sect Hyg & Publ Hlth, Dept GF Ingrassia, Catania, Italy; [Caraci, Filippo] Univ Catania, Dept Educ Sci, Catania, Italy; [Caraci, Filippo] IRCCS Assoc Oasi Maria SS, Inst Res Mental Retardat & Brain Aging, Troina, Enna, Italy	University of Catania; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Catania; University of Catania; IRCCS Oasi Maria SS	Grosso, G (corresponding author), Univ Catania, Sect Pharmacol & Biochem, Dept Clin & Mol Biomed, Catania, Italy.	giuseppe.grosso@studium.unict.it	Grosso, Giuseppe/ABA-1587-2020; Caraci, Filippo/K-2262-2016; Grosso, Giuseppe/K-6730-2016; Drago, Filippo/AAC-5090-2022; Galvano, Fabio/F-8122-2010; Castellano, Sabrina/GYI-8462-2022; Drago, Francesco/H-7563-2019; Drago, Filippo/K-5619-2018	Grosso, Giuseppe/0000-0003-3930-5285; Caraci, Filippo/0000-0002-9867-6054; Grosso, Giuseppe/0000-0003-3930-5285; Galvano, Fabio/0000-0003-0644-0755; Drago, Filippo/0000-0003-2887-5223; Marventano, Stefano/0000-0002-5985-7274; Bucolo, Claudio/0000-0002-4879-4140	International Ph.D. Program in Neuropharmacology, University of Catania, Catania, Italy	International Ph.D. Program in Neuropharmacology, University of Catania, Catania, Italy	Giuseppe Grosso and Sabrina Castellano were supported by the International Ph.D. Program in Neuropharmacology, University of Catania, Catania, Italy. The contributors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; Andreeva VA, 2012, AM J CLIN NUTR, V96, P208, DOI 10.3945/ajcn.112.035253; Antypa N, 2009, J PSYCHOPHARMACOL, V23, P831, DOI 10.1177/0269881108092120; Antypa N, 2012, J PSYCHOPHARMACOL, V26, P738, DOI 10.1177/0269881111424928; Appleton KM, 2006, AM J CLIN NUTR, V84, P1308, DOI 10.1093/ajcn/84.6.1308; Appleton KM, 2010, AM J CLIN NUTR, V91, P757, DOI 10.3945/ajcn.2009.28313; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Assies J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010635; Association AP, 2000, DIAGN STAT MAN MENT, P317; Balanza-Martinez V, 2011, EXPERT REV NEUROTHER, V11, P1029, DOI [10.1586/ERN.11.42, 10.1586/ern.11.42]; Barbui C, 2011, BRIT J PSYCHIAT, V198, P11, DOI 10.1192/bjp.bp.109.076448; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1978, DEPRESSION INVENTORY; Beezhold BL, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-9; BEHAN PO, 1990, ACTA NEUROL SCAND, V82, P209, DOI 10.1111/j.1600-0404.1990.tb04490.x; Bhattacharya A, 2007, J NUTR BIOCHEM, V18, P23, DOI 10.1016/j.jnutbio.2006.02.005; Bloch MH, 2012, MOL PSYCHIATR, V17, P1272, DOI 10.1038/mp.2011.100; Bot M, 2010, J AFFECT DISORDERS, V126, P282, DOI 10.1016/j.jad.2010.04.008; Bot M, 2011, NEUROPSYCHOBIOLOGY, V63, P219, DOI 10.1159/000321804; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Bradburn, 2001, SYSTEMATIC REV HLTH, DOI DOI 10.1002/9780470693926.CH15; Brooks JD, 2008, J BIOL CHEM, V283, P12043, DOI 10.1074/jbc.M800122200; Bylund DB, 2007, NEUROCHEM INT, V51, P246, DOI 10.1016/j.neuint.2007.06.025; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Caraci F, 2012, EUR NEUROPSYCHOPHARM, V22, P281, DOI 10.1016/j.euroneuro.2011.08.006; Caraci F, 2012, CELL TISSUE RES, V347, P291, DOI 10.1007/s00441-011-1230-6; Caraci F, 2011, CNS NEUROSCI THER, V17, P237, DOI 10.1111/j.1755-5949.2009.00115.x; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Carney RM, 2009, JAMA-J AM MED ASSOC, V302, P1651, DOI 10.1001/jama.2009.1487; Chang Chia-Yu, 2009, Acta Neurol Taiwan, V18, P231; Chiu CC, 2005, J CLIN PSYCHIAT, V66, P1613, DOI 10.4088/JCP.v66n1219b; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Clayton EH, 2009, EUR J CLIN NUTR, V63, P1037, DOI 10.1038/ejcn.2008.81; Cox GR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008324.pub2; da Silva TM, 2008, J AFFECT DISORDERS, V111, P351, DOI 10.1016/j.jad.2008.03.008; DeFina LF, 2011, AM J CLIN NUTR, V93, P455, DOI 10.3945/ajcn.110.002741; Do DP, 2010, PSYCHOSOM MED, V72, P613, DOI 10.1097/PSY.0b013e3181e2cca5; Doornbos B, 2009, PROG NEURO-PSYCHOPH, V33, P49, DOI 10.1016/j.pnpbp.2008.10.003; Fenton WS, 2001, AM J PSYCHIAT, V158, P2071, DOI 10.1176/appi.ajp.158.12.2071; Fontani G, 2005, EUR J CLIN INVEST, V35, P499, DOI 10.1111/j.1365-2362.2005.01540.x; Frangou S, 2006, BRIT J PSYCHIAT, V188, P46, DOI 10.1192/bjp.188.1.46; Frangou S, 2007, J PSYCHOPHARMACOL, V21, P435, DOI 10.1177/0269881106067787; Frasure-Smith N, 2004, BIOL PSYCHIAT, V55, P891, DOI 10.1016/j.biopsych.2004.01.021; Freeman MP, 2008, J AFFECT DISORDERS, V110, P142, DOI 10.1016/j.jad.2007.12.228; Freeman MP, 2006, J CLIN PSYCHIAT, V67, P1954, DOI 10.4088/JCP.v67n1217; Freund-Levi Y, 2008, INT J GERIATR PSYCH, V23, P161, DOI 10.1002/gps.1857; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Fux M, 2004, J PSYCHIATR RES, V38, P323, DOI 10.1016/S0022-3956(03)00077-3; Gao F, 2009, J LIPID RES, V50, P2463, DOI 10.1194/jlr.M900223-JLR200; Geddes JR, 2013, LANCET, V381, P1672, DOI 10.1016/S0140-6736(13)60857-0; Gertsik L, 2012, J CLIN PSYCHOPHARM, V32, P61, DOI 10.1097/JCP.0b013e31823f3b5f; Giltay EJ, 2004, AM J CLIN NUTR, V80, P1167, DOI 10.1093/ajcn/80.5.1167; Giltay EJ, 2011, AM J CLIN NUTR, V94, P1442, DOI 10.3945/ajcn.111.018259; Gracious BL, 2010, BIPOLAR DISORD, V12, P142, DOI 10.1111/j.1399-5618.2010.00799.x; Grenyer BFS, 2007, PROG NEURO-PSYCHOPH, V31, P1393, DOI 10.1016/j.pnpbp.2007.06.004; Grosso G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/313570; Hallahan B, 2007, BRIT J PSYCHIAT, V190, P118, DOI 10.1192/bjp.bp.106.022707; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hennebelle M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042142; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirashima F, 2004, AM J PSYCHIAT, V161, P1922, DOI 10.1176/appi.ajp.161.10.1922; Iovieno N, 2012, J CLIN PSYCHIAT, V73, P1300, DOI 10.4088/JCP.11r07485; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jazayeri S, 2008, AUST NZ J PSYCHIAT, V42, P192, DOI 10.1080/00048670701827275; Keck PE, 2006, BIOL PSYCHIAT, V60, P1020, DOI 10.1016/j.biopsych.2006.03.056; Kiecolt-Glaser JK, 2012, BRAIN BEHAV IMMUN, V26, P988, DOI 10.1016/j.bbi.2012.05.011; Kiecolt-Glaser JK, 2011, BRAIN BEHAV IMMUN, V25, P1725, DOI 10.1016/j.bbi.2011.07.229; Kotwal S, 2012, CIRC-CARDIOVASC QUAL, V5, P808, DOI 10.1161/CIRCOUTCOMES.112.966168; Krauss-Etschmann S, 2007, AM J CLIN NUTR, V85, P1392; Lin PY, 2012, MOL PSYCHIATR, V17, P1161, DOI 10.1038/mp.2012.111; Lin PY, 2007, J CLIN PSYCHIAT, V68, P1056, DOI 10.4088/JCP.v68n0712; Llorente AM, 2003, AM J OBSTET GYNECOL, V188, P1348, DOI 10.1067/mob.2003.275; Lucas M, 2009, AM J CLIN NUTR, V89, P641, DOI 10.3945/ajcn.2008.26749; Machado-Vieira R, 2012, MOL MED REP, V6, P915, DOI 10.3892/mmr.2012.1062; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507; Marangell LB, 2006, PROSTAG LEUKOTR ESS, V75, P315, DOI 10.1016/j.plefa.2006.07.008; Marangell LB, 2003, AM J PSYCHIAT, V160, P996, DOI 10.1176/appi.ajp.160.5.996; Markhus MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067617; Martins JG, 2012, MOL PSYCHIATR, V17, P1144, DOI 10.1038/mp.2012.25; Martins JG, 2009, J AM COLL NUTR, V28, P525, DOI 10.1080/07315724.2009.10719785; Mattes E, 2009, BRAIN BEHAV IMMUN, V23, P380, DOI 10.1016/j.bbi.2008.12.004; Mischoulon D, 2009, J CLIN PSYCHIAT, V70, P1636, DOI 10.4088/JCP.08m04603; Mocking RJT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049431; Montgomery P, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005169.pub2; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mozaffari-Khosravi H, 2013, EUR NEUROPSYCHOPHARM, V23, P636, DOI 10.1016/j.euroneuro.2012.08.003; Mozurkewich EL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.038; Nemets B, 2002, AM J PSYCHIAT, V159, P477, DOI 10.1176/appi.ajp.159.3.477; Nemets H, 2006, AM J PSYCHIAT, V163, P1098, DOI 10.1176/appi.ajp.163.6.1098; Ness AR, 2003, NUTR NEUROSCI, V6, P63, DOI 10.1080/1028415021000056069; Otto SJ, 2003, PROSTAG LEUKOTR ESS, V69, P237, DOI 10.1016/S0952-3278(03)00090-5; Parker GB, 2006, PSYCHIAT RES, V141, P279, DOI 10.1016/j.psychres.2005.08.005; Peet M, 2002, J PSYCHIAT RES, V36, P7, DOI 10.1016/S0022-3956(01)00048-6; Peet M, 2002, ARCH GEN PSYCHIAT, V59, P913, DOI 10.1001/archpsyc.59.10.913; Picardi A, 2009, CURR OPIN PSYCHIATR, V22, P42, DOI 10.1097/YCO.0b013e328315a4d2; PUOLAKKA J, 1985, J REPROD MED, V30, P149; Rees AM, 2008, AUST NZ J PSYCHIAT, V42, P199, DOI 10.1080/00048670701827267; Rees AM, 2009, PSYCHIAT RES, V166, P254, DOI 10.1016/j.psychres.2007.12.011; Rizzo AM, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-82; Rogers PJ, 2008, BRIT J NUTR, V99, P421, DOI 10.1017/S0007114507801097; Rondanelli M, 2011, J NUTR HEALTH AGING, V15, P37, DOI 10.1007/s12603-011-0011-y; Rondanelli M, 2010, J AM COLL NUTR, V29, P55, DOI 10.1080/07315724.2010.10719817; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Salomone S, 2012, BRIT J CLIN PHARMACO, V73, P504, DOI 10.1111/j.1365-2125.2011.04134.x; Sampalis Fotini, 2003, Altern Med Rev, V8, P171; Sarris J, 2012, J CLIN PSYCHIAT, V73, P81, DOI 10.4088/JCP.10r06710; Schins A, 2007, ACTA PSYCHIAT SCAND, V115, P35, DOI 10.1111/j.1600-0447.2006.00830.x; Severus WE, 2001, HARVARD REV PSYCHIAT, V9, P280, DOI 10.1093/hrp/9.6.280; Sierra S, 2008, NUTRITION, V24, P245, DOI 10.1016/j.nut.2007.11.005; Silvers KM, 2005, PROSTAG LEUKOTR ESS, V72, P211, DOI 10.1016/j.plefa.2004.11.004; Sinn N, 2012, BRIT J NUTR, V107, P1682, DOI 10.1017/S0007114511004788; Sohrabi N, 2013, COMPLEMENT THER MED, V21, P141, DOI 10.1016/j.ctim.2012.12.008; Souery D, 2006, J CLIN PSYCHIAT, V67, P16; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stoll AL, 1999, ARCH GEN PSYCHIAT, V56, P407, DOI 10.1001/archpsyc.56.5.407; Su KP, 2003, EUR NEUROPSYCHOPHARM, V13, P267, DOI 10.1016/S0924-977X(03)00032-4; Su KP, 2008, J CLIN PSYCHIAT, V69, P644, DOI 10.4088/JCP.v69n0418; Sublette ME, 2011, J CLIN PSYCHIAT, V72, P1577, DOI 10.4088/JCP.10m06634; Tajalizadekhoob Y, 2011, EUR ARCH PSY CLIN N, V261, P539, DOI 10.1007/s00406-011-0191-9; Umhau JC, 2006, EUR J CLIN NUTR, V60, P352, DOI 10.1038/sj.ejcn.1602321; van de Rest O, 2008, AM J CLIN NUTR, V88, P706, DOI 10.1093/ajcn/88.3.706; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Warren G, 1999, ACTA NEUROL SCAND, V99, P112, DOI 10.1111/j.1600-0404.1999.tb00667.x; Zanarini MC, 2003, AM J PSYCHIAT, V160, P167, DOI 10.1176/appi.ajp.160.1.167; Zhao Y, 2004, J AM COLL NUTR, V23, P71, DOI 10.1080/07315724.2004.10719345	128	285	288	3	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96905	10.1371/journal.pone.0096905	http://dx.doi.org/10.1371/journal.pone.0096905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805797	Green Published, gold			2022-12-27	WOS:000335728900116
J	Iovine, B; Oliviero, G; Garofalo, M; Orefice, M; Nocella, F; Borbone, N; Piccialli, V; Centore, R; Mazzone, M; Piccialli, G; Bevilacqua, MA				Iovine, Barbara; Oliviero, Giorgia; Garofalo, Mariangela; Orefice, Maria; Nocella, Francesca; Borbone, Nicola; Piccialli, Vincenzo; Centore, Roberto; Mazzone, Massimiliano; Piccialli, Gennaro; Bevilacqua, Maria Assunta			The Anti-Proliferative Effect of L-Carnosine Correlates with a Decreased Expression of Hypoxia Inducible Factor 1 alpha in Human Colon Cancer Cells	PLOS ONE			English	Article							MITOCHONDRIAL ROS; NITRIC-OXIDE; HIF-1-ALPHA; GROWTH; OVEREXPRESSION; ANTIOXIDANTS; TARGET; ATP	In recent years considerable attention has been given to the use of natural substances as anticancer drugs. The natural antioxidant dipeptide L-carnosine belongs to this class of molecules because it has been proved to have a significant anticancer activity both in vitro and in vivo. Previous studies have shown that L-carnosine inhibits the proliferation of human colorectal carcinoma cells by affecting the ATP and Reactive Oxygen Species (ROS) production. In the present study we identified the Hypoxia-Inducible Factor 1 alpha (HIF-1 alpha) as a possible target of L-carnosine in HCT-116 cell line. HIF-1 alpha protein is over-expressed in multiple types of human cancer and is the major cause of resistance to drugs and radiation in solid tumours. Of particular interest are experimental data supporting the concept that generation of ROS provides a redox signal for HIF-1a induction, and it is known that some antioxidants are able to suppress tumorigenesis by inhibiting HIF-1 alpha. In the current study we found that L-carnosine reduces the HIF-1 alpha protein level affecting its stability and decreases the HIF-1 transcriptional activity. In addition, we demonstrated that L-carnosine is involved in ubiquitin-proteasome system promoting HIF-1 alpha degradation. Finally, we compared the antioxidant activity of L-carnosine with that of two synthetic antioxidant bis-diaminotriazoles (namely 1 and 2, respectively). Despite these three compounds have the same ability in reducing intracellular ROS, 1 and 2 are more potent scavengers and have no effect on HIF-1 alpha expression and cancer cell proliferation. These findings suggest that an analysis of L-carnosine antioxidant pathway will clarify the mechanism underlying the anti-proliferative effects of this dipeptide on colon cancer cells. However, although the molecular mechanism by which L-carnosine down regulates or inhibits the HIF-1 alpha activity has not been yet elucidated, this ability may be promising in treating hypoxia-related diseases.	[Iovine, Barbara; Garofalo, Mariangela; Orefice, Maria; Nocella, Francesca; Bevilacqua, Maria Assunta] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Oliviero, Giorgia; Borbone, Nicola; Piccialli, Gennaro] Univ Naples Federico II, Dipartimento Farm, Naples, Italy; [Piccialli, Vincenzo; Centore, Roberto] Univ Naples Federico II, Dipartimento Sci Chim, Naples, Italy; [Mazzone, Massimiliano] Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Louvain, Belgium; [Mazzone, Massimiliano] Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Dept Oncol, Louvain, Belgium	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Bevilacqua, MA (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.	mabevil@unina.it	Garofalo, Mariangela/Q-9469-2018; Centore, Roberto/AID-6711-2022; Borbone, Nicola/A-6061-2009; Oliviero, Giorgia/M-9020-2014; Centore, Roberto/AAS-1871-2020	Garofalo, Mariangela/0000-0002-5001-7826; Borbone, Nicola/0000-0003-0216-9814; Oliviero, Giorgia/0000-0003-0765-2127; Mazzone, Massimiliano/0000-0001-8824-4015	Finanziamento per l'Avvio di Ricerche Originali; Italian Ministero dell'Universita` e della Ricerca	Finanziamento per l'Avvio di Ricerche Originali; Italian Ministero dell'Universita` e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the "Finanziamento per l'Avvio di Ricerche Originali'', Universita` degli Studi di Napoli Federico II, GO. "Progetti di Ricerca di Rilevante Interesse Nazionale'' grant 2009 from the Italian Ministero dell'Universita` e della Ricerca, GO NB GP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Asperger A, 2011, CANCER INVEST, V29, P272, DOI 10.3109/07357907.2010.550666; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015062; Bharadwaj LA, 2002, PHARMACOL RES, V45, P175, DOI 10.1006/phrs.2001.0911; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Brownson C, 2000, FREE RADICAL BIO MED, V28, P1564, DOI 10.1016/S0891-5849(00)00270-7; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Centore R, 2011, STRUCT CHEM, V22, P1095, DOI 10.1007/s11224-011-9805-0; Chun SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-293; Comito G, 2011, FREE RADICAL BIO MED, V51, P893, DOI 10.1016/j.freeradbiomed.2011.05.042; De Marino S, 2005, PLANTA MED, V71, P706, DOI 10.1055/s-2005-864191; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P7972, DOI 10.1158/1078-0432.CCR-04-1068; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hatakeyama K, 2011, PROTEOMICS, V11, P2275, DOI 10.1002/pmic.201100016; Iovine B, 2012, INT J MOL SCI, V13, P16444, DOI 10.3390/ijms131216444; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Iovine B, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/692846; Iovine B, 2011, BIOCHIMIE, V93, P867, DOI 10.1016/j.biochi.2010.12.017; Iovine B, 2009, BIOCHIMIE, V91, P364, DOI 10.1016/j.biochi.2008.10.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kimura S, 2004, EUR J CANCER, V40, P1904, DOI 10.1016/j.ejca.2004.04.035; Liu LL, 2008, CANCER SCI, V99, P121, DOI 10.1111/j.1349-7006.2007.00643.x; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Powis G, 2004, MOL CANCER THER, V3, P647; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Schindl M, 2002, CLIN CANCER RES, V8, P1831; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Welsh SJ, 2002, CANCER RES, V62, P5089	34	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96755	10.1371/journal.pone.0096755	http://dx.doi.org/10.1371/journal.pone.0096755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804733	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900091
J	MacDougall, MJ; LeBlanc, ARH; Reisz, RR				MacDougall, Mark J.; LeBlanc, Aaron R. H.; Reisz, Robert R.			Plicidentine in the Early Permian Parareptile Colobomycter pholeter, and Its Phylogenetic and Functional Significance among Coeval Members of the Clade	PLOS ONE			English	Article							OKLAHOMA; REPTILE; ORIGIN; TEETH	Once thought to be an exclusively anamniote characteristic, plicidentine, a pattern of infolding of dentine, is now known to be found in various amniote clades, including Parareptilia. In the absence of detailed analyses of parareptilian dentition, most parareptiles were assumed to lack plicidentine due to the absence of external indicators, such as plications on the tooth base. The clear presence of this dentinal feature in the largest premaxillary and maxillary teeth of Colobomycter pholeter, led us to the present detailed study within the dentition of this unusual parareptile, and those of coeval members of this clade. Our study reveals that there is large variability in the degree of dentine infolding within C. pholeter dentition, as well as within those of closely related parareptiles. This variability ranges from a lack of plications, to very complex anamniote-like plicidentine. Utilizing computed tomography scans in conjunction with histological sections we also demonstrate the utility of computed tomography scans in conducting non-destructive sampling in the identification of plicidentine. Given the variability of plicidentine in this sample of parareptiles, we hypothesize that one function of parareptilian plicidentine is to increase the surface area for attachment tissues, and we suggest that the use of plicidentine as a character in phylogenetic analyses of parareptiles may be misleading.	[MacDougall, Mark J.; LeBlanc, Aaron R. H.; Reisz, Robert R.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Toronto; University Toronto Mississauga	MacDougall, MJ (corresponding author), Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada.	mark.macdougall@mail.utoronto.ca		LeBlanc, Aaron/0000-0002-2497-1296	National Science and Engineering Research Council of Canada (NSERC)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by the National Science and Engineering Research Council of Canada (NSERC: www.nserc-crsng.gc.ca). Both MM and AL hold NSERC Postgraduate Scholarships-Doctoral (PGS-D). RR holds an NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besmer A., 1947, SCHWEIZ PALAEONTOL A, V65, P1; Bulanov VV, 2002, PALEONTOL J, P36; Cabreira SF, 2009, ACTA PALAEONTOL POL, V54, P743, DOI 10.4202/app.2008.0047; de Ricqles A., 1983, Journal of Vertebrate Paleontology, V3, P7, DOI 10.1080/02724634.1983.10011952; Edmund AG, 1969, DENTITION BIOL REPTI, P119; FOX RICHARD C., 1962, UNIV KANSAS PUBL MUS NAT HIST, V12, P297; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; IVACHNENKO MF, 1979, T PALEONTOLOGISHESKO, V164, P1; Kearney M, 2006, COPEIA, P337, DOI 10.1643/0045-8511(2006)2006[337:AIITOO]2.0.CO;2; LAURIN M, 1995, ZOOL J LINN SOC-LOND, V113, P165, DOI 10.1111/j.1096-3642.1995.tb00932.x; LeBlanc ARH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074697; LEE MSY, 1995, BIOL REV, V70, P459, DOI 10.1111/j.1469-185X.1995.tb01197.x; Macdougall MJ, 2012, J VERTEBR PALEONTOL, V32, P1018, DOI 10.1080/02724634.2012.679757; Macdougall MJ, 2011, J VERTEBR PALEONTOL, V31, P270, DOI 10.1080/02724634.2011.549436; Maxwell EE, 2011, J VERTEBR PALEONTOL, V31, P553, DOI 10.1080/02724634.2011.557117; MAZIN J-M, 1981, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V3, P317; Meunier FJ, ACTA ZOOL IN PRESS; Meunier FJ, 2013, CYBIUM, V37, P263; Modesto S, 2001, P ROY SOC B-BIOL SCI, V268, P2047, DOI 10.1098/rspb.2001.1766; Modesto SP, 2008, J VERTEBR PALEONTOL, V28, P677, DOI 10.1671/0272-4634(2008)28[677:NMOCPA]2.0.CO;2; Modesto SP, 1999, J VERTEBR PALEONTOL, V19, P466, DOI 10.1080/02724634.1999.10011159; Modesto SP, 2003, J VERTEBR PALEONTOL, V23; Muller J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000889; OWEN R, 1841, T GEOLOGICAL SOC, V2, P505; Peyer B, 1968, COMP ODONTOLOGY; Pretto FA, 2014, ACTA PALAEONTOL POL, V59, P125, DOI 10.4202/app.2011.0121; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; Reisz RR, 2002, J VERTEBR PALEONTOL, V22, P23, DOI 10.1671/0272-4634(2002)022[0023:ANEPBR]2.0.CO;2; Reisz RR, J VERTEBR P IN PRESS; SaiIa LK, 2010, J IBER GEOL, V36, P123, DOI 10.5209/rev_JIGE.2010.v36.n2.2; Sander P. Martin, 1999, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V38, P1; SAVAGE R J G, 1977, Palaeontology (Oxford), V20, P237; Scanlon JD, 2002, J HERPETOL, V36, P100; Schultze H-P., 1970, Am. Mus. Novit., VNo. 2408, P1; Tsuji LA, 2006, J VERTEBR PALEONTOL, V26, P849, DOI 10.1671/0272-4634(2006)26[849:CAAPAO]2.0.CO;2; Tsuji LA, 2010, J SYST PALAEONTOL, V8, P245, DOI 10.1080/14772010903461099; Tsuji LA, 2009, FOSS REC, V12, P71, DOI 10.1002/mmng.200800011; VAUGHN PP, 1958, J PALEONTOL, V32, P981; Warren A, 2005, T ROY SOC EDIN-EARTH, V96, P113, DOI 10.1017/S0263593300001267; WARREN AA, 1992, ALCHERINGA, V16, P107, DOI 10.1080/03115519208619036	40	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96559	10.1371/journal.pone.0096559	http://dx.doi.org/10.1371/journal.pone.0096559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804680	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900069
J	Rodriguez-Prieto, A; Igea, J; Castresana, J				Rodriguez-Prieto, Ana; Igea, Javier; Castresana, Jose			Development of Rapidly Evolving Intron Markers to Estimate Multilocus Species Trees of Rodents	PLOS ONE			English	Article							LUSITANIAN PINE VOLE; PHYLOGENETIC ANALYSES; MOLECULAR PHYLOGENY; NUCLEAR GENES; SEQUENCE; PHYLOGEOGRAPHY; DIVERSIFICATION; IMPROVEMENT; DIVERGENCE; GENERATION	One of the major challenges in the analysis of closely related species, speciation and phylogeography is the identification of variable sequence markers that allow the determination of genealogical relationships in multiple genomic regions using coalescent and species tree approaches. Rodent species represent nearly half of the mammalian diversity, but so far no systematic study has been carried out to detect suitable informative markers for this group. Here, we used a bioinformatic pipeline to extract intron sequences from rodent genomes available in databases and applied a series of filters that allowed the identification of 208 introns that adequately fulfilled several criteria for these studies. The main required characteristics of the introns were that they had the maximum possible mutation rates, that they were part of single-copy genes, that they had an appropriate sequence length for amplification, and that they were flanked by exons with suitable regions for primer design. In addition, in order to determine the validity of this approach, we chose ten of these introns for primer design and tested them in a panel of eleven rodent species belonging to different representative families. We show that all these introns can be amplified in the majority of species and that, overall, 79% of the amplifications worked with minimum optimization of the annealing temperature. In addition, we confirmed for a pair of sister species the relatively high level of sequence divergence of these introns. Therefore, we provide here a set of adequate intron markers that can be applied to different species of Rodentia for their use in studies that require significant sequence variability.	[Rodriguez-Prieto, Ana; Igea, Javier; Castresana, Jose] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain; [Igea, Javier] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Imperial College London	Castresana, J (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain.	jose.castresana@csic.es	Castresana, Jose/K-3437-2014	Castresana, Jose/0000-0002-9391-8050; Igea, Javier/0000-0001-9493-2076	Plan Nacional I+D+ I of the Ministerio de Economia y Competitividad (Spain) [CGL2008-00434/BOS, CGL2011-22640/BOS]; Ministerio de Economia y Competitividad (Spain) [BES-2009-029432]	Plan Nacional I+D+ I of the Ministerio de Economia y Competitividad (Spain); Ministerio de Economia y Competitividad (Spain)	This work was funded by grant numbers CGL2008-00434/BOS and CGL2011-22640/BOS from the Plan Nacional I+D+ I of the Ministerio de Economia y Competitividad (Spain) to JC.ARP was supported by fellowship BES-2009-029432 of the Ministerio de Economia y Competitividad (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral AR, 2010, CONSERV GENET, V11, P1143, DOI 10.1007/s10592-009-9903-3; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Brito PH, 2009, GENETICA, V135, P439, DOI 10.1007/s10709-008-9293-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Castresana J, 2002, GENOME BIOL, V3; Churakov G, 2010, MOL BIOL EVOL, V27, P1315, DOI 10.1093/molbev/msq019; Creer S, 2005, CLADISTICS, V21, P390, DOI 10.1111/j.1096-0031.2005.00072.x; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Honeycutt Rodney L., 2009, P490; Igea J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-115; Igea J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-369; Jaarola M, 2004, MOL PHYLOGENET EVOL, V33, P647, DOI 10.1016/j.ympev.2004.07.015; Jacobsen F, 2012, ECOL EVOL, V2, P2413, DOI 10.1002/ece3.365; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kepler RM, 2013, MOL ECOL RESOUR, V13, P210, DOI 10.1111/1755-0998.12058; Knowles L.L., 2010, ESTIMATING SPECIES T; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemmon AR, 2012, SYST BIOL, V61, P745, DOI 10.1093/sysbio/sys051; Li CH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-90; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Matthee CA, 2007, MOL PHYLOGENET EVOL, V42, P827, DOI 10.1016/j.ympev.2006.10.002; Mccormack JE, 2013, MOL ECOL, V22, P19, DOI 10.1111/mec.12050; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; Peng ZG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-247; Peters JL, 2008, EVOLUTION, V62, P1469, DOI 10.1111/j.1558-5646.2008.00372.x; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pons JM, 2011, J BIOGEOGR, V38, P311, DOI 10.1111/j.1365-2699.2010.02401.x; Ponsa M, 2011, MAMMALIA, V75, P305, DOI 10.1515/MAMM.2011.033; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Sanchez-Gracia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030239; Schneider H, 1996, AM J PHYS ANTHROPOL, V100, P153, DOI 10.1002/(SICI)1096-8644(199606)100:2<153::AID-AJPA1>3.0.CO;2-Z; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steiner C, 2005, MOL PHYLOGENET EVOL, V35, P363, DOI 10.1016/j.ympev.2004.12.013; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thomson RC, 2010, MOL ECOL, V19, P2184, DOI 10.1111/j.1365-294X.2010.04650.x; Townsend TM, 2008, MOL PHYLOGENET EVOL, V47, P129, DOI 10.1016/j.ympev.2008.01.008; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Ventura J, 2010, ANIM BIOL, V60, P1, DOI 10.1163/157075610X12610595764011; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Willows-Munro S, 2005, MOL PHYLOGENET EVOL, V35, P624, DOI 10.1016/j.ympev.2005.01.018; Wilson D. E., 2005, MAMMAL SPECIES WORLD	69	6	6	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96032	10.1371/journal.pone.0096032	http://dx.doi.org/10.1371/journal.pone.0096032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804779	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900033
J	Baron-Cohen, S; Murphy, L; Chakrabarti, B; Craig, I; Mallya, U; Lakatosova, S; Rehnstrom, K; Peltonen, L; Wheelwright, S; Allison, C; Fisher, SE; Warrier, V				Baron-Cohen, Simon; Murphy, Laura; Chakrabarti, Bhismadev; Craig, Ian; Mallya, Uma; Lakatosova, Silvia; Rehnstrom, Karola; Peltonen, Leena; Wheelwright, Sally; Allison, Carrie; Fisher, Simon E.; Warrier, Varun			A Genome Wide Association Study of Mathematical Ability Reveals an Association at Chromosome 3q29, a Locus Associated with Autism and Learning Difficulties: A Preliminary Study	PLOS ONE			English	Article							COGNITIVE-ABILITY; LOW PERFORMANCE; MICRODELETION; ACHIEVEMENT; MICROARRAYS; DISABILITY; LINKAGE; DESIGN	Mathematical ability is heritable, but few studies have directly investigated its molecular genetic basis. Here we aimed to identify specific genetic contributions to variation in mathematical ability. We carried out a genome wide association scan using pooled DNA in two groups of U. K. samples, based on end of secondary/high school national academic exam achievement: high (n = 419) versus low (n = 183) mathematical ability while controlling for their verbal ability. Significant differences in allele frequencies between these groups were searched for in 906,600 SNPs using the Affymetrix GeneChip Human Mapping version 6.0 array. After meeting a threshold of p, P<1.5 x 10(-5), 12 SNPs from the pooled association analysis were individually genotyped in 542 of the participants and analyzed to validate the initial associations (lowest p-value 1.14 x 10(-6)). In this analysis, one of the SNPs (rs789859) showed significant association after Bonferroni correction, and four (rs10873824, rs4144887, rs12130910 rs2809115) were nominally significant (lowest p-value 3.278 x 10(-4)). Three of the SNPs of interest are located within, or near to, known genes (FAM43A, SFT2D1, C14orf64). The SNP that showed the strongest association, rs789859, is located in a region on chromosome 3q29 that has been previously linked to learning difficulties and autism. rs789859 lies 1.3 kbp downstream of LSG1, and 700 bp upstream of FAM43A, mapping within the potential promoter/regulatory region of the latter. To our knowledge, this is only the second study to investigate the association of genetic variants with mathematical ability, and it highlights a number of interesting markers for future study.	[Baron-Cohen, Simon; Murphy, Laura; Chakrabarti, Bhismadev; Mallya, Uma; Lakatosova, Silvia; Wheelwright, Sally; Allison, Carrie; Warrier, Varun] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge CB2 1TN, Cambs, England; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust CPFT, CLASS Clin, Cambridge, Cambs, England; [Chakrabarti, Bhismadev] Univ Reading, Ctr Integrat Neurosci & Neurodynam, Sch Psychol & Clin Language Sci, Reading, Berks, England; [Craig, Ian] Kings Coll London, Inst Psychiat, MRC, Ctr Social Genet & Dev Psychiat, London, England; [Rehnstrom, Karola; Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Fisher, Simon E.] Max Planck Inst Psycholinguist, NL-6500 AH Nijmegen, Netherlands; [Fisher, Simon E.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	University of Cambridge; University of Reading; University of London; King's College London; Wellcome Trust Sanger Institute; Max Planck Society; Radboud University Nijmegen	Baron-Cohen, S (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge CB2 1TN, Cambs, England.	sb205@cam.ac.uk; vw260@medschl.cam.ac.uk	Fisher, Simon E./E-9130-2012; Craig, Ian/AAF-9167-2019	Fisher, Simon E./0000-0002-3132-1996; Warrier, Varun/0000-0003-4532-8571; Wheelwright, Sally/0000-0003-0657-2483; Baron-Cohen, Simon/0000-0001-9217-2544; Craig, Ian/0000-0002-4063-1005; Murphy, Laura/0000-0003-0029-0434; Chakrabarti, Bhismadev/0000-0002-6649-7895	Nancy Lurie Marks Family Foundation; Medical Research Council (MRC) UK; Autism Research Trust (ART); Max Planck Society; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	Nancy Lurie Marks Family Foundation; Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Autism Research Trust (ART); Max Planck Society(Max Planck Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by grants to SBC from the Nancy Lurie Marks Family Foundation, the Medical Research Council (MRC) UK, and the Autism Research Trust (ART). LM and SEF were supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2000, J SCHOOL PSYCHOL, V38, P63, DOI 10.1016/S0022-4405(99)00037-0; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2007, HUM NATURE-INT BIOS, V18, P125, DOI 10.1007/s12110-007-9014-0; Barratt BJ, 2002, ANN HUM GENET, V66, P393, DOI [10.1046/j.1469-1809.2002.00125.x, 10.1017/S0003480002001252]; Davis OSP, 2009, BIOINFORMATICS, V25, P281, DOI 10.1093/bioinformatics/btn587; Docherty SJ, 2010, GENES BRAIN BEHAV, V9, P234, DOI 10.1111/j.1601-183X.2009.00553.x; Kovas Y, 2007, J LEARN DISABIL-US, V40, P554, DOI 10.1177/00222194070400060601; Mulle JG, 2010, AM J HUM GENET, V87, P229, DOI 10.1016/j.ajhg.2010.07.013; Nava C, 2014, EUR J HUM GENET, V22, P71, DOI 10.1038/ejhg.2013.88; Oliver B, 2004, J EDUC PSYCHOL, V96, P504, DOI 10.1037/0022-0663.96.3.504; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sagar A, 2013, AM J MED GENET A, V161A, P845, DOI 10.1002/ajmg.a.35754; Schosser Alexandra, 2010, BMC Res Notes, V3, P274, DOI 10.1186/1756-0500-3-274; WADSWORTH SJ, 1995, BEHAV GENET, V25, P1, DOI 10.1007/BF02197237; Wijsman EM, 2004, BEHAV GENET, V34, P51, DOI 10.1023/B:BEGE.0000009476.33020.b9; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236	18	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96374	10.1371/journal.pone.0096374	http://dx.doi.org/10.1371/journal.pone.0096374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801482	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000338029800063
J	Halabi, MF; Shakir, RM; Bardi, DA; Al-Wajeeh, NS; Ablat, A; Hassandarvish, P; Hajrezaie, M; Norazit, A; Abdulla, MA				Halabi, Mohammed Farouq; Shakir, Raied Mustafa; Bardi, Daleya Abdulaziz; Al-Wajeeh, Nahla Saeed; Ablat, Abdulwali; Hassandarvish, Pouya; Hajrezaie, Maryam; Norazit, Anwar; Abdulla, Mahmood Ameen			Gastroprotective Activity of Ethyl-4-[(3,5-di-tert-butyl-2-hydroxybenzylidene) Amino]benzoate against Ethanol-Induced Gastric Mucosal Ulcer in Rats	PLOS ONE			English	Article						ethyl 4-(3, 5-di-ter-butyl-2-hydroxybenzylamino) benzoate; toxicity; antioxidant; gastric-ulcer; anti-ulcer; histology; immunohistochemistry	LIPID-PEROXIDATION; OXIDATIVE STRESS; ACUTE TOXICITY; LEAF EXTRACT; ANTIOXIDANT; COMPLEXES; LESIONS; CU(II); INJURY	Background: The study was carried out to determine the cytotoxic, antioxidant and gastro-protective effect of ethyl-4-[(3,5di- tert-butyl-2-hydroxybenzylid ene)amino] benzoate (ETHAB) in rats. Methodology/Principal Findings: The cytotoxic effect of ETHAB was assessed using a MTT cleavage assay on a WRL68 cell line, while its antioxidant activity was evaluated in vitro. In the anti-ulcer study, rats were divided into six groups. Group 1 and group 2 received 10% Tween 20 (vehicle). Group 3 received 20 mg/kg Omeprazole. Groups 4, 5 and 6 received ETHAB at doses of 5, 10, and 20 mg/kg, respectively. After an hour, group 1 received the vehicle. Groups 2-6 received absolute ethanol to induce gastric mucosal lesions. In the WRL68 cell line, an IC50 of more than 100 mu g/mL was observed. ETHAB results showed antioxidant activity in the DPPH, FRAP, nitric oxide and metal chelating assays. There was no acute toxicity even at the highest dosage (1000 mg/kg). Microscopy showed that rats pretreated with ETHAB revealed protection of gastric mucosa as ascertained by significant increases in superoxide dismutase (SOD), pH level, mucus secretion, reduced gastric lesions, malondialdehyde (MDA) level and remarkable flattened gastric mucosa. Histologically, pretreatment with ETHAB resulted in comparatively better gastric protection, due to reduction of submucosal edema with leucocyte infiltration. PAS staining showed increased intensity in uptake of Alcian blue. In terms of immunohistochemistry, ETHAB showed down-expression of Bax proteins and over-expression of Hsp70 proteins. Conclusion/Significance: The gastroprotective effect of ETHAB may be attributed to antioxidant activity, increased gastric wall mucus, pH level of gastric contents, SOD activity, decrease in MDA level, ulcer area, flattening of gastric mucosa, reduction of edema and leucocyte infiltration of the submucosal layer, increased PAS staining, up-regulation of Hsp70 protein and suppressed expression of Bax.	[Halabi, Mohammed Farouq; Bardi, Daleya Abdulaziz; Al-Wajeeh, Nahla Saeed; Hajrezaie, Maryam; Norazit, Anwar; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Shakir, Raied Mustafa] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur, Malaysia; [Ablat, Abdulwali] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Hassandarvish, Pouya] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Halabi, Mohammed Farouq] Taibah Univ, Coll Med, Al Moalim Mohamed Awad Ctr Sci Miracles Prophet M, Al Madinah Al Munawarah, Saudi Arabia; [Shakir, Raied Mustafa] Univ Baghdad, Dept Chem, Baghdad, Iraq	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Taibah University; University of Baghdad	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	ammeen@um.edu.my	Bardi, Daleya Abdulaziz M/C-9901-2010; NORAZIT, ANWAR/B-5263-2010; Halabi, Mohammed/N-4574-2019; SHAKIR, RAIED/I-8119-2019; Bardi/ABD-2699-2020; Norazit, Anwar/AFN-9512-2022; Hassandarvish, Pouya/K-8112-2012	Bardi, Daleya Abdulaziz M/0000-0001-9091-2908; Halabi, Mohammed/0000-0001-7114-515X; SHAKIR, RAIED/0000-0003-2668-2305; Norazit, Anwar/0000-0003-2724-7591; Hassandarvish, Pouya/0000-0003-0364-5587	University of Malaya Grant [PG054-2012B]; Ministry of Higher Education Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya Grant; Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	This research was supported by the University of Malaya Grant (PG054-2012B) and High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulaziz Bardi D, 2013, BIOMED RES INT, V2013, P10; Abdulla MA, 2010, AFR J PHARM PHARMACO, V4, P226; Al Batran R, 2013, J GASTROEN HEPATOL, V28, P1321, DOI 10.1111/jgh.12229; Alam MS, 2012, BIOORGAN MED CHEM, V20, P4103, DOI 10.1016/j.bmc.2012.04.058; ALRASHDI AS, 2012, EVID-BASED COMPL ALT, DOI DOI 10.1155/2012/786426; Anouar EH, 2013, J COMPUT AID MOL DES, V27, P951, DOI 10.1007/s10822-013-9692-0; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bardi D. A. A., 2011, Scientific Research and Essays, V6, P3232; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cozzi PG, 2004, CHEM SOC REV, V33, P410, DOI 10.1039/b307853c; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; Dwivedi A, 2013, J SAUDI CHE IN PRESS; El-Nawawy MA, 2011, NEW YORK SCI J, V4, P78; FERRARI M, 1990, J IMMUNOL METHODS, V131, P165, DOI 10.1016/0022-1759(90)90187-Z; Ganguly A, 2014, EUR J PHARM SCI, V51, P96, DOI 10.1016/j.ejps.2013.09.003; Garber JC, 2011, RES IFLA; Golbabapour S, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/974185; Golbabapour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075036; GROSSMAN MI, 1981, ANN INTERN MED, V95, P609, DOI 10.7326/0003-4819-95-5-609; Gwaram NS, 2012, ARABIAN J C IN PRESS; Gwaram NS, 2012, MOLECULES, V17, P5952, DOI 10.3390/molecules17055952; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Halabi MF, 2014, BIOMED RES  IN PRESS; Ibrahim MM, 2012, MOLECULES, V17, P12449, DOI 10.3390/molecules171012449; Katzung BG, 1995, BASIC CLIN PHARM, P949; Ketuly KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059296; Khan Muhammad Israr, 2013, Osong Public Health Res Perspect, V4, P271, DOI 10.1016/j.phrp.2013.09.006; Kobayashi T, 2001, PHARMACOL RES, V43, P23, DOI 10.1006/phrs.2000.0748; Kumar S, 2009, J SCI IND RES INDIA, V68, P181; Lednicer Daniel, 2007, ORGANIC CHEM DRUG SY; Li WF, 2014, CHEM-BIOL INTERACT, V208, P18, DOI 10.1016/j.cbi.2013.11.011; Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; Mei XT, 2013, FOOD CHEM TOXICOL, V60, P448, DOI 10.1016/j.fct.2013.07.075; OBERRINGER M, 1995, BIOCHEM BIOPH RES CO, V214, P1009, DOI 10.1006/bbrc.1995.2386; OECD, 2002, GUID DOC AC OR TOX, V01-24; Olfert ED, 1993, GUIDE CARE USE EXPT; Ottu OJ, 2013, ASIAN PAC J TROP MED, V6, P609, DOI 10.1016/S1995-7645(13)60105-4; Sahin M, 2013, SPECTROCHIM ACTA A, V103, P400, DOI 10.1016/j.saa.2012.11.006; Saikat Sen, 2009, Pharmacognosy Reviews, V3, P270; Salga MS, 2013, ARABIAN J C IN PRESS; Salga MS, 2012, CHEM-BIOL INTERACT, V195, P144, DOI 10.1016/j.cbi.2011.11.008; Salga MS, 2011, MOLECULES, V16, P8654, DOI 10.3390/molecules16108654; Shakir RM, 2010, ACTA CRYSTALLOGR E, V66, pO2915, DOI 10.1107/S1600536810041383; SHIMADA K, 1992, J AGR FOOD CHEM, V40, P945, DOI 10.1021/jf00018a005; Sumanont Y, 2004, BIOL PHARM BULL, V27, P170, DOI 10.1248/bpb.27.170; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; Tanaka A, 2002, ALIMENT PHARM THERAP, V16, P90, DOI 10.1046/j.1365-2036.16.s2.22.x; Thalamuthu S, 2014, SPECTROCHIM ACTA A, V118, P120, DOI 10.1016/j.saa.2013.08.065; Tytell M, 2001, Expert Opin Ther Targets, V5, P267, DOI 10.1517/14728222.5.2.267; Vinay Kumar, 2013, Free Radicals and Antioxidants, V3, P55, DOI 10.1016/j.fra.2013.07.001; Wang T, 2009, FOOD CHEM, V116, P240, DOI 10.1016/j.foodchem.2009.02.041; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Wong J-Y, 2013, EVID-BASED COMPL ALT, V2013, P9	56	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95908	10.1371/journal.pone.0095908	http://dx.doi.org/10.1371/journal.pone.0095908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800807	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800037
J	Nozuma, S; Matsuura, E; Matsuzaki, T; Watanabe, O; Kubota, R; Izumo, S; Takashima, H				Nozuma, Satoshi; Matsuura, Eiji; Matsuzaki, Toshio; Watanabe, Osamu; Kubota, Ryuji; Izumo, Shuji; Takashima, Hiroshi			Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; T-CELL LEUKEMIA; VIRUS TYPE-I; PROVIRAL LOAD; ANTIBODIES; FEATURES; HAM/TSP	Objective: HTLV-1 proviral loads (PVLs) and some genetic factors are reported to be associated with the development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, there are very few reports on HAM/TSP having family history. We aimed to define the clinical features and laboratory indications associated with HAM/TSP having family history. Methods: Records of 784 HAM/TSP patients who were hospitalized in Kagoshima University Hospital and related hospitals from 1987 to 2012 were reviewed. Using an unmatched case-control design, 40 patients of HAM/TSP having family history (f-HAM/TSP) were compared with 124 patients suffering from sporadic HAM/TSP, who were admitted in series over the last 10 years for associated clinical features. Results: Of the 784 patients, 40 (5.1%) were f-HAM/TSP cases. Compared with sporadic cases, the age of onset was earlier (41.3 vs. 51.6 years, p<0.001), motor disability grades were lower (4.0 vs. 4.9, p = 0.043) despite longer duration of illness (14.3 vs. 10.2 years, p = 0.026), time elapsed between onset and wheelchair use in daily life was longer (18.3 vs. 10.0 years, p = 0.025), cases with rapid disease progression were fewer (10.0% vs. 28.2%, p = 0.019), and protein levels in cerebrospinal fluid (CSF) were significantly lower in f-HAM/TSP cases (29.9 vs. 42.5 mg, p<0.001). There was no difference in HTLV-1 PVLs, anti-HTLV-1 antibody titers in serum and CSF, or cell number and neopterin levels in CSF. Furthermore, HTLV-1 PVLs were lower in cases with rapid disease progression than in those with slow progression in both f-HAM/TSP and sporadic cases. Conclusions: We demonstrated that HAM/TSP aggregates in the family, with a younger age of onset and a slow rate of progression in f-HAM/TSP cases compared with sporadic cases. These data also suggested that factors other than HTLV-1 PVLs contribute to the disease course of HAM/TSP.	[Nozuma, Satoshi; Matsuura, Eiji; Watanabe, Osamu; Takashima, Hiroshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 890, Japan; [Matsuzaki, Toshio; Kubota, Ryuji; Izumo, Shuji] Kagoshima Univ, Grad Sch Med & Dent Sci, Ctr Chron Viral Dis, Dept Mol Pathol, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Matsuura, E (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Neurol & Geriatr, Kagoshima 890, Japan.	pine@m.kufm.kagoshima-u.ac.jp	Kubota, Ryuji/A-7139-2009	Kubota, Ryuji/0000-0002-4158-3471	Health and Labour Sciences Research Grant from the Ministry of Health Labour and Welfare; JSPS KAKENHI [25293205, 24133701]	Health and Labour Sciences Research Grant from the Ministry of Health Labour and Welfare; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Health and Labour Sciences Research Grants from the Ministry of Health Labour and Welfare and JSPS KAKENHI Grant Numbers 25293205 and 24133701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprahamian T, 2008, CLIN EXP IMMUNOL, V152, P448, DOI 10.1111/j.1365-2249.2008.03658.x; Asquith B, 2005, J GEN VIROL, V86, P1515, DOI 10.1099/vir.0.80766-0; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; GESSAIN A, 1985, LANCET, V2, P407; Gotuzzo E, 2004, CLIN INFECT DIS, V39, P939, DOI 10.1086/423957; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; MANOUSSAKIS MN, 1987, CLIN EXP IMMUNOL, V69, P557; Matsuzaki T, 2001, J NEUROVIROL, V7, P228; MIYAMOTO Y, 1985, CANCER, V55, P181, DOI 10.1002/1097-0142(19850101)55:1<181::AID-CNCR2820550128>3.0.CO;2-E; MORI M, 1988, ANN NEUROL, V23, P100, DOI 10.1002/ana.410230119; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NAKAGAWA M, 1995, J NEUROVIROL, V1, P50, DOI 10.3109/13550289509111010; Olindo S, 2006, ARCH NEUROL-CHICAGO, V63, P1560, DOI 10.1001/archneur.63.11.1560; OSAME M, 1986, LANCET, V1, P1031; Pombo-de-Oliveira MS, 2001, LEUKEMIA LYMPHOMA, V42, P135, DOI 10.3109/10428190109097685; Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968; Saito Mineki, 2010, Interdiscip Perspect Infect Dis, V2010, P478461, DOI 10.1155/2010/478461; Takenouchi N, 2003, J NEUROVIROL, V9, P29, DOI 10.1080/13550280390173418; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481	20	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e86144	10.1371/journal.pone.0086144	http://dx.doi.org/10.1371/journal.pone.0086144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802839	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800014
J	Petersen, JW; Johnson, BD; Kip, KE; Anderson, RD; Handberg, EM; Sharaf, B; Mehta, PK; Kelsey, SF; Merz, CNB; Pepine, CJ				Petersen, John W.; Johnson, B. Delia; Kip, Kevin E.; Anderson, R. David; Handberg, Eileen M.; Sharaf, Barry; Mehta, Puja K.; Kelsey, Sheryl F.; Merz, C. Noel Bairey; Pepine, Carl J.			TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE)	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STABLE ANGINA-PECTORIS; MICROVASCULAR DYSFUNCTION; NATIONAL-HEART; ARTERY-DISEASE; FLOW VELOCITY; CARDIOVASCULAR EVENTS; CHEST PAIN; THROMBOLYSIS; OUTCOMES	Background: TIMI frame count (TFC) predicts outcomes in patients with obstructive coronary artery disease (CAD); it remains unclear whether TFC predicts outcomes in patients without obstructive CAD. Methods: TFC was determined in a sample of women with no obstructive CAD enrolled in the Women's Ischemia Syndrome Evaluation (WISE) study. Because TFC is known to be higher in the left anterior descending artery (LAD), TFC determined in the LAD was divided by 1.7 to provide a corrected TFC (cTFC). Results: A total of 298 women, with angiograms suitable for TFC analysis and long-term (6-10 year) follow up data, were included in this sub-study. Their age was 55 +/- 11 years, most were white (86%), half had a history of smoking, and half had a history of hypertension. Higher resting cTFC was associated with a higher rate of hospitalization for angina (34% in women with a cTFC >35, 15% in women with a cTFC <= 35, P<0.001). cTFC provided independent prediction of hospitalization for angina after adjusting for many baseline characteristics. In this cohort, resting cTFC was not predictive of major events (myocardial infarction, heart failure, stroke, or all-cause death), cardiovascular events, all-cause mortality, or cardiovascular mortality. Conclusions: In women with signs and symptoms of ischemia but no obstructive CAD, resting cTFC provides independent prediction of hospitalization for angina. Larger studies are required to determine if resting TFC is predictive of major events in patients without obstructive coronary artery disease.	[Petersen, John W.; Anderson, R. David; Handberg, Eileen M.; Pepine, Carl J.] Univ Florida, Div Cardiovasc Med, Gainesville, FL 32611 USA; [Johnson, B. Delia; Kelsey, Sheryl F.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Kip, Kevin E.] Univ S Florida, Coll Nursing, Tampa, FL USA; [Sharaf, Barry] Brown Univ, Div Cardiol, Providence, RI 02912 USA; [Mehta, Puja K.; Merz, C. Noel Bairey] Cedars Sinai Med Ctr, Div Cardiol, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA	State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of South Florida; Brown University; Cedars Sinai Medical Center	Petersen, JW (corresponding author), Univ Florida, Div Cardiovasc Med, Gainesville, FL 32611 USA.	john.petersen@medicine.ufl.edu		Handberg, Eileen/0000-0002-7805-9577; Pepine, Carl/0000-0002-6011-681X; Petersen, John/0000-0003-0401-5421; Anderson, R. David/0000-0003-3490-3286; Bairey Merz, C. Noel/0000-0002-9933-5155	National Heart, Lung and Blood Institutes [N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV68164]; National Institute on Aging [U0164829, U01 HL649141, U01 HL649241, T32HL69751, 1R03AG032631]; GCRC grant from National Center for Research Resources [MO1-RR00425]; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; Edythe L. Broad Women's Heart Research Fellowship; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program; Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D. C; NIH; NCRR CTSA grant [UL1 TR000064]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV068161, N01HV068162, N01HV068164, N01HV068163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG032631] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); GCRC grant from National Center for Research Resources; Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ; Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA; Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA; QMED, Inc., Laurence Harbor, NJ; Edythe L. Broad Women's Heart Research Fellowship; Cedars-Sinai Medical Center, Los Angeles, California; Barbra Streisand Women's Cardiovascular Research and Education Program; Cedars-Sinai Medical Center, Los Angeles; Society for Women's Health Research (SWHR), Washington, D. C; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR CTSA grant; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by contracts from the National Heart, Lung and Blood Institutes, nos. N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, grants U0164829, U01 HL649141, U01 HL649241, T32HL69751, 1R03AG032631 from the National Institute on Aging, GCRC grant MO1-RR00425 from the National Center for Research Resources and grants from the Gustavus and Louis Pfeiffer Research Foundation, Danville, NJ, The Women's Guild of Cedars-Sinai Medical Center, Los Angeles, CA, The Ladies Hospital Aid Society of Western Pennsylvania, Pittsburgh, PA, and QMED, Inc., Laurence Harbor, NJ, the Edythe L. Broad Women's Heart Research Fellowship, Cedars-Sinai Medical Center, Los Angeles, California, the Barbra Streisand Women's Cardiovascular Research and Education Program, Cedars-Sinai Medical Center, Los Angeles and The Society for Women's Health Research (SWHR), Washington, D. C. Dr. Carl Pepine receives support from the NIH and NCRR CTSA grant UL1 TR000064. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V100, P2219, DOI 10.1161/01.CIR.100.22.2219; Al Suwaidi J, 2000, CIRCULATION, V101, P948, DOI 10.1161/01.CIR.101.9.948; Barcin C, 2003, AM J CARDIOL, V91, P466, DOI 10.1016/S0002-9149(02)03250-2; Chugh SK, 2004, J AM COLL CARDIOL, V44, P778, DOI 10.1016/j.jacc.2004.05.048; Dodge JT, 1998, AM J CARDIOL, V81, P1268, DOI 10.1016/S0002-9149(98)00138-6; Erdogan D, 2007, ATHEROSCLEROSIS, V191, P168, DOI 10.1016/j.atherosclerosis.2006.03.016; French JK, 2000, J AM COLL CARDIOL, V35, P1516, DOI 10.1016/S0735-1097(00)00577-5; Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879; Gibson CM, 1999, CIRCULATION, V99, P1945, DOI 10.1161/01.CIR.99.15.1945; Gibson CM, 2002, CIRCULATION, V105, P1909, DOI 10.1161/01.CIR.0000014683.52177.B5; Gulati M, 2009, ARCH INTERN MED, V169, P843, DOI 10.1001/archinternmed.2009.50; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Jespersen L, 2012, EUR HEART J, V33, P734, DOI 10.1093/eurheartj/ehr331; Lee S, 2005, CIRC J, V69, P1022, DOI 10.1253/circj.69.1022; Manginas A, 1999, AM J CARDIOL, V83, P1562, DOI 10.1016/S0002-9149(99)00149-6; Mavrogeni SI, 2005, J CARDIOVASC MAGN R, V7, P545, DOI 10.1081/JCMR-200060641; Merz CNB, 1999, J AM COLL CARDIOL, V33, P1453; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; Ozdemir N, 2003, JPN HEART J, V44, P213, DOI 10.1536/jhj.44.213; Pauly DF, 2011, AM HEART J, V162, P678, DOI 10.1016/j.ahj.2011.07.011; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Reis SE, 2001, AM HEART J, V141, P735, DOI 10.1067/mhj.2001.114198; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Sharaf BL, 2001, AM J CARDIOL, V87, P937, DOI 10.1016/S0002-9149(01)01424-2; Sun HT, 2005, J CARDIOVASC PHARM, V46, P622, DOI 10.1097/01.fjc.0000181291.96086.ae; Umman Berrin, 2002, J Invasive Cardiol, V14, P125; von Mering GO, 2004, CIRCULATION, V109, P722, DOI 10.1161/01.CIR.0000115525.92645.16	27	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96630	10.1371/journal.pone.0096630	http://dx.doi.org/10.1371/journal.pone.0096630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800739	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000338029800096
J	Tan, JJ; Azmi, SM; Yong, YK; Cheah, HL; Lim, V; Sandai, D; Shaharuddin, B				Tan, Jun Jie; Azmi, Siti Maisura; Yong, Yoke Keong; Cheah, Hong Leong; Lim, Vuanghao; Sandai, Doblin; Shaharuddin, Bakiah			Tualang Honey Improves Human Corneal Epithelial Progenitor Cell Migration and Cellular Resistance to Oxidative Stress In Vitro	PLOS ONE			English	Article							NEURAL STEM-CELLS; ANTIBACTERIAL PROPERTIES; ANTIOXIDATIVE ACTIVITY; CHROMOSOMAL INSTABILITY; POPULATION; ABCG2; IDENTIFICATION; DETERMINANT; DEFICIENCY; GENERATION	Stem cells with enhanced resistance to oxidative stress after in vitro expansion have been shown to have improved engraftment and regenerative capacities. Such cells can be generated by preconditioning them with exposure to an antioxidant. In this study we evaluated the effects of Tualang honey (TH), an antioxidant-containing honey, on human corneal epithelial progenitor (HCEP) cells in culture. Cytotoxicity, gene expression, migration, and cellular resistance to oxidative stress were evaluated. Immunofluorescence staining revealed that HCEP cells were holoclonal and expressed epithelial stem cell marker p63 without corneal cytokeratin 3. Cell viability remained unchanged after cells were cultured with 0.004, 0.04, and 0.4% TH in the medium, but it was significantly reduced when the concentration was increased to 3.33%. Cell migration, tested using scratch migration assay, was significantly enhanced when cells were cultured with TH at 0.04% and 0.4%. We also found that TH has hydrogen peroxide (H2O2) scavenging ability, although a trace level of H(2)O(2)was detected in the honey in its native form. Preconditioning HCEP cells with 0.4% TH for 48 h showed better survival following H2O2-induced oxidative stress at 50 mu M than untreated group, with a significantly lower number of dead cells (15.3 +/- 60.4%) were observed compared to the untreated population (20.5 +/- 60.9%, p<0.01). Both TH and ascorbic acid improved HCEP viability following induction of 100 mM H2O2, but the benefit was greater with TH treatment than with ascorbic acid. However, no significant advantage was demonstrated using 5-hydroxymethyl-2-furancarboxaldehyde, a compound that was found abundant in TH using GC/MS analysis. This suggests that the cellular anti-oxidative capacity in HCEP cells was augmented by native TH and was attributed to its antioxidant properties. In conclusion, TH possesses antioxidant properties and can improve cell migration and cellular resistance to oxidative stress in HCEP cells in vitro.	[Tan, Jun Jie; Azmi, Siti Maisura; Cheah, Hong Leong; Lim, Vuanghao; Sandai, Doblin; Shaharuddin, Bakiah] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia; [Yong, Yoke Keong] Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor Darul, Malaysia	Universiti Sains Malaysia; Universiti Putra Malaysia	Tan, JJ (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia.	jjtan@amdi.usm.edu.my	Keong, Yong Yoke/AAL-3665-2020; Lim, Vuanghao/S-1783-2018; Shaharuddin, Bakiah/M-5962-2015; Tan, Jun Jie/D-9864-2012	Lim, Vuanghao/0000-0001-5081-0982; Shaharuddin, Bakiah/0000-0001-6191-8964; Tan, Jun Jie/0000-0002-7027-6657; Cheah, Hong Leong/0000-0001-9172-2487; Azmi, Siti Maisura/0000-0001-6824-9935; Yong, Yoke Keong/0000-0002-9442-7456	Universiti Sains Malaysia Short Term Grant [304/CIPPT/6311032]; Advanced Medical and Dental Institute	Universiti Sains Malaysia Short Term Grant; Advanced Medical and Dental Institute	This project was supported by the Universiti Sains Malaysia Short Term Grant (304/CIPPT/6311032)(http://www.research.usm.my/?tag=22) and Advanced Medical and Dental Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasi M, 2012, NEUROSCIENCE, V222, P404, DOI 10.1016/j.neuroscience.2012.07.009; Ahmad I, 2012, PHOTOCHEM PHOTOBIOL, V88, P1198, DOI 10.1111/j.1751-1097.2012.01100.x; Albietz JM, 2006, CORNEA, V25, P1012, DOI 10.1097/01.ico.0000225716.85382.7b; Alves H, 2013, TISSUE ENG PT A, V19, P928, DOI [10.1089/ten.TEA.2011.0700, 10.1089/ten.tea.2011.0700]; AOYAGI N, 1974, CHEM PHARM BULL, V22, P1008; Arpitha P, 2005, INVEST OPHTH VIS SCI, V46, P3631, DOI 10.1167/iovs.05-0343; Bashkaran K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-90; Brudzynski K, 2011, FOOD CHEM, V126, P1155, DOI 10.1016/j.foodchem.2010.11.151; Chatterjee S, 2012, AM J PHYSIOL-HEART C, V302, pH105, DOI 10.1152/ajpheart.00298.2011; Chaudhari P, 2012, ANTIOXID REDOX SIGNA; Chen YH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072900, 10.1371/journal.pone.0075805]; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; Cheng G, 2012, INT J NANOMED, V7, P3991, DOI 10.2147/IJN.S32961; Cho KA, 2012, CELL BIOL INT, V36, P1267, DOI 10.1042/CBI20110634; Choi KT, 2008, ACTA PHARMACOL SIN, V29, P1109, DOI 10.1111/j.1745-7254.2008.00869.x; Daniels-Wells TR, 2013, TOXICOL IN VITRO, V27, P220, DOI 10.1016/j.tiv.2012.10.006; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Ding HW, 2012, J CELL SCI, V125, P5564, DOI 10.1242/jcs.081703; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Frankel E. N, 1985, CHEM AUTOXIDATION ME; Fuster MD, 2000, J AGR FOOD CHEM, V48, P5600, DOI 10.1021/jf000605e; Ghashm AA, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-49; Gurusamy N, 2010, J CELL MOL MED, V14, P2235, DOI 10.1111/j.1582-4934.2010.01140.x; He Y, 2012, CURR EYE RES, V37, P879, DOI 10.3109/02713683.2012.688165; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Kannan RRR, 2012, FOOD CHEM, V135, P2470, DOI 10.1016/j.foodchem.2012.07.070; Kannan TP, 2009, FOOD CHEM TOXICOL, V47, P1696, DOI 10.1016/j.fct.2009.04.020; Khoo YT, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-48; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; Kishore RK, 2011, NUTR RES, V31, P322, DOI 10.1016/j.nutres.2011.03.001; Ko E, 2012, STEM CELLS DEV, V21, P1877, DOI 10.1089/scd.2011.0284; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kubota M, 2010, INVEST OPHTH VIS SCI, V51, P5617, DOI 10.1167/iovs.10-5463; Kulkarni A, 2008, J WOOD SCI, V54, P153, DOI 10.1007/s10086-007-0916-6; Kumar P. P., 2010, African Journal of Biochemistry Research, V4, P191; Lazim NM, 2013, INT J PEDIATR OTORHI, V77, P457, DOI 10.1016/j.ijporl.2012.11.036; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lee KG, 2000, J AGR FOOD CHEM, V48, P4290, DOI 10.1021/jf000442u; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Limoli CL, 2003, NEOPLASIA, V5, P339, DOI 10.1016/S1476-5586(03)80027-1; Liu AM, 2012, AM J BLOOD RES, V2, P71; Mansour AM, 2002, CLIN EXP OPHTHALMOL, V30, P149, DOI 10.1046/j.1442-6404.2002.00482.x; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; Mohamed SA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-40; Mohd Effendy N, 2012, EVID-BASED COMPL ALT, V2012; Nam S, 2012, J AGR FOOD CHEM, V60, P9097, DOI 10.1021/jf301800x; Nasir NAM, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-31; Osada Y, 2006, FOOD CHEM, V98, P522, DOI 10.1016/j.foodchem.2005.05.084; Palma M, 2001, J AGR FOOD CHEM, V49, P628, DOI 10.1021/jf001070s; Pan Q, 2011, INVEST OPHTH VIS SCI, V52, P1723, DOI 10.1167/iovs.10-5866; Pendergrass KD, 2013, STEM CELLS DEV; Priya CG, 2013, MICROSC RES TECHNIQ, V76, P242, DOI 10.1002/jemt.22159; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Ruiz CM, 2000, ALCOHOL, V20, P133, DOI 10.1016/S0741-8329(99)00065-8; Sakata H, 2012, STROKE, V43, P2423, DOI 10.1161/STROKEAHA.112.656900; Schauen M, 2006, J CELL PHYSIOL, V209, P103, DOI 10.1002/jcp.20711; Smith WM, 2012, CORNEA, V31, P130, DOI 10.1097/ICO.0b013e3182222779; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Suh DY, 1996, ARCH PHARM RES, V19, P112, DOI 10.1007/BF02976844; Sukur SM, 2011, INDIAN J PLAST SURG, V44, P112, DOI 10.4103/0970-0358.81459; Tan HT, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-34; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Urtasun R, 2012, HEPATOLOGY, V55, P594, DOI 10.1002/hep.24701; Uwaydat S, 2011, CURR EYE RES, V36, P787, DOI 10.3109/02713683.2010.544441; Wei A, 2001, J AGR FOOD CHEM, V49, P4097, DOI 10.1021/jf010325e; Westman J., 2007, LEVOGLUCOSENONE DERI; Yaacob NS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/989841; Yanagimoto K, 2002, J AGR FOOD CHEM, V50, P5480, DOI 10.1021/jf025616h; Yu XY, 2013, FOOD RES INT, V51, P397, DOI 10.1016/j.foodres.2012.12.044; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	73	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96800	10.1371/journal.pone.0096800	http://dx.doi.org/10.1371/journal.pone.0096800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802273	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800130
J	Batten, C; Darpel, K; Henstock, M; Fay, P; Veronesi, E; Gubbins, S; Graves, S; Frost, L; Oura, C				Batten, Carrie; Darpel, Karin; Henstock, Mark; Fay, Petra; Veronesi, Eva; Gubbins, Simon; Graves, Samantha; Frost, Lorraine; Oura, Christopher			Evidence for Transmission of Bluetongue Virus Serotype 26 through Direct Contact	PLOS ONE			English	Article							CULICOIDES-VARIIPENNIS DIPTERA; INFECTION KINETICS; ORAL INFECTION; PATHOGENESIS; REPLICATION; MIDGES; LINES	The aim of this study was to assess the mechanisms of transmission of bluetongue virus serotype 26 (BTV-26) in goats. A previous study, which investigated the pathogenicity and infection kinetics of BTV-26 in goats, unexpectedly revealed that one control goat may have been infected through a direct contact transmission route. To investigate the transmission mechanisms of BTV-26 in more detail an experimental infection study was carried out in which three goats were infected with BTV-26, three goats were kept uninfected, but were housed in direct contact with the infected goats, and an additional four goats were kept in indirect contact separated from infected goats by metal gates. This barrier allowed the goats to have occasional face-to-face contact in the same airspace, but feeding, watering, sampling and environmental cleaning was carried out separately. The three experimentally infected goats did not show clinical signs of BTV, however high levels of viral RNA were detected and virus was isolated from their blood. At 21 dpi viral RNA was detected in, and virus was isolated from the blood of the three direct contact goats, which also seroconverted. The four indirect barrier contact goats remained uninfected throughout the duration of the experiment. In order to assess replication in a laboratory model species of Culicoides biting midge, more than 300 Culicoides sonorensis were fed a BTV-26 spiked blood meal and incubated for 7 days. The dissemination of BTV-26 in individual C. sonorensis was inferred from the quantity of virus RNA and indicated that none of the insects processed at day 7 possessed transmissible infections. This study shows that BTV-26 is easily transmitted through direct contact transmission between goats, and the strain does not seem to replicate in C. sonorensis midges using standard incubation conditions.	[Batten, Carrie; Henstock, Mark; Fay, Petra; Graves, Samantha; Frost, Lorraine; Oura, Christopher] Pirbright Inst, Non Vesic Reference Lab, Woking, Surrey, England; [Veronesi, Eva] Entomology, Pirbright Inst, Woking, Surrey, England; [Gubbins, Simon] Pirbright Inst, Ctr Integrat Biol, Woking, Surrey, England; [Darpel, Karin] Pirbright Inst, Woking, Surrey, England; [Darpel, Karin] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England; [Oura, Christopher] Univ W Indies, Sch Vet Med, St Augustine, Trinidad Tobago	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Surrey; University West Indies Mona Jamaica; University West Indies Saint Augustine	Batten, C (corresponding author), Pirbright Inst, Non Vesic Reference Lab, Woking, Surrey, England.	carrie.batten@pirbright.ac.uk	Darpel, Karin/HIK-2423-2022	Darpel, Karin/0000-0002-1488-3233; Gubbins, Simon/0000-0003-0538-4173; Batten, Carrie/0000-0003-4274-7375; Fay, Petra C./0000-0001-5808-4284; Veronesi, Eva/0000-0003-3411-7891	European Union and Department for Environment, Food and Rural Affairs (Defra); Biotechnology and Biological Sciences Research Council (BBSRC); BBSRC [BBS/E/I/00001717, BBS/E/I/00001709, BBS/E/I/00001728] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001159, BBS/E/I/00001728, BBS/E/I/00001709, BBS/E/I/00001717] Funding Source: researchfish	European Union and Department for Environment, Food and Rural Affairs (Defra); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the European Union (http://europa.eu/index_en.htm) and Department for Environment, Food and Rural Affairs (Defra) (http://www.defra.gov.uk/) and carried out using facilities funded by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.ac.uk/home/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Batten CA, 2013, VET MICROBIOL, V162, P62, DOI 10.1016/j.vetmic.2012.08.014; Batten CA, 2012, VET MICROBIOL, V157, P119, DOI 10.1016/j.vetmic.2011.11.033; Batten CA, 2008, VIRUS RES, V137, P56, DOI 10.1016/j.virusres.2008.05.016; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Calvo-Pinilla E, 2010, J GEN VIROL, V91, P2821, DOI 10.1099/vir.0.024117-0; Carpenter S, 2008, VET REC, V163, P589, DOI 10.1136/vr.163.20.589; Carpenter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027987; Chaignat V, 2009, VET MICROBIOL, V138, P11, DOI 10.1016/j.vetmic.2009.02.003; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; FOSTER NM, 1979, J MED ENTOMOL, V15, P302, DOI 10.1093/jmedent/15.3.302; Hofmann M, 2008, SCHWEIZ ARCH TIERH, V150, P49, DOI 10.1024/0036-7281.150.2.49; HOWERTH EW, 1988, AM J VET RES, V49, P1906; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; Jauniaux TP, 2008, EMERG INFECT DIS, V14, P1496, DOI 10.3201/eid1409.080434; JONES RH, 1974, J MED ENTOMOL, V11, P316, DOI 10.1093/jmedent/11.3.316; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Mayo CE, 2010, TRANSBOUND EMERG DIS, V57, P277, DOI 10.1111/j.1865-1682.2010.01149.x; Mellor P. S., 1990, Bluetongue viruses., P143; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; Mertens PPC., 2005, VIRUS TAXONOMY, P466; OIE, 2012, MAN DIAGN TESTS VACC, V1; Planzer J, 2011, RES VET SCI, V91, pE163, DOI 10.1016/j.rvsc.2011.03.007; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; Vannier P, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2189; Venter GJ, 2005, VET PARASITOL, V131, P331, DOI 10.1016/j.vetpar.2005.05.002; Veronesi E, 2013, PLOS ONE, V8; Veronesi E, 2008, J MED ENTOMOL, V45, P129, DOI 10.1603/0022-2585(2008)45[129:QBVIAC]2.0.CO;2; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Vogtlin A, 2013, VET MICROBIOL, V166, P165, DOI 10.1016/j.vetmic.2013.06.001; WECHSLER SJ, 1989, J INVERTEBR PATHOL, V54, P385, DOI 10.1016/0022-2011(89)90123-7; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Wittmann EJ, 2002, MED VET ENTOMOL, V16, P147, DOI 10.1046/j.1365-2915.2002.00357.x	35	70	73	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96049	10.1371/journal.pone.0096049	http://dx.doi.org/10.1371/journal.pone.0096049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797910	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000034
J	Kim, SH; Yang, HK; Lee, JH; Lee, ES				Kim, Sung Han; Yang, Hyung-Kook; Lee, Jung Hoon; Lee, Eun-Sik			A Retrospective Analysis of Incidence and Its Associated Risk Factors of Upper Urinary Tract Recurrence following Radical Cystectomy for Bladder Cancer with Transitional Cell Carcinoma: The Significance of Local Pelvic Recurrence and Positive Lymph Node	PLOS ONE			English	Article							EAU INTERNATIONAL CONSULTATION; GEMCITABINE PLUS CARBOPLATIN; FROZEN-SECTION ANALYSIS; LONG-TERM SURVEILLANCE; UROTHELIAL CANCER; DIVERSION; CHEMOTHERAPY; NEOADJUVANT; TUMORS; DISSECTION	Objective: The aim of this study is to examine the incidence and risk factors of upper urinary tract recurrence (UUTR) following radical cystectomy (RC) in bladder cancer and to evaluate its relationship with neobladder (Neo) or ileal conduit (IC). Materials and Methods: All clinicopathologic parameters and perioperative parameters of 311 patients who underwent RC with either Neo or IC by a single surgeon from 1999 to 2012 were retrospectively included in this study. Patients with a history of renal surgery, concomitant UUTR, or a histopathology of non-transitional cell carcinoma were excluded. For statistical analyses of predictive risk factors of UUTR, a multivariate analysis was performed with known risk factors of UUTR, including type of urinary diversion with significance defined as P < 0.05. Results: During the median follow-up period of 53 months, 143 (46.0%) IC and 168 (54.0%) Neo were performed, resulting in 11 (3.5%) cases of UUTR (Neo 7 and IC 4) after RC and all patients then underwent nephroureterectomy. No significant differences in incidence and overall survival in UUTR were observed according different types of urinary diversion (p = 483), and the prognosis for survival of Neo was insignificantly better than that of IC (5-year overall survival 78% vs 74%, respectively, p. 0.05). Higher number of positive lymph nodes (HR 9.03) and the presence of pelvic local recurrence (HR 7286.08) were significant predictive factors of UUTR (p < 0.05). Conclusion: This study reports a UUTR rate of 3.5%, and positive lymph nodes and presence of local recurrence at the pelvis as important risk factors. No significant differences in incidence and survival were observed between Neo and IC.	[Kim, Sung Han] Natl Canc Ctr, Dept Urol, Goyang, Gyanggi, South Korea; [Yang, Hyung-Kook] Natl Canc Ctr, Natl Canc Control Res Inst, Dept Epidemiol & Stat, Goyang, Gyanggi, South Korea; [Yang, Hyung-Kook] Natl Canc Ctr, Natl Canc Control Res Inst, Canc Policy Branch, Goyang, Gyanggi, South Korea; [Lee, Jung Hoon; Lee, Eun-Sik] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital	Lee, ES (corresponding author), Natl Canc Ctr, Dept Urol, Goyang, Gyanggi, South Korea.	eslee@snu.ac.kr		KIM, Sung Han/0000-0002-1689-5203				Apolo AB, 2012, UROL ONCOL-SEMIN ORI, V30, P772, DOI 10.1016/j.urolonc.2012.01.012; Balaji KC, 1999, J UROLOGY, V162, P1603, DOI 10.1016/S0022-5347(05)68176-1; CHARBIT L, 1991, J UROLOGY, V146, P1243, DOI 10.1016/S0022-5347(17)38059-X; Dhar NB, 2008, J UROLOGY, V179, P873, DOI 10.1016/j.juro.2007.10.076; Fernandez MI, 2012, UROL ONCOL-SEMIN ORI, V30, P821, DOI 10.1016/j.urolonc.2010.08.006; Fukuta Fumimasa, 2009, Hinyokika Kiyo, V55, P469; Furukawa J, 2007, INT J UROL, V14, P496, DOI 10.1111/j.1442-2042.2007.01776.x; Hautmann RE, 2007, UROLOGY, V69, P17, DOI 10.1016/j.urology.2006.05.058; Hautmann RE, 2013, EUR UROL, V63, P67, DOI 10.1016/j.eururo.2012.08.050; Hosain GMM, 2012, ETHNIC DIS, V22, P295; Huang GJ, 2009, WORLD J UROL, V27, P21, DOI 10.1007/s00345-008-0344-2; Huguet J, 2013, ACTAS UROL ESP, V37, P376, DOI 10.1016/j.acuro.2013.01.005; Iwasaki K, 2013, JPN J CLIN ONCOL, V43, P193, DOI 10.1093/jjco/hys213; Kakizoe T, 2006, CANCER SCI, V97, P821, DOI 10.1111/j.1349-7006.2006.00264.x; Kenworthy P, 1996, J UROLOGY, V155, P501, DOI 10.1016/S0022-5347(01)66433-4; Kim B, 2012, ACTA RADIOL, V53, P943, DOI 10.1258/ar.2012.110700; Kim WJ, 2008, CANCER SCI, V99, P646, DOI 10.1111/j.1349-7006.2008.00735.x; Lee SE, 2006, UROL INT, V77, P13, DOI 10.1159/000092928; Li CC, 2008, EUR UROL, V54, P1127, DOI 10.1016/j.eururo.2008.01.054; MALKOWICZ SB, 1990, UROLOGY, V36, P20; Matsumoto K, 2011, BJU INT, V108, pE304, DOI 10.1111/j.1464-410X.2011.10188.x; Ohyama C, 2014, INT J UROL, V21, P3, DOI 10.1111/iju.12230; Pasin Erik, 2008, Rev Urol, V10, P31; Pejcic T, 2007, Acta Chir Iugosl, V54, P63; Perlis N, 2013, WORLD J UROL, V31, P161, DOI 10.1007/s00345-012-0905-2; Picozzi S, 2012, J UROLOGY, V183, P1757; Quek ML, 2003, CANCER, V98, P955, DOI 10.1002/cncr.11569; Rabbani F, 2001, J CLIN ONCOL, V19, P94, DOI 10.1200/JCO.2001.19.1.94; Raj GV, 2006, CANCER, V107, P2167, DOI 10.1002/cncr.22238; Robert H.Y, 2005, COMPREHENSIVE TXB GE, P365; SAKAMOTO N, 1991, EUR UROL, V20, P136; Sanderson KM, 2007, BJU INT, V100, P11, DOI 10.1111/j.1464-410X.2007.06841.x; Sanderson KM, 2007, J UROLOGY, V177, P2088, DOI 10.1016/j.juro.2007.01.133; Schoenberg MP, 1996, J UROLOGY, V155, P1218, DOI 10.1016/S0022-5347(01)66223-2; SIDRANSKY D, 1992, NEW ENGL J MED, V326, P737, DOI 10.1056/NEJM199203123261104; Skinner Eila C., 2012, CAMPBELL WALSH UROLO; Soukup V, 2012, EUR UROL, V62, P290, DOI 10.1016/j.eururo.2012.05.008; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sternberg CN, 2013, EUR UROL, V63, P58, DOI 10.1016/j.eururo.2012.08.010; Takayanagi A, 2012, INT J UROL, V19, P229, DOI 10.1111/j.1442-2042.2011.02916.x; Theresa M.K, 2005, COMPREHENSIVE TXB GE, P411; Tilki D, 2010, J UROLOGY, V183, P1757, DOI 10.1016/j.juro.2010.01.025; Tollefson MK, 2010, J UROLOGY, V183, P81, DOI 10.1016/j.juro.2009.08.158; Tran W, 2008, J UROLOGY, V179, P96, DOI 10.1016/j.juro.2007.08.131; Ubrig B, 2013, AKTUEL UROL, V44, P55, DOI 10.1055/s-0032-1328175; Volkmer BG, 2009, J UROLOGY, V182, P2632, DOI 10.1016/j.juro.2009.08.046; Yang WJ, 2006, UROLOGY, V68, P324, DOI 10.1016/j.urology.2006.02.015; Yee DS, 2011, UROLOGY, V78, P544, DOI 10.1016/j.urology.2011.02.042; Yoshimine S, 2010, INT J UROL, V17, P527, DOI 10.1111/j.1442-2042.2010.02516.x; Zehnder P, 2011, J UROLOGY, V186, P1261, DOI 10.1016/j.juro.2011.06.004	50	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96467	10.1371/journal.pone.0096467	http://dx.doi.org/10.1371/journal.pone.0096467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798444	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000079
J	Beringer, DN; Nussbaum, MA; Madigan, ML				Beringer, Danielle N.; Nussbaum, Maury A.; Madigan, Michael L.			Temporal Changes in the Required Shoe-Floor Friction when Walking following an Induced Slip	PLOS ONE			English	Article							FALL-RELATED INJURIES; UTILIZED COEFFICIENT; OLDER-ADULTS; GAIT; RESISTANCE; TRIP; BIOMECHANICS; ADAPTATIONS; PREVENTION; EXPERIENCE	Biomechanical aspects of slips and falls have been widely studied to facilitate fall prevention strategies. Prior studies have shown changes in gait after an induced slipping event. As such, most researchers only slip participants one time to avoid such changes that would otherwise reduce the external validity of experimental results. The ability to slip participants more than once, after allowing gait to return to a natural baseline, would improve the experimental efficiency of such studies. Therefore, the goal of this study was to characterize the temporal changes in required shoe-floor friction when walking following an induced slip. Two experiments were completed, and each employed a different potential strategy to promote the return of gait to a natural baseline after slipping. In the first experiment, extended time away from the laboratory was used to promote the return of gait to baseline. We measured required coefficient-of-friction among 36 young adult male participants over four sessions. The first three sessions provided measurements during baseline (i.e., natural gait) both prior to slipping and immediately after slipping. The fourth session provided a measurement 1-12 weeks after slipping. In the second experiment, an extensive number of walking trials was used to promote the return of gait to baseline. We measured required coefficient-of-friction among 10 young adult male participants in a single session. Measurements were collected during 10 baseline walking trials, immediately after slipping, and during 50-55 additional trials. In both experiments, required coefficient-of-friction decreased 12-16% immediately after a single slip, increased toward baseline levels over subsequent weeks/walking trials, but remained statistically different from baseline at the end of the experiments. Based on these results, experiments involving slipping participants multiple times may not have a high level of external validity, and researchers are encouraged to continue to limit experimental protocols to a single induced slip per participant.	[Beringer, Danielle N.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Nussbaum, Maury A.] Virginia Tech, Sch Biomed Engn & Sci, Dept Ind & Syst Engn, Blacksburg, VA USA; [Madigan, Michael L.] Virginia Tech, Dept Engn Sci & Mech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA	Wake Forest University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Madigan, ML (corresponding author), Virginia Tech, Dept Engn Sci & Mech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.	mlmadigan@vt.edu	Nussbaum, Maury A/A-9655-2008	Nussbaum, Maury A/0000-0002-1887-8431; Madigan, Michael/0000-0002-4299-3851	CDC-NIOSH [1R01OH009880]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH009880] Funding Source: NIH RePORTER	CDC-NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This project was supported by 1R01OH009880 from CDC-NIOSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieryla KA, 2007, GAIT POSTURE, V26, P208, DOI 10.1016/j.gaitpost.2006.09.010; Brady RA, 2000, J BIOMECH, V33, P803, DOI 10.1016/S0021-9290(00)00037-3; Burnfield JM, 2006, ERGONOMICS, V49, P982, DOI 10.1080/00140130600665687; Burnfield JM, 2007, J FORENSIC SCI, V52, P1328, DOI 10.1111/j.1556-4029.2007.00549.x; Cham R, 2002, GAIT POSTURE, V15, P159, DOI 10.1016/S0966-6362(01)00150-3; Chang WR, 2012, ERGONOMICS, V55, P308, DOI 10.1080/00140139.2011.642008; Council NS, 2011, SLIPS TRIPS FALLS; Courtney TK, 2001, ERGONOMICS, V44, P1118, DOI 10.1080/00140130110085538; Groqvist R, 2001, ERGONOMICS, V44, P1167; Hanson JP, 1999, ERGONOMICS, V42, P1619, DOI 10.1080/001401399184712; Heiden TL, 2006, GAIT POSTURE, V24, P237, DOI 10.1016/j.gaitpost.2005.09.004; Kim S, 2005, SAFETY SCI, V43, P425, DOI 10.1016/j.ssci.2005.08.004; Leclercq S, 1999, SAFETY SCI, V31, P95, DOI 10.1016/S0925-7535(98)00064-2; Lockhart TE, 2003, ERGONOMICS, V46, P1136, DOI 10.1080/0014013031000139491; Lockhart TE, 2007, GAIT POSTURE, V26, P142, DOI 10.1016/j.gaitpost.2006.08.009; Moyer BE, 2006, ERGONOMICS, V49, P329, DOI 10.1080/00140130500478553; Nawar EW, 2007, EMERGENCY, V110; Owings TM, 2001, CLIN BIOMECH, V16, P813, DOI 10.1016/S0268-0033(01)00077-8; Pavol MJ, 2002, J GERONTOL A-BIOL, V57, pM496, DOI 10.1093/gerona/57.8.M496; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Powers CM, 2002, J FORENSIC SCI, V47, P1303; REDFERN MS, 1994, ERGONOMICS, V37, P511, DOI 10.1080/00140139408963667; Redfern MS, 2001, ERGONOMICS, V44, P1138, DOI 10.1080/00140130110085547; Roudsari BS, 2005, INJURY, V36, P1316, DOI 10.1016/j.injury.2005.05.024; Siegmund GP, 2006, GAIT POSTURE, V24, P110, DOI 10.1016/j.gaitpost.2005.08.005; TISSERAND M, 1985, ERGONOMICS, V28, P1027, DOI 10.1080/00140138508963225; Troy KL, 2008, GAIT POSTURE, V28, P461, DOI 10.1016/j.gaitpost.2008.02.008	27	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96525	10.1371/journal.pone.0096525	http://dx.doi.org/10.1371/journal.pone.0096525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789299	Green Published, gold			2022-12-27	WOS:000336655700107
J	Hwee, DT; Kennedy, A; Ryans, J; Russell, AJ; Jia, ZH; Hinken, AC; Morgans, DJ; Malik, FI; Jasper, JR				Hwee, Darren T.; Kennedy, Adam; Ryans, Julie; Russell, Alan J.; Jia, Zhiheng; Hinken, Aaron C.; Morgans, David J.; Malik, Fady I.; Jasper, Jeffrey R.			Fast Skeletal Muscle Troponin Activator tirasemtiv Increases Muscle Function and Performance in the B6SJL-SOD1(G93A) ALS Mouse Model	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; TIME-COURSE; RILUZOLE; MUTATION; IGF-1; MICE	Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease characterized by progressive motor neuron loss resulting in muscle atrophy, declining muscle function, and eventual paralysis. Patients typically die from respiratory failure 3 to 5 years from the onset of symptoms. Tirasemtiv is a fast skeletal troponin activator that sensitizes the sarcomere to calcium; this mechanism of action amplifies the response of muscle to neuromuscular input producing greater force when nerve input is reduced. Here, we demonstrate that a single dose of tirasemtiv significantly increases submaximal isometric force, forelimb grip strength, grid hang time, and rotarod performance in a female transgenic mouse model (B6SJL-SOD1(G93A)) of ALS with functional deficits. Additionally, diaphragm force and tidal volume are significantly higher in tirasemtiv-treated female B6SJL-SOD1(G93A) mice. These results support the potential of fast skeletal troponin activators to improve muscle function in neuromuscular diseases.	[Hwee, Darren T.; Kennedy, Adam; Ryans, Julie; Russell, Alan J.; Jia, Zhiheng; Hinken, Aaron C.; Morgans, David J.; Malik, Fady I.; Jasper, Jeffrey R.] Cytokinet Inc, San Francisco, CA 94080 USA		Jasper, JR (corresponding author), Cytokinet Inc, San Francisco, CA 94080 USA.	jjasper@cytokinetics.com		Russell, Alan/0000-0001-7545-5008	Cytokinetics, Inc.	Cytokinetics, Inc.	Cytokinetics, Inc. funded this study and provided support in the form of salaries for all authors, whose roles included study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo-Arozena A, 2011, DIS MODEL MECH, V4, P686, DOI 10.1242/dmm.007237; [Anonymous], 2012, RIL PACK INS; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Da Cruz S, 2012, CELL METAB, V15, P778, DOI 10.1016/j.cmet.2012.03.019; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; Jasmin BJ, 1987, J APPL PHYSL, V63; Llado J, 2006, NEUROBIOL DIS, V21, P110, DOI 10.1016/j.nbd.2005.06.019; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Miciak JJ, 2013, MUSCLE NERVE; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; Morrison BM, 2009, EXP NEUROL, V217, P258, DOI 10.1016/j.expneurol.2009.02.017; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Russell AJ, 2012, NAT MED, V18, P452, DOI 10.1038/nm.2618; Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a; Shefner J, 2012, AMYOTROPH LATERAL SC, V13, P430, DOI 10.3109/17482968.2012.684214; Siirala W, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-26; Silani V, 2011, ARCH ITAL BIOL, V149, P5, DOI 10.4449/aib.v149i1.1260; Smittkamp SE, 2008, NEUROSCIENCE, V151, P613, DOI 10.1016/j.neuroscience.2007.10.017; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Tankersley CG, 2007, J APPL PHYSIOL, V102, P926, DOI 10.1152/japplphysiol.00193.2006; Vitacca M, 1997, EUR RESPIR J, V10, P1614, DOI 10.1183/09031936.97.10071614; Wijesekera LC, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-3	25	41	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96921	10.1371/journal.pone.0096921	http://dx.doi.org/10.1371/journal.pone.0096921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805850	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900117
J	Jin, QM; Giannobile, WV				Jin, Qiming; Giannobile, William V.			SDF-1 Enhances Wound Healing of Critical-Sized Calvarial Defects beyond Self-Repair Capacity	PLOS ONE			English	Article							CELL-DERIVED FACTOR-1-ALPHA; BONE MORPHOGENETIC PROTEINS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; MICE DEFICIENT; RECEPTOR CXCR4; MIGRATION; REGENERATION; MODEL; DIFFERENTIATION	Host blood circulating stem cells are an important cell source that participates in the repair of damaged tissues. The clinical challenge is how to improve the recruitment of circulating stem cells into the local wound area and enhance tissue regeneration. Stromal-derived factor-1 (SDF-1) has been shown to be a potent chemoattractant of blood circulating stem cells into the local wound microenvironment. In order to investigate effects of SDF-1 on bone development and the repair of a large bone defect beyond host self-repair capacity, the BMP-induced subcutaneous ectopic bone formation and calvarial critical-sized defect murine models were used in this preclinical study. A dose escalation of SDF-1 were loaded into collagen scaffolds containing BMP, VEGF, or PDGF, and implanted into subcutaneous sites at mouse dorsa or calvarial critical-sized bone defects for 2 and 4 weeks. The harvested biopsies were examined by microCT and histology. The results demonstrated that while SDF-1 had no effect in the ectopic bone model in promoting de novo osteogenesis, however, in the orthotopic bone model of the critical-sized defects, SDF-1 enhanced calvarial critical-sized bone defect healing similar to VEGF, and PDGF. These results suggest that SDF-1 plays a role in the repair of large critical-sized defect where more cells are needed while not impacting de novo bone formation, which may be associated with the functions of SDF-1 on circulating stem cell recruitment and angiogenesis.	[Jin, Qiming] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Giannobile, William V.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA; [Giannobile, William V.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jin, QM (corresponding author), Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.	jinqm@umich.edu		Giannobile, William/0000-0002-7102-9746	Osteology Foundation [09-039]	Osteology Foundation	This study was supported by a research grant from the Osteology Foundation (No. 09-039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Behnan J., 2013, STEM CELLS; Behr B, 2012, TISSUE ENG PT A, V18, P1079, DOI [10.1089/ten.tea.2011.0537, 10.1089/ten.TEA.2011.0537]; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Feisst V, 2014, STEM CELLS DEV, V23, P631, DOI 10.1089/scd.2013.0207; Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102; Fujio M, 2011, BONE, V49, P693, DOI 10.1016/j.bone.2011.06.024; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129; Guo Chun-Juan, 2011, World J Stem Cells, V3, P43, DOI 10.4252/wjsc.v3.i5.43; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Ji W, 2013, BIOMATERIALS, V34, P735, DOI 10.1016/j.biomaterials.2012.10.016; Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO;2-1; Jin QM, 2004, MOL THER, V9, P519, DOI 10.1016/j.ymthe.2004.01.016; Kim DS, 2013, INT ENDOD J; Kinzebach S, 2013, ADV BIOCHEM ENG BIOT, V129, P33, DOI 10.1007/10_2012_134; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Kucia M, 2006, ARCH IMMUNOL THER EX, V54, P121, DOI 10.1007/s00005-006-0015-1; Kumagai K, 2008, J ORTHOP RES, V26, P165, DOI 10.1002/jor.20477; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu NM, 2013, J CELL BIOCHEM, V114, P2677, DOI 10.1002/jcb.24615; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nagasawa T, 2001, ANN NY ACAD SCI, V947, P112; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nass N, 2010, INT J BIOCHEM CELL B, V42, P749, DOI 10.1016/j.biocel.2010.01.012; Odemis V, 2005, MOL CELL NEUROSCI, V30, P494, DOI 10.1016/j.mcn.2005.07.019; Otsuru S, 2008, STEM CELLS, V26, P223, DOI 10.1634/stemcells.2007-0515; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Rath SN, 2013, J TISSUE ENG REGEN M; RIPAMONTI U, 1992, CRIT REV ORAL BIOL M, V3, P1, DOI 10.1177/10454411920030010101; Rutherford R B, 1992, Int J Oral Maxillofac Implants, V7, P297; SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599; SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591; SHIGENOBU K, 1993, ANN CHIR GYNAECOL, V82, P85; Shinohara K, 2011, J ORTHOP RES, V29, P1064, DOI 10.1002/jor.21374; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Suzuki T, 2011, J DENT RES, V90, P1013, DOI 10.1177/0022034511408426; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068	47	34	36	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e97035	10.1371/journal.pone.0097035	http://dx.doi.org/10.1371/journal.pone.0097035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800841	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800139
J	Kikaya, V; Skolnik, L; Garcia, MC; Nkonyana, J; Curran, K; Ashengo, TA				Kikaya, Virgile; Skolnik, Laura; Garcia, Macarena C.; Nkonyana, John; Curran, Kelly; Ashengo, Tigistu Adamu			Voluntary Medical Male Circumcision Programs Can Address Low HIV Testing and Counseling Usage and ART Enrollment among Young Men: Lessons from Lesotho	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PREVENTION; RISK; MORTALITY; KISUMU; KENYA	Background: Early diagnosis of HIV and treatment initiation at higher CD4 counts improves outcomes and reduces transmission. However, Lesotho is not realizing the full benefits of ART because of the low proportion of men tested (40%). Public sector VMMC services, which were launched in district hospitals in February 2012 by the Lesotho MOH supported by USAID/MCHIP, include HIV testing with referral to care and treatment. The objective of this study was to better understand the contribution of VMMC services to HIV diagnosis and treatment. Methods: VMMC clients diagnosed with HIV were traced after 6 months to ascertain whether they: (1) presented to the referral HIV center, (2) had a CD4 count done and (3) were enrolled on ART. Linkages between VMMC and HIV services were assessed by comparing the proportion of HIV-infected males referred from VMMC services with those from other hospital departments. Results: Between March and September 2012, 72 men presenting for VMMC services tested positive for HIV, representing 65% of the total male tests at the hospital; 45 of these men (62.5%) received an immediate CD4 count and went to the HIV referral site; 40 (89%) were eligible for treatment and initiated ART. 27 clients did not have a CD4 count due to stock-out of reagents. Individuals who did not receive a CD4 count on the same day did not return to the HIV center. Conclusion: All VMMC clients testing positive for HIV and receiving a CD4 count on the testing day began ART. Providing VMMC services in a district hospital offering the continuum of care could increase diagnoses and treatment uptake among men, but requires an investment in communication between VMMC and ART clinics. In high HIV prevalence settings, investing in PIMA CD4 devices at integrated VMMC clinics is likely to increase male ART enrolment.	[Kikaya, Virgile; Skolnik, Laura] Jhpiego, Maseru, Lesotho; [Garcia, Macarena C.] US Agcy Int Dev, Lesotho PEPFAR Program, Maseru, Lesotho; [Nkonyana, John] Minist Hlth, Maseru, Lesotho; [Curran, Kelly; Ashengo, Tigistu Adamu] Jhpiego, Baltimore, MD USA; [Curran, Kelly; Ashengo, Tigistu Adamu] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Jhpiego; United States Agency for International Development (USAID); Jhpiego; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kikaya, V (corresponding author), Jhpiego, Maseru, Lesotho.	Virgile.Kikaya@Jhpiego.org	García, Macarena/GXG-8380-2022	Garcia, Macarena/0000-0003-3716-0369	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID) [GHS-A-00-08-00002-000]	President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID) under the terms of Cooperative Agreement No. GHS-A-00-08-00002-000. The funder played a significant technical role in study analysis, decision to publish and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID or U.S. Government opinions.	[Anonymous], CONS GUID USE ANT DR; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Druyts E, 2013, AIDS, V27, P417, DOI 10.1097/QAD.0b013e328359b89b; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Lesotho Ministry of Health, 2012, PROGR DAT      UNPUB; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Ministry of Health and Social Welfare (MOHSW) [Lesotho] and ICF Macro, 2010, LES DEM HLTH SURV 20; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; US department of Health and Human services, 2013, HIV AIDS CAR CONT; World Health Organization, 2012, SERV DEL APPR HIV TE	14	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e83614	10.1371/journal.pone.0083614	http://dx.doi.org/10.1371/journal.pone.0083614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801714	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800006
J	Youn, JC; Yu, HT; Jeon, JW; Lee, HS; Jang, Y; Park, YW; Park, YB; Shin, EC; Ha, JW				Youn, Jong-Chan; Yu, Hee Tae; Jeon, Jae-Won; Lee, Hye Sun; Jang, Yangsoo; Park, Young Woo; Park, Yong-Beom; Shin, Eui-Cheol; Ha, Jong-Won			Soluble CD93 Levels in Patients with Acute Myocardial Infarction and Its Implication on Clinical Outcome	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; INFLAMMATION; ATHEROSCLEROSIS; MORTALITY; PLASMA; RISK	Background: Inflammation plays a key role in the pathogenesis of acute myocardial infarction (MI). However, it is unclear whether marker of immune activation will provide prognostic information in these patients. We hypothesized that circulating levels of soluble CD93 (sCD93), a soluble form of transmembrane glycoprotein CD93, is increased in acute MI patients and its level would be associated with clinical outcomes in patients with acute MI. Methods: We measured circulating levels of sCD93 in 120 patients with acute MI (63 +/- 13 yrs, M:F = 85:35) and in 120 age, sex-matched control subjects. In patients with acute MI, clinical characteristics, echocardiographic and laboratory findings were assessed at the time of initial enrollment. The primary outcome was defined as all-cause and cardiovascular death. Results: Circulating sCD93 levels were significantly higher in patients with acute MI than in control subjects (552.1 +/- 293.7 vs. 429.8 +/- 114.2 ng/mL, p < 0.0001). Upon in vitro inflammatory stimulation, increased CD93 shedding was demonstrated in acute MI patients but not in control subjects. During follow up period (median 208 days, 3-1058 days), the primary outcome occurred in 18 (15%) patients (9 cardiovascular deaths). Circulating levels of sCD93 were associated with all cause (p < 0.0001) and cardiovascular (p < 0.0001) mortality in patients with acute MI. Multivariate Cox regression analysis revealed that initial sCD93 level was found to be an independent predictor of all cause (p = 0.002) and cardiovascular mortality (p = 0.033) when controlled for age and left ventricular ejection fraction. Conclusions: Circulating levels of sCD93 are elevated in patients with acute MI and their levels were associated with adverse clinical outcomes.	[Youn, Jong-Chan; Jang, Yangsoo; Ha, Jong-Won] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Youn, Jong-Chan; Yu, Hee Tae; Shin, Eui-Cheol] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea; [Jeon, Jae-Won; Park, Young Woo] Korea Res Inst Biosci & Biotechnol, Therapeut Antibody Res Ctr, Taejon, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Yonsei Cardiovasc Genome Ctr, Seoul, South Korea; [Park, Yong-Beom] Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, EC (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Lab Immunol & Infect Dis, Taejon 305701, South Korea.	ecshin@kaist.ac.kr; jwha@yuhs.ac	Shin, Eui-Cheol/C-1690-2011; Youn, Jong-Chan/AAS-1405-2020; Lee, Hye Sun/J-2154-2015	Shin, Eui-Cheol/0000-0002-6308-9503; Lee, Hye Sun/0000-0001-6328-6948; Ha, Jong-Won/0000-0002-8260-2958; Jang, Yangsoo/0000-0002-2169-3112; Youn, Jong-Chan/0000-0003-0998-503X	Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea [0412-CR02-0704-0001]; KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology	Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea; KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology	This study was supported by the grants of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (0412-CR02-0704-0001). This work was also supported by the KAIST (Korea Advanced Institute of Science and Technology) Future Systems Healthcare Project from the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Jeon JW, 2010, J IMMUNOL, V185, P4921, DOI 10.4049/jimmunol.0904011; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Malarstig A, 2011, J INTERN MED, V270, P229, DOI 10.1111/j.1365-2796.2011.02364.x; Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033; Shiffman D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002895; Suleiman M, 2006, J AM COLL CARDIOL, V47, P962, DOI 10.1016/j.jacc.2005.10.055; Suleiman M, 2003, AM J MED, V115, P695, DOI 10.1016/j.amjmed.2003.06.008; van der Net JB, 2008, EUR HEART J, V29, P2195, DOI 10.1093/eurheartj/ehn303	12	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96538	10.1371/journal.pone.0096538	http://dx.doi.org/10.1371/journal.pone.0096538			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801400	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800083
J	Ismail, MB; Shinohara, M; Shinohara, A				Ismail, Mohammad Bani; Shinohara, Miki; Shinohara, Akira			Dot1-Dependent Histone H3K79 Methylation Promotes the Formation of Meiotic Double-Strand Breaks in the Absence of Histone H3K4 Methylation in Budding Yeast	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; GENE ENCODES; RECOMBINATION; MEIOSIS; PROTEIN; RAD51; DOT1; CROSSOVER	Epigenetic marks such as histone modifications play roles in various chromosome dynamics in mitosis and meiosis. Methylation of histones H3 at positions K4 and K79 is involved in the initiation of recombination and the recombination checkpoint, respectively, during meiosis in the budding yeast. Set1 promotes H3K4 methylation while Dot1 promotes H3K79 methylation. In this study, we carried out detailed analyses of meiosis in mutants of the SET1 and DOT1 genes as well as methylation-defective mutants of histone H3. We confirmed the role of Set1-dependent H3K4 methylation in the formation of double-strand breaks (DSBs) in meiosis for the initiation of meiotic recombination, and we showed the involvement of Dot1 (H3K79 methylation) in DSB formation in the absence of Set1-dependent H3K4 methylation. In addition, we showed that the histone H3K4 methylation-defective mutants are defective in SC elongation, although they seem to have moderate reduction of DSBs. This suggests that high levels of DSBs mediated by histone H3K4 methylation promote SC elongation.	[Ismail, Mohammad Bani; Shinohara, Miki; Shinohara, Akira] Osaka Univ, Inst Prot Res, Grad Sch Sci, Suita, Osaka 565, Japan	Osaka University	Shinohara, A (corresponding author), Osaka Univ, Inst Prot Res, Grad Sch Sci, Suita, Osaka 565, Japan.	ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235; Bani Ismail, Mohammad/0000-0001-9278-7258	Ministry of Education, Science, Sport and Culture; Asahi-Glass Science Foundation; Uehara Science Foundation; Mochida Medical Science Foundation; Takeda Science Foundation; Japanese Society for the Promotion of Science through the Next Generation World-Leading Researchers program (NEXT); Grants-in-Aid for Scientific Research [26650007] Funding Source: KAKEN	Ministry of Education, Science, Sport and Culture; Asahi-Glass Science Foundation; Uehara Science Foundation(Uehara Memorial Foundation); Mochida Medical Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science through the Next Generation World-Leading Researchers program (NEXT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Sport and Culture to A. S. and M. S., as well as grants from the Asahi-Glass Science Foundation, the Uehara Science Foundation, the Mochida Medical Science Foundation and the Takeda Science Foundation to A. S. M. S. was supported by the Japanese Society for the Promotion of Science through the Next Generation World-Leading Researchers program (NEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva L, 2013, SCIENCE, V339, P215, DOI 10.1126/science.1225739; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Argunhan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065875; Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2008, P NATL ACAD SCI USA, V105, P3327, DOI 10.1073/pnas.0711864105; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Brick K, 2012, NATURE, V485, P642, DOI 10.1038/nature11089; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Carballo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003545; Choi KH, 2013, NAT GENET, V45, P1327, DOI 10.1038/ng.2766; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Conde F, 2008, GENETICS, V179, P1197, DOI 10.1534/genetics.108.089003; Conde F, 2010, DNA REPAIR, V9, P1038, DOI 10.1016/j.dnarep.2010.07.003; Conde F, 2009, GENETICS, V182, P437, DOI 10.1534/genetics.109.101899; Farmer S, 2011, METHODS MOL BIOL, V745, P33, DOI 10.1007/978-1-61779-129-1_3; Gray S, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130019; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLLINGSWORTH NM, 1990, CELL, V61, P73, DOI 10.1016/0092-8674(90)90216-2; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; LEEM SH, 1992, NUCLEIC ACIDS RES, V20, P449, DOI 10.1093/nar/20.3.449; Levesque N, 2010, J BIOL CHEM, V285, P35113, DOI 10.1074/jbc.M110.116855; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Sollier J, 2004, EMBO J, V23, P1957, DOI 10.1038/sj.emboj.7600204; Sommermeyer V, 2013, MOL CELL, V49, P43, DOI 10.1016/j.molcel.2012.11.008; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Trelles-Sticken E, 2005, J CELL SCI, V118, P4985, DOI 10.1242/jcs.02612; Wojtasz L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000702; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yamada S, 2013, NUCLEIC ACIDS RES, V41, P3504, DOI 10.1093/nar/gkt049; Yamada T, 2013, J BIOCH; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zalevsky J, 1999, GENETICS, V153, P1271; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	68	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96648	10.1371/journal.pone.0096648	http://dx.doi.org/10.1371/journal.pone.0096648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797370	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000110
J	Jin, L; Liu, QH; Scott, P; Zhang, DW; Shen, F; Balian, G; Li, XD				Jin, Li; Liu, Qihai; Scott, Phillip; Zhang, Dawei; Shen, Francis; Balian, Gary; Li, Xudong			Annulus Fibrosus Cell Characteristics Are a Potential Source of Intervertebral Disc Pathogenesis	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; NUCLEUS PULPOSUS; PROGENITOR CELLS; BONE-FORMATION; STROMAL CELLS; DEGENERATION; DEDIFFERENTIATION; EXPRESSION; DIFFERENTIATION; CULTURE	In the end stage of intervertebral disc degeneration, cartilage, bone, endothelial cells, and neurons appear in association with the worsening condition. The origin of the abnormal cells is not clear. This study investigated the properties of progenitor cells in the annulus fibrosus (AF) using one in vitro and two in vivo models. Cultivation of rabbit AF cells with chondrogenic media significantly increased expressions of collagen and aggrecan. Upon exposure to osteogenic conditions, the cultures showed increased mineralization and expression of osteopontin, runx2, and bmp2 genes. Two models were used in the in vivo subcutaneous implantation experiments: 1) rabbit AF tissue in a demineralized bone matrix (DBM) cylinder (DBM/AF), and, 2) rat intact and needle punctured lumbar discs. Bone formation in the AF tissue was detected and hypertrophic chondrocytes and osteoblasts were present 1 month after implantation of the DBM/AF to nude mice. In addition to collagen I and II, immunostaining shows collagen X and osteocalcin expression in DBM/AF specimens 4 months after implantation. Similar changes were detected in the injured discs. Almost the entire needle punctured disc had ossified at 6 months. The results suggest that AF cells have characteristics of progenitor cells and, under appropriate stimuli, are capable of differentiating into chondrocytes and osteoblasts in vitro as well as in vivo. Importantly, these cells may be a target for biological treatment of disc degeneration.	[Jin, Li; Liu, Qihai; Scott, Phillip; Zhang, Dawei; Shen, Francis; Balian, Gary; Li, Xudong] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA	University of Virginia	Jin, L (corresponding author), Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22903 USA.	lj7q@virginia.edu	Liu, Qihai/N-5941-2014		NIAMS [R01]; NASS [R01]	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NASS	The study was supported by NIAMS R01 (Li) and NASS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53; Adams MA, 2010, CLIN BIOMECH, V25, P961, DOI 10.1016/j.clinbiomech.2010.07.016; Anderson D Greg, 2005, Spine J, V5, p260S, DOI 10.1016/j.spinee.2005.02.010; Anderson DG, 2005, SPINE, V30, P1242, DOI 10.1097/01.brs.0000164097.47091.4c; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Awad JN, 2006, CLIN ORTHOP RELAT R, P183, DOI 10.1097/01.blo.0000198724.54891.3a; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; Battie MC, 2008, SPINE, V33, P2801, DOI 10.1097/BRS.0b013e31818043b7; Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; CHELBERG MK, 1995, J ANAT, V186, P43; Chen ZL, 2007, ANNU REV NEUROSCI, V30, P209, DOI 10.1146/annurev.neuro.30.051606.094337; COPPES MH, 1990, LANCET, V336, P189, DOI 10.1016/0140-6736(90)91723-N; Cui M, 2008, SPINE J, V8, P287, DOI 10.1016/j.spinee.2007.05.012; Diamond S, 2006, BEST PRACT RES CL RH, V20, P707, DOI 10.1016/j.berh.2006.04.002; Diaz-Romero J, 2008, J CELL PHYSIOL, V214, P75, DOI 10.1002/jcp.21161; Elaut G, 2006, CURR DRUG METAB, V7, P629, DOI 10.2174/138920006778017759; Feng G, 2010, J BONE JOINT SURG AM, V92A, P675, DOI 10.2106/JBJS.H.01672; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Freemont T.J., 2001, EXPERT REV MOL MED, V2001, P1, DOI DOI 10.1017/S1462399401002885; Gong MQ, 2010, MAT SCI ENG C-MATER, V30, P531, DOI 10.1016/j.msec.2010.01.015; Gruber HE, 1997, EXP CELL RES, V235, P13, DOI 10.1006/excr.1997.3647; Gurevitch O, 2007, EXP HEMATOL, V35, P128, DOI 10.1016/j.exphem.2006.09.010; Hadjipavlou AG, 2008, J BONE JOINT SURG BR, V90B, P1261, DOI 10.1302/0301-620X.90B10.20910; HEGEWALD AA, 2011, SPINE PHILA PA 1976; Henriksson HB, 2009, SPINE, V34, P2278, DOI 10.1097/BRS.0b013e3181a95ad2; Inoue G, 2006, SPINE, V31, P1433, DOI 10.1097/01.brs.0000219946.25103.db; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin L, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412454420; Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kelempisioti A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-153; Kempen DHR, 2010, TISSUE ENG PT A, V16, P3769, DOI [10.1089/ten.tea.2010.0173, 10.1089/ten.TEA.2010.0173]; Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d; Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040; Li XD, 2004, SPINE, V29, P2229, DOI 10.1097/01.brs.0000142427.82605.fb; Lotz JC, 2004, P ANN INT IEEE EMBS, V26, P5459; MALINSKY JII, 1959, ACTA ANAT, V38, P96; Mirza SK, 2007, SPINE, V32, P816, DOI 10.1097/01.brs.0000259225.37454.38; Mizrahi O, 2013, SPINE J, V13, P803, DOI 10.1016/j.spinee.2013.02.065; Nosikova Y, 2013, SPINE J, V13, P443, DOI 10.1016/j.spinee.2012.11.050; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Peng BG, 2009, SPINE, V34, pE178, DOI 10.1097/BRS.0b013e3181908ab3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Scott MA, 2012, STEM CELLS DEV, V21, P655, DOI 10.1089/scd.2011.0517; Seyedjafari E, 2011, J MATER SCI-MATER M, V22, P165, DOI 10.1007/s10856-010-4174-6; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; URIST MR, 1970, CLIN ORTHOP RELAT R, P271, DOI 10.1097/00003086-197007000-00031; Videman T, 2008, SPINE, V33, P2781, DOI 10.1097/BRS.0b013e31817e1d11; Wang JC, 2005, SPINE, V30, pS33, DOI 10.1097/01.brs.0000174559.13749.83; Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022; Zhang DW, 2013, J ORTHOP RES, V31, P210, DOI 10.1002/jor.22216	61	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96519	10.1371/journal.pone.0096519	http://dx.doi.org/10.1371/journal.pone.0096519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796761	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000086
J	Liptrot, MG; Sidaros, K; Dyrby, TB				Liptrot, Matthew G.; Sidaros, Karam; Dyrby, Tim B.			Addressing the Path-Length-Dependency Confound in White Matter Tract Segmentation	PLOS ONE			English	Article							TRACTOGRAPHY-BASED PARCELLATION; FIBER TRACKING; DIFFUSION; CONNECTIVITY; DISTORTION; CORTEX; BRAIN	We derive the Iterative Confidence Enhancement of Tractography (ICE-T) framework to address the problem of path-length dependency (PLD), the streamline dispersivity confound inherent to probabilistic tractography methods. We show that PLD can arise as a non-linear effect, compounded by tissue complexity, and therefore cannot be handled using linear correction methods. ICE-T is an easy-to-implement framework that acts as a wrapper around most probabilistic streamline tractography methods, iteratively growing the tractography seed regions. Tract networks segmented with ICE-T can subsequently be delineated with a global threshold, even from a single-voxel seed. We investigated ICE-T performance using ex vivo pig-brain datasets where true positives were known via in vivo tracers, and applied the derived ICE-T parameters to a human in vivo dataset. We examined the parameter space of ICE-T: the number of streamlines emitted per voxel, and a threshold applied at each iteration. As few as 20 streamlines per seed-voxel, and a robust range of ICE-T thresholds, were shown to sufficiently segment the desired tract network. Outside this range, the tract network either approximated the complete white-matter compartment (too low threshold) or failed to propagate through complex regions (too high threshold). The parameters were shown to be generalizable across seed regions. With ICE-T, the degree of both near-seed flare due to false positives, and of distal false negatives, are decreased when compared with thresholded probabilistic tractography without ICE-T. Since ICE-T only addresses PLD, the degree of remaining false-positives and false-negatives will consequently be mainly attributable to the particular tractography method employed. Given the benefits offered by ICE-T, we would suggest that future studies consider this or a similar approach when using tractography to provide tract segmentations for tract based analysis, or for brain network analysis.	[Liptrot, Matthew G.; Sidaros, Karam; Dyrby, Tim B.] Univ Copenhagen, Hvidovre Hosp, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark; [Liptrot, Matthew G.] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Liptrot, MG (corresponding author), Univ Copenhagen, Hvidovre Hosp, Ctr Funct & Diagnost Imaging & Res, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark.	matthew.liptrot@di.ku.dk	Liptrot, Matthew/C-2384-2009; Dyrby, Tim Bjørn/M-4823-2015	Liptrot, Matthew/0000-0002-3381-4380; Dyrby, Tim Bjørn/0000-0003-3361-9734	Future and Emerging Technologies (FET) program within the Seventh Framework Program for Research of the European Commission [238292]; Lundbeck Foundation [R59-A5399]	Future and Emerging Technologies (FET) program within the Seventh Framework Program for Research of the European Commission; Lundbeck Foundation(Lundbeckfonden)	The study was a part of the project "CONNECT" that acknowledges the financial support of the Future and Emerging Technologies (FET) program within the Seventh Framework Program for Research of the European Commission, under FET-Open grant number: 238292. T.B.D. was supported by the Lundbeck Foundation (Grant of Excellence: Mapping, Modulation & Modelling the Control of Actions, grant-no. R59-A5399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Cercignani M, 2012, NMR BIOMED, V25, P1224, DOI 10.1002/nbm.2793; Cook PA, 2006, P 13 SCI M, P2759; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Dyrby TB, 2011, HUM BRAIN MAPP, V32, P544, DOI 10.1002/hbm.21043; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hyam JA, 2012, NEUROSURGERY, V70, P162, DOI 10.1227/NEU.0b013e3182262c9a; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Jonasson L, 2005, MED IMAGE ANAL, V9, P223, DOI 10.1016/j.media.2004.07.004; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK., 2011, DIFFUSION MRI THEORY; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Liptrot M, 2010, P ISMRM, P4015; Mang SC, 2010, MAGN RESON MATER PHY, V23, P391, DOI 10.1007/s10334-009-0195-x; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Morris DM, 2008, NEUROIMAGE, V42, P1329, DOI 10.1016/j.neuroimage.2008.06.012; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.9.15; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Yushkevich PA, 2008, NEUROIMAGE, V41, P448, DOI 10.1016/j.neuroimage.2008.01.013	31	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96247	10.1371/journal.pone.0096247	http://dx.doi.org/10.1371/journal.pone.0096247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797510	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000051
J	Nunes-Silva, A; Bernardes, PTT; Rezende, BM; Lopes, F; Gomes, EC; Marques, PE; Lima, PMA; Coimbra, CC; Menezes, GB; Teixeira, MM; Pinho, V				Nunes-Silva, Albena; Bernardes, Priscila T. T.; Rezende, Barbara M.; Lopes, Fernando; Gomes, Elisa C.; Marques, Pedro E.; Lima, Paulo M. A.; Coimbra, Candido C.; Menezes, Gustavo B.; Teixeira, Mauro M.; Pinho, Vanessa			Treadmill Exercise Induces Neutrophil Recruitment into Muscle Tissue in a Reactive Oxygen Species-Dependent Manner. An Intravital Microscopy Study	PLOS ONE			English	Article							SKELETAL-MUSCLE; LEUKOCYTE RECRUITMENT; STERILE INFLAMMATION; NADPH OXIDASE; INJURY; PERFORMANCE; MECHANISMS; MARKERS; STRESS; DAMAGE	Intense exercise is a physiological stress capable of inducing the interaction of neutrophils with muscle endothelial cells and their transmigration into tissue. Mechanisms driving this physiological inflammatory response are not known. Here, we investigate whether production of reactive oxygen species is relevant for neutrophil interaction with endothelial cells and recruitment into the quadriceps muscle in mice subjected to the treadmill fatiguing exercise protocol. Mice exercised until fatigue by running for 56.3 +/- 6.8 min on an electric treadmill. Skeletal muscle was evaluated by intravital microscopy at different time points after exercise, and then removed to assess local oxidative stress and histopathological analysis. We observed an increase in plasma lactate and creatine kinase (CK) concentrations after exercise. The numbers of monocytes, neutrophils, and lymphocytes in blood increased 12 and 24 hours after the exercise. Numbers of rolling and adherent leukocytes increased 3, 6, 12, and 24 hours post-exercise, as assessed by intravital microscopy. Using LysM-eGFP mice and confocal intravital microscopy technology, we show that the number of transmigrating neutrophils increased 12 hours post-exercise. Mutant gp91(phox-/-)(non-functional NADPH oxidase) mice and mice treated with apocynin showed diminished neutrophil recruitment. SOD treatment promoted further adhesion and transmigration of leukocytes 12 hours after the exercise. These findings confirm our hypothesis that treadmill exercise increases the recruitment of leukocytes to the postcapillary venules, and NADPH oxidase-induced ROS plays an important role in this process.	[Nunes-Silva, Albena; Bernardes, Priscila T. T.; Rezende, Barbara M.; Lopes, Fernando; Pinho, Vanessa] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Resolucao Resposta Inflamatoria, Belo Horizonte, MG, Brazil; [Marques, Pedro E.; Menezes, Gustavo B.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Imunobiofoton, Belo Horizonte, MG, Brazil; [Lima, Paulo M. A.; Coimbra, Candido C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Lab Endocrinol & Metab, Belo Horizonte, MG, Brazil; [Gomes, Elisa C.; Teixeira, Mauro M.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Lab Imunofarmacol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Pinho, V (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Resolucao Resposta Inflamatoria, Belo Horizonte, MG, Brazil.	vpinho@icb.ufmg.br	Marques, Pedro Elias/U-5740-2019; Pinho, Vanessa/GXM-8532-2022; pinho, vanessa/AAC-8437-2020; Teixeira, Mauro M/A-4587-2008; Pinho, Vanessa/AAR-1686-2021; Rezende, BM/G-7071-2018; Menezes, Gustavo B/B-3350-2013	Marques, Pedro Elias/0000-0002-5613-8012; pinho, vanessa/0000-0003-1038-2324; Teixeira, Mauro M/0000-0002-6944-3008; Rezende, BM/0000-0001-7959-7732; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila TV, 2009, FUND CLIN PHARM; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Billat VL, 2003, SPORTS MED, V33, P407, DOI 10.2165/00007256-200333060-00003; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Castor MGM, 2011, J LEUKOCYTE BIOL, V89, P955, DOI 10.1189/jlb.0810464; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Cook-Mills JM, 2011, ANTIOXIDANTS REDOX S, V15; Cooper DM, 2007, J APPL PHYSIOL, V103, P700, DOI 10.1152/japplphysiol.00225.2007; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Frey RS, 2009, ANTIOXIDANTS REDOX S, V11; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Hattoria H, 2010, PNAS, V107, P3546; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kakanis MW, 2010, EXERC IMMUNOL REV, V16, P119; Kruger MJ, 2012, MED SCI SPORT EXER, V44, P872, DOI 10.1249/MSS.0b013e31823dbff3; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Lambeth JD, 2004, NATURE REV IMMUNOLOG; Lee IT, 2012, BIOCHEM PHARMACOL, V84, P581, DOI 10.1016/j.bcp.2012.05.005; Leite LHR, 2007, NEUROPEPTIDES, V41, P189, DOI 10.1016/j.npep.2007.01.002; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Malm C, 2000, J PHYSIOL-LONDON, V529, P243, DOI 10.1111/j.1469-7793.2000.00243.x; Marques PE, 2012, AFR J MICROBIOL RES, V6, P1603, DOI 10.5897/AJMR11.1645; Peake J. M., 2006, EXERCISE IMMUNOLOGY, V12; Peake JM, 2005, MED SCI SPORT EXER, V37, P737, DOI 10.1249/01.MSS.0000161804.05399.3B; Pedersen BK, 2000, PHYSL REV, V80; Pinheiro CHJ, 2012, SCAND J MED SCI SPOR, V22, P24, DOI 10.1111/j.1600-0838.2010.01143.x; Pinho V, 2011, METHODS MOL BIOL, V689, P81, DOI 10.1007/978-1-60761-950-5_6; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Schneider BSP, 2007, SPORTS MED, V37, P837; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004	35	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96464	10.1371/journal.pone.0096464	http://dx.doi.org/10.1371/journal.pone.0096464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798414	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000078
J	Baker, L; Chitas, AML; Hartley, CA; Coppo, MJC; Vaz, PK; Stent, A; Gilkerson, JR; Devlin, JM; Every, AL				Baker, Louise; Chitas, Andre M. L.; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Stent, Andrew; Gilkerson, James R.; Devlin, Joanne M.; Every, Alison L.			Recombinant Herpesvirus Glycoprotein G Improves the Protective Immune Response to Helicobacter pylori Vaccination in a Mouse Model of Disease	PLOS ONE			English	Article							INFECTIOUS LARYNGOTRACHEITIS VIRUS; CHEMOKINE BINDING-PROTEINS; THERAPEUTIC TARGETS; ORAL IMMUNIZATION; VOLUNTEERS; INFLAMMATION; VACCINES; UREASE; SAFETY; ENTEROTOXIN	Alphaherpesviruses, which have co-evolved with their hosts for more than 200 million years, evade and subvert host immune responses, in part, by expression of immuno-modulatory molecules. Alphaherpesviruses express a single, broadly conserved chemokine decoy receptor, glycoprotein G (gG), which can bind multiple chemokine classes from multiple species, including human and mouse. Previously, we demonstrated that infection of chickens with an infectious laryngotracheitis virus (ILTV) mutant deficient in gG resulted in altered host immune responses compared to infection with wild-type virus. The ability of gG to disrupt the chemokine network has the potential to be used therapeutically. Here we investigated whether gG from ILTV or equine herpesvirus 1 (EHV-1) could modulate the protective immune response induced by the Helicobacter pylori vaccine antigen, catalase (KatA). Subcutaneous immunisation of mice with KatA together with EHV-1 gG, but not ILTV gG, induced significantly higher anti-KatA IgG than KatA alone. Importantly, subcutaneous or intranasal immunisation with KatA and EHV-1 gG both resulted in significantly lower colonization levels of H. pylori colonization following challenge, compared to mice vaccinated with KatA alone. Indeed, the lowest colonization levels were observed in mice vaccinated with KatA and EHV-1 gG, subcutaneously. In contrast, formulations containing ILTV gG did not affect H. pylori colonisation levels. The difference in efficacy between EHV-1 gG and ILTV gG may reflect the different spectrum of chemokines bound by the two proteins. Together, these data indicate that the immuno-modulatory properties of viral gGs could be harnessed for improving immune responses to vaccine antigens. Future studies should focus on the mechanism of action and whether gG may have other therapeutic applications.	[Baker, Louise; Stent, Andrew; Every, Alison L.] Univ Melbourne, Fac Vet Sci, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia; [Chitas, Andre M. L.; Coppo, Mauricio J. C.; Vaz, Paola K.; Devlin, Joanne M.] Univ Melbourne, Fac Vet Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic 3052, Australia; [Hartley, Carol A.; Gilkerson, James R.] Univ Melbourne, Fac Vet Sci, Ctr Equine Infect Dis, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne	Every, AL (corresponding author), Univ Melbourne, Fac Vet Sci, Ctr Anim Biotechnol, Parkville, Vic 3052, Australia.	aevery@unimelb.edu.au	Vaz, Paola K./D-8713-2015	Vaz, Paola K./0000-0001-6877-7383; Coppo, Mauricio/0000-0002-4344-9532; Devlin, Joanne/0000-0003-0400-9670; Every, Alison/0000-0001-8275-4292; STENT, ANDREW/0000-0002-4432-8185; Hartley, Carol/0000-0001-6174-7341; Gilkerson, James/0000-0003-1801-4817	CASS Foundation Ltd Science Medicine Grant [SM/10/3137]; Special Virology Fund, Equine Infectious Diseases Laboratory, The University of Melbourne; Australian Research Council	CASS Foundation Ltd Science Medicine Grant; Special Virology Fund, Equine Infectious Diseases Laboratory, The University of Melbourne; Australian Research Council(Australian Research Council)	This work was supported by a CASS Foundation Ltd Science Medicine Grant SM/10/3137 and the Special Virology Fund, Equine Infectious Diseases Laboratory, The University of Melbourne. JM Devlin was supported by a fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2008, GUT, V57, P1065, DOI 10.1136/gut.2007.145839; Alcami A, 2010, CURR OPIN IMMUNOL, V22, P482, DOI 10.1016/j.coi.2010.06.004; Alcami A, 2009, ADV EXP MED BIOL, V666, P167; Angelakopoulos H, 2000, INFECT IMMUN, V68, P2135, DOI 10.1128/IAI.68.4.2135-2141.2000; Banerjee S, 2002, GUT, V51, P634, DOI 10.1136/gut.51.5.634; Bryant NA, 2003, EMBO J, V22, P833, DOI 10.1093/emboj/cdg092; Costes B, 2006, MICROBES INFECT, V8, P2657, DOI 10.1016/j.micinf.2006.07.014; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Czinn SJ, 2011, NAT REV GASTRO HEPAT, V8, P133, DOI 10.1038/nrgastro.2011.1; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; Devlin JM, 2008, AVIAN PATHOL, V37, P83, DOI 10.1080/03079450701802214; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Devlin JM, 2011, VACCINE, V29, P5699, DOI 10.1016/j.vaccine.2011.06.002; Devlin JM, 2010, VACCINE, V28, P1325, DOI 10.1016/j.vaccine.2009.11.013; Drummer HE, 1998, J GEN VIROL, V79, P1205, DOI 10.1099/0022-1317-79-5-1205; Every AL, 2013, TRENDS MICROBIOL, V21, P253, DOI 10.1016/j.tim.2013.02.007; Every AL, 2011, INFECT IMMUN, V79, P4186, DOI 10.1128/IAI.05602-11; Every AL, 2011, VACCINE, V29, P1514, DOI 10.1016/j.vaccine.2010.12.019; Fallon PG, 2006, TRENDS IMMUNOL, V27, P470, DOI 10.1016/j.it.2006.08.002; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Lucas A, 2004, J IMMUNOL, V173, P4765, DOI 10.4049/jimmunol.173.8.4765; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Michetti P, 1999, GASTROENTEROLOGY, V116, P804, DOI 10.1016/S0016-5085(99)70063-6; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Radcliff FJ, 1997, INFECT IMMUN, V65, P4668, DOI 10.1128/IAI.65.11.4668-4674.1997; Sayi A, 2009, J IMMUNOL, V182, P7085, DOI 10.4049/jimmunol.0803293; Skene CD, 2008, VACCINE, V26, P3880, DOI 10.1016/j.vaccine.2008.05.004; Sougioultzis S, 2002, VACCINE, V21, P194, DOI 10.1016/S0264-410X(02)00467-X; Stent A, 2012, VACCINE, V30, P7214, DOI 10.1016/j.vaccine.2012.10.022; STUDDERT MJ, 1979, AUST VET J, V55, P488, DOI 10.1111/j.1751-0813.1979.tb00377.x; Sutton P, 2001, GUT, V49, P467, DOI 10.1136/gut.49.4.467; Van de Walle GR, 2008, J VIROL, V82, P6090, DOI 10.1128/JVI.00098-08; Van de Walle GR, 2007, J IMMUNOL, V179, P4161, DOI 10.4049/jimmunol.179.6.4161; Van de Walle GR, 2009, J BIOL CHEM, V284, P5968, DOI 10.1074/jbc.M808127200; Viejo-Borbolla A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002497; Viejo-Borbolla A, 2010, J GEN VIROL, V91, P23, DOI 10.1099/vir.0.011940-0; Webb LMC, 2005, MINI-REV MED CHEM, V5, P833, DOI 10.2174/1389557054867110; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001	41	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96563	10.1371/journal.pone.0096563	http://dx.doi.org/10.1371/journal.pone.0096563			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794215	gold, Green Published			2022-12-27	WOS:000336655700113
J	Caley, P; Barry, SC				Caley, Peter; Barry, Simon C.			Quantifying Extinction Probabilities from Sighting Records: Inference and Uncertainties	PLOS ONE			English	Article							INFERRING EXTINCTION; ERADICATION; MANAGEMENT; INVASIONS	Methods are needed to estimate the probability that a population is extinct, whether to underpin decisions regarding the continuation of a invasive species eradication program, or to decide whether further searches for a rare and endangered species could be warranted. Current models for inferring extinction probability based on sighting data typically assume a constant or declining sighting rate. We develop methods to analyse these models in a Bayesian framework to estimate detection and survival probabilities of a population conditional on sighting data. We note, however, that the assumption of a constant or declining sighting rate may be hard to justify, especially for incursions of invasive species with potentially positive population growth rates. We therefore explored introducing additional process complexity via density-dependent survival and detection probabilities, with population density no longer constrained to be constant or decreasing. These models were applied to sparse carcass discoveries associated with the recent incursion of the European red fox (Vulpes vulpes) into Tasmania, Australia. While a simple model provided apparently precise estimates of parameters and extinction probability, estimates arising from the more complex model were much more uncertain, with the sparse data unable to clearly resolve the underlying population processes. The outcome of this analysis was a much higher possibility of population persistence. We conclude that if it is safe to assume detection and survival parameters are constant, then existing models can be readily applied to sighting data to estimate extinction probability. If not, methods reliant on these simple assumptions are likely overstating their accuracy, and their use to underpin decision-making potentially fraught. Instead, researchers will need to more carefully specify priors about possible population processes.	[Caley, Peter; Barry, Simon C.] Commonwealth Sci & Ind Res Org, Div Computat Informat, Canberra, ACT, Australia; [Caley, Peter; Barry, Simon C.] Commonwealth Sci & Ind Res Org, Biosecur Flagship, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Caley, P (corresponding author), Commonwealth Sci & Ind Res Org, Div Computat Informat, Canberra, ACT, Australia.	peter.caley@csiro.au	Caley, Peter/D-8638-2011	Caley, Peter/0000-0002-8077-6460	Australian Government through the CSIRO Biosecurity Flagship	Australian Government through the CSIRO Biosecurity Flagship(Australian Government)	The work was funded by the Australian Government through the CSIRO Biosecurity Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Boitani L, 2001, CONSERV BIOL SER, V5, P123; BOMFORD M, 1995, WILDLIFE SOC B, V23, P249; Brooks SP, 2000, BIOMETRICS, V56, P951, DOI 10.1111/j.0006-341X.2000.00951.x; Clements CF, 2013, J ANIM ECOL, V82, P345, DOI 10.1111/1365-2656.12005; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; DENNIS B, 1994, ECOL MONOGR, V64, P205, DOI 10.2307/2937041; EBERHARDT LL, 1987, J APPL ECOL, V24, P103, DOI 10.2307/2403790; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Lee TE, 2014, J APPL ECOL, V51, P251, DOI 10.1111/1365-2664.12144; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; Marks C, 2010, TASMANIAN TIMES 0721; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; MCCALLUM H, 1995, WILDLIFE RES, V22, P21, DOI 10.1071/WR9950021; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Polansky L, 2009, ECOLOGY, V90, P2313, DOI 10.1890/08-1461.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Regan TJ, 2006, ECOL LETT, V9, P759, DOI 10.1111/j.1461-0248.2006.00920.x; Regan TJ, 2011, J APPL ECOL, V48, P76, DOI 10.1111/j.1365-2664.2010.01915.x; Rejmanek M., 2002, TURNING TIDE ERADICA, P249; Rivadeneira MM, 2009, ECOLOGY, V90, P1291, DOI 10.1890/08-0316.1; Rout TM, 2009, J APPL ECOL, V46, P110, DOI 10.1111/j.1365-2664.2008.01586.x; Sarre SD, 2013, J APPL ECOL, V50, P459, DOI 10.1111/1365-2664.12011; Sarre Stephen D., 2007, P454; Saunders G, 2006, TECHNICAL REPORT; Saunders GR, 2010, MAMMAL REV, V40, P181, DOI 10.1111/j.1365-2907.2010.00159.x; Solow A, 2008, J APPL ECOL, V45, P424, DOI 10.1111/j.1365-2664.2007.01446.x; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; SOLOW AR, 1993, ECOLOGY, V74, P962, DOI 10.2307/1940821; SOLOW AR, 1993, J MATH BIOL, V32, P79, DOI 10.1007/BF00160376; Thompson CJ, 2013, J THEOR BIOL, V338, P16, DOI 10.1016/j.jtbi.2013.08.023; Venables WN, 2002, MODERN APPL STAT S, V4th, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015	33	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2014	9	4							e95857	10.1371/journal.pone.0095857	http://dx.doi.org/10.1371/journal.pone.0095857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AL1WP	24788945	Green Published, Green Submitted, gold			2022-12-27	WOS:000338917300020
J	Aubart, M; Gobert, D; Aubart-Cohen, F; Detaint, D; Hanna, N; d'Indya, H; Lequintrec, JS; Renard, P; Vigneron, AM; Dieude, P; Laissy, JP; Koch, P; Muti, C; Roume, J; Cusin, V; Grandchamp, B; Gouya, L; LeGuern, E; Papo, T; Boileau, C; Jondeau, G				Aubart, Melodie; Gobert, Delphine; Aubart-Cohen, Fleur; Detaint, Delphine; Hanna, Nadine; d'Indya, Hyacintha; Lequintrec, Janine-Sophie; Renard, Philippe; Vigneron, Anne-Marie; Dieude, Philippe; Laissy, Jean-Pierre; Koch, Pierre; Muti, Christine; Roume, Joelle; Cusin, Veronica; Grandchamp, Bernard; Gouya, Laurent; LeGuern, Eric; Papo, Thomas; Boileau, Catherine; Jondeau, Guillaume			Early-Onset Osteoarthritis, Charcot-Marie-Tooth Like Neuropathy, Autoimmune Features, Multiple Arterial Aneurysms and Dissections: An Unrecognized and Life Threatening Condition	PLOS ONE			English	Article							AORTIC-ANEURYSMS; MARFAN-SYNDROME; MUTATIONS; PHENOTYPE	Background: Severe osteoarthritis and thoracic aortic aneurysms have recently been associated with mutations in the SMAD3 gene, but the full clinical spectrum is incompletely defined. Methods: All SMAD3 gene mutation carriers coming to our centre and their families were investigated prospectively with a structured panel including standardized clinical workup, blood tests, total body computed tomography, joint X-rays. Electroneuromyography was performed in selected cases. Results: Thirty-four SMAD3 gene mutation carriers coming to our centre were identified and 16 relatives were considered affected because of aortic surgery or sudden death (total 50 subjects). Aortic disease was present in 72%, complicated with aortic dissection, surgery or sudden death in 56% at a mean age of 45 years. Aneurysm or tortuosity of the neck arteries was present in 78%, other arteries were affected in 44%, including dissection of coronary artery. Overall, 95% of mutation carriers displayed either aortic or extra-aortic arterial disease. Acrocyanosis was also present in the majority of patients. Osteoarticular manifestations were recorded in all patients. Joint involvement could be severe requiring surgery in young patients, of unusual localization such as tarsus or shoulder, or mimicking crystalline arthropathy with fibrocartilage calcifications. Sixty eight percent of patients displayed neurological symptoms, and 9 suffered peripheral neuropathy. Electroneuromyography revealed an axonal motor and sensory neuropathy in 3 different families, very evocative of type II Charcot-Marie-Tooth (CMT2) disease, although none had mutations in the known CMT2 genes. Autoimmune features including Sjogren's disease, rheumatoid arthritis, Hashimoto's disease, or isolated autoantibodies- were found in 36% of patients. Interpretation: SMAD3 gene mutations are associated with aortic dilatation and osteoarthritis, but also autoimmunity and peripheral neuropathy which mimics type II Charcot-Marie-Tooth.	[Aubart, Melodie; Detaint, Delphine; Jondeau, Guillaume] Hop Bichat Claude Bernard, INSERM U698, F-75877 Paris, France; [Gobert, Delphine; Papo, Thomas] Hop Bichat Claude Bernard, AP HP, Serv Med Interne, F-75877 Paris, France; [Aubart-Cohen, Fleur] Hop La Pitie Salpetriere, AP HP, Serv Med Interne, Paris, France; [Detaint, Delphine; Lequintrec, Janine-Sophie; Renard, Philippe; Vigneron, Anne-Marie; Muti, Christine; Roume, Joelle; Cusin, Veronica; Gouya, Laurent; Jondeau, Guillaume] Hop Bichat Claude Bernard, AP HP, Ctr Reference Syndromes Marfan & Apparentes, Serv Cardiol, F-75877 Paris, France; [Detaint, Delphine] Hop Bichat Claude Bernard, AP HP, Serv Cardiol, F-75877 Paris, France; [Hanna, Nadine; d'Indya, Hyacintha; Boileau, Catherine] AP HP Genet Mol, Boulogne, France; [Dieude, Philippe] Hop Bichat Claude Bernard, AP HP, Serv Rhumatol, F-75877 Paris, France; [Dieude, Philippe; Laissy, Jean-Pierre; Grandchamp, Bernard; Papo, Thomas; Jondeau, Guillaume] Univ Paris 07, UFR Med, Paris, France; [Laissy, Jean-Pierre; Koch, Pierre] Hop Bichat Claude Bernard, AP HP, Serv Radiol, F-75877 Paris, France; [Gouya, Laurent; Boileau, Catherine] Univ Versailles SQY, UFR Sci La Sante, Guyancourt, France; [LeGuern, Eric] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Jondeau, G (corresponding author), Hop Bichat Claude Bernard, INSERM U698, F-75877 Paris, France.	guillaume.jondeau@bch.aphp.fr	boileau, catherine/M-4482-2017; Aubart, Mélodie/AHA-5006-2022	boileau, catherine/0000-0002-0371-7539; Aubart, Mélodie/0000-0002-4383-7930; Dieude, Philippe/0000-0002-4814-0307; Gouya, Laurent/0000-0002-1326-7025; HANNA, Nadine/0000-0001-5434-3111	Agence Nationale pour la Recherche (ANR) [BLAN 1129]; Ministere des affaires sociales et de la sante (PHRC) [AOM09093]	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Ministere des affaires sociales et de la sante (PHRC)	This work was supported by Agence Nationale pour la Recherche (ANR 2010 BLAN 1129). Ministere des affaires sociales et de la sante (PHRC national AOM09093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boileau C, 2012, NAT GENET, V44, P916, DOI 10.1038/ng.2348; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Felgentreff K, 2014, CLIN IMMUNOL, V150, P43, DOI 10.1016/j.clim.2013.11.008; Frischmeyer-Guerrerio PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006448; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; SKRE H, 1974, CLIN GENET, V6, P98; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; van der Linde D, 2013, J VASC SURG, V57, P96, DOI 10.1016/j.jvs.2012.06.107; van der Linde D, 2012, J AM COLL CARDIOL, V60, P397, DOI 10.1016/j.jacc.2011.12.052; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	19	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96387	10.1371/journal.pone.0096387	http://dx.doi.org/10.1371/journal.pone.0096387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804794	Green Published, gold			2022-12-27	WOS:000335728900054
J	Pallotti, F; Binelli, G; Fabbri, R; Valentino, ML; Vicenti, R; Macciocca, M; Cevoli, S; Baruzzi, A; DiMauro, S; Carelli, V				Pallotti, Francesco; Binelli, Giorgio; Fabbri, Raffaella; Valentino, Maria L.; Vicenti, Rossella; Macciocca, Maria; Cevoli, Sabina; Baruzzi, Agostino; DiMauro, Salvatore; Carelli, Valerio			A Wide Range of 3243A > G/tRNALeu(UUR) (MELAS) Mutation Loads May Segregate in Offspring through the Female Germline Bottleneck	PLOS ONE			English	Article							MAMMALIAN MITOCHONDRIAL-DNA; RANDOM GENETIC DRIFT; MUTANT MTDNA; A3243G MUTATION; RAPID SEGREGATION; HUMAN OOCYTES; HUMAN-CELLS; HETEROPLASMY; DISEASE; COMPLEMENTATION	Segregation of mutant mtDNA in human tissues and through the germline is debated, with no consensus about the nature and size of the bottleneck hypothesized to explain rapid generational shifts in mutant loads. We investigated two maternal lineages with an apparently different inheritance pattern of the same pathogenic mtDNA 3243A > G/tRNA(Leu(UUR)) (MELAS) mutation. We collected blood cells, muscle biopsies, urinary epithelium and hair follicles from 20 individuals, as well as oocytes and an ovarian biopsy from one female mutation carrier, all belonging to the two maternal lineages to assess mutant mtDNA load, and calculated the theoretical germline bottleneck size (number of segregating units). We also evaluated "mother-to-offspring'' segregations from the literature, for which heteroplasmy assessment was available in at least three siblings besides the proband. Our results showed that mutation load was prevalent in skeletal muscle and urinary epithelium, whereas in blood cells there was an inverse correlation with age, as previously reported. The histoenzymatic staining of the ovarian biopsy failed to show any cytochrome-c-oxidase defective oocyte. Analysis of four oocytes and one offspring from the same unaffected mother of the first family showed intermediate heteroplasmic mutant loads (10% to 75%), whereas very skewed loads of mutant mtDNA (0% or 81%) were detected in five offspring of another unaffected mother from the second family. Bottleneck size was 89 segregating units for the first mother and 84 for the second. This was remarkably close to 88, the number of "segregating units'' in the "mother-to-offspring'' segregations retrieved from literature. In conclusion, a wide range of mutant loads may be found in offspring tissues and oocytes, resulting from a similar theoretical bottleneck size.	[Pallotti, Francesco; DiMauro, Salvatore] Columbia Univ, Dept Neurol, New York, NY USA; [Pallotti, Francesco] Univ Insubria, Dipartimento Sci Chirurg & Morfol, Varese, Italy; [Binelli, Giorgio] Univ Insubria, Dipartimento Sci Teor & Appl, Varese, Italy; [Fabbri, Raffaella; Vicenti, Rossella; Macciocca, Maria] Univ Bologna, Osped S Orsola Malpighi, Unita Operat Ginecol & Fisiopatol Riprod Umana, Bologna, Italy; [Fabbri, Raffaella; Vicenti, Rossella; Macciocca, Maria] Univ Bologna, Dipartimento Sci Med & Chirurg DIMEC, Bologna, Italy; [Valentino, Maria L.; Cevoli, Sabina; Baruzzi, Agostino; Carelli, Valerio] Osped Bellaria, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy; [Valentino, Maria L.; Cevoli, Sabina; Baruzzi, Agostino; Carelli, Valerio] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DIBINEM, Bologna, Italy	Columbia University; University of Insubria; University of Insubria; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna	Carelli, V (corresponding author), Osped Bellaria, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.	valerio.carelli@unibo.it		Pallotti, Francesco/0000-0001-9946-8516; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; CARELLI, VALERIO/0000-0003-4923-6404	FAR (Fondo di Ateneo per la Ricerca) from University of Bologna; FAR (Fondo di Ateneo per la Ricerca) from University of Insubria	FAR (Fondo di Ateneo per la Ricerca) from University of Bologna; FAR (Fondo di Ateneo per la Ricerca) from University of Insubria	This study was supported by FAR (Fondo di Ateneo per la Ricerca) from University of Bologna and from University of Insubria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Cao LQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000756; Carling PJ, 2011, MITOCHONDRION, V11, P686, DOI 10.1016/j.mito.2011.05.004; Cevoli S, 2010, CEPHALALGIA, V30, P919, DOI 10.1177/0333102409354654; Chinnery PF, 1999, AM J MED GENET, V85, P498; Chinnery PF, 1997, BRAIN, V120, P1713, DOI 10.1093/brain/120.10.1713; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; DEVRIES D, 1994, J NEUROL SCI, V124, P77, DOI 10.1016/0022-510X(94)90014-0; Dubeau F, 2000, ANN NEUROL, V47, P179, DOI 10.1002/1531-8249(200002)47:2<179::AID-ANA7>3.0.CO;2-Z; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Elliott HR, 2008, AM J HUM GENET, V83, P254, DOI 10.1016/j.ajhg.2008.07.004; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Fabbri R, 2003, GYNECOL ONCOL, V89, P259, DOI 10.1016/S0090-8258(02)00098-7; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Gilkerson RW, 2008, J CELL BIOL, V181, P1117, DOI 10.1083/jcb.200712101; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HOWELL N, 1992, HUM GENET, V90, P117; Huang CC, 1996, ACTA NEUROL SCAND, V93, P198; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KOEHLER CM, 1991, GENETICS, V129, P247; Koga Y, 2000, ARCH DIS CHILD, V82, P407, DOI 10.1136/adc.82.5.407; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Lehtinen SK, 2000, GENETICS, V154, P363; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; LIOU CW, 1994, ACTA NEUROL SCAND, V90, P354; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; Marchington DR, 1997, AM J HUM GENET, V60, P408; MARTINUZZI A, 1992, J NEUROL SCI, V113, P222, DOI 10.1016/0022-510X(92)90250-O; McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216; Monnot S, 2011, HUM MUTAT, V32, P116, DOI 10.1002/humu.21417; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Poe BG, 2010, ANAL BIOANAL CHEM, V397, P3397, DOI 10.1007/s00216-010-3751-3; Rahman S, 2001, AM J HUM GENET, V68, P238, DOI 10.1086/316930; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Takai D, 1997, J BIOL CHEM, V272, P6028, DOI 10.1074/jbc.272.9.6028; Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wonnapinij P, 2010, AM J HUM GENET, V86, P540, DOI 10.1016/j.ajhg.2010.02.023; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699; Zsurka G, 2007, AM J HUM GENET, V80, P298, DOI 10.1086/511282	57	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96663	10.1371/journal.pone.0096663	http://dx.doi.org/10.1371/journal.pone.0096663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805791	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900079
J	Bhat, P; Leggatt, G; Matthaei, KI; Frazer, IH				Bhat, Purnima; Leggatt, Graham; Matthaei, Klaus I.; Frazer, Ian H.			The Kinematics of Cytotoxic Lymphocytes Influence Their Ability to Kill Target Cells	PLOS ONE			English	Article							MEMORY T-CELLS; IN-VIVO; NATURAL-KILLER; KERATINOCYTES; MOTILITY; MICE; MIGRATION; RESPONSES; DYNAMICS; IMMUNITY	Cytotoxic lymphocytes (CTL) have been reported to show a range of motility patterns from rapid long-range tracking to complete arrest, but how and whether these kinematics affect their ability to kill target cells is not known. Many in vitro killing assays utilize cell lines and tumour-derived cells as targets, which may be of limited relevance to the kinetics of CTL-mediated killing of somatic cells. Here, live-cell microscopy is used to examine the interactions of CTL and primary murine skin cells presenting antigens. We developed a qualitative and quantitative killing assay using extended-duration fluorescence time-lapse microscopy coupled with large-volume objective software-based data analysis to obtain population data of cell-to-cell interactions, motility and apoptosis. In vivo and ex vivo activated antigen-specific cytotoxic lymphocytes were added to primary keratinocyte targets in culture with fluorometric detection of caspase-3 activation in targets as an objective determinant of apoptosis. We found that activated CTL achieved contact-dependent apoptosis of non-tumour targets after a period of prolonged attachment - on average 21 hours - which was determined by target cell type, amount of antigen, and activation status of CTL. Activation of CTL even without engagement of the T cell receptor was sufficient to mobilise cells significantly above baseline, while the addition of cognate antigen further enhanced their motility. Highly activated CTL showed markedly increased vector displacement, and velocity, and lead to increased antigen-specific target cell death. These data show that the inherent kinematics of CTL correlate directly with their ability to kill non-tumour cells presenting cognate antigen.	[Bhat, Purnima; Leggatt, Graham; Frazer, Ian H.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Bhat, Purnima] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	University of Queensland; Australian National University; Australian National University; John Curtin School of Medical Research	Bhat, P (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia.	purnima@purnima.com	Bhat, Purnima/I-5368-2016; Leggatt, Graham/G-1924-2010; Frazer, Ian/A-1137-2007	Bhat, Purnima/0000-0002-2980-0584; Leggatt, Graham/0000-0002-4078-5653; Frazer, Ian/0000-0002-8002-4680	NHMRC PROGRAM [569938]; CCQ grant; NIH [5U01CA141583]; UQ Postdoctoral Research Fellowship; QLD Govt Smart State Premier's Fellowship; NATIONAL CANCER INSTITUTE [U01CA141583] Funding Source: NIH RePORTER	NHMRC PROGRAM(National Health and Medical Research Council (NHMRC) of Australia); CCQ grant(Cancer Council Queensland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UQ Postdoctoral Research Fellowship; QLD Govt Smart State Premier's Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NHMRC PROGRAM grant No 569938(IHF), CCQ grant (IHF and PB), CCQ grant (GL), NIH grant 5U01CA141583 (IHF). PB was in receipt of a UQ Postdoctoral Research Fellowship. IHF was in receipt of a QLD Govt Smart State Premier's Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Baran K, 2006, J BIOL CHEM, V281, P30485, DOI 10.1074/jbc.M602007200; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Boissonnas A, 2009, CURR TOP MICROBIOL, V334, P265, DOI 10.1007/978-3-540-93864-4_11; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brenner D, 2008, CRIT REV ONCOL HEMAT, V66, P52, DOI 10.1016/j.critrevonc.2008.01.002; Broom JK, 2010, J INVEST DERMATOL, V130, P1581, DOI 10.1038/jid.2010.17; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; Choi PJ, 2013, P NATL ACAD SCI USA, V110, P6488, DOI 10.1073/pnas.1221312110; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; De Kluyver RL, 2010, J INVEST DERMATOL, V130, P1841, DOI 10.1038/jid.2010.49; Deguine J, 2010, IMMUNITY, V33, P632, DOI 10.1016/j.immuni.2010.09.016; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; Egawa G, 2011, J INVEST DERMATOL, V131, P977, DOI 10.1038/jid.2010.386; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Friedman RS, 2005, SEMIN IMMUNOL, V17, P387, DOI 10.1016/j.smim.2005.09.006; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; John B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000505; Kenna TJ, 2008, BLOOD, V111, P2091, DOI 10.1182/blood-2007-07-103200; Kim BS, 2009, J INVEST DERMATOL, V129, P2805, DOI 10.1038/jid.2009.176; Leggatt GR, 2002, IMMUNOL CELL BIOL, V80, P415, DOI 10.1046/j.1440-1711.2002.01105.x; Lyubchenko TA, 2001, IMMUNITY, V15, P847, DOI 10.1016/S1074-7613(01)00233-3; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mavin E, 2012, TRANSPLANTATION, V94, P456, DOI 10.1097/TP.0b013e31826205d6; Ruocco MG, 2012, J CLIN INVEST, V122, P3718, DOI 10.1172/JCI61931; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; Vanherberghen B, 2013, BLOOD, V121, P1326, DOI 10.1182/blood-2012-06-439851; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100; Zhou F, 2009, EXP DERMATOL, V18, P1053, DOI 10.1111/j.1600-0625.2009.00907.x; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95248	10.1371/journal.pone.0095248	http://dx.doi.org/10.1371/journal.pone.0095248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801876	Green Published, gold			2022-12-27	WOS:000338029800027
J	Kraal, P; Slomp, CP				Kraal, Peter; Slomp, Caroline P.			Rapid and Extensive Alteration of Phosphorus Speciation during Oxic Storage of Wet Sediment Samples	PLOS ONE			English	Article							AUTHIGENIC APATITE FORMATION; PYRITE OXIDATION; MARINE-SEDIMENTS; ORGANIC-CARBON; RATIOS; FRACTIONATION; PRESERVATION; REGENERATION; PHOSPHATE; BURIAL	The chemical forms of phosphorus (P) in sediments are routinely measured in studies of P in modern and ancient marine environments. However, samples for such analyses are often exposed to atmospheric oxygen during storage and handling. Recent work suggests that long-term exposure of pyrite-bearing sediments can lead to a decline in apatite P and an increase in ferric Fe-bound P. Here, we report on alterations in P speciation in reducing modern Baltic Sea sediments that we deliberately exposed to atmospheric oxygen for a period of either one week or one year. During oxidation of the sediment, extensive changes occurred in all measured P reservoirs. Exchangeable P all but disappeared during the first week of exposure, likely reflecting adsorption of porewater PO4 by Fe(III) (oxyhydr)oxides (i.e. ferric Fe-bound P formation). Detrital and organic P were also rapidly affected: decreases in both reservoirs were already observed after the first week of exposure to atmospheric oxygen. This was likely because of acidic dissolution of detrital apatite and oxidation of organic matter, respectively. These processes produced dissolved PO4 that was then scavenged by Fe(III) (oxyhydr) oxides. Interestingly, P in authigenic calcium phosphates (i.e. apatite: authigenic Ca-P) remained unaffected after the first week of exposure, which we attributed to the shielding effect of microfossils in which authigenic Ca-P occurs in Baltic Sea sediments. This effect was transient; a marked decrease in the authigenic Ca-P pool was observed in the sediments after one year of exposure to oxygen. In summary, we show that handling and storage of wet sediments under oxic conditions can lead to rapid and extensive alteration of the original sediment P speciation.	[Kraal, Peter; Slomp, Caroline P.] Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands	Utrecht University	Kraal, P (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci Geochem, Utrecht, Netherlands.	p.kraal@uu.nl	Slomp, Caroline P/A-9406-2012; Kraal, Peter/H-4899-2019	Slomp, Caroline P/0000-0002-7272-0109; Kraal, Peter/0000-0002-6650-5680	Netherlands Organization for Scientific Research (NWO Vidi, NWO Open Programma); European Research Council (ERC) under the European Community's Seventh Framework Programme for ERC Starting Grant [278364]	Netherlands Organization for Scientific Research (NWO Vidi, NWO Open Programma); European Research Council (ERC) under the European Community's Seventh Framework Programme for ERC Starting Grant(European Research Council (ERC))	This research was funded by the Netherlands Organization for Scientific Research (NWO Vidi, NWO Open Programma) (www.nwo.nl) and the European Research Council (ERC) under the European Community's Seventh Framework Programme for ERC Starting Grant 278364 (http://erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V256, P130, DOI 10.1016/j.palaeo.2007.02.029; Anderson LD, 2001, GLOBAL BIOGEOCHEM CY, V15, P65, DOI 10.1029/2000GB001270; BOESEN C, 1988, AM J SCI, V288, P575, DOI 10.2475/ajs.288.6.575; BRAY JT, 1973, SCIENCE, V180, P1362, DOI 10.1126/science.180.4093.1362; Chi R, 2006, MINER ENG, V19, P979, DOI 10.1016/j.mineng.2005.10.003; EVANGELOU VP, 1995, CRIT REV ENV SCI TEC, V25, P141, DOI 10.1080/10643389509388477; Gustafsson B. G., 2011, VALIDATION DATA SET, P25; INGALL E, 1994, GEOCHIM COSMOCHIM AC, V58, P2571, DOI 10.1016/0016-7037(94)90033-7; INGALL ED, 1993, GEOCHIM COSMOCHIM AC, V57, P303, DOI 10.1016/0016-7037(93)90433-W; Jilbert T, 2011, BIOGEOSCIENCES, V8, P1699, DOI 10.5194/bg-8-1699-2011; Jilbert T, 2013, GEOCHIM COSMOCHIM AC, V107, P155, DOI 10.1016/j.gca.2013.01.005; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Kraal P, 2010, CHEM GEOL, V277, P167, DOI 10.1016/j.chemgeo.2010.08.003; Kraal P, 2009, GEOCHIM COSMOCHIM AC, V73, P3277, DOI 10.1016/j.gca.2009.02.026; Lukkari K, 2007, LIMNOL OCEANOGR-METH, V5, P445, DOI 10.4319/lom.2007.5.445; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; Moodley L, 2005, GEOLOGY, V33, P889, DOI 10.1130/G21731.1; Mort HP, 2010, GEOCHIM COSMOCHIM AC, V74, P1350, DOI 10.1016/j.gca.2009.11.016; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Nordstrom D. K., 1982, ACID SULFATE WEATHER, P37, DOI DOI 10.2136/SSSASPECPUB10.C3; RUTTENBERG KC, 1993, GEOCHIM COSMOCHIM AC, V57, P991, DOI 10.1016/0016-7037(93)90035-U; Ruttenberg KC, 2005, TREATISE ON GEOCHEMISTRY, VOL 8: BIOGEOCHEMISTRY, P585; RUTTENBERG KC, 1992, LIMNOL OCEANOGR, V37, P1460, DOI 10.4319/lo.1992.37.7.1460; Slomp CP, 1996, J MAR RES, V54, P1179, DOI 10.1357/0022240963213745; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1	26	20	20	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96859	10.1371/journal.pone.0096859	http://dx.doi.org/10.1371/journal.pone.0096859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802813	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800134
J	Meier, R; Braren, R; Kosanke, Y; Bussemer, J; Neff, F; Wildgruber, M; Schwarzenbock, S; Frank, A; Haller, B; Hohlbaum, AM; Schwaiger, M; Gille, H; Rummeny, EJ; Beer, AJ				Meier, Reinhard; Braren, Rickmer; Kosanke, Yvonne; Bussemer, Johanna; Neff, Frauke; Wildgruber, Moritz; Schwarzenboeck, Sarah; Frank, Annette; Haller, Bernhard; Hohlbaum, Andreas M.; Schwaiger, Markus; Gille, Hendrik; Rummeny, Ernst J.; Beer, Ambros J.			Multimodality Multiparametric Imaging of Early Tumor Response to a Novel Antiangiogenic Therapy Based on Anticalins	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; POSITRON-EMISSION-TOMOGRAPHY; METASTATIC COLORECTAL-CANCER; VASCULAR TARGETING AGENT; RENAL-CELL CARCINOMA; DCE-MRI; ENHANCED-MRI; ANGIOGENESIS; BEVACIZUMAB; MODEL	Anticalins are a novel class of targeted protein therapeutics. The PEGylated Anticalin Angiocal (PRS-050-PEG40) is directed against VEGF-A. The purpose of our study was to compare the performance of diffusion weighted imaging (DWI), dynamic contrast enhanced magnetic resonance imaging (DCE)-MRI and positron emission tomography with the tracer [18 F] fluorodeoxyglucose (FDG-PET) for monitoring early response to antiangiogenic therapy with PRS-050-PEG40. 31 mice were implanted subcutaneously with A673 rhabdomyosarcoma xenografts and underwent DWI, DCE-MRI and FDG-PET before and 2 days after i.p. injection of PRS-050-PEG40 (n = 13), Avastin (n = 6) or PBS (n = 12). Tumor size was measured manually with a caliper. Imaging results were correlated with histopathology. In the results, the tumor size was not significantly different in the treatment groups when compared to the control group on day 2 after therapy onset (P = 0.09). In contrast the imaging modalities DWI, DCE-MRI and FDG-PET showed significant differences between the therapeutic compared to the control group as early as 2 days after therapy onset (P<0.001). There was a strong correlation of the early changes in DWI, DCE-MRI and FDG-PET at day 2 after therapy onset and the change in tumor size at the end of therapy (r = -0.58, 0.71 and 0.67 respectively). The imaging results were confirmed by histopathology, showing early necrosis and necroptosis in the tumors. Thus multimodality multiparametric imaging was able to predict therapeutic success of PRS-050-PEG40 and Avastin as early as 2 days after onset of therapy and thus promising for monitoring early response of antiangiogenic therapy.	[Meier, Reinhard; Braren, Rickmer; Kosanke, Yvonne; Wildgruber, Moritz; Rummeny, Ernst J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany; [Bussemer, Johanna; Schwarzenboeck, Sarah; Frank, Annette; Schwaiger, Markus; Beer, Ambros J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-80290 Munich, Germany; [Neff, Frauke] Helmholtz Zentrum Munchen, Inst Expt Genet, Munich, Germany; [Haller, Bernhard] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Hohlbaum, Andreas M.; Gille, Hendrik] Pieris AG, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Meier, R (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-80290 Munich, Germany.	reinhard.meier@tum.de	Meier, Reinhard/B-2882-2014; Beer, Ambros J./AAA-5539-2022; Braren, Rickmer/U-3254-2018; Haller, Bernhard/I-1943-2019	Meier, Reinhard/0000-0002-2169-4780; Beer, Ambros J./0000-0001-9042-7806; Braren, Rickmer/0000-0001-6039-6957; Haller, Bernhard/0000-0002-9723-393X; schwaiger, markus/0000-0002-2305-7144	Pieris AG; German Research Foundation (DFG) [SFB-Initiative 824]; Technische Universitat Munchen within the funding programme Open Access Publishing	Pieris AG; German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing	This work was supported by a grant from Pieris AG by the German Research Foundation (DFG) within the SFB-Initiative 824 (collaborative research center) "Imaging for Selection, Monitoring and Individualization of Cancer Therapies'' (ISMIC, projects C5 and C6) and by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomonte J, 2008, HEPATOLOGY, V48, P1864, DOI 10.1002/hep.22546; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Aref M, 2008, MAGN RESON IMAGING, V26, P1279, DOI 10.1016/j.mri.2008.02.015; Auguste P, 2005, CRIT REV ONCOL HEMAT, V54, P53, DOI 10.1016/j.critrevonc.2004.11.006; Braren R, 2011, J HEPATOL; Braren R, 2011, INVEST RADIOL; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flaherty KT, 2008, CANCER BIOL THER, V7, P496, DOI 10.4161/cbt.7.4.5624; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Gille H, 2008, DISCOVERY CHARACTERI; Haioun C, 2005, BLOOD, V106, P1376, DOI 10.1182/blood-2005-01-0272; Hoekstra CJ, 2005, J CLIN ONCOL, V23, P8362, DOI 10.1200/JCO.2005.01.1189; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jesberger JA, 2006, J MAGN RESON IMAGING, V24, P586, DOI 10.1002/jmri.20670; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kothari M, 2003, BRIT J RADIOL, V76, pS92, DOI 10.1259/bjr/25400972; Landgren E, 1998, ONCOGENE, V16, P359, DOI 10.1038/sj.onc.1201545; Landis CS, 2000, MAGNET RESON MED, V44, P563, DOI 10.1002/1522-2594(200010)44:4<563::AID-MRM10>3.0.CO;2-#; Leach MO, 2005, BRIT J CANCER, V92, P1599, DOI 10.1038/sj.bjc.6602550; Meyer T, 2009, J THROMB HAEMOST, V7, P171, DOI 10.1111/j.1538-7836.2008.03212.x; Morgan B, 2003, J CLIN ONCOL, V21, P3955, DOI 10.1200/JCO.2003.08.092; Mross K, 2011, MOL CANC THER, V10; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; O'Connor JPB, 2007, BRIT J CANCER, V96, P189, DOI 10.1038/sj.bjc.6603515; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Roberts C, 2006, J MAGN RESON IMAGING, V23, P554, DOI 10.1002/jmri.20529; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Steingoetter A, 2011, MAGN RESON MED, V65, P229, DOI 10.1002/mrm.22589; Swisher SG, 2004, CANCER, V101, P1776, DOI 10.1002/cncr.20585; Thoeny HC, 2005, NEOPLASIA, V7, P779, DOI 10.1593/neo.04748; Thoeny HC, 2005, RADIOLOGY, V237, P492, DOI 10.1148/radiol.2372041638; Thoeny HC, 2005, RADIOLOGY, V234, P756, DOI 10.1148/radiol.2343031721; Tortora G, 2004, CURR PHARM DESIGN, V10, P11, DOI 10.2174/1381612043453595; Veikkola T, 2000, CANCER RES, V60, P203; Weber WA, 2009, J NUCL MED, V50, p1S, DOI 10.2967/jnumed.108.057174; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94972	10.1371/journal.pone.0094972	http://dx.doi.org/10.1371/journal.pone.0094972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801709	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800026
J	Menon, V; Gold, E; Godbole, R; Castor, D; Mahler, H; Forsythe, S; Ally, M; Njeuhmeli, E				Menon, Veena; Gold, Elizabeth; Godbole, Ramona; Castor, Delivette; Mahler, Hally; Forsythe, Steven; Ally, Mariam; Njeuhmeli, Emmanuel			Costs and Impacts of Scaling up Voluntary Medical Male Circumcision in Tanzania	PLOS ONE			English	Article							HIV PREVENTION; MEN	Background: Given the proven effectiveness of voluntary medical male circumcision (VMMC) in preventing the spread of HIV, Tanzania is scaling up VMMC as an HIV prevention strategy. This study will inform policymakers about the potential costs and benefits of scaling up VMMC services in Tanzania. Methodology: The analysis first assessed the unit costs of delivering VMMC at the facility level in three regions-Iringa, Kagera, and Mbeya-via three currently used VMMC service delivery models (routine, campaign, and mobile/island outreach). Subsequently, using these unit cost data estimates, the study used the Decision Makers' Program Planning Tool (DMPPT) to estimate the costs and impact of a scaled-up VMMC program. Results: Increasing VMMC could substantially reduce HIV infection. Scaling up adult VMMC to reach 87.9% coverage by 2015 would avert nearly 23,000 new adult HIV infections through 2015 and an additional 167,500 from 2016 through 2025-at an additional cost of US$253.7 million through 2015 and US$302.3 million from 2016 through 2025. Average cost per HIV infection averted would be US$11,300 during 2010-2015 and US$3,200 during 2010-2025. Scaling up VMMC in Tanzania will yield significant net benefits (benefits of treatment costs averted minus the cost of performing circumcisions) in the long run-around US$4,200 in net benefits for each infection averted. Conclusion: VMMC could have an immediate impact on HIV transmission, but the full impact on prevalence and deaths will only be apparent in the longer term because VMMC averts infections some years into the future among people who have been circumcised. Given the health and economic benefits of investing in VMMC, the scale-up of services should continue to be a central component of the national HIV prevention strategy in Tanzania.	[Menon, Veena; Godbole, Ramona; Forsythe, Steven] HPI Costing Task Order, Washington, DC 20005 USA; [Menon, Veena; Godbole, Ramona] Futures Grp Inc, Washington, DC USA; [Gold, Elizabeth] Maternal & Child Hlth Integrated Program Jhpiego, Baltimore, MD USA; [Godbole, Ramona; Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Mahler, Hally] Maternal & Child Hlth Integrated Program Jhpiego, Dar Es Salaam, Tanzania; [Forsythe, Steven] Futures Inst, Glastonbury, CT USA; [Ally, Mariam] Minist Hlth & Social Welf, Dar Es Salaam, Tanzania	Jhpiego; United States Agency for International Development (USAID); Jhpiego	Menon, V (corresponding author), HPI Costing Task Order, Washington, DC 20005 USA.	vmenon@futuresgroup.com	Forsythe, Steven/AAL-7558-2020	Forsythe, Steven/0000-0002-4409-5991	United States Agency for International Development (USAID) Health Policy Initiative [AID-OAA-TO-10-00012]	United States Agency for International Development (USAID) Health Policy Initiative(United States Agency for International Development (USAID))	Produced with support from United States Agency for International Development (USAID) Health Policy Initiative, Costing Task Order # AID-OAA-TO-10-00012. USAID staff played a role in study design and data analysis, decision to publish, or preparation of the manuscript. USAID staff did not play a role in data collection. The view expressed in this manuscript does not represent USAID or USG opinion.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002679; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bollinger L, 2009, MALE CIRCUMCISION DE; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Ministry of Health and Social Welfare, 2010, NAT STRAT SCAL MAL C; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132	7	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e83925	10.1371/journal.pone.0083925	http://dx.doi.org/10.1371/journal.pone.0083925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802022	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800008
J	Negi, S; Sawano, M; Kohsaka, S; Inohara, T; Shiraishi, Y; Kohno, T; Maekawa, Y; Sano, M; Yoshikawa, T; Fukuda, K				Negi, Sayoko; Sawano, Mitsuaki; Kohsaka, Shun; Inohara, Taku; Shiraishi, Yasuyuki; Kohno, Takashi; Maekawa, Yuichiro; Sano, Motoaki; Yoshikawa, Tsutomu; Fukuda, Keiichi			Prognostic Implication of Physical Signs of Congestion in Acute Heart Failure Patients and Its Association with Steady-State Biomarker Levels	PLOS ONE			English	Article							CARDIAC TROPONIN-T; IN-HOSPITAL MORTALITY; NATRIURETIC-PEPTIDE; OUTCOMES; CARDIOMYOPATHY; MANAGEMENT; THERAPY; TRIAL; TIME	Background: Congestive physical findings such as pulmonary rales and third heart sound (S3) are hallmarks of acute heart failure (AHF). However, their role in outcome prediction remains unclear. We sought to investigate the association between congestive physical findings upon admission, steady-state biomarkers at the time of discharge, and long-term outcomes in AHF patients. Methods: We analyzed the data of 133 consecutive AHF patients with an established diagnosis of ischemic or non-ischemic (dilated or hypertrophic) cardiomyopathy, admitted to a single-center university hospital between 2006 and 2010. The treating physician prospectively recorded major symptoms and congestive physical findings of AHF: paroxysmal nocturnal dyspnea, orthopnea, pulmonary rales, jugular venous distension (JVD), S3, and edema. The primary endpoint was defined as rehospitalization for HF. Results: Majority (63.9%) of the patients had non-ischemic etiology and, at the time of admission, S3 was seen in 69.9% of the patients, JVD in 54.1%, and pulmonary rales in 43.6%. The mean follow-up period was 726 +/- 31days. Patients with pulmonary rales (p < 0.001) and S3 (p = 0.011) had worse readmission rates than those without these findings; the presence of these findings was also associated with elevated troponin T (TnT) levels at the time of discharge (odds ratio [ OR] 2.8; p = 0.02 and OR 2.6; p = 0.05, respectively). Conclusion: Pulmonary rales and S3 were associated with inferior readmission rates and elevated TnT levels on discharge. The worsening of the readmission rate owing to congestive physical findings may be a consequence of on-going myocardial injury.	[Negi, Sayoko; Sawano, Mitsuaki; Kohsaka, Shun; Inohara, Taku; Shiraishi, Yasuyuki; Kohno, Takashi; Maekawa, Yuichiro; Sano, Motoaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Yoshikawa, Tsutomu] Sakakibara Heart Inst, Tokyo, Japan	Keio University	Kohsaka, S (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	kohsaka@cpnet.med.keio.ac.jp	Sano, Motoaki/L-3405-2013; Fukuda, Keiichi/L-3777-2013	Kohsaka, Shun/0000-0003-3779-2972				Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; Del Carlo CH, 1999, AM HEART J, V138, P646, DOI 10.1016/S0002-8703(99)70178-X; Devroey D, 2011, VASC HEALTH RISK MAN, V7, P591, DOI 10.2147/VHRM.S24476; Drazner MH, 2008, CIRC-HEART FAIL, V1, P170, DOI 10.1161/CIRCHEARTFAILURE.108.769778; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; Fonarow GC, 2008, AM J CARDIOL, V101, P231, DOI 10.1016/j.amjcard.2007.07.066; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; Gaggin HK, 2012, J CARD FAIL, V18, P626, DOI 10.1016/j.cardfail.2012.05.005; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Januzzi JL, 2013, CIRCULATION, V127, P500, DOI 10.1161/CIRCULATIONAHA.112.120485; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Latini R, 2007, CIRCULATION, V116, P1242, DOI 10.1161/CIRCULATIONAHA.106.655076; Miller WL, 2007, CIRCULATION, V116, P249, DOI 10.1161/CIRCULATIONAHA.107.694562; Missov E, 1997, CIRCULATION, V96, P2953, DOI 10.1161/01.CIR.96.9.2953; Nishii M, 2008, J AM COLL CARDIOL, V51, P2329, DOI 10.1016/j.jacc.2007.11.085; Perna ER, 2004, CIRCULATION, V110, P2376, DOI 10.1161/01.CIR.0000145158.33801.F3; Pfisterer M, 2009, JAMA-J AM MED ASSOC, V301, P383, DOI 10.1001/jama.2009.2; Sato Y, 2001, CIRCULATION, V103, P369; Takashio S, 2013, J AM COLL CARDIOL, V62, P632, DOI 10.1016/j.jacc.2013.03.065	21	22	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96325	10.1371/journal.pone.0096325	http://dx.doi.org/10.1371/journal.pone.0096325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802880	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800055
J	Hanna, S; Miskolci, V; Cox, D; Hodgson, L				Hanna, Samer; Miskolci, Veronika; Cox, Dianne; Hodgson, Louis			A New Genetically Encoded Single-Chain Biosensor for Cdc42 Based on FRET, Useful for Live-Cell Imaging	PLOS ONE			English	Article							RHO-GTPASES; ACTIVATION; MEMBRANE; DESIGN; RAC1	Cdc42 is critical in a myriad of cellular morphogenic processes, requiring precisely regulated activation dynamics to affect specific cellular events. To facilitate direct observations of Cdc42 activation in live cells, we developed and validated a new biosensor of Cdc42 activation. The biosensor is genetically encoded, of single-chain design and capable of correctly localizing to membrane compartments as well as interacting with its upstream regulators including the guanine nucleotide dissociation inhibitor. We characterized this new biosensor in motile mouse embryonic fibroblasts and observed robust activation dynamics at leading edge protrusions, similar to those previously observed for endogenous Cdc42 using the organic dye-based biosensor system. We then extended our validations and observations of Cdc42 activity to macrophages, and show that this new biosensor is able to detect differential activation patterns during phagocytosis and cytokine stimulation. Furthermore, we observe for the first time, a highly transient and localized activation of Cdc42 during podosome formation in macrophages, which was previously hypothesized but never directly visualized.	[Hanna, Samer; Miskolci, Veronika; Cox, Dianne; Hodgson, Louis] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Cox, Dianne; Hodgson, Louis] Yeshiva Univ, Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cox, D (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	Dianne.cox@einstein.yu.edu; Louis.hodgson@einstein.yu.edu		Hodgson, Louis/0000-0001-9188-7580; Cox, Dianne/0000-0002-0591-9767	NIH [GM093121, GM071828, T32GM007491]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093121, R01GM071828, T32GM007491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH GM093121 (L.H.), NIH GM071828 (D.C., S.H.) and NIH T32GM007491 (V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blundell MP, 2009, P NATL ACAD SCI USA, V106, P15738, DOI 10.1073/pnas.0904346106; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Cervero P, 2013, METHODS MOL BIOL, V1046, P97, DOI 10.1007/978-1-62703-538-5_6; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fritz RD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004135; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Hodgson L, 2008, METHOD CELL BIOL, V85, P63, DOI 10.1016/S0091-679X(08)85004-2; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Liu H, 2011, CLIN CHIM ACTA, V412, P1180, DOI 10.1016/j.cca.2011.03.036; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miskolci V, 2013, METHODS MOL IN PRESS; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; PARK H, 2011, J BIOL CHEM; Park H, 2011, J BIOL CHEM, V286, P14762, DOI 10.1074/jbc.M110.185181; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Seth A, 2003, BIOCHEMISTRY-US, V42, P3997, DOI 10.1021/bi026881z; Spiering D, 2011, METHODS MOL BIOL; Spiering D, 2013, METHOD CELL BIOL, V114, P593, DOI 10.1016/B978-0-12-407761-4.00025-7; Spiering D, 2012, METHODS MOL BIOL, V827, P215, DOI 10.1007/978-1-61779-442-1_15; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Zawistowski J, 2013, PLOS ONE IN PRESS	40	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96469	10.1371/journal.pone.0096469	http://dx.doi.org/10.1371/journal.pone.0096469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798463	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000080
J	Ceretti, E; Feretti, D; Viola, GCV; Zerbini, I; Limina, RM; Zani, C; Capelli, M; Lamera, R; Donato, F; Gelatti, U				Ceretti, Elisabetta; Feretti, Donatella; Viola, Gaia C. V.; Zerbini, Ilaria; Limina, Rosa M.; Zani, Claudia; Capelli, Michela; Lamera, Rossella; Donato, Francesco; Gelatti, Umberto			DNA Damage in Buccal Mucosa Cells of Pre-School Children Exposed to High Levels of Urban Air Pollutants	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; MICRONUCLEUS FREQUENCY; ENVIRONMENTAL-POLLUTANTS; CIRCULATING LYMPHOCYTES; OCCUPATIONAL-EXPOSURE; CYTOGENETIC DAMAGE; GENETIC-DAMAGE; NUCLEAR BUDS; LUNG-CANCER; POLLUTION	Air pollution has been recognized as a human carcinogen. Children living in urban areas are a high-risk group, because genetic damage occurring early in life is considered able to increase the risk of carcinogenesis in adulthood. This study aimed to investigate micronuclei (MN) frequency, as a biomarker of DNA damage, in exfoliated buccal cells of pre-school children living in a town with high levels of air pollution. A sample of healthy 3-6-year-old children living in Brescia, Northern Italy, was investigated. A sample of the children's buccal mucosa cells was collected during the winter months in 2012 and 2013. DNA damage was investigated using the MN test. Children's exposure to urban air pollution was evaluated by means of a questionnaire filled in by their parents that included items on various possible sources of indoor and outdoor pollution, and the concentration of fine particulate matter (PM10, PM2.5) and NO2 in the 1-3 weeks preceding biological sample collection. 181 children (mean age +/- SD: 4.3 +/- 0.9 years) were investigated. The mean +/- SD MN frequency was 0.29 +/- 0.13%. A weak, though statistically significant, association of MN with concentration of air pollutants (PM10, PM2.5 and NO2) was found, whereas no association was apparent between MN frequency and the indoor and outdoor exposure variables investigated via the questionnaire. This study showed a high MN frequency in children living in a town with heavy air pollution in winter, higher than usually found among children living in areas with low or medium-high levels of air pollution.	[Ceretti, Elisabetta; Feretti, Donatella; Viola, Gaia C. V.; Zerbini, Ilaria; Limina, Rosa M.; Zani, Claudia; Donato, Francesco; Gelatti, Umberto] Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Unit Hyg Epidemiol & Publ Hlth, Brescia, Italy; [Capelli, Michela; Lamera, Rossella] Univ Brescia, Post Grad Sch Publ Hlth, Brescia, Italy	University of Brescia; University of Brescia	Feretti, D (corresponding author), Univ Brescia, Dept Med & Surg Special Radiol Sci & Publ Hlth, Unit Hyg Epidemiol & Publ Hlth, Brescia, Italy.	feretti@med.unibs.it	Donato, Francesco/AAQ-7477-2021	DONATO, Francesco/0000-0002-1402-1019; Ceretti, Elisabetta/0000-0002-4856-5364; Viola, Gaia Claudia Viviana/0000-0002-6904-7232; FERETTI, Donatella/0000-0002-8455-6174; Zani, Claudia/0000-0002-6454-597X	Q-TECH Research and Study Centre (Quality and Technology Assessment, Governance and Communication Strategies in Health Systems), University of Brescia; Lombardy Regional Authority	Q-TECH Research and Study Centre (Quality and Technology Assessment, Governance and Communication Strategies in Health Systems), University of Brescia; Lombardy Regional Authority	The study was funded by the Q-TECH Research and Study Centre (Quality and Technology Assessment, Governance and Communication Strategies in Health Systems), University of Brescia. The Lombardy Regional Authority provided a three-year research grant under agreements with the university for the promotion of research in the Lombardy region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson TF, 2008, J TOXICOL ENV HEAL A, V71, P238, DOI 10.1080/15287390701598234; Bolognesi G, 1997, ENVIRON MOL MUTAGEN, V30, P396; BONASSI S, 1995, CANCER GENET CYTOGEN, V79, P133, DOI 10.1016/0165-4608(94)00131-T; Bonassi S, 2007, CARCINOGENESIS, V28, P625, DOI 10.1093/carcin/bgl177; Bonassi S, 2011, MUTAT RES-REV MUTAT, V728, P88, DOI 10.1016/j.mrrev.2011.06.005; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Cavallo D, 2006, TOXICOLOGY, V223, P26, DOI 10.1016/j.tox.2006.03.003; Ceppi M, 2010, MUTAT RES-REV MUTAT, V705, P11, DOI 10.1016/j.mrrev.2009.11.001; Cerqueira EMM, 2004, MUTAT RES-GEN TOX EN, V562, P111, DOI 10.1016/j.mrgentox.2004.05.008; Chen C, 2006, MUTAGENESIS, V21, P131, DOI 10.1093/mutage/gel007; Claxton LD, 2007, MUTAT RES-REV MUTAT, V636, P36, DOI 10.1016/j.mrrev.2007.01.001; Claxton LD, 2004, MUTAT RES-REV MUTAT, V567, P347, DOI 10.1016/j.mrrev.2004.08.002; Coronas MV, 2009, ENVIRON INT, V35, P1023, DOI 10.1016/j.envint.2009.05.001; Desai SS, 1996, CANCER LETT, V109, P9, DOI 10.1016/S0304-3835(96)04390-X; EAA (European Environment Agency), 2012, 42012 EAA; ERS, 2010, AIR QUAL HLTH; Fenech M, 2002, MUTAT RES-FUND MOL M, V504, P131, DOI 10.1016/S0027-5107(02)00086-6; Grigg Jonathan, 2009, Proc Am Thorac Soc, V6, P564, DOI 10.1513/pats.200905-026RM; HAGMAR L, 1994, CANCER RES, V54, P2919; Holland N, 2008, MUTAT RES-REV MUTAT, V659, P93, DOI 10.1016/j.mrrev.2008.03.007; Holland N, 2011, MUTAGENESIS, V26, P51, DOI 10.1093/mutage/geq064; Huen K, 2006, ENVIRON MOL MUTAGEN, V47, P236, DOI 10.1002/em.20193; Janssen NAH, 2013, SCI TOTAL ENVIRON, V463, P20, DOI 10.1016/j.scitotenv.2013.05.062; Karahalil B, 1999, MUTAT RES-GEN TOX EN, V442, P29, DOI 10.1016/S1383-5718(99)00055-8; Kashyap B, 2012, J CANCER RES THER, V8, P184, DOI 10.4103/0973-1482.98968; Kirsch-Volders M, 2011, ARCH TOXICOL, V85, P873, DOI 10.1007/s00204-011-0691-4; Lahiri T, 2000, INDIAN J MED RES, V112, P21; Landrigan PJ, 2004, ENVIRON HEALTH PERSP, V112, P257, DOI 10.1289/ehp.6115; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Maffei F, 2005, MUTAT RES-GEN TOX EN, V583, P1, DOI 10.1016/j.mrgentox.2005.01.011; Moller P, 2008, CANCER LETT, V266, P84, DOI 10.1016/j.canlet.2008.02.030; Monarca S, 1997, SCI TOTAL ENVIRON, V205, P137, DOI 10.1016/S0048-9697(97)00194-0; Monarca S, 1999, MUTAT RES-FUND MOL M, V426, P189, DOI 10.1016/S0027-5107(99)00066-4; Mondal NK, 2011, MUTAT RES-GEN TOX EN, V721, P178, DOI 10.1016/j.mrgentox.2011.01.011; Montero R, 2003, ENVIRON MOL MUTAGEN, V42, P216, DOI 10.1002/em.10186; Neri M, 2006, MUTAT RES-REV MUTAT, V612, P14, DOI 10.1016/j.mrrev.2005.04.003; Nersesyan AK, 2005, MUTAT RES-GEN TOX EN, V588, P64, DOI 10.1016/j.mrgentox.2005.06.010; Pedersen M, 2009, ENVIRON RES, V109, P1012, DOI 10.1016/j.envres.2009.08.011; Pedersen M, 2006, MUTAT RES-GEN TOX EN, V608, P112, DOI 10.1016/j.mrgentox.2006.02.013; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Rossnerova A, 2011, MUTAT RES-FUND MOL M, V715, P72, DOI 10.1016/j.mrfmmm.2011.07.011; Samanta S, 2012, DIAGN CYTOPATHOL, V40, P84, DOI 10.1002/dc.21592; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Sisenando HA, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-6; Sorensen M, 2003, MUTAT RES-REV MUTAT, V544, P255, DOI 10.1016/j.mrrev.2003.06.010; de Brito KCT, 2013, ECOTOX ENVIRON SAFE, V94, P14, DOI 10.1016/j.ecoenv.2013.04.014; Thomas P, 2011, MUTAGENESIS, V26, P69, DOI 10.1093/mutage/geq072; Thomas P, 2009, NAT PROTOC, V4, P825, DOI 10.1038/nprot.2009.53; TOLBERT PE, 1992, MUTAT RES, V271, P69, DOI 10.1016/0165-1161(92)90033-I; Tovalin H, 2006, OCCUP ENVIRON MED, V63, P230, DOI 10.1136/oem.2005.019802; Traversi D, 2009, ENVIRON INT, V35, P905, DOI 10.1016/j.envint.2009.03.010; WHO, 2007, CHILDR HLTH ENV EUR; Wild CP, 2003, CANCER EPIDEM BIOMAR, V12, P1389; World Health Organization, 2005, WHO REGIONAL OFFICE; World Health Organization, 2006, AIR QUAL GUID GLOB U	56	52	57	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96524	10.1371/journal.pone.0096524	http://dx.doi.org/10.1371/journal.pone.0096524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789200	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700106
J	Wong, CKH; Wong, WCW; Lam, CLK; Wan, YF; Wong, WHT; Chung, KL; Dai, D; Tsui, ELH; Fong, DYT				Wong, Carlos K. H.; Wong, William C. W.; Lam, Cindy L. K.; Wan, Y. F.; Wong, Winnie H. T.; Chung, K. L.; Dai, Daisy; Tsui, Eva L. H.; Fong, Daniel Y. T.			Effects of Patient Empowerment Programme (PEP) on Clinical Outcomes and Health Service Utilization in Type 2 Diabetes Mellitus in Primary Care: An Observational Matched Cohort Study	PLOS ONE			English	Article							SELF-MANAGEMENT EDUCATION; RANDOMIZED CONTROLLED-TRIAL; DIAGNOSED DESMOND PROGRAM; FOLLOW-UP; CHRONIC DISEASE; PEOPLE; INTERVENTION; METAANALYSIS; QUALITY	Background: To evaluate the effects of a large population-based patient empowerment programme (PEP) on clinical outcomes and health service utilization rates in type 2 diabetes mellitus (T2DM) patients in the primary care setting. Research Design and Subjects: A stratified random sample of 1,141 patients with T2DM enrolled to PEP between March and September 2010 were selected from general outpatient clinics (GOPC) across Hong Kong and compared with an equal number of T2DM patients who had not participated in the PEP (non-PEP group) matched by age, sex and HbA(1c) level group. Measures: Clinical outcomes of HbA(1c), SBP, DBP and LDL-C levels, and health service utilization rates including numbers of visits to GOPC, specialist outpatient clinics (SOPC), emergency department (ED) and inpatient admissions, were measured at baseline and at 12-month post-recruitment. The effects of PEP on clinical outcomes and health service utilization rates were assessed by the difference-in-difference estimation, using the generalized estimating equation models. Results: Compared with non-PEP group, PEP group achieved additional improvements in clinical outcomes over the 12-month period. A significantly greater percentage of patients in the PEP group attained HbA(1c)<= 7% or LDL-C <= 2.6 mmol/L at 12-month follow-up compared with the non-PEP group. PEP group had a mean 0.813 fewer GOPC visits in comparison with the non-PEP group. Conclusions: PEP was effective in improving the clinical outcomes and reduced the general outpatient clinic utilization rate over a 12-month period. Empowering T2DM patients on self-management of their disease can enhance the quality of diabetes care in primary care.	[Wong, Carlos K. H.; Wong, William C. W.; Lam, Cindy L. K.; Wan, Y. F.; Wong, Winnie H. T.] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Chung, K. L.] Hong Kong Hosp Author, Hosp Author Head Off, Integrated Care Programs, Kowloon, Hong Kong, Peoples R China; [Dai, Daisy] Hong Kong Hosp Author, Hosp Author Head Off, Primary & Community Serv, Kowloon, Hong Kong, Peoples R China; [Tsui, Eva L. H.] Hong Kong Hosp Author, Hosp Author Head Off, Kowloon, Hong Kong, Peoples R China; [Fong, Daniel Y. T.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CKH (corresponding author), Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China.	carlosho@hku.hk	Fong, Daniel YT/C-4269-2009; Wong, Carlos King Ho/B-4322-2011	Fong, Daniel YT/0000-0001-7365-9146; Wong, Carlos King Ho/0000-0002-6895-6071	Hong Kong Hospital Authority [8011014157]; Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study [EPC-HKU-2]	Hong Kong Hospital Authority; Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study	This study has been funded by the Hong Kong Hospital Authority (Ref. no: 8011014157) and the Health and Health Services Research Fund, Food and Health Bureau, HKSAR Commissioned Research on Enhancing Primary Care Study (Ref. no EPC-HKU-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-467; American Diabetes Association, 2006, CLIN DIABETES, DOI DOI 10.2337/DIACLIN.24.4.154; Anderson RM, 2002, USING EMPOWERMENT AP; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; [Anonymous], 2010, MAN DIAB NAT CLIN GU; [Anonymous], 2009, NAT I HLTH CLIN EXC; Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Boren SA, 2009, DIABETES EDUCATOR, V35, P72, DOI 10.1177/0145721708326774; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Deakin TA, 2006, DIABETIC MED, V23, P944, DOI 10.1111/j.1464-5491.2006.01906.x; Ellis SE, 2004, PATIENT EDUC COUNS, V52, P97, DOI 10.1016/S0738-3991(03)00016-8; Fitzner K, 2008, POPUL HEALTH MANAG, V11, P329, DOI 10.1089/pop.2008.0012; Fung CSC, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-116; Gillett M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4093; Gordon C, 2007, REV FINDINGS CHRONIC; Gucciardi E, 2009, DIABETIC MED, V26, P510, DOI 10.1111/j.1464-5491.2009.02713.x; Hawthorne K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006424.pub2; Hornsten A, 2005, DIABETES RES CLIN PR, V68, P65, DOI 10.1016/j.diabres.2004.08.003; Hornsten A, 2008, DIABETES RES CLIN PR, V81, P50, DOI 10.1016/j.diabres.2008.02.005; Huang MC, 2010, DIABETES CARE, V33, P233, DOI 10.2337/dc09-1092; Jarvis J, 2010, DIABETES OBES METAB, V12, P12, DOI 10.1111/j.1463-1326.2009.01098.x; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Loveman E, 2008, HEALTH TECHNOL ASSES, V12, pIX; Loveman E, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7220; McGowan P, 2011, CAN J DIABETES, V35, P46, DOI 10.1016/S1499-2671(11)51008-1; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Robbins JM, 2008, DIABETES CARE, V31, P655, DOI 10.2337/dc07-1871; Rutten G, 2005, DIABETIC MED, V22, P671, DOI 10.1111/j.1464-5491.2005.01497.x; Sun JQ, 2008, ASIA PAC J CLIN NUTR, V17, P514; Tang TS, 2010, PATIENT EDUC COUNS, V79, P178, DOI 10.1016/j.pec.2009.09.029; Trento M, 2010, DIABETES CARE, V33, P745, DOI 10.2337/dc09-2024; Tshiananga JKT, 2012, DIABETES EDUCATOR, V38, P108, DOI 10.1177/0145721711423978; Wong KW, 2012, FAM PRACT, V29, P196, DOI 10.1093/fampra/cmr060	40	46	46	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e95328	10.1371/journal.pone.0095328	http://dx.doi.org/10.1371/journal.pone.0095328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG6EE	24788804	gold, Green Published, Green Submitted			2022-12-27	WOS:000335510600033
J	Khan, A; Khan, AAP; Asiri, AM; Rub, MA				Khan, Anish; Khan, Aftab Aslam Parwaz; Asiri, Abdullah M.; Rub, Malik Abdul			Synthesis of Silver Embedded Poly(o-Anisidine) Molybdophosphate Nano Hybrid Cation-Exchanger Applicable for Membrane Electrode	PLOS ONE			English	Article							ION-SELECTIVE ELECTRODE; INTERCALATION COMPOUNDS; THORIUM PHOSPHATE; CHEMISTRY	Poly(o-anisidine) molybdophosphate was expediently obtained by sol-gel mixing of Poly(o-anisidine) into the inorganic matrices of molybdophosphate, which was allowed to react with silver nitrate to the formation of poly(o-anisidine) molybdophosphate embedded silver nano composite. The composite was characterized by Fourier Transform Infrared Spectroscopy, X-ray powder diffraction, UV-Vis Spectrophotometry, Fluorescence Spectroscopy, Scanning Electron Microscopy/Energy-dispersive X-ray Spectroscopy and Thermogravimertic Analysis. Ion exchange capacity and distribution studies were carried out to understand the ion-exchange capabilities of the nano composite. On the basis of highest distribution studies, this nano composite cation exchanger was used as preparation of heavy metal ion selective membrane. Membrane was characterized for its performance as porosity and swelling later on was used for the preparation of membrane electrode for Hg(II), having better linear range, wide working pH range (2-4.5) with fast response in the real environment.	[Khan, Anish; Khan, Aftab Aslam Parwaz; Asiri, Abdullah M.; Rub, Malik Abdul] King Abdulaziz Univ, Dept Chem, Jeddah 21413, Saudi Arabia; [Khan, Anish; Khan, Aftab Aslam Parwaz; Asiri, Abdullah M.; Rub, Malik Abdul] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Khan, A (corresponding author), King Abdulaziz Univ, Dept Chem, Jeddah 21413, Saudi Arabia.	anishkhan97@gmail.com	Asiri, Abdullah M./C-3458-2009; Khan, Anish/X-6117-2019; Khan, Aftab Aslam Parwaz/H-5931-2012; Khan, Anish/H-6033-2012; Rub, Malik Abdul/H-6027-2012	Asiri, Abdullah M./0000-0001-7905-3209; Khan, Anish/0000-0002-3806-5956; Khan, Aftab Aslam Parwaz/0000-0002-3746-5034; Khan, Anish/0000-0002-3806-5956; Rub, Malik Abdul/0000-0002-4798-5308	King Abdulaziz University [D-004/431]	King Abdulaziz University	This paper was funded by King Abdulaziz University, under grant No. (D-004/431). The authors, therefore, acknowledge technical and financial support of KAU.	ALBERTI G, 1970, J CHROMATOGR, V50, P482, DOI 10.1016/S0021-9673(00)97976-7; Amarchand S, 1998, INDIAN J CHEM TECHN, V5, P99; Amini MK, 1999, FRESEN J ANAL CHEM, V364, P690, DOI 10.1007/s002160051415; Biju V, 2008, J MATER SCI, V43, P1175, DOI 10.1007/s10853-007-2300-8; BISSESSUR R, 1993, J CHEM SOC CHEM COMM, P687, DOI 10.1039/c39930000687; Bissessur R, 2006, MATER CHEM PHYS, V99, P214, DOI 10.1016/j.matchemphys.2005.10.012; BUCK RP, 1994, PURE APPL CHEM, V66, P2527, DOI 10.1351/pac199466122527; DE AK, 1974, J CHROMATOGR, V101, P63, DOI 10.1016/S0021-9673(01)94731-4; Demirel A, 2004, TALANTA, V62, P123, DOI 10.1016/S0039-9140(03)00414-4; DISALVO FJ, 1990, SCIENCE, V247, P649, DOI 10.1126/science.247.4943.649; Duval C., 1963, INORGANIC THERMOGRAV, P315; ENZEL P, 1989, J CHEM SOC CHEM COMM, P1326, DOI 10.1039/c39890001326; Finklea H.O., 1996, ELECTROANALYTICAL CH, P19; Gomez-Romero P, 2001, ADV MATER, V13, P163, DOI 10.1002/1521-4095(200102)13:3<163::AID-ADMA163>3.0.CO;2-U; Gupta VK, 2007, ANAL CHIM ACTA, V590, P81, DOI 10.1016/j.aca.2007.03.014; Hutchison JC, 1996, CHEM MATER, V8, P1597, DOI 10.1021/cm960039w; Ibrahim MA, 1999, SYNTHETIC MET, V105, P35, DOI 10.1016/S0379-6779(99)00037-5; Jumal J, 2012, APCBEE PROC, V3, P116, DOI 10.1016/j.apcbee.2012.06.056; KANATZIDIS MG, 1987, J AM CHEM SOC, V109, P3797, DOI 10.1021/ja00246a057; Khan A, 2013, J SOL-GEL SCI TECHN, V65, P160, DOI 10.1007/s10971-012-2920-6; Khan A, 2012, INT J ELECTROCHEM SC, V7, P3854; Khan AA, 2007, TALANTA, V72, P699, DOI 10.1016/j.talanta.2006.11.044; Kulkarni MV, 2005, SENSOR ACTUAT B-CHEM, V107, P791, DOI 10.1016/j.snb.2004.12.019; Ling JLW, 2012, TALANTA, V88, P477, DOI 10.1016/j.talanta.2011.11.018; Lira-Cantu M, 1998, CHEM MATER, V10, P698, DOI 10.1021/cm970107u; LIU YJ, 1991, CHEM MATER, V3, P992, DOI 10.1021/cm00018a004; Lu JQ, 2003, J ELECTROANAL CHEM, V540, P111, DOI 10.1016/S0022-0728(02)01298-6; MacLachlan MJ, 2000, ADV MATER, V12, P675, DOI 10.1002/(SICI)1521-4095(200005)12:9<675::AID-ADMA675>3.0.CO;2-O; Mahajan RK, 2009, J HAZARD MATER, V167, P237, DOI 10.1016/j.jhazmat.2008.12.107; Mazloum-Ardakani M, 2000, SENSOR ACTUAT B-CHEM, V63, P80, DOI 10.1016/S0925-4005(00)00300-2; Muller A, 1999, CHEM COMMUN, P1347, DOI 10.1039/a901436e; Murray R.W., 1992, MOL DESIGN MEMBRANE; Rao C.N.R., 1963, CHEM APPL INFRARED S, P355; Rao C.N.R., 1963, CHEM APPL INFRARED S, P338; Sadakane M, 1998, CHEM REV, V98, P219, DOI 10.1021/cr960403a; SRIVASTAVA SK, 1978, TALANTA, V25, P157, DOI 10.1016/0039-9140(78)80105-2; Umezawa Y, 2000, PURE APPL CHEM, V72, P1851, DOI 10.1351/pac200072101851; Vaillant J, 2006, PROG SOLID STATE CH, V34, P147, DOI 10.1016/j.progsolidstchem.2005.11.015; WHITTINGHAM MS, 1978, PROG SOLID STATE CH, V12, P41, DOI 10.1016/0079-6786(78)90003-1; Xu BH, 2007, MATER RES BULL, V42, P1633, DOI 10.1016/j.materresbull.2006.11.030; Zen JM, 2003, ELECTROANAL, V15, P1073, DOI 10.1002/elan.200390130	41	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96897	10.1371/journal.pone.0096897	http://dx.doi.org/10.1371/journal.pone.0096897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805257	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900114
J	Ren, W; Liu, YH; Wan, SH; Fei, C; Wang, W; Chen, YY; Zhang, ZH; Wang, T; Wang, JS; Zhou, L; Weng, YG; He, TC; Zhang, Y				Ren, Wei; Liu, Yuehong; Wan, Shaoheng; Fei, Chang; Wang, Wei; Chen, Yingying; Zhang, Zhihui; Wang, Ting; Wang, Jinshu; Zhou, Lan; Weng, Yaguang; He, Tongchuan; Zhang, Yan			BMP9 Inhibits Proliferation and Metastasis of HER2-Positive SK-BR-3 Breast Cancer Cells through ERK1/2 and PI3K/AKT Pathways	PLOS ONE			English	Article							NF-KAPPA-B; MONOCLONAL-ANTIBODY; ADJUVANT CHEMOTHERAPY; RECEPTOR; BONE; APOPTOSIS; MIGRATION; INVASION; GROWTH; PLUS	Bone morphogenetic protein 9 (BMP9), a member of TGF-beta superfamily, is reported to inhibit the growth and migration of prostate cancer, osteosarcoma and triple-negative MDA-MB-231 breast cancer cells. However, little is known about the effect of on the biological behaviors of HER2-positive SK-BR-3 breast cancer cells and the underlying mechanisms. This study aimed to investigate the effects of BMP9 on the proliferation and metastasis of SK-BR-3 cells with BMP9 over-expression or BMP9 down-regulated expression. Results indicated that exogenously expressed BMP9 inhibited the proliferation and metastasis of SK-BR-3 cells while decreased endogenous BMP9 expression in SK-BR-3 cells promoted the proliferation and migration of breast cancer cells in vitro and in vivo. In SK-BR-3 cells with BMP9 over-expression, the phosphorylation of HER2, ERK1/2 and AKT was markedly suppressed and the HER2 expression decreased at both mRNA and protein levels, while opposite results were observed in SK-BR-3 cells with BMP9 knock down. When the phosphorylation of ERK1/2 and PI3K/AKT was inhibited by PD98059 and LY294002, respectively, the decreased proliferation and invasion induced by BMP9 knock down were eliminated. These findings suggest that BMP9 can inhibit the proliferation and metastasis of SK-BR-3 cells via inactivating ERK1/2 and PI3K/AKT signaling pathways. Thus, BMP9 may serve as a useful agent in the treatment of HER-2 positive breast cancer.	[Ren, Wei] Chongqing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Chongqing, Peoples R China; [Liu, Yuehong; Wan, Shaoheng; Fei, Chang; Wang, Wei; Chen, Yingying; Zhang, Zhihui; Wang, Ting; Wang, Jinshu; Zhou, Lan; Weng, Yaguang; Zhang, Yan] Chongqing Med Univ, Minist Educ, Key Lab Diagnost Med, Chongqing, Peoples R China; [He, Tongchuan] Univ Chicago, Med Ctr, Dept Surg, Mol Oncol Lab, Chicago, IL 60637 USA	Chongqing Medical University; Chongqing Medical University; University of Chicago; University of Chicago Medical Center	Ren, W (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Chongqing, Peoples R China.	weiren0924@163.com; zy2753@hotmail.com	zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [81172017]; National Basic Research Program of China (973 Program) [2011CB707906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (81172017) and National Basic Research Program of China (973 Program, 2011CB707906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Chao X, 2010, BIOMED PHARMACOTHER, V64, P600, DOI 10.1016/j.biopha.2010.08.008; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Fan P, 2012, EUR J CANCER, V48, P3488, DOI 10.1016/j.ejca.2012.04.020; Ghosh R, 2011, CANCER RES, V71, P1871, DOI 10.1158/0008-5472.CAN-10-1872; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Kuo HP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/219472; Lai HW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/486568; Li B, 2012, INT J ONCOL, V41, P1809, DOI 10.3892/ijo.2012.1617; Li Q, 2013, CANCER SCI, V104, P398, DOI 10.1111/cas.12093; Lin Y, 2012, ONCOL REP, V27, P1976, DOI 10.3892/or.2012.1717; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Meng XJ, 2013, CANCER LETT, V333, P96, DOI 10.1016/j.canlet.2013.01.031; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Moasser MM, 2007, ONCOGENE, V26, P6469, DOI 10.1038/sj.onc.1210477; Osaki M, 2004, APOPTOSIS, V9, P667, DOI 10.1023/B:APPT.0000045801.15585.dd; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Reddi AH, 2009, CYTOKINE GROWTH F R, V20, P341, DOI 10.1016/j.cytogfr.2009.10.015; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Sehdev V, 2009, J ONCOL, V2009, DOI 10.1155/2009/121458; SESHADRI R, 1993, J CLIN ONCOL, V11, P1936, DOI 10.1200/JCO.1993.11.10.1936; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wang K, 2011, J CANCER RES CLIN, V137, P1687, DOI 10.1007/s00432-011-1047-4; Yang HL, 2013, J ETHNOPHARMACOL, V148, P254, DOI 10.1016/j.jep.2013.04.023; Ye L, 2008, MOL CANCER RES, V6, P1594, DOI 10.1158/1541-7786.MCR-08-0171; Ye L, 2009, INT J MOL MED, V24, P591, DOI 10.3892/ijmm_00000269; Zhang YJ, 2012, PRAC J CAN, V27, P98; Zhou NN, 2012, LIFE SCI, V90, P770, DOI 10.1016/j.lfs.2012.03.035	35	46	55	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96816	10.1371/journal.pone.0096816	http://dx.doi.org/10.1371/journal.pone.0096816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805814	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900101
J	Brisson, CD; Hsieh, YT; Kim, D; Jin, AY; Andrew, RD				Brisson, C. Devin; Hsieh, Yi-Ting; Kim, Danielle; Jin, Albert Y.; Andrew, R. David			Brainstem Neurons Survive the Identical Ischemic Stress That Kills Higher Neurons: Insight to the Persistent Vegetative State	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; SPREADING DEPRESSION; ANOXIC DEPOLARIZATION; LOCUS-COERULEUS; CARDIAC-ARREST; RAT; NUCLEUS; HYPOXIA; GLUTAMATE; DAMAGE	Global ischemia caused by heart attack, pulmonary failure, near-drowning or traumatic brain injury often damages the higher brain but not the brainstem, leading to a 'persistent vegetative state' where the patient is awake but not aware. Approximately 30,000 U. S. patients are held captive in this condition but not a single research study has addressed how the lower brain is preferentially protected in these people. In the higher brain, ischemia elicits a profound anoxic depolarization (AD) causing neuronal dysfunction and vasoconstriction within minutes. Might brainstem nuclei generate less damaging AD and so be more resilient? Here we compared resistance to acute injury induced from simulated ischemia by 'higher' hippocampal and striatal neurons versus brainstem neurons in live slices from rat and mouse. Light transmittance (LT) imaging in response to 10 minutes of oxygen/glucose deprivation (OGD) revealed immediate and acutely damaging AD propagating through gray matter of neocortex, hippocampus, striatum, thalamus and cerebellar cortex. In adjacent brainstem nuclei, OGD-evoked AD caused little tissue injury. Whole-cell patch recordings from hippocampal and striatal neurons under OGD revealed sudden membrane potential loss that did not recover. In contrast brainstem neurons from locus ceruleus and mesencephalic nucleus as well as from sensory and motor nuclei only slowly depolarized and then repolarized post-OGD. Two-photon microscopy confirmed non-recoverable swelling and dendritic beading of hippocampal neurons during OGD, while mesencephalic neurons in midbrain appeared uninjured. All of the above responses were mimicked by bath exposure to 100 mu M ouabain which inhibits the Na+/K+ pump or to 1-10 nM palytoxin which converts the pump into an open cationic channel. Therefore during ischemia the Na+/K+ pump of higher neurons fails quickly and extensively compared to naturally resilient hypothalamic and brainstem neurons. The selective survival of lower brain regions that maintain vital functions will support the persistent vegetative state.	[Brisson, C. Devin; Hsieh, Yi-Ting; Kim, Danielle; Jin, Albert Y.; Andrew, R. David] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	Queens University - Canada	Andrew, RD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	andrewd@queensu.ca			Heart and Stroke Foundation of Canada [T- 4478]; Faculty of Health Sciences, Queen's University	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Faculty of Health Sciences, Queen's University	This work was supported by the Heart and Stroke Foundation of Canada (grant T- 4478) and the Faculty of Health Sciences, Queen's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew R. D., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43; Andrew R. D., 2012, Society for Neuroscience Abstract Viewer and Itinerary Planner, V42; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Andrew RD, 2011, VAS 2011 11 INT C NE, P311; Artigas P, 2004, J GEN PHYSIOL, V123, P357, DOI 10.1085/jgp.200308964; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; Brisson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079589; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; BURCHIEL KJ, 1984, EXP NEUROL, V85, P257, DOI 10.1016/0014-4886(84)90139-0; BURES J, 1981, J NEUROBIOL, V12, P211, DOI 10.1002/neu.480120303; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; COWAN AI, 1992, J PHYSIOL-LONDON, V455, P89, DOI 10.1113/jphysiol.1992.sp019292; CZEH G, 1992, NEUROREPORT, V3, P197, DOI 10.1097/00001756-199202000-00019; de Oliveira RB, 2011, BRAIN RES, V1425, P27, DOI 10.1016/j.brainres.2011.09.053; Dijkhuizen RM, 1999, BRAIN RES, V840, P194, DOI 10.1016/S0006-8993(99)01769-2; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Falini A, 1998, AM J NEURORADIOL, V19, P648; Farkas E, 2010, NEUROIMAGE, V51, P734, DOI 10.1016/j.neuroimage.2010.02.055; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Funke F, 2009, J NEUROPHYSIOL, V101, P2395, DOI 10.1152/jn.91260.2008; Gadsby DC, 2009, PHILOS T R SOC B, V364, P229, DOI 10.1098/rstb.2008.0243; Gao H, 2009, BRAIN RES, V1291, P40, DOI 10.1016/j.brainres.2009.07.024; Gottron MA, 2009, CONTEMP NEUROSCI, P129, DOI 10.1007/978-1-60761-280-3_8; Hamann M, 2005, BRAIN, V128, P2408, DOI 10.1093/brain/awh619; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; HENDERSON G, 1982, EXP BRAIN RES, V45, P29; Higuchi T, 1997, MAGNET RESON MED, V37, P851, DOI 10.1002/mrm.1910370608; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; Kaminogo M, 1998, NEUROL RES, V20, P343, DOI 10.1080/01616412.1998.11740529; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Karunasinghe RN, 2013, BRAIN RES, V1527, P209, DOI 10.1016/j.brainres.2013.06.016; KAWAI K, 1992, J CEREBR BLOOD F MET, V12, P238, DOI 10.1038/jcbfm.1992.34; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Koroleva VI, 2000, ZH VYSSH NERV DEYAT+, V50, P612; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Longstreth WT, 2008, NEUROLOGY GEN MED, P163; Luigetti M, 2012, ACTA NEUROL BELG, V112, P105, DOI 10.1007/s13760-012-0007-3; Madry C, 2010, BRAIN, V133, P3755, DOI 10.1093/brain/awq284; Martin RL, 1999, J PHYSIOL-LONDON, V519, P131, DOI 10.1111/j.1469-7793.1999.0131o.x; MEMEZAWA H, 1992, STROKE, V23, P552, DOI 10.1161/01.STR.23.4.552; Moriguchi S, 2002, EXP BRAIN RES, V144, P238, DOI 10.1007/s00221-002-1039-3; Muller M, 1998, BRAIN RES, V812, P1, DOI 10.1016/S0006-8993(98)00812-9; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; PATON JFR, 1993, BRAIN RES, V604, P112, DOI 10.1016/0006-8993(93)90358-T; Richter F, 2012, J CEREBR BLOOD F MET, V32, P1535, DOI 10.1038/jcbfm.2012.40; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Rossini GP, 2011, TOXICON, V57, P429, DOI 10.1016/j.toxicon.2010.09.011; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Senatorov VV, 1997, J PHYSIOL-LONDON, V502, P387, DOI 10.1111/j.1469-7793.1997.387bk.x; SIEBER FE, 1995, STROKE, V26, P2091, DOI 10.1161/01.STR.26.11.2091; Tanaka E, 1999, J NEUROPHYSIOL, V81, P1872, DOI 10.1152/jn.1999.81.4.1872; Tanaka E, 1997, J NEUROPHYSIOL, V78, P891, DOI 10.1152/jn.1997.78.2.891; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; URBAN L, 1990, BRAIN RES, V520, P36, DOI 10.1016/0006-8993(90)91689-E; UTZSCHNEIDER DA, 1991, BRAIN RES, V551, P136, DOI 10.1016/0006-8993(91)90924-K; Vincent A, 1999, NEUROSCIENCE, V93, P293, DOI 10.1016/S0306-4522(99)00109-8; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; WYTRZES LM, 1989, ARCH NEUROL-CHICAGO, V46, P93, DOI 10.1001/archneur.1989.00520370095028; Yang JJ, 1997, LIFE SCI, V61, P1763, DOI 10.1016/S0024-3205(97)00800-X; Yokomizo Y, 2005, NEUROSCI RES, V51, P463, DOI 10.1016/j.neures.2004.12.016; Yoshida S, 1998, NEUROSCI RES, V30, P227, DOI 10.1016/S0168-0102(98)00003-0; Young GB, 2009, NEW ENGL J MED, V361, P605, DOI 10.1056/NEJMcp0903466; Zhang B, 2012, J PHYSIOL-LONDON, V590, P753, DOI 10.1113/jphysiol.2011.221051	75	32	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96585	10.1371/journal.pone.0096585	http://dx.doi.org/10.1371/journal.pone.0096585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802253	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800090
J	Li, HO; Lu, LY; Chen, R; Quan, LJ; Xia, XY; Lu, Q				Li, Haiou; Lu, Liyao; Chen, Rong; Quan, Lijun; Xia, Xiaoyan; Lu, Qiang			PaFlexPepDock: Parallel Ab-Initio Docking of Peptides onto Their Receptors with Full Flexibility Based on Rosetta	PLOS ONE			English	Article							COMPUTATIONAL DESIGN; PROTEINS; PREDICTION; MODULATORS	Structural information related to protein-peptide complexes can be very useful for novel drug discovery and design. The computational docking of protein and peptide can supplement the structural information available on protein-peptide interactions explored by experimental ways. Protein-peptide docking of this paper can be described as three processes that occur in parallel: ab-initio peptide folding, peptide docking with its receptor, and refinement of some flexible areas of the receptor as the peptide is approaching. Several existing methods have been used to sample the degrees of freedom in the three processes, which are usually triggered in an organized sequential scheme. In this paper, we proposed a parallel approach that combines all the three processes during the docking of a folding peptide with a flexible receptor. This approach mimics the actual protein-peptide docking process in parallel way, and is expected to deliver better performance than sequential approaches. We used 22 unbound protein-peptide docking examples to evaluate our method. Our analysis of the results showed that the explicit refinement of the flexible areas of the receptor facilitated more accurate modeling of the interfaces of the complexes, while combining all of the moves in parallel helped the constructing of energy funnels for predictions.	[Li, Haiou; Chen, Rong; Quan, Lijun; Xia, Xiaoyan; Lu, Qiang] Soochow Univ, Sch Comp Sci & Technol, Suzhou, Jiangsu, Peoples R China; [Lu, Liyao] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Xia, Xiaoyan; Lu, Qiang] Jiangsu Prov Key Lab Informat Proc Technol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; University of Wisconsin System; University of Wisconsin Madison	Lu, Q (corresponding author), Soochow Univ, Sch Comp Sci & Technol, Suzhou, Jiangsu, Peoples R China.	qiang@suda.edu.cn			National Science Foundation of China [61170125]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under the grant number 61170125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-451; Antes I, 2010, PROTEINS, V78, P1084, DOI 10.1002/prot.22629; Audie J, 2012, FUTURE MED CHEM, V4, P1619, DOI [10.4155/FMC.12.99, 10.4155/fmc.12.99]; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Davis IW, 2009, PROTEIN SCI, V18, P1998, DOI 10.1002/pro.192; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; King CA, 2010, PROTEINS, V78, P3437, DOI 10.1002/prot.22851; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Liu ZJ, 2004, J AM CHEM SOC, V126, P8515, DOI 10.1021/ja032018q; Lo YT, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S4-S4; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Luo XH, 2012, J MOL MODEL, V18, P2199, DOI 10.1007/s00894-011-1231-0; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Mandell JG, 1998, P NATL ACAD SCI USA, V95, P14705, DOI 10.1073/pnas.95.25.14705; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Niv MY, 2005, J AM CHEM SOC, V127, P14072, DOI 10.1021/ja054195s; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Petsalaki E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000335; Prasad PA, 2008, J COMPUT AID MOL DES, V22, P815, DOI 10.1007/s10822-008-9216-5; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raveh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018934; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Trellet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058769	31	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94769	10.1371/journal.pone.0094769	http://dx.doi.org/10.1371/journal.pone.0094769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801496	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800024
J	Peotta, VA; Bhandary, P; Ogu, U; Volk, KA; Roghair, RD				Peotta, Veronica A.; Bhandary, Prasad; Ogu, Ugochi; Volk, Kenneth A.; Roghair, Robert D.			Reduced Blood Pressure of CFTR-F508del Carriers Correlates with Diminished Arterial Reactivity Rather than Circulating Blood Volume in Mice	PLOS ONE			English	Article							CYSTIC-FIBROSIS; CHANNEL ACTIVITY; CFTR; CONDUCTANCE; TRANSPORT; MUTATION; CHLORIDE; MOUSE; CALSEQUESTRIN; ARRHYTHMIAS	The F508del mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) is the most common cause of cystic fibrosis (CF). Both CF patients and F508del carriers have decreased blood pressure. While this has been attributed to salt depletion, recent studies have shown F508del expression interferes with smooth muscle cell calcium mobilization. We tested the hypothesis that carriers of the F508del mutation have lower adult blood pressures and reduced aortic contractility without a reduction in circulating blood volume. By radiotelemetry, F508del heterozygous mice had significantly lower arterial pressures than wild-type C57BL/6 controls, with the greatest effect seen at the time of dark-to-light cycle transition (mean difference of 10 mmHg). To replicate the vascular effects of sympathetic arousal, isoproterenol and epinephrine were co-infused, and F508del mice again had significantly reduced arterial pressures. Aortas isolated from F508del heterozygous mice had significantly decreased constriction to noradrenaline (0.9 +/- 0.2 versus 2.9 +/- 0.7 mN). Inhibition of wild-type CFTR or the inositol triphosphate receptor replicated the phenotype of F508del aortas. CFTR carrier status did not alter circulating blood volume. We conclude the CFTR-F508del mutation decreases aortic contractility and lowers arterial pressures. As a cAMP-activated chloride channel that facilitates calcium mobilization, we speculate wild-type CFTR co-activation during adrenergic receptor stimulation buffers the vasodilatory response to catecholamines, and loss of this compensatory vasoconstrictor tone may contribute to the lower arterial pressures seen in heterozygote carriers of a CFTR-F508del mutation.	[Peotta, Veronica A.; Bhandary, Prasad; Ogu, Ugochi; Volk, Kenneth A.; Roghair, Robert D.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Roghair, RD (corresponding author), Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA.	robert-roghair@uiowa.edu	Ogu, Ugochi Olivia/ABG-4524-2021	Ogu, Ugochi Olivia/0000-0002-4662-1414; Roghair, Robert/0000-0002-0321-582X	National Institutes of Health [HL102659]; Children's Miracle Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Miracle Network; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the National Institutes of Health (HL102659 to RDR) and the Children's Miracle Network (RDR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TITLE ERROR; Antigny F, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00067; Bano-Rodrigo A, 2012, J CYST FIBROS, V11, P274, DOI 10.1016/j.jcf.2012.03.002; Barbero GJ, 1967, LANCET, V158; Bartoszewski R, AM J CELL MOL BIOL, V39, P448; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Denegri M, 2012, CIRC RES, V110, P663, DOI 10.1161/CIRCRESAHA.111.263939; Dirksen WP, 2007, CARDIOVASC RES, V75, P69, DOI 10.1016/j.cardiores.2007.03.002; Divangahi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000586; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Guo JJ, 2014, J CYST FIBROS, V13, P251, DOI 10.1016/j.jcf.2013.10.009; Haskell SE, 2013, PEDIATR RES, V73, P286, DOI 10.1038/pr.2012.183; Hull JH, 2009, EUR RESPIR J, V34, P1322, DOI 10.1183/09031936.00044009; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; LAKE CR, 1979, CLIN CHIM ACTA, V92, P141, DOI 10.1016/0009-8981(79)90107-4; Legris GJ, 1998, PEDIATRICS, V101, P48, DOI 10.1542/peds.101.1.48; LIEBERMAN J, 1975, ANN INTERN MED, V82, P806, DOI 10.7326/0003-4819-82-6-806; Makino M, 1997, CIRCULATION, V96, P1667, DOI 10.1161/01.CIR.96.5.1667; Martins JR, 2011, BBA-MOL BASIS DIS, V1812, P1385, DOI 10.1016/j.bbadis.2011.08.008; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Matchkov VV, 2013, J VASC RES, V50, P69, DOI 10.1159/000345242; Michoud MC, 2009, AM J RESP CELL MOL, V40, P217, DOI 10.1165/rcmb.2006-0444OC; Mock DM, 2008, PEDIATR RES, V64, P528, DOI 10.1203/PDR.0b013e318183f119; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Ozcelik N, 2013, PEDIATR CARDIOL, V34, P159, DOI 10.1007/s00246-012-0407-4; Poore S, 2013, CHEST, V143, P939, DOI 10.1378/chest.12-1934; Rab A, 2007, AM J PHYSIOL-CELL PH, V292, pC756, DOI 10.1152/ajpcell.00391.2006; Robert R, 2005, J PHYSIOL-LONDON, V568, P483, DOI 10.1113/jphysiol.2005.085019; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; Roghair RD, 2007, J MATERN-FETAL NEO M, V20, P833, DOI 10.1080/14767050701626540; ROSENTHAL A, 1977, PEDIATRICS, V59, P588; Sellers ZM, 2010, J PHYSIOL-LONDON, V588, P2417, DOI 10.1113/jphysiol.2010.188334; SLUITER W, 1984, J IMMUNOL METHODS, V73, P221, DOI 10.1016/0022-1759(84)90046-2; Super M, 2004, HYPERTENSION, V44, P878, DOI 10.1161/01.HYP.0000145901.81989.46; Tousson A, 1998, AM J PHYSIOL-CELL PH, V275, pC1555, DOI 10.1152/ajpcell.1998.275.6.C1555; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96756	10.1371/journal.pone.0096756	http://dx.doi.org/10.1371/journal.pone.0096756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801204	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800122
J	Tamada, T; Kanomata, N; Sone, T; Jo, Y; Miyaji, Y; Higashi, H; Yamamoto, A; Ito, K				Tamada, Tsutomu; Kanomata, Naoki; Sone, Teruki; Jo, Yoshimasa; Miyaji, Yoshiyuki; Higashi, Hiroki; Yamamoto, Akira; Ito, Katsuyoshi			High b Value (2,000 s/mm(2)) Diffusion-Weighted Magnetic Resonance Imaging in Prostate Cancer at 3 Tesla: Comparison with 1,000 s/mm(2) for Tumor Conspicuity and Discrimination of Aggressiveness	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; GLEASON SCORE; BIOPSY; TRENDS; DIFFERENTIATION; DETECTABILITY; COEFFICIENT; CONCORDANCE; PREVALENCE; MORTALITY	Objective: The objective of our study was to investigate tumor conspicuity and the discrimination potential for tumor aggressiveness on diffusion-weighted magnetic resonance imaging (DW-MRI) with high b value at 3-T. Materials and Methods: The institutional review board approved this study and waived the requirement for informed consent. A total of 50 patients with prostate cancer (69 cancer foci; 48 in the PZ, 20 in the TZ, and one in whole prostate) who underwent multiparametric prostate MRI including DW-MRI (b values: 0, 1000 s/mm(2) and 0, 2000 s/mm(2)) on a 3-T system were included. Lesion conspicuity score (LCS) using visual assessment (1 = invisible for surrounding normal site; 2 = slightly high intensity; 3 = moderately high; and 4 = very high) and tumor-normal signal intensity ratio (TNR) were assessed, and apparent diffusion coefficient (ADC, x10(-3) mm(2)/s) of the tumor regions and normal regions were measured. Results: Mean LCS and TNR at 0, 2000 s/mm(2) was significantly higher than those at 0, 1000 s/mm(2) (p<0.001 for both). In addition, ADC at both 0, 1000 and 0, 2000 s/mm(2) was found to distinguish intermediate or high risk cancer with Gleason score >= 7 from low risk cancer with Gleason score <= 6 (p<0.001 for both). Furthermore, ADC of tumor regions correlated with Gleason score at both 0, 1000 s/mm(2) (p = -0.602; p<0.001) and 0, 2000 s/mm(2) (p = -0.645; p<0.001). Conclusions: For tumor conspicuity and characterization of prostate cancer on DW-MRI of 3-T MRI, b = 0, 2000 s/mm(2) is more useful than b = 0, 1000 s/mm(2)	[Tamada, Tsutomu; Sone, Teruki; Higashi, Hiroki; Yamamoto, Akira; Ito, Katsuyoshi] Kawasaki Med Sch, Dept Radiol, Kurashiki, Okayama, Japan; [Kanomata, Naoki] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Jo, Yoshimasa; Miyaji, Yoshiyuki] Kawasaki Med Sch, Dept Urol, Kurashiki, Okayama, Japan	Kawasaki Medical School; Kawasaki Medical School; Kawasaki Medical School	Tamada, T (corresponding author), Kawasaki Med Sch, Dept Radiol, Kurashiki, Okayama, Japan.	ttamada@med.kawasaki-m.ac.jp			Kawasaki Medical School Project Grants [25-B31]	Kawasaki Medical School Project Grants	This study was supported by the Kawasaki Medical School Project Grants (25-B31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Burdette JH, 1999, RADIOLOGY, V212, P333, DOI 10.1148/radiology.212.2.r99au36333; Cookson MS, 1997, J UROLOGY, V157, P559, DOI 10.1016/S0022-5347(01)65201-7; Doo KW, 2012, EUR RADIOL, V22, P1812, DOI 10.1007/s00330-012-2430-5; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; Hoeks CMA, 2011, RADIOLOGY, V261, P46, DOI 10.1148/radiol.11091822; Kaji Y, 1998, RADIOLOGY, V206, P785, DOI 10.1148/radiology.206.3.9494502; Kim CK, 2007, J COMPUT ASSIST TOMO, V31, P449, DOI 10.1097/01.rct.0000243456.00437.59; Kim CK, 2010, AM J ROENTGENOL, V194, P1461, DOI 10.2214/AJR.09.3654; Kitajima K, 2012, J MAGN RESON IMAGING, V36, P198, DOI 10.1002/jmri.23627; Koo IH, 2013, KOREAN J RADIOL, V14, P61, DOI 10.3348/kjr.2013.14.1.61; Kvale R, 2009, BJU INT, V103, P1647, DOI 10.1111/j.1464-410X.2008.08255.x; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Metens T, 2012, EUR RADIOL, V22, P703, DOI 10.1007/s00330-011-2298-9; Nagarajan R, 2012, J MAGN RESON IMAGING, V36, P697, DOI 10.1002/jmri.23676; Noworolski SM, 2008, MAGN RESON IMAGING, V26, P1071, DOI 10.1016/j.mri.2008.01.033; Ohgiya Y, 2012, CLIN IMAG, V36, P526, DOI 10.1016/j.clinimag.2011.11.016; Oto A, 2011, AM J ROENTGENOL, V197, P1382, DOI 10.2214/AJR.11.6861; Oto A, 2010, RADIOLOGY, V257, P715, DOI 10.1148/radiol.10100021; Provenzale JM, 1999, AM J ROENTGENOL, V172, P537, DOI 10.2214/ajr.172.2.9930819; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Quinn M, 2002, BJU INT, V90, P174, DOI 10.1046/j.1464-410X.2002.02823.x; Rajinikanth A, 2008, UROLOGY, V72, P177, DOI 10.1016/j.urology.2007.10.022; Rosenkrantz AB, 2013, J MAGN RESON IMAGING, V38, P694, DOI 10.1002/jmri.24016; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takenaka A, 2006, INT J UROL, V13, P10, DOI 10.1111/j.1442-2042.2006.01221.x; Tamada T, 2008, RADIOLOGY, V248, P531, DOI 10.1148/radiol.2482070157; Tamada T, 2014, NMR BIOMED, V27, P25, DOI 10.1002/nbm.2956; Tamada T, 2011, AM J ROENTGENOL, V197, P664, DOI 10.2214/AJR.10.5923; Thoeny HC, 2012, RADIOLOGY, V263, P326, DOI 10.1148/radiol.12110446; Thormer G, 2012, EUR RADIOL, V22, P1820, DOI 10.1007/s00330-012-2432-3; Turkbey B, 2011, RADIOLOGY, V258, P488, DOI 10.1148/radiol.10100667; Ueno Y, 2013, J MAGN RESON IMAGING, V38, P154, DOI 10.1002/jmri.23953; van Oort IM, 2010, HISTOPATHOLOGY, V56, P464, DOI 10.1111/j.1365-2559.2010.03497.x; Verma S, 2011, AM J ROENTGENOL, V196, P374, DOI 10.2214/AJR.10.4441	38	52	55	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96619	10.1371/journal.pone.0096619	http://dx.doi.org/10.1371/journal.pone.0096619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802652	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800093
J	Wang, J; Xiang, B; Lin, HY; Liu, HY; Freed, D; Arora, RC; Tian, GH				Wang, Jian; Xiang, Bo; Lin, Hung-Yu; Liu, Hongyu; Freed, Darren; Arora, Rakesh C.; Tian, Ganghong			Pathological Mechanism for Delayed Hyperenhancement of Chronic Scarred Myocardium in Contrast Agent Enhanced Magnetic Resonance Imaging	PLOS ONE			English	Article							CORONARY COLLATERAL CIRCULATION; GD-DTPA; INFARCTION; VIABILITY; SWINE; REPRODUCIBILITY; DISCRIMINATION; SEVERITY; ISCHEMIA; RABBIT	Objectives: To evaluate possible mechanism for delayed hyperenhancement of scarred myocardium by investigating the relationship of contrast agent (CA) first pass and delayed enhancement patterns with histopathological changes. Materials and Methods: Eighteen pigs underwent 4 weeks ligation of 1 or 2 diagonal coronary arteries to induce chronic infarction. The hearts were then removed and perfused in a Langendorff apparatus. The hearts firstly experienced phosphorus 31 MR spectroscopy. The hearts in group I (n = 9) and II (n = 9) then received the bolus injection of Gadolinium diethylenetriamine pentaacetic acid (0.05 mmol/kg) and gadolinium-based macromolecular agent (P792, 15 mu mol/kg), respectively. First pass T-2* MRI was acquired using a gradient echo sequence. Delayed enhanced T-1 MRI was acquired with an inversion recovery sequence. Masson's trichrome and anti-von Willebrand Factor (vWF) staining were performed for infarct characterization. Results: Wash-in of both kinds of CA caused the sharp and dramatic T-2* signal decrease of scarred myocardium similar to that of normal myocardium. Myocardial blood flow and microvessel density were significantly recovered in 4-week-old scar tissue. Steady state distribution volume (Delta R-1 relaxation rate) of Gd-DTPA was markedly higher in scarred myocardium than in normal myocardium, whereas Delta R-1 relaxation rate of P792 did not differ significantly between scarred and normal myocardium. The ratio of extracellular volume to the total water volume was significantly greater in scarred myocardium than in normal myocardium. Scarred myocardium contained massive residual capillaries and dilated vessels. Histological stains indicated the extensively discrete matrix deposition and lack of cellular structure in scarred myocardium. Conclusions: Collateral circulation formation and residual vessel effectively delivered CA into scarred myocardium. However, residual vessel without abnormal hyperpermeability allowed Gd-DTPA rather than P792 to penetrate into extravascular compartment. Discrete collagen fiber meshwork and loss of cellularity enlarged extracellular space accessible to Gd-DTPA, resulting in the delayed hyper-enhanced scar.	[Wang, Jian] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan, Hubei, Peoples R China; [Wang, Jian; Xiang, Bo; Lin, Hung-Yu; Freed, Darren; Arora, Rakesh C.; Tian, Ganghong] CNR, Winnipeg, MB, Canada; [Wang, Jian; Xiang, Bo; Freed, Darren; Arora, Rakesh C.; Tian, Ganghong] Univ Manitoba, Fac Med, Dept Physiol, Winnipeg, MB, Canada; [Wang, Jian; Liu, Hongyu] Harbin Med Univ, Affiliated Hosp 1, Dept Cardiac Surg, Harbin, Heilongjiang, Peoples R China; [Freed, Darren; Arora, Rakesh C.] St Boniface Gen Hosp, Cardiac Sci Program, Inst Cardiovasc Sci, Winnipeg, MB R2H 2A6, Canada	Huazhong University of Science & Technology; University of Manitoba; Harbin Medical University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Wang, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan, Hubei, Peoples R China.	jianwang1030@126.com		Freed, Darren/0000-0002-6239-1444	National Natural Sciences Foundation of China [81200105]; China Postdoctoral Science Foundation [20100470050]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was supported by National Natural Sciences Foundation of China (81200105, http://www.nsfc.gov.cn/Portal0/default152.htm) and China Postdoctoral Science Foundation funded Project (20100470050, http://res.chinapostdoctor.org.cn/Program/Main.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSIO G, 1989, CIRCULATION, V80, P1846, DOI 10.1161/01.CIR.80.6.1846; Bulow H, 2005, HEART, V91, P1158, DOI 10.1136/hrt.2004.045609; CLEUTJENS JPM, 1995, AM J PATHOL, V147, P325; Cleutjens JPM, 2002, J CARD FAIL, V8, pS344, DOI 10.1054/jcaf.2002.129261; DONAHUE KM, 1994, MAGNET RESON MED, V32, P66, DOI 10.1002/mrm.1910320110; Flacke SJ, 2001, RADIOLOGY, V218, P703, DOI 10.1148/radiology.218.3.r01fe18703; GORGE G, 1989, BASIC RES CARDIOL, V84, P524; HOLMES JW, 1994, CIRCULATION, V90, P411, DOI 10.1161/01.CIR.90.1.411; JOHNSTON DL, 1988, MAGNET RESON MED, V8, P363, DOI 10.1002/mrm.1910080402; JUDD RM, 1995, CIRCULATION, V92, P1902, DOI 10.1161/01.CIR.92.7.1902; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; Klein C, 2002, CIRCULATION, V105, P162, DOI 10.1161/hc0202.102123; Klein C, 2007, J CARDIOVASC MAGN R, V9, P653, DOI 10.1080/10976640601105614; Kramer MF, 1998, CELL TISSUE RES, V291, P97; LIMA JAC, 1995, CIRCULATION, V92, P1117, DOI 10.1161/01.CIR.92.5.1117; Mahrholdt H, 2002, CIRCULATION, V106, P2322, DOI 10.1161/01.CIR.0000036368.63317.1C; Morales C, 2002, CARDIOVASC PATHOL, V11, P339, DOI 10.1016/S1054-8807(02)00115-1; MURRY CE, 1994, AM J PATHOL, V145, P1450; Pereira RS, 1996, MAGN RESON MED, V36, P684, DOI 10.1002/mrm.1910360506; Ramani K, 1998, CIRCULATION, V98, P2687, DOI 10.1161/01.CIR.98.24.2687; Rehwald WG, 2002, CIRCULATION, V105, P224, DOI 10.1161/hc0202.102016; ROTH DM, 1987, AM J PHYSIOL, V253, pH1279, DOI 10.1152/ajpheart.1987.253.5.H1279; SAEED M, 1994, CIRCULATION, V90, P1492, DOI 10.1161/01.CIR.90.3.1492; Saeed M, 1998, JMRI-J MAGN RESON IM, V8, P561, DOI 10.1002/jmri.1880080308; Saeed M, 2006, J AM COLL CARDIOL, V48, P1961, DOI 10.1016/j.jacc.2006.03.071; SCHWARTZ H, 1984, J AM COLL CARDIOL, V4, P1088, DOI 10.1016/S0735-1097(84)80126-6; Schwitter J, 1997, J AM COLL CARDIOL, V30, P1086, DOI 10.1016/S0735-1097(97)00245-3; Sun Y, 2000, J LAB CLIN MED, V135, P316, DOI 10.1067/mlc.2000.105971; TONG CY, 1993, MAGNET RESON MED, V30, P337, DOI 10.1002/mrm.1910300310; VRACKO R, 1989, AM J PATHOL, V134, P993; Wang Y, 2006, J MAGN RESON IMAGING, V24, P851, DOI 10.1002/jmri.20710; WHITE FC, 1992, CIRC RES, V71, P1490, DOI 10.1161/01.RES.71.6.1490; WHITTAKER P, 1989, AM J PATHOL, V134, P879	33	4	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96463	10.1371/journal.pone.0096463	http://dx.doi.org/10.1371/journal.pone.0096463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802515	Green Published, gold			2022-12-27	WOS:000338029800071
J	Assani, K; Tazi, MF; Amer, AO; Kopp, BT				Assani, Kaivon; Tazi, Mia F.; Amer, Amal O.; Kopp, Benjamin T.			IFN-gamma Stimulates Autophagy-Mediated Clearance of Burkholderia cenocepacia in Human Cystic Fibrosis Macrophages	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; INTERFERON-GAMMA; PSEUDOMONAS-AERUGINOSA; LUNG TRANSPLANTATION; CEPACIA COMPLEX; INFLAMMATORY RESPONSE; ALVEOLAR MACROPHAGES; APOPTOTIC CELLS; NADPH OXIDASE; INFECTION	Burkholderia cenocepacia is a virulent pathogen that causes significant morbidity and mortality in patients with cystic fibrosis (CF), survives intracellularly in macrophages, and uniquely causes systemic infections in CF. Autophagy is a physiologic process that involves engulfing non-functional organelles and proteins and delivering them for lysosomal degradation, but also plays a role in eliminating intracellular pathogens, including B. cenocepacia. Autophagy is defective in CF but can be stimulated in murine CF models leading to increased clearance of B. cenocepacia, but little is known about autophagy stimulation in human CF macrophages. IFN-gamma activates macrophages and increases antigen presentation while also inducing autophagy in macrophages. We therefore, hypothesized that treatment with IFN-gamma would increase autophagy and macrophage activation in patients with CF. Peripheral blood monocyte derived macrophages (MDMs) were obtained from CF and non-CF donors and subsequently infected with B. cenocepacia. Basal serum levels of IFN-gamma were similar between CF and non-CF patients, however after B. cenocepacia infection there is deficient IFN-gamma production in CF MDMs. IFN-gamma treated CF MDMs demonstrate increased co-localization with the autophagy molecule p62, increased autophagosome formation, and increased trafficking to lysosomes compared to untreated CF MDMs. Electron microscopy confirmed IFN-gamma promotes double membrane vacuole formation around bacteria in CF MDMs, while only single membrane vacuoles form in untreated CF cells. Bacterial burden is significantly reduced in autophagy stimulated CF MDMs, comparable to non-CF levels. IL-1 beta production is decreased in CF MDMs after IFN-gamma treatment. Together, these results demonstrate that IFN-gamma promotes autophagy-mediated clearance of B. cenocepacia in human CF macrophages.	[Assani, Kaivon; Kopp, Benjamin T.] Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Tazi, Mia F.; Amer, Amal O.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Tazi, Mia F.; Amer, Amal O.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Kopp, Benjamin T.] Nationwide Childrens Hosp, Sect Pediat Pulmonol, Columbus, OH USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Kopp, BT (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA.	Benjamin.Kopp@NationwideChildrens.org	Amer, Amal/E-2643-2011	kopp, Benjamin/0000-0002-2021-7990	Public Health Preparedness for Infectious Diseases program; Nationwide Children's Hospital institutional funds	Public Health Preparedness for Infectious Diseases program; Nationwide Children's Hospital institutional funds	This work was supported by funds provided by the Public Health Preparedness for Infectious Diseases program (phpid.osu.edu) (BK, AA) and Nationwide Children's Hospital institutional funds (BK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahman BA, 2013, J BIOL CHEM, V288, P2049, DOI 10.1074/jbc.M112.411728; Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Al-Khodor S, 2014, CELL MICROBIOL, V16, P378, DOI 10.1111/cmi.12223; Al-Zeer MA, 2013, AUTOPHAGY, V9, P50, DOI 10.4161/auto.22482; Alexander BD, 2008, AM J TRANSPLANT, V8, P1025, DOI 10.1111/j.1600-6143.2008.02186.x; Aubert DF, 2013, ENVIRON MICROBIOL, V15, P372, DOI 10.1111/j.1462-2920.2012.02828.x; Binder AM, 2013, AM J RESP CRIT CARE, V188, P807, DOI 10.1164/rccm.201307-1200OC; Brennan S, 2009, EUR RESPIR J, V34, P655, DOI 10.1183/09031936.00178508; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Chhajed PN, 2006, RESPIRATION, V73, P367, DOI 10.1159/000087945; Condos R, 2004, CHEST, V125, P2146, DOI 10.1378/chest.125.6.2146; De Soyza A, 2010, J HEART LUNG TRANSPL, V29, P1395, DOI 10.1016/j.healun.2010.06.007; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Diaz KT, 2012, J AEROSOL MED PULM D, V25, P79, DOI 10.1089/jamp.2011.0919; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Egan TM, 2002, EUR J CARDIO-THORAC, V22, P602, DOI 10.1016/S1010-7940(02)00376-7; Errante Paolo R, 2008, Recent Pat Antiinfect Drug Discov, V3, P225, DOI 10.2174/157489108786242378; EZEKOWITZ RAB, 1991, NEW ENGL J MED, V324, P509, DOI 10.1056/NEJM199102213240801; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gillette DD, 2013, J BIOL CHEM, V288, P3691, DOI 10.1074/jbc.C112.430298; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Grasemann H, 2013, LANCET RESP MED, V1, P148, DOI 10.1016/S2213-2600(13)70026-2; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hamad MA, 2010, APPL ENVIRON MICROB, V76, P3170, DOI 10.1128/AEM.03024-09; Hardinger KL, 2002, TRANSPLANTATION, V74, P739, DOI 10.1097/00007890-200209150-00025; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Holland SM, 2010, CLIN REV ALLERG IMMU, V38, P3, DOI 10.1007/s12016-009-8136-z; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Johansen HK, 1996, CLIN EXP IMMUNOL, V103, P212, DOI 10.1046/j.1365-2249.1996.d01-618.x; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Junkins RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072263; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kopp BT, 2012, BIOCHEM BIOPH RES CO, V424, P221, DOI 10.1016/j.bbrc.2012.06.066; Kotrange S, 2011, J LEUKOCYTE BIOL, V89, P481, DOI 10.1189/jlb.0910513; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Marciano BE, 2004, CLIN INFECT DIS, V39, P692, DOI 10.1086/422993; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; Mayer ML, 2013, J IMMUNOL, V190, P1227, DOI 10.4049/jimmunol.1201404; McKeon S, 2010, FEMS IMMUNOL MED MIC, V60, P36, DOI 10.1111/j.1574-695X.2010.00712.x; MCPHAIL LC, 1977, J PEDIATR-US, V90, P213, DOI 10.1016/S0022-3476(77)80632-X; Mitchell AJ, 2012, J IMMUNOL, V189, P4970, DOI 10.4049/jimmunol.1201687; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Moss RB, 2005, PEDIATR PULM, V39, P209, DOI 10.1002/ppul.20152; Murray S, 2008, AM J RESP CRIT CARE, V178, P363, DOI 10.1164/rccm.200712-1834OC; O'Grady EP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037611; Olland A, 2011, INTERACT CARDIOV TH, V13, P631, DOI 10.1510/icvts.2011.271874; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Sajjan SU, 2008, INFECT IMMUN, V76, P5447, DOI 10.1128/IAI.00451-08; Sanmun D, 2009, AM J PHYSIOL-CELL PH, V297, pC621, DOI 10.1152/ajpcell.00651.2008; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Subramoni S, 2012, FUTURE MICROBIOL, V7, P1373, DOI [10.2217/FMB.12.118, 10.2217/fmb.12.118]; SUN L, 1995, NAT MED, V1, P661, DOI 10.1038/nm0795-661; Van de Weert-van Leeuwen PB, 2013, AM J RESP CELL MOL, V49, P463, DOI 10.1165/rcmb.2012-0502OC; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vergunst AC, 2010, INFECT IMMUN, V78, P1495, DOI 10.1128/IAI.00743-09; Walsh NM, 2002, J PEDIATR-US, V141, P512, DOI 10.1067/mpd.2002.127665; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573	67	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96681	10.1371/journal.pone.0096681	http://dx.doi.org/10.1371/journal.pone.0096681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798083	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000116
J	Chetty, C; Khumalo, T; Dias, BD; Reusch, U; Knackmuss, S; Little, M; Weiss, SFT				Chetty, Carryn; Khumalo, Thandokuhle; Dias, Bianca Da Costa; Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn; Weiss, Stefan F. T.			Anti-LRP/LR Specific Antibody IgG1-iS18 Impedes Adhesion and Invasion of Liver Cancer Cells	PLOS ONE			English	Article							67-KDA LAMININ RECEPTOR; BINDING PROTEIN-PRECURSOR; MATRIX	Two key events, namely adhesion and invasion, are pivotal to the occurrence of metastasis. Importantly, the 37 kDa/67 kDa laminin receptor (LRP/LR) has been implicated in enhancing these two events thus facilitating cancer progression. In the current study, the role of LRP/LR in the adhesion and invasion of liver cancer (HUH-7) and leukaemia (K562) cells was investigated. Flow cytometry revealed that the HUH-7 cells displayed significantly higher cell surface LRP/LR levels compared to the poorly-invasive breast cancer (MCF-7) control cells, whilst the K562 cells displayed significantly lower cell surface LRP/LR levels in comparison to the MCF-7 control cells. However, Western blotting and densitometric analysis revealed that all three tumorigenic cell lines did not differ significantly with regards to total LRP/LR levels. Furthermore, treatment of liver cancer cells with anti-LRP/LR specific antibody IgG1-iS18 (0.2 mg/ml) significantly reduced the adhesive potential of cells to laminin-1 and the invasive potential of cells through the ECM-like Matrigel, whilst leukaemia cells showed no significant differences in both instances. Additionally, Pearson's correlation coefficients suggested direct proportionality between cell surface LRP/LR levels and the adhesive and invasive potential of liver cancer and leukaemia cells. These findings suggest the potential use of anti-LRP/LR specific antibody IgG1-iS18 as an alternative therapeutic tool for metastatic liver cancer through impediment of the LRP/LR-laminin-1 interaction.	[Chetty, Carryn; Khumalo, Thandokuhle; Dias, Bianca Da Costa; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, Gauteng, South Africa; [Reusch, Uwe; Knackmuss, Stefan; Little, Melvyn] Affimed Therapeut AG, Heidelberg, Baden Wuerttemb, Germany	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, Gauteng, South Africa.	stefan.weiss@wits.ac.za			National Research Foundation; Republic of South Africa; Medical Research Council	National Research Foundation; Republic of South Africa; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Research Foundation, the Republic of South Africa and the Medical Research Council, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ardini E, 2002, CANCER RES, V62, P1321; AZNAVOORIAN S, 1990, J CELL BIOL, V110, P1427, DOI 10.1083/jcb.110.4.1427; Broek IV, 2001, BRIT J CANCER, V85, P1387, DOI 10.1054/bjoc.2001.2078; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Canfield SM, 1999, J IMMUNOL, V163, P3430; Engvall E, 1996, J CELL BIOCHEM, V61, P493; FIDLER IJ, 1990, J NATL CANCER I, V82, P166, DOI 10.1093/jnci/82.3.166; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fulop T, 2002, SEMIN CANCER BIOL, V12, P219, DOI 10.1016/S1044-579X(02)00025-1; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; Malinda KM, 1996, INT J BIOCHEM CELL B, V28, P957, DOI 10.1016/1357-2725(96)00042-8; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Salama RHM, 2001, EXP CELL RES, V270, P13, DOI 10.1006/excr.2001.5341; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; StetlerStevenson M, 1997, BLOOD, V89, P1708, DOI 10.1182/blood.V89.5.1708.1708_1708_1715; Vana Karen, 2009, Infectious Disorders - Drug Targets, V9, P69; WEEKS BS, 1990, J NEUROSCI RES, V27, P418, DOI 10.1002/jnr.490270321; Zhou L, 2006, LARYNGOSCOPE, V116, P28, DOI 10.1097/01.mlg.0000184505.05662.b9; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	23	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96268	10.1371/journal.pone.0096268	http://dx.doi.org/10.1371/journal.pone.0096268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798101	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000057
J	Feldman, M; Al-Quntar, A; Polacheck, I; Friedman, M; Steinberg, D				Feldman, Mark; Al-Quntar, Abed; Polacheck, Itzhak; Friedman, Michael; Steinberg, Doron			Therapeutic Potential of Thiazolidinedione-8 as an Antibiofilm Agent against Candida albicans	PLOS ONE			English	Article							BIOFILM FORMATION; AUTOREGULATORY SUBSTANCE; IN-VITRO; GROWTH; SECRETION; FARNESOL; ADHESION; EFFICACY; FUNGI; UME6	Candida albicans is known as a commensal microorganism but it is also the most common fungal pathogen in humans, causing both mucosal and systemic infections. Biofilm-associated C. albicans infections present clinically important features due to their high levels of resistance to traditional antifungal agents. Quorum sensing is closely associated with biofilm formation and increasing fungal pathogenicity. We investigated the ability of the novel bacterial quorum sensing quencher thiazolidinedione-8 (S-8) to inhibit the formation of, and eradication of mature C. albicans biofilms. In addition, the capability of S-8 to alter fungal adhesion to mammalian cells was checked. S-8 exhibited specific antibiofilm and antiadhesion activities against C. albicans, at four-to eightfold lower concentrations than the minimum inhibitory concentration (MIC). Using fluorescence microscopy, we observed that S-8 dose-dependently reduces C. albicans-GFP binding to RAW macrophages. S-8 at sub-MICs also interfered with fungal morphogenesis by inhibiting the yeast-to-hyphal form transition. In addition, the tested agent strongly affected fungal cell wall characteristics by modulating its hydrophobicity. We evaluated the molecular mode of S-8 antibiofilm and antiadhesion activities using real-time RT-PCR. The expression levels of genes associated with biofilm formation, adhesion and filamentation, HWP1, ALS3 and EAP1, respectively, were dose-dependently downregulated by S-8. Transcript levels of UME6, responsible for long-term hyphal maintenance, were also significantly decreased by the tested agent. Both signaling pathways of hyphal formation-cAMP-PKA and MAPK-were interrupted by S-8. Their upstream general regulator RAS1 was markedly suppressed by S-8. In addition, the expression levels of MAPK cascade components CST20, HST7 and CPH1 were downregulated by S-8. Finally, transcriptional repressors of filament formation, TUP1 and NRG1, were dramatically upregulated by our compound. Our results indicate that S-8 holds a novel antibiofilm therapeutic mean in the treatment and prevention of biofilm-associated C. albicans infections.	[Feldman, Mark; Al-Quntar, Abed; Steinberg, Doron] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Biofilm Res Lab, Jerusalem, Israel; [Al-Quntar, Abed; Friedman, Michael] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, IL-91120 Jerusalem, Israel; [Polacheck, Itzhak] Hadassah Hebrew Univ, Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Steinberg, D (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Biofilm Res Lab, Jerusalem, Israel.	dorons@kmd.huji.ac.il		, Mark/0000-0003-2229-6263	International Association for Dental Research (IADR); GlaxoSmithKline (GSK) Dental Care Innovation [0304914]; internal Hebrew University sources	International Association for Dental Research (IADR); GlaxoSmithKline (GSK) Dental Care Innovation; internal Hebrew University sources	This work was partially supported by The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Dental Care Innovation Award No. 0304914 and by internal Hebrew University sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque P, 2012, MED MYCOL, V50, P337, DOI 10.3109/13693786.2011.652201; Alem MAS, 2006, EUKARYOT CELL, V5, P1770, DOI 10.1128/EC.00219-06; [Anonymous], 2012, INT J MICROBIOL, DOI DOI 10.1155/2012/528521; Baillie GS, 1998, ANTIMICROB AGENTS CH, V42, P1900, DOI 10.1128/AAC.42.8.1900; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Brackman G, 2013, BIOORGAN MED CHEM, V21, P660, DOI 10.1016/j.bmc.2012.11.055; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; de Souza RD, 2009, GERODONTOLOGY, V26, P157, DOI 10.1111/j.1741-2358.2008.00229.x; Feldman M, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-6; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Gerami-Nejad M, 2013, MICROBIOL-SGM, V159, P565, DOI 10.1099/mic.0.064097-0; Gomes PN, 2011, ARCH ORAL BIOL, V56, P1274, DOI 10.1016/j.archoralbio.2011.04.006; Grubb SEW, 2008, INFECT IMMUN, V76, P4370, DOI 10.1128/IAI.00332-08; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Kagan SH, 2014, GERIATR NURS, V35, P69, DOI 10.1016/j.gerinurse.2013.11.006; Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004; Li L, 2010, MOL ORAL MICROBIOL, V25, P384, DOI 10.1111/j.2041-1014.2010.00586.x; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; Nadas GC, 2013, MYCOPATHOLOGIA, V175, P221, DOI 10.1007/s11046-013-9613-8; Nickerson KW, 2006, APPL ENVIRON MICROB, V72, P3805, DOI 10.1128/AEM.02765-05; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Oh KB, 2001, P NATL ACAD SCI USA, V98, P4664, DOI 10.1073/pnas.071404698; Pereira CA, 2013, DIAGN MICR INFEC DIS, V76, P419, DOI 10.1016/j.diagmicrobio.2013.05.001; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Privett BJ, 2010, BIOFOULING, V26, P973, DOI 10.1080/08927014.2010.534552; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Ramage G, 2001, ANTIMICROB AGENTS CH, V45, P2475, DOI 10.1128/AAC.45.9.2475-2479.2001; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x; Roman E, 2009, FEMS YEAST RES, V9, P942, DOI 10.1111/j.1567-1364.2009.00545.x; Sato T, 2004, BIOL PHARM BULL, V27, P751, DOI 10.1248/bpb.27.751; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Srinivasan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019036; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Umeyama T, 2005, MOL MICROBIOL, V55, P381, DOI 10.1111/j.1365-2958.2004.04405.x; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Weber K, 2010, YEAST, V27, P727, DOI 10.1002/yea.1769; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x	47	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e93225	10.1371/journal.pone.0093225	http://dx.doi.org/10.1371/journal.pone.0093225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796422	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000003
J	Jaiswal, N; Singh, M; Thumburu, KK; Bharti, B; Agarwal, A; Kumar, A; Kaur, H; Chadha, N				Jaiswal, Nishant; Singh, Meenu; Thumburu, Kiran Kumar; Bharti, Bhavneet; Agarwal, Amit; Kumar, Ajay; Kaur, Harpreet; Chadha, Neelima			Burden of Invasive Pneumococcal Disease in Children Aged 1 Month to 12 Years Living in South Asia: A Systematic Review	PLOS ONE			English	Review							STREPTOCOCCUS-PNEUMONIAE DISEASE; ACUTE RESPIRATORY-INFECTIONS; ANTIMICROBIAL RESISTANCE; HOSPITALIZED CHILDREN; SEROTYPE DISTRIBUTION; CHILDHOOD INFECTIONS; ORAL AMOXICILLIN; SURVEILLANCE; ETIOLOGY; BANGLADESH	Objective: The primary objective was to estimate the burden of invasive pneumococcal disease (IPD) in children aged 1 month to 12 years in South Asian countries. Methods: We searched three electronic databases (PubMed, Embase and the Cochrane Library) using a comprehensive search strategy, we manually searched published databases (Index Medicus and Current Contents) and we also searched the bibliographies of the included studies and retrieved reviews. The searches were current through June 2013. Eligible studies (community-based and hospital-based) were pooled and a separate analysis for India was also completed. A meta-regression analysis and heterogeneity analysis were performed. The protocol was registered with PROSPERO registration number CRD42013004483. Results: A total of 22 studies surveying 36,714 children were included in the systematic review. Hospital-based prospective studies from South Asia showed that 3.57% of children had IPD, and 15% of all bacterial pneumonia cases were due to Streptococcus pneumoniae. Indian studies showed that the incidence of IPD was 10.58% in children admitted to hospitals with suspected invasive bacterial diseases, and 24% of all bacterial pneumonia cases were due to S. pneumonia. Population-based studies from South Asian countries showed that 12.8% of confirmed invasive bacterial diseases were caused by S. pneumonia whereas retrospective hospital-based studies showed that 28% of invasive bacterial diseases were due to S. pneumoniae. Meta-regression showed that there was a significant influence of the antigen testing method for diagnosing IPD on IPD prevalence. Conclusion: S. pneumoniae is responsible for a substantial bacterial disease burden in children of South Asian countries including India despite the presence of high heterogeneity in this meta-analysis. Treatment guidelines must be formulated, and preventive measures like vaccines must also be considered.	[Jaiswal, Nishant; Thumburu, Kiran Kumar; Agarwal, Amit] Post Grad Inst Med Educ & Res, ICMR Adv Ctr Evidence Based Child Hlth, Chandigarh, India; [Singh, Meenu; Bharti, Bhavneet] Post Grad Inst Med Educ & Res, Dept Pediat, Chandigarh, India; [Chadha, Neelima] Post Grad Inst Med Educ & Res, Tulsidas Lib, Chandigarh, India; [Kaur, Harpreet] Punjab Univ, Univ Business Sch, Chandigarh 160014, India; [Kumar, Ajay] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University; Wayne State University	Singh, M (corresponding author), Post Grad Inst Med Educ & Res, Dept Pediat, Chandigarh, India.	meenusingh4@gmail.com	Agarwal, Amit/HIK-0172-2022; Jaiswal, Nishant/GPW-5502-2022	Agarwal, Amit/0000-0001-7136-8206; Jaiswal, Nishant/0000-0001-5511-4572	ICMR, New Delhi [5/7/592/11-RHN]	ICMR, New Delhi(Indian Council of Medical Research (ICMR))	The review was supported and funded by ICMR, New Delhi (grant number 5/7/592/11-RHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya D, 2003, Indian J Public Health, V47, P7; Addo-Yobo E, 2004, LANCET, V364, P1141, DOI 10.1016/S0140-6736(04)17100-6; Agarwal J, 2009, TROP DOCT, V39, P109, DOI 10.1258/td.2008.080248; Arifeen SE, 2009, CLIN INFECT DIS, V48, pS103, DOI 10.1086/596543; Asghar R, 2008, BMJ-BRIT MED J, V336, P80, DOI 10.1136/bmj.39421.435949.BE; Awasthi S, 2004, BMJ-BRIT MED J, V328, P791; Awasthi S, 1997, Indian Pediatr, V34, P987; BAHL R, 1995, ANN TROP PAEDIATR, V15, P173, DOI 10.1080/02724936.1995.11747768; Bansal Arun, 2006, Indian Journal of Pediatrics, V73, P305, DOI 10.1007/BF02825824; Bansal S, 2004, Indian J Chest Dis Allied Sci, V46, P17; Baqui AH, 2007, J HEALTH POPUL NUTR, V25, P179; Batuwanthudawe R, 2009, CLIN INFECT DIS, V48, pS136, DOI 10.1086/596492; Bharti Bhavneet, 2006, Indian Journal of Pediatrics, V73, P33, DOI 10.1007/BF02758257; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Das RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066232; Deivanayagam N, 1993, Indian Pediatr, V30, P495; DEVI P S, 1982, Indian Pediatrics, V19, P317; Hazir T, 2008, LANCET, V371, P49, DOI 10.1016/S0140-6736(08)60071-9; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Hussain H, 2006, INT J HEALTH PLAN M, V21, P229, DOI 10.1002/hpm.847; Jebaraj R, 1999, EPIDEMIOL INFECT, V123, P383, DOI 10.1017/S0950268899003131; JOHN TJ, 1991, REV INFECT DIS, V13, pS463; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Kabra S. K., 2003, Indian Journal of Pediatrics, V70, P33, DOI 10.1007/BF02722742; Kanungo R, 2001, INDIAN J MED RES, V114, P127; Kelly DF, 2011, INT J INFECT DIS, V15, pE17, DOI 10.1016/j.ijid.2010.05.021; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mani R, 2007, Indian J Med Microbiol, V25, P108; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; MASTRO TD, 1991, LANCET, V337, P156, DOI 10.1016/0140-6736(91)90813-5; Mathisen Maria, 2010, Pediatr Infect Dis J, V29, pe1, DOI 10.1097/INF.0b013e3181c2a1b9; Mehta Parang N, 2003, Indian Pediatr, V40, P958; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Mulholland EK, 2004, J HEALTH POPUL NUTR, V22, P257; Naheed A, 2009, CLIN INFECT DIS, V48, pS82, DOI 10.1086/596485; Nizami Shaikh Qamaruddin, 2006, JPMA Journal of the Pakistan Medical Association, V56, P163; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Owais A, 2010, TROP MED INT HEALTH, V15, P1029, DOI 10.1111/j.1365-3156.2010.02591.x; PATWARI A K, 1988, Indian Pediatrics, V25, P613; Patwari AK, 1996, J TROP PEDIATRICS, V42, P15, DOI 10.1093/tropej/42.1.15; Rijal B, 2010, Kathmandu Univ Med J (KUMJ), V8, P164; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Saha SK, 1999, J CLIN MICROBIOL, V37, P798, DOI 10.1128/JCM.37.3.798-800.1999; Saha SK, 1997, J CLIN MICROBIOL, V35, P785, DOI 10.1128/JCM.35.3.785-787.1997; Sahai Sashi, 2001, Indian Journal of Pediatrics, V68, P839, DOI 10.1007/BF02762107; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; Shah Aparna S, 2009, Indian J Med Sci, V63, P498; Shameem Sultana, 2008, Journal of Communicable Diseases, V40, P111; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Song JH, 1999, CLIN INFECT DIS, V28, P1206, DOI 10.1086/514783; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; Thomas K, 1999, LANCET, V353, P1216, DOI 10.1016/S0140-6736(98)07228-6; Viswanath G, 2007, Indian J Pathol Microbiol, V50, P97; WHO, 2007, WORLD HLTH STAT; Williams EJ, 2009, CLIN INFECT DIS, V48, pS114, DOI 10.1086/596488; World Health Organization, 2009, GLOB LIT REV HAEM IN; Zaidi AKM, 2009, CLIN INFECT DIS, V48, pS129, DOI 10.1086/596491	58	14	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96282	10.1371/journal.pone.0096282	http://dx.doi.org/10.1371/journal.pone.0096282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798424	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000336656000059
J	Kida, T; Kozai, S; Takahashi, H; Isaka, M; Tokushige, H; Sakamoto, T				Kida, Tetsuo; Kozai, Seiko; Takahashi, Hiroaki; Isaka, Mitsuyoshi; Tokushige, Hideki; Sakamoto, Taiji			Pharmacokinetics and Efficacy of Topically Applied Nonsteroidal Anti-Inflammatory Drugs in Retinochoroidal Tissues in Rabbits	PLOS ONE			English	Article							BROMFENAC OPHTHALMIC SOLUTION; INDUCED OCULAR INFLAMMATION; MACULAR DEGENERATION; CATARACT-SURGERY; KETOROLAC TROMETHAMINE; VISUAL IMPAIRMENT; POTENTIAL UTILITY; UNITED-STATES; NEPAFENAC; PREVALENCE	Purpose: To evaluate the pharmacokinetics and efficacy of topically applied nonsteroidal anti-inflammatory drugs (NSAIDs) in the retinochoroidal tissues of rabbits. Methods: The cyclooxygenase (COX) inhibitory activity of diclofenac, bromfenac, and amfenac, an active metabolite of nepafenac, were determined using human-derived COX-1 and COX-2. Each of the three NSAIDs was applied topically to rabbits, and after 0.5 to 8 hrs, the concentration of each drug in the aqueous humor and the retinochoroidal tissues was measured by liquid chromatography-tandem mass spectrometry. The pharmacokinetics of the drugs in the tissues after repeated doses as is done on patients was calculated by a simulation software. The inhibitory effect of each NSAID on the breakdown of the blood-retinal barrier was assessed by the vitreous protein concentration on concanavalin A-induced retinochoroidal inflammation in rabbits. Results: The half-maximal inhibitory concentration (IC50) of diclofenac, bromfenac, and amfenac was 55.5, 5.56, and 15.3 nM for human COX-1, and 30.7, 7.45, and 20.4 nM for human COX-2, respectively. The three NSAIDs were detected in the aqueous humor and the retinochoroidal tissue at all-time points. Simulated pharmacokinetics showed that the levels of the three NSAIDs were continuously higher than the IC50 of COX-2, as an index of efficacy, in the aqueous humor, whereas only the bromfenac concentration was continuously higher than the IC50 at its trough level in the retinochoroidal tissues. The intravitreous concentration of proteins was significantly reduced in rabbits that received topical bromfenac (P = 0.026) but not the other two NSAIDs. Conclusions: Topical bromfenac can penetrate into the retinochoroidal tissues in high enough concentrations to inhibit COX-2 and exerts its inhibitory effect on the blood-retinal barrier breakdown in an experimental retinochoroidal inflammation in rabbits. Topical bromfenac may have a better therapeutic benefit than diclofenac and nepafenac for retinochoroidal inflammatory diseases.	[Kida, Tetsuo; Kozai, Seiko; Takahashi, Hiroaki; Isaka, Mitsuyoshi; Tokushige, Hideki] Senju Pharmaceut Co Ltd, Res Labs Drug Dev, Kobe, Hyogo, Japan; [Kida, Tetsuo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan	Senju Pharmaceutical Co. Ltd.; Kagoshima University	Sakamoto, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima 890, Japan.	tsakamot@m3.kufm.kagoshima-u.ac.jp			Senju Pharmaceutical Co., Ltd.	Senju Pharmaceutical Co., Ltd.	Senju Pharmaceutical Co., Ltd. supported and funded the research described in this article. The funder provided support in the form of salaries for authors TK, SK, H. Takahashi, MI, and H. Tokushige, and authorized the authors' decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ahuja M, 2008, AAPS J, V10, P229, DOI 10.1208/s12248-008-9024-9; Baklayan GA, 2008, J OCUL PHARMACOL TH, V24, P392, DOI 10.1089/jop.2007.0082; Bucolo C, 2014, J PHARM PHARMACOL, V66, P954, DOI 10.1111/jphp.12224; Bucolo C, 2011, J OCUL PHARMACOL TH, V27, P571, DOI 10.1089/jop.2011.0120; Chan CC, 1999, J PHARMACOL EXP THER, V290, P551; CHASTAIN JE, 2003, OPHTHALMIC DRUG DELI, P59; Cho H, 2009, CLIN OPHTHALMOL, V3, P199; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Do DV, 2013, OPHTHALMOLOGY, V120, pS8, DOI 10.1016/j.ophtha.2013.01.058; Donnenfeld ED, 2007, OPHTHALMOLOGY, V114, P1653, DOI 10.1016/j.ophtha.2006.12.029; Duong HVQ, 2007, J CATARACT REFR SURG, V33, P1925, DOI 10.1016/j.jcrs.2007.07.017; Flaxel C, 2012, RETINA-J RET VIT DIS, V32, P417, DOI 10.1097/IAE.0b013e318229b0af; Freund KB, 2013, EXPERT OPIN PHARMACO, V14, P1017, DOI 10.1517/14656566.2013.787410; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gamache DA, 2000, INFLAMMATION, V24, P357, DOI 10.1023/A:1007049015148; Gomi F, 2012, RETINA-J RET VIT DIS, V32, P1804, DOI 10.1097/IAE.0b013e31825be87f; GWON A, 1993, INVEST OPHTH VIS SCI, V34, P3483; ISAKA M, 1999, DRUG METAB PHARMACOK, V14, P32; Ishii K, 2003, INVEST OPHTH VIS SCI, V44, P1169, DOI 10.1167/iovs.02-0482; Jones J, 2009, EXPERT OPIN PHARMACO, V10, P2379, DOI 10.1517/14656560903188425; Kapin MA, 2003, INFLAMMATION, V27, P281, DOI 10.1023/A:1026024409826; Ke TL, 2000, INFLAMMATION, V24, P371, DOI 10.1023/A:1007001131987; Kim SJ, 2010, SURV OPHTHALMOL, V55, P108, DOI 10.1016/j.survophthal.2009.07.005; Miller JW, 2013, OPHTHALMOLOGY, V120, P106, DOI 10.1016/j.ophtha.2012.07.038; Miyake K, 2008, J OCUL PHARMACOL TH, V24, P573, DOI 10.1089/jop.2007.0132; Miyanaga M, 2009, ACTA OPHTHALMOL, V87, P300, DOI 10.1111/j.1755-3768.2008.01433.x; Mizuno K, 2009, INVEST OPHTH VIS SCI, V50, P2839, DOI 10.1167/iovs.08-2922; Ogawa Takahiro, 1995, Nippon Ganka Gakkai Zasshi, V99, P406; Pascolini D, 2004, OPHTHAL EPIDEMIOL, V11, P67, DOI 10.1076/opep.11.2.67.28158; Polansky J, 1984, PHARM EYE, P460; Raizman M, 1996, ARCH OPHTHALMOL-CHIC, V114, P1000, DOI 10.1001/archopht.1996.01100140208016; RUIZ J, 1993, J COMPUT AID MOL DES, V7, P183, DOI 10.1007/BF00126444; Schalnus R, 2003, OPHTHALMOLOGICA, V217, P89, DOI 10.1159/000068563; SCHOENWALD RD, 1978, J PHARM SCI-US, V67, P786, DOI 10.1002/jps.2600670614; SINGH P, 1994, J PHARMACOL EXP THER, V268, P144; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Turgut B, 2013, DRUG DES DEV THER, V7, P19, DOI 10.2147/DDDT.S39453; Uchio E, 2007, OPHTHALMOLOGICA, V221, P153, DOI 10.1159/000099294; WALSH DA, 1984, J MED CHEM, V27, P1379, DOI 10.1021/jm00377a001; Walters T, 2007, J CATARACT REFR SURG, V33, P1539, DOI 10.1016/j.jcrs.2007.05.015; WATERBURY L, 1987, J OCUL PHARMACOL, V3, P43, DOI 10.1089/jop.1987.3.43; Waterbury LD, 2006, CURR MED RES OPIN, V22, P1133, DOI 10.1185/030079906X112471; Yasuda K, 2012, J OCUL PHARMACOL TH, V28, P283, DOI 10.1089/jop.2011.0133; Yoshinaga N, 2011, LAB INVEST, V91, P1277, DOI 10.1038/labinvest.2011.101	44	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96481	10.1371/journal.pone.0096481	http://dx.doi.org/10.1371/journal.pone.0096481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796327	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000082
J	Loubeau, G; Boudra, R; Maquaire, S; Lours-Calet, C; Beaudoin, C; Verrelle, P; Morel, L				Loubeau, Gaelle; Boudra, Rafik; Maquaire, Sabrina; Lours-Calet, Corinne; Beaudoin, Claude; Verrelle, Pierre; Morel, Laurent			NPM1 Silencing Reduces Tumour Growth and MAPK Signalling in Prostate Cancer Cells	PLOS ONE			English	Article							FACTOR-ALPHA; EXPRESSION; NUCLEOPHOSMIN/B23; PROTEIN; LOCALIZATION; RECEPTOR; BINDING; MATRIX	The chaperone nucleophosmin (NPM1) is over-expressed in the epithelial compartment of prostate tumours compared to adjacent healthy epithelium and may represent one of the key actors that support the neoplastic phenotype of prostate adenocarcinoma cells. Yet, the mechanisms that underlie NPM1 mediated phenotype remain elusive in the prostate. To better understand NPM1 functions in prostate cancer cells, we sought to characterize its impact on prostate cancer cells behaviour and decipher the mechanisms by which it may act. Here we show that NPM1 favors prostate tumour cell migration, invasion and colony forming. Furthermore, knockdown of NPM1 leads to a decrease in the growth of LNCaP-derived tumours grafted in Nude mice in vivo. Such oncogenic-like properties are found in conjunction with a positive regulation of NPM1 on the ERK1/2 (Extracellular signal-Regulated Kinases 1/2) kinase phosphorylation in response to EGF (Epidermal Growth Factor) stimulus, which is critical for prostate cancer progression following the setting of an autonomous production of the growth factor. NPM1 could then be a target to switch off specifically ERK1/2 pathway activation in order to decrease or inhibit cancer cell growth and migration.	[Loubeau, Gaelle; Boudra, Rafik; Maquaire, Sabrina; Lours-Calet, Corinne; Beaudoin, Claude; Morel, Laurent] Univ Clermont Ferrand 2, Univ Blaise Pascal, GReD, Clermont Ferrand, France; [Loubeau, Gaelle; Boudra, Rafik; Maquaire, Sabrina; Lours-Calet, Corinne; Beaudoin, Claude; Morel, Laurent] Univ Clermont Ferrand 2, Photochim Mol & Macromol Lab, CNRS, UMR 6293,GReD, F-63177 Clermont Ferrand, France; [Loubeau, Gaelle; Boudra, Rafik; Maquaire, Sabrina; Lours-Calet, Corinne; Beaudoin, Claude; Morel, Laurent] INSERM, UMR 1103, GReD Genet Reprod & Dev, Clermont Ferrand, France; [Loubeau, Gaelle; Boudra, Rafik; Maquaire, Sabrina; Lours-Calet, Corinne; Beaudoin, Claude; Morel, Laurent] CRNH, Clermont Ferrand, France; [Verrelle, Pierre] Univ Clermont Ferrand 2, Univ Auvergne, EA CREaT Canc Resistance Exploring & Targeting 72, Clermont Ferrand, France; [Verrelle, Pierre] Ctr Jean Perrin, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); UNICANCER; Centre Jean Perrin	Morel, L (corresponding author), Univ Clermont Ferrand 2, Univ Blaise Pascal, GReD, Clermont Ferrand, France.	laurent.morel@univ-bpclermont.fr	LOBACCARO, Jean-Marc/L-6151-2015		Centre National de la Recherche Scientifique (CNRS); Region Auvergne	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Auvergne(Region Auvergne-Rhone-Alpes)	This work was supported by the Centre National de la Recherche Scientifique (CNRS) and by the Region Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; DAVIES P, 1989, PROSTATE, V14, P123, DOI 10.1002/pros.2990140206; Di Fiore PP, 2008, J CELL BIOL, V182, P7, DOI 10.1083/jcb.200806069; Inder Kerry L, 2010, Commun Integr Biol, V3, P188; Inder KL, 2009, J BIOL CHEM, V284, P28410, DOI 10.1074/jbc.M109.001537; Jones HE, 1997, PROSTATE, V30, P219, DOI 10.1002/(SICI)1097-0045(19970301)30:4<219::AID-PROS1>3.0.CO;2-G; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Leotoing L, 2008, ONCOGENE, V27, P2858, DOI 10.1038/sj.onc.1210942; Li QF, 2010, CANCER INVEST, V28, P1004, DOI 10.3109/07357900902918452; Lindstrom MS, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/195209; Liu Y, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-53; Nozawa Y, 1996, J PATHOL, V178, P48; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Sari A, 2012, APMIS, V120, P187, DOI 10.1111/j.1600-0463.2011.02835.x; Scher HI, 1995, CLIN CANCER RES, V1, P545; Shandilya J, 2009, MOL CELL BIOL, V29, P5115, DOI 10.1128/MCB.01969-08; Shields LBE, 1997, J SOC GYNECOL INVEST, V4, P298, DOI 10.1016/S1071-5576(97)00068-3; SZEBENI A, 1995, BIOCHEMISTRY-US, V34, P8037, DOI 10.1021/bi00025a009; Takemura M, 1999, J BIOCHEM-TOKYO, V125, P904, DOI 10.1093/oxfordjournals.jbchem.a022367; TANAKA M, 1992, CANCER RES, V52, P3372; TILLOTSON JK, 1991, CANCER LETT, V60, P109, DOI 10.1016/0304-3835(91)90216-5; TRAISH AM, 1987, ENDOCRINOLOGY, V121, P1461, DOI 10.1210/endo-121-4-1461; Weber MJ, 2004, J CELL BIOCHEM, V91, P13, DOI 10.1002/jcb.10683	26	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96293	10.1371/journal.pone.0096293	http://dx.doi.org/10.1371/journal.pone.0096293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796332	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000062
J	Zatloukal, B; Kufferath, I; Thueringer, A; Landegren, U; Zatloukal, K; Haybaeck, J				Zatloukal, Bernhard; Kufferath, Iris; Thueringer, Andrea; Landegren, Ulf; Zatloukal, Kurt; Haybaeck, Johannes			Sensitivity and Specificity of In situ Proximity Ligation for Protein Interaction Analysis in a Model of Steatohepatitis with Mallory-Denk Bodies	PLOS ONE			English	Article							HEPATOTOXICITY; MICROSCOPY; BODY	The in situ proximity ligation assay (isPLA) is an increasingly used technology for in situ detection of protein interactions, post-translational modifications, and spatial relationships of antigens in cells and tissues, in general. In order to test its performance we compared isPLA with immunofluorescence microscopy by analyzing protein interactions in cytoplasmic protein aggregates, so-called Mallory Denk bodies (MDBs). These structures represent protein inclusions in hepatocytes typically found in human steatohepatitis and they can be generated in mice by feeding of 3,5-diethoxy-carbonyl-1,4-dihydrocollidine (DDC). We investigated the colocalization of all three key MDB components, namely keratin 8 (K8), keratin 18 (K18), and p62 (sequestosome 1) by isPLA and immunofluorescence microscopy. Sensitivity and specificity of isPLA was assessed by using Krt8(-/-) and Krt18(-/-) mice as biological controls, along with a series of technical controls. isPLA signal visualization is a robust technology with excellent sensitivity and specificity. The biological relevance of signals generated critically depends on the performance of antibodies used, which requires careful testing of antibodies like in immunofluorescence microscopy. There is a clear advantage of isPLA in visualizing protein co-localization, particularly when antigens are present at markedly different concentrations. Furthermore, isPLA is superior to confocal microscopy with respect to spatial resolution of colocalizing antigens. Disadvantages compared to immunofluorescence are increased costs and longer duration of the laboratory protocol.	[Zatloukal, Bernhard; Kufferath, Iris; Thueringer, Andrea; Zatloukal, Kurt; Haybaeck, Johannes] Med Univ Graz, Inst Pathol, Graz, Austria; [Landegren, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Medical University of Graz; Uppsala University	Haybaeck, J (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	johannes.haybaeck@medunigraz.at	Landegren, Ulf D/A-8197-2019		Austrian Genome Programme GEN-AU; Christian Doppler Laboratory BRBT	Austrian Genome Programme GEN-AU; Christian Doppler Laboratory BRBT	This work was funded by the Austrian Genome Programme GEN-AU (to KZ) and the Christian Doppler Laboratory BRBT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubele M, 2010, BRIT J CANCER, V103, P663, DOI 10.1038/sj.bjc.6605836; Haybaeck J, 2012, LAB INVEST, V92, P857, DOI 10.1038/labinvest.2012.49; Holden SJ, 2010, BIOPHYS J, V99, P3102, DOI 10.1016/j.bpj.2010.09.005; Magin TM, 2007, EXP CELL RES, V313, P2021, DOI 10.1016/j.yexcr.2007.03.005; Micheva K.D., 2010, COLD SPRING HARB PRO, V2010; Pietraszewska-Bogiel A, 2011, J MICROSC-OXFORD, V241, P111, DOI 10.1111/j.1365-2818.2010.03437.x; Stumptner C, 2002, HEPATOLOGY, V35, P1053, DOI 10.1053/jhep.2002.32674; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zatloukal K, 2000, AM J PATHOL, V156, P1263, DOI 10.1016/S0002-9440(10)64997-8; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	11	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96690	10.1371/journal.pone.0096690	http://dx.doi.org/10.1371/journal.pone.0096690			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798445	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000119
J	Lungkaphin, A; Arjinajarn, P; Pongchaidecha, A; Srimaroeng, C; Chatsudthipong, L; Chatsudthipong, V				Lungkaphin, Anusorn; Arjinajarn, Phatchawan; Pongchaidecha, Anchalee; Srimaroeng, Chutima; Chatsudthipong, Lisa; Chatsudthipong, Varanuj			Impaired Insulin Signaling Affects Renal Organic Anion Transporter 3 (Oat3) Function in Streptozotocin-Induced Diabetic Rats	PLOS ONE			English	Article							PROTEIN-KINASE-C; ESTRONE SULFATE TRANSPORT; PROXIMAL TUBULES; P-AMINOHIPPURATE; TYROSINE KINASE; MESANGIAL CELLS; ACTIVATION; GLUCOSE; EXPRESSION; ZETA	Organic anion transporter 3 (Oat3) is a major renal Oats expressed in the basolateral membrane of renal proximal tubule cells. We have recently reported decreases in renal Oat3 function and expression in diabetic rats and these changes were recovered after insulin treatment for four weeks. However, the mechanisms by which insulin restored these changes have not been elucidated. In this study, we hypothesized that insulin signaling mediators might play a crucial role in the regulation of renal Oat3 function. Experimental diabetic rats were induced by a single intraperitoneal injection of streptozotocin (65 mg/kg). One week after injection, animals showing blood glucose above 250 mg/dL were considered to be diabetic and used for the experiment in which insulin-treated diabetic rats were subcutaneously injected daily with insulin for four weeks. Estrone sulfate (ES) uptake into renal cortical slices was examined to reflect the renal Oat3 function. The results showed that pre-incubation with insulin for 30 min (short term) stimulated [3H] ES uptake into the renal cortical slices of normal control rats. In the untreated diabetic rats, pre-incubation with insulin for 30 min failed to stimulate renal Oat3 activity. The unresponsiveness of renal Oat3 activity to insulin in the untreated diabetic rats suggests the impairment of insulin signaling. Indeed, pre-incubation with phosphoinositide 3-kinase (PI3K) and protein kinase C zeta (PKC zeta) inhibitors inhibited insulin-stimulated renal Oat3 activity. In addition, the expressions of PI3K, Akt and PKC zeta in the renal cortex of diabetic rats were markedly decreased. Prolonged insulin treatment in diabetic rats restored these alterations toward normal levels. Our data suggest that the decreases in both function and expression of renal Oat3 in diabetes are associated with an impairment of renal insulin-induced Akt/PKB activation through PI3K/PKC zeta/Akt/PKB signaling pathway.	[Lungkaphin, Anusorn; Pongchaidecha, Anchalee; Srimaroeng, Chutima] Chiang Mai Univ, Dept Physiol, Fac Med, Chiang Mai 50000, Thailand; [Arjinajarn, Phatchawan] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai 50000, Thailand; [Chatsudthipong, Lisa] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Chatsudthipong, Varanuj] Mahidol Univ, Fac Sci, Dept Physiol, Bangkok 10700, Thailand	Chiang Mai University; Chiang Mai University; Mahidol University; Mahidol University	Lungkaphin, A (corresponding author), Chiang Mai Univ, Dept Physiol, Fac Med, Chiang Mai 50000, Thailand.	onanusorn@yahoo.com		Srimaroeng, Chutima/0000-0002-5537-1023	Medicine Research Fund [105/2555]; Chiang Mai University, Chiang Mai, Thailand; National Research Council of Thailand [2556A10402022]	Medicine Research Fund; Chiang Mai University, Chiang Mai, Thailand; National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by Faculty of Medicine Research Fund (Grant # 105/2555), Chiang Mai University, Chiang Mai, Thailand and National Research Council of Thailand (Grant # 2556A10402022) AL. The URLs of the funder's websites are http://www.med.cmu.ac.th and http://nrpm.nrct.go.th, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjinajarn P, 2013, AM J MED SC IN PRESS; Aslamkhan AG, 2006, AM J PHYSIOL-REG I, V291, pR1773, DOI 10.1152/ajpregu.00326.2006; Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Barros SA, 2009, J BIOL CHEM, V284, P2672, DOI 10.1074/jbc.M808078200; Bernardo AA, 2003, J MEMBRANE BIOL, V191, P141, DOI 10.1007/s00232-002-1051-3; Chu TS, 1996, AM J PHYSIOL-CELL PH, V271, pC763, DOI 10.1152/ajpcell.1996.271.3.C763; du Cheyron D, 2003, KIDNEY INT, V64, P939, DOI 10.1046/j.1523-1755.2003.00189.x; Duan P, 2010, EUR J PHARMACOL, V627, P49, DOI 10.1016/j.ejphar.2009.10.048; Feliers D, 2001, KIDNEY INT, V60, P495, DOI 10.1046/j.1523-1755.2001.060002495.x; Gabriels G, 1999, J PHARMACOL EXP THER, V290, P710; Hodgkinson CP, 2002, BIOCHEMISTRY-US, V41, P10351, DOI 10.1021/bi026065r; Inui K, 2000, KIDNEY INT, V58, P944, DOI 10.1046/j.1523-1755.2000.00251.x; Inui K.-I., 1998, CLIN EXP NEPHROL, V2, P100; Kang NL, 1999, KIDNEY INT, V56, P1737, DOI 10.1046/j.1523-1755.1999.00725.x; Kwan J, 2005, KIDNEY INT, V68, P2526, DOI 10.1111/j.1523-1755.2005.00660.x; Laviola L, 2001, DIABETES, V50, P2709, DOI 10.2337/diabetes.50.12.2709; Lee MJ, 2007, AM J PHYSIOL-RENAL, V292, pF617, DOI 10.1152/ajprenal.00278.2006; Liu LZ, 2010, CELL SIGNAL, V22, P1513, DOI 10.1016/j.cellsig.2010.05.020; Lungkaphin A, 2012, SCIENCEASIA, V38, P18, DOI 10.2306/scienceasia1513-1874.2012.38.018; Moglia BB, 1996, PEDIATR RES, V39, P241, DOI 10.1203/00006450-199602000-00009; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sekine T, 2000, PFLUG ARCH EUR J PHY, V440, P337, DOI 10.1007/s004240000297; Shen W, 2006, J AM SOC NEPHROL, V17, P2414, DOI 10.1681/ASN.2005111157; Sheu ML, 2004, MOL PHARMACOL, V66, P187, DOI 10.1124/mol.66.1.187; Soodvilai S, 2005, AM J PHYSIOL-RENAL, V289, pF1057, DOI 10.1152/ajprenal.00185.2005; Soodvilai S, 2004, AM J PHYSIOL-RENAL, V287, pF1021, DOI 10.1152/ajprenal.00080.2004; Sweet DH, 2003, AM J PHYSIOL-RENAL, V284, pF763, DOI 10.1152/ajprenal.00405.2002; Sweet DH, 2002, J BIOL CHEM, V277, P26934, DOI 10.1074/jbc.M203803200; Takano M, 1996, AM J PHYSIOL-RENAL, V271, pF469, DOI 10.1152/ajprenal.1996.271.2.F469; VanWert AL, 2010, BIOPHARM DRUG DISPOS, V31, P1, DOI 10.1002/bdd.693; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Wolff NA, 2003, J AM SOC NEPHROL, V14, P1959, DOI 10.1097/01.ASN.0000079040.55124.25; Xia L, 2007, AM J PHYSIOL-ENDOC M, V293, pE1280, DOI 10.1152/ajpendo.00223.2007; Zdychova J, 2008, PHYSIOL RES, V57, P709, DOI 10.33549/physiolres.931337; Zhang Qiang, 2012, Int J Biochem Mol Biol, V3, P242	37	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96236	10.1371/journal.pone.0096236	http://dx.doi.org/10.1371/journal.pone.0096236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801871	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800047
J	Zhang, WL; Jia, N; Su, JZ; Lin, JX; Peng, F; Niu, WQ				Zhang, Wenli; Jia, Nan; Su, Jinzi; Lin, Jinxiu; Peng, Feng; Niu, Wenquan			The Comparison between Robotic and Manual Ablations in the Treatment of Atrial Fibrillation: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							PULMONARY VEIN ISOLATION; CATHETER ABLATION; NAVIGATION SYSTEM; EXPERIENCE; ATTENUATION; DESIGN; TRIAL	Objective: To examine in what aspects and to what extent robotic ablation is superior over manual ablation, we sought to design a meta-analysis to compare clinical outcomes between the two ablations in the treatment of atrial fibrillation. Methods and Results: A literature search was conducted of PubMed and EMBASE databases before December 1, 2013. Data were extracted independently and in duplicate from 8 clinical articles and 792 patients. Effect estimates were expressed as weighted mean difference (WMD) or odds ratio (OR) and the accompanied 95% confidence interval (95% CI). Pooling the results of all qualified trials found significant reductions in fluoroscopic time (minutes) (WMD; 95% CI; P: -8.9; -12.54 to -5.26; <0.0005) and dose-area product (Gy x cm(2)) (WMD; 95% CI; P: -1065.66; -1714.36 to -416.96; 0.001) for robotic ablation relative to manual ablation, with evident heterogeneity (P<0.0005) and a low probability of publication bias. In subgroup analysis, great improvement of fluoroscopic time in patients with robotic ablation was consistently presented in both randomized and nonrandomized clinical trials, particularly in the former (WMD; 95% CI; P: -12.61; -15.13 to -10.09; <0.0005). Success rate of catheter ablation was relatively higher in patients with robotic ablation than with manual ablation (OR; 95% CI; P: 3.45; 0.24 to 49.0; 0.36), the difference yet exhibiting no statistical significance. Conclusions: This study confirmed and extended previous observations by quantifying great reductions of fluoroscopic time and dose-area product in patients referred for robotic ablation than for manual ablation in the treatment of atrial fibrillation, especially in randomized clinical trials.	[Zhang, Wenli] Fujian Med Univ, PLA, Fuzhou Gen Hosp Nanjing Command, Dept Cardiol, Fuzhou, Fujian, Peoples R China; [Jia, Nan] Fourth Peoples Hosp Shenzhen, Dept Cardiol, Shenzhen, Guangdong, Peoples R China; [Su, Jinzi; Lin, Jinxiu; Peng, Feng] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Fujian, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Inst Hypertens, Shanghai 200030, Peoples R China	Fujian Medical University; Fujian Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Peng, F (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Fujian, Peoples R China.	pengfeng@medmail.com.cn; niuwenquan_shcn@163.com			Shanghai Rising Star Program [11QA1405500]	Shanghai Rising Star Program	Funding provided by Shanghai Rising Star Program (11QA1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai R, 2012, J CARDIOVASC ELECTR, V23, P820, DOI 10.1111/j.1540-8167.2012.02316.x; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Dagres N, 2009, AM HEART J, V158, P15, DOI 10.1016/j.ahj.2009.05.012; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Di Biase L, 2009, J CARDIOVASC ELECTR, V20, P1328, DOI 10.1111/j.1540-8167.2009.01570.x; Duncan ER, 2012, PACE, V35, P730, DOI 10.1111/j.1540-8159.2012.03381.x; Kautzner J, 2009, PACE, V32, pS163, DOI 10.1111/j.1540-8159.2008.02277.x; Malcolme-Lawes LC, 2013, EUROPACE, V15, P41, DOI 10.1093/europace/eus244; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nazarian S, 2010, MINERVA CARDIOANGIOL, V58, P731; Nolker G, 2012, EUROPACE, V14, P1715, DOI 10.1093/europace/eus169; Petru J, 2012, COR VASA, V54, pE408, DOI 10.1016/j.crvasa.2012.11.016; Picano E, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-35; Piccini JP, 2009, EUR HEART J, V30, P1245, DOI 10.1093/eurheartj/ehp100; Rillig A, 2013, J CARDIOVASC ELECTR, V24, P40, DOI 10.1111/j.1540-8167.2012.02418.x; Rillig A, 2012, CIRC-ARRHYTHMIA ELEC, V5, P15, DOI 10.1161/CIRCEP.111.967497; Smilowitz NR, 2012, CURR CARDIOL REP, V14, P642, DOI 10.1007/s11886-012-0300-z; Steven D, 2010, J CARDIOVASC ELECTR, V21, P6, DOI 10.1111/j.1540-8167.2009.01592.x; Thomas D, 2012, J ELECTROCARDIOL, V45, P95, DOI 10.1016/j.jelectrocard.2011.05.005; Tilz RR, 2010, J CARDIOVASC ELECTR, V21, P853, DOI 10.1111/j.1540-8167.2010.01742.x; Verma A, 2012, AM HEART J, V164, P1, DOI 10.1016/j.ahj.2012.04.002; Willems S, 2010, J CARDIOVASC ELECTR, V21, P1079, DOI 10.1111/j.1540-8167.2010.01773.x	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96331	10.1371/journal.pone.0096331	http://dx.doi.org/10.1371/journal.pone.0096331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800808	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800057
J	Alisoltani, A; Fallahi, H; Ebrahimi, M; Ebrahimi, M; Ebrahimie, E				Alisoltani, Arghavan; Fallahi, Hossein; Ebrahimi, Mahdi; Ebrahimi, Mansour; Ebrahimie, Esmaeil			Prediction of Potential Cancer-Risk Regions Based on Transcriptome Data: Towards a Comprehensive View	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY REGION; PANCREATIC-CANCER; LOCI; GENE; EXPRESSION; SUBTYPE; SCAN; 8Q24	A novel integrative pipeline is presented for discovery of potential cancer-susceptibility regions (PCSRs) by calculating the number of altered genes at each chromosomal region, using expression microarray datasets of different human cancers (HCs). Our novel approach comprises primarily predicting PCSRs followed by identification of key genes in these regions to obtain potential regions harboring new cancer-associated variants. In addition to finding new cancer causal variants, another advantage in prediction of such risk regions is simultaneous study of different types of genomic variants in line with focusing on specific chromosomal regions. Using this pipeline we extracted numbers of regions with highly altered expression levels in cancer condition. Regulatory networks were also constructed for different types of cancers following the identification of altered mRNA and microRNAs. Interestingly, results showed that GAPDH, LIFR, ZEB2, mir-21, mir-30a, mir-141 and mir-200c, all located at PCSRs, are common altered factors in constructed networks. We found a number of clusters of altered mRNAs and miRNAs on predicted PCSRs (e.g. 12p13.31) and their common regulators including KLF4 and SOX10. Large scale prediction of risk regions based on transcriptome data can open a window in comprehensive study of cancer risk factors and the other human diseases.	[Alisoltani, Arghavan] Univ Shahrekord, Dept Plant Breeding & Biotechnol, Shahrekord, Iran; [Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Kermanshah, Iran; [Ebrahimi, Mahdi] Univ Saarland, Dept Informat, D-66123 Saarbrucken, Germany; [Ebrahimi, Mansour] Univ Qom, Bioinformat Res Grp, Qom, Iran; [Ebrahimi, Mansour] Univ Qom, Dept Biol, Qom, Iran; [Ebrahimie, Esmaeil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia	Shahrekord University; Razi University; Saarland University; University of Adelaide	Ebrahimie, E (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	esmaeil.ebrahimie@adelaide.edu.au	Ebrahimi, Mansour/AAO-9096-2021; Ebrahimie, Esmaeil/AAN-2611-2020; Ebrahimi, Mahdi/A-5042-2012; Alisoltani, Arghavan/AAV-9681-2020; Fallahi, Hossein/I-7541-2019	Ebrahimi, Mansour/0000-0001-7011-2567; Ebrahimie, Esmaeil/0000-0002-4431-2861; Ebrahimi, Mahdi/0000-0002-3827-7369; Fallahi, Hossein/0000-0002-8754-3491; Alisoltani, Arghavan/0000-0003-3638-2218				Alanazi I, 2013, APOPTOSIS, P1; Bakhtiarizadeh MR, 2013, GENE, V521, P122, DOI 10.1016/j.gene.2013.03.045; Bakhtiarizadeh MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027118; Balatti V, 2012, BLOOD, V119, P329, DOI 10.1182/blood-2011-10-386144; Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chan WY, 1998, AM J PATHOL, V152, P11; Chen RW, 1999, J NEUROSCI, V19, P9654; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Couturier J, 2006, INT J CANCER, V38, P17; Cropp CD, 2011, INT J CANCER, V129, P2400, DOI 10.1002/ijc.25906; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Fehringer G, 2012, CANCER EPIDEM BIOMAR, V21, P1097, DOI 10.1158/1055-9965.EPI-11-1123-T; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Guenthoer J, 2012, GENOME RES, V22, P232, DOI 10.1101/gr.117226.110; Hobbs MR, 2008, J INFECT DIS, V197, P340, DOI 10.1086/525540; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Hosseinpour B, 2013, GENE; Hosseinpour B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049931; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang LM, 2012, CARCINOGENESIS, V33, P94, DOI [10.1093/carcin/bgq230, 10.1093/carcin/bgr228]; Izumi K, 2012, AM J MED GENET A, V158A, P3033, DOI 10.1002/ajmg.a.35500; Karambataki M, 2010, NEUROMOL MED, V12, P260, DOI 10.1007/s12017-009-8111-0; Lan Q, 2012, NAT GENET, V44, P1330, DOI 10.1038/ng.2456; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Mazurek A, 2012, CANCER DISCOV, V2, P812, DOI 10.1158/2159-8290.CD-12-0116; Merup M, 2009, EUROPEAN J HAEMATOLO, V58, P174; Monzon FA, 2011, MODERN PATHOL, V24, P1470, DOI 10.1038/modpathol.2011.107; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nana-Sinkam S, 2012, CLIN PHARMACOL THER; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; POLASCIK TJ, 1995, CANCER RES, V55, P5396; Schafmayer C, 2009, INT J CANCER, V124, P75, DOI 10.1002/ijc.23872; Shum G, 2012, ONCOGENE; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Wang DJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011932; Wee EJ, 2012, ONCOGENE; Weng YX, 2013, CANCER EPIDEMIOL, V37, P913, DOI 10.1016/j.canep.2013.05.003; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhu Y, 2006, ONCOGENE, V25, P2901, DOI 10.1038/sj.onc.1209314	49	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96320	10.1371/journal.pone.0096320	http://dx.doi.org/10.1371/journal.pone.0096320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796549	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000064
J	Goodell, DJ; Eliseeva, TA; Coultrap, SJ; Bayer, KU				Goodell, Dayton J.; Eliseeva, Tatiana A.; Coultrap, Steven J.; Bayer, K. Ulrich			CaMKII Binding to GluN2B Is Differentially Affected by Macromolecular Crowding Reagents	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NR2B SUBUNIT; AUTOPHOSPHORYLATION; CALCIUM/CALMODULIN; PHOSPHORYLATION; MECHANISM; AUTONOMY; SITES	Binding of the Ca2+/calmodulin(CaM)-dependent protein kinase II (CaMKII) to the NMDA-type glutamate receptor (NMDAR) subunit GluN2B controls long-term potentiation (LTP), a form of synaptic plasticity thought to underlie learning and memory. Regulation of this interaction is well-studied biochemically, but not under conditions that mimic the macromolecular crowding found within cells. Notably, previous molecular crowding experiments with lysozyme indicated an effect on the CaMKII holoenzyme conformation. Here, we found that the effect of molecular crowding on Ca2+/CaMinduced CaMKII binding to immobilized GluN2B in vitro depended on the specific crowding reagent. While binding was reduced by lysozyme, it was enhanced by BSA. The ATP content in the BSA preparation caused CaMKII autophosphorylation at T286 during the binding reaction; however, enhanced binding was also observed when autophosphorylation was blocked. Importantly, the positive regulation by nucleotide and BSA (as well as other macromolecular crowding reagents) did not alleviate the requirement for CaMKII stimulation to induce GluN2B binding. The differential effect of lysozyme (14 kDa) and BSA (66 kDa) was not due to size difference, as both dextran-10 and dextran-70 enhanced binding. By contrast, crowding with immunoglobulin G (IgG) reduced binding. Notably, lysozyme and IgG but not BSA directly bound to Ca2+/CaM in an overlay assay, suggesting a competition of lysozyme and IgG with the Ca2+/CaM-stimulus that induces CaMKII/GluN2B binding. However, lysozyme negatively regulated binding even when it was instead induced by CaMKII T286 phosphorylation. Alternative modes of competition would be with CaMKII or GluN2B, and the negative effects of lysozyme and IgG indeed also correlated with specific or non-specific binding to the immobilized GluN2B. Thus, the effect of any specific crowding reagent can differ, depending on its additional direct effects on CaMKII/GluN2B binding. However, the results of this study also indicate that, in principle, macromolecular crowding enhances CaMKII binding to GluN2B.	[Bayer, K. Ulrich] Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; Univ Colorado Denver, Sch Med, Neurosci Program, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bayer, KU (corresponding author), Univ Colorado Denver, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA.	ulli.bayer@ucdenver.edu			National Institutes of Health [T32HD041697, R21DA036300, R01NS081248]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD041697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081248, T32NS099042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA036300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research was supported by National Institutes of Health grants T32HD041697 (to D.J.G.), R21DA036300, and R01NS081248 (to K.U.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcomb K, 2013, MOL PHARMACOL, V84, P834, DOI 10.1124/mol.113.089045; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BAUER M, 1992, FEBS LETT, V313, P288, DOI 10.1016/0014-5793(92)81211-4; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2002, J BIOL CHEM, V277, P20991, DOI 10.1074/jbc.M202154200; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Chao LH, 2011, CELL, V146, P732, DOI 10.1016/j.cell.2011.07.038; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Coultrap S.J., 2012, NEUROMETHODS PROTEIN, P49; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Coultrap SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037176; Coultrap SJ, 2010, J BIOL CHEM, V285, P17930, DOI 10.1074/jbc.M109.069351; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; HANSON PI, 1992, J BIOL CHEM, V267, P17216; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Singla SI, 2001, J BIOL CHEM, V276, P29353, DOI 10.1074/jbc.M101744200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Takeda S, 1997, BIOPHYS CHEM, V69, P175, DOI 10.1016/S0301-4622(97)00084-7; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96522	10.1371/journal.pone.0096522	http://dx.doi.org/10.1371/journal.pone.0096522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796865	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000087
J	Chen, XY; Xiao, W; Wang, WC; Luo, LX; Ye, SB; Liu, YZ				Chen, Xiaoyun; Xiao, Wei; Wang, Wencong; Luo, Lixia; Ye, Shaobi; Liu, Yizhi			The Complex Interplay between ERK1/2, TGF beta/Smad, and Jagged/Notch Signaling Pathways in the Regulation of Epithelial-Mesenchymal Transition in Retinal Pigment Epithelium Cells	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINAL DISEASES; TISSUE GROWTH-FACTOR; FACTOR-BETA; EXPRESSION; SMAD; INVOLVEMENT; ACTIVATION; INHIBITOR; FIBROSIS; KINASE	Epithelial-mesenchymal transition (EMT) of retinal pigment epithelium (RPE) cells is a major pathologic change in the development of proliferative vitreoretinopathy (PVR), which leads to severe visual impairment. ERK1/2 pathway has been reported to play a key role in the carcinogenesis, cancer metastasis, and multiple fibrotic diseases. We hypothesized that ERK1/2 signaling could cross-interact with transforming growth factor beta 2 (TGF beta 2)/Smad and Notch signaling pathways in the regulation of EMT in RPE cells. Here, we demonstrated that ERK1/2 signaling was activated in TGF beta 2-induced EMT in human RPE cells, while blockade of the canonical TGF beta 2/Smad2/3 signaling with SB431542 could not inhibit TGF beta 2-induced the activation of ERK1/2. Meanwhile, blockade of ERK1/2 signaling with a specific MEK/ERK1/2 inhibitor U0126 strongly prevented TGF beta 2-induced the downregulation of P-cadherin, and the upregulation of alpha-SMA, collagen type IV, N-cadherin and fibronectin in RPE cells. In addition, we also identified that blockade of ERK1/2 signaling could inhibit not only the canonical TGF beta/Smad signaling, but also the Jagged/Notch pathway. Finally, we found that blockade of Notch pathway with a specific inhibitor DAPT could inhibit TGF beta 2-induced the activation of ERK1/2 pathway conversely. Therefore, our study provides evidence that ERK1/2 signaling can cross-interact with the canonical TGF beta/Smad and the Jagged/Notch signaling pathways in RPE cells EMT. ERK1/2 inhibitor may have therapeutic value in the prevention and treatment of PVR and other fibrotic diseases.	[Chen, Xiaoyun; Xiao, Wei; Wang, Wencong; Luo, Lixia; Ye, Shaobi; Liu, Yizhi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Liu, YZ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yizhi_liu@aliyun.com	liu, yi/GXE-9662-2022		National Nature and Science Grant [81370994]; Guangdong Province Nature and Science Grant [S2013010015960]	National Nature and Science Grant; Guangdong Province Nature and Science Grant	The research was funded by the National Nature and Science Grant (81370994) and the Guangdong Province Nature and Science Grant (S2013010015960). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Aomatsu K, 2011, INVEST OPHTH VIS SCI, V52, P2437, DOI 10.1167/iovs.10-5635; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chen X, 2014, CURRENT MOL MED; Chen XF, 2012, MOL BIOL REP, V39, P3549, DOI 10.1007/s11033-011-1128-0; Chung EJ, 2011, BIOCHEM BIOPH RES CO, V415, P367, DOI 10.1016/j.bbrc.2011.10.074; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; Ding ZY, 2013, CELL SIGNAL, V25, P1981, DOI 10.1016/j.cellsig.2013.05.027; Fernandes AF, 2006, EXP EYE RES, V83, P1472, DOI 10.1016/j.exer.2006.07.024; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; GLASER BM, 1987, OPHTHALMOLOGY, V94, P327; Kita T, 2008, P NATL ACAD SCI USA, V105, P17504, DOI 10.1073/pnas.0804054105; Kita T, 2007, DIABETES, V56, P231, DOI 10.2337/db06-0581; Kroll P, 2007, OPHTHALMOLOGICA, V221, P78, DOI 10.1159/000098253; Leask A, 2010, J CELL COMMUN SIGNAL, V4, P197, DOI 10.1007/s12079-010-0101-3; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Neuzillet C, 2014, PHARMACOL THERAPEUT, V141, P160, DOI 10.1016/j.pharmthera.2013.10.001; Pacheco-Dominguez RL, 2008, EXP EYE RES, V86, P207, DOI 10.1016/j.exer.2007.10.011; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Tanahashi T, 2013, INT J ONCOL, V42, P556, DOI 10.3892/ijo.2012.1726; Wang ZW, 2010, CURR DRUG TARGETS, V11, P745, DOI 10.2174/138945010791170860; Xiao W, 2014, J CELL MOL MED, V18, P646, DOI 10.1111/jcmm.12212; Yao K, 2008, OPHTHALMIC RES, V40, P69, DOI 10.1159/000113884; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zheng XZ, 2010, BOSNIAN J BASIC MED, V10, P204, DOI 10.17305/bjbms.2010.2686	27	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96365	10.1371/journal.pone.0096365	http://dx.doi.org/10.1371/journal.pone.0096365			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788939	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700080
J	Eguchi, H; Wada, K; Smith, DR				Eguchi, Hisashi; Wada, Koji; Smith, Derek R.			Sociodemographic Factors and Prejudice toward HIV and Hepatitis B/C Status in a Working-Age Population: Results from a National, Cross-Sectional Study in Japan	PLOS ONE			English	Article							C VIRUS; DISCRIMINATION; WORKPLACE; STIGMA; EMPLOYMENT; HIV/AIDS; WORKERS; RISK	Background: In many countries, HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) infected individuals may face discrimination and mistreatment from coworkers. Effective interventions to reduce workplace discrimination are therefore needed to protect these vulnerable populations. The current study investigated potential associations between sociodemographic factors and prejudice toward HIV and HBV/HCV infected colleagues within a Japanese working population. Methods: An online anonymous, nationwide internet survey was administered to a cross-section of approximately 3,000 individuals in Japan. The survey comprised 14 questions focusing on demographics (five items), basic HIV or HBV/HCV knowledge (eight items), and potential prejudice toward HIV or HBV/HCV infected colleagues (one item). The sociodemographic characteristics evaluated were sex, age, educational level, employment status, and individual income; with multiple logistic regression used for the analysis. Results: In total, 3,055 individuals were recruited for the HIV related survey and 3,129 for the HBV/HCV related survey. Older age was significantly and positively associated with prejudice toward HIV infected colleagues (p<0.01) and negatively associated with prejudice toward HBV/HCV infected colleagues (p<0.01). Statistically significant associations were not observed between other sociodemographic characteristics and potential prejudice toward HIV and HBV/HCV infected coworkers. Conclusion: Overall, this study suggests that age may be associated with prejudice toward HIV and HBV/HCV infected colleagues among the working age population of Japan. As such, policy makers should consider the age of participants when formulating efforts to reduce prejudice toward HIV and HBV/HCV infected workers.	[Eguchi, Hisashi] Kitasato Univ, Sch Med, Dept Publ Hlth, Sagamihara, Kanagawa 228, Japan; [Wada, Koji] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Smith, Derek R.] Univ Newcastle, Fac Hlth, Sch Hlth Sci, Ourimbah, Australia	Kitasato University; National Center for Global Health & Medicine - Japan; University of Newcastle	Wada, K (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	kwada-sgy@umin.ac.jp		Smith, Derek/0000-0002-8202-2523	Health Labour Sciences Research Grant of the Ministry of Health, Labour, and Welfare [H23-practical-Hepatitis-general-005]	Health Labour Sciences Research Grant of the Ministry of Health, Labour, and Welfare	This study was funded by the Health Labour Sciences Research Grant of the Ministry of Health, Labour, and Welfare (H23-practical-Hepatitis-general-005). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Akena D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048671; Bermingham S, 1998, AUST NZ J PUBL HEAL, V22, P92, DOI 10.1111/j.1467-842X.1998.tb01151.x; Cabinet office, 2000, OP POLL AIDS; Corrigan PW, 1999, AM PSYCHOL, V54, P765, DOI 10.1037/0003-066X.54.9.765; Dray-Spira R, 2008, OCCUP ENVIRON MED, V65, P112, DOI 10.1136/oem.2007.034363; Eguchi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076921; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Gifford SM, 2005, J GASTROEN HEPATOL, V20, P79, DOI 10.1111/j.1440-1746.2004.03514.x; Hirata S, 1995, JPN J HLTH HUMAN ECO, V61, P2; Ikegami C, 1997, J ACQ IMMUN DEF SYND, V14, pS51, DOI 10.1097/00042560-199700002-00010; Kontos EZ, 2012, AM J PUBLIC HEALTH, V102, P1911, DOI 10.2105/AJPH.2011.300435; Krauskopf K, 2011, J VIRAL HEPATITIS, V18, P785, DOI 10.1111/j.1365-2893.2010.01383.x; Kubo Norihiko, 2003, Journal of Infection and Chemotherapy, V9, P260, DOI 10.1007/s10156-003-0247-5; Lau JTF, 2005, SEX TRANSM INFECT, V81, P113, DOI 10.1136/sti.2004.011767; Lim V. K. G., 1999, SMJ, V40, P410; McGoldrick C, 2012, OCCUP MED-OXFORD, V62, P242, DOI 10.1093/occmed/kqs051; Ministry of Education C Sports Science and Technology and Ministry of Health Labour and Welfare, 2002, ETH GUID EP RES; Narai R, 2007, J OCCUP HEALTH, V49, P9, DOI 10.1539/joh.49.9; National Tax Agency, 2013, SAL PRIV SECT EMPL A; Nyamathi A, 2013, AIDS BEHAV, V17, P329, DOI 10.1007/s10461-011-0041-9; OECD (Organization for Economic Cooperation and Development), 2013, ED GLANC 2013; Sako A, 2011, HEPATOL RES, V41, P39, DOI 10.1111/j.1872-034X.2010.00745.x; Smith DR, 2009, PUBLIC HEALTH, V123, P196, DOI 10.1016/j.puhe.2008.12.003; Smith DR, 2010, WORK, V37, P297, DOI 10.3233/WOR-2010-1081; Tanaka J, 2004, INTERVIROLOGY, V47, P32, DOI 10.1159/000076640; Veen YJJ, 2013, J IMMIGR MINOR HLTH; Wang GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068495; Yamada N, 2008, KANZO, V49, P553; Yasunaga H, 2007, LANCET, V370, P2063, DOI 10.1016/S0140-6736(07)61867-4; Yoshizawa H, 2002, ONCOLOGY-BASEL, V62, P8, DOI 10.1159/000048270; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	32	14	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96645	10.1371/journal.pone.0096645	http://dx.doi.org/10.1371/journal.pone.0096645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZS	24792095	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700122
J	Wadhawan, S; Gautam, S; Sharma, A				Wadhawan, Surbhi; Gautam, Satyendra; Sharma, Arun			Involvement of Proline Oxidase (PutA) in Programmed Cell Death of Xanthomonas	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; ESCHERICHIA-COLI; DEHYDROGENASE; APOPTOSIS; METABOLISM; EXPRESSION; PROTEIN; STRESS; ACCUMULATION; ACTIVATION	Xanthomonas campestris strains have been reported to undergo programmed cell death (PCD) in a protein rich medium. Protein hydrolysates used in media such as nutrient broth comprise of casein digest with abundance of proline and glutamate. In the current study, X. campestris pv. campestris (Xcc) cells displayed PCD when grown in PCD inducing medium (PIM) containing casein tryptic digest. This PCD was also observed in PCD non-inducing carbohydrate rich medium (PNIM) fortified with either proline or proline along with glutamate. Surprisingly, no PCD was noticed in PNIM fortified with glutamate alone. Differential role of proline or glutamate in inducing PCD in Xcc cells growing in PNIM was studied. It was found that an intermediate product of this oxidation was involved in initiation of PCD. Proline oxidase also called as proline utilization A (PutA), catalyzes the two step oxidation of proline to glutamate. Interestingly, higher PutA activity was noticed in cells growing in PIM, and PCD was found to be inhibited by tetrahydro-2-furoic acid, a competitive inhibitor of this enzyme. Further, PCD was abolished in Xcc Delta putA strain generated using a pKNOCK suicide plasmid, and restored in Xcc DputA strain carrying functional PutA in a plasmid vector. Xanthomonas cells growing in PIM also displayed increased generation of ROS, as well as cell filamentation (a probable indication of SOS response). These filamented cells also displayed enhanced caspase-3-like activity during in situ labeling using a fluorescent tagged caspase-3 inhibitor (FITC-DEVD-FMK). The extent of PCD associated markers such as DNA damage, phosphatidylserine externalization and membrane depolarization were found to be significantly enhanced in wild type cells, but drastically reduced in Xcc DputA cells. These findings thus establish the role of PutA mediated proline oxidation in regulating death in stressed Xanthomonas cells.	[Wadhawan, Surbhi; Gautam, Satyendra; Sharma, Arun] Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Sharma, A (corresponding author), Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India.	ksarun@barc.gov.in			Department of Atomic Energy	Department of Atomic Energy(Department of Atomic Energy (DAE))	This work was supported by the Department of Atomic Energy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON JLA, 1983, EUR J BIOCHEM, V134, P77, DOI 10.1111/j.1432-1033.1983.tb07533.x; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Amin S, 2004, MICROBIOL-SGM, V150, P1937, DOI 10.1099/mic.0.26830-0; ANDERSON CB, 1982, APPL ENVIRON MICROB, V43, P1501, DOI 10.1128/AEM.43.6.1501-1503.1982; [Anonymous], 2006, BD BION TECHN MAN; Asplund-Samuelsson J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049888; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bayles KW, 2014, NAT REV MICROBIOL, V12, P63, DOI 10.1038/nrmicro3136; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Cecchini NM, 2011, PLANT SIGNAL BEHAV, V6, P1195, DOI 10.4161/psb.6.8.15791; CHEN LM, 1991, J BACTERIOL, V173, P783, DOI 10.1128/jb.173.2.783-790.1991; Curtis J, 2004, PLANT PHYSIOL, V136, P3313, DOI 10.1104/pp.104.044024; DENDINGER S, 1970, J BACTERIOL, V103, P144, DOI 10.1128/JB.103.1.144-152.1970; Donald SP, 2001, CANCER RES, V61, P1810; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Erental A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001281; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Gautam S, 2002, J GEN APPL MICROBIOL, V48, P67, DOI 10.2323/jgam.48.67; Gautam S, 2002, MOL MICROBIOL, V44, P393, DOI 10.1046/j.1365-2958.2002.02837.x; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; HAHN DR, 1986, GENETICS, V114, P687; Janion C, 2008, INT J BIOL SCI, V4, P338; KOHL DH, 1994, PLANT CELL ENVIRON, V17, P1257, DOI 10.1111/j.1365-3040.1994.tb00527.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lee JH, 2003, J BACTERIOL, V185, P3842, DOI 10.1128/JB.185.13.3842-3852.2003; Liu W, 2012, BIOFACTORS, V38, P398, DOI 10.1002/biof.1036; Liu Y, 2006, ONCOGENE, V25, P5640, DOI 10.1038/sj.onc.1209564; Liu YM, 2009, CANCER RES, V69, P6414, DOI 10.1158/0008-5472.CAN-09-1223; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Luo M, 2012, BIOCHEMISTRY-US, V51, P10099, DOI 10.1021/bi301312f; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Maxwell SA, 2003, J BIOL CHEM, V278, P9784, DOI 10.1074/jbc.M210012200; Cecchini NM, 2011, PLANT PHYSIOL, V155, P1947, DOI 10.1104/pp.110.167163; Miller G, 2009, J BIOL CHEM, V284, P26482, DOI 10.1074/jbc.M109.009340; MILNER JL, 1987, J GEN MICROBIOL, V133, P1851; Nagata K, 2003, MICROBIOL-SGM, V149, P2023, DOI 10.1099/mic.0.26203-0; Natarajan SK, 2012, CELL HEALTH CYTOSKEL, V4, P11, DOI 10.2147/CHC.S4955; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060; Raju KK, 2006, J BACTERIOL, V188, P5408, DOI 10.1128/JB.00056-06; Ratnakar PVAL, 1996, P NATL ACAD SCI USA, V93, P5522, DOI 10.1073/pnas.93.11.5522; Rice KC, 2003, MOL MICROBIOL, V50, P729, DOI 10.1046/j.1365-2958.2003.t01-1-03720.x; Sambrook J, 1989, MOL CLONING; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; TURNER P, 1984, MOL GEN GENET, V195, P101, DOI 10.1007/BF00332731; van Dillewijn P, 2001, APPL ENVIRON MICROB, V67, P3860, DOI 10.1128/AEM.67.9.3860-3865.2001; Wadhawan S, 2013, ARCH MICROBIOL, V195, P545, DOI 10.1007/s00203-013-0906-6; Wadhawan S, 2010, FEMS MICROBIOL LETT, V312, P176, DOI 10.1111/j.1574-6968.2010.02114.x; Wanduragala S, 2010, ARCH BIOCHEM BIOPHYS, V498, P136, DOI 10.1016/j.abb.2010.04.020; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Zhang M, 2004, BIOCHEMISTRY-US, V43, P12539, DOI 10.1021/bi048737e; Zhou YZ, 2008, AMINO ACIDS, V35, P711, DOI 10.1007/s00726-008-0053-6	60	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96423	10.1371/journal.pone.0096423	http://dx.doi.org/10.1371/journal.pone.0096423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788936	Green Submitted, Green Published, gold			2022-12-27	WOS:000335510600100
J	Forbes, EE; Rodriguez, EE; Musselman, S; Narendran, R				Forbes, Erika E.; Rodriguez, Eric E.; Musselman, Samuel; Narendran, Rajesh			Prefrontal Response and Frontostriatal Functional Connectivity to Monetary Reward in Abstinent Alcohol-Dependent Young Adults	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; HEALTHY ADOLESCENTS; STRIATAL ACTIVATION; BRAIN ACTIVATION; VENTRAL STRIATUM; POSITIVE AFFECT; NEURAL BASIS; RISK-TAKING; ADDICTION	Although altered function in neural reward circuitry is widely proposed in models of addiction, more recent conceptual views have emphasized the role of disrupted response in prefrontal regions. Changes in regions such as the orbitofrontal cortex, medial prefrontal cortex, and dorsolateral prefrontal cortex are postulated to contribute to the compulsivity, impulsivity, and altered executive function that are central to addiction. In addition, few studies have examined function in these regions during young adulthood, when exposure is less chronic than in typical samples of alcohol-dependent adults. To address these issues, we examined neural response and functional connectivity during monetary reward in 24 adults with alcohol dependence and 24 psychiatrically healthy adults. Adults with alcohol dependence exhibited less response to the receipt of monetary reward in a set of prefrontal regions including the medial prefrontal cortex, lateral orbitofrontal cortex, and dorsolateral prefrontal cortex. Adults with alcohol dependence also exhibited greater negative correlation between function in each of these regions and that in the nucleus accumbens. Within the alcohol-dependent group, those with family history of alcohol dependence exhibited lower mPFC response, and those with more frequent drinking exhibited greater negative functional connectivity between the mPFC and the nucleus accumbens. These findings indicate that alcohol dependence is associated with less engagement of prefrontal cortical regions, suggesting weak or disrupted regulation of ventral striatal response. This pattern of prefrontal response and frontostriatal connectivity has consequences for the behavior patterns typical of addiction. Furthermore, brain-behavior findings indicate that the potential mechanisms of disruption in frontostriatal circuitry in alcohol dependence include family liability to alcohol use problems and more frequent use of alcohol. In all, these findings build on the extant literature on reward-circuit function in addiction and suggest mechanisms for disrupted function in alcohol dependence.	[Forbes, Erika E.; Rodriguez, Eric E.; Musselman, Samuel; Narendran, Rajesh] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; [Forbes, Erika E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; [Forbes, Erika E.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Narendran, Rajesh] Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Forbes, EE (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA.	forbese@upmc.edu	Forbes, Erika/J-2445-2015	Forbes, Erika/0000-0003-0659-7744	NIH [R01 AA018330]; National Institutes of Health [R01 DA026222, R01 MH093605, R21DA 033612]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA033612, R01DA026222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by NIH R01 AA018330 (www.niaaa.nih.gov). The authors' work on this project was also supported by National Institutes of Health grants R01 DA026222 (Dr. Forbes, PI), R01 MH093605 (Dr. Forbes, PI), and R21DA 033612 ( Dr. Forbes, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Loeches S, 2011, CRIT REV CL LAB SCI, V48, P19, DOI 10.3109/10408363.2011.580567; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Beck A, 2012, ARCH GEN PSYCHIAT, V69, P842, DOI 10.1001/archgenpsychiatry.2011.2026; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Bjork JM, 2008, ADDICTION, V103, P1308, DOI 10.1111/j.1360-0443.2008.02250.x; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Braskie MN, 2008, J NEUROSCI, V28, P14320, DOI 10.1523/JNEUROSCI.3729-08.2008; Braus DF, 2001, J NEURAL TRANSM, V108, P887, DOI 10.1007/s007020170038; Claus ED, 2011, NEUROPSYCHOPHARMACOL, V36, P2086, DOI 10.1038/npp.2011.99; Crunelle CL, 2012, BRAIN BEHAV, V2, P499, DOI 10.1002/brb3.65; Cservenka A, 2012, ALCOHOL CLIN EXP RES, V36, P604, DOI 10.1111/j.1530-0277.2011.01650.x; Dixon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051637; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2010, CEREB CORTEX, V20, P198, DOI 10.1093/cercor/bhp092; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fecteau S, 2010, SUBST USE MISUSE, V45, P1766, DOI 10.3109/10826084.2010.482434; First MB, 2002, STRUCTURED CLIN INTE; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Forbes EE, 2010, J AM ACAD CHILD PSY, V49, P162, DOI 10.1016/j.jaac.2009.11.006; Forbes EE, 2009, AM J PSYCHIAT, V166, P64, DOI 10.1176/appi.ajp.2008.07081336; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; George MS, 2001, ARCH GEN PSYCHIAT, V58, P345, DOI 10.1001/archpsyc.58.4.345; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; Hingson RW, 2006, ARCH PEDIAT ADOL MED, V160, P739, DOI 10.1001/archpedi.160.7.739; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Levy DJ, 2012, CURR OPIN NEUROBIOL, V22, P1027, DOI 10.1016/j.conb.2012.06.001; Li CSR, 2009, ALCOHOL CLIN EXP RES, V33, P740, DOI 10.1111/j.1530-0277.2008.00891.x; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lodge DJ, 2011, NEUROPSYCHOPHARMACOL, V36, P1227, DOI 10.1038/npp.2011.7; Muller KU, 2013, JAMA PSYCHIAT, V70, P847, DOI 10.1001/jamapsychiatry.2013.44; Murphy A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00101; Nees F, 2012, NEUROPSYCHOPHARMACOL, V37, P986, DOI 10.1038/npp.2011.282; Park SQ, 2010, J NEUROSCI, V30, P7749, DOI 10.1523/JNEUROSCI.5587-09.2010; Peters J, 2011, AM J PSYCHIAT, V168, P540, DOI 10.1176/appi.ajp.2010.10071024; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Rudebeck PH, 2011, ANN NY ACAD SCI, V1239, P1, DOI 10.1111/j.1749-6632.2011.06267.x; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Skinner H.A., 1984, ALCOHOL DEPENDENCE S; Spear LP, 2014, NEUROTOXICOL TERATOL, V41, P51, DOI 10.1016/j.ntt.2013.11.006; Stoltenberg SF, 1998, ADDICTION, V93, P1511, DOI 10.1046/j.1360-0443.1998.931015117.x; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Volkow ND, 2011, MOL PSYCHIATR, V16, P818, DOI 10.1038/mp.2011.30; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Weiland BJ, 2013, DRUG ALCOHOL DEPEN, V128, P130, DOI 10.1016/j.drugalcdep.2012.08.019; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Yau WYW, 2012, J NEUROSCI, V32, P2544, DOI 10.1523/JNEUROSCI.1390-11.2012; ZUCKER RA, 1994, ANN NY ACAD SCI, V708, P134, DOI 10.1111/j.1749-6632.1994.tb24706.x	62	56	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94640	10.1371/journal.pone.0094640	http://dx.doi.org/10.1371/journal.pone.0094640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804780	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000335728900013
J	Adamidis, GC; Kazakou, E; Fyllas, NM; Dimitrakopoulos, PG				Adamidis, George C.; Kazakou, Elena; Fyllas, Nikolaos M.; Dimitrakopoulos, Panayiotis G.			Species Adaptive Strategies and Leaf Economic Relationships across Serpentine and Non-Serpentine Habitats on Lesbos, Eastern Mediterranean	PLOS ONE			English	Article							PLANT FUNCTIONAL TRAITS; COMMUNITIES; ADAPTATION; PATTERNS; SOILS; DRY; CONVERGENCE; VARIABILITY; MECHANISMS; GENERALITY	Shifts in species' traits across contrasting environments have the potential to influence ecosystem functioning. Plant communities on unusually harsh soils may have unique responses to environmental change, through the mediating role of functional plant traits. We conducted a field study comparing eight functional leaf traits of seventeen common species located on both serpentine and non-serpentine environments on Lesbos Island, in the eastern Mediterranean. We focused on species' adaptive strategies across the two contrasting environments and investigated the effect of trait variation on the robustness of core 'leaf economic' relationships across local environmental variability. Our results showed that the same species followed a conservative strategy on serpentine substrates and an exploitative strategy on non-serpentine ones, consistent with the leaf economic spectrum predictions. Although considerable species-specific trait variability emerged, the single-trait responses across contrasting environments were generally consistent. However, multivariate-trait responses were diverse. Finally, we found that the strength of relationships between core 'leaf economic' traits altered across local environmental variability. Our results highlight the divergent trait evolution on serpentine and non-serpentine communities and reinforce other findings presenting species-specific responses to environmental variation.	[Adamidis, George C.; Dimitrakopoulos, Panayiotis G.] Univ Aegean, Dept Environm, Biodivers Conservat Lab, Mitilini, Greece; [Kazakou, Elena] CNRS, Montpellier SupAgro, UMR Ctr Ecol Fonct & Evolut, UMR 5175, Montpellier, France; [Fyllas, Nikolaos M.] Univ Athens, Dept Systemat & Ecol, Fac Biol, Athens, Greece	University of Aegean; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; National & Kapodistrian University of Athens	Adamidis, GC (corresponding author), Univ Aegean, Dept Environm, Biodivers Conservat Lab, Mitilini, Greece.	adamidis@env.aegean.gr	Fyllas, Nikolaos/AAJ-7807-2020; Adamidis, George C./J-2670-2015	Fyllas, Nikolaos/0000-0002-5651-5578; Adamidis, George C./0000-0001-8704-6623; Dimitrakopoulos, Panayiotis/0000-0002-8374-4392	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II.	European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II.	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2002, OECOLOGIA, V130, P449, DOI 10.1007/s004420100805; Adamidis GC, 2014, PLANT ECOL DIVERS, V7, P433, DOI 10.1080/17550874.2013.802050; Al Haj Khaled R, 2005, J VEG SCI, V16, P391, DOI 10.1111/j.1654-1103.2005.tb02378.x; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Anacker B, 2011, PLANT ECOL DIVERS, V4, P179, DOI 10.1080/17550874.2011.633573; [Anonymous], 2002, GEOLOGY PLANT LIFE E; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; CHAPIN FS, 1991, BIOSCIENCE, V41, P29, DOI 10.2307/1311538; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Damschen EI, 2012, J ECOL, V100, P1122, DOI 10.1111/j.1365-2745.2012.01986.x; Damschen EI, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P359; de Bello F, 2012, J VEG SCI, V23, P709, DOI 10.1111/j.1654-1103.2012.01389.x; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Dimitrakopoulos PG, 2005, OECOLOGIA, V143, P428, DOI 10.1007/s00442-004-1808-8; Donovan LA, 2011, TRENDS ECOL EVOL, V26, P88, DOI 10.1016/j.tree.2010.11.011; Elmendorf SC, 2009, ECOLOGY, V90, P1492, DOI 10.1890/08-1677.1; Fernandez-Going BM, 2012, ECOLOGY, V93, P2104, DOI 10.1890/11-2003.1; Fonseca CR, 2000, J ECOL, V88, P964, DOI 10.1046/j.1365-2745.2000.00506.x; Fyllas NM, 2009, BIOGEOSCIENCES, V6, P2677, DOI 10.5194/bg-6-2677-2009; Garnier E, 2001, NEW PHYTOL, V152, P69, DOI 10.1046/j.0028-646x.2001.00239.x; Gotsch SG, 2010, PLANT ECOL, V211, P133, DOI 10.1007/s11258-010-9779-9; Grassein F, 2010, ANN BOT-LONDON, V106, P637, DOI 10.1093/aob/mcq154; Grime J. P., 2001, PLANT STRATEGIES VEG; Grime JP, 2008, P NATL ACAD SCI USA, V105, P10028, DOI 10.1073/pnas.0711567105; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Grime JP, 2000, SCIENCE, V289, P762, DOI 10.1126/science.289.5480.762; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grime JP, 1997, OIKOS, V79, P259, DOI 10.2307/3546011; Harrison S, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P1, DOI 10.1525/california/9780520268357.001.0001; Kazakou E, 2008, BIOL REV, V83, P495, DOI 10.1111/j.1469-185X.2008.00051.x; Kazakou E, 2007, FUNCT ECOL, V21, P235, DOI 10.1111/j.1365-2435.2006.01242.x; Kazakou E, 2010, PLANT SOIL, V332, P369, DOI 10.1007/s11104-010-0302-9; Lamont BB, 2000, PHYSIOL PLANTARUM, V110, P64, DOI 10.1034/j.1399-3054.2000.110109.x; Liu GF, 2010, NEW PHYTOL, V188, P543, DOI 10.1111/j.1469-8137.2010.03388.x; Navas ML, 2010, PLANT BIOLOGY, V12, P183, DOI 10.1111/j.1438-8677.2009.00208.x; O'Dell RE, 2011, SERPENTINE: THE EVOLUTION AND ECOLOGY OF A MODEL SYSTEM, P97; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1999, ECOLOGY, V80, P1955, DOI 10.1890/0012-9658(1999)080[1955:GOLTRA]2.0.CO;2; Roche P, 2004, PLANT ECOL, V174, P37, DOI 10.1023/B:VEGE.0000046056.94523.57; Spehn EM, 2002, OIKOS, V98, P205, DOI 10.1034/j.1600-0706.2002.980203.x; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wright JP, 2012, FUNCT ECOL, V26, P1390, DOI 10.1111/1365-2435.12001	52	16	18	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96034	10.1371/journal.pone.0096034	http://dx.doi.org/10.1371/journal.pone.0096034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800835	gold, Green Published, Green Submitted			2022-12-27	WOS:000338029800039
J	Rech, D; Spyrelis, A; Frade, S; Perry, L; Farrell, M; Fertziger, R; Toledo, C; Castor, D; Njeuhmeli, E; Loykissoonlal, D; Bertrand, JT				Rech, Dino; Spyrelis, Alexandra; Frade, Sasha; Perry, Linnea; Farrell, Margaret; Fertziger, Rebecca; Toledo, Carlos; Castor, Delivette; Njeuhmeli, Emmanuel; Loykissoonlal, Dayanund; Bertrand, Jane T.			Implications of the Fast-Evolving Scale-Up of Adult Voluntary Medical Male Circumcision for Quality of Services in South Africa	PLOS ONE			English	Article							HIV PREVENTION; MEN	Background: The scale-up of voluntary medical male circumcision (VMMC) services in South Africa has been rapid, in an attempt to achieve the national government target of 4.3 million adult male circumcisions for HIV prevention by 2016. This study assesses the effect of the scale-up on the quality of the VMMC program. Methods and Findings: This analysis compares the quality of services at 15 sites operational in 2011 to (1) the same 15 sites in 2012 and (2) to a set of 40 sites representing the expanded program in 2012. Trained clinicians scored each site on 29 items measuring readiness to provide quality services (abbreviated version of the WHO Quality Assessment [QA] Guide) and 29 items to assess quality of surgical care provided (pre-op, surgical technique and post-op) based on the observation of VMMC procedures at each site. Declines in quality far outnumbered improvements. The negative effects in terms of readiness to provide quality services were most evident in expanded sites, whereas the declines in provision of quality services tended to affect both repeat sites and expanded sites equally. Areas of notable concern included the monitoring of adverse events, external supervision, post-operative counselling, and some infection control issues. Scores on quality of surgical technique tended to be among the highest across the 58 items observed, and the South Africa program has clearly institutionalized three "best practices'' for surgical efficiency. Conclusions: These findings demonstrate the challenges of rapidly developing large numbers of new VMMC sites with the necessary equipment, supplies, and protocols. The scale-up in South Africa has diluted human resources, with negative effects for both the original sites and the expanded program.	[Rech, Dino; Spyrelis, Alexandra; Frade, Sasha] Ctr HIV AIDS Prevent Studies CHAPS, Johannesburg, South Africa; [Perry, Linnea; Farrell, Margaret; Bertrand, Jane T.] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Fertziger, Rebecca] US Agcy Int Dev, Pretoria, South Africa; [Toledo, Carlos] Ctr Dis Control & Prevent, Pretoria, South Africa; [Castor, Delivette; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA; [Loykissoonlal, Dayanund] South African Natl Dept Hlth, Johannesburg, South Africa	Tulane University; United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Rech, D (corresponding author), Ctr HIV AIDS Prevent Studies CHAPS, Johannesburg, South Africa.	Dino@chaps.org.za	Frade, Sasha/AAQ-3284-2021	Frade, Sasha/0000-0001-9683-3020; Spyrelis, Alexandra/0000-0001-7719-5414	USAID | Project SEARCH; U.S. Agency for International Development [GHH-I-00-07-00032-00]	USAID | Project SEARCH(United States Agency for International Development (USAID)); U.S. Agency for International Development(United States Agency for International Development (USAID))	The article was supported by USAID | Project SEARCH, Task Order No. 2, funded by the U.S. Agency for International Development (www.usaid.gov) under Contract No. GHH-I-00-07-00032-00, beginning September 30, 2008, and supported by the President's Emergency Plan for AIDS Relief. The Research to Prevention (R2P) Project is led by the Johns Hopkins Center for Global Health and managed by the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs (CCP). USAID staff played a role in study design and data analysis, decision to publish, and preparation of the manuscript. USAID staff did not play a role in data collection. The views expressed in this manuscript do not represent USAID's or the United States Government's opinion.	Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2012, DECREASE HIV PREVALE; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bertrand JT, 2013, PLOS MED    IN PRESS; Bertrand JT, 2012, SYSTEMATIC MONITORIN; Fajans P, 2007, SCALING UP HEALTH SERVICE DELIVERY: FROM PILOT INNOVATIONS TO POLICIES AND PROGRAMMES, P31; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Horizons Program YRG CARE International HIV/AIDS Alliance, 2004, EXP CAR SUPP S IND S; Johnson S., 2010, 2 NATL HIV COMMUNICA; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Oliver K, 2012, REV SYSTEMATIC CHALL; Rech D, 2013, PLOS MED    IN PRESS; South Africa Department of Health, 2011, IMPL PLAN SCAL UNPUB; Statistics South Africa, 2012, MID POP EST 2011; UNAIDS, 2010, COUNTR OV S AFR; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; WHO, 2008, MAL CIRC QUAL ASS GU; World Health Organization, 2009, MAL CIRC SERV QUAL A; World Health Organization, 2006, QUAL CAR PROC MAK ST; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO; World Health Organization (WHO), 2012, PROGR SCAL VOL MED M	21	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e80577	10.1371/journal.pone.0080577	http://dx.doi.org/10.1371/journal.pone.0080577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801209	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800002
J	Sanfelice, D; Puglisi, R; Martin, SR; Di Bari, L; Pastore, A; Temussi, PA				Sanfelice, Domenico; Puglisi, Rita; Martin, Stephen R.; Di Bari, Lorenzo; Pastore, Annalisa; Temussi, Piero Andrea			Yeast Frataxin Is Stabilized by Low Salt Concentrations: Cold Denaturation Disentangles Ionic Strength Effects from Specific Interactions	PLOS ONE			English	Article							IRON-BINDING; PROTEIN; CYAY; NMR	Frataxins are a family of metal binding proteins associated with the human Friedreich's ataxia disease. Here, we have addressed the effect of non-specifically binding salts on the stability of the yeast ortholog Yfh1. This protein is a sensitive model since its stability is strongly dependent on the environment, in particular on ionic strength. Yfh1 also offers the unique advantage that its cold denaturation can be observed above the freezing point of water, thus allowing the facile construction of the whole protein stability curve and hence the measurement of accurate thermodynamic parameters for unfolding. We systematically measured the effect of several cations and, as a control, of different anions. We show that, while strongly susceptible to ionic strength, as it would be in the cellular environment, Yfh1 stability is sensitive not only to divalent cations, which bind specifically, but also to monovalent cations. We pinpoint the structural bases of the stability and hypothesize that the destabilization induced by an unusual cluster of negatively charged residues favours the entrance of water molecules into the hydrophobic core, consistent with the generally accepted mechanism of cold denaturation.	[Sanfelice, Domenico; Puglisi, Rita; Martin, Stephen R.; Pastore, Annalisa; Temussi, Piero Andrea] Natl Inst Med Res, MRC, London NW7 1AA, England; [Puglisi, Rita; Di Bari, Lorenzo] Dipartimento Chim & Chim Ind, Pisa, Italy; [Puglisi, Rita] Scuola Normale Super Pisa, Pisa, Italy; [Temussi, Piero Andrea] Univ Naples Federico II, Dipartimento Chim, Naples, Italy	MRC National Institute for Medical Research; Scuola Normale Superiore di Pisa; University of Naples Federico II	Pastore, A (corresponding author), Natl Inst Med Res, MRC, London NW7 1AA, England.	apastor@nimr.mrc.ac.uk; temussi@unina.it	Di Bari, Lorenzo/H-4804-2015; Sanfelice, domenico/E-8083-2018; Temussi, Piero A/N-5830-2017; Puglisi, Rita/AAA-3486-2021	Di Bari, Lorenzo/0000-0003-2347-2150; Sanfelice, domenico/0000-0002-8908-0347; Temussi, Piero A/0000-0001-6032-4291; Puglisi, Rita/0000-0002-2980-442X	MRC [U117584256]; Medical Research Council [MC_U117584256, MC_PC_13054, MC_U117533887] Funding Source: researchfish; MRC [MC_PC_13054, MC_U117533887, MC_U117584256] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC (Grant ref. U117584256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2004, BIOCHEMISTRY-US, V43, P6511, DOI 10.1021/bi036049+; BAX A, 1990, J MAGN RESON, V86, P304, DOI 10.1016/0022-2364(90)90262-8; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; He YN, 2004, BIOCHEMISTRY-US, V43, P16254, DOI 10.1021/bi0488193; Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI [DOI 10.1007/BF01918191, 10.1007/BF01918191]; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Martin SR, 2008, J AM CHEM SOC, V130, P9963, DOI 10.1021/ja803280e; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nair M, 2004, STRUCTURE, V12, P2037, DOI 10.1016/j.str.2004.08.012; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Ortega G, 2011, SCI REP-UK, V1, DOI 10.1038/srep00006; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pastore A, 2007, J AM CHEM SOC, V129, P5374, DOI 10.1021/ja0714538; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pastore C, 2007, FEBS J, V274, P4199, DOI 10.1111/j.1742-4658.2007.05946.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Roman EA, 2013, BBA-PROTEINS PROTEOM, V1834, P1168, DOI 10.1016/j.bbapap.2013.02.015; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	22	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95801	10.1371/journal.pone.0095801	http://dx.doi.org/10.1371/journal.pone.0095801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802807	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800034
J	Song, BC; Wang, ZN; Liu, Y; Xu, S; Huang, GR; Xiong, Y; Zhang, S; Xu, LL; Deng, XM; Guan, S				Song, Bocui; Wang, Zhenning; Liu, Yan; Xu, Sisi; Huang, Guoren; Xiong, Ying; Zhang, Shuang; Xu, Linli; Deng, Xuming; Guan, Shuang			Immunosuppressive Activity of Daphnetin, One of Coumarin Derivatives, Is Mediated through Suppression of NF-kappa B and NFAT Signaling Pathways in Mouse T Cells	PLOS ONE			English	Article							PROTEIN-KINASE-II; IN-VITRO; CYCLOSPORINE-A; TNF-ALPHA; ACTIVATION; PROLIFERATION; CALCINEURIN; FK506; TRANSPLANTATION; LYMPHOCYTES	Daphnetin, a plant-derived dihydroxylated derivative of coumarin, is an effective compound extracted from a plant called Daphne Korean Nakai. Coumarin derivates were known for their antithrombotic, anti-inflammatory, and antioxidant activities. The present study was aimed to determine the immunosuppressive effects and the underlying mechanisms of daphnetin on concanavalin A (ConA) induced T lymphocytes in mice. We showed that, in vitro, daphnetin suppressed ConA-induced splenocyte proliferation, influenced production of the cytokines and inhibited cell cycle progression through the G0/G1 transition. The data also revealed that daphnetin could down-regulate activation of ConA induced NF-kappa B and NFAT signal transduction pathways in mouse T lymphocyte. In vivo, daphnetin treatment significantly inhibited the 2, 4-dinitrofluorobenzene (DNFB)-induced delayed type hypersensitivity (DTH) reactions in mice. Collectively, daphnetin had strong immunosuppressive activity both in vitro and in vivo, suggesting a potential role for daphnetin as an immunosuppressive agent, and established the groundwork for further research on daphnetin.	[Song, Bocui; Liu, Yan; Xiong, Ying; Deng, Xuming; Guan, Shuang] Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China; [Wang, Zhenning; Xu, Sisi; Huang, Guoren; Zhang, Shuang; Xu, Linli; Guan, Shuang] Jilin Univ, Coll Light Ind Econ & Management, Dept Food Qual & Safety, Changchun 130023, Peoples R China	Jilin University; Jilin University	Deng, XM (corresponding author), Jilin Univ, Coll Vet Med, Minist Educ, Key Lab Zoonosis, Changchun 130023, Peoples R China.	xumingdeng@126.com; gshuang1973@126.com			National Nature Science Foundation of China [31130053]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for help received from the College of Veterinary Medicine of Jilin University. This study was supported by the National Nature Science Foundation of China (No. 31130053). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Actor JK, 2002, INT IMMUNOPHARMACOL, V2, P475, DOI 10.1016/S1567-5769(01)00189-8; Al-Shanti N, 2009, BIOL REV, V84, P637, DOI 10.1111/j.1469-185X.2009.00090.x; Jimenez-Orozco FA, 2011, EUR J PHARMACOL, V668, P35, DOI 10.1016/j.ejphar.2011.06.024; Alfantis I, 2001, NATURE IMMUNOL, V2, P403; Anzellotti D, 2003, J BIOL CHEM, V278, P6854; Bultynck G, 2003, BIOCHEM BIOPH RES CO, V311, P1181, DOI 10.1016/j.bbrc.2003.08.084; Chen J, 2004, ANAL CHIM ACTA, V523, P29, DOI 10.1016/j.aca.2004.07.027; Datta S, 2009, TRENDS IMMUNOL, V30, P430, DOI 10.1016/j.it.2009.06.002; DiRenzo M, 1997, IMMUNOLOGY, V92, P99, DOI 10.1046/j.1365-2567.1997.00325.x; Dujovny N, 2002, AM J TRANSPLANT, V2, P526, DOI 10.1034/j.1600-6143.2002.20606.x; Finn GJ, 2004, BIOCHEM PHARMACOL, V67, P1779, DOI 10.1016/j.bcp.2004.01.014; Gangopadhyay JP, 2010, BIOCHEM BIOPH RES CO, V396, P515, DOI 10.1016/j.bbrc.2010.04.129; Gao Q, 2008, J ETHNOPHARMACOL, V120, P259, DOI 10.1016/j.jep.2008.08.031; Gautam M, 2009, J ETHNOPHARMACOL, V121, P41, DOI 10.1016/j.jep.2008.10.028; Huang F, 2006, BIOMED ENVIRON SCI, V19, P367; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; JANOSSY T, 1993, IMMUNOBIOLOGY, V188, P172, DOI 10.1016/S0171-2985(11)80496-1; Lederer JA, 1996, J IMMUNOL, V156, P56; Li X.M., 1986, JILIN MED J, V7, P28; Liao MJ, 2013, FUND CLIN PHARMACOL, V27, P510, DOI 10.1111/j.1472-8206.2012.01049.x; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Pearce EL, 2010, CURR OPIN IMMUNOL, V22, P314, DOI 10.1016/j.coi.2010.01.018; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; QU S-Y, 1986, Yaoxue Xuebao, V21, P498; Quesada AJ, 2003, NEFROLOGIA, V23, P44; Sakuma S, 2000, BRIT J PHARMACOL, V130, P1655, DOI 10.1038/sj.bjp.0703472; Sakuma S, 2001, INT IMMUNOPHARMACOL, V1, P749, DOI 10.1016/S1567-5769(01)00008-X; Shifman JM, 2006, P NATL ACAD SCI USA, V103, P13968, DOI 10.1073/pnas.0606433103; Snell GI, 2013, DRUGS, V73, P1793, DOI 10.1007/s40265-013-0136-x; Strauss G, 2002, CLIN EXP IMMUNOL, V128, P255, DOI 10.1046/j.1365-2249.2002.01777.x; Tian ZQ, 2013, GENET MOL RES, V12, P4595, DOI 10.4238/2013.October.17.2; Tu LN, 2012, INT IMMUNOPHARMACOL, V13, P417, DOI 10.1016/j.intimp.2012.04.001; van Sandwijk MS, 2013, NETH J MED, V71, P281; Wang GJ, 2012, BRAZ J MED BIOL RES, V45, P1045, DOI [10.1590/S0100-879X2012001100008, 10.1590/S0100-879X2012007500121]; Yang EB, 1999, BIOCHEM BIOPH RES CO, V260, P682, DOI 10.1006/bbrc.1999.0958; Yesilada E, 2001, CYTOKINE, V13, P359, DOI 10.1006/cyto.2001.0838; Zhang SD, 2010, APMIS, V118, P288, DOI 10.1111/j.1600-0463.2010.02589.x	39	39	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96502	10.1371/journal.pone.0096502	http://dx.doi.org/10.1371/journal.pone.0096502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800925	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800080
J	Akiho, H; Tokita, Y; Nakamura, K; Satoh, K; Nishiyama, M; Tsuchiya, N; Tsuchiya, K; Ohbuchi, K; Iwakura, Y; Ihara, E; Takayanagi, R; Yamamoto, M				Akiho, Hirotada; Tokita, Yohei; Nakamura, Kazuhiko; Satoh, Kazuko; Nishiyama, Mitsue; Tsuchiya, Naoko; Tsuchiya, Kazuaki; Ohbuchi, Katsuya; Iwakura, Yoichiro; Ihara, Eikichi; Takayanagi, Ryoichi; Yamamoto, Masahiro			Involvement of Interleukin-17A-Induced Hypercontractility of Intestinal Smooth Muscle Cells in Persistent Gut Motor Dysfunction	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CROHNS-DISEASE; TH17 CELLS; IMMUNE ACTIVATION; UP-REGULATION; T-CELLS; ULCERATIVE-COLITIS; P38 MAPK; MOTILITY; MICE	Background and Aim: The etiology of post-inflammatory gastrointestinal (GI) motility dysfunction, after resolution of acute symptoms of inflammatory bowel diseases (IBD) and intestinal infection, is largely unknown, however, a possible involvement of T cells is suggested. Methods: Using the mouse model of T cell activation-induced enteritis, we investigated whether enhancement of smooth muscle cell (SMC) contraction by interleukin (IL)-17A is involved in postinflammatory GI hypermotility. Results: Activation of CD3 induces temporal enteritis with GI hypomotility in the midst of, and hypermotility after resolution of, intestinal inflammation. Prolonged upregulation of IL-17A was prominent and IL-17A injection directly enhanced GI transit and contractility of intestinal strips. Postinflammatory hypermotility was not observed in IL-17A-deficient mice. Incubation of a muscle strip and SMCs with IL-17A in vitro resulted in enhanced contractility with increased phosphorylation of Ser19 in myosin light chain 2 (p-MLC), a surrogate marker as well as a critical mechanistic factor of SMC contractility. Using primary cultured murine and human intestinal SMCs, I kappa B zeta- and p38 mitogen-activated protein kinase (p38MAPK)mediated downregulation of the regulator of G protein signaling 4 (RGS4), which suppresses muscarinic signaling of contraction by promoting inactivation/desensitization of G alpha(q/11) protein, has been suggested to be involved in IL-17A-induced hypercontractility. The opposite effect of L-1 beta was mediated by IkB zeta and c-jun N-terminal kinase (JNK) activation. Conclusions: We propose and discuss the possible involvement of IL-17A and its downstream signaling cascade in SMCs in diarrheal hypermotility in various GI disorders.	[Akiho, Hirotada; Nakamura, Kazuhiko; Ihara, Eikichi; Takayanagi, Ryoichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan; [Akiho, Hirotada] Kitakyushu Municipal Med Ctr, Dept Gastroenterol, Fukuoka, Japan; [Tokita, Yohei; Satoh, Kazuko; Nishiyama, Mitsue; Tsuchiya, Naoko; Tsuchiya, Kazuaki; Ohbuchi, Katsuya; Yamamoto, Masahiro] Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Lab Anim, Chiba, Japan; [Iwakura, Yoichiro] JST, CREST, Saitama, Japan	Kyushu University; Tsumura & Company; Tokyo University of Science; Japan Science & Technology Agency (JST)	Akiho, H (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 812, Japan.	akiho@med.kyushu-u.ac.jp	Iwakura, Yoichiro/E-5457-2011; Ihara, Eikichi/AAU-2690-2021; Nishiyama, Mitsue/ABQ-1118-2022; Akiho, Hirotada/AAE-5324-2020	Iwakura, Yoichiro/0000-0002-9934-5775; Ihara, Eikichi/0000-0002-7070-6610; Ohbuchi, Katsuya/0000-0001-6756-3260; Nishiyama, Mitsue/0000-0002-3878-1290	Tsumura Co.	Tsumura Co.(Tsumura & Company)	This project has been executed using the institutions' (Kyushu University and Tsumura & Co.) budgets including a grant from Tsumura & Co. providing to HA and KN for this collaborative research. The funders provided support in the form of salaries for authors YT, KS, MN, SN, KT, KO and MY (Tsumura & Co.) and HA & KN (Kyushu University), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Al-Khatib K, 2009, GUT LIVER, V3, P14, DOI 10.5009/gnl.2009.3.1.14; Amrani Y, 1999, J IMMUNOL, V163, P2128; Anderson CA, 2009, GASTROENTEROLOGY, V136, P523, DOI 10.1053/j.gastro.2008.10.032; Aube AC, 1996, GUT, V39, P470, DOI 10.1136/gut.39.3.470; Bassotti G, 2008, J GASTROEN HEPATOL, V23, pE23, DOI 10.1111/j.1440-1746.2007.04868.x; Bickelhaupt S, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12088; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V302, pG1075, DOI 10.1152/ajpgi.00537.2011; CANN PA, 1983, GUT, V24, P405, DOI 10.1136/gut.24.5.405; Castellanos-Rubio A, 2009, AUTOIMMUNITY, V42, P69, DOI 10.1080/08916930802350789; Ciaccio EJ, 2012, DIGEST DIS SCI, V57, P2936, DOI 10.1007/s10620-012-2225-1; Cremon C, 2009, AM J GASTROENTEROL, V104, P392, DOI 10.1038/ajg.2008.94; Cullmann JL, 2013, NEUROGASTROENT MOTIL, V25, P749, DOI 10.1111/nmo.12162; De Backer O, 2008, NEUROGASTROENT MOTIL, V20, P700, DOI 10.1111/j.1365-2982.2007.01073.x; De Schepper HU, 2008, ALIMENT PHARM THER, V27, P621, DOI 10.1111/j.1365-2036.2008.03624.x; Dunlop SP, 2003, GASTROENTEROLOGY, V125, P1651, DOI 10.1053/j.gastro.2003.09.028; El-Salhy M, 2012, WORLD J GASTROENTERO, V18, P5151, DOI 10.3748/wjg.v18.i37.5151; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Facco M, 2008, AM J GASTROENTEROL, V103, P1598, DOI 10.1111/j.1572-0241.2008.01956.x; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Frasko R, 2008, EUR SURG RES, V41, P197, DOI 10.1159/000134918; Geremia A, 2012, EXPERT REV GASTROENT, V6, P223, DOI [10.1586/EGH.11.107, 10.1586/egh.11.107]; Grover M, 2009, CLIN GASTROENTEROL H, V7, P48, DOI 10.1016/j.cgh.2008.08.032; Gujral N, 2012, WORLD J GASTROENTERO, V18, P6036, DOI 10.3748/wjg.v18.i42.6036; Gwee KA, 1999, GUT, V44, P400, DOI 10.1136/gut.44.3.400; Hu WH, 2008, BIOCHEM J, V412, P35, DOI 10.1042/BJ20080042; Hu WH, 2007, AM J PHYSIOL-CELL PH, V293, pC1991, DOI 10.1152/ajpcell.00300.2007; Hu WH, 2009, AM J PHYSIOL-CELL PH, V296, pC1310, DOI 10.1152/ajpcell.00573.2008; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Khan WI, 2001, INFECT IMMUN, V69, P838, DOI 10.1128/IAI.69.2.838-844.2001; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kinoshita K, 2003, AM J PHYSIOL-GASTR L, V285, pG483, DOI 10.1152/ajpgi.00038.2003; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Liebregts T, 2007, GASTROENTEROLOGY, V132, P913, DOI 10.1053/j.gastro.2007.01.046; Menys A, 2013, NEUROGASTROENT MOTIL, V25, P967, DOI 10.1111/nmo.12229; Merger M, 2002, GUT, V51, P155, DOI 10.1136/gut.51.2.155; Miura N, 2005, INT IMMUNOL, V17, P513, DOI 10.1093/intimm/dxh231; Mizutani T, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01396.x; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Ohama T, 2003, J BIOL CHEM, V278, P48794, DOI 10.1074/jbc.M310166200; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Ortega C, 2013, INT REV IMMUNOL, V32, P534, DOI 10.3109/08830185.2013.834898; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]; Reynolds A M, 2000, Respirology, V5, P153, DOI 10.1046/j.1440-1843.2000.00240.x; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sadik R, 2010, EUR J GASTROEN HEPAT, V22, P102, DOI 10.1097/MEG.0b013e32832ffd9b; Schwarz NT, 2004, GASTROENTEROLOGY, V126, P159, DOI 10.1053/j.gastro.2003.10.060; Shan XY, 2006, AM J PHYSIOL-LUNG C, V291, pL324, DOI 10.1152/ajplung.00056.2006; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Tovey SC, 2004, MOL PHARMACOL, V66, P1453, DOI 10.1124/mol.104.005827; Tursi A, 2004, J CLIN GASTROENTEROL, V38, P642, DOI 10.1097/01.mcg.0000118792.58123.c1; Wu ZX, 2002, AM J PHYSIOL-LUNG C, V283, pL909, DOI 10.1152/ajplung.00363.2001; Yanai T, 2004, J PEDIATR SURG, V39, P927, DOI 10.1016/j.jpedsurg.2004.02.004; Zhang YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046820, 10.1371/journal.pone.0035646]	61	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e92960	10.1371/journal.pone.0092960	http://dx.doi.org/10.1371/journal.pone.0092960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796324	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000002
J	Gabe, ME; Murphy, F; Davies, GA; Russell, IT; Jordan, S				Gabe, Marie E.; Murphy, Fiona; Davies, Gwyneth A.; Russell, Ian T.; Jordan, Susan			Medication Monitoring in a Nurse-Led Respiratory Outpatient Clinic: Pragmatic Randomised Trial of the West Wales Adverse Drug Reaction Profile	PLOS ONE			English	Article							HOSPITALIZED-PATIENTS; TRIGGER TOOL; EVENT RATES; STRATEGIES; HEALTH; IMPACT; INTERVENTION; METAANALYSIS; INFORMATION; PREVENTION	Objective: To assess the clinical effect of medication monitoring using the West Wales Adverse Drug Reaction (ADR) Profile for Respiratory Medicine. Design: Single-site parallel-arm pragmatic trial using stratified randomisation. Setting: Nurse-led respiratory outpatient clinic in general hospital in South Wales. Participants: 54 patients with chronic respiratory disease receiving bronchodilators, corticosteroids or leukotriene receptor antagonists. Intervention: Following initial observation of usual nursing care, we allocated participants at random to receive at follow up: either the West Wales ADR Profile for Respiratory Medicine in addition to usual care ('intervention arm' with 26 participants); or usual care alone ('control arm' with 28 participants). Main Outcome Measures: Problems reported and actions taken. Results: We followed up all randomised participants, and analysed data in accordance with treatment allocated. The increase in numbers of problems per participant identified at follow up was significantly higher in the intervention arm, where the median increase was 20.5 [inter-quartile range (IQR) 13-26], while that in the control arm was -1 [-3 to + 2] [Mann-Whitney U test: z = 6.28, p < 0.001]. The increase in numbers of actions per participant taken at follow up was also significantly higher in the intervention arm, where the median increase was 2.5 [1-4] while that in the control arm was 0 [-1.75 to + 1] [Mann-Whitney U test: z = 4.40, p < 0.001]. Conclusion: When added to usual nursing care, the West Wales ADR Profile identified more problems and prompted more nursing actions. Our ADR Profile warrants further investigation as a strategy to optimise medication management.	[Gabe, Marie E.; Murphy, Fiona; Jordan, Susan] Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales; [Davies, Gwyneth A.] ABM Univ Hlth Board, Swansea, W Glam, Wales; [Davies, Gwyneth A.; Russell, Ian T.] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Russell, Ian T.] Swansea Univ, West Wales Org Rigorous Trials Hlth, Swansea, W Glam, Wales	Swansea University; Swansea University; Swansea University	Jordan, S (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Swansea, W Glam, Wales.	s.e.jordan@swansea.ac.uk	jordan, sue/O-1297-2019; Davies, Gwyneth/C-3838-2017	jordan, sue/0000-0002-5691-2987; Davies, Gwyneth/0000-0003-1218-1008	Research Capacity Building Collaboration (RCBC) Wales	Research Capacity Building Collaboration (RCBC) Wales	This research was funded by Research Capacity Building Collaboration (RCBC) Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V318, P1209; ALTMAN DG, 1985, J ROY STAT SOC D-STA, V34, P125; Alvarez-Requejo A, 1998, EUR J CLIN PHARMACOL, V54, P483, DOI 10.1007/s002280050498; *AM LUNG ASS, 2011, FIGHT AIR; [Anonymous], 2006, SAF PLAC PAT LEARN I; Arditi C, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001175.pub3; Aronson J.K., 2006, MEYLERS SIDE EFFECTS, V15th ed.; ARONSON JK, 2013, STEPHENS DETECTION E, P1; Audit Commission, 2001, SPOONF SUG MED MAN N; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Aziz Z, 2007, PHARMACOEPIDEM DR S, V16, P223, DOI 10.1002/pds.1313; Baines RJ, 2013, BMJ QUAL SAF, V22, P290, DOI 10.1136/bmjqs-2012-001126; Beijer HJM, 2002, PHARM WORLD SCI, V24, P46, DOI 10.1023/A:1015570104121; Bell J. Simon, 2010, Pharmacy Pract (Granada), V8, P147; Blenkinsopp A, 2007, BRIT J CLIN PHARMACO, V63, P148, DOI 10.1111/j.1365-2125.2006.02746.x; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brenner S, 2012, BMJ QUAL SAF, V21, P670, DOI 10.1136/bmjqs-2011-000643; *BRIT NAT FORM, 2013, 65 BNF BRIT MED ASS; *BRIT THOR SOC, 2011, ASTHM GUID; British Thoracic Society, 2006, BURD LUNG DIS STAT R; Brunton L. L., 2006, GOODMAN GILMANS PHAR, P1587; Bultman Dara C, 2002, J Am Pharm Assoc (Wash), V42, P36; Caplan Liron, 2012, Int J Risk Saf Med, V24, P81, DOI 10.3233/JRS-2012-0561; Chopra V, 2013, BMJ QUAL SAF, V22, P93, DOI 10.1136/bmjqs-2012-001480; Cleary A, 2012, J PSYCHIATR MENT HLT, V19, P395, DOI 10.1111/j.1365-2850.2011.01807.x; COLEMAN JJ, 2008, EVIDENCE BASED MED M, P194; Cunningham G, 1997, AGE AGEING, V26, P375, DOI 10.1093/ageing/26.5.375; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; *DEP HLTH, 2008, MED MAN EV BUS; Department of Health, 2000, HLTH SERV ALL TAL DE; Deshmukh CT, 2007, INDIAN J DERMATOL VE, V73, P218, DOI 10.4103/0378-6323.33633; Dilles T, 2011, J NURS SCHOLARSHIP, V43, P171, DOI 10.1111/j.1547-5069.2011.01386.x; Eldridge S, 2010, FAM PRACT, V27, P591, DOI 10.1093/fampra/cmq099; European Lung Foundation, 2011, LUNG HLTH EUR FACTS; Ferner RE., 2012, MEDICINE, V40, P366; Forster AJ, 2005, J GEN INTERN MED, V20, P317, DOI 10.1111/j.1525-1497.2005.30390.x; Fortnum H, 2012, J CLIN PHARM THER, V37, P161, DOI 10.1111/j.1365-2710.2011.01273.x; Francis R., 2013, REPORT MID STAFFORDS; Gabe ME, 2011, J NURS MANAGE, V19, P377, DOI 10.1111/j.1365-2834.2011.01204.x; GABE ME, 2012, THESIS; GABE ME, 2013, J NURS MANAGE, DOI DOI 10.1111/J0NM.12067; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Glasziou P, 2008, EVIDENCE BASED MED M, P3, DOI [10.1002/9780470696323, DOI 10.1002/9780470696323]; Global Initiative for Chronic Obstructive Lung Disease, 2011, GLOB STRAT DIAGN MAN; Golder S, 2009, J MED LIBR ASSOC, V97, P84, DOI 10.3163/1536-5050.97.2.004; Gonzalez-Rubio F, 2011, PHARMACOEPIDEM DR S, V20, P1287, DOI 10.1002/pds.2172; Gurwitz JH, 2000, AM J MED, V109, P87, DOI 10.1016/S0002-9343(00)00451-4; Gurwitz JH, 2005, AM J MED, V118, P251, DOI 10.1016/j.amjmed.2004.09.018; Hakkarainen KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073166; Hazell L, 2006, DRUG SAFETY, V29, P385, DOI 10.2165/00002018-200629050-00003; Heeley E, 2001, LANCET, V358, P1872, DOI 10.1016/S0140-6736(01)06898-2; Herxheimer A, 2008, EUR J CLIN PHARMACOL, V64, P107, DOI 10.1007/s00228-007-0429-7; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000; Hohl CM, 2011, ANN EMERG MED, V58, P270, DOI 10.1016/j.annemergmed.2011.01.003; Howard RL, 2007, BRIT J CLIN PHARMACO, V63, P136, DOI 10.1111/j.1365-2125.2006.02698.x; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; *HSCE, 2011, CAR COMP REP HLTH SE; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Jarernsiripornkul N, 2002, BRIT J CLIN PHARMACO, V53, P318, DOI 10.1046/j.0306-5251.2001.01547.x; Jarernsiripornkul N, 2012, EPILEPSY BEHAV, V24, P102, DOI 10.1016/j.yebeh.2012.03.023; Jha AK, 2010, QUAL SAF HEALTH CARE, V19, P42, DOI 10.1136/qshc.2008.029165; Jordan S, 2002, J ADV NURS, V38, P437, DOI 10.1046/j.1365-2648.2002.02205.x; Jordan S, 2002, J ADV NURS, V37, P155, DOI 10.1046/j.1365-2648.2002.02064.x; Jordan S, 2007, Nurs Stand, V21, P35; Jordan S, 1999, J ADV NURS, V30, P796, DOI 10.1046/j.1365-2648.1999.01176.x; Jordan S, 2008, PRESCRIPTION DRUG GU; Jordan S, 2014, SCI WORLD J, DOI 10.1155/2014/843621; Jordan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067912; Jordan S, 2011, J NURS MANAGE, V19, P287, DOI 10.1111/j.1365-2834.2011.01265.x; Jordan S, 2009, J ADV NURS, V65, P2258, DOI 10.1111/j.1365-2648.2009.05129.x; KEOGHBROWN MR, 2007, HLTH TECHNOLOGY ASSE, V11, pR9; Krska J, 2001, AGE AGEING, V30, P205, DOI 10.1093/ageing/30.3.205; Kvasz M, 2000, MedGenMed, V2, pE3; Kyriacos U, 2005, J ADV NURS, V52, P91, DOI 10.1111/j.1365-2648.2005.03555.x; Lampela P, 2007, EUR J CLIN PHARMACOL, V63, P509, DOI 10.1007/s00228-007-0283-7; Lapane KL, 2011, J AM GERIATR SOC, V59, P1238, DOI 10.1111/j.1532-5415.2011.03418.x; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LE Wales, 2020, US ADD FUND SOC CAR; LEWIS DA, 1983, J AFFECT DISORDERS, V5, P319, DOI 10.1016/0165-0327(83)90022-8; Lewis KE, 2010, SIDE EFFECT, V32, P311, DOI 10.1016/S0378-6080(10)32016-2; Loke YK, 2012, BRIT J CLIN PHARMACO, V73, P908, DOI 10.1111/j.1365-2125.2012.04235.x; Lorimer S, 2012, J CLIN PHARM THER, V37, P148, DOI 10.1111/j.1365-2710.2011.01258.x; Mant D., 2008, EVIDENCE BASED MED M, P15; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Medawar C., 2003, INT J RISK SAF MED, V6, P5; Miguel A, 2012, PHARMACOEPIDEM DR S, V21, P1139, DOI 10.1002/pds.3309; Molokhia Mariam, 2009, Clin Epidemiol, V1, P75; Montesi G, 2009, BRIT J CLIN PHARMACO, V67, P651, DOI 10.1111/j.1365-2125.2009.03422.x; Morello RT, 2013, BMJ QUAL SAF, V22, P11, DOI 10.1136/bmjqs-2011-000582; Narhi U, 2000, J CLIN PHARM THER, V25, P177; Narhi U, 2002, INT J PHARM PRACT, V10, P55, DOI DOI 10.1111/J.2042-7174.2002; Nash M, 2011, J NURS MANAGE, V19, P360, DOI 10.1111/j.1365-2834.2011.01244.x; *NAT CO ORD COUNC, 2005, 1 10 YEARS DEF PROBL; National Patient Safety Agency, 2007, SAF DOS MED SAF INC; NORRBY SR, 1987, J INFECT DIS, V155, P170, DOI 10.1093/infdis/155.2.170; O'Leary KJ, 2013, BMJ QUAL SAF, V22, P130, DOI 10.1136/bmjqs-2012-001102; Onder G, 2013, AGE AGEING, V42, P284, DOI 10.1093/ageing/aft038; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Post PN, 2013, J EVAL CLIN PRACT, V19, P638, DOI 10.1111/j.1365-2753.2012.01888.x; ROSENTHA.R, 1966, PSYCHOL REP, V19, P115, DOI 10.2466/pr0.1966.19.1.115; Rottenkolber D, 2011, PHARMACOEPIDEM DR S, V20, P626, DOI 10.1002/pds.2118; Russell D, 2011, STAT MED, V30, P922, DOI 10.1002/sim.4175; Schulz KF, 2006, LANCET HDB ESSENTIAL; SHADISH SW, 2002, EXPT QUASIEXPERIMENT; Shojania KG, 2013, BMJ QUAL SAF, V22, P273, DOI 10.1136/bmjqs-2013-001935; Sirois F, 2003, GEN HOSP PSYCHIAT, V25, P27, DOI 10.1016/S0163-8343(02)00241-4; Steinman MA, 2011, J AM GERIATR SOC, V59, P1513, DOI 10.1111/j.1532-5415.2011.03500.x; Thompson A, 2011, AUST NZ J PSYCHIAT, V45, P740, DOI 10.3109/00048674.2011.595370; Tierney WM, 2003, NEW ENGL J MED, V348, P1587, DOI 10.1056/NEJMe030026; Tsang R, 2009, J CLIN EPIDEMIOL, V62, P609, DOI 10.1016/j.jclinepi.2008.08.005; Uitenbroek DG, 1997, SISA SIMPLE INTERACT; Valentin A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b814; van Hunsel F, 2012, DRUG SAFETY, V35, P45, DOI 10.2165/11594320-000000000-00000; Wightman R, 2011, PSYCHIAT DANUB, V23, pS126; Winkeljohn D, 2010, CLIN J ONCOL NURS, V14, P461, DOI 10.1188/10.CJON.461-466; Wu TY, 2010, J ROY SOC MED, V103, P239, DOI 10.1258/jrsm.2010.100113; Yee JL, 2005, ANN PHARMACOTHER, V39, P1990, DOI 10.1345/aph.1E541; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	121	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96682	10.1371/journal.pone.0096682	http://dx.doi.org/10.1371/journal.pone.0096682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24798210	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000117
J	Luciano, AA; Arbona-Ramirez, IM; Ruiz, R; Llorens-Bonilla, BJ; Martinez-Lopez, DG; Funderburg, N; Dorsey, MJ				Luciano, Angel A.; Arbona-Ramirez, Ileana M.; Ruiz, Rene; Llorens-Bonilla, Braulio J.; Martinez-Lopez, Denise G.; Funderburg, Nicholas; Dorsey, Morna J.			Alterations in Regulatory T Cell Subpopulations Seen in Preterm Infants	PLOS ONE			English	Article							SUPPRESSIVE FUNCTION; DIFFERENTIATION; EXPRESSION; IMMUNITY; ALPHA; BLOOD; IL-7; REG	Regulatory T cells are a population of CD4+ T cells that play a critical role in peripheral tolerance and control of immune responses to pathogens. The purpose of this study was to measure the percentages of two different regulatory T cells subpopulations, identified by the presence or absence of CD31 (Recent thymic emigrants and peripherally induced naive regulatory T cells), in term and preterm infant cord blood. We report the association of prenatal factors, intrauterine exposure to lipopolysaccharide and inflammation and the percentages of these regulatory T cell subpopulations in term and preterm infants. Cord blood samples were collected from both term and preterm infants and mononuclear cells isolated over a Ficoll-Hypaque cushion. Cells were then stained with fluorochrome-labeled antibodies to characterize regulatory T cell populations and analyzed with multi-color flow cytometry. Cord blood plasma C-reactive protein, and lipopolysaccharide were also measured. Placental pathology was also examined. We report a gestational age-dependent difference in the percentage of total regulatory T cells, in which preterm infants of lower gestational ages have an increased percentage of regulatory T cells. We report the presence of two populations of regulatory T cells (CD31+ and CD31-) in cord blood of term and preterm infants and their association with different maternal and fetal characteristics. Factors associated with differences in the percentage of CD31- Tregs included the use of prenatal antibiotics, steroids and magnesium sulfate. In addition, the percentage of CD31- Tregs was significantly higher in cord blood of preterm pregnancies associated with inflammation and prenatal lipopolysaccharide exposure. The peripheral Treg pool of preterm infants could be altered by prenatal exposure to inflammation and chorioamnionitis; however, the clinical implications of this finding are not yet understood.	[Luciano, Angel A.; Arbona-Ramirez, Ileana M.; Ruiz, Rene; Llorens-Bonilla, Braulio J.; Martinez-Lopez, Denise G.] Univ S Florida, Morsani Coll Med, Div Neonatol, Dept Pediat, Tampa, FL USA; [Funderburg, Nicholas] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Dorsey, Morna J.] Univ Calif San Francisco, Dept Pediat, Div Allergy Immunol & Bone Marrow Transplant, San Francisco, CA 94143 USA	State University System of Florida; University of South Florida; University System of Ohio; Ohio State University; University of California System; University of California San Francisco	Dorsey, MJ (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Allergy Immunol & Bone Marrow Transplant, San Francisco, CA 94143 USA.	morna.dorsey@ucsf.edu	Funderburg, Nicholas/L-8022-2013; Dorsey, Morna/V-7270-2018	Dorsey, Morna/0000-0002-9432-3542; Funderburg, Nicholas/0000-0003-3113-1217	HRSA [R60 MC 00003-01-06]; Signature Program in Allergy Immunology Infectious Disease University of South Florida	HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Signature Program in Allergy Immunology Infectious Disease University of South Florida	This study was supported by HRSA R60 MC 00003-01-06; Signature Program in Allergy Immunology Infectious Disease University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou I, 2002, NAT IMMUNOL, V3, P756, DOI 10.1038/ni816; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Correa-Rocha R, 2012, PEDIATR RES, V71, P590, DOI 10.1038/pr.2012.6; Crespo M, 2012, PEDIATR RES, V71, P136, DOI 10.1038/pr.2011.26; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Housley WJ, 2011, J IMMUNOL, V186, P6779, DOI 10.4049/jimmunol.1003868; Kim H, 2012, J MATERN-FETAL NEO M, V25, P2058, DOI 10.3109/14767058.2012.666591; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Luciano AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016698; Martinez D FN, 2013, PEDIAT RES IN PRESS; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Redjimi N, 2012, CANCER RES, V72, P4351, DOI 10.1158/0008-5472.CAN-12-0579; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; TQ P, 2014, ANN PEDIAT CHILD HLT, V2, P1006; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963	21	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95867	10.1371/journal.pone.0095867	http://dx.doi.org/10.1371/journal.pone.0095867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796788	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000026
J	Mathas, M; Nusshag, C; Burk, O; Godtel-Armbrust, U; Herlyn, H; Wojnowski, L; Windshugel, B				Mathaes, Marianne; Nusshag, Christian; Burk, Oliver; Goedtel-Armbrust, Ute; Herlyn, Holger; Wojnowski, Leszek; Windshuegel, Bjoern			Structural and Functional Similarity of Amphibian Constitutive Androstane Receptor with Mammalian Pregnane X Receptor	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; XENOBIOTIC RECEPTOR; PHARMACOLOGICALLY DISTINCT; RESPONSE ELEMENTS; NUCLEAR RECEPTORS; CAR; PXR; TRANSACTIVATION; ALPHA; METABOLISM	The nuclear receptors and xenosensors constitutive androstane receptor (CAR, NR1I3) and pregnane X receptor (PXR, NR1I2) induce the expression of xenobiotic metabolizing enzymes and transporters, which also affects various endobiotics. While human and mouse CAR feature a high basal activity and low induction upon ligand exposure, we recently identified two constitutive androstane receptors in Xenopus laevis (xlCARa and a) that possess PXR-like characteristics such as low basal activity and activation in response to structurally diverse compounds. Using a set of complementary computational and biochemical approaches we provide evidence for xlCARa being the structural and functional counterpart of mammalian PXR. A three-dimensional model of the xlCARa ligand-binding domain (LBD) reveals a human PXR-like L-shaped ligand binding pocket with a larger volume than the binding pockets in human and murine CAR. The shape and amino acid composition of the ligand-binding pocket of xlCAR suggests PXR-like binding of chemically diverse ligands which was confirmed by biochemical methods. Similarly to PXR, xlCARa possesses a flexible helix 119. Modest increase in the recruitment of coactivator PGC-1a may contribute to the enhanced basal activity of three gain-of-function xlCARa mutants humanizing key LBD amino acid residues. xlCARa and PXR appear to constitute an example of convergent evolution.	[Mathaes, Marianne; Nusshag, Christian; Goedtel-Armbrust, Ute; Wojnowski, Leszek] Univ Med Ctr, Dept Pharmacol, Mainz, Germany; [Burk, Oliver] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Herlyn, Holger] Johannes Gutenberg Univ Mainz, Inst Anthropol, D-55122 Mainz, Germany; [Windshuegel, Bjoern] Univ Hamburg, Ctr Bioinformat, Hamburg, Germany; [Windshuegel, Bjoern] European ScreeningPort GmbH, Hamburg, Germany	Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Johannes Gutenberg University of Mainz; University of Hamburg	Windshugel, B (corresponding author), Univ Hamburg, Ctr Bioinformat, Hamburg, Germany.	bjoern.windshuegel@screeningport.com		Mathas, Marianne/0000-0003-4557-0608	University Medical Center, Mainz; Institute of Clinical Pharmacology, Stuttgart; Institute of Anthropology, Johannes Gutenberg-University Mainz; European ScreeningPort GmbH, Hamburg	University Medical Center, Mainz; Institute of Clinical Pharmacology, Stuttgart; Institute of Anthropology, Johannes Gutenberg-University Mainz; European ScreeningPort GmbH, Hamburg	The work was supported by the institutions employing the authors: University Medical Center, Mainz; Institute of Clinical Pharmacology, Stuttgart; Institute of Anthropology, Johannes Gutenberg-University Mainz; European ScreeningPort GmbH, Hamburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Katja A, 2004, Nucl Recept, V2, P1, DOI 10.1186/1478-1336-2-1; Auerbach SS, 2005, MOL PHARMACOL, V68, P1239, DOI 10.1124/mol.105.013417; BAES M, 1994, MOL CELL BIOL, V14, P1544, DOI 10.1128/MCB.14.3.1544; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bros M, 2003, J IMMUNOL, V171, P1825, DOI 10.4049/jimmunol.171.4.1825; Burk O, 2002, J BIOL CHEM, V277, P24280, DOI 10.1074/jbc.M202345200; Burk O, 2012, BRIT J PHARMACOL, V167, P666, DOI 10.1111/j.1476-5381.2012.02033.x; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Carnahan VE, 2005, CURR DRUG METAB, V6, P357, DOI 10.2174/1389200054633844; Chen T, 2010, J PHARMACOL EXP THER, V332, P106, DOI 10.1124/jpet.109.159210; Choi HS, 1997, J BIOL CHEM, V272, P23565, DOI 10.1074/jbc.272.38.23565; di Masi A, 2009, MOL ASPECTS MED, V30, P297, DOI 10.1016/j.mam.2009.04.002; Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002; Frank C, 2004, J BIOL CHEM, V279, P33558, DOI 10.1074/jbc.M403946200; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Godtel-Armbrust U, 2007, N-S ARCH PHARMACOL, V375, P377, DOI 10.1007/s00210-007-0172-8; Grun F, 2002, J BIOL CHEM, V277, P43691, DOI 10.1074/jbc.M206553200; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; Hwang-Verslues WW, 2010, CURR OPIN PHARMACOL, V10, P698, DOI 10.1016/j.coph.2010.08.010; Jinno H, 2004, MOL PHARMACOL, V65, P496, DOI 10.1124/mol.65.3.496; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Jyrkkarinne J, 2005, J BIOL CHEM, V280, P5960, DOI 10.1074/jbc.M411241200; Krasowski MD, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-5; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mathas M, 2012, MOL ENDOCRINOL, V26, P14, DOI 10.1210/me.2011-1235; Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200; Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977; Ross J, 2010, TOXICOL SCI, V116, P452, DOI 10.1093/toxsci/kfq118; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Tolson AH, 2010, ADV DRUG DELIV REV, V38, P2091; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang YM, 2012, EXPERT OPIN DRUG MET, V8, P803, DOI 10.1517/17425255.2012.685237; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Windshugel B, 2005, J MOL MODEL, V11, P69, DOI 10.1007/s00894-004-0227-4; Windshugel B, 2007, J MOL GRAPH MODEL, V25, P644, DOI 10.1016/j.jmgm.2006.05.002; Windshugel B, 2011, J MOL RECOGNIT, V24, P875, DOI 10.1002/jmr.1132; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042	37	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96263	10.1371/journal.pone.0096263	http://dx.doi.org/10.1371/journal.pone.0096263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797902	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000054
J	Panagopoulos, I; Torkildsen, S; Gorunova, L; Tierens, A; Tjonnfjord, GE; Heim, S				Panagopoulos, Ioannis; Torkildsen, Synne; Gorunova, Ludmila; Tierens, Anne; Tjonnfjord, Geir E.; Heim, Sverre			Comparison between Karyotyping-FISH-Reverse Transcription PCR and RNA-Sequencing-Fusion Gene Identification Programs in the Detection of KAT6A-CREBBP in Acute Myeloid Leukemia	PLOS ONE			English	Article							8P11 MYELOPROLIFERATIVE SYNDROME; RT-PCR; MOZ-CBP; TRANSLOCATION; T(8/16)(P11,P13); REARRANGEMENT; SUBTYPE; DEFINES; P13); T(8	An acute myeloid leukemia was suspected of having a t(8;16)(p11;p13) resulting in a KAT6A-CREBBP fusion because the bone marrow was packed with monoblasts showing marked erythrophagocytosis. The diagnostic karyotype was 46, XY, add(1)(p13), t(8;21)(p11;q22), der(16) t(1;16)(p13; p13)[9]/46, XY[1]; thus, no direct confirmation of the suspicion could be given although both 8p11 and 16p13 seemed to be rearranged. The leukemic cells were examined in two ways to find out whether a cryptic KAT6A-CREBBP was present. The first was the "conventional" approach: G-banding was followed by fluorescence in situ hybridization (FISH) and reverse transcription PCR (RT-PCR). The second was RNA-Seq followed by data analysis using FusionMap and FusionFinder programs with special emphasis on candidates located in the 1p13, 8p11, 16p13, and 21q22 breakpoints. FISH analysis indicated the presence of a KAT6A/CREBBP chimera. RT-PCR followed by Sanger sequencing of the amplified product showed that a chimeric KAT6A-CREBBP transcript was present in the patients bone marrow. Surprisingly, however, KATA6A-CREBBP was not among the 874 and 35 fusion transcripts identified by the FusionMap and FusionFinder programs, respectively, although 11 sequences of the raw RNA-sequencing data were KATA6A-CREBBP fragments. This illustrates that although many fusion transcripts can be found by RNA-Seq combined with FusionMap and FusionFinder, the pathogenetically essential fusion is not always picked up by the bioinformatic algorithms behind these programs. The present study not only illustrates potential pitfalls of current data analysis programs of whole transcriptome sequences which make them less useful as stand-alone techniques, but also that leukemia diagnosis still relies on integration of clinical, hematologic, and genetic disease features of which the former two by no means have become superfluous.	[Panagopoulos, Ioannis; Torkildsen, Synne; Gorunova, Ludmila; Heim, Sverre] Univ Oslo, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway; [Panagopoulos, Ioannis; Torkildsen, Synne; Gorunova, Ludmila; Heim, Sverre] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway; [Torkildsen, Synne; Tjonnfjord, Geir E.] Oslo Univ Hosp, Dept Hematol, Oslo, Norway; [Tierens, Anne] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Tjonnfjord, Geir E.; Heim, Sverre] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Panagopoulos, I (corresponding author), Univ Oslo, Norwegian Radium Hosp, Inst Canc Genet & Informat, Sect Canc Cytogenet, Oslo, Norway.	ioannis.panagopoulos@rr-research.no	Tjønnfjord, Geir Erland/AAH-8739-2020	tierens, anne/0000-0002-5350-8313; Panagopoulos, Ioannis/0000-0003-2159-5341	Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN R, 1987, CANCER GENET CYTOGEN, V24, P213, DOI 10.1016/0165-4608(87)90101-4; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Brown T, 2012, LEUKEMIA LYMPHOMA, V53, P338, DOI 10.3109/10428194.2011.614703; Carrara M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S2; Carrara M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340620; Chaffanet M, 1999, GENE CHROMOSOME CANC, V26, P161, DOI 10.1002/(SICI)1098-2264(199910)26:2<161::AID-GCC8>3.3.CO;2-Y; Francis RW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039987; Fujiki A, 2012, J PEDIAT HEMATOL ONC, V34, P402, DOI 10.1097/MPH.0b013e318238818f; Ge HY, 2011, BIOINFORMATICS, V27, P1922, DOI 10.1093/bioinformatics/btr310; Gervais C, 2008, LEUKEMIA, V22, P1567, DOI 10.1038/leu.2008.128; Giles RH, 1997, LEUKEMIA, V11, P2087, DOI 10.1038/sj.leu.2400882; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Haferlach T, 2009, LEUKEMIA, V23, P934, DOI 10.1038/leu.2008.388; HANSLIP JJ, 1992, LEUKEMIA LYMPHOMA, V6, P479, DOI 10.3109/10428199209053586; HEIM S, 1987, BRIT J HAEMATOL, V66, P323, DOI 10.1111/j.1365-2141.1987.tb06917.x; Jackson CC, 2010, HUM PATHOL, V41, P461, DOI 10.1016/j.humpath.2009.11.003; LAI JL, 1987, CANCER GENET CYTOGEN, V27, P101, DOI 10.1016/0165-4608(87)90265-2; Lee CH, 2012, P NATL ACAD SCI USA, V109, P929, DOI 10.1073/pnas.1115528109; LIU P, 1993, SCIENCE, V261, P1041, DOI 10.1126/science.8351518; Ma ZG, 2001, NAT GENET, V28, P220, DOI 10.1038/90054; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mercher T, 2001, P NATL ACAD SCI USA, V98, P5776, DOI 10.1073/pnas.101001498; Micci F, 2013, LEUKEMIA, V27, P980, DOI 10.1038/leu.2012.266; Nyquist KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049705; Panagopoulos I, 2000, GENE CHROMOSOME CANC, V28, P415, DOI 10.1002/1098-2264(200008)28:4<415::AID-GCC7>3.0.CO;2-I; Panagopoulos I, 2002, GENE CHROMOSOME CANC, V35, P372, DOI 10.1002/gcc.10131; Panagopoulos I, 2013, ONCOL REP, V30, P2587, DOI 10.3892/or.2013.2751; Panagopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063663; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P733, DOI 10.1002/gcc.22068; Panagopoulos I, 2013, GENE CHROMOSOME CANC, V52, P610, DOI 10.1002/gcc.22057; Rozman M, 2004, GENE CHROMOSOME CANC, V40, P140, DOI 10.1002/gcc.20022; Schaffer LG, 2009, ISCN 2009 INT SYSTEM; Schmidt HH, 2004, LEUKEMIA, V18, P1115, DOI 10.1038/sj.leu.2403353; SCHOUTEN TJ, 1983, CANCER-AM CANCER SOC, V52, P1229, DOI 10.1002/1097-0142(19831001)52:7<1229::AID-CNCR2820520717>3.0.CO;2-N; Tanas MR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002409; Terui K, 2008, HAEMATOL-HEMATOL J, V93, P1591, DOI 10.3324/haematol.13020; Wang QG, 2013, BRIEF BIOINFORM, V14, P506, DOI 10.1093/bib/bbs044	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96570	10.1371/journal.pone.0096570	http://dx.doi.org/10.1371/journal.pone.0096570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798186	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000097
J	Tabarean, IV				Tabarean, Iustin V.			Electrical Remodeling of Preoptic GABAergic Neurons Involves the Kv1.5 Subunit	PLOS ONE			English	Article							GATED K+ CHANNELS; HYPOTHALAMIC NEURONS; BLOCKERS; CURRENTS	The electrogenic machinery of an excitable cell can adapt in response to changes in input, genetic deficit or in pathological conditions, however the underlying molecular mechanisms are not understood. In cases of genetic deletion it is commonly observed that a channel subunit from the same family replaces the missing one. We have previously reported that Kv4.2-/- preoptic GABAergic neurons display identical firing characteristics to those of wild-type neurons despite having reduced A-type currents, and that, surprisingly, they present a robust upregulation of a delayed rectifier current, the nature of which is unknown. Here, using pharmacology, qPCR and Western blots we report that, although the wild-type neurons express several Kv subunits, the upregulated current is conducted by the Kv1.5 subunit exclusively. Thus, this study reveals the molecular nature of a novel mechanism of electrical remodeling in central neurons.	Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Tabarean, IV (corresponding author), Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA.	tabarean@scripps.edu			NIH [NS0607099, NS082255]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS082255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants NS0607099 and NS082255. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarwani S, 2003, J PHYSIOL-LONDON, V551, P751, DOI 10.1113/jphysiol.2003.040014; Barnwell LFS, 2009, EPILEPSIA, V50, P1741, DOI 10.1111/j.1528-1167.2009.02086.x; BURGESS DL, 1995, NAT GENET, V10, P461, DOI 10.1038/ng0895-461; Chen WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049758; Cox RH, 2005, CELL BIOCHEM BIOPHYS, V42, P167, DOI 10.1385/CBB:42:2:167; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Kerschbaum HH, 2002, BRAIN RES, V927, P55, DOI 10.1016/S0006-8993(01)03324-8; Koschak A, 1998, J BIOL CHEM, V273, P2639, DOI 10.1074/jbc.273.5.2639; Lagrutta A, 2006, J PHARMACOL EXP THER, V317, P1054, DOI 10.1124/jpet.106.101162; LEONARD RJ, 1992, P NATL ACAD SCI USA, V89, P10094, DOI 10.1073/pnas.89.21.10094; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Morrison SF, 2012, FRONT ENDOCRINOL LAU, V3; Nerbonne JM, 2008, J PHYSIOL-LONDON, V586, P1565, DOI 10.1113/jphysiol.2007.146597; Owen DG, 1997, BRIT J PHARMACOL, V120, P1029, DOI 10.1038/sj.bjp.0701004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Sethi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029134; Tabarean IV, 2006, NEUROSCIENCE, V141, P1685, DOI 10.1016/j.neuroscience.2006.05.007; Tanaka M, 1999, P NATL ACAD SCI USA, V96, P1088, DOI 10.1073/pnas.96.3.1088; Wu SD, 2006, BIOORG MED CHEM LETT, V16, P6213, DOI 10.1016/j.bmcl.2006.09.021; Yang KC, 2012, CARDIOVASC RES, V93, P252, DOI 10.1093/cvr/cvr283; Zsiros E, 2009, J IMMUNOL, V183, P4483, DOI 10.4049/jimmunol.0803003	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96643	10.1371/journal.pone.0096643	http://dx.doi.org/10.1371/journal.pone.0096643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797243	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000109
J	Cuesta-Vargas, A; Gine-Garriga, M				Cuesta-Vargas, Antonio; Gine-Garriga, Maria			Development of a New Index of Balance in Adults with Intellectual and Developmental Disabilities	PLOS ONE			English	Article							POSTURAL STABILITY; MENTAL-RETARDATION; PHYSICAL-FITNESS; OLDER-PEOPLE; RISK-FACTORS; GO TEST; RELIABILITY; FALLS; INDIVIDUALS; IMPAIRMENTS	Purposes: The first objective was to propose a new model representing the balance level of adults with intellectual and developmental disabilities (IDD) using Principal Components Analysis (PCA); and the second objective was to use the results from the PCA recorded by regression method to construct and validate summative scales of the standardized values of the index, which may be useful to facilitate a balance assessment in adults with IDD. Methods: A total of 801 individuals with IDD (509 males) mean 33.1 +/- 8.5 years old, were recruited from Special Olympic Games in Spain 2009 to 2012. The participants performed the following tests: the timed-stand test, the single leg stance test with open and closed eyes, the Functional Reach Test, the Expanded Timed-Get-up-and-Go Test. Data was analyzed using principal components analysis (PCA) with Oblimin rotation and Kaiser normalization. We examined the construct validity of our proposed two-factor model underlying balance for adults with IDD. The scores from PCA were recorded by regression method and were standardized. Results: The Component Plot and Rotated Space indicated that a two-factor solution (Dynamic and Static Balance components) was optimal. The PCA with direct Oblimin rotation revealed a satisfactory percentage of total variance explained by the two factors: 51.6 and 21.4%, respectively. The median score standardized for component dynamic and static of the balance index for adults with IDD is shown how references values. Conclusions: Our study may lead to improvements in the understanding and assessment of balance in adults with IDD. First, it confirms that a two-factor model may underlie the balance construct, and second, it provides an index that may be useful for identifying the balance level for adults with IDD.	[Cuesta-Vargas, Antonio] Univ Malaga, Dept Phys Therapy, E-29071 Malaga, Spain; [Cuesta-Vargas, Antonio] Queensland Univ Technol, Fac Hlth, Sch Clin Sci, Brisbane, Qld 4001, Australia; [Gine-Garriga, Maria] Univ Ramon Llull, FPCEE Blanquerna, Dept Phys Act & Sport Sci, Barcelona, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, FCS Blanquerna, Dept Phys Therapy, Barcelona, Spain	Universidad de Malaga; Queensland University of Technology (QUT); Universitat Ramon Llull; Universitat Ramon Llull	Cuesta-Vargas, A (corresponding author), Univ Malaga, Dept Phys Therapy, E-29071 Malaga, Spain.	acuesta@uma.es	Giné-Garriga, Maria/F-4089-2016; Giné-Garriga, Maria/AAF-9828-2019	Giné-Garriga, Maria/0000-0003-4449-3524; Giné-Garriga, Maria/0000-0003-4449-3524; Cuesta-Vargas, Antonio I/0000-0002-8880-4315	OTRI-UMA [806/423505 code 00334]; Spanish Ministry of Education [EX-2008-0641]	OTRI-UMA; Spanish Ministry of Education(Spanish Government)	This research was partially funded by grants from the OTRI-UMA (ref 806/423505 code 00334) and by grants from the Spanish Ministry of Education (EX-2008-0641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CURR GERONTOL GERIAT; Bartlett M S, NOTE MULTIPLYING FAC; Birmingham TB, 2000, CLIN J SPORT MED, V10, P264, DOI 10.1097/00042752-200010000-00007; Bodfish JW, 2001, AM J MENT RETARD, V106, P123, DOI 10.1352/0895-8017(2001)106<0123:SAMCDI>2.0.CO;2; Carmeli E, 2008, MOTOR CONTROL, V12, P348, DOI 10.1123/mcj.12.4.348; Chiba Y, 2009, AJIDD-AM J INTELLECT, V114, P225, DOI 10.1352/1944-7558-114.4:225-236; Cox CR, 2010, J INTELL DISABIL RES, V54, P1045, DOI 10.1111/j.1365-2788.2010.01333.x; Dellavia C, 2009, PERCEPT MOTOR SKILL, V108, P608, DOI 10.2466/PMS.108.2.608-622; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Evenhuis HM, 2009, J INTELL DISABIL RES, V53, P19, DOI 10.1111/j.1365-2788.2008.01114.x; Finlayson J, 2010, J INTELL DISABIL RES, V54, P966, DOI 10.1111/j.1365-2788.2010.01319.x; Franciosi E, 2010, J STRENGTH COND RES, V24, P1059, DOI 10.1519/JSC.0b013e3181ca503c; Frey GC, 2006, INT J OBESITY, V30, P861, DOI 10.1038/sj.ijo.0803196; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Hale L, 2007, J INTELL DISABIL RES, V51, P260, DOI 10.1111/j.1365-2788.2006.00873.x; Hilgenkamp TIM, 2010, RES DEV DISABIL, V31, P1027, DOI 10.1016/j.ridd.2010.04.012; Jette AM, 2005, J REHABIL MED, V37, P339, DOI 10.1080/16501970500302793; Lahtinen U, 2007, ADAPT PHYS ACT Q, V24, P125, DOI 10.1123/apaq.24.2.125; Lundin-Olsson Lillemor, 2010, Evid Based Nurs, V13, P96, DOI 10.1136/ebn1078; NEWCOMER KL, 1993, J RHEUMATOL, V20, P21; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; Oppewal A, 2013, RES DEV DISABIL, V34, P2743, DOI 10.1016/j.ridd.2013.05.040; Pardasaney PK, 2012, PHYS THER, V92, P388, DOI 10.2522/ptj.20100398; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Sibley KM, 2011, PHYS THER, V91, P1583, DOI 10.2522/ptj.20110063; Tamse TR, 2010, J STRENGTH COND RES, V24, P695, DOI 10.1519/JSC.0b013e3181c7b46b; Temple VA, 2006, AM J HEALTH PROMOT, V21, P2, DOI 10.4278/0890-1171-21.1.2; Wall JC, 2000, J REHABIL RES DEV, V37, P109; Wu CL, 2010, RES DEV DISABIL, V31, P713, DOI 10.1016/j.ridd.2010.01.013; Yu ji, 2008, QUANTITATIVE EVALUAT	31	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96529	10.1371/journal.pone.0096529	http://dx.doi.org/10.1371/journal.pone.0096529			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789336	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700108
J	Pfeifer, K; Schaub, C; Domsch, K; Dorresteijn, A; Wolfstetter, G				Pfeifer, Kathrin; Schaub, Christoph; Domsch, Katrin; Dorresteijn, Adriaan; Wolfstetter, Georg			Maternal Inheritance of Twist and Analysis of MAPK Activation in Embryos of the Polychaete Annelid Platynereis dumerilii	PLOS ONE			English	Article							DROSOPHILA FGF-RECEPTOR; EVOLUTIONARY CONSERVATION; MESSENGER-RNA; BETA-CATENIN; STEM-CELLS; GERM-CELLS; EXPRESSION; MESODERM; CLEAVAGE; SPECIFICATION	In this study, we aimed to identify molecular mechanisms involved in the specification of the 4d (mesentoblast) lineage in Platynereis dumerilii. We employ RT-PCR and in situ hybridization against the Platynereis dumerilii twist homolog (Pdu-twist) to reveal mesodermal specification within this lineage. We show that Pdu-twist mRNA is already maternally distributed. After fertilization, ooplasmatic segregation leads to relocation of Pdu-twist transcripts into the somatoblast (2d) lineage and 4d, indicating that the maternal component of Pdu-twist might be an important prerequisite for further mesoderm specification but does not represent a defining characteristic of the mesentoblast. However, after the primordial germ cells have separated from the 4d lineage, zygotic transcription of Pdu-twist is exclusively observed in the myogenic progenitors, suggesting that mesodermal specification occurs after the 4d stage. Previous studies on spiral cleaving embryos revealed a spatio-temporal correlation between the 4d lineage and the activity of an embryonic organizer that is capable to induce the developmental fates of certain micromeres. This has raised the question if specification of the 4d lineage could be connected to the organizer activity. Therefore, we aimed to reveal the existence of such a proposed conserved organizer in Platynereis employing antibody staining against dpERK. In contrast to former observations in other spiralian embryos, activation of MAPK signaling during 2d and 4d formation cannot be detected which questions the existence of a conserved connection between organizer function and specification of the 4d lineage. However, our experiments unveil robust MAPK activation in the prospective nephroblasts as well as in the macromeres and some micromeres at the blastopore in gastrulating embryos. Inhibition of MAPK activation leads to larvae with a shortened body axis, defects in trunk muscle spreading and improper nervous system condensation, indicating a critical function for MAPK signaling for the reorganization of embryonic tissues during the gastrulation process.	[Pfeifer, Kathrin; Schaub, Christoph; Domsch, Katrin; Dorresteijn, Adriaan; Wolfstetter, Georg] Univ Giessen, Inst Allgemeine & Spezielle Zool, D-35390 Giessen, Germany	Justus Liebig University Giessen	Wolfstetter, G (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	Georg.Wolfstetter@molbiol.umu.se		Schaub, Christoph/0000-0003-3714-0050; Domsch, Katrin/0000-0003-1040-4474; Dorresteijn, Adriaan/0000-0003-2314-1634; Pfeifer, Kathrin/0000-0002-2680-8425; Wolfstetter, Georg/0000-0001-8763-1419				Ackermann C, 2005, J MORPHOL, V266, P258, DOI 10.1002/jmor.10375; Agee SJ, 2006, DEV BIOL, V298, P1, DOI 10.1016/j.ydbio.2006.04.473; Amiel AR, 2013, DEV BIOL, V379, P107, DOI 10.1016/j.ydbio.2013.04.011; Arenas-Mena C, 2007, DEV DYNAM, V236, P1611, DOI 10.1002/dvdy.21164; Arendt D, 2002, DEVELOPMENT, V129, P1143; Bae YK, 2012, CELL ADHES MIGR, V6, P397, DOI 10.4161/cam.21103; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Brunet T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3821; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; COSTELLO DP, 1945, J EXP ZOOL, V100, P19, DOI 10.1002/jez.1401000103; Dill KK, 2008, DEV GENES EVOL; Dorresteijn A.W.C., 1988, Microfauna Marina, V4, P335; DORRESTEIJN AWC, 1993, ROUX ARCH DEV BIOL, V202, P270, DOI 10.1007/BF00363216; DORRESTEIJN AWC, 1991, ROUX ARCH DEV BIOL, V200, P342, DOI 10.1007/BF00665530; DORRESTEIJN AWC, 1987, ROUX ARCH DEV BIOL, V196, P51, DOI 10.1007/BF00376021; DORRESTEIJN AWC, 1990, ROUX ARCH DEV BIOL, V199, P14, DOI 10.1007/BF01681530; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Fischer AHL, 2013, J EXP ZOOL PART B, V320B, P94, DOI 10.1002/jez.b.22486; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Giani VC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-10; Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003; Gonsalves FC, 2007, P NATL ACAD SCI USA, V104, P531, DOI 10.1073/pnas.0609851104; Goueli S A, 1998, Expert Opin Investig Drugs, V7, P121, DOI 10.1517/13543784.7.1.121; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Hauenschild C., 1969, GROSSES ZOOLOGISCH B; Henry JQ, 2010, INTEGR COMP BIOL, V50, P707, DOI 10.1093/icb/icq076; HOLTON B, 1994, ROUX ARCH DEV BIOL, V204, P46, DOI [10.1007/BF00744872, 10.1007/BF00189067]; Kang D, 2002, DEV BIOL, V245, P28, DOI 10.1006/dbio.2002.0615; Koop D, 2007, DEV BIOL, V311, P200, DOI 10.1016/j.ydbio.2007.08.035; Lambert JD, 2008, J EXP ZOOL PART B, V310B, P15, DOI 10.1002/jez.b.21176; Lambert JD, 2010, CURR BIOL, V20, pR72, DOI 10.1016/j.cub.2009.11.041; Lambert JD, 2003, DEV BIOL, V263, P231, DOI 10.1016/j.ydbio.2003.07.006; Lambert JD, 2002, NATURE, V420, P682, DOI 10.1038/nature01241; Lambert JD, 2001, DEVELOPMENT, V128, P45; Lidke AK, 2013, GEN COMP ENDOCRINOL; Lyons DC, 2012, EVODEVO, P3; Meyer NP, 2010, INTEGR COMP BIOL, V50, P756, DOI 10.1093/icb/icq120; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Petit V, 2004, MOL CELL BIOL, V24, P3769, DOI 10.1128/MCB.24.9.3769-3781.2004; Pfeifer K, 2013, DEV GENES EVOL, V223, P319, DOI 10.1007/s00427-013-0448-6; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Shishido E, 1997, DEVELOPMENT, V124, P2119; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Soto JG, 1997, GENE, V199, P31, DOI 10.1016/S0378-1119(97)00327-2; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; Wilson E. B., 1892, Journal of Morphology, Vvi, P361; Wilson EB, 1897, ANN NY ACAD SCI, V1, P1	57	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96702	10.1371/journal.pone.0096702	http://dx.doi.org/10.1371/journal.pone.0096702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24792484	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700127
J	Teng, S; Lu, CF; Wang, PS; Li, CT; Tu, PC; Hung, CI; Su, TP; Wu, YT				Teng, Shin; Lu, Chia-Feng; Wang, Po-Shan; Li, Cheng-Ta; Tu, Pei-Chi; Hung, Chih-I; Su, Tung-Ping; Wu, Yu-Te			Altered Resting-State Functional Connectivity of Striatal-Thalamic Circuit in Bipolar Disorder	PLOS ONE			English	Article							WHITE-MATTER; BASAL GANGLIA; RATING-SCALE; DEFAULT-MODE; AMYGDALA; DEPRESSION; CORTEX; EMOTION; NETWORK; MRI	Bipolar disorder is characterized by internally affective fluctuations. The abnormality of inherently mental state can be assessed using resting-state fMRI data without producing task-induced biases. In this study, we hypothesized that the resting-state connectivity related to the frontal, striatal, and thalamic regions, which were associated with mood regulations and cognitive functions, can be altered for bipolar disorder. We used the Pearson's correlation coefficients to estimate functional connectivity followed by the hierarchical modular analysis to categorize the resting-state functional regions of interest (ROIs). The selected functional connectivities associated with the striatal-thalamic circuit and default mode network (DMN) were compared between bipolar patients and healthy controls. Significantly decreased connectivity in the striatal-thalamic circuit and between the striatal regions and the middle and posterior cingulate cortex was observed in the bipolar patients. We also observed that the bipolar patients exhibited significantly increased connectivity between the thalamic regions and the parahippocampus. No significant changes of connectivity related to the frontal regions in the DMN were observed. The changed resting-state connectivity related to the striatal-thalamic circuit might be an inherent basis for the altered emotional and cognitive processing in the bipolar patients.	[Teng, Shin; Hung, Chih-I; Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lu, Chia-Feng] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Lu, Chia-Feng] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Teng, Shin; Lu, Chia-Feng; Wang, Po-Shan; Hung, Chih-I; Wu, Yu-Te] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Wang, Po-Shan] Taipei Municipal Gan Dau Hosp, Neurol Inst, Taipei, Taiwan; [Wang, Po-Shan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Li, Cheng-Ta; Su, Tung-Ping] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tu, Pei-Chi] Taipei Vet Gen Hosp, Dept Med Educ & Res, Taipei, Taiwan; [Su, Tung-Ping] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei 112, Taiwan; [Su, Tung-Ping] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Wu, Yu-Te] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Su, TP (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	tpsu@vghtpe.gov.tw; ytwu@ym.edu.tw	Li, Cheng-Ta/AAI-5759-2021	Li, Cheng-Ta/0000-0002-0670-1153	National Science Council [NSC 101-2221-E-010-004-MY2, NSC102-2314-B-010-059, NSC 102-2911-I-008-001]; Taipei City Hospital [102TPECH10]; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan	National Science Council(Ministry of Science and Technology, Taiwan); Taipei City Hospital; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	The study was funded in part by the National Science Council (NSC 101-2221-E-010-004-MY2, NSC102-2314-B-010-059), the National Science Council supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC 102-2911-I-008-001), the Taipei City Hospital (102TPECH10) and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1984, J COMP NEUROL, V222, P56, DOI 10.1002/cne.902220106; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Almeida JRC, 2009, PSYCHIAT RES-NEUROIM, V174, P195, DOI 10.1016/j.pscychresns.2009.04.015; Anand A, 2009, PSYCHIAT RES-NEUROIM, V171, P189, DOI 10.1016/j.pscychresns.2008.03.012; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk M, 2007, ACTA PSYCHIAT SCAND, V116, P41, DOI 10.1111/j.1600-0447.2007.01058.x; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bluhm R, 2009, PSYCHIAT CLIN NEUROS, V63, P754, DOI 10.1111/j.1440-1819.2009.02030.x; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Calzavara R, 2007, EUR J NEUROSCI, V26, P2005, DOI 10.1111/j.1460-9568.2007.05825.x; Cerullo MA, 2009, INT REV PSYCHIATR, V21, P314, DOI 10.1080/09540260902962107; Chepenik LG, 2010, PSYCHIAT RES-NEUROIM, V182, P207, DOI 10.1016/j.pscychresns.2010.04.002; CLARK DM, 1982, J ABNORM PSYCHOL, V91, P87, DOI 10.1037/0021-843X.91.2.87; Clark L, 2002, BRIT J PSYCHIAT, V180, P313, DOI 10.1192/bjp.180.4.313; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Delvecchio G, 2012, EUR NEUROPSYCHOPHARM, V22, P100, DOI 10.1016/j.euroneuro.2011.07.003; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haznedar MM, 2005, BIOL PSYCHIAT, V57, P733, DOI 10.1016/j.biopsych.2005.01.002; Hebb Donald O., 1949, ORG BEHAV; Hwang J, 2006, AM J PSYCHIAT, V163, P276, DOI 10.1176/appi.ajp.163.2.276; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Li CT, 2012, BIPOLAR DISORD, V14, P831, DOI 10.1111/bdi.12017; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Lyoo IK, 2006, BIPOLAR DISORD, V8, P65, DOI 10.1111/j.1399-5618.2006.00284.x; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Metzger CD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00024; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Minassian A, 2004, J AFFECT DISORDERS, V82, P203, DOI 10.1016/j.jad.2003.11.010; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Ongur D, 2010, PSYCHIAT RES-NEUROIM, V183, P59, DOI 10.1016/j.pscychresns.2010.04.008; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Price JL, 2012, TRENDS COGN SCI, V16, P61, DOI 10.1016/j.tics.2011.12.011; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Sussmann JE, 2009, BIPOLAR DISORD, V11, P11, DOI 10.1111/j.1399-5618.2008.00646.x; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang F, 2009, BIOL PSYCHIAT, V66, P516, DOI 10.1016/j.biopsych.2009.03.023; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wilke M, 2004, PSYCHIAT RES-NEUROIM, V131, P57, DOI 10.1016/j.pscychresns.2004.01.004; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; ZIHL J, 1979, BRAIN, V102, P835, DOI 10.1093/brain/102.4.835; Zubieta JK, 2001, PSYCHIAT RES, V102, P9, DOI 10.1016/S0165-1781(01)00242-6	61	22	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96422	10.1371/journal.pone.0096422	http://dx.doi.org/10.1371/journal.pone.0096422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788849	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700090
J	Wang, SC; Ma, ZX; Xu, XH; Wang, Z; Sun, LX; Zhou, YH; Lin, XS; Hong, WJ; Wang, TL				Wang, Shicong; Ma, Zexu; Xu, Xiaohui; Wang, Zhen; Sun, Lixiang; Zhou, Yunhe; Lin, Xiaosi; Hong, Wanjin; Wang, Tuanlao			A Role of Rab29 in the Integrity of the Trans-Golgi Network and Retrograde Trafficking of Mannose-6-Phosphate Receptor	PLOS ONE			English	Article							RAB34 INTERACTION; ENDOSOMES; CARGO; MAINTENANCE; RETROMER; EFFECTOR; TIP47	Rab29 (also referred as Rab7L1) is a novel Rab protein, and is recently demonstrated to regulate phagocytosis and traffic from the Golgi to the lysosome. However, its roles in membrane trafficking have not been investigated extensively. Our results in this study revealed that Rab29 is associated with the trans-Golgi network (TGN), and is essential for maintaining the integrity of the TGN, because inhibition of the activity of Rab29 or depletion of Rab29 resulted in fragmentation of the TGN marked by TGN46. Expression of the dominant negative form Rab29T21N or shRNA-Rab29 also altered the distribution of mannose-6-phosphate receptor (M6PR), and interrupted the retrograde trafficking of M6PR through monitoring the endocytosis of CD8-tagged calcium dependent M6PR (cdM6PR) or calcium independent M6PR (ciM6PR), but without significant effects on the anterograde trafficking of vesicular stomatitis virus G protein (VSV-G). Our results suggest that Rab29 is essential for the integrity of the TGN and participates in the retrograde trafficking of M6PRs.	[Wang, Shicong; Ma, Zexu; Xu, Xiaohui; Wang, Zhen; Sun, Lixiang; Zhou, Yunhe; Lin, Xiaosi; Hong, Wanjin; Wang, Tuanlao] Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Hong, Wanjin] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore	Xiamen University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Wang, TL (corresponding author), Xiamen Univ, Sch Pharmaceut Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	xmuibrwtl@xmu.edu.cn	ma, zexu/AAG-1431-2019		National Natural Science Foundation of China [31071176, 30971442, 30928011]; International S & T Cooperation Program of China [2013DFG32730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S & T Cooperation Program of China	This work was supported by National Natural Science Foundation of China (No. 31071176, No. 30971442 and No. 30928011); International S & T Cooperation Program of China (No. 2013DFG32730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Brown FC, 2011, J CELL BIOL, V194, P779, DOI 10.1083/jcb.201104019; Caster AH, 2013, J BIOL CHEM, V288, P14788, DOI 10.1074/jbc.M113.453621; Chen L, 2010, MOL MEMBR BIOL, V27, P23, DOI 10.3109/09687680903417470; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; GIESELMANN V, 1995, BBA-MOL BASIS DIS, V1270, P103, DOI 10.1016/0925-4439(94)00075-2; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Hinners I, 2003, J CELL SCI, V116, P763, DOI 10.1242/jcs.00270; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Lippincott-Schwartz J, 1998, TRENDS CELL BIOL, V8, P16, DOI 10.1016/S0962-8924(97)01199-9; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Markgraf DF, 2007, FEBS LETT, V581, P2125, DOI 10.1016/j.febslet.2007.01.090; McKenzie JE, 2012, TRAFFIC, V13, P1140, DOI 10.1111/j.1600-0854.2012.01374.x; Ng EL, 2007, BIOCHEM BIOPH RES CO, V361, P751, DOI 10.1016/j.bbrc.2007.07.076; Pfeffer SR, 2013, CURR OPIN CELL BIOL; Pfeffer SR, 2009, FEBS LETT, V583, P3811, DOI 10.1016/j.febslet.2009.10.075; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Rodriguez-Gabin AG, 2010, J NEUROSCI RES, V88, P589, DOI 10.1002/jnr.22236; Rodriguez-Gabin AG, 2009, EXP CELL RES, V315, P2215, DOI 10.1016/j.yexcr.2009.03.020; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; van Ijzendoorn SCD, 2003, INT REV CYTOL, V232, P59, DOI 10.1016/S0074-7696(03)32002-9; Vieira OV, 2005, J CELL BIOL, V170, P521, DOI 10.1083/jcb.200503078; Wang TL, 2005, METHOD ENZYMOL, V403, P675, DOI 10.1016/S0076-6879(05)03058-2; Wang TL, 2002, MOL BIOL CELL, V13, P4317, DOI 10.1091/mbc.E02-05-0280; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200	36	50	53	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96242	10.1371/journal.pone.0096242	http://dx.doi.org/10.1371/journal.pone.0096242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788816	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700068
J	Manni, L; Gasparini, F; Hotta, K; Ishizuka, KJ; Ricci, L; Tiozzo, S; Voskoboynik, A; Dauga, D				Manni, Lucia; Gasparini, Fabio; Hotta, Kohji; Ishizuka, Katherine J.; Ricci, Lorenzo; Tiozzo, Stefano; Voskoboynik, Ayelet; Dauga, Delphine			Ontology for the Asexual Development and Anatomy of the Colonial Chordate Botryllus schlosseri	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; STEM-CELLS; PROTOCHORDATE ALLORECOGNITION; BLASTOGENETIC CYCLE; CIONA-INTESTINALIS; NATURAL APOPTOSIS; GENE-EXPRESSION; LIFE-SPAN; UROCHORDATE; REGENERATION	Ontologies provide an important resource to integrate information. For developmental biology and comparative anatomy studies, ontologies of a species are used to formalize and annotate data that are related to anatomical structures, their lineage and timing of development. Here, we have constructed the first ontology for anatomy and asexual development (blastogenesis) of a bilaterian, the colonial tunicate Botryllus schlosseri. Tunicates, like Botryllus schlosseri, are non-vertebrates and the only chordate taxon species that reproduce both sexually and asexually. Their tadpole larval stage possesses structures characteristic of all chordates, i.e. a notochord, a dorsal neural tube, and gill slits. Larvae settle and metamorphose into individuals that are either solitary or colonial. The latter reproduce both sexually and asexually and these two reproductive modes lead to essentially the same adult body plan. The Botryllus schlosseri Ontology of Development and Anatomy (BODA) will facilitate the comparison between both types of development. BODA uses the rules defined by the Open Biomedical Ontologies Foundry. It is based on studies that investigate the anatomy, blastogenesis and regeneration of this organism. BODA features allow the users to easily search and identify anatomical structures in the colony, to define the developmental stage, and to follow the morphogenetic events of a tissue and/or organ of interest throughout asexual development. We invite the scientific community to use this resource as a reference for the anatomy and developmental ontology of B. schlosseri and encourage recommendations for updates and improvements.	[Manni, Lucia; Gasparini, Fabio] Univ Padua, Dept Biol, Padua, Italy; [Hotta, Kohji] Keio Univ, Fac Sci & Technol, Dept Biosci & Informat, Kouhoku Ku, Yokohama, Kanagawa 223, Japan; [Ishizuka, Katherine J.; Voskoboynik, Ayelet] Inst Stem Cell Biol & Regenerat Med, Stanford, CA USA; [Ishizuka, Katherine J.; Voskoboynik, Ayelet] Hopkins Marine Stn, Stanford, CA USA; [Ricci, Lorenzo; Tiozzo, Stefano] Univ Paris 06, Sorbonne Univ, CNRS, Lab Biol Dev Villefranche Sur Mer, Villefranche Sur Mer, France; [Dauga, Delphine] Bioself Commun, Marseille, France	University of Padua; Keio University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Gasparini, F (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	fabio.gasparini@unipd.it	Tiozzo, Stefano/AAN-3099-2020; Gasparini, Fabio/F-4485-2011; Hotta, Kohji/D-1162-2014	Gasparini, Fabio/0000-0002-7574-0834; Hotta, Kohji/0000-0003-4614-7473; tiozzo, stefano/0000-0003-2822-2783; Dauga, Delphine/0000-0003-3152-1194; Manni, Lucia/0000-0003-4257-8946	MIUR PRIN Project [2009XF7TYT]; University of Padova Senior post-doc Project [GRIC120LSZ]; Marie Curie IRG [276974]; AFMTelethon [16611]; UPMC-Emergence Grant; Keio Academic Development Fund B; MEXT/JSPS KAKENHI [12844617, 12903189, 25127715]; National Institutes of Health (NIH) [RO1GM100315, RO1AG037968]; Grants-in-Aid for Scientific Research [24657164] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037968] Funding Source: NIH RePORTER	MIUR PRIN Project(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Padova Senior post-doc Project; Marie Curie IRG(European Commission); AFMTelethon(Association Francaise contre les Myopathies); UPMC-Emergence Grant; Keio Academic Development Fund B; MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project has been supported by: MIUR PRIN 2009 Project (http://www.istruzione.it, grant number 2009XF7TYT) to LM and FG, University of Padova Senior post-doc 2012 Project (http://www.unipd.it, grant number GRIC120LSZ) to FG, Marie Curie IRG (http://ec.europa.eu/research/mariecurieactions/, grant number 276974) and AFMTelethon (http://www.afm-telethon.com/, grant number 16611) to ST, UPMC-Emergence Grant (http://www.upmc.fr/) to LR, Keio Academic Development Fund B and MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/, Grant Numbers 12844617, 12903189, 25127715) to KH, National Institutes of Health (NIH) (www.nih.gov, grant numbers RO1GM100315 and RO1AG037968) to AV (Co-Investigator with Irving L Weissman PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Ballarin L, 2008, CURR PHARM DESIGN, V14, P138, DOI 10.2174/138161208783378798; Ballarin L, 2008, CELL TISSUE RES, V331, P555, DOI 10.1007/s00441-007-0513-4; BERRILL NJ, 1951, BIOL REV, V26, P456, DOI 10.1111/j.1469-185X.1951.tb01207.x; Brown FD, 2009, DEVELOPMENT, V136, P3485, DOI 10.1242/dev.037754; Brunetti R, 1969, PUBBL STAZ ZOOL NAPO, V37, P137; BURIGHEL P, 1984, CELL TISSUE RES, V235, P309; BURIGHEL P, 1971, Bollettino di Zoologia, V38, P273; BURIGHEL P, 1973, Z ZELLFORSCH MIK ANA, V145, P541, DOI 10.1007/BF00306723; BURIGHEL P, 1975, CELL TISSUE RES, V158, P481; Burighel P, 1998, J COMP NEUROL, V394, P230, DOI 10.1002/(SICI)1096-9861(19980504)394:2<230::AID-CNE7>3.0.CO;2-3; Burighel P, 1997, MICROSCOPICAL ANATOM, V15, P221; Burighel P, 1970, B ZOOL, V37, P273; Carpenter MA, 2011, BIOL BULL-US, V220, P57, DOI 10.1086/BBLv220n1p57; Casagrande Luca, 1993, Animal Biology, V2, P111; Cima F, 2010, DEV COMP IMMUNOL, V34, P272, DOI 10.1016/j.dci.2009.10.005; Cooper L, 2013, PLANT CELL PHYSIOL, V54, pE1, DOI 10.1093/pcp/pcs163; Day-Richter J, 2007, BIOINFORMATICS, V23, P2198, DOI 10.1093/bioinformatics/btm112; De Tomaso AW, 1998, GENETICS, V149, P277; De Tomaso AW, 2004, SCIENCE, V303, P977, DOI 10.1126/science.1094952; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Degasperi V, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-48; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Gasparini F, 2008, EVOL DEV, V10, P591, DOI 10.1111/j.1525-142X.2008.00274.x; Gasparini F, 2007, DEV DYNAM, V236, P719, DOI 10.1002/dvdy.21073; Gasparini F, 2013, DEV DYNAM, V242, P752, DOI 10.1002/dvdy.23957; Gasparini F, 2011, J EXP ZOOL PART B, V316B, P562, DOI 10.1002/jez.b.21431; Gasparini F, 2011, DEV GENES EVOL, V220, P329, DOI 10.1007/s00427-011-0351-y; Gaudet P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-130; Graham A, 2013, J ANAT, V222, P32, DOI 10.1111/j.1469-7580.2012.01506.x; Harris MA, 2013, BIOINFORMATICS, V29, P1671, DOI 10.1093/bioinformatics/btt266; Hellbach A, 2011, J EXP ZOOL PART A, V315A, P476, DOI 10.1002/jez.695; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Kawamura K, 2011, DEV DYNAM, V240, P299, DOI 10.1002/dvdy.22542; KOTT P, 1990, Memoirs of the Queensland Museum, V29, P1; Kott P, 1991, MEM QUEENSL MUS; Kurn U, 2011, BIOL BULL-US, V221, P43, DOI 10.1086/BBLv221n1p43; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Laird DJ, 2005, DEV DYNAM, V234, P997, DOI 10.1002/dvdy.20583; Laird DJ, 2004, DEV COMP IMMUNOL, V28, P201, DOI 10.1016/j.dci.2003.08.007; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; LAUZON RJ, 1993, CELL TISSUE RES, V272, P115, DOI 10.1007/BF00323577; Lauzon RJ, 2007, DEV BIOL, V301, P92, DOI 10.1016/j.ydbio.2006.08.055; Lauzon RJ, 2013, DEV BIOL, V374, P357, DOI 10.1016/j.ydbio.2012.11.006; Lemaire P, 2008, CURR BIOL, V18, pR620, DOI 10.1016/j.cub.2008.05.039; Manni L, 2007, DEV DYNAM, V236, P335, DOI 10.1002/dvdy.21037; MANNI L, 1993, ACTA ZOOL-STOCKHOLM, V74, P103, DOI 10.1111/j.1463-6395.1993.tb01226.x; Manni L, 2002, DEV DYNAM, V224, P303, DOI 10.1002/dvdy.10112; Manni L, 2001, EVOL DEV, V3, P297, DOI 10.1046/j.1525-142X.2001.01040.x; MANNI L, 1994, TISSUE CELL, V26, P403, DOI 10.1016/0040-8166(94)90023-X; Manni L, 1999, J COMP NEUROL, V412, P527, DOI 10.1002/(SICI)1096-9861(19990927)412:3<527::AID-CNE11>3.0.CO;2-U; Manni L, 2006, BIOESSAYS, V28, P902, DOI 10.1002/bies.20462; McKitrick TR, 2011, IMMUNITY, V34, P616, DOI 10.1016/j.immuni.2011.01.019; MILKMAN R, 1967, BIOL BULL, V132, P229, DOI 10.2307/1539891; NUNZI MG, 1979, DEV BIOL, V68, P371, DOI 10.1016/0012-1606(79)90211-2; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; Oren M, 2010, MOL IMMUNOL, V47, P2083, DOI 10.1016/j.molimm.2010.04.007; RINKEVICH B, 1992, P NATL ACAD SCI USA, V89, P3546, DOI 10.1073/pnas.89.8.3546; Rinkevich B, 2002, BIOESSAYS, V24, P730, DOI 10.1002/bies.10123; Rinkevich Y, 2013, DEV CELL, V24, P76, DOI 10.1016/j.devcel.2012.11.010; Rosner A, 2007, DEV BIOL, V304, P687, DOI 10.1016/j.ydbio.2007.01.018; Rosner A, 2009, DEV BIOL, V331, P113, DOI 10.1016/j.ydbio.2009.04.025; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; Sabbadin A., 1960, Archivio di Oceanografia e Limnologia, V12, P97; SABBADIN A, 1958, Arch Ital Anat Embriol, V63, P178; Sabbadin A., 1956, Rendiconti Accad Lincei (8), V20, P485; SABBADIN A, 1975, DEV BIOL, V46, P79, DOI 10.1016/0012-1606(75)90088-3; SABBADIN A., 1955, ARCH ITAL ANAT E EMBRIOL, V60, P33; SABBADIN A, 1971, DEV BIOL, V24, P379, DOI 10.1016/0012-1606(71)90087-X; SABBADIN A, 1962, REND ACCAD NAZ LINCE, V32, P1031; Sabbadin A, 1964, RIC SCI B 2, V47, P439; SABBADIN ARMANDO, 1955, BOLL ZOOL, V22, P243; Satoh N., 1994, DEV BIOL ASCIDIANS; Satou Y, 1999, CURR OPIN GENET DEV, V9, P542, DOI 10.1016/S0959-437X(99)00012-X; Satou Y, 2001, DEVELOPMENT, V128, P2893; SCHLUMPBERGER JM, 1984, J EXP ZOOL, V229, P401, DOI 10.1002/jez.1402290308; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Stewart-Savage J, 2001, BIOL BULL, V201, P52, DOI 10.2307/1543525; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Tassy O, 2010, GENOME RES, V20, P1459, DOI 10.1101/gr.108175.110; Tiozzo S, 2006, TISSUE CELL, V38, P193, DOI 10.1016/j.tice.2006.02.003; Tiozzo S, 2005, DEV DYNAM, V232, P468, DOI 10.1002/dvdy.20250; Tiozzo Stefano, 2008, P95, DOI 10.1007/978-1-4020-8274-0_6; Tiozzo S, 2008, DEV BIOL, V315, P243, DOI 10.1016/j.ydbio.2007.12.035; Tiozzo S, 2009, EVOL DEV, V11, P152, DOI 10.1111/j.1525-142X.2009.00316.x; Tiozzo S, 2009, DEV DYNAM, V238, P2081, DOI 10.1002/dvdy.22023; Voskoboynik A, 2002, MECH AGEING DEV, V123, P1203, DOI 10.1016/S0047-6374(02)00002-7; Voskoboynik A, 2008, CELL STEM CELL, V3, P456, DOI 10.1016/j.stem.2008.07.023; Voskoboynik A, 2007, FASEB J, V21, P1335, DOI 10.1096/fj.06-7337com; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Voskoboynik A, 2013, SCIENCE, V341, P384, DOI 10.1126/science.1238036; Watanabe H., 1953, SCI REP TOKYO BUNRIK, V7, P183; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; ZANIOLO G, 1981, Bollettino di Zoologia, V48, P169; Zaniolo G, 2002, J COMP NEUROL, V443, P124, DOI 10.1002/cne.10097; ZANIOLO G, 1987, CAN J ZOOL, V65, P1181, DOI 10.1139/z87-183; Zeng LY, 2005, CAN J ZOOL, V83, P24, DOI 10.1139/z05-010	98	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96434	10.1371/journal.pone.0096434	http://dx.doi.org/10.1371/journal.pone.0096434			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789338	gold, Green Published, Green Submitted			2022-12-27	WOS:000335510600101
J	Camargo, A; Papadopoulou, D; Spyropoulou, Z; Vlachonasios, K; Doonan, JH; Gay, AP				Camargo, Anyela; Papadopoulou, Dimitra; Spyropoulou, Zoi; Vlachonasios, Konstantinos; Doonan, John H.; Gay, Alan P.			Objective Definition of Rosette Shape Variation Using a Combined Computer Vision and Data Mining Approach	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LEAF GROWTH; MODEL; GROWSCREEN; TRAITS; IMAGE	Computer-vision based measurements of phenotypic variation have implications for crop improvement and food security because they are intrinsically objective. It should be possible therefore to use such approaches to select robust genotypes. However, plants are morphologically complex and identification of meaningful traits from automatically acquired image data is not straightforward. Bespoke algorithms can be designed to capture and/or quantitate specific features but this approach is inflexible and is not generally applicable to a wide range of traits. In this paper, we have used industry-standard computer vision techniques to extract a wide range of features from images of genetically diverse Arabidopsis rosettes growing under non-stimulated conditions, and then used statistical analysis to identify those features that provide good discrimination between ecotypes. This analysis indicates that almost all the observed shape variation can be described by 5 principal components. We describe an easily implemented pipeline including image segmentation, feature extraction and statistical analysis. This pipeline provides a cost-effective and inherently scalable method to parameterise and analyse variation in rosette shape. The acquisition of images does not require any specialised equipment and the computer routines for image processing and data analysis have been implemented using open source software. Source code for data analysis is written using the R package. The equations to calculate image descriptors have been also provided.	[Camargo, Anyela; Doonan, John H.; Gay, Alan P.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales; [Papadopoulou, Dimitra; Spyropoulou, Zoi; Vlachonasios, Konstantinos] Aristotle Univ Thessaloniki, Fac Sci, Sch Biol, Dept Bot, GR-54006 Thessaloniki, Greece	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Aristotle University of Thessaloniki	Doonan, JH (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales.	john.doonan@aber.ac.uk; abg@aber.ac.uk		doonan, john/0000-0001-6027-1919; Vlachonasios, Konstantinos/0000-0003-1755-1645	Biological and Biosciences Research Council; Welsh Government; BBSRC [BBS/E/W/10962A01D, BBS/E/W/10961A01] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10961A01, BBS/E/W/10962A01D] Funding Source: researchfish	Biological and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Welsh Government; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by the Biological and Biosciences Research Council and the Welsh Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson S, 2011, NEW PHYTOL, V191, P895, DOI 10.1111/j.1469-8137.2011.03756.x; Bensmihen S, 2008, HFSP J, V2, P110, DOI 10.2976/1.2836738; Casler MD, 2006, CROP SCI, V46, P1277, DOI 10.2135/cropsci2005.0196; Clark RT, 2011, PLANT PHYSIOL, V156, P455, DOI 10.1104/pp.110.169102; Cote JF, 2012, AGR FOREST METEOROL, V166, P72, DOI 10.1016/j.agrformet.2012.06.007; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Devlin PF, 1996, PLANT J, V10, P1127, DOI 10.1046/j.1365-313X.1996.10061127.x; Ferrier T, 2011, CURR OPIN BIOTECH, V22, P260, DOI 10.1016/j.copbio.2010.11.010; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Herridge RP, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-3; Hoffmann MH, 2002, J BIOGEOGR, V29, P125, DOI 10.1046/j.1365-2699.2002.00647.x; Ikram S, 2012, J EXP BOT, V63, P91, DOI 10.1093/jxb/err244; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; Juenger T, 2005, EVOL DEV, V7, P259, DOI 10.1111/j.1525-142X.2005.05028.x; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Kover PX, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000551; LemnaTec, 2010, LEMNALAUNCHER IM AN, P112; Perez-Perez JM, 2011, PLANT CELL ENVIRON, V34, P2200, DOI 10.1111/j.1365-3040.2011.02415.x; Massonnet C, 2010, PLANT PHYSIOL, V152, P2142, DOI 10.1104/pp.109.148338; Octave community, 2014, GNU OCT 3 8; Paproki A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-63; Passardi F, 2007, J PLANT PHYSIOL, V164, P980, DOI 10.1016/j.jplph.2006.06.008; Pinheiro J, 2001, MIXED EFFECTS MODELS; Preuss D, 2002, ARABIDOPSIS LAB MANU; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robnik-Sikonja M., 1997, MACHINE LEARNING P 1, P296, DOI [10.5555/645526.657141, DOI 10.1119/1.880454]; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scilab Enterprises, 2012, SCIL FREE OP SOURC S; Somerville C, 2002, NAT REV GENET, V3, P883, DOI 10.1038/nrg927; The MathWorks Inc, 2012, MATLAB STAT TOOLB RE; Walter A, 2007, NEW PHYTOL, V174, P447, DOI 10.1111/j.1469-8137.2007.02002.x; Weight C, 2008, PLANT J, V53, P578, DOI 10.1111/j.1365-313X.2007.03330.x; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6	37	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96889	10.1371/journal.pone.0096889	http://dx.doi.org/10.1371/journal.pone.0096889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804972	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900112
J	Lencova-Popelova, O; Jirkovsky, E; Mazurova, Y; Lenco, J; Adamcova, M; Simunek, T; Gersl, V; Sterba, M				Lencova-Popelova, Olga; Jirkovsky, Eduard; Mazurova, Yvona; Lenco, Juraj; Adamcova, Michaela; Simunek, Tomas; Gersl, Vladimir; Sterba, Martin			Molecular Remodeling of Left and Right Ventricular Myocardium in Chronic Anthracycline Cardiotoxicity and Post-Treatment Follow Up	PLOS ONE			English	Article							GENE-EXPRESSION; HEART-FAILURE; INDUCED CARDIOMYOPATHY; ANIMAL-MODELS; RABBIT MODEL; LIGHT-CHAIN; IN-VIVO; DOXORUBICIN; CELLS; CARDIOMYOCYTES	Chronic anthracycline cardiotoxicity is a serious clinical issue with well characterized functional and histopathological hallmarks. However, molecular determinants of the toxic damage and associated myocardial remodeling remain to be established. Furthermore, details on the different propensity of the left and right ventricle (LV and RV, respectively) to the cardiotoxicity development are unknown. Hence, the aim of the investigation was to study molecular changes associated with remodeling of the LV and RV in chronic anthracycline cardiotoxicity and post- treatment follow up. The cardiotoxicity was induced in rabbits with daunorubicin (3 mg/kg/week for 10 weeks) and animals were sacrificed either at the end of the treatment or after an additional 10 weeks. Daunorubicin induced severe and irreversible cardiotoxicity associated with LV dysfunction and typical morphological alterations, whereas the myocardium of the RV showed only mild changes. Both ventricles also showed different expression of ANP after daunorubicin treatment. Daunorubicin impaired the expression of several sarcomeric proteins in the LV, which was not the case of the RV. In particular, a significant drop was found in titin and thick filament proteins at both mRNA and protein level and this might be connected with persistent LV down-regulation of GATA-4. In addition, the LV was more affected by treatment-induced perturbations in calcium handling proteins. LV cardiomyocytes showed marked up-regulation of desmin after the treatment and vimentin was mainly induced in LV fibroblasts, whereas only weaker changes were observed in the RV. Remodeling of extracellular matrix was almost exclusively found in the LV with particular induction of collagen I and IV. Hence, the present study describes profound molecular remodeling of myocytes, non-myocyte cells and extracellular matrix in response to chronic anthracycline treatment with marked asymmetry between LV and RV.	[Lencova-Popelova, Olga; Jirkovsky, Eduard; Gersl, Vladimir; Sterba, Martin] Charles Univ Prague, Fac Med Hradec Kralove, Dept Pharmacol, Hradec Kralove, Czech Republic; [Mazurova, Yvona] Charles Univ Prague, Fac Med Hradec Kralove, Dept Histol & Embryol, Hradec Kralove, Czech Republic; [Lenco, Juraj] Univ Def, Fac Mil Hlth Sci, Inst Mol Pathol, Hradec Kralove, Czech Republic; [Lenco, Juraj; Simunek, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Biochem Sci, Hradec Kralove, Czech Republic; [Adamcova, Michaela] Charles Univ Prague, Fac Med Hradec Kralove, Dept Physiol, Hradec Kralove, Czech Republic	Charles University Prague; University Hospital Hradec Kralove; Charles University Prague; University Hospital Hradec Kralove; University of Defence - Czech Republic; Charles University Prague; Charles University Prague; University Hospital Hradec Kralove	Sterba, M (corresponding author), Charles Univ Prague, Fac Med Hradec Kralove, Dept Pharmacol, Hradec Kralove, Czech Republic.	sterbam@lfhk.cuni.cz	Sterba, Martin/E-8123-2017; Jirkovsky, Eduard/A-7297-2017; Lenčo, Juraj/AAL-4281-2020; Simunek, Tomas/A-3938-2008; Lenčová, Olga/D-8278-2017; Adamcova, Michaela/A-6672-2017	Jirkovsky, Eduard/0000-0003-4286-4811; Simunek, Tomas/0000-0001-5464-4176; Lenčová, Olga/0000-0001-7178-8470; Adamcova, Michaela/0000-0003-3320-9735; Lenco, Juraj/0000-0002-8526-9249	European Social Fund and the state budget of the Czech Republic [CZ. 1.07/2.3.00/30.0022]; Internal Grant Agency of the Ministry of Health of the Czech Republic [NT13457-4-2012]; Charles University Research Program PRVOUK [P37/05]	European Social Fund and the state budget of the Czech Republic; Internal Grant Agency of the Ministry of Health of the Czech Republic; Charles University Research Program PRVOUK	This study was funded by the European Social Fund and the state budget of the Czech Republic (Project No. CZ. 1.07/2.3.00/30.0022), by the Internal Grant Agency of the Ministry of Health of the Czech Republic (Project No. NT13457-4-2012) and by the Charles University Research Program PRVOUK (P37/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai M, 1998, J MOL CELL CARDIOL, V30, P243, DOI 10.1006/jmcc.1997.0588; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Berry GJ, 2005, PEDIATR BLOOD CANCER, V44, P630, DOI 10.1002/pbc.20346; BILLINGHAM ME, 1978, CANCER TREAT REP, V62, P865; Boucek RJ, 1999, J MOL CELL CARDIOL, V31, P1435; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; CHAPMAN D, 1990, CIRC RES, V67, P787, DOI 10.1161/01.RES.67.4.787; Chen B, 2012, PLOS ONE, V7, DOI DOI 10.1056/NEJMoa1716984; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; De Beer EL, 2000, MOL PHARMACOL, V57, P1152; EGHBALI M, 1988, J MOL CELL CARDIOL, V20, P267, DOI 10.1016/S0022-2828(88)80059-2; Ewer MS, 2006, CANC HEART, P9; Goldstein JA, 2002, J AM COLL CARDIOL, V40, P841, DOI 10.1016/S0735-1097(02)02048-X; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Herman EH, 1998, SEMIN ONCOL, V25, P15; Hernandez OM, 2007, AM J PHYSIOL-HEART C, V292, pH1643, DOI 10.1152/ajpheart.00931.2006; Institute of Laboratory Animal Resources CoLS National Research Council, 1996, GUIDE CARE USE LAB A; ITO H, 1990, P NATL ACAD SCI USA, V87, P4275, DOI 10.1073/pnas.87.11.4275; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Jones RL, 2006, EXPERT OPIN DRUG SAF, V5, P791, DOI 10.1517/14740338.5.6.791; Kim Y, 2003, MOL PHARMACOL, V63, P368, DOI 10.1124/mol.63.2.368; Kobayashi S, 2010, J BIOL CHEM, V285, P793, DOI 10.1074/jbc.M109.070037; Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Luchner A, 2001, CARDIOVASC RES, V51, P601, DOI 10.1016/S0008-6363(01)00316-9; Makarenko I, 2004, CIRC RES, V95, P708, DOI 10.1161/01.RES.0000143901.37063.2f; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Milani-Nejad N, 2014, PHARMACOL THERAPEUT, V141, P235, DOI 10.1016/j.pharmthera.2013.10.007; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Moretti A, 2002, P NATL ACAD SCI USA, V99, P11860, DOI 10.1073/pnas.182373099; Palumbo A, 2008, ANN ONCOL, V19, P1160, DOI 10.1093/annonc/mdn018; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popelova O, 2009, BRIT J CANCER, V101, P792, DOI 10.1038/sj.bjc.6605192; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; RHODEN W, 1993, BRIT HEART J, V70, P499; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Simunek T, 2004, EUR J HEART FAIL, V6, P377, DOI 10.1016/j.ejheart.2003.05.003; Simunek T, 2005, BIOMETALS, V18, P163, DOI 10.1007/s10534-004-4491-7; Sterba M, 2013, ANTIOXID REDOX SIGN, V18, P899, DOI 10.1089/ars.2012.4795; Sterba M, 2011, J MOL CELL CARDIOL, V50, P849, DOI 10.1016/j.yjmcc.2011.01.018; TATSUMI R, 1995, ANAL BIOCHEM, V224, P28, DOI 10.1006/abio.1995.1004; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; VANVLEET JF, 1980, AM J VET RES, V41, P1462; VANVLEET JF, 1980, AM J PATHOL, V99, P13; Vejpongsa P, 2014, CLIN PHARMACOL THER, V95, P45, DOI 10.1038/clpt.2013.201; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Walker LA, 2009, CURR CARDIOL REV, V5, P22, DOI 10.2174/157340309787048077; Yi XM, 2006, AM J PHYSIOL-HEART C, V290, pH1098, DOI 10.1152/ajpheart.00832.2005; Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE	51	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96055	10.1371/journal.pone.0096055	http://dx.doi.org/10.1371/journal.pone.0096055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804796	gold, Green Published, Green Submitted			2022-12-27	WOS:000335728900034
J	Van Kampen, JM; Baranowski, D; Kay, DG				Van Kampen, Jackalina M.; Baranowski, David; Kay, Denis G.			Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; CELL APOPTOSIS; HOST-DEFENSE; EXPRESSION; MUTATIONS; DEFICIENCY; INCLUSIONS; TOXICITY	Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by tremor, rigidity and akinesia/bradykinesia resulting from the progressive loss of nigrostriatal dopaminergic neurons. To date, only symptomatic treatment is available for PD patients, with no effective means of slowing or stopping the progression of the disease. Progranulin (PGRN) is a 593 amino acid multifunction protein that is widely distributed throughout the CNS, localized primarily in neurons and microglia. PGRN has been demonstrated to be a potent regulator of neuroinflammation and also acts as an autocrine neurotrophic factor, important for long-term neuronal survival. Thus, enhancing PGRN expression may strengthen the cells resistance to disease. In the present study, we have used the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of PD to investigate the possible use of PGRN gene delivery as a therapy for the prevention or treatment of PD. Viral vector delivery of the PGRN gene was an effective means of elevating PGRN expression in nigrostriatal neurons. When PGRN expression was elevated in the SNC, nigrostriatal neurons were protected from MPTP toxicity in mice, along with a preservation of striatal dopamine content and turnover. Further, protection of nigrostriatal neurons by PGRN gene therapy was accompanied by reductions in markers of MPTP-induced inflammation and apoptosis as well as a complete preservation of locomotor function. We conclude that PGRN gene therapy may have beneficial effects in the treatment of PD.	[Van Kampen, Jackalina M.; Baranowski, David; Kay, Denis G.] Neurodyn Inc, Charlottetown, PE, Canada; [Van Kampen, Jackalina M.] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada; [Kay, Denis G.] Univ Prince Edward Isl, Dept Pathol & Microbiol, Charlottetown, PE, Canada	University of Prince Edward Island; University of Prince Edward Island	Van Kampen, JM (corresponding author), Neurodyn Inc, Charlottetown, PE, Canada.	jvankampen@neurodyn.ca		Baranowski, David/0000-0002-5372-7727	Michael J. Fox Foundation; Neurodyn Inc.	Michael J. Fox Foundation; Neurodyn Inc.	This work was funded by the Michael J. Fox Foundation (https://www.michaeljfox.org/). Neurodyn Inc., provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.10.1436817, 10.1358/dnp.2009.22.10.1443391]; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cruts Marc, 2006, Current Alzheimer Research, V3, P485, DOI 10.2174/156720506779025251; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Dun YY, 2012, NEUROSCI LETT, V525, P83, DOI 10.1016/j.neulet.2012.07.030; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; FRIM DM, 1994, P NATL ACAD SCI USA, V91, P5104, DOI 10.1073/pnas.91.11.5104; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Guo A, 2010, BRAIN RES; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Irwin D, 2009, J NEUROL SCI, V276, P9, DOI 10.1016/j.jns.2008.08.024; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kang KA, 2010, INT J MOL SCI, V11, P4348, DOI 10.3390/ijms11114348; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kelley BJ, 2007, NEUROBIOLOGY AGING; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kumar-Singh S, 2011, J MOL NEUROSCI, V45, P561, DOI 10.1007/s12031-011-9625-0; L'Episcopo F, 2011, NEUROBIOL DIS, V41, P508, DOI 10.1016/j.nbd.2010.10.023; L'Episcopo F, 2012, J NEUROSCI, V32, P2062, DOI 10.1523/JNEUROSCI.5259-11.2012; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; Monami G, 2006, CANCER RES, V66, P7103, DOI 10.1158/0008-5472.CAN-06-0633; Nedachi T, 2011, NEUROSCIENCE, V185, P106, DOI 10.1016/j.neuroscience.2011.04.037; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Olanow CW, 2005, MOVEMENT DISORD, V20, pS3, DOI 10.1002/mds.20457; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petoukhov E, 2013, J CELL SCI, V126, P5412, DOI 10.1242/jcs.132076; Piscopo P, 2010, NEUROCHEM INT, V57, P893, DOI 10.1016/j.neuint.2010.09.008; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Qin R, 2011, TOXICOL LETT, V202, P1, DOI 10.1016/j.toxlet.2011.01.001; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; SPINA MB, 1992, J NEUROCHEM, V59, P99, DOI 10.1111/j.1471-4159.1992.tb08880.x; Tao J, 2012, BRAIN RES, V1436, P130, DOI 10.1016/j.brainres.2011.11.063; Tapia L, 2011, J NEUROSCI, V31, P11126, DOI 10.1523/JNEUROSCI.6244-10.2011; Tauffenberger A, 2013, HUM MOL GENET, V22, P782, DOI 10.1093/hmg/dds485; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	62	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e97032	10.1371/journal.pone.0097032	http://dx.doi.org/10.1371/journal.pone.0097032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804730	Green Published, Green Submitted, gold			2022-12-27	WOS:000335728900130
J	Bollinger, L; Adesina, A; Forsythe, S; Godbole, R; Reuben, E; Njeuhmeli, E				Bollinger, Lori; Adesina, Adebiyi; Forsythe, Steven; Godbole, Ramona; Reuben, Elan; Njeuhmeli, Emmanuel			Cost Drivers for Voluntary Medical Male Circumcision Using Primary Source Data from Sub-Saharan Africa	PLOS ONE			English	Article							HIV PREVENTION; MEN	Background: As voluntary medical male circumcision (VMMC) programs scale up, there is a pressing need for information about the important cost drivers, and potential efficiency gains. We examine those cost drivers here, and estimate the potential efficiency gains through an econometric model. Methods and Findings: We examined the main cost drivers (i.e., personnel and consumables) associated with providing VMMC in sub-Saharan Africa along a number of dimensions, including facility type and service provider. Primary source facility level data from Kenya, Namibia, South Africa, Tanzania, Uganda, and Zambia were utilized throughout. We estimated the efficiency gains by econometrically estimating a cost function in order to calculate the impact of scale and other relevant factors. Personnel and consumables were estimated at 36% and 28%, respectively, of total costs across countries. Economies of scale (EOS) is estimated to be eight at the median volume of VMMCs performed, and EOS falls from 23 at the 25th percentile volume of VMMCs performed to 5.1 at the 75th percentile. Conclusions: The analysis suggests that there is significant room for efficiency improvement as indicated by declining EOS as VMMC volume increases. The scale of the fall in EOS as VMMC volume increases suggests that we are still at the ascension phase of the scale-up of VMMC, where continuing to add new sites results in additional start-up costs as well. A key aspect of improving efficiency is task sharing VMMC procedures, due to the large percentage of overall costs associated with personnel costs. In addition, efficiency improvements in consumables are likely to occur over time as prices and distribution costs decrease.	[Bollinger, Lori; Adesina, Adebiyi; Forsythe, Steven; Godbole, Ramona] Hlth Policy Initiat Costing Task Order, Washington, DC USA; [Bollinger, Lori; Adesina, Adebiyi; Forsythe, Steven; Godbole, Ramona] Hlth Policy Project, Washington, DC USA; [Bollinger, Lori; Adesina, Adebiyi; Forsythe, Steven] Futures Inst, Glastonbury, CT USA; [Godbole, Ramona] Futures Grp Inc, Washington, DC USA; [Godbole, Ramona; Reuben, Elan; Njeuhmeli, Emmanuel] US Agcy Int Dev, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Bollinger, L (corresponding author), Hlth Policy Initiat Costing Task Order, Washington, DC USA.	lbollinger@futuresinstitute.org	Forsythe, Steven/AAL-7558-2020	Forsythe, Steven/0000-0002-4409-5991	U. S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U. S. Agency for International Development (USAID) | Health Policy Initiative Costing Task Order [GPO-I-00-05-00040-00]; Health Policy Project; U.S. Agency for International Development [AID-OAA- A-10-00067]; PEPFAR	U. S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U. S. Agency for International Development (USAID) | Health Policy Initiative Costing Task Order; Health Policy Project; U.S. Agency for International Development(United States Agency for International Development (USAID)); PEPFAR	Funding support for this work was provided by the U. S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U. S. Agency for International Development (USAID) | Health Policy Initiative Costing Task Order, contract number GPO-I-00-05-00040-00, beginning July 1, 2010. The Costing Task Order is implemented by Futures Group, in collaboration with the Futures Institute and the Centre for Development and Population Activities. The funder played a significant technical role in study design, analysis, decision to publish and preparation of the manuscript. Funding support was also provided through The Health Policy Project. The Health Policy Project is a five-year cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA- A-10-00067, beginning September 30, 2010. The project's HIV activities are supported by PEPFAR. It is implemented by Futures Group, in collaboration with CEDPA (part of Plan International USA), Futures Institute, Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International and the White Ribbon Alliance for Safe Motherhood (WRA). The information provided in this document is not official U. S. Government information and does not necessarily represent the views or positions of USAID.	[Anonymous], 2013, AFR DEV IND 2012 201; [Anonymous], 2012, GLOB REP UNAIDS REP; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barnum H., 1993, PUBLIC HOSP DEV COUN; Bertrand J. T., 2013, SYSTEMATIC MONITORIN; Bertrand JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027562; Bollinger L, 2009, MALE CIRCUMCISION DE; Bratt JH, 2013, JAIDS-J ACQ IMM DEF, V63, pE109, DOI 10.1097/QAI.0b013e31828e9526; Bureau of Economic Analysis, 2013, NAT INC ACC; Caro JJ, 2010, HEALTH ECON, V19, P1117, DOI 10.1002/hec.1629; Cummings B, 2012, EFFECTIVENESS TASK S; Duffy K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063134; Edgil D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001128; Ford N, 2012, AIDS, V26, P559, DOI 10.1097/QAD.0b013e32834f3264; Forsythe S, 2013, COMMUNICATION; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Kamae MS, 2011, J MED ECON, V14, P187, DOI 10.3111/13696998.2011.557111; Male Circumcision Decision-Makers' Program Planning Tool (DMPPT), 2010, MOD MAN; Menzies NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048726; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Stata Corp, 2012, STAT STAT SOFTW REL; Tumwesigye NM, 2013, AJAR-AFR J AIDS RES, V12, P61, DOI 10.2989/16085906.2013.815416; Weaver M, 2004, SOC SCI MED, V59, P199, DOI 10.1016/j.socscimed.2003.10.014; World Health Organization (WHO), 2010, CONS IMPL MOD OPT VO	27	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e84701	10.1371/journal.pone.0084701	http://dx.doi.org/10.1371/journal.pone.0084701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802593	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800012
J	Feng, JY; He, WF; Song, YJ; Wang, Y; Simpson, RJ; Zhang, XR; Luo, GX; Wu, J; Huang, CB				Feng, Jiayu; He, Weifeng; Song, Yajun; Wang, Ying; Simpson, Richard J.; Zhang, Xiaorong; Luo, Gaoxing; Wu, Jun; Huang, Chibing			Platelet-Derived Growth Factor Receptor Beta: A Novel Urinary Biomarker for Recurrence of Non-Muscle-Invasive Bladder Cancer	PLOS ONE			English	Article							PROTEOMICS; EXPRESSION; PROTEINS	Non-muscle-invasive bladder cancer (NMIBC) is one of the most common malignant tumors in the urological system with a high risk of recurrence, and effective non-invasive biomarkers for NMIBC relapse are still needed. The human urinary proteome can reflect the status of the microenvironment of the urinary system and is an ideal source for clinical diagnosis of urinary system diseases. Our previous work used proteomics to identify 1643 high-confidence urinary proteins in the urine from a healthy population. Here, we used bioinformatics to construct a cancer-associated protein-protein interaction (PPI) network comprising 16 high-abundance urinary proteins based on the urinary proteome database. As a result, platelet-derived growth factor receptor beta (PDGFRB) was selected for further validation as a candidate biomarker for NMIBC diagnosis and prognosis. Although the levels of urinary PDGFRB showed no significant difference between patients pre- and post-surgery (n = 185, P>0.05), over 3 years of follow-up, urinary PDGFRB was shown to be significantly higher in relapsed patients (n = 68) than in relapse-free patients (n = 117, P<0.001). The levels of urinary PDGFRB were significantly correlated with the risk of 3-year recurrence of NMIBC, and these levels improved the accuracy of a NMIBC recurrence risk prediction model that included age, tumor size, and tumor number (area under the curve, 0.862; 95% CI, 0.809 to 0.914) compared to PDGFR alone. Therefore, we surmise that urinary PDGFRB could serve as a non-invasive biomarker for predicting NMIBC recurrence.	[Feng, Jiayu; Song, Yajun; Huang, Chibing] Third Mil Med Univ, Xinqiao Hosp, Dept Urol, Chongqing, Peoples R China; [He, Weifeng; Wang, Ying; Zhang, Xiaorong; Luo, Gaoxing; Wu, Jun] Third Mil Med Univ, Southwest Hosp, Chongqing Key Lab Dis Prote, Inst Burn Res, Chongqing, Peoples R China; [He, Weifeng; Wang, Ying; Zhang, Xiaorong; Luo, Gaoxing; Wu, Jun] Third Mil Med Univ, Southwest Hosp, State Key Lab Trauma Burns & Combined Injury, Inst Burn Res, Chongqing, Peoples R China; [Simpson, Richard J.] La Trobe Univ, Dept Biochem, La Trobe Inst Mol Sci, Bundoora, Vic 3083, Australia	Army Medical University; Army Medical University; Army Medical University; La Trobe University	Wu, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Chongqing Key Lab Dis Prote, Inst Burn Res, Chongqing, Peoples R China.	junwupro1@aliyun.com; huangchibing@medmail.com.cn	Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209; Simpson, Richard/0000-0002-9834-0796	Chongqing Key Laboratory for Disease Proteomics Project	Chongqing Key Laboratory for Disease Proteomics Project	This work was supported by the Chongqing Key Laboratory for Disease Proteomics Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Black PC, 2011, J UROLOGY, V185, P693, DOI 10.1016/j.juro.2010.09.082; Cheung G, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-13; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Fauconnet S, 2009, ONCOL REP, V21, P1495, DOI 10.3892/or_00000380; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; He WF, 2012, PROTEOMICS, V12, P1059, DOI 10.1002/pmic.201100400; Kentsis A, 2009, PROTEOM CLIN APPL, V3, P1052, DOI 10.1002/prca.200900008; Laxman B, 2008, CANCER RES, V68, P645, DOI 10.1158/0008-5472.CAN-07-3224; Li QR, 2010, RAPID COMMUN MASS SP, V24, P823, DOI 10.1002/rcm.4441; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Marzioni D, 2009, INT J IMMUNOPATH PH, V22, P627, DOI 10.1177/039463200902200308; Mason RA, 2009, CARCINOGENESIS, V30, P1155, DOI 10.1093/carcin/bgp077; Nagaraj N, 2011, J PROTEOME RES, V10, P637, DOI 10.1021/pr100835s; NEAL DE, 1985, LANCET, V1, P366; Proctor I, 2010, HISTOPATHOLOGY, V57, P1, DOI 10.1111/j.1365-2559.2010.03592.x; Ranzato E, 2013, BURNS TRAUMA, V1, DOI 10.4103/2321-3868.113333; Risk Michael C, 2009, Curr Urol Rep, V10, P179; Roobol MJ, 2011, ACTA ONCOL, V50, P85, DOI 10.3109/0284186X.2010.524935; Shao C, 2011, SCI CHINA LIFE SCI; Smith ZL, 2013, BJU INT, V112, P13, DOI 10.1111/j.1464-410X.2012.11762.x; Sun W, DYNAMIC URINARY PROT; Tamborini E, 2010, NEURO-ONCOLOGY, V12, P776, DOI 10.1093/neuonc/noq003; Theodorescu D, 1998, CELL GROWTH DIFFER, V9, P919; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Thongboonkerd V, 2006, J PROTEOME RES, V5, P183, DOI 10.1021/pr0502525	28	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96671	10.1371/journal.pone.0096671	http://dx.doi.org/10.1371/journal.pone.0096671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801713	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800107
J	Hoan, RP; Ormond, RA; Barton, KE				Hoan, Ryan P.; Ormond, Rhys A.; Barton, Kasey E.			Prickly Poppies Can Get Pricklier: Ontogenetic Patterns in the Induction of Physical Defense Traits	PLOS ONE			English	Article							ARGEMONE-MEXICANA L.; PHENOTYPIC PLASTICITY; PLANT DEFENSE; LEAF TOUGHNESS; HERBIVORY; TOLERANCE; TRICHOMES; LIFE; RESISTANCE; EVOLUTION	Plant ontogeny is a common source of variation in defense and herbivory. Yet, few studies have investigated how the induction of physical defense traits changes across plant ontogeny. Physical defense traits are costly to produce, and thus, it was predicted that induction as a cost-saving strategy would be particularly favorable for seedlings, leading to ontogenetic declines in the inducibility of these traits. We tested for induction of three different physical defense traits (prickles, latex and leaf toughness) in response to mechanical defoliation and jasmonic acid application using prickly poppies (Argemone glauca and A. mexicana, Papaveraceae) as a model system. Genetic variation in the induction of physical defenses was tested using maternal sib-ships sampled from multiple populations. Both species induced higher densities of laminar prickles, although the magnitude of induction was much higher in the endemic Hawaiian prickly poppy, A. glauca, than in the cosmopolitan A. mexicana. The magnitude of prickle induction was also higher in young compared to older juvenile plant stages in A. glauca, demonstrating a strong role of ontogeny. Neither latex exudation nor leaf toughness was induced in either species. Although significant genetic variation was detected within and among populations for constitutive expression of physical defense traits in Argemone, there was no evidence for genetic variation in the induction of these traits. This study provides the first evidence for the induction of physical defenses in prickly poppies, emphasizing how an ontogenetically explicit framework can reveal new insights into plant defense. Moreover, this study illustrates how sister species comparisons between island vs. continental plants can provide new insights into plant functional and evolutionary ecology, highlighting a fruitful area for future research on more species pairs.	[Hoan, Ryan P.; Barton, Kasey E.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Ormond, Rhys A.] Willamette Univ, Dept Biol, Salem, OR 97301 USA	University of Hawaii System; University of Hawaii Manoa; Willamette University	Barton, KE (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	kbarton@hawaii.edu			College of Natural Sciences, University of Hawaii at Manoa	College of Natural Sciences, University of Hawaii at Manoa	Funding was provided by the College of Natural Sciences, University of Hawaii at Manoa to KEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2002, EVOLUTION, V56, P2206, DOI 10.1111/j.0014-3820.2002.tb00145.x; Agrawal AA, 2006, ECOLOGY, V87, pS132, DOI 10.1890/0012-9658(2006)87[132:PDS]2.0.CO;2; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; Agrawall AA, 2012, TRENDS PLANT SCI, V17, P239, DOI 10.1016/j.tplants.2012.03.011; Baldwin R. E., 1979, HAWAIIS POISONOUS PL; Barton KE, 2014, OECOLOGIA, V174, P1273, DOI 10.1007/s00442-013-2836-z; Barton KE, 2013, ANN BOT-LONDON, V112, P711, DOI 10.1093/aob/mct083; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; BAUR R, 1991, OECOLOGIA, V87, P219, DOI 10.1007/BF00325259; BAZELY DR, 1991, OIKOS, V61, P327, DOI 10.2307/3545240; Benz BW, 2006, J PLANT PHYSIOL, V163, P648, DOI 10.1016/j.jplph.2005.05.008; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2005, AM J BOT, V92, P1632, DOI 10.3732/ajb.92.10.1632; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Bowen L, 1997, CONSERV BIOL, V11, P1249, DOI 10.1046/j.1523-1739.1997.96368.x; Carlquist S., 1970, HAWAII NATURAL HIST; Cipollini D., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105005; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Cunningham SA, 1999, ECOL MONOGR, V69, P569, DOI 10.1890/0012-9615(1999)069[0569:EDILSA]2.0.CO;2; Funk JL, 2010, OECOLOGIA, V162, P815, DOI 10.1007/s00442-009-1497-4; GIVNISH TJ, 1994, P NATL ACAD SCI USA, V91, P2810, DOI 10.1073/pnas.91.7.2810; GOEDEN RD, 1985, ANN ENTOMOL SOC AM, V78, P214, DOI 10.1093/aesa/78.2.214; Gomez JM, 2002, ECOLOGY, V83, P885, DOI 10.1890/0012-9658(2002)083[0885:TAIMDI]2.0.CO;2; Gowda JH, 1997, FUNCT ECOL, V11, P106, DOI 10.1046/j.1365-2435.1997.00065.x; Hagel JM, 2008, TRENDS PLANT SCI, V13, P631, DOI 10.1016/j.tplants.2008.09.005; Hanley ME, 2007, PERSPECT PLANT ECOL, V8, P157, DOI 10.1016/j.ppees.2007.01.001; Heil M, 2012, PLOS ONE, V7, P9; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Holeski LM, 2010, AM NAT, V175, P391, DOI 10.1086/651300; James HF, 1997, BIOL J LINN SOC, V62, P279, DOI 10.1111/j.1095-8312.1997.tb01627.x; Joe SM, 2008, BIOL INVASIONS, V10, P245, DOI 10.1007/s10530-007-9126-9; Jordan GJ, 2005, AM J BOT, V92, P789, DOI 10.3732/ajb.92.5.789; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kitajima K, 2012, NEW PHYTOL, V195, P640, DOI 10.1111/j.1469-8137.2012.04203.x; Kitajima K, 2010, NEW PHYTOL, V186, P708, DOI 10.1111/j.1469-8137.2010.03212.x; Koricheva J, 2012, ECOL REV, P34; Liakopoulos G, 2006, ANN BOT-LONDON, V98, P257, DOI 10.1093/aob/mcl097; Lilleeng-Rosenberger K.E., 2005, GROWING HAWAIIS NATI; Massad TJ, 2013, OECOLOGIA, V172, P1, DOI 10.1007/s00442-012-2470-1; Melendez PA, 2002, ANN TROP MED PARASIT, V96, P209, DOI 10.1179/000349802125000600; Muola A, 2010, J EVOLUTION BIOL, V23, P2185, DOI 10.1111/j.1420-9101.2010.02077.x; Neal M.C., 1965, GARDENS HAWAII, VFirst; Osho A, 2010, J MED PLANTS RES, V4, P19; Penuelas J, 2010, J CHEM ECOL, V36, P1255, DOI 10.1007/s10886-010-9862-7; Pigliucci M, 1998, CURR OPIN PLANT BIOL, V1, P87, DOI 10.1016/S1369-5266(98)80133-7; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; Quintero C, 2013, PERSPECT PLANT ECOL, V15, P245, DOI 10.1016/j.ppees.2013.08.003; Rasmann S, 2009, J CHEM ECOL, V35, P1326, DOI 10.1007/s10886-009-9719-0; Sakthivadivel M, 2003, BIORESOURCE TECHNOL, V89, P213, DOI 10.1016/S0960-8524(03)00038-5; Sardans J, 2010, J CHEM ECOL, V36, P210, DOI 10.1007/s10886-010-9744-z; Schaller A, 2010, INDUCED PLANT RESIST; Schwarzbach AE, 1999, PLANT SYST EVOL, V218, P257, DOI 10.1007/BF01089231; Shaukat SS, 2002, PLANT SOIL, V245, P239; Swihart RK, 2001, J MAMMAL, V82, P1, DOI 10.1644/1545-1542(2001)082&lt;0001:IOBAOO&gt;2.0.CO;2; Traw MB, 2002, OECOLOGIA, V131, P526, DOI 10.1007/s00442-002-0924-6; van der Westhuizen L, 2011, AFR ENTOMOL, V19, P223, DOI 10.4001/003.019.0226; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Watts SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018463; Young TP, 2003, OIKOS, V101, P171, DOI 10.1034/j.1600-0706.2003.12067.x; Ziegler AC, 2002, HAWAIIAN NATURAL HIS	61	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96796	10.1371/journal.pone.0096796	http://dx.doi.org/10.1371/journal.pone.0096796			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802133	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800129
J	Nguyen, GD; Gokhan, S; Molero, AE; Yang, SM; Kim, BJ; Skoultchi, AI; Mehler, MF				Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Yang, Seung-Min; Kim, Byung-Ju; Skoultchi, Arthur I.; Mehler, Mark F.			The Role of H1 Linker Histone Subtypes in Preserving the Fidelity of Elaboration of Mesendodermal and Neuroectodermal Lineages during Embryonic Development	PLOS ONE			English	Article							CELLS IN-VITRO; STEM-CELLS; CHROMATIN-STRUCTURE; DIFFERENTIATION; MOUSE; GENE; PLURIPOTENCY; PROTEINS; NEURONS; EXPRESSION	H1 linker histone proteins are essential for the structural and functional integrity of chromatin and for the fidelity of additional epigenetic modifications. Deletion of H1c, H1d and H1e in mice leads to embryonic lethality by mid-gestation with a broad spectrum of developmental alterations. To elucidate the cellular and molecular mechanisms underlying H1 linker histone developmental functions, we analyzed embryonic stem cells (ESCs) depleted of H1c, H1d and H1e subtypes (H1-KO ESCs) by utilizing established ESC differentiation paradigms. Our study revealed that although H1-KO ESCs continued to express core pluripotency genes and the embryonic stem cell markers, alkaline phosphatase and SSEA1, they exhibited enhanced cell death during embryoid body formation and during specification of mesendoderm and neuroectoderm. In addition, we demonstrated deregulation in the developmental programs of cardiomyocyte, hepatic and pancreatic lineage elaboration. Moreover, ectopic neurogenesis and cardiomyogenesis occurred during endoderm-derived pancreatic but not hepatic differentiation. Furthermore, neural differentiation paradigms revealed selective impairments in the specification and maturation of glutamatergic and dopaminergic neurons with accelerated maturation of glial lineages. These impairments were associated with deregulation in the expression profiles of pro-neural genes in dorsal and ventral forebrain-derived neural stem cell species. Taken together, these experimental observations suggest that H1 linker histone proteins are critical for the specification, maturation and fidelity of organ-specific cellular lineages derived from the three cardinal germ layers.	[Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Roslyn & Leslie Goldstein Lab Stem Cell Biol & Re, Bronx, NY 10467 USA; [Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA; [Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Nguyen, Giang D.; Mehler, Mark F.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Nguyen, Giang D.; Gokhan, Solen; Molero, Aldrin E.; Mehler, Mark F.] Albert Einstein Coll Med, Rose F Kennedy Ctr Res Intellectual & Dev Disabil, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY USA; [Mehler, Mark F.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Biol &, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Ctr Epigen, Bronx, NY 10467 USA; [Mehler, Mark F.] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10467 USA; [Yang, Seung-Min; Kim, Byung-Ju; Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Mehler, MF (corresponding author), Albert Einstein Coll Med, Roslyn & Leslie Goldstein Lab Stem Cell Biol & Re, Bronx, NY 10467 USA.	mark.mehler@einstein.yu.edu	Molero, Aldrin/AAN-5240-2020	Molero, Aldrin/0000-0001-8250-1236	National Institutes of Health [NS071571, HD071593, MH66290]; Alpern Family, Mildred and Bernard H. Kayden and Roslyn and Leslie Goldstein Foundations; National Institute of Health [CA079057]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (NIH) [P30HD071593]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD001799] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330, R56CA079057, R01CA079057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alpern Family, Mildred and Bernard H. Kayden and Roslyn and Leslie Goldstein Foundations; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.F.M. is supported by grants from the National Institutes of Health (NS071571, HD071593, and MH66290), as well as by the F.M. Kirby, Alpern Family, Mildred and Bernard H. Kayden and Roslyn and Leslie Goldstein Foundations. A.I.S. is supported by a grant from National Institute of Health (CA079057). Research reported in this publication was also supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (NIH) under Award Number P30HD071593. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrajano JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007665; Aquino JB, 2008, GENE EXPR PATTERNS, V8, P217, DOI 10.1016/j.gep.2008.01.001; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Barra JL, 2000, MOL CELL BIOL, V20, P61, DOI 10.1128/MCB.20.1.61-69.2000; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Dodd J, 1992, Curr Opin Neurobiol, V2, P3, DOI 10.1016/0959-4388(92)90153-C; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fantz DA, 2001, BIOL REPROD, V64, P425, DOI 10.1095/biolreprod64.2.425; Fassler R, 1996, J CELL SCI, V109, P2989; George EM, 2010, J BIOL CHEM, V285, P20891, DOI 10.1074/jbc.M110.108639; Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Harikumar A, 2013, METHODS MOL BIOL, V1042, P173, DOI 10.1007/978-1-62703-526-2_12; Harshman S.W., 2013, NUCL ACIDS RES; Harvey AC, 2004, MOL MICROBIOL, V53, P771, DOI 10.1111/j.1365-2958.2004.04195.x; Kalashnikova AA, 2013, NUCLEIC ACIDS RES, V41, P4026, DOI 10.1093/nar/gkt104; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; LENNOX RW, 1983, J BIOL CHEM, V258, P262; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002879; Lin QC, 2000, MOL CELL BIOL, V20, P2122, DOI 10.1128/MCB.20.6.2122-2128.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Nagy A., 2006, CSH PROTOC; Nguyen GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064368; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PINA B, 1987, EUR J BIOCHEM, V164, P71, DOI 10.1111/j.1432-1033.1987.tb10994.x; Schroeder IS, 2006, NAT PROTOC, V1, P495, DOI 10.1038/nprot.2006.71; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Trollope AF, 2010, BBA-GENE REGUL MECH, V1799, P642, DOI 10.1016/j.bbagrm.2010.08.007; Wang ZF, 1997, J MOL BIOL, V271, P124, DOI 10.1006/jmbi.1997.1166; Wierzbicki AT, 2005, GENETICS, V169, P997, DOI 10.1534/genetics.104.031997; Xiao BT, 2012, MOL BIOL CELL, V23, P4864, DOI 10.1091/mbc.E12-07-0518; Yamashita JK, 2004, INT J HEMATOL, V80, P1, DOI 10.1532/ijh97.04043; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zaret KS, 2001, CURR OPIN GENET DEV, V11, P568, DOI 10.1016/S0959-437X(00)00234-3; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691; Zlatanova J, 1999, CRIT REV EUKAR GENE, V9, P245, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.90; Zwaka TP, 2006, DEV CELL, V10, P1, DOI 10.1016/j.devcel.2005.12.007	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96858	10.1371/journal.pone.0096858	http://dx.doi.org/10.1371/journal.pone.0096858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802750	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800133
J	Pinto, TM; Wedemann, RS; Cortez, CM				Pinto, Thiago M.; Wedemann, Roseli S.; Cortez, Celia M.			Modeling the Electric Potential across Neuronal Membranes: The Effect of Fixed Charges on Spinal Ganglion Neurons and Neuroblastoma Cells	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE; SURFACE-CHARGE; PROFILE; DIFFERENTIATION; STRENGTH; CHANNELS; AXONS	We present a model for the electric potential profile across the membranes of neuronal cells. We considered the resting and action potential states, and analyzed the influence of fixed charges of the membrane on its electric potential, based on experimental values of membrane properties of the spinal ganglion neuron and the neuroblastoma cell. The spinal ganglion neuron represents a healthy neuron, and the neuroblastoma cell, which is tumorous, represents a pathological neuron. We numerically solved the non-linear Poisson-Boltzmann equation for the regions of the membrane model we have adopted, by considering the densities of charges dissolved in an electrolytic solution and fixed on both glycocalyx and cytoplasmic proteins. Our model predicts that there is a difference in the behavior of the electric potential profiles of the two types of cells, in response to changes in charge concentrations in the membrane. Our results also describe an insensitivity of the neuroblastoma cell membrane, as observed in some biological experiments. This electrical property may be responsible for the low pharmacological response of the neuroblastoma to certain chemotherapeutic treatments.	[Pinto, Thiago M.; Wedemann, Roseli S.; Cortez, Celia M.] Univ Estado Rio de Janeiro, Inst Matemat & Estat, BR-20550011 Rio De Janeiro, Brazil; [Pinto, Thiago M.] Univ Sao Paulo, Dept Fis, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil	Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo	Pinto, TM (corresponding author), Univ Estado Rio de Janeiro, Inst Matemat & Estat, BR-20550011 Rio De Janeiro, Brazil.	thiagomatos@ime.uerj.br	Cortez, Celia/X-3247-2018	Cortez, Celia/0000-0002-7857-1167	Brazilian National Council for Scientific and Technological Development (CNPq); Rio de Janeiro State Research Foundation (FAPERJ); Sao Paulo Research Foundation (FAPESP); Brazilian agency	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rio de Janeiro State Research Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian agency	The authors acknowledge support from the Brazilian National Council for Scientific and Technological Development (CNPq), the Rio de Janeiro State Research Foundation (FAPERJ), the Sao Paulo Research Foundation (FAPESP), and the Brazilian agency which funds graduate studies (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECCHETTI A, 1992, BIOPHYS J, V63, P954, DOI 10.1016/S0006-3495(92)81665-X; BELAN P V, 1987, Neirofiziologiya, V19, P130; Bolintineanu DS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000277; Chapman DL, 1913, PHILOS MAG, V25, P475, DOI 10.1080/14786440408634187; Clay JR, 2001, BIOL BULL, V201, P186, DOI 10.2307/1543333; COOK GMW, 1960, NATURE, V188, P1011, DOI 10.1038/1881011a0; COOK GMW, 1968, BIOL REV, V43, P363, DOI 10.1111/j.1469-185X.1968.tb00964.x; Cortez CM, 2008, PHYSICA B, V403, P644, DOI 10.1016/j.physb.2007.09.078; CORTEZMAGHELLY C, 1993, BIOELECTROCH BIOENER, V32, P305, DOI 10.1016/0302-4598(93)80054-X; Cruz FAO, 2000, BRAZ J PHYS, V30, P403, DOI 10.1590/S0103-97332000000200023; Debye P, 1923, PHYS Z, V24, P185; DEHLINGER PJ, 1971, J BIOL CHEM, V246, P2574; DOLGAYA E V, 1984, Neirofiziologiya, V16, P176; DOLGAYA E V, 1985, Neirofiziologiya, V17, P168; ENGELHARDT H, 1984, NATURE, V307, P378, DOI 10.1038/307378a0; Gerard V, 1998, J EXP BIOL, V201, P21; Gouy M., 1910, J PHYS-PARIS, V9, P457, DOI DOI 10.1051/JPHYSTAP:019100090045700; GUYTON AC, 1997, HUMAN PHYSL MECH DIS; HEINRICH R, 1982, J THEOR BIOL, V96, P211, DOI 10.1016/0022-5193(82)90222-3; Hernandez M, 1996, J Fluoresc, V6, P77, DOI 10.1007/BF00732046; Iglic A, 1997, BIOELECTROCH BIOENER, V43, P97, DOI 10.1016/S0302-4598(96)05181-1; Inoue H, 2002, APPL RADIAT ISOTOPES, V56, P659, DOI 10.1016/S0969-8043(01)00266-4; Jackle J, 2007, J THEOR BIOL, V249, P445, DOI 10.1016/j.jtbi.2007.07.027; KURAMOTO T, 1981, J NEUROSCI RES, V6, P441, DOI 10.1002/jnr.490060402; KURAMOTO T, 1977, NEUROSCI LETT, V4, P151, DOI 10.1016/0304-3940(77)90130-6; Lindskog M, 2004, J NATL CANCER I, V96, P1457, DOI 10.1093/jnci/djh273; Michaelis M, 2001, ANTI-CANCER DRUG, V12, P467, DOI 10.1097/00001813-200106000-00008; MIRONOV SL, 1985, J MEMBRANE BIOL, V86, P197, DOI 10.1007/BF01870598; RAVAL PJ, 1984, BIOCHEM J, V223, P555, DOI 10.1042/bj2230555; Rosenheck K, 1998, BIOPHYS J, V75, P1237, DOI 10.1016/S0006-3495(98)74043-3; Rosenthal JJC, 2002, J EXP BIOL, V205, P1819; SCHUBERT D, 1971, DEV BIOL, V25, P514, DOI 10.1016/0012-1606(71)90004-2; Tosetti P, 1999, PFLUG ARCH EUR J PHY, V437, P441, DOI 10.1007/s004240050799; Verwey E.J., 1948, THEORY STABILITY LYO; WALKER J., 2011, FUNDAMENTALS PHYS; Zheng Q, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3581031	36	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96194	10.1371/journal.pone.0096194	http://dx.doi.org/10.1371/journal.pone.0096194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801682	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800046
J	Puri, RV; Reddy, PV; Tyagi, AK				Puri, Rupangi Verma; Reddy, P. Vineel; Tyagi, Anil K.			Apurinic/Apyrimidinic Endonucleases of Mycobacterium tuberculosis Protect against DNA Damage but Are Dispensable for the Growth of the Pathogen in Guinea Pigs	PLOS ONE			English	Article							BASE EXCISION-REPAIR; ABASIC SITES; APURINIC ENDONUCLEASE; NITROSATIVE STRESS; SENSITIVE MUTANT; INDUCIBLE REPAIR; MITOMYCIN-C; YEAST APN2; BOVIS BCG; SURVIVAL	In host cells, Mycobacterium tuberculosis encounters an array of reactive molecules capable of damaging its genome. Non-bulky DNA lesions are the most common damages produced on the exposure of the pathogen to reactive species and base excision repair (BER) pathway is involved in the repair of such damage. During BER, apurinic/apyrimidinic (AP) endonuclease enzymes repair the abasic sites that are generated after spontaneous DNA base loss or by the action of DNA glycosylases, which if left unrepaired lead to inhibition of replication and transcription. However, the role of AP endonucleases in imparting protection against DNA damage and in the growth and pathogenesis of M. tuberculosis has not yet been elucidated. To demonstrate the biological significance of these enzymes in M. tuberculosis, it would be desirable to disrupt the relevant genes and evaluate the resulting mutants for their ability to grow in the host and cause disease. In this study, we have generated M. tuberculosis mutants of the base excision repair (BER) system, disrupted in either one (Mtb Delta end or Mtb Delta xthA) or both the AP endonucleases (Mtb Delta end Delta xthA). We demonstrate that these genes are crucial for bacteria to withstand alkylation and oxidative stress in vitro. In addition, the mutant disrupted in both the AP endonucleases (Mtb Delta end Delta xthA) exhibited a significant reduction in its ability to survive inside human macrophages. However, infection of guinea pigs with either Mtb Delta end or Mtb Delta xthA or Mtb Delta end Delta xthA resulted in the similar bacillary load and pathological damage in the organs as observed in the case of infection with wild-type M. tuberculosis. The implications of these observations are discussed.	[Puri, Rupangi Verma; Reddy, P. Vineel; Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India	University of Delhi	Tyagi, AK (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	aniltyagi@south.du.ac.in			Department of Biotechnology, Government of India, India.; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India, India.(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a research grant from the Department of Biotechnology, Government of India, India. Council of Scientific and Industrial Research, Government of India is acknowledged for Junior/Senior research fellowships to RVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banos B, 2008, NUCLEIC ACIDS RES, V36, P5736, DOI 10.1093/nar/gkn526; Banos B, 2010, P NATL ACAD SCI USA, V107, P19219, DOI 10.1073/pnas.1013603107; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Carpenter EP, 2007, EMBO J, V26, P1363, DOI 10.1038/sj.emboj.7601593; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; DEMPLE B, 1986, P NATL ACAD SCI USA, V83, P7731, DOI 10.1073/pnas.83.20.7731; DOETSCH PW, 1990, MUTAT RES, V236, P173, DOI 10.1016/0921-8777(90)90004-O; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Durbach SI, 2003, INFECT IMMUN, V71, P997, DOI 10.1128/IAI.71.2.997-1000.2003; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Ferrari CKB, 2011, ARCH IMMUNOL THER EX, V59, P441, DOI 10.1007/s00005-011-0144-z; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; Hornback ML, 2006, J BACTERIOL, V188, P1295, DOI 10.1128/JB.188.4.1295-1300.2006; IMAE Y, 1968, J BACTERIOL, V95, P1191, DOI 10.1128/JB.95.3.1191-1192.1968; JACKETT PS, 1978, J GEN MICROBIOL, V104, P37, DOI 10.1099/00221287-104-1-37; Jain R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003869; Johnson RE, 1998, GENE DEV, V12, P3137, DOI 10.1101/gad.12.19.3137; Kanno S, 1999, NUCLEIC ACIDS RES, V27, P3096, DOI 10.1093/nar/27.15.3096; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Kurthkoti K, 2011, TUBERCULOSIS, V91, P533, DOI 10.1016/j.tube.2011.06.005; LJUNGQUIST S, 1976, J BACTERIOL, V126, P646, DOI 10.1128/JB.126.2.646-653.1976; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Mizrahi V, 1998, MOL MICROBIOL, V29, P1331, DOI 10.1046/j.1365-2958.1998.01038.x; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Nilsen L, 2012, NUCLEIC ACIDS RES, V40, P2000, DOI 10.1093/nar/gkr933; Parsons JL, 2004, NUCLEIC ACIDS RES, V32, P3531, DOI 10.1093/nar/gkh676; Piddington DL, 2001, INFECT IMMUN, V69, P4980, DOI 10.1128/IAI.69.8.4980-4987.2001; POPOFF SC, 1990, P NATL ACAD SCI USA, V87, P4193, DOI 10.1073/pnas.87.11.4193; Puri RV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071535; Rand L, 2003, MOL MICROBIOL, V50, P1031, DOI 10.1046/j.1365-2958.2003.03765.x; Reddy PV, 2013, J INFECT DIS, V208, P1255, DOI 10.1093/infdis/jit250; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Sander P, 2001, INFECT IMMUN, V69, P3562, DOI 10.1128/IAI.69.6.3562-3568.2001; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Soldati T, 2012, TRAFFIC, V13, P1042, DOI 10.1111/j.1600-0854.2012.01358.x; Springer B, 2004, MOL MICROBIOL, V53, P1601, DOI 10.1111/j.1365-2958.2004.04231.x; Suvarnapunya AE, 2003, MOL MICROBIOL, V48, P549, DOI 10.1046/j.1365-2958.2003.03460.x; TOMASZ M, 1987, SCIENCE, V235, P1204, DOI 10.1126/science.3103215; Torres-Ramos CA, 2000, MOL CELL BIOL, V20, P3522, DOI 10.1128/MCB.20.10.3522-3528.2000; Unk I, 2000, J BIOL CHEM, V275, P22427, DOI 10.1074/jbc.M002845200; Unk I, 2002, MOL CELL BIOL, V22, P6480, DOI 10.1128/MCB.22.18.6480-6486.2002; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Warner DF, 2010, P NATL ACAD SCI USA, V107, P13093, DOI 10.1073/pnas.1002614107; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Yang MY, 2011, DNA REPAIR, V10, P595, DOI 10.1016/j.dnarep.2011.03.007; Yu SL, 2003, MOL CELL BIOL, V23, P382, DOI 10.1128/MCB.23.1.382-388.2003	57	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e92035	10.1371/journal.pone.0092035	http://dx.doi.org/10.1371/journal.pone.0092035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800740	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800016
J	Tse, K; Puttachary, S; Beamer, E; Sills, GJ; Thippeswamy, T				Tse, Karen; Puttachary, Sreekanth; Beamer, Edward; Sills, Graeme J.; Thippeswamy, Thimmasettappa			Advantages of Repeated Low Dose against Single High Dose of Kainate in C57BL/6J Mouse Model of Status Epilepticus: Behavioral and Electroencephalographic Studies	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; KAINIC ACID; ANIMAL-MODELS; RAT MODEL; SEIZURE SUSCEPTIBILITY; HIPPOCAMPAL NEURODEGENERATION; CONVULSANT STIMULI; FUNCTIONAL-ANATOMY; STRAIN DIFFERENCES; INTERICTAL SPIKES	A refined kainate (KA) C57BL/6J mouse model of status epilepticus (SE) using a repeated low dose (RLD) of KA (5 mg/kg, intraperitoneal; at 30 min intervals) was compared with the established single high dose (SHD) of KA (20 mg/kg, intraperitoneal) model. In the RLD group, increased duration of convulsive motor seizures (CMS, Racine scale stage >= 3) with a significant reduction in mortality from 21% to 6% and decreased variability in seizure severity between animals/batches were observed when compared to the SHD group. There was a significant increase in the percentage of animals that reached stage-5 seizures (65% versus 96%) in the RLD group. Integrated real-time video-EEG analysis of both groups, using NeuroScore software, revealed stage-specific spikes and power spectral density characteristics. When the seizures progressed from non-convulsive seizures (NCS, stage 1-2) to CMS (stage 3-5), the delta power decreased which was followed by an increase in gamma and beta power. A transient increase in alpha and sigma power marked the transition from NCS to CMS with characteristic 'high frequency trigger' spikes on the EEG, which had no behavioral expression. During SE the spike rate was higher in the RLD group than in the SHD group. Overall these results confirm that RLD of KA is a more robust and consistent mouse model of SE than the SHD of KA mouse model.	[Tse, Karen; Beamer, Edward] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Puttachary, Sreekanth; Thippeswamy, Thimmasettappa] Iowa State Univ, Dept Biomed Sci, Coll Vet Med, Ames, IA 50011 USA; [Sills, Graeme J.] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Iowa State University; University of Liverpool	Thippeswamy, T (corresponding author), Iowa State Univ, Dept Biomed Sci, Coll Vet Med, Ames, IA 50011 USA.	tswamy@iastate.edu	Puttachary, Sreekanth/S-3639-2019	Puttachary, Sreekanth/0000-0002-4071-7896; Sills, Graeme/0000-0002-3389-8713; Beamer, Edward/0000-0003-1947-7346	Biotechnology 436 and Biological Sciences Research Council, UK; University of Liverpool, UK; Iowa State University, USA	Biotechnology 436 and Biological Sciences Research Council, UK; University of Liverpool, UK; Iowa State University, USA	Funding for EB and KT was from Biotechnology 436 and Biological Sciences Research Council, UK and the University of Liverpool, UK through TT as PI during his appointment in the University of Liverpool until 31 October 2012. SP was supported by TT's start-up fund from the Iowa State University, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; Bankstahl M, 2012, NEUROTOXICOLOGY, V33, P127, DOI 10.1016/j.neuro.2011.12.011; Beamer E, 2012, EUR J NEUROSCI, V36, P3194, DOI 10.1111/j.1460-9568.2012.08234.x; Behr J, 1996, NEUROSCI LETT, V220, P41, DOI 10.1016/S0304-3940(96)13242-0; Benkovic SA, 2006, BRAIN RES, V1070, P215, DOI 10.1016/j.brainres.2005.11.065; Bertram EH, 1997, EPILEPSIA, V38, P95, DOI 10.1111/j.1528-1157.1997.tb01083.x; Borges K, 2003, EXP NEUROL, V182, P21, DOI 10.1016/S0014-4886(03)00086-4; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; CASCINO GD, 1992, EPILEPSIA, V33, P639, DOI 10.1111/j.1528-1157.1992.tb02340.x; Chen ZG, 2002, BRAIN RES, V931, P135, DOI 10.1016/S0006-8993(02)02268-0; COLLINS RC, 1983, ANN NEUROL, V13, P223, DOI 10.1002/ana.410130235; Coulter DA, 2002, BRAIN PATHOL, V12, P240; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Crawley JN, 1996, TRENDS NEUROSCI, V19, P181, DOI 10.1016/S0166-2236(96)20021-9; Dalby NO, 2001, CURR OPIN NEUROL, V14, P187, DOI 10.1097/00019052-200104000-00009; De Sarro G, 2004, NEUROSCI RES, V50, P37, DOI 10.1016/j.neures.2004.05.007; De Sarro G, 2004, PHARMACOL BIOCHEM BE, V77, P761, DOI 10.1016/j.pbb.2004.01.012; Dudek FE, 2002, EPILEPSIA, V43, P1275, DOI 10.1046/j.1528-1157.2002.35102.x; Ekstrand JJ, 2011, NEUROSCIENCE, V192, P699, DOI 10.1016/j.neuroscience.2011.05.022; ENGSTROM FL, 1988, EPILEPSIA, V29, P389, DOI 10.1111/j.1528-1157.1988.tb03736.x; Fitzgibbon SP, 2004, CLIN NEUROPHYSIOL, V115, P1802, DOI 10.1016/j.clinph.2004.03.009; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; Hellier Jennifer L, 2005, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0919s31; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; KOSOBUD AE, 1990, BRAIN RES, V526, P8, DOI 10.1016/0006-8993(90)90243-5; Krendl R, 2008, NEUROLOGY, V71, P413, DOI 10.1212/01.wnl.0000310775.87331.90; Kurschner VC, 1998, BRAIN RES, V780, P1, DOI 10.1016/S0006-8993(97)01081-0; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Lehmkuhle MJ, 2009, J NEUROPHYSIOL, V101, P1660, DOI 10.1152/jn.91062.2008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; da Silveira MRM, 2013, ARQ NEURO-PSIQUIAT, V71, P931, DOI 10.1590/0004-282X20130201; Maria Tito MA, 2009, P CAHSI ANN M 2009; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; McLin JP, 2006, EUR J NEUROSCI, V24, P3134, DOI 10.1111/j.1460-9568.2006.05198.x; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Miller JW, 2008, NEUROLOGY, V71, P392, DOI 10.1212/01.wnl.0000324256.00488.69; Miltiadous P, 2013, STEM CELL TRANSL MED, V2, P185, DOI 10.5966/sctm.2012-0074; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Rattka M, 2012, EUR J NEUROSCI, V36, P2505, DOI 10.1111/j.1460-9568.2012.08143.x; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Rogove AD, 2002, CELL DEATH DIFFER, V9, P801, DOI 10.1038/sj.cdd.4401041; Rosati A, 2003, NEUROLOGY, V60, P1290, DOI 10.1212/01.WNL.0000058761.12715.0E; Schauwecker PE, 2011, GENES BRAIN BEHAV, V10, P100, DOI 10.1111/j.1601-183X.2010.00644.x; Schauwecker PE, 2012, NEUROBIOL DIS, V45, P297, DOI 10.1016/j.nbd.2011.08.013; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Schauwecker PE, 2010, EXP NEUROL, V224, P207, DOI 10.1016/j.expneurol.2010.03.013; Schauwecker PE, 1997, J COMP NEUROL, V380, P82, DOI 10.1002/(SICI)1096-9861(19970331)380:1<82::AID-CNE6>3.0.CO;2-P; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Sitnikova E, 2009, EPILEPSY RES, V84, P159, DOI 10.1016/j.eplepsyres.2009.01.016; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; Williams R, 2009, LANCET NEUROL, V8, P608, DOI [10.1016/S1474-4422(09)70163-2, 10.1016/S1474-4422(09)70283-2]; Yang J, 2005, NEUROSCIENCE, V131, P853, DOI 10.1016/j.neuroscience.2004.09.064; Yang Y, 2013, NEUROCHEM RES, V38, P123, DOI 10.1007/s11064-012-0899-6; Zhang XM, 2007, EXP NEUROL, V205, P64, DOI 10.1016/j.expneurol.2007.01.019; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	64	47	47	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96622	10.1371/journal.pone.0096622	http://dx.doi.org/10.1371/journal.pone.0096622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802808	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000338029800094
J	Wang, C; Wang, X; Xu, XL; Yuan, XL; Gou, WL; Wang, AY; Guo, QY; Peng, J; Lu, SB				Wang, Cheng; Wang, Xin; Xu, Xiao-long; Yuan, Xue-ling; Gou, Wen-long; Wang, Ai-yuan; Guo, Quan-yi; Peng, Jiang; Lu, Shi-bi			Bone Microstructure and Regional Distribution of Osteoblast and Osteoclast Activity in the Osteonecrotic Femoral Head	PLOS ONE			English	Article							STRENGTH; CELLS; OSTEOPOROSIS; EXPRESSION; QUALITY; FUSION; RATS; MICE	Objective: To detect and compare the bone microstructure and osteoblast and osteoclast activity in different regions of human osteonecrotic femoral heads. Methods: Osteonecrotic femoral heads were obtained from 10 patients (6 males, 4 females; Ficat IV) undergoing total hip arthroplasty between 2011 and 2013. The samples were divided into subchondral bone, necrotic, sclerotic, and healthy regions based on micro-computed tomography (CT) images. The bone microstructure, micromechanics, and osteoblast and osteoclast activity were assessed using micro-CT, pathology, immunohistochemistry, nanoindentation, reverse transcription polymerase chain reaction (RT-PCR), tartrate-resistant acid phosphatase staining and Western blotting. Results: (1) The spatial structure of the bone trabeculae differed markedly in the various regions of the osteonecrotic femoral heads. (2) The elastic modulus and hardness of the bone trabeculae in the healthy and necrotic regions did not differ significantly (P >0.05). (3) The subchondral bone and necrotic region were positive on TRAP staining, while the other regions were negative. (4) On immunohistochemical staining, RANK and RANKL staining intensities were increased significantly in the subchondral bone and necrotic region compared with the healthy region, while RUNX2 and BMP2 staining intensities were increased significantly in the sclerotic region compared with the necrotic region. (5) OPG, RANK, RANKL, RUNX2, BMP2, and BMP7 protein levels were greater in the necrotic and sclerotic region than in subchondral bone and the healthy region. Conclusion: The micromechanical properties of bone trabeculae in the necrotic region did not differ significantly from the healthy region. During the progress of osteonecrosis, the bone structure changed markedly. Osteoclast activity increased in subchondral bone and the necrotic region while osteoblast activity increased in the sclerotic region. We speculate that the altered osteoblast and osteoclast activity leads to a reduction in macroscopic mechanical strength.	[Wang, Cheng; Wang, Xin; Xu, Xiao-long; Yuan, Xue-ling; Gou, Wen-long; Wang, Ai-yuan; Guo, Quan-yi; Peng, Jiang; Lu, Shi-bi] Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Peng, J (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthoped, Beijing, Peoples R China.	pengjiang301@126.com	Yuan, Xueling/Y-6086-2019		NSFC [30930092, 31240048, 31170946]; NTRDP [2012AA020502, 2012CB518106, BWS11J025]	NSFC(National Natural Science Foundation of China (NSFC)); NTRDP	This work was funded by NSFC (30930092, 31240048, 31170946), NTRDP (2012AA020502, 2012CB518106, BWS11J025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaloo TL, 2013, J BONE MINER RES; Amanatullah Derek F, 2011, Am J Orthop (Belle Mead NJ), V40, pE216; Amanatullah Derek F, 2011, Am J Orthop (Belle Mead NJ), V40, pE186; Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Bi WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078198; Boyan BD, 2003, J ORTHOP RES, V21, P638, DOI 10.1016/S0736-0266(02)00261-9; Chen F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024638; Chen JF, 2012, J BONE MINER RES, V27, P1659, DOI 10.1002/jbmr.1607; Dai RC, 2008, J BONE MINER METAB, V26, P342, DOI 10.1007/s00774-007-0830-4; Hengsberger S, 2005, BONE, V36, P134, DOI 10.1016/j.bone.2004.09.013; Jian SR, 2010, NANOSCALE RES LETT, V5, P935, DOI 10.1007/s11671-010-9582-5; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li WZ, 2009, J ORTHOP RES, V27, P694, DOI 10.1002/jor.20802; Li ZY, 2012, BIOL TRACE ELEM RES, V145, P39, DOI 10.1007/s12011-011-9158-y; Little DG, 2003, J BONE MINER RES, V18, P2016, DOI 10.1359/jbmr.2003.18.11.2016; Liu YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P856, DOI 10.1093/abbs/gms070; Medici M, 2006, J BONE MINER RES, V21, P845, DOI [10.1359/jbmr.060306, 10.1359/JBMR.060306]; Mochizuki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048795; Oliver W. C., 1992, J MATER RES, V7, P1546; Perez-Amodio S, 2004, J BONE MINER RES, V19, P1722, DOI 10.1359/JBMR.040509; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Shen LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026267; Sung B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064118; Takarada T, 2013, J BONE MINER RES, V28, P2064, DOI 10.1002/jbmr.1945; To TT, 2012, DEVELOPMENT, V139, P141, DOI 10.1242/dev.071035; Turner CH, 2002, OSTEOPOROSIS INT, V13, P97, DOI 10.1007/s001980200000; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; Xue J, 2011, BONE, V48, P485, DOI 10.1016/j.bone.2010.10.166	30	47	52	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96361	10.1371/journal.pone.0096361	http://dx.doi.org/10.1371/journal.pone.0096361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800992	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800060
J	Worthington, TA; Brewer, SK; Farless, N; Grabowski, TB; Gregory, MS				Worthington, Thomas A.; Brewer, Shannon K.; Farless, Nicole; Grabowski, Timothy B.; Gregory, Mark S.			Interacting Effects of Discharge and Channel Morphology on Transport of Semibuoyant Fish Eggs in Large, Altered River Systems	PLOS ONE			English	Article							PECOS RIVER; RIO-GRANDE; HABITAT FRAGMENTATION; SAMPLING EFFICIENCY; SIMULATED TRANSPORT; COMMUNITY STRUCTURE; IRRIGATION RELEASE; BIOTIC FACTORS; PATCH SHAPE; CYPRINIDAE	Habitat fragmentation and flow regulation are significant factors related to the decline and extinction of freshwater biota. Pelagic-broadcast spawning cyprinids require moving water and some length of unfragmented stream to complete their life cycle. However, it is unknown how discharge and habitat features interact at multiple spatial scales to alter the transport of semi-buoyant fish eggs. Our objective was to assess the relationship between downstream drift of semi-buoyant egg surrogates (gellan beads) and discharge and habitat complexity. We quantified transport time of a known quantity of beads using 2-3 sampling devices at each of seven locations on the North Canadian and Canadian rivers. Transport time was assessed based on median capture time (time at which 50% of beads were captured) and sampling period (time period when 2.5% and 97.5% of beads were captured). Habitat complexity was assessed by calculating width: depth ratios at each site, and several habitat metrics determined using analyses of aerial photographs. Median time of egg capture was negatively correlated to site discharge. The temporal extent of the sampling period at each site was negatively correlated to both site discharge and habitat-patch dispersion. Our results highlight the role of discharge in driving transport times, but also indicate that higher dispersion of habitat patches relates to increased retention of beads within the river. These results could be used to target restoration activities or prioritize water use to create and maintain habitat complexity within large, fragmented river systems.	[Worthington, Thomas A.; Farless, Nicole] Oklahoma State Univ, Oklahoma Cooperat Fish & Wildlife Res Unit, Stillwater, OK 74078 USA; [Brewer, Shannon K.] Oklahoma State Univ, US Geol Survey, Oklahoma Cooperat Fish & Wildlife Res Unit, Stillwater, OK 74078 USA; [Grabowski, Timothy B.] Texas Tech Univ, US Geol Survey, Texas Cooperat Fish & Wildlife Res Unit, Lubbock, TX 79409 USA; [Gregory, Mark S.] Oklahoma State Univ, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; United States Department of the Interior; United States Geological Survey; Texas Tech University System; Texas Tech University; United States Department of the Interior; United States Geological Survey; Oklahoma State University System; Oklahoma State University - Stillwater	Brewer, SK (corresponding author), Oklahoma State Univ, US Geol Survey, Oklahoma Cooperat Fish & Wildlife Res Unit, Stillwater, OK 74078 USA.	shannon.brewer@okstate.edu	Worthington, Thomas/N-5121-2015; Worthington, Thomas A/H-2025-2019	Worthington, Thomas/0000-0002-8138-9075; Worthington, Thomas A/0000-0002-8138-9075; Grabowski, Timothy/0000-0001-9763-8948	U.S. Fish and Wildlife Service, Great Plains Landscape Conservation Cooperative (U.S. Fish and Wildlife Service) [F11AP00112]	U.S. Fish and Wildlife Service, Great Plains Landscape Conservation Cooperative (U.S. Fish and Wildlife Service)	Funding was provided by the U.S. Fish and Wildlife Service, Great Plains Landscape Conservation Cooperative (http://www.greatplainslcc.org/) (U.S. Fish and Wildlife Service agreement F11AP00112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenbach CS, 2000, T AM FISH SOC, V129, P296, DOI 10.1577/1548-8659(2000)129<0296:ANDFCD>2.0.CO;2; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; Bergey LL, 2003, N AM J FISH MANAGE, V23, P558, DOI 10.1577/1548-8675(2003)023<0558:VOACSB>2.0.CO;2; BESTGEN KR, 1989, AM MIDL NAT, V122, P228, DOI 10.2307/2425907; Bond NR, 2000, J ANIM ECOL, V69, P608, DOI 10.1046/j.1365-2656.2000.00420.x; Bonner TH, 2000, J FRESHWATER ECOL, V15, P189, DOI 10.1080/02705060.2000.9663736; Bonner TH, 2000, LIFE HIST REPRODUCTI, P147; BOTTRELL CLYDE E., 1964, TRANS AMER MICROSCOP SOC, V83, P391, DOI 10.2307/3224757; BRITTAIN JE, 1988, HYDROBIOLOGIA, V166, P77, DOI 10.1007/BF00017485; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Cook RD, 1982, RESIDUALS INFLUENCE; Costigan KH, 2012, J HYDROL, V444, P90, DOI 10.1016/j.jhydrol.2012.04.008; Dieterman DJ, 2004, T AM FISH SOC, V133, P577, DOI 10.1577/T03-002.1; Doak DF, 1995, CONSERV BIOL, V9, P1370, DOI 10.1046/j.1523-1739.1995.09061370.x; Dudley RK, 1999, J FRESHWATER ECOL, V14, P423, DOI 10.1080/02705060.1999.9663700; Dudley RK, 2007, ECOL APPL, V17, P2074, DOI 10.1890/06-1252.1; Durham BW, 2008, ECOL FRESHW FISH, V17, P528, DOI 10.1111/j.1600-0633.2008.00303.x; Durham BW, 2006, T AM FISH SOC, V135, P1644, DOI 10.1577/T05-133.1; Durham BW, 2009, COPEIA, P21, DOI 10.1643/CE-07-166; Durham BW, 2005, ENVIRON BIOL FISH, V72, P45, DOI 10.1007/s10641-004-4186-5; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fausch Kurt D., 1997, Ecological Studies, V125, P131; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Friedman JM, 1998, WETLANDS, V18, P619, DOI 10.1007/BF03161677; Gido KB, 2010, J N AM BENTHOL SOC, V29, P970, DOI 10.1899/09-116.1; Gordon ND, 2004, STREAM HYDROLOGY INT; Graf WL, 2006, GEOMORPHOLOGY, V79, P336, DOI 10.1016/j.geomorph.2006.06.022; HARDT RA, 1989, ECOLOGY, V70, P1252, DOI 10.2307/1938183; HARVEY BC, 1991, CAN J FISH AQUAT SCI, V48, P1476, DOI 10.1139/f91-175; Hoagstrom CW, 2008, COPEIA, P5, DOI 10.1643/CE-07-002; Hoagstrom CW, 2011, BIOL CONSERV, V144, P21, DOI 10.1016/j.biocon.2010.07.015; Hoagstrom CW, 2010, SOUTHWEST NAT, V55, P78, DOI 10.1894/GG-38.1; Hoagstrom CW, 2013, FISH FISH   IN PRESS; Hughes Robert M., 2005, V45, P1; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Jiang W, 2010, ZOOL SCI, V27, P402, DOI 10.2108/zsj.27.402; Johnston TA, 1995, CAN J FISH AQUAT SCI, V52, P2423, DOI 10.1139/f95-833; Julian JP, 2012, EARTH SURF PROC LAND, V37, P449, DOI 10.1002/esp.2272; LIMBIRD RL, 1993, RESTORATION PLANNING, P81; Luttrell GR, 1999, COPEIA, P981, DOI 10.2307/1447973; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Magana HA, 2012, ENVIRON BIOL FISH, V95, P201, DOI 10.1007/s10641-012-9977-5; MATTHEWS WJ, 1988, J N AM BENTHOL SOC, V7, P387, DOI 10.2307/1467298; McGarigal K., 2012, TECH REP; Medley CN, 2007, J FRESHWATER ECOL, V22, P499, DOI 10.1080/02705060.2007.9664180; Moore George A., 1944, COPEIA, V1944, P209, DOI 10.2307/1438675; Mueller J, 2013, EFFECTS TEMPERATURE, P48; Nathans L. L., 2012, PRACTICAL ASSESSMENT, V17, P9, DOI DOI 10.7275/5FEX-B874; O'Neill RV, 1988, LANDSCAPE ECOL, V1, P153, DOI 10.1007/BF00162741; PAVLOV DS, 1994, FOLIA ZOOL, V43, P193; Perkin JS, 2013, T AM FISH SOC, V142, P1287, DOI 10.1080/00028487.2013.806352; Perkin JS, 2011, FISHERIES, V36, P371, DOI 10.1080/03632415.2011.597666; Platania SP, 1998, COPEIA, P559, DOI 10.2307/1447786; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 1996, FRESHWATER BIOL, V36, P71, DOI 10.1046/j.1365-2427.1996.00073.x; POFF NL, 1989, CAN J FISH AQUAT SCI, V46, P1805, DOI 10.1139/f89-228; Reinert TR, 2004, N AM J FISH MANAGE, V24, P704, DOI 10.1577/M02-186.1; Rohde S, 2004, ENVIRON MANAGE, V34, P574, DOI 10.1007/s00267-004-0158-y; TAYLOR CM, 1990, AM MIDL NAT, V123, P32, DOI 10.2307/2425757; TURNER MG, 1990, LANDSCAPE ECOL, V4, P21, DOI 10.1007/BF02573948; Turner TF, 2010, AM FISH S S, V73, P427; Weldon AJ, 2005, ECOLOGY, V86, P1422, DOI 10.1890/04-0913; Widmer AM, 2012, RIVER RES APPL, V28, P192, DOI 10.1002/rra.1454; Wilde GR, 2013, J FRESHWATER ECOL, V28, P445, DOI 10.1080/02705060.2013.785984; WINSTON MR, 1991, T AM FISH SOC, V120, P98, DOI 10.1577/1548-8659(1991)120<0098:UEOFMS>2.3.CO;2; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811; Worthington TA, 2014, GLOBAL CHANGE BIOL, V20, P89, DOI 10.1111/gcb.12329; Worthington TA, 2013, N AM J FISH MANAGE, V33, P79, DOI 10.1080/02755947.2012.741557; Zymonas ND, 2009, J FRESHWATER ECOL, V24, P671, DOI 10.1080/02705060.2009.9664347	69	18	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96599	10.1371/journal.pone.0096599	http://dx.doi.org/10.1371/journal.pone.0096599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802361	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800091
J	Yi, SB; Lu, DQ; Peng, W; Wang, T; Zhang, Y; Lin, HR				Yi, Shibai; Lu, Danqi; Peng, Wan; Wang, Ting; Zhang, Yong; Lin, Haoran			Differential Expression Profiling of Spleen MicroRNAs in Response to Two Distinct Type II Interferons in Tetraodon nigroviridis	PLOS ONE			English	Article							C-MYC; MOLECULAR CHARACTERIZATION; DOWN-REGULATION; IFN-GAMMA; BACTERIAL-INFECTION; TRANSCRIPTION 1; GASTRIC-CANCER; MESSENGER-RNA; NITRIC-OXIDE; GENES	MicroRNAs are endogenous, small non-coding RNAs approximately 18-26 nucleotides in length that regulate target gene expression at the post-transcription level. Interferon-gamma (IFN-gamma) is a Th1 cytokine that is involved in both the innate and adaptive immune responses. We previously identified two IFN-gamma genes in green-spotted puffer fish (Tetraodon nigroviridis). To determine whether miRNAs participate in IFN-gamma-related immune responses, T. nigroviridis spleen cells were treated with recombinant IFN-gamma isoforms, and a Solexa high-throughput sequencing method was used to identify miRNAs. In total, 1,556, 1,538 and 1,573 miRNAs were found in the three samples, and differentially expressed miRNAs were determined. In total, 398 miRNAs were differentially expressed after rIFN-gamma 1 treatment, and 438 miRNAs were differentially expressed after rIFN-gamma 2 treatment; additionally, 403 miRNAs were differentially expressed between the treatment groups. Ten differentially expressed miRNAs were chosen for validation using qRT-PCR. Target genes for the differentially expressed miRNAs were predicted, and GO and KEGG analyses were performed. This study provides basic knowledge regarding fish IFN-gamma-induced miRNAs and offers clues for further studies into the mechanisms underlying fish IFN-gamma-mediated immune responses.	[Yi, Shibai; Lu, Danqi; Peng, Wan; Wang, Ting; Zhang, Yong; Lin, Haoran] Sun Yat Sen Zhongshan Univ, Coll Life Sci, State Key Lab Biocontrol, Inst Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China; [Yi, Shibai; Lu, Danqi; Peng, Wan; Wang, Ting; Zhang, Yong; Lin, Haoran] Sun Yat Sen Zhongshan Univ, Guangdong Prov Key Lab Aquat Econ Anim, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Lu, DQ (corresponding author), Sun Yat Sen Zhongshan Univ, Coll Life Sci, State Key Lab Biocontrol, Inst Aquat Econ Anim, Guangzhou, Guangdong, Peoples R China.	ludanqi@mail.sysu.edu.cn; lsslhr@mail.sysu.edu.cn	lin, haoran/GXH-3030-2022		National Natural Science Foundation of China [31001126]; Specialized Research Fund for the Doctoral Program of Higher Education [20110171130005]; State Key Laboratory of Biocontrol [SKLBC12K01]; Fundamental Research Funds for the Central Universities [11lgpy64]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Laboratory of Biocontrol; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 31001126), the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20110171130005), the Open Project of the State Key Laboratory of Biocontrol (No. SKLBC12K01) and the Fundamental Research Funds for the Central Universities (No. 11lgpy64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggad D, 2010, J IMMUNOL, V185, P6774, DOI 10.4049/jimmunol.1000549; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alsaleh G, 2009, J IMMUNOL, V182, P5088, DOI 10.4049/jimmunol.0801613; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Barozai MYK, 2012, GENE, V499, P163, DOI 10.1016/j.gene.2012.03.006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartoszewski R, 2011, J BIOL CHEM, V286, P41862, DOI 10.1074/jbc.M111.304956; Bi YJ, 2009, J CELL PHYSIOL, V218, P467, DOI 10.1002/jcp.21639; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Bizuayehu TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061378; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Cao Q, 2013, PHYSL GENOMICS; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen Z, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-151; Collison A, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-29; Dai RJ, 2008, BLOOD, V112, P4591, DOI 10.1182/blood-2008-04-152488; Ding S, 2012, ARTHRITIS RHEUM-US, V64, P2953, DOI 10.1002/art.34505; Fang Y, 2013, ACTA BIOCH BIOPH SIN, V45, P963, DOI 10.1093/abbs/gmt106; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Gits CMM, 2013, BRIT J CANCER, V109, P1625, DOI 10.1038/bjc.2013.483; Grayfer L, 2009, DEV COMP IMMUNOL, V33, P235, DOI 10.1016/j.dci.2008.09.001; Grayfer L, 2010, J BIOL CHEM, V285, P23537, DOI 10.1074/jbc.M109.096925; Grayfer L, 2009, MOL IMMUNOL, V46, P3050, DOI 10.1016/j.molimm.2009.06.004; Gregersen LH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008836; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Huang Y, 2011, BLOOD, V118, P6793, DOI 10.1182/blood-2011-05-356162; Igawa D, 2006, MOL IMMUNOL, V43, P999, DOI 10.1016/j.molimm.2005.05.009; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jung YJ, 2013, J MED VIROL, V85, P969, DOI 10.1002/jmv.23534; KAMIJO R, 1993, J EXP MED, V178, P1435, DOI 10.1084/jem.178.4.1435; KUBIN M, 1994, BLOOD, V83, P1847; Kumar P, 2013, MOL CELL BIOL, V33, P1782, DOI 10.1128/MCB.01228-12; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CC, 2013, DEV COMP IMMUNOL, V39, P110, DOI 10.1016/j.dci.2012.01.001; Liu Z, 2013, MOL CANC RES; Lopez-Munoz A, 2011, MOL IMMUNOL, V48, P1073, DOI 10.1016/j.molimm.2011.01.015; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; LORSBACH RB, 1993, J BIOL CHEM, V268, P1908; Lu DQ, 2012, J FISH BIOL, V81, P165, DOI 10.1111/j.1095-8649.2012.03321.x; Lu DQ, 2014, DEV COMP IMMUNOL, V44, P270, DOI 10.1016/j.dci.2014.01.001; Lu Y, 2013, BIOCH BIOPHYS RES CO; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Ma TH, 2011, J APPL GENET, V52, P481, DOI 10.1007/s13353-011-0055-z; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Milev-Milovanovic I, 2006, IMMUNOGENETICS, V58, P70, DOI 10.1007/s00251-006-0081-x; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nishiyama T, 2012, BIOCHEM BIOPH RES CO, V425, P755, DOI 10.1016/j.bbrc.2012.07.148; Noguchi S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.11; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Philippe L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00070; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Poitz DM, 2013, MOL IMMUNOL, V56, P442, DOI 10.1016/j.molimm.2013.06.014; Purcell MK, 2009, FISH SHELLFISH IMMUN, V26, P293, DOI 10.1016/j.fsi.2008.11.012; Ramana CV, 2000, EMBO J, V19, P263, DOI 10.1093/emboj/19.2.263; Reinsbach SE, 2012, RNA BIOL, V9, P978, DOI 10.4161/rna.20494; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Saba R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030832; Savan R, 2009, CYTOKINE GROWTH F R, V20, P115, DOI 10.1016/j.cytogfr.2009.02.006; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Semaan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019827; Shao Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-51; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Singh R.P., 2013, AUTOIMMUN REV; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stephens JM, 1998, J BIOL CHEM, V273, P31408, DOI 10.1074/jbc.273.47.31408; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Sun YP, 2013, J IMMUNOL, V190, P4005, DOI 10.4049/jimmunol.1202911; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Vilcek J, 2003, NAT IMMUNOL, V4, P8, DOI 10.1038/ni0103-8; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Wu BL, 2011, WORLD J GASTROENTERO, V17, P79, DOI 10.3748/wjg.v17.i1.79; Wu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016264; Wu TH, 2012, FISH PHYSIOL BIOCHEM, V38, P1299, DOI 10.1007/s10695-012-9617-1; Xiang J, 2010, CURR GENOMICS, V11, P129, DOI 10.2174/138920210790886853; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Yabu T, 2011, J BIOCHEM, V150, P635, DOI 10.1093/jb/mvr108; Yin Y, 2013, BBA-GENE REGUL MECH, V1829, P239, DOI 10.1016/j.bbagrm.2012.11.006; YOSHIDA A, 1994, BIOCHEM BIOPH RES CO, V198, P857, DOI 10.1006/bbrc.1994.1122; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070300; ZHANG L, 2010, J APPL TOXICOL; Zhang M, 2013, BRAIN RES, V1503, P43, DOI 10.1016/j.brainres.2013.01.052; Zhang Y, 2013, FEBS LETT, V587, P3069, DOI 10.1016/j.febslet.2013.06.058; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zhu DH, 2013, J ALLERGY CLIN IMMUN, V132, P426, DOI 10.1016/j.jaci.2013.02.005; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484; Zou J, 2004, FISH SHELLFISH IMMUN, V17, P403, DOI 10.1016/j.fsi.2004.04.015	101	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96336	10.1371/journal.pone.0096336	http://dx.doi.org/10.1371/journal.pone.0096336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800866	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800059
J	Fernandez-Ruiz, I; Arnalich, F; Cubillos-Zapata, C; Hernandez-Jimenez, E; Moreno-Gonzalez, R; Toledano, V; Fernandez-Velasco, M; Vallejo-Cremades, MT; Esteban-Burgos, L; de Diego, RP; Llamas-Matias, MA; Garcia-Arumi, E; Marti, R; Bosca, L; Andreu, AL; Lopez-Sendon, JL; Lopez-Collazo, E				Fernandez-Ruiz, Irene; Arnalich, Francisco; Cubillos-Zapata, Carolina; Hernandez-Jimenez, Enrique; Moreno-Gonzalez, Raul; Toledano, Victor; Fernandez-Velasco, Maria; Vallejo-Cremades, Maria T.; Esteban-Burgos, Laura; Perez de Diego, Rebeca; Llamas-Matias, Miguel A.; Garcia-Arumi, Elena; Marti, Ramon; Bosca, Lisardo; Andreu, Antoni L.; Luis Lopez-Sendon, Jose; Lopez-Collazo, Eduardo			Mitochondrial DAMPs Induce Endotoxin Tolerance in Human Monocytes: An Observation in Patients with Myocardial Infarction	PLOS ONE			English	Article							IMPAIRED ANTIGEN PRESENTATION; IRAK-M; INFLAMMATORY RESPONSES; CYSTIC-FIBROSIS; M EXPRESSION; KINASE-M; ACTIVATION; CELLS; DNA; PATHOPHYSIOLOGY	Monocyte exposure to mitochondrial Danger Associated Molecular Patterns (DAMPs), including mitochondrial DNA (mtDNA), induces a transient state in which these cells are refractory to further endotoxin stimulation. In this context, IRAKM up-regulation and impaired p65 activity were observed. This phenomenon, termed endotoxin tolerance (ET), is characterized by decreased production of cytokines in response to the pro-inflammatory stimulus. We also show that monocytes isolated from patients with myocardial infarction (MI) exhibited high levels of circulating mtDNA, which correlated with ET status. Moreover, a significant incidence of infection was observed in those patients with a strong tolerant phenotype. The present data extend our current understanding of the implications of endotoxin tolerance. Furthermore, our data suggest that the levels of mitochondrial antigens in plasma, such as plasma mtDNA, should be useful as a marker of increased risk of susceptibility to nosocomial infections in MI and in other pathologies involving tissue damage.	[Fernandez-Ruiz, Irene; Cubillos-Zapata, Carolina; Hernandez-Jimenez, Enrique; Toledano, Victor; Fernandez-Velasco, Maria; Vallejo-Cremades, Maria T.; Esteban-Burgos, Laura; Lopez-Collazo, Eduardo] Hosp La Paz, IdiPAZ, Tumor Immunol Lab, Madrid, Spain; [Fernandez-Ruiz, Irene; Cubillos-Zapata, Carolina; Hernandez-Jimenez, Enrique; Toledano, Victor; Esteban-Burgos, Laura; Perez de Diego, Rebeca; Bosca, Lisardo; Lopez-Collazo, Eduardo] La Paz Hosp, IdiPAZ, Innate Immun Grp, Madrid, Spain; [Arnalich, Francisco] La Paz Hosp, Internal Med Serv, Madrid, Spain; [Moreno-Gonzalez, Raul; Luis Lopez-Sendon, Jose] La Paz Hosp, Serv Cardiol, Madrid, Spain; [Fernandez-Velasco, Maria; Bosca, Lisardo] Alberto Sols, Inst Biomed Res, Madrid, Spain; [Perez de Diego, Rebeca] Hosp La Paz, IdiPAZ, Lab Immunogenet Dis, Madrid, Spain; [Llamas-Matias, Miguel A.] EMPIREO Lab, Madrid, Spain; [Garcia-Arumi, Elena; Marti, Ramon; Andreu, Antoni L.] Vall DHebron Res Inst, Dept Mitochondrial & Neuromuscular Pathol, Barcelona, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Lopez-Collazo, E (corresponding author), Hosp La Paz, IdiPAZ, Tumor Immunol Lab, Madrid, Spain.	elopezc@salud.madrid.org	Arnalich, Francisco/K-7723-2014; Moreno, Raul/AAB-9983-2021; Zapata, Carolina Cubillos/H-3058-2017; Arnalich, Francisco/AAF-5924-2021; Bosca, Lisardo/A-2059-2008; Garcia-Arumi, Elena/ABH-4229-2020; velasco, maria fernandez/AAO-5062-2021; Martí, Ramon/Q-3442-2016; Arnalich, Francisco/J-8184-2017; Lopez-Collazo, Eduardo/U-6634-2018	Zapata, Carolina Cubillos/0000-0002-1948-4514; Arnalich, Francisco/0000-0003-2943-0373; Bosca, Lisardo/0000-0002-0253-5469; Martí, Ramon/0000-0002-8273-9540; Garcia, Felipe/0000-0002-4099-0120; Fernandez Ruiz, Irene/0000-0001-5138-1649; Perez de Diego, Rebeca/0000-0001-8426-8765; ANDREU, antonio luis/0000-0002-3936-3234; Lopez-Collazo, Eduardo/0000-0003-1957-877X; Garcia-Arumi, Elena/0000-0003-0096-3336; Esteban-Burgos, Laura/0000-0002-4881-9803; Moreno, Raul/0000-0001-7179-1426; Hernandez Jimenez, Enrique/0000-0002-8232-8151	Fondos de Investigacion Sanitaria (FIS)	Fondos de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III)	This work was supported by "Fondos de Investigacion Sanitaria" (FIS) to ELC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; Arnalich F, 2013, CRIT CARE, V17, DOI 10.1186/cc12735; Arnalich F, 2010, CRIT CARE, V14, DOI 10.1186/cc8934; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Crouser ED, 2009, CRIT CARE MED, V37, P2000, DOI 10.1097/CCM.0b013e3181a001ae; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; del Fresno C, 2005, J IMMUNOL, V174, P3032, DOI 10.4049/jimmunol.174.5.3032; del Fresno C, 2007, J ENDOTOXIN RES, V13, P39, DOI 10.1177/0968051907078623; del Fresno C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002667; del Fresno C, 2009, J IMMUNOL, V182, P6494, DOI 10.4049/jimmunol.0803350; Escoll P, 2003, BIOCHEM BIOPH RES CO, V311, P465, DOI 10.1016/j.bbrc.2003.10.019; Evans BJ, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/780502; Frellstedt L, 2012, VET IMMUNOL IMMUNOP, V149, P97, DOI 10.1016/j.vetimm.2012.05.012; Garrabou G, 2012, J INFECT DIS, V205, P392, DOI 10.1093/infdis/jir764; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Jain K, 2012, EXPERT REV RESP MED, V6, P407, DOI [10.1586/ERS.12.39, 10.1586/ers.12.39]; Kuang DM, 2007, BLOOD, V110, P587, DOI 10.1182/blood-2007-01-068031; Kwon AH, 2004, TRANSPLANT P, V36, P2432, DOI 10.1016/j.transproceed.2004.08.058; Lopez-Collazo E, 2006, CURR OPIN INFECT DIS, V19, P237, DOI 10.1097/01.qco.0000224817.35105.7d; Lopez-Collazo E, 2013, CRIT CARE, V17, DOI 10.1186/cc13110; Lu CH, 2010, QJM-INT J MED, V103, P169, DOI 10.1093/qjmed/hcp201; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Monneret G, 2008, MOL MED, V14, P64, DOI 10.2119/2007-00102.Monneret; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Petzl W, 2012, INNATE IMMUN-LONDON, V18, P467, DOI 10.1177/1753425911422407; Pier GB, 2012, J EXP MED, V209, P1235, DOI 10.1084/jem.20121248; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Sly PD, 2004, THORAX, V59, P1008, DOI 10.1136/thx.2004.025924; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Xiong YB, 2011, J LEUKOCYTE BIOL, V90, P1141, DOI 10.1189/jlb.0611273; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	38	34	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95073	10.1371/journal.pone.0095073	http://dx.doi.org/10.1371/journal.pone.0095073			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797663	Green Published, gold			2022-12-27	WOS:000336656000012
J	Karousis, ED; Sideris, DC				Karousis, Evangelos D.; Sideris, Diamantis C.			A Subtle Alternative Splicing Event Gives Rise to a Widely Expressed Human RNase K Isoform	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; LARGE NONCODING RNAS; NAGNAG ACCEPTORS; TRITON X-114; CELL-GROWTH; GENE; CANCER; SITES; PRODUCTS; REVEALS	Subtle alternative splicing leads to the formation of RNA variants lacking or including a small number of nucleotides. To date, the impact of subtle alternative splicing phenomena on protein biosynthesis has been studied in frame-preserving incidents. On the contrary, mRNA isoforms derived from frame-shifting events were poorly studied and generally characterized as non-coding. This work provides evidence for a frame-shifting subtle alternative splicing event which results in the production of a novel protein isoform. We applied a combined molecular approach for the cloning and expression analysis of a human RNase kappa transcript (RNase kappa-02) which lacks four consecutive bases compared to the previously isolated RNase kappa isoform. RNase kappa-02 mRNA is expressed in all human cell lines tested end encodes the synthesis of a 134-amino-acid protein by utilizing an alternative initiation codon. The expression of RNase kappa-02 in the cytoplasm of human cells was verified by Western blot and immunofluorescence analysis using a specific polyclonal antibody developed on the basis of the amino-acid sequence difference between the two protein isoforms. The results presented here show that subtle changes during mRNA splicing can lead to the expression of significantly altered protein isoforms.	[Karousis, Evangelos D.; Sideris, Diamantis C.] Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens, Greece	National & Kapodistrian University of Athens	Sideris, DC (corresponding author), Univ Athens, Fac Biol, Dept Biochem & Mol Biol, Athens, Greece.	dsideris@biol.uoa.gr	Karousis, Evangelos/ABB-7945-2021	Karousis, Evangelos/0000-0002-0390-0181	European Union (European Social Fund - ESF); National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II	European Union (European Social Fund - ESF)(European Social Fund (ESF)); National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II	This work was financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley RK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001229; BRUSCA JS, 1994, METHOD ENZYMOL, V228, P182; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Dou YM, 2006, RNA, V12, P2047, DOI 10.1261/rna.151106; Economopoulou MAI, 2007, NUCLEIC ACIDS RES, V35, P6389, DOI 10.1093/nar/gkm718; Ermakova Ekaterina O, 2007, J Bioinform Comput Biol, V5, P991, DOI 10.1142/S0219720007003089; Fu XQ, 2006, DNA CELL BIOL, V25, P135, DOI 10.1089/dna.2006.25.135; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hiller M, 2006, AM J HUM GENET, V78, P291, DOI 10.1086/500151; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; Hiller M, 2008, TRENDS GENET, V24, P246, DOI 10.1016/j.tig.2008.03.003; Hiller M, 2008, RNA, V14, P616, DOI 10.1261/rna.883908; Hiller M, 2007, NUCLEIC ACIDS RES, V35, pD188, DOI 10.1093/nar/gkl762; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Iida K, 2008, MOL BIOL EVOL, V25, P709, DOI 10.1093/molbev/msn015; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kiritsi MN, 2012, FEBS J, V279, P1318, DOI 10.1111/j.1742-4658.2012.08526.x; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nie L, 2012, AM J TRANSL RES, V4, P127; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Petrovics G, 2004, ONCOGENE, V23, P605, DOI 10.1038/sj.onc.1207069; Raho G, 2007, ONCOGENE, V26, P5247, DOI 10.1038/sj.onc.1210335; Rampias TN, 2012, CURR ISSUES MOL BIOL, V14, P1; Rampias TN, 2008, FEBS J, V275, P6217, DOI 10.1111/j.1742-4658.2008.06746.x; Salamov AA, 1998, BIOINFORMATICS, V14, P384, DOI 10.1093/bioinformatics/14.5.384; Schindler S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-159; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; TAKEDA H, 1994, GENE DEV, V8, P45, DOI 10.1101/gad.8.1.45; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai KW, 2006, GENOMICS, V88, P855, DOI 10.1016/j.ygeno.2006.07.004; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Unoki M, 2006, J BIOL CHEM, V281, P34677, DOI 10.1074/jbc.M606296200; Vogan KJ, 1996, MOL CELL BIOL, V16, P6677; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weakley SM, 2011, WORLD J SURG, V35, P1751, DOI 10.1007/s00268-010-0951-0; Wilson LOW, 2014, BIOINFORMATICS, V30, P151, DOI 10.1093/bioinformatics/btt668; Wong Diana M., 2009, V519, P273, DOI 10.1007/978-1-59745-281-6_17; Xu QL, 2004, PLANT PHYSIOL, V136, P2652, DOI 10.1104/pp.104.046094; Yan MH, 2000, SCIENCE, V290, P523, DOI 10.1126/science.290.5491.523; Zhang YJ, 2009, SCI CHINA SER C, V52, P195, DOI 10.1007/s11427-009-0035-2	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96557	10.1371/journal.pone.0096557	http://dx.doi.org/10.1371/journal.pone.0096557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797913	gold, Green Submitted, Green Published			2022-12-27	WOS:000336656000094
J	Khan, MT; van Dijl, JM; Harmsen, HJM				Khan, M. Tanweer; van Dijl, Jan Maarten; Harmsen, Hermie J. M.			Antioxidants Keep the Potentially Probiotic but Highly Oxygen-Sensitive Human Gut Bacterium Faecalibacterium prausnitzii Alive at Ambient Air	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; RESISTANT STARCH; HOST RESPONSES; HUMAN-COLON; MICROBIOTA; HEALTH; INULIN; OLIGOSACCHARIDES; MICROORGANISMS; METABOLISM	The beneficial human gut microbe Faecalibacterium prausnitzii is a 'probiotic of the future' since it produces high amounts of butyrate and anti-inflammatory compounds. However, this bacterium is highly oxygen-senstive, making it notoriously difficult to cultivate and preserve. This has so far precluded its clinical application in the treatment of patients with inflammatory bowel diseases. The present studies were therefore aimed at developing a strategy to keep F. prausnitzii alive at ambient air. Our previous research showed that F. prausnitzii can survive in moderately oxygenized environments like the gut mucosa by transfer of electrons to oxygen. For this purpose, the bacterium exploits extracellular antioxidants, such as riboflavin and cysteine, that are abundantly present in the gut. We therefore tested to what extent these antioxidants can sustain the viability of F. prausnitzii at ambient air. The present results show that cysteine can facilitate the survival of F. prausnitzii upon exposure to air, and that this effect is significantly enhanced the by addition of riboflavin and the cryoprotectant inulin. The highly oxygen-sensitive gut bacterium F. prausnitzii can be kept alive at ambient air for 24 h when formulated with the antioxidants cysteine and riboflavin plus the cryoprotectant inulin. Improved formulations were obtained by addition of the bulking agents corn starch and wheat bran. Our present findings pave the way towards the biomedical exploitation of F. prausnitzii in redox-based therapeutics for treatment of dysbiosis-related inflammatory disorders of the human gut.	[Khan, M. Tanweer; van Dijl, Jan Maarten; Harmsen, Hermie J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen	Harmsen, HJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	h.j.m.harmsen@umcg.nl			Graduate School GUIDE of the University of Groningen	Graduate School GUIDE of the University of Groningen	M.T.K. was supported by a grant from the Graduate School GUIDE of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x; BOZOGLU F, 1987, ENZYME MICROB TECH, V9, P531, DOI 10.1016/0141-0229(87)90082-2; Butterworth AD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006634.pub2; Chassard C, 2012, ALIMENT PHARM THER, V35, P828, DOI 10.1111/j.1365-2036.2012.05007.x; CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763; de Jonge J, 2007, EUR J PHARM SCI, V32, P33, DOI 10.1016/j.ejps.2007.05.112; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Floch MH, 2011, J CLIN GASTROENTEROL, V45, pS168, DOI 10.1097/MCG.0b013e318230928b; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Ganzle MG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00340; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Goldin BR, 1998, BRIT J NUTR, V80, pS203, DOI 10.1017/S0007114500006036; Hague A, 1997, GASTROENTEROLOGY, V112, P1036, DOI 10.1053/gast.1997.v112.agast971036; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Jedrzejczak-Krzepkowska Marzena, 2011, Postepy Biochem, V57, P392; Kayama H, 2012, INT IMMUNOL, V24, P673, DOI 10.1093/intimm/dxs094; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Kim CJ, 2009, BBA-GEN SUBJECTS, V1790, P1161, DOI 10.1016/j.bbagen.2009.05.018; Klaenhammer TR, 2012, NAT REV IMMUNOL, V12, P728, DOI 10.1038/nri3312; Kolida S, 2011, ANNU REV FOOD SCI T, V2, P373, DOI 10.1146/annurev-food-022510-133739; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Miyamoto-Shinohara Y, 2000, CRYOBIOLOGY, V41, P251, DOI 10.1006/cryo.2000.2282; Morgan CA, 2006, J MICROBIOL METH, V66, P183, DOI 10.1016/j.mimet.2006.02.017; Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568; Neyrinck AM, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2011.24; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Paturi G, 2012, J FOOD SCI, V77, pH216, DOI 10.1111/j.1750-3841.2012.02911.x; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ross RP, 2005, J APPL MICROBIOL, V98, P1410, DOI 10.1111/j.1365-2672.2005.02654.x; SAKATA T, 1987, BRIT J NUTR, V58, P95, DOI 10.1079/BJN19870073; Savini M, 2010, NUTRIENTS, V2, P330, DOI 10.3390/nu2030330; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V126, P203, DOI 10.1016/S1095-6433(00)00194-X; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x; Toh ZQ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00171; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; van Drooge DJ, 2005, EUR J PHARM SCI, V26, P231, DOI 10.1016/j.ejps.2005.06.007; Videlock EJ, 2012, JAMA-J AM MED ASSOC, V308, P665, DOI 10.1001/jama.2012.8735; Vyas U, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/872716; Ze X, 2012, ISME J	45	56	65	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96097	10.1371/journal.pone.0096097	http://dx.doi.org/10.1371/journal.pone.0096097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798051	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000036
J	Moriarity, BS; Rahrmann, EP; Beckmann, DA; Conboy, CB; Watson, AL; Carlson, DF; Olson, ER; Hyland, KA; Fahrenkrug, SC; Mclvor, RS; Largaespada, DA				Moriarity, Branden S.; Rahrmann, Eric P.; Beckmann, Dominic A.; Conboy, Caitlin B.; Watson, Adrienne L.; Carlson, Daniel F.; Olson, Erik R.; Hyland, Kendra A.; Fahrenkrug, Scott C.; Mclvor, R. Scott; Largaespada, David A.			Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells	PLOS ONE			English	Article							GENE; TALEN; VIVO	The advent of Transcription Activator-Like Effector Nucleases (TALENs), and similar technologies such as CRISPR, provide a straightforward and cost effective option for targeted gene knockout (KO). Yet, there is still a need for methods that allow for enrichment and isolation of modified cells for genetic studies and therapeutics based on gene modified human cells. We have developed and validated two methods for simple enrichment and isolation of single or multiplex gene KO's in transformed, immortalized, and human progenitor cells. These methods rely on selection of a phenotypic change such as resistance to a particular drug or ability to grow in a selective environment. The first method, termed co-transposition, utilizes integration of a piggyBac transposon vector encoding a drug resistance gene. The second method, termed co-targeting, utilizes TALENs to KO any gene that when lost induces a selectable phenotype. Using these methods we also show removal of entire genes and demonstrate that TALENs function in human CD34(+) progenitor cells. Further, cotransposition can be used to generate conditional KO cell lines utilizing an inducible cDNA rescue transposon vector. These methods allow for robust enrichment and isolation of KO cells in a rapid and efficient manner.	[Moriarity, Branden S.; Rahrmann, Eric P.; Beckmann, Dominic A.; Conboy, Caitlin B.; Watson, Adrienne L.; Mclvor, R. Scott; Largaespada, David A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Moriarity, Branden S.; Rahrmann, Eric P.; Beckmann, Dominic A.; Carlson, Daniel F.; Fahrenkrug, Scott C.; Mclvor, R. Scott; Largaespada, David A.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN USA; [Moriarity, Branden S.; Rahrmann, Eric P.; Beckmann, Dominic A.; Carlson, Daniel F.; Fahrenkrug, Scott C.; Mclvor, R. Scott; Largaespada, David A.] Univ Minnesota, Inst Human Genet, Minneapolis, MN USA; [Moriarity, Branden S.; Rahrmann, Eric P.; Beckmann, Dominic A.; Conboy, Caitlin B.; Watson, Adrienne L.; Largaespada, David A.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN USA; [Olson, Erik R.; Hyland, Kendra A.; Mclvor, R. Scott; Largaespada, David A.] Discovery Genom Inc, Minneapolis, MN USA; [Largaespada, David A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Carlson, Daniel F.; Fahrenkrug, Scott C.] Univ Minnesota, Dept Anim Sci, Minneapolis, MN USA; [Carlson, Daniel F.; Fahrenkrug, Scott C.] Recombinet Inc, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Largaespada, DA (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	larga002@umn.edu	Wilson, Matthew H/K-3193-2013; Watson, Adrienne L/GRO-1978-2022	Watson, Adrienne L/0000-0002-9752-3689; Carlson, Daniel/0000-0001-6095-2108; Fahrenkrug, Scott/0000-0002-7176-6551; Conboy, Caitlin/0000-0001-8280-056X	NIH/NIAMS Musculoskeletal Training Grant [AR050938]; Children's Tumor Foundation Young Investigators Award [2011-01-018]; National Institutes of Health [P50CA101955, R01CA113636, P50NS057531]; Discovery Genomics, Inc.; Recombinetics, Inc.; NATIONAL CANCER INSTITUTE [F30CA171547, P50CA101955, R01CA113636, T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR050938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS057531] Funding Source: NIH RePORTER	NIH/NIAMS Musculoskeletal Training Grant; Children's Tumor Foundation Young Investigators Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Discovery Genomics, Inc.; Recombinetics, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.S.M was supported by NIH/NIAMS AR050938 Musculoskeletal Training Grant. A.L.W is funded by the 2011 Children's Tumor Foundation Young Investigators Award (2011-01-018). Funding also provided by P50CA101955, R01CA113636, and P50NS057531 from the National Institutes of Health (DAL). Discovery Genomics, Inc., and Recombinetics, Inc., provided support in the form of salaries for authors E.O., K.H., R.S.M., D.A.L., D.F.C. & S.F., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALBERTINI RJ, 1985, MUTAT RES, V150, P411, DOI 10.1016/0027-5107(85)90138-1; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Ding Q, 2012, CELL STEM CELL; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Gori JL, 2007, J PHARMACOL EXP THER, V322, P989, DOI 10.1124/jpet.107.123414; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Howell VM, 2012, CANCER LETT, V317, P1, DOI 10.1016/j.canlet.2011.11.006; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056476; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim SY, 1998, GENOME RES, V8, P404, DOI 10.1101/gr.8.4.404; Li L, 2013, MOL THERAPY; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manuri PVR, 2010, HUM GENE THER, V21, P427, DOI 10.1089/hum.2009.114; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moriarity BS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt115; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rahrmann EP, 2013, FORWARD GENETIC SCRE; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	33	19	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96114	10.1371/journal.pone.0096114	http://dx.doi.org/10.1371/journal.pone.0096114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798371	gold, Green Published, Green Submitted			2022-12-27	WOS:000336656000038
J	Phillips, T; Li, JW; Kendall, G				Phillips, Tim; Li, Jiawei; Kendall, Graham			The Effects of Extra-Somatic Weapons on the Evolution of Human Cooperation towards Non-Kin	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; NICHE-CONSTRUCTION; STRONG RECIPROCITY; SEXUAL SELECTION; STRATEGY; PUZZLE	Human cooperation and altruism towards non-kin is a major evolutionary puzzle, as is 'strong reciprocity' where no present or future rewards accrue to the co-operator/altruist. Here, we test the hypothesis that the development of extra-somatic weapons could have influenced the evolution of human cooperative behaviour, thus providing a new explanation for these two puzzles. Widespread weapons use could have made disputes within hominin groups far more lethal and also equalized power between individuals. In such a cultural niche non-cooperators might well have become involved in such lethal disputes at a higher frequency than cooperators, thereby increasing the relative fitness of genes associated with cooperative behaviour. We employ two versions of the evolutionary Iterated Prisoner's Dilemma (IPD) model - one where weapons use is simulated and one where it is not. We then measured the performance of 25 IPD strategies to evaluate the effects of weapons use on them. We found that cooperative strategies performed significantly better, and non-cooperative strategies significantly worse, under simulated weapons use. Importantly, the performance of an 'Always Cooperate' IPD strategy, equivalent to that of 'strong reciprocity', improved significantly more than that of all other cooperative strategies. We conclude that the development of extra-somatic weapons throws new light on the evolution of human altruistic and cooperative behaviour, and particularly 'strong reciprocity'. The notion that distinctively human altruism and cooperation could have been an adaptive trait in a past environment that is no longer evident in the modern world provides a novel addition to theory that seeks to account for this major evolutionary puzzle.	[Li, Jiawei; Kendall, Graham] Univ Nottingham, Sch Comp Sci, Automated Scheduling Optimisat & Planning ASAP Re, Nottingham NG7 2RD, England; [Kendall, Graham] Univ Nottingham, Broga, Malaysia	University of Nottingham		Ptjp2749@aol.com	Li, Jiawei/I-1213-2014	Li, Jiawei/0000-0002-5002-0857; Li, Jiawei/0000-0003-4685-2615	EPSRC [EP/H000968/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H000968/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Alexander R. D., 1979, DARWINISM HUMAN AFFA; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Boehm C., 1999, HIERARCHY FOREST EVO; Bowles S, 2003, DAHL WS ENV, P429; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Chong S. Y., 2007, ADV NATURAL COMPUTAT, V4, P23; Churchill SE, 2009, VERTEBR PALEOBIOL PA, P201, DOI 10.1007/978-1-4020-9699-0_15; Dawkins Richard, 1976, SELFISH GENE; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E., 2003, GENETIC CULTURAL EVO; Gintis H, 2003, RATION SOC, V15, P155, DOI 10.1177/1043463103015002001; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H., 2007, OXFORD HDB EVOLUTION, P605; HAWKES K, 1993, CURR ANTHROPOL, V34, P341, DOI 10.1086/204182; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Johnson DDP, 2003, NATURE, V421, P911, DOI 10.1038/421912a; Kelly RC, 2005, SERIES INAUGURAL ART; KNAUFT BM, 1991, CURR ANTHROPOL, V32, P391, DOI 10.1086/203975; Laland KN, 2008, PHILOS T R SOC B, V363, P3577, DOI 10.1098/rstb.2008.0132; Laland KN, 2001, J EVOLUTION BIOL, V14, P22, DOI 10.1046/j.1420-9101.2001.00262.x; Lee R. B., 1979, KUNG SAN MEN WOMEN W; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Li JW, 2009, EVOL COMPUT, V17, P257, DOI 10.1162/evco.2009.17.2.257; Lumsden C. J., 1981, GENES MIND CULTURE; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Phillips T, 2008, BRIT J PSYCHOL, V99, P555, DOI 10.1348/000712608X298467; Schmitt David P., 2005, HDB EVOLUTIONARY PSY, P258; Shea JJ, 2009, VERTEBR PALEOBIOL PA, P189, DOI 10.1007/978-1-4020-9699-0_14; Sigmund K., 1993, GAMES LIFE EXPLORATI; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Stevens JR, 2004, BEHAV ECOL, V15, P255, DOI 10.1093/beheco/arh006; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; Suzuki S, 2005, P ROY SOC B-BIOL SCI, V272, P1373, DOI 10.1098/rspb.2005.3072; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Trivers R. L., 1985, SOCIAL EVOLUTION; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755	49	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95742	10.1371/journal.pone.0095742	http://dx.doi.org/10.1371/journal.pone.0095742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI1ZV	24796325	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000022
J	Wang, LZ; Feng, D; Yan, HH; Wang, ZP; Pei, L				Wang, Lizhao; Feng, Dan; Yan, Huanhuan; Wang, Zhongping; Pei, Lei			Comparative Analysis of P2X1, P2X2, P2X3, and P2X4 Receptor Subunits in Rat Nodose Ganglion Neurons	PLOS ONE			English	Article							PRIMARY AFFERENT NEURONS; ATP-GATED CHANNELS; PURINERGIC RECEPTORS; SENSORY NEURONS; COEXPRESSION; P2X(2); CELLS; DESENSITIZATION; ANTAGONIST; PLASTICITY	Nodose ganglion (NG) neurons are visceral primary sensory neurons. The transmission and regulation of visceral sensation is mediated mainly by the P2X purinoceptor (P2X receptor). Although the characteristics of different P2X receptor subunits in the NG have been studied previously, comprehensive analyses have not been performed. In this study, we used immunohistochemistry, immunocytochemistry, and whole cell patch clamp techniques to compare the expression and function of P2X1, P2X2, P2X3, and P2X4 receptor subunits in adult rat NG neurons. Polyclonal antibodies against the four P2X subunits labeled different subpopulations of NG neurons. P2X1 and P2X3 were expressed mainly in small-to-medium sized NG neurons, whereas P2X2 and P2X4 were located mostly in medium-and larger-sized NG neurons. Over 36% of NG neurons were P2X3 positive, which was higher than the other three P2X subunits. In addition, different types of currents were recorded from neurons expressing different P2X subunits. The fast type of ATP current was recorded from neurons containing P2X1-4 subunits, the intermediate type of current was recorded from neurons containing the P2X1, P2X3, and P2X4 subunits, the slow type was recorded from neurons expressing P2X1-3, and/or P2X4 subunits, whereas the very slow type was recorded from neurons containing the P2X2 and P2X3 subunits. These comparative results provide an anatomical verification of the different subunits in NG neurons, and offer direct support for the idea that various functional NG populations have distinct responses to ATP, which might be in part due to the different expression profiles of diverse P2X subunits.	[Wang, Lizhao; Yan, Huanhuan; Pei, Lei] Huazhong Univ Sci & Technol, Tongji Med Coll, Minist Educ, Key Lab Neurol Dis, Wuhan 430074, Peoples R China; [Wang, Lizhao] CNS Pharmacol & Ion Channel Grp Shanghai Chempart, Shanghai, Peoples R China; [Feng, Dan] Huazhong Univ Sci & Technol, Tongji Med Coll, Inst Anesthesia & Crit Care, Dept Pain Clin, Wuhan 430074, Peoples R China; [Wang, Zhongping] Jiujiang Univ, Dept Physiol & Pathophysiol, Jiujiang, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Jiujiang University	Wang, ZP (corresponding author), Jiujiang Univ, Dept Physiol & Pathophysiol, Jiujiang, Peoples R China.	wzp20040224@163.com; neurolei@gmail.com			National Natural Science Foundation of China [81200863, 81260211]; China Postdoctoral Science Foundation [2013M530345, 2013M540583]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (81200863 to L. Pei, 81260211 to Z. Wang) and China Postdoctoral Science Foundation (2013M530345 and 2013M540583 to L. Pei). Shanghai Chempartner provided support in the form of a salary for author L. Wang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Bardoni R, 1997, J NEUROSCI, V17, P5297; Bobryshev AY, 2012, NEUROPHYSIOLOGY+, V43, P432, DOI 10.1007/s11062-012-9247-3; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; Brown SG, 2002, J PHARMACOL EXP THER, V300, P673, DOI 10.1124/jpet.300.2.673; Burnstock G, 2009, CURR PHARM DESIGN, V15, P1717, DOI 10.2174/138161209788186335; Collo G, 1996, J NEUROSCI, V16, P2495; Cook SP, 1998, J NEUROSCI, V18, P9238; DEKONINCK P, 1993, J NEUROSCI, V13, P577; Dunn PM, 2000, BRIT J PHARMACOL, V130, P1378, DOI 10.1038/sj.bjp.0703404; Florenzano F, 2006, ADV EXP MED BIOL, V557, P77; GALLEGO R, 1978, J NEUROPHYSIOL, V41, P1217, DOI 10.1152/jn.1978.41.5.1217; Hubscher CH, 2001, NEUROREPORT, V12, P2995, DOI 10.1097/00001756-200109170-00048; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Khakh BS, 2001, NAT REV NEUROSCI, V2, P165, DOI 10.1038/35058521; KHAKH BS, 1995, BRIT J PHARMACOL, V115, P177, DOI 10.1111/j.1476-5381.1995.tb16336.x; King BF, 2000, J NEUROSCI, V20, P4871; Le KT, 1999, J BIOL CHEM, V274, P15415, DOI 10.1074/jbc.274.22.15415; LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411, DOI 10.1152/jn.1993.70.6.2411; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Li Y, 2007, CURR MED CHEM, V14, P2554, DOI 10.2174/092986707782023334; MacKenzie AB, 1999, ANN NY ACAD SCI, V868, P716, DOI 10.1111/j.1749-6632.1999.tb11351.x; Martin JL, 2009, J NEUROCHEM, V108, P450, DOI 10.1111/j.1471-4159.2008.05781.x; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Pei L, 2011, BRIT J ANAESTH, V107, P948, DOI 10.1093/bja/aer299; Pei Lei, 2007, Neurosci Bull, V23, P92, DOI 10.1007/s12264-007-0013-2; Ratcliffe EM, 2011, AUTON NEUROSCI-BASIC, V161, P1, DOI 10.1016/j.autneu.2010.11.003; ROSE RD, 1988, J COMP NEUROL, V272, P365; Salih SG, 2002, NEUROPHARMACOLOGY, V42, P386, DOI 10.1016/S0028-3908(01)00184-8; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Spelta V, 2002, BRIT J PHARMACOL, V135, P1524, DOI 10.1038/sj.bjp.0704591; STANSFELD CE, 1985, J NEUROPHYSIOL, V54, P245, DOI 10.1152/jn.1985.54.2.245; Tan Y, 2009, NEUROSCI LETT, V459, P25, DOI 10.1016/j.neulet.2009.04.054; UNDEM BJ, 1993, J AUTONOM NERV SYST, V44, P17, DOI 10.1016/0165-1838(93)90375-5	35	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96699	10.1371/journal.pone.0096699	http://dx.doi.org/10.1371/journal.pone.0096699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798490	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000121
J	Wood, A; Margrain, T; Binns, AM				Wood, Ashley; Margrain, Thomas; Binns, Alison Mary			Detection of Early Age-Related Macular Degeneration Using Novel Functional Parameters of the Focal Cone Electroretinogram	PLOS ONE			English	Article							FREQUENCY-DOMAIN ANALYSIS; FELLOW EYES; A-WAVE; RETINAL MORPHOLOGY; ROD; ERG; RESPONSES; LIGHT; MACULOPATHY; DYSFUNCTION	The focal cone electroretinogram is a sensitive marker for macular disease, but have we unlocked its full potential? Typically assessment of waveform parameters is subjective and focuses on a small number of locations (e.g. the a-wave). This study evaluated the discriminatory and diagnostic potential of 4 conventional and 15 novel, objectively determined, parameters in patients with early Age-related Macular Degeneration. Focal cone electroretinograms were recorded in 54 participants with early Age-related Macular Degeneration (72.9 +/- 8.2 years) and 54 healthy controls (69 +/- 7.7 years). Conventional a and b wave amplitudes and implicit times were measured and compared to novel parameters derived from both the 1st and 2nd derivatives and the frequency-domain power spectrum of the electroretinogram. Statistically significant differences between groups were shown for all conventional parameters, the majority of 1st and 2nd derivative parameters and the power spectrum at 25 and 30 Hz. Receiver operating characteristics showed that both conventional and 1st and 2nd derivative implicit times had provided the best diagnostic potential. A regression model showed a small improvement over any individual parameter investigated. The non-conventional parameters enhanced the objective evaluation of the focal electroretinogram, especially when the amplitude was low. Furthermore, the novel parameters described here allow the implicit time of the electroretinogram to be probed at points other than the peaks of the a and b waves. Consequently these novel analysis techniques could prove valuable in future electrophysiological investigation, detection and monitoring of Age-related Macular Degeneration.	[Wood, Ashley; Margrain, Thomas] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Binns, Alison Mary] City Univ London, Sch Hlth Sci, Div Optometry & Visual Sci, London EC1V 0HB, England	Cardiff University; City University London	Wood, A (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales.	wooda2@cardiff.ac.uk		Binns, Alison/0000-0001-8621-498X; Margrain, Tom/0000-0003-1280-0809	institutional funding at Cardiff University	institutional funding at Cardiff University	This research was carried out and supported by institutional funding at Cardiff University, no external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; ASI H, 1992, CLIN VISION SCI, V7, P9; Bach M, 2013, CELL TISSUE RES, V353, P287, DOI 10.1007/s00441-013-1598-6; Binns AM, 2007, INVEST OPHTH VIS SCI, V48, P2806, DOI 10.1167/iovs.06-0392; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BRETON ME, 1992, DOC OPHTHALMOL, V79, P337, DOI 10.1007/BF00160948; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; Chamie J, 2005, WORLD POPULATION PRO; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Falsini B, 1999, GRAEF ARCH CLIN EXP, V237, P193, DOI 10.1007/s004170050218; Falsini B, 2000, INVEST OPHTH VIS SCI, V41, P1498; Friedburg C, 2001, J PHYSIOL-LONDON, V534, P217, DOI 10.1111/j.1469-7793.2001.t01-1-00217.x; FULTON AB, 1978, VISION RES, V18, P793, DOI 10.1016/0042-6989(78)90119-0; Gerth C, 2009, DOC OPHTHALMOL, V118, P63, DOI 10.1007/s10633-008-9133-x; Granit R, 1933, J PHYSIOL-LONDON, V77, P207, DOI 10.1113/jphysiol.1933.sp002964; GUR M, 1980, J OPT SOC AM, V70, P53, DOI 10.1364/JOSA.70.000053; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hogg RE, 2006, PROG RETIN EYE RES, V25, P249, DOI 10.1016/j.preteyeres.2005.11.002; HOOD DC, 1990, INVEST OPHTH VIS SCI, V31, P2070; HOOD DC, 1990, VISUAL NEUROSCI, V5, P379, DOI 10.1017/S0952523800000468; LACHAPELLE P, 1986, DOC OPHTHALMOL, V63, P337, DOI 10.1007/BF00220225; Lei B, 1999, VISUAL NEUROSCI, V16, P743, DOI 10.1017/S0952523899164137; Mentzer AE, 2005, DOC OPHTHALMOL, V111, P95, DOI 10.1007/s10633-005-4517-7; Miyake Y, 1998, Nagoya J Med Sci, V61, P79; Mortlock KE, 2010, DOC OPHTHALMOL, V121, P123, DOI 10.1007/s10633-010-9239-9; Neelam K, 2009, SURV OPHTHALMOL, V54, P167, DOI 10.1016/j.survophthal.2008.12.003; Nishihara H, 2008, INVEST OPHTH VIS SCI, V49, P3121, DOI 10.1167/iovs.08-1835; Paupoo AAV, 2000, J PHYSIOL-LONDON, V529, P469, DOI 10.1111/j.1469-7793.2000.00469.x; PEACHEY NS, 1987, VISION RES, V27, P859, DOI 10.1016/0042-6989(87)90002-2; Piccardi M, 2009, OPHTHALMIC RES, V41, P194, DOI 10.1159/000217723; REMULLA JFC, 1995, BRIT J OPHTHALMOL, V79, P558, DOI 10.1136/bjo.79.6.558; Sandberg MA, 1998, OPHTHALMOLOGY, V105, P441, DOI 10.1016/S0161-6420(98)93025-1; SANDBERG MA, 1993, INVEST OPHTH VIS SCI, V34, P3477; Shiells RA, 1999, VISUAL NEUROSCI, V16, P503, DOI 10.1017/S0952523899163119; Stroud K.A., 1986, FURTHER ENG MATH; SUNNESS JS, 1985, ARCH OPHTHALMOL-CHIC, V103, P811; Terasaki H, 2002, INVEST OPHTH VIS SCI, V43, P1540; Vincent A, 2013, RETINA-J RET VIT DIS, V33, P5, DOI 10.1097/IAE.0b013e31827e2306; WALI N, 1992, DOC OPHTHALMOL, V80, P1, DOI 10.1007/BF00161226; Walter P, 1999, GRAEF ARCH CLIN EXP, V237, P962, DOI 10.1007/s004170050331; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008	46	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96742	10.1371/journal.pone.0096742	http://dx.doi.org/10.1371/journal.pone.0096742			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796326	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000336656000122
J	Horner, AM; Jayne, BC				Horner, Angela M.; Jayne, Bruce C.			Lungfish Axial Muscle Function and the Vertebrate Water to Land Transition	PLOS ONE			English	Article							EEL ANGUILLA-ROSTRATA; TERRESTRIAL LOCOMOTION; HEMISCYLLIUM-OCELLATUM; TETRAPOD ICHTHYOSTEGA; ESCAPE RESPONSE; EPAULETTE SHARK; BODY FORM; KINEMATICS; EVOLUTION; WALKING	The role of axial form and function during the vertebrate water to land transition is poorly understood, in part because patterns of axial movement lack morphological correlates. The few studies available from elongate, semi-aquatic vertebrates suggest that moving on land may be powered simply from modifications of generalized swimming axial motor patterns and kinematics. Lungfish are an ideal group to study the role of axial function in terrestrial locomotion as they are the sister taxon to tetrapods and regularly move on land. Here we use electromyography and high-speed video to test whether lungfish moving on land use axial muscles similar to undulatory swimming or demonstrate novelty. We compared terrestrial lungfish data to data from lungfish swimming in different viscosities as well as to salamander locomotion. The terrestrial locomotion of lungfish involved substantial activity in the trunk muscles but almost no tail activity. Unlike other elongate vertebrates, lungfish moved on land with a standing wave pattern of axial muscle activity that closely resembled the pattern observed in terrestrially locomoting salamanders. The similarity in axial motor pattern in salamanders and lungfish suggests that some aspects of neuromuscular control for the axial movements involved in terrestrial locomotion were present before derived appendicular structures.	[Horner, Angela M.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA; [Jayne, Bruce C.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	California State University System; California State University San Bernardino; University System of Ohio; University of Cincinnati	Horner, AM (corresponding author), Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.	ahorner@csusb.edu			NSF [IBN 9983003]; University of Cincinnati	NSF(National Science Foundation (NSF)); University of Cincinnati	NSF grant IBN 9983003 to BCJ and two University of Cincinnati Wieman Awards to AMH provided support for research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ashley-Ross MA, 2004, J EXP BIOL, V207, P461, DOI 10.1242/jeb.00769; BLIGHT AR, 1976, NATURE, V264, P352, DOI 10.1038/264352a0; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Brinkmann H, 2004, P NATL ACAD SCI USA, V101, P4900, DOI 10.1073/pnas.0400609101; CARRIER DR, 1993, J EXP BIOL, V180, P75; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Cullum A. J, 1999, DIDGE IMAGE DIGITIZI; Deban SM, 2009, J EXP BIOL, V212, P2949, DOI 10.1242/jeb.032961; Delvolve I, 1997, J NEUROPHYSIOL, V78, P638, DOI 10.1152/jn.1997.78.2.638; Donley JM, 2003, J EXP BIOL, V206, P1117, DOI 10.1242/jeb.00206; Ellerby DJ, 2001, J EXP BIOL, V204, P2231; Fishman AP, 1987, BIOL EVOLUTION LUNGF, P383; FRICKE H, 1992, ENVIRON BIOL FISH, V34, P329, DOI 10.1007/BF00004739; FROLICH LM, 1992, J EXP BIOL, V162, P107; Gatesy SM, 1996, EVOLUTION, V50, P331, DOI 10.1111/j.1558-5646.1996.tb04496.x; Gillis GB, 2000, J EXP BIOL, V203, P471; Gillis GB, 1998, J EXP BIOL, V201, P3245; Goto T, 1999, ICHTHYOL RES, V46, P281, DOI 10.1007/BF02678514; Hale ME, 2002, EVOLUTION, V56, P993; Horner AM, 2008, J EXP BIOL, V211, P1612, DOI 10.1242/jeb.013029; Ijspeert AJ, 2007, SCIENCE, V315, P1416, DOI 10.1126/science.1138353; JAYNE BC, 1988, J MORPHOL, V197, P159, DOI 10.1002/jmor.1051970204; JAYNE BC, 1995, J EXP BIOL, V198, P585; JAYNE BC, 1993, J COMP PHYSIOL A, V173, P495; Johnels A, 1967, OIKOS, V8, P122; King HM, 2011, P NATL ACAD SCI USA, V108, P21146, DOI 10.1073/pnas.1118669109; Long JH, 1998, AM ZOOL, V38, P771; Pace CM, 2011, J EXP BIOL, V214, P530, DOI 10.1242/jeb.047902; Pace CM, 2014, J FISH BIOL; Pierce SE, 2012, NATURE, V486, P523, DOI 10.1038/nature11124; PRIDMORE PA, 1994, ZOOL-ANAL COMPLEX SY, V98, P278; Ritter D, 1996, J EXP BIOL, V199, P2499; Rosen D. E., 1981, B AMNH, V167, P4; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; WARDLE CS, 1995, J EXP BIOL, V198, P1629; WILLIAMS TL, 1989, J EXP BIOL, V143, P559; Williams TL, 1995, BIOL FLUID DYNAMICS, P49	40	18	18	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96516	10.1371/journal.pone.0096516	http://dx.doi.org/10.1371/journal.pone.0096516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788982	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700104
J	Higgins, BT; VanderGheynst, JS				Higgins, Brendan T.; VanderGheynst, Jean S.			Effects of Escherichia coli on Mixotrophic Growth of Chlorella minutissima and Production of Biofuel Precursors	PLOS ONE			English	Article							WASTE-WATER TREATMENT; ALGINATE BEADS; VULGARIS; ACID; MICROALGAE; REMOVAL; VITAMIN-B12; CULTIVATION; BACTERIA; PIGMENT	Chlorella minutissima was co-cultured with Escherichia coli in airlift reactors under mixotrophic conditions (glucose, glycerol, and acetate substrates) to determine possible effects of bacterial contamination on algal biofuel production. It was hypothesized that E. coli would compete with C. minutissima for nutrients, displacing algal biomass. However, C. minutissima grew more rapidly and to higher densities in the presence of E. coli, suggesting a symbiotic relationship between the organisms. At an initial 1% substrate concentration, the co-culture produced 200-587% more algal biomass than the axenic C. minutissima cultures. Co-cultures grown on 1% substrate consumed 23-737% more of the available carbon substrate than the sum of substrate consumed by E. coli and C. minutissima alone. At 1% substrate, total lipid and starch productivity were elevated in co-cultures compared to axenic cultures indicating that bacterial contamination was not detrimental to the production of biofuel precursors in this specific case. Bio-fouling of the reactors observed in co-cultures and acid formation in all mixotrophic cultures, however, could present challenges for scale-up.	[Higgins, Brendan T.; VanderGheynst, Jean S.] Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	VanderGheynst, JS (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	jsvander@ucdavis.edu		Higgins, Brendan/0000-0001-6854-9612	NSF [DGE-0948021, MCB-1139644]	NSF(National Science Foundation (NSF))	This research was supported by NSF grants DGE-0948021 and MCB-1139644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers E, 1996, APPL ENVIRON MICROB, V62, P3187, DOI 10.1128/AEM.62.9.3187-3195.1996; [Anonymous], 1998, [No title captured]; ATCC, 2013, ATCC MED 5 SPOR AG; Atkins P, 2002, ATKINS PHYS CHEM, P1077; Bajguz A, 2013, PLANT PHYSIOL BIOCH, V71, P290, DOI 10.1016/j.plaphy.2013.08.003; Bianco C, 2006, ARCH MICROBIOL, V185, P373, DOI 10.1007/s00203-006-0103-y; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BRADBEER C, 1976, J BACTERIOL, V128, P99, DOI 10.1128/JB.128.1.99-104.1976; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Clarens AF, 2010, ENVIRON SCI TECHNOL, V44, P1813, DOI 10.1021/es902838n; CLARK DP, 1989, FEMS MICROBIOL LETT, V63, P223, DOI 10.1111/j.1574-6968.1989.tb03398.x; Craggs RJ, 1996, ECOL ENG, V6, P149, DOI 10.1016/0925-8574(95)00056-9; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Davis R, 2011, APPL ENERG, V88, P3524, DOI 10.1016/j.apenergy.2011.04.018; de-Bashan LE, 2002, CAN J MICROBIOL, V48, P514, DOI [10.1139/w02-051, 10.1139/W02-051]; de-Bashan LE, 2008, J PHYCOL, V44, P938, DOI 10.1111/j.1529-8817.2008.00533.x; Devore J. L., 2008, PROBABILITY STAT ENG, P391; FENG C, 1991, J APPL PHYCOL, V3, P203; Garrett R. H., 2012, BIOCHEMISTRY-US, P578; GLADU PK, 1995, J PHYCOL, V31, P774, DOI 10.1111/j.0022-3646.1995.00774.x; GLASS KA, 1992, APPL ENVIRON MICROB, V58, P2513, DOI 10.1128/AEM.58.8.2513-2516.1992; Green FB, 1996, WATER SCI TECHNOL, V33, P207, DOI 10.1016/0273-1223(96)00356-3; Guardabassi L, 2002, WATER RES, V36, P1955, DOI 10.1016/S0043-1354(01)00429-8; HARRIS EH, 1994, MICROBIOL REV, V58, P700, DOI 10.1128/MMBR.58.4.700-754.1994; HUMENIK FJ, 1971, J WATER POLLUT CON F, V43, P580; Kind T, 2012, J CHROMATOGR A, V1244, P139, DOI 10.1016/j.chroma.2012.04.074; Lebsky VK, 2001, CAN J MICROBIOL, V47, P1, DOI 10.1139/cjm-47-1-1; Lee AK, 2009, J APPL PHYCOL, V21, P559, DOI 10.1007/s10811-008-9391-8; Lee YK, 1996, J APPL PHYCOL, V8, P163, DOI 10.1007/BF02186320; Liang YN, 2009, BIOTECHNOL LETT, V31, P1043, DOI 10.1007/s10529-009-9975-7; Silva-Benavides AM, 2012, J APPL PHYCOL, V24, P267, DOI 10.1007/s10811-011-9675-2; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Myers J L, 2010, RES DESIGN STAT ANAL, P191; Ogbonna JC, 2000, J APPL PHYCOL, V12, P277, DOI 10.1023/A:1008188311681; Oppliger A, 2008, ANN OCCUP HYG, V52, P405, DOI 10.1093/annhyg/men021; Oswald W, 1996, SYSTEMS EC ANAL MICR; OSWALD WJ, 1953, SEWAGE IND WASTES, V25, P692; PRATT R, 1965, J PHARM SCI, V54, P871, DOI 10.1002/jps.2600540611; PRATT R, 1966, J PHARM SCI, V55, P799, DOI 10.1002/jps.2600550809; Raszka A, 2006, ACTA HYDROCH HYDROB, V34, P411, DOI 10.1002/aheh.200500640; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; ROESSNER CA, 1995, PROTEIN EXPRES PURIF, V6, P155, DOI 10.1006/prep.1995.1019; Salim S, 2011, J APPL PHYCOL, V23, P849, DOI 10.1007/s10811-010-9591-x; SAWAYAMA S, 1992, APPL MICROBIOL BIOT, V38, P135, DOI 10.1007/BF00169433; Scott D, 2014, INTRO STAT; Sforza E, 2012, BIORESOURCE TECHNOL, V104, P523, DOI 10.1016/j.biortech.2011.10.025; Tanadul OU, 2014, BIOTECHNOL IN PRESS; VANDERDRIFT C, 1977, APPL ENVIRON MICROB, V34, P315, DOI 10.1128/AEM.34.3.315-319.1977; Vazhappilly R, 1998, J AM OIL CHEM SOC, V75, P393, DOI 10.1007/s11746-998-0057-0; Wan MX, 2011, APPL MICROBIOL BIOT, V91, P835, DOI 10.1007/s00253-011-3399-8; Wang HY, 2012, BIORESOURCE TECHNOL, V104, P215, DOI 10.1016/j.biortech.2011.11.020; Wang LA, 2010, APPL BIOCHEM BIOTECH, V162, P1174, DOI 10.1007/s12010-009-8866-7; Woertz I, 2009, J ENVIRON ENG-ASCE, V135, P1115, DOI 10.1061/(ASCE)EE.1943-7870.0000129; Yan RM, 2012, J APPL PHYCOL, V24, P657, DOI 10.1007/s10811-011-9683-2; Zhang K, 2007, WATER RES, V41, P2816, DOI 10.1016/j.watres.2007.03.010; Zhou WG, 2012, BIORESOURCE TECHNOL, V110, P448, DOI 10.1016/j.biortech.2012.01.063	57	46	47	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96807	10.1371/journal.pone.0096807	http://dx.doi.org/10.1371/journal.pone.0096807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805253	Green Submitted, gold, Green Published			2022-12-27	WOS:000335728900098
J	Huang, JC; Chen, SC; Lin, MY; Chang, JM; Hwang, SJ; Tsai, JC; Chen, HC				Huang, Jiun-Chi; Chen, Szu-Chia; Lin, Ming-Yen; Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun			Association of Relatives of Hemodialysis Patients with Metabolic Syndrome, Albuminuria and Framingham Risk Score	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; STAGE RENAL-DISEASE; FAMILY-HISTORY; CARDIOVASCULAR-DISEASE; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; PUBLIC-HEALTH; POPULATION; ARECA	Background and Aim: Metabolic syndrome (MetS), albuminuria, and the Framingham Risk Score (FRS) are significant predictors for cardiovascular disease (CVD). However, the relationship and clinical significance of these CVD predictors in individuals with a family history of end-stage renal disease (ESRD) are unclear. We investigated the association of relatives of hemodialysis (HD) patients with MetS, albuminuria, and the FRS. Methods: One hundred and sixty-six relatives of HD patients and 374 age- and sex-matched community controls were enrolled. MetS was defined using the Adult Treatment Panel III for Asians. Albuminuria was defined as urine albumin-to-creatinine ratio >= 30 mg/g. CVD risk was evaluated by the FRS. Results: A significantly higher prevalence of MetS (19.9% vs. 12.5%, P=0.026), albuminuria (12.7% vs. 5.1%, P=0.002) and high FRS risk >= 10% of 10-year risk (15.7% vs. 8.5%, P=0.013) was found in relatives of HD patients compared to their counterpart controls. In multivariate analysis, being relatives of HD patients (vs. controls) was an independent determinant for MetS (odds ratio [OR], 1.785; 95% confidence interval [CI], 1.045 to 3.050), albuminuria (OR, 2.891; 95% CI, 1.431 to 5.841), and high FRS risk (OR, 1.863; 95% CI, 1.015 to 3.418). Higher low-density lipoprotein cholesterol (OR, 1.034; 95% CI, 1.017 to 1.052) and betel nut chewing (OR, 13.994; 95% CI, 3.384 to 57.871) were independent determinants for having a high FRS risk in relatives of HD patients. Conclusions: Being relatives of HD patients was independently associated with MetS, albuminuria and high FRS risk, suggesting family members of ESRD patients may have higher CVD risks through the interactions of renal risk factors. Proactive surveillance of these CVD predictors and preventive strategies should be targeted to this high-risk population.	[Huang, Jiun-Chi; Chen, Szu-Chia; Lin, Ming-Yen; Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan; [Huang, Jiun-Chi; Chen, Szu-Chia; Chang, Jer-Ming] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Med Univ, Fac Med, Kaohsiung, Taiwan; [Chang, Jer-Ming; Hwang, Shang-Jyh; Tsai, Jer-Chia; Chen, Hung-Chun] Kaohsiung Med Univ, Coll Med, Fac Renal Care, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Tsai, JC (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Nephrol, Kaohsiung, Taiwan.	jerchia@kmu.edu.tw	Lin, Ming Yen/A-8637-2010; 蘇, 河名/AAE-9843-2019; Huang, Jiun-Chi/AAI-2494-2021	Lin, Ming Yen/0000-0002-8194-4833; Huang, Jiun-Chi/0000-0002-5897-2860				Alexander MP, 2009, AM J KIDNEY DIS, V53, P751, DOI 10.1053/j.ajkd.2009.01.255; Bello AK, 2008, AM J KIDNEY DIS, V52, P434, DOI 10.1053/j.ajkd.2007.12.034; Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guh JY, 2006, AM J CLIN NUTR, V83, P1313, DOI 10.1093/ajcn/83.6.1313; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hong YL, 1997, AM J HUM GENET, V60, P143; Jurkovitz C, 2005, AM J KIDNEY DIS, V46, P11, DOI 10.1053/j.ajkd.2005.04.012; Jurkovitz C, 2002, AM J KIDNEY DIS, V40, P1173, DOI 10.1053/ajkd.2002.36866; Kong XL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-19; Lai KC, 2006, MUTAT RES-FUND MOL M, V599, P66, DOI 10.1016/j.mrfmmm.2006.01.005; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Lei HH, 1998, J AM SOC NEPHROL, V9, P1270; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Massy ZA, 2013, KIDNEY INT, V84, P451, DOI 10.1038/ki.2013.181; McClellan W, 2007, J AM SOC NEPHROL, V18, P1344, DOI 10.1681/ASN.2006090952; McClellan WM, 2012, AM J KIDNEY DIS, V59, P25, DOI 10.1053/j.ajkd.2011.09.018; McClellan WM, 2009, AM J KIDNEY DIS, V53, pS100, DOI 10.1053/j.ajkd.2008.07.059; McCullough PA, 2007, ARCH INTERN MED, V167, P1122, DOI 10.1001/archinte.167.11.1122; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; O'Dea DF, 1998, AM J KIDNEY DIS, V32, P794, DOI 10.1016/S0272-6386(98)70135-0; Palaniappan L, 2003, AM J HYPERTENS, V16, P952, DOI 10.1016/S0895-7061(03)01009-4; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Shafique K, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-22; Singh AK, 2013, CURR OPIN NEPHROL HY, V22, P198, DOI 10.1097/MNH.0b013e32835dda78; Speckman RA, 2006, AM J KIDNEY DIS, V48, P50, DOI 10.1053/j.ajkd.2006.03.086; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Tsai JC, 2010, AM J KIDNEY DIS, V55, P856, DOI 10.1053/j.ajkd.2009.12.021; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Xiang AH, 2001, CIRCULATION, V103, P78; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070679; Yoon PW, 2002, GENET MED, V4, P304, DOI 10.1097/00125817-200207000-00009	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96362	10.1371/journal.pone.0096362	http://dx.doi.org/10.1371/journal.pone.0096362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804770	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900052
J	Richman, NI; Gibbons, JM; Turvey, ST; Akamatsu, T; Ahmed, B; Mahabub, E; Smith, BD; Jones, JPG				Richman, Nadia I.; Gibbons, James M.; Turvey, Samuel T.; Akamatsu, Tomonari; Ahmed, Benazir; Mahabub, Emile; Smith, Brian D.; Jones, Julia P. G.			To See or Not to See: Investigating Detectability of Ganges River Dolphins Using a Combined Visual-Acoustic Survey	PLOS ONE			English	Article							YANGTZE FINLESS PORPOISE; PLATANISTA-GANGETICA; INIA-GEOFFRENSIS; NEOPHOCAENA-PHOCAENOIDES; DETECTION PROBABILITY; IRRAWADDY DOLPHINS; ABUNDANCE; CONSERVATION; PATTERN; POPULATIONS	Detection of animals during visual surveys is rarely perfect or constant, and failure to account for imperfect detectability affects the accuracy of abundance estimates. Freshwater cetaceans are among the most threatened group of mammals, and visual surveys are a commonly employed method for estimating population size despite concerns over imperfect and unquantified detectability. We used a combined visual-acoustic survey to estimate detectability of Ganges River dolphins (Platanista gangetica gangetica) in four waterways of southern Bangladesh. The combined visual-acoustic survey resulted in consistently higher detectability than a single observer-team visual survey, thereby improving power to detect trends. Visual detectability was particularly low for dolphins close to meanders where these habitat features temporarily block the view of the preceding river surface. This systematic bias in detectability during visual-only surveys may lead researchers to underestimate the importance of heavily meandering river reaches. Although the benefits of acoustic surveys are increasingly recognised for marine cetaceans, they have not been widely used for monitoring abundance of freshwater cetaceans due to perceived costs and technical skill requirements. We show that acoustic surveys are in fact a relatively cost-effective approach for surveying freshwater cetaceans, once it is acknowledged that methods that do not account for imperfect detectability are of limited value for monitoring.	[Richman, Nadia I.; Turvey, Samuel T.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Richman, Nadia I.; Gibbons, James M.; Jones, Julia P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Akamatsu, Tomonari] Fisheries Res Agcy, Natl Res Inst Fisheries Engn, Kamisu, Ibaraki, Japan; [Ahmed, Benazir] Univ Chittagong, Dept Zool, Chittagong, Bangladesh; [Ahmed, Benazir; Mahabub, Emile; Smith, Brian D.] Wildlife Conservat Soc, Bangladesh Cetacean Div Project, Khulna, Bangladesh; [Smith, Brian D.] Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA	Zoological Society of London; Bangor University; Japan Fisheries Research & Education Agency (FRA); University of Chittagong; Wildlife Conservation Society	Richman, NI (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	nadia.richman@ioz.ac.uk	Gibbons, James/A-1143-2010; Jones, Julia P G/ABD-5629-2021; Jones, Julia P G/A-3031-2011	Gibbons, James/0000-0002-0083-9872; Jones, Julia P G/0000-0002-5199-3335; Jones, Julia P G/0000-0002-5199-3335; Richman, Nadia/0000-0003-4072-1622	Natural Environment Research Council [NE/I528734/1]; CREST; Japan Science and Technology Agency; Natural Environment Research Council [958878] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council [grant number NE/I528734/1] and CREST, Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T., 2008, HDB SIGNAL PROCESSIN, P1897; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Akamatsu T, 2013, J ACOUST SOC AM, V134, P2418, DOI 10.1121/1.4816554; Akbar M, 2004, J APPL SCI, V4, P21; Aliaga-Rossel Enzo, 2002, Aquatic Mammals, V28, P312; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Barlow J, 1997, MAR MAMMAL SCI, V13, P44, DOI 10.1111/j.1748-7692.1997.tb00611.x; Barlow Jay, 2005, Journal of Cetacean Research and Management, V7, P263; Bashir T, 2013, MAMM STUDY, V38, P9, DOI 10.3106/041.038.0110; Bashir T, 2010, AQUAT MAMM, V36, P19, DOI 10.1578/AM.36.1.2010.19; Bashir Tawqir, 2010, Journal of Threatened Taxa, V2, P1087; Beasley I, 2013, MAR MAMMAL SCI, V29, pE226, DOI 10.1111/j.1748-7692.2012.00614.x; Behera S, 2006, CONSERVATION GANGES; Biswas SP, 2000, HYDROBIOLOGIA, V430, P97, DOI 10.1023/A:1004077215276; Braulik Gillian T., 2012, Endangered Species Research, V17, P201, DOI 10.3354/esr00425; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Gerrodette T, 2000, TRENDS VERSION 3 0; GONZALEZ FT, 1994, MAR MAMMAL SCI, V10, P348, DOI 10.1111/j.1748-7692.1994.tb00489.x; Gregory Paul R., 2001, Aquatic Mammals, V27, P105; HERALD ES, 1969, SCIENCE, V166, P1408, DOI 10.1126/science.166.3911.1408; Jensen FH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059284; KANNAN K, 1993, MAR POLLUT BULL, V26, P159, DOI 10.1016/0025-326X(93)90128-7; KANNAN K, 1994, TOXICOL ENVIRON CHEM, V42, P249, DOI 10.1080/02772249409358010; Katsanevakis S, 2012, AQUAT BIOL, V16, P31, DOI 10.3354/ab00426; Keane A, 2012, ANIM CONSERV, V15, P457, DOI 10.1111/j.1469-1795.2012.00575.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Khatri Top Bahadur, 2010, Journal of Threatened Taxa, V2, P1365; Kimura S, 2010, J ACOUST SOC AM, V128, P1435, DOI 10.1121/1.3442574; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Kojima J, 2011, OCEANS, V4, P1; Kooyman G, 2008, ENCY MARINE MAMMALS, P327; Kreb D., 2004, Journal of Cetacean Research and Management, V6, P269; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2010, J ACOUST SOC AM, V128, P1476, DOI 10.1121/1.3455829; Liu Renjun, 1994, Aquatic Mammals, V20, P39; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; McConville A. J., 2009, Endangered Species Research, V6, P231, DOI 10.3354/esr00166; Mei ZG, 2012, BIOL CONSERV, V153, P192, DOI 10.1016/j.biocon.2012.04.029; Motwani MP, 1961, J BOMBAY NAT HIST SO, V58, P285; Pilleri G, 1976, INVESTIG CETACEA, V6, P13; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reeves R.R., 2000, BIOL CONSERVATION FR; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Secchi Eduardo R., 2001, Journal of Cetacean Research and Management, V3, P95; Singh Hari, 2012, Zoos' Print, V27, P18; Sinha R. K., 2003, Journal of the Bombay Natural History Society, V100, P27; Sinha R.K., 1997, International Journal of Ecology and Environmental Sciences, V23, P343; Sinha RK, 2010, CURR SCI INDIA, V98, P230; Smith BD, 2001, ORYX, V35, P61, DOI 10.1046/j.1365-3008.2001.00153.x; Smith BD, 1998, ENVIRON MANAGE, V22, P323, DOI 10.1007/s002679900108; Smith BD, 2000, BIOL CONSERVATION FR, P97, DOI DOI 10.1177/004057368303900411; Smith BD, 2008, IUCN 2011 IUCN RED L; Smith BD, 2006, MAR MAMMAL SCI, V22, P527, DOI 10.1111/j.1748-7692.2006.00041.x; Smith Brian D., 2012, Journal of Marine Biology, P1; Sutaria D, 2011, MAR MAMMAL SCI, V27, pE338, DOI 10.1111/j.1748-7692.2011.00471.x; SYLVESTRE J-P, 1985, Aquatic Mammals, V11, P58; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Vidal O, 1997, MAR MAMMAL SCI, V13, P427, DOI 10.1111/j.1748-7692.1997.tb00650.x; Wakid A., 2009, PROTECTION ENDANGERE; WaveMetrics Inc, 2011, LAK OSW; Weber PW, 2009, J EXP BIOL, V212, P2149, DOI 10.1242/jeb.029868; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams R, 2009, BIOL CONSERV, V142, P1542, DOI 10.1016/j.biocon.2008.12.028; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zhou K., 1998, Aquatic Mammals, V24, P123	79	21	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e96811	10.1371/journal.pone.0096811	http://dx.doi.org/10.1371/journal.pone.0096811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24805782	Green Published, gold, Green Submitted			2022-12-27	WOS:000335728900100
J	Chetty-Makkan, CM; Fielding, K; Feldblum, PJ; Price, MA; Kruger, P; Makkan, H; Charalambous, S; Latka, MH				Chetty-Makkan, Candice M.; Fielding, Katherine; Feldblum, Paul J.; Price, Matt A.; Kruger, Petra; Makkan, Heeran; Charalambous, Salome; Latka, Mary H.			Pregnancy Incidence and Correlates in a Clinical Trial Preparedness Study, North West Province South Africa	PLOS ONE			English	Article							HIV PREVENTION TRIALS; CONTRACEPTIVE USE; WOMEN; ACQUISITION; OUTCOMES; RATES; GEL	Introduction: Women in HIV prevention trials often must typically agree to avoid pregnancy. Regardless, some become pregnant. Screening tools predicting pregnancy risk could maximize trial safety and efficiency. Objectives: We assessed incidence and correlates of pregnancy among women at high HIV risk. Methods: We enrolled sexually-active, HIV-negative women into an observational cohort (2008-2011). At enrolment demographic, contraceptive, reproductive, pregnancy intention and behavioural data were collected. Women reported if one or both partners wanted or intended for the couple to become pregnant. We measured gender role beliefs using a locally validated eight-point index. We tested HIV and pregnancy, and inquired about sexually transmitted infection symptoms (STIs) at enrollment and monthly. HIV testing included behavioural counselling and condom provision, but did not specifically counsel women to avoid pregnancy. Cox proportional hazard modelling evaluated the associations with pregnancy. The multivariate model included the following variables "Recent pregnancy attempts'', "Gender Roles Beliefs'', "Self-reported STIs'' and "Age''. Results: We screened 1068 women and excluded (24.6%, 263/1068) who did not report risk behaviour. Non-pregnant, non-sterilized women aged 18-35 (median = 21 years) enrolled (n = 438). Most women reported one partner (74.7%) and a prior live birth (84.6%). Median follow-up time was 6 months (range 0.7-15.5). Pregnancy incidence was 25.1 per 100 women-years (n = 57 pregnancies). Conservative beliefs on gender roles (Adjusted Hazard Ratio (aHR) 1.8; 95% confidence interval [CI] 1.1-2.9), recent pregnancy attempts (aHR 1.9; 95% CI 1.1-3.4) and baseline self-reported STI (aHR 2.5; 95% CI 1.4-4.4) were associated with increased incident pregnancy. Report of no pregnancy intention was associated with lowered pregnancy risk (aHR 0.3; 95% CI 0.1-0.7). Conclusions: We identified new and confirmed existing factors that can facilitate screening for pregnancy risk.	[Chetty-Makkan, Candice M.; Kruger, Petra; Makkan, Heeran; Charalambous, Salome; Latka, Mary H.] Aurum Inst, Rustenburg, South Africa; [Fielding, Katherine] London Sch Hyg & Trop Med, London WC1, England; [Feldblum, Paul J.] FHI 360, Durham, NC USA; [Price, Matt A.] Int Aids Vaccine Initiat, New York, NY USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of London; London School of Hygiene & Tropical Medicine; FHI 360; International AIDS Vaccine Initiative; University of California System; University of California San Francisco	Chetty-Makkan, CM (corresponding author), Aurum Inst, Rustenburg, South Africa.	cchetty@auruminstitute.org	Makkan, Heeran/GXI-0465-2022; Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Charalambous, Salome/0000-0001-7143-1009; Makkan, Heeran/0000-0002-4737-7804	U.S. Agency for International Development Contraceptive and Reproductive Health Technologies Research and Utilization agreement [GPO-A-00-05-00022-00]; Medical Research Council [MR/K012126/1] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, R25MH064712] Funding Source: NIH RePORTER	U.S. Agency for International Development Contraceptive and Reproductive Health Technologies Research and Utilization agreement(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by U.S. Agency for International Development Contraceptive and Reproductive Health Technologies Research and Utilization agreement (GPO-A-00-05-00022-00). The funders were involved in the study design of the protocols that were implemented at the site. The Aurum Institute conceptualised the idea for the manuscript and the funders provided technical guidance. The funders were part of the review process while the manuscript was being compiled.	[Anonymous], 2003, STAND TREATM GUID ES; [Anonymous], 2011, STAT S AFRICA CENSUS; [Anonymous], 2002, ECRI HLTH TECHN ASS, V74, P1; Baggaley R, 2011, HIV PREVENTION GENER; Bojanala Platinum District Municipality, 2009, REV INT DEV PLAN; Dott M, 2010, MATERN CHILD HLTH J, V14, P373, DOI 10.1007/s10995-009-0458-1; Gupta GR, 2000, PROJECT NEWSLETTER, V30, P18; Halpern V, 2011, CONTRACEPTION, V83, P436, DOI 10.1016/j.contraception.2010.08.018; Haub Carl, 2007, WORLD POPULATION DAT; Heinrich J, 2001, WOMEN SUFFICIENTLY R; Johnson LF, 2005, SEX TRANSM INFECT, V81, P287, DOI 10.1136/sti.2004.013904; Kapina M, 2009, SEX TRANSM DIS, V36, P129, DOI 10.1097/OLQ.0b013e318190191d; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kost K, 1998, FAM PLANN PERSPECT, V30, P79, DOI 10.2307/2991664; Latka MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031387; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Meinert CL, 2000, CONTROL CLIN TRIALS, V21, P462, DOI 10.1016/S0197-2456(00)00086-6; Meyer-Weitz A, 1998, AIDS CARE, V10, pS39, DOI 10.1080/09540129850124352; Nanda Geeta, 2011, COMP GEND SCAL; Nel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035278; Odutola A, 2012, SEX TRANSM INFECT, V88, P436, DOI 10.1136/sextrans-2011-050412; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Price MA, 2012, JAIDS-J ACQ IMM DEF, V59, P185, DOI 10.1097/QAI.0b013e31823d8693; Ramjee G, 2008, JAIDS-J ACQ IMM DEF, V47, P93, DOI 10.1097/QAI.0b013e31815c71f7; Reid SE, 2010, JAIDS-J ACQ IMM DEF, V53, P606, DOI 10.1097/QAI.0b013e3181bc4869; Shisana O., 2009, S AFRICAN NATL HIV P; Sibeko S, 2011, OBSTET GYNECOL, V118, P895, DOI 10.1097/AOG.0b013e31822be512; Sidibe M, 2012, UNAID REPORT GLOBAL; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Skoler S, 2006, MICROBICIDE Q, V4, P1; ULIN PR, 1992, SOC SCI MED, V34, P63, DOI 10.1016/0277-9536(92)90068-2; Vallely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010661	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95708	10.1371/journal.pone.0095708	http://dx.doi.org/10.1371/journal.pone.0095708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802651	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000338029800033
J	de Hevia, MD; Girelli, L; Addabbo, M; Cassia, VM				de Hevia, Maria Dolores; Girelli, Luisa; Addabbo, Margaret; Cassia, Viola Macchi			Human Infants' Preference for Left-to-Right Oriented Increasing Numerical Sequences	PLOS ONE			English	Article							LINE BISECTION; SPATIAL REPRESENTATION; MENTAL REPRESENTATION; READING HABITS; BRAIN-DAMAGE; NUMBER-SPACE; MAGNITUDE; TIME; DISCRIMINATION; SPECIALIZATION	While associations between number and space, in the form of a spatially oriented numerical representation, have been extensively reported in human adults, the origins of this phenomenon are still poorly understood. The commonly accepted view is that this number-space association is a product of human invention, with accounts proposing that culture, symbolic knowledge, and mathematics education are at the roots of this phenomenon. Here we show that preverbal infants aged 7 months, who lack symbolic knowledge and mathematics education, show a preference for increasing magnitude displayed in a left-to-right spatial orientation. Infants habituated to left-to-right oriented increasing or decreasing numerical sequences showed an overall higher looking time to new left-to-right oriented increasing numerical sequences at test (Experiment 1). This pattern did not hold when infants were presented with the same ordinal numerical information displayed from right to left (Experiment 2). The different pattern of results was congruent with the presence of a malleable, context-dependent baseline preference for increasing, left-to-right oriented, numerosities (Experiment 3). These findings are suggestive of an early predisposition in humans to link numerical order with a left-to-right spatial orientation, which precedes the acquisition of symbolic abilities, mathematics education, and the acquisition of reading and writing skills.	[de Hevia, Maria Dolores] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France; [de Hevia, Maria Dolores] INSERM, U992, NeuroSpin, Cognit NeuroImaging Unit, Saclay, France; [Girelli, Luisa; Addabbo, Margaret; Cassia, Viola Macchi] Univ Milano Bicocca, Dept Psychol, Milan, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Milano-Bicocca	de Hevia, MD (corresponding author), Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8158, Paris, France.	dehevialola@gmail.com	addabbo, margaret/ABD-5240-2020; Macchi Cassia, Viola/HCI-2058-2022	addabbo, margaret/0000-0002-8414-6853; macchi cassia, viola/0000-0002-9983-8254				Balas B, 2011, DEVELOPMENTAL SCI, V14, P892, DOI 10.1111/j.1467-7687.2011.01039.x; Barth H, 2008, DEV PSYCHOL, V44, P1466, DOI 10.1037/a0013046; Berch DB, 1999, J EXP CHILD PSYCHOL, V74, P286, DOI 10.1006/jecp.1999.2518; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Brannon EM, 2006, J EXP PSYCHOL-ANIM B, V32, P120, DOI 10.1037/0097-7403.32.2.120; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Brannon EM, 2002, COGNITION, V83, P223, DOI 10.1016/S0010-0277(02)00005-7; Brannon EM, 2000, J EXP PSYCHOL ANIM B, V26, P31, DOI 10.1037/0097-7403.26.1.31; Briars D.J., 1988, CHILDRENS COUNTING C, P63; Bulf H, 2011, COGNITION, V121, P127, DOI 10.1016/j.cognition.2011.06.010; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Cassia VM, 2012, COGNITION, V124, P183, DOI 10.1016/j.cognition.2012.05.004; Chokron S, 1995, COGNITIVE BRAIN RES, V3, P51, DOI 10.1016/0926-6410(95)00018-6; Chokron S, 1998, COGNITIVE BRAIN RES, V7, P173, DOI 10.1016/S0926-6410(98)00022-6; CHOKRON S, 1993, COGNITIVE BRAIN RES, V1, P219, DOI 10.1016/0926-6410(93)90005-P; Dadda M, 2009, P ROY SOC B-BIOL SCI, V276, P4399, DOI 10.1098/rspb.2009.1406; de Hevia MD, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00466; de Hevia MD, 2011, COGNITION, V121, P253, DOI 10.1016/j.cognition.2011.04.002; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; de Hevia MD, 2006, EXP BRAIN RES, V168, P254, DOI 10.1007/s00221-005-0084-0; de Hevia MD, 2014, P NATL ACAD SCI; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; DESCHONEN S, 1990, CHILD DEV, V61, P1192, DOI 10.2307/1130887; Doricchi F, 2002, NEUROPSYCHOLOGIA, V40, P1118, DOI 10.1016/S0028-3932(02)00011-8; Farroni T, 2000, PERCEPTION, V29, P355; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2006, CORTEX, V42, P1066, DOI 10.1016/S0010-9452(08)70218-1; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Galton F., 1880, NATURE, V21, P252, DOI [10.1038/021252a0, DOI 10.1038/021252A0]; Gebuis T, 2011, COGNITION, V121, P248, DOI 10.1016/j.cognition.2010.09.008; Gelman R., 1978, CHILDS UNDERSTANDING; Gevers W, 2003, COGNITION, V87, pB87, DOI 10.1016/S0010-0277(02)00234-2; Haith MM, 1980, RULES BABIES LOOK O; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hyde DC, 2010, NEUROIMAGE, V53, P647, DOI 10.1016/j.neuroimage.2010.06.030; Izard V, 2008, PLOS BIOL, P6; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kamii C., 2001, J MATH BEHAV, V20, P33, DOI [10.1016/S0732-3123(01)00060-8, DOI 10.1016/S0732-3123(01)00060-8]; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Lewkowicz DJ, 2004, DEVELOPMENTAL SCI, V7, P175, DOI 10.1111/j.1467-7687.2004.00336.x; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; Loetscher T, 2010, CURR BIOL, V20, pR264, DOI 10.1016/j.cub.2010.01.015; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; Macchi Cassia VM, INFANTS ASYMME UNPUB; McCourt ME, 1997, NEUROPSYCHOLOGIA, V35, P369, DOI 10.1016/S0028-3932(96)00143-1; McCrink K, 2004, PSYCHOL SCI, V15, P776, DOI 10.1111/j.0956-7976.2004.00755.x; McCrink K, 2011, PARENTAL TRANSMISSIO; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Opfer JE, 2010, DEVELOPMENTAL SCI, V13, P761, DOI 10.1111/j.1467-7687.2009.00934.x; Patro K, 2012, J EXP CHILD PSYCHOL, V111, P534, DOI 10.1016/j.jecp.2011.09.006; Picozzi M, 2010, J EXP CHILD PSYCHOL, V107, P359, DOI 10.1016/j.jecp.2010.05.005; Previtali P, 2010, EXP BRAIN RES, V201, P599, DOI 10.1007/s00221-009-2063-3; Ranzini M, 2012, ATTEN PERCEPT PSYCHO, V74, P1001, DOI 10.3758/s13414-012-0302-3; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; Rosen G.D., 1987, DUALITY UNITY BRAIN, P29; Rugani R, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00150; Rugani R, 2011, NEUROBIOL LEARN MEM, V95, P231, DOI 10.1016/j.nlm.2010.11.012; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Rusconi E, 2006, COGNITION, V99, P113, DOI 10.1016/j.cognition.2005.01.004; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Shaki S, 2008, COGNITION, V108, P590, DOI 10.1016/j.cognition.2008.04.001; Shaki S, 2012, J EXP CHILD PSYCHOL, V112, P275, DOI 10.1016/j.jecp.2011.12.005; Shinskey JL, 2009, J EXP CHILD PSYCHOL, V103, P409, DOI 10.1016/j.jecp.2009.01.012; SLATER A, 1977, CHILD DEV, V48, P545, DOI 10.1111/j.1467-8624.1977.tb01196.x; SLATER A, 1985, J EXP CHILD PSYCHOL, V39, P37, DOI 10.1016/0022-0965(85)90028-1; STARKEY P, 1980, SCIENCE, V210, P1033, DOI 10.1126/science.7434014; Suanda SH, 2008, INFANCY, V13, P308, DOI 10.1080/15250000802188800; Thiebaut de Schotten M, 2011, NAT NEUROSCI, V14, P1245, DOI 10.1038/nn.2905; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P454, DOI 10.1006/nimg.2001.0979; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; van Dijck JP, 2011, NEUROPSYCHOLOGIA, V49, P2570, DOI 10.1016/j.neuropsychologia.2011.05.005; van Dijck JP, 2011, COGNITION, V119, P114, DOI 10.1016/j.cognition.2010.12.013; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Zebian S, 2005, J COGN CULT, V5, P165, DOI 10.1163/1568537054068660; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a; Zorzi M, 2006, NEUROPSYCHOLOGIA, V44, P1061, DOI 10.1016/j.neuropsychologia.2005.10.025	91	89	89	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96412	10.1371/journal.pone.0096412	http://dx.doi.org/10.1371/journal.pone.0096412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802083	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800068
J	Ravenna, L; Principessa, L; Verdina, A; Salvatori, L; Russo, MA; Petrangeli, E				Ravenna, Linda; Principessa, Lorenzo; Verdina, Alessandra; Salvatori, Luisa; Russo, Matteo Antonio; Petrangeli, Elisa			Distinct Phenotypes of Human Prostate Cancer Cells Associate with Different Adaptation to Hypoxia and Pro-Inflammatory Gene Expression	PLOS ONE			English	Article							NF-KAPPA-B; LUNG EPITHELIAL-CELLS; UP-REGULATION; SESQUITERPENE LACTONE; PARTHENOLIDE; METASTASIS; INHIBITOR; SURVIVAL; INVASION; HIF-1	Hypoxia and inflammation are strictly interconnected both concurring to prostate cancer progression. Numerous reports highlight the role of tumor cells in the synthesis of pro-inflammatory molecules and show that hypoxia can modulate a number of these genes contributing substantially to the increase of cancer aggressiveness. However, little is known about the importance of the tumor phenotype in this process. The present study explores how different features, including differentiation and aggressiveness, of prostate tumor cell lines impact on the hypoxic remodeling of pro-inflammatory gene expression and malignancy. We performed our studies on three cell lines with increasing metastatic potential: the well differentiated androgen-dependent LNCaP and the less differentiated and androgen-independent DU145 and PC3. We analyzed the effect that hypoxic treatment has on modulating pro-inflammatory gene expression and evaluated the role HIF isoforms and NF-kB play in sustaining this process. DU145 and PC3 cells evidenced a higher normoxic expression and a more complete hypoxic induction of pro-inflammatory molecules compared to the well differentiated LNCaP cell line. The role of HIF1 alpha and NF-kB, the master regulators of hypoxia and inflammation respectively, in sustaining the hypoxic pro-inflammatory phenotype was different according to cell type. NF-kB was observed to play a main role in DU145 and PC3 cells in which treatment with the NF-kB inhibitor parthenolide was able to counteract both the hypoxic pro-inflammatory shift and HIF1a activation but not in LNCaP cells. Our data highlight that tumor prostate cell phenotype contributes at a different degree and with different mechanisms to the hypoxic pro-inflammatory gene expression related to tumor progression.	[Ravenna, Linda; Salvatori, Luisa; Petrangeli, Elisa] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Ravenna, Linda; Verdina, Alessandra; Salvatori, Luisa] Regina Elena Inst Canc Res, CRS, Dept Dev Therapeut Programs, Rome, Italy; [Principessa, Lorenzo] Univ Roma La Sapienza, Dept Sensory Organs, I-00185 Rome, Italy; [Principessa, Lorenzo; Petrangeli, Elisa] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Russo, Matteo Antonio; Petrangeli, Elisa] IRCCS San Raffaele Pisana, Dept Cellular & Mol Pathol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Sapienza University Rome; IRCCS San Raffaele Pisana	Ravenna, L (corresponding author), CNR, Inst Mol Biol & Pathol, Rome, Italy.	linda.ravenna@uniroma1.it	Russo, Matteo/AAD-7733-2021; Verdina, Alessandra/ABH-7405-2020; Salvatori, Luisa/AAK-9365-2021; Verdina, Alessandra/H-8868-2017	Verdina, Alessandra/0000-0001-9972-9237; Verdina, Alessandra/0000-0001-9972-9237	Ministry of Education University and Research (MIUR) [COFIN 2006062242]	Ministry of Education University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported in part by the Ministry of Education University and Research (MIUR, COFIN 2006062242). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi T, 2008, CANCER SCI, V99, P539, DOI 10.1111/j.1349-7006.2007.00712.x; Bruning U, 2012, CELL MOL LIFE SCI, V69, P1319, DOI 10.1007/s00018-011-0876-2; Burrows N, 2011, J THROID RES, V2011, DOI 10.4061/2011/762905; Chien CW, 2008, CLIN CANCER RES, V14, P8043, DOI 10.1158/1078-0432.CCR-08-1651; Dai Y, 2011, INT J RADIAT ONCOL, V81, P521, DOI 10.1016/j.ijrobp.2011.04.027; Dalrymple S, 2005, CANCER RES, V65, P9269, DOI 10.1158/0008-5472.CAN-04-3989; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; De Santis E, 2013, BIOMED PHARMACOTHER, V67, P7, DOI 10.1016/j.biopha.2012.08.003; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Ferrando M, 2011, ANGIOGENESIS, V14, P467, DOI 10.1007/s10456-011-9230-4; Fitzpatrick SF, 2011, J IMMUNOL, V186, P1091, DOI 10.4049/jimmunol.1002256; Gueron G, 2012, PROSTATE CANCER P D, V15, P213, DOI 10.1038/pcan.2011.64; Gueron G, 2009, MOL CANCER RES, V7, P1745, DOI 10.1158/1541-7786.MCR-08-0325; Hehner SP, 1999, J IMMUNOL, V163, P5617; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Marignol L, 2008, CANCER TREAT REV, V34, P313, DOI 10.1016/j.ctrv.2008.01.006; Mathema VB, 2012, INFLAMMATION, V35, P560, DOI 10.1007/s10753-011-9346-0; Matsuo Y, 2014, J HEPATO-BIL-PAN SCI, V21, P105, DOI 10.1002/jhbp.6; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Patra N, 2013, BIOMED PHARMACOTHER, V67, P407, DOI 10.1016/j.biopha.2013.01.006; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rane JK, 2012, NAT REV UROL, V9, P595, DOI 10.1038/nrurol.2012.157; Ratcliffe PJ, 2007, J CLIN INVEST, V117, P862, DOI 10.1172/JCI31750; Ravenna L, 2009, PROSTATE, V69, P1245, DOI 10.1002/pros.20966; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rojas A, 2010, CARCINOGENESIS, V31, P334, DOI 10.1093/carcin/bgp322; Salvatori L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031467; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sharma P, 2012, CANCER MED-US, V1, P176, DOI 10.1002/cam4.16; Stewart GD, 2010, BJU INT, V105, P8, DOI 10.1111/j.1464-410X.2009.08921.x; Tafani M, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00013; Tafani M, 2011, CARCINOGENESIS, V32, P1167, DOI 10.1093/carcin/bgr101; Tafani M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-32; Tafani M, 2010, CANCER SCI, V101, P1014, DOI 10.1111/j.1349-7006.2010.01493.x; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Taylor CT, 2009, ANN NY ACAD SCI, V1177, P178, DOI 10.1111/j.1749-6632.2009.05024.x; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Webber MM, 1997, PROSTATE, V30, P58; Wong CP, 2009, CANCER LETT, V276, P38, DOI 10.1016/j.canlet.2008.10.025	46	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96250	10.1371/journal.pone.0096250	http://dx.doi.org/10.1371/journal.pone.0096250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801981	gold, Green Submitted, Green Published			2022-12-27	WOS:000338029800048
J	Tomic, S; Dokic, J; Vasilijic, S; Ogrinc, N; Rudolf, R; Pelicon, P; Vucevic, D; Milosavljevic, P; Jankovic, S; Anzel, I; Rajkovic, J; Rupnik, MS; Friedrich, B; Colic, M				Tomic, Sergej; Dokic, Jelena; Vasilijic, Sasa; Ogrinc, Nina; Rudolf, Rebeka; Pelicon, Primoz; Vucevic, Dragana; Milosavljevic, Petar; Jankovic, Srda; Anzel, Ivan; Rajkovic, Jelena; Rupnik, Marjan Slak; Friedrich, Bernd; Colic, Miodrag			Size-Dependent Effects of Gold Nanoparticles Uptake on Maturation and Antitumor Functions of Human Dendritic Cells In Vitro	PLOS ONE			English	Article							IMMUNE-SYSTEM; CANCER-CELLS; CYTOTOXICITY; TOXICITY; TLR4; PATHWAY	Gold nanoparticles (GNPs) are claimed as outstanding biomedical tools for cancer diagnostics and photo-thermal therapy, but without enough evidence on their potentially adverse immunological effects. Using a model of human dendritic cells (DCs), we showed that 10 nm- and 50 nm-sized GNPs (GNP(10) and GNP(50), respectively) were internalized predominantly via dynamin-dependent mechanisms, and they both impaired LPS-induced maturation and allostimulatory capacity of DCs, although the effect of GNP(10) was more prominent. However, GNP(10) inhibited LPS-induced production of IL-12p70 by DCs, and potentiated their Th2 polarization capacity, while GNP(50) promoted Th17 polarization. Such effects of GNP(10) correlated with a stronger inhibition of LPS-induced changes in Ca2+ oscillations, their higher number per DC, and more frequent extra-endosomal localization, as judged by live-cell imaging, proton, and electron microscopy, respectively. Even when released from heat-killed necrotic HEp-2 cells, GNP(10) inhibited the necrotic tumor cell-induced maturation and functions of DCs, potentiated their Th2/Th17 polarization capacity, and thus, impaired the DCs' capacity to induce T cell-mediated anti-tumor cytotoxicity in vitro. Therefore, GNP(10) could potentially induce more adverse DC-mediated immunological effects, compared to GNP(50).	[Tomic, Sergej; Dokic, Jelena; Vasilijic, Sasa; Vucevic, Dragana; Colic, Miodrag] Univ Def, Mil Med Acad, Fac Med, Belgrade, Serbia; [Tomic, Sergej; Vasilijic, Sasa; Vucevic, Dragana; Milosavljevic, Petar] Univ Def, Mil Med Acad, Inst Med Res, Belgrade, Serbia; [Ogrinc, Nina; Pelicon, Primoz] Jozef Stefan Inst, Microanalyt Ctr, Ljubljana, Slovenia; [Ogrinc, Nina] LOTRIC Metrol, Selca, Slovenia; [Rudolf, Rebeka; Anzel, Ivan] Univ Maribor, Fac Mech Engn, SLO-2000 Maribor, Slovenia; [Rudolf, Rebeka] Zlatarna Celje Dd, Celje, Slovenia; [Jankovic, Srda] Univ Childrens Hosp, Belgrade, Serbia; [Rajkovic, Jelena; Colic, Miodrag] Univ Nis, Fac Med, Nish, Serbia; [Rupnik, Marjan Slak] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Friedrich, Bernd] Univ Aachen, Rhein Westfal TH Aachen, Dept Proc Met & Met Recycling, Aachen, Germany	University of Belgrade; University of Belgrade; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Maribor; University of Belgrade; University of Nis; University of Maribor; RWTH Aachen University	Colic, M (corresponding author), Univ Def, Mil Med Acad, Fac Med, Belgrade, Serbia.	fakultet.vma@mod.gov.rs	Ogrinc, Nina/AID-6927-2022; Friedrich, Bernd/AAM-7029-2021; Friedrich, Bernd/AAM-7005-2021; Rupnik, Marjan Slak/R-4738-2019; Vasilijic, Sasa/ABG-1353-2021; Ogrinc, Nina/AAQ-1010-2020; Slak Rupnik, Marjan/E-6246-2015	Ogrinc, Nina/0000-0002-0773-0095; Friedrich, Bernd/0000-0002-2934-2034; Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882; Dokic, Jelena/0000-0002-3594-1519; Pelicon, Primoz/0000-0003-2469-3342; Vasilijic, Sasa/0000-0002-3923-3448; Tomic, Sergej/0000-0003-2570-1295; Dokic, Jelena/0000-0002-5669-8175	Ministry of Science, Serbia [175102]; Military Medical Academy, Serbia [MFVMA/8/12-14]; EUREKA E!4953 GoNANO [L2-4212]; European Community's SPIRIT program [227012]	Ministry of Science, Serbia(Ministry of Education, Science & Technological Development, Serbia); Military Medical Academy, Serbia; EUREKA E!4953 GoNANO; European Community's SPIRIT program	This study was supported by the Ministry of Science, Serbia (No: 175102), Military Medical Academy, Serbia (MFVMA/8/12-14), EUREKA E!4953 GoNANO, Applied Project L2-4212, and the European Community's SPIRIT program (227012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bamrungsap S, 2012, NANOMEDICINE-UK, V7, P1253, DOI [10.2217/NNM.12.87, 10.2217/nnm.12.87]; Chiodo F, 2014, ACS CHEM BIOL, V9, P383, DOI 10.1021/cb4008265; Chuang YC, 2010, BIOMATERIALS, V31, P6087, DOI 10.1016/j.biomaterials.2010.04.026; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Dokic J, 2013, EUR J IMMUNOL, V43, P1862, DOI 10.1002/eji.201243010; Dokic J, 2012, J BIOMED NANOTECHNOL, V8, P528, DOI 10.1166/jbn.2012.1405; Dumitriu IE, 2005, TRENDS IMMUNOL, V26, P381, DOI 10.1016/j.it.2005.04.009; Dykman L, 2012, CHEM SOC REV, V41, P2256, DOI 10.1039/c1cs15166e; Garcia CP, 2013, SCI REPORTS; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205; Hainfeld JF, 2012, NANOMEDICINE, V20, P1; Heinemann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058604; Huang KY, 2012, ACS NANO, V6, P4483, DOI 10.1021/nn301282m; Huang XH, 2006, PHOTOCHEM PHOTOBIOL, V82, P412, DOI 10.1562/2005-12-14-RA-754; Huang XH, 2007, NANOMEDICINE-UK, V2, P681, DOI 10.2217/17435889.2.5.681; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; Joh DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062425; Kandil H, 2005, CLIN EXP IMMUNOL, V140, P54, DOI 10.1111/j.1365-2249.2005.02730.x; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Koido S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059280; Krpetic Z, 2010, NANO LETT, V10, P4549, DOI 10.1021/nl103142t; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lin AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063550; Liu XS, 2013, LANGMUIR, V29, P9138, DOI 10.1021/la401556k; Magister S, 2012, EUR J CELL BIOL, V91, P391, DOI 10.1016/j.ejcb.2012.01.001; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mironava T, 2010, NANOTOXICOLOGY, V4, P120, DOI 10.3109/17435390903471463; Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905; Ogrinc N, 2013, NUCL INSTRUM METH B, V306, P121, DOI 10.1016/j.nimb.2012.12.060; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Pathak SK, 2012, J BIOL CHEM, V287, P13731, DOI 10.1074/jbc.M111.336545; Qi WH, 2013, CELL IMMUNOL, V285, P18, DOI 10.1016/j.cellimm.2013.06.001; Rahir G, 2012, CANCER IMMUNOL IMMUN, V61, P751, DOI 10.1007/s00262-012-1253-1; Rudolf R, 2012, J BIOMATER APPL, V26, P595, DOI 10.1177/0885328210377536; Singh S, 2010, NEW J CHEM, V34, P294, DOI 10.1039/b9nj00277d; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Speshock JL, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9746-3; Stankovic JA, 2004, LIFE SCI, V75, P3053, DOI 10.1016/j.lfs.2004.06.007; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Tsai CY, 2012, J IMMUNOL, V188, P68, DOI 10.4049/jimmunol.1100344; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Villiers CL, 2010, J NANOPART RES, V12, P55, DOI 10.1007/s11051-009-9692-0; Vukcevic M, 2010, J BIOL CHEM, V285, P16003, DOI 10.1074/jbc.M109.066704; Wang LM, 2011, NANO LETT, V11, P772, DOI 10.1021/nl103992v; Wathelet N, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23973; Wenink MH, 2009, J IMMUNOL, V183, P6960, DOI 10.4049/jimmunol.0900713; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Yuan HK, 2012, NANOMED-NANOTECHNOL, V8, P1355, DOI 10.1016/j.nano.2012.02.005; Zanoni I, 2010, IMMUNOBIOLOGY, V215, P709, DOI 10.1016/j.imbio.2010.05.026; Ziegler A, 2009, BLOOD, V113, P3494, DOI 10.1182/blood-2008-08-175109	58	89	89	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96584	10.1371/journal.pone.0096584	http://dx.doi.org/10.1371/journal.pone.0096584			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802102	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800089
J	Varghese, F; Bukhari, AB; Malhotra, R; De, A				Varghese, Frency; Bukhari, Amirali B.; Malhotra, Renu; De, Abhijit			IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples	PLOS ONE			English	Article							ESTROGEN-RECEPTOR STATUS; BREAST-CANCER; EXPRESSION; QUANTIFICATION; ANTIBODY; PATHOLOGY; STAINS; TOOL	In anatomic pathology, immunohistochemistry (IHC) serves as a diagnostic and prognostic method for identification of disease markers in tissue samples that directly influences classification and grading the disease, influencing patient management. However, till today over most of the world, pathological analysis of tissue samples remained a time-consuming and subjective procedure, wherein the intensity of antibody staining is manually judged and thus scoring decision is directly influenced by visual bias. This instigated us to design a simple method of automated digital IHC image analysis algorithm for an unbiased, quantitative assessment of antibody staining intensity in tissue sections. As a first step, we adopted the spectral deconvolution method of DAB/hematoxylin color spectra by using optimized optical density vectors of the color deconvolution plugin for proper separation of the DAB color spectra. Then the DAB stained image is displayed in a new window wherein it undergoes pixel-by-pixel analysis, and displays the full profile along with its scoring decision. Based on the mathematical formula conceptualized, the algorithm is thoroughly tested by analyzing scores assigned to thousands (n = 1703) of DAB stained IHC images including sample images taken from human protein atlas web resource. The IHC Profiler plugin developed is compatible with the open resource digital image analysis software, ImageJ, which creates a pixel-by-pixel analysis profile of a digital IHC image and further assigns a score in a four tier system. A comparison study between manual pathological analysis and IHC Profiler resolved in a match of 88.6% (P<0.0001, CI = 95%). This new tool developed for clinical histopathological sample analysis can be adopted globally for scoring most protein targets where the marker protein expression is of cytoplasmic and/or nuclear type. We foresee that this method will minimize the problem of inter-observer variations across labs and further help in worldwide patient stratification potentially benefitting various multinational clinical trial initiatives.	[Varghese, Frency; Bukhari, Amirali B.; Malhotra, Renu; De, Abhijit] Tata Mem Hosp, ACTREC, Mol Funct Imaging Lab, Kharghar, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	De, A (corresponding author), Tata Mem Hosp, ACTREC, Mol Funct Imaging Lab, Kharghar, Navi Mumbai, India.	ade@actrec.gov.in	DE, ABHIJIT/AAR-5631-2021; Bukhari, Amirali/L-5610-2014	DE, ABHIJIT/0000-0002-5818-0206; Bukhari, Amirali/0000-0003-0543-1339	TMC-IRG [14]; ICMR, New Delhi [5/13/25/10/NCD-III]	TMC-IRG; ICMR, New Delhi(Indian Council of Medical Research (ICMR))	The authors would like to thank TMC-IRG (#14) and ICMR, New Delhi (Ref # 5/13/25/10/NCD-III) for funding support to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Chatterjee S, 2013, PLOS ONE, V8; Choudhury KR, 2010, J HISTOCHEM CYTOCHEM, V58, P95, DOI 10.1369/jhc.2009.953554; Chung GG, 2007, LAB INVEST, V87, P662, DOI 10.1038/labinvest.3700543; Dobson L, 2010, HISTOPATHOLOGY, V57, P27, DOI 10.1111/j.1365-2559.2010.03577.x; Ellis CM, 2005, J CLIN PATHOL, V58, P710, DOI 10.1136/jcp.2004.023424; Gavrielides MA, 2011, ARCH PATHOL LAB MED, V135, P233, DOI 10.1043/1543-2165-135.2.233; Gokhale S, 2007, APPL IMMUNOHISTO M M, V15, P451, DOI 10.1097/PAI.0b013e31802ee998; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jahne B., 1997, PRACTICAL HDB IMAGE, P76; Jaraj SJ, 2009, VIRCHOWS ARCH, V455, P375, DOI 10.1007/s00428-009-0833-8; Kampf C, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-103; Konsti J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-3; Ma WB, 1999, BIOTECH HISTOCHEM, V74, P1, DOI 10.3109/10520299909066470; Matkowskyj KA, 2000, J HISTOCHEM CYTOCHEM, V48, P303, DOI 10.1177/002215540004800216; MCCARTY KS, 1986, CANCER RES, V46, P4244; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Ponten F, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.93; Prasad K, 2011, WORLD J CLIN ONCOL, V2, P187, DOI 10.5306/wjco.v2.i4.187; Rangan GK, 2007, NEPHROLOGY, V12, P553, DOI 10.1111/j.1440-1797.2007.00855.x; Rexhepaj E, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2187; Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Turbin DA, 2008, BREAST CANCER RES TR, V110, P417, DOI 10.1007/s10549-007-9736-z; Vrekoussis T, 2009, ANTICANCER RES, V29, P4995; Yagi Y, 2005, J TELEMED TELECARE, V11, P109, DOI 10.1258/1357633053688705	29	644	655	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96801	10.1371/journal.pone.0096801	http://dx.doi.org/10.1371/journal.pone.0096801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802416	Green Submitted, gold, Green Published			2022-12-27	WOS:000338029800131
J	Hua, F; Fang, NZ; Li, XB; Zhu, SW; Zhang, WS; Gu, JD				Hua, Feng; Fang, Nianzhen; Li, Xuebing; Zhu, Siwei; Zhang, Weisan; Gu, Jundong			A Meta-Analysis of the Relationship Between RAR beta Gene Promoter Methylation and Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DNA METHYLATION; SPUTUM; TUMOR	Background: Hypermethylation of CpG islands in tumor suppressor gene plays an important role in carcinogenesis. Many studies have demonstrated that hypermethylation in promoter region of RAR beta gene could be found with high prevalence in tumor tissue and autologous controls such as corresponding non-tumor lung tissue, sputum and plasma of the NSCLC patients. But with the small number subjects included in the individual studie, the statistical power is limited. Accordingly, we performed this meta-analysis to further asses the relationship of methylation prevalence between the cancer tissue and atuologous controls (corresponding non-tumor lung tissue, sputum and plasma). Methods: The published articles about RAR beta gene promoter hypermethyltion were identified using a systematic search strategy in PubMed, EMBASE and CNKI databases. The pooled odds ratio (OR) of RAR beta promoter methylation in lung cancer tissue versus autologous controls were calculated. Results: Finally, eleven articles, including 1347 tumor tissue samples and 1137 autologous controls were included in this meta-analysis. The pooled odds ratio of RAR beta promoter methylation in cancer tissue was 3.60 (95% CI: 2.46-5.27) compared to autologous controls with random-effect model. Strong and significant correlation between tumor tissue and autologous controls of RAR beta gene promoter hypermethylation prevalence across studies (Correlation coefficient 0.53) was found. Conclusion: RAR beta promoter methylation may play an important role in carcinogenesis of the NSCLC. With significant methylation prevalence correlation between tumor tissue and autologous of this gene, methylation detection may be a potential method for searching biomarker for NSCLC.	[Hua, Feng] Shandong Canc Hosp, Dept Surg Oncol, Jinan, Peoples R China; [Fang, Nianzhen; Li, Xuebing; Gu, Jundong] Tianjin Med Univ, Gen Hosp, Tianjin Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Zhu, Siwei; Gu, Jundong] Tianjin Union Med Ctr, Dept Oncol, Tianjin, Peoples R China; [Zhang, Weisan] Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Tianjin Medical University; Tianjin Medical University	Zhang, WS (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Geriatr, Tianjin, Peoples R China.	Weisan_zhang@yeah.net; jundonggu@aliyun.com			National Natural Science Foundation of China [81302002]; Science and technology foundation of Tianjin Municipal Health Bureau [2010KZ040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology foundation of Tianjin Municipal Health Bureau	This project was supported by the grants from National Natural Science Foundation of China (to XBL) (No. 81302002). Science and technology foundation of Tianjin Municipal Health Bureau (to JDG) (2010KZ040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choy MK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-519; Cirincione R, 2006, INT J CANCER, V118, P1248, DOI 10.1002/ijc.21473; DeSantis C, 2013, CA-CANCER J CLIN, V63, P151, DOI 10.3322/caac.21173; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Osta A, 2003, BIOESSAYS, V25, P1071, DOI 10.1002/bies.10345; Feng QH, 2008, CANCER EPIDEM BIOMAR, V17, P645, DOI 10.1158/1055-9965.EPI-07-2518; Gu JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060107; Hanabata T, 2004, ONCOL REP, V12, P177; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hsu HS, 2007, J PATHOL, V213, P412, DOI 10.1002/path.2246; Hsu HS, 2007, CANCER-AM CANCER SOC, V110, P2019, DOI 10.1002/cncr.23001; [胡海亮 HU Hailiang], 2011, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V38, P890; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lou JT, 2011, ASIAN PAC J CANCER P, V12, P2349; MATTEI MG, 1988, HUM GENET, V80, P189, DOI 10.1007/BF00702867; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Song Haizhu, 2011, Zhongguo Fei Ai Za Zhi, V14, P233, DOI 10.3779/j.issn.1009-3419.2011.03.09; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Yang ZH, 2005, J CLIN INTER MED, V22, P708; Zhang Chen-ye, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P23, DOI 10.3760/cma.j.issn.1003-9406.2011.01.006; Zhang YW, 2011, CANCER LETT, V303, P21, DOI 10.1016/j.canlet.2010.12.011; Zhao XD, 2011, ACTA U MED ANHUI, V46, P409	24	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96163	10.1371/journal.pone.0096163	http://dx.doi.org/10.1371/journal.pone.0096163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796328	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000042
J	Ivanov, M; Mihailovic-Stanojevic, N; Milanovic, JG; Jovovic, D; Markovic-Lipkovski, J; Cirovic, S; Miloradovic, Z				Ivanov, Milan; Mihailovic-Stanojevic, Nevena; Milanovic, Jelica Grujic; Jovovic, Durdica; Markovic-Lipkovski, Jasmina; Cirovic, Sanja; Miloradovic, Zoran			Losartan Improved Antioxidant Defense, Renal Function and Structure of Postischemic Hypertensive Kidney	PLOS ONE			English	Article							II RECEPTOR BLOCKER; ANGIOTENSIN-II; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; REPERFUSION INJURY; RATS; FAILURE; HYPERTROPHY; APOPTOSIS; ISCHEMIA	Ischemic acute renal failure (ARF) is a highly complex disorder involving renal vasoconstriction, filtration failure, tubular obstruction, tubular backleak and generation of reactive oxygen species. Due to this complexity, the aim of our study was to explore effects of Angiotensin II type 1 receptor (AT1R) blockade on kidney structure and function, as well as oxidative stress in spontaneously hypertensive rats (SHR) after renal ischemia reperfusion injury. Experiments were performed on anaesthetized adult male SHR in the model of ARF with 40 minutes clamping the left renal artery. The right kidney was removed and 40 minutes renal ischemia was performed. Experimental groups received AT1R antagonist (Losartan) or vehicle (saline) in the femoral vein 5 minutes before, during and 175 minutes after the period of ischemia. Biochemical parameters were measured and kidney specimens were collected 24h after reperfusion. ARF significantly decreased creatinine and urea clearance, increased LDL and lipid peroxidation in plasma. Treatment with losartan induced a significant increase of creatinine and urea clearance, as well as HDL. Lipid peroxidation in plasma was decreased and catalase enzyme activity in erythrocytes was increased after losartan treatment. Losartan reduced cortico-medullary necrosis and tubular dilatation in the kidney. High expression of pro-apoptotic Bax protein in the injured kidney was downregulated after losartan treatment. Our results reveal that angiotensin II (via AT1R) mediates the most postischemic injuries in hypertensive kidney through oxidative stress enhancement. Therefore, blockade of AT1R may have beneficial effects in hypertensive patients who have developed ARF.	[Ivanov, Milan; Mihailovic-Stanojevic, Nevena; Milanovic, Jelica Grujic; Jovovic, Durdica; Miloradovic, Zoran] Univ Belgrade, Inst Med Res, Dept Cardiovasc Physiol, Belgrade, Serbia; [Markovic-Lipkovski, Jasmina; Cirovic, Sanja] Univ Belgrade, Inst Pathol, Fac Med, Belgrade, Serbia	University of Belgrade; University of Belgrade	Ivanov, M (corresponding author), Univ Belgrade, Inst Med Res, Dept Cardiovasc Physiol, Belgrade, Serbia.	ivmilan@imi.bg.ac.rs	Ivanov, Milan/ABD-4357-2021; Milanovic, Jelica Grujic/D-7052-2015	Milanovic, Jelica Grujic/0000-0001-8014-3121; Ivanov, Milan/0000-0001-8683-5751; Mihailovic-Stanojevic, Nevena/0000-0001-5356-8706	Ministry of Education, Science and Technological development of Serbia [OI175096, OI175047]	Ministry of Education, Science and Technological development of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by a grant (projects OI175096 and OI175047) from the Ministry of Education, Science and Technological development of Serbia (http://www.mpn.gov.rs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy VE, 2002, CRIT CARE CLIN, V18, P203, DOI 10.1016/S0749-0704(01)00002-1; Aizawa T, 2001, KIDNEY INT, V59, P645, DOI 10.1046/j.1523-1755.2001.059002645.x; Bayrak O, 2008, WORLD J UROL, V26, P285, DOI 10.1007/s00345-008-0253-4; Beutler E., 1982, RED CELL METABOLISM, P105; Bolterman RJ, 2005, HYPERTENSION, V46, P943, DOI 10.1161/01.HYP.0000174602.59935.d5; BOWMER CJ, 1983, BRIT J PHARMACOL, V79, P471, DOI 10.1111/j.1476-5381.1983.tb11020.x; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Fang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071433; Fortuno MA, 1998, HYPERTENSION, V32, P280, DOI 10.1161/01.HYP.32.2.280; GLATZLE D, 1974, EXPERIENTIA, V30, P665; Gobe G, 2000, J AM SOC NEPHROL, V11, P454, DOI 10.1681/ASN.V113454; Heeba GH, 2011, PHARMACOLOGY, V87, P232, DOI 10.1159/000325457; Inal M, 2002, CELL BIOCHEM FUNCT, V20, P291, DOI 10.1002/cbf.953; Ivanov M, 2011, ACTA PHYSIOL HUNG, V98, P1, DOI 10.1556/APhysiol.98.2011.1.1; Jerkic M, 2004, NEPHROL DIAL TRANSPL, V19, P83, DOI 10.1093/ndt/gfg521; Koh KK, 2003, J AM COLL CARDIOL, V42, P905, DOI 10.1016/S0735-1097(03)00846-5; Kontogiannis J, 1998, AM J PHYSIOL-RENAL, V274, pF79, DOI 10.1152/ajprenal.1998.274.1.F79; Kyriazis I, 2013, WORLD J UROL, V31, P597, DOI 10.1007/s00345-012-0980-4; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MILLER GJ, 1975, LANCET, V1, P16; Miloradovic Z, 2007, NEPHROL DIAL TRANSPL, V22, P2476, DOI 10.1093/ndt/gfm213; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Radovic M, 2006, AM J NEPHROL, V26, P388, DOI 10.1159/000094936; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Ritz E, 2003, J AM SOC NEPHROL, V14, P2985, DOI 10.1097/01.ASN.0000096784.86791.21; Silici S, 2011, WORLD J UROL, V29, P127, DOI 10.1007/s00345-010-0543-5; Therrien F, 2009, EUR J PHARMACOL, V607, P126, DOI 10.1016/j.ejphar.2009.01.040; Thiemermann C, 2003, J AM SOC NEPHROL, V14, P1833, DOI 10.1097/01.ASN.0000075552.97794.8C; Wolf G, 2005, NEPHROL DIAL TRANSPL, V20, P1222, DOI 10.1093/ndt/gfh727; Xu XH, 2010, EXP PHYSIOL, V95, P1008, DOI 10.1113/expphysiol.2010.054221; Zafari AM, 1998, HYPERTENSION, V32, P488, DOI 10.1161/01.HYP.32.3.488	32	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96353	10.1371/journal.pone.0096353	http://dx.doi.org/10.1371/journal.pone.0096353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24796787	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000066
J	Jia, FZ; Lo, N; Ho, SYW				Jia, Fangzhi; Lo, Nathan; Ho, Simon Y. W.			The Impact of Modelling Rate Heterogeneity among Sites on Phylogenetic Estimates of Intraspecific Evolutionary Rates and Timescales	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SUBSTITUTION RATES; DNA-SEQUENCES; MOLECULAR EVOLUTION; BAYESIAN SELECTION; EMPIRICAL-DATA; NUCLEOTIDE; ASSUMPTIONS; DISTANCES; INFERENCE	Phylogenetic analyses of DNA sequence data can provide estimates of evolutionary rates and timescales. Nearly all phylogenetic methods rely on accurate models of nucleotide substitution. A key feature of molecular evolution is the heterogeneity of substitution rates among sites, which is often modelled using a discrete gamma distribution. A widely used derivative of this is the gamma-invariable mixture model, which assumes that a proportion of sites in the sequence are completely resistant to change, while substitution rates at the remaining sites are gamma-distributed. For data sampled at the intraspecific level, however, biological assumptions involved in the invariable-sites model are commonly violated. We examined the use of these models in analyses of five intraspecific data sets. We show that using 6-10 rate categories for the discrete gamma distribution of rates among sites is sufficient to provide a good approximation of the marginal likelihood. Increasing the number of gamma rate categories did not have a substantial effect on estimates of the substitution rate or coalescence time, unless rates varied strongly among sites in a non-gamma-distributed manner. The assumption of a proportion of invariable sites provided a better approximation of the asymptotic marginal likelihood when the number of gamma categories was small, but had minimal impact on estimates of rates and coalescence times. However, the estimated proportion of invariable sites was highly susceptible to changes in the number of gamma rate categories. The concurrent use of gamma and invariable-site models for intraspecific data is not biologically meaningful and has been challenged on statistical grounds; here we have found that the assumption of a proportion of invariable sites has no obvious impact on Bayesian estimates of rates and timescales from intraspecific data.	[Jia, Fangzhi; Lo, Nathan; Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Jia, FZ (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	fangzhi.jia@sydney.edu.au	Ho, Simon YW/A-8417-2008; Lo, Nathan/E-6115-2010	Ho, Simon YW/0000-0002-0361-2307; Lo, Nathan/0000-0003-2176-2840; Jia, Fangzhi/0000-0001-6421-8074	Australian Postgraduate Award; Australian Research Council [DP1097265, DP110100383]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council)	FJ was supported by an Australian Postgraduate Award. NL and SYWH were supported by the Australian Research Council (DP1097265 and DP110100383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2012, ANNU REV ECOL EVOL S, V43, P115, DOI 10.1146/annurev-ecolsys-110411-160257; Akaike H, 1981, ENG TECHNOLOGY APPL, V19, P716; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Buckley TR, 2001, SYST BIOL, V50, P67, DOI 10.1080/106351501750107495; De MacPhee R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-49; de St Pierre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051311; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J, 2001, J MOL EVOL, V53, P447, DOI 10.1007/s002390010234; Fitch W.M., 1986, Progress in Clinical and Biological Research, V218, P149; FITCH WALTER M., 1967, BIOCHEM GENET, V1, P65, DOI 10.1007/BF00487738; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; GU X, 1995, MOL BIOL EVOL, V12, P546; Haag-Liautard C, 2007, NATURE, V445, P82, DOI 10.1038/nature05388; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jarman SN, 2000, J EVOLUTION BIOL, V13, P624; JUKES T H, 1969, P21; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Luo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-242; Mayrose I, 2005, BIOINFORMATICS, V21, P151, DOI 10.1093/bioinformatics/bti1125; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; PALUMBI SR, 1989, J MOL EVOL, V29, P180, DOI 10.1007/BF02100116; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ren FR, 2005, SYST BIOL, V54, P808, DOI 10.1080/10635150500354688; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHOEMAKER JS, 1989, MOL BIOL EVOL, V6, P270; Simon C, 1996, MOL BIOL EVOL, V13, P923, DOI 10.1093/oxfordjournals.molbev.a025660; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Soubrier J, 2012, MOL BIOL EVOL, V29, P3345, DOI 10.1093/molbev/mss140; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A., 2006, P 20 IEEE INT PAR DI, P8, DOI DOI 10.1109/IPDPS.2006.1639535; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Sullivan J, 2001, SYST BIOL, V50, P723, DOI 10.1080/106351501753328848; Sullivan J, 1999, MOL BIOL EVOL, V16, P1347, DOI 10.1093/oxfordjournals.molbev.a026045; TATENO Y, 1994, MOL BIOL EVOL, V11, P261; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tourasse NJ, 1997, MOL BIOL EVOL, V14, P287, DOI 10.1093/oxfordjournals.molbev.a025764; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; WAKELEY J, 1993, J MOL EVOL, V37, P613; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Wu CH, 2013, MOL BIOL EVOL, V30, P669, DOI 10.1093/molbev/mss258; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	54	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95722	10.1371/journal.pone.0095722	http://dx.doi.org/10.1371/journal.pone.0095722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798481	Green Submitted, gold, Green Published			2022-12-27	WOS:000336656000021
J	Park, SJ; Ghai, R; Martin-Cuadrado, AB; Rodriguez-Valera, F; Chung, WH; Kwon, K; Lee, JH; Madsen, EL; Rhee, SK				Park, Soo-Je; Ghai, Rohit; Martin-Cuadrado, Ana-Belen; Rodriguez-Valera, Francisco; Chung, Won-Hyong; Kwon, KaeKyoung; Lee, Jung-Hyun; Madsen, Eugene L.; Rhee, Sung-Keun			Genomes of Two New Ammonia-Oxidizing Archaea Enriched from Deep Marine Sediments	PLOS ONE			English	Article							METAGENOMIC ANALYSIS; MESOPHILIC CRENARCHAEOTA; MICROBIAL COMMUNITY; MOLECULAR-BIOLOGY; NITROUS-OXIDE; RIBOSOMAL-RNA; NITRIC-OXIDE; SEQUENCE; BACTERIUM; NITRIFICATION	Ammonia-oxidizing archaea (AOA) are ubiquitous and abundant and contribute significantly to the carbon and nitrogen cycles in the ocean. In this study, we assembled AOA draft genomes from two deep marine sediments from Donghae, South Korea, and Svalbard, Arctic region, by sequencing the enriched metagenomes. Three major microorganism clusters belonging to Thaumarchaeota, Epsilonproteobacteria, and Gammaproteobacteria were deduced from their 16S rRNA genes, GC contents, and oligonucleotide frequencies. Three archaeal genomes were identified, two of which were distinct and were designated Ca. "Nitrosopumilus koreensis" AR1 and "Nitrosopumilus sediminis" AR2. AR1 and AR2 exhibited average nucleotide identities of 85.2% and 79.5% to N. maritimus, respectively. The AR1 and AR2 genomes contained genes pertaining to energy metabolism and carbon fixation as conserved in other AOA, but, conversely, had fewer heme-containing proteins and more copper-containing proteins than other AOA. Most of the distinctive AR1 and AR2 genes were located in genomic islands (GIs) that were not present in other AOA genomes or in a reference water-column metagenome from the Sargasso Sea. A putative gene cluster involved in urea utilization was found in the AR2 genome, but not the AR1 genome, suggesting niche specialization in marine AOA. Co-cultured bacterial genome analysis suggested that bacterial sulfur and nitrogen metabolism could be involved in interactions with AOA. Our results provide fundamental information concerning the metabolic potential of deep marine sedimentary AOA.	[Rhee, Sung-Keun] Chungbuk Natl Univ, Dept Microbiol, Cheongju, South Korea; [Park, Soo-Je] Jeju Natl Univ, Dept Biol, Cheju, South Korea; [Ghai, Rohit; Martin-Cuadrado, Ana-Belen; Rodriguez-Valera, Francisco] Univ Miguel Hernandez, Dept Prod Vegetal & Microbiol, Evolutionary Genom Grp, Alicante, Spain; [Chung, Won-Hyong] KRIBB, Korean Bioinformat Ctr, Taejon, South Korea; [Kwon, KaeKyoung; Lee, Jung-Hyun] Korea Inst Ocean Sci & Technol, Ansan, South Korea; [Madsen, Eugene L.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Chungbuk National University; Jeju National University; Universidad Miguel Hernandez de Elche; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Institute of Ocean Science & Technology (KIOST); Cornell University	Rhee, SK (corresponding author), Chungbuk Natl Univ, Dept Microbiol, Cheongju, South Korea.	rhees@chungbuk.ac.kr	Park, SJ/AAB-1372-2020; Ghai, Rohit/E-7086-2012; Rodriguez-Valera, Francisco/M-2782-2013	Ghai, Rohit/0000-0002-0591-6152; Rodriguez-Valera, Francisco/0000-0002-9809-2059	Basic Science Research Program through the National Research Foundation of MEST (Ministry of Education, Science, and Technology) [2012R1A1A2A10039384]; Marine and Extreme Genome Research Center Program of the MLTM (Ministry of Land, Transport, and Maritime Affairs); Energy Efficiency & Resources Core Technology Program of the KETEP (Korea Institute of Energy Technology Evaluation and Planning) - MTIE (Ministry of Trade, Industry & Energy), Republic of Korea [20132020000170]; NSF [DEB-0841999]	Basic Science Research Program through the National Research Foundation of MEST (Ministry of Education, Science, and Technology); Marine and Extreme Genome Research Center Program of the MLTM (Ministry of Land, Transport, and Maritime Affairs); Energy Efficiency & Resources Core Technology Program of the KETEP (Korea Institute of Energy Technology Evaluation and Planning) - MTIE (Ministry of Trade, Industry & Energy), Republic of Korea; NSF(National Science Foundation (NSF))	This study was supported by the Basic Science Research Program (2012R1A1A2A10039384) through the National Research Foundation of MEST (Ministry of Education, Science, and Technology), Marine and Extreme Genome Research Center Program of the MLTM (Ministry of Land, Transport, and Maritime Affairs), and the Energy Efficiency & Resources Core Technology Program (20132020000170) of the KETEP (Korea Institute of Energy Technology Evaluation and Planning) granted financial resource from the MTIE (Ministry of Trade, Industry & Energy), Republic of Korea. ELM was supported by NSF grant #DEB-0841999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON IC, 1993, APPL ENVIRON MICROB, V59, P3525, DOI 10.1128/AEM.59.11.3525-3533.1993; Bartossek R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00208; BEDARD C, 1989, MICROBIOL REV, V53, P68; Blainey PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016626; Bock E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P457, DOI 10.1007/0-387-30742-7_16; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cavallaro G, 2008, J PROTEOME RES, V7, P4946, DOI 10.1021/pr8004309; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; Gardner AM, 2002, J BIOL CHEM, V277, P8166, DOI 10.1074/jbc.M110470200; Ghai R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00490; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Ghiglione JF, 2011, ENV MICROBIOL; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Gorman-Lewis D, 2014, GEOBIOLOGY, V12, P157, DOI 10.1111/gbi.12075; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herman DC, 1998, J ENVIRON QUAL, V27, P750, DOI 10.2134/jeq1998.00472425002700040004x; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Jung MY, 2013, ISME J; Kampschreur MJ, 2007, WATER ENVIRON RES, V79, P2499, DOI 10.2175/106143007X220815; Kester RA, 1997, APPL ENVIRON MICROB, V63, P3872, DOI 10.1128/AEM.63.10.3872-3877.1997; Kim BK, 2011, J BACTERIOL, V193, P5539, DOI 10.1128/JB.05717-11; Kim JG, 2012, ENVIRON MICROBIOL, V14, P1528, DOI 10.1111/j.1462-2920.2012.02740.x; Koch M, 2006, FEMS MICROBIOL ECOL, V57, P55, DOI 10.1111/j.1574-6941.2006.00088.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Loscher CR, 2012, BIOGEOSCIENCES, V9, P2419, DOI 10.5194/bg-9-2419-2012; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Merkl R, 2006, J MOL EVOL, V62, P1, DOI 10.1007/s00239-004-0311-5; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Mosier AC, 2012, J BACTERIOL, V194, P2121, DOI 10.1128/JB.00013-12; Mosier AC, 2012, J BACTERIOL, V194, P2119, DOI 10.1128/JB.00007-12; Muller F, 2010, ENVIRON MICROBIOL, V12, P2371, DOI 10.1111/j.1462-2920.2010.02309.x; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Norton JM, 2008, APPL ENVIRON MICROB, V74, P3559, DOI 10.1128/AEM.02722-07; Park BJ, 2010, APPL ENVIRON MICROB, V76, P7575, DOI 10.1128/AEM.01478-10; Park SJ, 2008, EXTREMOPHILES, V12, P605, DOI 10.1007/s00792-008-0165-7; Park SJ, 2008, FEMS MICROBIOL LETT, V284, P28, DOI 10.1111/j.1574-6968.2008.01180.x; Park SJ, 2012, J BACTERIOL, V194, P6948, DOI 10.1128/JB.01869-12; Park SJ, 2012, J BACTERIOL, V194, P6940, DOI 10.1128/JB.01857-12; Park SJ, 2012, J BACTERIOL, V194, P4128, DOI 10.1128/JB.00741-12; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; RITCHIE GAF, 1972, BIOCHEM J, V126, P1181, DOI 10.1042/bj1261181; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Sasaki K, 2001, GEOCHEM J, V35, P295, DOI 10.2343/geochemj.35.295; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Spang A, 2012, ENVIRON MICROBIOL, V14, P3122, DOI 10.1111/j.1462-2920.2012.02893.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stahl DA, 2012, ANNU REV MICROBIOL, V66, P83, DOI 10.1146/annurev-micro-092611-150128; Stein LY, 2007, ENVIRON MICROBIOL, V9, P2993, DOI 10.1111/j.1462-2920.2007.01409.x; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; THERKILDSEN MS, 1994, MAR ECOL PROG SER, V109, P77, DOI 10.3354/meps109077; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Tully BJ, 2012, ENVIRON MICROBIOL, V14, P254, DOI 10.1111/j.1462-2920.2011.02628.x; Urakawa H, 2011, NITRIFICATION, P117; Vajrala N, 2013, P NATL ACAD SCI USA, V110, P1006, DOI 10.1073/pnas.1214272110; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yakimov MM, 2007, ISME J, V1, P743, DOI 10.1038/ismej.2007.83; Yan J, 2012, ENVIRON MICROBIOL, V14, P3146, DOI 10.1111/j.1462-2920.2012.02894.x; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	87	22	28	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96449	10.1371/journal.pone.0096449	http://dx.doi.org/10.1371/journal.pone.0096449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798206	Green Submitted, Green Published, gold			2022-12-27	WOS:000336656000077
J	Cedergreen, N				Cedergreen, Nina			Quantifying Synergy: A Systematic Review of Mixture Toxicity Studies within Environmental Toxicology	PLOS ONE			English	Review							ANTIFOULING BIOCIDES; HEAVY-METALS; ORGANOPHOSPHATE INSECTICIDES; PYRETHROID INSECTICIDE; ENCHYTRAEUS-CRYPTICUS; FUNGICIDE PROCHLORAZ; TRIAZINE HERBICIDES; VIBRIO-FISCHERI; ZINC PYRITHIONE; BINARY-MIXTURES	Cocktail effects and synergistic interactions of chemicals in mixtures are an area of great concern to both the public and regulatory authorities. The main concern is whether some chemicals can enhance the effect of other chemicals, so that they jointly exert a larger effect than predicted. This phenomenon is called synergy. Here we present a review of the scientific literature on three main groups of environmentally relevant chemical toxicants: pesticides, metal ions and antifouling compounds. The aim of the review is to determine 1) the frequency of synergy, 2) the extent of synergy, 3) whether any particular groups or classes of chemicals tend to induce synergy, and 4) which physiological mechanisms might be responsible for this synergy. Synergy is here defined as mixtures with minimum two-fold difference between observed and predicted effect concentrations using Concentration Addition (CA) as a reference model and including both lethal and sublethal endpoints. The results showed that synergy occurred in 7%, 3% and 26% of the 194, 21 and 136 binary pesticide, metal and antifoulants mixtures included in the data compilation on frequency. The difference between observed and predicted effect concentrations was rarely more than 10-fold. For pesticides, synergistic mixtures included cholinesterase inhibitors or azole fungicides in 95% of 69 described cases. Both groups of pesticides are known to interfere with metabolic degradation of other xenobiotics. For the four synergistic metal and 47 synergistic antifoulant mixtures the pattern in terms of chemical groups inducing synergy was less clear. Hypotheses in terms of mechanisms governing these interactions are discussed. It was concluded that true synergistic interactions between chemicals are rare and often occur at high concentrations. Addressing the cumulative rather than synergistic effect of co-occurring chemicals, using standard models as CA, is therefore regarded as the most important step in the risk assessment of chemical cocktails.	Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark	University of Copenhagen	Cedergreen, N (corresponding author), Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark.	ncf@plen.ku.dk	Cedergreen, Nina/F-6731-2014	Cedergreen, Nina/0000-0003-4724-9447	University of Copenhagen	University of Copenhagen	No funding provided apart from my own salary from the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabaster J.S., 1980, WATER QUALITY CRITER; Altenburger R, 1996, FOOD CHEM TOXICOL, V34, P1155, DOI 10.1016/S0278-6915(97)00088-4; Altenburger R, 2000, ENVIRON TOXICOL CHEM, V19, P2341, DOI 10.1002/etc.5620190926; Altenburger R, 2011, METAL IONS LIFE SCI, V8, P1, DOI 10.1039/978184973211600001; Amorim MJB, 2012, ENVIRON POLLUT, V160, P145, DOI 10.1016/j.envpol.2011.09.005; Anderson TD, 2002, ENVIRON TOXICOL CHEM, V21, P1507, DOI [10.1897/1551-5028(2002)021<1507:ITTIAW>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1507:ITTIAW&gt;2.0.CO;2]; Backhaus T, 2000, ENVIRON TOXICOL CHEM, V19, P2348, DOI 10.1002/etc.5620190927; Bao VWW, 2008, MAR POLLUT BULL, V57, P616, DOI 10.1016/j.marpolbul.2008.03.041; Belden JB, 2007, INTEGR ENVIRON ASSES, V3, P364, DOI 10.1002/ieam.5630030307; Belden JB, 2000, ENVIRON TOXICOL CHEM, V19, P2266, DOI [10.1002/etc.5620190917, 10.1897/1551-5028(2000)019&lt;2266:IOAOOI&gt;2.3.CO;2]; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; BOLWELL GP, 1994, PHYTOCHEMISTRY, V37, P1491, DOI 10.1016/S0031-9422(00)89567-9; Boobis A, 2011, CRIT REV TOXICOL, V41, P369, DOI 10.3109/10408444.2010.543655; Brander SM, 2009, ENVIRON TOXICOL CHEM, V28, P1493, DOI 10.1897/08-374.1; Buchwalter DB, 2008, P NATL ACAD SCI USA, V105, P8321, DOI 10.1073/pnas.0801686105; Burkhead JL, 2009, NEW PHYTOL, V182, P799, DOI 10.1111/j.1469-8137.2009.02846.x; Cassi R, 2008, MAR POLLUT BULL, V56, P1943, DOI 10.1016/j.marpolbul.2008.07.011; Cedergreen N, 2005, PEST MANAG SCI, V61, P1152, DOI 10.1002/ps.1117; Cedergreen N., 2013, ENCY ENV MANAGEMENT, P2601; Cedergreen N, 2004, SETAC GLOBE, V5, P33; Cedergreen N, 2008, ENVIRON TOXICOL CHEM, V27, P1621, DOI [10.1897/07-474.1, 10.1897/07-474]; Cedergreen N, 2007, PEST MANAG SCI, V63, P282, DOI 10.1002/ps.1353; Cedergreen N, 2007, ENVIRON TOXICOL CHEM, V26, P149, DOI 10.1897/06-196R.1; Cedergreen N, 2013, ENVIRON TOXICOL CHEM, V32, P2274, DOI 10.1002/etc.2274; Cedergreen N, 2012, SCI TOTAL ENVIRON, V427, P229, DOI 10.1016/j.scitotenv.2012.03.086; Cacciatore LC, 2012, CHEMOSPHERE, V88, P450, DOI 10.1016/j.chemosphere.2012.02.069; Colborn T., 1996, OUR STOLEN FUTURE AR; Deneer JW, 2000, PEST MANAG SCI, V56, P516, DOI 10.1002/(SICI)1526-4998(200006)56:6<516::AID-PS163>3.0.CO;2-0; Dong XL, 2009, CHEMOSPHERE, V77, P404, DOI 10.1016/j.chemosphere.2009.06.052; ELLIOTT NG, 1986, MAR BIOL, V93, P395, DOI 10.1007/BF00401107; Fernandez-Alba AR, 2002, ANAL CHIM ACTA, V456, P303, DOI 10.1016/S0003-2670(02)00037-5; Forget J, 1999, ENVIRON TOXICOL CHEM, V18, P912, DOI [10.1002/etc.5620180514, 10.1897/1551-5028(1999)018&lt;0912:JAOPCP&gt;2.3.CO;2]; Fraser TR, 1892, BMJ-BRIT MED J, V2, P485; Fu Y, 2013, ECOTOX ENVIRON SAFE, V94, P28, DOI 10.1016/j.ecoenv.2013.04.018; Grung M, 2011, J TOXICOL ENV HEAL A, V74, P439, DOI 10.1080/15287394.2011.550555; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hartmann NB, 2010, TOXICOLOGY, V269, P190, DOI 10.1016/j.tox.2009.08.008; Henczova M, 2008, COMP BIOCHEM PHYS C, V148, P53, DOI 10.1016/j.cbpc.2008.03.010; Jin-Clark Y, 2002, ENVIRON TOXICOL CHEM, V21, P598, DOI [10.1897/1551-5028(2002)021&lt;0598:EOAACO&gt;2.0.CO;2, 10.1002/etc.5620210319]; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; JOHNSTON G, 1994, ENVIRON TOXICOL CHEM, V13, P615, DOI [10.1897/1552-8618(1994)13[615:IEBEFP]2.0.CO;2, 10.1002/etc.5620130410]; JOHNSTON G, 1994, ENVIRON TOXICOL CHEM, V13, P115, DOI [10.1897/1552-8618(1994)13[115:IEOPAM]2.0.CO;2, 10.1002/etc.5620130116]; KENNAUGH L, 1993, PESTIC BIOCHEM PHYS, V45, P234, DOI 10.1006/pest.1993.1026; Kepner J, 2004, PESTICIDES YOU, V23, P17; Koutsaftis A, 2006, ENVIRON TOXICOL, V21, P432, DOI 10.1002/tox.20202; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Lawler SP, 2008, PEST MANAG SCI, V64, P843, DOI 10.1002/ps.1575; Lister LJ, 2011, ENVIRON INT, V37, P663, DOI 10.1016/j.envint.2011.01.006; Lock K, 2001, ENVIRON TOXICOL CHEM, V20, P2067, DOI [10.1897/1551-5028(2001)020&lt;2067:ZACBBI&gt;2.0.CO;2, 10.1002/etc.5620200928]; LOEWE S., 1926, ARCH EXP PATH U PHARMAKOL, V114, P313, DOI 10.1007/BF01952257; Lydy MJ, 2004, ARCH ENVIRON CON TOX, V48, P49, DOI 10.1007/s00244-004-0056-6; Lydy MJ, 2003, ARCH ENVIRON CON TOX, V45, P343, DOI 10.1007/s00244-002-0218-y; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; MARKING L L, 1975, U S Fish and Wildlife Service Investigations in Fish Control, V67, P1; Martin JD, 2003, PESTICIDES STREAMS, P1; MCLEESE DW, 1979, CHEMOSPHERE, V8, P59, DOI 10.1016/0045-6535(79)90050-X; Meyer JS, 2013, SETAC EUR 23 ANN M G; Mochida K, 2006, ENVIRON TOXICOL CHEM, V25, P3058, DOI 10.1897/05-688R.1; Moher D, 2009, PLOS MED, V6, P1; Mohr S, 2008, AQUAT TOXICOL, V90, P109, DOI 10.1016/j.aquatox.2008.08.004; NAKAJIMA K, 1990, J CHROMATOGR, V502, P379, DOI 10.1016/S0021-9673(01)89602-3; Norgaard KB, 2010, ENVIRON SCI POLLUT R, V17, P957, DOI 10.1007/s11356-009-0284-4; Nriagu JO, 1998, SCI TOTAL ENVIRON, V223, P99, DOI 10.1016/S0048-9697(98)00284-8; Okamura H, 2006, HANDB ENVIRON CHEM, V50, P201; PapeLindstrom PA, 1997, ENVIRON TOXICOL CHEM, V16, P2415, DOI [10.1002/etc.5620161130, 10.1897/1551-5028(1997)016&lt;2415:STOAAO&gt;2.3.CO;2]; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Posthuma L, 1997, ECOTOX ENVIRON SAFE, V38, P108, DOI 10.1006/eesa.1997.1568; Rahman MS, 2014, SOIL SEDIMENT CONTAM, V23, P353, DOI 10.1080/15320383.2014.829025; Readman JW, 2006, HANDB ENVIRON CHEM, V50, P1; Schuler LJ, 2005, ARCH ENVIRON CON TOX, V49, P173, DOI 10.1007/s00244-004-0224-8; SNEGAROFF J, 1989, XENOBIOTICA, V19, P255, DOI 10.3109/00498258909042271; Stephenson GR, 2007, PESTICIDES ENV, P57; Suzuki T, 2004, TOXICOLOGY, V204, P97, DOI 10.1016/j.tox.2004.06.025; Svendsen C, 2010, ENVIRON TOXICOL CHEM, V29, P1182, DOI 10.1002/etc.140; Taiz L., 2010, PLANT PHYSIOL, P163; Tomlin C., 2002, E PESTICIDE MANUAL; VANDERWEIDEN MEJ, 1993, CHEMOSPHERE, V27, P1297, DOI 10.1016/0045-6535(93)90177-7; Vanegas C, 1997, B ENVIRON CONTAM TOX, V58, P87, DOI 10.1007/s001289900304; Vermeirssen ELM, 2010, ENVIRON TOXICOL CHEM, V29, P2575, DOI 10.1002/etc.311; Vijver MG, 2011, ENVIRON TOXICOL CHEM, V30, P1482, DOI 10.1002/etc.499; Walker C. H., 2009, ORGANIC POLLUTANTS, P17; Wang H, 2011, ENVIRON TOXICOL CHEM, V30, P692, DOI 10.1002/etc.440; WARNE MSJ, 1995, ECOTOX ENVIRON SAFE, V31, P23, DOI 10.1006/eesa.1995.1039; Woods M, 2002, B ENVIRON CONTAM TOX, V68, P801, DOI 10.1007/s00128-002-0026-5; Xu X, 2011, TOXICOL IN VITRO, V25, P294, DOI 10.1016/j.tiv.2010.09.007; Zhou XJ, 2006, J HEALTH SCI, V52, P243, DOI 10.1248/jhs.52.243; Zhu B, 2011, ECOTOX ENVIRON SAFE, V74, P2193, DOI 10.1016/j.ecoenv.2011.07.033	89	432	436	14	400	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96580	10.1371/journal.pone.0096580	http://dx.doi.org/10.1371/journal.pone.0096580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794244	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700116
J	Disanto, G; Dobson, R; Pakpoor, J; Elangovan, RI; Adiutori, R; Kuhle, J; Giovannoni, G				Disanto, Giulio; Dobson, Ruth; Pakpoor, Julia; Elangovan, Ramyiadarsini I.; Adiutori, Rocco; Kuhle, Jens; Giovannoni, Gavin			The Refinement of Genetic Predictors of Multiple Sclerosis	PLOS ONE			English	Article							RISK; MECHANISMS; GENOTYPE	A recent genome wide association study (GWAS) demonstrated that more than 100 genetic variants influence the risk of multiple sclerosis (MS). We investigated what proportion of the general population can be considered at high genetic risk of MS, whether genetic information can be used to predict disease development and how the recently found genetic associations have influenced these estimates. We used summary statistics from GWAS in MS to estimate the distribution of risk within a large simulated general population. We profiled MS associated loci in 70 MS patients and 79 healthy controls (HC) and assessed their position within the distribution of risk in the simulated population. The predictive performance of a weighted genetic risk score (wGRS) on disease status was investigated using receiver operating characteristic statistics. When all known variants were considered, 40.8% of the general population was predicted to be at reduced risk, 49% at average, 6.9% at elevated and 3.3% at high risk of MS. Fifty percent of MS patients were at either reduced or average risk of disease. However, they showed a significantly higher wGRS than HC (median 13.47 vs 12.46, p = 4.08x10(-10)). The predictive performance of the model including all currently known MS associations (area under the curve = 79.7%, 95%CI = 72.4%-87.0%) was higher than that of models considering previously known associations. Despite this, considering the relatively low prevalence of MS, the positive predictive value was below 1%. The increasing number of known associated genetic variants is improving our ability to predict the development of MS. This is still unlikely to be clinically useful but a more complete understanding of the complexity underlying MS aetiology and the inclusion of environmental risk factors will aid future attempts of disease prediction.	[Disanto, Giulio; Dobson, Ruth; Adiutori, Rocco; Kuhle, Jens; Giovannoni, Gavin] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Pakpoor, Julia; Elangovan, Ramyiadarsini I.] Univ Oxford, John Radcliffe Hosp, Oxford Med Sch, Oxford OX3 9DU, England	University of London; Queen Mary University London; University of Oxford	Giovannoni, G (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England.	g.giovannoni@qmul.ac.uk	Kuhle, Jens/AGE-3474-2022	McKeating, Jane/0000-0002-7229-5886	Medical Research Council [G0801976]; FISM-Fondazione Italiana Sclerosi Multipla-Cod. [2010/B/5]; MS Society of Great Britain and Northern Ireland Clinical Research Fellowship [940/10]; MRC [G0801976] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FISM-Fondazione Italiana Sclerosi Multipla-Cod.(Fondazione Italiana Sclerosi Multipla (FISM)); MS Society of Great Britain and Northern Ireland Clinical Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council [GRANT NUMBER G0801976], a research fellowship FISM-Fondazione Italiana Sclerosi Multipla-Cod.: [2010/B/5 to GD] and an MS Society of Great Britain and Northern Ireland Clinical Research Fellowship [GRANT NUMBER 940/10 to RD]. The study sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. All authors state that this research was carried out independently of the influence of funding bodies.	Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crouch DJM, 2013, EUR J HUM GENET, V21, P109, DOI 10.1038/ejhg.2012.107; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; Disanto G, 2014, HUM MOL GENET, V23, P942, DOI 10.1093/hmg/ddt489; Goddard GHM, 2010, GENET EPIDEMIOL, V34, P624, DOI 10.1002/gepi.20519; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Isobe N, 2013, GENES IMMUN, V14, P434, DOI 10.1038/gene.2013.37; JERSILD C, 1973, LANCET, V2, P1221; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V104, P587, DOI 10.1093/oxfordjournals.aje.a112335; Sailani MR, 2013, GENOME RES, V23, P1410, DOI 10.1101/gr.147991.112; Sawcer S, 2012, ANN NEUROL, V72, P502, DOI 10.1002/ana.23613; Sawcer S, 2011, MULT SCLER J, V17, P1174, DOI 10.1177/1352458511421106; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; van Heyningen V, 2004, HUM MOL GENET, V13, pR225, DOI 10.1093/hmg/ddh254; van Pelt ED, 2013, NEUROLOGY; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	22	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96578	10.1371/journal.pone.0096578	http://dx.doi.org/10.1371/journal.pone.0096578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24794218	Green Published, gold, Green Submitted			2022-12-27	WOS:000336655700115
J	Liu, GH; Poppe, L; Aoki, K; Yamane, H; Lewis, J; Szyperski, T				Liu, Gaohua; Poppe, Leszek; Aoki, Ken; Yamane, Harvey; Lewis, Jeffrey; Szyperski, Thomas			High-Quality NMR Structure of Human Anti-Apoptotic Protein Domain Mcl-1(171-327) for Cancer Drug Design	PLOS ONE			English	Article							TORSION ANGLE DYNAMICS; RESONANCE ASSIGNMENTS; MCL-1; PROGRAM; INHIBITOR; MUTATIONS; PROTOCOL; BINDING; SYSTEM	A high-quality NMR solution structure is presented for protein hMcl-1(171-327) which comprises residues 171-327 of the human anti-apoptotic protein Mcl-1 (hMcl-1). Since this construct contains the three Bcl-2 homology (BH) sequence motifs which participate in forming a binding site for inhibitors of hMcl-1, it is deemed to be crucial for structure-based design of novel anti-cancer drugs blocking the Mcl1 related anti-apoptotic pathway. While the coordinates of an NMR solution structure for a corresponding construct of the mouse homologue (mMcl-1) are publicly available, our structure is the first atomic resolution structure reported for the 'apo form' of the human protein. Comparison of the two structures reveals that hMcl-1(171-327) exhibits a somewhat wider ligand/inhibitor binding groove as well as a different charge distribution within the BH3 binding groove. These findings strongly suggest that the availability of the human structure is of critical importance to support future design of cancer drugs.	[Liu, Gaohua; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Poppe, Leszek] Amgen Inc, Mol Struct, Thousand Oaks, CA USA; [Aoki, Ken; Yamane, Harvey; Lewis, Jeffrey] Amgen Inc, Prot Sci, Thousand Oaks, CA USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Amgen; Amgen	Szyperski, T (corresponding author), SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA.	szypersk@buffalo.edu			Amgen Inc.	Amgen Inc.(Amgen)	This study was funded by Amgen Inc. (www.amgen.com). LP, KA, HY and JL are employees of Amgen Inc. and Amgen Inc. played a role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Acton TB, 2005, METHOD ENZYMOL, V394, P210, DOI 10.1016/S0076-6879(05)94008-1; Atreya HS, 2004, P NATL ACAD SCI USA, V101, P9642, DOI 10.1073/pnas.0403529101; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; du Penhoat Catherine Herve, 2005, Journal of Structural and Functional Genomics, V6, P51, DOI 10.1007/s10969-005-5277-z; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Fire E, 2010, PROTEIN SCI, V19, P507, DOI 10.1002/pro.329; Friberg A, 2013, J MED CHEM, V56, P15, DOI 10.1021/jm301448p; Gelinas W, 2005, GENE DEV, V19, P1263, DOI 10.1101/gad.1326205; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Huang YPJ, 2005, METHOD ENZYMOL, V394, P210; Jansson M, 1996, J BIOMOL NMR, V7, P131; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee EF, 2008, J CELL BIOL, V180, P341, DOI 10.1083/jcb.200708096; Lee EF, 2009, J BIOL CHEM, V284, P30508, DOI 10.1074/jbc.M109.040725; Liu GH, 2005, P NATL ACAD SCI USA, V102, P10487, DOI 10.1073/pnas.0504338102; Liu Q, 2010, J BIOL CHEM, V285, P19615, DOI 10.1074/jbc.M110.105452; Moseley HNB, 2001, METHOD ENZYMOL, V339, P91, DOI 10.1016/S0076-6879(01)39311-4; Muppidi A, 2012, J AM CHEM SOC, V134, P14734, DOI 10.1021/ja306864v; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Shen Y, 2005, J AM CHEM SOC, V127, P9085, DOI 10.1021/ja0501870; Simmons MJ, 2008, ONCOGENE, V27, P1421, DOI 10.1038/sj.onc.1210771; Stewart ML, 2010, NAT CHEM BIOL, V6, P595, DOI [10.1038/NCHEMBIO.391, 10.1038/nchembio.391]; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Warr MR, 2008, CURR MOL MED, V8, P138; Word JM, 2000, PROTEIN SCI, V9, P2251, DOI 10.1110/ps.9.11.2251	42	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96521	10.1371/journal.pone.0096521	http://dx.doi.org/10.1371/journal.pone.0096521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789074	Green Published, Green Submitted, gold			2022-12-27	WOS:000336655700105
J	Eberle, JJ; Gottfried, MD; Hutchison, JH; Brochu, CA				Eberle, Jaelyn J.; Gottfried, Michael D.; Hutchison, J. Howard; Brochu, Christopher A.			First Record of Eocene Bony Fishes and Crocodyliforms from Canada's Western Arctic	PLOS ONE			English	Article							PRECIPITATION; CROCODILIANS; ALLIGATORS; MORPHOLOGY; PHYLOGENY; EVOLUTION; RADIATION	Background: Discovery of Eocene non-marine vertebrates, including crocodylians, turtles, bony fishes, and mammals in Canada's High Arctic was a critical paleontological contribution of the last century because it indicated that this region of the Arctic had been mild, temperate, and ice-free during the early - middle Eocene (similar to 53-50 Ma), despite being well above the Arctic Circle. To date, these discoveries have been restricted to Canada's easternmost Arctic - Ellesmere and Axel Heiberg Islands (Nunavut). Although temporally correlative strata crop out over 1,000 km west, on Canada's westernmost Arctic Island - Banks Island, Northwest Territories - they have been interpreted as predominantly marine. We document the first Eocene bony fish and crocodyliform fossils from Banks Island. Principal Findings: We describe fossils of bony fishes, including lepisosteid (Atractosteus), esocid (pike), and amiid, and a crocodyliform, from lower - middle Eocene strata of the Cyclic Member, Eureka Sound Formation within Aulavik National Park (similar to 76 degrees N. paleolat.). Palynology suggests the sediments are late early to middle Eocene in age, and likely spanned the Early Eocene Climatic Optimum (EECO). Conclusions/Significance: These fossils extend the geographic range of Eocene Arctic lepisosteids, esocids, amiids, and crocodyliforms west by approximately 40 degrees of longitude or similar to 1100 km. The low diversity bony fish fauna, at least at the family level, is essentially identical on Ellesmere and Banks Islands, suggesting a pan-High Arctic bony fish fauna of relatively basal groups around the margin of the Eocene Arctic Ocean. From a paleoclimatic perspective, presence of a crocodyliform, gar and amiid fishes on northern Banks provides further evidence that mild, year-round temperatures extended across the Canadian Arctic during early - middle Eocene time. Additionally, the Banks Island crocodyliform is consistent with the phylogenetic hypothesis of a Paleogene divergence time between the two extant alligatorid lineages Alligator mississippiensis and A. sinensis, and high-latitude dispersal across Beringia.	[Eberle, Jaelyn J.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Eberle, Jaelyn J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Gottfried, Michael D.] Michigan State Univ, Dept Geol Sci & Museum, E Lansing, MI 48824 USA; [Hutchison, J. Howard] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Brochu, Christopher A.] Univ Iowa, Dept Earth & Environm Sci, Iowa City, IA USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Michigan State University; University of California System; University of California Berkeley; University of Iowa	Eberle, JJ (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.	Jaelyn.Eberle@Colorado.edu			National Science Foundation [ARC 0804627, DEB 1257786]; University of Colorado Boulder Libraries Open Access Fund	National Science Foundation(National Science Foundation (NSF)); University of Colorado Boulder Libraries Open Access Fund	This research was supported financially by the National Science Foundation (ARC 0804627 to JE; DEB 1257786 to CB). MDG thanks Michigan State University for travel support related to participating in the 2012 field component of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund.	Brinkmann W., 1992, BERLINER GEOWISSENSC, V5, P1; BRISBIN IL, 1982, AM MIDL NAT, V107, P209, DOI 10.2307/2425371; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P857, DOI 10.1671/0272-4634(2004)024[0857:APATSO]2.0.CO;2; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Buscalioni AD, 2011, ZOOL J LINN SOC-LOND, V163, pS199, DOI 10.1111/j.1096-3642.2011.00718.x; Dawson M. R., 1984, CURRENT RES B, P359; Dawson Mary R., 1993, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V3, P179; DAWSON MR, 1975, ARCTIC, V28, P110; Eberle JJ, 2012, GEOL SOC AM BULL, V124, P3, DOI 10.1130/B30571.1; Eberle JJ, 2010, EARTH PLANET SC LETT, V296, P481, DOI 10.1016/j.epsl.2010.06.005; ESTES R, 1980, PALAEOGEOGR PALAEOCL, V30, P325, DOI 10.1016/0031-0182(80)90064-4; FREY RW, 1978, PALAEOGEOGR PALAEOCL, V23, P199, DOI 10.1016/0031-0182(78)90094-9; GEOMAR, 2011, OC DRILL STRAT NETW; Gerdeaux D, 2012, RAPID COMMUN MASS SP, V26, P785, DOI 10.1002/rcm.6165; Grande L, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011114; Grande L, 2010, COPEIA, P1; Greenwood DR, 2010, GEOLOGY, V38, P15, DOI 10.1130/G30218.1; Hopkins WS, 1975, KT10WSH1975 GEOL SUR; Hopkins WS, 1974, KT01WSH1974 GEOL SUR; Irving E., 1991, B GEOLOGICAL SURVEY, V403, P209; Lehman J-P, 1951, ARSHEFTER TROMSO MUS, V70, P1; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; Martin JE, 2010, ZOOL J LINN SOC-LOND, V158, P608, DOI 10.1111/j.1096-3642.2009.00582.x; MIALL A D, 1986, Bulletin of Canadian Petroleum Geology, V34, P240; Miall A.D., 1991, GEOLOGICAL SURVEY CA, V3, P437; Miall AD, 1979, GEOLOGICAL SURVEY CA, V387; MICHARD JG, 1990, CR ACAD SCI II, V311, P365; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Nilsson J, 2014, HYDROBIOLOGIA, V721, P145, DOI 10.1007/s10750-013-1656-9; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; Patterson R.T., 2002, PALAEONTOL ELECTRON, V4, P1; Pol D, 2009, B AM MUS NAT HIST, P1; Rogers JV, 2003, J VERTEBR PALEONTOL, V23, P128, DOI 10.1671/0272-4634(2003)23[128:PTANPC]2.0.CO;2; Romer A, 1956, OSTEOLOGY REPTILES; Roos J, 2007, MOL PHYLOGENET EVOL, V45, P663, DOI 10.1016/j.ympev.2007.06.018; Salisbury SW, 2003, PALAEONTOGR ABT A, V270, P3; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Schubert BA, 2012, GEOLOGY, V40, P523, DOI 10.1130/G32856.1; Schubert BA, 2011, GEOCHIM COSMOCHIM AC, V75, P7291, DOI 10.1016/j.gca.2011.08.002; Scott W.B., 1973, Bulletin Fish Res Bd Canada, V184, P1; Sluijs A, 2009, NAT GEOSCI, V2, P777, DOI 10.1038/NGEO668; Snyder D, 2007, J PALEONTOL, V81, P917, DOI 10.1666/pleo05-104.1; Sweet A. R., 2012, ARS201201 GEOL SURV; TAPLIN LE, 1989, AM ZOOL, V29, P885; Thorbjarnarson J., 2010, CHINESE ALLIGATOR EC; THORSTEINSSON R, 1962, GEOLOGICAL SURVEY CA, V330; Weijers JWH, 2007, EARTH PLANET SC LETT, V261, P230, DOI 10.1016/j.epsl.2007.06.033; Wu XB, 2003, CHINESE SCI BULL, V48, P2050, DOI 10.1360/03wc0076; XU QQ, 1984, VERTEBRAT PALASIATIC, V22, P49	50	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96079	10.1371/journal.pone.0096079	http://dx.doi.org/10.1371/journal.pone.0096079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24788829	gold, Green Published, Green Submitted			2022-12-27	WOS:000335510600073
J	Moon, EK; Park, HJ; Oh, CM; Jung, KW; Shin, HY; Park, BK; Won, YJ				Moon, Eun-Kyeong; Park, Hyeon Jin; Oh, Chang-Mo; Jung, Kyu-Won; Shin, Hee Young; Park, Byung Kiu; Won, Young-Joo			Cancer Incidence and Survival among Adolescents and Young Adults in Korea	PLOS ONE			English	Article							CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; CHILDREN; ENGLAND; CLASSIFICATION; VACCINATION; PREVALENCE; INFECTION; EUROPE; TRENDS	Background: In Korea, cancer is the third leading cause of death among adolescents and young adults (AYAs). However, cancer incidence and survival trends among AYAs (15-29 years) have never been studied in Korea. Therefore, this study aimed to investigate the incidence and relative survival rates and their trends among AYAs in Korea. Materials and Methods: Cancer incidence data from 1999-2010 were obtained from the Korea Central Cancer Registry (KCCR). Each cancer was classified into subgroups according to the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) AYA site recode. Percent distributions, age-specific incidence rates, age-standardized incidence rates per million, and annual percent changes (APCs) were calculated for AYAs according to sex. Five-year relative survival rates were estimated for cases diagnosed between 1993 and 2010 and followed up to 2011. Results: The age-standardized incidence rates of all cancers combined were 196.4 and 367.8 per million for males and females, respectively (male-to-female (M/F) ratio: 0.5). The age-standardized incidence rates increased from 208.7 per million in 1999 to 396.4 per million in 2010, and the APC was 6.3% (P < 0.001). The five most common cancers among AYAs were thyroid carcinoma, non-Hodgkin lymphoma, stomach carcinoma, breast carcinoma, and acute myeloid leukemia. In males, the 5-year relative survival rate improved, from 46.5% in 1993-1995 to 75.9% in 2006-2010. In females, the 5-year relative survival rate also improved, from 66.7% in 1993-1995 to 89.1% in 2006-2010. Conclusions: Our study showed increases in cancer incidence and improvements in the 5-year relative survival rate among Korean AYAs. This study also provides additional data regarding temporal and geographic trends in cancer that may enhance future efforts to identify factors affecting cancer incidence and responses to treatment among AYAs.	[Moon, Eun-Kyeong; Oh, Chang-Mo; Jung, Kyu-Won; Won, Young-Joo] Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea; [Park, Hyeon Jin; Park, Byung Kiu] Natl Canc Ctr, Goyang, South Korea; [Shin, Hee Young] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Seoul National University (SNU)	Won, YJ (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea.	astra67@ncc.re.kr			National Cancer Center [NCC-1310222]	National Cancer Center	This work was supported by the National Cancer Center Grant (NCC-1310222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben KK, 2012, ACTA ONCOL, V51, P922, DOI 10.3109/0284186X.2012.705891; Aben KK, 2012, ACTA ONCOL, P1; Alston RD, 2008, CANCER-AM CANCER SOC, V113, P2807, DOI 10.1002/cncr.23901; [Anonymous], CANC INC 5 CONT, VX; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Barr RD, 2006, CANCER, V106, P1425, DOI 10.1002/cncr.21773; Barr RD, 2011, CANCER-AM CANCER SOC, V117, P2245, DOI 10.1002/cncr.26052; Birch JM, 2002, BRIT J CANCER, V87, P1267, DOI 10.1038/sj.bjc.6600647; Bleyer A, 2006, NIH PUB; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Bleyer A, 2007, CA-CANCER J CLIN, V57, P242, DOI 10.3322/canjclin.57.4.242; Brenner H, 1997, J CLIN EPIDEMIOL, V50, P211, DOI 10.1016/S0895-4356(97)00280-1; Canadian Cancer Society Steering Committee, 2009, CAN CANC STAT 2009; Carreira H, 2012, PEDIATR HEMAT ONCOL, V29, P663, DOI 10.3109/08880018.2012.719069; Cotterill S, 2000, BRIT J CANCER, V83, P397, DOI 10.1054/bjoc.2000.1313; Cuzick J, 2010, BRIT J CANCER, V102, P933, DOI 10.1038/sj.bjc.6605528; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Desandes E, 2013, PEDIATR HEMAT ONCOL, V30, P291, DOI 10.3109/08880018.2012.762569; Ederer F, 1959, INSTRUCTIONS IBM 650; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; Fritz A, 2000, INT CLASSIFICATION D; Gondos A, 2013, INT J CANC; Haggar FA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-151; Han MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035469; Hogan AR, 2009, J SURG RES, V156, P167, DOI 10.1016/j.jss.2009.03.098; Howlader N., 2016, SEER CANC STAT REV; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kim YT, 2009, J GYNECOL ONCOL, V20, P1, DOI 10.3802/jgo.2009.20.1.1; Korea Central Cancer Registry, CANC REG SYST KOR; Marrett Loraine D, 2002, Chronic Dis Can, V23, P58; Oh CM, 2013, PLOS ONE IN PRESS; Park Hyeon Jin, 2012, Korean J Hematol, V47, P28, DOI 10.5045/kjh.2012.47.1.28; Patel A, 2012, BRIT J CANCER, V106, P1753, DOI 10.1038/bjc.2012.148; Pritchard-Jones K, 2006, EUR J CANCER, V42, P2183, DOI 10.1016/j.ejca.2006.06.006; Segi M., 1960, CANC MORTALITY SELEC; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Shin HR, 2004, J INFECT DIS, V190, P468, DOI 10.1086/421279; SMITH PG, 1992, IARC SCI PUBL, V120, P865; Steliarova-Foucher E, 2004, LANCET, V364, P2097, DOI 10.1016/S0140-6736(04)17550-8; The Korea Central Cancer Registry National Cancer Center, 2012, ANN REP CANC STAT KO; Tricoli JV, 2011, JNCI-J NATL CANCER I, V103, P628, DOI 10.1093/jnci/djr094; Vaccarella S, 2006, CANCER EPIDEM BIOMAR, V15, P326, DOI 10.1158/1055-9965.EPI-05-0577	43	35	35	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2014	9	5							e96088	10.1371/journal.pone.0096088	http://dx.doi.org/10.1371/journal.pone.0096088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG6EE	24789075	Green Published, Green Submitted, gold			2022-12-27	WOS:000335510600075
J	Bauso, D; Dia, B; Djehiche, B; Tembine, H; Tempone, R				Bauso, Dario; Dia, Ben Mansour; Djehiche, Boualem; Tembine, Hamidou; Tempone, Raul			Mean-Field Games for Marriage	PLOS ONE			English	Article								This article examines mean-field games for marriage. The results support the argument that optimizing the long-term wellbeing through effort and social feeling state distribution (mean-field) will help to stabilize marriage. However, if the cost of effort is very high, the couple fluctuates in a bad feeling state or the marriage breaks down. We then examine the influence of society on a couple using mean-field sentimental games. We show that, in mean-field equilibrium, the optimal effort is always higher than the one-shot optimal effort. We illustrate numerically the influence of the couple's network on their feeling states and their well-being.	[Bauso, Dario] Dipartimento Ingn Chim, Palermo, Italy; [Dia, Ben Mansour; Tembine, Hamidou; Tempone, Raul] King Abdullah Univ Sci & Technol, SRI Ctr Uncertainty Quantificat Computat Sci & En, Thuwal, Saudi Arabia; [Djehiche, Boualem] Royal Inst Technol KTH, Dept Math, Stockholm, Sweden	King Abdullah University of Science & Technology; Royal Institute of Technology	Tembine, H (corresponding author), King Abdullah Univ Sci & Technol, SRI Ctr Uncertainty Quantificat Computat Sci & En, Thuwal, Saudi Arabia.	tembine@ieee.org	TEMPONE, RAUL/G-6557-2014; tembine, hamidou/H-3589-2013	TEMPONE, RAUL/0000-0003-1967-4446; tembine, hamidou/0000-0002-1604-8223; Dia, Ben Mansour/0000-0003-0762-7749	SRI Uncertainty Quantification Center in Computational Science and Engineering, KAUST	SRI Uncertainty Quantification Center in Computational Science and Engineering, KAUST	This study is supported the SRI Uncertainty Quantification Center in Computational Science and Engineering, KAUST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Djehiche B, 2014, STOCHASTIC IN PRESS; Gottman J. M., 2005, MATH MARRIAGE DYNAMI; Lasry JM, 2007, JAP J MATH, V2, P229, DOI 10.1007/s11537-007-0657-8; Maynard Smith J., 1982, pi; Rey JM, 2013, MATH COMPUT MODEL, V57, P1965, DOI 10.1016/j.mcm.2012.01.019; Rey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009881; Tembine H, 2012, DISTRIBUTED STRATEGIC LEARNING FOR WIRELESS ENGINEERS, P1; Tembine H, 2014, IEEE T AUTOMATIC CON, V59; Yong J., 1999, STOCHASTIC CONTROLS, DOI [DOI 10.1007/978-1-4612-1466-3, 10.1007/978-1-4612-1466-3]	9	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94933	10.1371/journal.pone.0094933	http://dx.doi.org/10.1371/journal.pone.0094933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	24804835	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000335728900015
J	Ives, A; Masina, S; Castiglioni, P; Prevel, F; Revaz-Breton, M; Hartley, MA; Launois, P; Fasel, N; Ronet, C				Ives, Annette; Masina, Slavica; Castiglioni, Patrik; Prevel, Florence; Revaz-Breton, Melanie; Hartley, Mary-Anne; Launois, Pascal; Fasel, Nicolas; Ronet, Catherine			MyD88 and TLR9 Dependent Immune Responses Mediate Resistance to Leishmania guyanensis Infections, Irrespective of Leishmania RNA Virus Burden	PLOS ONE			English	Article							CUTANEOUS LEISHMANIASIS; MUCOSAL LEISHMANIASIS; MAJOR INFECTION; MUCOCUTANEOUS LEISHMANIASIS; BRAZILIENSIS INFECTION; RECEPTOR; PROTEIN; SUSCEPTIBILITY; MICE; POLYMORPHISM	Infections with Leishmania parasites of the Leishmania Viannia subgenus give rise to both localized cutaneous (CL), and metastatic leishmaniasis. Metastasizing disease forms including disseminated (DCL) and mutocutaneous (MCL) leishmaniasis result from parasitic dissemination and lesion formation at sites distal to infection and have increased inflammatory responses. The presence of Leishmania RNA virus (LRV) in L. guyanensis parasites contributes to the exacerbation of disease and impacts inflammatory responses via activation of TLR3 by the viral dsRNA. In this study we investigated other innate immune response adaptor protein modulators and demonstrated that both MyD88 and TLR9 played a crucial role in the development of Th1-dependent healing responses against L. guyanensis parasites regardless of their LRV status. The absence of MyD88- or TLR9-dependent signaling pathways resulted in increased Th2 associated cytokines (IL-4 and IL-13), which was correlated with low transcript levels of IL-12p40. The reliance of IL-12 was further confirmed in IL-12AB(-/-) mice, which were completely susceptible to infection. Protection to L. guyanensis infection driven by MyD88- and TLR9-dependent immune responses arises independently to those induced due to high LRV burden within the parasites.	[Ives, Annette; Masina, Slavica; Castiglioni, Patrik; Prevel, Florence; Hartley, Mary-Anne; Fasel, Nicolas; Ronet, Catherine] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Revaz-Breton, Melanie; Launois, Pascal; Ronet, Catherine] WHO, Immunol Res & Training Ctr, Dept Biochem, Epalinges, Switzerland	University of Lausanne; World Health Organization	Ronet, C (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	Catherine.Ronet@unil.ch	Fasel, Nicolas/O-4253-2016; Ronet, Catherine/O-6866-2017	Fasel, Nicolas/0000-0003-0136-7245; Ronet, Catherine/0000-0003-1479-2873; Hartley, Mary-Anne/0000-0002-8826-3870; Ives, Annette/0000-0002-7407-960X	FNRS [3100A0-116665/1, IZ70Z0-131421]; association Institute for Arthritis Research	FNRS(Fonds de la Recherche Scientifique - FNRS); association Institute for Arthritis Research	This work was funded by the grants FNRS No 3100A0-116665/1 (NF), IZ70Z0-131421 (NF) and the association Institute for Arthritis Research (NF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259; Carvalho LP, 2012, J IMMUNOL, V188, P1394, DOI 10.4049/jimmunol.1101018; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; De Trez C, 2004, INFECT IMMUN, V72, P824, DOI 10.1128/IAI.72.2.824-832.2004; de Veer MJ, 2003, EUR J IMMUNOL, V33, P2822, DOI 10.1002/eji.200324128; Debus A, 2003, INFECT IMMUN, V71, P7215, DOI 10.1128/IAI.71.12.7215-7218.2003; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; LARA ML, 1991, HUM IMMUNOL, V30, P129, DOI 10.1016/0198-8859(91)90081-J; Liese J, 2007, EUR J IMMUNOL, V37, P3424, DOI 10.1002/eji.200737182; Martinez JE, 2000, J PARASITOL, V86, P792, DOI 10.1645/0022-3395(2000)086[0792:CDITEA]2.0.CO;2; Muraille E, 2003, J IMMUNOL, V170, P4237, DOI 10.4049/jimmunol.170.8.4237; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; Raman VS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00144; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Revaz-Breton M, 2010, EUR J IMMUNOL, V40, P1697, DOI 10.1002/eji.200939821; Rhee EG, 2002, J EXP MED, V195, P1565, DOI 10.1084/jem.20020147; Schulz SM, 2008, J IMMUNOL, V181, P7891, DOI 10.4049/jimmunol.181.11.7891; Scott P, 2003, IMMUNOL RES, V27, P489, DOI 10.1385/IR:27:2-3:489; Stacey KJ, 1999, INFECT IMMUN, V67, P3719, DOI 10.1128/IAI.67.8.3719-3726.1999; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Vargas-Inchaustegui DA, 2009, INFECT IMMUN, V77, P2948, DOI 10.1128/IAI.00154-09; Walker J, 2006, MOL BIOCHEM PARASIT, V145, P254, DOI 10.1016/j.molbiopara.2005.10.008; Weigle K, 1996, CLIN DERMATOL, V14, P433, DOI 10.1016/0738-081X(96)00036-3; Weinkopff T, 2013, INFECT IMMUN, V81, P1575, DOI 10.1128/IAI.01401-12	31	22	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96766	10.1371/journal.pone.0096766	http://dx.doi.org/10.1371/journal.pone.0096766			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801628	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800125
J	Lee, MH; Lu, SN; Yuan, Y; Yang, HI; Jen, CL; You, SL; Wang, LY; L'Italien, G; Chen, CJ				Lee, Mei-Hsuan; Lu, Sheng-Nan; Yuan, Yong; Yang, Hwai-I; Jen, Chin-Lan; You, San-Lin; Wang, Li-Yu; L'Italien, Gilbert; Chen, Chien-Jen		REVEAL-HCV Study Grp	Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies	PLOS ONE			English	Article							C VIRUS-INFECTION; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; GEOGRAPHIC VARIATIONS; B-VIRUS; FIBROSIS; THERAPY; IL28B; POLYMORPHISM; MORTALITY	Background: The development of a risk assessment tool for long-term hepatocellular carcinoma risk would be helpful in identifying high-risk patients and providing information of clinical consultation. Methods: The model derivation and validation cohorts consisted of 975 and 572 anti-HCV seropositives, respectively. The model included age, alanine aminotransferase (ALT), the ratio of aspirate aminotransferase to ALT, serum HCV RNA levels and cirrhosis status and HCV genotype. Two risk prediction models were developed: one was for all-anti-HCV seropositives, and the other was for anti-HCV seropositives with detectable HCV RNA. The Cox's proportional hazards models were utilized to estimate regression coefficients of HCC risk predictors to derive risk scores. The cumulative HCC risks in the validation cohort were estimated by Kaplan-Meier methods. The area under receiver operating curve (AUROC) was used to evaluate the performance of the risk models. Results: All predictors were significantly associated with HCC. The summary risk scores of two models derived from the derivation cohort had predictability of HCC risk in the validation cohort. The summary risk score of the two risk prediction models clearly divided the validation cohort into three groups (p<0.001). The AUROC for predicting 5-year HCC risk in the validation cohort was satisfactory for the two models, with 0.73 and 0.70, respectively. Conclusion: Scoring systems for predicting HCC risk of HCV-infected patients had good validity and discrimination capability, which may triage patients for alternative management strategies.	[Lee, Mei-Hsuan] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lee, Mei-Hsuan; Yang, Hwai-I; Jen, Chin-Lan; You, San-Lin; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Lu, Sheng-Nan] Chang Gung Univ, Kaohsiung, Taiwan; [Yang, Hwai-I] China Med Univ Hosp, Mol & Genom Epidemiol Ctr, Taichung, Taiwan; [Yang, Hwai-I] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, Li-Yu] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [L'Italien, Gilbert] Bristol Myers Squibb Co, Global Hlth Econ & Outcomes Res, Princeton, NJ USA; [L'Italien, Gilbert] Yale Univ, Sch Med, New Haven, CT USA; [Chen, Chien-Jen] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Medical College; Bristol-Myers Squibb; Yale University; National Taiwan University	Lee, MH (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	meihlee@ntu.edu.tw; juten@ms17.hinet.net; chencj@gate.sinica.edu.tw	Lee, Mei-Hsuan/J-8880-2015; Yang, Hwai-I/A-9470-2008; Chen, Chien-Jen/C-6976-2008; Chen, Chien-Jen/N-4723-2019	Lee, Mei-Hsuan/0000-0002-0222-2251; Yang, Hwai-I/0000-0002-3433-942X; You, San-Lin/0000-0002-3192-3356	Department of Health, Executive Yuan, Taipei, Taiwan; Bristol-Myers Squibb Co., USA; Academia Sinica, Taipei, Taiwan; National Health Research Institutes, Chunan, Taiwan [NHRI-EX98-9806PI]	Department of Health, Executive Yuan, Taipei, Taiwan; Bristol-Myers Squibb Co., USA(Bristol-Myers Squibb); Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan); National Health Research Institutes, Chunan, Taiwan(National Health Research Institutes - Taiwan)	The R.E.V.E.A.L.-HCV Study was funded by: the Department of Health, Executive Yuan, Taipei, Taiwan; Bristol-Myers Squibb Co., USA; Academia Sinica, Taipei, Taiwan; and the National Health Research Institutes (NHRI-EX98-9806PI), Chunan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Dayyeh BK, 2011, GASTROENTEROLOGY, V141, P141, DOI 10.1053/j.gastro.2011.03.045; Alter MJ, 2004, ANN INTERN MED, V141, P715, DOI 10.7326/0003-4819-141-9-200411020-00013; [Anonymous], 1999, J Hepatol, V30, P956; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Deuffic-Burban S, 2012, CLIN INFECT DIS, V54, P1272, DOI 10.1093/cid/cis047; Eurich D, 2012, TRANSPLANTATION, V93, P644, DOI 10.1097/TP.0b013e318244f774; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fontana RJ, 2010, GUT, V59, P1401, DOI 10.1136/gut.2010.207423; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2010, GASTROENTEROLOGY, V138, P136, DOI 10.1053/j.gastro.2009.09.007; Hatzakis A, 2011, J VIRAL HEPATITIS, V18, P1, DOI 10.1111/j.1365-2893.2011.01499.x; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Huang YC, 2011, J GASTROEN HEPATOL, V26, P129, DOI 10.1111/j.1440-1746.2010.06476.x; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lee MH, 2012, J INFECT DIS, V206, P469, DOI 10.1093/infdis/jis385; Lee MH, 2011, GUT, V60, P688, DOI 10.1136/gut.2010.220889; Lee MH, 2010, J CLIN ONCOL, V28, P4587, DOI 10.1200/JCO.2010.29.1500; Liu CH, 2011, J GASTROEN HEPATOL, V26, P1348, DOI 10.1111/j.1440-1746.2011.06842.x; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Lu SN, 2008, CANCER EPIDEM BIOMAR, V17, P1813, DOI 10.1158/1055-9965.EPI-07-2746; Lu SN, 2006, INT J CANCER, V119, P1946, DOI 10.1002/ijc.22045; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tsai MC, 2007, J GASTROEN HEPATOL, V22, P92, DOI 10.1111/j.1440-1746.2006.04489.x; Tseng PL, 2010, J GASTROEN HEPATOL, V25, P1426, DOI 10.1111/j.1440-1746.2010.06285.x; Varela M, 2010, MED CLIN-BARCELONA, V134, P569, DOI 10.1016/j.medcli.2009.10.042; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Yeh SH, 2004, J HEPATOL, V41, P659, DOI 10.1016/j.jhep.2004.06.031; Yu ML, 2006, HEPATOLOGY, V44, P1086, DOI 10.1002/hep.21363; Yu ML, 2011, HEPATOLOGY, V53, P7, DOI 10.1002/hep.23976	36	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e94760	10.1371/journal.pone.0094760	http://dx.doi.org/10.1371/journal.pone.0094760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801353	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800023
J	Lou, QQ; Chen, YF; Guo, XH; Yuan, L; Chen, T; Wang, C; Shen, L; Sun, ZL; Zhao, F; Dai, X; Huang, J; Yang, HY				Lou, Qingqing; Chen, Yufeng; Guo, Xiaohui; Yuan, Li; Chen, Tao; Wang, Chun; Shen, Li; Sun, Zilin; Zhao, Fang; Dai, Xia; Huang, Jin; Yang, Huiying		Chinese Diabet Educ Status Survey	Diabetes Attitude Scale: Validation in Type-2 Diabetes Patients in Multiple Centers in China	PLOS ONE			English	Article							GLYCEMIC CONTROL; PROBLEM AREAS; DISTRESS; DEPRESSION; CARE; HEALTH; ASSOCIATION; PHYSICIANS; EDUCATION; VERSION	Objective: The aim of the paper is to report the development and psychometric testing of Diabetes Attitude Scale. Method: A prospective study was performed. The cultural equivalency and content validity of the Diabetes Attitude Scale were determined by panels of endocrinologists, physiologists, nurses and dieticians. An accurate and usable translation was obtained for each of five subscales examining attitudes on need for special training, the seriousness of type-2 diabetes, the need for controlling the condition, its psychosocial impact and the degree of autonomy given to patients in decision making. The validation was derived from 5961 patients with type-2 diabetes, recruited from 50 centers in 29 provinces throughout China between March 1st and September 30th, 2010. Results: The modified Diabetes Attitude Scale showed an acceptable level of internal consistency. The strength of the inter-correlations among the domains of five subscales suggests that the instrument measures related but separate domains of patients' attitudes toward diabetes. Moreover, the test-retest intraclass correlation coefficients were high enough to support the stability of the Chinese version of the third version of the scale. Conclusions: The psychometric properties of the Chinese version of Diabetes Attitude Scale demonstrated satisfactory validity and reliability and appeared to effectively evaluate attitudes toward diabetes in patients with type-2 diabetes.	[Lou, Qingqing] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China; [Lou, Qingqing] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yufeng] Nanjing Univ Tradit Chinese Med, Sch Nursing, Nanjing, Jiangsu, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Yuan, Li; Chen, Tao; Wang, Chun] Sichuan Univ, West China Hosp, West China Med Sch, Dept Endocrinol, Chengdu 610064, Sichuan, Peoples R China; [Shen, Li] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Sun, Zilin] Southeast Univ, Sch Med, Zhongda Hosp, Inst Diabet, Nanjing, Jiangsu, Peoples R China; [Zhao, Fang] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Dai, Xia] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Jiangsu, Peoples R China; [Huang, Jin] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China; [Yang, Huiying] Kunming Med Coll, Affiliated Hosp 1, Kunming, Yunnan Province, Peoples R China	Nanjing University of Chinese Medicine; Zhejiang University; Nanjing University of Chinese Medicine; Peking University; Sichuan University; Peking University; Southeast University - China; China-Japan Friendship Hospital; Guangxi Medical University; Central South University; Kunming Medical University	Guo, XH (corresponding author), Beijing Tsinghua Hosp, Beijing, Peoples R China.	guoxh@medmail.com.cn			Novo Nordisk (China) Pharmaceutical Co., Ltd (NNCP)	Novo Nordisk (China) Pharmaceutical Co., Ltd (NNCP)(Novo Nordisk)	Funding to support this study was provided by Novo Nordisk (China) Pharmaceutical Co., Ltd (NNCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I., 1980, UNDERSTANDING ATTITU; Alberti G., 2002, PRACT DIABETES INT, V19, P22, DOI [DOI 10.1002/pdi.305, DOI 10.1002/PDI.305/PDF]; American Diabetes Association, 2006, CLIN DIABETES, DOI DOI 10.2337/DIACLIN.24.4.154; Anderson R, 2000, NAT HIST, V109, P23; ANDERSON RM, 1993, DIABETES EDUCATOR, V19, P287, DOI 10.1177/014572179301900407; Anderson RM, 2003, DIABETES CARE, V26, P1641, DOI 10.2337/diacare.26.5.1641-a; ANDERSON RM, 1989, DIABETES CARE, V12, P120, DOI 10.2337/diacare.12.2.120; Anderson RM, 1998, DIABETES CARE, V21, P1403, DOI 10.2337/diacare.21.9.1403; Anderson Robert M, 2009, Ther Patient Educ, V1, P3; Bannister E.W., 1991, PHYSL TESTING HIGH P, V2; Baradaran HR, 2013, INT J PREVENTIVE MED, V4, P580; Berk KAC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1026; Brislin R.W., 1986, FIELD METHODS CROSS, P137; Chen AL, 2012, DIABETES CARE, V35, P474, DOI 10.2337/dc11-1638; Chen B, 2013, PAK J MED SCI, V29, P1147; DONNELLY MB, 1990, MED CARE, V28, P175, DOI 10.1097/00005650-199002000-00008; Dziemidok P, 2011, ANN AGR ENV MED, V18, P318; Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842; Fisher L, 2010, DIABETES CARE, V33, P1034, DOI 10.2337/dc09-2175; Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087; Gagliardino JJ, 2007, REV PANAM SALUD PUBL, V22, P304, DOI 10.1590/S1020-49892007001000002; Hayashino Y, 2012, DIABETES RES CLIN PR, V97, P405, DOI 10.1016/j.diabres.2012.04.005; Hendrieckx C, 2014, DIABETES RES CLIN PR, V103, P430, DOI 10.1016/j.diabres.2013.12.005; Hsu HC, 2013, J NURS RES, V21, P212, DOI 10.1097/01.jnr.0000432048.31921.e2; Hu BB, 2011, J NURSING CHINA, V46, P225; Indrayan A, 2001, MED STAT; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; JACKSON C, 2000, DESIGNING ANAL QUEST; Kong LL, 2013, J BIOMED RES, V27, P380, DOI 10.7555/JBR.27.20120112; Leyva B, 2011, ETHNIC DIS, V21, P322; Mahjouri MY, 2011, J DIABETES METAB DIS, V10, P1; Mani N, 2011, J COMMUN HEALTH, V36, P728, DOI 10.1007/s10900-011-9366-6; MAZZUCA SA, 1986, DIABETES CARE, V9, P1, DOI 10.2337/diacare.9.1.1; Mosnier-Pudar H, 2010, DIABETES METAB, V36, P476, DOI 10.1016/j.diabet.2010.08.004; Pandit AU, 2014, J EPIDEMIOL COMMUN H, V68, P557, DOI 10.1136/jech-2013-203063; Peyrot M, 2006, DIABETOLOGIA, V49, P279, DOI 10.1007/s00125-005-0048-8; Peyrot M, 2012, DIABETIC MED, V29, P682, DOI 10.1111/j.1464-5491.2012.03605.x; Polly R K, 1992, Diabetes Educ, V18, P321, DOI 10.1177/014572179201800411; POLONSKY WH, 1995, DIABETES CARE, V18, P754, DOI 10.2337/diacare.18.6.754; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Reddy J, 2013, PSYCHOSOMATICS, V54, P44, DOI 10.1016/j.psym.2012.08.004; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Samoocha David, 2010, J Med Internet Res, V12, pe23, DOI 10.2196/jmir.1286; Shah VN, 2009, INT J DIABETES DEV C, V29, P118, DOI 10.4103/0973-3930.54288; Shiu ATY, 2012, PATIENT EDUC COUNS, V87, P258, DOI 10.1016/j.pec.2011.09.008; Shiu ATY, 2003, DIABETES CARE, V26, P2817, DOI 10.2337/diacare.26.10.2817; Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612; Tol A, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-6; Welch GW, 1997, DIABETES CARE, V20, P760, DOI 10.2337/diacare.20.5.760; Williams ACD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub3; Yan XX, 2012, ARCH OPHTHALMOL-CHIC, V130, P761, DOI 10.1001/archophthalmol.2012.145; Yang Q., 2010, J NURS, V17, P8; Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1289, DOI 10.2147/NDT.S49798; Zhou X, 2011, NURSING REHAB, V10, P947	54	3	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96473	10.1371/journal.pone.0096473	http://dx.doi.org/10.1371/journal.pone.0096473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ9KS	24802805	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800073
J	Tanaka, M; Mun, S; Harada, A; Ohkawa, Y; Inagaki, A; Sano, S; Takahashi, K; Izumi, Y; Osada-Oka, M; Wanibuchi, H; Yamagata, M; Yukimura, T; Miura, K; Shiota, M; Iwao, H				Tanaka, Masako; Mun, Saya; Harada, Akihito; Ohkawa, Yasuyuki; Inagaki, Azusa; Sano, Soichi; Takahashi, Katsuyuki; Izumi, Yasukatsu; Osada-Oka, Mayuko; Wanibuchi, Hideki; Yamagata, Masayo; Yukimura, Tokihito; Miura, Katsuyuki; Shiota, Masayuki; Iwao, Hiroshi			Hsc70 Contributes to Cancer Cell Survival by Preventing Rab1A Degradation under Stress Conditions	PLOS ONE			English	Article							SMALL GTPASE RAN; HEAT-SHOCK-PROTEIN-70 FAMILY; ABERRANT EXPRESSION; DOWN-REGULATION; HSP70; PROTEINS; ACTIVATION; RESISTANCE; AUTOPHAGY; ONCOGENE	Heat shock cognate protein 70 (Hsc70) acts as a molecular chaperone for the maintenance of intracellular proteins, which allows cancer cells to survive under proteotoxic stress. We attempted to use Hsc70 to identify key molecules in cancer cell survival. Here, we performed mass-spectrometry-based proteomics analysis utilizing affinity purification with anti-Hsc70 antibodies; as a result, 83 differentially expressed proteins were identified under stress conditions. This result implies that there was a change in the proteins with which Hsc70 interacted in response to stress. Among the proteins identified under both serum-depleted and 5-fluorouracil-treated conditions, Rab1A was identified as an essential molecule for cancer cell survival. Hsc70 interacted with Rab1A in a chaperone-dependent manner. In addition, Hsc70 knockdown decreased the level of Rab1A and increased the level of its ubiquitination under stress conditions, suggesting that Hsc70 prevented the degradation of Rab1A denatured by stress exposure. We also found that Rab1A knockdown induced cell death by inhibition of autophagosome formation. Rab1A may therefore contribute to overcoming proteotoxic insults, which allows cancer cells to survive under stress conditions. Analysis of Hsc70 interactors provided insight into changes of intracellular status. We expect further study of the Hsc70 interactome to provide a more comprehensive understanding of cancer cell physiology.	[Tanaka, Masako; Mun, Saya; Takahashi, Katsuyuki; Izumi, Yasukatsu; Osada-Oka, Mayuko; Shiota, Masayuki; Iwao, Hiroshi] Osaka City Univ, Sch Med, Dept Pharmacol, Osaka 545, Japan; [Harada, Akihito; Ohkawa, Yasuyuki] Kyushu Univ, Fac Med Sci, Dept Adv Med Initiat, Fukuoka 812, Japan; [Inagaki, Azusa; Wanibuchi, Hideki] Osaka City Univ, Sch Med, Dept Pathol, Osaka 545, Japan; [Sano, Soichi] Osaka City Univ, Sch Med, Dept Cardiovasc Med, Osaka 545, Japan; [Yamagata, Masayo; Yukimura, Tokihito] Osaka Ohtani Univ, Fac Pharm, Lab Clin Pharmacol, Tondabayashi, Japan; [Miura, Katsuyuki] Osaka City Univ, Sch Med, Osaka 545, Japan	Osaka Metropolitan University; Kyushu University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Shiota, M (corresponding author), Osaka City Univ, Sch Med, Dept Pharmacol, Osaka 545, Japan.	sio@med.osaka-cu.ac.jp	Ohkawa, Yasuyuki/C-4087-2016; Ohkawa, Yasuyuki/ABG-1839-2021	Ohkawa, Yasuyuki/0000-0001-6440-9954; Ohkawa, Yasuyuki/0000-0001-6440-9954; TAKAHASHI, KATSUYUKI/0000-0001-9183-0760; Tanaka, Masako/0000-0002-4484-1712	JSPS KAKENHI [24650637, 23650617];  [24-2543]; Grants-in-Aid for Scientific Research [13J04024, 221S0001, 24390064] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by JSPS KAKENHI (http://www.jsps.go.jp/english/index.html) Grant Numbers 24650637 (Masayuki Shiota) and 23650617 (Hiroshi Iwao), and Grant-in-Aid for JSPS Fellows (24-2543 for Masako Tanaka). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Florin L, 2004, J VIROL, V78, P5546, DOI 10.1128/JVI.78.11.5546-5553.2004; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Gluckmann M, 2007, PROTEOMICS, V7, P1564, DOI 10.1002/pmic.200600836; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jego G, 2013, CANCER LETT, V332, P275, DOI 10.1016/j.canlet.2010.10.014; Kakehashi A, 2011, TOXICOL SCI, V119, P61, DOI 10.1093/toxsci/kfq307; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Kodiha M, 2005, AM J PHYSIOL-CELL PH, V289, pC1034, DOI 10.1152/ajpcell.00590.2004; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Liu T, 2012, PHARMACOL THERAPEUT, V136, P354, DOI 10.1016/j.pharmthera.2012.08.014; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Maeda A, 2000, CANCER RES, V60, P1914; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moran DM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-32; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Quimby BB, 2003, CURR OPIN CELL BIOL, V15, P338, DOI 10.1016/S0955-0674(03)00046-2; Ren AX, 2008, CANCER RES, V68, P2266, DOI 10.1158/0008-5472.CAN-07-6248; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Saitoh H, 1996, MOL BIOL CELL, V7, P1319, DOI 10.1091/mbc.7.9.1319; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Shiota M, 2003, MOL ENDOCRINOL, V17, P534, DOI 10.1210/me.2002-0187; Shiota M, 2009, ARTERIOSCLER THROMB, V30, P491; Shiota M, 2010, HYBRIDOMA, V29, P453, DOI 10.1089/hyb.2010.0024; Steel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052351; Taddei ML, 2013, CANC LETT; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Tietze N, 2008, OLIGONUCLEOTIDES, V18, P161, DOI 10.1089/oli.2008.0112; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zhai H, 2013, ONCOGENE, V32, P1570, DOI 10.1038/onc.2012.167; Zhang L, 2013, CANC LETT	45	29	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96785	10.1371/journal.pone.0096785	http://dx.doi.org/10.1371/journal.pone.0096785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24801886	Green Published, Green Submitted, gold			2022-12-27	WOS:000338029800127
J	Verbeurgt, C; Wilkin, F; Tarabichi, M; Gregoire, F; Dumont, JE; Chatelain, P				Verbeurgt, Christophe; Wilkin, Francoise; Tarabichi, Maxime; Gregoire, Francoise; Dumont, Jacques E.; Chatelain, Pierre			Profiling of Olfactory Receptor Gene Expression in Whole Human Olfactory Mucosa	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; ODORANT RECEPTORS; FAMILY; MOUSE; IDENTIFICATION; SENSITIVITY; CELLS; QUANTIFICATION; SPECIFICITY; CLUSTER	Olfactory perception is mediated by a large array of olfactory receptor genes. The human genome contains 851 olfactory receptor gene loci. More than 50% of the loci are annotated as nonfunctional due to frame-disrupting mutations. Furthermore haplotypic missense alleles can be nonfunctional resulting from substitution of key amino acids governing protein folding or interactions with signal transduction components. Beyond their role in odor recognition, functional olfactory receptors are also required for a proper targeting of olfactory neuron axons to their corresponding glomeruli in the olfactory bulb. Therefore, we anticipate that profiling of olfactory receptor gene expression in whole human olfactory mucosa and analysis in the human population of their expression should provide an opportunity to select the frequently expressed and potentially functional olfactory receptors in view of a systematic deorphanization. To address this issue, we designed a TaqMan Low Density Array (Applied Biosystems), containing probes for 356 predicted human olfactory receptor loci to investigate their expression in whole human olfactory mucosa tissues from 26 individuals (13 women, 13 men; aged from 39 to 81 years, with an average of 67611 years for women and 63612 years for men). Total RNA isolation, DNase treatment, RNA integrity evaluation and reverse transcription were performed for these 26 samples. Then 384 targeted genes (including endogenous control genes and reference genes specifically expressed in olfactory epithelium for normalization purpose) were analyzed using the same real-time reverse transcription PCR platform. On average, the expression of 273 human olfactory receptor genes was observed in the 26 selected whole human olfactory mucosa analyzed, of which 90 were expressed in all 26 individuals. Most of the olfactory receptors deorphanized to date on the basis of sensitivity to known odorant molecules, which are described in the literature, were found in the expressed olfactory receptors gene set.	[Wilkin, Francoise; Chatelain, Pierre] ChemCom SA, Brussels, Belgium; [Verbeurgt, Christophe] Erasme Univ Hosp, Dept Otorhinolaryngol, B-1070 Brussels, Belgium; [Tarabichi, Maxime; Dumont, Jacques E.] Free Univ Brussels, Inst Interdisciplinary Res Human & Mol Biol, Brussels, Belgium; [Gregoire, Francoise] Free Univ Brussels, Dept Biochem, Lab Pathophysiol & Nutr Biochem, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Wilkin, F (corresponding author), ChemCom SA, Brussels, Belgium.	fwi@chemcom.be	Tarabichi, Maxime/ABA-9246-2020	Tarabichi, Maxime/0000-0002-1635-2348; Gregoire, Francoise/0000-0003-0452-8868	FRIA/FNRS grant; Fonds Erasme, Universite Libre de Bruxelles, Brussels, Belgium; Innoviris (Brussels Institute for Research and Innovation)	FRIA/FNRS grant(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme, Universite Libre de Bruxelles, Brussels, Belgium; Innoviris (Brussels Institute for Research and Innovation)(Innoviris)	M. Tarabichi is supported by FRIA/FNRS grant. URL: http://www.fnrs.be/. C. Verbeurgt is supported by Fonds Erasme, Universite Libre de Bruxelles, Brussels, Belgium. URL: http://www.fondserasme.org/fonds-erasme-pour-la-recherche-medicale. ChemCom S. A. is supported by Innoviris (Brussels Institute for Research and Innovation) URL: http://www.innoviris.be/site/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; Braun T, 2007, GASTROENTEROLOGY, V132, P1890, DOI 10.1053/j.gastro.2007.02.036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Durzynski L, 2005, BIOCHEM BIOPH RES CO, V333, P264, DOI 10.1016/j.bbrc.2005.05.085; Escada PA, 2009, EUR ARCH OTO-RHINO-L, V266, P1675, DOI 10.1007/s00405-009-1073-x; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fuessel S, 2006, CANCER LETT, V236, P95, DOI 10.1016/j.canlet.2005.05.005; Fujita Y, 2007, J RECEPT SIG TRANSD, V27, P323, DOI 10.1080/10799890701534180; Fuss SH, 2013, MOL CELL NEUROSCI, V56, P212, DOI 10.1016/j.mcn.2013.05.002; Gaudin JC, 2001, CHEM SENSES, V26, P1157, DOI 10.1093/chemse/26.9.1157; Gaudin JC, 2006, GENE, V381, P42, DOI 10.1016/j.gene.2006.06.006; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Goto T, 2001, MOL HUM REPROD, V7, P553, DOI 10.1093/molehr/7.6.553; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Itakura S, 2006, PLACENTA, V27, P103, DOI 10.1016/j.placenta.2004.12.006; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Katotomichelakis M, 2007, RHINOLOGY, V45, P273; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keydar I, 2013, HUM MUTAT, V34, P32, DOI 10.1002/humu.22212; Khan M, 2013, MOL CELL NEUROSCI, V57, P120, DOI 10.1016/j.mcn.2013.08.001; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Leopold DA, 2000, LARYNGOSCOPE, V110, P417, DOI 10.1097/00005537-200003000-00016; Mainland JD, 2014, NAT NEUROSCI, V17, P114, DOI 10.1038/nn.3598; Mashukova A, 2006, J NEUROSCI, V26, P9902, DOI 10.1523/JNEUROSCI.2897-06.2006; Matarazzo V, 2005, CHEM SENSES, V30, P195, DOI 10.1093/chemse/bji015; Mcrae JF, 2012, CHEM SENSES, V37, P585, DOI 10.1093/chemse/bjs049; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Nibu K, 1999, CELL TISSUE RES, V298, P405, DOI 10.1007/s004419900098; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Otaki JM, 2004, J NEUROBIOL, V58, P315, DOI 10.1002/neu.10272; PARMENTIER M, 1992, NATURE, V355, P453, DOI 10.1038/355453a0; Pavlath GK, 2010, CELL ADHES MIGR, V4, P502, DOI 10.4161/cam.4.4.12291; Pluznick JL, 2013, P NATL ACAD SCI USA, V110, P4410, DOI 10.1073/pnas.1215927110; Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shirasu M, 2014, NEURON, V81, P165, DOI 10.1016/j.neuron.2013.10.021; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; VANDERHAEGHEN P, 1993, J CELL BIOL, V123, P1441, DOI 10.1083/jcb.123.6.1441; Vanderhaeghen P, 1997, BIOCHEM BIOPH RES CO, V237, P283, DOI 10.1006/bbrc.1997.7043; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vanti WB, 2003, BIOCHEM BIOPH RES CO, V305, P67, DOI 10.1016/S0006-291X(03)00709-5; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; Volz A, 2003, J BIOL CHEM, V278, P19691, DOI 10.1074/jbc.M212424200; Weng JS, 2006, INT J CANCER, V118, P1471, DOI 10.1002/ijc.21527; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Witt M, 2009, MOVEMENT DISORD, V24, P906, DOI 10.1002/mds.22464; Xu LL, 2000, CANCER RES, V60, P6568; Yuan TTT, 2001, GENE, V278, P41, DOI 10.1016/S0378-1119(01)00709-0; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86	67	73	74	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96333	10.1371/journal.pone.0096333	http://dx.doi.org/10.1371/journal.pone.0096333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24800820	Green Submitted, Green Published, gold			2022-12-27	WOS:000338029800058
J	Wu, S; Liu, ZP; Qiu, X; Wu, HL				Wu, Shuang; Liu, Zhi-Ping; Qiu, Xing; Wu, Hulin			Modeling Genome-Wide Dynamic Regulatory Network in Mouse Lungs with Influenza Infection Using High-Dimensional Ordinary Differential Equations	PLOS ONE			English	Article							GENE NETWORKS; ADAPTIVE IMMUNITY; COMPOUND-MODE; EXPRESSION; INNATE; ACTIVATION; INFERENCE; DISCOVERY; PATHWAYS; SYSTEM	The immune response to viral infection is regulated by an intricate network of many genes and their products. The reverse engineering of gene regulatory networks (GRNs) using mathematical models from time course gene expression data collected after influenza infection is key to our understanding of the mechanisms involved in controlling influenza infection within a host. A five-step pipeline: detection of temporally differentially expressed genes, clustering genes into co-expressed modules, identification of network structure, parameter estimate refinement, and functional enrichment analysis, is developed for reconstructing high-dimensional dynamic GRNs from genome-wide time course gene expression data. Applying the pipeline to the time course gene expression data from influenza-infected mouse lungs, we have identified 20 distinct temporal expression patterns in the differentially expressed genes and constructed a module-based dynamic network using a linear ODE model. Both intra-module and inter-module annotations and regulatory relationships of our inferred network show some interesting findings and are highly consistent with existing knowledge about the immune response in mice after influenza infection. The proposed method is a computationally efficient, data-driven pipeline bridging experimental data, mathematical modeling, and statistical analysis. The application to the influenza infection data elucidates the potentials of our pipeline in providing valuable insights into systematic modeling of complicated biological processes.	[Wu, Shuang; Liu, Zhi-Ping; Qiu, Xing; Wu, Hulin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA	University of Rochester	Wu, HL (corresponding author), Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14627 USA.	Hulin_Wu@urmc.rochester.edu	Liu, Zhi-Ping/C-9846-2010	Liu, Zhi-Ping/0000-0001-7742-9161	NIH [HHSN272201000055C, AI087135]; University of Rochester CTSI pilot award from the National Center For Research Resources [UL1RR024160]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000042]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087135] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester CTSI pilot award from the National Center For Research Resources; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was partially supported by the NIH grants HHSN272201000055C, AI087135; the University of Rochester CTSI pilot award (UL1RR024160) from the National Center For Research Resources; and Award Number UL1TR000042 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2000, BIOINFORMATICS, V16, P727, DOI 10.1093/bioinformatics/16.8.727; Alberts R, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-61; [Anonymous], [No title captured]; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bansal M, 2006, BIOINFORMATICS, V22, P815, DOI 10.1093/bioinformatics/btl003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Cao JG, 2012, J COMPUT GRAPH STAT, V21, P42, DOI 10.1198/jcgs.2011.10021; Chen HC, 2004, BIOINFORMATICS, V20, P1914, DOI 10.1093/bioinformatics/bth178; Chen T, 1999, Pac Symp Biocomput, P29; Chiu BC, 2004, AM J PATHOL, V165, P1199, DOI 10.1016/S0002-9440(10)63380-9; D'haeseleer P, 1999, Pac Symp Biocomput, P41; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; de Hoon Michiel J L, 2003, Pac Symp Biocomput, P17; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Denoeud J, 2011, J LEUKOCYTE BIOL, V89, P195, DOI 10.1189/jlb.0610351; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hirose O, 2008, BIOINFORMATICS, V24, P932, DOI 10.1093/bioinformatics/btm639; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002234; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim Sun Yong, 2003, Briefings in Bioinformatics, V4, P228, DOI 10.1093/bib/4.3.228; Kim Y, 2008, J AM STAT ASSOC, V103, P1665, DOI 10.1198/016214508000001066; Kojima Kaname, 2010, V22, P56; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Liang H, 2008, J AM STAT ASSOC, V103, P1570, DOI 10.1198/016214508000000797; Lien CY, 2010, P NATL ACAD SCI USA, V107, P4664, DOI 10.1073/pnas.0911193107; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Luan YH, 2003, BIOINFORMATICS, V19, P474, DOI 10.1093/bioinformatics/btg014; Ma P, 2006, NUCLEIC ACIDS RES, V34, P1261, DOI 10.1093/nar/gkl013; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mattila PK, 2013, IMMUNITY, V38, P461, DOI 10.1016/j.immuni.2012.11.019; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Miao HY, 2011, SIAM REV, V53, P3, DOI 10.1137/090757009; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Needham CJ, 2007, PLOS COMPUT BIOL, V3, P1409, DOI 10.1371/journal.pcbi.0030129; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Pommerenke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041169; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rangelova S, 2008, IMMUNOLOGY, V125, P549, DOI 10.1111/j.1365-2567.2008.02869.x; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Shimamura T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-41; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Voit E. O., 2000, COMPUTATIONAL ANAL B; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Wu H, 2005, NONPARAMETRIC REGRES; Wu H, 2013, J AM STAT ASS ACCEPT; Wu S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-6; Xue HQ, 2010, ANN STAT, V38, P2351, DOI 10.1214/09-AOS784; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991; Zhao F, 2005, NUCLEIC ACIDS RES, V33, pD103, DOI 10.1093/nar/gki004; Zou M, 2005, BIOINFORMATICS, V21, P71, DOI 10.1093/bioinformatics/bth463	82	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e95276	10.1371/journal.pone.0095276	http://dx.doi.org/10.1371/journal.pone.0095276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24802016	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800028
J	Burgos, K; Malenica, I; Metpally, R; Courtright, A; Rakela, B; Beach, T; Shill, H; Adler, C; Sabbagh, M; Villa, S; Tembe, W; Craig, D; Van Keuren-Jensen, K				Burgos, Kasandra; Malenica, Ivana; Metpally, Raghu; Courtright, Amanda; Rakela, Benjamin; Beach, Thomas; Shill, Holly; Adler, Charles; Sabbagh, Marwan; Villa, Stephen; Tembe, Waibhav; Craig, David; Van Keuren-Jensen, Kendall			Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology	PLOS ONE			English	Article							CIRCULATING MICRORNAS; ALPHA-SYNUCLEIN; EXPRESSION; BIOMARKERS; DIFFERENTIATION; IDENTIFICATION; PROTEIN; DOPAMINE; DEMENTIA; SYSTEM	The discovery and reliable detection of markers for neurodegenerative diseases have been complicated by the inaccessibility of the diseased tissue-such as the inability to biopsy or test tissue from the central nervous system directly. RNAs originating from hard to access tissues, such as neurons within the brain and spinal cord, have the potential to get to the periphery where they can be detected non-invasively. The formation and extracellular release of microvesicles and RNA binding proteins have been found to carry RNA from cells of the central nervous system to the periphery and protect the RNA from degradation. Extracellular miRNAs detectable in peripheral circulation can provide information about cellular changes associated with human health and disease. In order to associate miRNA signals present in cell-free peripheral biofluids with neurodegenerative disease status of patients with Alzheimer's and Parkinson's diseases, we assessed the miRNA content in cerebrospinal fluid and serum from postmortem subjects with full neuropathology evaluations. We profiled the miRNA content from 69 patients with Alzheimer's disease, 67 with Parkinson's disease and 78 neurologically normal controls using next generation small RNA sequencing (NGS). We report the average abundance of each detected miRNA in cerebrospinal fluid and in serum and describe 13 novel miRNAs that were identified. We correlated changes in miRNA expression with aspects of disease severity such as Braak stage, dementia status, plaque and tangle densities, and the presence and severity of Lewy body pathology. Many of the differentially expressed miRNAs detected in peripheral cell-free cerebrospinal fluid and serum were previously reported in the literature to be deregulated in brain tissue from patients with neurodegenerative disease. These data indicate that extracellular miRNAs detectable in the cerebrospinal fluid and serum are reflective of cell-based changes in pathology and can be used to assess disease progression and therapeutic efficacy.	[Burgos, Kasandra; Malenica, Ivana; Metpally, Raghu; Courtright, Amanda; Rakela, Benjamin; Villa, Stephen; Tembe, Waibhav; Craig, David; Van Keuren-Jensen, Kendall] Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA; [Beach, Thomas; Shill, Holly; Sabbagh, Marwan] Banner Sun Hlth Res Inst, Sun City, AZ USA; [Adler, Charles] Mayo Clin, Scottsdale, AZ USA	Translational Genomics Research Institute; Banner Research; Banner Health; Banner Sun Health Research Institute; Mayo Clinic; Mayo Clinic Phoenix	Van Keuren-Jensen, K (corresponding author), Translat Genom Res Inst TGen, Phoenix, AZ 85004 USA.	kjensen@tgen.org	Adler, Charles/ABD-5276-2021; Malenica, Ivana/J-2007-2019; Craig, David Wesley/K-6961-2019	Malenica, Ivana/0000-0002-7404-8088; Craig, David Wesley/0000-0003-2040-1955; Rakela, Benjamin/0000-0002-4264-0562	Michael J Fox Foundation for Parkinsons Research	Michael J Fox Foundation for Parkinsons Research	Michael J Fox Foundation for Parkinsons Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Alexandrov Peter N, 2012, Int J Biochem Mol Biol, V3, P365; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Apaydin H, 2002, ARCH NEUROL-CHICAGO, V59, P102, DOI 10.1001/archneur.59.1.102; Barak B, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.77; Bartos A, 2012, J NEUROIMMUNOL, V252, P100, DOI 10.1016/j.jneuroim.2012.08.001; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cho HJ, 2013, HUM MOL GENET, V22, P608, DOI 10.1093/hmg/dds470; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; De Smaele E, 2010, BRAIN RES, V1338, P100, DOI 10.1016/j.brainres.2010.03.103; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Delay C, 2012, NEUROBIOL DIS, V46, P285, DOI 10.1016/j.nbd.2012.01.003; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fang MR, 2012, TOXICOL LETT, V209, P94, DOI 10.1016/j.toxlet.2011.11.032; Filatova EV, 2012, BIOCHEMISTRY-MOSCOW+, V77, P813, DOI 10.1134/S0006297912080020; Folgoas E, 2013, NEUROSCI LETT, V551, P62, DOI 10.1016/j.neulet.2013.07.016; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Geekiyanage H, 2012, EXP NEUROL, V235, P491, DOI 10.1016/j.expneurol.2011.11.026; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gillardon F, 2008, PROTEOM CLIN APPL, V2, P697, DOI 10.1002/prca.200780025; Gustincich S, 2006, J PHYSIOL-LONDON, V575, P321, DOI 10.1113/jphysiol.2006.115568; Haramati S, 2010, P NATL ACAD SCI USA, V107, P13111, DOI 10.1073/pnas.1006151107; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Holohan Kelly N., 2013, Frontiers in Genetics, V3, P323, DOI 10.3389/fgene.2012.00323; Hu YY, 2002, NEUROSCI LETT, V320, P156, DOI 10.1016/S0304-3940(02)00047-2; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Junn E, 2009, P NATL ACAD SCI USA, V106, P13052, DOI 10.1073/pnas.0906277106; Khoo SK, 2012, J PARKINSON DIS, V2, P321, DOI 10.3233/JPD-012144; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kutner M., 2005, APPL LINEAR STAT MOD; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; Lau P, 2010, SEMIN CELL DEV BIOL, V21, P768, DOI 10.1016/j.semcdb.2010.01.009; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Liu Quan, 2011, Open Neurol J, V5, P58, DOI 10.2174/1874205X01105010058; Liu W, 2012, NEUROBIOL AGING, V33, P522, DOI 10.1016/j.neurobiolaging.2010.04.034; Lukiw WJ, 2007, J INORG BIOCHEM, V101, P1265, DOI 10.1016/j.jinorgbio.2007.06.004; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Lukiw WJ, 2012, MOL NEUROBIOL, V46, P11, DOI 10.1007/s12035-012-8234-4; Maarouf CL, 2012, NEUROL RES, V34, P669, DOI 10.1179/1743132812Y.0000000063; Margis R, 2011, J BIOTECHNOL, V152, P96, DOI 10.1016/j.jbiotec.2011.01.023; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Minones-Moyano E, 2011, HUM MOL GENET, V20, P3067, DOI 10.1093/hmg/ddr210; Mouradian MM, 2012, NEUROBIOL DIS, V46, P279, DOI 10.1016/j.nbd.2011.12.046; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Pasinetti GM, 2012, J ALZHEIMERS DIS PAR, P2, DOI [10.4172/2161-0460.1000e118, DOI 10.4172/2161-0460.1000E118]; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Provost P, 2010, AGING-US, V2, P166, DOI 10.18632/aging.100131; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Sheinerman KS, 2012, AGING-US, V4, P590, DOI 10.18632/aging.100486; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Smith P, 2011, J NEUROCHEM, V116, P240, DOI 10.1111/j.1471-4159.2010.07097.x; Sonntag KC, 2010, BRAIN RES, V1338, P48, DOI 10.1016/j.brainres.2010.03.106; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; Vilardo E, 2010, J BIOL CHEM, V285, P18344, DOI 10.1074/jbc.M110.112664; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Xu SJ, 2012, INT J MOL SCI, V13, P16945, DOI 10.3390/ijms131216945; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Zhu HC, 2012, BRAIN RES BULL, V88, P596, DOI 10.1016/j.brainresbull.2012.05.018; Zovoilis A, 2011, EMBO J, V30, P4299, DOI 10.1038/emboj.2011.327	77	244	252	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e94839	10.1371/journal.pone.0094839	http://dx.doi.org/10.1371/journal.pone.0094839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797360	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000010
J	Gedik, N; Thielmann, M; Kottenberg, E; Peters, J; Jakob, H; Heusch, G; Kleinbongard, P				Gedik, Nilguen; Thielmann, Matthias; Kottenberg, Eva; Peters, Juergen; Jakob, Heinz; Heusch, Gerd; Kleinbongard, Petra			No Evidence for Activated Autophagy in Left Ventricular Myocardium at Early Reperfusion with Protection by Remote Ischemic Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting	PLOS ONE			English	Article							CONTROLLED-TRIAL; CARDIOPROTECTION; SURGERY; PROTEIN; INJURY; HEART; P62/SQSTM1; KINASE	Objective: Remote ischemic preconditioning (RIPC) by repeated brief limb ischemia/reperfusion reduces myocardial injury in patients undergoing coronary artery bypass grafting (CABG). Activation of signal transducer and activator of transcription 5 (STAT5) in left ventricular (LV) myocardium at early reperfusion is associated with such protection. Autophagy, i.e., removal of dysfunctional cellular components through lysosomes, has been proposed as one mechanism of cardioprotection. Therefore, we analyzed whether or not the protection by RIPC is associated with activated autophagy. Methods: CABG patients were randomized to undergo RIPC (3x5 min blood pressure cuff inflation/5 min deflation) or placebo (cuff deflated) before skin incision (n = 10/10). Transmural myocardial biopsies were taken from the LV before cardioplegia (baseline) and at early (5-10 min) reperfusion. RIPC-induced protection was reflected by decreased serum troponin I concentration area under the curve (194 +/- 17 versus 709 +/- 129 ng/ml x 72 h, p = 0.002). Western blotting for beclin-1-phosphorylation and protein expression of autophagy-related gene 5-12 (ATG5-12) complex, light chain 3 (LC3), parkin, and p62 was performed. STAT3-, STAT5- and extracellular signal-regulated protein kinase 1/2 (ERK1/2)-phosphorylation was used as positive control to confirm signal activation by ischemia/reperfusion. Results: Signals of all analyzed autophagy proteins did not differ between baseline and early reperfusion and not between RIPC and placebo. STAT5-phosphorylation was greater at early reperfusion only with RIPC (2.2-fold, p = 0.02). STAT3- and ERK1/2-phosphorylation were greater at early reperfusion with placebo and RIPC (>= 2.7-fold versus baseline, p <= 0.05). Conclusion: Protection through RIPC in patients undergoing CABG surgery does not appear to be associated with enhanced autophagy in LV myocardium at early reperfusion.	[Gedik, Nilguen; Heusch, Gerd; Kleinbongard, Petra] Univ Duisburg Essen, Universitatsklinikum Essen, Inst Pathophysiol, Essen, Germany; [Thielmann, Matthias; Jakob, Heinz] Univ Duisburg Essen, Universitatsklinikum Essen, Klin Thorax & Kardiovaskulare Chirurg, Essen, Germany; [Kottenberg, Eva; Peters, Juergen] Univ Duisburg Essen, Universitatsklinikum Essen, Klin Anasthesiol & Intensivmed, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Kleinbongard, P (corresponding author), Univ Duisburg Essen, Universitatsklinikum Essen, Inst Pathophysiol, Essen, Germany.	petra.kleinbongard@uk-essen.de	Heusch, Gerd/ABE-6675-2020		Dr. Heinz-Horst Deichmann Foundation; Hans und Gerti Fischer Foundation	Dr. Heinz-Horst Deichmann Foundation; Hans und Gerti Fischer Foundation	This research was supported by the Dr. Heinz-Horst Deichmann Foundation and the Hans und Gerti Fischer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Andres AM, 2014, ANTIOXID REDOX SIGN, V21, P1960, DOI 10.1089/ars.2013.5416; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; DECKER RS, 1980, AM J PATHOL, V98, P425; Dong Y, 2010, J CARDIOVASC PHARM T, V15, P220, DOI 10.1177/1074248410370327; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gottlieb RA, 2009, BASIC RES CARDIOL, V104, P169, DOI 10.1007/s00395-009-0011-9; Gurusamy N, 2009, J CELL MOL MED, V13, P373, DOI 10.1111/j.1582-4934.2008.00495.x; Hausenloy DJ, 2007, LANCET, V370, P575, DOI 10.1016/S0140-6736(07)61296-3; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Heusch G, 2012, CIRC RES, V110, P111, DOI 10.1161/CIRCRESAHA.111.259556; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Jahania SM, 2013, J AM COLL SURGEONS, V216, P719, DOI 10.1016/j.jamcollsurg.2012.12.034; Kassiotis C, 2009, CIRCULATION, V120, pS191, DOI 10.1161/CIRCULATIONAHA.108.842252; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Thielmann M, 2010, BASIC RES CARDIOL, V105, P657, DOI 10.1007/s00395-010-0104-5; Venugopal V, 2009, HEART, V95, P1567, DOI 10.1136/hrt.2008.155770; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246	25	41	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96567	10.1371/journal.pone.0096567	http://dx.doi.org/10.1371/journal.pone.0096567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797938	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000095
J	Jagodzinski, LL; Liu, Y; Hack, HR; Kibirige, C; Peel, SA; Manak, MM				Jagodzinski, Linda L.; Liu, Ying; Hack, Holly R.; Kibirige, Catherine; Peel, Sheila A.; Manak, Mark M.			Discrepant Amplification Results during the Development of an Assay Leads to Reclassification of Two AIDS Reagent Repository HIV-2 Isolates as HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; VIRAL LOAD ASSAY; CLINICAL-USE; QUANTIFICATION; VALIDATION	The development and verification of HIV-2 assays depends in part on the availability of well-characterized samples, including those from reagent repositories. During the development of an HIV-2 RNA quantification assay, two HIV-2 viral isolates (CDC 301340 and CDC 301342) obtained from the NIAID AIDS Reagent and Reference Repository were not detected leading to an investigation. Two HIV-2 primers/probe sets of known performance in real-time viral RNA quantification assays, targeting different regions of the virus, also failed to generate RT-PCR products for these two isolates. These isolates were tested in the HIV-1 specific COBAS AmpliPrep/COBAS TaqMan HIV-1 Test v2.0 (Roche Molecular Diagnostics) and were quantified at high copy number. Other HIV-2 isolates tested were not amplified in the COBAS HIV-1 TaqMan assay. Furthermore, the discrepant isolates were highly reactive in an HIV-1 p24 antigen test while the other HIV-2 isolates showed very weak, if any, cross-reactivity with the HIV-1 p24 assay. Phylogenetic tree analysis of sequences from the protease-reverse transcriptase regions of the discrepant HIV-2 isolates mapped with HIV-1 Group M, Subtype CRF02_AG confirming these isolates were of HIV-1 origin and had been misclassified as HIV-2. The use of misclassified isolates in the verification of molecular and immunological assays can lead to misinterpretation of test results, misdirection of efforts into assay redesign and increased development costs. The results of this study were shared with the NIAID AIDS Reagent Program, leading to the reclassification of the two discrepant isolates as HIV-1.	[Jagodzinski, Linda L.; Peel, Sheila A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA; [Liu, Ying; Hack, Holly R.; Kibirige, Catherine; Manak, Mark M.] Henry M Jackson Fdn Adv Mil Med, US Mil HIV Res Program, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR)	Jagodzinski, LL (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD 20910 USA.	ljagodzinski@hivresearch.org	Manak, Mark/Q-6553-2019; Kibirige, MBiochem, PhD, Dr. Catherine Namugga/AEF-5731-2022; Kibirige, MBiochem, PhD, Dr. Catherine Namugga/AAH-2516-2022	Manak, Mark/0000-0002-9217-9129; Kibirige, MBiochem, PhD, Dr. Catherine Namugga/0000-0001-8092-6599; Kibirige, MBiochem, PhD, Dr. Catherine Namugga/0000-0001-8092-6599	US Army Medical Research and Materiel Command [W81XWH-07-2-0067]; Henry M. Jackson Foundation for the Advancement of Military Research [W81XWH-07-2-0067]; US Army Medical Command	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Research; US Army Medical Command	This work was performed under a Cooperative Agreement W81XWH-07-2-0067 between the US Army Medical Research and Materiel Command and the Henry M. Jackson Foundation for the Advancement of Military Research and executed using funding provided by the US Army Medical Command. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry N, 2011, METHODS MOL BIOL, V665, P133, DOI 10.1007/978-1-60761-817-1_9; Campbell-Yesufu OT, 2011, CLIN INFECT DIS, V52, P780, DOI 10.1093/cid/ciq248; Chang M, 2012, J CLIN VIROL, V55, P128, DOI 10.1016/j.jcv.2012.06.024; Damond F, 2011, J CLIN MICROBIOL, V49, P3491, DOI 10.1128/JCM.02389-10; Damond F, 2001, VIROLOGY, V280, P19, DOI 10.1006/viro.2000.0685; Delarue S, 2013, J CLIN VIROL, V58, P461, DOI 10.1016/j.jcv.2013.08.003; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; Ibe S, 2010, JAIDS-J ACQ IMM DEF, V54, P241, DOI 10.1097/QAI.0b013e3181dc98c1; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; New York State Department of Health AIDS Institute, 2012, HUM IMM VIR TYP 2 HI; Owen SM, 1998, J VIROL, V72, P5425, DOI 10.1128/JVI.72.7.5425-5432.1998; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Styer LM, 2013, J CLIN VIROL, V58, pE127, DOI 10.1016/j.jcv.2013.09.007; Torian Lucia V., 2011, Morbidity and Mortality Weekly Report, V60, P985; Zhang YJ, 2000, J VIROL, V74, P6893, DOI 10.1128/JVI.74.15.6893-6910.2000	18	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96554	10.1371/journal.pone.0096554	http://dx.doi.org/10.1371/journal.pone.0096554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797800	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000093
J	Millet, G; Bentley, DJ; Roels, B; Mc Naughton, LR; Mercier, J; Cameron-Smith, D				Millet, Gregoire; Bentley, David J.; Roels, Belle; Mc Naughton, Lars R.; Mercier, Jacques; Cameron-Smith, David			Effects of Intermittent Training on Anaerobic Performance and MCT Transporters in Athletes	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; BLOOD LACTATE REMOVAL; MONOCARBOXYLATE TRANSPORTER; SUPRAMAXIMAL EXERCISE; CYCLING PERFORMANCE; HYPOBARIC HYPOXIA; FATIGUE INDEXES; TEAM SPORTS; CAPACITY; ALTITUDE	This study examined the effects of intermittent hypoxic training (IHT) on skeletal muscle monocarboxylate lactate transporter (MCT) expression and anaerobic performance in trained athletes. Cyclists were assigned to two interventions, either normoxic (N; n = 8; 150 mmHg PIO2) or hypoxic (H; n = 10;similar to 3000 m, 100 mmHg P1O2) over a three week training (5X1 h-1h30.week(-1)) period. Prior to and after training, an incremental exercise test to exhaustion (EXT) was performed in normoxia together with a 2 min time trial (TT). Biopsy samples from the vastus lateralis were analyzed for MCT1 and MCT4 using immuno-blotting techniques. The peak power output (PPO) increased (p<0.05) after training (7.2% and 6.6% for N and H, respectively), but VO(2)max showed no significant change. The average power output in the TT improved significantly (7.3% and 6.4% for N and H, respectively). No differences were found in MCT1 and MCT4 protein content, before and after the training in either the N or H group. These results indicate there are no additional benefits of IHT when compared to similar normoxic training. Hence, the addition of the hypoxic stimulus on anaerobic performance or MCT expression after a three-week training period is ineffective.	[Millet, Gregoire] ISSUL, Lausanne, Switzerland; [Millet, Gregoire] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Bentley, David J.] Univ Adelaide, Fac Hlth Sci, Adelaide, SA, Australia; [Roels, Belle] Clin Serv Ltd, ORION, London, England; [Mc Naughton, Lars R.] Edge Hill Univ, Dept Sport & Phys Activ, Ormskirk, Lancs, England; [Mercier, Jacques] Inst Biol, Lab Physiol Interact EA 701, Montpellier, France; [Cameron-Smith, David] Deakin Univ, Sch Nutr & Exercise Sci, Melbourne, Vic, Australia; [Cameron-Smith, David] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Lausanne; University of Adelaide; Edge Hill University; Deakin University; University of Auckland	Mc Naughton, LR (corresponding author), Edge Hill Univ, Dept Sport & Phys Activ, Ormskirk, Lancs, England.	lars.mcnaughton@edgehill.ac.uk	Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019; Naughton, Lars R Mc/J-9928-2013	Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; Naughton, Lars R Mc/0000-0002-3743-3171; Cameron-Smith, David/0000-0002-0144-5816; Bentley, David/0000-0002-0390-7308	International Olympic Committee; French Ministry of Sport; Molecular and Medical Research Strategic Research Cluster, Deakin University, Melbourne, Australia	International Olympic Committee; French Ministry of Sport; Molecular and Medical Research Strategic Research Cluster, Deakin University, Melbourne, Australia	The International Olympic Committee (http://www.olympic.org/ioc) and the French Ministry of Sport (http://www.sports.gouv.fr/) supported this study. Additional funding was provided by the Molecular and Medical Research Strategic Research Cluster, Deakin University (www.deakin.edu.au), Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL GJ, 1988, EUR J APPL PHYSIOL O, V58, P158, DOI 10.1007/BF00636620; Bickham DC, 2006, EUR J APPL PHYSIOL, V96, P636, DOI 10.1007/s00421-005-0100-x; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V279, pE1131, DOI 10.1152/ajpendo.2000.279.5.E1131; Brooks GA, 1999, J APPL PHYSIOL, V87, P1713, DOI 10.1152/jappl.1999.87.5.1713; Clark SA, 2004, J APPL PHYSIOL, V96, P517, DOI 10.1152/japplphysiol.00799.2003; Eydoux N, 2000, INT J SPORTS MED, V21, P393, DOI 10.1055/s-2000-3830; Faiss R, 2013, BRIT J SPORT MED, V47, P45, DOI 10.1136/bjsports-2013-092741; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Gore CJ, 2001, ACTA PHYSIOL SCAND, V173, P275, DOI 10.1046/j.1365-201X.2001.00906.x; Hintze J, 2011, USING PASS 11; Jones S., 1998, ENG, V3, P265; Juel C, 1996, ACTA PHYSIOL SCAND, V156, P369, DOI 10.1046/j.1365-201X.1996.206000.x; Juel C, 2004, AM J PHYSIOL-ENDOC M, V286, pE245, DOI 10.1152/ajpendo.00303.2003; Juel C, 2003, J PHYSIOL-LONDON, V548, P639, DOI 10.1113/jphysiol.2002.035899; Juel C, 1998, PFLUG ARCH EUR J PHY, V436, P560, DOI 10.1007/s004240050672; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; Levine BD, 2002, HIGH ALT MED BIOL, V3, P177, DOI 10.1089/15270290260131911; Lundby C, 2012, BRIT J SPORT MED, V46, P792, DOI 10.1136/bjsports-2012-091231; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; McClelland GB, 2002, J APPL PHYSIOL, V92, P1573, DOI 10.1152/japplphysiol.01069.2001; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Medbo JI, 2002, SCAND J CLIN LAB INV, V62, P211, DOI 10.1080/003655102317475470; MEDBO JI, 1988, J APPL PHYSIOL, V64, P50, DOI 10.1152/jappl.1988.64.1.50; Meeuwsen T, 2001, EUR J APPL PHYSIOL, V84, P283, DOI 10.1007/s004210000363; Millet GP, 2013, BRIT J SPORT MED, V47, P6; MIZUNO M, 1990, J APPL PHYSIOL, V68, P496, DOI 10.1152/jappl.1990.68.2.496; Morton JP, 2005, ERGONOMICS, V48, P1535, DOI 10.1080/00140130500100959; Mujika I, 1996, MED SCI SPORT EXER, V28, P251, DOI 10.1097/00005768-199602000-00015; Perry CGR, 2008, APPL PHYSIOL NUTR ME, V33, P1112, DOI 10.1139/H08-097; Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, pE843, DOI 10.1152/ajpendo.1999.276.5.E843; Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, pE255, DOI 10.1152/ajpendo.1999.276.2.E255; Py G, 2005, METABOLISM, V54, P634, DOI 10.1016/j.metabol.2004.12.007; Roels B, 2005, MED SCI SPORT EXER, V37, P138, DOI 10.1249/01.MSS.0000150077.30672.88; Roels B, 2007, EUR J APPL PHYSIOL, V101, P359, DOI 10.1007/s00421-007-0506-8; Roels B, 2007, J APPL PHYSIOL, V102, P79, DOI 10.1152/japplphysiol.01319.2005; Rusko HR, 1996, AM J SPORT MED, V24, pS48, DOI 10.1177/036354659602406S15; Stolen T, 2005, SPORTS MED, V35, P501; Thomas C, 2004, J APPL PHYSIOL, V97, P2132, DOI 10.1152/japplphysiol.00387.2004; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Wilber RL, 2001, SPORTS MED, V31, P249, DOI 10.2165/00007256-200131040-00002; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920	43	11	11	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e95092	10.1371/journal.pone.0095092	http://dx.doi.org/10.1371/journal.pone.0095092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797797	Green Published, gold, Green Submitted			2022-12-27	WOS:000336656000013
J	Montes-Borrego, M; Metsis, M; Landa, BB				Montes-Borrego, Miguel; Metsis, Madis; Landa, Blanca B.			Arbuscular Mycorhizal Fungi Associated with the Olive Crop across the Andalusian Landscape: Factors Driving Community Differentiation	PLOS ONE			English	Article							OLEA-EUROPAEA L.; MYCORRHIZAL FUNGI; FIELD RESPONSE; PCR PRIMERS; DIVERSITY; TREES; SOIL; ROOTS; RHIZOSPHERE; MANAGEMENT	Background: In the last years, many olive plantations in southern Spain have been mediated by the use of self-rooted planting stocks, which have incorporated commercial AMF during the nursery period to facilitate their establishment. However, this was practised without enough knowledge on the effect of cropping practices and environment on the biodiversity of AMF in olive orchards in Spain. Methodology/Principal Findings: Two culture-independent molecular methods were used to study the AMF communities associated with olive in a wide-region analysis in southern Spain including 96 olive locations. The use of T-RFLP and pyrosequencing analysis of rDNA sequences provided the first evidence of an effect of agronomic and climatic characteristics, and soil physicochemical properties on AMF community composition associated with olive. Thus, the factors most strongly associated to AMF distribution varied according to the technique but included among the studied agronomic characteristics the cultivar genotype and age of plantation and the irrigation regimen but not the orchard management system or presence of a cover crop to prevent soil erosion. Soil physicochemical properties and climatic characteristics most strongly associated to the AMF community composition included pH, textural components and nutrient contents of soil, and average evapotranspiration, rainfall and minimum temperature of the sampled locations. Pyrosequencing analysis revealed 33 AMF OTUs belonging to five families, with Archaeospora spp., Diversispora spp. and Paraglomus spp., being first records in olive. Interestingly, two of the most frequent OTUs included a diverse group of Claroideoglomeraceae and Glomeraceae sequences, not assigned to any known AMF species commonly used as inoculants in olive during nursery propagation. Conclusions/Significance: Our data suggests that AMF can exert higher host specificity in olive than previously thought, which may have important implications for redirecting the olive nursery process in the future as well as to take into consideration the specific soils and environments where the mycorrhized olive trees will be established.	[Montes-Borrego, Miguel; Landa, Blanca B.] Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Cordoba, Spain; [Metsis, Madis] Tallinn Univ, Inst Math & Nat Sci, EE-10120 Tallinn, Estonia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Tallinn University	Landa, BB (corresponding author), Inst Sustainable Agr IAS CSIC, Dept Crop Protect, Cordoba, Spain.	blanca.landa@csic.es	Landa, Blanca B/K-9629-2014; Metsis, Madis/F-7080-2016; Montes Borrego, Miguel/K-9585-2014	Landa, Blanca B/0000-0002-9511-3731; Metsis, Madis/0000-0003-1667-677X; Montes Borrego, Miguel/0000-0001-6346-2788	Ministerio de Ciencia e Innovacion [AGL2008-00344/AGR]; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia [P10-AGR-5908]; 'Ministerio de Economia y Competitividad' of Spain [AGL-2012-37521]; Fondo Europeo de desarrollo regional (FEDER) "Una manera de hacer Europa" from the European Union; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) [219262]; 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, Spain	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia; 'Ministerio de Economia y Competitividad' of Spain(Spanish Government); Fondo Europeo de desarrollo regional (FEDER) "Una manera de hacer Europa" from the European Union; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, Spain	This research was supported by grants from Projects AGL2008-00344/AGR from 'Ministerio de Ciencia e Innovacion', Project P10-AGR-5908 from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, Project AGL-2012-37521 from 'Ministerio de Economia y Competitividad' of Spain, and Fondo Europeo de desarrollo regional (FEDER) "Una manera de hacer Europa" from the European Union. The grant 219262 ArimNET_ERANET FP7 2012-2015 Project PESTOLIVE from Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA), also provided partial financial support. M. Montes-Borrego enjoyed a contract from 'Consejeria de Economia, Innovacion y Ciencia' of Junta de Andalucia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda S, 2011, MICROB ECOL, V62, P446, DOI 10.1007/s00248-011-9840-9; Aranda S, 2011, PLANT SOIL, V343, P329, DOI 10.1007/s11104-011-0721-2; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Binet MN, 2007, IN VITRO CELL DEV-PL, V43, P473, DOI 10.1007/s11627-007-9097-7; Calvente R, 2004, APPL SOIL ECOL, V26, P11, DOI 10.1016/j.apsoil.2003.10.009; CAP, 2011, EST AGR; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castillo P, 2006, PLANT PATHOL, V55, P705, DOI 10.1111/j.1365-3059.2006.01400.x; Castillo P, 2010, PLANT DIS, V94, P148, DOI 10.1094/PDIS-94-2-0148; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dag A, 2009, CROP PASTURE SCI, V60, P427, DOI 10.1071/CP08143; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Dickie IA, 2007, MYCORRHIZA, V17, P259, DOI 10.1007/s00572-007-0129-2; Dunbar J, 2000, APPL ENVIRON MICROB, V66, P2943, DOI 10.1128/AEM.66.7.2943-2950.2000; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Estaun V, 2003, J AM SOC HORTIC SCI, V128, P767, DOI 10.21273/JASHS.128.5.0767; Estaun V, 2010, ARBUSCULAR MYCORRHIZAS: PHYSIOLOGY AND FUNCTION, P279, DOI 10.1007/978-90-481-9489-6_13; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IOC, 2011, WORLD OL OIL FIG; Ivarez S, 2013, SPAIN RENEW IN PRESS, DOI [10.1017/S1742170512000361, DOI 10.1017/S1742170512000361]; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Kohout P, 2014, SOIL BIOL BIOCHEM, V68, P482, DOI 10.1016/j.soilbio.2013.08.027; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Landis FC, 2004, NEW PHYTOL, V164, P493, DOI 10.1111/j.1469-8137.2004.01202.x; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Meddad-Hamza A, 2010, AFR J BIOTECHNOL, V9, P1159; Milgroom J, 2007, RENEW AGR FOOD SYST, V22, P1, DOI 10.1017/S1742170507001500; Moebius-Clune DJ, 2013, SOIL BIOL BIOCHEM, V64, P191, DOI 10.1016/j.soilbio.2012.12.014; Montes-Borrego M, 2013, AGR ECOSYST ENVIRON, V181, P169, DOI 10.1016/j.agee.2013.09.021; Mummey DL, 2007, J MICROBIOL METH, V70, P200, DOI 10.1016/j.mimet.2007.04.002; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Opik M, 2014, BOTANY, V92, P135, DOI 10.1139/cjb-2013-0110; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Opik M, 2010, NEW PHYTOL, V188, P223, DOI 10.1111/j.1469-8137.2010.03334.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Palomares-Rius JE, 2012, SOIL BIOL BIOCHEM, V45, P168, DOI 10.1016/j.soilbio.2011.11.009; pik M, 2012, PLOS ONE, V7; Porras-Soriano A, 2009, J PLANT PHYSIOL, V166, P1350, DOI 10.1016/j.jplph.2009.02.010; Redecker D, 2006, MYCOLOGIA, V98, P885, DOI 10.3852/mycologia.98.6.885; Schreiner RP, 2009, MYCOLOGIA, V101, P599, DOI 10.3852/08-169; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; Verbruggen E, 2012, APPL ENVIRON MICROB, V78, P7384, DOI 10.1128/AEM.01372-12	53	22	23	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96397	10.1371/journal.pone.0096397	http://dx.doi.org/10.1371/journal.pone.0096397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797669	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000072
J	Pauly, D; Nagel, BM; Reinders, J; Killian, T; Wulf, M; Ackermann, S; Ehrenstein, B; Zipfel, PF; Skerka, C; Weber, BHF				Pauly, Diana; Nagel, Benedikt M.; Reinders, Joerg; Killian, Tobias; Wulf, Matthias; Ackermann, Susanne; Ehrenstein, Boris; Zipfel, Peter F.; Skerka, Christine; Weber, Bernhard H. F.			A Novel Antibody against Human Properdin Inhibits the Alternative Complement System and Specifically Detects Properdin from Blood Samples	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; IMMUNE-COMPLEXES; FACTOR-H; IN-VITRO; FACTOR-B; ACTIVATION; PATHWAY; DEFICIENCY; CONVERTASE; PROTEINS	The complement system is an essential part of the innate immune system by acting as a first line of defense which is stabilized by properdin, the sole known positive regulator of the alternative complement pathway. Dysregulation of complement can promote a diversity of human inflammatory diseases which are treated by complement inhibitors. Here, we generated a novel blocking monoclonal antibody (mAb) against properdin and devised a new diagnostic assay for this important complement regulator. Mouse mAb 1340 specifically detected native properdin from human samples with high avidity. MAb 1340 inhibited specifically the alternative complement mediated cell lysis within a concentration range of 110 mg/mL. Thus, in vitro anti-properdin mAb 1340 was up to fifteen times more efficient in blocking the complement system as compared to anti-C5 or anti-Ba antibodies. Computer-assisted modelling suggested a three-dimensional binding epitope in a properdin-C3(H2O)-clusterin complex to be responsible for the inhibition. Recovery of properdin in a newly established sandwich ELISA using mAb 1340 was determined at 80-125% for blood sample dilutions above 1:50. Reproducibility assays showed a variation below 25% at dilutions less than 1:1,000. Systemic properdin concentrations of healthy controls and patients with age-related macular degeneration or rheumatic diseases were all in the range of 13-30 mg/mL and did not reveal significant differences. These initial results encourage further investigation into the functional role of properdin in the development, progression and treatment of diseases related to the alternative complement pathway. Thus, mAb 1340 represents a potent properdin inhibitor suitable for further research to understand the exact mechanisms how properdin	[Pauly, Diana; Nagel, Benedikt M.; Killian, Tobias; Wulf, Matthias; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Reinders, Joerg] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Ackermann, Susanne; Zipfel, Peter F.; Skerka, Christine] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Ehrenstein, Boris] Asklepios Klinikum Bad Abbach, Klin & Poliklin Rheumatol & Klin Immunol, Bad Abbach, Germany; [Zipfel, Peter F.] Univ Jena, Dept Infect Biol, Jena, Germany	University of Regensburg; University of Regensburg; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Pauly, D (corresponding author), Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany.	Diana.pauly@klinik.uni-regensburg.de; bweb@klinik.uni-regensburg.de		Reinders, Joerg/0000-0003-1025-7849; Ackermann, Susanne/0000-0001-8179-5201; Wulf, Matthias/0000-0002-6240-4874; Weber, Bernhard H.F./0000-0002-8808-7723	PRO RETINA foundation; German Research Foundation (DFG) [DFG Sk46/2-1, WE1259/18-1, WE1259/19-1]; Ruth and Milton Steinbach Foundation New York; Alcon Research Institute	PRO RETINA foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Ruth and Milton Steinbach Foundation New York; Alcon Research Institute(Novartis)	This work was supported by a grant from the PRO RETINA foundation (http://www.pro-retina.de, DP) and in part by grants from the German Research Foundation (DFG, http://www.dfg.de/) DFG Sk46/2-1 (CS) WE1259/18-1 (BHFW), WE1259/19-1 (BHFW), The Ruth and Milton Steinbach Foundation New York (BHFW) and the Alcon Research Institute (http://www.alcon.com/, BHFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorlo M, 2013, P NATL ACAD SCI USA, P1; BAATRUP G, 1988, J CLIN LAB IMMUNOL, V26, P73; Bee C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080501; BENBASSAT C, 1993, IMMUNOL RES, V12, P312, DOI 10.1007/BF02918260; Bergseth G, 2013, MOL IMMUNOL, V56, P232, DOI 10.1016/j.molimm.2013.05.221; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Chen Q, 2011, NEW ENGL J MED, V365, P2340, DOI 10.1056/NEJMc1107484; DAOUDAKI ME, 1988, J IMMUNOL, V140, P1577; DAVIS P, 1977, CLIN EXP IMMUNOL, V28, P226; Diaz-Rubio E, 2010, HDB THERAPEUTIC ANTI, P779; Dimitrova P, 2010, MOL IMMUNOL, V47, P1458, DOI 10.1016/j.molimm.2010.02.007; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ELGHOBAREY AF, 1980, J RHEUMATOL, V7, P453; Elter T, 2010, HDB THERAPEUTIC ANTI, P733; Esparza-Gordillo J, 2006, MOL IMMUNOL, V43, P1769, DOI 10.1016/j.molimm.2005.11.008; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; FARRIES TC, 1988, BIOCHEM J, V253, P667, DOI 10.1042/bj2530667; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fredrikson GN, 1998, J CLIN IMMUNOL, V18, P272, DOI 10.1023/A:1027385806871; Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; GOUNDIS D, 1988, NATURE, V335, P82, DOI 10.1038/335082a0; GREENAWAY S, 1994, LEUKEMIA LYMPHOMA, V13, P323, DOI 10.3109/10428199409056297; Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Harlow E., 1988, USING ANTIBODIES LAB; Havea P, 1998, J DAIRY RES, V65, P79, DOI 10.1017/S0022029997002641; Heinen S, 2013, MOL IMMUNOL, V54, P84, DOI 10.1016/j.molimm.2012.10.044; Higgins JMG, 1995, CHARACTERIZATION MUT; HOFFMANN LG, 1987, J IMMUNOL METHODS, V98, P161, DOI 10.1016/0022-1759(87)90001-9; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; ISH C, 1993, SCAND J IMMUNOL, V38, P113, DOI 10.1111/j.1365-3083.1993.tb01701.x; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Jozsi M, 2007, BLOOD, V110, P1516, DOI 10.1182/blood-2007-02-071472; Karsten CM, 2012, IMMUNOBIOLOGY, V217, P1067, DOI 10.1016/j.imbio.2012.07.015; Kemper C, 2008, P NATL ACAD SCI USA, V105, P9023, DOI 10.1073/pnas.0801015105; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Kimura Y, 2010, J CLIN INVEST, V120, P3545, DOI 10.1172/JCI41782; Kupper H, 2010, HDB THERAPEUTIC ANTI, P697; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lesher AM, 2013, MOL IMMUNOL, V56, P191, DOI 10.1016/j.molimm.2013.06.002; Linton SM, 1999, CLIN EXP IMMUNOL, V118, P189; Martin ACR, 2010, HDB THERAPEUTIC ANTI, P95; Miwa T, 2013, J IMMUNOL; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; NOLAN KF, 1993, METHOD ENZYMOL, V223, P35; Olimpieri PP, 2013, BIOINFORMATICS, V29, P2285, DOI 10.1093/bioinformatics/btt369; PANGBURN MK, 1989, J IMMUNOL, V142, P202; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; PETERSEN S, 1991, ACTA PAEDIATR SCAND, V80, P1037; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PILLEMER L, 1954, SCIENCE, V120, P279, DOI 10.1126/science.120.3112.279; Reichert JM, 2012, MABS-AUSTIN, V4, P1, DOI 10.4161/mabs.4.1.18719; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195; ROBSON KJH, 1988, NATURE, V335, P79, DOI 10.1038/335079a0; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Saldanha JW, 2010, HDB THERAPEUTIC ANTI, P119; Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548; Schmidtko J, 2013, AM J KIDNEY DIS, V61, P289, DOI 10.1053/j.ajkd.2012.07.028; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; SCHWAEBLE W, 1994, EUR J BIOCHEM, V219, P759, DOI 10.1111/j.1432-1033.1994.tb18555.x; Schwochau GB, 1998, KIDNEY INT, V53, P1647, DOI 10.1046/j.1523-1755.1998.00902.x; SJOHOLM AG, 1982, CLIN EXP IMMUNOL, V50, P291; SMITH AJ, 1987, ANN RHEUM DIS, V46, P468, DOI 10.1136/ard.46.6.468; Somani R, 2012, DIABETES CARE, V35, P894, DOI 10.2337/dc11-1483; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Thomas A, 2013, J PROTEOMICS, V80, P107, DOI 10.1016/j.jprot.2012.12.027; Thurman JM, 2005, MOL IMMUNOL, V42, P87, DOI 10.1016/j.molimm.2004.07.043; Veszeli N, 2014, MOL IMMUNOL, V57, P200, DOI 10.1016/j.molimm.2013.09.010; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Weber BHF, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0133; Wolf-Schnurrbusch UEK, 2009, RETINA-J RET VIT DIS, V29, P966, DOI 10.1097/IAE.0b013e3181a2f40f; Zhou HF, 2012, P NATL ACAD SCI USA, V109, pE415, DOI 10.1073/pnas.1119000109; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214	84	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96371	10.1371/journal.pone.0096371	http://dx.doi.org/10.1371/journal.pone.0096371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24797388	Green Published, Green Submitted, gold			2022-12-27	WOS:000336656000070
J	Yu, CC; Ai, T; Weiss, JN; Chen, PS				Yu, Chih-Chieh; Ai, Tomohiko; Weiss, James N.; Chen, Peng-Sheng			Apamin Does Not Inhibit Human Cardiac Na+ Current, L-type Ca2+ Current or Other Major K+ Currents	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; SMALL-CONDUCTANCE; FUNCTIONAL ROLES; PULMONARY VEIN; QT SYNDROME; SK2; LOCALIZATION; TRAFFICKING; EXPRESSION; MUTATION	Background: Apamin is commonly used as a small-conductance Ca2+-activated K+ (SK) current inhibitor. However, the specificity of apamin in cardiac tissues remains unclear. Objective: To test the hypothesis that apamin does not inhibit any major cardiac ion currents. Methods: We studied human embryonic kidney (HEK) 293 cells that expressed human voltage-gated Na+, K+ and Ca2+ currents and isolated rabbit ventricular myocytes. Whole-cell patch clamp techniques were used to determine ionic current densities before and after apamin administration. Results: Ca2+ currents (CACNA1c+CACNB2b) were not affected by apamin (500 nM) (data are presented as median [25 th percentile; 75 th percentile] (from -16 [-20;-10] to -17 [-19;-13] pA/pF, P = NS), but were reduced by nifedipine to -1.6 [-3.2;-1.3] pA/pF (p = 0.008). Na+ currents (SCN5A) were not affected by apamin (from -261 [-282;-145] to -268 [-379;-132] pA/pF, P = NS), but were reduced by flecainide to -57 [-70;-47] pA/pF (p = 0.018). None of the major K+ currents (I-Ks, I-Kr, I-K1 and I-to) were inhibited by 500 nM of apamin (KCNQ1+KCNE1, from 28 [20; 37] to 23 [18; 32] pA/pF; KCNH2+KCNE2, from 28 [24; 30] to 27 [24; 29] pA/pF; KCNJ2, from -46 [-48;-40] to -46 [-51;-35] pA/pF; KCND3, from 608 [505; 748] to 606 [454; 684]). Apamin did not inhibit the I-Na or I-CaL in isolated rabbit ventricular myocytes (I-Na, from -67 [-75;-59] to -68 [-71;-59] pA/pF; I-CaL, from -16 [-17;-14] to -14 [-15;-13] pA/pF, P = NS for both). Conclusions: Apamin does not inhibit human cardiac Na+ currents, L-type Ca2+ currents or other major K+ currents. These findings indicate that apamin is a specific SK current inhibitor in hearts as well as in other organs.	[Yu, Chih-Chieh; Ai, Tomohiko; Chen, Peng-Sheng] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Yu, Chih-Chieh; Ai, Tomohiko; Chen, Peng-Sheng] Indiana Univ Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Yu, Chih-Chieh] Natl Taiwan Univ, Dept Integrated Diagnost & Therapeut, Taipei 10764, Taiwan; [Ai, Tomohiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Div Pathophysiol, Tokyo, Japan; [Weiss, James N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Weiss, James N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Cardiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA; [Weiss, James N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Cardiovasc Res Lab, Los Angeles, CA 90095 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Taiwan University; Tokyo Medical & Dental University (TMDU); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, PS (corresponding author), Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.	chenpp@iu.edu		Yu, Chih-Chieh/0000-0002-2136-2444; Ai, Tomohiko/0000-0003-0376-0227	National Heart, Lung and Blood Institute of the National Institutes of Health [P01HL78931, R01HL71140]; Medtronic-Zipes Endowment; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078931, R01HL071140] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medtronic-Zipes Endowment; Indiana University Health-Indiana University School of Medicine Strategic Research Initiative; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this manuscript was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number P01HL78931, R01HL71140, a Medtronic-Zipes Endowment (P.-S.C.) and the Indiana University Health-Indiana University School of Medicine Strategic Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams CJ, 1996, J PHYSIOL-LONDON, V493, P643, DOI 10.1113/jphysiol.1996.sp021411; Adelman JP, 2012, ANNU REV PHYSIOL, V74, P245, DOI 10.1146/annurev-physiol-020911-153336; Ai T, 1998, PFLUG ARCH EUR J PHY, V436, P168, DOI 10.1007/s004240050619; Allen D, 2011, NAT NEUROSCI, V14, P744, DOI 10.1038/nn.2832; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Aoike F, 2006, EUR J PHARMACOL, V532, P24, DOI 10.1016/j.ejphar.2005.12.021; Ballester Leomar Y, 2006, Hum Mutat, V27, P388, DOI 10.1002/humu.9418; Benton DCH, 2003, J PHYSIOL-LONDON, V553, P13, DOI 10.1113/jphysiol.2003.054551; BKAILY G, 1991, J MOL CELL CARDIOL, V23, P25, DOI 10.1016/0022-2828(91)90036-L; BKAILY G, 1992, AM J PHYSIOL, V262, pH463, DOI 10.1152/ajpheart.1992.262.2.H463; BKAILY G, 1985, AM J PHYSIOL, V248, pH961, DOI 10.1152/ajpheart.1985.248.6.H961; CASTLE NA, 1989, TRENDS NEUROSCI, V12, P59, DOI 10.1016/0166-2236(89)90137-9; Chang PC, 2013, HEART RHYTHM; Chang PC, 2013, HEART RHYTHM, V10, P1516, DOI 10.1016/j.hrthm.2013.07.003; Chang PC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004713; Chen WT, 2013, EUR J CLIN INVEST, V43, P957, DOI 10.1111/eci.12125; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Dalton S, 2005, J PHYSIOL-LONDON, V567, P757, DOI 10.1113/jphysiol.2005.093195; Dong MQ, 2010, BBA-BIOMEMBRANES, V1798, P995, DOI 10.1016/j.bbamem.2010.01.010; Faivre JF, 1999, CARDIOVASC RES, V41, P188, DOI 10.1016/S0008-6363(98)00215-6; Giudicessi JR, 2011, HEART RHYTHM, V8, P1024, DOI 10.1016/j.hrthm.2011.02.021; Grunnet M, 2001, PFLUG ARCH EUR J PHY, V441, P544, DOI 10.1007/s004240000447; Gui L, 2013, AM J PHYSIOL-HEART C, V304, pH118, DOI 10.1152/ajpheart.00820.2011; HABERMANN E, 1984, PHARMACOL THERAPEUT, V25, P255, DOI 10.1016/0163-7258(84)90046-9; Hsieh YC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P410, DOI 10.1161/CIRCEP.111.000152; Hsueh CH, 2013, HEART RHYTHM, V10, P891, DOI 10.1016/j.hrthm.2013.01.033; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Ishikawa T, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1098, DOI 10.1161/CIRCEP.111.969972; Kamp TJ, 2000, AM J PHYSIOL-HEART C, V278, pH126, DOI 10.1152/ajpheart.2000.278.1.H126; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; KOUMI S, 1994, EUR J PHARMACOL, V261, P213, DOI 10.1016/0014-2999(94)90322-0; Lee YS, 2013, J CARDIOVASC ELECTR, V24, P1144, DOI 10.1111/jce.12176; Lee YS, 2013, J CARDIOVASC ELECTRO; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Lu L, 2009, P NATL ACAD SCI USA, V106, P18402, DOI 10.1073/pnas.0908207106; Nagy N, 2009, J MOL CELL CARDIOL, V47, P656, DOI 10.1016/j.yjmcc.2009.07.019; Nie LP, 2004, J NEUROPHYSIOL, V91, P1536, DOI 10.1152/jn.00630.2003; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Sakaguchi T, 2008, J PHARMACOL SCI, V108, P462, DOI 10.1254/jphs.08178FP; Schetz JA, 1995, CARDIOVASC RES, V30, P755, DOI 10.1016/S0008-6363(95)00114-X; Shuraih M, 2007, J CARDIOVASC ELECTR, V18, P434, DOI 10.1111/j.1540-8167.2007.00777.x; Sosunov EA, 2005, CARDIOVASC RES, V67, P274, DOI 10.1016/j.cardiores.2005.04.009; Strobaek D, 2000, BRIT J PHARMACOL, V129, P991, DOI 10.1038/sj.bjp.0703120; Templin C, 2011, EUR HEART J, V32, P1077, DOI 10.1093/eurheartj/ehr076; Turker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070450; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Tuteja D, 2010, CIRC RES, V107, P851, DOI 10.1161/CIRCRESAHA.109.215269; VESELOVSKII N S, 1986, Neirofiziologiya, V18, P313; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Yamashita F, 2001, J MOL CELL CARDIOL, V33, P197, DOI 10.1006/jmcc.2000.1300; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	54	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 5	2014	9	5							e96691	10.1371/journal.pone.0096691	http://dx.doi.org/10.1371/journal.pone.0096691			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZV	24798465	gold, Green Published			2022-12-27	WOS:000336656000120
J	Ohoka, Y; Yokota-Nakatsuma, A; Maeda, N; Takeuchi, H; Iwata, M				Ohoka, Yoshiharu; Yokota-Nakatsuma, Aya; Maeda, Naoko; Takeuchi, Hajime; Iwata, Makoto			Retinoic Acid and GM-CSF Coordinately Induce Retinal Dehydrogenase 2 (RALDH2) Expression through Cooperation between the RAR/RXR Complex and Sp1 in Dendritic Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; T-CELLS; SMALL-INTESTINE; BETA-CATENIN; TNF-ALPHA; ALL-TRANS; RECEPTOR; MATURATION; DIFFERENTIATION; CYTOKINE	Retinoic acid (RA)-producing dendritic cells (DCs) play critical roles in gut immunity. Retinal dehydrogenase 2 (RALDH2) encoded by Aldh1a2 is a key enzyme for generating RA in DCs. Granulocyte-macrophage colony-stimulating factor (GM-CSF) potently induces RALDH2 expression in DCs in an RA-dependent manner, and RA alone weakly induces the expression. However, how GM-CSF and RA induce RALDH2 expression remains unclear. Here, we show that GM-CSF-induced activation of the transcription factor Sp1 and RA-dependent signaling via the RA receptor (RAR)/retinoid X receptor (RXR) complex contribute to Aldh1a2 expression. The RAR antagonist LE540 and the Sp1 inhibitor mithramycin A inhibited GM-CSF-induced Aldh1a2 expression in fms-related tyrosine kinase 3 ligand-generated bone marrow-derived DCs (BM-DCs). ERK and p38 MAPK inhibitors suppressed GM-CSF-induced nuclear translocation of Sp1 and Aldh1a2 expression. Sp1 and the RAR alpha/RXR alpha complex bound to GC-rich Sp1-binding sites and an RA response element (RARE) half-site, respectively, near the TATA box in the mouse Aldh1a2 promoter. The DNA sequences around these sites were highly conserved among different species. In the presence of RA, ectopic expression of RAR alpha/RXR alpha and Sp1 synergistically enhanced Aldh1a2 promoter-reporter activity. GM-CSF did not significantly induce Aldh1a2 expression in plasmacytoid DCs, peritoneal macrophages, or T cells, and the Aldh1a2 promoter in these cells was mostly unmethylated. These results suggest that GM-CSF/RA-induced RALDH2 expression in DCs requires cooperative binding of Sp1 and the RAR/RXR complex to the Aldh1a2 promoter, and can be regulated by a DNA methylation-independent mechanism.	[Ohoka, Yoshiharu; Yokota-Nakatsuma, Aya; Maeda, Naoko; Takeuchi, Hajime; Iwata, Makoto] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Immunol Lab, Sanuki, Kagawa, Japan; [Ohoka, Yoshiharu; Yokota-Nakatsuma, Aya; Maeda, Naoko; Takeuchi, Hajime; Iwata, Makoto] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan	Tokushima Bunri University; Japan Science & Technology Agency (JST)	Ohoka, Y (corresponding author), Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Immunol Lab, Sanuki, Kagawa, Japan.	ookay@kph.bunri-u.ac.jp; iwatam@kph.bunri-u.ac.jp			JSPS [24590106]; MEXT [23390023, 25111514]; Uehara Memorial Foundation; JST, CREST	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by JSPS KAKENHI Grant Number 24590106 (Y. O.), MEXT KAKENHI Grant Number 23390023 and 25111514 (M. I.), and grants from Uehara Memorial Foundation (M. I.) and JST, CREST (M. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Brown AL, 2012, DIFFERENTIATION, V83, P47, DOI 10.1016/j.diff.2011.08.003; CANTORNA MT, 1994, J IMMUNOL, V152, P1515; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curry JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003405; Dawson HD, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-27; Dickerson SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000356; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; Fukuzawa H, 2003, BIOCHEM BIOPH RES CO, V312, P897, DOI 10.1016/j.bbrc.2003.11.009; Guilliams M, 2010, BLOOD, V115, P1958, DOI 10.1182/blood-2009-09-245274; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hsu LC, 2000, BBA-GENE STRUCT EXPR, V1492, P289, DOI 10.1016/S0167-4781(00)00108-1; Huang GH, 2013, J IMMUNOL, V191, P650, DOI 10.4049/jimmunol.1300398; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Husmann M, 2000, BIOCHEM J, V352, P763, DOI 10.1042/0264-6021:3520763; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jaensson-Gyllenback E, 2011, MUCOSAL IMMUNOL, V4, P438, DOI 10.1038/mi.2010.91; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Ohoka Y, 2011, J IMMUNOL, V186, P733, DOI 10.4049/jimmunol.1000913; Pilette C, 2010, IMMUNOL CELL BIOL, V88, P486, DOI 10.1038/icb.2009.120; Sato K, 1999, J IMMUNOL, V162, P3865; Sato T, 2013, J IMMUNOL, V191, P3152, DOI 10.4049/jimmunol.1203517; Sennikov SV, 2002, J GASTROENTEROL, V37, P1048, DOI 10.1007/s005350200176; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Stock A, 2011, J EXP MED, V208, P761, DOI 10.1084/jem.20101967; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Suzuki Y, 1999, BRAIN DEV-JPN, V21, P1; Szatmari I, 2006, J EXP MED, V203, P2351, DOI 10.1084/jem.20060141; Tezuka H, 2011, IMMUNITY, V34, P247, DOI 10.1016/j.immuni.2011.02.002; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Villablanca EJ, 2011, GASTROENTEROLOGY, V141, P176, DOI 10.1053/j.gastro.2011.04.010; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Wang XS, 2001, GENOMICS, V74, P245, DOI 10.1006/geno.2001.6546; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Yokota A, 2009, INT IMMUNOL, V21, P361, DOI 10.1093/intimm/dxp003	53	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96512	10.1371/journal.pone.0096512	http://dx.doi.org/10.1371/journal.pone.0096512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788806	Green Submitted, Green Published, gold			2022-12-27	WOS:000336655700102
J	Yoo, HS; Qiao, LP; Bosco, C; Leong, LH; Lytle, N; Feng, GS; Chi, NW; Shao, JH				Yoo, Hyung Sun; Qiao, Liping; Bosco, Chris; Leong, Lok-Hei; Lytle, Nikki; Feng, Gen-Sheng; Chi, Nai-Wen; Shao, Jianhua			Intermittent Cold Exposure Enhances Fat Accumulation in Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; C57BL/6J MICE; NONSHIVERING THERMOGENESIS; ENERGY-EXPENDITURE; ADULT HUMANS; WHITE; METABOLISM; RATS; LIPOLYSIS; EXERCISE	Due to its high energy consuming characteristics, brown adipose tissue (BAT) has been suggested as a key player in energy metabolism. Cold exposure is a physiological activator of BAT. Intermittent cold exposure (ICE), unlike persistent exposure, is clinically feasible. The main objective of this study was to investigate whether ICE reduces adiposity in C57BL/6 mice. Surprisingly, we found that ICE actually increased adiposity despite enhancing Ucp1 expression in BAT and inducing beige adipocytes in subcutaneous white adipose tissue. ICE did not alter basal systemic insulin sensitivity, but it increased liver triglyceride content and secretion rate as well as blood triglyceride levels. Gene profiling further demonstrated that ICE, despite suppressing lipogenic gene expression in white adipose tissue and liver during cold exposure, enhanced lipogenesis between the exposure periods. Together, our results indicate that despite enhancing BAT recruitment, ICE in mice increases fat accumulation by stimulating de novo lipogenesis.	[Yoo, Hyung Sun; Qiao, Liping; Bosco, Chris; Leong, Lok-Hei; Lytle, Nikki; Shao, Jianhua] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Feng, Gen-Sheng] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Chi, Nai-Wen] Univ Calif San Diego, Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA; [Chi, Nai-Wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Shao, JH (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	jishao@ucsd.edu		Yoo, Hyung sun/0000-0002-5625-7687	NIH [DK080418, HD069634, DK095132, R01DK075916, 5-I01-BX000702]; Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080418, R01DK075916, R01DK095132] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by grants DK080418 (J.S.), HD069634 (J.S.), DK095132 (J.S.), R01DK075916 (G. F.) and 5-I01-BX000702 (N.-W.C.) from the NIH and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD J, 1987, J PHYSIOL-LONDON, V390, P45, DOI 10.1113/jphysiol.1987.sp016685; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Bauwens JD, 2011, AM J PHYSIOL-REG I, V301, pR473, DOI 10.1152/ajpregu.00444.2010; Bing C, 1998, AM J PHYSIOL-REG I, V274, pR62, DOI 10.1152/ajpregu.1998.274.1.R62; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Diraison F, 1998, AM J PHYSIOL-ENDOC M, V274, pE321, DOI 10.1152/ajpendo.1998.274.2.E321; Dong M, 2013, CELL METAB, V18, P118, DOI 10.1016/j.cmet.2013.06.003; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Harju T, 2010, CLIN RESPIR J, V4, P176, DOI 10.1111/j.1752-699X.2009.00172.x; HARRI M, 1984, J APPL PHYSIOL, V57, P1489, DOI 10.1152/jappl.1984.57.5.1489; Jakus PB, 2008, J LIPID RES, V49, P332, DOI 10.1194/jlr.M700316-JLR200; KAWATE R, 1994, PHYSIOL BEHAV, V55, P921, DOI 10.1016/0031-9384(94)90080-9; Komulainen S, 2004, J HUM HYPERTENS, V18, P905, DOI 10.1038/sj.jhh.1001758; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; OMATA K, 1990, PHYSIOL BEHAV, V47, P743, DOI 10.1016/0031-9384(90)90088-L; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; Richard D, 2011, FRONT BIOSCI-LANDMRK, V16, P1233, DOI 10.2741/3786; Saito M, 2009, DIABETES; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shefer VI, 1997, EXP GERONTOL, V32, P695, DOI 10.1016/S0531-5565(97)00085-5; STEINER G, 1964, AM J PHYSIOL, V207, P840, DOI 10.1152/ajplegacy.1964.207.4.840; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; Vaanholt LM, 2009, PHYSIOL BIOCHEM ZOOL, V82, P314, DOI 10.1086/589727; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; WAHRENBERG H, 1989, J CLIN INVEST, V84, P458, DOI 10.1172/JCI114187; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yu XX, 2002, FASEB J, V16, P155, DOI 10.1096/fj.01-0568com	42	24	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96432	10.1371/journal.pone.0096432	http://dx.doi.org/10.1371/journal.pone.0096432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24789228	gold, Green Published, Green Submitted			2022-12-27	WOS:000336655700092
J	Zheng, LY; Harner, CD; Zhang, XD				Zheng, Liying; Harner, Christopher D.; Zhang, Xudong			The Morphometry of Soft Tissue Insertions on the Tibial Plateau: Data Acquisition and Statistical Shape Analysis	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; HUMAN KNEE-JOINT; ANATOMIC CHARACTERISTICS; TUNNEL PLACEMENT; FIBER-BUNDLES; IN-VITRO; RECONSTRUCTION; ATTACHMENTS; MENISCI; MODEL	This study characterized the soft tissue insertion morphometrics on the tibial plateau and their inter-relationships as well as variabilities. The outlines of the cruciate ligament and meniscal root insertions along with the medial and lateral cartilage on 20 cadaveric tibias (10 left and 10 right knees) were digitized and co-registered with corresponding CT-based 3D bone models. Generalized Procrustes Analysis was employed in conjunction with Principal Components Analysis to first create a geometric consensus based on tibial cartilage and then determine the means and variations of insertion morphometrics including shape, size, location, and inter-relationship measures. Step-wise regression analysis was conducted in search of parsimonious models relating the morphometric measures to the tibial plateau width and depth, and basic anthropometric and gender factors. The analyses resulted in statistical morphometric representations for Procrustes-superimposed cruciate ligament and meniscus insertions, and identified only a few moderate correlations (R-2 : 0.37-0.49). The study provided evidence challenging the isometric scaling based on a single dimension frequently employed in related morphometric studies, and data for evaluating cruciate ligament reconstruction strategies in terms of re-creating the native anatomy and minimizing the risk of iatrogenic injury. It paved the way for future development of computer-aided personalized orthopaedic surgery applications improving the quality of care and patient safety, and biomechanical models with a better population or average representation.	[Zheng, Liying; Harner, Christopher D.; Zhang, Xudong] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Zhang, Xudong] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA USA; [Zhang, Xudong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, XD (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA.	xuz9@pitt.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR059939] Funding Source: NIH RePORTER; NIAMS NIH HHS [R03 AR059939] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abdelkafy A, 2012, ARTHROSC TEC, V1, pE149, DOI 10.1016/j.eats.2012.05.008; Amis A A, 1998, Knee Surg Sports Traumatol Arthrosc, V6 Suppl 1, pS2, DOI 10.1007/s001670050215; Araujo P, 2013, KNEE SURG SPORT TR A, V21, P1495, DOI 10.1007/s00167-012-2153-9; Bookstein F, 1999, ANAT RECORD, V257, P217, DOI 10.1002/(SICI)1097-0185(19991215)257:6<217::AID-AR7>3.0.CO;2-W; Brody JM, 2007, AM J ROENTGENOL, V188, pW446, DOI 10.2214/AJR.06.0509; Colombet P, 2006, ARTHROSCOPY, V22, P984, DOI 10.1016/j.arthro.2006.04.102; Dennis Michael G, 2004, J Knee Surg, V17, P133; Donahue TLH, 2002, J BIOMECH ENG-T ASME, V124, P273, DOI 10.1115/1.1470171; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Edwards A, 2007, KNEE SURG SPORT TR A, V15, P1414, DOI 10.1007/s00167-007-0417-6; Edwards A, 2007, ARTHROSCOPY, V23, P284, DOI 10.1016/j.arthro.2006.11.005; Ferretti M, 2012, KNEE SURG SPORT TR A, V20, P62, DOI 10.1007/s00167-011-1592-z; Gadikota HR, 2012, AM J SPORT MED, V40, P882, DOI 10.1177/0363546511434276; Galloway MT, 1996, AM J SPORT MED, V24, P437, DOI 10.1177/036354659602400406; Guess TM, 2010, MED ENG PHYS, V32, P505, DOI 10.1016/j.medengphy.2010.02.020; Harner CD, 1999, ARTHROSCOPY, V15, P741, DOI 10.1016/S0749-8063(99)70006-X; Harner CD, 1998, AM J SPORT MED, V26, P471, DOI 10.1177/03635465980260032301; Iriuchishima T, 2012, KNEE SURG SPORT TR A, V20, P964, DOI 10.1007/s00167-011-1680-0; Johannsen AM, 2012, AM J SPORT MED, V40, P2342, DOI 10.1177/0363546512457642; JOHNSON DL, 1995, ARTHROSCOPY, V11, P386, DOI 10.1016/0749-8063(95)90188-4; Kantaras AT, 2002, ARTHROSCOPY, V18, P99, DOI 10.1053/jars.2002.25345; Kennedy NI, 2014, J BONE JOINT SURG CA, V4, P1; Khalfayan EE, 1996, AM J SPORT MED, V24, P335, DOI 10.1177/036354659602400315; Klos T V, 2000, Comput Aided Surg, V5, P28, DOI 10.1002/(SICI)1097-0150(2000)5:1<28::AID-IGS4>3.0.CO;2-P; KOHN D, 1995, ARTHROSCOPY, V11, P96, DOI 10.1016/0749-8063(95)90095-0; Lamy T, 1997, AM J MED, V102, P14, DOI 10.1016/S0002-9343(96)00351-8; Lawing AM, 2010, J ZOOL, V280, P1, DOI 10.1111/j.1469-7998.2009.00620.x; Li G, 1999, J BIOMECH ENG-T ASME, V121, P657, DOI 10.1115/1.2800871; Li K, 2009, J BIOMECH, V42, P2624, DOI 10.1016/j.jbiomech.2009.06.042; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Lorenz S, 2009, KNEE SURG SPORT TR A, V17, P683, DOI 10.1007/s00167-009-0770-8; Lubowitz JH, 2009, ARTHROSCOPY, V25, P95, DOI 10.1016/j.arthro.2008.10.012; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moorman CT, 2008, ARTHROSCOPY, V24, P269, DOI 10.1016/j.arthro.2007.08.032; Osti M, 2012, AM J SPORT MED, V40, P1558, DOI 10.1177/0363546512445166; Pena E, 2006, J BIOMECH, V39, P1686, DOI 10.1016/j.jbiomech.2005.04.030; Petersen W, 2007, CLIN ORTHOP RELAT R, P35, DOI 10.1097/BLO.0b013e31802b4a59; Pinczewski LA, 2008, J BONE JOINT SURG BR, V90B, P172, DOI 10.1302/0301-620X.90B2.20104; Plaweski S, 2011, ORTHOP TRAUMATOL-SUR, V97, pS75, DOI 10.1016/j.otsr.2011.07.004; Sandholm A, 2011, VISUAL COMPUT, V27, P161, DOI 10.1007/s00371-010-0538-7; Sheps DM, 2005, ARTHROSCOPY, V21, P820, DOI 10.1016/j.arthro.2005.04.105; Siebold R, 2008, ARTHROSCOPY, V24, P154, DOI 10.1016/j.arthro.2007.08.006; Simmons R, 2003, J BONE JOINT SURG AM, V85A, P1018, DOI 10.2106/00004623-200306000-00006; Sullivan JP, 2012, AM J SPORT MED, V40, P2236, DOI 10.1177/0363546512458086; Tajima G, 2009, J BONE JOINT SURG AM, V91A, P859, DOI 10.2106/JBJS.H.00991; Tallay A, 2008, KNEE SURG SPORT TR A, V16, P741, DOI 10.1007/s00167-008-0552-8; Zantop T, 2008, AM J SPORT MED, V36, P678, DOI 10.1177/0363546508314414; Zhang XD, 2012, J HEALTHC ENG, V3, P443, DOI 10.1260/2040-2295.3.3.443	48	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2014	9	5							e96515	10.1371/journal.pone.0096515	http://dx.doi.org/10.1371/journal.pone.0096515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI1ZS	24788908	Green Published, gold, Green Accepted			2022-12-27	WOS:000336655700103
J	Wang, X; Xu, Z; Miao, CH				Wang, Xin; Xu, Zheng; Miao, Chang-Hong			Current Clinical Evidence on the Effect of General Anesthesia on Neurodevelopment in Children: An Updated Systematic Review with Meta-Regression	PLOS ONE			English	Review							EARLY EXPOSURE; DEVELOPMENTAL DISORDERS; CHILDHOOD EXPOSURE; SURGERY	Background: Several epidemiological studies have been conducted to address the later effect of anesthesia on neurodevelopment in children. However, the results are still inconclusive. Methods: We here conducted a systematic review and meta-analysis to summarize the currently available clinical and epidemiologic evidence on the association of anesthesia/surgery with neurodevelopmental outcomes in children by searching PubMed, EMBASE, and Web of Science database (from January-1 2000 to February-1, 2013). The evaluation of neurodevelopment includes language and learning disabilities, cognition, behavioral development, and academic performance. Both retrospective and prospective studies were included. Data were abstracted from seven eligible studies. We estimated the synthesized hazard ratios (HR) and 95% confidence interval (CI) according to inter-study heterogeneity. Results: The pooled HR for the association of anesthesia/surgery with an adverse behavioral or developmental outcome was 1.25 (95% CI, 1.13-1.38, P, 0.001; random-effects model) in children undergoing the first anesthesia before the age of 4-year. Then we analyzed the factors for this association using meta-regression method. It showed that it was the number of times of exposure (HR = 1.75, 95% CI 1.31-2.33; P<0.001) rather than the time at exposure before 4-year (HR = 1.08, 95% CI 0.87-1.34 for the effect of per 1-year early exposure; P = 0.47) is a risk factor for neurodevelopmental impairment. Conclusion: The current clinical evidence suggests modestly elevated risk of adverse neurodevelopmental outcomes in children who were exposed to anesthesia/surgery during early childhood, especially for those with multiple times of exposure. Due to limitation of retrospective studies, prospective investigations are needed to determine whether anesthesia/surgery is causative.	[Wang, Xin] Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Dept Anesthesiol, Shanghai Canc Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China.	xinwang79@gmail.com; miaochh@yahoo.com.cn	Cammeraat, Erik L.H./G-2863-2010; Kalbitz, Karsten/A-9641-2013	Cammeraat, Erik L.H./0000-0003-4398-206X; 				Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; DiMaggio C, 2012, J NEUROSURG ANESTH, V24, P376, DOI 10.1097/ANA.0b013e31826a038d; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Guerra GG, 2011, PEDIATR ANESTH, V21, P932, DOI 10.1111/j.1460-9592.2011.03581.x; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; HATTORI R, 1991, LANCET, V337, P1357, DOI 10.1016/0140-6736(91)93045-B; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Roze JC, 2008, ARCH PEDIAT ADOL MED, V162, P728, DOI 10.1001/archpedi.162.8.728; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d	21	236	240	16	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2014	9	1							e85760	10.1371/journal.pone.0085760	http://dx.doi.org/10.1371/journal.pone.0085760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297FH	24465688	Green Published, Green Submitted, gold			2022-12-27	WOS:000330240500070
J	Wang, X; Cammeraat, ELH; Romeijn, P; Kalbitz, K				Wang, Xiang; Cammeraat, Erik L. H.; Romeijn, Paul; Kalbitz, Karsten			Soil Organic Carbon Redistribution by Water Erosion-The Role of CO2 Emissions for the Carbon Budget	PLOS ONE			English	Article							DIOXIDE EVOLUTION; VARIABLE RAINFALL; INTERRILL EROSION; ENRICHMENT RATIO; MATTER; RUNOFF; DEPOSITION; FRACTIONS; STABILITY; SEDIMENT	A better process understanding of how water erosion influences the redistribution of soil organic carbon (SOC) is sorely needed to unravel the role of soil erosion for the carbon (C) budget from local to global scales. The main objective of this study was to determine SOC redistribution and the complete C budget of a loess soil affected by water erosion. We measured fluxes of SOC, dissolved organic C (DOC) and CO2 in a pseudo-replicated rainfall-simulation experiment. We characterized different C fractions in soils and redistributed sediments using density fractionation and determined C enrichment ratios (CER) in the transported sediments. Erosion, transport and subsequent deposition resulted in significantly higher CER of the sediments exported ranging between 1.3 and 4.0. In the exported sediments, C contents (mg per g soil) of particulate organic C (POC, C not bound to soil minerals) and mineral-associated organic C (MOC) were both significantly higher than those of non-eroded soils indicating that water erosion resulted in losses of C-enriched material both in forms of POC and MOC. The averaged SOC fluxes as particles (4.7 g C m(-2) yr(-1)) were 18 times larger than DOC fluxes. Cumulative emission of soil CO2 slightly decreased at the erosion zone while increased by 56% and 27% at the transport and depositional zone, respectively, in comparison to non-eroded soil. Overall, CO2 emission is the predominant form of C loss contributing to about 90.5% of total erosion-induced C losses in our 4-month experiment, which were equal to 18 g C m(-2). Nevertheless, only 1.5% of the total redistributed C was mineralized to CO2 indicating a large stabilization after deposition. Our study also underlines the importance of C losses by particles and as DOC for understanding the effects of water erosion on the C balance at the interface of terrestrial and aquatic ecosystems.	[Wang, Xiang; Cammeraat, Erik L. H.; Romeijn, Paul; Kalbitz, Karsten] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Wang, X (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	X.Wang@uva.nl	Cammeraat, Erik L.H./G-2863-2010; Kalbitz, Karsten/A-9641-2013	Cammeraat, Erik L.H./0000-0003-4398-206X; 	China Scholarship Council (CSC); University of Amsterdam (UvA)	China Scholarship Council (CSC)(China Scholarship Council); University of Amsterdam (UvA)	This work was supported by China Scholarship Council (CSC) and University of Amsterdam (UvA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Berhe AA, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001790; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Blake G.R., 1986, METHODS SOIL ANAL, V5, P363, DOI DOI 10.2136/SSSABOOKSER5.1.2ED.C13; Borselli L, 2001, EARTH SURF PROC LAND, V26, P329, DOI [10.1002/1096-9837(200103)26:3<329::AID-ESP177>3.0.CO;2-Y, 10.1002/1096-9837(200103)26:3&lt;329::AID-ESP177&gt;3.0.CO;2-Y]; Bremenfeld S, 2013, CATENA, V104, P14, DOI 10.1016/j.catena.2012.12.011; Buishand TA, 1980, EXTREME NEERSLAGHOEV, P104; Casals P, 2009, SOIL BIOL BIOCHEM, V41, P1915, DOI 10.1016/j.soilbio.2009.06.015; Cerli C, 2012, GEODERMA, V170, P403, DOI 10.1016/j.geoderma.2011.10.009; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Chen FS, 2010, APPL SOIL ECOL, V44, P42, DOI 10.1016/j.apsoil.2009.09.003; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Creed IF, 2013, BIOGEOCHEMISTRY, V112, P149, DOI 10.1007/s10533-012-9713-4; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P2145, DOI 10.1016/S0038-0717(01)00153-5; Doetterl S, 2012, GLOBAL CHANGE BIOL, V18, P2218, DOI 10.1111/j.1365-2486.2012.02680.x; Feng WT, 2014, SOIL BIOL BIOCHEM, V69, P398, DOI 10.1016/j.soilbio.2013.11.024; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Franzluebbers AJ, 1999, SOIL BIOL BIOCHEM, V31, P1083, DOI 10.1016/S0038-0717(99)00022-X; GHADIRI H, 1993, J ENVIRON MANAGE, V37, P37, DOI 10.1006/jema.1993.1003; GHADIRI H, 1991, J ENVIRON QUAL, V20, P634, DOI 10.2134/jeq1991.00472425002000030021x; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Gregorich EG, 1998, SOIL TILL RES, V47, P291, DOI 10.1016/S0167-1987(98)00117-2; Harden JW, 1999, GLOBAL BIOGEOCHEM CY, V13, P885, DOI 10.1029/1999GB900061; HEIMOVAARA TJ, 1990, WATER RESOUR RES, V26, P2311, DOI 10.1029/90WR01239; Huxman TE, 2004, OECOLOGIA, V141, P254, DOI 10.1007/s00442-004-1682-4; Intergovernmental Panel on Climate Change (IPCC), 2014, INTERGOVERNMENTAL PA; IUSS Working Group, 2006, WORLD REF BAS SOIL R, DOI DOI 10.1017/S0014479706394902; Jacinthe PA, 2002, SOIL TILL RES, V66, P23, DOI 10.1016/S0167-1987(02)00010-7; Jacinthe PA, 2001, LAND DEGRAD DEV, V12, P329, DOI 10.1002/ldr.454; Kaiser K, 2003, EUR J SOIL SCI, V54, P219, DOI 10.1046/j.1365-2389.2003.00544.x; Kuhn NJ, 2007, EARTH SURF PROC LAND, V32, P794, DOI 10.1002/esp.1486; KWAAD FJPM, 1994, CATENA, V23, P253, DOI 10.1016/0341-8162(94)90071-X; Kwaad FJPM, 2006, SOIL EROSION EUROPE; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Nadeu E, 2012, BIOGEOSCIENCES, V9, P1099, DOI 10.5194/bg-9-1099-2012; Palis RG, 1997, AUST J SOIL RES, V35, P891, DOI 10.1071/S92060; Polyakov VO, 2008, GEODERMA, V143, P216, DOI 10.1016/j.geoderma.2007.11.005; Schiettecatte W, 2008, SOIL SCI SOC AM J, V72, P50, DOI 10.2136/sssaj2007.0201; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Smith SV, 2005, ECOL APPL, V15, P1929, DOI 10.1890/05-0073; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Strickland TC, 2005, J SOIL WATER CONSERV, V60, P142; Truman CC, 2007, J ENVIRON QUAL, V36, P1495, DOI 10.2134/jeq2006.0018; Van Hemelryck H, 2010, BIOGEOSCIENCES, V7, P3971, DOI 10.5194/bg-7-3971-2010; Van Hemelryck H, 2011, EARTH SURF PROC LAND, V36, P427, DOI 10.1002/esp.2055; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Wan Y, 1998, J ENVIRON QUAL, V27, P132, DOI 10.2134/jeq1998.00472425002700010019x; Wang X, 2013, EUR J SOIL SCI, V64, P219, DOI 10.1111/ejss.12018; Wang ZG, 2010, GEOMORPHOLOGY, V124, P65, DOI 10.1016/j.geomorph.2010.08.010; Zhang JH, 2006, GLOBAL CHANGE BIOL, V12, P1834, DOI 10.1111/j.1365-2486.2006.01206.x	53	236	240	16	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2014	9	5							e96299	10.1371/journal.pone.0096299	http://dx.doi.org/10.1371/journal.pone.0096299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ9KS	24465688	Green Published, gold, Green Submitted			2022-12-27	WOS:000338029800051
J	Tanaka, K; Kanno, T; Yanagisawa, Y; Yasutake, K; Inoue, S; Hirayama, N; Ikeda, JE				Tanaka, Kazunori; Kanno, Takuya; Yanagisawa, Yoshiko; Yasutake, Kaori; Inoue, Satoshi; Hirayama, Noriaki; Ikeda, Joh-E			A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; OXIDATIVE STRESS; SPINAL-CORD; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; NRF2-ARE PATHWAY; FAMILIAL ALS; ACTIVATION; ASTROCYTES; GENES	Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron degenerative disease. Given that oxidative stress and resulting chronic neuronal inflammation are thought to be central pathogenic, anti-oxidative agents and modulators of neuronal inflammation could be potential therapies for ALS. We report here that the novel small molecular compound, 2-[mesityl(methyl) amino]-N-[4-(pyridin-2-yl)-1H-imidazol-2-yl] acetamide trihydrochloride (WN1316) selectively suppresses oxidative stress-induced cell death and neuronal inflammation in the late-stage ALS mice. WN1316 has high blood-brain-barrier permeability and water solubility, and boosts both neuronal apoptosis inhibitory protein (NAIP) and NF-E2-related factor 2 (Nrf2) which governed glutathione (GSH)-related anti-oxidation pathway protecting motor neurons against oxidative injuries. Post-onset oral administration of low dose (1-100 mu g/kg/day) WN1316 in ALS(SOD1(H46R)) and ALS(SOD1(G93A)) mice resulted in sustained improved motor function and post onset survival rate. Immunohistochemical analysis revealed less DNA oxidative damage and motor neuronal inflammation as well as repression of both microgliosis and astrocytosis, concomitant down regulation of interleukin-1 beta and inducible nitric oxide synthase, and preservation of the motoneurons in anterior horn of lumbar spinal cord and skeletal muscle (quadriceps femoris). Thus, WN1316 would be a novel therapeutic agent for ALS.	[Tanaka, Kazunori; Kanno, Takuya; Yanagisawa, Yoshiko; Yasutake, Kaori; Ikeda, Joh-E] Kitasato Univ, Sch Med, NGP Biomed Res Inst, Neugen Pharma Inc, Sagamihara, Kanagawa 228, Japan; [Inoue, Satoshi] Wakunaga Pharmaceut Co Ltd, Hiroshima, Japan; [Hirayama, Noriaki; Ikeda, Joh-E] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Ikeda, Joh-E] Kitasato Univ, Sch Med, Dept Mol Neurol, Sagamihara, Kanagawa 228, Japan; [Ikeda, Joh-E] Univ Ottawa, Dept Pediat, Childrens Hosp Eastern Ontario, Apoptosis Res Ctr,Fac Med, Ottawa, ON K1N 6N5, Canada	Kitasato University; Wakunaga Pharmaceutical Co., Ltd.; Tokai University; Kitasato University; University of Ottawa; Children's Hospital of Eastern Ontario	Ikeda, JE (corresponding author), Kitasato Univ, Sch Med, NGP Biomed Res Inst, Neugen Pharma Inc, Sagamihara, Kanagawa 228, Japan.	alspd@med.kitasato-u.ac.jp	Coppola, Vincenzo/D-5352-2014	Coppola, Vincenzo/0000-0001-6163-1779	National Institute of Biomedical Innovation (NIBIO)	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This work was supported by the National Institute of Biomedical Innovation (NIBIO) (JEI). The funders had no role in study design, data cellection and analysis, decision to publish, or preparation of the manuscript.	Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Esposito Emilio Xavier, 2004, Methods Mol Biol, V275, P131; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Fitzmaurice PS, 1996, MUSCLE NERVE, V19, P797; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Horio K, 2007, CHEM PHARM BULL, V55, P980, DOI 10.1248/cpb.55.980; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Jyrkkanen HK, 2008, CIRC RES, V103, pE1, DOI 10.1161/CIRCRESAHA.108.176883; Kanno T, 2012, FREE RADICAL BIO MED, V53, P2028, DOI 10.1016/j.freeradbiomed.2012.09.010; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kim KH, 2010, NUCLEIC ACIDS RES, V38, P48, DOI 10.1093/nar/gkp865; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee M, 2010, FASEB J, V24, P2533, DOI 10.1096/fj.09-149997; Lewis CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/803701; Limpert AS, 2013, BEILSTEIN J ORG CHEM, V9, P717, DOI 10.3762/bjoc.9.82; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; McGeer Patrick L, 2002, Sci Aging Knowledge Environ, V2002, pre3, DOI 10.1126/sageke.2002.29.re3; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; Pratt AJ, 2012, DEGENER NEUROL NEURO, V2, P1, DOI 10.2147/DNND.S19803; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Wang XJ, 2010, CHEM BIOL, V17, P75, DOI 10.1016/j.chembiol.2009.12.013; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	44	53	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2014	9	1							e87728	10.1371/journal.pone.0087728	http://dx.doi.org/10.1371/journal.pone.0087728			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302RF	24498180	Green Submitted, gold, Green Published			2022-12-27	WOS:000330621900162
J	Harvey, AE; Lashinger, LM; Hays, D; Harrison, LM; Lewis, K; Fischer, SM; Hursting, SD				Harvey, Alison E.; Lashinger, Laura M.; Hays, Drew; Harrison, Lauren M.; Lewis, Kimberly; Fischer, Susan M.; Hursting, Stephen D.			Calorie Restriction Decreases Murine and Human Pancreatic Tumor Cell Growth, Nuclear Factor-kB Activation, and Inflammation-Related Gene Expression in an Insulin-like Growth Factor-1-Dependent Manner	PLOS ONE			English	Article							FACTOR-KAPPA-B; ENERGY-BALANCE; FACTOR-I; DIETARY MODULATION; CANCER; OBESITY; CARCINOGENESIS; PROGRESSION; SERUM; INDUCTION	Calorie restriction (CR) prevents obesity and has potent anticancer effects that may be mediated through its ability to reduce serum growth and inflammatory factors, particularly insulin-like growth factor (IGF)-1 and protumorigenic cytokines. IGF-1 is a nutrient-responsive growth factor that activates the inflammatory regulator nuclear factor (NF)-kB, which is linked to many types of cancers, including pancreatic cancer. We hypothesized that CR would inhibit pancreatic tumor growth through modulation of IGF-1-stimulated NF-kB activation and protumorigenic gene expression. To test this, 30 male C57BL/ 6 mice were randomized to either a control diet consumed ad libitum or a 30% CR diet administered in daily aliquots for 21 weeks, then were subcutaneously injected with syngeneic mouse pancreatic cancer cells (Panc02) and tumor growth was monitored for 5 weeks. Relative to controls, CR mice weighed less and had decreased serum IGF-1 levels and smaller tumors. Also, CR tumors demonstrated a 70% decrease in the expression of genes encoding the pro-inflammatory factors S100a9 and F4/80, and a 56% decrease in the macrophage chemoattractant, Ccl2. Similar CR effects on tumor growth and NF-kB-related gene expression were observed in a separate study of transplanted MiaPaCa-2 human pancreatic tumor cell growth in nude mice. In vitro analyses in Panc02 cells showed that IGF-1 treatment promoted NF-kB nuclear localization, increased DNA-binding of p65 and transcriptional activation, and increased expression of NF-kB downstream genes. Finally, the IGF-1-induced increase in expression of genes downstream of NF-kB (Ccdn1, Vegf, Birc5, and Ptgs2) was decreased significantly in the context of silenced p65. These findings suggest that the inhibitory effects of CR on Panc02 pancreatic tumor growth are associated with reduced IGF-1-dependent NF-kB activation.	[Harvey, Alison E.; Lashinger, Laura M.; Hays, Drew; Harrison, Lauren M.; Lewis, Kimberly; Hursting, Stephen D.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Fischer, Susan M.; Hursting, Stephen D.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA	University of Texas System; University of Texas Austin; University of Texas System; UTMD Anderson Cancer Center	Hursting, SD (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.	shursting@austin.utexas.edu		Callan, Mitchell/0000-0002-6737-8281; Lewis, Kimberly/0000-0002-2590-8627	National Institutes of Health (NIH) [R01 CA135386]; NIH-sponsored postdoctoral fellowship [R25T CA57730, T32 CA135386]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA135386, R25CA057730] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-sponsored postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health (NIH) grant, R01 CA135386, awarded to S. D. Hursting and S. M. Fischer and NIH-sponsored postdoctoral fellowship grants, R25T CA57730 and T32 CA135386, awarded to L. M. Lashinger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2010, WORLD J GASTROENTERO, V16, P5779, DOI 10.3748/wjg.v16.i46.5779; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bellone G, 2006, CANCER IMMUNOL IMMUN, V55, P684, DOI 10.1007/s00262-005-0047-0; Bhattacharya A, 2006, BIOCHEM BIOPH RES CO, V349, P925, DOI 10.1016/j.bbrc.2006.08.093; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; CORBETT TH, 1984, CANCER RES, V44, P717; CRAVENGILES T, 1994, CANCER RES, V54, pS1964; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Ford NA, 2013, ENDOCR-RELAT CANCER, V20, P39, DOI 10.1530/ERC-12-0329; Goecke H, 2000, SURGERY, V128, P806, DOI 10.1067/msy.2000.108613; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Harvey AE, 2012, MOL CARCINOGENESIS; Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x; Hursting SD, 2012, ANN NY ACAD SCI, V1271, P82, DOI 10.1111/j.1749-6632.2012.06737.x; Hursting SD, 2010, J CLIN ONCOL, V28, P4058, DOI 10.1200/JCO.2010.27.9935; Karin M, 2005, NAT MED, V11, P20, DOI 10.1038/nm0105-20; Karna E, 2002, INT J EXP PATHOL, V83, P239, DOI 10.1046/j.1365-2613.2002.00237.x; Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6; Kim HJ, 2002, FREE RADICAL BIO MED, V32, P991, DOI 10.1016/S0891-5849(02)00798-0; Kokawa A, 2001, CANCER, V91, P333, DOI 10.1002/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N; Lashinger LM, 2014, J NUTR, V144, P109, DOI 10.3945/jn.113.178533; Lashinger LM, 2013, CANCER PREV RES, V6, P1046, DOI 10.1158/1940-6207.CAPR-13-0185; Lashinger LM, 2011, CANCER PREV RES, V4, P1041, DOI 10.1158/1940-6207.CAPR-11-0023; Lashinger LM, 2011, CANCER PREV RES, V4, P1030, DOI 10.1158/1940-6207.CAPR-11-0027; Lin YS, 2004, INT J CANCER, V110, P584, DOI 10.1002/ijc.20147; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Luedde T, 2006, J GASTROEN HEPATOL, V21, pS43, DOI 10.1111/j.1440-1746.2006.04588.x; Ma JC, 2010, J SURG RES, V160, P90, DOI 10.1016/j.jss.2008.08.016; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mancino A, 2010, CLIN CANCER RES, V16, P784, DOI 10.1158/1078-0432.CCR-09-1015; Monti P, 2003, CANCER RES, V63, P7451; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Olivo-Marston SE, 2009, MOL CARCINOGEN, V48, P1071, DOI 10.1002/mc.20577; ROEBUCK BD, 1993, CANCER RES, V53, P46; ROEBUCK BD, 1981, CANCER RES, V41, P888; Rouet-Benzineb R, 2004, J BIOL CHEM, V279, P16495, DOI 10.1074/jbc.M312999200; Shaib YH, 2006, ALIMENT PHARM THER, V24, P87, DOI 10.1111/j.1365-2036.2006.02961.x; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Wang WX, 1999, CLIN CANCER RES, V5, P119; Wheatley KE, 2008, NUTR CANCER, V60, P61, DOI 10.1080/01635580701510150; Xiong Henry Q, 2004, Surg Oncol Clin N Am, V13, P737, DOI 10.1016/j.soc.2004.06.010; YEBRA M, 1995, MOL BIOL CELL, V6, P841, DOI 10.1091/mbc.6.7.841	47	54	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2014	9	5							e94151	10.1371/journal.pone.0094151	http://dx.doi.org/10.1371/journal.pone.0094151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG9HB	25036011	Green Submitted, Green Published, gold			2022-12-27	WOS:000335728900009
J	Liu, N; Lin, ZF; Guan, LL; Gaughan, G; Lin, GZ				Liu, Nan; Lin, Zhifang; Guan, Lanlan; Gaughan, Gerald; Lin, Guizhu			Antioxidant Enzymes Regulate Reactive Oxygen Species during Pod Elongation in Pisum sativum and Brassica chinensis	PLOS ONE			English	Article							HYDROXYL RADICALS; HYDROGEN-PEROXIDE; CELL-WALL; ROOT; SUPEROXIDE; GROWTH; LEAVES; H2O2	Previous research has focused on the involvement of reactive oxygen species (ROS) in cell wall loosening and cell extension in plant vegetative growth, but few studies have investigated ROS functions specifically in plant reproductive organs. In this study, ROS levels and antioxidant enzyme activities were assessed in Pisum sativum and Brassica chinensis pods at five developmental stages. In juvenile pods, the high levels of O-2(-) and OH indicates that they had functions in cell wall loosening and cell elongation. In later developmental stages, high levels of. OH were also related to increases in cell wall thickness in lignified tissues. Throughout pod development, most of the O-2(-) was detected on plasma membranes of parenchyma cells and outer epidermis cells of the mesocarp, while most of the H2O2 was detected on plasma membranes of most cells throughout the mesocarp. This suggests that these sites are presumably the locations of ROS generation. The antioxidant enzymes superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT) apparently contributed to ROS accumulation in pod wall tissues. Furthermore, specifically SOD and POD were found to be associated with pod growth through the regulation of ROS generation and transformation. Throughout pod development, O-2(-) decreases were associated with increased SOD activity, while changes in H2O2 accumulation were associated with changes in CAT and POD activities. Additionally, high POD activity may contribute to the generation of. OH in the early development of pods. It is concluded that the ROS are produced in different sites of plasma membranes with the regulation of antioxidant enzymes, and that substantial ROS generation and accumulation are evident in cell elongation and cell wall loosening in pod wall cells.	[Liu, Nan; Lin, Zhifang; Guan, Lanlan; Lin, Guizhu] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Gaughan, Gerald] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, ZF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	linzhif@scbg.ac.cn	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	China Scholarship Council [201204910138]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	China Scholarship Council(China Scholarship Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The current study was supported by China Scholarship Council (No. 201204910138, http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; BARRETO JC, 1994, LIFE SCI, V56, pPL89, DOI 10.1016/0024-3205(94)00925-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carol RJ, 2006, J EXP BOT, V57, P1829, DOI 10.1093/jxb/erj201; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Dunand C, 2007, NEW PHYTOL, V174, P332, DOI 10.1111/j.1469-8137.2007.01995.x; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Gapper C, 2006, PLANT PHYSIOL, V141, P341, DOI 10.1104/pp.106.079079; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; GILBERT DL, 1981, OXYGEN LIVING PROCES; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Ivakov A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00439; Ivanchenko MG, 2013, ANN BOT, DOI [10.1093/aob/mct181, DOI 10.1093/A0B/MCT181]; Johnansen DA, 1940, PLANT MICROTECHNIQUE; Kranner I, 2010, J PLANT PHYSIOL, V167, P805, DOI 10.1016/j.jplph.2010.01.019; Kukavica B, 2009, PLANT CELL PHYSIOL, V50, P304, DOI 10.1093/pcp/pcn199; Li SW, 2009, ENVIRON EXP BOT, V65, P63, DOI 10.1016/j.envexpbot.2008.06.004; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu N, 2013, J PLANT GROWTH REGUL, V32, P83, DOI 10.1007/s00344-012-9278-4; Liu N, 2010, ECOTOX ENVIRON SAFE, V73, P1238, DOI 10.1016/j.ecoenv.2010.06.017; Muller K, 2009, PLANT PHYSIOL, V150, P1855, DOI 10.1104/pp.109.139204; Perl RT., 2002, OXIDATIVE STRESS PLA, P1; Romero-Puertas MC, 2004, PLANT CELL ENVIRON, V27, P1122, DOI 10.1111/j.1365-3040.2004.01217.x; Barcelo AR, 2009, SIGNAL COMMUN PLANTS, P73, DOI 10.1007/978-3-642-00390-5_5; Schopfer P, 2006, BIOFACTORS, V28, P73, DOI 10.1002/biof.5520280202; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; Yang XF, 2001, ANALYST, V126, P928, DOI 10.1039/b100085n; ZENG S-X, 1991, Acta Phytophysiologica Sinica, V17, P177; [张玲玲 ZHANG LingLing], 2006, [生态学报, Acta Ecologica Sinica], V26, P1330, DOI 10.1016/S1872-2032(06)60025-5	32	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2014	9	2							e87588	10.1371/journal.pone.0087588	http://dx.doi.org/10.1371/journal.pone.0087588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VA	24671213	Green Published, gold, Green Submitted			2022-12-27	WOS:000330631800048
J	Hobbelen, PHF; Paveley, ND; van den Bosch, F				Hobbelen, Peter H. F.; Paveley, Neil D.; van den Bosch, Frank			The Emergence of Resistance to Fungicides	PLOS ONE			English	Article							STRESS-INDUCED MUTAGENESIS; MYCOSPHAERELLA-GRAMINICOLA; PESTICIDE RESISTANCE; SPRAY HETEROGENEITY; SEPTORIA-TRITICI; SELECTION; MIXTURES; PATHOGEN; MODEL; POPULATIONS	Many studies exist about the selection phase of fungicide resistance evolution, where a resistant strain is present in a pathogen population and is differentially selected for by the application of fungicides. The emergence phase of the evolution of fungicide resistance - where the resistant strain is not present in the population and has to arise through mutation and subsequently invade the population - has not been studied to date. Here, we derive a model which describes the emergence of resistance in pathogen populations of crops. There are several important examples where a single mutation, affecting binding of a fungicide with the target protein, shifts the sensitivity phenotype of the resistant strain to such an extent that it cannot be controlled effectively('qualitative' or 'single-step' resistance). The model was parameterized for this scenario for Mycosphaerella graminicola on winter wheat and used to evaluate the effect of fungicide dose rate on the time to emergence of resistance for a range of mutation probabilities, fitness costs of resistance and sensitivity levels of the resistant strain. We also evaluated the usefulness of mixing two fungicides of differing modes of action for delaying the emergence of resistance. The results suggest that it is unlikely that a resistant strain will already have emerged when a fungicide with a new mode of action is introduced. Hence, 'anti-emergence' strategies should be identified and implemented. For all simulated scenarios, the median emergence time of a resistant strain was affected little by changing the dose rate applied, within the range of doses typically used on commercial crops. Mixing a single-site acting fungicide with a multi-site acting fungicide delayed the emergence of resistance to the single-site component. Combining the findings with previous work on the selection phase will enable us to develop more efficient anti-resistance strategies.	[Hobbelen, Peter H. F.; van den Bosch, Frank] Rothamsted Res, Harpenden, Herts, England; [Paveley, Neil D.] ADAS UK Ltd, Malton, N Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	van den Bosch, F (corresponding author), Rothamsted Res, Harpenden, Herts, England.	frank.vandenbosch@rothamsted.ac.uk	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Biological and Biotechnological Research Council of the United Kingdom; Department for Environment, Food and Rural Affairs of the United Kingdom [PS2712]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Biological and Biotechnological Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs of the United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Rothamsted Research receives support from the Biological and Biotechnological Research Council of the United Kingdom. Part of this research was funded by the Department for Environment, Food and Rural Affairs of the United Kingdom (project number PS2712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch CPD, 1997, J APPL ECOL, V34, P1032, DOI 10.2307/2405292; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Carnegie SF, 2008, POTATO RES, V51, P113, DOI 10.1007/s11540-008-9094-1; DOSTER MA, 1990, PHYTOPATHOLOGY, V80, P1190, DOI 10.1094/Phyto-80-1190; Eyal Z, 1999, EUR J PLANT PATHOL, V105, P629, DOI 10.1023/A:1008716812259; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Fraaije BA, 2012, MOL PLANT PATHOL, V13, P263, DOI 10.1111/j.1364-3703.2011.00746.x; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Genet JL, 2006, PEST MANAG SCI, V62, P188, DOI 10.1002/ps.1146; Grabski C., 1985, BRIT CROP PROT C MON, V31, P315; Grimmer M, 2011, RESISTANCE 2011, P94; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Hall RJ, 2007, B MATH BIOL, V69, P525, DOI 10.1007/s11538-006-9139-z; Hall RJ, 2004, B MATH BIOL, V66, P825, DOI 10.1016/j.bulm.2003.11.006; HOARE FA, 1986, PLANT PATHOL, V35, P506, DOI 10.1111/j.1365-3059.1986.tb02048.x; Hobbelen PHF, 2013, PHYTOPATHOLOGY, V103, P690, DOI 10.1094/PHYTO-06-12-0142-R; Hobbelen PHF, 2011, PHYTOPATHOLOGY, V101, P1224, DOI 10.1094/PHYTO-10-10-0290; Hobbelen PHF, 2011, PLANT PATHOL, V60, P304, DOI 10.1111/j.1365-3059.2010.02380.x; Horsten JAHM, 1979, THESIS WAGENINGEN U; HUNTER T, 1987, ANN APPL BIOL, V110, P515, DOI 10.1111/j.1744-7348.1987.tb04169.x; Iwasa Y, 2004, J THEOR BIOL, V226, P205, DOI 10.1016/j.jtbi.2003.08.014; JOSEPOVITS G, 1989, CROP PROT, V8, P106, DOI 10.1016/0261-2194(89)90084-7; Kang JM, 2006, FASEB J, V20, P2476, DOI 10.1096/fj.06-6209com; LaMondia J. A., 2001, Journal of Environmental Horticulture, V19, P51; Mavroeidi VI, 2006, PLANT PATHOL, V55, P715, DOI 10.1111/j.1365-3059.2006.01441.x; McCartney C, 2007, CROP PROT, V26, P1272, DOI 10.1016/j.cropro.2006.10.027; Metcalfe RJ, 2000, PLANT PATHOL, V49, P546, DOI 10.1046/j.1365-3059.2000.00486.x; MILGROOM MG, 1990, PHYTOPATHOLOGY, V80, P410, DOI 10.1094/Phyto-80-410; Parnell S, 2006, PHYTOPATHOLOGY, V96, P549, DOI 10.1094/PHYTO-96-0549; Parnell S, 2005, PHYTOPATHOLOGY, V95, P632, DOI 10.1094/PHYTO-95-0632; Paveley ND, 2011, HGCA WHEAT DIS MANAG; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; SANDERS PL, 1985, PLANT DIS, V69, P939; SANOAMUANG N, 1995, MYCOL RES, V99, P677, DOI 10.1016/S0953-7562(09)80527-3; Serra MC, 2007, THEOR POPUL BIOL, V72, P167, DOI 10.1016/j.tpb.2007.01.005; Serra MC, 2006, J APPL PROBAB, V43, P296, DOI 10.1239/jap/1143936262; Shaw MW, 2000, PHYTOPATHOLOGY, V90, P333, DOI 10.1094/PHYTO.2000.90.4.333; SHAW MW, 1993, CROP PROT, V12, P120, DOI 10.1016/0261-2194(93)90138-9; Tenaillon O, 2004, TRENDS MICROBIOL, V12, P264, DOI 10.1016/j.tim.2004.04.002; Thornley JHM., 1990, PLANT CROP MODELLING; Thygesen K, 2009, EUR J PLANT PATHOL, V123, P435, DOI 10.1007/s10658-008-9381-3; Turechek WW, 2004, PLANT HLTH PROG; VALI RJ, 1992, PLANT DIS, V76, P919, DOI 10.1094/PD-76-0919; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; van den Bosch F, 2008, ANNU REV PHYTOPATHOL, V46, P123, DOI 10.1146/annurev.phyto.011108.135838; WAGGONER PE, 1987, PHYTOPATHOLOGY, V77, P393; Zhang CQ, 2008, ANN APPL BIOL, V153, P205, DOI 10.1111/j.1744-7348.2008.00248.x	48	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e91910	10.1371/journal.pone.0091910	http://dx.doi.org/10.1371/journal.pone.0091910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000333355300044
J	da Silva, VCP; Bertin, A; Blin, A; Germain, JF; Bernardi, D; Rignol, G; Botton, M; Malausa, T				Pacheco da Silva, Vitor C.; Bertin, Aline; Blin, Aurelie; Germain, Jean-Francois; Bernardi, Daniel; Rignol, Guylene; Botton, Marcos; Malausa, Thibaut			Molecular and Morphological Identification of Mealybug Species (Hemiptera: Pseudococcidae) in Brazilian Vineyards	PLOS ONE			English	Article							FERRISIA FULLAWAY HEMIPTERA; SCALE INSECTS HEMIPTERA; EXPORT GRAPE PRODUCTION; MULTIPLEX PCR; PEST; PHYLOGENY; MARKERS	Mealybugs (Hemiptera: Pseudococcidae) are pests constraining the international trade of Brazilian table grapes. They damage grapes by transmitting viruses and toxins, causing defoliation, chlorosis, and vigor losses and favoring the development of sooty mold. Difficulties in mealybug identification remain an obstacle to the adequate management of these pests. In this study, our primary aim was to identify the principal mealybug species infesting the major table grape-producing regions in Brazil, by morphological and molecular characterization. Our secondary aim was to develop a rapid identification kit based on species-specific Polymerase Chain Reactions, to facilitate the routine identification of the most common pest species. We surveyed 40 sites infested with mealybugs and identified 17 species: Dysmicoccus brevipes (Cockerell), Dysmicoccus sylvarum Williams and Granara de Willink, Dysmicoccus texensis (Tinsley), Ferrisia cristinae Kaydan and Gullan, Ferrisia meridionalis Williams, Ferrisia terani Williams and Granara de Willink, Phenacoccus baccharidis Williams, Phenacoccus parvus Morrison, Phenacoccus solenopsis Tinsley, Planococcus citri (Risso), Pseudococcus viburni (Signoret), Pseudococcus cryptus Hempel, four taxa closely related each of to Pseudococcus viburni, Pseudococcus sociabilis Hambleton, Pseudococcus maritimus (Ehrhorn) and Pseudococcus meridionalis Prado, and one specimen from the genus Pseudococcus Westwood. The PCR method developed effectively identified five mealybug species of economic interest on grape in Brazil: D. brevipes, Pl. citri, Ps. viburni, Ph. solenopsis and Planococcus ficus (Signoret). Nevertheless, it is not possible to assure that this procedure is reliable for taxa that have not been sampled already and might be very closely related to the target species.	[Pacheco da Silva, Vitor C.; Botton, Marcos] Embrapa Uva & Vinho, Bento Goncalves, Brazil; [Bertin, Aline; Bernardi, Daniel] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Blin, Aurelie; Rignol, Guylene; Malausa, Thibaut] INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, F-06903 Sophia Antipolis, France; [Germain, Jean-Francois] ANSES, Lab Sante Vegetaux, Unite Entomol & Plantes Invas, Montferrier Sur Lez, France	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	Malausa, T (corresponding author), INRA, Inst Sophia Agrobiotech, UMR INRA UNSA CNRS, BP 167, F-06903 Sophia Antipolis, France.	tmalausa@sophia.inra.fr	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	European Union [265865, 269196, 324475]; French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS) [1001001]; Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	European Union(European Commission); French grants Agropolis Fondation (RTRA - Montpellier, BIOFIS); Bibliotheque du Vivant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Union Seventh Framework Programme FP7-KBBE #265865 "PURE'', FP7-IRSES #269196 "IPRABIO'' and FP7-IAPP #324475 "COLBICS'' and by the French grants Agropolis Fondation (http://www.agropolis-fondation.fr/) (RTRA - Montpellier, BIOFIS project number 1001001) and 'Bibliotheque du Vivant'. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Rabou S, 2012, B ENTOMOL RES, V102, P515, DOI 10.1017/S0007485312000041; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Ben-Dov Y, 2012, SCALENET DATABASE SC; Bertin S, 2010, PHYTOPARASITICA, V38, P401, DOI 10.1007/s12600-010-0109-5; Beuning LL, 1999, J ECON ENTOMOL, V92, P463, DOI 10.1093/jee/92.2.463; Camargo UA, 2011, REV BRAS FRUTIC, V33, P144, DOI 10.1590/S0100-29452011000500017; Cavalieri V, 2008, ZOOTAXA, P65, DOI 10.11646/zootaxa.1816.1.6; Charles J. G., 2006, New Zealand Plant Protection, V59, P330; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa L. R. B., 2005, Laranja, V26, P265; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; Correa M, 2011, ZOOTAXA, P46, DOI 10.11646/zootaxa.2926.1.2; Santa-Cecilia LVC, 2009, ACTA SCI-AGRON, V31, P13, DOI 10.4025/actasciagron.v31i1.6603; Culik Mark Paul, 2007, Biota Neotrop., V7, P61, DOI 10.1590/S1676-06032007000300006; Culik MP, 2005, ZOOTAXA, P1; Daane KM, 2008, CALIF AGR, V62, P167, DOI 10.3733/ca.v062n04p167; Daane Kent M., 2012, P271; Daane KM, 2011, ENVIRON ENTOMOL, V40, P1595, DOI 10.1603/EN11075; Granara De Willink María Cristina, 2007, Rev. Soc. Entomol. Argent., V66, P29; Demontis MA, 2007, J APPL ENTOMOL, V131, P59, DOI 10.1111/j.1439-0418.2006.01126.x; Foldi Imre, 2005, Nouvelle Revue d'Entomologie, V22, P305; GARAU R, 1995, VITIS, V34, P67; Gimpel William F. Jr, 1996, Contributions on Entomology International, V2, P1; Golino D. A., 2002, California Agriculture, V56, P196, DOI 10.3733/ca.v056n06p196; Gonzalez R. H., 2004, Revista Fruticola, V25, P41; Gullan PJ, 2010, SYST ENTOMOL, V35, P329, DOI 10.1111/j.1365-3113.2009.00513.x; Gullan PJ, 2003, ANN ENTOMOL SOC AM, V96, P723, DOI 10.1603/0013-8746(2003)096[0723:ANPSOT]2.0.CO;2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kaydan MB, 2012, ZOOTAXA, P1; Kuniyuki Hugo, 2006, Summa phytopathol., V32, P151, DOI 10.1590/S0100-54052006000200009; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Mello LMR, 2013, VITICULTURA BRASILEI; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Morandi Filho WJ, 2008, ARQ I BIOL-SAO PAULO, V76, P427; Morse GE, 2006, SYST ENTOMOL, V31, P338, DOI 10.1111/j.1365-3113.2005.00316.x; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Saccaggi DL, 2008, B ENTOMOL RES, V98, P27, DOI 10.1017/S000748530700538X; SANTA-CECÍLIA LENIRA V.C., 2002, Neotrop. entomol., V31, P333, DOI 10.1590/S1519-566X2002000200024; Selwyn B, 2007, J AGRAR CHANGE, V7, P526, DOI 10.1111/j.1471-0366.2007.00155.x; Selwyn B, 2010, J AGRAR CHANGE, V10, P537, DOI 10.1111/j.1471-0366.2009.00245.x; Souza B., 2008, Coffee Science, V3, P104; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Villard P, 2013, MOL ECOL RESOUR, V13, P755, DOI 10.1111/1755-0998.12116; Walton V. M., 2004, South African Journal of Enology and Viticulture, V25, P54; Walton VM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.4701; Willians DJ, 1992, MEALYBUGS CENTRAL S; Yokogawa T, 2009, GENES GENET SYST, V84, P57, DOI 10.1266/ggs.84.57	50	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 25	2014	9	7							e103267	10.1371/journal.pone.0103267	http://dx.doi.org/10.1371/journal.pone.0103267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RP	24671213	Green Submitted, Green Published, gold			2022-12-27	WOS:000339992600050
J	Ramos, JE; Pecl, GT; Moltschaniwskyj, NA; Strugnell, JM; Leon, RI; Semmens, JM				Ramos, Jorge E.; Pecl, Gretta T.; Moltschaniwskyj, Natalie A.; Strugnell, Jan M.; Leon, Rafael I.; Semmens, Jayson M.			Body Size, Growth and Life Span: Implications for the Polewards Range Shift of Octopus tetricus in South-Eastern Australia	PLOS ONE			English	Article							CLIMATE-CHANGE; COMMON OCTOPUS; REPRODUCTIVE-CYCLE; UPWELLING SYSTEM; VULGARIS; SQUID; EVOLUTIONARY; ECOLOGY; AGE; TEMPERATURE	Understanding the response of any species to climate change can be challenging. However, in short-lived species the faster turnover of generations may facilitate the examination of responses associated with longer-term environmental change. Octopus tetricus, a commercially important species, has undergone a recent polewards range shift in the coastal waters of south-eastern Australia, thought to be associated with the southerly extension of the warm East Australian Current. At the cooler temperatures of a polewards distribution limit, growth of a species could be slower, potentially leading to a bigger body size and resulting in a slower population turnover, affecting population viability at the extreme of the distribution. Growth rates, body size, and life span of O. tetricus were examined at the leading edge of a polewards range shift in Tasmanian waters (40 degrees S and 147 degrees E) throughout 2011. Octopus tetricus had a relatively small body size and short lifespan of approximately 11 months that, despite cooler temperatures, would allow a high rate of population turnover and may facilitate the population increase necessary for successful establishment in the new extended area of the range. Temperature, food availability and gender appear to influence growth rate. Individuals that hatched during cooler and more productive conditions, but grew during warming conditions, exhibited faster growth rates and reached smaller body sizes than individuals that hatched into warmer waters but grew during cooling conditions. This study suggests that fast growth, small body size and associated rapid population turnover may facilitate the range shift of O. tetricus into Tasmanian waters.	[Ramos, Jorge E.; Pecl, Gretta T.; Leon, Rafael I.; Semmens, Jayson M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Moltschaniwskyj, Natalie A.] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia; [Strugnell, Jan M.] La Trobe Univ, Dept Genet, La Trobe Inst Mol Sci, Bundoora, Vic, Australia	University of Tasmania; University of Newcastle; La Trobe University	Ramos, JE (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jeramos@utas.edu.au	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Consejo Nacional de Ciencia y Tecnologia of Mexico [308672]; University of Tasmania; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Consejo Nacional de Ciencia y Tecnologia of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); University of Tasmania; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J. Ramos was awarded the scholarship 308672 by Consejo Nacional de Ciencia y Tecnologia of Mexico, a Tasmania Graduate Research scholarship from the University of Tasmania and a Bookend Lynchpin Ocean Scholarship 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amundsen PA, 2012, BIOL INVASIONS, V14, P1501, DOI 10.1007/s10530-012-0175-3; Anderson RC, 2008, MAR ECOL PROG SER, V371, P199, DOI 10.3354/meps07649; Arenas M, 2012, MOL BIOL EVOL, V29, P207, DOI 10.1093/molbev/msr187; Arkhipkin AI, 2005, MAR FRESHWATER RES, V56, P371, DOI 10.1071/MF04274; Barratt IM, 2010, ICES J MAR SCI, V67, P1452, DOI 10.1093/icesjms/fsq047; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Calosi P, 2013, INTEGR COMP BIOL, V53, P660, DOI 10.1093/icb/ict041; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Canali E, 2011, MAR ECOL PROG SER, V441, P141, DOI 10.3354/meps09399; Carrasco JF, 2006, AQUAC RES, V37, P1601, DOI 10.1111/j.1365-2109.2006.01594.x; CHEN Y, 1992, CAN J FISH AQUAT SCI, V49, P1228, DOI 10.1139/f92-138; Clarke MR, 1996, PHILOS T ROY SOC B, V351, P1105, DOI 10.1098/rstb.1996.0096; Colautti RI, 2006, BIOL INVASIONS, V8, P1023, DOI 10.1007/s10530-005-3735-y; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Dia M.A., 1988, THESIS U W BRITTANY THESIS U W BRITTANY; Domain F, 2000, J MAR BIOL ASSOC UK, V80, P699, DOI 10.1017/S0025315400002526; Doubleday Z, 2006, J EXP MAR BIOL ECOL, V338, P35, DOI 10.1016/j.jembe.2006.06.027; Edgar G, 2000, AUSTR MARINE LIFE PL; Engel Katharina, 2011, Communicative & Integrative Biology, V4, P247, DOI 10.4161/cib.4.3.14885; Forsythe J.W., 1987, P135; FORSYTHE JW, 1988, MAR BIOL, V98, P369, DOI 10.1007/BF00391113; Forsythe JW, 2004, MAR FRESHWATER RES, V55, P331, DOI 10.1071/MF03146; Fox J., 2019, R COMPANION APPL REG, V.; Fulton EA, 2011, ICES J MAR SCI, V68, P1329, DOI 10.1093/icesjms/fsr032; Guzik MT, 2005, MOL PHYLOGENET EVOL, V37, P235, DOI 10.1016/j.ympev.2005.05.009; Hanlon RT, 1996, CEPHALOPOD BEHAV; Harrington JJ, 2006, FISH RES, V77, P10, DOI 10.1016/j.fishres.2005.09.003; Hermosilla CA, 2010, ICES J MAR SCI, V67, P1458, DOI 10.1093/icesjms/fsq054; Herwig JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043679; Hill KL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032912; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holt RD, 2003, EVOL ECOL RES, V5, P159; Hoving HJT, 2013, GLOBAL CHANGE BIOL, V19, P2089, DOI 10.1111/gcb.12198; Jackson GD, 2004, MAR FRESHWATER RES, V55, P357, DOI 10.1071/MF03152; Jackson GD, 2003, MAR BIOL, V142, P925, DOI 10.1007/s00227-002-1005-4; Jackson GD, 2001, MAR ECOL PROG SER, V218, P167, DOI 10.3354/meps218167; Johnson CR, 2011, J EXP MAR BIOL ECOL, V400, P17, DOI 10.1016/j.jembe.2011.02.032; Katsanevakis S, 2006, ICES J MAR SCI, V63, P151, DOI 10.1016/j.icesjms.2005.07.004; Last PR, 2011, GLOBAL ECOL BIOGEOGR, V20, P58, DOI 10.1111/j.1466-8238.2010.00575.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Leporati SC, 2008, MAR ECOL PROG SER, V367, P213, DOI 10.3354/meps07558; Leporati SC, 2008, MAR BIOL, V155, P375, DOI 10.1007/s00227-008-1033-9; Leporati SC, 2007, MAR BIOL, V151, P1375, DOI 10.1007/s00227-006-0575-y; Lourenco S, 2012, FISH RES, V127, P116, DOI 10.1016/j.fishres.2012.04.006; Mangold K., 1983, P335; Mangold K., 1987, P157; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Moreno A, 2012, J MAR BIOL ASSOC UK, V92, P1619, DOI 10.1017/S0025315411002141; Norman M.D., 2000, GUIDE SQUID CUTTLEFI; Okei N, 1999, STOCK ENHANCEMENT AND SEA RANCHING, P468; Oosthuizen A, 2003, J MAR BIOL ASSOC UK, V83, P535, DOI 10.1017/S0025315403007458h; Otero J, 2008, MAR ECOL PROG SER, V362, P181, DOI 10.3354/meps07437; Otero J, 2007, FISH RES, V85, P122, DOI 10.1016/j.fishres.2007.01.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pecl GT, 2008, REV FISH BIOL FISHER, V18, P373, DOI 10.1007/s11160-007-9077-3; Pecl GT, 2004, MAR FRESHWATER RES, V55, P387, DOI 10.1071/MF03153; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030392; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Rosa R, 2008, P NATL ACAD SCI USA, V105, P20776, DOI 10.1073/pnas.0806886105; Rosas C, 2008, AQUACULTURE, V275, P291, DOI 10.1016/j.aquaculture.2008.01.015; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Scandol J, 2008, STATUS FISHERIES RES, P193; Schwarz R, 2010, FISH RES, V106, P177, DOI 10.1016/j.fishres.2010.06.008; Semmens J, 2011, J EXP BIOL, V214, P2799, DOI 10.1242/jeb.051631; Semmens JM, 2004, MAR FRESHWATER RES, V55, P367, DOI 10.1071/MF03155; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Spiess A, 2013, QPCR MODELLING ANAL; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Tasmania Wild Fisheries Management Branch Tasmania Department of Primary Industries and Water, 2009, SACL FISH MAN PLAN R; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Villanueva R, 1995, CAN J FISH AQUAT SCI, V52, P2639, DOI 10.1139/f95-853; VILLANUEVA R, 1992, J EXP MAR BIOL ECOL, V159, P157, DOI 10.1016/0022-0981(92)90034-8; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Wolf BM, 1997, J SHELLFISH RES, V16, P533	85	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2014	9	8							e103480	10.1371/journal.pone.0103480	http://dx.doi.org/10.1371/journal.pone.0103480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM4GX	24671213	Green Accepted, Green Published, gold			2022-12-27	WOS:000339812700029
J	Wu, KL; Zeng, SJ; Lin, DI; da Silva, JAT; Bu, ZY; Zhang, JX; Duan, J				Wu, Kunlin; Zeng, Songjun; Lin, Danni; da Silva, Jaime A. Teixeira; Bu, Zhaoyang; Zhang, Jianxia; Duan, Ju			In Vitro Propagation and Reintroduction of the Endangered Renanthera imschootiana Rolfe	PLOS ONE			English	Article							ASYMBIOTIC SEED-GERMINATION; CALCIUM HYPOCHLORITE; ESTABLISHMENT; REGENERATION; GROWTH; ORCHID	Renanthera imschootiana Rolfe is an endangered tropical epiphytic orchid that is threatened with extinction due to over-collection and the loss of suitable habitats. In vitro propagation is a useful way to mass produce plants for re-establishment in the wild and for commercial propagation. Seeds collected 150 days after pollination (DAP) were the optimum stage for in vitro culture. Seed germination reached 93.1% on quarter-strength MS (i.e., MS containing a quarter of macro-and micronutrients) medium containing 0.5 mg l(-1) a-naphthaleneacetic acid (NAA), 20% coconut water (CW), 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 1.0 g l(-1) activated charcoal (AC). Quarter-strength MS medium supplemented with 1.0 mg l(-1) BA, 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 10 g l(-1) sucrose and 20% CW was suitable for the sub-culture of protocorm-like bodies (PLBs) in which the PLB proliferation ratio was 2.88. Quarter-strength MS medium containing 1.0 mg l(-1) NAA, 1.0 g l(-1) peptone, 100 g l(-1) banana homogenate (BH), and 1.0 g l(-1) AC was suitable for plantlet formation and 95.67% of plantlets developed from PLBs within 60 days of culture. Hyponex N016 medium supplemented with 0.5 mg l(-1) NAA, 1.0 g l(-1) peptone, 20 g l(-1) sucrose, 150 g l(-1) BH, and 1.0 g l(-1) AC was suitable for the in vitro growth of plantlets about 2-cm in height. Plantlets 3-cm in height or taller were transplanted to Chilean sphagnum moss, and 95% of plantlets survived after 60 days in a greenhouse. Three hundred transplanted of seedlings 360-days old were reintroduced into three natural habitats. Highest percentage survival (79.67%) was observed in Yuanjiang Nature Reserve two years after reintroduction, followed by Huolu Mountain forest park (71.33%). This protocol is an efficient means for the large-scale propagation and in vitro and in vivo germplasm conservation of R. imschootiana.	[Wu, Kunlin; Zeng, Songjun; Lin, Danni; Zhang, Jianxia] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Duan, Ju] Chinese Acad Sci, South China Bot Garden, Key Lab S China Agr Plant Mol Anal & Gene Improve, Guangzhou, Guangdong, Peoples R China; [da Silva, Jaime A. Teixeira] Kagawa Ken, Takamatsu, Kagawa, Japan; [Bu, Zhaoyang] Guangxi Acad Agr Sci, Flower Res Inst, Nanning 150931, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Guangxi Academy of Agricultural Sciences	Zeng, SJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	zengsongjun@scib.ac.cn; yangnv@126.com	刘, 芳延/AAO-8535-2021; Strugnell, Jan M/P-9921-2016; Moltschaniwskyj, Natalie/AAB-7236-2019; Pecl, Gretta/D-7267-2011; Bertin, Aline/T-5005-2017; van den Bosch, Frank C./ABH-3801-2020; Malausa, Thibaut/X-1614-2018; León, Rafael I/N-6510-2014; Botton, Marcos/I-1731-2016; Deary, Ian/C-6297-2009; Aidar, Marcos Pereira Marinho/B-2212-2013; Inskip, Hazel/L-5467-2018; Persinoti, Gabriela/C-5933-2016; Silva-Rocha, Rafael/H-4929-2012; Sujii, Edison Ryoiti/H-7715-2015; Benzeval, Michaela/J-3163-2015; Apparecida Desiderio, Janete/F-5848-2012; Leimar, Olof/L-3781-2014; Guazzaroni, Maria-Eugenia/E-2599-2013; Dodds, Richard/D-7772-2016; Sujii, Edison/H-7715-2015	刘, 芳延/0000-0002-5155-1916; Pecl, Gretta/0000-0003-0192-4339; Bertin, Aline/0000-0003-4232-4241; van den Bosch, Frank C./0000-0003-3236-2068; Malausa, Thibaut/0000-0003-1681-7958; León, Rafael I/0000-0003-3197-4185; Botton, Marcos/0000-0002-0554-3157; Deary, Ian/0000-0002-1733-263X; Favati, Anna/0000-0002-6435-011X; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749; Fernandes, Odair/0000-0003-3489-4754; Aihie Sayer, Avan/0000-0003-1283-6457; Der, Geoff/0000-0002-8677-073X; Choo, Robin/0000-0002-3240-3029; Dennison, Elaine/0000-0002-3048-4961; Strugnell, Jan/0000-0003-2994-637X; Germain, Jean-Francois/0000-0001-7927-6031; Inskip, Hazel/0000-0001-8897-1749; Persinoti, Gabriela/0000-0002-0975-7283; Silva-Rocha, Rafael/0000-0001-6319-631X; Moltschaniwskyj, Natalie/0000-0001-9709-9876; Sujii, Edison Ryoiti/0000-0001-7602-8999; Benzeval, Michaela/0000-0002-0372-2098; Teixeira da Silva, Jaime A./0000-0003-3299-2772; Apparecida Desiderio, Janete/0000-0001-7723-3070; Souza, Silvia/0000-0001-6293-7665; Semmens, Jayson/0000-0003-1742-6692; Ramos, Jorge E/0000-0002-8690-761X; Wong, Joshua/0000-0001-8268-5610; timbo, renata/0000-0003-1989-7412; Gale, Catharine/0000-0002-3361-8638; Jagger, Carol/0000-0002-6377-9926; Paveley, Neil/0000-0002-1709-4563; Leimar, Olof/0000-0001-8621-6977; Wong, Jason/0000-0002-8167-540X; Cooper, Cyrus/0000-0003-3510-0709; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Pacheco da Silva, Vitor/0000-0002-8420-1779; Gan, Victor/0000-0002-6966-2729; Tilling, Kate/0000-0002-1010-8926; R. Silva, Rogerio/0000-0002-0599-2155; Lawlor, Debbie A/0000-0002-6793-2262; Vucicevic, Katarina/0000-0001-9676-5785; Robinson, Sian/0000-0003-1766-7269; Dodds, Richard/0000-0003-4968-7678; Lye, David/0000-0003-0324-0205; Sujii, Edison/0000-0002-0702-0181; N. Silva, Roberto/0000-0002-8992-7130; De Vivo, Immaculata/0000-0002-7185-7402; Cooper, Rachel/0000-0003-3370-5720	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences [211026]; Guangzhou Key Technology Research and Development Program [Y233051001]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005198] Funding Source: researchfish	Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences; Guangzhou Key Technology Research and Development Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by a fund of the Key Laboratory of Plant Resources Conservation and Sustainable Utilization, South China Botanical Garden, Chinese Academy of Sciences (No. 211026), and the Guangzhou Key Technology Research and Development Program (Y233051001). Songjun Zeng received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeroyd J., 1995, HDB BOT GARDENS REIN; [Anonymous], 2014, WORLD CHECKLIST SELE; Arditti J., 1993, MICROPROPAGATION ORC; Arditti J, 1982, ORCHID BIOL REV PERS, P352; Chu Chin-Chang, 1994, Lindleyana, V9, P153; Chugh S, 2009, SCI HORTIC-AMSTERDAM, V122, P507, DOI 10.1016/j.scienta.2009.07.016; da Silva JAT, 2006, PLANT CELL TISS ORG, V84, P135, DOI 10.1007/s11240-005-9003-0; da Silva JAT, 2005, PROPAG ORNAM PLANTS, V5, P129; DASILVA JAT, 2012, ASIAN AUSTRALASIAN J, V6, P121; DeMarie E., 1991, HORTSCIENCE, V26, P272; Dix L., 1982, PLANT CELL TISSUE OR, V12, P39; Ernst R., 1975, American Orchid Society Bulletin, V44, P12; Ernst R., 1974, American Orchid Society Bulletin, V43, P35; Goh C. J., 1982, Orchid Review, V90, P295; GOH CJ, 1990, SCI HORTIC-AMSTERDAM, V44, P315, DOI 10.1016/0304-4238(90)90132-X; HARVAIS G, 1973, CAN J BOT, V51, P327, DOI 10.1139/b73-040; Hossain MM, 2013, CRIT REV PLANT SCI, V32, P69, DOI 10.1080/07352689.2012.715984; Kauth P.J., 2008, FLORICULTURE ORNAMEN, P375; Kishor R, 2009, EUPHYTICA, V165, P247, DOI 10.1007/s10681-008-9755-9; Knudson Lewis, 1946, AMER ORCHID SOC BULL, V15, P214; Lee YI, 2006, ANN BOT-LONDON, V98, P1311, DOI 10.1093/aob/mcl222; Lin DL, 2008, J FOOD DRUG ANAL, V16, P1; Lo SF, 2004, IN VITRO CELL DEV-PL, V40, P528, DOI 10.1079/IVP2004571; McNaughton S.J., 1989, P109; Miyoshi K, 1998, PHYSIOL PLANTARUM, V102, P481, DOI 10.1034/j.1399-3054.1998.1020401.x; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Mweetwa AM, 2008, SCI HORTIC-AMSTERDAM, V117, P257, DOI 10.1016/j.scienta.2008.03.035; NAGASHIMA T, 1982, J JPN SOC HORTIC SCI, V51, P94, DOI 10.2503/jjshs.51.94; PIERIK RLM, 1988, SCI HORTIC-AMSTERDAM, V34, P139, DOI 10.1016/0304-4238(88)90084-2; Raghavan V., 1977, CRC HDB SERIES NUTR, P361; Ren H, 2012, ORYX, V46, P391, DOI 10.1017/S0030605311000615; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; SEENI S, 1992, PLANT CELL TISS ORG, V29, P167, DOI 10.1007/BF00034349; Seeni S, 2000, PLANT CELL TISS ORG, V61, P1, DOI 10.1023/A:1006444614657; Teixeira da Silva J., 2013, FLORIC ORNAM BIOTECH, V7, P1, DOI DOI 10.1016/0168-1656(90)90117-T; Thomale H., 1954, ORCHIDEEN, P62; Thomas TD, 2008, BIOTECHNOL ADV, V26, P618, DOI 10.1016/j.biotechadv.2008.08.003; Tsi Z. H., 1999, FLORA REIPUBLICAE PO, V19, P291; VACIN EF, 1949, BOT GAZ, V110, P605, DOI 10.1086/335561; van der Kinderen G., 1987, LINDLEYANA, V2, P84; VANWAES JM, 1986, PHYSIOL PLANTARUM, V66, P435, DOI 10.1111/j.1399-3054.1986.tb05947.x; Vyas S, 2009, SCI HORTIC-AMSTERDAM, V121, P32, DOI 10.1016/j.scienta.2009.01.012; Wu KL, 2012, SCI HORTIC-AMSTERDAM, V135, P194, DOI 10.1016/j.scienta.2011.11.028; Wu KunLin, 2010, Acta Horticulturae Sinica, V37, P685; Wu Z.Y., 2009, FLORA CHINA, V25; YAM T W, 1990, Lindleyana, V5, P256; Yong JWH, 2009, MOLECULES, V14, P5144, DOI 10.3390/molecules14125144; Zeng SJ, 2015, CRIT REV BIOTECHNOL, V35, P279; Zeng SJ, 2011, HORTSCIENCE, V46, P460, DOI 10.21273/HORTSCI.46.3.460; Zeng SJ, 2012, SCI HORTIC-AMSTERDAM, V138, P198, DOI 10.1016/j.scienta.2012.02.026	51	446	498	61	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2014	9	10							e110033	10.1371/journal.pone.0110033	http://dx.doi.org/10.1371/journal.pone.0110033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS0BH	24671213	Green Published, Green Submitted, gold			2022-12-27	WOS:000343943100017
